>KACEBFPM_00001 hypothetical protein
MQQEEIAEIADFEKALGIKFEKFEKPNPESIEENNAYLWAKQIFKTKPNHELSIDIKEKI
KTVFHHLTKDELIEKLMANYFLQNKPDTTPVVKRQKMK
>KACEBFPM_00002 Inosine-5'-monophosphate dehydrogenase
MKNSIAESIANFLKDFKPFSFLSFDDLKSISKTIRVIHLEKNQTLFQINDTLHDVFYVMN
SGVIHLSVISDAEETLLNKCYSGDVFGLRPFFAKNNYQMTAKTNEEAILYAIPIESFKPF
VLKNTEVLHFLLESFAQNSNNLADKNSDKLISDSVQLSEFQNDFSYFQTLNYNKNPLIVT
YDQTIREVAIIMADNLLDAAFINNNTKLVGIVTDADFREKVATGKHAIQSHIDKIMTHAV
ITVPENISLAEAQLVMLSHKVHHLCVTIDGTIYTQIKGIITQNDLVQAQANSPGVLVKEI
KRAINAAQLKSVRNSLSNIIQQAVTKNIPLQHIFNISGEITLAIIRRAIEIGILELGSPP
APFVFLSIGSQGRKEQLLLTDHDSLLIFNDVDIQQVRSVKDYFNQLTKKVNETLEKIGYK
HCNFGHNSNNQNYSKSLTEWIKQYESWINTPGEFTNEHCAIFFDYEFVFGDSNLENSITE
TIYKIKNKALFFDYLGNDALKKPAPLNFFKKFNEEEEGLYKYKFNIKEKGINQLVDIARL
LSIHHGLKGIKNTFSRYKELAIKDTQNAEIFLKAADTFLLLSRYRTLEGIKNDNAGEYID
LEKISKSDKEKLKESLHVLKDLEEILKDTFQLTQFS
>KACEBFPM_00003 DNA polymerase III PolC-type
MLDWLKKIGKDYPEFWKNYLVQFEMQTERKVALYIETTGINPAKDKIISIGAIAIEKNQI
RIDNCLEIELNKAEILEGKDFSYQEIQAIESLINFIGNATLVGHRIHYDIQIINEYLHKL
QSGRIKNNLLDVEVMHGRIIDQNAKQFSLTELLSIYKIDSPHIPTSANMAFSIALLFLKL
KSRLKMTN
>KACEBFPM_00004 Acetyl-coenzyme A synthetase
MSYYKIDNLEQYFKHYNKSIREPRKFWGKIASENFTWYQECEKVVEFDMVEAKIEWFKGA
KVNIVKNCIDRHLARRGEKTAIIFEPNNPNEEALHISYNELYVRVSKMANVLREQGIEKG
DRVCIYLPMIPELAIATLACARIGAIHSVVFAGFSESAVASRINDSECKMVITSDGGFRG
EKTIDLKAIIDEALEKCPCVTKVLVVKRTNTSVKMKEGRDIWLQPLLDEALDNNMPEIMD
AEDPLFILYTSGSTGKPKGMVHTTAGYMVYSAYTFKNVFNYEDDDIFWCTADIGWITGHS
YILYGPLLNGATTVIFEGVPSYPDFSRFWEVIEKHKVTQFYTAPTAIRALAKENLSYVQK
YPLKSLKVIGSVGEPINEEAWHWYNDHVGGKRCPMVDTWWQTETGGIMISPIAFVTPTKP
TYASLPLPGIQPILMNEKRNEIEENQVSGSLCIKFPWPGIARTIWGNHQRYKETYFSAFP
GKYFTGDGALRDEVGYYRITGRVDDVVIVSGHNLGTAPIEDAINEHPAVAESAIVGFPHD
LKGNALYGFVMLKESGETRDKTNLAKEINQNVSDHIGPIAKLDKIQFVSGLPKTRSGKIM
RRILRKIAEGDFANFGDITTLLNPEIVEEIKEGKL
>KACEBFPM_00005 hypothetical protein
MFNFVTINSVSKLIKAVMLYIRNLTSRKQEYFVFRIFFFILIPLIIAGFTIFEMYLLTND
SIGYSSQTYL
>KACEBFPM_00006 hypothetical protein
MRKTYSEKGIDGLLFDGRVGFKPSKINSEIHLAIEKRLTSPKDAFTSYVDLINWIVENNI
PGGINYHTVNKYVKRHFGAKLKVSRKSHIKKDPNAVESFKKTSK
>KACEBFPM_00007 hypothetical protein
MLQKHLLLSIFMCKMKVDLDYLQEWRQFSNGTTAHGVKLSTTIKNILRMIINLC
>KACEBFPM_00008 hypothetical protein
MKTTNYNFPFIKKQFTAEQFFMFSMVFVNAGNYLYNLLLGRILGPQKFADAAILITFLLI
LSFVGMAFQIVTTKYIVIYDQNKTSFFTKLMYKAALFLGFFIGFLIIFCSKYLQSIFKTD
TFLMFVIFGFSVPLYFLMSVKRGICQGKNKLIDLSKTYIFEMLSRLLLTFILIFLFYKFT
ASILVAIGIAVSFIFGLIPVKISNSSNLISNLDNQVKIKEIASFFALTAFYEFTQIIINN
SDVIMVKYFFDNTNSGLYASLALIGRVVYFVAWMFVMLLLPKVLQLKKENKNTKPILLKY
VLYIFCLSASIVIVTWLFPETAILLLFGNKYLAISFLLWKYAVATSIFAIANIFAYYFLS
INKYVPVVITGILGLLQIVLICLFHSSLEQVVNMQILAMSILLFFQLFFYFYQNKTAQF
>KACEBFPM_00009 D-inositol-3-phosphate glycosyltransferase
MKIAIVTAFPPSKVTLNEYGYHLVKNFVKKEAVSSLVIISDKTIQTKQLDFDNSEKVIVN
ECWQFNSYWNFFTIIKAVYKEKPDAVLFNLQFVKFGDKKIPAALGLITPMFLRFFGFKTI
VLLHNILEQVDLENAGFTSNKLAQKIYTFIGTTLTRCMLKANFLAVTINKYVAVLNKKYK
TNNIILIPHGSFETPQNPNFDLPDGPKKIMAFGKFGTYKKVEILIEALQIIRKTNTQPIQ
VVIAGTDSPNTPGYLKSVQEKYAAVEGIIFTGYVEENDVERIFTESTIVAFPYTSTTGSS
GVLHQAGSYGKAVVMPDLGDLALLVEDEGYKGEFFSPESASSLAIAINKILENDSYRKEI
AQANYKAACTLSMDKITDMYLEKFNQIA
>KACEBFPM_00010 Endoglucanase E-5
MSFINNKNTIRIVLISSFIILNACLLFGLSSILQYLNSGASRSSMLHLEKETINTYLPKV
TWQNNINVGREMEPNTLKMIEKDYLFSWYVRNKSLEKNKKQGIEDFYSKSARINLYQSIA
YNLKNKIAIESTTIKHNPKLEFYSEDGQQVVFTDKNVIEYQKVFKDEKLITEVQDTATYK
VLMLLEDGFWRVRHFQKMKPEPFAKDTLKSNPEFKIDAKKIKYKNADFIIKGINYYPKKS
AWDTFGVLFNKDTIAKDFDIIKKAKLNSIRIFVQYDDFGKANVNPEKLKKLKILLDLAEE
KNLKVIVTLFDFYSDYTLESWTLTSRHAEKIVSEFKKHKAVLAWDIKNEPNLDFENRNKK
NVLSWLQQMITIVKENDPNHLVTIGWSNSYEATNLEDKVDFVSYHFYNSIADFETENATL
EKFTKKPVVIQEFGVPSYHGFWNWTGNNEEDQAEYYKKIQAKFKKNKVSFMSWTLYDFPN
VPDQVAGKWPWQKNKQKNFGFINSKGKIKPSFEFITYD
>KACEBFPM_00011 hypothetical protein
MKKVIYTVFLLGTLLLLAFGTAWVSSNNKVVFELVSKNKKNIAGHSIKLEFYSKSENEKP
QLFIVHSYGKTILDATLKKGNYVFKLPLNYCQKTGNVSWFLINQNETINSGIFEILPNDK
TKTVIENYLGPRTILAGAKEFTMMVTVPTDSFDNPKEEDTEIILKHQFLQNITNLKLKTK
NFIAWYDIFSPTKSGKMLVSSECNAIETKEIETEVYPNLPTNFTINYTRNHDFADGNQIT
HFTTSVIKDKYGNIASNGTMITFIIKTKKNIILKTFGTTINGIAIAQILHPDHQEIYSVK
AFIMGIAESNLLFISYKPILSSFNYLFTNKNRTIKIGPIKSFMNQIAPDGIKVILKIFNQ
NILVATLQEDTSKGMATFQLSQDFFTAKSYRFEIIALGIIKKTETINYELHK
>KACEBFPM_00012 hypothetical protein
MTALLVGIVFHASAIFFTLENTYDALIHLFFGNHYAQSWFEPWNYSWYTGFTVMGYPPLV
HQCIGLLSFVGGLKFGLFTVAIIGIILFITGVFRFSLLITGNRNVAGYAALLSVFSSSFI
ETLHIFGQLPSIIGISILMHALPEIYLWIKTGIKKYYFTSISLIAVTVCSHHVTPLFGMI
FFIFPLIGMTVIDAAREKVNSYKEVTLKLFIQTLFPLLKRIIIFGATSVFLIVFCILPYW
INSKNNPITQVPIPHGSRDNFIQVTSSGLMFFLIPWGILLFLLPYIFYRYYSKRYLFFGL
SISLLFVLGTGGTTPIPLKILGANAFNILTLDRFTLWAAIMSLPMFGEFVYRLLEGDLRI
NFQERFGSVYYKIISGLLAGSFLFVAIVTITLGYFRPFQPQKINTLPIINFLNQDQHDQW
RYLPLGFGDQMATLSYQTNALTVDGNYHSARRLPELTSRAVERLENSKFRGLEGIGSLQQ
FLTVPEKYNLKYVFSNDKFYDPILYFCGWHRLTQLENGIMVWEKLNVPPLSKIRPFEDVP
LYQKLMWGIIPLLTVIIAFVLNIQMILYQALKLKTIRKPDFFKFALEYNKFPQKMVTLLH
LWTGFLVVIIFYFTYQFYLNNSSQLSPINVIKAYYDAIDFKEFEKAHSFLDPKSDKSLSQ
FMLETAVQDGILNSYAKMDAIDIQVLSQTKKAAKIIAKTKWITPLEIIKKDYIHEVIKEN
GKWFIVPNKIDLDIPPDQFIANNNTQYFKHGRRAVSTQQTYHDDVLKQPVLEILSAKLIQ
YNKQYIIIGEVQNVDNVPADVVLKASLYGYNDKKLASFNSKYEIKHKLMPKEITSFKVNF
EDIAWLKNTDIKPKTFNPNEFTPLEIQENPVTFDIQCAGNVAITDLYTQVALSDFAIESN
HIKGTLFNFGIQESTIPEILVSYYNEKKELIYVDHLFMNAGVRVQRKNYFDYKLLNLMNC
KILKSSLENCFVNGLANASISKAVVPNRKFAQNDEQLQMIKGKGFNFIKIEINNYIGNPR
>KACEBFPM_00013 Alkaline phosphatase synthesis transcriptional regulatory protein PhoP
MKILIIDDQELVLLSLEKCLIDLGYQVYTSKTVAHAISIYDKEIPDLVITDINLSTTDQN
IETSTTDAGLDIVKYIKITKNHKTPVMILTGSTDENVLSKGFELGIDDYMKKPLSFTEIA
LRVKKLIGSSNLENTKIEKNRYIQSNIIGVVIPCYNEESRLLGEDFKIFIHKNLGYHLCF
VNDGSKDKTLQVLQELALGNEDRISVYDCTKNGGKAEAVRLGMLHLAKQSQFNYIGFLDA
DLSTNFEDFNDLATTISNSNFKIVSGSRINRMGADITKQSARAIISKTINFFIRKTLDMD
FKDTQCGAKIMTKEIVEKTFQKKFLTKWLFDVEIFMRMKKIYGHKEAQNLICEQPLKKWI
HADGSKLSMKDSVKIVFQIFQIAFHYR
>KACEBFPM_00014 Stress response protein NhaX
MNKVLIALDYNPTAQKIAEVGFSLAKSMNAEIILLHVLSAPVNYTTVYNPIMGFDGFVNL
DIVEIDNEFLKKMALEFLENVKKHLEDTTISAIVKEGDYSEAILETANMQRADIIIVGNH
NKKWLEKVLLGSTTQKILHDTNIPVLIVPTNKDL
>KACEBFPM_00015 Solvent efflux pump outer membrane protein SrpC
MQALDNQLDIVKQNIILQSNALEIIKIQKQAARATELAVQKFEAEVLSSKSKEFDILQDI
KQTENRINFLLARYPQEIKRDNSNFLKLLPSIIRSGIPSQLLANRPDIKQAELQLVAAKL
DVKVARAEFYPSLDISGAIGLQAFNPSYLFQLPESLLYSLAGDIAGPLINRNAIKAEFKN
ANARQLQAMYNYERTILNAYLEISNQLSKIDNLQKRYDLKSQQVEALNKSIEVSNDLFKS
ARVDYFEVLMTQRDALETKLELIETKKEQLNSVVHVYKELGGGWK
>KACEBFPM_00016 hypothetical protein
MKNKITTLINKCVFVFVLMAFFSTAKTFGQIGIPTYPFSQICASPSFNTFTLNFTFSTAN
TYVLEMSDANGSFATLTGITILSSQTSTSPGSFTFKVPTTTAGENYRFRVRGGTTTGPQS
SPALAAYYKAFNADFTLNGGISPINICGSGIFQLLIDNGPASNDSPVDFPSLKYKWKKNG
VFVPGETGSFLNINSSGDYQAFVDYGNCSTLDDGQIEKSVKVTVNIVAAGSTFTIASSSG
NTICPPATSILSVTAGYSYQWSRDGVAISGAQANTYVASQAGSYTVIVNQGGCSSTSTPF
VLSTEGFNSSIDVQQEPLANIISAGETKTITVTTDAVSPTFEWYLNGTLIPLATTNSYTT
SDVGNYKVKIKQTSGCNTFKEFFFLLKEGINPKQVPNLISPNADGVNDTWVIPQDYVNAN
TEVLIIDPQGNVDFQTVNYQNNWPVKEIVFKSTNPVYYYIISKDGSPVKKGSITIIK
>KACEBFPM_00017 hypothetical protein
MKNLLQIKWMLLFVVFTASAQQEKGIIGASNWLSNWTEFKPANATYNETNQILYGKITAN
TTLFKKNTYLLQGPVYVTNNAILTIEPGTVIKGDYETNGALIITKGSQIVANGLETDPIV
FTSNRPQPKPGDWGGVAILGDAPMNKFGGASSLNFDLDPSQTIYGGTNPQSNSGIVRFLR
IEFAGKKIKGFKDYNAFSLASVGSKTVIENVMCSFAAGNSFEILGGDVTVSKLVSLRSSS
DDFKFTQGAQCKIDNSLAIRHSLYSSSTRSRCMNVTSYEKKEEADLSKNQTNVTAINCSL
VNTTLTLSDDIAKGLVKEAIYVGNNASFSIKRSVVSGFYPAAILSSEIKLEASAFKKIKF
EEIYFNNCKGNIFVENTNTNDDLEDYYGSGSYYNLYQNTDNKEMFLDIYNTKNNPDFRIK
ISKITASNSK
>KACEBFPM_00018 hypothetical protein
MKKIVLFSLFILFTVSDANAQKTNKPVGIISSGASLKKFYEKTELDGMNKGLLLELYIER
IKVLVNTLPYIALTTKPGVTMQDVGVPASSENDKTLSLQKQNTETFLNSTVDFQRAMTPY
ADKGNLVSSILYYEAMLKALEQINE
>KACEBFPM_00019 DNA polymerase III subunit gamma/tau
MQFSQIVGHEHIKNHLIQSATAGRIPHAQLFVGPEGAGVLQTAIAYAQYVLCNNIGNENQ
GGNESCNLKFEHFSHPDLHFVYPTVTTDEVKTKPKSLDFITDWRKFLAQKPYGSIFDWYN
ILDVKNKQGEIRVEDAQEVLKSLSLKAYEGGYKIMIVWMADKMNIAASNKLLKLLEEPTE
KTLFILITENEEDIIQTIRSRCQVLHFSALSENAITEALITNENIEAKKAQKIAHKSQGN
YNKALQFCHEINEDLPFEECFVTWVRAAFRAKGNAAAIQDLILWSEQIAGLGRETQKKFL
HFCIEMFRQALLLNYQTQKLVYLETTVEKFSLEKFAPFVNGNNINDIFKEISDAIYHIER
NGNAKIILTDLSIKLTRLIHKK
>KACEBFPM_00020 hypothetical protein
MENLASLFVLFFLAITFLQSGYDKYTDWNGNVSWLTQHFSGTIFANKIPLALKTLLAFEI
IAGILCVVGMIEMSISGGTTFGKYGACLSCVTLLMLLFGQRIAKDYDGARTIVIYFIPAI
MGVYWLS
>KACEBFPM_00021 hypothetical protein
MTEIKDLSEKTLVLERNQYLKVKGSIDTNIYFVESGSLRIFVSDDYEEQIIRFGYENDLI
ASLDSFLTEKPSGFCIQAIKKTIVKVIPKQKIIALINLNEANKQTWTKLLENIVLQQIER
EKDILTSSPKLRFERVLKRSPKLFQEIPNKHIANYLRMSPETLSRLKKS
>KACEBFPM_00022 hypothetical protein
MQKITPMKTQSETLIFNLIETTKQNINFVELLKQKNDAQLNWKQNPESWSVLECLEHLNL
YGYFYIPEIEKTILKAKYKNETMFKSGVLGNHFAISMLPKQKLNKMKTFKDKNPLNSNLE
RKVIDEFINQQRKTIDLLNKSRSVNLNKEKVKISVTKWIKLNLGDTFRFTTNHNIRHLKQ
IENNINLQS
>KACEBFPM_00023 1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase
MRIIPAIDIIDGKCVRLSKGDYNTKIIYNENPLEVAKKFEAHGVQYLHLVDLDGAKSSQI
INYKILEKIASQTALKIDFGGGLKSDNDLRIAFESGANQITGGSIAVKNPEVFNEWIIKY
GADKIILGADANNEKVAISGWLEESKEELIPFIQNYQNQGIKYVICTDIAKDGMLAGPSF
NLYAKILSETKGIKLIASGGISTFDELPKLAQLGCEGTIIGKAIYENRITLKQLENFILN
K
>KACEBFPM_00024 Imidazole glycerol phosphate synthase subunit HisH
MKIVIINYGAGNIQSIQFALQRLGYEGILSKNIAEIQGADKVIFPGVGQASSAMKKLRES
GLDKIIPNLKQPVLGICLGMQLMCNSSEEGNTKGLGIFDIDIIKFSNKVKVPQMGWNNIY
NLKSSLFEGISENEYLYLVHSFYAPKCAEAIAFTNYETEYSSALQKNNFYGVQFHPEKSG
KIGEQILSNFLQL
>KACEBFPM_00025 Histidine biosynthesis bifunctional protein HisB
MTKKVLFIDRDGTMIKETIDEQIDGFDKMIFYPKCIPFLSKIAQELNYELVMITNQDGLG
TASFPEETFWPVHNFIMKTFENEGVIFNKVCIDRTFPSENANTRKPKTGLLTNYFSDDYD
LQNSFVIGDRLTDVELGKNLGSKAIFINDNTNLGTGEISVKKEELNPYIALETNDWQKIY
EFLKLENRRASIVRKTNETDISILLNLDGTGKSNINTGIAFFDHMLDQIARHGQMDLEIL
VKGDLQVDEHHTIEDTAIALGEVFAQALGNKLGIERYGFCLPMDDCLAQVAIDFGGRNWL
VWEANFKREMIGQMPTEMFFHFFKSFSDGAKANLNIKAEGTNEHHKIEAIFKAFAKAIKA
AVKRDSEKMILPSTKGML
>KACEBFPM_00026 Histidinol-phosphate aminotransferase
MNNFNINNLVRENIKNMQAYASARDEFKDFTHNMVYLDANENPFSNGINRYPDPQQKKLK
GFLAQQNKINENQMLLGNGSDEVLDLVFRAFCEPNVDNVITLPPTYGMYGVLANINAIEN
KEVLLSANFQPNINEILKNVNSHTKIIFLCSPNNPTGNSFDDQAVLTLLKNFNGLVVIDE
AYIDFSKNGSWLHVISDYPNLLITQTLSKAYAMAGLRIGILYASAAIISILNKIKPPYNI
NNLSQESALKKLEQSTLNFHVKKIINERKKMVQSLISIPFIEKIYPSDANFILIKVEDAN
KRYNQLIEKGIVIRNRTNQPLCENCLRITIGTKEENEKLITVLKAL
>KACEBFPM_00027 Histidinol dehydrogenase
MNKIYNPKPETWSEILKRPTQSFNDIEETVKGIFKEVQQKGDVAVRKYTSLFDGIVLDNI
EVSNNEINEAINLVSTELKQAIALAKSNIEKFHTAQKTSKIEVETTEGVNCWQEKRPIQK
VGLYIPGGTAPLFSTVLMLAIPAQIAGCNDIILCSPPDKSGKINPAILYAANLCGVTKIL
KVGGIQAIAGMTFGTQTIPKVYKIFGPGNQFVTLAKQFATRFGVAIDMPAGPSELLIVAD
DTAIPSFVASDLLSQAEHGTDSQVILVSTSKKLIDAVEIEINKQIEVLPRKNIAQKAIEN
SKLIYVENDEIALNLINDYAPEHFIICTKNEDFYINNIQDAGSVFIGNYTPESAGDYASG
TNHTLPTNGYAKNYSGVNLDSFLKSMTFQKITKKGIQNIGSAIEIMAEAEGLQAHKNAVS
LRLKAIENE
>KACEBFPM_00028 ATP phosphoribosyltransferase
MSTLKIAIQKSGRLNEDSLKILKDCGISIDNGNDQLKASASNFPLEVLFLRNSDIPQYLI
DGVVDIAIVGDNILVEKGGNIKIAEKLGFSKCRVSVAVPKSFNFKSLDDLKNKRMATSYP
NTTLNYFKNNHIKVELHEISGSVEIAPNIGLADAIVDIVSSGNTLFKNNLKEVAVIMKSE
AVLAVSPLITLKKQEILDKLRFRIQSVLRARKAKYILMNVPNDKIQAITEILPVLKSPTV
VPLSEVGWCSVQSVIDEDQFWEVIDKLKAAGAEGILVCPIEKMVI
>KACEBFPM_00029 hypothetical protein
MNNAHLHMVVNHFPIIGIIFGFGILISGIFIKNNTVKNTAYFVFIVSAIFAFTSMYTGDG
AEEMVEDMPNIGKKIIHIHEEWAEKLAIVLYILGAISIGGLYLNLKKQAKANFISFLVLI
IAIAGVILAKFTGTSGGEIRHTEIRTN
>KACEBFPM_00030 Lipoteichoic acid synthase 1
MKFFKIFSPFYNLALLYILVSVISRIVLLAHPITQSSFGFLETIKIFCFGLLSDFFVFVI
ASFFLWLYLIFLSNSKYLKPYGYIIFALLVLLLIYVSFFNTILNEYGGSLPEIGITFISI
KTILFGLFLFLPKYRSIFRFWMFSFVLFIFVVCILQNAISEYLFWNEFGVRYNFIAVDYL
VYTNEVIGNIMQSYPVIPIFSALFLIAGLITYVIVKKSKNYLDEIPNFVDKIKISAIYFS
LFALSLVTIPIISDKENSQNIFVNEMQANGLHKFYLAFTNSELDYFKFYKTLPNNKAFAV
LKNQIPTISNESTLRNIKAKAAENHKNVVLITIESYSADFLKTYGNEQNITPFLDSLATK
SLLFTNLYAVGNRTVRGLESVTLCVPPTAGESVVKRKDNKNKFSTGSIFAKKGYNVKYIY
GGDAYFDNMEDFFAGNGYGIVDKKTFKPEEITFSNVWGVCDEDLYKKAIKTMNEEAKENK
PFFNHIMTVSNHRPFTYPNGKIDISGDAKSREGGVKYTDYAMKQFFIMAKKQPWFKNTVF
VILADHCASSSGKTELPLDKYRIPAMIYAPEFVQPTHYNNMMSQIDVMPTVLGLLNFNYQ
SKFFGQDVLNTDYKPRALIATYQNLGLIKDNILTIISPKQGVKQFGLTVIENSKLGADFQ
IMYDEKLLNKERTDLINETISYYQTASDMLKKKKYQK
>KACEBFPM_00031 hypothetical protein
MNTNTILLIILSLVTAGGLSFYQYFYKNKNYNKVNFLLALLRFISIFSIILLLINPVISR
KTYETSKTPLPIIVDNSQSISELKQEKISKELSQKLLENTQLNDKYDVQLFSFDNDFYTN
KPIDYKGKQTNIHKVAQNMKQLYRNQNFPIVLLSDGNQTIGNDYVYSFPQNNQLYPLVLG
DTTSFLDIKINQLNVNKYAFLKNKFPVEVFLQYNGDKSINTTFSIQEGNHTIHKQIISFS
ANKKSQEISVLLNANKVGVHSYKASITTSEIEKNKYNNTKNFAVEIIDQRSEIALISAIN
HPDLGALKRAIETNVQHKVTLVKPQQIKSLNSYNVLILYQPNIQFKPILEQNKNLQLNTF
VITGLSTDYNILNEYQDQLKFRMSNQNENFTAQFNPEFNLFALDNIGFEQFPPLENSFGN
INITGNVNTLLQSQIRNINTKNPLLAFAESGIKRNAYLFGENIWKWRLESHVKTKSFEQF
DIFIDKIIQFLASNVSKKSLIVTHESFYNSGENIEVSAQFFNKNYEFEENAKLTIQLKNN
KTKTTKVYDFLKGNGEYKVNLDGLEAGNYSFTVKENNSKASYSNKFEVLYFEIEKQFVNP
DISRLTQLARNTNSKIFYPNQVDKLITELLKKESFPAIQKEIVKKSALIESIWLLILLAI
TLATEWFIRKYNGML
>KACEBFPM_00032 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKLLEGKVAIITGASRGIGSGIAKVFAQHGANVAFTYSSSVESAMALETELNALGIKAKG
YQSNAADFNEAQTFVDAVIAEFGTIDILINNAGITKDNLLMRMSEEDFDKVINVNLKSVF
NMTKAIQKTFLKQRSGSIINMSSVVGIKGNPGQTNYAASKAGVIGFTKSVALELGSRNIR
CNAIAPGFIETEMTAKLNEEVVQTWRETIPLRRGGTPEDVANACLFLASDLSAYVTGQVL
NVDGGMLT
>KACEBFPM_00033 Orotate phosphoribosyltransferase
MAAVFSYGFQVATDNFANAKVDLFTLSNYESLLELAVAKEYITKKEQNLLQEWRKNPSEW
NVVI
>KACEBFPM_00034 hypothetical protein
MNLESQKVTVQKSSEYIFNELCQVKNFEKLMPDNIAKFEVLDENAFIFGLKGMPEIKLKM
KEKKANSQIILGAASDKLPFTLTANITEISSDSTEVQLLFDGDFNAMMAMMIKGPISKFI
ETLTENMHKL
>KACEBFPM_00035 hypothetical protein
MGLMKIFSGSEILAQALQAKIEAVGVNTIVKNNIQSAKLAGFGTADQAVEVFIQEIDFGK
ANPVIEEFRMSI
>KACEBFPM_00036 ATP-dependent RNA helicase DbpA
MKLKKINENLQQALIENGLTQANELQKETFSTIKSGADAVIAAPKGAGKSTTIILNVIQR
MEKSFGESTRALIIVENKERVLEMENMFLKYGKYHDLSVFGVHEKGDVDYDKNVISMGLD
VLIGTPNRINAMFSSAGFNISTVKMFVVDDCDILFRNRMDAVVDRLSNSIDKTQRLFFTT
DLTERVESLADKIMIEPLFFEMEDQENNEEEENIEQQ
>KACEBFPM_00037 Transcriptional regulatory protein ZraR
MPKILIIEDEPAIRRVLTKILSEESDTYIVSQAEDGLQGLEKIKNEDYDLVLCDIKMPKM
DGVEVLEAAKKIKPEIQMVMISGHADLETAVNTMRLGAYDYISKPPDLNRLLNTVRNALD
KKKLVIENKILKKKISKKYEIIGESQPINQIKDMIEKVALTEARVLITGPNGTGKELVAH
QLHEKSERANFPIIEVNCAAIPSELIESELFGHVKGAFTSAIKDRAGKFEAADGGTIFLD
EIGDMSLSAQAKVLRALQENLIQRVGADKDIKVNVRIIAATNKDLKLEIAQGRFREDLYH
RLAVILIKVPALNDRRDDIPLLIEYFKDKITSEEGNIAKTFSKQAIKLLQEYDWTGNIRE
LRNVVERLIILGGNQISEDDVKLFASK
>KACEBFPM_00038 hypothetical protein
MSVLSLIIKREFIAKVRNKSFIIMTFLSPLLIVGLSFFVGYLANMNKDEVTKIAIHDESG
VLISNFKNTKETTYVDLSRMPLQLAKNTANKNYEGLIFVPKVTNIQELATKVEYISDDSP
SMKFIIETEKTIDNKLTRNNLTTLGFDYTKIEKAKVNANIHLTKFSGENTIKGINEIKIA
IGGAFGYLIMMFIIIYGNFVMRSVIEEKTSRIIEIIISSVKPYQLMMGKIIGNSLAGILQ
FAIWAIVGAILLFGVSTFFGIQTGAQASVDPAMINAVQHELGTTIQSYIKEIFNLPLATL
LTCFIIYFIGGYFLYSSFYAAIGAAVDSETDSQQFLLPIITPLMLAVYIGFFTVVNDPHG
TVATIFSMIPLTSPIVMLMRIPFGVPWWQLALSITLLFTTFLGVVWFASKIYRVGILMYG
KKPTWKELYKWLKY
>KACEBFPM_00039 ABC transporter ATP-binding protein NatA
MSNILEVKNVIKQYGNYTALNSVSLQVPKGSIYGLLGPNGAGKTSLIRIINQITMPDSGE
IILDGQKLAPHHVQHIGYMPEERGLYKTMKVGEQCLYLAQLKGLSKAEAQKQLKYWFEKF
EIEGWWNKKIQELSKGMAQKVQFVVTVLHQPKLLIFDEPFSGFDPVNANLIKDEILELKK
KGSTIIFSTHRMESVEELCDDIALIHKSNKLIEGKLEDVKRQYRKNTFQIGIMTNNIEGL
MYDLTQKFAVTQTNFKSLNDDLKLEIDLGNSTSNELLQILTNHGQVTHFAENIPSVNDIF
IQTVSN
>KACEBFPM_00040 Chaperone protein DnaJ
MLDKKPANADAQGMILEDETVSIKIPAGVVDGMQLKVSNKGNDAPGNGIPGDLIVAIEEI
EHEFLKREGENLHYDLYISFAEAVLGVSKDIEAVNGKVRIKLEEGIQSGKILRLKGKGIP
SVNSYGNGDLLVHVNVWTPKTLNKEQRQFFENNLSNENFIPSPEKSEKSFFEKVKDMFS
>KACEBFPM_00041 hypothetical protein
MPFTFSHPAIILPLRYLPRQWFSLTGLIIGSLTPDFEYFLRMRIKSNYSHTIGGLFCFDL
LLGLLLAFIFHNVVRNSLFDNLPKFLKSRFSIFKQFNWNRYFKEKGLVVMISILIGAASH
IFWDSFTHYNGYFVQKIPALQNSVGFLGSQIPISKILQHSSTLLGGLVVTFTIYKLPTNK
VESESINFRYWTILLGLTLIIIVARFLSGLTLKQYGSLIVTVFSAGLISLILTPWLINRK
>KACEBFPM_00042 hypothetical protein
MTKKILLLLSLIQFSISYCQQLTISESTKVSIITVGVADEVHSLYGHTALRIQDYKSNFD
LVYNYGMFDFATENFVAKFAKGNLQYYAAAYPYADFEYNYREDNRSIYEQVLNFSFLEKQ
SLFNKLNASLLPENTFYTYKFIDRNCTTKVIDIVNEVLENKPIAKKNRDHTTYREVLFPY
AKNHFYEQLGINIIFGQKADNQATTIFLPLDLFDNLKTISYKNEPLVSETNTIFEANRTT
PVSYLDSIYSLIIILLLFVVLNKKATNIIYFSVLGLIGLLFSFMSIYSFHKELFWNYNIL
LLNPLFLFLVFFIIKNNTKWIKKTSLLCLLCLGSYCIYMFGKIHFIIVLPIIIATFVLLL
RMKIKK
>KACEBFPM_00043 hypothetical protein
MKKFILFIFLIIFSFTKAQTIRKYSNEFMNIGVDARAFGMANSMVAHTSDVNSGYWNPTG
LLKIKDSEAALMHANYFANIAQYDYAAYAKKIDDRSAWGASILRFGVDNILNTTELIDAS
GNIDYNRISLFSAADYGFTFSYARKLPVQGFQYGANAKVIRRIIGNFASSWGFGFDLGLQ
FEKNNWQIGLMVRDITTTYNIWNINEKEFKKIKNAQTINPLQNQDLPESTEITIPKVQFG
VAKKYEFHNETSLLASANLNMQFQQTNDIIATRFASIDPALGFEYGYNNLAFLRAGFGNF
QKIQQIDGSKKIGFQPNFGVGFQYKGIAIDYALTDLANQSAALYSNVFSLKVDLSIFR
>KACEBFPM_00044 hypothetical protein
MMNIKKHIPNIITLLNLFCGCIALVFAVDMNFEMAFFFVSLGIFLDFFDGFFARLFKVSS
PLGLQLDSLADMVTSGVVPGFVMFCLLASSQNQIYGYTILPYLGFIITLGSCYRLANFNI
DTRQTDSFIGLPTPANALFILSLPLVLLDSNNEFITNALQNHWVLIAISVASAYIMNAEI
PLFSLKIKDFTFKKNALQILFLASSVLLLLFFRYLGIAMVIVFYVLLSVVNNLINKK
>KACEBFPM_00045 Lysozyme M1
MAVRKSVKSKKQKSFSSSNTFYGCFFIAFLLLFLYSQRNILAYYLGFKTDKIILETRTAS
LDKVLDAHIEKSFGIDISEYQDKINWDHLKEINGGFPIEFVFVRATVGNDRRDYKFKKYW
EKAKENKFICGAYHYYRPNENSIEQANNFIKNVRLRKGDFPPVLDIEKLPRAQSIERLKV
GLQRWLDVVEEHYGVKPIIYSSESYYNDFLKEDFSDYPFWIANYTAFYKEINSDWSMWQV
TENGKVKGIKGCVDVNIYNGNSVNLKELLIH
>KACEBFPM_00046 Lipopolysaccharide export system ATP-binding protein LptB
MKLRAENLVKTYKGRSVVKGISVEVNQGEIVGLLGPNGAGKTTSFYMVVGLVKPNSGNIY
LDDMNITSFPMYKRAQNGIGYLAQEASVFRKLSIEDNILSVLQLTKLSKAAQEAKMESLI
DEFSLQHIRTNRGDLLSGGERRRTEIARCLATDPKFILLDEPFAGVDPVAVEDIQRIVAK
LKNKNIGILITDHNVQETLAITDKTYLMFEGRILKAGVPEELVEDEMVRRVYLGQNFELR
RKKLEF
>KACEBFPM_00047 Alkyl hydroperoxide reductase AhpD
MSNLVTEFNDYRSKMNEKLLADNNKVIKRIFNLDTNTYAEGALDVRTKELLGLVASAVLR
CDDCIKYHLETAYKLGVTKEEMMETMSVATLVGGTIVIPHLRRAYEFWEALEETK
>KACEBFPM_00048 Sec-independent protein translocase protein TatCy
MSFLDHLEELRWLLVRSTIAIIIMAFITYFISDYLFDTIIFGPTRATFFTYRFFCDLSHY
LGFADSICITELPFIIQNTEMEGQVNIFVWMCLLAGFILSFPYILWEIWKFISPALYEKE
RKNAKLFIFVSSLLFFIGVLFGYFVVIPMSVNFVATFTVSDIVKNQFTLDSYIGMVKTSV
LASGLFFELPIIIYFLTKLGLVSPTFLRTYRKYAIIIVLIVAAIVTPPDVVSQTIVAIPM
LLIFEISVIISSIVYKRKQKHEQLSN
>KACEBFPM_00049 Arabinose 5-phosphate isomerase KdsD
MLSESLSITKLVDYLTDDFAKAVEIIYQSKGRLVVTGIGKSAIIAQKMVATYNSTGTPSV
FLHAAEAIHGDLGMVQPGDIVICISKSGNSPEIKALIPILKRFGNILIAITGNMTSFLAK
ESNFVLNTTVDAESCPINLAPTNSTTAQLVMGDALGVCLMEMKNFKSEDFAKYHPGGALG
KKLLLRVSDMLDMSHKPTVSPDSSIKNVIFEISEKRLGVTAVVENKKIIGIITDGDIRRM
LNNNDTFSHLTAKDIMTKNPKTIQYSAMVVDAFNILEDFAITQLVVENQGEYTGVLHLHD
ILKEGIV
>KACEBFPM_00050 ATP-dependent DNA helicase RecQ
MNSHEIDIHKELKKYFGFNQFKGLQEQVIKSIVAKHNSFVIMPTGGGKSLCYQLPALMQG
GTAIVVSPLIALMKNQVDAIRSLSSEAGIAHVLNSSLTKTEIAQVKKDISSGLTKLLYVA
PESLTKEEYVTFLQKEKISFVAIDEAHCISEWGHDFRPEYRNLKNIIKLLGDVPIIGLTA
TATPKVQEDILKNLDMANANTFKASFNRPNLYYEVRTKTKNVESDIIRFIKQHKGKSGII
YCLSRKKVEAIAQVLQVNGISAVPYHAGLDAKTRAKHQDMFLMEDVDVVVATIAFGMGID
KPDVRFVIHHDIPKSLESYYQETGRAGRDGGEGHCLAYYSYKDVEKLEKFMSGKPVAEQE
VGFALLQEVVAYAETSMSRRKFLLHYFGEEFDSETGDGCDMDDNMRNPKAQVEAKDQVVK
LIEVIRDTKHIYKSKEIVYTLMGRMNAMIKAHKTDAQKLFGCGKAFDERYWMAVLRLALV
GGLLSKDIETYGIIKVTEKGLDFIKNPQSFMMSEDHEYSETEDEAIVSASKVSGTADEVL
MSMLRDLRKKVAKKLGVPPFVVFQDPSLEDMALKYPITLDELSNVHGVGEGKAKKYGKDF
IELISSYVEDNEVMRPDDLVVKSTGANSVNKLYIIQNIDRKLSLKDIAKAKGLDMNTLLK
EMEQIVNSGTKLNIKYWIDEMLDDDQQEEIHDYFMESESDDIEDALKEFDGDYDINELRL
MRIKFISEVAN
>KACEBFPM_00051 hypothetical protein
MSRQIKLIWDFRGPAATKTAEHHEIHLKEYIVIENFPLNITGFEVINDMHAIAFMVVTDE
NMIAIRDALKPHRGEVYLV
>KACEBFPM_00052 hypothetical protein
MKKLIDLDQTTLTKLKMLSVFEHLSVKALIENAVCTYVKNKEKERFDKLTNEEKEDLGLL
MLMQEVDRTEFVSREEIVKTLQS
>KACEBFPM_00053 hypothetical protein
MIVKFSNPFFKDLCKIKDSILKNNLIQVIVLFENSENIEGISNIIKMKGQTEAYRMKIDK
YRLGFYFDGATIKLGRFAKINDIYKLFP
>KACEBFPM_00054 Putative thiazole biosynthetic enzyme
MPKELLLQVTPEIAANENLLKDYLSKQIKVSAKDVQHVSILKRSIDARQKAIKINLKVNI
FLQGENFVEQKIVLPEYKEVSNSQEVIVVGAGPAGLFAALQLIELGLKPILIERGKDVRG
RRRDLKAINVDHLVNEDSNYCFGEGGAGTYSDGKLYTRSKKRGDIDRILKLLVAFGATPD
ILVEAHPHIGTNKLPQIIQDIREKIIEMGGKVLFETRVTDILVKNNEVQGVVIQNGDTIV
SNKIILATGHSARDIFELLDKKKIFIEAKPFALGVRAEHPQSLIDQIQYSCDYRGEHLPP
APYSIVKQVNGRGMYSFCMCPGGVIAPCATSPGEVVTNGWSPSKRDQVTANSGIVIELKL
EDFKPFDKFGALAGMEFQKSIEQKAWHLAGETQKVPAQRMIDFTQNKVSKEIPKTSYVPG
TTSVEMGQVFPGFLSQILREGFSEFGKSMKGYLTNEAILHAPESRTSSPVRIPRDEITLE
HLQIKGLYPCGEGAGYAGGIISAAIDGEKCALKIGACLLG
>KACEBFPM_00055 hypothetical protein
MKYFLAIIISVLLLSSCDDGNLITENFVFENATVQKCSDSNVLYKINGAEALIFKSLDIY
FENIEQVKTYSISGNANLIYRKFATTTSTNNICNTPTIPVLEEWTVTGGTVQITTTKILD
SNRTTVVAYTHNIVFKNITFTTPSKQIVYDTYVFGNYRTEVVDLHFGYDLITTQNCGGSN
LILKYNNNNALLLDVDATLFPNSTVGSPRTRVINSTTNKVVYRVYNGSLNTNFFCSAITP
STPNLTEEWIAQNGVEGASGEIRVVTVAIDATHFKHTITLYKTTFKKGVLTYIFPTSDNF
IFGTYITTI
>KACEBFPM_00056 L-fucose-proton symporter
MTSQTHKTNYPALYTLITVFFFWGFIAAGNSIFIPFCKSYFSLDQFQSQLIDFAFYTAYY
IGALLLFALGDITGNDIVGKWGYKKSIVYGLLFSALGAGAMIVAVEANIYAGMLIGLFIV
ALGFSLQQTAANPFAILLGDPKTGASRVSLGGGINSLGTTVGPIIVALALFGTAASVTEE
QIKLLELNKVVILYICVGLLFLASAALFYFSKKVPSGIANEPMEKANKALLTLVMMTLLL
AVCFTPIFRSYKSEEALKIEILNTEINKRKETLKISKFTKEGITLYNNVTSKKELEVKLL
REPLEQKRMFWLTGALFVILGGIFFSYVSAQKKSEGWGAMQYPQLVLGMLAIFTYVGVEV
AIGSNLGELLKLKDFGNLASSDIAPYISMYWGSLMIGRWAGAISVFNLKGTNKKIALIII
PLTAFAIILGVNIISGKDMKPLYYYIVCVFIQIGAFFLSKDKPARTLMIFGSFGVIAMLI
GLSTTGIVAIYAFLSGGLACSIMWPAIFSLSIIGLGKYTSQGSAFLIMMILGGGIIPPIQ
GKLSDIIGIHQSYIVACVCFAYLTLFAVLVKGILKKQNIDVDAIEVEASH
>KACEBFPM_00057 hypothetical protein
MQINKYYLSALSSFVIWGFFSLVLKPLHNYPSLDILFYRVFYATGLSIIINLLFRKEKLK
NDWKSYLTLEKKEKIKTLLLTVLGGFLLTFNWFMFIYAINHVSLKSASFAYLICPIVTTI
LAYFILKEKLSKWQWFSVFLCIISCAMLSYGDLKGLIYSLVIAISFALYLISQRENNKFD
RFVVLTVQLLIASMVLLPFFPVYRGEIPTEPIFYILMTIIVVLFTIIPLFLNLFALRGIT
SSAVGILMYSNPMINLLLAIFYFKEEINSVQIGSYLLILFSIIIFNEKLLRVSKD
>KACEBFPM_00058 Competence protein ComM
MLVKVFGSAVFGVEATTITVEVNIDKGVGYHLVGLPDNAIKESSYRIAAALKNNGYNLPV
KKITINMAPADLRKEGSAYDLTLAIGILAASGQIKSEEVDKYIIMGELSLDGSLQPIKGV
LPIAIKAKEEGFKGFFLPKQNVKEAAIVAGLDVYGVENVLEVIDFFEGKGTLEPTVINTR
EEFYKTLDFPEFDFSEVRGQESIKRCMEIAAAGGHNIILIGPPGSGKTMIAKRLPSILPP
MTLKEALETTKIHSVAGKVKDVGLMNQRPFRSPHHTASSVALVGGGSYPQPGEISLAHNG
VLFLDELPEFKREVLEVMRQPLEDREVTISRAKFTITYPSSFMLVASMNPSPSGFFNDPD
APNTSSPHEMNRYLSKISGPLLDRIDIHIEVTPVPFDKLTEKRNGESSVEIRKRVTVARE
IQTARFELFDNIHYNAQMSTKQIREHCALDEASLQLLKTAMERLNLSARAFDRILKVSRT
IADLEGTDKVNSSHIAEAIQYRSLDREGWLG
>KACEBFPM_00059 hypothetical protein
MAKPNYVFIMKKIALLALFVFCGNVYSQKKKAPAKTPPVVIAKGNNYSAELAKNKFYLVV
NNTVSKDTLSLKIYPDKTTPTDCKITAFTTKGVPMYLVSWTEKLITETKLKTEDNLITES
QIWNPATKNLLVGNTQTVTKIKEIIFLDKLKTASETQEKIRRSGYEFTFLGGEEFSLSDK
YSNTKYSYNPTSMKYEIFRPKVAESAPKKKRK
>KACEBFPM_00060 hypothetical protein
MKLLVDSGSTKADWIAINDEGKILFTTQSLGLNPEVLTKEEIIKRLDGRFDISNNKDKVT
QLFFYGAGCGTDRMKIFLAEVFQDYFQNAKTTVHEDTYAAVYATTPKNEKAIVCILGTGS
NCSYFDGQVLHQKVQSLGYIAMDDCSGNRFGRHLLRAYYFNKMPANLAQEFETTYDIEPD
AVKNNLYKEPNPNAYLATFAQFLIKHKDSDFCQKIIKDEIEIFVENYIKQFENYKEVPVH
FIGSIPFYLKEELQNVLNNHEIKLGNVLRRPVDGLIDFHIF
>KACEBFPM_00061 Glyceraldehyde-3-phosphate dehydrogenase A
MKIKLAINGFGRIGRLVFRETCNRDNVEVVAINDLLNVEHLAYLLKYDSVHGRFSGKVEV
KDDKLYVNNKHIRVTTQKDPATLKWDEVGVDVVAECTGIFTTIETAQAHLKGGAKKVVIS
SPSADAPMFVMGVNHEKATAADTIVSNASCTTNCLAPLAKVINDNFGIVEGLMTTIHATT
ATQLTVDGPSKKDYRGGRSALLNIIPASTGAAKAVGKIIPELNGKLTGMSMRVPTANVSV
VDLTVKLAKETTYQEIMTVLKNASETTMKGILGFTQDDVVSQDFIGEKFTSIIDSKAGIG
LNSTFFKLVSWYDNEYGYSSKLIDLSIHISELK
>KACEBFPM_00062 ATP-dependent 6-phosphofructokinase 1
MPKTIKKIGVLTSGGDAPGMNAAIRSVVRTCAYHNIDCIGIYRGYQGMIEGDFEEMGPRS
VNNIVNKGGTILKSARSKEFMTAQGRQKAHKHLINSNIDALVVIGGDGTFTGAEIFNNEF
NYPVIGIPGTIDNDIYGTSHTLGYDTALNTVVEVIDKIRDTASSHNRLFFVEVMGRDAGH
IALNAGIGAGAEEILIPEENLGLDRLLESLKKSKTSGKSSSIVVVSEGDKIGKNVFELKD
YVEENLPEYDVRVSVLGHMQRGGAPSCFDRVLASRLGVKAVESLLEGKSNYMVGLFQDKV
SLTPLEQAIKAKSQIDKELLRVSEIMST
>KACEBFPM_00063 hypothetical protein
MEEKKKNTALKKLRKYTLLFLTGLVLLLLGLGIALSLPSVQTMLGQYATEQLNKEFGTNI
TIQEANFTIFGGVKLKKVLIRDHKKDTLFYINRLKTNILDAKKLIDGDLHFGDVALDGLF
FNLKNYKGEKDNNLDKFIDLLDDGKPSKSKKKFLLTANKFNLTNGKFSFNDYNIEKPLLF
SAKRLNAVTKNFKILGPDVTTYIQEMSFVDNRGLVIDDLISKFTYTKKHILLEKLTVKTP
KSDLEGSIALRYDRKDFSDFNNKVIFDVKVDKASISSNDLQHFYGEFGKNQRFNLSGKLL
GTLNNFSTKKLKLIDYNKSEIIGDFTFKNLFSKNKGDFYMKGNYSKISSTYNNLNAILPR
VLGNNLPTTFKKFGTFTISGTTEVTLKTIKAAVLLKTALGNVKSNLTMTNINNIDNATYI
GNVKLDNFNLGKLLSRTDVGVVNLDVNVDGKGFNQKYLNTKLQGNIQSVSYDQYNYKNIV
VDGTMIKSIFTGNITVNDPNLQMNFDGILNLNNKVNKYDFHANVEYANLEQLKLYTADSI
SVFHGDVTMKLQGNSIDNLYGEVFINSTSYENNKDTYFFDDFVVKSSFDENRIRTMTINS
PDIIEGKVVGKFQFNQLQKLIENSLGSLYANYLPNKVSKGQFLKFDFNVYSKLIEIFLPE
VSLGQNTFMKGMISADNDEFKFNFKSPNITAYNNYFDNISIDIDNKNPLYNVYVEMDSIK
TKHYKVSDFSLINVTANDTLFFRTEFKGGKKADDFYNLNLYHTINKDKNSVVGIKKSEIN
FKNYLWFINEDESKDNKIIFNKKLTDFSIEKISMSHKNQAMELMGILRDSTYKDLKLSLK
NVDLDKITPSVDSLKFKGKVNGLVNFKQNKSIYEPTASVTIDSLKINNLALGKLAIDVTG
DDSFKNFKINSVLKNDGLESFSADGNVFIENKKPLLDLDLRLNNFNIGVFSALGGDVITN
IRGLASGTASFEGELENPEIKGRLYLNKSGLKIPYLNLDYDFENNSVVDVTENQFSFRNI
KITDSKYSTKGILSGGIKHHNFGDWFLDLNLASNRLLALDTKDAEEVLYYGTAFIDGDAT
IKGPTNGLVITVNAKSEKGTSVKIPITDSEVSSENDYIKFKSRKDDFVNKTKNKKQKTYK
GVELNFELDITKDAEIEVIIDKNSGHSLKGRGAGTLALEINTLGKFKMNGDFQVYEGVYN
FKYGGIIDKKFKIKPLGSISWDGDPLNATLNMEAVYVTEANPGILLENSSFTKKIPTEVV
IKLTDKLTSPTPDISINFPTLSSVLKSEIEYKLSDSDKRQTQAMALLSSGNFLSDKGVGE
NIITGNLLEKANSLFQDIFSNPDDKLKIDPYFIQANKRSLDSRTEGQVGVTLSTKINDKV
TINGKLGIPVGGVNESVIVGDVEVQLRLNDDGSLKARFFNRGNDTNYTGESIGYTQGFGV
SYEVDFNTFKELLSKILNSKNNKKEKESKKEEAPDSDLLPEFIQFTEKRHKKTTEKPKNI
PETAPDLN
>KACEBFPM_00064 tRNA N6-adenosine threonylcarbamoyltransferase
MHQKNIFILAIESSCDDTAAAVMQNDKVLSNIVAQQAIHEQYGGVVPELASRAHQQNIVP
VIDVALKKANITKEQLSAIAFTQGPGLMGSLLVGSSFAKSMAMALNIPLIAVNHMHAHIL
AHFIDEDGYDKPEFPFLALTISGGHTQIVKVNSFFDMQIIGETTDDAVGEAFDKSAKILG
LPYPGGPLVDKYAQLGNPKAYKFTKPKMPNLDFSFSGLKTQILYFIQNNVKENPNFIDEN
RNDICASIQHIIIEILIEKLKLAVQQTGIKQIAIGGGVSANSGIRSTLKEAEKKYGWKTF
IPKFEYTTDNAAMIGIVGYQRFLENKFNDASVVSKARIDF
>KACEBFPM_00065 Ribosomal RNA small subunit methyltransferase E
MQLFYNPEINTELKEFSFDKEESKHIVKVLRKTEGDILHVTNGLGNLFSTEIILASEKKC
TVKIETTETYQPTDFYIHLAVAPTKMNDRFEWFLEKATEMGIHEITPIICDRSERKIVKN
ERFDKIILSAMKQSLQFFLPKLNEPISFKDFINQQHDGNLCIAHCEETNKKLLKNTIKAK
EKYTILIGPEGDFSEKEIQLALANNYIPVSLGNTRLRTETAAVVACHSVVFVNE
>KACEBFPM_00066 hypothetical protein
MKKIILFLILITTPVLSQEIALLKYSGGGDWYANPTSLPNLIKFCNQNINTTIKTKPVTV
TPASADIFSYPFIHMTGHGNVVFNDAEVQNLQNYLRSGGFLHIDDNYGMNQYIRKEISKL
FPNEALVEIPANHAIFQKPFPFPDGLPKIHEHDGKRPQAFGIFIDTKLVLLYTYECDLGD
GWEDPEVHNDPPAVREKALKMGANIMSYIFKN
>KACEBFPM_00067 hypothetical protein
MKKLLLTASVVFFMFSCQKDNESTVNAAQPNATPSAIASIENRGCASEQMLALDLQKDPA
LAARMANIETQTKNVLSTSRIVNGVIEIPMVFNVLYNTAADNTSLAQIQSQVDALNKDFN
ATNSDYNTANNPYSSVRANIGIRFVLDRVIRKQSPKTIWYSEDGYMKIAAQGGMAPTSPT
TKLNVWVVNNLASRTSGQLLGYAQFPGGSSATDGYVCGNYCLGTIGTAAAPYNLGRTATH
EIGHWMNLRHIWGDGNGCASDLVSDTPLHDSPNFGVPAVGHRSTCTGTPLEMYMNYMDYT
DDRGMYMFSLGQKSRMNALFAVGGARASFRL
>KACEBFPM_00068 hypothetical protein
MTSKIIANGIIKALLIIVAIAMLLFFLYQIQSVIIYLIVSLILTLITSPFVGFLKRKLKF
SNTIAVVFTMFLLMLTFVGLIMMFVPLILAQSENLSLLDTKSIENSATQLTNQFKIYLTN
HHINAGNLLNFSSLTSKINFNFIPTILNSILGTISSFGMGLASVLFITFFFLKDKIIFTN
GMKIILPDNHEEKILNSFTKINEMLSRYFIGLLIQLSIVFILYLIVLLIFGVENAFVIAF
LCALLNIVPYVGPLIGSVLAAILTMISNLGGDFQNDILPTTLYVMFGFWVVQLIDNNISQ
PLIFSKSVNSHPLEIFLVTLISGFLFGITGMIIAIPFYTMLKVIAKEFLPENKIVQLITK
NI
>KACEBFPM_00069 hypothetical protein
MISSLLSFEIQEFIALNIDANISKLALQKNPFPEIPWVEILTQISAKSKAKEKLPTWYAH
QNIMYPNKISVEQTSSEKTAYYKSNLVSGQSLIDLTGGFGVDDYYFSKKINQVYHCELNR
ELSEIVVHNFEVLNQKNITCLQGDSFETLKKLNQKFDWIYIDPSRRSDTKGKVFMLKDCL
PNVPKLLEDYFKFSNKILIKTAPILDITSGLNELQNVKTIHIIAINNEVKELLWEIEQNY
KDAITIKTINFNKEKEDVFNFILNTEIENKKYTLPKKYIYEPNAALLKSGAFELIANHFK
IEKLHQHSHLYTSNEIIDFPGRIFEIKNRFEYNKNEMKEFLENTKANITTRNFPETVENI
RKKWKISDGGNSYVFFTTDANNYKIVLICAKI
>KACEBFPM_00070 hypothetical protein
MRVPIIILFFWFQSTLFAQKPCEYSVNITDSIGTLKETKSCLVYEKVFGNSAQLIFLSLI
SDNGTPILNLQLIQKSTDFITPKCLDKNSKIYFQLSNGKIYTLINASQNECDHLIYNTKE
KLNNRLLNAHFLFMKDNFEDLKKYPITTMRIKLASETKDYILQKELRGEKTFGIFEPENL
FIDNFLCIE
>KACEBFPM_00071 D-alanyl-D-alanine dipeptidase
MKIKKLLLLGFMLNGIICCKAQNAQQNQVIISDTTLVNIKDYSSNFILDMKYATEDNFLK
RKVYDCQSCFLRLKTINSLIRANKEFIKKGYRIKLLDCYRPLDIQKKMWQIIPNANYVAN
PASGSIHNRGGAVDITLVDEKGVGLNMGTVFDFFGIESSHNYSNFSVKILKNRQLLKKIM
TKNNFESLDSEWWHYNLIDSRKDNLSNFKWKCE
>KACEBFPM_00072 hypothetical protein
MKKTPAIGLALLLVTIAYSCKQASEEAPTAEEFVTENSNGKEVISSAAAVEPKNSKRKFV
RTSDIKFKVKNVPKSTYAIENATTKFGGFVTYTNLQSTVSNKDETKVSPDSTLVTTKYTV
ENNITIRVPNKRLDTVIKTIAKQIDFLDFRVIKADDVTLQILSNQMAQRSSNISEKRLEK
AIDSRGKKLDDIVGAEDHLDAKKAQNDASKLENLSINDQVNFSTLTLQIYQREAVKQEMV
GNEKSINAYRPNIGLQIWDSLKTGWFMLEAIIAFVVQLWGVALIIGLGYFGYKKYIKK
>KACEBFPM_00073 Aminodeoxychorismate synthase component 1
MAWGNQFREVIFLDSNHYPQQYSSYDCVLAVDAFTSIKTDSYNAFEDLKQYQCQARDWIF
GYLSYDLKNDTEDLISKNRDGLFFPDLFFFQPKKLFLLKGNQIEIQYLNMCDDEVEYDFI
DISKKQEIKGKSDVNLKIEPQISKEKYLAKVGEMLSRINRGDIYEANFCMAYFAENATIN
PLEIYTKLNTISEPPFSVFFKNNTNYLLSASPERYLRKEGTTIISEPIKGTSKRFSDAIE
DEKSKLELSQNPKERSENVMIVDLVRNDLSHTATKGTVVVEELCKIYTFKQVHHLISRIT
SQVLHTTSPIDILKTTFPMGSMTGAPKISAMKIIEELEETKRGLYSGTIGYFTPTGDFDF
NVVIRSILYNSEEKYVSFSVGSAITAGSIAENEYQECILKAKAMLEVLQ
>KACEBFPM_00074 tRNA(Ile)-lysidine synthase
MLLKLENHLTKNLPFLKEKKLLLATSGGIDSMVMLHLFQKLNYNIAIAHCNFQLRGLESF
GDQQFVQEYASKNKIPAFVTHFDTENFAKDYKLSTQIAARELRYNWFYELLETENFDFIL
TAHHADDNLETFIINLTRGTGLDGLTGIPEQNEQIIRPLLPFSRSEIEEYTKENSIQWRE
DSSNASDKYLRNKIRHDLIPILKVLNPNFLDSFLKTQNYLQEAQVMIEDATIMIYQQVAK
EDNEIISFDLKKLTQLPNYKSYLYQWLREYDFTAWEDIYNLVESQSGKQIFSKKYRLLKD
RDFLILSVIKELENEAYFIKTNQKEVKIPLNFSICKVNDISSPKNTIIFVDEDKLQFPLT
IRKRNEGDSFYPSGMKGKKKLSKYFKDEKMSLIEKENTWLLCSKNKIVWVIGKRADQQFV
ANKTTQNIIKLELL
>KACEBFPM_00075 Thiol:disulfide interchange protein DsbD
MKSKIQNPSFCKLKKQFPNNKIKSFMSTKIIAVLLFFTVLNTQAQILDPVKWNSRVEKIS
ETEYNLILEGKIDAGWHMYSQFTPDGGPLPAVLKFEKGKYELVGKTKESKTKTAFNDVFE
VNETFFEKNVTLTQKVKITNLDLKNIKTDLDYQVCKESCINVNKSFLFTFSKSDIQATKP
VIALKNVDSSTITKQTVKTDIAKQNNANISQKKEEKSENNGIWSIFLLSILGGLFATITP
CVFPMIPMTVSFFLKQSSSKSKGKFNAFFYGFCIVAICVLITIPFHLIEGINRDIFSEIS
NNVYLNIFFFIIFTVFAISFFGAFEITIPNKFANKVDNASNKGGLVGVFFMALTLIIVSF
SCIGPAIGLVMGTSLNSDGGATILSIAMLGFGLGLALPFMFFALAPSLLSNLPKSGGWLN
TVKVVFGFIELALAMKFISNADIGLDLHLLEREVFIAIWIAIFGALSLYLFGKFTLPHDS
PITHIAVGRMVLAVITLSFTIYMIPGLWGAPLKIISAFPPPSTYSESPQGFGNNNIASNT
AQLPKNAVYGVHNLVSFEDYEEGLAYAKEVNKPILIDFTGKQCQNCRVMENNVWSDETVL
KILKNDIVLISLYGDDRKELATNEQYLSKETGNKITTIGQKWSEFQRLNYGTNARPYYVL
IGLDEKKLNKPVPYTPNIQEYKTWLEEGISNFKKQ
>KACEBFPM_00076 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase
MKNLQTIIEQAWENRALLQEETTTNAIREVIDLLDAGTLRVAEPKGDAWQVNEWVKKAVV
MYFPIQKMETFEVGIFEYHDKIPLKRGYAEKGIRVVPHAVARHGAYIARGVILMPSYVNI
GAYVDEGTMVDTWATVGSCAQIGKNVHLSGGVGIGGVLEPLQAAPVIIEDGAFIGSRCIV
VEGVHVGKEAVLGANVCLTASTKIIDVTGETPIERKGYVPARSVVIPGSYTKKFAAGEFQ
VPCALIIGTRKASTDLKTSLNDALREYDVAV
>KACEBFPM_00077 hypothetical protein
MENLKLFFEGNDYCTIFFKKNVKHISVNYNECDFVVSSNFEFGNANKEYIQKSLNKYNNS
PKRVIVFLISDYNNELKIPSNVILFRTSIYKSIKKQNEYVLPYIWESFYDDFQSLAKTKK
PIVGFCGNVKNNTGLRESTMQKIESDTRIATNFIKHIGFGGGKSELIERFKNNILNSHFT
ICNRGMGNFSIRFYQVLSLGRIPVLLDTDMVFPFDKKINWDSYIIKAKTETQLTQKINNW
WTQKNETDVIEVQQKCRQLFEDYFSEKGFGSQIFNFLIIEKNNPKIIKSEKPFFLKFPHL
KYKIKKKIATIKINLNKKS
>KACEBFPM_00078 hypothetical protein
MNLFFILNNGKNPKWKYYLKNIALGFLPKIIFRIRLKPILKEFEKRIDKEYILDRVNYYN
KLTVITSLHENAKKLKENTIQKEGSVYYYDTQEIIRYFKPNLKWFYCYGDITHIPENPSI
LKSRPISNNNQNSILLKLDKVRHFIFLKDRKTYQDKANKVIFRGKIIGKQQRVDFMQKFF
GNDLFDIGDVSKHLINPQWKTPKKTLWEHLNYKFIMAIEGNDVASNLKWVMSSNSIAVMP
KPTCETWFMEAKLIPNFHYIEVNPDFSDLEVKIQYYLKHPEKALEIIKNANEYCAQFFDY
KREKIISLLVMVKYFEKTNQSY
>KACEBFPM_00079 N-acetylgalactosamine-N,N'-diacetylbacillosaminyl-diphospho-undecaprenol 4-alpha-N-acetylgalactosaminyltransferase
MNIGYEAKRIFHNKTGLGNYSRDLVRILATYYPKNSYFLYNPKKNKEALFTTNSPVIFEK
LPTTSFYTKFYNLWRQKGIINDLEADKIELFHGLSGEIPSGLKSKNIKSVVTIHDLIFMR
YPHLYSFLDRKIHYYKFKKSAKNANLIIAISQQTKEDIITYLKVPAHKIKVIYQGCQAVF
KEKYSVEEKNKVTAKYNLPATFILNVGTIEERKNALTIVKAIKNIDTKLVLIGKKTAYAD
KIKTYIKENNLEEKVIFLQGLTSKELAITYQLATVFVYPSVFEGFGIPIIEALFSKTPVI
TTNSGVFPEAGGPNSIYINPNNAEDLKVEIEKLLLSEPLRNEISDKGFNFVQKFNDNLIA
KEIMQCYESLF
>KACEBFPM_00080 SPBc2 prophage-derived glycosyltransferase SunS
MQKISVFIIAYNEEKIIEKCLKKLSWANEIIVVDSGSTDKTIRICEKLGAKVIYNKFENF
GKQKQFALNQTTNNWVLSLDADEVLSDELISEIKNIDFSCNGYLIPRTHVFLHKIFKSGS
ENKKPILRFFNKKQGKFIENKVHEIITVDGEIGVLKNEMLHFTVFDISTAIQKQIKYSLL
SGEFLFEKGKKASLAKVIIKFPFDFIRFYFLHRNFLNGYQGFIWSMLSAFGSFIKYAKLY
DLHQNKDS
>KACEBFPM_00081 Peptidoglycan-N-acetylmuramic acid deacetylase PdaA
MVLLSFDIEEFDMPFEYGKSISFEEQIAISIEGTTAILNLLEKNKVKATFFSTVIFAQNA
PDIINRIIANGHEIASHSYYHSDFTIEHLRESREKLEEITNTKVVGYRMPRMFPVDEKEI
FKAGYLYNSSINPTYLPGRYNHFDKPRTYFKQVGVWQIPASVSPIIRFPLFWLSFHNLPL
WLYQILIKWTINKDNYLNIYFHPWEFTNLKQPEKFGFPAYVSKNSGKEMIARFDRMLVWM
NKRNYKFGSFKDFLTTI
>KACEBFPM_00082 Putative glycosyltransferase CsbB
MSLNNKISIVIPCFNESLNISKIINEIENVFAEITYDFELIFVDDGSIDDSVSILKTEAE
NKSFVKYIEFSRNFGKDQALKAGIDIAKGDALVTIDADLQHPPALIKEMIKKWENGYEVI
YAFRKENNPDASFKNRIGSKVFYKLVNYLSDINLENGIADYRLMDKKVIKSLKNINEYEL
FLRGMVKWIGFKQIGIPYIPEQRFAGESTYSIKSLIKLALHGITSFSTKPLYLSIYLGFL
LSGIGFLFYCTYVFYSLFYSLAISGWASVIFTIVFFGGLNLIVLGIVGIYVGKIFMQSKG
RPNYLIKETNYK
>KACEBFPM_00083 hypothetical protein
MNNFFRNIFKHPFFTDKKYIIVIWLLVTIVSVVKQLFIGRYNNYKIFKAVYFHTINKLPL
YSEYPSEYFDHNHYGPVFSLLIAPFAMLPDCVGLVLWGIFNASVLVWAITKLPLKQTQIT
AVLWICFHEFLTTLLGLQFNPLMTALIILSFVYVDKEKVFWAAFFIVLGVFVKLYGIVGL
AFFFFTKDKIKFIASLIFWSVILFALPMLISSPDYIIQTYQQWFYDIIDKNTENTNLTSY
QDICLMGMVRRFMQDSNISNLPFLFSGIILFGLQYLRIKQYKEKGFRLMLLASVLIFTVI
FSTGSESPTYIIAFLGVAIWFVIQPKPISKFHVFLFVFAMILTSLSPSDLMPKFLRENYI
RPYALKALPCVLIWIAIIYEMLTKQFNKYRSITT
>KACEBFPM_00084 hypothetical protein
MNNELLNIITNFDSLGSDFVIGKRNKIKTIPYNDIILNVKSFKIPFFFNGIVYKFFRKSK
AERSYNYAKILSEKGIGTPNPIGFYENKSAFRLLDSYYICEHLSPDYVFKDLFNTPNENL
DDILRQFTYFTFNLHERGIEFLDHSSGNTLLKKVSQDKYEFYLVDLNRMKFHKEMDFKTR
MKNFNRITPSEAMIKIISFEYAKLYGKPEEETFQLMWKYASEFQEKARRKIRLKKKLGIK
>KACEBFPM_00085 hypothetical protein
MSQKICIISFDHWNYDKHIVDKLNEKGIDSFHIKIGGFKHKNIGTRIINTFSKIVLGKNP
KIKKRQEHIIKMLEEKGFQDQILVINPEVISLEYHQKIKKFTPKYIAYLYDSVERCPIEH
LLHGVFNEIYSFDKGDVKEYGFKETTNYNYLEKQPITDGLSIKNQVLYIASFDNRLEKVM
LLKQAFEKIKVSYKFIIVGKKTSLYKLKNVFSSKILGIEFKRNRIKQNDLKKLYAQTQTI
LDLVRDNQSGLSFRVFEAMAFQKKLITNNKNIKTYNFYNPNNILVLENENYDFDKCFFET
NYEPLSDKIYYQYSLDNWVNTIFKI
>KACEBFPM_00086 Putative glycosyltransferase EpsE
MKTSVALCTYNGEKYIKEQLDSILNQTKKVDEIIVCDDCSSDKTVEILNHYSSTNPGLFK
IYINEQNLRSVKNFEKAITLCTGDIIFLSDQDDFWVNKKVEEYADYFALNPNIKVLASNG
YCVNDNSQIEDKYALWDVPVFLKEIEVSYNYHDIINYVANLATGASIAFRKEIISNIVPF
PIIKGFHHDEWIAMIASSNNEFTLLNKKYFYYRTHNGQQVGGVFYDKTKKNKLFLSQFFN
LQDDNIPFYILKKRLSKIVSANHLNKKILKTHDKYQIMFQENSKNIAFIYSETRRKMKKK
YPINSFLLNISDKLLSKRRF
>KACEBFPM_00087 hypothetical protein
MKEKIGVNVFGYINGEFGLGEAVRLLIKAMQSVDIPVALINLDIKTNHRHEDKTFENFTK
EAPYSINLVLLGPGEASLPLTYFEDSGLFKNKYNIYYLNWESEYFPQEYVDNISFFDEIW
VPAKYCQNVISKVTNIPVTVIHYPIEIVIPDTIDEEAENFYNKSSFNFLFIFDYNSTLER
KNPINLIKAFKKAFDKNDKSVSLTIKTSRATRFAKEKSKLLDEIDGYENIHIVEKIFEKD
TLHNIIKGCDSYVSLHRSEGFGLTMAEAMFFGKPVIATGYSGNLDFMNSENSFLVDYKTC
TVNSKIINYDKNTIWSNPDFEHMAELMKKVKENSDTIKAIAKKGNETILHDFSTSKIGNQ
IKHRVELILKNFRVDPIKNAYISLYLENRKLTNELRLVYKSKLITTILDIKLYFRNRKLK
RKNKNF
>KACEBFPM_00088 GDP-mannose 4,6-dehydratase
MKKAIITGITGQDGAYLAELLLSKGYEVYGTYRRSSSMNFWRIEELGIQNNPNLHLLEYD
LNDQTSNIRLIDKVQPDEIYNLAAQSFVGVSFDQPISTAQTTGIGALHLLEAIRIINPKI
RFYQASTSEMFGKVQQVPQTEDTPFYPRSPYGFSKLFAHWATINYRESYDIFGVSGILFN
HESPLRGREFVTRKITDTVAKISLKKQSILELGNLDAQRDWGYAKEYVEGMYKMLQYKDA
ETFVLATNKTFTVKTFVELSFKQIGVDLVWKGQGVDEKGFNQKTNELLVQINPAFFRPSE
VELLIGDAKKANDLLNWHPETSLEKLCSIMVEADIRXXPTVSQHLKELKNAKIIQGSIEG
TAICYCINTETLKKFENYFFNITKKLKAKCC
>KACEBFPM_00089 hypothetical protein
MKLSEFKNQLENATQLEFVLQNGQKVPSHFHITEIGMITKKFTDCGNTFRISKKATLQLW
SSIDFKHRLEPKKVLSIINATSGMFEGEDLEIEIEFQQETVGKFGLEYINNQFLLTNTKT
DCLAKDNCGIPTEKTKLKPSELQENTNQCCAPNSNCC
>KACEBFPM_00090 hypothetical protein
MENKKAHWENVFTTKTETEVSWFQEKPETSLNFVKEFNLQKNAKIIDIGAGDSHFIDALL
DLGFTNLYLLDISAKAIERIQERLGEKSKNVTFIVSDILDFHSEILFDFWHDRASFHFLT
AEDQIRKYAQIVSQSIAKKGKLVIGTFSENGPKKCSGLDIMQYSENKMNAIFEEHFEKIN
CFTEDHKTPFSTIQNFIFCSFNKK
>KACEBFPM_00091 Glutaredoxin arsenate reductase
MINILVLCTGNSCRSQIAHGYLDHFTDDKKVKIYSAGVETHGLNPKAIEIMQEEDINISH
HTSNNIDEYFDISFDYVITVCDNAKERCPFFPTKAVKLHYNFPDPAKATGTEIEIKNEFR
KTREMIKQYCNHFVQNII
>KACEBFPM_00092 UDP-3-O-acylglucosamine N-acyltransferase
MKIYSIQEINEILKGEILGNTTYKITAPEQLELAKETQISFIGHKKYEKFWQTSKACAAI
VNEDISIAPGENRVFIKVKNADLAMSQVLALFAPPASVFRTNIHATAIIDTTAIIGEDTK
IGAGSYIGLDVKIGKNVIIYPNVTILDECTIGDNTIIWSGVVIRERCHIGSDCILHPNAT
IGADGFGFRPDPEKGLVKIPQIGNVIIGNNVEIGANSCVDRGKFSSTILGDGCKIDNLVQ
IAHNCTLGKYCIMAGNSGLAGSVTLGNGVIIGGSVSVKDHLTLGDGAMVGAGSGVASDVA
AGKVVLGYPAADARDTLKQWAFLKKLVKDSK
>KACEBFPM_00093 2-succinylbenzoate--CoA ligase
MIKPTHKNIHNKFKLNGFHFTKEELCIAAFSYIKEGLAHEKPLGSFILDWFDEKTYLEIM
TSGTTGIPKIIRIEKQAMINSALATGDFFELKSGDKALNCLPVKYIAGKMMFVRALILGL
DLDFVAPSSAPMVGNKNNYDFVAMVPLQVENSLMQLHQIKTLIIGGAKINIDLEKKLIQS
KCNAFETYSMTETVTHIAAKRVGEKAFLVLPNISIWQDNRNCLVISAPNLSKKNIVTNDI
VELVSEHQFIWLGREDNVINSGGIKLFPEQIEAKLLGKITNRFFVAGIASEEFGEQLLLF
IEGNPYEIEPSIFNDLDKFEKPKQIKFIPSFAETETGKIKRNEVVASFL
>KACEBFPM_00094 hypothetical protein
MTFLLRAFKSENYFWKYIVGSILIIIASTLGQLPLMGFVMAKLISEGKGFYHINETDLMT
VLDKNFTLFLLLFSFLVALYAIYLVLKFLHKQSLLDIITCRKKIDWKRIFFAFSIWGIFQ
IITTIISYYTAPEDFVLNFKPLQFAILAVIAIVMIPIQTSVEELIFRGYLMQGFGLLAKN
RWFPLLMTSLIFGLLHLGNPEVAKMGYITMVYYISTGLFLGILVLMDDGLELSLGFHAAN
NLFTALLVTSDWTAFQTYSILKEVSKPEVGLEIVFPVFIVFPILLFVFAKKYNWTNWKEK
LTGKLAVIPEQINIKND
>KACEBFPM_00095 Arsenate reductase
MITIYHNSRCSKSREGVCFLENTKEDFQIINYLENIPTKDQLKELLRKLNMTPIELVRKK
ETIWLSDYKNKNLSNDQIIQAMIDNPKLIERPIVVNGDKAVIARPTERIKEIL
>KACEBFPM_00096 Ferrienterobactin receptor
MISTKKAFASILLLSISTLFAQLKTESKKITITGKIIEKATSLPLEYATITLKKPNTTQA
LFGGITDNKGNFSIEINPSIYDLKFEFISFKTIEIKEKLLKFNTNLGQISLEDDAQKLDA
VEIRGEKTTIDIKLDKKVYNVGKDILVRGGTVSDVLDNVPSVAISAEGAVSLRGNENVRI
LIDGKPSSAINVNDALRLIPADAIDKVEVVTNPSARYDAEGGGGIINIILKKGKNQGVNG
TLIVSAGEPENSSASANINLKSELFNFFTTIGYNKRKNPGTTKIDQENLNPSGSLKSYLE
ERRDSKKFGQGANINFGIELYLSKNTSWTNTLSYRNNDGGNKENVLYYNYNQNKSFTNTG
QRFNDLIADNQNVEYTTNLITKFKKDGHKLSIDGAFSKEKENEFSDIEGTILETNTFVSS
EKTKKTNTQTRNLLQADYVLPIGKNTQIEAGFRGNYVNLLADYLVQERTTPNSPFTNIIA
FTNTLAYKENVNALYTQFGSKIGKFSYLFGMRYEDSHIEVNQLTSNIYKPKKYNNFFPSA
FLTYQLSENSSISLNYSKRITRPRDRFINPFASYTSNINLFQGNPDINPALSDAYDIGYL
HKWDKVTLSTSAYFNHTTNSFQIVRKERGDQINGVPVIINTPFNLAIEDKTGFEFTLNYN
FKKWFKLNGNFNFFNNKTTGNYTYTNSQNTLKVQNFDFNTNTWFTRITSKISLPHKIDWQ
TNATYTAPQKYRQGTMNGVAAVNMGFSKDILKDMGTISINVNDIFNSRKRIQDLQLPTVN
SYSEMQNRKRQITISFTYRFNKKKTDKDPKQKQNENGESENMG
>KACEBFPM_00097 hypothetical protein
MLGINKLRFIMVEFPQYLGFILFLTILTIGFWLLFFLVGFVQYWIGGALWEFYKEKRAKK
EEESN
>KACEBFPM_00098 Fumarate hydratase class II
MEYRIEKDTMGEVQVPATKYWGAQTERSRNNFKIGPSASMPKEIIEGFAYLKKAAAYANC
DLGVLPTEKRDAIAAVCDEILAGKLDDEFPLVIWQTGSGTQSNMNVNEVVANRAQVLAGH
KIGEGEQFIKANDDVNKSQSSNDTYPTGMHIAAYKAVVEITIPGLEKLRDTLQAKATAYN
NIVKIGRTHLMDATPLTLGQEISGYVAQLNYGIKAVKNTLAHLSEVALGGTAVGTGLNTP
AGYDVKVAQYIAQFTGHPFVTAPNKFEALAAHDAIVETHGALKQIAVSLNKIANDVRMLA
SGPRSGIGEILIPENEPGSSIMPGKVNPTQCEALTMVCAQVMGNDVAISVGGMQGHYELN
VFKPLMAANFLQSARLLGDACMSFDEHCAQGIEPNYKRIEELVNNSLMLVTALNTKIGYY
KAAEIAQTAHKNGTTLKEESVRLGYVTAEDFDAWVKPEEMVGSLK
>KACEBFPM_00099 Kynureninase
MIFQNTLEFAQQLDNQDELKEYKNEFIFPQHEGKNVIYFTGNSLGLQPKSARNYVDEVMN
DWANLAVEGHFYADKPWWDYQERFANPLSKIVGAKPSEVTVMNTLTVNLHLLMVSFYRPT
KKRYKIICEEKAFPSDQYMFQSQVNFHGYKPEDAIVEIKRREGEHNIRLEDILSKIEAVG
DELALVLFGGVNYYTGQVFDMKTITEAGHKQGAKVGFDLAHAAGNIKLELHDWNVDFAAW
CSYKYMNSGPGNASGCFVHEKHHNDSNLPRFAGWWGHNKERRFKMEPTFDPVHGADGWQI
SNLPILSLAPYLASVEMFAEVGIEKLITKRNQITAYLEFILHEIDKEVKGHFEILTPTNQ
EERACQLSVFLHGEGRSLFDYLMKNGVVTDWREPNVIRLAPVPLYCSFEDMYNFGQILKK
GILEN
>KACEBFPM_00100 N(1)-aminopropylagmatine ureohydrolase
MNKQQKIESFDPSQPGLADATIFGLPFTAEESEIIIIPVPWEVTVSYGAGTSEGPEAILE
ASFQVDLQHQEFPELWKLGMYYDQVPAHWKKNSDKYKSFAQPIIEALENGEIIESVPVLK
ADLDKINKACAELHTEVKERVLHWIKKGKKVVLLGGDHSTPLGYYQALATIHDNFGILHL
DAHMDLRIAYEGFTYSHASIMYNALQIPQISKIVQVGIRDFCEQEVQIAQSNRVVVHTDM
DMKAQTFEGKTWQQQCDDIIAALPQNVTVSFDIDGMYSWYCPNTGTPVPGGFSFEQATYL
LSKLANSGKNIIGFDLVEVAPSEDDDWDGNVGARMLYHMCGMLAKNNGMNVGEKIYFNKK
>KACEBFPM_00101 Acyl-homoserine lactone acylase QuiP
MKKFKKILFVFVLFIAFIAVLLYGYLLSTKPNYEGELFIKNISKETTVYFDDYGVPHIYA
ANQKDAMTALGYVHAQDRLWQMELIRRIAPGKLAEIFGSRALKNDKFFIGLGINENSEKA
IATLNKNGKPYQMAMAYLDGVNQYLENGKTPIEFNILGIKKEKFTLKDVYNTFGYMAFSF
AMAQKTDPLLTDIKNKYGEEYLKDLGIDYSLNTTRIKISKEKTQQYIEISKSITTLLENS
PVPPFIGSNSWVLSPKKTKTGKVLFCNDPHIEYSQPGTWYEAHISCPETEMYGYYLAGTP
FPLLGHNRDYAYGITMFENDDADLFEEENNPKNENQYKTVTGFQNYKIRTQTIKVKDSTS
IILNVKETQHGPIINDLIDNFKNQKPVSFSWIYTQQPNKILDAVYSLSHAKNMTQFQKGV
SYIVAPGLNIMYGDAKNNIAWFTSGKLYKLEKGVNANLILNGTNGIDDKKKFLEYAKNPS
AINPSWNYVYSSNNMPEAIDGYNYPGYYLPEDRARRITNLLDNKSNWSKEEVSKMTNDNT
SPVSIETVKTMLLVINNKNLSSQEKAAINLLKNWKGTNQLIDVAPTIYTKWLYFYLKNTY
QDEMGEISFKQFLKTHIMKQSIAFQTKNINSPWWDNIHTKSKKETRSDILNMSFKQAISS
LNNQLGNDVNSWTWNKVHKVEYKHPLGSVALFKPFFNVGKFSISGTNEVINNTMFDYSDE
AQHIVKAGPSTRRIIDFSDIENSWSILPTGQSGNPMSTHYNDQAEMYLQGKFRKMKLNKE
EIIKTSTKLIFKAK
>KACEBFPM_00102 Kynurenine 3-monooxygenase
MQKSQKIAIVGSGLVGSLLAIYLKKEGHTVHVYDRSPDIRTIQFSGRSINLAMSNRGWNA
LDGAGVGDKVRHIAIAMEKRAIHIGDQLNFQHYGLQGECIYSISRGVLNRKMIDLAEEAG
AEFFFEQKIWDVNLTDATLQMGETERGEWTNVSYDMVFGADGAFSRIRHRMQRQSMFNYS
QDFLNTGYKELHIPANPDGSYKLDKHSLHIWPRGKYMLIALPNLDGSFTCTLFMPFEGEN
SFASLDNRQKVEAFFAENLPDTVDVIPDLAEDFFKNPTSTLVTMKCFPWTYSDKVALIGD
AAHAIVPFYGQGMNAGFEDITILYQMMQEYGNDWKTIFSEYEKSRKPDADAIAELSYRNF
MEMSTKTANEKFLLQKKIERWFASKYPEKWIPLYDRVTFSTRPYSEALAIGDFQETIMQE
ILKIENIETNWETEEIEHKIIQLLNSK
>KACEBFPM_00103 hypothetical protein
MTENEISDINSKSKLVAKYSEEIDRESAYEILTKKMEEISEEVSEKEDKKNASREPSTAS
VVGKSVLKVVTSASFIRGAFSVLMKVLRK
>KACEBFPM_00104 Regulatory protein RecX
MRTPINKKESVSEATQKLEYYCAYQERSHLEVIEKLKTLSITHEEADSIIVYLIENNFLN
EERFACSFARGKHRIKCWGKIRIVNELKFRKISQYNINTALKEITTDEYLENFYKLAARH
WETMREPNVLKKRKKFCDFLLRKGWESNLIYEKVKELEVM
>KACEBFPM_00105 hypothetical protein
MSLFTIVNVAVDAIQVVCTIFIAPVVAPRGTITTNCNAELEIIVAAVPLKLTVEFNKLPE
LAFIVTDVPAGPDNGKTDAITGIVHGG
>KACEBFPM_00106 hypothetical protein
MAGLIATVAGSIPNLESQTPDANIVVDQSVSTNTARGEYAPKFLTI
>KACEBFPM_00107 hypothetical protein
MSQVISFPAALQEFAQTAVSPTRLMYDFVAESSLSFAVAVTVICLFSLKRFAVSLITAKA
SGRISFSVFSEIS
>KACEBFPM_00108 hypothetical protein
MYWTLELASYLSDAPWPATKDELIDYAIRTGAPLEVVENLQSIEDEDETYESMEEIWPDY
PTDEDYLWNEDEY
>KACEBFPM_00109 Cob(I)yrinic acid a,c-diamide adenosyltransferase
MKVYTKTGDKGTTALFGGTRVPKDHSRIESYGTVDELNSYIGLIRDQEINQHYKNILIEI
QDRLFTVGAILATPPEKEVMKNGQLRLQKLGIIESDIELLENEIDTMENSLPQMTHFVLP
GGHTTVSYCHIARCVCRRAERLAVHLSHNEPVADIAIKYLNRLSDYLFVLARKLTSDLHA
DEVKWIPRK
>KACEBFPM_00110 putative ABC transporter ATP-binding protein YknY
MSQSLIRITNIKRDFVLGSEIINVLKGIDLQINKGEYVALMGPSGSGKSTLMNILGCLDT
PTSGTYILNNKDVSQMIDDELAEIRNKEIGFVFQTFNLLPRTTALDNVALPMIYAGFSKA
ERNIRATEVLNQVNLGDRMDHQPNQLSGGQRQRVAIARALVNKPSIILADEPTGNLDSKT
SEEIMKLFSEIHSNGNTVILVTHEEDIAAHAHRIIRLRDGLIESDNTK
>KACEBFPM_00111 hypothetical protein
MKHSIKSYLKFLWNSKNEHGVHSPFVFDLVTKCFYDKSSKIEYLLLKNYRNALLANKNTI
EVTDFGAGSRVFKSNTRQIAKIAKTAGISSKRAKLLFRIVNYFQPNSILEIGTSLGLATS
ALSLGNKKAKITTLEGCKNTVNELQLQKFNFDNVEFINTNFCEYLKNLQPTTHNLIYFDG
NHAKKATLDYFELLLPTITNDTVWIFDDIHWSQDMEEAWKIIKNHKKVKVTIDTFQWGMV
FFREEQEKEHFVIRV
>KACEBFPM_00112 hypothetical protein
MNNFNELGVRFYKYLRGKNLGINDTARILDLSGSQISNIKNGKIFGTDKMYKILNEFKDL
DANWLFRGVSIDVPNIDINQLSYMIELQKERIIDLKKENAQLKNEMKELNEKLKR
>KACEBFPM_00113 hypothetical protein
MKKQIIILFNLLIISFVLQSCENKTSVNKQKDKIQDTIKSISIEADENKIKGKLPKIFTD
TFEFEYYNDNGDYMWLYAKKGNDSYGFVNDNNNLRNLLRGDICEIKWRKDTIYIAGDGET
PEIDDWLISIKKTQDGNVSKFRKEYKKELKYHYSSESYSKSGLDDLYLSAEYYIANSKNK
LIQFAIQEKEQLEYSIESRTENNRYYEVLGIGYTFEHRFTIMQWIYIDVETQKIYEYDVA
NEKLIEFK
>KACEBFPM_00114 hypothetical protein
MTIIDSTKSLVENLYLISGPILAVLGFVAILQLRLTKKAIIITSKRQAAELSSKQIDYYT
NQIIPLQDELYLIEEEQKIERLIFKDLIQFTYEEIEKKINNNLIKKKIKELDVNADKILR
IVNAMESFSTYFIKGVADEEIAYSSIGRTFCHSVENYSFDISFMRREDDLQVFNNLVALY
HIWKSRLNSEKISKELLNKQNELKKIQIKKVDILGAK
>KACEBFPM_00115 hypothetical protein
MNLLKNNTSFLYLIFVWFCCTQIGFAQFSIPDIPKFQTSVYDYANVLSADQKSQLEKKLI
KYSDSTTTQIVVITIESLQGENVNQLATKWGQKWGIGGTAKDDNGVVILLAKEERKIAIN
PGYGLEDRLTAGIGGEIIRNIIIPEFKAGSYYNGLDKGSDAIFDVFKGKYKGTRKGDKDD
GGGIPIVFLIIVFIIILILISKNNKGNGSGIGRTPSLLDAIILSSMGRSSGGFGGSSGGG
FSGGGGFGGGFGGGGFSGGGSSGSW
>KACEBFPM_00116 hypothetical protein
MSKVEDFLTKAEEQEIVKAICIAEKNTSGEIRVHLEKKTTTDAITRAVAVFNELKMHNTK
DANGVLIYVAVKSKQFAICGDDGINKLVPTDFWESTKNIMASHFQKGNFKQGLVDGILKA
GEQLKNYFPYQDDDTNELPNEISKG
>KACEBFPM_00117 hypothetical protein
MKRFLPWIIGAVVIFGIYSWVKEINNTAVVLGQTVEQTWGDVQTSYQRRNDLIGNLVNTV
KGYATHEKETLTAVIEARAKATSVTVDPSNITPEQLAQFNQAQSGVSSSLSRLLVSVEQY
PNLKADQSFLKLQDELASTENQILTARTRFNEAVKPYNTHIKTFPNSLFAGMFGFKEKAY
FQSVAGAEKPVEVKF
>KACEBFPM_00118 HTH-type transcriptional repressor BluR
MHIDLPKDKRYYSMGEIAKAFEVNQSLIRFWDKEFDILKPKKNAKGNRMFTPEDVQHLQL
IFHLVKERGFTLEGAKVRLKEGQKKTLDKFAIVSKLESIRSQLINIKNEL
>KACEBFPM_00119 Murein DD-endopeptidase MepM
MKKVKYYYDAENLAYRKIKTKKAKSFGYIALFLVAAALFGFLCFIALLNTPYFETPKDKL
LARENENLKLNYTILNKQIDELDAVLANITDRDNNIYRVYFNNAPISEIPKKKGIITENR
FKQLLGYNNEQLVTNTSERVDMISRQLAVQSKSLDEILKLSKAKEKFLGSIPAIQPVKNE
QLKHMASGFGYRSDPFTKARKMHKGMDFTAPTGTPVFATGDGVIQRADNTASGFGNHIVI
QHGFGYETLYAHLSRYNKRAGQHVNRGDIIGFVGSTGRSEAPHCHYEVHKNGNAINPINF
YYGNISAVEYTAIAKLATQENQSLD
>KACEBFPM_00120 Alanine--tRNA ligase
MTSKEIRQQYLKFFESKGHLIVPSAPIVLKDDPTLMFNNSGMAQFKEYFLGNGTPKSPRI
ADTQKCLRVSGKHNDLEDVGFDTYHHTMFEMLGNWSFGDYFKKEAINWAWELLTEVYKIP
KQNLYVSVFEGSKEDNVPFDQEAWDIWKGLIDEDRIILGNKKDNFWEMGDQGPCGPCSEI
HVDLRTPEEKAQVSGKSLVNNDHPQVVEIWNNVFMEFNRKADGSLEKLPAQHVDTGMGFE
RLCMALQGKTSNYDTDVFTPLIEKVTQITGYKYTSNEVKNISEEQNKTNIAIRVIVDHVR
AVAFAIADGQLPSNTGAGYVIRRILRRAIRYGFTFLDTKEPFITKLVAVLASQMGEFFPE
IKSQQQLVTNVIREEEASFLRTLEQGLQLLDKVVAETKGKEVSGAKAFELYDTFGFPIDL
TALILREKGYELDEAGFNAAMQEQKNRSRAASEVSTEDWSVLIPGNVETFVGYDKTENDV
KITRIRKVNSKKDGILYQIVLDNTPFYPEGGGQVGDKGTLVSANDSSDSEQAKQTIDIID
TKKENNLILHFAKQLPENIETGFVAKVNTNLRASTSKNHSATHLMHLALRSILGTHVEQK
GSLVNPDYLRFDFSHFSKVSDDQLRQVEASVNAQIEAQLQLTEHRNIPIKEALDKGAMAL
FGEKYGDNVRMIEFGESKELCGGIHVKNTAQIWHFKILSEGAVAAGIRRIEAITGDAVKA
FYTNQENTLSEIKEVLKKPQDILKSVTSLQDDNVKLKKQIEQLLKEKIEGLKNTLVSEFQ
EINGINFLSKQVDLSMSSTKDLVQALGSLKPNSFVVLASIEENLPNIHCYIAKELVAGKG
LNANVVIKELGKYIEGNGGGQPFFASGKGKNVSGIKEALQKAIEFVK
>KACEBFPM_00121 Fused isobutyryl-CoA mutase
MEPQTPYIPINKVRIVTAAALFDGHDAAINIMRRIIQSTGVEVIHLGHDRSVEEVVNTAI
QEDANAIAITSYQGGHNEYFKFMHDLLKEKGAGHIKIFGGGGGVILPSEIADLQDYGITR
IYAPDDGRAMGLQGMINDLVQRSDFPVGDKLNGELKHIQEKNPTAIARLISAAENFPEIA
KPYFDKIHKQNQTSKIPVLGITGTGGSGKSSLVDELVRRFLIDFPTKTIGLISVDPSKRK
TGGALLGDRIRMNAINNPRVYMRSLATRQSNLALSKYVAEAIQVLKAAKYDIIILETSGI
GQSDTEIMDHSDVSLYVMTPEFGAATQLEKIDMLDFADLVALNKFDKRGALDAIRDVKKQ
YQRNHNLWDSNPDDMPVFGTIASQFNDPGMNTLYKSIMDKIVEKTNSDLKSTFKITREMS
EKIFVIPPHRTRYLSEIAENNRKYDEIALTQVEVAQKLYGIFKTIESVSEKSLVLNKAGI
DDSFAILTKEESHPFIILLLKEFDRVKMNLDPYNWEIILTWNEKVNKYKNPFYTFKVRDK
EIKIATHTESLSHSQIPKISLPKYQAWGDILKWNLQENVPGEFPFASGLYPFKREGEDPS
RMFAGEGGPERTNKRFHYVSAGLPAKRLSTAFDSVTLYGNDPHVRPDIYGKIGNAGVSIC
CLDDSKKLYSGFDLVHAMTSVSMTINGPAPMLLGFFMNAAIDQQCEHYIKENNLEVEVQE
KINEIYKKKGITRPSYQGEIPAGNNGLGLMLLGVTGDQVLPADVYNDIKIRTLSQVRGTV
QADILKEDQAQNTCIFSTEFALRLMGDVQEYFIKENVRNFYSVSISGYHIAEAGSNPITQ
LAFTLSNGFTYVEYYLSRGMNINDFGPNLSFFFSNGIDPEYAVIGRVARKIWAKAMKNKY
GANERAQMLKYHIQTSGRSLHAQEIDFNDIRTTLQALYAIYDNCNSLHTNAYDEAITTPT
EESVRRAMAIQLIINKELGLAKNENPIQGSFIIEELTDLVEAAVLQEFDRITERGGVLGA
METMYQRSKIQEESLYYETLKHTGEFPIIGVNTFLSSKGSPTVIPAEVIRATEEEKQYQI
DMLTNLHKGSANKVEEHLNILQEAAIKNENLFAHLMEATKVCSLGQITSALFEVGGQYRR
NM
>KACEBFPM_00122 hypothetical protein
MDIQSRKIEFVQAFLKLQSEEVISQFESLLKKKSTTNVEQDSDFKPMSIKEFNDRIDKSE
SDFKNGRYKNTSELLKKYI
>KACEBFPM_00123 hypothetical protein
MSYKVIWSNFAESELDKIFEYYIEQASVKVAKKIIKNILAEPKRLINNSEMFQTEELLID
REEIYRYIVCDDYKIIYSVDIKLKFIKIADVFDTRENPIKIKRNK
>KACEBFPM_00124 hypothetical protein
MKKFLFLFLSAIILTSCEKNVEFNNPAFQGFIDNSIWKATNFSATKSASGEMTIKGFATG
NVTLNLNSATLGTHVLGTTDASNFASYTVTKASSNFIYTTGIASSSVNKITLSTGGTGYT
TSSLVPTVGGSGFGLKVDIIANTNGVITSVTTNAMGNNYRAGDIITIASGDANATFIVQN
VSKSNGEITITEYNGTTISGNFKFIAYDAVNRKIASCQNGVFYKIPVK
>KACEBFPM_00125 30S ribosomal protein S16
MSVKIRLQRHGKKGKPFYWVVAADARSKRDGKYLEKIGTYNPNTNPATVDLNLDAAVKWL
HNGAQPTDTARAILSYKGALLKHHLDGGVRKGALTQDQADAKLATWIEAKSGKVDAKKEG
LTKAQSDAKAKAFKAETVANEKRIATQTEAAKALEAVVEEATTEEVVETATEEANEEKEA
>KACEBFPM_00126 Ribosome maturation factor RimM
MRKEDCFYLGKIAKKFSFKGEVLVYLDTDEPEMYEDLESVFVEVNKNLVPFFIENSNLHK
ADFLRVRFEDVDNEEEADAIMNCEVYLPLKMLPKLTGNKFYFHEVIGFEIEDKRVGVFGK
IVSINDTTAQPLFEVLNGEVEMLIPMIDHFIVKIDRENKKVVMDLPEGLVEMYL
>KACEBFPM_00127 tRNA1(Val) (adenine(37)-N6)-methyltransferase
MFSFKQFSVQQDKTAMKVGTDGVLLGAWTPINHNPISILDIGAGTGLIALMLAQRTSAVQ
IDALEIDEEAYEQATDNFENSPWSDRLFCYHAGLDEFVEEPEDEYDLIVCNPPFYAENYK
TNSEQRDLARFSDAMPFEELIEAADLLLSENGILSVIIPYKEEEKFVTLANEFELYPIKI
TRVKGTPTSETKRSLLVFSRNKQNCEQDILVIETDRHVYTKEYIALTKGFYLKM
>KACEBFPM_00128 Acyl-CoA dehydrogenase
MKPDLFQSPDYYLLDDLLSEEHKLVRDAARAWVKKEVSPIIEDFAQRAEFPKQIVKGLGE
IGGFGPYIPVEYGGAGLDQISYGLIMQEIERGDSGVRSTSSVQSSLVMYPIWKYGNEEQR
MKYLPKLATGEFIGCFGLTEPNYGSDPGSMITNYKDMGDHYLLNGAKMWISNAPFADIAV
VWAKNEEGRIHGLIVERGMEGFSTPETHNKWSLRASATGELIFDNVKVPKANLLPNKSGL
GAPLGCLDSARYGIAWGAIGAAMDCYDTALRYAKERIQFDKPIAGTQLQQKKLAEMITEI
TKAQLLTWRLGVLRNEGRATTAQISMAKRNNVDMAINIAREARQILGGMGITGEYSIMRH
MMNLESVITYEGTHDIHLLITGMDITGIPAFK
>KACEBFPM_00129 Guanylate kinase
MNKGKLLVFSAPSGSGKTTIVRHLLNQEDLNLEFSVSCTTREARGEETNEKDYYFISLED
FKKHIKAEEFVEWEEVYRDNFYGTLKSEVERIWAKGKNVIFDIDVSGGLRIKSKFQQETL
AVFVKPPSIDELKIRLKKRSTESEDKINMRIAKASVELATAPQFDKIIKNYDLDVAKVDA
YELVKNFLKEQ
>KACEBFPM_00130 hypothetical protein
MKFGKTIKIFLIDGDPNGRMSCELSNWTGKAYKIPRIKIKDCSDRSDLTSTGVYLLFGKN
ENGKDQVYIGEAESILKRLGQHLTQKDFWHETIVFISKDENLNKAHIKYIENRLHDIAKN
ANRYSIENSIIPTKSSISESDTAEMEEFIENIKMLVATLGHKVFEDKREFKPAQKQDVFY
LKGIGGADAQGEPTSDGFVVFKGSKVRSEDTNSLSNSFIKLKQKLINDNILIKNKDTFEF
PEDYIFSSPSTAAAIIMGRNANGLTEWKLSNGMTLKDFEIK
>KACEBFPM_00131 hypothetical protein
MIQSMTGFGKASLQLPTKKITVEVKSLNSKGLDLNTRMPSVYREMELSLRNQIAQQLERG
KIDFSLFIEVTGEETSTKVNAPIVKAYMNQMRAILVNADETELMKMAVRMPDALKTEREE
IDENEWTEIQKVIIKALNNILNFREAEGKSLEKEFTLRIANIRQYLQEAISLDHERIQNI
KDKLQTAITELKVNIDENRFEQELIYYLEKLDVTEERVRLNNHLDYFLETINGSEANGRK
LGFITQEMGREINTLGSKSNHAGMQKLVVMMKDELEKIKEQVLNVL
>KACEBFPM_00132 hypothetical protein
MSKRNLALIGATIVSIIYGVTFTIAKDVMPKHIDAFGFILLRVGGTTLLFWLISLFIKTE
KIDKADFPRIIAAAFFGVALNMLTFFKGLSYTSPIMGAVIMVTTPMIVLVLSAILIKERM
KTKKILGLILGLTGTLFLILYGKSMNNAPKAGLGNLLIFINAVSYGFYLIIVKKLMDKYN
DFSFVKWIYLFGLLMVLPFGYTEFQAVNWSNLPVTIFYKISFVVIFSTFLTYLLNLLSMK
ELKPTTVAVFIYLQPLFATIFAIGLGKDELNVIKIGSALLIFSGVYLVTQKNEK
>KACEBFPM_00133 Regulatory protein Spx
MNKIYYLASCDTCRKIIKGLPNANKLNYIDIRQNPISEADLEEMYQLSGSYESLFSKKAQ
LYKSMDLKNKNLTETDYKKYLLEHYTFLSRPVVMLNHEIYIGNTQPNILKLTKAMTSV
>KACEBFPM_00134 hypothetical protein
MQTTFEINQSSRNVLLQFLENHSLAQLNKVPEGFANNLIWNIGHVVTAQQMLVYKLSGLP
MMISDEMVETYKKGTKPEREITQEEVNELKKLLFSTLEQTKNDFANDIFDNYMEFTTGIG
FTVKSAKSAMEFNNYHEGLHTGIIMQIKKFI
>KACEBFPM_00135 Cystathionine beta-lyase
MKFNTKVIHGGQHHDPSTGAVMPPVYQTSTFVQTSPGQPLNPDYEYSRAANPTRSALENA
LASIENGTRGLAFSSGLAATDCVLRSFKAGDEIIAMDDLYGGTYRMFTRIYANSGIKFHF
VDMNDLENFESLINENTKLVWVETPTNPLMKIADIAEIAKITKKHKILFAVDNTFATPYL
QKPLDLGADIVMHSATKYLGGHSDVIAGALIVKDEELGSQLHFQQFATGATLGPMDSFLV
LRGIKTLHLRVQRHCENGAKVAEFLLNHSKIEKVYYPGLPSHPYHDIAKKQMIGGFGGMV
TFTFKSGKKEEAISFLEKVKVFTLAESLGGVESLANHPALMTHASIPEDKRKEIGITDDL
VRLSVGVEDAEDLIADLKQALL
>KACEBFPM_00136 hypothetical protein
MKKYILLTVLMLSGIVFAQPIEPRYEIEGNLIKTTYYYDNGHIKQIGFYKDGKVEGKWVS
FSELGEKIAQGEYNNGVKTGKWFFWNKNTLNEVDYANNKIAEVQRWSKEALVQRTN
>KACEBFPM_00137 hypothetical protein
MKKLIFSLSIIALIFTGCSSNNDDPIAIPVATAPASGTITGTIASNITYAYGNYTLVGIV
KINPGVTVTFDAGSTITCDKTVAVDNALVVLNGGKLNINGTASNPVVFTEKSQIPGKWGG
IIIYGDAPINAAGGATTSTSEDGNNIVYGGTNPAHNGGSLNYARVEYAGSQLASGVKENN
GFTFYSCGSGTKLDHLVSYKGADDGYEFFGGTVSATNLISYGNYDDAFDWQDGWQGQNNS
NWYAYQTGKGNYGMEIESSANNNAYYPVVTNITLKRAAGCRSEIDDNQVDAFQFKREGNG
SFNNIIIDGYTGLTTTATPAVTFEGAAVRIEEATTNTNQVNASKIKVTNVKVTNTNILTP
IGRSASISVSFPGTNWSTSASATGCSSLVTGSWSTVNGVNLIP
>KACEBFPM_00138 hypothetical protein
MKFSITFLLLLITTSIFAQNATVSGFVLDKDLKNEPLPFANVNIKGTLIATTTDATGKYT
IDVPTGNHEIVFSFLGYESKSVLFSITNNEKKTISQSIGSGSVTMEDVVIKSTISREKET
ALLLDQKKAVEIKQSIGSQEMSRKGVSDVEAGLTKITGISKVDSRGLFVRGLEDRYNNLL
INDLAAPTNNPFTKIIPLDLFPTDIVSIIDVYKTFNPNIYGDFAGGTFNIQTSKGAKSIT
KLNIGTSFTTNNNLNNFLISEEANNTKGFFGFNGKDRELPSIVGSTPLSHTFTTEESRKY
FKSGFNATETKSPLNTSIGFLHSEKFNLKNERNFSYLISLNFDNKYAVKSGIERTINNDL
TGYKFSNDFMATEYLYKTSATTLFGLNYNTQRIKLSLNTFYIKTTENSIKDQFGVVDRKT
DDPNHIIRTNQLTKTDYLNAQLLGEYALAKDKSQIFRTGFSFANTKYSQPDRKSFSGSLN
NNNITTFYGATNFSHQYLSIDGNKFLSGLAEYSYKFGNKEKQNKIILGYNGNTSAMESSY
RFIATQSNLTGFTTNINSIDTHINNDLIDRDVIANGPDAPYLFNIENSNATYKVKLNEFT
NAGYLNLLLKFNNKWEINGGLRVEKSNRETKFRKLGMQTAPFETRKYDKIYFLPSLNLKY
GVSDKANIRFATSKTYTKPVIMEAFPLTYLNADGTSIQGNSLLKNSDNYNADLKFEIFPT
SKEMFSLGIFTKYIKNPIERTYVSNATTATVTTFLNSDSANIYGAEAEFILDLERINKNL
SDFSLGFNATLMSTKVKVSPTYDSQDEDGNITYNIPSRETYQSRELQGASKWILNSDLKY
QFDFDKKWSNTISLVYSVFSKRIYAIGTNKQDNTYELPYQQLDFVWGSKLSDHFDVKFSA
TNLLNPSRNREFGSAGVIKINEPSLISDSYKKGIGFGLNLGYTF
>KACEBFPM_00139 Alkaline phosphatase synthesis transcriptional regulatory protein PhoP
MKKKEIRILLVDDEPDVLEIVGYNLSQEGYQIFTAENGKEAVQKAKKHNPHLIIMDVMMP
EMDGMEACEIIRKVPELNNVIITFLTARNEDYSQVAGFDAGADDYIAKPIKPKLLVSKVK
ALLRRIKEEESPKSETLIIGDIEINREEYNVIKDGVEIILPRKEFELFYLLASKPGKVFK
REEILDKVWGSEVVVGGRTIDVHIRKLREKIGDEYFKTTKGIGYKFEL
>KACEBFPM_00140 Alkaline phosphatase synthesis sensor protein PhoR
MNFNFKKTYKFAVISALYITIFAAGLFCLLDCFFMKLKTNNLILVASVLSISIYIFALFL
MQYRTEKFIYQRVKKLYEEISFLDTNSILNQPVNSDLSQITTQVQQFATNKKLEIESLND
REEFRREFLGNVSHELKTPLFTVQGYISTLLDGAMKDKIIRKKYLERAEKGVERLIYIVE
DLDTIAKLEIAEGRIEMTNFDIISLIQGVFDLLEMKANKKEIMLSFDSKYHKPIMVLGNY
EKIQQVVTNLVENSIKYGKIGGSTEIGVEEVINNKILINVKDNGEGIEKQNISRLFERFY
RVDKSGSRSEGGSGLGLAIVKHIIEAHNERIFVESKFRVGSEFSFTLQKTINQK
>KACEBFPM_00141 hypothetical protein
MKKLLLLLLIISPCLANAQEIVNDTIKKEVSIDSLKQSLDEHTMKFGDIDERLATIESDL
SKLTKIKLSGYMQVQYDMYDFQDDKGPVLGSSAQAPVTNSFHIRRARLKFAYETIEGIKF
VLQPDFAVDKVSLKDAYVVLNDRWFMQTYSLTFGQFNRINYDVEFSSGTREFLERSRMTT
TLYPNERDLGAKLEANFMTKYEIPLKLQLAIFNGNFGQGAIANQVRDVDSNKDVMARATY
SFQFPSKGLGIDIGAHGYFGSTKVLPQAVTNPVTPPAVFSDQNNNNFTPVVGTTLKKDWF
GVEAQIYYDFLGGTSLKGEYISGTISGSSNPLQTYTAFGANKVRKFDGFYLSFTKNVGKH
LQAAVRYDSFDPNSKLSGSNITRADDLKYNTWTFAWQYFYDENVKIILGYTMPINEKSDL
VAGDYATINKDKKDNIFSIRLQARF
>KACEBFPM_00142 Phosphate-binding protein PstS
MKTSNIKLAAILLVVMTIGFSFTTVNKITIKGSDTMVILAQKWAEVYMSKNPSTAIQVTG
GGSGVGLSALINGSTDIATSSRPLKQSELEKIKGRYGTLGVEIACAKDGITIYLNKANGV
SELTLKELSDIYSGKITNWNQVGGANANIKLYGRENSSGTYVYFKDNVIKKDYALTCQSL
PGTAAIVNAVKKDKNGIGYGGAAFDSGVKDCKVKKEANSPALLATEETIRNKTYPITRYL
YLYLATRPTGETKKFVDWVLSTEGQKITSQVGYFPVK
>KACEBFPM_00143 Phosphate transport system permease protein PstC 1
MKTNIPNNDFSKESLKKQFRLSEFLAEKIISSVAYTSIAIIVLIFVFVFKEALPIFNFRK
ASKAKTEISNNNNLKPETYGAETTEVLKPEVYGTETTSEPATLKPETYGDLVANEAQPTE
EIRESENQGADNTWSSFLTTEWVPVSDNPRFGLIALLLGTLKVTIIAMLFAGPLGVLAAL
YTSAFASKKAKEIIKPLIELLAAFPSVVIGFFALMILATFFQDVFGYETRLNAFVGGVAM
ALAAIPIIYTISEDALSAVPKTYTEASLALGASKWQTAFFVTLPAAIPGIFAAILLGIGR
VFGETMIALMATGNAALNTASPFESVRTFAATIGSEMAETVFGDTHYSVLFFIGSLLFIF
SFGLNALAEFYVKGKLIKKIQGK
>KACEBFPM_00144 Phosphate transport system permease protein PstA
MSTTTTEEKSLFFSRNTKSSDLKGRLIIGATLAAVILIIAVLFLIIGIIVYNGSDMFSWE
FISSFPTDGMTKGGILPAIIGTFILVIVMSLAAVPFGTITALYLTEYAAENSKFAAAVRF
SVRTLAVVPSIIFGLFGLGFFIQFIGAGIDNTFNDGQLHWGQPNILWASLTMALLTLPVI
IVSVEEALKTVPRELREASLALGATKWQTIRKVVLPESISGIMTGTILAVSRGAGEVAPI
LFTGAAYYLATLPKSVSDQFMNLGYHIYIMSTQSSDVEKTMPIQFATTLVLLMLTISLNI
VAVIIRSRIRRKKVS
>KACEBFPM_00145 Phosphate import ATP-binding protein PstB 3
MKDIKIEVNKLSLYYGEKLALNEISMQIPRNKVTALIGPSGCGKSTFLRSINRMNDLIPS
VRITGEMLVEGVNIYDKDVDVVNIRKKIGMVFQKSNPFPKSIYENIAYGPRINGIKDKTQ
LDEIVETSLRQAAIWDEVKDRLGDSAMGMSGGQQQRLCIARTLAVSPDIVLMDEPASALD
PISTSKIEELVHQLKEQYTIIIVTHNMQQAARTSDYTAFFYLGELIEIDKTKSIFTKPSK
KQTEDYITGRFG
>KACEBFPM_00146 Phosphate-specific transport system accessory protein PhoU 
MTLNFLSFLNFLNFLNFKLKNMASLLEIELAKLKTVIVKIGVLSENQIIEAMKSLLSDPN
ATTKKLKKTENKIDKLDVKIDEICQNIFALQQPVASDLRFIISAMQISSEIERIGDLAIS
VIKNSKNVKEKYDLIIKFDIASIAKNIELITKKTNECFDKQQEKTIGEIFLLNKNIRVET
QQVIENIISEMKTNSKAVGSGTNLILALKHLERIGEHCTNIAESIYFVINAKTIKHEKTK
IE
>KACEBFPM_00147 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MNKNILVAPLNWGLGHATRCIPIIRALETEGFSPILASDGVALEILRKEFPQLPSIELPS
YHIEYPKNGFFFKLKILANSPKMVLAIILEKKITTKLIKEYNISGIISDNRLGVRNKKIP
SVFITHQLNVMTGNTTWFTSKMHQYIIKKYNECWVPDINTTPNLTGKLGHLSHKIETIKY
IGPLSRLQKKTLKKKYDLMVILSGPEPQRTFLEEKLIIELEHYKGNIIFIKGKIEAIQII
EKKDQITFYNYMNSQELENSFNESDLILCRSGYTTVMDLAQLEKKAFFIPTPGQYEQEYL
AKKYKKEGLVPYCNQEKFKTEKLLEVNFYKGLKDFKTQINWKSLFDIF
>KACEBFPM_00148 UDP-2,3-diacylglucosamine hydrolase
MEKRKLEIVVISDVHLGTYGCHAKELLNYLSSIKPKILILNGDIIDIWQFRKSYFPKNHL
KVIQKIISLSTKGTKVYYLTGNHDEFLRKFTDLHLGNISLLNKLTLELDGKKAWIFHGDV
FDASINHAKWLAKLGAWGYDSLILINRFLNWCLARMNKEPYSLSKKIKDNVKSAVKFITN
FEKICIDLAIEKNYDYVICGHIHEPKIELFENAHGKTTYLNSGDWIENLTSLEYNHKKWK
LYKHITTENFQENDLDFEYETKLAEQFISVLRK
>KACEBFPM_00149 tRNA (guanine-N(7)-)-methyltransferase
MGSKNKLKRFGENEAFGNVFQPTREEVVSNSFGLRGKWKQDFFKNDNPIVLELGCGKGEY
SVGLATKFPNKNFVGIDIKGARFWRGAKTAVETGLHNVAFVRTQIELINHIFAENEVDEI
WITFPDPQIKYKRTKHRMTNSEFLQLYKKILKPDGIMNLKTDSEFMHGYTLGLLHGEGHQ
VLYANHNVYTNEGSPEEVTEIQTFYEKQYLAINKSITYIRFKIK
>KACEBFPM_00150 hypothetical protein
MSIITPLFLGFITSLVGVFPPGLINMTAAKISTQDGKNRALLFTAGALVVVFFQTLVALI
FARYIAKHQEIVILLREIGFGIFAILTIYFLWIAKEPQKKEQKEFKIKSKKSRFFLGMFI
SVINFLPIPYYVFASVGLASFGCFTFNINSICSFVVGVVFGSLLVFYSYISFFKKIEAKT
DFLVKNMNTIIGSITGFIAILALYHILKYYFKL
>KACEBFPM_00151 Methylated-DNA--protein-cysteine methyltransferase
MSATGDNFFERVYVLVRQIPCGKVTSYGAIARVLGTARSARMVGWAMNAAHNINDVPAHR
VVNRKGLLTGKHHFEGANMMQQLLENEGIVIIDNQIQDFDAVFWEPIMAK
>KACEBFPM_00152 hypothetical protein
MRILTFKRSFYGIAFLMFLPFNSFSQEMKNSVLQDPRFEQLLNEKRKLNGSITINDRFKI
QIFTGESVTSKKALTDFRKENKNIDATIVFSTPIYKVWVGNYKTRIEAENKLRALKKKYP
NAFLVKPNK
>KACEBFPM_00153 Menaquinone reductase, multiheme cytochrome c subunit
MKKVGNHKSISRIIALSLALVMSVSLNSFAQTAAPVVDATTAPAAGGDAVQGKALFNSNC
AACHKLDAKMTGPALRGVTAKHDKKWFYGWIKNSSALIASGDADAVKVFNENNKAVMTAF
PQLSNADIDNILAYTDTEIEKPAVLTPTAGAEGASSEGGISNNLILGLLTGILAVLVAML
FMVNNVLGKIAKANGIEVAAKEKTLPIWKAFAKNQFLVLVSVVLLMLVSAFFVYGYLSQI
GVDKDYAPIQPIHYSHKIHAGDNGIECKYCHSSARVSKNAGIPSLNVCMNCHKNISEFQG
DKDSTYVEYTKEYYTGEIQKLYDAVGWDKTSQKYTGKTKPVKWIRIHNLPDFVYFNHSQH
VTVAGIECQKCHGPVQTYEIQKQFAPLTMGWCINCHRATDVKVEGNDYYKKIHTELSKKY
GVDKLTAAQMGGLECGKCHY
>KACEBFPM_00154 Cytosol non-specific dipeptidase
MSQEIRNLEPKDLWNKFADLNAVPRPSKKEDKVIEFMKEFGNSLGLETFEDEIRNVIIRK
PATAGMENRKALVLQGHLDMVHQKNGDTIFDFDTQGIDMYADGDWVRARGTTLGADNGLG
VAMIMAILESKTIKHPAIEALFTIDEETGMTGALNLKGGILRGDILLNMDTEEDDEIDIG
CAGGIDVTATRSYNEEETPESSVGYLITVKGLNGGHSGMDIHKGLGNANKIMNRLLFDGF
ENFGLQVAEINGGSLRNAIPRESVAKVIVAGMYDEAFVFDMQEIITDIKTEFKTTEPNLT
IEIVKSDLPSKVMDLGVQEGIIRSIYAAHNGVYRMSADMEDLVETSNNVARVIIKEGEIT
IGCLTRSSVETSKFDLANALRSAFELCGCEVNLAGSYPGWTPNVKSEILDVLVSIYEKQN
SEKPKVVACHAGLECGILGTNYPDMDMISFGPTIHGAHSPDERASIKSSQKFYKFVLEIL
ENIPVKN
>KACEBFPM_00155 hypothetical protein
MKKYILIVTSVFLLLSCKKDNQKITTTEEKTPKEQVGGKSELLEGELSIGFEVSSFRPCN
EKLDYWIDDSTSRMDSLYTNIVRENNLGKYKAVYCKLKVYKLPKATDGFASDYDGLMNVD
EIIEMSAITPKNKCK
>KACEBFPM_00156 hypothetical protein
MKKLILPAIALALSILGCSSDEQNVYSKPLPDQNLATQAPVTQTTVGNTTVLPELSDTEM
GRLSWASLKPNPEIFYKSVDIEELTTNKAKFTIDFLKQFITIQSLSLSSSISHVFNEEDL
RYVVIHDFNYDRRNNKITFKTSYKGIISTLESVITFDSNVYYRYQITINTDYVSKHYMRG
LYEDIGGATDNLLMYDHDKYSIEYAVDSRFKNDYSDYLRFSFDVTDKRRNKVVARLSSDD
IRGFKKLDLIGTEMKVFWTPSLVEVVREKIATLRNLNPNDLDLTNRLAGIFINNKWMMRT
RIEVNDNQLTWRDDYLSGRGLRHDIYLKSPRFVLESAIRNGNDLKFRIRFMQANEVVITD
AYFEFVLQNVM
>KACEBFPM_00157 DNA polymerase III subunit alpha
MSAVAMTDHANLMGAFHFVRDVLNQNKTAARKNATAIENGEEATEVEMKPIVGCEFFVCD
NHKDKSKKDNGYQVVFLAKNKKGYHNLAKMSSIAYTEGFYYVPRIDRNVIEQYKEDIIVL
SGNLYGEIPSKILNLGENQAEEALLWWKSKFKDDFYLELMRHNQEDENRVNQTLISFANK
HEVKLIATNNTFYISKDDANAHDILLCVKEGEKQATPIGRGRGYRFGLPNQEYYFKSGEE
MKQLFSDLPDAIVNIQEIVDKIEIYSLYRDVLLPKFEIPTEFLVPEDQTDGGVRGENKYL
HHLTYQGAKRRYAEITPEIEERIDFELLTIQNSGYPGYFLIVQDFIAEARKMDVSVGPGR
GSAAGSVVAYCLGITNIDPLLYNLLFERFLNPDRVSLPDIDIDFDDEGRSKVMDYVIEKY
GKKQVAQIITYGTMAAKSAIRDTARVLDLPLFEADKIAKLLPGMLPGKWNLARFMNDTEV
EIKKVLRPEDFDRMKELILLSKEEDLGGETIQQAQILEGNLRNTGIHACGVIITPSDITN
FVPVTTAKDSDLYVTQFDNSVAESAGLLKMDFLGLKTLTLIKDTVKLVKYRTGIQLDPDT
FPIDDVKTYELFQRGETVGIFQYESAGMQKYMKELKPTVFNDLIAMNALYRPGPIAYIPS
FIKRKNGEEPIEYDLEACEELLKDTYGITVYQEQVMLLSQRLADFSKGDADVLRKAMGKK
QRDVLDKMKPKFVSQAVAKGHAEDKLEKIWKDWEAFAEYAFNKSHSTCYAWIAYQTAYLK
ANYPAEYMAAVLSNNMSDIKQVSFFMEECKRMGLAVLGPDVNESFYKFTVNDDYAVRFGI
GAVKGVGMGAVNTIVENRKDGSYKSIFDLAKRVDQRAANKKAIENLILAGGFDCFENTHR
AQYFHTDGDNLTFYEKAIRFGAKFQENENSSQVSLFGDTSDVQISEPLIPPCEEWNTMEK
LAKEKEVVGIYISGHPLDDYKFEMKYFCNNKLESLKNLEQFVGKNLAFGGIVTNVQHRTA
KNGKGWATFVLEGYDENNEFRIFNEEYLKFRHFLVQNQFVYIRVNIKDGWVNRDTGKKSD
PQINFLQVESIQDVLRIFAKKLVIHLDINVLQEELVSQLITIFDANKGDNTVSFDILELE
RIKKQIEAVPLEANDIEVALDENGDIQESENPEPTITTEVEETKIINKISMNSRKLKIKI
SNELLNELEGLQINFKLN
>KACEBFPM_00158 Microcin C7 self-immunity protein MccF
MKTLIKPKALKPGDKVATISLSWGGAGEFPYRYQTGKKQLEDNFKVEVIETKNALKSADW
LNKNPQARADDLMEAFSDNSIKAIITNIGGEDSVRILPYLDLSIITKNPKIFLGFSDSTI
THLTCYKAGLSSFYGTSILVGFAENGGMLQYQIDDIKKTLFSSEPIGQILPNSNGWTSER
LEWTDKSLANKKRELTPNNGWNFLQGKTKVQGKLIGGCLEVLEFLKSTEYWFQPSDWEDS
ILFLETSEVMMPPMNFKWIIWNYAAQGVFHKIKAVILGRPYNNQFTKEYNKILLQIIRDE
LQLTELPIVTEMNFGHTSPTFTIPYGLNAEINCKEKSFSIIENGVID
>KACEBFPM_00159 Inorganic pyrophosphatase
MTTDKIETFDVLVEIPRGSRNKYEYDFDLKRMRFDRMLFSSMMYPADYGFIPETLALDGD
PLDVLVLLTKPTFPGCVIEVKPIGIFNMADDKGQDEKIICVPVSDPIWNSLNDLSDINAH
LVKEIEHFFQVYKDLENKKVEVKGWGDVKEAKEIIAQCVARFQAIENKPAGLFSIK
>KACEBFPM_00160 hypothetical protein
MKKIFIIFGFLLSISNVAQTKVSGVVYDDTNATVPYANLCFKGTRECVTSDENGRFYLES
ESDRKILSISFVGFKTKEIILTKAVNYDMKISFSGANTLDEVKIFSGKTSKKNNPALDIL
RKIWERKRKNGLRQFNQYQMNKYEKVEFDMNTIDSAFMKNIVFKGMEFIFKQVDTSKITG
KTYLPVFINESLSEVYGDNTNGKTKEVLKANKNSGLGTGNGVDTFIKDLYPQYDIYNNYL
SFFDKNFVSPLSKTGINTYNYVLSDSAFVDKKWCYNIVFYPRRKNELTFKGDFWVNDTTF
AIKKINLTASKSANVNWVKEIYIEQEFDVLNDSVFLLKRDYMMSDFALNKKESSKGVYGK
RTTLYSDHKFNEVKSDKFYKEDVNNFDQSIFTKSDEFWQENRAESLNKDEAGIYKMLDTL
KTVRKFKQMYTLAGILGTGYVLNGKIDYGPIFSFIGYNDVEGLRLRVGGRTYFSPNDKWR
LQGYTAYGFKDDKVKYGFSGKWMVDPKSRLILSAGNRRDIEQIGVSLTTSNDIMGRSFAS
SSIFAGGDRSKLTNVNLTSIGAGFEPYKNLIFKAGLSYRTLASASSKFSLDFYKTLPSTL
NPNGIKQSEVRQSEIEIGVDYMPGRKVVGYGVEQLQVDKNYPRIYINYNQGFKGILNSDF
EYKKLQLYYRQPILIAGMGRLLTTFEVGKIFGGVPLGLIAVIPGNQSYFIIENTYSQLNY
YELVTDQYASLHLEHDFNGRLFSRIPYLKKLNLREIIGIKSIYGSVSDQNIALNASGFKY
QAPTNGYWEYHAGIGNIFKVFRLDFAWRGSYENLPEANKFSIKGSFGFYF
>KACEBFPM_00161 Pyruvate dehydrogenase E1 component subunit beta
MRTIQFREAICEAMSEEMRRDESVYLMGEEVAEYNGAYKASKGMLDEFGAKRVIDTPIAE
LGFAGIAVGSAMNGCRPIVEYMTFNFSLVGIDQIINNAAKMRQMSAGQFPMPMVFRGPTA
SAGQLGATHSQAFENWFANTPGLKVVVPSTVYDAKGLLKAAIRDNDPVIFMESEQMYGDK
GEVPEGDYIIPLGVADIKRAGTDVTIVSFGKIIKEAHIAADELAKEGISCEIIDLRTVRP
MDYETILTSVKKTNRLVVLEEAWPFASVASEITYIVQERAFDFLDAPIQRITTADTPAPY
SPTLLKEWLPNAQDVVKAVKKVMYK
>KACEBFPM_00162 Electron transfer flavoprotein subunit beta
MKILVCISHVPDTTSKINFTNGDSEFDTNGVQFVINPNDEFGLTRAIWFQEQQGANVTVV
NVGGPDTEPTLRKALAIGANEAIRINANPTDGFFVAKQLAEVIKNGGYDLVIAGKESLDY
NGGMVPGMIAGILDMNFVNSCTELTIDGTTAKASREIDGGKEIVSTTLPLIVGGQKGLVE
EKDLRIPNMRGIMTARTKALTILEPISATSETKAVKFEKPAAKSAVKLINADNLDELINL
LHNEAKVI
>KACEBFPM_00163 Caffeyl-CoA reductase-Etf complex subunit CarE
MSILIYAESAEGKFKKVAFELASYAKKIAETTGQTVTAITVNMNDVSELSNYGIDKVLKV
TNDKLANFTAKAYADTIKQAAQKENAKLILLSSSTDSLYLAPLVSVSLEAGFASNVVGLP
TNMSPFQVKRTAFSNKAFNITQINTDIKVLCLSKNSYGIFENTGAATAEDFAPTISDADF
SVQVQSVEKGSGKVTIADADVVVSGGRGLKGPENWAMIEDLAAVLGAATACSKPVSDLGW
RPHSEHVGQTGKPVATNLYIAVGISGAIQHIAGINSSKVKVVINTDPEAPFFKVADYGIV
GDAFEILPRLTEKLKAFKAQNS
>KACEBFPM_00164 hypothetical protein
MSLVKLTIKGISYSQTQNGAYALILNEVDGDRKLPIVIGAFEAQSIAIALEKEIKPPRPL
THDLFKTFAERFDIIIKQVIIHKLVDGVFYSSMICERDKIEEIIDARTSDAIALALRFNA
PIFTYKNILDKAGIFLKINPDSDSPEHDLDSVLSASEPFSQESNDSKNLFTKYSLSELQE
ILEAAVNDEDYEKAAKIRDEISKREI
>KACEBFPM_00165 Thymidylate synthase
MKQYLDLVKHVLNNGTQKGDRTGTGTKSVFGYQMRFNLAEGFPMVTTKKLHLKSIIHELL
WFLKGETNIAYLQQNGVKIWDDWADENGELGPVYGHQWRNWNNEEIDQITELIETLKTNP
NSRRMLVSAWNPSVLPDTTKSFAENVANAKVALPPCHAFFQFYVSEGKLSCQLYQRSADI
FLGVPFNIASYALFTMMIAQVCDLQAGEFIHTFGDAHIYNNHFEQVALQLSREPKPLPKM
ILNPAVKNIFAFKFEDFTLEGYESHAHIKGAVAV
>KACEBFPM_00166 hypothetical protein
MEQNTTTLDIRAINEKIERESAFIDLLTMEMNKVIVGQKHMIERLLIGLLGQGHILLEGV
PGLAKTLAINTLSQAIQGSFSRIQFTPDLLPADVVGTMIYNIKANEFSIKKGPIFANFVL
ADEINRAPAKVQSALLEAMQEKQVTIGDTTFKLERPFLVLATQNPIEQEGTYPLPEAQVD
RFMLKTVIDYPKMEDERMVIRQNLNGGFAKVNPVVSVEQIIRAQEAVREVYMDEKIEKYI
LDIIFATRYPEKYKLESLKPLIGFGASPRGSINLAMAAKCYAFIKRRGYVIPEDVRAVVH
DVLRHRIGITYEAEAENVTSVDIINKIVNEIEVP
>KACEBFPM_00167 hypothetical protein
MVKTYLKDSILRMIYDTICLFLRIEKKHTVLINKRLLIKNLLAHNDECSFYDKKRQLNLH
SREGKAKFLKHICALSNSNPSNNSYIVVGVEDDDNEIVGDDFFDDSRIQNLVNAFLENPP
KIQYENVPFPNLPKDKVVGLVTIKPNNKVSFFRKGIHTIVANSTFKRVGSNTIPAEGKIP
FSKENTEAVISIENNSRNSIGYTLEGVLDFINIRHKDMFSNYKVFKELFVVCWSGNKKKI
KNQTYFSRVDIELINEQIKLFYSAQDEVSITFDDNCFVITEYISIGLNDKTSYYPLEKVT
ITFFDNGYYKITNKILFEPPEFNRKMLYHIYNSNLSLISKLENRFALTEKENKDLENLPS
TLMICYLNGFNEAKQKLIDAKCLLKPYPTIYLSFKEALRVLRKMKYDKNYE
>KACEBFPM_00168 Serine/threonine-protein phosphatase 1
MTKITNRTLVIGDIHGGLKALIQVLDRAKVTKTDVLIFLGDYVDGWSESPQVLDFLISLQ
ETNHCVFLRGNHDELLLDWLARKTENINLELWYKSGGEATVLAYQTVSERKKQKHILFLK
SLQNYYLDSDNRLFVHAGFTNANGVHHEYFPKILYWDRTLWETALALNEGLETTHKYYPK
RFVLYKEIYIGHTAVTKIEETTPINKANIWNIDTGAAFLGPLTIFDINTKQFWQSDHLPC
LYSNEKGRN
>KACEBFPM_00169 hypothetical protein
MKKIMTLLLVLSASIANAQAYKGKGDIKAQVGANIQTGTQGIFASGDYGIGENISIGLSA
NYSLSANQEYFNYLTLSSESPAFLDRVDLKARFNANIGNVLGLDKKMDVYPGLDLGTRNF
GIHAGFRYFFTDGFGVFGEAGLPLAKYSTNASVFSNYNNQFAFNVGASFNL
>KACEBFPM_00170 hypothetical protein
MTPIEKKLYDRSGSKCELCGSADDLRIHLTKEEAISVDNSVLVCTTCKNQVENTTTTDPN
HWRCLSDSMWNENKPVQVVAWRMLNRLRPEGWSQDLLDMMYLDEETLVWAAATGEGEDEE
GKIIHKDGNGNILKDGDSVVLIKDLDVKGATFTAKRGAAVHNIKLVWDNADQIEGRVEGQ
HIVILTQYVKKTK
>KACEBFPM_00171 Glycerol-3-phosphate dehydrogenase [NAD(P)+]
MTTKPKFAVIGGGSWATAITKMLCVNLNEVAWYMRNEDAVNHIKTYKHNPNYLTGVQFDT
TKLRLTTNINEAIAYADYIIFAIPSAFLSNELEKMTENLDGKIIFSAIKGIVPETSLIVG
EHFNKTYNIPFDNIGVITGPCHAEEVALERLSYLTIACGDAKKAKIVANCLSGHFIKAKI
SDDIIGTEYAAMLKNIYAIAAGIAHGLGYGDNFQSVLMSNGIREMKKFIKKVHKMKRNIN
DSAYLGDLLVTGYSVFSRNRMFGNMIGKGYTVKSAQMEMSMVAEGYYATKSAWKLNQNYK
AKTPIINAVYEILYEGKNAKKVFEKLTDKLD
>KACEBFPM_00172 Alcohol dehydrogenase YqhD
MLNFELYNPTNYIFGKDQIEKLSTLVPKNAKILLAYGGGSIFKNGIHEQVIKNLKGFDVI
EFGGIEPNPRFETLMTAVEIIRKEKINFILAVGGGSVIDGVKFISGATNFEGNPIDILKN
RVLFTDLSKVIPFGTVLTLPATGSEMNSGAVVTIEATQEKLVLGGSALFPKFSICDPTVI
ASLPKRQLENGVVDAFTHVMEQYLTYPHDAILQDRIAESILQTLVEIGPNVVKNPTDYKL
ASNFMWCATMALNGLIQKGVPSDWATHMIGHELTALYGIDHARTLAVIAPSLYKAMFETK
KDKLAQYGERIFNITGNSTEEKAAKAIEKTVDFFHKMGMQTKLSEYTEDYKKSADFIVNR
FETRGWKALGEKQNITLQKVKEIVEGSY
>KACEBFPM_00173 Nicotinate-nucleotide adenylyltransferase
MKIGLYFGTFNPIHIGHLIIANHMAENSDLDQVWMVVTPHNPLKKKDTLLDDYQRLHLVN
LATEDYPKLKPSDIEFKLPQPNYTVNTLAHLQDKFPSYEFSLIMGEDNLNSLHKWKNYEA
ILQNHQIYVYPRLNTDTIDNQFINHQKIHIIKAPIVEISSTFIRENIKNKKNIQPLLPPK
VWEYIDHSNFYKK
>KACEBFPM_00174 Vitamin B12 transporter BtuB
MKKWFLATFLITVSSVFGQGKITGFVYDENGPLPGASILIEGDTNAISASFDGSFTINSA
SKNGKIEISFLGYKTKKVTYSFAQGEKMNLGNIILSNDSNLLGEVVIKSTVIDLAKDRKT
PVAVSTIKGAEIREKLGSQEFPEILANTPSVYVTKAGGGFGDSRINIRGFDQKNIAVMVN
GVPVNDMESGAVYWSNWSGLSDVTSALQVQRGLGSSKLAISSVGGTINVITRTADMKEGG
TVSAMLGNNDYLKTLASYSTGKMKNGLSASVLFCNTQGSGYVNGTKFSEQNYFIGLGYEF
NEKHNIQFTFTGAPQWHNQRSTSPTIAKFIKYGKNGEPNIHYNSDYGYLNGEEYSFKTNY
YHKPVASFNYDFKINDKTKLSTILYGSWGRGGGSNGAGAIRGNTFNADNLRNSDGTINVN
LIQAWNSGSPVSITPSTGGLPITTPRTQTGGAYQNDLTTTNNGANGISKISSINSHDWYG
GVINLSRKLTDKLTLDFGIDARTYKGFHYTNLNDLLGATNYKDVANINNTNGLGVTQPRL
LSEVYDTKSNWNPFFNSNNQERINFNNDGIVKWLGAFTQLEYSTEKITAFIQGAVSQQGF
KRVDYFKYKTSDPLSATANEKILGGNVKGGVNYNLNEKMNVFVNAGYYSKQPFFNAVYPN
NASLVNGNLVNEKIIGFEAGYGFKSSKFNANLNVYHTTWKDRYQRQNDTTDPLNVGGYYD
FSGITEVHSGAELEMNAKPLAKLGLNAMVSVGNWVYKGNSLSNRYDNANNSIGGGTPTTL
YLDGLKVGDAAQMTASIGANYEVAKGLKVDANYRLSDKLYAGISPNNFKNQINKGSLELP
NYGLMDAGITYKINRIKDSKDSFTLRVNVNNVLDKIYISESRTNQFTATEAEFNSPTTGS
DGLVDPTKTVTATNALKGTGNGQYTSYQDYQNRGVYNGVDVRNQVYFGFGRTWNFGISYN
F
>KACEBFPM_00175 Glucose-6-phosphate isomerase
MPLQNTNPTTTEAWQKLEKHFLETKNISMQEMFQEDNNRAEKFHIKWEDFLVEYSKNKIN
QTTINLLLDLANQVGLKDAIESYFSGKKINTTEDRSVLHTALRAHKNDTILVDGKNIIPE
IYEVKDKMKLFSEAIISGKRTGYSGKTFTDIVNIGIGGSDLGPTMVVEALQFYKNHLKTH
FVSNIDGDHVTEIIKKLNPETTLFVIVSKTFTTQETLTNSETIKEWFLKSANNEDIAKHF
VAVSTNIKNATDFGIDQDNIFPMWNWVGGRFSLWSSVGLTISLAIGFDNFDKLLAGANKM
DNHFRNTTFDKNIPVILALLSIWYNNFFGSESEAVIPYTQYLQKFVPYLQQGTMESNGKS
IDRNGNRINYQTGTIIWGEPGTNCQHAFLQLIHQGTKLIPTDFIGFTKPLHGNKEHHDML
MSNFFAQTEALLYGKTEAQVRLELEKQSISEEKTDFLIPFKVFEGNKPTNTILIKALTPE
NLGSLIAMYEHKIFTQGIIWNIFSYDQWGVELGKQLANSILEEINTKNVKNHDVSTNFLI
NFFTHNS
>KACEBFPM_00176 General stress protein CTC
MKSITIKGSERESVGKVATKALRNAGAVPCVLYGGDQPVHFSADERAFKSLVYTPNAHTV
VIEVEGGKSYNAVMQDIQVHPVTDKILHLDFYQLFEDKEVTMEVPVRIIGTSPGVLLGGV
LRLNSRKLKVKALPANLPDFLDADISPLEMGNKIYVTALANEKYKILHPENTVVCQVRIS
RAAMKAAQEAAKAAKAPAGKKKK
>KACEBFPM_00177 Ribose-phosphate pyrophosphokinase
MPHLEPEAKVFACSQSVYLAEKIAASYGTTLGKVTFSQYSDGEFQPSYEESIRGLRVFIV
CSTFPSADNLMELLLMIDAAKRASARHITAVIPYFGWARQDRKDKPRVPIGAKLVAKLLE
TAGATRIMTMDLHADQIQGFFEKPVDHLFASTIFLPYVESLGLENLTIASPDMGGSKRAY
AYSKFLGSDVVICYKQRKIANVIDTMELIGEVKGRHVILVDDMIDTGGTLAKAADLMIEK
GALSVRAICTHAILSGEAYEKIENSKLLELIVTDSIPLKKASKKIRVVSCAPLFAEVMNM
VHHNNSISGKFLM
>KACEBFPM_00180 N-formyl-4-amino-5-aminomethyl-2-methylpyrimidine deformylase
MNTIKKYVQENKQRFIDELIELLKIPSVSADAAYSKDVIKTSEAVKISLEKAGCHFVEIC
ETPGYPIVFGEHIIDKNLPTVLVYGHYDVQPADPIELWTSPPFEPVIKITDIHPEGAIFA
RGSCDDKGQMYMHVKAFEYMIANNNLPCNVKFMIEGEEEVGSKSLSWFVEQNQEKLSCDV
ILISDTGMISNQQPSITTGLRGLSYVEVQVTGPNRDLHSGLYGGAVANPINVLAKMIASL
HDENNHITIPGFYDNVEELSLEERAEMAKAPFNLDNYKKALNLNDIYGEKGYLTNERNSI
RPTLDVNGIWGGYTGEGAKTVIASQAFAKISMRLVPNQDWEVITNLFAKHFESIAPAGVT
VKVKPHHGGQGYVTPIDSIGYKAANMAYTETFGVPAIPVRSGGSIPIVALFEKELKSKTI
LMGFGLDSDAIHSPNEHFGIFNYLKGIETIPLFYKYFVELSK
>KACEBFPM_00181 Ribosomal RNA small subunit methyltransferase A
MSKKKFISEVFKSGGTIGALSPSSSFLAKKMLKPIHFDTANCIVEFGAGTGIFTHKLLEK
MNPNALLLAFEINTAFYEELIKIKDKRLVVINDSAEKIEHYLKVNHKEKADYIISSLPFA
MIPDEVVEGILKNSFKVLSEKGKYIQFQYSLNALSKLKSLYRKVKINFTFLNLPPAFVFD
CGK
>KACEBFPM_00182 hypothetical protein
MLKRFFILCSGSDRDLLSTCSEGEQTKYAGIGATVFFTAIMAFLASSYALFTVFDDVFAA
SFFGFIWGLLIFNLDRFIVSTIRKRDQLKNEFLQAMPRIVLAIIIAIVISKPLEIKIFEK
EINTVLLKEKNQLAMANKKQVSDYFKSDLDKNKSEIDSLKSQISKKEKEVNAYYQTYIAE
AEGTAGTKKLGKGPVFKEKIAKHDLAKKELDTLQKHNLVKIAEKEKKSKTLQTDLDKKIT
ETQPIIDSFDGLMARINALGKLPSLPSFFIMLLFLAIETSPIIAKLLSPKGEYDYKLADN
DTALKAHIEQNDYQRKLQIQTDASIYDKIYADIKDEKALYEYKKKGAIELLRLQSDSYIE
KQKKIM
>KACEBFPM_00183 Xaa-Pro aminopeptidase
MKYHQIDSQLFIKNRAKFIAQMKPNSVAIFNSNDIYPVSADSTLPFAQHRDIFYLSGVDQ
EESVLLLFPDAPYEHLKQILFLKETSEHIAIWEGEKLTKDRAFEVSGIKSVIWLQDFHKT
LKEIMAYAETMYINTNEHYRATIETETRESRFIKWWKENYPAHKVEKSNPILQRIRSIKE
SEELDLMQEACNITEKGFRRLLSFVKPNVMEYEIEAELMHEFLRNRSKGFAYTPIIASGN
NGNVLHYIENNQPCKEGDLILLDVGAEYANYSSDMTRMIPVSGRFTNRQKAVYNAVLNVK
NEATKMLTPGTLWKPYQVEVGKIMTSELLGLGLLDKADVQNENPEWPAYKKYFMHGTSHH
MGLDTHDYGLLHEPMKANMVFTVEPGIYIPAEGFGIRLEDDLIIQEKGEPFNLMKNIPIE
VEEIESLMNS
>KACEBFPM_00184 hypothetical protein
MNNLRIIFLSIYLKIKTAYIAVNRFKTYDKNYEFIKLSISSTSIGIFFIKLKGSPFS
>KACEBFPM_00185 2-hydroxy-6-oxononadienedioate/2-hydroxy-6-oxononatrienedioate hydrolase
MMNNLRYKNTKISYSDVGKGIAIVLLHGFLENSTMWDSYISSFAANYRIITIDLLGHGKS
ECLGYVHTMEDQADMVYSVLQHLKIKKSIFVGHSMGGYIALAFAELYPENTNGFVLLNST
TYADDHERKINRNRAIKMAHKEYASLVQISIANLFSINNRENLISEINQVKTEALKTPLQ
GYIAAQEGMKLRKNKEHLLHLTTYPKLLILGKKDGVLNYEENIKQIEGTNVQLVFFPDGH
MSHIENRDQLEKILFDFFKKY
>KACEBFPM_00186 hypothetical protein
MTNNTFLENLVSKLLSEKNTILSETTIILPNKRAKIFLLEAFKKKLPHFTFAPEITSIED
FIQEIANIRSIDSIELLFEFYTVYLSVTAKEKQQTFEQFSNWGKTLLQDFNEIDRYLLDP
KHVFSYLQDIEVIKRWGIEIEDKTTLIDNYLEFWKLLPLYYDTFYTHLKNKEIGYQGLIY
REAVTNLEEFITAFKNKKIVFAGFNALNQAEEKIVQQLIAKDIASIYWDIDAVFLNDYSH
DAGLFVRRFKSSWSHYKTNPFEWVSTNFSEDKNIQIIGTAKAIGQAKIVSGIINKQISDN
PNASLDKVALVLGDENMLIPMLHSLPASVGSLNITMGYSSKNNPIQLLIAKLFKMHNNAL
NRSESSYVFYYKDVLDVLSNPIIESYVNASKVIYTIKKNNYTFITHQKVVSFQENPNRLF
ELLFQKWNQKPIEILELICEILLIIKSNLESISEEDKVVKTFLYSIYKVINKLITYCSKN
EYIENIDTLHTIYKQVIDLAEVSFEGEPLSGLQIMGVLESRVLDFETVIITSLNEGKFPA
GKTVNSFIPYDVKRELGLPTYKEKDAIYTYHFYHLLQRAKNIYLLYNTESDGLDGGEKSR
FITQLEVEKQPKHNLTHEIIQPVVPNIASKTIVIPKAKSAMIRLKEIATGKGFSPSALTT
YIRNPIQFYFQRILSIRESEEVEENIALNTLGTIIHQTLEALYKPIINKFLTTDDLNKML
AVANDEVLKQFKEIYKEGEVKKGKNLLAFEVAKRNVFNFLIEEKKQIENGDVVKILALET
PLERILEDNSLPFPIKIAGNVDRIEIRNNKIRIIDYKTGKVEKNSVQLKDWNGLTLDIKN
DKIIQLLCYAFMYEKQANGLEIEAGIISFKNMKGGFLPFGIKQGKEILININSEILEHFK
TEIIILINEILNIEIPFEEKTI
>KACEBFPM_00187 Outer membrane porin F
MKDKCPKVAGPRDNGGCPWPDTDGDSVLDKDDKCPTVKGTVANNGCPEVSEEAIKKLNDY
AKTILFDNAKFTFQKQTLPILDAMVAILNEFPTSKFSIEGNTDNSGKKATNQTLSENRAK
AVADFLISKGISSDRLTSIGYGDSMPIASNKTKAGKAQNRRVEVKVVK
>KACEBFPM_00188 hypothetical protein
MITNAFIKIWDEIVGAVSWNLETGIASFEYEPKFISKNWDLAPLKMPLASSNRRVFSFPE
LKNIKTFKGLPGLLADVLPDDYGNQLINNWLAQNGRPENSMNPVEMLCFIGTRGMGALEF
EPSQFKANKRAFDIEVDNLVNISQKMLQKREGFETNLNKDEQQAMIDILKIGTSAGGARP
KAIIAYNEKTGLVKSGQTNAPKGFEHWLIKLDTVSDIQFGESTGYGRIEMAYYLMAKACE
IDMMECRLMEENGRAHFMTKRFDRQDGETKHHIQTLCAMQHYDFNQITSFSYEQLFQTMR
LLKLPYPQAEQLFRRMAFNVIARNCDDHTKNFAFKLKQNESWELTPAYDVCFAYRPESTW
VSQHNLSINGKRKDFTKEDLLQVAKSMNIRKANQIIQQINDVVSKWATFADEAKVKNDFM
EQISKSHLFL
>KACEBFPM_00189 hypothetical protein
MNDKQYINWVASSDVALAQTIGAFIKHHRLVQNKTQEEVANAANISRSTLSLLEKGETIT
VPTLLQVLRVLDLLYIINVFKIEEQISPIELAKMDQQKRQRARNNDSDNSKKSDW
>KACEBFPM_00190 Cold shock-like protein CspLA
MKQSLGLVKWFDNDKGFGRIGSVNGDDVFLHIDQFIVKPEKVLKLKALFFEIENNNKGNK
ATNLSNPDTYEHFLYIMSLLESNPKVNIEFTIKGKSRWGNEFIKKEYRDCSIFDSALYQL
VRNKDAETIYNYFTNYFDENHWNSIEKIKKLFNVTREVIKDLKVTNTFVDAADDNLQAFI
SNSELIKKIFHHFLSKIQEEFLFELWKNDDYHLVKTSYSVDKNNSNYFNFPDVIFLDNYK
VIDSYCLKKIIALENKESICSKIISNQINDYLIFNKTETLKIAESINYLIESEIFSELYE
NLISRNIELIITNETDSKDELSRFKEFLTVIGNYQWKYSKLKVIDLVNSKILNDIIFYFW
KETRYFVPCNEFILKNINKLTRNDFLNTSLEFRNEFLLSEFQKSNYDNSLSSFCNVIFLV
FEISKCEIQVIENEFLESYKVAIWLYNSYFNKSNHYQIANNPFETSFKNEHFIQYLVKVE
NLSEIITLVKIICEIDKLYRSHTIPENATGLFKFTSIDRTKIIDEVCSKQDFSIEITELI
ILKNFLEENANENNQEISKYFLPNFINPEEDLVFNELLEFSDFFENNIVHKNNFYTHISE
LVSFPKVVTLWYNNYINTIDLYQALEFLHTFDDEDQFSFLKKIFSLIHLKKALISAELFN
KFENLASNPSINLDARIALYVVITLKSESKFINDKTIFDLVSQRLNENVYELIKIDELID
KCGGRVWKAFSYNADENEEWLISINGHEFLVNEDLISINGKSYSINKENKSICINGVYYN
FKWVKRKNVFHTENYGVPDGLTFCDAVKSQLDESLKSNFYWCCNSKCYSPCQKDYNPFQW
EKYTLRDFIKILSIPFDNDLYYRFVSVVNRVNRLLEKLKCNSCNKLMRDAATSEFAFYRV
NTFQCTDSNCSEFHKTVYLTHCLNWRCLNIIDTRVSKACSNGWYICDKCDNCCSQEKIDM
RYQNLLTNAAFNPNNSRHQKLKFQVDNKLGHLERNEVYSFRTGEKK
>KACEBFPM_00191 hypothetical protein
MEDFNELEWINQFFNNAVDLQQNEGLERIKNFALFWNMFENFACENFANVQKIGALVNEL
NDRTPITSELVHPYLEYFVERYTQNGTLNIEGLSFRNRQDDISAKEKVVAVLSRQVATPR
EILEALLLILLRFRNNLFHGNKQIVNLDTQVTNFTMANKLLAQVLTLMKQNHLITF
>KACEBFPM_00192 hypothetical protein
MEAKTTIGEILNGRNKIIVPNYQRAYAWEIPKENRNRPTQVDIFIQDLEEYLKSNPTSPY
YFGHFLFEKKGDFVFNIIDGQQRLTTIVIYLSAIFKKITETRILTEEEEFLSETMIKRRS
TIHFETVDYDNLLFKDYVITQEKKDKNGIDTESGKRLVAAFDYFNNLLKDKSDDYCTRML
KAVTTAVSTTHEVSDESEAIQMFIFQNNRGKKPTNLEIIKAQFMYQAHLYGGDEKETIIK
DIKERFEKIYKSISSIEYKISEDDVLTYTLRVHFNSLWENNAVARVNEELTKNNGIEFVK
EFTKSLAVSFEHLTLFFGKDERENFAIHSLITLGGIGIAVPFILKAYRFALPTTIIAELC
QNFETIVLRNRLIGTRADITSRLNGVYNEFAQNNTDITPIISRINYLRTTYDGWWDYWNN
IELKKSIQGKLNHTTAKFILWKYENTLESKGKSGYSASRFDKIENPELEHMAPSTEPALK
PHGYGVYDDEFKNQYLNCLGNYLLLSKSHNCSVSNNHLKDKIETYNHLAQQREIKDFITE
SGLWDKEAITNRKTKIVKFVMDNF
>KACEBFPM_00193 hypothetical protein
MNTNNIKSFAKQARIILMEGVKQRLLYWGFDANGNSNQTVETTTGGYIFRGNVFNDESVP
PKWQKLKSKLTSKQAVQDTIEEAAYTWFNRLMAINILEKRGYIQPTLTYTSELKTPQIVQ
NAKRGQHQLKQQKYIDLLQQYLVDDQEEQALGLLLTRLCNNNILLHDVFGRIDDYTEILL
PNNLLQRNGIIDLLNSDVITNTEYKEVELIGWLYQFYISDKKDEVFKGFKANKKARPEDI
PAATQIFTPKWIVKYMVENTVGKIYLDFDKTSSLKPEMKYLVESEEDALSARAHSIGLIH
NLEELTLIDPASGSGHILVTGFELLFKMYREQGYTAKNAVISILQNNLFGLDIDDRAMQL
ARFAVLLKAAEFYPEVLNATDSNPLLLPHIYSFPETQHFQIEELQSFLTAKGGTYVAELK
EALQLLNQGKNIGAALKMTLSPEAQTFIRQQVNNWNQQEIAGTLDILQQDLWRNLKPFLE
VLLVMTKKYTAVVANPPYMGQNNMNAELKNYVNDKYPLSKSDLFGVFMEVCLSMNVAKGL
MGMINQHSWMFLSSFELLRREMLNKFGVESMLHLGPRTFEELTGEVVQSTAFVVNKNKSD
LGHYFRLVDYKDNISKEKAFLERKNSFLNIPISNFDEIPSKRIGYWLSKLFLTVFNNESL
GELYEPKSGVLTGKDPLFVRNWYECFKSDIGFNIDSHNSMIEQNFKWIPITNGGAYKKWY
GNLYNVVNMQDNGHAIKNLPNNNHRLRNPNLYFKHGVNWTLFMSGMFCVRESPSNVLFGN
GSRTFFPDEKDIKYLSCLFNSIVARLILELYNPTTNFVNEDISCVPIIYIDKDKEKFVSI
IYDVVYLISKNDWNSRETSWDFEQSPLLNESTSLKEAYQKWQDSVTQDFFQLHENEEELN
RIFIDIYGLQEELTPEVVLKDITILQEELNGKELEQLEATFRTQGKNAIVLPIKKDQVIN
QFISYCIGVFMGRYRLDKPGLHIAHPNPTEEELSPYEMSLRGTKQSVEIDDDAIIPIMGS
ECAFPDDALVRIKNLIHDLWGEATLTENLNFINECLGADLDKYLNEQFWKDHTSRYKKKP
IYWLFSSNPSKPNIAAFKVLVYMHRMDKYTVSKIQRNYLHPHQEWIKQEIEKAIANETNL
SKTELKRLDKLRTWELECRDYNEILKTLALQEIVFDLDNGVSVNYEKFESAVAKI
>KACEBFPM_00194 hypothetical protein
MIAIKELYDKEITRRINPAVVVSEMEEYFINQEIDEYVFTQGITKNVYKFLDAIANKKEG
KTGVWISGYYGSGKSHFIKYLFYCLNKKYREKAFVNFKEAVKNVGALEEPNPNLLALLQK
KLDALKMDEIMFNIDAVSDNEDEKDRITRVLLNQINQFRGFNNTNIALALYLEKPLQEIG
KFDEFKNQIKKEFNENWSGNQLRFTRMSLSKVLDIAKGCNSEFDTESLKKVILDKSQDYN
IDFLINEFQDFLKNKPENYRLIFLLDEVSQYIGSNSALLLNLQTIVEEIGTKIGTKIWMV
CTAQQDLSNLIDTTDTKTGDFGKILGRFETIISLESQDATYITKKRVLEKKADGIGTLSE
YYKKNKGAIDNQFVFNHDLYENFQNINDFTLTYPFIPYQFRLISDVFESFSNVGYVGQGV
KNTERSILGITHYTAEKCKDEEVGYFVPFDLFFNDQFDKNLTFIARSILDRAYNINEVKE
TEFARRVVNTLFMISNLGESHRVNFPATVENLALLLMNAVDTPKLEVQKQVTAILELLVE
KNIIQVSEGKYRFLKNDEIDVAQLIKNTSINSEDRLDYFYKDIIEKVLKPKPDINFFGNR
NFKAAISIDDKEIIRNGDFKIKFSVFDISDIQQLAYSSPAQDLVIAISDWFNFDKDLKAK
VQDYVRTQKFIVNNSANATGTRVETLNNFRLNNLILLNEIKLRFEQKFLNTSIVSNQQII
GAEQLTGANTTSRLEDMIKKHLEETYKKHPLSNAYAASNADLINNAKSKQIKANTGLDPA
EEELVNKMKLMGENPNVGDVVKNFEKAPYGWKDIATLDILLKIAQKGVKRFEWKNDSIDF
TQFVDKGLNNRERDSILILNQKAHSQDEINEFIHTINHEIFAENIIANSSDLKEAIDQLK
LKVAAKLLEVNKLKDEYEVYTFGIHLKKFHKGLTELYSARDQEQVLELVKQNKSALKADR
DQFMYVVEFIEHNLKSYLQIKDFISDNKSNFTALDDAEQVRAETVAEYIQNDKEPWDRLP
QMKKAFKEIHDALQNKIKDLRTETVKLYEQVFKEIEDHKNKLGITEANLTTDPIFINRIE
KEKNYNQLEVYNVKINDFRIENIKILEDYKAKAEAKKAGKEYQQSVTISVANEMPPTTIE
TAEQLEEYITKLRERLMFKLAKNQKIFLN
>KACEBFPM_00195 hypothetical protein
MILDSNKLYDLMADRGFQEPRTGNLFFPAYIYTYNPELEYEMRKEIAFLIEKLKRPNNYL
ECLVINMYEEMIDFLKAEEFSGRTLFDLITEKEKEDADEALAWVKDEINEGNFYKNFTKK
VKMHFGEKNDKKVYLVLHGFGSAYPYLRVSDFLKKTEQLIKEFKVIVFYPGDYNNNNYNL
FGLLNDDNLYRANHLNKYIATA
>KACEBFPM_00196 hypothetical protein
MVDIKIKYSTAFTAGALLTRETEAFISAISNIENFLEGNEIVDFDIIPVNAESSKKRLKH
EIEKRLLSLNNENLINLFSNSDKNTKNLILFYGICKCYPIIKHFMLEIVLNKWQNLDYEL
EVSDFKNFLYRKMDFHPELEKITEKSIYKCGQVAVKMLIDLGMVNKNKIQKIQISSLFIK
ECNKVGDHWYMDVLLLNDIEKQEI
>KACEBFPM_00197 hypothetical protein
MNRIKEELEIKGLTQTWLAENLGKSYNMVNSYVQNRRQPSIEQLYKIANLLKIEAKELLV
ENNSVVK
>KACEBFPM_00198 hypothetical protein
MKDEVTCFQYQIDLNKGILLSGPVGCGKTSLLNLMKYLTPTEHKFFVKSTRDISFEFIQD
GYEIIHKYSKGKLYESQPKIICFDDLGTENNLKYYGNECNVMAEILLSRYDIFTSKKIQT
HITTNLSASEIQNVYGNRVHSRLRELCNLIAFEKQVVDKRK
>KACEBFPM_00199 hypothetical protein
MNYIKHLTGFFEKVAIDKTLNPTHVSLYVALFQFWNCNRFKNPISISRDEVMRISKISSK
ATYHKCLKNLHSLGYINYEPSYNPFKGSHVYLFNFSDDLKPTPKSDKKTSSNSELVFELV
NEQVVNKLCTSSETGTEQALVSYINNTNITNNQNISKIVNLDEQAKNFEFDDVIARNEAI
SEKEKKLREKKKDFFVTSSVSSRAQSRDEKPSIENVKAYFLENNFPEIEAIKFFNYFSSN
GWLVGGKTPMVNWKAAAENWILNAPKFFSNEQPNRAKHLNKGTDKDYSEPL
>KACEBFPM_00200 hypothetical protein
MAIEVITREDLNEFRTLLLSDLNTMFNSKPQQQKQWLKSIEVRKLLNISSGTLQNLRVNG
TITYTKIGGILYYSNADLEKLLESNKVEATPNLFNPKWLVR
>KACEBFPM_00201 hypothetical protein
MIWTANKVALTELLYALHTKGAFNNGAAELKEIASYFEEVFSIDLRQYRRTFLEIRERKS
DRTKFLNTLAVGLNKRMEETDESF
>KACEBFPM_00202 hypothetical protein
MNPKFKQTLFELNEQLNFINLEMDDLVTKSVKSTEITLKVINNIKKQFLKDKTMSLDSEI
DFFKNIKPKFTSLYIYHNAIFKIETKMPHGGEKITKKYLNNELKKLKRFFDNNLDFYNYH
RTGSSYLDFKYFVRGNYDVSLRLDSFYFEVDHNFSTSHDFKLAKVLAYDRIQVYLETKLS
NIGKKLDV
>KACEBFPM_00203 Tyrosine recombinase XerD
MKTKVSILFYAKRAKASVNGLVPIYTRITINGKRIELSSNRFVEMSKWSTEAGKMKGNSE
EARSINSHLDMLRIQIIDMQMELIHKKIPVTTETLKSKILGVDERQRMLIPIFQDHNNKI
KELVGKEYAPGTLERYKTSLSHTIEFLQWKYKVSDIEINKIDHAFVTDYEFWLRSVRNCA
NNTAVKYIKNFSKIIKLCLANDWLDKNPFANYKSKVKEVERVYLSEEEIQNIIEKDFKTE
RLSLVRDIFLFSCFTGLAYIDVKNLTKSHISIGIDGEKWIFTHRQKTETASKIPILPVTQ
MIIDKYSDHPKSNNEDRLFPILTNQKMNVYLKEIAGVCEIEKDLTFHIARHTFATTVTLT
NGVPIESVSKMLGHKNLRTTQHYAKVLDKKVSEDMKILRDKFVMISIEKEQKII
>KACEBFPM_00205 Riboflavin biosynthesis protein RibBA
MTANNKIILNTIEEAIEDIRQGKIIIVVDDEDRENEGDFLAAAEKVTPEMINFMATHGRG
LICAPLTESRCKELELRPMVSNNTDHMETAFTVSIDLKGNGVTTGISASDRAKTILSLVD
SRTKPHELARPGHIFPLVAKQGGVLRRTGHTEAAIDFARLAGFKSAGVIVEIMNEDGTMA
RLSELYEVAKKFDLKLVSIEDLVAYRMQHDSLIVKKEDFDIETRFGSFRLRAYEQTTNKQ
IHIALTKGTWNLGDAVLTRINSSQVNNDLLGTLTNNADKQLDDMFKVINEEGRGAVIFIN
QDMQSVSLLNRIHELRSLQSIGEMKAPKIVIDSKDFGIGAQILHDIDISKIRLVSNTEVG
KRVGMIGYGLDIVEYVNY
>KACEBFPM_00206 hypothetical protein
MKILDKYLLKTYLTSFFGVFIILIFIFILQTVWLFISELAGKDLDLILILKFLLFKMPGL
IPLVLPLSVLLSAIMTFGDMAENYEFAAMKSAGISFQRTMKGLTFFIFLLSVGAFFFANN
VIPYAEFKFNNFRKNIAQVKPAMAIAEGQFSTIGNINIKVNKKSGTNGEFLEGVTIHKKS
DLGEGAKTVIKSKSGQLISSEESSLLQLVLIDGYYYEDITPKSYEDRQKMPFAKVNFKRY
TINIDLSKLNKVDGAEENITNACYMLNLVELKYTVDSLSTSYNKELVSVADNVYQRIGFN
SNLQPDSLRPKKPKTIGLLSFLSRSEKVKILEIASSDAMSAKQNFDINNFSLDYKKKDIN
SFWISIYEKFVIAFACILMFFIGAPLGAIIRKGGLGLPIVFAMLIFITFHFLNTFGKKVA
QESGMAPFLGAWISFFLLVPLAIFLTRKAINDTGGISFDVITEPIKKIFIKLTQRNKQQN
NDCK
>KACEBFPM_00207 hypothetical protein
MKKIISLLLIVFSFSVQAQDAVKAKALLDKVSEKVKSYKNIQIDFKYSLQNFKENVNQES
KGNVTLSGNQYVLNFMGVTKLCDGKKLYSIVPEDEEIAVSNIGGSAEDHDTPAKMLTFFS
KGFKYAWDIVQNVKGKKIQYVKLTPISSKDERKQILVGVDVATSQIYKTISVAKNGTEIT
LTVNSFKTNQTLPKNQFTFVQSKYPKYYINKLD
>KACEBFPM_00208 DNA translocase SpoIIIE
MAKAKKEINPTEPEETNLLSRFSTSRQQKITIGVLLVLFAIALGLSFISYFVNGKYDQSE
LGSFTSRNPDIQNWLGKFGAFMSDFFIYKGFGVASFLFIRLLFITGSYLVLDLAVGKLKR
TWFWDIFVIIILSILFGFFGNFLPELGGVIGYEMNLFSQDYIGKSGTLLALVFGIVIYLI
FKIKISPDKVKGFFEKTKNDIKEELKPIKSTNSTYNLEEFATDEEIELPTKKNEFQSEEE
ELGEITLRSVSQFEINKESLKPTISNSSELILEPTIKEEILTDNNNKANENEFVIQKVEE
EDIVEENLASRLVADFGEFDPTLDLSNFKFPGIDLLKDYSSGGITINQGELEENKNKIVE
TLRNYKIEIAQIKATVGPSVTLYEIVPEAGIRISKIKSLEDDIALSLSALGIRIIAPIPG
KGTIGIEVPNKNPSMVSMKSVIGSAKFQDAEMELPIALGKTISNETFVVDLAKMPHLLMA
GATGQGKSVGLNAVLTSLLYKKHPAEVKFVLVDPKKVELTLFNKIERHYLAKLPDTDEAI
ITDNAKVVATLNSLCVEMDNRYSLLKDAMVRNIKEYNEKFKQRKLNPEAGHRFLPYIVLV
VDEFADLIMTAGKEVELPIARLAQLARAIGIHLIIATQRPSVNVITGMIKANFPARIAFR
VTSKIDSRTILDSGGADQLIGRGDMLFSNGNDLVRVQCAFVDTPEVEKITEFIGSQKAYA
TAYLLPEFVGEDGGIQLDIDISERDSLFRDAAEVIVTAQQGSASLIQRKLKLGYNRAGRL
IDQLEAAGIVGPFEGSKARGVNIPDLVALEQFFNNEKNNN
>KACEBFPM_00209 Undecaprenol kinase
MSEKFEKDNTFVTGRFKSIGFAVKGVIKLITTEHSVMVQSSIAIILIFAGFYFQISRTDW
MFQILAFGLVLGIEGLNTAVEKIADFVHPDYHERIGFIKDIAAGSVFFAAMTAIAIGLMI
YLPIFL
>KACEBFPM_00210 putative thiol peroxidase
MASVTLGGNAINTSGNLPEIGTNAPDFKLVKSDLSVVSLADYKGSRVVLNIFPSVDTGTC
AASVRTFNAKASGLENTKVLCISRDLPFAQKRFCGAEGLENVENLSDFKDGSFGKNYGLE
ITDSVLAGLHSRVVMVLDENGIVKYSEQVPEIADEPNYENALAVL
>KACEBFPM_00212 Elongation factor Tu
MAKETFNRSKPHLNIGTIGHVDHGKTTLTAAITKVLSDAGYCQAKSFDQIDNAPEEKERG
ITINTSHVEYETANRHYAHVDCPGHADYVKNMVTGAAQMDGAILVVAATDGPMPQTREHI
LLGRQVGIPRMVVFMNKVDMVDDEELLELVEMEIRDLLSFYEYDGDNGPVVQGSALGGLN
NDPAWVPKIIELMEACDSWIQEPIRDTEKPFLMPVEDVFTITGRGTVATGRIETGICNTG
DPVEIIGMGAEKLTSTVTGIEMFRQILDRGEAGDNAGILLRGVAKEDIKRGMVIIKPGSV
KPHAKFKAEVYILKKEEGGRHTPFHNNYRPQFYVRTTDVTGVIMLPTGVEMVMPGDNLTI
DVTLLSPIAMSVGLRFAIREGGRTVGAGQVTEITE
>KACEBFPM_00214 Protein translocase subunit SecE
MTKVVNYISEAFEELKSNVSWPAWEETQKYAIIVAIFSVVFSLATWGVDTVFAKAVSGFF
NWIKS
>KACEBFPM_00215 Transcription termination/antitermination protein NusG
MADVNVKKWYVVRAVSGQENKVKAYIEAEINRLELSDYVSQVLVPTEKVVTVKDGKKIIK
DKVYFSGYVMVEANLAGEITHIIKSITSVIGFLGETKNGDPVPLRIAEVNRMLGKVDELA
VTADHGSIPFTVGETVKVTDGPFNGFNGTVEKINEEKRKLEVMVKIFGRKTPLELSFMQV
EKV
>KACEBFPM_00216 50S ribosomal protein L11
MAKEVSKVVKLQVKGGAANPSPPVGPALGAAGVNIMEFCKQFNARTQDKAGKVCPVQITV
YKDKSFDFVVKTPPAAVQLMEAAKLKSGSGEPNRKKVASVTWDVIKAIAEDKMVDLNAFT
AESAMSMIAGTARSMGITVTGDSPLKK
>KACEBFPM_00217 50S ribosomal protein L1
MAKLTKKQKEAVSKIEKNKLYSLKDASVLIKQIASAKFDESVDIAVKLGVDPRKANQMVR
GVVALPHGTGKNMRVLALVTPDKEAEAKEAGADFVGLDDYLQKIKDGWTDVDVIVTMPAV
MGKLGPLGRILGPRGLMPNPKTGTVTMEIGKAVTEIKAGKIDFKVDKTGIVHAGIGRISF
DADKIMENAHEIIQTLIKLKPTAAKGTYIKSIHLTSTMSPAIALDPKAV
>KACEBFPM_00218 50S ribosomal protein L10
MTREEKSIAIGDLTEKLAGTNILYVADISGLNAETTSNLRRACFKAGIKLEVVKNTLLVK
AMEASDKDFGDLPLTLKGNTSIFFADVANGPAKIIKDFRKKSDKPLLKGAFINDEIYIGD
NLLDSLVNLKSRDEVIGEIIGLLQSPAKRVIAALLNNAESKGEVAE
>KACEBFPM_00219 50S ribosomal protein L7/L12
MADLKQFAEQLVNLTVKEVNDLATILKDEYGIEPAAAAVVMQSGGGEAAEEAQTEFTVVL
KEAGASKLAVVKAVKELTGLGLKEAKDLVDAAPSNVKEGVSKDEAEGLKKSLEEAGAVVE
LK
>KACEBFPM_00220 DNA-directed RNA polymerase subunit beta
MITNQTERLNFASTKNIPAYPDFLDVQVKSFQDFFQLETKSDERGNEGLYNTFMENFPIT
DTRNNFVLEFIDYFVDPPRYTIQECIERGLTYSVPLKARLKLYCTDPEHEDFETIVQDVY
LGTIPYMTPSGTFVINGAERVVVSQLHRSPGVFFGQSFHANGTKLYSARVIPFKGSWIEF
ATDINSVMYAYIDRKKKLPVTTLFRAIGFQSDKDILEIFDLAEEIKVSKSGLKKYIGRKL
AARVLNTWHEDFVDEDTGEVVSIERNEIILDRDTILDKDNVEEIVESNVKSILLHKEDNN
VVDYSIIHNTLQKDPTNSEKEAVEHIYRQLRNAEPPDEETARGIIDKLFFSDQRYNLGEV
GRYRINKKLGLDTPMEKQVLTKEDIITIVKYLIELINAKADIDDIDHLSNRRVRTVGEQL
SQQFGVGLARMARTIRERMNVRDNEVFTPIDLINAKTLSSVINSFFGTNQLSQFMDQTNP
LAEITHKRRLSALGPGGLSRERAGFEVRDVHYTHYGRLCPIETPEGPNIGLISSLGVYAK
VNGMGFIETPYRKVTNGVVDLTSVPKYLSAEEEEGMLIAQANIQMDENGKITADNVIARQ
EGDFPVIDPTAVHYTDVAPNQIASISASLIPFLEHDDANRALMGSNMMRQAVPLIRPEAP
IVGTGLERQVASDSRVLINAEGAGVVEYVDADMITIKYDRTDAERAVSFESDEKTYKLIK
FRKTNQGTSINLKPIVRKGDKVIKGQVLCEGYATQNGELALGRNLKVAFMPWKGYNFEDA
IVISEKVVRDDIFTSIHVDDYSLEVRDTKLGNEELTNDIPNVSEEATKDLDENGMIRIGA
EVKPGDILIGKITPKGESDPTPEEKLLRAIFGDKAGDVKDASLKASPSLHGVVLDKKLFA
RAVKDKRKRTQDKDALSDLEMEFEVKFVELKDKLVDKLFTIVNGKTSQGVMNDLGEEVLP
KGKKYTQKMLYAVEDFAHLTRGQWVADDETNKMVNDLIHNYKIKLNDLQGALRREKFTIT
VGDELPAGILKLAKVYIAKKRKLKVGDKMAGRHGNKGIVARIVRHEDMPFLEDGTPVDIV
LNPLGVPSRMNIGQIYETVLGWAGQNLGRKYATPIFDGASLDQINAITDEAGVPRFGHTH
LYDGGTGERFHQAATVGVIYMLKLGHMVDDKMHARSIGPYSLITQQPLGGKAQFGGQRFG
EMEVWALEAYGASSTLREILTVKSDDVIGRAKTYEAIVKGETMPEPGLPESFNVLMHELK
GLGLDIRLEE
>KACEBFPM_00221 DNA-directed RNA polymerase subunit beta'
MENRNNNNNRDKNPVKRFNKISIGLASPESILAESRGEVLKPETINYRTHKPERDGLFCE
RIFGPVKDFECACGKYKRIRYKGIVCDRCGVEVTEKKVRRDRVGHINLVVPIAHIWYFRS
LPNKIGYILGLPSKKLDMIIYYERYVVIQAGIAQNAEGESIKRLDFLTEEEYLNILDTLP
ADNQYLDDFDPNKFVAKMGAECIMDLLARINLDELSYDLRHKANNETSKQRKTEALKRLQ
VVESFRESNKNRENRPEWMIMKVVPVIPPELRPLVPLDGGRFATSDLNDLYRRVIIRNNR
LKRLMEIKAPEVILRNEKRMLQESVDSLFDNTRKASAVKTESNRPLKSLSDSLKGKQGRF
RQNLLGKRVDYSARSVIVVGPELRLFECGIPKDMAAELYKPFVIRKLIERGIVKTVKSAK
KIIDKKEPVVWDILENVIKGHPILLNRAPTLHRLGIQAFQPKLIEGKAIQLHPLVCTAFN
ADFDGDQMAVHLPLGPEAILEAQLLMLASHNILNPANGAPVTVPSQDMVLGLYYMTKERL
TTEGHIILGQDLVFYSAEETNIALNEGRVELNARVKIRAKDFNEEGELVYKIIQTTAGRV
LFNEVVPEAAGYINDVLTKKNLRDIIGKILAVTDVPTTAAFLDNIKDMGYKFAFKGGLSF
SLGDIRIPEQKTQLIADARAQVEGISGNYNMGLITNNERYNQVIDIWTSANAQLTELAMK
NIREDQQGFNSVYMMLDSGARGSKEQIRQLTGMRGLMAKPKKSTAGGGEIIENPILSNFK
EGLSILEYFISTHGARKGLADTALKTADAGYLTRRLHDVSQDVIVNIEDCGTLRGVEVSA
LKKNEEIVESLGERILGRVVLQDVVNPLTNDILVHAGEQITEAIMKVIENSPVEKVEVRS
PLVCEATKGICAKCYGRNLATGKMTQRGEAVGVIAAQSIGEPGTQLTLRTFHVGGVAGGI
SEESNILAKFAGRLEIEDLKTVKGEDGEGNLVDIVISRSTEMKLIDQKTGILLATNNIPY
GSSIYVNDAQVVEKGDVICKWDPYNGVIVSEFTGKIAYEDLEQGQSFMVEIDEQTGFQEK
VISEGRNKKLIPTLLVYGKNDELIRSYNLPVGAHLMVNDGEKIKAGKILVKIPRRSSKTG
DITGGLPRITELLEARNPSNPAVVSEIDGVVSFGKIKRGNREIVIESKFGEIKKYLVKLS
SQILVQENDFVRAGVPLSDGAITPDDILRIQGPAAVQQYLVNEIQEVYRLQGVKINDKHF
EVVIRQMMRKVRVQDPGDTLFLEDQLIHTKDFIVENDKLYGMKVVEDSGDSSNLKAGQII
TPRELRDENSLLKRTDKNLVIARDVITATATPVLQGITRASLQTKSFISAASFQETTKVL
NEAAVAGKIDYLEGLKENVIVGHRIPAGTGMREYDHTIVGSKEEYNDLMVAKEEFNY
>KACEBFPM_00222 hypothetical protein
MNENNQQGQINIELDEQIADGIYSNLAIINHSNTEFVLDFVNIMPGVPKAKVKSRIILTP
QHAKRLVKAIADNIQRFESVNGKIVESEQPPIPLNFGAAGQA
>KACEBFPM_00223 Peptide chain release factor 3
MQYYNNKRMSFLKEIERRRTFGIISHPDAGKTTLTEKLLLFGGAIQEAGAVKNNKIKKGA
TSDFMEIERQRGISVSTSVLAFIYKDKKINILDTPGHKDFAEDTFRTLTAVDSVIVVIDV
AKGVEEQTEKLVAVCRMRKIPILVFINKLDREGKDAFDLMDEVEQKLGLTVTPMSFPIGM
GYDFQGIYNIWEKNINLFSSDSRKNIDDVVAISDVQSPELEKIIGQKPADTLRENLELLT
EVYPKFDRQDYLDGKLQPVFFGSALNNFGVRELLDCFVEIAPSPRPKESETRLVDPTEAK
LSGFVFKIHANMDPKHRDRLAFVKIVSGTFERNKPYLHVRQGKNLKFSSPNAFFAEKKEI
VDISYPGDIVGLHDTGNFKIGDTLTEGEQMSFKGIPSFSPEHFRYINNADPLKSKQLDKG
IDQLMDEGVAQLFTLEMNNRKIIGTVGALQYEVIQYRLEHEYGAKCTYENLPVHKACWVK
PTDPKSEEFKEFKRIKQKFLAHDKYKQLVFLADSDFTIQMTQSKFPNVKLHFTSEFD
>KACEBFPM_00224 hypothetical protein
MVALPGPALLAVNVNVTSQPICGDILLTVFVTAKSVFIIPSIISINTPESSPGSPASAIT
TLNVYVAPGVNPVIVLLINFVKPLNTT
>KACEBFPM_00225 hypothetical protein
MIKLLFKYKYQIILIIIGILWVSFLNELMQIKHQNNICNDCDNYRESASYLYNNFKTHYF
RPIGMAIITGVPYLFRATDATIYQFSLIINIMAWLGTTLLLFNFLKKQLPINKALLWTLL
FYSILSFVFINFQLLTESIFTFLMITVFYFLEKYYTKKSFHFLSLAVSILLFAMLIKPSV
KFFAIIIFIYFGKTLLKNHRNKSILFIYLSLSLIAFQYVKMKNDYGNYTLSYIDSVTYYN
YLGSKAFYYKTNHTLNQNTNKRAKFLAKFSYPDQRNIATKDLLSQINNNKFNLIKAYISD
LSENTKTPNGSIETSKNLKNKDYYNTLKKCLSIISKYQNRFFTIVGFILALYYLFKSYKH
EFLYSLISFYILYTITISGVSCSQGDRFHIVFFPFVIILFAKLYNEKINLFSKKHK
>KACEBFPM_00226 Dodecaprenyl-phosphate galacturonate synthase
MKKLSIIIPVFNEARTVHLILNKIEHVNLSQNIVKEIIIVDDCSTDDTLEVVKNYISTHI
ELPIELLQHNKNKGKGASLQTGIKNATGDYIIIQDADLEYDPKEYNILLQPILDGHADVV
YGSRFMGGNPHRVLFFWHTIGNRFLTFLSNMFTNLNLTDMETCYKMFDTKILQSISLQEK
RFGFEPEVTAKVSRIKKIRIYEVGISYYGRTYDEGKKINWKDGFHAIYCIIKYGFLRL
>KACEBFPM_00227 Ribosomal RNA small subunit methyltransferase B
MRLHRNLVYTTIDSLNAIFNEGEYADKVVARALKKDKRWGSSDRKFVAETIYEIVRWKRL
YSEIAEVKEPFDRDNIWRMFASWAVMRGYTIPDWRQLEGTPERKIKGRFDELSKTRAIKE
SIPDWIDALGVKELGEKIWATEIAAQNQPAKVILRTNTLKTTREKLRAILMDLNIDTDTL
KDQPDALVLKERANVFLTDAFKQGFFEVQDANSQLVAAFLDVKPGMRVVDTCAGAGGKTL
HLASLMENKGQLIAMDLYESKLKQLKLRAKRNGAFNIEYKIIDSTKVIKKLAEKADRVLI
DAPCSGLGVLKRNPDAKWKLQPEFIENIKKIQAEVLESYSRIVKPGGKLVYATCSILPSE
NQEQIEKFLTTETGKSFTFIEDRKILASESGFDGFYMALLERKA
>KACEBFPM_00228 Extracellular ribonuclease
MVFLIKKIRFTFANPILLNLITMKKIYLLLLLSASLGFAQIPTGYYSTATGTGYTLKTQL
FNKIKAHTAISYSPGLWNLYYTSDVRPDGKVWDIYSDCIFVFGTFAATGGNQDTGTLGSN
ECERYNREHTFPKSWFGGPSGVPMYTDAFHVMPTDKHDNSLRGNMPYGIVGGTSSYTTNN
GAKIGICTAANTPASLIVFEPADQYKGDVARNYFYMATCYEDKIASWQKITTDGDAVLDG
TSDHVYENWYLNLMLKWHAQDPVSQKEIDRNNAVYAVQGNRNPYIDHPEYACKIWSVACA
ALNTNSFELIADINIYPNPSNNQRVNIETENELDDIQLININGQIMQEIKKPSAQNHTYT
LENLPKGFYFLKLSADSRSITKKIIIN
>KACEBFPM_00229 Phosphoribosylformylglycinamidine synthase
MIHFFGNQTNTVFAVQTQNELSAEDINKLNWLFSSAHKIEKSVLSDFFVGPRATMVTPWS
TNAVEITQNMGILGIIRIEEFEKVSNDFTHFDPMLSQKYPELNQDIYTINIQPEPILNID
DIAAYNKQEGLALSQEEVDYLNNLSVKLDRKLTDSEVFAFSQANSEHCRHKIFNGTFVID
GEEMPTSLFKLIKKTSSENPNGIISAYKDNVAFVKGPRVQQFAPKTADKPDFYEIKEFDS
VISVKAETHNFPTTVEPFNGAATGSGGEIRDRLAGGQGSLPLAGTAVYMTSYSRLEETRP
WENAMNERPWLYQTPMDILIKASNGASDFGNKFGQPLITGSILTFEHEEEARKLGFDKVI
MQAGGIGYGKLDQAIKKKPQEGDKIVILGGENYRIGMGGAAVSSADTGAFSTGIELNAIQ
RSNPEMQKRAANAIRGLVESDNNPIVSIHDHGAGGHLNCLSELVEETGGLIDLDKLPIGD
PTLSAKEIIGNESQERMGLVIGTKDIDILQRIANRERSPMYQVGDVTADHRFTFKSKSTG
AKPMDYALEDFFGSSPKVVMTDKTIDRKYSELEYTEDKIATYLEQVLQLEAVACKDWLTN
KVDRCVGGKVAKQQCAGPLQLPLNNCGVMALDYQGKEGIATSIGHSPIASLIDPVAGTRT
AIAESLSNIIWAPIKDGLNGISLSANWMWACKNEGEDARLYAAVKSCSDFAIELGINIPT
GKDSLSMKQKYPNDEVIAPGTVIISAAGNCTNITKVVEPVLQHNAGAIYYINLSQDGFKL
GGSSFAQTLNKIGTEAPTIKDASFFKNAFNTIQDLIKDRQIVAGHDIGSGGLITTLLEMC
FADVNLGAKISFDSFEEKDLIKILFSENIGIVFQAKNDQTVEAKLKESNVNFYKIGSVTS
TETLDLTHATFDVSKYRDIWFKTSFLLDTKQSKNGMAQERYDNYKKQPLTYTFPSHFDGK
APILDHSKPRPKAAIIREKGSNSEREMANAMYLAGFDVKDVHMTDLISGRETLEDIQFIG
AVGGFSNSDVLGSAKGWAGAFLYNEKANTALKNFFKREDTLSVGICNGCQLFMELELVNP
EHKVHGKMLHNNSQKHESIFTSVTVQKNNSVMLSTLEGATLGVWVSHGEGKFNLPEAEEN
YNIVGKYGYKSYPANPNGSDYNTAMMCDITGRHLVMMPHIERSTFPWNWANYPTDKKDEV
SPWHEAFVNAKKWIEKK
>KACEBFPM_00230 hypothetical protein
MMGFFLLNSLKMATEFIYDKEYNNITFSQYEISQKEYENCVFNHCDLTACNFTGTVFVDC
TFSFCNFKDAKIGHVGLRNVQFNDCNFIAVNFAMTDQIIYEFNFKNCKLDYVQFYDLKLR
GISFIDCSMVAVDFMQSDLTEALFDNCNLHLAVFSDAIANKTDFYSSYFFSIDPEKTRLK
KAVFSQENIKGLLDKYEIIIK
>KACEBFPM_00232 hypothetical protein
MYKIIAKLNKIILPSFSKQRLDLAKAKKWQMAIIGYRYFVTKKALES
>KACEBFPM_00233 hypothetical protein
MKTISNYLFIIIVTLFLTSCETPIDVSLDTANPKLVIDAVIKWQKGTSGNEQKIKLTTTT
NFYANTIPIVSGATVYITNSTNAVFNFIEMPNTGEYLCTNFVPVINENYTLTVINNGQTY
KATDKLLATPDIDNISQIAVPGVGGANLIQVKFFYQDNGLEDNFYLIGFKNSTKAFGEFG
VVKDRFFQGNQMFGFYSNDKLKAGNKLNVYLQGISERYNNYMEKLLNIAATDGGNPFSTP
PATLRGNIINQTNEDNFALGYFSLGEVDTDIYTVQ
>KACEBFPM_00234 TonB-dependent receptor SusC
MITKKILTLLVFLLVFATNFAQDRFTISGIISDAKNNETLIGVNISSKNTKAFAVTNEYG
FYSLTLPKGDYQIAISYVGFQKIEETISLTQNIKKNYSLLDSEQQLEEVVITEKTKSNIR
KPEMSVNKLSIATIKQMPVVLGEVDVLKAILLLPGVTNAGEGQSGFNVRGGGADQNLILL
DEATIFNSSHVFGFFSVFNPDAIKDLKLYKGGIPARFGGRASSVLDIYQKDGNSKNFHVN
GGIGLISSRLLAEGPIVKDKGSFLIGGRASYAHLFLKLTDNKNVAYFYDLNTKLNYKLNK
NNNLYVSGYFGRDVFSLNKTFTNTYGNSTLNLRWNHLYSDKLFSNLSMIYSDYYYGLTLD
FVGFNWNSGIKNYNLKYDFKYYLSDKIKLNYGANGIYYNFNPGTIEPVNSQSGINYKQLE
KKYAFEPALYIDAEQKITNNLSVNYGLRYSMFYRLGNSTVNLYENNQPVFYDSDLKIYEK
AKPIGTEYFGKNKTIASFNNLEPRFSVAYELNNNQSVKASYNRMVQYLQLISNTASPTPL
DVWTPSDNYIKPQIADQVAIGYFNNFSDDKYSVEIESFYKKIQNRIDYIDGADLIANEAI
EQVILNGRMRSYGLEFMIRKNTGKLNGWIAYTISKSQQQTPGRTLNEVGINNGDWYRSAY
DKLHNLAVTSTYNLNKKWTFGANFTLQTGQPVTYPNGQYVYQGITIPSYELRNKNSLPTY
HHLDISATYTPKPDKKKGRQSEWVFSIYNIYARKNAASISFRQNADSGNTEAIKLSIFGI
VPSVSYNFKF
>KACEBFPM_00235 hypothetical protein
MLKKEKLKENFDFIKYLDFKDIVYLASMKKIVLLTVFLLSSLAHCQDTNPVVSKIASEFI
EADQYIGQDAFGYKYYIKNWVLFKIKKAENYQYKNISLGKISKVDIQNSLKIVLFYENFN
TVIITDNQLNEIHKISFSQNSKNIIASAVGISSHSNLWVFDSVNLQIGLYDYLKNEYKNI
AVPLTLGLKYYETSFNNFYWIDENNYSYSCDIFGKIKPLGKIPDFDLIQFTSNLSVIYKK
NDLLYYYDLNNSKKTLILLDQKSYNSFYYKDQNLSIFTLEDITNYKINLP
>KACEBFPM_00236 Deoxyadenosine/deoxycytidine kinase
MHIAIAGNIGAGKTTLTKLLAKHFNWEPHFEDVVDNPYLDDFYHQMERWSFNLQIYFLNS
RFRQVLQIRESGKKIIQDRTIYEDAHIFAPNLHAMGLMTNRDFQNYSSLFELMEGLVGPP
DLLIYLRSSIPNLVGQIHKRGRDYENSISIDYLSRLNERYEAWAESYNKGKLLIIDVDNV
DFVNNPEDLGMIINRIDAEINGLF
>KACEBFPM_00237 hypothetical protein
MKKKIFLLGLMASAMTMVAQESKKNESWYFKLGGSYFTQTAATEFPTVDGQLPNSDTYTT
NAIGINTLASRETNHGSFGEGFRTSLNIGYRFSTHLGAEMGINYFTGNSKTMVETKNRLV
GVEPTFVTGKAEGKIRALDLAPALVLFLGETKGFEPYTKVGVIIPIVGDLTIETNRTYTN
PLATTNTHAKDVVKPNPTLGFMAALGTSYKLGKNISVFGELEYRNFTVHGKSKETTEYTE
NGIDKLNTPTAFRPDATYSASHVNYVDQINSTSNSKVTNSANFDSSRAKDDISSYVGISG
LGLTLGLRYHL
>KACEBFPM_00238 Thioredoxin C-1
MALTITDATFEEVVLKSSQPVLVDFWAAWCGPCRMVGPVIEEIATEFEGKAIVGKVDVDA
NQEFAAKYGVRNIPTVLVFQNGEVVGRQVGVAPKQTYADSLTALL
>KACEBFPM_00239 hypothetical protein
MNIDSQIAKTSSFQHLELLANQIVEGFISGMHKSPFHGFSAEFAEHKTYNIGESTKHIDW
KLFAKTDRLYTKKYEEETNLRCHLIIDNSSSMHYPKLKEKQFFYENKIGFSVLASAVLMK
LLKKQRDAVGLSIFSDTYEYYAPEKGSERHHRMLLDKLENTLQTPKEAKQTNTITFLHQI
AEKMHRRSMIVLFTDMLQPEEDERLFKALQHLKHNKHKVVLFHVIDKKTEQNLDYDNTPR
KFIDLETGDEVNLFAQTIKDNYEKAVNNYFNKVANTCSLYKIKYVPVSVDENFEKIITTY
LIEKQKFG
>KACEBFPM_00241 L-methionine gamma-lyase
MSTQKFATNALHAGHDVTKNGGTRAVPIYQTSSYVFNNSDHAANLFGLAEAGFIYTRLNN
PTNDVLEQRLAALEGGIGAVVTASGTAALSTALLVLLKSGDHIVASNSLYGGTYNLLKVT
LPRLGITTTFVDPSNPENFTKAAQENTRVFFAESLGNPKLDVLDLKAISKEAKAFKVPFI
VDNTVPSPYLLNPIQHGANIVIHSLTKYISGNGTSLGGVIIDAGNFDWSNGKFPEFTEPS
AGYHGLVYHEALGNTAFIAKVRIEGLRDFGAALSPFNAFQIIQGLETLPIRVQKHSQNAL
ALAQWLENQEDVAWVNYPGLKSSKYYDLAQEYLPKGQNGVVTFGLKGGYEAAKKVADQTT
LFSLLANIGDTKSLIIHPTSTTHQQLTNEEQVATGVTKDLIRLSVGLEDIEDLKADLKAV
FENIKNPQLV
>KACEBFPM_00242 Homoserine O-acetyltransferase
MEKLKKIIISDFITEGGKLQKNLPLFYQIFGKPIGIAPIVLINHALTGNSQVTNENGWWK
ELIGKNKTIDTNHFTVLAFNIPGNGYDGLKENLIHNYTHFTARDIAKIFWKGLVQLRVEN
LFSVIGGSLGGGIAWEMAVINPIAIENLIPIASDWKASDWVIANTLIQDKILNNSNYPIP
DARSHAMLLYRTPQSLKQKFNREKNELKNIFQIESWLIHHEEKLQKRFQLASYKMMNHLI
KTIDITRNRKDFVTVAKVIQSNIHIIAVDTDYFFTADENRETYQDLKKVKQNVFYHEIKS
IHGHDAFLIEYKQLSKILESVFNKQKQQNYANN
>KACEBFPM_00243 Bifunctional aspartokinase/homoserine dehydrogenase 1
MPTIRINIVLFGIGNVGSTLINQVLESQKFFLEKKNIELRFPVIANSSLAFFEKEGITNQ
WEAHFLQTAIPYKIEDIFEYIQSKNLENLIAVDATASQEITKNYISLIQNGFNIVAANKK
ANTLQFNFYKELRENLTLFHKFFLYETNVGAGLPVVQTINNLHFSGEKITKIRGVFSGSL
SYIFNRFSDEEIPFSNILVDAEKIGLTEPDSREDLSGNDVARKLLILAREIDHEFELSDI
KIESLLLPNLNESNTKAEYLTNKSLFDKPFEIAKITQAENHVLRYIGEFDIEKKLLEVKL
VSTLKNSPLGQLKGADNLIEIYTKSYGEIPIVIQGAGAGKQVTARGVLTDILKIAETVKI
KETVLV
>KACEBFPM_00244 NAD(P)H azoreductase
MKNKILVTGATGYQGNAVIQELLKQDFSVSALVSPNKEAKDLENQNIEIFEGRFEDLESL
KNAFKNVSKVVLSFPLLFDEKQLMLFAENVVNAWKSSKVELIIFNTNLPVYPEKVGLIAF
DSKLLIEQYFDKEKLPYISLRPTLYMDNFSAPFLLPVIQNNGILPYPVPPNEKIAWISHF
DLAKFIVEALKKPELKGRKFNVGGIELLTGEEMASTISKYAGKPIRFVPVSPDDFELQIS
PAFGDETAKEISNIYRFVKDNITYLQVQDLKENTLKNLPISLETFDDWTSKINW
>KACEBFPM_00245 HTH-type transcriptional activator HxlR
MKNNFLEEEECPVKRSLNILGGKWKLRIIGQIGIEIRRYGDLKRQIPDISEKMLIQELKS
LVEFNILDKKSYNEIPPKVEYSLTKKGLKVLPILESLSEFGKEN
>KACEBFPM_00246 putative ABC transporter ATP-binding protein
MKAFDTTLFKRILEYTKPYKKRFYSVIVWAILLAIFAALRPYLLKNIIDDYVLPKDKNGF
SLFVILMASSLILEVLSQFYFVYWANWLGQDIIKDIRIKLFKHMTSFKISYFDHEPVGKL
VTRSVSDIESIARIFSQGLFMIISDLLKMAVVLLFMLYMNWKLTMIILAAMPILVYITRI
FQKKMQLAFEEVRNQISNLNTFVQERVTGMKIVQLFTREDIELEKFKEINDKHRKAWVKN
VWYNSIFFPIADIISSLSLSFIVYYGAMLILNDDPLTKQGDLFAFTMYISIFFTPLRQIA
DKFNEMQMGMIAAHRVFEVLDTNDHIEDIGTEIAPKFEGRINFKNVTFGYKPDEDVLKSI
NLSINEGKTIAIVGATGAGKSTIINLLNRFYEIKSGTISIDGNDITHYTLDSLRQQIAIV
LQDVFLFADTIYNNITLNNLAISKEEVVAAAKEIGAHEFIMSLPNGYDYNVKERGNMLSS
GQRQLIAFLRAYVSKPSILILDEATSSIDVYLEELIQKATETITKNRTSIVIAHRLATII
NADKIVVLDKGIVVEEGTHNQLLQKENGYYRKLYDSQFVALEKI
>KACEBFPM_00247 tRNA pseudouridine synthase A
MRYFIEFAYNGTQYHGWQYQPNATSVQETLNKVFSTLLQEKIDIMGAGRTDAGVHAKQMY
GHFDTDISIDNAKFIHKANSFLPKDIVIFNIIPVHNQAHARFDATSRTYNYHISTYKNVF
TNNLAWYSSKKIDVIAMNEAAKVLLKFTDFKCFSKTNTDVNTYNCKITEAFWSIEKEQLI
FTITADRFLRNMVRAIVGTLINIGLHKITIENFIQIIESQNRENAGFSVPAHGLFLTNIE
YPYIKKDESI
>KACEBFPM_00248 Septum formation protein Maf
MLRKKFENTKIILASGSPRRQEFFKNLDLDFEVRLKEIEEIFPKTLQSLEITDYLAKLKA
SAFDGDLLQNELLVTSDTLVWLQNEALGKPKDYDDAFAMLQKLSNQTHEVITSVCFKTKN
KTEIINDITQVTFGTLSDEAIKYYLDNYKPFDKAGSYGIQEWIGLIGITNIHGSYTNVVG
LPTEKVYLYLLNHTF
>KACEBFPM_00249 1,4-dihydroxy-2-naphthoate octaprenyltransferase
MDQDADTENKPKKVIIGKTITEALAYNLYVLFTVIGVGIGFYLSRLIMRPNFVTVFILCA
ALLYIYATNLKQIMILKNVIVASLLAFSIIIIDLFMIFPATDITNKEQMRPVFSVLIDFA
TIAFILNFIREIVKDLEDTKGDKKQEIRTLPVVFGVYKTSKLVFILSFVPVLCILYYVYN
YLFHLQYATGYIFLFLIGPLLYFMIKIWFAQTKKDFYYLSNVLKMVILFGIISIAVIGIN
MKYYVA
>KACEBFPM_00250 hypothetical protein
MRNYFLNAILFFVCFQGLSQVGIGTLTPTKSLDINGELRIQTLPISSDPLNASWTLTADN
DGNITKVNRKNPTSILLEASPDYTGYKWNTNTVSCDPAYLSNWNTSYNITTNTGISFTTT
KANQLVEVSSYIPYRILESCSVATLAYDANTRVVASKINITGPSSFSKTVAASTQYFSGG
MINQTENYYINLSGSVVLPTIGTYTFLINVATRNIAGTDASNNSLFRVNFVKSEILAPSA
LTITTLN
>KACEBFPM_00251 Isoleucine--tRNA ligase
MSAKFTEYKGLNLPTVASEILDFWKKENIFEKSVATREGNTPFVFFEGPPSANGLPGIHH
VMARAIKDIFCRYKTLKGFQVKRKAGWDTHGLPVELGTEKELGITKEDIGKTISIEEYNE
ACKKTVMRYTDVWNDLTEKMGYWVDMQDPYVTYKPKYMESVWWILKQIYNKDLMYKGYTV
QPYSPKAGTGLSSHEVNQPGSYRDVTDTTVVAQFKALNESLPDFLQNLGEIYILAWTTTP
WTLSSNTALTVGSKIDYVLVETFNQYTFLPAKVILAKNLVGKQFSKGFFQSDEISDFENF
KTADKKIPYKILAEFKGSDLVGIRYEQLMPLALPYQNPENAFRVISGDFVTTEDGTGIVH
TAPTFGADDAKVAKEATPEVPPMLVLDENGNLVPLVNLQGKFIDGLGHYSGKYVKNEYYT
NGEAPERSADVEIAIQLKEENKAFKVEKYVHSYPHCWRTDTPILYYPLDSWFIKITDVRD
RMFDLNETINWKPKATGEGRFGNWLKNANDWNLSRSRFWGIPLPIWRTEEGTEEILIGSV
EELYNEIEKAIAAGFQSVNPFKNFQVGNMSEENYDLIDLHKNVVDEITLVSASGKPMKRE
SDLIDVWFDSGSMPYAQWHYPFENKDKIDENKDFPADFIAEGVDQTRGWFYTLHAIGTLV
FDKVAYKNVVSNGLVLDKNGQKMSKRLGNAADPFETLTEYGPDATRWYMISNANPWDNLK
FDLEGIAEVRRKFFGTLYNTYSFFALYANIDGFKYAEAEIPLNERPEIDRWILSELNTLV
KVVDDAYADYEPTKAARAISDFVQENLSNWYVRLCRRRFWKGDYAQDKIAAYQTLYTCLI
TVSKLGAPIAPFFMDKLYRDLTLTTQSEKYDSVHLAEFPKQVENFVDKSLESRMQKAQTI
SSLVLSLRKKEMIKVRQPLQKIMIPVLDNGFKAEIEAVSDLIMAEVNVKEIQLLDDASGI
LVKQIKPNFKALGPRFGKDMGLIAKEIQGFTAVQISQLDKEGMLDIVISGKEITLSAEDV
EIASQDIEGWLVANSGGITVALDITISDELRKEGIARELVNRIQNLRKDSGYDVTDKITV
SVEKNDKINQAIIDNQDYIKSETLTKELILLDSIENGTIIEFDDIKTMILISK
>KACEBFPM_00252 General stress protein 16O
MVDEQIRFSDAELAEFKELILGKLDKAKIDLDLIRSAYMNDLNNGTDDTSPTFKAFEEGS
ETMSKEANSQLAIRQEKFIRDLRNALVRIESKTYGVCKVTGKLIDKERLKIVPHATMSIE
AKNLQK
>KACEBFPM_00253 Lipoprotein signal peptidase
MNLKKAYFIVFLVLLIDQISKIYVKTHFVLHQEVPVFSWFKILFIENEGMAWGVEIPGIY
GKLTLTLFRILAVGGIGYWLWDAVKKRSSTVLVIAISLIMAGAFGNIIDSVFYGKIFNDS
TYSLATLFSEQPYGSWFYGKVVDMLYFPIWEGNLPTWLPVWGGSHFTFFNAIFNVADMAI
STGVGILIVFNKKAFAK
>KACEBFPM_00254 5-formyltetrahydrofolate cyclo-ligase
MNKKELRLKYKKLRQNLSQNDIEEMSLEIANAILKLNIWNKTYFHVFLPIEEQKEVNTEF
VLHLLQGKDKEIVVSKANFETREMTHFLLTDNTKIKKNQYNIPEPIDGLEVPVHKIEVVF
VPLLAYDKLGNRVGYGKGFYDKFLSECKPETIKIGLSFFESEAFISDIFEHDVTLNFCVT
PKTIYKY
>KACEBFPM_00255 N-alpha-acetyl-L-2,4-diaminobutyric acid deacetylase
MKKTKTITILGESIKAGESKTIDMEIARLHTTTKLKTPVIVERSTIDGPVILFSAGIHGD
EINGVEIIRQLIIQKINKPKTGTIICIPIINMFGFVNKSREFPDGRDLNRVFPGSKKGSL
ASRFAHHILEEIMPVVDYAIDFHAGGASRFNAPQIRITPNNLELKKLADVFDAPFTLYSK
NIAGSFRNSADKMNIKMLLFEGGKSLDINKSVANEGVNGVKRILEHLAMLNNNLTTEKQT
NKTIYIQKSGWLRAKRSGLFHDNNLIGSFVEKGTILGTITDPFGKFEQKVKAPANGYVIN
ANHSPIIYQGDAIYHISNIVGDGGE
>KACEBFPM_00256 UvrABC system protein C
MSISSLELQIQTLPDNPGVYQYYDKDGKILYVGKAKNLKKRVSSYFNKVHDTAKTNVLVK
KIVTIKHIVVPTETDALLLENNLIKTLQPRYNILLRDDKTYPWICIKKEPFSRLFPTRKM
VKDGSEYFGPYTSFKTVSVILDLIKELYPLRSCNFDLSQKNIENYKFKVCLEYHIGNCKG
ACEGLETLENYQTQINAIREILKGNFKDSMKDFKKVMTNLAQNMHFEEAQKIKEKIEILE
NYQSRSTIINPKITNIDVFSIVSDEAAAFINFLQISHGSIIRSHTLEIKKKLDETDQELL
ELAIVELRERFQLLSREIIVPFEVEVGENIKVTVPQLGDKKQILELSVRNAKFYRIEQLK
QLQIVDPERHVNRIMAQMKKDLRLSVEPRHIECFDNSNIQGTNPVAACVVFKDGKPSKKD
YRHFNIKTVEGPNDFASMEEVVYRRYKRLLDENQPLPNLIIIDGGKGQLSSALKIIDELD
LRGKIAIIGIAKRLEELFYPGDSIPLYLDKKSETLKIIQQLRNEAHRFGITFHRDKRSKA
ALNSSIETIPGIGEKTMLTLIKHFKSVKRLKLAKEKEISDLIGISKAKKITDFCSKLDN
>KACEBFPM_00257 putative NTE family protein
MRLLYLLTFCLTSLICFSQTQDSSRRLKIGLVLSGGGAKGFAHIGVLKEIERAGIKIDYI
GGTSMGAIIGGLYASGYNASQLDSIFKETNFDELVQDFVPRKNKTFYEKSNDELYALSLP
FQKFKITIPKGLSKGMYNYNLISKLTHNVRHVQDFSKLKIPFLCVATNLETGEEKVFKNG
CLPLVLSASSAFPSLFSPVEIDGDLYVDGGVTNNYPVEEVRKMGADVIIGVDVQDDLKDR
ESLNSVLVILNQISNYQTIEKMREKKLQTDIYIKPNIEGFSVVSFDRGEQIVNKGIEAAL
LVREKLERLGTHYQEAPENTKGIDSLHIQEIGIEGNENYTRSYVIGKLRFKPGSKISYSD
LHNGINNLNATQNFSSLNYKLTKQDNQDNLIINVKENPVKTYFKLGVHYDDLFKSSALVN
VTQRNLYFKNDVASLDVILGDAFRYNLDYYIDNGFHWSFGFKSKLNQFKRASETDFNDGK
TLQNKGLENINIDYLDLSNQAYLQTIFAQKFLFGIGVEHKYINVTANLSANTRKYLDKNN
YMSLIGFLKYDSFSNKYFPKRGWYFMGDIQSFLSSSNHYDDFTRFTSLKADVGIVQTVFK
KVAVKLQTEGGFLVDTKTNTVFDYVLGGYGFTKINNLKPFYGYNYLDLSGNSYVKASLSF
DYEFIKKNHLNLCSNFANIGNNIFDTNAWISSPKYTGYALGYGIETLVGPIEIKQSWSPE
TGKSFTWFTVGFVF
>KACEBFPM_00258 NADH-quinone oxidoreductase subunit J
MSILLIIFYFLSAITLATALLTIISKNPIHSAIYLVICFFSVAGHYLLFNAQFLAIVHII
VYSGAIMVLFLFTIMLMNLNEEGEPHKKMATKLAAVVSFGLVCFVMLAVFIKAMPKMETY
RASGQDFQSIKVLGKVLLNEYMVPFEFASILLLVAMMGVVLLSKKEKKIQ
>KACEBFPM_00259 NADH-quinone oxidoreductase subunit 9
MSTTIQNISLSGRKKQVSNKEMTFLESLYLVAIVKGLLITIKHFFRKKVTIHYPEQVREM
SPVYRGQHMLKRDEQGRENCTACGLCALSCPAEAITMKAAERKSNEKHLYREEKYAEIYE
INMLRCIFCGLCEEACPKDAIYLTTSKVLVPSNYERENFIFGKDKLVMPLDIAMQNAQLK
NAN
>KACEBFPM_00260 NADH-quinone oxidoreductase subunit H
MDSAFIIEKSVVIVAVFALTMLMAMYSTWAERKVAAFLQDRVGPNRAGWGGLLQPLADGL
KLFSKEEFEPNTPNKFLFVVGPAIAMSTALMTSAVIPWGDKLHLFGRDILLQATDIDNAL
LYIFAVVSVGVYGIMIGGWASNNKFSLMGAVRAASQMVSYEVAMGLSMIALLMMTGTLSL
KEISAQQSGWHWNVIYQPVSFLIFLICAFAETNRTPFDLAECESELIGGYHTEYSSMKMG
FYLFAEYANMFISSAILAILFFGGYNYPGMQWMVENVGVNTANILGFLALFIKICGFIFF
YMWVRWTIPRFRYDQLMHLGWRILIPLAILNIMVTGICLLLFK
>KACEBFPM_00261 NADH-quinone oxidoreductase chain 3
MKVTIDGHSIEVEPGTTILQAARMIGGEVVPPAMCYYSKLKGSGGKCRCCLVDVTKGSEA
DPRPMPKLMASCVTGCQDGMEIASKASPRVQEARKSVTEFLLINHPLDCPVCDQAGECDL
QNLSFEHGNPKSRFIEEKRTFEPEDIGPNIQLHMNRCILCQRCVQVADQLTDNRVHGVMD
RGDHANISTCISKAIDNEFSGNMIDVCPVGALTDKTFRFKSRVWFNKPYNAHRACTTPGC
CGKTTVWMFGGEIQRVTGRKDEYHEVEEFICNGCRFDHKDVNDWTIEGPREFEKDSVINQ
NNYTQKLEKVEIATEKLILEGRQIDHKKISMSEIDYNEKIDGNLIDSKKNG
>KACEBFPM_00262 hypothetical protein
MINRIKLILPFLILAISANAQISISNVKDIEKVKGTTTYITMNDPNDAVSLKYAEIFKKY
WTFSKIEFIKYADINKYLNANSSFLNLGGYTTNVESYKLYSNGSRNLGIKWENTHLYLEL
WTCSEKFLKKKGDSSKEFKEKDKNQIARLELYTDFQTLRTPENLFLTNFGCENHIRNWGE
GLLKNHLQNMIMYLEMGKEKSLYSPIINDSEIKKLQNKTLYIPDYAFTKFNAFTGDESKK
HDEKELLEDYKPKYQVISTKELNEKILKNEEPFFYLQYIKSSTDKYVSVINSQTGEVVYS
SYSPASYNLKSGDLKDLSKKISK
>KACEBFPM_00263 NADH-quinone oxidoreductase subunit 1
MSKKILLDKINVPGIRTYEVYRKEGGYASVEKALKTLTPDEVVEEVKTSGIRGRGGAGFP
AGMKWSFIDKKSGKPRHLVCNADESEPGTFKDRYLMEFIPHLLIEGMITSSYALGANLSY
IYIRGEYMWVYKILERAIAEAKAAGWLGKNILGTGYDLDLYVQIGGGAYICGEETALIES
LEGKRGNPRIKPPFPAVSGLWGNPTVVNNVETISAVPWIVNNSGAKYAEIGIGRSTGTKL
ISASGNIKNPGVYEIEMGLSVYEFMNSDEYLGGMATNRPLKALVPGGSSVPILPAHLIYK
TANNEDRLMSYESLSDGGFPTGSMLGSGGFIVYDDRACIVRNTWNFSRFYHHESCGQCTP
CREGTGWMEKILHRIENGHGREEDIDLLLSIQSKIEGNTICPLGDAAAWPVAAAIRHFRE
EFEYHVRFPEKIKNRDHFVNEPFEKVKHLIKNEIV
>KACEBFPM_00264 NADH-quinone oxidoreductase subunit 2
MEKTNIKQTINITEALMTRIEELCSHYPEDKRKSALLPVLHEVQDAHENWLSIELQDKVA
EILHIKPVEVYEVVSFYTMYNRRPIGKYMFEFCQTSPCCLNGTENLMDYTCDKLGVKVGE
PTADGLFEVRGVECLGACGYAPMMQLGDFYQEHLTEAKIDQLITDCKDNKIILHDK
>KACEBFPM_00265 50S ribosomal protein L34
MSKRTFQPSKRKRRNKHGFMDRMASANGRKVLARRRAKGRHKLTVSCEPRHKK
>KACEBFPM_00266 hypothetical protein
MFHRNIKLVIAALIIFTGIWQFTEGNIGNGIFLILLTAIPVFLYFKNEFILLAFLKLRKQ
DFVGAQNWLNKIKNPETALVQKQQGYFNYLHGLMLSQSNLIQAEKYFKKAISLGLSMDQD
LALAKLNLAGIALSRRRKIEATNLLSEVKKLDKQNMLKDQVKMMKDQMKKI
>KACEBFPM_00267 60 kDa chaperonin
MAKNIKFDIEARDGLKRGVDALANAVKVTLGPKGRNVIIGKSFGGPTVTKDGVTVAKEIE
LQDPLENMGAQMVKEVASKTNDLAGDGTTTATVLAQAIVKEGLKNVAAGANPMDLKRGID
KAVEAIVADLTKQAKVVGSDSEKIKQIASISANNDEVIGELIANAFAKVGKEGVITVEEA
KGTDTYVDVVEGMQFDRGYLSPYFVTNPEKMDAELENPYILLYDKKVSSLKELLPVLEPV
AQSGKPLLIIAEDVDGEALSTLVVNKLRGALKIAAVKAPGFGDRRKAMLEDIAILTGGTV
ISEERGFTLENTTIEMLGTAKRVTIDKDNTTIVSGAGEADMIKNRVNQIKGQMEASTSDY
DKEKLQERLAKLAGGVAVLYVGAASEVEMKEKKDRVDDALHATRAAVEEGIVAGGGVALL
RAKNVLKDIKADNADEATGIQIVSRAVEAPLRTIVENAGLEGSVVVAKVAEGSGDFGYNA
KTDEYVDMLKAGIIDPKKVTRVALENAASVAGMILTTECALVEIKEENAGGGQMGGGMPG
MM
>KACEBFPM_00268 10 kDa chaperonin
MALNIKPLADRVLIEPVAAETKTASGIFIPDTAKEKPQKGTVVAIGNGKKDEPLTVKVGD
SVLYGKYAGTELKLEGKDYLIMREEDILAIV
>KACEBFPM_00269 hypothetical protein
MSTFTIFLVLITIVCFLLIVVIMVQNPKGGGLSSSISGSTQMGGVQKTTDFLDKSTWYLG
AILIVLILMSSLSFNGNNSDTGSKVIDESALAAPAIPTAPQATPAATKTTETPATKPVTE
GTKK
>KACEBFPM_00270 hypothetical protein
MNVTEYTYLLNNPEAFNNRQIIALEKILDDFPYFQSARSLQLKNLYKQGSFKYNSELKKT
ATFTTDRSILFDLITSENFISINKEPLEEAKTLHTTLAENTTLIIENDVKPEINKLEKSI
ISSIKKANQDLQEKTTPEVAKNLTTEEKLEIGKPLIFNNSETHSFQEWLQLAKIKPIIRE
ENQISENNLSSKLEIIDKFIETNPKISPAKKDTLTPVITIKTEDNSYLMTETLAKVYLEQ
KKYSKAIQAYEILILKYPEKITFFADRISDIKMLQQNNNS
>KACEBFPM_00271 hypothetical protein
MNKIKHIILISSFFVLQGCSVYNFTGTGKIDAKTFQVSYFQNVSPLVEPGIDRDFTRRLQ
DLIQNQTNLNLTATDGDLVYEGEIVDYRISPMSATADLTAAQSRLSITINLKFSNKKKPE
EDFEKRFSFYDDFPGNNLPTGAQLKKSLEIIFERISQDMFKDTLAKW
>KACEBFPM_00272 Nif-specific regulatory protein
METVQSIKQRFEIIGNDPKLNRAIEKAIQVAPTDISVLVAGESGVGKENIPRIIHSLSHR
KHGKYIAVNCGAIPEGTIDSELFGHEKGAFTGATGTREGYFEVADGGTIFLDEVGELPLT
TQVRLLRVLENGEFIKVGSSQVQKTNVRIVAATNVNLFDAIEKGKFREDLYYRLSTVDIL
LPPLRDRKDDIHLLFRKFAADFAHKYKMPPLRLDDNAVSVLQKFRWSGNIRQLRNMAEQI
SVLETNRDISGNTLLSYLPQEGTNLPSVIKNKKSENDFSTERDILYKVLFDMKSDLHDLK
KLTLELIKNGPANAQEINTSLIQKIYGSKEVNSEISFEEEPRNPTFNNHNEESVFDENEE
EFHFAETIEEEEVLKLEQREIEMIKKSLEKNKGKRKAAADELGISERTLYRKIKQFDL
>KACEBFPM_00273 tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase
MAEIQDLWHKGFKEITLLGQNVDSYLWYGGGLKKDFTNASEIQKATAVDFDQLLEMVAVG
FPKMRIRFSTSNPQDMHESILHVMAKHSNICKHIHLPVQSGSNRILKEMNRLHTREEYMI
LIDKIRAIIPNASISQDMIAGFPSETEEDHQDTISLMQYVKYNFGYMYSYSERPGTLAGR
KMKDDVSDEIKARRLQEIVDLQQKHAWWRSEDFIGQTVEVLVEKVSKKSTEEFSGRNSQS
ITVVFPKEHYKIGDFVNVKIKSCTSGTLKGEAVGYSEMN
>KACEBFPM_00274 hypothetical protein
MKNQVTTVYKQAERFAEITKKAIITGNITRAKKCLDLAERLFATGSQETKNAISNVYIFS
VSSFMELRHCSISNLFPKLLKAEYIKQINTSGV
>KACEBFPM_00275 Alginate biosynthesis transcriptional regulatory protein AlgB
MKNILIIDDEEKLRHLLARIIKSEGFEVFEASDLKSGFKKLEANDIDVVLCDVKLPDGNG
VDFLQKIKATFPLSEVILLTAFGKISDGVQAMKNGAFDYIVKGDDNDKIIPLLYKALEKV
QLQKKVKQLEKRISDKYSFDNIIGKSKGLEQVIDLAKKVSKTDSTVLLTGETGTGKEVFA
QAIHENSNRVGKTFVALNCSTFSKEILESELFGHKQGAFTGAIKDKKGFIEEANGGTLFL
DEIGEMPLELQAKLLRVLETSEYIQIGDTTPRKSNFRLIAATNRDLKKESDEHHFRSDLY
FRLNIFEIKIPPLRERIKDIAPLTNYFVEQFASRGNKKRLSIDTNFMSKLETYHWPGNVR
ELRNVIERSVILVNGEILTQDVLPYEIQHQIDNTNKTLSAFSMQSVEKLHIQKVLNYTKG
NKAEASRLLEIGIATLYRKLDEYNIQ
>KACEBFPM_00276 hypothetical protein
MKIKIIAVAILGIFIYSCSPKVVAPIVEVKKIELTPELAAGKNIYENNCVGCHKLPKVNE
LSQEGWKPVLVRMQKKARLNDAQMVVISNYIFSQL
>KACEBFPM_00277 Aspartate aminotransferase
MPKISNKGHQMPESPIRKLVPYSEIAKKNGNKVYHLNIGQPDIKTPEVALNAVKNADIEI
LEYSHSAGFDSYRTKLALSYQKIGLPINKEDIIITTGGSEALLFAMGSTIDAGEEIIIPE
PFYANYNGFATASGVKVVPVISTIDTGFALPPISDFEKLITPKTKAILICNPGNPTGYLY
SEEEIEQLAALVKKHDLFLIADEVYREFTYDGYKHYSIMNIAGIEENAIMIDSVSKRYSM
CGARIGCIVSKNAAVMATAMKFAQARLSPPTYEQIASEAALDTPQSYFDEVITEYKERRD
TLIVELNKIPGVKVATPKGAFYCIAQLPVTDADHFAQWLLEHYNYNKETVMVAPAAGFYS
SPNVGKNEVRIAYVLKKEDLIKSVQILGEALKVYKN
>KACEBFPM_00278 hypothetical protein
MRNFFAIILVFTFGFLSHAQSGAKIEFTAKDNTIDYGTVSKNDDSGIRSFEFTNTGNEPL
IIKEVKSSCGCTVPTKPTDPILPGKMGKIDVKYNMNPGPIRKTITVESNAINYEGGMVPL
KIKGTVVAPEEVNMMEKKKSLPSN
>KACEBFPM_00279 Valine--tRNA ligase
MTAQFNAKETEQKWYDYWMKNNYFHSTPDHRTPYTIVIPPPNVTGVLHMGHMLNNTIQDV
LIRRARLKGFNACWVPGTDHASIATEAKVVAKLKAEGINKNDLTREEFLKHAWQWTDKYG
GTILEQLKQLGCSCDWNRTKFTMDPDMSASVIKSFVDLYNKGQIYRGYRMVNWDPEAKTT
LSDEEVIFEERQGKLYYIKYKIEGSEDFLTVATTRPETIFGDTAICINPNDERHFSLKGK
KAIIPISGRIIPIIEDDYVDLEFGTGCLKVTPAHDMNDKTLGEKHNLEIIDIFNEDATLN
SFGLHYQGKDRFVVREEISKELETLGALSKIENHINNVGTSERTKAVIEPRLSDQWFLRM
EDLVKPAIKAVLETEEVKLYPSRFNNTYRHWLENIRDWNISRQLWWGQQIPAYFYGDGKE
DFVVAESIEEALVLAKAKTNTQNLTIQDLKQDPDALDTWFSSWLWPMAVFGGITNPENED
FKYYYPTNDLVTGPDILFFWVARMIIAGYEYTGKKPFSNVYLTGLVRDSQRRKMSKSLGN
SPEPLGLIEKFGADGVRVGLLLSASAGNDIMFDEELCNQGKGFTNKIWNAFKLIKGWEVS
ETIAQPESSKVAIEWYEAKLQQTLLAIEDDFEKYRISDALMAIYKLVWDDFCSWFLEMIK
PAYQQPIDSVTFAKAIEMLENNLKLLHPFMPFLTEEIWQIIAERTPEEALIISTWPEIKP
FNESLISHFDNTIEVISGIRTIRKDKNIPFKDSIELRIINNDKASTYFDSVVTKLGNITS
LEYVSEKVDGALSYRVKSNEYFIPITGNIDVEAEIYKLTEELNYTKGFLKSVQGKLSNEK
FVTGAPEKVLEMERKKEADALAKIATIEQSLASLK
>KACEBFPM_00280 hypothetical protein
MTNKKSNNSGLKAVIVILSLLLLGNLWYVYKITNDCKAVETVLISEKDAVLKDLMIQKDS
LNAAISSNTTLSDELIAERDKVQQLMADVEKSKGDVASMSKFKTEALKLRSNVAVLMKQV
DHLKKENVKLTVQRDSTAVVLGESRKFADTLVNRNFKMANTIEKGSKLSVLNLEASAVRQ
KKSGKQISTDKASRADVLKISFMIAENQIAKSGDKTYYVQIIDTKNNILGEKNTYVSGEK
SLTYSFVAAVKYENKTVKVEKDLEVKDVQSGAYFVNIFDKTELVSKTSFTLK
>KACEBFPM_00281 Formimidoylglutamase
MENLIRFKQSDLAKITNFRNGEVKFGEKMITVPKDENITEFITNSEAKYVILGIPEDVGI
RANLGRSGADSAWNSAIQSIANIQHNRFCKGNLVIILGQVDVSQEIDLAKNLDQTKPEDR
KQLFKIVEQIDKEVSHIIFSIVKAGKIPIIIGGGHNNAYGNIKGTALAKGKSINVINFDA
HSDFRILEGRHSGNGFSYAFDEGFLKRYFIFGLHESYTSKSVLDSIKKIEDRVKYNTYDE
IKIRHQKYFEQEMIQSLDFIKKDFFGIEIDLDAIPNIASSAMTLSGFSVEELRQFIYYFS
QNQNASYIHICEGAPSLGEEKNNHLIGKLIGYLITDFIKGNSQG
>KACEBFPM_00282 ATP-dependent RNA helicase RhlE
MLFEDLSLSKSIQRAVFEEGYLSATPIQEQSIPIILAGQDLIGCAQTGTGKTAAFAIPII
HNLHRIVGSSKKEKLIRTLVVTPTRELAVQIGESFDTYGKYTNLKQLTIFGGVSQNPQVE
QLKSGIDILIATPGRLLDLHKQGFINLDHMHHLVLDEADQMLDMGFINDVKKIVKLTPKN
RQTLLFSATMPIAIRELAEMFLTDPATVQVAPVSSTIETVDQRLYYVDKADKRQLLYHII
KEEKLSNILVFSRTKHGADNIAKALKKQGLNAEAIHGDKSQNARQRALDNFKNKACDILV
ATDIAARGIDIEFLPYVINFDLPNIPETYVHRIGRTGRAGREGMAISFCAKDEEGYWKDI
IKLTKAKVTTIDEHPFPWKKGAQEATKVNSSNRSGEKEKSRKSDASKKNKKRWY
>KACEBFPM_00283 3-dehydroquinate dehydratase
MFVFYLGCTKIKINLLKRYCYTQFKQKNKQKLFISMKIIIVNGPNLNLLGKREPEIYGSK
NFEDYFEALKTKFPMAELSYYQSNVEGEIINKLQEVGFTYHGIILNAGAYTHTSIAIADC
LKAITTPVVEVHISNTFSRETFRHQSYISPNAKGVIIGFGLKSYDLAVASYL
>KACEBFPM_00284 hypothetical protein
MKKVLLTAIAVFAFGFANAQEVKFGAKAALDVSTLSDSESKALIGFQVGGFAEIKLTDKF
ALQPELLFSTQGGKFEDSENYYGINTTTKVTTRLNYINLPIMAKYFATEKLSFEFGPQVG
FLVSANSKIENSRTFMGKTETTNRDVDVKSSVTSTTFGLNVGAGFDVTKNINVGLRYNLG
LTKVNKNSISGESDTKNNVFSLSLGYKF
>KACEBFPM_00285 Tyrosine recombinase XerD
MNWNGYINSFKSYLKIERGLSKNSVANYVLDIEKLNHYLSDNNIHVSPVNINEQTIQQFI
YEISKRVNPRSQARTISGLKSFFSYLIFEDYRPDNPLALIETPRLGRKLPDTLNIEDIDK
LIAAINLTTNEGERNRAMLETLYACGLRVSELVSLKISDLFFAEGFIKITGKGNKQRFVP
ISEYTQKYIEIYKNTDRNLLSIQKGHEDTLFLNRRGRQLTRAMIFTIIKNLAVEIGLNKV
ISPHTFRHSFATHLLENGADLRSIQLMLGHESITTTEIYMHVDRKHLSQVMQTFHPRSK
>KACEBFPM_00286 Histidine--tRNA ligase
MKPSIPKGTRDFSPAEVAKRQYIIQKMRTHFEKFGYQPIETPSFENSETLMGKYGEEGDR
LIFKILNSGNFFFNKKKIELPESIQSLQLNSAETIAVNELVELNKFTNNISEKALRYDLT
VPFARYVVQHQNDIEFPFKRYQIQPVWRADRPQKGRFREFYQCDADVVGSTSLWQEVELV
QLYDSVFTDLGLNGVTIKINNRKILSGIAEVIGASNKLIDFTVALDKLDKIGEDGVKKEM
IEKGISETAIEKVQPLFNFAGSISEKIAKLSVLLAASTEGMKGVEELQFICDNVTDLGLS
SAILDLDVTLARGLNYYTGAIFEVAPPKAVAMGSIGGGGRYDDLTGIFGLKNMSGVGISF
GLDRIYLVIEELGLFPETVTTTSKAIFLNFGQEETKYAMKAITQLRKEGIKVELYPDNAK
IAKQFQYAEKRGILLAIIVGNDEMQNNQFAVKNLVSGEQQKVSFDELKSLLQ
>KACEBFPM_00287 Macrolide export ATP-binding/permease protein MacB
MLGLFKENVKIALGSIRTQMLRTILTVLIIAIGITALVGILTVVSALENTLSNDFASMGS
NTFSINQYKNLTRRRGGDEREKINPTITYTEAKAFKENYKYPFTNTSVSFTATSKAEVKF
ETKKTDPEASVLGVDEYFMPNAGLKVVKGRNFTNFDIENNTYVCVLGADFEKKLLKDINP
IDKTIVIRGAKFKVIGVLEEKGSTFGNSQDLRVMIPIQVARTLFTTPNINYTTSIMVEKK
ELLSNAIDNATIAMRKVRKLSPIEDDNFSVSRSDDLINKILGITQYLGWSAWLIGIITIL
GSSIALMNIMLVSVTERTREIGVRKALGAKKSTIALQFFMETLVIGQLGGLLGIVFGILI
GYAIAILIKFEFVIPWLAIIAAFIVSFIVAVVSGSYPAIKASKLDPIEALRYE
>KACEBFPM_00288 Release factor glutamine methyltransferase
MLIKNYRTQFVQALASIFDEKEIESFFYIILEAFHQLKRVDLVLSPDLKLDNIQLLQWET
VLLQLKEQKPIQYILGETQFFGLPFYVNENTLIPRPETEELVEWIIKENLKISSLKNLKI
LDIGTGSGCIAISLAKNLPNASVFAIDVSDKALATAQKNAVLNEVDITFIEKNILQTEDL
NQEFDIIVSNPPYVRNLEKKEIHKNVLEYEPHLALFVEDNDSLLFYRKITELATRNLSNN
GQLYFEINQYLGKETVELLEKYNFKNTTLKKDIYGNDRMIKVNFR
>KACEBFPM_00289 putative N-acetyltransferase YsnE
MIIIREIQQEDNQVIAKIVRNVLMEFGAPKVGTAYADPQLDFLFETYQNPKTKYFIVQKN
ENIIGGAGIAPLENEANTICELQKMYFLPEARGLGIGLQLMNKCLTIAKNFGYEKCYLET
MPYMEAAQKLYKKVGFEYLCEPMGNTGHTSCPVWMIKHLTIDNK
>KACEBFPM_00290 hypothetical protein
MAAGIKAVGGIPRLIETNAHIYPEMLIGNKRDLQNVIYLIKKVLFVEESKNKEIHYHIDE
RGQIWLNLDYTANYPGGKFMSEEILGQLTLNN
>KACEBFPM_00291 Uracil-DNA glycosylase
MINANSWLGFFEIEKEKPYFEDLMKTIDQEYENYSCFPAKDLIFNAFNFCDFTNLKVVII
GQDPYHGVGEANGLCFSVNDGVKIPPSLKNIFAEINAEYDLVFSPTSGNLESWAKQGILL
LNASLTVRKDLANSHKHLKWNIFTDAVIEYVSTHSQRVVFLLWGSFAHKKGRKIDRERHL
VLESGHPSPLSANRGFWFGNNHFRLTNEYLKLNGFSEIEW
>KACEBFPM_00292 Endonuclease MutS2
MGLCNLEPLQLKKMISITEKTLQDLQFSTVLETVSSICNTDIGAAKALEITPFKDEETMM
TALHQTSEYIASFQNNNAIPNHGFDAITYEIKFLGIEDSFLEVGSFRKIATLSENTNVLL
QYFKKFEDYYPNLYKKSSQIELTKYIISSIADVVDKYGEIKDNASPNLLEIRRDMNLVRG
KVNQSFGMALTQYNSLGYLDDIKESFVNNRRVLAVLAMYRRKVKGTILGSSKTGSLAFIE
PEATLRYSRELSNLEYEEKEEITRILKLLTNIIRPYLPLLIQYQDFLSDIDVIAAKAKYA
NRINGILPKITKERRIYFRDAYHPILYLTNKGKNEITHPQTIEFDSKNRIIVISGPNAGG
KTISLKTVGLLQLMLQSGMLIPVHERSETCLFDRILTDIGDNQSIENHLSTYSYRLKNMN
YFLKKCNAKTLFLIDEFGTGSDPDLGGALAEIFLEEFYHREAFGIITTHYTNLKILANEL
PFATNANMLFDEKSLEPMYKLALGQAGSSFTFEVAQKNGIPFGLINRAKKKIETGKVRFD
KTIANLQKERSKMEKTSINLKEEETKAREESKKMETINAKVKQKLENYQELYDSNQKTIY
LGQKIEALSEKYFNNKNKKELLGEFLKVVEIENSKRIKATKTEIKAIAEKKKVIIEEVTV
QVEEIRKEKKEKKLKANLVPEKVKVILKIGDRVRMLDGKSVGTIDKIEKNKAIVNYGVFT
SKVNLEALEFVQPK
>KACEBFPM_00293 hypothetical protein
MYKELKNFKVSNSFTFTIDDSLEVACNATETASGVFLVYAVDGEVKELIMVGSTGTIQND
GSLKSKGGGLYDKIVNGHQFAKTGRKYSWPAQMKKENIARLEVYWYDTYNDTTKGIPTFV
EGQILQNFLDQNNRLPRWNVAF
>KACEBFPM_00294 Phenylalanine--tRNA ligase beta subunit
MKISYNWLKQFIKTDWDSEKTASMLTDLGLEIEGIEKYQSIKGGLEGIVVGHVLTCIQHP
NADKLKITTVDLGDGNPIQIVCGASNVAAGQKVPVATIGTILYDKEGKSFEIKKGKIRGE
ESHGMICAEDELGLGHSHEGIMILDEKLTPGTPAAAVFNIENDEVFEIGLTPNRADAMSH
WGTARDLKAGMLQNGTNIELITPSVSNFKIEKRTLKIDVKVDDNKLVPRYCGVTISDIKI
GISPAWLQNRLKAIGITPKNNVVDVTNYVLHELGQPLHAFDATKINGKIIIKNVAEGTKF
TTLDDVERSLSTEDIMICDENGPLCIAGVLGGKDSGVSQNTTSIFLESAYFNAVSVRKTA
KRHTISTDASFRFERGIDPSITEYALKRAAILICEVSGGQITSDIIDIYPKKIEDHQVML
NIEKVNKIIGQEIPDDTIKKILASLDIKVNSISKVALGLVIPAYRVDVTREIDVIEEILR
VYGYNNINFTQKLNATTSHSSRTEDYKIQNIIANLLVANGFNEMMANSLTTPTYTSLSDS
LNESNNVLIINPLSNDLSAMRQSLLFSGLEAISFNINRKNSDLRLFEFGKTYHKLLSGNQ
ENSHLTLFMTGNKISESWTNPQKASDFFLFKGYVLAILERLGLSKIISSPLNTDVFAEGM
VYEMGNSTLVEFGTVKKSILKHFDIKQEVFFADFNWNSIIKQISNNIKFTEISKYPEVRR
DLALLIDNEIQFVQLFDIAKKTEKNLLKNINLFDVYEGKNLPEGKKSYAISFILQDNAKT
LTDAQIDKVMSKLTQNFETELGATLR
>KACEBFPM_00295 putative ABC transporter ATP-binding protein YbiT
MLTISNLSVQFGKRILFDEVNTTFTQGNCYGIIGANGAGKSTFLKIIAGEIDPTSGRVIL
EPGKRMSVLNQNHNMFDDLTVLETVMMGNKVLFAVKKEMDDLYADYTDANADRIGELQVR
FEEMNGWNAESDAGAMLSNLGISADYHYTLMGDMEGKLKLRVLLAQALFGNPDVLIMDEP
TNDLDFETIGWLENFLANYENTVLVVSHDRHFLDSVCTHVSDIDYGKINHYSGNYTFWYE
SSQLAAKQRAQQNKKAEEKKQELEEFIRRFSANVAKSKQATSRKKMIDKLNLSDIKPSSR
RYPAIIFDTEREAGDQILNVENLSASIDGEVLFKNVDLNMAKGDKVVIFSKDSRATSAFY
EILNGNMTPDSGTFDWGITTNQSYLPADNHSFFENDLTLVDWLRQWAKTEEERDEVYVRG
FLGKMIFSGEEALKTGRVLSGGEKVRCMLSRMMMMRANVLMLDEPTNHLDLESITAFNNS
LKNFKGSILFTTHDHEFAQTVANRVLEITPKGVIDRYTTFDEYLEDEKIQELRKKMYS
>KACEBFPM_00296 Prolipoprotein diacylglyceryl transferase
MNFPVTFNIFETVAPIHYFFETMAFVIGIRLYYHQKNGIIDPISDMNRLWIMLGAMLGAL
VGSRLIAILESPETLNQITLLSLYQSKTVAGGFLGGLFGVEITKKIIKVSIASGDVYVIP
IIIAVFIGRIGCFLSGIAEPTFGIETTFFMGMNLGDGKLRHPVALYEMMYMVLLFVLFSK
LKSKSMKNGERFKLFMILYFTYRFAVEFIKPYHPIFLNLSSIQWSAIFIFVYYWKFMIRT
FKNLFS
>KACEBFPM_00297 Antilisterial bacteriocin subtilosin biosynthesis protein AlbA
MKTRDYIYYDYTKSLCPECLHTIDAKIVFQDDKVFMLKHCKTHGDSKVMIADDVEYYKQI
RNYNKQSEMPLKFNTKVHYGCPYDCGLCTDHEQHSCLTVIEVTDRCNLSCPTCYASSAPN
YGRHRTLEEIEKMFDAVVANEGEPDVIQISGGEPTVHPDFFRILDIAKSKPIKHLMVNTN
GIRIAKDIKFVEKLATYMPDFELYLQFDSFKKEVLEKLRGEDLTEVRKKAIDHLNQFNIS
TTLVVTLQKGENDDEIGEIIKYALTQKCIRGVTFQPTQVAGRNKDYNDGEGRITLTEVRR
KIYEQYPLFTPQDLIPVPCNPDALCMAYALKIDDDVFPMTHLINPEDLLNNSKNTIVFEH
DEKLKTHMLNLFSTGISVDCAEDQIMGELMCCLPRVQSDNLHYDNLFRILIMNFMDPYDF
DVRAVKKSCVHIVDKRYKIVPFETMNIFYRDNKIEEIRKELNM
>KACEBFPM_00298 hypothetical protein
MENFFLTLYLIIMTLTVFTFVIAFFMAIFSKKKNKLASKLLIGSVIVFIIGFGGCIALIS
LS
>KACEBFPM_00299 hypothetical protein
MIAYFKKTIYLLPITAISLLCSCKQGTTEEGFKAYFGGEIINPNSKYVFLCKDNEVIDTI
ILDHKNRFLKKYDSLVPGMYTFKHEPEYQQIYFEKNDSLMVRLNTNEFDNSLTFCGRGDE
KNNFLMELFLKNEAEKNASFDLYDKDFKTFSKDIEKNYNTSKAFYLRRQTELGWSEDFDL
YAKAMLEMPYFTKKEMYPFVHERRTNKKSCNDIPKDYYNFRKKIDFNNEKLTTFSPFVRY
LTSMLNNVTCKDNDEKSLENNIKKLQVADSLFTNVKIKNSVLNNITFMYLLEDQNMISNK
SFLDKYFKLSTDMEKQKEIKKIQESIQYLLANKLLPTINLVDKNEKPVTIKNLFPKKTVL
FFWSSEAKSHLELVHLRITELKIKYPNWNFVAINIDTSDKQWRNTLSKYNFKNTTELHAT
NFQDIKNKWVITKIHRAMLINPGGKIKNGFVSLFDANFENYLK
>KACEBFPM_00300 Transaldolase
MKFFIDTANLAQIKEAQALGVLDGVTTNPSLMAKEGITGKNNILKHYVDICNIVEGDVSA
EVNAMDYDGMIREGEELAELHDQIVVKLPMTKEGIMACKYFSDRGIRTNVTLIFSAGQAL
LAAKAGATYCSPFIGRLDDISTDGLNLIQEIRDIYDNYGFETQILAASVRHTMHVVNCAK
IGADVMTGPLSSILGLLKHPLTDIGIAQFIADFEKGNR
>KACEBFPM_00301 putative oxidoreductase
MNKVVLITGGSSGIGKSIGEFLHQKGFIVYGTSRNPERINNSIFPLVALDVRDAISIERA
VAEVIEKSGRLDVVINNAGVGITGPIEEIPIQEIKNHFDTNFFGAIEVMKAVLPQMRTQK
SGLIINITSIAGYMGLPYRGIYSASKGALGLITEAIRMETKSFGIHVTNIAPGDFATNIA
AGRYHAPVIKGSAYEIPYQNTLKSMDEHVDSGSNPNEMAQAVFAIIRNPNPKIHYKVGAF
MQKISIVLKRILPDKVYEKMLMNHYKL
>KACEBFPM_00302 hypothetical protein
MSDLKNGKRPTSHRSTTYLCCVPTLEESAGAGRVGLAVANIQPFYIFASTFVYIK
>KACEBFPM_00303 hypothetical protein
MKKYKTLVITSLTFIFIGCGDKNNSKNLFSIDESKFKSMFHNSDTINLTLKNEANKTIDS
VTYYNNDTKIGTAKGNSSFNFSLINQKIGYQNLKAVAHFEGLKEENSTRIEMLSSIEPKI
LTYKLLNTYPHNIDSFTEGLEFYGDYLYESTGQKGSSYFVKTDHKTGKTLQKTILDSKYF
GEGITFINGKMYQLTWQEATGFIYDANTLKLEKTFQFDKNIEGWGMTNDKKYIYQSDGTE
KIWKMNPENQKMISFINVYTNTSKIKKINELEWIDQKIYANIWEKDAIIIINPLTGAVEA
LVDLSGLRKLAKVSDADTLNGIAYNPKTKTIFVTGKNWDKMFEIKIDYSH
>KACEBFPM_00304 hypothetical protein
MGMNKNTILGWATLMMVVMGLVLIGLGAYRYADVAGWGFATVGLGFLLNAWVFSSLKGRL
>KACEBFPM_00305 hypothetical protein
MDEVLKIINDIKAGNIKPIYFLMGEEPYYIDKLSEYIEKNILQEHERDFNQTVLYGRDVT
IEDVVSNAKRYPMMADRQVVIVKEAQDLIRTIDKLESYAENPQPTTVLVICYKYKTLDKR
KKITKILAQKGVVYESKKLYENQVGEWLKRVLSGKKLNIEPKASAMLVDFLGTDLSKIAN
ELDKLAIILPQGSTITPAIIEENIGFSKDFNIFEFRKAIGERNQLKSYKIADHFAQNPKD
NPMVVTTSLVFSFFIQLLKYHGLKDKNPKTVAPILGVSPFFLKDYDIALRNYPMKKVSQI
VASLRDIDVKSKGVGANALPQSDLLKEMLVKIFN
>KACEBFPM_00306 hypothetical protein
MQKLNFPTYTFRFKNSENKVSIFDEIRKKFIVLTPEEWVRQNVICFLLEEKKYPKSYINV
EKIIKINGLTKRYDIVVFEPNGKIFLLIECKAPEVPISQNTFDQIARYNIVLEAKYLMVT
NGLNHYFCKMDFENQKYLFLKELPEFIK
>KACEBFPM_00307 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase
MKDKKIAVVILNWNGQKLLEQFLPSIVRHSDQATIYVADNASTDASITFVKSHFPEVKII
QNNKNFGFAKGYNQALQDVEEEIYALVNSDIEVTKNWLQPIISLFENEPKTSIVQPKILD
FKNKKCFEYAGAGGGFIDKYGFPFCRGRIFDTIEKDNAQYNDTTEIFWASGACFFIRKEI
FRELNGFDVDFFAHQEEIDLCWRAFNKGYIAKYCGKSTVYHVGGATLNTENPKKTFLNFR
NSLWMLAKNLPKNKLFPVLFIRMCLDAIAAIRFLTKGKFKHFWAVLESHFYLYYFLLKFL
GKRNTNQSERYYKTKSIVYLYFIKNIKLFRNNF
>KACEBFPM_00308 hypothetical protein
MTKSLEKKGLFTGLIEQDENGNFFCGEYLLDYKMVVSNFKLGDKITLKTAITNPSDISFK
AYEKKSKNFALFNLKPDHE
>KACEBFPM_00309 hypothetical protein
MSRNTEKNIKKHNDKLHKAQDKVKKAKTDRAAQLKAIVKKFNEQKE
>KACEBFPM_00310 hypothetical protein
MLINKFKPNSKSFKNTFCVFNEVEIKTVEFLIPNYKSQSGSDYFYTEVGMYRLSNHWGRL
ANSKWRLVAFEPESESKRKLGFAKWDSFYPDNNLEKLYYLEANFDKKTINYQHKNNPNFN
NKPVLRNTLETAKRIKQARNILTLTSWAKYFSNKNIDELREKIINELIFTNKNLEEIKRN
YHE
>KACEBFPM_00311 Adenine deaminase
MVLLLTFITLFKIKQMQIQGQIVDIENKRIYSGEITIQNGKIISIIEKNHEVKNYILPGF
IDAHIHIESSMLVPSEFAKIAVLHGTVATISDPHEIANVLGKKGVYYMIENGKQVPLKFH
FGAPSCVPATAFETAGAIIDSEEIKELMASPDIYYLSEMMNYPGVLFDDDEVLKKIAWAK
NFNKPIDGHAPGLRGEPIKKYISAGITTDHECFTYSEAQEKLSLGMKVIIREGSAAKNFE
ALISLLPANYENMMFCSDDKHPDDLILGHINLLCARAVAKGIDVFKILQVACVNPVHHYK
MKVGLLKKNDAADFIVVEDLVNFKVNKTYINGELVAENGQSFVENINFETPNNFNITKKK
ISDFEIPSLAEKIRVIEALEGQLITNEIHHNSFIKNGKLVSDIENDILKMAVVNRYQNTT
PAIAFIKNFGLKKGAIASSVAHDCHNIVVVGTSDEEICNAVNLIIKNTGGICAVNGTQNK
SLALPVAGIMSDKDAWETGKLYQEIDAMAKDLGSTLKAPFMTLSFMALLVIPDLKLSDKG
LFSGNTFSFVDLNVE
>KACEBFPM_00312 hypothetical protein
MQLKDFIKKLHESPIRITFEETIAVIEQNYIFTPTAFKNGSQYNNIGENSGSCKLFAFGL
LQELSVNQMLACFGSYYFEDVLGNPEGTNHQNIRNFIKTGWNEIQFEGEALILKA
>KACEBFPM_00313 Ribosomal RNA small subunit methyltransferase I
MGKLYLVPTPIGNLEDMTFRAIRVLKEVDLILAEDTRTSGKLLKHFEISTHMHSHHMHNE
HKTIENIIKRIQTGENIALISDAGTPAISDPGFLLTRACVENNIEVDCLPGATAFVPALV
NSGFPNDKFIFEGFLPEKKGRQTRYLALAEETRTMILYVSPHKLVKTLAEFVQYFGAERP
VSVSREISKLHEETIRGTAEEVLSHFEIKPPKGEIVVIVGGKIAAKEKKESKFDNED
>KACEBFPM_00314 hypothetical protein
MKKKLEAELISIAHKILKLKNKEDVRELHHQTQRLYEKLSVLLFVEENFGDIKPTISLYD
IENKLEKAFDFDEKIIVAEIKEEELLVKINDEPTIVHIINEEILPVGAIAEEIIVVVEEP
EIATEEWPIIEISKPEKKQVSIDDFLSNMQPEPVFERVSNIKKAEDSAIAVEILEDKTEK
ETFSDKVDLKPVTNLNDKLNKSINIGLNDKLAFEKQLFDGSTEDFNRVVSQISTFDSLED
AKNFIEEMVKPDYNDWKGKEEFANRFMEFVASKFV
>KACEBFPM_00315 Thymidine kinase
MFLENTVNHKEQFGWIEVICGSMFSGKTEELIRRLKRAQFAKQKVEIFKPTIDTRYDDEM
VVSHNKNEIRSTPVPAAANIAILAQGCDVVGIDEAQFFDDEIVKICNDLANSGIRVIVAG
LDMDFKGNPFGPMPALMATAEYVTKVHAVCTRTGNLANYSFRKTDNDKLVMLGETEEYEP
LSRAAYYNAMRENMIVKDAEHL
>KACEBFPM_00316 Alanine racemase 1
MTISLHNIIPILDANFQGIDENIYYDTISIDSRSLQNNENTLFFALVGPNNDAHIYIGDL
ISKGVKNFVVTYIPKRLTGKANFLIVKNTLVALQIFARYYRNLFHFPIIGITGSNGKTIV
KEWLNFLLSPDYNIIRSPKSYNSQVGVPLSVIAINENHNLGIFEAGISTKDEMENLQKII
QPTIGILTNIGTAHDEGFADISEKIKEKLKLFTAVEVLILNKNKTIETFINKEINTFTWS
TNDQSADVFFQKKTLNDHALLNITNQGKYFKIKIPFIDEASLENSMHCILVMLYLKYDLD
TIKHRISQLFPVEMRLKVKNGINNCTLIDDSYSSDFQSLKIALDFLENQKQHLKKTLILS
DIYQSGLENEDLYVRVSQLIISNKINRVICIGGVISKYKNKFLNVISYLSTNDFIEDFDN
LDFTNETILIKGSRHFEFEKIVTLLEEKTHETVLEINLNAISHNLNYFKSKLNPKTKIMV
MVKAFGYGSGSFEIAKLLAHHKVNYLGVAFADEGIELRQAGIQLPIMVLNPEMTSFPSII
QYNLEPEIYSIRGLKAFIKITQQKELTSYPIHIKINTGMNRLGFDAQIIPELISILQKHD
SVLVKSILSHLAASDDLAQDIFTRKQISDFDTISNKITAKLKINPIRHISNTSAISNYPQ
AQFDMVRLGIGLYGVSNDANETKKLENVGTLKSIISQIRNLNSGQSVGYNRRFMVKKPTT
IATIPIGYADGISRAWGNEVGYVLVNEQKAPIVGSICMDMLMIDVTKINCSEGNQVIIFG
KTPSVTTIAKATKTIPYEILTSISSRVKRVFYRE
>KACEBFPM_00317 Large-conductance mechanosensitive channel
MGFFADFKASLMKGDVLSLATAVVIGGAFGKIVGSAVDDIIMPIVGVLTGGVDFTTKFIA
LNGQSYADLAAAKTAGAACLTYGNLVQAIINFIIISFFIFVVLRAAEKAKKKEEAAPTAP
AGPSQEELLTQIRDLLKK
>KACEBFPM_00318 Multidrug resistance protein MdtB
MEHKNHEFSISSWAVDNRVTVYILTLLIVVTGVMAYITMPREDFPEIIENKIYISSIFPG
NSAEDVEKLIVKPLEKEIKNITGVEKITSSSFQDYGMIVVEFSDNVSVAQAKTKVKDKVD
VIKADTDWPNLDNGSKVEPNVFELNISEEVPILNINLQGNYTTQQLKKYGELLQDDIEEI
PEVKKVDILGVDDKEVEIAVDIFKMTAAQVSFDEIQNAVKYENMTLSGGNLISQGSRNNI
RIVGEIKNPKELENIIVKHNGGTVYLKDIAVVSFKEKEKTTYAREKGTEVVMLNVKKRSN
QNMISAIDQVKEKLEKAKVSYLPKDLKLELSNDQSSRVEHQVDELSNHIIFGIVLVMIVL
MFTMGLRNSLFVGAAIPLSMMMAFTILSAFGLTLNTMVLFGLVMGLGMLVDDGIVVVDNV
FANMKKGMPRIEASKIGIGEIAWPVISSTATTLMAFLPFALWPGTMGKFMKYFPITLTVT
LSASLFVAMVVNAAMTGGSMDIEDKNVSKKSAKTYSIVFTIIAVIFVLLGNIYDSKIAKA
IGHLAIISLGLMWLYKIKLYQWTQDFQHSFFPRMEEKYKDFLAKILTGKRAWIALGTIVG
MLFFSFILLGIFPRKVLFFPDNIPNQVITYIEYPQGTDIGKTNKATLFVEKQVISILSKY
VDPKTNKNYLAESIISQVGKGAGNPNVDAGSASETPYKGKVTVNFSEFKFRKGINTADIL
EEIRGKVKAIAGAKVTVEKDAAGPPAGYPISIQLTGTDYDVMLKEADKMITFINAKNIPG
IERLNVDVNKQSPELEVKVDRVSAGSLGVSTGQLGFNLRRSVYGQEISTYKEGDDDYNIT
MRMQDDQRKNESILFNQSLTFRNQGNGQMMQVPISAISKTEKTTTYNQIKRKNQKRIMTI
YSNVLTGYNGDAITKNIGADLKDYQLPKTVTYSFSGVQEEQGKNASFLMYALFLALAGIT
IIIVLQFNSVSKTMVILFTVILSFSGVFYGYVIANMDFVILMTMMGIISLAGIVVKNGIV
LMDFFVLLLDKKMIDKQVESHDDLTLEEIKEVIIESGKSRLRPVLLTALTAILGLIPLAI
GLNFDFFSLITDLNPHIFMGGDNVIFWGPLAWTIIFGLSYATVLTLVMVPVMFYLVKRTK
YWLRDKRNATQVTI
>KACEBFPM_00319 Cobalt-zinc-cadmium resistance protein CzcB
MKKIILIFTASILLFSCGQKEEAVTTDALIETKNVANIKAKRDLLQAEISKIDAALATLE
VKTTQEALVSVLTVKDTVFNHYLEVQGNVNTKENILIQPEMPGTLVSLNVIAGQRVAKGQ
ILGRTDDGGMGQQLASVENQYALARTTFERQKNLWDQKIGSEIQFLQAQTQMIGLQKAVL
QMKAQLSKTLIKAPFTGVIDAVFVERGQVVSITPQGLMRIVNLSNMYVSTEVPETYIGKL
KVGSLVNVSLTSLGKTYQGKVRQVGNNINPANRSFGIEVWVPNPGNLLRPNQVAKLQIID
YTKKNAIVVPTNTIQANGDGTKFVYIANNVNGKTGIAKKVVVTTGQSSENVTEILSGIKT
TDIIITEGINTIQEGTKLNF
>KACEBFPM_00320 hypothetical protein
MKNKLILTLFLFASILQAQEKKQSYSFTLQQAIAHATQNNYSAINASRDIEVAKEKKWET
TTIGLPQINGTVSYLNNLQYTKQGVTGGGAFGGAPGSVSTIAFGTKHSANAGVTLSQLIF
DGSYLVGLQSAKVYLKISENAKLKTNQEVKEIVINSYGNVLLADESISIFEKNKVILEKT
LSDTKQIFKNGLIEEENVEQLQITLASVNSALANVKRQKTIALNMLKLILGINLDNELIL
TEKLEDLTQKNVDLLLLQEEFKATNNIDYQIGENLQESKRLLLKYEKSKELPSLGAALNY
GYNAFENKFDFFSKDQKWNNFANLGVSLHVPIFSSLGTSAKKQQAKIALEQATTKLTETE
QKLKLQFEKARSDYEFTIEELATNKNNLKLAERIETKQQIKFKEGLSTSFNLSEAQRQLY
TAQQTYLQSMVDVINKRASLEKIINKK
>KACEBFPM_00321 hypothetical protein
MKDKIIKKATDMFLKIGFKSVTMDDIACEMCISKKTIYKYFSNKETLIEEGTEVIHQNIH
ALINQVVAKDYNAIEENFEMRKMFKEMFQSFDHSPAYQLKKHYPEIYEKMMVNEMEDCNE
LFTQNIYKGISQNLYRKNIDVQAYVKFYYTLIFSINETTQQESEALKLELDALEYHTRAL
ATVEGIKELEKQLSNLI
>KACEBFPM_00322 (2E,6E)-farnesyl diphosphate synthase
MHTISHYQELISDYFSELHLTKEPKNLYNPIDYILSLGGKRMRPILTLMATEVFDVDCKK
SLAAATAIEIFHNFSLVHDDIMDDAPLRRGNETVHEKWNINTGILSGDAMLILAYQHFEE
YEPKIFRDLAKLFSKTALEVCEGQQYDVDFETRDDVIIAEYLKMIEYKTAVLVGAAMKMG
AIVAQTSTENANLIYDFGLNLGIAFQLQDDYLDAFGNPETFGKQVGGDIIENKKTYLYLK
AIEFSQPQEKEQLLHLFSIQPNDSSDKIISVKEIFNKTKASEATQKAIQDYTFKAFETLE
KMNISNNKKTILRTFGENLMSRNV
>KACEBFPM_00323 hypothetical protein
MNFITPISTDLLLFEATSENLYLKLIEQINKDFNLANEAIDLPMSTLPEELKIQLHEKIY
RLIQYKFAEYLNLLYIIDVPEDQIKKLDGSDISELSAQVAFLILKREWMKVWFRNKY
>KACEBFPM_00324 hypothetical protein
MNIILNMLQKYNICNKYILFFHTFMVNNLDIYLMILKRLKKVSKKQLLLVVFSVSLSGFS
QDFNNVRSKSEFWKKVQIGGGLGLNVGGGFTNIAIAPSAIYNINDYFSLGVGLQGSYVSV
KSNYDSFIYGGSLIGLIHPIEQIQLSVELEELRVNTTFESSFRVPSRDFWNTGLFLGAGY
RANNVTIGARYNVLYHANDNVYNDAFMPFIRFYF
>KACEBFPM_00327 hypothetical protein
MIQYILGNGIPLGIFLSFMIGPVFFVLLEISITKGFRAALIFDLGVILADIFFISIAYLG
SYRLIQSLKDDPALFILGGIIMVTYGLISFFRLRKAHKAADEEEVVELIKKDYLNLFIKG
FLLNFINIGVLGFWLLIIITFVPKLQSEVPNVIWFFTTVILTYIVTDICKILLSKQLRNK
LTTENIIKVKKISSILLIIFGAFLLSQGWFPSDKTFVTNTIEKIEKK
>KACEBFPM_00328 hypothetical protein
MKKLFIIPFLVVTNLITAQVTKNVGNFIKVTAFDKISVQLIQSTENKIELKGKFENEAIL
INNNGELKIRLPLGNFLNGDDLVAKVYFTKLEGLEANEGSYVSCDTEIKALDFSLIAKEG
SQIKAIVNAQRISIKSSNGSIIKLSGNAQNLDAVTNSGGKLEAEKCLTSQAKISVNAGGF
ADIYATDLVDAKTRAGGTITIYGNPKQINQKTILGGHIIISKR
>KACEBFPM_00329 Ribonuclease R
MSKMPKKFGKKEKDFSTKILKVLSQNANKPFNYKQISALLEVDDTKSRNEIIKDLKILAS
QKKIVETEPGKYLVKGISQDYYEGKIDMTSRKTAYFVCPDFGEDVFIPTNNLNHALDKDI
VKVYVYNRRKGKRPEGEVIEVVERAKTDFVGVIDIQKNFAFVSTANPKMYTDIFIPLAKI
AEAQQGDVVLVHIEDWPKKADSPFGAVTKVLGKPGEHNTEIHAILAEYGLPSEFPVEVEI
FAQKIDTSIQESEIAKRRDMRQTLTFTIDPKDAKDFDDALSFKKLENGNYEIGIHIADVS
HYLQEGTILDDEAYQRATSVYLVDRVVPMLPEVLSNFACSLRPNEEKYTFSAIFEIDEKA
TVINQWFGRTVIDSNQRFAYEEAQYIIETKDNTIPVETSITGSSYIVSDEIVAATLKLDE
LAKIMRRKRMNDGAISFDKVEVKFNLSQDGEPEGVFFKVSKDANHLIEEFMLLANRKVAE
YIGKQKKTFIYRIHDEPNEDKLFAMQAVIAKFGYKIDFRGGEISKSLNALMAEVNGTKEQ
NLIDTLAIRTMSKAKYSTENIGHYGLAFDYYSHFTSPIRRYPDVMVHRLLQFYLDGGKSV
DQETYETKCQHTSNMESLATNAERDSIKYMQVKYMQNHQDQEFLGVISGVTEWGIYVEII
ENKCEGMVRIRDIKDDYYTFDEKQYALVGEISKSLLQLGDQVWVKVKNADLVKKQLDFNF
LRKQ
>KACEBFPM_00330 Ribose-5-phosphate isomerase B
MYNSLLKFVATKTTTMKISIGNDHAGPDYKKAIVQFLEQKGHIITNHGTDSFDSVDYPDF
GHKVAIDVTNRKADFGIIICGSGNGIAMSANKHQGIRAALCWTKEIASLARQHNDANIIS
IPARYTSIQQAIEMVDTFLNTTFEGGRHATRVGKISC
>KACEBFPM_00331 hypothetical protein
MFNKKDYTSLSLAELLLKQTSLSYWKKIFITIAVVLVGMTLFAVYAKSKNMHPFLILGSL
FFIFYNSSELKKVQLEIEKRKK
>KACEBFPM_00332 Cadmium, cobalt and zinc/H(+)-K(+) antiporter
MPHHHSPHEVQGKNLLFSIVLNVVITVAQAVGGILSGSLALISDALHNFSDVLTLIFSYI
ANVLSKRKASLDQTFGYKRAELIAAFVNAITLIIVAVYLIFEASHRFSNPQRIKSNLVIW
LSILGILVNGISALMLKKDANHNINMKSAYIHLFTDMMASVVVLVGGILMKRYQIYWIDS
ILTFAIAIYLIYVGYDLLKESTKMLMLFTPSDIDIKEIVREVHKVSGVNKLHHIHVWHLN
DHELHLEAHLDCLEDIKMSEFNLLLHKIEVVLLEKFQINHTNIQPEFQKEDSKNFIVQD
>KACEBFPM_00333 hypothetical protein
MVAILIYFFIINTIGFFLIGYDKRMAIAHQYRISEKTLLSIVFLGGIIGSGLAMLFFKHK
TSKTSYLLKFFGIISLQIMILFLVLYYKIF
>KACEBFPM_00334 hypothetical protein
MSDLEVKAIRKNLDISQTELAKLLGISLRTVQNWEAGEKIPNTKHEMLRNLLNDNKKPKH
TKEQEFEYKFGSCLHPKGMPLIPIEAMAGYGGGQTQVLELDCEYFSVPTFKGADFLIQVK
GSSMYPKYNSGDIVACKKLQLNDLFFQWNKVYVLDTEQGAIIKRIDIGPDDDHVMIVSDN
EKYRPFSLHKSKINAISIVMGVIRLE
>KACEBFPM_00335 hypothetical protein
MRIIFFYMKCCVYIYITHLKKIVKTNSFKRKDMKILIHPDLKNDIAKEFKTSNQNVLTSL
SYFNNSQKAQAIRKRAKELLLAEAEKVQIEKFIITEN
>KACEBFPM_00336 hypothetical protein
MKIEIKHLLNADYATGIESTQKTIKLFGIVIFRKTHYYPKLKEFEILFKF
>KACEBFPM_00337 hypothetical protein
MENELWNKLEMFIGTPLVNMAIPHYVNEIEQQLTPEQLEPLGDLTEMLTERFSEKTDTPA
KEIINGLIHLAKLGVIKKNN
>KACEBFPM_00338 hypothetical protein
MSTETPYEYYDKKLGVKIKFLISDLDRKHPDSLYLFKYMTLYKRMKSNNACEQELRRSCF
GSDSLVLFSSLDRETKDAIVFKFGKPQEEIKKSWFAQHYMPDRLAYDFYLKHTYGDDNKK
LDLKYVDTYTFNASVMNTVLTMKTNRKAYIKALGITTVDIWQSLSNDVNAFREVEHNLPP
SKDGLRRKVTQYAKEGYMAIISDKFGMQNALKVKEKEQMALLDELIAKHTNLDNVLIANI
YEMVATRMGWPTITAQTVSNRKKESNLITYAGRNGVSALSNKILMQHKRTKPTIPMLYWT
LDGWDAELMYQKTTVDKKGYTTTTYHNRLTMVVVLDAYNKYPIGYAIGSHESPELIKEAM
RNAINHTAELFGQRFNPRQLQSDNYQSKTLTPVYEACTKYYTPAKVKNAKAKIIEPYFNH
INKTYCRLMDNWSGYNVNSGSKNQPNDEMLNKLKKFFPDEQGCRAQLESIISAERSKKGK
EYFENWQNVPEDLKLPMSQENYLLALGKDTGNTNKLEGSGLHVTIEGMKLTYDCFDLNFR
KQLHQDWKIIYDAQNINQVLAVSPDSKHRFMLERKYIQAMALDDRKENDAIELKRIDDFN
VKAIEYITEERKENASLIENLFQNPLLSDTLAKHLLVDSRGQHKDQKSRQRLEHNGEKVL
IKQETAIKKKAEKTWQDEQDEYINQKIDINKYLQI
>KACEBFPM_00339 hypothetical protein
MTPTTKQQIVQELENYLVKYKMSANVFAAKSGINEAYISNMRNGTYMIVETEIAPRWFDK
VARFIGLQLTKSYWNPVATNQMSAMLAILEDSKEHGLTNVVIGETGCGKTYTSSLFAKSN
PHDSFIIKVGSSDNLSDLIDKILEKAKIPYAKTKSKNINGIVKFMQKQKFDGQKPQLIFD
ECEYMRQPTLGMMKEFYDDLSGHCSIVLIGTDELIDNLDKLRKRKKAGMRQFYRRIKFGI
RVLPTIDKTFKGFLNTIEDKPLKTFLQRNCENYGELHDVLVPAIREADRTGEPLTEQFVR
KVLNIPNNMFA
>KACEBFPM_00340 hypothetical protein
MSASKKEKPKVLPKALTVANIINQRVKRILFTWKWYDAFKQPQDKGVWFVWGGSGSGKST
FVMMLCKEMALLKHKVFFNLLEEETDDTDFIERVDMLEMNDVEDCFLAKTYNYDEMIIYL
KRKNSAKVVVIDSATYFFESFEQYQNFKKMFRDKIIIITGHARGNNPKFELEDRIKFDAK
MKIFVNGYLALCKGRTIGPNGGRFIIWQEGYDKANGS
>KACEBFPM_00341 hypothetical protein
MSKILKFLKKTPEDYETAFFKTYLHWCMAFATNYGNDLQKVVANSSISKYYNMEYAKCEA
KFLELISFYHTEIGITPKEAQKLYDKCIFDMNNRFCKPLIDQAKKTNIYHDITKN
>KACEBFPM_00342 hypothetical protein
MILQKIRAKINQLEQSLIHNPNNPERAAIETDLRKLKQELQEQESPRTFERDTFDISEQK
LHKNE
>KACEBFPM_00343 hypothetical protein
MSNRRLEILETRSEILETVLRYDSEKKGKFTVGERIMINQERAHLYKQMGDPEVDNYNQS
LAIETKIYKCLALIRQENWKPKAFVPEY
>KACEBFPM_00344 hypothetical protein
MSILFYIPPIPKVKRILKPRKKVTPFNNRRYKLHQKVKGLCDLRVKERTIIIGNSIPIID
KYIIELQTKFQYNIQSEIFDANDIEVKEPETVTN
>KACEBFPM_00345 hypothetical protein
MSAETKENAIDLSKLSTKELEAVLKKRKASETKKLANEKEAYERKRDEVVENIFTTANVL
FKELGEFKQYCHIEMENQAVKLSEYGKIRGNSKGGFTVTNSDDTMRITRRRDTEPSWDER
SVKAVELIKDFLSDTIKKRDIKLYEILIGFLEKNSKGDLDYSSVMNLYSHEDKFDDERWK
EGLRLIKESFSNHFKGFGYEFKHKALDGKWENIILNFSSL
>KACEBFPM_00346 hypothetical protein
MAIKTYKFDYNIGEAFAEFKVDTEIFTEETAKLLLDFFGWNYEEDTIIDDLLKKYAMKAI
SVATSNSYNEFGVKRWFEEQEGFLALDGSQGIELIHVSEYEFDADLLEVTAN
>KACEBFPM_00347 hypothetical protein
MTATLEKPITPFQIKRIMQNCSYQVETKNEWVQWVTGDVNRTSLKSITHDQAVKIMLAQT
GSTLLSEAKENWGYFDNQNSQHRYITVLLRNADIVVKSNKWGEVADMEGWFSKFLQSNRC
PVKKPLKKMTPREVSKIITALEGVALWKNSI
>KACEBFPM_00348 hypothetical protein
MWLFGKIQFNMVHIVISALLIISPIAVLIRMYYLIKKKTEQDDCRHKNTFTAVAHVVVTC
ETTTVTCLDCGKKLKTETDCR
>KACEBFPM_00349 hypothetical protein
MKVEIKTTYDQLLFLNQFIADNLPVQIVNQEKEVKSLFYLITEIATKILKKTIDKKGISK
PFKLSLKYYEAYALHQFILTFIDYEEGENKRVIREILGKTNKELT
>KACEBFPM_00350 hypothetical protein
MYINQKRKKALEKTESIYDYEARLKKEALEISKNFVHTKPVKYLLK
>KACEBFPM_00351 hypothetical protein
MELATYKVTFKETKDEWIFQYRKEDGIIYNFTNLKGNRILSLLDKNQFPGIISRIEDWAK
LKGILTIELKLDDYSFETFWKKYNLKQKKELCEKAYEKLSLVDKIKCFANLPLYDEFLLK
TKQNKALMVTWINQKRYNDEFV
>KACEBFPM_00352 hypothetical protein
MKIFKQIFDFYINSSVHVALSVCALVLITQYMFHILHDQSMVCFAFFGTIVGYNFVKYDA
LARAKKLKMRKALKAIAFFSFFSLLAVGFCFFQLQIHTKIVAVGFVGLILLYTLPFFPNK
KNARNWAGVKIYIVSLSWVGVTVILPILNADISITSDFYLKCMQRFILVFVLVLIFEIID
LQYDDPHLKTVPQQIGVRRTKYLGYFLLLVFCALEIFNVTANDNLSLYFFSLSLQSIISV
LIAIFMFFAHERRSKYYTSFWVESVPIILWVLVCFSIKTHNIGEYMH
>KACEBFPM_00353 hypothetical protein
MIIRDLTSKVKANLHKGKAIVLIGPRQVGKTTLINTLLTNIPYLFLDGDDAVVAETLANA
NTETLKSIIGIYKCVFIDEVQRIPNIGLKLKIIVDQIKDVQVIVSGSSVFDINHLTQEPL
TGRKFEYHLFPISWEEFENNVGFMKGQQQLELRLL
>KACEBFPM_00354 hypothetical protein
MYPDVINNFGNEYEILKNLVSSYLYKDVLSLAGIRKPEILEKIVRALALQVGNEVSYNEI
AQLVGVDKNTVNNYIDLLEKAFVIFRLNSFSKNLRNEIKLNRKIYFYDNGVRNMLIGNFN
SLEFRQDKGALWENFLVSERMKLLSYSQSVAKPYFWRTIQQQEIDYVEVEAEKISAFEFK
WAPTKKAKLPKSFIDAYEPNFLVVNKDNFRDFLKI
>KACEBFPM_00355 hypothetical protein
MTTITLTTKVNAPIQKVFDINRDIDIHQKSASKTNEVAIAGVTSGLINLNETVTWRGKHF
GIYLTHKSRITAMNFYDYFVDEMVEGKFKSFRHEHFFEEQNGITTMTDKLCYETPFGIFG
QLFDYLFLKKYLTTFLLERNRVLKELSEN
>KACEBFPM_00356 hypothetical protein
MKLIKLVLIPIIFALLLRISFGATIFNDFLSVMTWTFFLLVPAGIGALFIYFSPIEKVKS
IAYRILAPWIPIILVIALTIVIGLEGWACWIMISPLFLIFASIGGLIAGHFKNKKNENLN
ISILVLLPFLIGPIENAIPRNAKTYTTYTSIEINSDAQTIWNNVTSVKEIKSNEDNSKLI
SWLGFPKPIKAELDTLAVGGYRKAIFQKGLIFNETVTKYENLKLMEFQIKANTYEIPSTT
LDEHILIGGEYFDMLNGTYKLKKISTNKYNLILYSNFSMKTTFNSYASIWGNWIMKDIQN
NILNVIKRRSEKIVNDNNNPNN
>KACEBFPM_00357 hypothetical protein
MAKSKTINVQGKEIKIIQKENSDFISLTDMVKGFGDDTMIYSWMRNRNTLEFIGIWEEIN
NPLFKGNEFVTFKIQAGLNSFNLTPRKWIEATNAIGITSKAGRYGGGTFAHKDIAFEFGS
WLSPSFKLYLIKEFQRLKEDENDRLKLDWNFQRTLAKVNYHIHTDAIKANLIPETLDKSK
INFIYANEADLLNVALFGITAKQWRDKNPNADENIRDVATIEQLVVLSNLESLNSVFIHQ
GQSQSERLIQLNAIAITQMKALLNSKMVEKLI
>KACEBFPM_00358 Oligopeptidase A
MKILTQKFDTKHDTAPFSQIKLEDYKPAFIKNIATAKAEINTIINNPENPTFENTIEALD
FSGNALDRLSSIFFNLNSAETSDEMQKIAQEVTPLLTEFSNDITLNEDLFKKIKSVYEQK
DSLNLSTEQATLLDKKFKSFSRNGALLSEEKKSKLREIDTELAKLKLTYSENVLAETNNY
QLHITNESDLKGLPEGTIEAAKALAKAKNLEGYIFTLDMPSYLPFVTYAENRELRKAITI
AAGKKAFQNNEFDNQEITLKIAKLRFERANLLGYKTHSHFVLEERMAQNPETVKSFLNDL
LIKAKPAAEREFAELTAFAKTLDGIEQLEKWDSSYYSEKLKQKLFNLDDEKLKPYFQLEN
VLNGAFTIANKLFGLTFTEVFDIEKYHEEVSIYEVKDEFGELIAIFYADFFPRKGKRNGA
WMTSFKSQYIKDTKNERPHISNVCNFTPPTNSKPSLLTFNEVTTLFHEFGHGLHGMLANT
VYPSLSGTSVYWDFVELPSQVMENWCYEPEALALFAKHYETGEIIPQEYVEKIKESASFQ
EGMATLRQLSFGLLDMAFHSNNPTEITHVKAFEKAAFEGTTLYPDVAENCMSVSFSHIFA
GGYSSGYYSYKWAEVLDADAFAYFQEKGIFNKEVATKFKENVLSKGGTELPMELYKRFRG
QEPKPDALLKRAGLI
>KACEBFPM_00359 N5-carboxyaminoimidazole ribonucleotide mutase
MSPLPIIGVPVKSSNSIDGWDSVLSILQMPGGVPVATVALNGAKNAGILAAQIIGSANKS
VLDKIISYKESLKEAVNKSSENLKK
>KACEBFPM_00360 hypothetical protein
MDLQDQLKNLFPNHEPAPEEAIPEVEHELYVQKEPMICKYEKRKGKATTIIEGYEGSDED
FKILAKEIKTKLSVGGTFKDDSIIIQGDYRDKIMEILKVKGFKVKRVGG
>KACEBFPM_00361 hypothetical protein
MKNFPHQELTKSLIGIYYDVYNELGYGFLEKVYHNAMQIELKKRGFEVENQKKLNVHYKN
EIVGEYIPDLIVNNSVIIELKCVEYMVEAHECQLLNYLKATDCEVGLLLNFGKDPQFIRK
IFTNEFKKHNKY
>KACEBFPM_00362 hypothetical protein
MQNIPSVDLRDFLSGNPERKQKFVNEIGKAFEEIGFVALKGHFLDDKLVGELYGEIRNFF
SLPLETKDGYEIPGIGGQRGYVSFGKEHAKGRKEGDLKEFWHFGQYVDKDSKYAAEYPDN
VEVKELPRFNEVGKEAYQMLEKTGITVLQALALHLGLDEFYFDQYGYEGNSILRPIHYPP
ITVEPENAIRAAAHGDINLITLLMGAQGRGLQVQNHDGEWIDAIAEPDELVINVGDMLSR
HTNNRLKSTIHQVVNPPRELWGTSRYSIPFFMHPVSEMRLDVLENCVDAENPKLYEDISA
GEFLYERLVDLGLIKK
>KACEBFPM_00363 2-oxoisovalerate dehydrogenase subunit beta
MNFDRKNISNQTLLDLYKRILKPRLIEEKMLILIRQGKVSKWFSGIGQEAISVGITAVLD
KDEYILPMHRNLGVFTGRDIPLHRLFSQWQGKANGFTKGRDRSFHFGTQEYNIIGMISHL
GPQLGVADGIALANKLKKNGKVTAVFTGEGATSEGDFHEALNIASVWELPVLFVIENNGY
GLSTPTNEQYRCENLADKGIGFGMESHIVDGNNILDVYNLISELKASMKENPRPVLLEFK
TFRMRGHEEASGTKYVPQQLMDMWAIKDPVENFRSYLKATAVLSDDDDEAFRAELKKEID
TDWALVQKEPEIIASLSEELNDVYKSYDFEEVNHSEEVENIRMIDAISNSLRQSMERHDN
LVIMGQDIAEYGGAFKITDGFVAQFGKERVRNTPICESAVVSAAMGLSINGHKAIVEMQF
ADFVSTGFNPIVNLLAKSHYRWLENADVVVRMPCGGGTQAGPFHSQTNEAWFTKTPGLKV
IYPAFPYDAKGLLNTAINDPNPVMFFEHKQLYRSMYQDVPKDYYTIPFGKAAMIKEGTAV
TVISFGAGVHWALDTLNKNPEISADLIDLRSLQPLDTETIFASVKKTGKCIILQEDSMFG
GIASDISALIMENCFEYLDAPVKRVGSLESAIPFVKALEDQYLPKVRFEEGLLELLKY
>KACEBFPM_00364 putative protease YdcP
MKKKIEILAPAKNLVQGIAAINAGADAVYIGAPLFGARTNATNSIEDIAEMVTYAHLFKA
QVFVVINTILYENELEPCRQLIHQLYTIGVDALIVQDMSIMEMDIPPIVIHASTQANNRD
PKHVKFLKDAGMQRVVLARELNLDQIREISQATNVELEFFVSGALCVSFSGNCYMSIAGG
ERSANRGSCAQNCRLPYNLTDGTGKTLIENSHLLSIKDLDLSDQLPNLIEAGVTSFKIEG
RLKDMVYVKNNTSYLRKKLDAFLENNDTFQKASSGRTFYNFEAEMDRSFNRGYTDYFVNK
RKEKIGNWESPKSQGQVIGKLIEIKANGYVIENYEKLNNGDGLYFINEQGEADGTQVNII
INNIVVPNTLKPLAIGTMIYRNSDAEFNKMVEKENSVVRKIGVTLQFTETLEGFQLLAID
EDGHQSIATLTIEKEVAKNETSTVPNIKTNLAKTGNTPFIIDDIQVNFSNNWFLPISKVN
EVRREVLEQLIDIRVNEYHREEFQITKTDHPYPVEKLDFTYNVSNHLAKAFYKRHGVTEI
EKAFELQWDPGKARVMTTKYCVKYELGKCARFQRETMGEKVVEPLTLTHGENAYKLKFNC
KPCEMEIWEKDADLEFEDEDEQLGYVAQKR
>KACEBFPM_00365 Ureidoglycolate lyase
MKLLTYKTSATEPRLGFIHNNQIIDMQDFGEISNFPLPNDMLELIDLGFEIITEINDLIS
ETTQAQIDQISYTIDQITILAPIEKPRKNIIGIGLNYTQHITESAKILGTTGKLPTKPII
FSKPTTTVTGTNTNIIKNTKLTQQLDWEVELAVVIGKKGKYIQKTQALDYVFGYTIINDI
SARDCRREGQWIVSKGQDTFAPMGPYLITKDEIENPHNLNLSLKVNGLEKQNSNTKYLLF
NINDIIEDLSIIFTLEPGDIIATGTPSGVGAGRNPQEFMNHGDIVEATIQQIGTIINTVQ
EI
>KACEBFPM_00366 Glutamate synthase [NADPH] large chain
MRKAFLIISMTILSLTGILIYINLKFSFLLIIFVPLLIMGLYDMLQSKKTIRRNFPLLGR
MRYLLESIGPEMRQYFVETDLEGKPFNRLQRSIVYQRSKKETDSMPFGTQLDVYKEGYEW
INHSIRSIPFSQVNQNPRVHIGSSQCTKPYQASLFNISAMSFGSLSKNAILALNNGAKQG
EFYHNTGEGGLSPYHLQGGDVVWNIGTGYFSCRTQDGKFNYDQYTKRATLHNVKMIEIKF
SQGAKPGHGGILPKEKVTDEIATIRLVSKDQDILSPPSHSAFTTPLELIDFIKLLRKGSG
GKPIGIKICIGNKSEFLSICKAMVETKTYLDFITVDGGEGGTGAAPQEYSDHVGMPLRDA
IAFVYDALNGYGIKDQIKIICSGKVITGFDIIRNLSLGADLCNSARGMMFALGCIQALEC
HANTCPTGVATQKPELTKGLVPEEKSIRVARFQHETVKSAMDLMASAGIDHPDKVDRSVV
STRTHLGKTQTFEETYPEIKTNSLLEANTVPNELFPAWKKASIAKF
>KACEBFPM_00367 hypothetical protein
MEILACPKCQNNVIIKSGVINNKQRYLCKKCNYYFTVNKLGKKIDDYYVVKALQLYLEGL
SYREIERIIGVSHVTVSNWVKEYRIKKKSQGNYHPTYKILNHLELVEYIKNKDLLSGAGM
IITELGDKFMLMKWKRFKD
>KACEBFPM_00368 hypothetical protein
MNNKNYLCILLFFLITFTTFAQNKVGCGVKLSQKEEVLFRQSLPKLENFKNKANKSPTAL
PYVIPVVFHILTDGAASFTKADMKCRIDDALQIANKDFNGLFPGFLTTDPRFNSVKSKMD
IQFVMATVDPTGNLMETPGLDWHPEAHIIDGYNPAIYNYMWYGSNSKYYLDVVIVDEPNT
GQGASGSGHAFLPVQNVVPHVTFNYRYIGSTCGSSSSVTFAKVFSHELGHYFGLRHTFQD
DCDPINDGMADTPPTKVAEGCTRNVLNSCGVYANSENHMDYNVDCQNMFTLNQTSAMTFW
LEDGTVANYPRKFLWQPSNLIATGVLASIPTANFTANTTAICPGKGIVFKDISLGLPVSR
VWSFSGGSPSTSTAVSPTVTYATAGLYPVTLTVTNALGTNPKTVTNYIKVGQPTSGNYTE
SFTGIFPPNGWLITNPDAGLAWEKRSNVGNGDTACMIMNNSDNSVLNELDYIQLPYYNFT
SGVNSQMFFDVAYTKFNDLSPDQLSVEVSTNCGLTWTNVYTKSLDALQTTVVPTALTNNW
FPTAENNWRKEVINLSSYIGNPNVTIRFKNKSGYGTRIWIDNVNVAITQNSTPVSDFTSS
VRKTNCSSISIPFLDTSTGNPTTWAWSFPGGSPSTSILKNPTINYNTPGTYLVSLTTTNA
AGAGTTNNKSSFITIANPVGTNFTQDFEGSFLPAGWEITNSGSNLTWQKRADVGHNSSSS
MVINNADNPTGDIDEIMLQPLKLTVGVTDFSFDLAYAKFDANSPDKLDVLASSDCGVTWV
NIYSKNNLQLETYLSADPNNWVPTLDSHWRTERINLNSFIGSPNVLIKFVSTSGYGSRIW
IDNVKLTFDSHEKPYSDFKVANSKLCIDLPITFSDTSIGLPTSWLWSFPGGSPSASTLQN
PIVTYNTPGNYSATLVTTNTYGTGTTIEKSNIIKIKGRSTVPYTENFAGVFPIQDWETIN
IDNDAITWEKRSDVGKGDLSCLVINNADNPTNLTDEIILKPINFATTATPYLHFDLAYTQ
YFSATDPTPAPDQIDIFASSDCGTTWTNVYSKNQIQLQTVLPAIQDNPTTTTQNETNDWK
PTVDSDWRHEIVNLSTVANQSSVLIKIKNTSGYGTRVWFDNIKINSNAVLNTEENSFDTV
SIYPNPSKDIFNISLPFSNEEYSITIYNILGQLVLKDSFSGSNTNQNTINLSGKEKGIYY
VKVESKSKKIIIKKIIKI
>KACEBFPM_00369 Peptide chain release factor 1
MLDRLQIIKQKFDEISDLIIQPDVIADQKRYVALNQEYKGLKSLVEKRDEYVILMANIEE
ANEIIADGSDADMAEMAKMQLEEAKERLPELEEEIKFLLIPKDAEDAKNVMVEIRAGTGG
DEASIFAGDLFRMYTKYCENRGWRTSVVDMNEGTSGGFKEVIFEVTGEDVYGTLKFEAGV
HRVQRVPQTETQGRVHTSAATVMVLPEAEEFDVQIDMNDVRVDFFCSSGPGGQSVNTTKS
AVRLTHIPTGLVAQCQDQKSQHKNKDKAFGVLRSRLYEQELAKKQADDAVKRTSQVSSGD
RSAKIRTYNYSQGRVTDHRIGLDVFDMDGVMNGKIQKFVDELQLVNNMEKLKESEIF
>KACEBFPM_00370 Ferrichrome-iron receptor
MCKYILFPSVALLLCATSFAQKSTLSEAENEYSENRTMVNDTVKNKKRQILDEVTIISNQ
QKTPVSATRSGIKAIDLPQSIQVVGSETIAQQQSIRLSDVIKNANGIYISSARGGAQESL
YSRGYDMSTNNMFKNGFRFSSGSIPEVSSLEKVEILKGSAALLYGNVAPGGILNMVTKSP
SFTKGGELAMQMGSYSFYKPSLDIYGPLSNAIAYRLTGSYENSKSFRDIVKKERYYINPS
FLFKVSPKTEITLQGDYLHDDWTPDFGTGIVGKTIANLPRNTYLGANWSTGQTKQVSLSA
LVNHNFNTNWKLNFNTSFQDYSRTSKGTERIQPSDAIATYGNLKRNLGQNQNVEQITGQQ
LSLQGNFNTGSVKHQLFTGIDFENSVVESNTFVFKKTNNPFILQDGIYDLVNIFTFDSNS
QTNLIPNAIKTKRIETETNRFGVYAQDLVSITEKIKLLAGLRWSWQEAEVNTYDLLVNTS
VMTPKRKDEAFSPKVGLVFQPTKNTSLFVSYANSFTPNSGTTADLVAIKPSIIDQYEVGI
KKYFWKNVLSTNITLYQITNSNLAQTAEFKANGSINTDSSIKVLSGETKSKGIEVDITAR
PFEGFNIIAGYSYNDMRYTKTSGLNGSFIQGDRLVRTPQNTANLSFFYTLPTGLLKGLSF
GALGNYVGNRFGGWNNQVVISSTGAVSINDRAIPLTDYKTVDLSAGYTWGQFSILCKLAN
VANELNYTVHENYSVNPIAPRQVIATIKYKF
>KACEBFPM_00371 hypothetical protein
MKLIKARNLHRDLGYFYIGLIISFAFSGVLMNHREHWHPEKYTTETKEIQVKLPLESDIN
EKYAENLAKTLGIDDKIRRHNVKKGTFKISFEKHDLEIDMKTGKGEIVSFFKTPIISQTM
KLHKSDSIWWIYYSDIFGISLITIAITGAIMIPAGKFTFKRRGWKLALAGLIFPLLILIL
LS
>KACEBFPM_00372 hypothetical protein
MDDKKKLNDIWTSRWNDRYSKDEFAYGEEPNNYLKEQLTKLNIGTILFPAEGEGRNAVFA
AKLGWTVSAFDISNEGKNKATKLAEKNNVTIDYKVGELQTLDFGNEQFDAIALIYAHFPA
DIKSLYHKKIDRFLKNNGIIIFESFSKKHIDYVTANEKVGGPKDIESLFSIDEIKSDFPN
YEIIELVEKEIELNEGLYHNGTGSVIRFIGQKKATSH
>KACEBFPM_00373 L-threonine dehydratase biosynthetic IlvA
MSLLDKIYQAQKNINGVAVNTPLVKNVNLSDEFAANIYLKREDLQPVRSYKIRGAYNKIV
SLSESDQEKGVVCASAGNHAQGVAYACNKLNISATIFMPVTTPKQKVKQVKLFGKEKVEI
VLKGDTFDESFHEASRFCKAQKAIFIHPFDDQEVIAGQGTVALELLKDTQQPIDYLFVPI
GGGGLAAGLCLVFQQLSPTTKIIGVEPSGAASMKTSIANKKNTTLNEIDKFVDGAAVKRV
GDLTFEICKDGLHDIISVPEGKVCTTILRLYNEEAIVVEPAGALTISALDFYKDKIKEKN
VVCIVSGSNNDITRTEEIRERSLLYEGLKHYFIINFPQRPGALKEFVNEVLSPNDDITYF
QFSKKNNRESGPAVVGIELKNKKDFIKIDEQLKRRKFNYRYLNDNEDLFTHLIG
>KACEBFPM_00374 Ketol-acid reductoisomerase (NAD(+))
MATINFGGVVENVVKRNEFPLEKAKEVLKNETVAVIGYGVQGPGQALNLKDNGINVIVGQ
RKGTDSWDKAIADGWQENVTLFELEAACEKATVVMNLLSDAGQIQAWEGMKKYLTKDKTL
YFSHGFGIAFQEKTGIVPPKDVDVVLVAPKGSGTSLRSLFLKGHGLNSSYAVYQNATGNA
VEKALALGIAIGSGYLFETTFQKEAYSDLTGERGVLMGAIAGIFEAQYAVLRQRGHSPSE
AFNETVEELTQSLMPLVAENGMDWMYANCSTTAQRGALDWKEKFRKANEPLLNELYDSVA
SGREAEIVIAANSKPDYRVKLQEELATLQQSELWQTGVEVRKLRPTKS
>KACEBFPM_00375 Acetolactate synthase small subunit
MQTTYTISVFTENSIGMMNRITIIFTRRHLNIDSITASESEVKGVFRYTIVLKTSKEKVE
KVIGQLEKLIDVLKAFAHEEFEIVHQEIALYKIQTGTLANGDIEKVIREHHARILTVDSK
FMVIEKTGHAEETQLLFEKLKPFGVLEFARSGRVAVTKPMKQLSTYLEELEESNKK
>KACEBFPM_00376 Acetolactate synthase isozyme 2 large subunit
MTLQELGTILQTKVDIKIIILNNRFLGMVRQWQQMFFEKRYSFTNMVSPDFVALAKAYSI
EAKKIEARADLKENLLKMINHNESYLLEIMVAKEENVFPMMATGASVSEIRLN
>KACEBFPM_00377 hypothetical protein
MMTIMAIKARDLNVDLIGTTIDVTKIMQSEPRKISRIEIIMNIPITTDEKTKTILERTAI
NCPVLLSLNPDIEKDITINWKK
>KACEBFPM_00378 hypothetical protein
MDQNQKQLIKLAHTKMPFGKYEGYFLIDIPEYYIVWYSNKGFPKGELGEQLKLIYELKLN
GLEELIRNIKKKYPKP
>KACEBFPM_00379 CTP synthase
MNQTKYIFVTGGVTSSLGKGIIAASLAKLLQARGYRTTIQKFDPYINVDPGTLNPYEHGE
CYVTNDGAETDLDLGHYERFLNVPTSQANNVTTGRIYLSVIEKERRGEFLGKTVQVVPHI
TNEIKERMQLLGKSGDYDIVITEIGGTVGDIESLPYIESVRQLVWELGENNGIVIHLTLV
PFLAAAGELKTKPTQHSVKTLMESGIKADILVCRTEYELSEDLRHKLALFCNVKREAVIQ
SIDASTIYDVPNLMLEEGLDKVALKKLDLPEKSTPDLKQWNEFLQKHKNPKHEVSIGLVG
KYVELQDSYKSILEAFIHAGATNETKVNVISIHSEFLDVNSADEQLKGLDGILVAPGFGG
RGIEGKIETVRYAREKNIPFLGICLGMQMAVIEYSRNVLGYTDANSTEMNQNTSHPVINL
MEEQKTITDKGGTMRLGAWKCHLSENTLAHKIYGQSDILERHRHRYEFNSEYLEVLQKAG
LKASGVNPETGLVEVIELQNHPFFIGVQYHPEYKSTVLAPHPLFVSFIAAAVKHKNK
>KACEBFPM_00380 Membrane protein insertase YidC
MEKKKLDLNSIIGFVLIFGIMMWIMYQNKPTQAEIDKKAKQELTEKTKSEANQVAKNSQK
TILPTDSVQVAKMKATLGSFAYSATLPSAKSEFTTLENELLVLKIANKGGYIAEATLKNF
KQISKDSGKLVQLIKDNNAGLNITLQTQDNRTLNTKDLFFEPTLTKVGTNQILSMKLKAG
ANQFLEYKYVLKPNDYMLDFDVHSQGLASVLNTTKPADLEWDLKSYRSEKSISNENRFTD
IRYEYEDGKHNNVGQGKDKEETLDKVTYVAFKQHFFSSILLTNTPFEKAKLYSSNVVDEE
KGDTIYTKHFKANVPLAFNNGEVDYKMNWYYGPSDYKLLKDYHKNLEKIIPLGWGIFGWI
NMFIFMPLFGFLSSYISLGIAIIVFTVIIKIAMSPITYKSFLSQAKMKVLRPEINELNEK
FSKDPMKKQQETMKLYNKAGVNPMAGCIPALIQIPFMYASFQFFPSAIELRQKGFLWSQD
LSSFDTVLSWKQHIPIISSVYGNHVSLFALLAAIAIFFYTKMTAGDQQMQAPQQEGMPDM
AKIMKMMLYISPIMMLIFFNNYGSGLSLYTLISNVITIGIMFVIKRYIVDNDKIHAQIQE
NKLKEPKKKGKFQQKLQEVMEQAEAQKAKDKNK
>KACEBFPM_00381 hypothetical protein
MKNKKIKKYIALIMLANCSFVLAQINKIETPKPEPINPIVSPNSFDEGGLRQGLWNGFYN
DSKILRYTGNFNHGKEIGLFTYYANSDKKLVMATRNFDNKNNAYTIFFDENKDKVSEGNM
HNKLREGPWKYYHKGLKTVMTTENYIKDKLEGSRKVFYPNEKLAEEISYKNNLKEGISKK
YSKEGKLVEESTFSKNVLQGPYKVYEGSGKVVISGQFKEDKKNGIWNYFEKGKLVRQMNA
DTINGHKKPSLKVKK
>KACEBFPM_00382 Adenylosuccinate synthetase
MTVDLLLGLQWGDEGKGKIVDVLTSKYDIIARFQGGPNAGHTLEFDGIKHVLRTIPSGIF
HKNNINIIGNGVVIDPVVFKTEVDGLAKFNLDLKSKLIISRKAHLILPTHRLLDAASEAS
KGKAKIGSTLKGIGPTYMDKTGRNGIRVGDIELVDFKEKYRALANKHEEMIKFYDVSIQY
NLAELEKEFFEAIEDLKKLDFIDSEEYLHQAQKAGKSILCEGAQGSLLDVDFGTYPFVTS
SNTTAAGACTGLGIAPNKIKEVYGIFKAYTTRVGSGPFPTEDFEDAGTTMAKVGNEFGSV
TGRQRRCGWLDLVALKYAVQINGVTQLMMMKGDVLSGFETLKVCTSYKYKGQEIAHLPYN
IEPENIEPVYTEFKGWKADLTGMSSYDELPKELKDYIDFIEKEVEVPIKIVSVGPDRKQT
ITK
>KACEBFPM_00383 Ferric uptake regulation protein
MTLIATNNNNNQEIVKNVFTMYLENKGHRKTPERYAILQEIYDSEEHFDIENLYIKMKNK
NYRVSRATLYNTIELLLDCALVRKHQFGQNQAHYEKSYFDKQHDHIIMIDSGEVIEFCDP
RIQTIKKTMEEIFGIEIVNHSLYFYANKKA
>KACEBFPM_00384 hypothetical protein
MKRFKIYFFIVTLLLISNANYATPVIPNNHFYIEQYKILAEKLSKEYKIPACIILGIAIV
ESASGTSKIARKLNNHFGFVGKNNVSWSRYKQYESIEDSYRDFCKKISQKAFYSKIKDSA
NYLEWIDKISKTGYSTAPKAWRKKITTTIVKHKLI
>KACEBFPM_00385 hypothetical protein
MPKKRYSKYNMISKYFSVVLLLVLSTVANAQDMTLFMTKNLDSLTTNLTINKQENNIKNK
QAMLPLLQKLYRLKSDSLQKVTFIHIGDSHIQADMMTEVIRTEMQKYYGNAGRGFVFPYQ
LANSNTPSDYIFSSSTLWKGNRLIKKDSTLHCGVSGFCIENKLENHSINFRFRKTDSIAQ
YFNKITLFSSKKNCLVNDSPFTEYTSDGLAAIANFTTSRCSFNLKFTDTSAVQIQGLVLE
NTQNKGVLYNSIGVNGAKFSDYNQTPLFWKQLNHLKGDCYIFSMGTNEAQNYTLTPEIYT
EYLKNTVNEVRQINPEAVILFTFPPASYYQKKAPNAMLIKLSNCMQEFCNNNNIAYWDLF
TVTNQLKGAVEWKNKSLLRPDLVHFSKKGYQLQGLLFVEAFAQLWNNYIKTANK
>KACEBFPM_00386 Peptidoglycan O-acetyltransferase
MLIGGFWHGASWNFIIWGALHGVGLIINKIWNILFKKYILLPKIITNTIYGLLTFHFVCF
CWIFFKAQNLEIANTFISQIAYNFTFEGYQIFINNYKFPLLMIVLGYTLHLMPESWSEKY
IKLQTKLPLVYHITIVLCFIALYSYFKSSESVLPIYLQF
>KACEBFPM_00388 Putative multidrug export ATP-binding/permease protein
MARFVENDLPKSKINASSLNKAKLIFKYAGNHKWKFYVGLFFLLLTSITALAFPKFLGLL
VDCVANKDAAKANKIALGLFGILILQSCFSFFRLSLFINFTENTLANLRFALYQNLIKLP
MSFYAQKRVGELNSRLSADISQLQDTLTSTIAEFLRQFILIIGGFIILATISPKLTLMMM
SIVPVVAVAAVIFGRFIRKYGKKTQDKIAESQVVVEETLQGITNVKAFANEWYEIERYKN
KINEIVKIAIKGGQYRGFFASFIIICLFGAVVSVVWYGVTLTISGEMKNVGQLISFVLYS
AFIGASFGGIAELYSQLQKAIGSTERIFELLEETPEKISGIQSSIKEKIKGEVTFQNVAF
TYPSRKEIQVLKDVSFKATFGQKIAIVGPSGAGKSTISSLLLRFYDIESGTILIDDKNIY
DYDLENLRGNMSIVPQDVILFGGSIRENIAYGKPDATEEEIMIAAKQANALNFVNGFPEK
FDTIVGERGIKLSGGQRQRIAIARALLKNPSILILDEATSSLDSESEKLVQEALETLMEG
RTSIIIAHRLSTIRNADAILVLDNGIIAEQGTHKELIEIENGIYKNLSNLQFRDY
>KACEBFPM_00389 putative transcriptional regulatory protein
MGRAFEFRKGRKMKRWSAMAKAFTRIGKDIVMAVKEGGPNPEANSRLRAVIQNSKAVNMP
KENVERAIKKATDKDTANYKEILFEGYAPHGIAILIETASDNNNRTVANIRSYFNKCNGT
MGTQGSVEFMFDHTCNFRIPANGMDPEELELELIDFGAEEVFEDEDGILIYAPFGSFGTI
QKELETRGIEILSSGFERIPQITKELTEAQIADVEKLIEKIEEDEDVMNVYHTMQE
>KACEBFPM_00390 Aminomethyltransferase
MKNTALTNIHESLGAKMVPFAGYNMPVQYEGVNAEHEIVRTGVGVFDVSHMGEFFLKGEN
ALALIQKVTSNDASKLVDGKAQYSCLPNNEGGIVDDLIIYKIADNHYMLVVNASNIEKDW
NWISSHNDLGVDMQNLSDSYSLLAIQGPKAAEAMQSLTSIDLVNMPYYSFQIGEFAGLKD
VTVSATGYTGSGGFEIYFKNEDAEAIWNKIFEAGKPFGIKPIGLAARDTLRLEMGFCLYG
NDINDTTSPLEAGLGWITKFDKEFTNSANLKKQKEEGVARKLVAFEMQERAVPRHDYEIV
DASGNVIGIVTSGTMSPSMNIGIGLGYVPTSFSTVDSDIFIRIRKNDVLAKVVKLPFYKK
>KACEBFPM_00391 Bifunctional NAD(P)H-hydrate repair enzyme Nnr
MRDFCQIDTQEIIKRYKPIDKYTHKGLQGHALIIGGSYGKMGSVVLASKACIRSGAGLVT
AYIPKCGCDILQISVPEVMVITDDYLEHIALINFDLNLKSIGIGVGMGQHPDTQHAFFNF
LKSNKLPLVIDADALNILSQNIEWLSLLPKKAILTPHQKELERLIGKWSSEEEKLEKVKR
LCLEYNLIFVLKGAPTMIVNNKSTYENTTGNQALATAGSGDVLTGIITSLLAQSYEPINA
AIIGVYLHGLTADIAYPKVGYQSFIASDIIETLGEAYLHIIK
>KACEBFPM_00392 Histidine ammonia-lyase
MNNTHYITSDVISIEEVAQIIYERKQIALSEEAILNIEKCRAYLDTKMLNNDKPIYGINT
GFGSLCNVIISDENLSKLQENLVKSHACGTGDEVPHEIVKLMLLLKIQSLSYGHSGVQLQ
TVNRLIDFYNNDILPIIYTQGSLGASGDLAPLAHLSLPLLGEGEVYYDGLRQPSRKVLEK
MNWKPIVLQSKEGLALLNGTQFMSAYGVYSLIKISKLSYLADVIAAISLEGFDGRIEPFN
ELIHMVRPHKGQINTARRFNDLLEGSQIIAQEKKHVQDPYSFRCIPQVHGASKDAFDYAK
KTFKTEINSVTDNPNIFIESDIIISGGNFHGQPLALALDFLGIAVAELGSISERRTYQLI
SGLRDLPPFLVSNPGLNSGFMIPQYTAASIASQNKQLATPASIDSIVSSNGQEDHVSMGA
NAATKTLKIVENLERILAIELMNASQAIEFRRPLQSSDFLEMFLKSFRDEVPLVTEDRIL
HYDIEKAILFLNSFQIDDVA
>KACEBFPM_00393 hypothetical protein
MLENPKIVTFPKTKLIGNKLEMSFANDKTFQLWSNFMPRHGAIINRIGTYKFSLQNYSDN
FQSNPTIPFYKWALIEVSDYNHIPEGMETYSINEGLFAVFKYNGPSNNAFPIFEYIFNTW
LPNSLYELDNREHFEILNENYNPQGNADEEIYIPIRLK
>KACEBFPM_00394 Polyamine aminopropyltransferase
MNFKRLLSYLIPIKIEEVKSSINKNLEITWNNGQLVLDSKNTNFSYGSLQKVLHFGLKEV
GFERIKSFKNILVLGVAGGSVIKTLIDEIQYEGEITGIEIDPKTIIFANKYFGLDKIKNL
QITITDAKKFITGTKETYHLIIIDIFEDDIMPAFLFENEFISNILKILKANSYVVFNTIV
NNNADEIRNENFVKLIALKHIKIERIANLEGNNELLILNNLL
>KACEBFPM_00395 hypothetical protein
MNYLKYTQYIYLVAAIFFAYDGFSQLNSGTDMAYLSFILAATAVFMFFFRRKFAKKFENQ
NKNQ
>KACEBFPM_00396 Lipopolysaccharide export system protein LptC
MTINFKILKTIKKVLLLIVTTLFFISCESNINEFRKINVVEFNPIGEAKDFNLKYTDSGK
IKVVLVSPQMLDFSQLDFPFTEFPKGIKVTIYDTQGNKSFVTSNYAISYTNSNLIDLSGK
VKITTNDGKILETEQLYYDQKNEWFFTQKSYKFTNKGSVIEGLGIDFSKDFKVLDTQSIT
GVYSI
>KACEBFPM_00397 hypothetical protein
MIKKILLSSFILLSFHSFAQEGTASPYSFYGIGNVKFQGTVENKSMGGLGILPDSIHINL
QNPASLSALKLTTFGVAGTYNTVKLENQYVAEKARRTTLDYLVVAFPAGKLGLSLGLMPY
SAVGYKIKKTTDVSTSLYSGSGGLNKAFVAAGYKLMPKLSVGIDVGVNFGKIERLSQVVY
ANAQNGIGETNTSQVSGISLNAGLIYKSKFKNYDVISSFTLSPSTNLVSKNTSVLTTIPS
TTVGSRELIVADSKIKIPSKLAFGAGLGEIKKWFVGFESTFQGSNDQENIEGSKVSYENA
TRISLGGYYTPNYNSFSNYFNKVTYRAGFRYENTGLVINEKSINDTAFTLGLGLPVGVGS
SNINIGMELGKKGTTNAGLIQENYMNISVGLSFNERWFVKRKFD
>KACEBFPM_00398 Type III pantothenate kinase
MILTIDVGNTRIKSAVFKYNTIIETTFFSNKNFQSEIENILNLNNKIKVLVVASVGKLEK
EAFELFSNRVYVCFISRESTFPFQNNYATQSTLGIDRMVLSAGAVFQFPKKNRLIIDAGT
CLTYDFVDENDVYQGGAISPGIRLRYEVMHNYTAKLPLLTLQEPQSLIGNTTNQSLHSGV
VNGLTFEIEGYIEAVRGKNENFIIILTGGDANFLAKRLKNTIFANSNFLLESLNNLYQYQ
K
>KACEBFPM_00400 hypothetical protein
MELNEYHKKLSIELVKIVEEQQKKPLTIEQVREQVRRINDGIDVEKRERMLTKMRERRNS
K
>KACEBFPM_00401 hypothetical protein
MKKSIIIILFLFTVTFSYGQQETLAIFKITEATENGDDVTKDYINSGGYIVFFTEPDGTF
YMSNVRPEKDSQSFGKLSPIKYDKPKENNNRIFLYTWNYKNNYNGNSGTATVELFKIYKP
QGGITYECKIATDKLIFLTYKGDFNENIAFRKWYN
>KACEBFPM_00402 hypothetical protein
MKKQLKISFVILILALITSCKSNRDECVDGLMKEEGYDYESACEACDEEASAIDHY
>KACEBFPM_00403 hypothetical protein
MGFILIFGILCFLVYVFKFNERGKYSDHQNFYDSTATANKSKFVSSKNVNEDAFTRELTN
TLEMEIQKLFRKYPREEDDVLLSLFIEQLIYSYREVYEKNVVEISNETNISISKVEEIIK
KCTNNCFDKYLLY
>KACEBFPM_00404 hypothetical protein
MKIYFKKYKYTHQIFYSSAVGASIDITNDGIIFDLPMHPQLSGTYFTFGEVKRTNSKITH
EARKLGYSTTFFIDEEIDGSKFSIYLSNLEGIILRP
>KACEBFPM_00405 hypothetical protein
MKYLEIETQDSYQHLTEIVQATLQVHLLKLKMAHNAI
>KACEBFPM_00406 hypothetical protein
MKKIVLVFFCAVFLSSLNSCVQQSEYDKLSEENKELREQLDELENGAVRLYGQAVELSKN
NELENAEEKLKILFDRHSETDESKKGRLLAIQIKSKKIEITNYKNALSINTLESLEKYIA
DNPKGRFVSECKKNIALVIKENEQKDKELDDFLNNVRSNSRDVSTPPKGGFTNSIPINIP
AQRPKYESFSKERPSDMYHTLSSGKQVAKYEHYIPGADNNELSAQNQTAYEQVIKALKYS
EKK
>KACEBFPM_00407 hypothetical protein
MISEEVFIIRLGTQIRKIREQKNLSQQNLADLCNVPKSTIARVERAEVNVTIKTLLKIAN
AIEISPTEFFTFLFNSDTK
>KACEBFPM_00408 hypothetical protein
MLDFFKNILLTQKVNQPQSNTTPKKINPFLINRKIDRIHILDYYGNRFDDNQFYSLNLKT
GLIFFIDKTNNNEFENYINENHTNLKESLAIKGRVFIKEINDVELPSNLDINYFFPFIDD
LNLSFFRINKNKYILDFIGYKGNIETGFLSFTSSGITFFSIKENENFNEFVSQYIDDLSI
DNHNKIPIFYSLRKKTEDDEPQIEIDSETKLLLNQIEDNLLKLEKSGQYFLIAPKIENLI
KNLFKHDKDHDFMISEVLINYDFQIILPQYQNREIKLSHLTKSIYILFLKHPEGILLREL
YKYENELLSIYKAISYQVSLDKMKKSVQHLITNEKAIFVHFSRIKSVFMKNFTNNYARYY
YIQGEKGQKKLIKLPLSKIIFQSKI
>KACEBFPM_00409 hypothetical protein
MTKKPDISKLYNYHNEEGVLLEMSSDYKLISRELKSINVDYEKRAIHEIIQELTEIRTLY
YLEFCDENNVLDPDIIDDEDFIKINFLIAYMENLKLYLQEQHKINTKTHSKC
>KACEBFPM_00410 DNA processing protein DprA
MTETELHYLLALQKVEGVGDIMAKKLLNHCGSAEAVFTTKTSQLATIDGIGKVLLNNLKN
ETVFGQAEVELKYIQNNNINVSYFKDENYPERLKHCIDSPVLLFTAGNINLNQSRIISIV
GTRQITPYGIDFCKKLIADLAPLNPIIVSGFAYGVDIVAHQVALENNLQTIGVLAHGLNQ
IYPKVHKKYMSKVEENGGFMTEFWSNSSPERENFVRRNRIVAGISEATIVIESADSGGSL
ITANLANDYNRDVFAVPGRISDKYSQGCNNLIKTQRAHLLSSAADLIYILNWELEKKEKT
IQKQLFVSLEPEEQLIHDFLQKKGKELLDTIAIECNLPVFKLSSILLNMELKGLIRPLPG
KLFEII
>KACEBFPM_00411 hypothetical protein
MLITLFFSLVFYNFALMNIANHISQLLYRFQCVNVPGFGAFLAETISANIQESNQTFYPP
KKVISFNSHLKNNDGLLANHISISEKMSYDQAIIAIENAVSLWKIELESNRLLSLKNIGE
LRLNLENNLVFEPSNHLNYLTSSFGLSSFVSPLMKRELAITKTEETQETQDIEVVYQIPA
TANKRYLNTYLKYAAVFLLSVGTTSIGYKAYLNEAEQAETLMVQADVQKEVNAKIQEATF
FINNSALEAETKKTLPFHIMAGAFRNEKNANRELENLISKGYNARILDKNSNGLIPVVYG
SFATYTEAQYKTTQIQNTINPVAWLLIEEL
>KACEBFPM_00412 putative acyl-CoA thioester hydrolase
MQVKYPSESLTILTDMVLPGETNPLNNLFGGELLARMDRAASISARRHSRRITVTASVNH
VAFNKAIPLGSVVTVEAKVSRSFRTSMEIFIDVWVEDRESGNKSKANEAIYTFVAVDETG
HPVEVPAIEPQTDEEKSRFDAALRRKQLSLVLAGKMKPSDATELRALFL
>KACEBFPM_00413 Beta-barrel assembly-enhancing protease
MNTKSKIITGLLFFSLATFAQKDEMKALKKIYTKEVITDNDLADYKKYAMKFGDVAIEEE
DKVYSEFYKCMLPILEINALGANATSIQKSNFVNMQTISNLSLGLNATLDFEKKTGKKLY
TDKIIETVKNFKPILWEYVITLDGQKKYKEVSQAAHLIYQLDKKDLERLYIAAEYATSGQ
EYDKAIEYYNELNAQKYTGESTSYIAKNKLNDQYNAFSTIAERDLAVKIGTHTDPKVEKT
PSKKGRIDKNIVESYIGKNDIPGAKKAIIDAKLTNPDDTSLIITEANLYLKTEDYDTYKK
LIAEVLLKNPNDADLFFNLGVISGKAKDGQAEAEKNYLKAIEIDPQYKEAYLNLALLKLE
GEVKLSEQMNKLGTTPADNKKYDVLKAKKRELYKSSLPYLEKAEELFVGDDQIKGVLLNV
YNALDMTEKSKALKAKK
>KACEBFPM_00414 2-iminobutanoate/2-iminopropanoate deaminase
MKKIIFTDKAPAPIGPYNQAVLSGNTLYTSGQIAINPATGNLVLDTIEIETEQVMQNLKA
VLEAANMTFDDVIKTTIFIMNMEDFARINTIYGKYFTEQSAPARETVQVACLPKNVNIEI
SVIAVK
>KACEBFPM_00415 hypothetical protein
MSLQKLRHIFTKIVFIALRTNLFHIVFLAFLLTSSYNTSYSQELREKSTSIPSKNQKDSI
NIGIKKDSVTKKKALLEGQIKYKSKNYAKINQKKRQITLYDKAEVYYKDIELKAGTIVID
YEKSEVYAGRIKDSANSYSQYPYFKQGNNIVEPDSIRFNFKTKKALIWNSRTDQDQFKVK
GEITKRENDSVYFIKNARFTTSKNLEDPEYYFLARKIKLVPGKKVVTGFTNMVIVGVPTP
LAIPFAYFPLSKERSVSGIIIPTFGDSNAQGYFLQNGGYYFALSKHYDLAVLGDYYTNGS
FAFRAETSYAKIYKYRGNFSFKFENQIAGERGLPGYLKNNIYNLQWSHAPDPKATPNSRF
SASVNLGSTKYFKNSFNQINTSASLNNTLSSSISYSKTFNTVPQANIAIIANHSQNTNTG
QINMTLPTVTASLDRIYPFAKRAESKKGFIKNINFTYGLSARNEIQTVESLFFKPQMFND
AKNGMQQTIPLSSSFKILKHLNISTSSNYTETWYIKTIEKKYNALTNLVDETTKNGFDAF
RTYNFNTGLATTIYGTFNISKDKKIQAIRHVMTPSLSYTYKPSFEKYYDTYASDGSGKMA
DYTRFEKGIFGAPDKYFSNNLNFSVNNTFEAKVRDRDSTKVEPKKIMLLNNLQFSTGYNM
SAQNGAQAWQPVRVSGGTNLFKEKMNVNFAATLNPYAIDANGNPLNILNINNGGSLFRMT
SANMTLNYSLSSKKDDKKKEDPLHNKGLQNGGREDDLFGKTTDFSNRQESQFGKDDKEDK
FAGFFKAQIPWDLKLAYSLTYSNDKRETKITSSSLMFSGNIDITPKWKAGVSSGYDFVQN
GVTYTQLRFERDLLSWRMNFNWMPFGNQASWYFFIGISSSVLSDIKWDKRNTADKKL
>KACEBFPM_00416 N-acetylmuramoyl-L-alanine amidase AmiB
MKFTLKIKPLVFILSLFFVANALAQTNYKFKVVLDAGHGNHDFGATYHGFVEKNINLAIV
LKLGKILELDPNVQVIYTRNNDTFVDLVERANIANRASANFFVSIHCNANKNNDAYGSET
FVMGLSKSASSLAIAKKENAVITLEDNYKKKYSGYDPNSPESLISATIAQEEYLDQSIEL
ASKIQEGLENKLNRKSRGVAQAPFMVLHKAFMPRVLVETGFISNLDEGTYLNSEEGQQNI
AKTIADAVFRMKAEYFGGTVPVIDIKKYEKPEIKDSTPKVTLPVQAKDTSKEQKKIVDTK
KIDTSKVIFKVQLKASASKIEAKPKNFNGLDKISFVLEKEYYKYMYGETNDYLVAKMQLL
EAKTKGYDSAFIVVFKNGIKISLNEALKK
>KACEBFPM_00417 hypothetical protein
MLKIFTLKITREIKTAILVIASILLFIWGYSFLKGQNLFNSHKKLFVEYDNVEGLATSAP
ITVSGKVIGKVNSITLNTNGKLLVELQIDDDEFPISKTSIAQIYEPGVIAGKQIAIIPNY
KDANITNDGDKLLSGIKLGLTDALGQKLEPLQARLDKVLANADALITNVNTVLDAQTQTN
LKNAIAGLNKTMTNFGKVSSDIDGILIENKVKLGSALGNLDKTTQNFAKISSDLDKANLG
ATVKNLDATLTNVNAIVANLESGKGTMGKLLKDDAMYTNLSKASKELELLLQDVRLHPTR
YVNVSLFGKKEKPYIEQAVQKK
>KACEBFPM_00418 hypothetical protein
MSYLDNILFFIILCIGIGYFAINVKKIIRNIKLGQEINRSDNPSARWKNMAMIALGQSKM
VKRPVAGILHIFVYVGFVVINLEVLEIIIDGLFGTHRIFSFLGTLYNLLIGSFEILALLV
LVAVIAFWIRRNIIKLKRFIHSDLKGWPKSDANYILYFEIVLMSLFLLMNAADYHLQLLN
VGEYHKVGSFPISQFLEPIFNGMSESLVIMIERGAWWIHICGILVFLNYLYFSKHLHILL
AFPNTYFANLKPQGQFDNLESVTKEVKLMMDPNADPFAAPAPESNAVVSKFGAQDVQDLN
WVQLLNAYTCTECGRCTSSCPANQTGKKLSPRKIMMDTRDRLVEVGNNIDANKGVFIPDS
KFLLGDYITPEELWACTSCNACVEECPVNISPLSIIIDMRRYLVMEQSAAPQPLNAMMTN
IENNSAPWQYNQQDRLNWKNE
>KACEBFPM_00419 hypothetical protein
MSIEYLDKTLIAISENGQTISPILSEGIKNYLIGIGGTICDDILNEQPERMLRGQLYPEA
LATLNKWYDEEHIICFFTSRTEEYRKYTKIWLDKHGFKYHRILMGKPRGGNYHWIDNHLV
KATRYQEKFTNLINKQVTIQVFDDGQHQYKFGYLFNCLIY
>KACEBFPM_00420 Lactate utilization protein A
MQETLIVPTMAEMLAQGKQPEVLFWVGCSGSFDDRAKRITKAFVRILNRAKVEFAVLGTE
EGCTGDPAKRAGNEFLFQMQAMMNIEVLNAYEAKKIVTACPHCFNTLKNEYPELGGQYEV
VHHTEFLKSLLDDGRLTIEGGQFKGKRITFHDPCYLGRANKIYEAPRELIQKLDAELVEM
KRSKANGLCCGAGGAQMFKDAEPGNKEINIERTEDALETKPEIIAAGCPFCNTMLTDGVK
NKEREADVKVMDIAELIANAQDL
>KACEBFPM_00421 hypothetical protein
MYIPFENLPLESKIWIYQSNRKFTDEEFTEIQIAAEAFIQNWSAHGASLEASYLLKYNRF
IIFAVNPEVQPATGCSIDKSVQFIQELEQKYKVDLLDKMNVTFKNGEFVAHKTLIEFKKM
AKDKAVTGSTIVFNNLVNSIEEFNESWEVAAEDSWHSRFF
>KACEBFPM_00422 Peptidase T
MQHIIDRFISYVTIDTESDPNSETTPSTAKQWDLANKLVEELKAIGMQDVTIDDKAYIMA
TLPSNVSHEVPTIGFVSHFDTTPDFTGKDVKPQIIKNYDGNDIVLNAEKNIVLSPKYFKD
LLQYKGQTLITTDGTTLLGADDKAGITEIVSAMEFLIKNPEIKHGKIRVGFTPDEEIGRG
AHHFDVQKFACDWAYTMDGSQIGELEYENFNAAGAKIIFKGKSVHPGYAKGKMINSMLLA
NEFINELPKDEIPQKTKGYKGFFHVTQLSGSIEETQLELIIRDHDARKFKKRKELIHKIT
KKMNKKYAKQFGEDIVITVLNDQYYNMKEKVVPVFHIIDIAEKAMKNLGIKPLIKPIRGG
TDGCQLSYKGLPCPNIFAGGHNFHGKYEYVPVESMQKAMEVIVQIAQITASGDYKKTEKN
DDLI
>KACEBFPM_00423 hypothetical protein
MKETVEDKLDIIAKIWNNFILEYKVCSSEIKFNDDVKTNYFGNILGCFKDTFDIIFTTNK
YSNYTEKFSFTISFLQAIYIQQDFIQEMLEIFRTGIEKGDLKKDQTYYINRDLRNELIGH
PIRKDVSRAETIQKKCDSCGKILKPKNKLALLSSTFFSYQESEDEIEYLLYHRDNDFRFE
SKTFKIIDIQERHRLFLETYLDIILEKFKIILNDYLSEISKLEKVIEKGNFETVLKLVKL
YLEAIFKYSPIYNKESLIKIHARANEHRRYKNFIDTFNIYLRKNLSEKKNSVNKILDTKV
IDKSPFQNSSLPKFKIAINTTNTKGFNVKPHKDDYHYEIGKITEKRNFSKFGNLLKDKCK
DNKLVQNELIHMQKNIQDDIEYYTALRLISTELNTD
>KACEBFPM_00424 tRNA dimethylallyltransferase
MNYLITIIGPTAIGKTSLSIALAKQYNCDIISCDSRQFFKEMRIGTAVPSDEELSQATHH
FIQNKSIFEEYTVGDFEKEAITKLDELFSKNNIQIMVGGSGLYADAVLKGFDSFPNIKPE
IREKIQEQYDENGIQYLQQKLQELDTEYYSKILSQNPQTLQNPQRMMRFVEVCLGTGKPY
SSFLNKDKITRNFTPIIIGLEADREIMYDRINQRVDIMINEGLLAEAEKLYPNKDLNALQ
TVGYRELFSFFDADFTLNFAIEEIKKNTRRFSKRQITWFKRTENTIWFDYKADISKIIEV
INTKMKH
>KACEBFPM_00425 putative ATP-dependent helicase DinG 
MYAILDIETTGGQFNEEGITEIAIYKFDGHQIVDQFISLVNPEIPIQPFVVKLTGINNAM
LVSAPKFHEVAKRIVEITKDCIIVAHNTVFDYRILRTEFSRLGYDFQAKTLCTVELAKIL
IPEQPSYSLGKLVRALGIPMTNRHRAEGDALATVKLFKMLLDKDLEKIIVKEQIKTEITK
GIAPKLLNIIESLPNKTGVYYIHKENGTIIFIGKSRNIKKRVNQHFTGITKSALKIQQEV
FTVTYQETGSELIALLKETEEIKRNRPIYNRISPKTHFPVAIYCEKDANGYLNLKLQKFD
GRKKEITAYTSLQEGKNNLFRITSQYNLCQKLTGLYETKTHCFQQKINECDGACIGKITP
QEYNKRVQEFITKSTLENQSIIIIDSGRTTREHSAVLIENGVYKGYAFFDLNYQISNIQI
LKNLITPMPNNRDTRNIIQGYLRKNKVMKIMKF
>KACEBFPM_00426 hypothetical protein
MEKNNIFNEKIFNFEDRLVRFAGECILFTRNLNKSYENEYYKNQLIRSSGSSSLNFGEAQ
GTITDKDFIFKVSVVVKELKESRNSLKILNYIKEGDENQRILMLNETEELIAIASKMIIN
KQ
>KACEBFPM_00427 hypothetical protein
MSIAQNLNKIKASIPESVTLVAVSKTKPISDLMEAYQAGQRIFGENKIQEMTQKWEVMPK
DIQWHMIGHVQTNKVKFMAEYVSLIHGVDSLKLLEEINKQAKKCDRIIACLLQIYIAKEE
TKFGLDEKELNELLASTEFKSFQNIKIVGLMGMATFTENQNQIKKEFTHLKSIFDNSKSS
SIVNCQLSILSMGMSGDYKLAIESGSTMVRIGSSIFGGR
>KACEBFPM_00428 hypothetical protein
MAKIIPFKAVRPSADKVGLVTCRTYDDYNSAELAAWLSYNPYSFLHVIHPAFANAQKITI
DKRFKSVAHKYQDFKDEEILIKEEIPVLYLYEIQTKSDIFSGIIAGTSVEDYKSNVIKKH
EDTLQFRVELIKDYMKHTDFNAEPVLITYPDNVEINNYINSHKKKKPLYEFATTKKEKHR
LWKIDAQNEIDWLQNHFEKIPALYIADGHHRSAAAKLLAEEKKDTKNENINHFMSFLIAE
SNLKIHEFNRIIRDLNGFTKEGFIAKIAQHFNIENKNQELWKPKNKHEFGMYLDGNFYAL
FYKGEINENFNNKKKILKNLDAQILYDTILHPLLGLEDLRNDERIDYIPGKQSVSAIKDL
IDEGEFKVGFMLYPSDISEIKTLADNNLIMPPKSTYIEPKFRSGLVIYEL
>KACEBFPM_00429 putative 3-hydroxybutyryl-CoA dehydrogenase
MKNIAVIGAGTMGNGIAHTFAQSGFTVKLIDISEKSLEKGIATIAANLDRMVAKGTITEE
DKHKTIGNIITYTDIKDGVTGCDLVVEAATENLTLKLNIFKQLSEICDHNTILATNTSSI
SITQIAASVVHPERVIGMHFMNPVPIMKLVEIIRGYNTTNEVTKIIMDLSVKLGKTPTEV
NDYPGFVANRILMPMINEAIETLYNKVAGVQEIDTVMKLGMGHPMGPLQLADFIGLDVCL
AILNVMYDGFKNPKYAPCPLLVNMVMAGKLGAKSGEGFYDYAESKKAEKVSKQFS
>KACEBFPM_00430 Putative oxidoreductase YceM
MLKVGVLGAGHLGKIHLRLLQQSEKYELVGFYDENQENGAKIAAEFGYKQFDTIAKLIHA
VDVIDIVTPTLSHYKCAKVAIKSGKHVFIEKPISTTVEEAEEIIALAKEYNIKGQVGHVE
RFNPAFKAVKDQIKNPMFIETHRLAEFNPRGTDVPVVLDLMIHDIDAILSVVNSKVKNIS
ASGVSVISDSPDIANARIAFENGCVANITASRISMKNMRKSRFFQKDAYISVDFLDKVCE
VVKMKDAPETPGDFDMILQNAEGIKKQIYYENPSVEPNNAILDELDSFADAINNNTTPVV
TLEQATDALRVAYQIINCMEK
>KACEBFPM_00431 Protein-L-isoaspartate O-methyltransferase
MKDTPKHQGLRNQLVTVLQQKGITNKNILEAISKIPRHLFLNSSFEDYAYQDLAFPIGAG
QTISQPYTVAFQTELLEVKKGDKVLEIGTGSGYQTAVLCMVGAVVYSVERQNELFKKTSL
LLPKLGIRAKHLSFGDGYKGLPNYAPFDSIIVTAGAPEIPKALMAQLKIGGKLVIPVGEN
SQIMTLIIRKDETQFEKHEFGDFKFVPLLEDKN
>KACEBFPM_00432 putative peptidyl-prolyl cis-trans isomerase
MENGIYAKFNTAKGSVLVKLTHDLTPGTVGNFVALAEGNLENKVKPQGTPYYDGLTFHRV
IPDFMIQGGCPQGTGTGDGGYKFDDEFHPSLKHDRPGILSMANAGPGTNGTQFFITHVPT
SWLDGKHTVFGHVIEGQDVVDAVEGNDVLKTLEIVRVGEEAQKWNAVEAFRTFEGSRAKR
EAAEKAEAEAKMEQLAAGFDKTQSGLRYKMIQKGSGKKAENGKTVSVHYEGSLESGKVFD
SSYPRKKPIDFKLGQGQVIEGWDEGIALLQVGDKARFVIPSHLAYGSRGAGGAIPPNATL
IFDVELMDVK
>KACEBFPM_00433 hypothetical protein
MNNNKKVLILVLSVSFIYGICSFFNSFLIGYFPSFKNVNLIADITKEIPKKAKNKNLEQK
KLPLLASTAYTNFEDYLKKDELIDFDNNSKSATLGNIAEKLLLLSENKNIKIRIAWFGDS
QIEGDLITQDIRKMLQAYFHNHNGVGYLPIKSVSSDLRQSANIKTSDNVEVSNFKKGSAI
NNLFLSGYHFTSPNLTITAKDNTKKDSTQHLQKWLLFGKGDSIAVTYNGAIKKYAATKSF
NRVLIDKLPSNKIYFEVQANKTPVYGISFEPEKGIVLDNFSFRGITGVELKKVQNQLLQQ
LNTEGYYDLIVFQYGVNLMFRANDTDYSYYQKIMNPVLDKYKKNLPKSKFLMLSCSDRAF
RYNNQWESAVGIDSLIKTQAKLAFDNKIPFYNLFASMGGRGTMKKWCDTLPSLANKDYIH
FNHRGAKKVAQIIFDVLIKDFKKSIKYQKKQKDKQQKDSIFKAKDHE
>KACEBFPM_00434 Divalent metal cation transporter MntH
MGKSLEEVHESVSTQNKTSILKKILAFFGPAYLVSVGYMDPGNWATDIAGGSQFGYTLLW
VLLMSNMMALLLQSLSARLGIVTQRDLAQASRETYSPFINYILYFLAEIAIAACDLAEVL
GMAIGINLLFGIPLMQGVMITVLDTFLLLFLINKGIKKMEAFIIALVMIIGVSFIFEMIF
AAPEVGSVLKGLIPSMPNENALYIAIGIIGATVMPHNLYLHSSLVQTRKFDRSTAGIKQA
LKYNFIDSTIALNLAFFVNAAILILAAATFYKNGLFEVAEIQDAHKLLAPMLGTNWAPVL
FAVALIAAGQSSTITGTLAGQIIMEGYLNLRIQPWVRRIITRLIAIVPAVIVISVFGESV
TGKMLILSQVILSLQLGFAIIPLIHFVSDKDRMKGFAISKTTQIASWIVAVIIVSLNAKL
VFNEIKDWLETAENPIILWFTVVPLSIGFLILLLYIVFKPFMTKSKINIQNHLPHNMVLK
FSASETYSKKDIAISVDFSSADELAINAAFELGGIEASYTLIHVVETVGAMLFGKNADDH
ETSIDEKLLKEYEVMLCKKGFKVFTILGFGKPDKAIPKIINQGNYDVLVMGTHGHRGIKD
LLFGTTVNKLRHEISIPLFIVKK
>KACEBFPM_00435 hypothetical protein
MFLIVSKYLISKKYRGFTFFPFIIIRNVFDKTDKILINHEKIHIRQQLELLILPFYIWYF
LDFLIQMIRYKDSNKAYRNIIFEKEAYANEKNLDYLKSRSFWKFLNYK
>KACEBFPM_00436 hypothetical protein
MNQNYFQKKDTKAYFFVVFAVLLLLNTFSISAQTTIIGPVTGGGFEAGTTFAANGWSTIG
GSATQNVWFDGTSAATGFSGSRCAYISNTAGGAHLYDISSSRASFLYRNITIPAGEVDIS
LSFKWINAGESSYDKIRVWVVPTTFTPTSGTAISASGAAPTGIIQIGGDFSVKTSWTSEN
LLLPSAYAGTTVRLVFEWTNDSSIGAQPPGAIDDVLLVSKTTCYGSGIGTTTLGCPNTVS
GGLGLGGSPAPTITCSTAACANLEATFTPIKQTTSYTVSSIAYAPPYQFNCMKNPVSVNV
DDMWSPVVNLPFNFCFYGNTYSQCVIGSNGVLTFNTAKANTASGYSFSDNLPSTTGNLFA
NSIYGVYHDMDPAIGGEVGWELITLNTGCRALVASWNNVPMYSCTSDNYTGMMVLYENTN
IIEVYIKNKTVCATWNGGNAIVGLQNATGTAATVAPGRNALDPDWTTTNEAWRFTPSGAS
VPTSIKWYEGAGTSGPVVGNTAVINVCPLVTTTYTAELNYTLCNGLAYSNTAQTTVNVNT
DKTWNGSLSADWNVAGNWTPSGIPTIAQAVNIPSTVNNPIIGTGVDALACSVKIQSGAIL
TVNSGFSITVANVVNVLAGGTFNIKNTGSLVQTNNVTNSGNINMERIANLRLQDYCYWSS
PVGNLLAGTFPVQSVSPLTPAGFIYKWGTTAVNTNGGFGNWISTTENMIPTTGYILRAPN
GFTNAAPSALKANFIGTPNNGIFTPSIIRGTDVTGVAPNGIIRTIEDDNWNLIGNPYPSA
IDALTFLNLAANNMIDGSIRLWTHGTLPSTGVTDPFYADYAYNYTDTDYIIYNKLGASAG
PSVFNGKIAAGQSFLVLMNNGPAGSGTVTFNNTMRVTNNNSQFYKKASFTKNTTEEKHRF
WIDLISPTTTANRILIGYANDATHEKENLYDAITDYKSSQNFYSLINDEPMVIQGRALPF
DINDNVPVGIKIPANGTYKIAIAAVDAMFAAGAQTIYLEDKFLNVIHNLTETPYQFTAVA
GITNNRFVIRYTENALSNNDFNYSNNINVFANNGINIISTKENIKDVVIYDVLGKTLLDK
KSIIKNEVKLTELPATTSVLIVKVTLENNKVVIKKVIY
>KACEBFPM_00437 hypothetical protein
MSAIWYECKVKYRKTDDTGVQKVTTEPYLVDALTYTEAETRINEEMSAYISEEFKITNIK
VANYAEIHPFENTDRWFKSKVSLLAFDEESGKERKTNMYILLQANDVKEAYDNTVAVMNG
TMGDYTIPAISESPIMDVFPYFSGEEEKTEQFEKFNRTKDSKLTKAEEVEVLDTMEFDAA
FVSENALS
>KACEBFPM_00438 GTPase Der
MNNIVAIVGRPNVGKSTLFNRLIQRREAIVDSVSGVTRDRNYGKSEWNGKEFSVIDTGGY
IRGSDDIFEGEIRKQVELAIDESDVIIFVVDVEEGITPMDDAVAKMLRKVTKPVLLAVNK
VDNAMREKDAVEFYNLGLGEYYTFASISGSGTGDLLDALIDAFPIKPLPTQEEIVLPRFA
VVGRPNAGKSSFINALIGKERFMVTDIAGTTRDSIDTKYDRFGFEFNLVDTAGIRRKAKV
KEDLEFYSVMRSVRAIEHADVCILIIDATRGFEGQDQSIFWLAEKNRKGVVILVNKWDLV
EKDTMSTRDYEAKIREELMPFVDVPILFVSALTKQRLLKALEATVQVYENRQQRISTSKF
NEYMLKIIENHPPPALKGKFVKIKYCMQLPTPTPQFVFFANLPQYVKDAYKRFLENKIRE
NWDFEGVPIDIYIREK
>KACEBFPM_00439 CMP-N,N'-diacetyllegionaminic acid synthase
MKNKTIVIIPARGNSKRLPGKNTRLLGGIPLLAHSIKYAQQFSFIKDIYVTTDNLEIKNI
ALQFGAQVIDRPAEISGDFEPTVSALKHVIASLPNDVENVILLQPTNPLRPLSLLAEAFQ
IYLNSDSDSLFTVSRNQNKLGKIVQEKFQPFNYKIGQRSQDLEPLFYENGLLYITKASLI
RNDIIISNQAFPLEVNHIFAKVDIDTQEDFDYAEYLFKKETFY
>KACEBFPM_00440 hypothetical protein
MIIFSVLITTKNRLEDLKITLQKIAHLIERSDVTCVVYDDGSADGTSVYLKNNYPNIQLH
TNINSKGYIYNRNYLLNHCEGKYAISLDDDSNILTENCLEIIKNHFNSNKNCAVIACRIF
WGKEEPFTFDAKELVERVNGFVGCGHVWNLKAWKDIPNYPEWFEFYGEENFASFQLLKKG
WAIHYVPQILVHHRVDVIARKNNNDYQIRRRRSLRAGWYNYFIFYPISKIPRNMASSVWQ
QLKNHTFKGNLKATVAMVQATFDLFLHSAVIFKTSNRLTKKEYSAYCNLPEAKIYWNPTH
EK
>KACEBFPM_00441 hypothetical protein
MRFLIITQDLHITGTSQGIIERSFLSKLRIVYPEAHIDVLYLCTSNQEDHLEILPVNSIL
KKTINIKIPFAVKWINRLTSRLFQVLYAENYIHNQFAKEIKKIDYTLYDHIMVRSAGLNH
ETLLAMHNLPILKHAVVNFHDPYPYSWYKGLSLRVTNLELVRLQKMIQIVAQAKTCCASA
YYMAKDLQYLYASNKCFYTLPHQFAFAGFDLSDKNMVRKKERKIQISYHGALMFGRDIFT
LVAAFIQLMNQYDWIKNEVEMVLRVKGDGLEKLKQLVTGYNNIWVLETLNFSNSANEQIH
ESDITIVLENGPYYSNILGGKVPFLFALNKKVFISSPERSELKKHFPNYPFLADMNDLAD
TKAKLYAVLTSHDRHEASTKQFFSDECFKTALDVILHNQTKLK
>KACEBFPM_00442 hypothetical protein
MKNDLAIVIPYYKINFFKETLDSLASQTNKNFKVYIGNDASLDNPWELLSKYQGDFDFEY
HEFQENLGGTSLVNQWHRCVDLAKKEQWLMLLCDDDTISENYIEAFYNHIKEVNSLNVAV
VRYASQVIDENNIPLSVIVQHPKLESAIDFLFRKLKGGTRSTLSEYIFKREMVLKVRFKN
LPLAWFSDLLGVLEFSEFKNIYTINEALLKFRLSGINITSKTDDVVLKNEATFQFYYYLL
TIHEKCFNKYQIFVLLNTLENTFFNNKKNTKHWLLYTKLCFLNLKISRYIAFINRIFITV
VKKI
>KACEBFPM_00443 putative glycosyltransferase EpsJ
MSLVSIIIPVYNQEQFLSETVQAVVNQTYANWECILVNDGSTDGSVLILARTLAKDNRFS
CINSENKGVSHARNLGLQQAKGEYVLFLDGDDLIHPEKLQQAIAGFQENASLSIVFNTTN
YFQDTIQNTLYPIKINTQLLNFNDLLLYWGEKIIIPIHSAIIKKSLFEGIEFNGDLTAQE
DWLVWLRLFQKKPKVLVLDTVLSYYRKHNSSRTQSFSLKEDHFKALEIFEKYIGSDNHKK
LLLHQAERYYVRANANAFKLSEIKKSKTYRTAFFVKKIAVKLKLLGIIKLLSAKFFKDEK
>KACEBFPM_00444 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MKIKENQNNKKKIVFKISEFPHVSETFIIAQIITAIQLNYAVVILVNKALDFEQSLHEDL
LLKYKLNEFIVLEDVKIPKNKIIKCFKIFYLFISNLSHLKNMLNFYKFQKEKSFSWIFYW
IFYKQFDDSNTIFHIQYGNNKFPIDVLKAKCNFKAKVITTFHGHDAFFPMQGFIPNNGYY
DLLFESANIITANTPYLADKIKKLNCPPEKLKIIPVGVDTNFFNVLDRVQKSKSILKLIN
VGRLDPVKGQKYLIQIVNQILEKGINVHLDIVGEGAERNNLEQIIRKYNLAESIKLVGEK
SESEIKEMYLKSDLYLFAAVPLPNGRRETQGLATLEAQACGLPVIAYNSGGVKYTIKDNV
TGFLFDEFEIEKVVKKLLFLNENRAVIYEMSNNCYKFVAKNYSQNVVTEKWFSIYSNL
>KACEBFPM_00445 O-acetyltransferase WecH
MKISKTVPTHYGISLLRILATLSVIIIHVAAPLVMKFGKISNFDWNVANIYDSMSRYAVP
VFFMISGALLLGRDSEIKDFLKNRLGKILPPFLFWSLFYSVTNRYVFTQETFSISKIIRD
VFYGSKYHLWFVYALIGVYLITPIIQKWLKFSENKEILYFLIIWVITLFLTIPGIAIYFP
KINLAYFSGYLGYFILGYYLKNYGMQRKLISYSLLFVGLAITILGSYYMTQKNGVFYDYF
YEYLCINTLLVSMGIFLLFNTIETINDNLKPIISKLNECSFGIYLVHPLVLNIFGLLGIG
GSFISPVIGILIVSLTCFLLSFFLIFSIKKIKFGHLIA
>KACEBFPM_00446 Putative glycosyltransferase EpsE
MLISVVLPVYNVAPYIDEAIDSILNQTIQDFEIIVIDDCSTDKTIEIIESFNDQRIKILT
KSENKGLIDSLNIGFKAAKGKYIARMDGDDISDFMRFEKQLHVLENNPTIKVCGSWLQAF
GKENKIIKHKENHEQILVHMMAHCSMSLGAVMIDRAWVKDECFNEEKKHVEDYDFWSRVI
WKGKLYNIQEVLYHYRTHENQVSNKYNHIQRKGDIPIKLVFFKKLNYNQEKFKDSFFEKM
FLQKEYFTIEEFSLFLAWFSIVQEQNKKLKIYNQSDFNKVIKKYKTSLIYKIYFHSNFCK
IDKKWRITALTKLSFPDFFFVFKLKIKEKLKF
>KACEBFPM_00447 Glycosyltransferase Gtf1
MSKVKVLFVVGSLCRAGAERFAYEIDTALNKKKIQTTIFCLELENEISHNWKERYYDKKH
LELGTPIVFKDKFLDEKKTFIDRLEGYLYRKLKITKPKKPNSDLVAFLNSFDVIHWMGEY
TYIQSIPKNIQNKSLIHIMSARFQDDTIYKSFDFSNHYNFCSPFKKEELLYELNLFKDYN
HTFIPLVLKMNNLNNQWKFNHEPIKKIGIFTRLDRYKPLDPFLYAFHLLLDKMPNCELHI
YGNGDPKTEGIIGIIERLNIKEKVFFRGHQDNIVETVFKENLSLSWFQGYNNDRPAGYAG
IDICTTGLPLLCWDFHPKPNNIVNTIYPHFKNLNEFVNYTLEILNDKEKAIVLSENQFKQ
TKKDRNIDLYIQVLEQEYLRIYNLC
>KACEBFPM_00448 dTDP-4-amino-4,6-dideoxygalactose transaminase
MIPFNKPFLTGKETIYIEQAVQSGKLSGNGNFTQKCQQFFEDKYKFKKCLLTTSCTDALE
MCAMLINCNQDDEIIVPSYTFVSSALAFVRQGAKIIFADSQDNNPNIDANKIEHLITPKT
KAIVVVHYAGIAADMDKIMQLAHQYNLVVIEDAAQAIDSFYKGKPLGSIGHLAAFSFHET
KNVISGEGGMLAINDDKYIARAEVIWEKGTNRASFFRGEINKYGWVDTGSSFLPSEVIAA
FLWAQLENLELIQEKRKAIWNTYYNTLKSFEKEAKIKLPIVPDYASNNGHLFYLICNSID
ERTDLINKLKNNNIHAVFHYISLHSSDYYSKTNEVPALKWSDYYTDRLLRLPLFFELTEE
QVIMICNTIIHE
>KACEBFPM_00449 UDP-N-acetylbacillosamine N-acetyltransferase
MKTLAIIGSGTLGLQMAHYAIADKHYDKVVFIDDFATEKEKNGYPIIGKTTEVEKLYKQG
FLEELIIGIGYKHLEVKKELYDFFLGKIPFGKIIHSSCWVDPTSVIEEGCFIYPCCVLDA
NVIIKANTILNLNCTIAHDTVIGNHSFLSPRIAVAGFVTIGELCFLGINATIIDNINIAK
QTQIGGGAVVIQSIKKNGLYVGNPAKFIR
>KACEBFPM_00450 hypothetical protein
MKKIAILQSNYIPWKGYFDLIASVDEFIIYDEMQYTKNDWRNRNKIKTKNGIEWITIPVK
VTSISQKINETLIFDKKWFKKHQATLQTNYAKAKCFNETKDIIFGLYKQAQSKDKLSEIN
QIFIKGICDFLDIKTKISVSSDYNLIAGKTERLVDLCRQTNATNYLSGPSARDYIDESLF
KEKNIILEWMNYADYKEYKQPNLPFEHGVSILDLIFNEGKNARSFLKY
>KACEBFPM_00451 Teichoic acids export ATP-binding protein TagH
MSKTIIKAEDISKQYRLGLVGTGTLKDDIKRWWHNIRGKEDPFLKIGQANNRATKGESDY
VWSLQDINFEINQGDSVGIIGRNGAGKSTLLKILSQVTQPTTGKIYTKGRIASLLEVGTG
FHPELTGRENIFLNGAILGMRKHEIARKLDEIIAFSGVERYIDTPVKRYSSGMYVRLAFA
VAAHLESEILIIDEVLAVGDADFQKKCLGKMNQVSKGEGRTVLFVSHNMAAVEALCNTAI
TLKNGRLIDSGNPSKLIKNYLIENSNTNRKIRFSNIEEAIGNNAIKILSASVNNASSNNT
DDIIDLSSDIEITFELLNLTNNPEISIGFDLKTTRGEILFGSGRVISCPNHKNTTVTCQI
PGNLLNDDTYQILLYVHTKAMGLLFMKDEILSFEIKDAKREEGYLGKVNGFIRPTLTWK
>KACEBFPM_00452 hypothetical protein
MKEYKETAEAWDSVIQSQTALFDLRLKELWHYRDLLILFVRRDFVTVYKQTILGPLWFFI
QPILTTITFTIIFGNVAQLSTDGAPKVVFYMAGIILWNYFSTCLTSVAGVFNANAGIFGK
VYFPRLIMPLTIVISNLMKFGVQFVLFLVFVSYFYYQGQILPNLWILCTPLVVFLMAVIS
MGTGLILSAMTTKYKDLNQLISFGVQLFMYATPVIYPSSSIPKNYQWITHLNPLSSLFDY
MRYAYLGVGKFDFTTLLFPTCFSVVILAFGVIVFNKVQKTFMDTV
>KACEBFPM_00453 hypothetical protein
MKNIYFLILSLNFFNAFSQTEVNVMGIPICGTSISSSVPANYDGFAGYKSWAGMIYNSSS
INQTGLIKSISFAVDCTSYACNFLTASNQKIYIAEVNYSSFASNTKPDLSSFTKVFEGDI
TWSRGGYAGGAVWHTINLSTPFNYTGTKNLLIYFENNNNGVLGGVSCGTKPLFLVESASE
RASLYSNFNTVPSATGRYSNQVPYLKLIFKNNLSTKIFDSNDGFVMFIDNNNSMNISINS
LIASNASLIISAMTGQVLVEKVFFMQEGKNDIVLSNALAKGFYIAQIKIGDKTTTAKFYI
D
>KACEBFPM_00454 hypothetical protein
MIKVKFFISVFLFAGMLSSCSKNELEVVYNSKKIQASDPIPIPTPIPTPTPTPTPIPIPI
PTPIPSGSILGLWKGTFYSEKSCYSNMKMELNVLSYTQTTSQVTADLKIIHENDSDNPWL
TNYMEARYTCTGTFANNKLTIIPGNAYLNLHDSQCRFCENQTFEMTLTSPIKLTGSLLSS
SCTNILSGQNTINLQK
>KACEBFPM_00455 hypothetical protein
MKKVLLFLCLIMIHSSFSQDRIYIAAELEGGFLITHYKSQSPSLSSIVNEEEKNHNIKIS
ASVILEWDNKMSFEAGIAQNMRQWNILGKKPNSTLEVKQTQYYPSVFVGGYYDIPFNASN
TNLRFYIGSKLSADFLNYNSLNKTDGTDLDNVNSVTEESNKFAFNVIPEIGIKGRFKNGN
IWLFGIKYCHPLSKNILNGYIKHNLNKVTQEQIDYYSTGQIFALSFKYGFSI
>KACEBFPM_00456 Tyrosine-protein phosphatase YwqE
MLFFKKNKTILKDLIPDNHIDIHSHLLPGIDDGAQTFDETLFLIDSLKNMGVSSFITTPH
IFSGFWDNTKDKIQALELETNLNLNNKVPLKAAAEYLMNDHFVSLIKKGEILTLKDNYVL
VEMSYLNPPIQLYDILFDLQLGGYIPVLAHPERYTFYHNDFNQYQKLKNAGCLFQINLLS
TVGYYGESVAQTAEKLLKKGLIDFVGSDVHHKKHIASFDKIVTIKDLQPLKEAFANNQLF
K
>KACEBFPM_00457 Tyrosine-protein kinase ptk
MFNTVNNNEENTLNIKDLVFNYLSHWKWFLLSITLFFIGAKLYLRYSIPEYKSQTTLLIK
GDESGGMLSELSAFQDLGGFSGAKKDIDDEMEVLKSRSLIEKTIKAGKFYLSYVLEGRIK
SSEVYKENLIAIDFKQKTEKFFEKDTALIVKVLSPKKFELFNADNNSVGNFNFGQLIYSK
ELGSYVVNIKPKYLKDLNSKVVVHLESLKKATNKFKAKLNVGTITKSTNVLEISFTDPIK
EKAEDFLNQLVAIYNNDAIIDKNSISEKTAKFINERLAIITGELDGVEKDVEKYKNQNQI
TDLSTEAELNLKNSSESTKEEIIVATQLKVVGIMIDFIRKNNNEDIIPANIVPDDNNSSA
LIAEYNNLVIERNRVLKSSTSENPVVIRVNDKIDLLKSSISESLNRLKSSLVVKNNAIIN
QGNIVEGRISKIPRQEREFRGIFRQQQIKEELYLYLFKKREETAITLAATAPISRVVDYA
YSSDSPISPKKSFIYLFSLILGFFIPFSIIYILDLLDTKVKTRHDLDNNLSIPFIGDVPH
SDENNQIMQAGSRTSSSEAIRIVRTNLEFVLSNIENDNNAKTIFLTSTLSGEGKTFIAIN
LAATIAISGKKVLLIGMDIRNPKLDEYVKLPSRGLTNYLSARDSDIKDFIVNQKGYESFD
ILPAGVIPPNPAELLMGKKLDSMFEKLKLEYDYIVVDTAPVTLVTDTLLIAKNADAFVYV
VRANYLDKSFLKKPEALYVENKLPNMCVLLNDTNNVAGYGYGYYKDAPKQSWYEKMFNFS
FFSRSK
>KACEBFPM_00458 hypothetical protein
MKNRNLLLFFLLGLNLLLVTSCVNKKQIAYYQNLDQVATQEVTNHFESKIQPDDLLMIVV
STPDPEAAVPFNLETILTPAAIGQTNLAQRQQQLYLVDTNGLIQFPVLGEIKTGGQTKSE
VIAVIKSKLKKYINDAIVNVRIVNFKVTVQGEVTRPGSFTIASERVTLPEALSLAGDLTI
FGKRDNIILVREINNKKTFNRVDITKADFIHSPYYYLSQNDLIYVEPNKAKSRTATGFTQ
NGPIWIAIASLLASIVTSIFIINKK
>KACEBFPM_00459 UDP-N-acetyl-alpha-D-glucosamine C6 dehydratase
MEIEKKKIIQSALQQIYRYSSKSNFTIRNLGYLPRWIILFIDIGVISMAGFLTFYLFKGI
GLQYFASHNEGCKFVLFFVTNIFFFWWFRTYSGIIRHSSFIDAIKILFSQFFTFLVLVVF
NFLFSIYFNDDLFLNTALVVNVIISFCLLFLYRVLVKQFFESYLKGVGSTKLVRAIVYGS
DANAISVSNALISEIPMRFKLLGFIDKHNSNSTKRILDLPILNQKKRIPVLMRSMHATAL
IIADKALTKEEQIAIVDECLEFNIKVYTVPLISDWENQEEIAKKIKSFQIEDLLERKPIV
LDNKLISSQIKGKVILITGAAGSIGSEIVRQIICFSPDILIVLDQAETPLHELTLEIQKL
NLKTKLVSLVADVRNLVGLERIFDQYRPSLVYHAAAYKHVPLMEENPSQAIFVNVMGTKN
LADLSLKYNVEKFVMVSTDKAVNPSNVMGASKRIAEKYVQSLYFENKNNPSYTTKFITTR
FGNVLGSNGSVVPLFSKQIAEGGPITITHKDIIRYFMTIPEACQLVLEAGAMGQGGEIYI
FDMGKPVRIYDLATKMIRLAGFVPDKDIKIKIVGLRPGEKLYEELLNDNSKTLPTHHEKI
MVAQEQIEVYHEVQTAILEIIKASNAYDNNLIVTKMKMLIPEFKSMNSTFEMLDN
>KACEBFPM_00460 Putative pyridoxal phosphate-dependent aminotransferase EpsN
MNNTKIWLSSPHMGGAEQDFVNEAFATNWVAPLGPNVTGFEADLEKYIAQESHVAALSSG
TAALHLGLILLGVKPQDEVICQSMTFSASANPIMYLGATPIFIDSELDTWNMCPIALEEA
IKDSISKGKKPKAIISVHLYGMPYKIDDVKAISQKYDIPVLEDSAEALGSSYKGQKCGTF
GDISVLSFNGNKIITTSGGGALVARNKATKDKAVFLATQARDNAPHYQHSEVGYNYRMSN
ICAGIGRGQMQVLDQHVGFRRDMHQLYVDFFATIDGVTVLTEPNPDYYSNHWLSAIVINP
DKTNGKTREDLRLALEKANIESRPLWKPMHLQPVFESYPYYGTQVSEQLFANGLCLPSGS
NLTNEEKKRIFAEIKLFFY
>KACEBFPM_00461 hypothetical protein
MILTIFGDVHGNLVALEKMFEIEKAQTDFFVCHGDVVNYGPWTKECIEFLKNIQNVKLLK
GNHEKYFIDGNYDGTNIVAKAFFNHCFVNFDDELVRIISEYENDFQVNEFSIQHTINNQY
VFADTNLSNLQIDRNYIIGHSHQQFELEKDNFKIYNTGSLGQNRQFINQSCYLKLDTETG
KLELKNFLHNIDLVINQMKSARYPQICIDYYLLKNRI
>KACEBFPM_00462 GDP-L-fucose synthase
MRILVFGANGFLGKEVVNLLKSNDFEVFTISRSDKSCNFNLNISKFDDFQVLPNHFFDVI
INCATVLPGGNYLDNDYLDAIYKTNILGSQNICKWIESQQTVIKIINCSTLAVAQKPWEI
DLKETVETYPYGNHVLYCSSKLMQELLFKTLSDAKEISLVQIRFSALYGKTMAWNGIICN
LIDQAKKYKVIKLTNATKINADFLNVKDAAKIILASIQNPIIGILNAASGEEISLLDLAK
MIVDNCDGEIEINSIDSEGFEESRAKININKLTKYIDTSNFINLNKGIKELLER
>KACEBFPM_00463 Carbamoyl-phosphate synthase large chain
MTKNILVTGAGALLGQGILRLLQISDFSKKIFTADPDIRSTGHWLGDYAITIPKATEENY
ISTIKKIVVEHKIDAILVGTDVELPILSQYKNEFLKDFNCKIIVSNKEVIDISNDKFLTA
KFLEKNNFPFPFSVMANDKEKLSLIEKKLGFPLFAKPYDGARSLGILKIDNHEQLLSIYC
ENSNLVVQQFLPETDGEFTSGCVVIGGKCKAIVTLKRDLRDGNTYRAYVDKDTSKYDSYI
IAIAEKLNADGPVNFQFRIVDDKPIVFEINGRFSGTTPIRHFFGFNEVEAILKYELFGIE
IEKTALKNGIVLRAWSDIFIEENEFNSFKSNSSLENPNAEFYDFNLKK
>KACEBFPM_00464 Undecaprenyl phosphate N,N'-diacetylbacillosamine 1-phosphate transferase
MYKLFIKQIIDFLVSLVAVVILTPLLLIITIGLFFANNGKPFFFQLRPGKNGKIFKIIKF
KTMNEAKDAQGNLLSDAERLTPIGKFVRKTSLDEIPQLLNVLNGDMSLIGPRPLLPQYLH
LYNNFQNRRHEVKPGITGWAQVNGRNAISWDKKFELDVWYVDHISFSLDFKIVLLTLKKI
IKSSEVTADGHATMPRFDKLNN
>KACEBFPM_00465 hypothetical protein
MRVLFLTLIGIHSINERGIYQDLLRKFVDQGHDVTIVTPSERRKKIATNLVVNDKVTILQ
VKTFNIQKTNKIEKGIGTLAIEYQYLHAIKKHLSGYKFDLVLYSTPPITFYKVINFIKKR
DNAYAYLLLKDIFPQNAVDMKMIKQGGFLHKMFVKKEKKLYKISDTIGCMSQANVDFVLK
HNPEIPRDKIEVNPNSIEPKFIDYSAIEKKQIKVKYNLPLDRKILVYGGNLGKPQGLEFL
LETIAKAAVSDVFFLIVGDGTEYAKINQWFSNNKPQNANLIKFLPKNDYDLLLAACDIGM
IFLDKNFTIPNFPSRLLSYLEMKIPVIAATDINTDIGKIITDANCGASVTAGEIGEMRQA
ILKCLSNIESMSENSRRLLLDKYTVGVSYQLIFNRIKNNV
>KACEBFPM_00466 UDP-2,3-diacetamido-2,3-dideoxy-D-glucuronate 2-epimerase
MKKLKVMTVVGTRPEIIRLSRVLMALDQSEAIEHIIVHTGQNYDYELNQIFFEDLGLRKP
DYFLEAAGKTATETVGNILIKIDPLLEQLQPDAFLVLGDTNSCLCAIPAKKRQIPIFHME
AGNRCFDQRVPEETNRKIVDHTSDVNLTYSDIAREYLLREGLPADRIIKTGSPMFEVLHH
YLPQIKKSDVLSRLNLEEGKYFVVSSHREENINSEKNFKGLIESLNLIAEKYNYPIIVST
HPRTRNMIDKMKVQVRPEVQFLKPLGFHDYNALQMRSYAVLSDSGTISEESSTLNFRALN
IRDAHERPEAMEEASVMMVGLSPERIMQGLVQLQSQEIGEKRNFRSVADYSMPNVSQKMV
RIILSYTDYINRVVWSKK
>KACEBFPM_00467 UDP-2-acetamido-2,6-beta-L-arabino-hexul-4-ose reductase
MKKVGITGQNGFVGNHLYNTLGLYSDDFERIEFKKEFFDDPSQLDLFVQQCDVIVHLAAM
NRHESQAFIYDTNIELVKRLAASLERTSSQAHVLFSSSSQEEKDNLYGKSKKEGRQILAN
WAKNNNGKFTGLLIPNVFGPFGMPNYNSFIATFCYKLTHGESPKIDSDGEVKLIYVGELV
QEIINQIKIATTNNLYEVRHTSTNKVSEVLATLTHFKATYFDKSEVPELKTTFDFNLFNT
FRCYFDIKNHYPVQFKQNIDPRGAFVEVIRLGMGGQVSYSTTVPGITRGNHYHTRKIERF
AVIKGKALIQLRKIGTTEVLDFYLDGENPAFVDMPIWYTHNIKNIGEEELFTMFWINEPY
NPEDADTYFVEV
>KACEBFPM_00468 hypothetical protein
MNPRIIKGNCHTDTRGKLKYNNDFDASQIKRIYCLENANVQLKRGWQGHKIEQRWFSAVS
GEFEIKVAKINDWDTLDLNHNPSIFQLSSDTLDYLHIPPGYVTCIQAKDENAILLVMANY
FLGEVNDEYRFSLDEF
>KACEBFPM_00469 UDP-glucose 4-epimerase
MMQDITGKTLLITGGTGSFGTAVLNRFLESDHFKEIRIFSRDEKKQDDMRNVYKNDKLKF
YIGDVRDISSVEKAMNGVDYVFHAAALKQVPSCEFFPMEAVKTNVFGTQNVIDAAVKYEV
KKVICLSTDKAAYPINAMGISKAMMEKVAVAASRNLEKTTVCLTRYGNVMASRGSVIPLF
VKQIKNGEDITITDPNMTRFLMSLEEAVELVLFAFEHGNSGDLFVNKAPAGTIGDLAQAL
KEMFKATTNIKIIGTRHGEKLYETLCTREEMVKAQDMGDFYRIPADNRDLNYAQYFSEGE
EDVSKIEDYHSHNTKQEDVEGMKQLLLKLPLIRKEILGEDAVRQYPD
>KACEBFPM_00470 hypothetical protein
MKIAFVCVNYNNSKITQEYILNVLALKQHHDLKIIVVDNASESNDVKQLSAYVDQINKDQ
VVLIKSDSNLGYFKGLNLGIKWALEKGYNQYQVVGNNDLMFYPDFINNLEGLSISKGDMV
LAPDVITIDKIHENPHVIHKMSFFRKLKYKIYFSNYYLAKLITQFYSAERKPKAFDPEAK
YIYMGIGALYVLTPHFFSHFNSLWDDVFLYGEEAVLTGQVNSVGGKIWYEPSLKCDHNES
ASTSKIGSKTKYKIIQNSYRIYKKYL
>KACEBFPM_00471 hypothetical protein
MILYFILLIALAILFCFRKGFSIYFFSPTGLLCVTWMVFVFLKFLFAEDYFFSVEAISLF
SLFIFSFFIGEFLMYFHIRVKRNSISSCSINKVNLESDLKIFRNKKVVRKFNAIILLTGL
STIVGTGMYVNIFVGYFGSITGVLTAGWALRGAMQEISLPLFVRAFMMLGYSSIILTLIY
FIVYNKFKWYFLFPYISMLIMGITQAGRAGFIMILFQVFIMTYWREIFNYVINSKDNSFT
FFNSPEYKLIKSSFRLLTFVIIIFVGGDMLRSQDFSFNSDIVIQGFSSFKAYLFGGIAAF
STYLDQGIPEDLGWGRFSFSSLYELLGIHKNEIGIYTDYLRVSASNIDDTTNIFTAFRQY
MDDFGVLGTVFFMMILGAFSHFFFQKAVKGDLASIGFMIVFYTYLFHTPLLSITVHNSVL
ISAILPYFIIQRLKKTII
>KACEBFPM_00472 hypothetical protein
MENESHSSNLNKDVLKYMLVKILPAISGLLTIYLLTRVLSAGLYSDYAFVMATILLFGQL
ISGWINSSVIYFYPDYIQKNKIDVLKLNIILLQFILYVLGAIGFSVMCYLGIKSFAILIL
GLLFMLSQTFINLLYSFLQAERRVLVQIRSTFIQSLVQIIGMVICFFYFKENLSAVFFVL
FISYFLASNYVMYCDKIYQLILHKKAFLVIDMSISKEILSYGLPICIWFFASQFFVIGDR
IVFKYFNITNLVGNYASFRDLSVGLSGFITMPLLMASHPIIIQMAKGNVQKEKIENIISQ
NIKLLSTLFTLVFIGIFFFGEWVLTYVVGTKYLLNANLMFLVVFSIFTGCISMYLHKGLE
VKGKTLLMSKIALIVAVVSLVLNVFLIPIYGIQAACVTAVFSQVLYSFVVYRFSSGIFKI
HIPFAFVLKNSSLILMSCIISNYILAGNSFLVIRMFIFVLLAVFLILSSAEIKLMVKIIK
K
>KACEBFPM_00473 hypothetical protein
MVAFIFIVLLSISSLYFKKSKTLFVLFFLSMWGLFGWNYSNADFHMYKGMYSVPLSEMIF
FKFEGGYNILMYGFKSLGLNFRQFYIAVSGAVLLLVFRFFYQFSNFSALLAVCFFWFLFP
LQYVIFRNFIAFSIILQGFLAVLKNEKYYKAKYVFFVLIAATIHISSLLYLLFLLAFKEN
EIKIKTVLLWVIGLLVVVMVSHHLIFAVCSFYSKCKAMFYATSLRLFLFYSSIQLANLYV
VGYFLKPKNAIANDEDSRLNTIIININIVMLLLIVVYYEMAVFVRILLSMTILNIVFITN
KLFLTDGKKRPKVLFLGYLFFWFFCFIFLVREKTLFSLFSHNLLFK
>KACEBFPM_00474 Glucose-1-phosphate thymidylyltransferase 1
MKGIILAGGSGTRLHPLTQVVSKQLLPIYDKPMIYYPLSVLMLAGIKEILIISTPQDLPN
FRRLFGDGSQIGLTLSYVEQPSPDGLAQAFILGEDFIGDDDVCLVLGDNIFYGAGLQNLL
NNAVEIVTEKKEATVFGYYVDDPERYGVAEFDEKGKVLSIEEKPLEPKSNFAVIGLYFYP
NSVVQIAKKVKPSHRGELEITTVNQEYLEDKKLNLQLMGRGFAWLDTGTHESLTEATEFV
KAVEKRTGLKIACIEEVAYRKGFITKEQFAATATNLGKSSYADYLRKIAKNLD
>KACEBFPM_00475 dTDP-glucose 4,6-dehydratase
MKNILITGGAGFIGSHVVRRFVQNYPNYHIYNLDALTYAGNLENIKDIEKESNYTFVKGD
IVDEHFINELFAKHNFEGVLHLAAESHVDRSIEDPLSFVKTNVIGTMNLLNAAKNIWKEN
MEGKRFYHISTDEVYGSLGAEGLFTETTAYDPNSPYSASKASSDHFVRAYGETYGLPYVL
TNCSNNYGPYHFPEKLIPLFINNIINNKPLPVYGDGNYTRDWLFVKDHAIAIDLVFHEGN
NHETYNIGGFNEWKNIDLVKLLCKVMDEKLGRSEGESSKLITYVKDRPGHDLRYAIDASK
INKALGWKPTVTFEEGLEQTIDWYLANTNWLDNVTSGEYANYYKKQYN
>KACEBFPM_00476 UDP-glucose 6-dehydrogenase
MKINSICCIGAGYVGGPTMAVIAQKCPNIKVTVVDLNESRIAAWNDTNLENLPVYEPGLD
AVVAEARGRNLFFSTEVDKAIDEAQMIFISVNTPTKNYGTGKGMAADLKYIELCARQIAR
ISTQDKIVVEKSTLPVRTAEAIKNILDHTGNGVQFKILSNPEFLAEGTAIQDLHNPDRVL
IGGEDTEAIQSLVEIYSNWVASEKILTTNVWSSELSKLTANAFLAQRVSSINAISELCEK
TGADVSEVAKAIGMDARIGSKFLKASVGFGGSCFQKDILNLVYIAKSYGLHEVANYWEQV
VIMNDHQKNRFSANIVQTLYNTVSGKKITLLGWAFKKDTNDTRESAAINIAQNLIAEQAN
IAVYDPKVSKKQVKEDLINLDENQIKLIQVNENPYEACHESHAIAILTEWDEFITYDWKK
IYNNMLKPAFVFDGRNLLDKKQMETIGFTYIAVGSSNL
>KACEBFPM_00477 UDP-N-acetyl-D-glucosamine 6-dehydrogenase
MKIAVIGLGYVGLPLARLFATKYDVVGFDINTKRVSELHSGLDSTLEVSQELLQSVLKTE
NTNTEGLFCSTNIDDIKDCNHYIVTVPTPVDKNNKPDLTPLYKSSETVGQVLKKGDIVIY
ESTVYPGVTEEECVPVLEKTSGLKFNIDFFAGYSPERINPGDKEHTVDKILKVTSGSTPE
IGEKVNELYKSVITAGTHLAPTIRVAEAAKVIENSQRDINIAFVNELAKIFNVLGIDTQD
VLAAAGTKWNFLPFKPGLVGGHCIGVDPYYLAQKAQQMGYHPEIILAGRRLNDSMGEYVA
SQVVKLMSKREIGVNNAELLMLGIAFKENCPDVRNTKIVDVISSLKEYGIHVTIYDPWVN
PADVLHEYNLQTVKELPSIKFDAVVLGVAHQEFLSLDFKSLQKEKSILYDVKGILGNHVD
GKL
>KACEBFPM_00478 UDP-N-acetylglucosamine 4-epimerase
MQQSKFKILITGGAGFIGSNLSEYFLDKGHEVVCLDNFVTGHRYNIEHLLANKNYSLIEG
DIRNLSDCQKALIGVDYVLHQAALGSVPRSISDPITTNEVNVSGFLNMLSAAKEAKVKRF
IYAASSSTYGDSESLPKVENVIGKPLSPYAITKYINELYADIFSKTYAIETIGLRYFNVF
GRKQDPKGAYAAVIPKFVQQFINYENPVINGDGNYSRDFTYIDNVIQMNELAMFTQNPEA
VNTVYNTAFGDSTTLNDLVKKLQFELSQFDPKIANVNIIYGPNRAGDIPHSLASIDKAKK
LLGYNPKFSMQEGLKQSVKWYWEHLK
>KACEBFPM_00479 Tyrosine-protein kinase wzc
MLDTKDFSFFETQNNFDFKGFFIKILGHWSWFLVSLIIAFTIAYQVNVRKEKIYGVSTTI
AYKEENNPFFTANTNLVFNWGGTSDQVQTIVTTIKSRSHNEMVVKELKYYIEYLRQGKYN
IEDAYGEVPFYVNINKNLPQLTEQPITIKFVSSSQYEISINFQEPSVPLMNYTTEKPSNT
NVQVGLFKKRYKIGEQVSLPFLHWKLELTDNPGYYESSSHIVRFANFNGVVERYKNLEIN
ADAKGGAIIGLDLQGTNKARMVDYLNGTIAVLMNRQLEAKNQFTTNTIRFIDSTLVAMET
QLKDTENELKDFSKGKNIFEVEQGGEKYADKITDLDLEKDLINRKNAYYNSLKSYLVNSV
DYSKLPAPSVAGIDDPNIVLNVSKLTALSAERAEMSYAVKNDKKFKDFDIQMDALKRVLL
ENISSAKTAIQYDLNTVNEKLNSAENTIKNLPEQQQALVKINRKYDLNKNVYNSFLEKRS
EADIIRAANLSDIQVIDPAKDTGGGLLGPKTNVNYVLALFLGLLIPLIMVFGVTIIDNTI
KNTDDIAKLTKIPILGVVGKKNTKNNLAVFEKPKSGLAESFRAVRSSLQFLYKKQQQTGS
KTLMLTSSISGEGKTFCSINIATVFALSEKKTVIVGLDLRKPKIFEDFHLENTIGAVNYL
IGQKTLEEITQKTPIPFLDFIPSGPVPPNPAELIMGESMKEMLEELKKKYDYIILDTPPV
GLVSDALELTPYCDATLYIVRQNVTKKDMLTLVNNKHKRGELNNISIVFNGFENKAKYGY
DYGYGYGYGTYADGYHEKEKPDNVFVSWIKKNLKK
>KACEBFPM_00480 hypothetical protein
MFPKLLLEMNKIYAFCTFVVLFLFTSCIPNKDLLYLQNKNNSNQETVITPVVLKPYRAQV
NDVLSVRIKALDQKLVEMFYTSAGEIQSNSADGLYFDGFSVNDHGAIRVPVLGEVNVLGL
TLDEIRLKIEKQLLADYFNKAADIFVTVKLAGMRYTVNGEIASPGTRTLFQDKVTILEAI
ANSGDITITGNRKEVMVVRQYPHGTEIHSIDLTNIDAMKSPYYYVQPNDYIYIKPLKQKS
WGTGTTGLQSFTAIFSVFTVLFTTFLLIKK
>KACEBFPM_00481 Recombination protein RecR
MEFSSKLLEKAVNEMAQLPGIGKRTALRLVLYLLKQPKDRTDFLAQSLLTMREGIIFCEN
CHNISDVAVCEICSNKNRNHQIVCVVEDVRDVMAIENTGQFRGVYHVLGGKISPIDGVGP
SQLNISSLVEKVKSGSVSEIIFALSSTMEGDTTNFYIYKQIKDCEIITSSIARGISVGDE
LEYADEVTLGRSILNRIPFENSFKNN
>KACEBFPM_00482 Sodium/glucose cotransporter
MTPFAILSLIVIYFGILFVISHIVSKKDNGNDAFFKANKNSKWYLVAFGMIGTALSGVTF
ISVPGEVGNPDLQFKYFQFVLGNAIGFIIIAKVLLPLYYRMNLTSIYGYIEQRLGVVSYK
TAATIFLISRTIGSSFRLYLVVIVLQRYVFDYYGIPFTFTVLISLLLIFAYTYRGGLKTI
IITDTLQTFFLVLSVFLTIFFICRSLDLSFFTAFEEVKNSHYSKIFFFDDYNKGNYFWKQ
ILGGIFVTIAMVGLDQDLMQKNLSCKNIEEAQKNMFTFTGIFVIINIFFLSVGALLYMFA
EKNAIQVPMVDGIARTDFLFPEIALKSLGLIPAVVFLLGLTAATFATTDSALTALTTSFC
VDFLGMDKTENLNKPNIVRTRHLVHIGFSGLMFLVIVIFNSVNDASVVKMIFKIASYTYG
PLLGLYSFGLFVKSKTVHDKLVPFICLISPAICFLISIYSKELLGDYVFDNELIIVNGLI
TFVGLLLISKPATKETRF
>KACEBFPM_00483 hypothetical protein
MSNKKTLVLGASTKPERYAFKAVTMLVEKGHSVIAIGQNTGEVAGINIRTKNIPLASIHT
VTLYLNPTRQRDYYNYILETKPKRVIFNPGTENPEFYQLLKANGIKVEEACTLVLLATNQ
Y
>KACEBFPM_00484 hypothetical protein
MELFIYLFFALFSVLNPIGTIPIFVGLTQHDDKKERSRISLWTSINVCVILIISFFVGQY
ILSFFGITINALRITGGIIIASSGFSLLSGKFSKKRGIGKKVKSDVENRNDIALTPLAMP
MLAGPGSMSLLIAFYQEHHTSNEMIISSGAIIVVSLSIYLVLRSAHYLSKILGASGIVAI
SRIVGFLTIAIGVQYIISSILSIVRGI
>KACEBFPM_00485 hypothetical protein
MNEQTAVNNYYQKVIDGLSPETVNAKAQEEFDTFVNKLRMVGVDVTVVDDTLEPSTPDSI
FPNNWISFHESGDVALYPMFAENRRLERREEILDILEDKGFLVNEIMDYSSAEEDGFFLE
GTGSIVLDRENDKAYCALSPRADEELFIEFCEDFEYTPVIFEAFQTVENERKLIYHTNVM
MCVADTFAVICADCIDDKKERKMVLDSLKSDGKEIVLITEDQMNNFAGNMLEIQGADERR
YLIMSASAHKSLTKKQIAQLEEHITILSSSLDTIEACGGGSARCMMAEIFLPKE
>KACEBFPM_00486 hypothetical protein
MKKYLILVLFLFAIISCSKKSEIQKKVAEIPVSIKVDRYDKAFFETPPSELPKLKLQYPE
FFPPSISDSILVDKMTNPLWRELYAEVEKRYGSFDKETTEIEDLFRYIKYYYPKTQIPKV
YTVIQEMDTDYKVIYTEKALIISLELYLGKNHKFYEFPNYMKQTFEPSQILPDIVESFSR
TKVKPPVTKDLLSLMIYSGKQLYFNDVLLPEYSDGDKICYTPEQLKYAQDNEANMWRFFI
EEKLLYDTDAKLSQRFISPSPFSKFGLISDNETPGRIGAWFGLQIVRSFMKNNDIPMQEM
MAMDAAAIFQKSKYKPKK
>KACEBFPM_00487 hypothetical protein
MTSEIKFNVQLDENRVPEKLHWSAQDGGVETEETKAIMLSIWDNKTQETMRIDLWTKDMP
VDEMKIFFHQTLVAMAATFYRATGDEKMTDTMKDFCEYFAEKLELKK
>KACEBFPM_00488 putative GTP-binding protein EngB
MKINTAEFIISNSIVSLCPQEHLPEYAFIGRSNVGKSSLINMLTNHKSLAKTSGRPGKTQ
LINHFKINNNWFLVDLPGYGYAKVSKKTKEVFQQFITDYFEKREQLVCAFVLIDIRHEAQ
KIDLEFITYLGEIELPFCIVFTKADKISKGKVAQHVAAYRTALLKNNWEEMPHHFVTSAT
EHTGKESLLSYIDEVNQDIFKQNGF
>KACEBFPM_00489 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase
MNNLKKEGKYEYFEAGEGTPIIILHGLMGGLSNFDGVANYFPAKGYKVIIPQLPLYTQNI
LKTNVKSFSKYVKDFITFKGFDRVILVGNSLGGHIALYFTKMYPERVSGLVITGSSGLYE
SAMGDSYPKRGDYEYIRKKAESVFYDPAIATKEIIDDVYNTVNDRIKLIKTLTIAKSAIR
HNMAKDLPKMHVPIGIIWGRNDGVTPPSVAEEFHKLLPNSTLYWIEKCGHAAMMEHPEEF
NRLLDEWLTTKAEH
>KACEBFPM_00490 Transcriptional regulator MraZ
MNTIVGTYECKVDSKGRLMMPNPLKKQLNVSLQEGFVLKRSVFQQCLELYPMKEWDLMMQ
KINKLNRFVKKNNDFIRRFTAGVRIIEIDATGRLLIPKDLAVFASVTKDIVLSSAVNIIE
IWDKDLYEKAIDDSVGDFADLAEEVMGNVNDDEYGIS
>KACEBFPM_00491 Ribosomal RNA small subunit methyltransferase H
MNMEYHNPVLLKETVDGLNIKPDGVYVDVTFGGGGHSKEILSRLGPEGKLFGFDQDEDAW
ENALPDERFTLIQENFRYIKRFLRFNGIKKVDGILADLGVSSHQFDVPERGFSTRFDAEL
DMRMSKKNDLTAFNIVNEYDETNLRRIFAEYGELGNALAIARAIIEAREKEKIVNTEDLK
QVLARFLPNNKAHKILAQIYQSIRIEVNQEMDVLKEFLEQSLEVLDQGGRLSVISYHSLE
DRLVKRFMKNGLFEGEPEKDFFGRFEVPFKLIGKMIIPSNQEIKINNRARSAKLRIAEKK
>KACEBFPM_00492 hypothetical protein
MKGDIYNILKARFLINEDATKNWRFIVFLLLLAIIMIANTHSYEKKIFKIADLTNDVKEL
RSEFVDRRSELMKIKMESTVAGQMVDKGILPSSVPPKKIKVIEEKKPWYKIWQ
>KACEBFPM_00493 Stage V sporulation protein D
MAIEDRNILKRIYVIALVILIMVTAVGVKLTNIQWVEGDYYRKLAKERSIKNFVIPANRG
NVYSSDGSLLATSIPKYTIRFDALAPSKENFDAHIKDLSDSLSVLLEKSSSTYLNEFRKA
RANKNRYFLLAKDLSYTQYAAVKKFPLFNLGSNKGGMITEQRTVREHPIGKIAARTIGYE
RYDDNGDLLPVGIEGAYGKYLNGKDGKVLKQKIAQGQWKPIRDNNEVEPQDGYDIVSTID
VYIQDIAHHALLKQLLEYDADHGCVVVMETKTGAVKAISNLGKDKDGSYYETINYAVGES
HEPGSTFKLVDLIALIDDNKIDTSKVYDSNGGQITYRGRKVRDSHTGGYGKISLARGFEV
SSNTIMVRAVYENYKNNPKQFTDRLVNLGLNKPLGLPFRGEGIPYIPEPSDKNWSAISLP
WMAFGYGVSVTPLQTLTLYNAIANDGQMVKPIFVQEVKEWNKTIKKFDKQVINPKICSDD
ALKKIKTILKNVVKRGTASKLYSKDFSMAGKTGTAAASYGTNGGSGKYYISSFVGYFPAE
NPKYSCIVVVHKPNTSKNDYYGADVAGPVFKRIAQKVFTDVPSTNVVKNLKKNNPAQDKN
YLTYNDKVNKKPKYIPNLHGMSGMDAVALLENLGMKVKAIGVGKVKKQSIQAGQPILKKN
TIILELS
>KACEBFPM_00494 HTH-type transcriptional regulator DdrOC
MDVREKIGQRIKDLRELSSMSQKDLAYSADLDRSYIASVENGSRNISIVNIEKIAIALNV
NLKDFFDYAEFKQ
>KACEBFPM_00495 hypothetical protein
MPNLNNNNTGIPFVQVQMQDALNQIKADIEAAIIANGESGKNALIRTQKPIKLIHNVVKT
AFLNAGVHPSLINPELSRLRKVANPPARVNNRPVVLRDKELPLAGYLKTKNQDVSIVPNN
IHINEETLGFPTYLNGFKDRYGSAFTEGVLSVNVRSQLSSVAKNFDTLYERTFAEALNFH
LRLPQMVLGEVYMIVVKEYDSDAAARNTVAFKNSEHIEKFILAFQALNNRLDITDPLYKY
ERIALLIVDFSQAVPKLYNTTQELINDGLIPNTSIANMDSLSFNEFVNDLMNIYDTRFPV
NTFN
>KACEBFPM_00496 Modification methylase PaeR7I
MKKGILNEMVKSYNLKEIENHLIYSFLNSNKLDYSKNEILNNYFIDFKENSKLYFDTFNL
EITTIKELENYLELLIPAEDRKFNGAFFTPTYIVDFIINEVKPNEKDKNLDPSCGCGAFL
IGLAEYYKTTFEKSVKKTVQENIFGSDILDYNIHRAKLLLTIFALQNKENLEESDFNLYI
QDSLKAKWNNEFDNVVGNPPYVKFQDLSDENRTYLTKNWTSIEGGTFNLYFAFFELGHKL
LTSTGKLGYITPNNYFTSLAGVSIRKYFQQKKCVTRIIDFSHRKVFDAQTYTALTFLNKK
ENEALTFDRIKEGYKPEDFLPIANGSLNYFKNLDVKKWRLLKSDEQKNIKNIESIGTPIS
TLFDICVGIATLKDEVFFVDGSIEKNGYYIKITKNGTFEIEKEITKSVYKISNFKSQEEI
EKNTKRIICPYHLGKGNANPISEQEFKIKYPKCYAYLLSEKENLASRDKGKVIFEPFFVW
GRTQGLNKLGKKILNPTFSQFPRFLLVEEEDAFFTNGYGLFFREEKTNLSLFEEIVNPIT
LIENIDVVQKVLNSHLMHYYVSKTSVSIEGGYPCYQKNFIEKFTIPHFSDNEIKLLKSLN
DKQEIDNFLIDKYQLNVFTGNLVS
>KACEBFPM_00497 Translation initiation factor IF-2
MSEGTIRINKVLREFNISLERAVDYLKDKGHVIESNPNTKISDEVYNVLSNQFAGDKGNK
DASKEVGEEKRKEKEALRVERENEIEEKRKVDEERQRQEVIRAKAVVTGLKQVGTIDLSA
KSVIKPTIIPGVKAEAKAEVKTEAKVEAKTEVKVEVKVEPKAEMPVAKTPEKSEQPKQHV
AKETLVKEKIFAKEPAKNVAKPIVGKTPEATSKPSVEDAPVDETHETKYTKLTGPTFSGQ
TIDLSQFNKPKKIIEPNKGGAKPAGAGNNNNNKNKRKRIPTKPGEANATPRVPGTNLIRP
NTGGNATGGGFNRANKPGFVKGARPAIVPKVEPTEEDVKNQIKETLERLQGKGNKSKAAK
YRRDKRDTHRQKSDDEQRELEAGSKTIKVTEFVTVGEVATMMDVPITKVIGTCMSLGIMV
TMNQRLDAETLTIVCDEFGFEVEFITTDLEENIEVVEDSAEDLVHRAPIVTVMGHVDHGK
TSLLDYIRKTNVIAGESGGITQHIGAYGVELENGQKIAFLDTPGHEAFTAMRARGAQVTD
IAIIVVAADDDIMPQTKEAISHAQAANVPIIFAINKVDKQNANPEKIKEKLAAMNFLVED
WGGKYQSQDISAKTGIGMKELLEKVLLEAEVLDLKANPNKPATGTVVEAFLDKGRGYVST
VLVQAGTMRVGDYILAGKNHGKIKAMQDERGNNVTEAGPSTPISILGLAGAPTAGDKFNI
FADEREAKAIAAKRTQLMREQSVRVQRHITLDEIGRRIALGQFKELNIILKGDVDGSVEA
LSDSFSKLSTPEIQINIIHKGVGAITETDVMLASASDAIIIGFNVRPAGNAKQLAEKEEI
DIRHYSIIYAAIDDLRDAMEGMLSPEMKEEITGLAGVRELFKISKVGTIAGCMITDGKIL
RANKVRVIRDNVVIHTGDIIALKRFKDDVKEVAKGYDCGIQIKGFNEIEIDDIIEGFTEV
AVKRKLK
>KACEBFPM_00498 Transcription termination/antitermination protein NusA
MENLALIDSFSEFKDDKSIDRPTLMAILEDVFRNALKKKYGSDDNFDIIINPDKGDMEIW
QRRVIVADDDLDLDHLEITLTDARKIEPDFEIGEEVSEEVKLIDLGRRAILALRQNLISK
IHEHDNTNLYKQFKDLIGDIYTGEVHHVRPRVVILVDDEGNEIILPKEKQIPSDFFRKGD
NVRGIIESVELKGNKPQIIMSRTSEKFLEKLFEQEIPEVFDGLIMVKNVVRIPGEKAKVA
VDSYDDRIDPVGACVGMKGSRIHGIVRELGNENIDVINYTTNTQLYITRALSPAKVSSIK
INEETKRAEVFLKLEEVSKAIGRGGHNIKLAGQLTGYELDVIREGTVAADDDVELTEFSD
EIEAWVIEEFAKIGLDTAKSILSQDVNDLVRRTDLEEETILEVVKILKEEFEE
>KACEBFPM_00499 Ribosome maturation factor RimP
MHIIKYLYLNNEGSIASLFLYNMAFKEKVKELLEQGLAEYPNLFLIDLNINDSNKIIITL
DGDNGVQLQDCINISRSIDNNLDREEVDFALEVASAGVSLPLKLVRQYKKNIGRTLKIKT
ATQTIEALLLEVSDQDITVEWSSREPKKIGKGKETVVHNEKIAYAAIQEAIVIIIF
>KACEBFPM_00500 TRAP-T-associated universal stress protein TeaD
MKRILVPTDFSKNAEHALKVAAQIAKKNNSEILLVHMLELPQQNSDAVSQGREIPEVMFF
KNAVLQKLEDLMAQDYLSEIAVSEIIQFELAFDGILKISKAHDIDLVVMGSHGASGFKEM
FVGSNAEKVVRNSEIPVLIIKEEDNDFAINNFVFASDFSDEIKKPFQEVVNFANNFGAKL
HLVTINTPNQFVPTSTAEEKMANFVSNFKINDFQTHIYNETSVEKGILKFSNSVKADLIG
ISTHGRKGLAHFFNGSLAEGIVNHATKPIITFKI
>KACEBFPM_00501 hypothetical protein
MSFSDLFDSEFKTRNKGHFSAIVRVAIADGDLSAEEKQFLDKLKIRLEISDAEYDEILEN
PLKYPINPPVLHSQRLERLYDLSRMVYADHVLGPKQKEVLTKFALALGFTPGNVNYIVDK
ALSLLLLDVDLDTFLYEIQHMNK
>KACEBFPM_00502 hypothetical protein
MSEFWLYFNIGLKHVLNISAYDHVLFLIALTVPYAFKDWRRLLLLISLFTLGHTLALVLS
VFGILYVKANLIEFIIPITILLVALFNLFTAGKNNKGEGISLLSFITLFFGIIHGLGFSN
YFKTILPGNATQKLLPLSEFALGIETAQIIVVILILIISYIAQTVFRFSKRDWTLVMSAF
IIGVVVPLLIQNPVWGR
>KACEBFPM_00503 tRNA-specific adenosine deaminase
MKEIKQNKYDKAYLRLAKEWSKLSYCNRKQVGAIIVRDKMIISDGYNGSPSGFENCCEEQ
DGTTKWYILHAEANAILKVARSTQSCEGATLYITLSPCKECSKLIHQSGIKRVVYLEDYK
DNSGLEFLEKAGVLVEQIEEIE
>KACEBFPM_00504 hypothetical protein
MLFRAMVLRMTFRSNFLFVDFLKIVRITGEFGSPFSFEYNFSVVIFLPKIFSLLADKILS
PGLIPAFSEGPFSMGLMTAMVSLSIKKLIPMPTKPPFMLSAMPCASFFAIYTECGSSFSS
IPFTVWFTIESVFTLSTYSSLMKSMSLLSFCLVWFWVFSFAVTGILTNIPPNKKPIAIAA
KMSNGKYTLSTFI
>KACEBFPM_00505 hypothetical protein
MPIISLYGDNKKPKAEQLAGIDIMIFDLQDVGARFYTYISSLHYIMEACAENNIQLLILD
RPNPNGSIVDGPVLENEFTSFVGMHRIPTLHGMTIGEYGKMINGEKWLKNGIQCKLTVIP
CLNYKREMTYSLPVKPSPNLPNDQAINLYASLCFFEGTNVSVGRGTEKQFQVYGSPYLEK
KSFSFTPIPNFGSKDPLWKGKECFGEDLSAVAKVKQLELKWLIRAYKENSGIMTPFFNGF
FTKLAGTKKLQQQIEAGMSETEIRKSWESGLVAFKKMREKYLIYK
>KACEBFPM_00506 hypothetical protein
MKQILQQLPKEAKDKHIENKKYFVKLKNKPPKNLDYVMQDLHDAEFKKTNCLDCANCCKT
TGPLFTSADIERVSKHLRQKPQQFIDRYLRIDEDQDYVLQTVPCDFLDQDNTCFIYDVRP
KACREFPHTDRKKFNQITDLTLNNVAICPAAFNIVEKMKVKMPL
>KACEBFPM_00507 Dihydroneopterin aldolase
MGIIKLKNIRTFSYHGCLVEESKIGSNYKVDLEIKTDLRKSSLSDNLCDTVDYVLLNQIV
VEEMAVRSQLLEHVAYRIIKRIFAESASVSRIIVAVSKLNPPIGGDVEAVTIEIEEYRN
>KACEBFPM_00508 Glutamine--tRNA ligase
MSTEEKSLNFIEQIIEDSLASGFPQDKLRFRFPPEPNGYLHIGHAKSICLNFGLGLRYNA
PVNLRFDDTNPAKEEQEYVDAIKEDLQWLGFNWAEERYASDYFQQLYDWAVVMIKNGKAY
IDSQSSSAMAIQKGTPTQPGVDGPFRNRSVAENLTLFEGMKNGDFEEGTHVLRAKIDMSS
KNMLMRDPLMYRVLHRHHHRTGNDWKIYPMYDFAHGQSDYIEQISHSICTLEFVMHRELY
NWFLDQIYDTTKVRPNQYEFARLNLNYTVMSKRKLLQLVQDKVVNGWDDPRMPTISGLRR
RGYTAKSIRNFCETIGVAKRENVIDVSLLDFCLREDLNKTAPRVMAVLDPVKLVITNYPE
GKEEWLEAENNQEDESAGFRKVPFSRELYIEREDFLEVAPAKFFRLSIGNEVRLKNGYII
KAESVTKDLEGNITQIEASYDTDSLSGSGTEASKRKVAGTLHWVSVSHAIEAEVRLYDRL
FIDEAPDAHKEKNFLDFMNKTSLEIVKGFVEPSLINVKVNDKFQFQRLGYFTVDKESSTS
KLVFNKTVGLKDAWEEKGKKEENLLMNMLKEINKYVKEKDENTAKNTLIPIIENIKSIDN
YSLVINTIVKNIKNDNNALLFANLILKHSDKVIAKDIEIDHLTKLYSMSLKSQLASVRIL
AINNLKNDSENFSNFQTQLAELKNSEKNEKVLELL
>KACEBFPM_00509 hypothetical protein
MKIIKTLFLVRLRRLVAKDDFLAMFLIVIAYLLIPFFLNGVFDKVKNYLLFITLEGLAYH
TNRKDLELLKLNKNYKLILFGEYFIYTLPYLILFNPLGVII
>KACEBFPM_00510 Esterase YbfF
MLFSKIEGQGFPLLILHGFLGMSDNWKTLATKYAEQGFQVHALDLRNHGKSFHSDDFNYQ
IMVQDVVNYCKFHHLTSVNLIGHSMGGKVVMLLATVYPELVNKLVVADIGPKFYPAHHQT
ILAALNAVDFSKKPSRTEAEAIVSKYISDFGTRQFLLKNLYWQEPGQLAFRFNLKVFNEK
IESIGKALPFNNIFKKETLFLRGDKSDYILDSDFETILHHFPKAEIQTISNAGHWLHAEN
PADFFEKTIQFFKKK
>KACEBFPM_00511 hypothetical protein
MKLLLRLLITTIIVVALSYFMTGVQVDSIAIAIKVAVVLALLNTFLKPVLVFFTFPITMF
TLGLFLLVINAAMVLLCDYCLEGFTISSFLTALFFSVLLSISQSVLYKFIPDNK
>KACEBFPM_00512 Trigger factor
MDIRRIAISPVMEIIEITVMPTDYKGQVAKRINEKMPLATVKGFRKGAVPKDLVEKQYGK
AIKQEEVKKVVDLALERFITAERLALLGTPLAIEKEIFNWEVEALTFQYEVGLAPFFTLD
LDAKTNVVKYVVTADDKLIDGQVTRIQKQFGKAIPQEIVSEKTEISGTFTNQEAGINNPI
TISLDIFKDKETAQKFIGKKSGDIVTVNTKGLFQDDHQLMDYLKVSHDDVHGLEVEVNFT
IENINETEPAELNQELFDKLFGEGNVATLEELKAKIKEDAESQFAEQAEQKLTDDVVNAL
IENTKFDLPKEFLIKWLQTAGEKNLSPAEAEIEYIRSEKGLRFQMIEGRALAQSDIKINF
EDLKTFTSKSIRQQMAQFGQTNPTDQEVEGIVARVLSNQEEVKRLSEQVTKDKLLQMLVE
KANPTTKEVTYEQFVAAMYGE
>KACEBFPM_00513 ATP-dependent Clp protease proteolytic subunit
MNYRKDPRAMLEQAKEFKKFATKHQGVNAMYYDKIVGAMSPTNMTPYIIEERQLNISQLD
VFSRLMMDRIIFLGTGIDDQIANIVQAQLLFLESADASKDIQIYLNSPGGSVYAGLGIYD
TMQYIKPDVATICTGMAASMGAVLLCAGAAGKRSALPHSRVMIHQPSGGAQGVATDMEIN
LREMLKLKDELYNIISHHSGQTFDKVHADSERDYWMIADQAKEYGMIDEVLRR
>KACEBFPM_00514 hypothetical protein
MLFSKKSFDISDRVVRMITQSEKREQISKKQLKANEEKEEQKDKIEDNPALAERQKILEE
KKALREKIIKERKESAAQNKKEYEEKHKKILENKTGAIIDSAATSKPNANINKIEKRKLA
QDSIKKAKEAVRLKTIENNKKTIEDRNKALEEKKKKIAADKEAAKTKK
>KACEBFPM_00515 hypothetical protein
MKQIKTLLIAAVIFFGASTMNAQTKVAHIDVSELLAKMPEMTAAKAQLDKLSKTFDTEYG
TMVTEYQTKMKKYEAEATTATEAINETRAKEMQDMGQRIQQYRDSAQKQLQEKEQEIVKP
IMDKAKTAIVKVGKSKGYQYVMDSASLILADGPNLFEDVKKELKF
>KACEBFPM_00516 Glutamate racemase
MLQNSAVFFYICFMSNNNPIGLFDSGIGGTSIWKEIHQLLPNENTIYLADSKNAPYGKKS
KQEIIELCFKNIDYLVSQNCKMIVVACNTATTNAIIQIREKYKIPIIGIEPAIKPAANKT
KTQTIGILATKGTINSELFNKQVESYTNIKIIEQIGYGLVELIENGEIESPEMTKLLTSY
LEPMIKANIDYLVLGCSHYPYLVPAIKKIIPENIKIIDSGQAVARQTKTILEKNNLLNTT
TKNSQQIFYANSNPTVLKNILGFSENVFAKDF
>KACEBFPM_00517 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase
MVIREVNGKYPQIPEDCFVAENATIVGDVAFGANCSVWFNAVIRGDVNFIRFGDKVNIQD
GAVVHCTYEKHPTIIGNNVSIGHNAIVHGCTIHDNVLIGMGAIVMDNCVVHSNSIIGAGS
VVTQNTVVESGAIYAGIPAKKVKDIDQSNFAGEIGRISNNYVMYSGWFKDEQ
>KACEBFPM_00518 hypothetical protein
MNFKKIILVLAFISTQFAFSQEGIAVYSDYLSDNYYLLHPSMAGASSCNKIRLTARKQWF
GSSEAPSLQTLSYNGSLGESGKSGIGVILFNDKNGYHSQKGGKITYAHHIMFSRTTTDLN
QLSFGLSAGMVQNQLDETSFDLQDFDPIIGGILQRSSYFNVDFGASYNFLDFYAHATVKN
ALFQSRGLYTSYESNNLRKYLVSVGYTFGDAKKLLWEPSLLFQLTDRTKEKALDVNIKVY
KSVDFGKIWAAMSYRRSFDGAQYDNGRELKNQYLQYITPIVGVNYNKFMFAYTYSQVTGD
IKFDTGGYHQITLGFDFGCKKERYDCNCPAVN
>KACEBFPM_00519 Fe/S biogenesis protein NfuA
MKLITIKDTNNPNILKFEFSYFITPNQSYEYKNIDEAGASPLAQQLFYLPFVKTVYISGN
FIAIEKYNIVQWEDVKHDVADQMEAFVSNGGEVVKQTETPKKSPVTVYAESTPNPAVMKF
VASKKLTKTIVECKNIDQTHASPLAKELFKFPFVKEIFIDENYLSITKYAVAEWQEITLE
LRTFIKEFIENGKIVVDETKIVATKHEEKQEITNFDNLDVTSQKIINIIEEYIRPAVAAD
GGNILFDSYCQDTKQVKVILQGACSGCPSSTFTLKNGIESMLKDMLNQPELRVEALNA
>KACEBFPM_00520 hypothetical protein
MKKITLLVASFLLLGNMGNASENLFFSNNTIISRFNFDEPITFTERGIGFYVFPNGEFDF
NTRPQNSQADYYYKTGKKREINKRPENYAVRIEHDDFGRIRRIGNTFINYDYNNRVTRIG
TVYMRYNSFALSQVGGLKIIYNRRGQIINVFGTVKGYNSRYYNDYNYPEYDQNESQNNYN
NQSSNSNDDYYYYKTDGTKSKIEISANDRREG
>KACEBFPM_00521 Isoaspartyl peptidase/L-asparaginase
MKIIIHGGFFSESSTNHQTKVAKQNALERIVKSSYEFMKTHSALETVVFAVSLLEDDALF
NAGTGSQIQSDGKIRMSAAIMDGETQKMSGVINIEEVKNPIRVAQVLMGEEDRVLGGSGA
TNYARQNGFEAFSTEIAQRKAEYEAKLKSLGTGTVGCVALDNDNKLAVATSTGGKGFELV
GRISDSATVAGNYANKFCGVSLTGVGEDIVSNATAAKIVTRVTDGFTLEKAFEKTFEELK
PYDGFAGAIGIDNKGNIFHQDSHPSMVFASYDGALFAVFD
>KACEBFPM_00522 Cyanophycinase
MFTGGDQLRLTSILGGTLFHDLLLEKYHKEDFIYAGTSAGAAAASNNMIYQGSSSEALLK
GEVKITSGLGLIDGVIIDTHFVQRGRIGRLFQSVVGNPKVFGIGLGEDTGLLITNGKQME
AIGSGLVILVDGREIKDTNLTEIELGQPISISHLVTHVMSKFDTFNLGTFKMTIQSSQYV
>KACEBFPM_00523 Enoyl-[acyl-carrier-protein] reductase [NADH]
MIIEPRMRGFICLTAHPTGCEQNIKNQIAYIKSKGHIEGAKRVLVIGASTGFGLASRITS
AFGCDASTIGVFFEKPASQGKTASPGWYNSAAFENEAKKAGLYAKSINGDAFSNDVKQQT
INLIKKDLGQIDLIIYSLASPVRLHPTTGVLHRSVLKPIGATFTNKTVDFHSGKVSEISI
APCEGDDIENTVTVMGGEDWSMWIDALKKENLLANNATTIAYSYIGPEVTEAVYRKGTIG
KAKDHLEATAFSITDSLADLGGKAYVSVNKALVTQASSAIPVIPLYISLLYKIMKSEGIH
EGCIEQMQRLYAQRLYTGNEIPTDDKGRIRIDDWEMRADVQEKVAKLWLEATTETLPEIG
DLEGYRSDFHNLFGFGFEGVEYKADTNEMVNVSSII
>KACEBFPM_00524 DNA repair protein RecN
MLASLSIKNFALIEQLEINFSDQFSIITGETGAGKSILLGALGLVLGKRADLTSLKDKEQ
KCIIEAQFQISKYNLQDFFATNDLDYEEITIIRREILPSGKSRAFVNDSPVNLTELQDLS
EYLLDIHSQHQTQELSSEAYQIQIIDAIANNQPLLLNYKQNLAQYKSAKNELKKLHAEKE
ALSKEQDYNSFLLEELLLANLKTGEQEELESVSEKLNNVEFIKESLDKSLALANDEQLGI
IQNLKEVKLSLQKISGLSSEFQDFFERVSSTLIEFEDVFIELSQQAEKLVNDPEKLELVN
QKLQTIYSLQKKHQVESVADLLVIQTNLDNKLVLVDDLENKILKIENTLNESILILDKIA
SQISQNRSKAIPVLVTQINEILVQLGMPNARFQFEISNTKNYLPLGKDEVQLLFSANKGT
DFGLLKKVASGGEMSRIMLAVKAILANYSKLPTIIFDEIDTGVSGEIAHKMGDIMKRMSS
KMQVFAITHLPQIAAKGNQHYKVFKSSEGENTISELKLLSQDERVIEIAEMLSGKDISDS
ALNHAKALLN
>KACEBFPM_00525 hypothetical protein
MRKIIVFLFLLFFGFTQAQELNCAVNFNTDQVAATNQQVFKTLKKSLTEFVNNTKWSDKT
YKGIEKIECSFFFTIATYNADQFTGTLQVQASRPIYNSNYLSPILNINDKDIDFKYLEFQ
NLTFDANSFDSNLLSIMAFYSNLIVGLDADTFSLEGGSKSLENAQNIATLAQQSQIKGWS
QSDKTQNRYFLINDMLSPTFVAFRKTMYEYHLKALDKMADNPKEAKENIKIALKTLSEIA
DTRPNAYLTRVFFDAKADEILSIYADGPKVDVTEVINSLNRLSPTNSSKWGKIIY
>KACEBFPM_00526 Coenzyme A biosynthesis bifunctional protein CoaBC
MSVLSGKKIILGVSGGIAAYKSASLVRLFIKAGAHVQVVMTPASKDFVTPLTLSTLSKNP
VHSSFFNEHDQDAVWNNHVDLALWADYIVIAPATANTMSKMVSGNCDNLLIAIYLSAKCP
VYIVPAMDLDMYKHPSTKINFEAFAKFGNTIIPAESGELASGLSGEGRMAEPEHIISFLE
KDIENKLPLKGKKILITAGPTYEAIDPVRFIGNHSSGKMGFDIAMVAANLGAQVTLVSGP
THFKVKNSLINLVSVTSAEEMYNACHQYFNDANVMIAAAAVADYRPKNVALQKIKKNEAT
FTIELEKTKDILSSLGQIKKKQFLIGFALETENEIENAKLKIQKKNLDLIVLNSLNDLGA
GFGKPTNKVTFIDKNFKIEPQELKSKEAVAIDIVNKIVSYYA
>KACEBFPM_00527 hypothetical protein
MDLKKTTAPVNTVTYNKTVIEEPTGNVYEAITIMAKRASQINAEIKKELIEKLEEFATYN
DSLEEVFENKEQIEVSKFYEKLPKAHALAVEEWLDDKIYYKSTK
>KACEBFPM_00528 Outer membrane protein assembly factor BamD
MKKILYTFLIIALFSSCSEYQKAIKSEDVAVKTAAATKMYEKGKYAKAIRLFEQISPVLK
GKPEAENVFYMFSQSYYKTGQYYLSGYQFESFAALYPKSKNTEEAAFLGAKSYSELSPTY
SLDQTDTDKAINKLQNFINKYPNSKYLADANVVVKDLREKLEKKAFEIAKQYNTISDFKP
AIKALDNFIADYPGTPYKEKALFYKLNASYQLAINSVPSKMQARLNVAKEAQEALLNFNP
NTEFKKTADEMLVRIDKDLQQFSK
>KACEBFPM_00529 4-hydroxy-tetrahydrodipicolinate synthase
MQAFIGTGVALVTPFKKDFSVDTQALKRIVNYVIDGGVEYLVVLGTTAESATLSQDEKEL
VIATIVDANNGRLPLVLGIGGNNTMKVVEELKTRDFSKFSAVLSVSPYYNKPTQEGIYQH
FKMVAEASPIPVILYNVPGRTASNMLPETVLRLAKDFKNLIGIKEAAGDIVQAMKLIQGK
PKDFLVISGDDMITLPMILAGGSGVISVIGEGYPKEFSQMVRLGLQRKVDEAYILHYKLM
NSIDMIFEQGNPSGVKEIFKSLGLSENTVRLPLVSVNEDLSNRLDLFTKQLSK
>KACEBFPM_00530 hypothetical protein
MFIKYIKEISLKKILKRSLHNVKPSLLTTPILTVGLVIDESYFSDKEQLTKELVACGVKE
SNIKMIVFRDKIKKNETFSQPTFSNNDMSWKGTLSPIFVKDFINIPFDMLISYYDTEKAP
LLLITNHSKALFKVGFSTVDKRLNHLMINTNAENYKVFVHELFRYLKILNKI
>KACEBFPM_00531 Mannosylglucosyl-3-phosphoglycerate phosphatase
MVNVKKSALVLKHFVLILTLIAFGSNCAAQLAISKIEGKQININEKTYSLAEYNAYISPY
KAHIDNELNTVLAICPETLDKSKGKWQTNIGDFLADITLKKTNPIFKKREKLDIDICILN
HGGIRSILPQGEVTTRTAFEIMPFENTTVVVGLLGEQIAEFVDYFIKEKKPHPISGITFT
IDTENKATDIMVGEKPLDLTKIYYVVTSDYLSNGGDSMNFFKKNTKTYDLDYKLRNILID
YFKDVDTIPITKKVKVNQK
>KACEBFPM_00532 Trifunctional nucleotide phosphoesterase protein YfkN
MKRRDFIQKTAASATLLTLGGLSLSSFTTNNIKKITILHTNDVHSHIDPFPATDPKNPNM
GGVARRAAIVEQIRREEKNVLLLDAGDIFQGTPYFNYYGGELEFKLMSMMKYDLATIGNH
DFDNGIDGLLAQMPHAEFDFVSANYDFKNTILDTFIKPYKIFKKAGLKIGVFGLGVELQG
LVDAKLYKETKYNNPIEVAQDMSHILKENEKCDIVICLSHLGFNYKNEPEKASDINLARK
TKNIDLIIGGHTHTFLDKPVIEKNIDGKEVLINQVGCYGINLGRIDFYLDSQKNVAAAGG
RKIIV
>KACEBFPM_00533 hypothetical protein
MLTFEEKIIYLQNRLSKTEGNYYDNFKEDIVVFLMNLMSKTNAYFF
>KACEBFPM_00534 hypothetical protein
MKKITLLLLLLAVSWQINAQVSVNEGFEGATTPVGWTYSSFSRSTTTPCVGLASVRKNFW
SSGLTGSVTSQNYTGVSNGTQINVSFDWKSTEFSVGSGVGINVDVQYSIDNGTSWITFGN
VTTTAVTTCATWTGSIPAGTVPNGSDFKLKFNGTRTSGDCYFYLDKIIAIQATATPPNCT
VLSTPSNGAVSVNSSILSWAAATGAPTGYKLNVGTTPGGTSVLNNFDVSNVLSYNLGALL
AGTTYYVTVIPYNPNGNATGCTESSFTTCSAYTIPYFEGFEAGYTHNTPLTSCLIQESTT
GSGVWTANTSFTTYNRTPRTGSWNAFLGYGNEDWIFVPINLVGGTSYTASLFTRQDGATT
TDSDVSISYGTAANAVSMTNTVVAATGITNGNYQQIVGSFTPATTGTYYVGVKGKMNSTP
FYLSLDDISITVTPACPNPLSLVVSAVTNSAATTTWAATTGNYEYVLDNVATDPAGAGTV
LTVETYNALLLAQSTTYYFHVRTVCAGSTYSPWSTVSFTTIATPPSNDNCSTATVLVPGV
NFSSNSIVGTNVGATTSVGEVAPGCASYLGGDVWYSVTVPASGSLTFENNTELGGITDTG
GAVYSGSCGSLALISCNDSSSLAGNDHPLITVTARTPGEVLYYRVWEYGNNSFGQFKVST
YDASLSAQSFDMAGFSAYPNPVNEVLNLSYTKEISNVSVHNLLGQEVMAKAVNASQSKID
MSNLSNGTYLVKVTVDGLVKTLKVVKQ
>KACEBFPM_00535 Hyaluronan synthase
MNFSFIIPVYNRPEEIEELLESLTKQSYKAPFDIIIVEDGSTIPCEHIIDKYKSKLDITY
YLKYNSGPGDSRNFGMSQSKSDYFIILDSDCIIPENYLTEVSKSLSDKYVDCYGGPDAML
PSFSAVQKAINFTMTSVITTGGIRGGSEKIEKFQPRSFNMGISRKAFIASKGFSNIHPGE
DPDLSIRLWQLGFETKLITAAFVYHKRRIDWEKFYIQVNKFGKARPILNHWYPEYAKPTF
FLPSIFVIGFFLGIISFFLNNDIILQLYFVYTVLIFIISSIKNKNIYVGYLSIIAVWKQF
FGYGLGFIESFFKINILKKKPQEAFPELFFKI
>KACEBFPM_00536 Dephospho-CoA kinase
MTKIIGLTGGIGSGKTTIVRLFEAEGIPVYIADDEAKKIMILPETIHLVRECFGQEVIVN
HQIDRKKLSEIVFNHPEKLKELNKIIHPLVKKHFDNWVKKQKSPFVIKETAILFESGSYK
HCDQIITVIASEETRVNRVMLRDKCTKEAVLERIKNQYTDSQKTSKSNYIIENENLNEAK
LQFQEILKKLKNLY
>KACEBFPM_00537 Signal-transduction histidine kinase senX3
MNKTLFRIVVILMTLSLLGIVVVQGYLINASFKNKDEQFKYQVKQVIDNVSKKLQEQETY
TFLSTYNKLKDSIGKNPQQSELLKFFYVEKNAVTNETIIYSNSLIAEDYSLPSSFFDKNK
DSAKLKNYISKRVTEVYNGNTINDNNLSSKLLPDEKIEKSGRMDILDKATFGVYFKDIAA
TRSITQRVSNKQLYGLLAYELSGYGIKTPFEFGIYSNGLATKVKSEKFKYDKKNTYDIPV
FTDNDGVSKYQLLVSFPKKKEFLISDLIGIAILAFLFTAIIIVAYYSGLNQLNKQRHISQ
IKTDFINNMTHEFKTPIATINLALDAIKNPKVIDDKEKVFRYLQMIKDENKRMHAQVENV
LQISKLEKRELDITKEAYNMNDIIEEAIEHVNLIIEDREGKISINLKAKQTNVLLNDVHF
TNVLVNILENAIKYSPEKPIIEVTSENVKNFIIIKIKDQGLGISKASQKKIFDKFYREHT
GDIHNVKGHGLGLAYVKRIVGDHHGEVMVESEKGKGSTFIIKLPLIY
>KACEBFPM_00538 Transcriptional regulatory protein SrrA
MEANKKILLVEDDPNFGSILRDYLSMNDFEVTLAKNGMEGFEKFKKDNYDLCILDVMMPY
KDGYTLAKEIREKNKEVPIVFLTAKSMKEDVLKGYKVGADDYLNKPFDSEVLLMKIKAII
QRKASETKADVAKFEFKIGKFDLNSKLRFLDFPGQETIKLSPKENELLKMLALHENDLMP
RELALTKIWRDDNYFTSRSMDVYIAKLRKYLKPDEGVEIINIHGEGFRLAIKK
>KACEBFPM_00539 hypothetical protein
MSLFENIFGHSEVEKTVSKLNWVQLTDLGQLNEIKDLSHEKTVVIFKHSTRCSVSRMVLK
QFENEYKLENKLALYFLDLLEHRDISNEIANSFGIVHQSPQLIVIQNGVAVYNASHESID
ANDLGRFL
>KACEBFPM_00540 hypothetical protein
MLWFLEHNGLKQINIEGGYAKYTRADLLRPIII
>KACEBFPM_00541 hypothetical protein
MQSFNHCLGVLIDYTVNKKTLHKELISLGWDLKKGSTKNPKKINAPSMSDLLKHNTALEE
LL
>KACEBFPM_00542 hypothetical protein
MNKNNHINVDFKNAEAKVKANIILISFKAR
>KACEBFPM_00543 hypothetical protein
MRKFTLLLAISLIIYSCGVKKTQSLLSDGDYDSAINRAVSALRTKKEAKGKQDYVYLLEE
AFAKAKDRDLRNIDLLAKDANPANLEKIYNTYLQLNNRQERIRPLLPLQLLREGRSAYFP
FDNYSDPIINSKNALSKYLYDNATKLLKSYNKIDFRKSYDDLAYLESINPGYKDVKNLMS
EALQKGTDFVSVYTKNQTNMVIPDRLQNDLLDFSTFRLNDKWTVYHSNKQKGISYDYGLI
VNFREINISPEQLKEKEFIKEKQIKDGVKTLLDSRGNVIKDSLGRPIKVDNFKTIRVDIY
EMKQFKSCQVTAKVDYIDFRNNQLIETFPISSEFVFENIYATYNGDKKACDDSYTPYFNK
RAVAFPTNEQMVYDSGEDLKAKLKDIIVRNRFRR
>KACEBFPM_00544 Dihydroorotate dehydrogenase (quinone)
MIFTSSGASTFRCFKVFNFQYLIFLILKFSNLKSKTNFIFLQNTTQQQMYKLIIRPILFC
FDPEKVHYFTFSLIRTIAKIPGFTSIFKSLYEVNDKRLEREVFGLKFKNPVGLAAGFDKD
AKLYKELSNFGFGFIEIGTLTPKGQEGNPKKRLFRLQEDSAIINRMGFNNGGVLEAVERL
KKNNGVLIGGNIGKNKLTPNENATSDYEICFDALYAYVDYFVVNVSSPNTPNLRELQEKE
PLTQLLNTLQNKNQNKQKQTRDGAQSSGAKPILLKIAPDLTNEQLLDIIDIVKTTKIAGI
IATNTTISREGLQSINRIEMGGLSGKPLTNRSTEVIRFLSQKSNKAFPIIGVGGIHCVQD
AIEKLEAGASLIQLYTGFIYEGPALVKAINKEILKKSL
>KACEBFPM_00545 Hydroxymethylglutaryl-CoA lyase YngG
MNQPIKIIECPRDAMQGIKAFIPTEKKVAYIQSLLRVGFDTIDFGSFVSPKAIPQMQDTV
EVLAQLDLSQTQSKLLAIIANTQGAQNASIYKEIKYLGFPFSISENFQMRNTHKTIAESL
VTLQEILHIADRTNKEVVTYISMGFGNPYGDPWNVEIVGEWTEKLANMGVKILSLSDTVG
SSTPEVISYLFSNLIPQYPNIEFGAHLHTTPNKWHEKIDAAYKAGCRRYDGAIQGFGGCP
MAKDDLTGNMPTEKILSYFTTQKENTNTSPMSFESAYNEASKIFNLYH
>KACEBFPM_00546 2-amino-3-ketobutyrate coenzyme A ligase
MYGKIQQHLQNELNAIEENGIFKRERVITSPQGAEITVNGETVLNFCANNYLGLSSHPEV
VQAAKDALDSHGFGMSSVRFICGTQDIHKTLEQKIANFYGTEDTILYAAAFDANGGVFEP
LLGAEDCIISDSLNHASIIDGVRLCKAARYRYENSNMEDLEQQLIKATEAGTRFKLIVTD
GVFSMDGLVAPLDKICDLADKYDAMVMVDECHAAGFIGATGKGTLEAKGVMGRVDIITGT
LGKALGGAMGGYTTAKKEIIEILRQRSRPYLFSNSLAPAIVGASIKVFELLEKDTTLRDK
LEWNTNYFKEGMRKAGLDFINGDSAIVPVMLYDAKLSQIMAEKLLEKGIYVIGFFFPVVP
KDKARIRVQLSAAHTIAHLDKAIRAFAEVGEELNIIKK
>KACEBFPM_00547 ATP-dependent helicase/nuclease subunit A
MKTPAFSIYNASAGSGKTYTLVKEYLKIILKAKHNDAYKNILAITFTNKAVFEMKTRIID
SLFDFSKDNPTEKSIQLMNDLGKEINLNQSQIKTKAQSIIKNIIHNYAAFDISTIDKFTH
KVIRAFAFDLGLPITFDVSLDTENLLQEAVDAIVAQAGEDQVLTKLLVDFTMEKTDDDKS
WDISSEIMNTGRLILNENYREEILSLKDKTIPEFIALKEKMDLLSETLQLESIDLAKQSI
ALIENNGIEFNSFYSSYVPKHFLKLTSGEIIKHTGHYKYLEEVEGKRYSAKTPQTQKEAV
DAIANQLLDNLKNINSIAEKYMFYEAFLKNITPLSLLNTVSNELAKIQEDQNILSISEFN
KLIFEHIQNQPAPFIYERLGEKYKHFFIDEFQDTSEMQWQNLIPLIDNALSSEDLQGIQG
SLMIVGDPKQSIYRWRGGKAEQFIDLAKTKNPFSNKDKEVFNLETNYRSFEAVIDFNNDF
FKFLSQKFSNEDYKDLYENYSFQKSNAKKGGYVNISFIPEIDTDFVSEEDEENIDKNDIY
LTTTLQTIIKVAAEGFLYNEIVLLTRNNKHGILLANYLTENDIPVISSESLLINASSEVK
FILNMLRYLNDKNDIESLANGLYYLDQNLENNIETHDFIYQGIQYKDEIELEKWLANFGI
QLSFQNSRRKSLYEIAELIAAKCINSENNNAYVQYFLDIVLERDVKYQMGISDFLEYWDK
NGHKLSIPSAEGSNAIRIMTIHKSKGLEFPVVIFPFVEENYSAPKREKMWIDSQSDDLDF
DKFLIDKSSKVKEYGENAASVYNQKSQEDLLDNINVLYVALTRAEEQLFIISNSKKRNSK
GELPNNSASFFIEFLEDYKNFDSNILNYEFGNCKRISKQKPLEAKRKNIEAINSVINPNA
IKIAQRESLMWGTHQQEAIEFGNVLHEILSFVQTKKDIPLALKKALETGLISENQQEEVA
KTVIEIVFHPELNDFFHENSKVYNEQSIIKKGLQTIKPDRVTISGQNAYLLDYKTGKHQS
KYENQLKEYELALIEMGFNVQKKSLIYIGENLEIVHL
>KACEBFPM_00548 Superoxide dismutase [Mn]
MAFELPQLPYAYDALEPHIDARTMEIHHSKHHNAYTTNLNAAIAGTDLEGKSIEDILKNL
DLTKAAVRNNGGGFFNHNLFWTVMSPNGGGLPTGELAAAIDANFGTFADFKAAFAKAGAT
QFGSGWAWLCVKEGKLEVCGTPNQDNTLMPGVGCGGTPILGMDVWEHAYYLHYQNRRPDY
IEAFFNVINWSEVARRFAEAK
>KACEBFPM_00549 Aspartate--tRNA ligase
MYRSHNCGELNATHINKEVTLAGWVQKSRDKGFMNWVDLRDRYGITQLMFDESRSDKTVF
ELAKTLGREFVIQVKGTVIEREAKNKNISTGEIEILVTQMTILNSSLTPPFTIEDETDGG
EDIRMKYRYLDIRRNPVKNSLLFRHKVAMEVRKYLSDLDFCEVETPYLIKSTPEGARDFV
VPSRMNEGQFYALPQSPQTFKQLLMVGGMDKYFQIVKCFRDEDLRADRQPEFTQIDCEMA
FVEQEDILNVFEGLTRHLLKELKGIEVEKFPRMTYNHAMKTYGNDKPDIRFGMEFGELNE
YAKHKDFPVFNAAELVVAIAVPGVGEYSRKEIDALIEWVKRPQVGASGMVYVKCNEDGTY
KSSVDKFYDQGDLSHWAKTTGAKAGDMIFVLSGPADKTRAQLSALRMELATRLGLRNPAE
FAPLWVVDFPLLEFDEESGRYHAMHHPFTSPKPEDMHLLETDPKSVRANAYDMVLNGNEI
GGGSIRIHDKNTQALMFKYLGFTEEEAKNQFGFLMDAFQFGAPPHGGLAFGLDRLVAILG
GQETIRDFIAFPKNNSGRDVMIDAPSIIDDSQLKELHIQLDLK
>KACEBFPM_00550 Cold shock protein CspV
MRTGTVKFFNESKGYGFITDDETGKDIFVHASGIKAEELREGDKVSYEEEEGRKGRVAAQ
VVVIEG
>KACEBFPM_00551 tRNA-specific adenosine deaminase
MENIFTDEYFMRKALQEAYVAFDKEEIPVGAIVVINNRIIAKSHNLTELLNDVTAHAEMQ
AITASANFLGGKYLTNCILYVTLEPCQMCAGALYWSQISKIVFGASDPQRGFTKMGTQLH
PKTIVVNGVLESECGELMKEFFRKKR
>KACEBFPM_00552 hypothetical protein
MEVKYTLTISKPCHEDWNAMPPNSIGRFCENCEKSVVDFTNMNSTEIQNYFVSNQGKKIC
GRFSNQQLNLVIIQIPNQVLHSQTNFYKIFLLALLISMGTTLFSCTDKNGNKQKINKVEV
ADSLVIENTAVEVISPAGNDSLYKSDPANPKNSEVRIMKPTKKYKGLKKPETNIIYREIM
GNISVEPIIDSLKTK
>KACEBFPM_00553 1-deoxy-D-xylulose-5-phosphate synthase
MKNNLLQNINNPNDLRQLDVNQLPQIAQELRNFIIDVVSKNEGHLGASLGVVELTIALHY
VFNTPDDLLVWDVGHQAYGHKILTGRRDNFHTNRKLGGISGFPKRSESIYDAFGVGHSST
SISAILGMAIASHIKGDFNKQHIAVIGDASIASGMAFEGLNHAGVTNANLLVILNDNAIG
IDPSVGALKDYLTAVKEGKNHKDNNMIKSLNFDYSGPIDGHDIFAVVKELQRLQNIKGPK
FLHIITTKGKGLQLAEADQVKYHAPGKFDAATGEIHLKAEENLPPKFQDVFGLTLVELAK
QNEKIIGITPAMPSGSSMKFMMEAFPNRAFDVGIAEQHAVTLSAGMATQGMVVFCNIYSS
FMQRAYDQIIHDVALQNLPVVFCLDRAGLVGEDGATHHGVFDISYLNCIPNMIIYAPINE
IELRNIMFTAQLGLKHPMAIRYPRGRGVIKDWQLPFQKIEIGKGVQLKKGTTIAVLSTGT
IGNNVIKSLSKNKKPDLFSHYHFPFIKPLDEKLLKDIFMRYDQIITVEENAIIGGFGSTV
NQFFNNNNNNKDAILIKNIGILDCFIEQGSVSELHKICGIDEMSLIQLFDSMV
>KACEBFPM_00554 UDP-N-acetylglucosamine 1-carboxyvinyltransferase
MGTFKIEGGIRLKGEITPQGAKNEALQVLCPALLTSEKVRITNIPDIIDVNKLIVLLGNL
GVKIQKNGPGDYTFQADEVNIDYLKTEAFKKEGGSLRGSIMIVGPLLARFGCGYIPKPGG
DKIGRRRLDTHFEGFINLGAKFRYEREDHFYGVEVDGKLKGAYMLLDEASVTGTANIVMA
AVLAQGITTIYNAACEPYLQQLCKMLNSMGAKITGVGSNLLTIEGVDSLGGCEHRILPDM
IEIGSWIGLAAMTRSEITIKNVSWDNLGIIPNTFRKLGITLEKRGDDIYIPTHENYEIKT
DIDGSILTIADAPWPGLTPDLLSIILVVATQAKGDVLIHQKMFESRLFFVDKLIDMGAKI
MLCDPHRAVIMGHDFESQLKATTMSSPDIRAGISLLIAALTAKGTSIIQNIEQIDRGYER
IDERLRAIGANIVRE
>KACEBFPM_00555 hypothetical protein
MNIKYTKEIAGDVVQNLEYNSERKPLIIPEYGRYLHVLVDQATAIEDRDERNKAAKYIIS
VMGNLNPHLRDVIDFQHKLWDQIFIMSDFKLEVDSPYPIPSREVLKMRPDPLKYPQNFPK
YRFYGNNIKYMIDVANKWEEGELKNALCKVIATHMKKSYLSWNKDTVTDEVIFEHLLELS
DGKINLTQSTEELLNSNDLMRTNKRMSNKIQTNNNNGKPKIVKNGKPMMNKNNNRKPI
>KACEBFPM_00556 hypothetical protein
MDKKIEEFYERLKVELDNSNNWPAEYLFKFIVPTVDDNVMRVENAFDCMGAVIKTTKSKT
GKFTSVSVDVTMKNADEIIAKYQEVGTIKGIVSL
>KACEBFPM_00557 hypothetical protein
MQKEIVVIIGGPGTGKTTIIDGLLSKGYCCYPEISREVILEAKKEGIEQLFLEKPLLFSE
LLLEGRKKQFENALAETHDIVFLDRGIPDILAYMHYIGDSYPSFFDAACRSNTYTKIFIL
PPWEDIYVSDNERYESYEQAKLIYNHLVETYQKYGYNLIEVPKDSVDNRILFILEQI
>KACEBFPM_00558 ATP-dependent DNA helicase RecQ
MQRALQILQKHWHYDSFRPVQDTIIQSVLEGNDTFGLMPTGGGKSLCFQVPAMVNDGLCL
VISPLVALMKDQVNQLQARNIKAIALTGAIKANELINLLDNCQFGNYKFLYLSPERLEQD
WVLERIKALPISLIAIDEAHCVSQWGHDFRPSYLKIKNLKSHFNKTPFVALTASATPQVK
DDIIALLGLENPKVFQQSFARDNLGYFIIPAEDKIYKLHQILQKNPESAIIYVRNRKNCH
EYASHLSVLGHKTTFYHAGLSVKEKEANMNSWMRDEKNVMIATSAFGMGIDKPNVKTVIH
INLPENLESYYQEAGRAGRNGEKAFAVLISSPSDIIMAESQFIAVLPDTVFLKNVFVKLC
NYLRIAYGEGINEEFSFNLNQFCSYYKLPTLKTYNALQFLDRQSIISLSQEFSEKAQVQF
LIESKEVIRYISLNRDDEPIVSIILRTYPGIFDLQTNINTDFIAKKSNATEAKVLNLLEK
LQKLQIVAYFSQKNESKITFLEVREDDRTINRVSRHLEKQNLVKKQQLQSVVNYVSNKDT
CKSKLLLQYFGETATKDCGVCSYCSNKKKATHNREEIRAKMIRLLTKNPMNSRALTAMLS
VEESEILKILQQLLEHNIISINTKNEYIIR
>KACEBFPM_00559 Methionyl-tRNA formyltransferase
MKALRIVFMGTPEFAVGILDAIAKQNKHEIVGVITAADKPAGRGQKIKYSAVKEYALKKE
LTLLQPTNLKDESFLLALKSLNANLHIVVAFRMLPKVVWAMPELGTFNLHASLLPNYRGA
APINWAIINGETKTGVTTFFIDDKIDTGAMILSKELEISESENVGDLHDKLMVLGCDAVL
ETLDKIAHGNVVTTIQEDTSDIKTAYKLDRDNCKIDFTKNITEVYNLIRGLSPYPSAWCN
FRDADQEFSIKIYDTKQEVLLHDYTIGSVITTKKEIKIAVLGGFIQVLSLQFPGKKKMMA
HELLNGLTFSEFAMVF
>KACEBFPM_00560 DNA-binding protein HU-beta
MNKSDLIDAMSASAGITKAAAKLALESFLGNIEETLQKGGRVSLVGFGSWSVSNRAARDG
RNPQTGATIKIAAKNVVKFKAGAELEIAVNK
>KACEBFPM_00561 hypothetical protein
MIAVKPKKGHLLVAEPSITGDLSFNRSVVLLADHNCEGSVGFILNKPLGYTINDLIPEIS
ARFKVYNGGPIEQDNLYFIHNIPQLIPNSIEIAEGIYWGGCFDSTRDLINQGKITQNNIR
FFLGYSGWDAAQLQEELESNSWIISENNLHNKIIGKSSTDLWREKIKEQGGDYLIWSNAP
ENPILN
>KACEBFPM_00562 D-alanine aminotransferase
MQNNRAFLYGDAVFETVKILDNKILFLEDHYFRLMSSMRILRMEIPMNFTMEFFEGELLS
KAKEENVQASGRARITVFRKDGGYYLPENNNVAYDISVSKIEKPLYAIQKANYEVDLYKD
FYISKQLFSTLKTTNKLINITGSIYANENGLDNCILINEDKNVIEALNGNIFMLKEGVLY
TPPISEGCLNGIMRKQILSLAKTIENIEITEAVISPFDLQKADELFITNVITGIQPITKY
RKKEFQSSIAAQLITKLNAKIRLG
>KACEBFPM_00563 hypothetical protein
MQNKIRYELEFPINSSPQLLYQYISTPSGLQEWFADNVNSRGEFYTFIWNDSEEKARLYS
KKTGEKIKFKWMDNDNKDTEYYFELKILVDEITKDVSLMIVDYAEPNDIQESKLLWENQI
SDLKHVIGSV
>KACEBFPM_00565 6,7-dimethyl-8-ribityllumazine synthase
MATANKNLSNYDKNTIPNAKNFRFGIVISEWNDRITEGLYSGVIEALTDCGALHKNIIRW
NVPGSFELIYGAKKMIETQKPDVVITIGCVIKGETMHFEFVCEGVTQGIKDLNVLSDIPT
IFCLLTDNTEQQSIDRSGGIHGNKGTEAAIAAIKMAYLREQANLGFHQSDKLLKTNQLQI
EGLPLKIQE
>KACEBFPM_00566 hypothetical protein
MATYNKRGYKAPKPEEEKVETDVNDIENEINIDEKDSATAGVFNTLDETASRTEEFVAKN
QNIILSIVGGIALLTAGYLLYNKFVSGPKESEAASDMFQAQQYFKKAVEGTASDSLYNLA
LNGGDGKQGFLDIIKSHSGTDAGNLAEYYAGMALLNTKKFQAAIDHLANFKSDDAFTNAI
AIGATGDAYSELKKPEQALEFYIKAAESNKNDVTTPRFLLKAGQTAMSLGKKADALKYFT
DIKDNFEATPEAQNIDALIGMTQ
>KACEBFPM_00567 DNA replication and repair protein RecF
MYLKKISLFNFKNFSDTSFNFEHKINCFVGKNGVGKTNVLDAIYHLSFGKSYFNTLAVQN
IKHDEDFFVIDGEFDKQERSENILCSLKKGQKKILKRNGKIYEKFSDHLGFIPLVIISPT
DADLIREGSETRRKFIDSVISQLDNQYLQGLILYQKVLSQRNALLKYFAVNRVFETGTLD
IYNEQLNDLGQSIFEKRKQFLNDFIPIFNSFYQNISNSAETVQLEYESQLEKQDLLSLLQ
ENINKDRSLQYTSVGVHKDDLSFNIAHYPIKKFGSQGQQKSFLIALKLAQFEFVKKQSGE
KPILLFDDIFDKLDETRVEKIVAMVNNDDFGQLFISDTHSQRTENIVKMTHQSYKIFNL
>KACEBFPM_00568 Thioredoxin 1
MKKIISILFISLLFISCKGQTEKAIQTIDVKAFAQKLQTTKNPQLLDVRTPQEYAVEHIG
DATNVNWNATSFVLEVEKYDKTKPVFVYCKVGGRSAQAADKLAQLGFTTIYNLDGGMMKW
NASGMAQPNNKIIGMCNQEFNELLKSNKKVMVNFYAEWCAPCKKMSPYIIKMQDEMKDKV
NIVRLDADKNKTLVEALKLDGLPVIILYENGKEIWRNIGYITEEDLKKHL
>KACEBFPM_00569 hypothetical protein
MITKEAIQFIDDLKANNNTEWMHANKKRYESYKKDYHQFIASVLQEMKPLDKSLDLLEIK
NCTFRINRDIRFSKDKQPYKTNIALWLSTNRNRKNSPGYYIHFEKGSSFIAGGVWCPEAN
ELKSIRKEIAFFYDDLEAIVNNSIFKKQFVAITREDSNLLKKAPKGYEPNHPAIEFLKLK
SYTCSQKIDDKFFLDKDFSKKIAQKLIALKPLNEFLNRALETEE
>KACEBFPM_00570 Putative glycosyltransferase EpsD
MQKKRILFLGETYRADAITWMNGLKEFGDFEIVTWELKTRSSGISRLKRLIELARTFVTI
KSIARKFNANMVIAERTTSYGFLAALSGIEPVVIAQQGITDLWPLNSPLYPFKKIIQDYA
FKKADLIHAWGGVMVANMQKCHVDRARILVLPKGINLTRFQYQENCNKPYIKAIVTRSLL
AEYKHDLILKAFAILKKQHIPFELTIVGDGILLKSLKLRAKELKIEEHVTFTGLISNNDL
PQLLQNANIYISMPTTEGVSASLFEAMACGCFPIVTDLPGNRSWITQKENGILVASENTK
QLAEEIIWAFKNTEIRQKAVLENRKFVEKNANYAVNMKIIADKYHQLINQKSI
>KACEBFPM_00571 Asparagine synthetase [glutamine-hydrolyzing] 1
MCGINGILHLSSKLVDKNQLVKMRDVLAHRGPDDAGIFIEKNIGLGHRRLAIIDTSSAGH
QPFYSENGRYVIVFNGEIYNYKDFYAELKDKGVALKSDSDTEVLLKLYELYGLEILPRLN
GMFAFAIWDKEQKKLVLARDRMGVKPLYYSLYQSTLYFASEQKALFAAGIPIQISESGLE
EYFFNRFVAGENTLYNHVNKILPGHYMTIYENGNSKTTKWWNLKEEIQNHETIANPKKWF
EETFFESVRLRMVSDVPVGVLLSGGLDSGSILSSLYHQDYKNIQTFNIGFSEEKHNESYL
AKNITEEYNYEYNSMKVEGDLLYDSLLESSYFQDEPLMHLNEPHLLAVSKLANAKVKVLL
SGEGADELMGGYVRYKALRRPTLLKAISYLSNFNFLNNNPRFNKLLRYSKITNNSDLVLF
NSTSIYPNDIHEFYGEKKEPINEYRYQLLNEAKELYPNSLQRQALYFDQHTYMCSLLDRN
DRCTMGASIECREPFLDQRLVAGLGTLDDNWLFSGKKGKYILKNTMQDKLPQDILNFKKI
GLSVPWENQLLSNDKFKEELRNFAKSEIFSMPFLENLNGKKIVEQIEKGDKKIIPYIMPL
FMLHIWQKKYFQKFI
>KACEBFPM_00572 UDP-N-acetylenolpyruvoylglucosamine reductase
MTIISNFSLKKHNTFGIDAKAKQFVAVHSVDDLQIILKENQTEKKFILGGGSNMLLTKDI
DALVIHIDLKGKKIIQEDDNFVWVESQAGENWHEFVLWTINQNFGGLENMSLIPGNVGTT
PVQNIGAYGAEIKDTFVSCKAMNIATQEMKIFTNTECHFGYRESVFKHEAKDQYIITSVI
YKLTKKEHKINISYGDIKLELANKNIETPSLIDVSNAIITIRQSKLPDPKVLGNSGSFFK
NPIVLKSEFEPIHKKFPEMKFYEISDTQVKVPAGWLIEQAGFKGKRFGDAGIHKNQALVL
VNYGNATGQEILNVSEDIQKTVFEMFGISIEAEVNVI
>KACEBFPM_00573 Fe(3+) dicitrate transport ATP-binding protein FecE
MNKKNILSTSNLSIGYKAKNTTIVIAKNLNLNFQEGKLITLIGANGIGKSTLLRTLTGIQ
KPISGNVFLNNKLIESYDNHTLAQNLSLVLTEKLPPSNLTVYELVALGRQPYTNWIGKLS
TTDIQKINEAIQLTNIAHLSDKKHFEISDGQLQKVLVARALAQDTPLIILDEPTTHLDLL
HKVSLFKLLKKLTKETGKCILFSTHDIDLAIQLSDEMVVMTSGKIFQNQPCNLISDGTFN
TLFKDENIVFDNQKGKFVVT
>KACEBFPM_00574 tRNA (cytidine(34)-2'-O)-methyltransferase
MLNIVLVEPEIPNNTGNIGRLCVGTGNRLHLIHPFGFEINDKNLKRSGLDYWVHLDWFQY
KNTQEWIDQIPDKSRVFMMSSHAQTSYYEANFQEGDWLVFGKESVGLSKEILNLFENHLT
IPMSDKIRSYNIANSVAFVVGEARRQIALKI
>KACEBFPM_00575 Ribosomal large subunit pseudouridine synthase E
MKMYFCKMTIHQHFIIHKPYGYLSQFKYELKRKKKLLGELYDFPEGIMAIGRLDEDSEGL
LLLTTDGKMSEIVRSKKVEKEYYVQVDGLITQEAIEKMKNGVEIGFEGTKYMTKPCKAFI
VNEIPNFGERGKKIRDERHGPTSWASIVVTEGKFRQVRKMTAAVGFPTLRLVRVRVGNIH
LGNLQAREVLETSDFSKINENINVKN
>KACEBFPM_00576 hypothetical protein
MSEVLVLASFIIALFIGIFIGKIIFTAKFQSEKNVFEEKLNALKEQSQIEKSSFDKVLLQ
LNTEKEQIRTEKEVANIQLAKKEADFDSLLEKNKDQKQEVEQLQEKFTKEFENLANKILE
EKTNKFTEQNKENMKNILTPLQDKILHFEKKVEDTHKESIDYHAALRQQILGLSEMNAQM
SKETLNLTKALKGDSKMQGNWGELVLERVLEKSGLEKGREYIVQQSFTTAEGNRVFPDVV
INLPDGKKMIVDSKVSLTAYEKYINEEDDILKSGYLKEHINSIKRHVEQLGDKNYHDLYQ
MESPDFVLLFIPIEPAFALALNEDTTLYNKAFEKNIVIVTPSTLLATLRTIDSMWANQKQ
QENALEIARQAGALYDKFEGFVADLIKIGKKIDESKVEYSGAMNKLIEGKGNLVTSVEKL
KKMGAKAKKSLPESIINRAEANENNLLN
>KACEBFPM_00577 hypothetical protein
MLRKSLFIIITTLVLVIMGYFTFLYYATYSEGVRSGELIKFSHKGMIFKTWEGEISQGIS
GAQIFSFSIMDSEKKVISDFKEMEGQYVKITYIERYKTFPWWGDSKYFITAVKKDVSPFK
LK
>KACEBFPM_00578 putative acyl-CoA thioester hydrolase
MNSIFKTVKASKVTISELMLPSHTNFSGKIHGGYILSLLDQIAFACASKFSGNYCVTASV
DTVDFLNPIEVGELVTMKASVNYVGKSSMIIGIRVEAENIRTGVAKHCNSSYFTMVSKET
DGKNALVPGLILSNHDEIRRFYNCLKMIAVRKEKQEHEDVFDFKSDAAILNLKNYNVQLE
L
>KACEBFPM_00579 Inward rectifier potassium channel Kirbac3.1
MKVFKKTRKNLKTDNQTGFGTNASNYGGRFLAKDGSANIEKRGLPFFDQISWFHTLLRLP
AWKFQLMIFLVFIFVNFIFATIYYFIGIEHLNGIIASSEIEKFGQIYFFSAQTFTTVGYG
HISPEGFLTSAVASGEALIGLLGFAIATGLFYGRFSRPKAHLKFSENAIIAPFQGGKSLM
IRVASYKNTNLTDAEAKLTLAMTVEENGVYVNRFFPLDLEYSTINALTLSWTLVHHITEE
SPLFEFTKDDFANEKGEVLVFLKAFDEMFSNTVAIRTSYIFKEIVYGAKFLQMFKHSNDN
TKTIIHIDKLNLFEEINF
>KACEBFPM_00580 Carbamoyl-phosphate synthase large chain
MPKDNSIKSVLIIGSGPIVIGQACEFDYAGSQSARSIREEGIEVILINSNPATIMTDPTM
ADHVYLLPLTTKSIIQILKEHPQIDAVLPTMGGQTALNLCLEADEKGIWKDFNVKLIGVD
VNAIEITEDREKFKNLLNKIGIPQAPAKTATSFLKGKEIAQEFGFPLVIRPSFTLGGTGA
AIVYKKEDFDEKLTYGLEMSPIHEVLIDKALMGWKEYELELLRDKNDNVVIICTIENMDP
MGIHTGDSITVAPAMTLSDTTFQKMRDMAILMMRSIGNFAGGCNVQFAVSPDDKEDIVAI
EINPRVSRSSALASKATGYPIAKIASKLALGYHLDELQNQITKSTSALFEPTLDYVIVKI
PRWNFDKFEGADRTLGLQMKSVGEVMGIGRSFQEALHKATQSLEIKRNGLGADGKGYKNY
EQIIDKLTHASWDRVFVIYDAIAMGIPLSRIHEITKIDMWFLKQYEELYSLEKEISKYKI
DTLPRDLLLEAKQKGFADRQIAHMMGCLESQVYKLREEQNINRVYKLVDTCAAEFKALTP
YYYSTFEAEIETASGEKHVHNESIVTPKKKVVVLGSGPNRIGQGIEFDYSCVHGVLAAKE
CGYETIMINCNPETVSTDFDTADKLYFEPVFWEHIYDIIRHEKPEGVIVQLGGQTALKLA
EKLSKYGIKILGTSFDALDLAEDRGRFSELLTDLKIPFPQFGIAENADEASALADVLDFP
LLVRPSYVLGGQGMKIVINKQELEEHVIDLLKNIPGNKLLLDHYLDGAIEAEADAICDGE
NVYIIGIMEHIEPCGIHSGDSNATLPPFNLGEFVMQQIKDHTKKIALALRTVGLINIQFA
IKDDTVYIIEANPRASRTVPFIAKAYGEPYVNYATKVMLGHHKVTDFTFNPQLKGYAIKQ
PVFSFSKFQNVNKALGPEMKSTGESILFIDDLKDDQFYELYSRRKMYLSK
>KACEBFPM_00581 hypothetical protein
MVITNKDLIQSYIITASRYDYSVPEKRILYRIVELLQQYTQGKILNQKYSVVKNIFDDVD
IVMPVSAFLKNEDSTNHAEVKKAMKSLQNKTIEYEDEHIWMSLNLIERPVFTKNQMTVSF
RVSPLIASAFNDFSKGYSKYELETAMSFESVYAMRFYELLSSQKNKITYSIDKLKIMFQI
EDKYVGKNNDFIRKVVDKAKEELDKKSPVSFVYEKQTLGKKIIGIHFYPVAKPENRDPVL
EALQLKKNVSLRWDLDLMIINYLKENYIFSESEIKNNLDLFKQCQKELPDFILTLSKMRV
LASKKSNPKGYLINALKKMLAGENSKKVTVKKPKKEVVNDAMDKILGLSKNKNI
>KACEBFPM_00582 hypothetical protein
MEMWLNRMSVEEKKWLEFFLLDKLEEYRKNRVSPMDDEVYKLPETEVEVYKRFCKYEIST
CESLIYKYNIDFDEFLQKRVPPPF
>KACEBFPM_00583 hypothetical protein
MLENLKITKESKNGLEWLKKNYSFNTYSIAIDTAIQFFKNNNISPRERIYNNYSEAIFNF
KNELFLKLDEFEKKENENTERIIKLNRRFELDYLKPINVKLFDVHKNSIDDFNDKNNSKV
ISNIIGNSAIETSNLQNIEENKKLNETIIKQENAIKFWKEQNEILEKEKKEYHRCMEKLN
RNMKVEKTLMGKKPYINLSVEETEKLFYLIP
>KACEBFPM_00584 hypothetical protein
MIVISSREFRDHQKKYFDLIDTNEQVIVQRGKNKSYKLVPVLEDDTLMTEAEFYAKIDKS
IEQAKNGQVTRIAKEDLKSFLGL
>KACEBFPM_00585 Toxin RelK
MSYHIEFSAQAETDIAILKKSGDKAVLKKLKSLLDELSEHPRTGTGQLEILKHYSEETFS
RRINREHRIVYRIHENTVTVLVLSAYGHY
>KACEBFPM_00586 hypothetical protein
MITISVSEFRGNIKKYLDIAQEEKILIHRGKGKTYAIVPIAEINEEPYNPEFVAKIMRSK
EDSEKGRVTFIKTEDLWK
>KACEBFPM_00587 Beta-barrel assembly-enhancing protease
MKSFQKTITILFIFIGFIGNAQNMNEGFSNLEKGEFDKAEIFFTTILKDYPQNKTARLCY
ARAIGLNKQPQKALALFTTLKSEFPDDLEIKLNYAESLLWNKNFDSAKLYYTKLVDENAT
NFVAHLGFANTLSNLKEFEQALFNVNKALGISSGNIGALVSRKYIKLGYANQMISEKKYA
NAESFYDEILVDFPNDKETLLNKANLYLITKNSKKGRESYNLLSSLDPILALNGLSLVEH
IAGKEKKALVISDKAMAKINETSDSVLIKQTKERNVQALIWNKKYNLAITKINELNKQYP
NENWVLALSATLAIYKSNFEESIKYYESILANDAQSFDGNLGIANAFYASGEIKKSIKAV
YQTLEIFKNQNDAMIFLKKLNEEHTPSIEEKLSYSFDNGNNNAISSRTQITFPVSTKWSV
NTAYQYRKTENTVTNVSANTNDFLIGASYKFHPKISFNLDSGITSANLTTASYTSLLLNS
YFKIKPLKLQDLEVGYKRDLQNFNTDLIGKQIAANNYYFNYNIGSNFKLGWFTQYFYTTQ
SDNNTRNLLFTSLYYSFLSKPILKAGFNYQYISFKNQLPTVYFSPSEFNAYEVFVELLKD
EKITETHSWFYNLNAATGFQYIEKLDKQATYRVQAKLGYKFSNRLLVNIYGLKSNIASAA
ASGFTFTEFGLRLKWDLRSKPVFKL
>KACEBFPM_00588 Transcriptional regulatory protein YpdB
MNCIIIDDEEMARAIINQMIANHNTLNLVQEFSNAIQAIKYLNQNNIDLIFLDIHMPDFT
GFDFMQTIKNPPKIILITSDKNFAIEAFEYECVVDYLVKPITKERFEKAIAKAIAKAIAK
TNAAQISNRNSTIEIKSLTEDNNKEFYVNIDRRLIKIEFDLVTIVQAKGDYIHIKTEGKN
YVVHSTLKKIEQKLPKDTFLKVHRSYIINTKKIIDIEDNSVLIAKDVIPVSRANRPELMK
FLNLL
>KACEBFPM_00589 hypothetical protein
MEKPNSSYINQLSGDNEDFKTKVIGILKKELPEEITIYEHLIQTKKYKLASESVHKLKHK
ISILGLEKSYYIAEEFENNLKENSTKLQPDFETILKSMQDFVNTL
>KACEBFPM_00590 Phytochrome-like protein cph1
MNSLLKRQIDKKLKNGLDDIAPFINAVNDSYNNFEDQISMLQRAMKISSDELFLANQKLR
DEAKGLKEINKNLQNVLNSMNLENNNIDNDDHLNSADYVKQQSDEIIRINKQREELLKNL
EKQNQALNQYAHVVSHDLKAPLRSIDTLINWFKEDNAAILDDNNNKSLDLVLSNVEKMDL
LIKGILDYSAIDKLEVKDRTIDLNILIHKIIRTITIPNHIEIILKNKMPKIVGNDITLKQ
LFQNLIQNAIKYNDKEMGFVEIGSKENDNEIEFYIKDNGIGIKERYQDKIFNLFSKLENT
DQSSGIGLSIVKKIIDLYQGKIWLESQETIGTTFYFTIPKQ
>KACEBFPM_00591 hypothetical protein
MKIVQATKTENQDWKFLQEKIILKNPLVLVFANRFLLDDEKVINDIRVQFPYEHIVFGST
SGEISNINVNENSISVVAIEFEKSSFIVKSDNIINYNKNAKILGKTLYNKMPKENLKHLF
VLSEGSFVNGSDLIDGLEQDMNPNISITGGMCGDDARFEKTLASYKENPKIGEVVLIGFY
GDTLEISFASFGGWTPFGPERTITSSEGNILFEIDAKPALDLYKYYLGDKASQLPQASLL
YPLNVIPEGKTEAVVRTILSINENNNSMVLAGDVPLNSRVQLMMASIDAIASGAQHAAEI
ANENRKKPAELALIISCIGRKLIMNQRVEEEIEQVQEIIGNQVAIAGFYSYGEIAPFNGK
NNSCELHNQTMTLTLISE
>KACEBFPM_00592 Phytochrome-like protein cph1
MSDVIEKKLTLHDFAIHDPLLDLLHILNNQENTANELKELLTTINDQKNKLKQANKEIHD
IALFPTQNPDPIIRIDTKGNLLKRNPAAEKLSSFIYDEINYKIEDFFKFIITKIDPEKER
WIFEIQNDQKYYSFVCISLKEDNYINIYGRDITQQKKTEEESNRLSLVASANQNGVVFTN
PNGIIFWCNNAYLKLTGFSREEVIGKTPIEIGKTNHTNKSDLKKMIEPFYKGIPFDIDLI
HARKDGSSFWSKNKGQPILNSKGEVIQYFAMIEDISLKKRYDESLQNEKEKYRSIIANMN
LGLLEVDLNDVITLANNSFLTISGYSSEELIGKKAAELLLTQESKKLVKSKNEIRKKGKT
DSYEVKVIDKFGKNRHWLISGAPNYNAMGELIGTIGIHLDITLQKEQEEKLYLLSLIAEK
NINSVIIANPEGKIEWANKSFIEISGYTIEELIGKRPGNLLQGKETNPETIIYLRDQIKK
GLPFNCEIINYSKQGKKYWINIQGQALYNKKGQIVKFFAIEENITKKKELEEKQDFLVKS
LAKSNKELEDYASIVSHDLKSPLRSIHSLISWIKEDNDNQLNDQTLQYLSLIEGKVEKMD
YLIEGILTYAKIDKINLASEKVNIHEIIENIINIIHIPNHINVSIIGKLPIINADKFRIQ
QLFQNIISNAVNYIDKPIGTVNVSCIEKDGKYIFSIQDNGPGIAKENQEKIFKIFQSLQK
SDKSTGLGLSIVKKIIETYNGKIWLESQINHGTTFFISLNDQ
>KACEBFPM_00593 Multidrug resistance ABC transporter ATP-binding and permease protein
MKLLYSYLIKHKTLLLFALLMAAINICFSLSDSIITGKLMQDCGVGIAKYKGQELNFIKA
VGFWIGLSLGAAMISRITKNFQDYFTNLVIQRTGAEMYTDGIKKSLDLPYEDFEDQRSGE
TLSKLQKARTDSEKLITLSISLIFQTIIGFIFVIVYISRIDYRIAFVFILTAPIIAFISS
FLGKKIKVVSRRIVQQTNSLAGSTTESLRNIELVKSLGLTQQEESRLNSNTHKILKLEIE
KIRFIRSLSFIQGTTVHFMRTSVVFTLYYFLFSHKIVVGDLLTMVFFTFFIFNPLQELSA
FIIAKNETKVSMENFENLLKAKSEFRPEKPKSIGKISSLQFLNVSFKHKTAKFSAVENID
FHINQGETVAFVGPSGAGKTTLVKLLVGLYPPAEGQVLYNGVNSNEIDLLDLRRQLGFVT
QDAQLFSGTIRENLLFVKPDATNEELYDALNRASCENLLNRAEDGLNSTIGEGGIKVSGG
EKQRLSIARAILRNPNLLIFDEATSALDSITEEEINTTIRNISDQNRITVLIAHRLSTIM
HADRIFVLEQGKIIEQGKHEDLLLEKGLYYAMWRQQIGERKSVT
>KACEBFPM_00594 hypothetical protein
MKRFVILLNPLTSGSELRIDFQSESIATDFYDLSKLDEYKIYQYIQSDYTYIMPIEELEQ
KNISFIKLEREEKTWFGLFKKKVTDILIEPTEEFYYPYSYGYYLYIFTKHKINKTEFEDW
LNKKYLTKGIDESFTEIKSEFEDLMKKDDYLLVTNHDLQQHFGICGNENIINQITSKFNK
LNLNEFEIRKTNAK
>KACEBFPM_00595 hypothetical protein
MQNTKINIKYWTNPEGEDFKGISVLFNTNYLLKINKKRTDTCGGGLYDIVIKITEDISFI
ELAKSYLEDGLKVLIGLAIKPVFVSLKKLFKTNKVLNPSIQELVLDFSDCKIKIYNHLQN
DIEDIFDDLVIELFNLRLKNKKFFKRVKTIHIPIVKRPDYYKLCNNRVIFTIDEPIRKIT
KEFYFGYWGLSTSKGKHIYDVKVKTISKEKFYTYKSYEKLFNKASKSGKLD
>KACEBFPM_00596 Toxin YoeB
MKYVFVDESWEDYLYWQKIDKKKVKKINDLLKDISKNPFEGIGKPEPLKHKYAGFWSRRI
DDEHRLIYRFIDDEIQILKCRHHYD
>KACEBFPM_00597 Antitoxin YefM
MVVANISDFRKDIKSYFDRVAINFETLIINRGKDSGIVVISLEEYNSLIATNYELSNRTN
ESRLDSAIDKFKSGKSFSKDLIEE
>KACEBFPM_00598 Formate-dependent phosphoribosylglycinamide formyltransferase
MKILLLGSGELGKEFAIAAQRIGQTIIAVDNYPNAPAMQVAHQFEVINMLDGSELDRIVA
KHQPDFIVPEIEAIRTERFYEYEKQGITVVPSAKAANFTMNRKAIRDLAAKELGLKTANY
RYATSAEELQKGVQAVGMPCVVKPLMSSSGKGQSTIKTVEDIEKAWNYAVEGSRGDVVEV
IVEAFVKFNSEITLLTVAQNNNPTLFCAPIGHRQERGDYQESWQPARISDKDLHEAQDMA
RKVTEALGGAGLFGVEFFLTNDGVYFSELSPRPHDTGMVTLAGTQNFNEFELHLRAILSL
PIFDITLEKAGASAVILAYKNSNNPTYSGIENIACLPKSDFRIFGKPTSRPYRRMGVVLT
NDTLETPVEEIVERAKKIATLVKVNL
>KACEBFPM_00599 hypothetical protein
MKRIFLVLAIFLLLTACGPRRLGCGPGKRCVEVCKKNNFEKNKDSKVQV
>KACEBFPM_00600 hypothetical protein
MKKVFTLLLLLIAFLVNAQESKTTQKTKIVEASCGQCQFGINAKGCDLAVRIDGKSYFVE
GTKIDDHGNAHAKDGFCKTIRKAEVAGKIVNKRFIATYFRLLAEITK
>KACEBFPM_00601 Malonyl CoA-acyl carrier protein transacylase
MKAYVFPGQGAQFSGMGKDLYENSELAKALFEKANEILGFRITDIMFEGTAEELKETKVT
QPAVFLHSVILAKTLADFKPEMVAGHSLGEFSALVANGALSFEDGLKLVSKRALAMQKAC
EIAPSTMAAVLNLDDKIVEDICASIEGVVVAANYNCPGQLVISGEYKAVELACEKMKEAG
AKRALILPVGGAFHSPMMEPAREELAAAIEATTFSVPICPVYQNVTASAVSDPNEIKKNL
ITQLTAPVKWTQSVQQMIQDGATLFTEVGPGKVLVGLVNKINKEIETHSA
>KACEBFPM_00602 hypothetical protein
MKKLILSLAIVTLIVSCKEETKDKVEVATEAVTSEVKETVDSAKIKTETTLDTVKAKTEQ
KLKNAVDKGADKIIDAADKVKKSVK
>KACEBFPM_00603 UDP-glucose 4-epimerase
MKILVTGGLGFIGSHTVVELQNEGFEVVIIDNLSNSSEEVLKGIVAITGKTPLYEKLDLR
EKKSVQDFFKKHDNINGVIHFAASKAVGESVENPLLYYENNINTLVYILQELQQKDNANF
IFSSSCTVYGQAKKMPITEKAPIQPAISPYGNTKQIGEEIITHVCAISNINAILLRYFNP
IGAHSSSEIGELPIGVPQNLVPYITQTAFGLRKELSIYGNNYPTPDGTCIRDYIHVVDLA
KAHVLALQRLINKNNILNIETYNLGTGTGTSVLEVVHAFEKISGKKMPYTIVNRREGDVV
SAYADTKKANVVLGWKAQFSLEEALSSAWKWEQKIRKKQEDYK
>KACEBFPM_00604 hypothetical protein
MLLKPVLPVVEYLVNYDYIAKVLCVNKETPIMGCDGKCYLISQLAKSSDTEKPFSDKKII
VKEFEVLFFQEITAVIFPNASFLPIRVLNFNYSNLYNYLNSTTTFHPPSIIL
>KACEBFPM_00605 hypothetical protein
MKFQLKKIMAIMALVLVFASCSKNEDPINVITGEGRVGLEFDNVFGSSNLILNTQVNTTS
QGEKLKISECKYIVSNIVLTKDDGSIYVYPKANSYFIIDEAKETSRKIVLKSIPAGNYTK
VTFGIGVDEAQFRLGATGQGDFLTQAQDAGMMWSWSAGYKFVMFEGMFTSPTATTDTSFM
VHTGKIAAAYNYKEVTINFPQNATVRTTITPDVHIFADVAKIIDGTNKIKLSDNNRNGMG
AMIMGGANLPLITSNLSEMFVVDHVHND
>KACEBFPM_00606 Cytochrome c551 peroxidase
MKTKYILLLIMPFFWSCSKVDNTDNYVNIPIDYKVPSNFPPLAYDLNNNPLTEKGFELGK
KIFYDGRLSSDGLISCGFCHIQENAFTHHGHSVSHGVNNEVGIRNAPPIQNLAFQTSFMW
DGAASHLDMQSILPFTNPVEMNGNFGNTIAMMKSDAEYQKLFKIAFINREINSENMLKAL
GQFMVMVTSSNSRFDKYRRHETGGTLTQEELGGYTIFNQKCASCHATDLFTDNSFRNNGL
AINPQVNDIGRFRVTELAQDLHKFKVPSLRNIEKTAPYMHDGRFFTLDAVLDHYSNGIVN
SATLDPSLHTNGVLGISLTSLEKTKLIAFLKTLTDNQYLTDKRFSEY
>KACEBFPM_00607 hypothetical protein
MKKYILIVLITFQFANAIEKDSLLFNKNPFTKHYLFPEKVMCDACGCSASGGSMGFASMI
NSNFVGIRYFNQQYKSSDGLYSNSPWYNENYQTAQVWARIPVYKNIQVTALVPFHFHTRE
TKIGNQDIKGIGDITVLAMYQLYQTHKDSTYFVHTLQLGGGVKLPTGEFNDKNNTGSINQ
SFQVGTGSWDYLFATEYTIKRKKIGLNTMLNYIVKTENTKFYQFGNQFNYAGTFFYLYEK
NSISIAPQLGFAGEVYQDNYHHKQKLKDTAGDIIFGKLGFEIGKDKLSFGANAMLPINQN
LASGNVEANYRWSFNLNYSL
>KACEBFPM_00608 Protein translocase subunit SecA
MKKAYESQGKQLVADFEKNITLAIVDDAWKKHLRKMDEMKQSVQLAVHEQKDPLLIYKFE
AFKLFKNMLDGINKEVISFLFKGDLPQQQNNIQEATQIRQKENYIESKDEILNIEEQAER
NHEAGQTQQHQVTETIVRDMPKINRNDTVKIQNVANGQIEELKFKKAEILLNAGTWVLVS
E
>KACEBFPM_00609 FeS cluster assembly protein SufB
MSEKGIIFCPISEAIREFPELVQKYLGTVVPQKDNFYAALNSAVFSDGSFCYIPKGVRCP
MELSTYFRINQAGTGQFERTLLIADEGSYVSYLEGCTAPSRDENQLHAAVVELIALDDAE
IKYSTVQNWFPGNKEGKGGVYNFVTKRGLCEKNAKISWTQVETGSAVTWKYPSCILKGDN
SIGEFYSIAVTNNFQQADTGTKMIHIGKNTKSTIISKGISAGKSQNSYRGLVRISAGADN
ARNFSQCDSLLMGNNCGAHTFPYIESKNTSAKIEHEATTSKIGEDQVFYCNQRGIPTEKA
IALIVNGFSKEVLNKLPMEFAVEAQKLLEISLEGSVG
>KACEBFPM_00610 putative ATP-dependent transporter SufC
MLSIKNLHASIEDKEILKGINLEVKAGEVHAIMGPNGAGKSTLSSIIAGNENYTVTQGEI
LLEGEDISELAPEERAHKGVFLSFQYPVEIPGVSVTNFMKTAINESRKARGQEDMPANEM
LKFIREKSELLEIDRKFLSRSLNEGFSGGEKKRNEIFQMAMLEPKLAILDETDSGLDIDA
LRIVANGVNKLKSKDNAVIVITHYQRLLDYIVPDFVHVLHDGKIVKSGGKELALELEEKG
YDWLKQEVN
>KACEBFPM_00611 FeS cluster assembly protein SufD
MELKEKLLSSFMAFEEKIDFHQELHDVRSQAIKNFESKGFPTKKEEAWKYTSLNTILKND
FSVFPKKENTIEFKEVKKYFIHEIDTFKVVFIDGIFSSFLSSTSHDGLDVCLMSSALNKP
KYKIQIDEYFNKIASKEESLTSLNTAFASEGAYINIPKSKVVEKPIEIIYFSTGAEAALM
VQPRNLVIVGENAHVQIMERHQSLNDNPVLTNSVTEIFAQKRAVVDYYKVQNDVQTANLI
DNTYIAQKQESHVSVHTFSFGGNITRNNLNFYHQGERIYSTLKGVTIIGDKQHVDHYTLV
QHATPNCESHQNYKTILDGASTGVFNGKIFVEKEAQKTDAFQKNNNILLSDKATINAKPQ
LEIFADDVKCSHGCTIGQLDENAMFYMQQRGIPKKEAKALLMYAFTSEVTGSIKIPELRS
KIARIIADKLGVKMGFDL
>KACEBFPM_00612 6-aminohexanoate-dimer hydrolase
MKKIFKILGLVILLFLVYFGVTTYPKLDLISGFSAKSVASGHFIDNRSLEIIEKGDNDID
LIDLAKNKINENSKSASASVYGLKTRKAIYREGLGATLINDGFDESKPYEVPKRTKLNNN
LPFPYGNNEAQKVVFKNIDYKKLELAVENAFDKKGQKNKRTRALLVIYKDKIIAEKYDTG
FTKNSKILGWSMTKSITATYFGILQKQGKLDINKPAPIAEWQNDERKNITTNDLLHMNSG
LEWEEDYAKISDATKMLFHEEDMTRSQILKPAKFKPNTHWNYSSGTTNLLSGILRKQFKT
HQEYLDFWYSALIDKIGMNSMVVETDMAGNYIGSSYGWATARDWSKFGLLYLHKGNWNGE
QIFDESWAKYVATPTNDSNGIYGAQFWLNSNKKYPDAPKDLYSANGFQGQNVFIIPSQDI
VIVRMGLKENGIFDFNELLKGILASVKK
>KACEBFPM_00613 Cysteine desulfurase SufS
MLEINKIRADFPILTQKVNGKPLVYFDNGATSQKPKVVIDAIAAYYQEINANIHRGVHTL
SQLATNAYEESRIKIQNHINAKFAHEVLFTSGTTFGINLVAHGFAAVLKPNDEVMVSALE
HHSNIVPWQMLCQKTGAKLVVIPMNENGELILSEYDRLLSNKTKIVAVNHISNALGTINP
IKYMINKAHEVGAAILIDGAQAVPHIKPNMQELDCDFYVFSGHKMCGPTGTGILYGKEAW
LNKLPPYLGGGEMIKEVTFEKTTYSDLPHKFEAGTPNIAGGIVLGTAVDYMNSIGFENIQ
EQEKELLAYGTKKLLAIEGLKIFGTSKEKTSVISFNIDGIHPYDIGTIIDKLGIAVRTGH
HCAQPIMNYFNIPGTIRASFSFYNTKEEIDIFVEAVRKAKTMLS
>KACEBFPM_00614 hypothetical protein
MKTIALVFLSLLLTKSCQPKKESGLSQQTKETIDNNATPEVEKPEMTNNKVQTGTKAEYE
AFSRGFFSKITFENNQLTIASDRNNPEKITIIVLTKNDISDLSNLIKAVNLDQLPSLKSP
SEARMYDGAAHANLTITSGGTVYTGAGFDAGKPPVEIEKLVSKLVSYSEKK
>KACEBFPM_00615 Cysteine desulfuration protein SufE
MTIKEIQEEIVAEFSMFDDWMQRYEYIIDLGKNLPLISEEFKTEENIIKGCQSKVWLQGE
QHDDKIVFTADSDAILTKGIIAILIRTFSNQKAVAILEADMSFIDEIGLKEHLSPTRANG
LVSMIKQIKMYALAFQSKN
>KACEBFPM_00616 hypothetical protein
MEEFNDTINLGEAAVKVLKTIYDPEIPVDIYELGLIYDVFVNEALDVKILMTLTSPNCPV
AETLPREVEEKIKKIDTVKSCEVEITFDPPWTKDLMSEEAKLELGML
>KACEBFPM_00617 hypothetical protein
MQDEIINKVANSVLEVFDLEDYYAKEIRTQIDISHWLYEGLLLKEKDFREVLKKHDWSQY
ENHYVAIHCSTEAIIPAWASILVTIHVSPFAKKVVSGSLQDLETALYQEILPTIDYSKYQ
DKPVIIKGCSKKPVPESAYILAVQKLQPFAKSIMYGEACSAVPLFKRK
>KACEBFPM_00618 hypothetical protein
MKKTILVLAVLLLGINANAQLSEKELLEKNALLANKADDTTNAGWKRGGNIVFLFNQSAF
NNDWLGGGTANTAGNLGLNYDFNYKAEKIVWDNKIIAAYGLTQTKGQKTTKSDDRLEFTS
LLGRKAGQGYWYYSWYLNAKTQMDSGFDKAKGIKISHFFSPAYLQSGPGMLWKKSNNLKV
NIAPATSRLIFVDGQFTQSGAAFGVAQGKTSRFEFGAALNGYYKLNLMENISVENILNLY
SNYLDRPKNVDIDYQMNLVMKVNKYISTNLAFQALYDDNARGAFQIREVFGLGVNYGF
>KACEBFPM_00619 Hercynine oxygenase
MKVNKIVTVRVLFSLIVLFGFTSCSKKSSSKNTSSATGWKINDPNGGFQYNNNFTKQATA
PGLVLVEGGTFTMGKVQDDVMHDWNNTPTQQHVQSFYMDETEVTNLMYMEYLDWTKRVFP
PTEENYKNIYEGALPDTLVWRNRLGYNETMTNNYLRHPAYSQYPVVGVNWIQSSEFAKWR
TDRVNESVLEKEGYMKKGAKVVDADANNTFSTEAYLASPSTAFSGNEEIILKKTGRKSGK
SAKKSSASATTTSADPAATDGPKNVYAQKTSGILLPEYRLPTEAEWEYASAADVGNREYN
LYRGQKKYPWKGSYTRSGSRSTKGDQLANFKQGKGDYGGIAGWSDDGADITAPVKSYKPN
DFGLYDMAGNVAEWVQDVYRPMVDDEANDFNYVRGNVYTKNKIGEDGKIELVTSENIKYD
TLSNGKVIARNKPGEIVQVPVNEKETYLRQNFDKSNEINYRDGDKQSTRFFDYGASEEGE
AKKDEKNRMYDSPMHKVSADSTGKMDRKFDKSAKRTTLIGDDVRVYKGGSWKDRAYWLDP
AQRRYCQQDIASDYIGFRCAMSRVGPKSDKPKRARN
>KACEBFPM_00620 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase
MKIEEIYQCYLQCTSVSTDTRKIENNSLFIALKGDNFDANTFAEEAISKGALFVIIDDKK
HHTNKDKMILVLDSLQTLQELAKYHRQQLGLPIIALTGSNGKTTTKELINVVLSKKYNAK
ATIGNLNNHIGVPLTLLSFDEDTDIGIVEMGANHQKEIELLCSIAEPNFGYITNFGKAHL
EGFGGIDGVIKAKSELYNYLEENKQTAFVNLDDEIQNQKTMQIMRYSFSIAKESDVKIDF
VVANPMVEINYKKMKIKSHLIGLYNANNISAAIAIGKYFNIADDDIKDAIQNYIPTNNRS
QLIEKNSNNIILDAYNANPSSMEAAITNFIQLKAKDKIAILGDMFELGNDSLIEHKKIIE
LFINGPEIETYFIGKDFYCNKIEMKNIHFFDTYESFSKSFKTRKTSKNTILIKGSRGMSL
ERTLEIL
>KACEBFPM_00621 hypothetical protein
MESYIELLKLMLLEFLIENFNLTSFKNSEEKLHLYFEEQAKPPKEFAAIKLVSKGFMEEI
TIQDFPLRGQFVYLHIKRRRWTNKSTSEIIKRDWNLVAKGTHMTQEFMFFF
>KACEBFPM_00622 Purine nucleoside phosphorylase DeoD-type
MIQSSELILNPDGSVYHLNLLPENIAHDIIFVGDQERVSKITQHFDSIEFSTQKREFKTQ
TGTIKGKRITVMSTGIGPDNIDIVMNELDALVNIDLATRKPKENLTSLNIIRIGTSGSLQ
ADIPCDSFVMAKFGLGLDNMLRSYLIDEVSIPEMEDAFIKHTNWDLRKGKPYIIPCSEEL
EKLIESEKIHKGITATAGGFYGPQGRVLRLNIQDESLNSKMDNFNFEDNRITNLEMETSA
IYGLGKLLGHHCLSLNAIIANRASGTFSQDPYKAVDELIAYALEKLSK
>KACEBFPM_00623 hypothetical protein
MNFRLARHTNNLEEIKFFYISILGFELLGNFENHDSYDGIFIGKPNLDWHLEFTKSNEII
KFNFNEDDIYVFYPKTISEYHKLIESVLKNNISFIEPKNPYWNENGKMILDPDGFRIIIS
NLKTK
>KACEBFPM_00624 hypothetical protein
MNLILETDRLMLRPFELSDAEALFDMDKNPEVHNYLWQKPVTKIEEVHEYIKMVRQQYLE
NNIGRFSTIIKETGELIGWTGIKFVNNHIENGNTNFYDYGYRLNEKFWNKGYATEASMAW
LDYGFNQMKIEKMNAYTHFDNGASNHILQKVGMNFIEDYPDKEGIIWKWWQMKNPNL
>KACEBFPM_00625 hypothetical protein
MTWQETINFVKQIPYGRNTNRHDFSLVISENKGTCSSKHAYLKDYANKNNIANVQLIIGI
YKMSETNTNIGKILTDNNINYIPEAHCYLKIDQKIVDATSNESNFEKIKSDLLQEIEIEP
YQVANFKVKYHQEFIKNWLTESNTAFSFEKIWEIREKCIQKLSI
>KACEBFPM_00626 hypothetical protein
MKIILTGATGVLGSHIMYEILELFITNSISGKLFLITRNKGKNSAKDRINELLSSSYTPQ
ILAEKGLEKLHSYLEIIDTDLSEIEDNNAQKIRGAYFIHSAGYVNLSTDENQKEKIFNEN
AQITKDIFKTFSPFIKKFIYISTAFSSGVRNGLIGNDFHNLDFIPEHRNAYENAKFHSES
FVKQQCKTLGLPYQILRPSVIGGKMLGKENNYFIPKYMVFYLLAKFFHFTAQRKNEQENV
RFQINEATGLNIIPVDYVAKVIVNSFQREDIQQLNIVHNKSFNIVKGVQLIMQEVGYTNF
SLIQNTLDFNYKTSIEKLYYESIGKHLKPYFTTNPNEYDTTLLNSILEIPKLDTEAFINM
IRYAKLHNFKDINV
>KACEBFPM_00627 hypothetical protein
MTTIKIVGVPEHFNLPWQLCLENGEFEAENIDLQWTDIPEGTGKMCQMLRDKQTDIAVIL
TEGIVKDIVSGNPSKIVQIYVQSPLIWGIHVDANSKYHKLSDLENKKPAISRLGSGSHLM
SIINAQNQGWKTSNLQFEIVNTINGAVEALTNQTADYFMWEQFMTKPLVDNGIFRKIANC
PTPWPCFVIAVREEILAKHPKIIHKILEIINTKTSKFKEITNINTTLSSRYNLKTEDVQE
WLTLTQWSQEQLSEKMLNKVQNQLFELSIIHKKITFDTIVR
>KACEBFPM_00628 hypothetical protein
MMINTGMVSKMFNKKMTILSQGFGKESVSLHFLINPFVNCNILYCKNDKNKQLSDYGIKS
NLFMNNR
>KACEBFPM_00629 hypothetical protein
MSKIYFILFFLFFIFPSKLFSQVTISGQIADKNNKPIEFLEIQLQNKDSIIVKSELTYGD
GKFTIATVKGEYQLLIKQLGKILQQQKISAIQDLNLGIIEVTENPQQLKEVTVTSKKKLI
ERKVDRLVFNVENSISASSGDALDALKVTPNIRVDNDEISIIGKSNVLVMVDDRLMQLSG
EDLTNFLKTIPANSIKNIEVIKTPPAKYDANGNSGLVNINLKKVKKGEFFKASINSAYQQ
GTKATGSIGGNVTSQIKKVSIYSNLNYKDGANQIIEDRQYHYPTKLWIGNSVRKRNTNIL
SGRVGFDYKQNNKNELGVLYFGSSTQSLDNSFDNIKIYTNQNQPTGFYTKTDSKTDKNDY
FHSVSTHFKRTIDTLGKSITASVDYLIINQETNRKFNTNSFVDATPFNADALTNGNQNIK
ITTSNIDVELPYSKIKYAFGGKISFIDTNNNFNYFDVSTGVNIIDFNQSNEFNYAENTQA
LYLSAQKSIKKWEFNIGLRGENTQTKGYSKTLNQTNTNAYFKIYPTFYATYTANKKNIFS
LNYSRRVGRPSYNMTNPFRTYYSNFSYLEGNPFIQPDFSNNIEVSHTYDNNLNTSIALSY
YENGKSQILLSDPVTNISKLTYLNFFKAFLYSLNLDYTFKKWDWLESNNSANLFYRKTIA
NELLNNQIVEKISYAISSNNTFLINKSKTFLSSLEFSYRSPQIMNIFLIKETFNTNVSFR
YLMLNKNLQISLNFFDIFKTNTYKSDSYSNDVLLKARNYSDSQHSRISALYKFGNKKINV
KESKSGNEAELGRAK
>KACEBFPM_00630 hypothetical protein
MNSIFDPSSNVMIVARINYLGDTLSDPIA
>KACEBFPM_00631 Dipeptidyl carboxypeptidase
MQIFSKIIKASTFFVLIFSLQNQSLQAQKKTIKMTNPLLQKSTLQYQVPPFNLIKDEHFK
PAFDYGLKIHDQEITTIANNPAKPTFQNTVLALEICGVDLGRATGVFYNLTGSNTNPTLQ
AIEAEYAPIFSAHNDKIYLNSKLYSRIKSLNLNILKNEDKKLTQYYLQQFELAGANLSDA
DKEKMKKINEDLATLGTLFTNKLLIARKNGAVLFDNPSDLDGLTTDEIAAAKSKATETGH
DGKYLIGLQNTTQQPLLQSLKNRATREKTFKASWSRAQKNDDGDTREVLEKMARLRLQKA
NLMGKKSFAEWRLQDQMAQIPANAMNLLAKIATPAVEKAKAEAQEIQNLIDAQKGGFKLE
PWDWNFYSEQVRKAKYDLDESQIKPYFELTSVLEKGVFFAAKQMYGITFKERHDLPVYHQ
DVKVYEVFDNDAKSIAIYYLDFYTRDNKNGGAWMNNFVSQSHYLKQKPVIVNVYNFAKPA
NGNPSLISFDDVTTMFHEFGHTLHGLFANQQYVTLSGTAVPRDYVEFPSQINEHAALDPI
VLRNYAIHYQTKQPIPQELINKIKKAETFNKGYDVTELLAAATLDMAWHSVENEADFKPA
LQFENEALQKYGLLVNEVPTRYHTPYFAHIWGGGYSAGYYAYTWSKTLDYNVYDWMQSHG
GMTRENGDRFRKYILSVGNSVDLNQAFKDMIGHDMQIEPYLRISGLSDKK
>KACEBFPM_00632 SsrA-binding protein
MLKTVNILNKRAKFEYEIIDRYTAGMVLTGTEIKSIRLGKANIAESFCEFQGDELFVINS
HIEEYLFGHQYNHKPKSERKLLLNKRELKGLLKDVQNKGLTIIPLRLFTNEKGMAKLDIA
LCKGKKTFDKRETIKDRDNKRDLDRIKKEF
>KACEBFPM_00633 DNA-binding protein
MIYICKMENNKSKDPLHGITLQQILEKLIGFYGFDTLGELINIKCFRENPTIKSSLTFLR
KTDWARKKVEELYVKTLPKF
>KACEBFPM_00634 Spermidine N(1)-acetyltransferase
MTSFSFLPFTNLESETLLLRQITSNDINEVFELRRNPETMKYIPRPLITTIDEAMGHVKM
IQDKIETNEGINWAITLKGNPKMIGIIGHYRIKWEHFRSEIGYMLLPEYHGKGIVTQAIQ
LIVSYGFDEMKMHSLEAIIDPKNTASAKVLEKNNFVKEAHLLQNEFYDGKFLDTVIYSLL
KKE
>KACEBFPM_00635 hypothetical protein
MNTNYEVIEKEAIENLHFPEIDVLDDIEAINQRNSDLERALSLGNLEHSKIKIYFEDNKS
KKMVETTIWGVTDKRVILKKGVVIPINRIYKSI
>KACEBFPM_00636 Aminopeptidase N
MKSNMIKGLFVTAIFLGSNIISAQQVTNYNYHDAFAPGFYTKNATETRSASGQPGAKYWQ
NRADYSLTASLNEVKNEISGSAIVTYTNNSPDKLDFLWMQVDQNLFKKESRGNAIIPLKG
SRNGAKGEDFDGGYKIKSIKIITTSNGKPTESEAKFTIVDTRMQVDLPQELKGNGASIKL
KIDYSFVSPFYGSDRMGVLETTNGKIYTVAQWYPRMCVYDDVKGWNTLPYLGAGEFYLEY
GDLEVAITAPANHIVVCSGELLNPSEVYTTEQQKRWATAKLSDKTVMIRSANEITNTNSR
PVGKQTLTWKFKIKNARDMSWASSPAFIIDAAKINLPSGKKSLAISAYPVESNGNDAWGR
STEYTKASIENYSKRWYEYPYPAATNVAGNEGGMEYPGIVFCGWKDTKEDLWGVTDHEFG
HIWFPMIVGSNERLFAWMDEGFNTFINSLSAEDFNKGEYKQPAMNMHESSRMLTNPDMEP
VYTAPDGLKEVNLGILAYAKPGSGLTMLREQILGKERFDKAFRTYVARWAFKHPTPDDFF
RTIENVSGEDLNWFWRSWFINNWKFDQAITKVKYVKNDPKQGVLITIENLQKMPMPVIAE
VKTKSGATSIIKLPVEIWQRNKSWTFKHNSTEELESITIDPNNVFPDENSENNIWTNAKN
ATEKGTGLDAYLGNFSSTQIPVKVNFTQDEENLMMNATGQQSLPLDNLENGKFTFEQAGL
TVQFNDLKTGFKLSVGGQNFEFTKDK
>KACEBFPM_00637 hypothetical protein
MPFLNKDYICIKNIITMKINPKIGIDQLIFGMKQKDVIAIYGNPDKEYKDEESNVIFLYD
SKKLRLTFYEDENLKLGYMISSNPDLELFSEKIIGKQIDEVEKNVTSKGIKSLEIESFDT
VDNYFNESNWIIFQVEYKEVIRFELGATINDKDDFDWKFKG
>KACEBFPM_00638 putative peptidyl-prolyl cis-trans isomerase
MKNKLNLLLVFLFVIANGYAQKGAKKVVKSKTITTQTTTPKYTEGIFAEFDTSKGKILVQ
LEYAKTPITVANFVSLAEGTNTTVKNDLKGKPFYNGLKFHRVIADFMIQGGDPLGNGSGD
PGYKFKDEFTDAKFEKAGILAMANSGPATNGSQFFITHKDTPWLNGKHTIFGYVVSGQDV
VNTIAQDDVINKVVIIRKGALAKKFNASSIFTDYYAAKDINAKIEAEKAEKERAIANEVA
LKEFATGQTTTSGLKYIVLKEGSGLIPTAASNVKVHYTGSFTSGKVFDSSVQRGQPIDFN
LNQVIKGWTEGLQLMKEGAKYKFFIPYNLAYGEQGYPGAIPAKSDLIFEVELIKINSDTK
Q
>KACEBFPM_00639 putative peptidyl-prolyl cis-trans isomerase
MNKITKLVLSLTTLVLFSCNSKHDKLSDGLYAEMQTSKGKILLQLEFEKTPITVANFVSL
AEGTNTFVEEKFIKKPFYDGLKFHRVIADFMIQGGDPDGNGSGGPGYKFNDEFRDDLIMN
KAGILAMANGGPGTNGSQFFITHKETNYLNGRHTVFGHVIEGQDVVNKVAQDDEIIKIEI
IRKGEAAKKFDAPKVFKDYFDKQLVAQKENDTKYAKVIADKIAYFATVKAKATKTESGLM
YAIVSKGTGKKPAAGTTFFFHYAGYFEDGNLFDSSYENVNREFGKFDPSRSEQNGYEPFP
FEAGKKEGLIPGFIEGLEKMSFGDKAVVFIPSALGYGPQGMGGVIPPNTNLIFELEMLEK
MPQK
>KACEBFPM_00640 hypothetical protein
MKTLKIIGCMLLGINLVTCCTKKQEPRRPVSQTSGEFMKQSVARNKKLNESEENIIAKII
KKDTAVSYIASTKGYWYYYNTKNTTQTAKPIKGNIAFYDCEIKDINGNVIYSQLDLKQQQ
YVVDKQTIMIGLRDGIKLMQKGETVTFLFPSHMAFGYHGDNKKIGTNEPLICTVTLNDIR
KMPNTTQN
>KACEBFPM_00641 Bifunctional oligoribonuclease and PAP phosphatase NrnA
MMTETQIEAIKILLASPKKITIIPHRNPDGDAMGSTLGLYHFLIQQNHEVVVMSPNEFPD
FLAWLPASENTFIFEKDKENCIEILNKSDIIFTLDFNALHRTGNIMQATLETLQKTFVMI
DHHEFPDDFAKYTFSDTKYGSTCEMVYHFIHQLKQEELINTTVATCIYTGIVTDSGSFRF
PKTTSTTHRIVADLIDKGVENSTIYNQLFDKSSYSRLQLLGRALQNMKLMTHYKTSYITL
SQEELDTYNFEKGDTEGIVNYGLSIDGIDFTAIFIENSAEGIVKISFRSQGSFDVNQFSR
NYFGGGGHINAAGGKSDKSLQETIADFERIVKEIKK
>KACEBFPM_00642 putative ABC transporter ATP-binding protein YbiT
MITVNDISVQFGGTTLFSDVSFAINENDKIALMGKNGAGKSTLLKIISGQSKPSTGNVSA
PKDAVVAYLPQHLLTTDGATVMEETSKAFGEVFAMKAEIDQINEQLTVRTDYESDEYMKL
IERVSDLSEKFYAIEEINYEAEVEKILTGLGFMREDFTRQTSEFSGGWRMRIELAKILLQ
KPDLILLDEPTNHMDIESIQWLEDFLINSAKAVVVISHDRAFVDNITNRTIEVTMGRIYD
YKAKYSHYLELRKDRRIHQQKAYDEQQRMIADNRTFIDRFKGTFSKTDAVQSRVKMLEKL
VIVQVDEVDTSALKLKFPPAIRSGQYPVVVKDMTKSYGDKVIFQDANIVIERGEKVAFVG
KNGEGKSTMIKAIMKEIEINSGSVEIGHNSQIGYFAQNQAALLDENGTIFSTIDDIAVGD
VRTKIKDILGAFMFQGDDITKKVKVLSGGEKTRLAMIKLLLEPVNLLILDEPSNHLDMKT
KDIIKDALRDFDGTLILVSHDRDFLDGLATKVFEFGNKRVKEHFEDITGFLASKKMDSMK
EIEK
>KACEBFPM_00643 TonB-dependent receptor SusC
MKSLKIISASIMMLMSTLFFGQDKTITGIVTDASGPMPGVNVMVKETKKGTSTDFAGSYK
IQANVGETLVYSFIGMNDETRVVGTSTVINVSMKDNNQKLVEVVVMSLGISSKKSQKPLA
KQKIKNTNQKKVNSNVTNFVDEIIIKAKKKYNINNEPIFYLNGYNVSRAQLSLQEFKNFE
DIEVIKIDEAKKAFGKNGKNGIILIKTKNRTNDEYEKIEKFEEKLHKKDIDYYSIGFDDL
QENYDNFLENPFESPKTAPLSTFSIDVDNASYTNIRRLINNGQKVPKDAVRVEEMINFFK
YQYPQPKDNHPFSITTQYSECPWNSKHKLVQIGLQGKNIPTNDLPASNLVFLIDVSGSMN
ADNKLPLLIESLKILVEQLRKQDKVAIVVYAGAAGLVLPPTAGNEKQTIINALEKLNAGG
STAGGAGIELAYKTAQENFIKDGNNRVILATDGDFNVGSTSDSAMQALIENKRESGVFLT
CLGYGMGNYKDSKMEILADKGNGNYAYIDNIQEANRFLGKEFKGSMFAIAKDVKIQIEFN
PKHVQSYRLIGYENRKLRPEDFKNDAIDAGELGSNHTVTALYEIIPIGTNSDFYNQTSDL
KYTKTEVTDNNYNDELATIKFRYKKPDAQKSIEMVQIIENKSTVLENATNDLKFATAVAW
FGLKLRDSKLITNKSSEDIKKLARLGLSNDLDGYKAEFIRLVEAVK
>KACEBFPM_00644 hypothetical protein
MKNQDKIFEQFKSAAKKAETKDFPEIEKIWSRVDAKLDTVVYKKQNNNWKKLAVAASVVL
LGIIAFQFLKTEDKIITPENEIVVSDVKKEMRPETITQENTILNTKKPIIKSGAEEILQK
QITNAQTVVVNDEPTQSSEKAEEMVVEAYSTAEKSKKSAASTSNSVLKGNVYDAVSVKSY
AKDAEDDKSEIQEKKNIPLVVIDGKPITHNKKSGEEIISELDKETFETVYLKEPLYIING
TYYSEESLFGKNPTSPYAPLDKQEIKTIKILQDQKATAIYGEKGKKGVVIITTKTGKPVA
PQ
>KACEBFPM_00645 ECF RNA polymerase sigma factor SigE
MHRDAQRQVYEQMAPKLYRTCKRYLKKEEEIEEVLADTFYTIFIKIDMLKELGAFEAWAR
KIAVNNCLHQLKHKVNFNIYLEDTKLQLQPESLPNTHLEEEDLLKLLDYIPAGCKTIFNL
FAIEGYSHKEIAMLLNISEGTSKSQLNVAKTKLKDLVNNLYYKQAK
>KACEBFPM_00646 hypothetical protein
MKKIILILLISTFRIYGQEITELKKFTKTELQNDFDIAVNALKEAHPGLYWYTTFAQFDS
LCNNQKLKIEDNLNALDFYRILAPIIVATKEGHCKISLSDDIDEYFSKYGKYPPVFIKFF
EDKPYIINDIDDLKIKGSILSKINGRTVNEIIETIFNTISSDGYNLTKKYQTINGQDFSY
YYSDVFNQSNSYELEVIDPKTNKISVYTIRSVSEDWLEKQWNGIDELYFNKSKISSSLTF
SNNNKTALLTYNTFKSDKYNNFKKITDDYFKKILQYKVTDLIIDLRNNGGGEEGFEDYVF
SYLTNKPYKKYKYVQSTAFLYSFYTFTDRNTIEKQKSLENALQTEQQLESDGRILRKPNI
LIPEKTKNNSFKGNLYILISGSTYSGGSEFASLIKEHRKSTFIGEECGGGFYGNTSGFSI
ELTLPNSKLHIKIPLLKFVVDVKDKNIPLGRGVLPDYEVQPNYENFINGRDTEIEFTKKL
IEKK
>KACEBFPM_00647 hypothetical protein
MGFFSSLKGQVGRDTGRAISNKVLGNRHATKYQRVDKEKSLKLEQKHELEFLKQERNNEI
AFLKKQEEFKNIQEKKVFVDQNLKKIIAMKVPLTKELLIEQLHSLSIEITSNDWKDYEEE
INKISNSYTDAVFKKYEQLLFTLQTKFPNSAEIIYFEKQYNKYRKQAFFQKYKLVFIGIL
LAILGGIGMYFEKDEPKETPIKDFFKSLTEKVENN
>KACEBFPM_00648 hypothetical protein
MADLSISGKMKVKTFKANFKEEYGSTLRVYVGKKFADDDATLASIRKEDAKGGEVKINGK
MLVGNFEKKIFEEFGIKIQVATPDDTKLSDDGITLTASGK
>KACEBFPM_00649 hypothetical protein
MKIFNQIKDTFTSTEFEVEITMKVTDLTKQFKNKFGLSLRVYKGKKLADDGRMTLKTLDQ
RTTQTSVNFDSSKMKIKATQKVLEVENLFLENFGIVVQIADIENKKLLADDITLGDAKRM
KL
>KACEBFPM_00650 hypothetical protein
MGLFSILKSAMTDKKPKKKSTSLVDSLTKMKKTVKKNSATKTATHYKKSAKEQSKTIDYQ
IKKLKGK
>KACEBFPM_00651 hypothetical protein
MFQFEKFYGFPHSVNLFSKNLFLSWICFGFLSLETDAQRFAAWRSGGFRSTYFQFSTNVY
LKTESSI
>KACEBFPM_00652 Modification methylase HpaII
MKTNNKIKIIDLFAGIGGIRLGFELASKNNIECVFTSEWNKYSEQTYLANYPNEIVHGDI
TQISETQIPEHDILLAGFPCQPFSQAGLKKGFSDTRGTLFFDIERILIAKKPQAFLLENV
KQLKGHDKGKTLATIIEHLKNIGYENVQYEVLKAKEFGLPQNRERIYIVGFLDNSIKFKF
PTPTKLPTKVGDILEQKVDEKYTISDRLWEGHQRRKIANKEKGKGFGFGIVNENSEYTNT
ISARYYKDGSEILVEQKDKNPRKLTPREAGRLQGFPDTFKIPVSDNQAYQQFGNSVAVNV
IEKVAEQILKHIKIKMDKKHYAQQQFGKMAGSVLN
>KACEBFPM_00653 hypothetical protein
MSKIDEIPVIIDIPKKELDKFDTLIKQYRTKYIRTSQEIVEFALAQNQEYLKQIKSKQVS
KCISELREIVWQEYLLDEVNFNAILMRDLHKLLETPKDILEVLLNKNITDKKGEELIETV
KEICGEYAGRVFPYIYRLSLSNTQSRRSRAGKSFEAIIYKIYENLGYEYDSQSKVGRKTF
DTLGLGKKVDSILPNIKCYAERRNKTIIGTMKTSLRERWQEVAEEIERTKIPEIHLLTAD
ESIPKSKAQEMANHNIIVVTYEWVANSVALKSMKNIISFEEYLFEEIPNILKFWNENK
>KACEBFPM_00654 Superoxide dismutase [Fe-Zn] 1
MNRKDFLKSGLILGGATLLPTNSVFSQSLIENKTDLLVDKDGNFFQQPLLYSESFLEPFM
DAETLHLHYTFHHGGAVKGANKDLQMIKKSLDENNLETVDYWTRKLSYHLSSHILHSIFW
TNLTNKANLPKGDLLKRIEKDFGSFDKLKMYLAKTSKDVDGNGWGILGYQPYTDKLTILQ
CENHEKLTQWGVIPLLVIDVWEHAYYLKFRNKRTDFVDNLFSIINWDNASERLENALKMM
K
>KACEBFPM_00655 hypothetical protein
MPKTASIFLIFFVFASCKYKENSWLNNYKEIKCKYAKIEELRRNDSLNKINKLGKELAEI
KTEISKIDKPIIEELANLENSRSEIVVEYLSKSNQIIDQQTDKFGHNSTPEFEKKLSQNE
KEANSKTKVFENKIEFLNQKLAENNKYQELKAKEGKIKSEIAEEYISIKEKYSKQLENLQ
YDLNYLNAQFKKLTSNLNTQELKTLTKKRDSIKQNPCNFTIKN
>KACEBFPM_00656 DNA polymerase III PolC-type
MTFTAIDFETATAFHPCSVGIVTVQNGVIVDEFVTLIKPPNNQYSPFTIAVHGIRPRDTV
NAKSFLEVYPEIKKRLQNKTVVAHNESFDRNVLAKSMALYGLDYETLNISNRWECTLKIY
KAKGFKPTKLSDCCQEMNIKLNHHEALSDARACAKLYLLR
>KACEBFPM_00657 hypothetical protein
MKEDFLHHIWQYKKFDFTNLKTTSGENVSIFNTGNFTQLAGPDFFNAQIEIDNQKWAGNI
EIHLKSSDWYIHNHERNEHYDSVILHVVWEHDAAIFRKDNSEIPVLEIKNYVSPTLIHQY
EKLKATKSWIYCENEIKNIPSFVFENWKERLFFERLERKSNPIEVLLLENHNDWEATFFC
FLAKNFGLNTNGESFFKIAQSVPFSIIRKEAFEVENLEAIFFGRANLLAQDKEDNYFKDL
KFRWNYIQNKYQLEGIFVNTVQFFKHRPDNFPTIRLSQLANLHHTHQNLFSKVIRAKNIE
ELYQIFQVSVSEYWQTHYNFDKISTKKAKSLSKSFVDLLIINTIIPFRFAYEKSLGKETS
EENIKFLSQITAEKNTVIDKFKSVGIITKNAFETQSLLQLKKEYCDKSNCLQCAVGLAFL
KN
>KACEBFPM_00658 hypothetical protein
MRFVIKLKYLFEKQGFHIASRLADRLGMRANSVRLFFIYISFVTAGLWFGVYLTLGFLIK
LKDLVRAKRSSVFDL
>KACEBFPM_00659 hypothetical protein
MSFKQYFIFNKEQKIGITILVVLIISVQLLYFFVDFSTAKTSTKEEEQWLAMQTEIDSLK
PVSNNDTYKMYPFNPNFITDFKGYKLGMKAAEIDRLLAFRKTNKYVNSAQEFQKVTQISD
SLLAIIAPYFKFPDWVTNKKNYPTYAKSNFKDFSKKEKITIVNINEASKDDLMKIYGIGD
AISDRILKQKEVFGSFVSMDQMQDIWGLSPEVITQLNSHFKVLGTTTINKIDINNIATKE
LAKFPYFKYALAKEIVTYRSMNNGIKNIEDLTKIKGFPIDKIKVIALYLKF
>KACEBFPM_00660 Acyl-CoA dehydrogenase
MNSIYFTEEHELFRKSLQDFLQKEVVPHIEKWEKIGTIERFIWKKFGDMGYFGLKCPEAY
GGLNLDLFYTVIFLEELQKIKSSGFAAAMWAHAYLAMTHLNAEGSERIKQEYLVPSILGE
KIGALCVTEPFGGSDVAGMRTTAVKQGNKFIINGSKTFITNGIYADYYVVAAKTSPELGN
KGISIFLVDTNLKGITATKLDKLGWRASDTAEIAFDNVEIPEENLMGEQGKGFPYIMQHF
AFERLIMAINAHARAEYAIEYTINYMSQREAFGTTINKFQALRHTIVEHATEIEHCKIFN
YAASARLDQGEYVVKEATMAKLKSTKVADLAIYDCLQMLGGYGYMEEYPLARLLRDSRLG
PIGGGTSEILKEILSKMIFEKQDYKPAVK
>KACEBFPM_00661 30S ribosomal protein S21
MLIIPIKDGENIDRALKRYKRKFDKTGVVRQLRKRQAFIKPSVINRAMIQKAAYVQNMRE
GLENM
>KACEBFPM_00662 Tyrosine recombinase XerC
MQNNQQKFQDYLLKEKNYSPLTALAYGKDLQFFQTFLEIKFDNTPLEEVSYTLIRSWIVS
MVDAEMSNTSVNRKIASLKAFYKFLLKTKQIEINPLSKHKALKTPKKIQIPFSEAELDTV
LTQIQYKAGFEGLRDKLIIDLFYTTGIRRSELISLQISNTNLVAGTIKVIGKRNKERIIP
LLPVIIKQIKVYLAERKQLSLIVAKENLILLSNGNKANETFVYRLINDYFSNVSEKVKKS
PHMLRHTFATHMLNHGADLNSIKELLGHSSLASTQVYTNSSLAELKNVYQNAHPRNQK
>KACEBFPM_00663 Ribosome hibernation promotion factor
MKVNVHAVNFNVDKKLVDFVEERIVKLEKFYDKIVSYDVFLKVEKTSDKENKIVEVKVIV
PGDEFIVKKQCKTFEEGVELASDSLERLLLKRKEKVKAHI
>KACEBFPM_00664 hypothetical protein
MQKSSNLFWKLEIHPYICIRIKVASVAQLARAADL
>KACEBFPM_00665 hypothetical protein
MANVKNLKKDINFVLGDIIEAVYLYEMTTTGKPTEATNALIDQAIAAFDGLIVKVNAKNV
ENKKAHFKQINIELEQVANQMVEKINAL
>KACEBFPM_00666 Mannose-6-phosphate isomerase ManA
MSTNLYPLVFEPILKERIWGGTKLQSILEKKISSQTTGESWEISTVSGDVSIVKEGHLQG
KTLNELLEKFPEEILGTKNYKQFGKQFPLLFKFLDAREDLSIQLHPNDELAKKRHNSFGK
TEMWYVMQADHEARIIVGFKEKSSPKQYFHHLENKTLTTILEEIPVKKGDMFFLETGTIH
AIGAGIVIAEIQQTSDITYRIYDFDRKDAQGNTRELHNDLALEAINYNKVAAYKKYDKTT
NTSNKAVSCPYFTTNFIPLDGQLDFKTNTNTFRVFMCTDGKFDLIYHNQKYTFKKGETVL
VPAVITHYILVGKASILEIYIS
>KACEBFPM_00667 Putative peroxiredoxin bcp
MKPIKVGDKMPIFGAKDQDGNNFYIESVLHKKILVIYFYPKDETPGCTKQACSFRDEYED
IKNAGAEVIGISSDSPNSHKKFAQNHKLPYTLLSDNDKNIRKLFGVPSAMLGLIPGRVTY
VIDLKGTVQMVYNNLNASQHIPKSLEAIQKLK
>KACEBFPM_00668 6-carboxy-5,6,7,8-tetrahydropterin synthase
MKVTISRKAHFNAAHRLYRKDWTFEKNDAVFGKCNNPNFHGHNYDLTVSVTGKIDPETGY
VIDVKLLSDIIKEEIEDKFDHKNLNLDVPEFQDLNPTAENIVVVIWNKIRKRINPDMSLE
VILYETPRNFVTYKGE
>KACEBFPM_00669 Isopentenyl-diphosphate Delta-isomerase
MIEEKVILVNEKDEQIGLMPKLEAHEKAILHRAFSVFVLNSNNEIMLQQRAHHKYHSPLL
WTNTCCSHQREGETNIQAGTRRLQEEMGFVTPLKELFHFIYKAPFDNGLTEHELDHVMIG
YYNEKPLINKDEVENWKWMSIDEVKTDMNENPAIYTVWFKIIFDEFYHYLEDHKI
>KACEBFPM_00670 30S ribosomal protein S1
MSETLKSQEQFLADFNWHNYSEGIDPVDAANLREFEELVAKTFIATDQEEVVEGVVVRIT
DRDVIVDINAKSEGVISLNEFRYNPSLKVGDKVEVLIDIREDKTGQLVLSHRKARTIKAW
DRVISANETGEIVNGFVKCRTKGGMIVDVFGIEAFLPGSQIDVKPIRDYDQYVNKMMEFK
VVKINHEFKNVVVSHKALIEADIEVQKKEIIGQLQKGQVLEGVVKNITSYGVFIDLGGVD
GLIHITDLSWSRINHPSEVLELDQKLNVVILDFDDEKTRIQLGLKQLNAHPWDALDANLA
IGDKVKGKVVVIADYGAFIEVAEGVEGLIHVSEMSWSTHLRSAQDFVKVGDIVEGVILTL
DRSERKMSLGIKQMTQDPWTDITSKYPVGSKHTGTVRNFTNFGIFVELEEGIDGLVYISD
LSWTKKIKHPSEFIAVGEKLDIVVLELDVDARKLSLGHKQTTANPWDKHEAAFAVGTIHN
GEIAEIVEKGATVDFGDDVVAFIPTRHLEKEDGKKLKKGDTADFKVIEFNKEFKRVVASH
TAIFREEEEKNVKTASDNNSNSNTSSSNNNASASTLGDNNDVLAALKAKMEQSEKK
>KACEBFPM_00671 hypothetical protein
MKVEEKGHTTIVKDTQGDLTSFLLKLDHEVSFNDKNLIVDLSSYKSLTTKDILLFDPFYK
KHVKYKKSFVIVVSEFDFNANTKKIVVVPSVLEANDIIEMEEIERDLGF
>KACEBFPM_00672 Aspartate carbamoyltransferase
MKELSVNNLLGIKYINENDINLVFETADHFKEVINRPIKKVPSLRDITIANIFFENSTRT
KLSFELAQKRLSADVINFAASSSSVTKGETLVDTVNNILSMKVDMVVMRHASPGAAVFLS
KNVKASIVNAGDGAHEHPTQALLDAYTIREKLGDVAGKKIVIVGDILHSRVALSNIYSLQ
KLGAEVRVCGPKALIPKYIEALGVKVEPNLRKALEWCDVANMLRVQNERLDISYFPSTRE
YAMQYGLDKNLLDSLNKEIVIMHPGPINRGVEITSDVADSRQSVILNQVENGVAVRMAVI
YLLASKIK
>KACEBFPM_00673 Bifunctional protein pyrR
MSQKILLNHKEVSIILHRLACQLIENHLDFSNTILIGIQPRGTQLANRLKQILEEEYQVK
GILLGFLDITFFRDDFRRGETLEANKTQIDFLVENKKVIFIDDVLYTGRSINAALSAIQS
FGRPSEVELLVLIDRRFSRHLPIQPDYRGRQVDAINNETVVVNWQEKAGEDSVALITK
>KACEBFPM_00674 hypothetical protein
MKKVLIITYYWPLAGGPGVQRWLKFVKYLPDYNIQPIVYIPENPTYPIIDEGLISEVSEQ
AIILKNKIIEPYQLASVFSKKSTKGISSGIIPNQKKQSFIQKILLLVRGNLFIPDARILW
VKPSVKYLEKYISENNIDTIITSGPPHSLHLIGLKLKQNLNVKWFADFRDPWTTIGYHSA
LKLSSYAEKKHKNLERKVLNTADTIIVTSKTTKTEFQAITTKPIEVITNGYDVENISKQT
LDEKFTLAHIGSFLSDRNPTILWESLSELVAENEKFATLFQLKLIGKVSQEILDTIDGFN
LNSYVNNLGYVSHKEAIEHQKKSQVLLLIEIDSEDTKSIIPGKLFEYMVSERPIIAIGPK
GSDFAEIITETNTGVFFTYNEKEKLKKQILSYFELYLTQKLTVSAVGLQQYSRKKLTEKL
SKLIS
>KACEBFPM_00675 Putative fluoride ion transporter CrcB
MKTIFYIALGGGLGSVLRYLTTLVINKYVQTTFPYATFVTNIAGCLLIGLFFGYLEKQNA
VSPYLKFFLITGLCGGYTTFSAFSNENIQLLQSNQILIAFLYISLSVFLGLMATWTGLII
AKEL
>KACEBFPM_00676 hypothetical protein
MNKLQRFYPHALAIFAFALVSVIYFYPILQGKKILQSDIVQYTAMAKEQNDFRTETNTEP
YWTNSAFGGMPTYQLGAKYPHNYIKNIDELIRFLPRPADYMFLYFLGFYVLLLVLKVNPL
KAFFGALAFGFSTYLVIILGVGHNAKAHAIAYMPLVIAGVLLVFQQRKYILGGLLTMFAA
ALEINANHPQMTYYLLIFLLVILVYYAYQLIKNKELKPLLYSFVTFAIAGLFAIGANATS
LMATSEYAKESTRGKSKLTYNPDGTKNTNFGGMTYDYITEYSYGIAESLNLISPRIFGGS
NSENLGTDSAMYEYAIAQNVPEDQAKEIVKGLPTYWGDQPIVAAPAYIGAVVFFLAVIAL
FCDKRKIKYIFLAGAIIALLLSWGKNFPILTDFFINFVPMYDKFRAVSSIQIILEICMPV
LAMMGLQSFFILEDKEKWTNLWKSASVSIGILALLFVFKGSFSFAAGSDRYLAESYGPEF
IDALKLDRKTMFTADLLRSSFLILMAFGVLWLSIKNTISHKVAVIIVGIIMISDLFFIDK
NYLNNSNFVSKQEVEQPIEETELDATILKDKSYYRVFEVSQNVMSDPRASYFHKSIGGYS
AVKPKRMQDLFDYQIANNNMEVINMLNVKYLIQTNKKGEKIAIHNTQANGNAWFIKNIVS
VKSADAEMKALNKLDTKNKVVIHYEEVKEALVNKFATEGATIKLTSYEPNDLKYISNNTN
NGFAVFSEMYYKNGWNAYIDGKLNDHYRVDYALRGLPIPKGKHTIEFKFEPQVIKTGSMI
SLISFIGILLLLGGGVYYETKRKKA
>KACEBFPM_00677 hypothetical protein
MQEASFNGFFRTIIYMIGFYYLIKFLSRIFLPILLQKAVNKVQDNFDKNQNPFNQQNNQD
FQTPKKENPKPTKQVGDYIDYEEVE
>KACEBFPM_00678 hypothetical protein
MKLLKSIITIGILLTSITNYGQFTDQINSNRPGKSMGAFAVGKKIYQVESGLYYINESNE
VPNYDARGFGLDFAARGGFIKEQLEFVLEAQFQLDKYSVTDSINKNRNGLKQTTFGAKYL
FYDPFKKAPAKPNIYSWKANHKMSWKQFVPAISGYVGINYVMKNDYSIPNESAISPKVML
VTQHHFGVKWVLVSNIIADKITSNNANFGSVFTLTRAISEKWAAFIENKAIKGNYYSDGI
FTIGATHLLKNNIQIDASISKNIKSTPSLLYGGIGFSWRFDKKHKDIQMKDGKEVKDKKE
DKNKKTKGSLSQEELDKEKAKAEKKSRKNKPDAAQEKPTQETKKKRLDDIEETPAP
>KACEBFPM_00679 hypothetical protein
MITIKEAKTKKELTDYIKFPFSLYKNNKYWVPPIIDDELETFDKTKNPAFENAEAYFYLA
YRDNKIVGRIAAIINWSEVNDQQKSKVRFGWFDVIDDIEVTKILLEKVRELGKKNNLDHI
EGPMGFSNLDKVGVLTEGFEEIGTMITWYNFPYYATHFEQLGFVVEKEYLENKFPFANVK
LEFFDKAQELIKRRYNLKALNFKKTKDVLPYVDKMFDLFNASYANLSSFVAISDIQKEYF
KKKYISFINPEYIKFVEDKDQNLVAFAIVMPSFSRALQKAKGKLFPFGLFHLLNARKNSK
DVTFYLIGVHPEYQNKGVHAIIFKEMHTTFTEKGIQNCIRTPELADNHAIHLLWKNFDPK
IICRRKTFRIQISDN
>KACEBFPM_00680 hypothetical protein
MNNKHFTFIKSDKKLIKLYFNKITFIKGLGNYVEILTTENKKYIYYKSLKDLIENLPDEF
MRVHNSHIVNLTNIDVLEDNHIILKNVKVAVGKSYKECLNSAINKLML
>KACEBFPM_00681 hypothetical protein
MSKTILKLILILIMTKQNSKAQEFSKNYPLEKDISTIDGIIKAFYEVVSGEAGEKRQWER
DLSIHNPSAIYSYLENINGELQQVTMSLKDFHKETDAMIMETAFYESEINREVRMFGNIA
QVWSTYETRLLKDGPVARRGINSIQLFFDKGKWSIVSLIFEREGAEKIPKTFDPN
>KACEBFPM_00682 Putative pyridoxal phosphate-dependent acyltransferase
MVKDLFERIQNNKGPLGKWASQAEGYFVFPKLEGELGPRMQFKGKNILNWSLNDYLGLAN
HPEVRQADTDAAMRYGAAYPMGARMMSGHTDAHEQLEKELAAFVMKESAYLLNFGYQGMV
SIIDALVTKNDVIVYDVDAHACIIDGVRLHMGKRFTYRHNDIESMEKNLQRATKLAEETG
GGILFITEGVFGMRGQQGKLKEIVEMKKKYNFRLLVDDAHGFGTLGKTGAGAGEEQGCQD
DIDVYFSTFAKSMANIGAFVAADKEIIDYLKYNLRSQMFAKALPMIQTVGSLKRLELLRK
SSEIKDKLWVNVNALQSGLREKGFNIGDTNTCITPVYLEGSIPEAMIMVNDLRENYGIFL
SIVVYPVIPKGMILLRMIPTASHTIADIDETLTAFEAIREKLVNGTYKEIADRTTVDVS
>KACEBFPM_00683 Adenylosuccinate lyase
MQLTELNAVSPIDGRYRSKTKSLSTYFSEEALIKYRVLVEIEYFIALCEANLPQLSGINP
TIYPDLRNIYENFSTEEALWIKETEKTTNHDVKAVEYFIKEAFEKLGLSQYKEFIHFGLT
SQDINNTAIPLSTKEAFEKVYLPSLIGLVSKLKELSVEWAAVPMLARTHGQPASPTRLGK
EIGVFVERLEEQMRLLFNIPFAAKFGGATGNYNAHHVAYPNTDWRKFGSNFVEDTLGLHH
SFPTTQIEHYDHFAAFFDALKRINTIIIDLDRDIWTYVSMEYFKQKIKAGEIGSSAMPHK
VNPIDFENSEGNLGIANAIFEHLSAKLPLSRLQRDLTDSTVLRNIGVPMGHTLIAFEATL
KGLNKLLLNEPKFHEDLEKNWAVVAEAIQTILRREGYPNPYEALKGLTRTNTTIDKKAIH
DFIATLDVSEAIKNELLVITPSNFLGI
>KACEBFPM_00684 NAD-dependent protein deacylase
MKKKLVILTGAGISAESGIKTFRDSGGLWEGHNVDDVATPQGWHKNPTLVLDFYNKRRQE
LKTVKPNEAHLILADLENDFDIQIITQNVDNLHERAGSKNVLHLHGELLKVRSTKNENYI
LDWSENLHLGDFDDKKNQLRPHIVWFGEDVPALEYAVELVQLADILIIIGTSLQVYPAAS
LMHFAPEDCLVYYIDPNPANVSNTPQNFKIIEALASKGMQILQKELKKQQ
>KACEBFPM_00685 tRNA (guanosine(18)-2'-O)-methyltransferase
MIDLDYLAFLENILTDNRKEKFLKVLENRTNHFTIAVEDIFQMHNTSAVMRSCEVFGIQE
LNVIEERYGKSIDKEIAMGAQKWVDINTFDSVTNCIESLKNKGYQIIATTPHENDCLLED
FDISKPSALFFGTERDGLSEEILKQADGFLKIPMVGFTESLNISVSAAIIIQNLTERLRK
SDVNWKLSDDEILEKRLAWAKNSIKDIKRIEARYYNI
>KACEBFPM_00686 hypothetical protein
MKNKIFRIIVGSFILISLLLSIYVNQNWLWFTAFIGVNLFQSGITKWCLLEIILSKLGFK
D
>KACEBFPM_00687 hypothetical protein
MKLLIITAIADFDKDIKKMLKLASVKTFTYKEVKGFNDISEESIDSNWFGSEINENESIL
YYAFVKKENVDLLFELVNDFNKKQESLSTVHVAVLNIEKSN
>KACEBFPM_00688 Swarming motility protein SwrC
MAGALESPVYAILGMNEKLQKMHLPKGYKVNELYMDQPSDESDFTVKWDGEWQITLEVFR
DLGVAFMVVIVIIYMLIVGWFQNFKTPMVMMMAIPLSLIGIVFGHWLLGAFFTATSFIGM
IALAGVMVRNSVLLIDFIEIRLNDGIPLKQAIIEAGAVRTTPILLTTGAVVIGASIILFD
PIFQGLAISLVFGAIVSTILTLLVVPIIYYVTERKKWEKTVEETDNDIPNS
>KACEBFPM_00689 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase
MSIIDRKQAIKTACQLAQPNDIILIAGKGHETYQEINGVRHDFDDMQIVKEILEQLNK
>KACEBFPM_00690 Phospho-N-acetylmuramoyl-pentapeptide-transferase
MLYYLFQYLDKYFDFPGAGVFQYITFRSALAIIMSLLISTIFGKRVISYLSRLQVGETVR
ELGLEGQTQKAGTPTMGGLIIIFSTLLPVLLLAKLNNIYIILLIVTTIWMGAIGFLDDYI
KIFKKDKAGLKGIFKVIGQVGLGLIVGTTLYFHQDVTIRENISKNKIEVYSTQKGANTLS
SDKKSTATTIPFFKNNEFDYAELLAWTGDGYRNYAWLIFIPIVIFIITAVSNGANLTDGI
DGLAAGTSAISVIAIGVFTFVSGNVIFSNYLNIMFIPNSGEMTVFIAAFVGALIGFLWYN
SYPAAVFMGDTGSLTIGGIIAVLAIAVRKEMLIPVFCGIFLAENLSVVLQVSYFKYTKKR
FGEGRRIFLMSPLHHHYQKKGYHESKIVTRFWIVGILLAIVSIVTLKLR
>KACEBFPM_00691 UDP-N-acetylmuramoylalanine--D-glutamate ligase
MRLVILGGGESGVGTAILGKKKGYDVFVSDFGKIKNNYKEILILNKIKFEDEQHTEDLIL
NADVVMKSPGIPDKSPIVKKLKEKNIPVISEIEFTAPFTNAKTIGITGSNGKTTTTMLVY
HLLKQGGLNVGLAGNIGKSFAWQVSEDTHDFYVLELSSFQLDGIQKYKPHIAIITNISPD
HLDRYDYQYEKYIESKFRITMNQTEEDYLIYDADDQAINNWLKNNKTKAQLVPFSLTKQF
EFGAYEANNNININTNNDPFVMQTSELSLEGKHNVKNALAATSVAQLLKIRKATIRESLA
DFQGVEHRLEKVLKIQNVQYINDSKATNVNATFYALDSMTSPTIWIVGGVDKGNDYSELM
ELVNKNVKTIICLGVDNKKIIDAFSNVVDELIEVSTMTDAVRQAYKMAEKGDTVLLSPAC
ASFDLFENYEDRGRQFKQAVQNL
>KACEBFPM_00692 putative peptidoglycan glycosyltransferase FtsW
MKQLLHNLKGDKVIWSFVALLALFSFIPVYSASSNLAYLHHGTGNTFVYLLKHFMHLIMG
FVILYQVQKVPYHYFRSLSRLLLPFAWLLLVYTLLKGTMIEGANASRWIQVPFLGITFQP
SAFASMALLIFVARYLSKTAIEEMTFQKSLLELWAPVFFTLMLILPANFSTAALIFSMVL
MLTFIGKYPIKNIGIIIGLGILSFAFFILVVKAFPNAFPNRVDTWMSRIENFTSDKPGED
DYQIEKAKTAIATGGIYGLGPGKSIQKNFLPQSSSDFIFAIIIEEFGLLGGFAIMFLYIM
LFIRFIIASYKAPTLFGKLLVAGLGFPIIFQAFINMGVAVELLPTTGQTLPLISSGGTSI
WMTCAALGIIINVTKKEEEITEENIEKQKRDDALQKLIDKQLVDDSQVEDYTIEDHTNNP
MNAVLNKK
>KACEBFPM_00693 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MEQYKFILSGGGTGGHIYPAIAIANELKSRFPNCKILFVGAKDKMEMQKVPQAGYDIKGL
SIAGLQRKITLQNAMFPFKLLSSLVKSFGIVQQFKPDVVIGTGGFASGAVLKVASILGIA
TVIQEQNSYPGITNKLLSKKANKICVAYENLEQFFPKDKMILTGNPVRQDLISVDGKRNE
AIDYFKLDANKKTILILGGSLGARRINQLIAKEIDWLLSQNVQIIWQCGKLYFEDYKPFS
GKENVQILSFIDRMDLVYAAADIVISRSGASSVSELAIVGKPVIFIPSPNVAEDHQTKNA
QAIVNKQGAILLKESQLDSEFKFVFEALLKDKGKQEDLSKNIKQLALPNATKDIVDEIIK
LVESQKS
>KACEBFPM_00694 UDP-N-acetylmuramate--L-alanine ligase
MNLNQIHNVYFIGIGGIGMSALARYFKFIGKNVSGYDKTPSILTSELIESGIAIHFEDNI
DLIPKDYFVENTLVIITPAVPKSHSEWNYFLEREYHVKKRAEVLGIITKDTFCLAVAGTH
GKTTTSSILGHILYESGADVTAFIGGIVENYNSNLIGSGKTVTVVEADEFDRSFLHLYPN
IACVTSMDADHLDIYGDDAAIKASFKEFADKVEDKNKLFVINGLPLKGITVGANDDSQFV
AHNIRIENGWYIFDVKTPTENIKNLKFGLPGKHNLTNALLALAMARTFGTPTESIAKALA
SFKGVKRRFSFQIRKPKFVYIDDYAHHPTEINAVHQAVRELYPNEKVLAVFQPHLFSRTK
DFANDFAKSLSQFDEILLLDIYPARELPIEGITSGWLLDKVENKNKKLVHKNELIQLLKK
SDATVIVTIGAGDIGEMVVNIKKELDEK
>KACEBFPM_00695 hypothetical protein
MKNNLILNIQLVAIFVLVGFLYSFTSKRNEHRKISKPTIEFLNSESPFVTHEMVNNLLKD
NFGGTFSIQKDRVNLKNIEQTINKHNLIEKSEVFLSVDGELEAVIKQKTPIARVFNGNTS
FYIDYKGGRMPLSSNFTARVPLVYGDFNNRYDKDFVGLLQCIYNDDFLKKNIIGIRVLPD
GSVIMKNRDYSYDIIFGRTICMERKFNNYKAFFQKAVQDTLIKSYKKINLKFTKQVVCTK
>KACEBFPM_00696 Cell division protein FtsA
MERDNIAVGLDIGTTKIVAMIGKKNEYGKLEILGVGKSKSLGVARGVVNNITQTIQSIQE
AISLAEADSGYKIKDVVVGIAGQHIRSIQHSDYISRPNPEEVISEIDIDVLINQVQKLAM
LPGEEIIHVLPQEYKIDGQSEIKEPIGMYGGRLESSFHVVVGQASSIRNVGRCIKSSGLD
LSGLTLEPLASADAVLSQEEKEAGVALIDIGGGTTDLAIFKDGIIRHTAVVPFGGNVITE
DIKEGCSIIEKQAELLKTKFGSAWPGENKDNEIVSIPGLRGRDPKEISLKNLSKIIHARV
VEIIEQVYTEIKIYGHEDPRKKLIAGIVLTGGGSQLKHIKQLVEYITGMDTRIGYPNEHL
AGNSSEEISSPLYATAVGLVMNSIRNNTVSAVPHENFIAEPVLIPKPIITEKIEIKKEED
AIEETKTEPKPETRKDSKSSEKMIRKSFFDKYIDKIKDFLDNAE
>KACEBFPM_00697 Cell division protein FtsZ
MESNSEFGSISFDLPKNQSNVIKVIGVGGGGSNAINHMFKQGIKGVDFIVCNTDSQALDN
SVVPNKIQLGVNLTEGLGAGANPEVGQQSAIESIAEIEKMLDGNTKMVFITAGMGGGTGT
GAAPVIAQLARERDILTVGIVTIPFQFEGKVRIEQALLGVEKLRKQVDSLIVINNNKLRE
VYGNLGFKAGFSKADEVLATASRGIAEVITHHYTQNIDLKDAKTVLSNSGTAIMGSATAE
GENRAKEAIVSALDSPLLNDNKIAGAKNVLLLIVSGTNEITIDEIGEINDYIQAEAGHSA
NIIMGVGEEEELGDKIAVTIIATGFCVEQQAEIVNIEPKKIIHALEDDQKIVRDLTQKYQ
AQGFDFSSNVITEPLKILETPIAEEKIVFALDEELPNPVEAYFKMDLVPTTELIKNLDVT
FEVVSSKAIDVNDFYFTSPPVKDTIDSELAKQIEVVDPQFLIKEQEQIAFTFDLPIQKTT
QTANTDRLTFDLTTEIKDIKVNQAVEFVPMTEVTQNGVIKHSLEAYMEVENQLFEAKKAE
NVVVETIPTELNITMKQVETPKYSTPNTANEISPLEMSIEDSLRMRSEERRRKMKEFNYK
FHNNASKVDEFEKEPAYKRMGIDISNNTIDNSRSRISLGIDGNDEIQLRSNNSFLHDNVD
>KACEBFPM_00698 hypothetical protein
MSLSTHIMDEMKTAMRAKDTVALEALRAIKSEILLAQTATGTKEDITEADEIKILQKLVK
MRKDSATIFAAQNRPDLAEPELAQIVVIEKFLPAQLSEQEVEAIIAKIIAETGASGIASM
GKVMGLASAQLGGQAEGKTISSIVKKLLV
>KACEBFPM_00700 hypothetical protein
MFVIYLSLVIIIGIVYLFKIIVQPIYILIYKKPLILRFCLFSKKINPHYKDILTHHFPFY
KKLKPKDQNHFDQRVLNFIEDIQFISRDDIEITFEMKLLIASTSIMLTFGMQEYLHTVVR
TIIVYPSSFYSTTNQNMHIGEFNPKLKVVVFSWEDFYKGIKLNDDNLNLGIHEFSHVLLF
ESLKKNKYDAVANPVFLDCYNAIIIDLKKPEFIEKLVASHYFRDYAFVNSVEFIAVILEQ
FFETPEKFKELFPELFYKVKMMINYNDNSLSS
>KACEBFPM_00701 Ribulose-phosphate 3-epimerase
MNNTLIAPSVLAADFANLQRDIEMINNSQADWFHIDVMDGHFVPNISYGMPVIEAIKKHA
TKPLDVHLMIEKPERYIEEFAKIGADIITVHYESTVHLHRTLTQIKNAGCKAGVVLNLTT
PVSVLEDILSECYMVLIMSINPGFGGQKFEEITYNKVRKLRKMITDQGLHTLIEIDGGVT
DKNAKQLVEAGANVLVAGSYVFKAQSPAQAIIDLKNLTR
>KACEBFPM_00702 hypothetical protein
MSFLLLKFISFLSSIFFIIPEIFCTGIYSGSWPLSPNITARSVACPVPVSEREPYKSTFT
RIVFSKISLFVNSSRNFSAARQGPRVCELDGPTPIFNISNTEIHSSINFILLCYKYIRTN
KLFFCHELHHFISLCQNIYDI
>KACEBFPM_00703 Lipoteichoic acid synthase
MSKFFRFQEYKVLSYRLLLSFLFYSIARLGFFLYNYKLLKVDSVSQYLSLAYHGLVFDTT
AILYINGLFILFSILPFWINTSKKYQIFLFWIYFIFNSLAYATNFLDFIYYRFTYARTTI
TILDIARNETNKGIMFSRFIVNYWHVYVLFFMVLALWVYLYKKVKIKQLPISISKIKYFT
YSLIGLLIITTLAIGGIRSDFKKSTRPINMIDANRYVEKPQHADIVLNTPFALIRTMNTN
TFKKINLVSESQIKNTIEPIKQYKNNPLTKPNIVLIITESMGREYLGAFNKNNNIPDYKS
YTPFLDSLAGQSLIFTNAFANGSKSIHGMSSVIAGIPSFRDAFTSSPYPKQKIQSLVSTL
QELGYDTSFFHGAANGSMGFLGFGNILGFDHYYGRTEFNNDNEFDGSWGIWDEPFLQFMK
GELDKKKTPFFSTIFTVSSHEPFVLPEKYKNTFPKGNIPMHKVVGYTDFSFKKFFESARK
QPWFNNTIFIITADHCNQTYYPFYNQIINRSAVPILIYKPNSNLKGVNTDFAQQIDIYPT
LLDIIGYKKPFRSWGRSLVGDKKIAPFACNFNGGQYQFMQGNYICTFDGKEIVGIYDKKD
LGLEHNLIGKINNQEIIRIKTSAKAFIQDYMRRIIDKKLTAN
>KACEBFPM_00704 hypothetical protein
MSSKVKKIVIPISIIILLFVGKYVYDMNINHNFETITEGKVYKSGVIPPDEIESYVKKYN
IKSIVDLRFPGTTDLVNNPEIPTELTAEKEAIAKIKGVNYFNNGSDQVPTPENVKTFLKI
MDNKSNYPVLIHCYHGIGRAELYSAIYRIEYENFTNKDARNGVRTLVKFSSFDDGKPKGE
YLMHYKPRKDSLK
>KACEBFPM_00705 hypothetical protein
MAIGQSLVAYTNTNSEKKYPCKIILIGKDFSANRSTEVHCHFINYDKTLLPGMYMNAEIE
IKSQQSNVLPSDAIVRYENKNYIFIAKQNKQFEMKEVIIGNTENEFTEILSDDLKTVTIV
TKGAYSLLMKIKNTEEE
>KACEBFPM_00706 Malate:quinone oxidoreductase
MSVPHIDTRMIDGKKALLFGPYAGFSTKFLKNGSYFDLIKSIEFSNIKPMLGAGVKNIPL
TKYLIEQVIQSSDDRLKALKEYVPSAKKEDWVLENAGQRVQVIKKDKDGHGILEFGTEVV
TAHDGSLAVLLGASPGASTAVQIMVDLITKCFPEEVKTTIWQNKLKEMIPSYGQSLNENT
VLCDQIRAKTNEILKLKV
>KACEBFPM_00707 Peptide deformylase
MILPIVGYGDPVLRKVCEEITKDYINLEETIANMYETMYNACGVGLAAPQVGLPIRLFIV
DADPFSDSDDISKEEAAALKGFKKTFINAKMLKEEGEEWSFNEGCLSIPDVREDVYRNPN
ITIEYYDENFNKKTEEYNGLIARVIQHEYDHIEGVLFTDKITVFKKQFIKKKLQNIMEGK
ARPDYRMKLVPKKR
>KACEBFPM_00708 hypothetical protein
MNLEKILAISGKPGLYALKVQTRTGFVAESFIDGKRITVGLRSNVSLLSEVSIYTTSDEK
PLVDVMRNIAKKENNGPTPVFKDDKVQLAAYFLEVLPDYDQERVYGSDIKKVLNWYNILQ
ARGLVSSEESQITEEKTEKVVVSTEAKPAKATKTVAPKNAGMAAAKKAPAQKATKSTKK
>KACEBFPM_00709 Nucleoside triphosphate pyrophosphohydrolase
MNNRQQQLDAFNRLLDVMNELREKCPWDKKQTLQTLRHLTIEETYELGDAILDNDLKEVK
NELGDLLLHIVFYAKIGSETNSFDIGNVANDICEKLIHRHPHIYGDVVVKNEEEVKQNWE
KLKLKEGKKSVLEGVPKSLPALVKASRIQDKVKGVGFDWEEPHQVWDKVQEELQELQVEV
EAGNQDKIEAEFGDVLFSMINYARFLNINPEDALERTNKKFIKRFQYLESKAGELGKNLA
EMTLAEMDVFWEEAKRL
>KACEBFPM_00710 Ferri-bacillibactin esterase BesA
MKKIILVLFFINLNSFAQEKDFVLGKIETLNSLELNEIRTINIYLPEGYNKEENYPVIYL
LDGSAHEDFIHIVGLVQYCNFEWIKLLPKSIVVGIENVDRKRDFTYPTTVEKDKKEYPTT
GGSKKFISFIEKEVQPFIENKYKTTTSKTIIGQSLGGLLATEILFKKPNLFSNYIIISPS
LWWDKESLLKQASVFLDSHFNQKTTIFIGVGNEGEIMINDAENLFEIIKNKPMVNAKYNY
FSEKKHGDILHTAVFKAFEVLKL
>KACEBFPM_00711 Virulence regulon transcriptional activator VirF
MIIQNIPKVFLQLKTEPTELFVYDFKMTKDAVNTKVNLTHNMFSFLQLGEKKVKFEDVFV
EVNNKQSVLIKSGNCLMTELIDNNEIYFCKLFFFTNNNVLNFLKKHSEHISKLNKKTNTE
TPFFVIENDDFIHSFVTSISSILNLKTNTTLLLELKLEEILLYLLQKYGASFIHYLQSLA
SAEKNTTLKNIVEANLNSNLSLTEIAFLANMSLSTFKRHFLLEYNVNPGKWLRQKRLVLA
KHLIKNEDKKPSEIHKQFGYNSLSNFSIAFKNEFGFSPKELK
>KACEBFPM_00712 hypothetical protein
MNITLEQAEKMILAAKKKAVELDTKMNICVVDAGANILAFVRMDGAWLGSADISLKKAKT
ARFFDFPTGVIGSLSQPGGSLFGIEHSNGGLISFPGGVPVKNSTGEVIGAIGVSGSTVEH
DNLVAEAGANSL
>KACEBFPM_00713 hypothetical protein
MIHLFVQIIFIMVIANILDFRKDIKSYFETLFIIAKNIQEL
>KACEBFPM_00714 hypothetical protein
MKLFYIIIFVFVFSANNFAQEASSIPSTGIPRVDIAIPKNQNATPQFSISKPFEITKFKK
SSKIYDATQLQKPNPFNLPISDLNPGKINAAKMNKAMQEEHPEFYARDQIFGVIRTKSQY
AKVIYFDYAEPDGDNIRIWENEIVIIQNAYLTNSRKELILDLFQSSNKIEFEALNEGLSP
PNTAQFDIYDDKGNLLFSNQWALSKGYRASIIIEKER
>KACEBFPM_00715 Alkaline phosphatase PafA
MKKLILFSVIVISSIIHAQQQRPKLVVGIVVDQMKMEYLYRFSSDFSQNGFKKLLDDGYT
FHNMNYNYMPTYTAPGHASLYTGTTPAVHGIVANDWFNKTTGKNIYCTDDTSVKILGDGI
AKEGEMSPKNLQSTTITDELRMATNFKGKVIGLSIKDRGAILPAGHFANWAFWFSSTGSF
ISSTFYGEKLPDWVTEFNQEKKYMTYINKGWDLLNPIDTYNESLSDNNPYEGKIDKTKEP
VFPYDLKKIYDQKGAEIIKSTPYGNDILADFAIRTIEKEALGKDDITDFLTVSFSSTDYI
GHTFGAHSIELQDTYLRLDKTIANLIANLDQTVGKENYLLFLSADHAGAENASYLRDHKY
DVKNINVNDLTASLKKFSEETFGVNLVLNYSNANLFFNKAIIKEKGLELNKIKQSFKDYL
MTLKEVKRAYTEEEILNSTGNDYYLNFILKGYDPKQNGDIVVLYGTGNIDHGVTGTTHGT
PYSYDTHVPCIFYGWNIKKGETHDKKEITQIVPTIAQKIQIPFPNGVQSNVLIEILK
>KACEBFPM_00716 Nitronate monooxygenase
MNKITSLFNIKYPIIQGGMIWNSGYKLASAVSNAGGLGLIGAGSMYPEILREHIQKCKKA
TDKPFGVNVPMLYPNVEEIMNIIIEEGVKIVFTSAGNPKTWTNFLKEKGITVVHVVSSSK
FALKAQEAGVDAVVAEGFEAGGHNGREETTTLTLIPMVKEQISIPLIAAGGIATGRGMLA
VMVLGANGVQVGSRFAASTESSCHDDFKKTIIDVKEGGTQLTLKELAPVRLIKNKFYNDL
QDLYTKCPTPEDLKTLLGRARAKRGMFEGDLVDGELEIGQIAGLIHDIKPAANIIEDMVA
EFQKAKHEMANL
>KACEBFPM_00717 hypothetical protein
MFFSKTSCPKLLYNLIEYPILLAGLEIVISLVAGFGYKFKATVETSGIESAAVSAA
>KACEBFPM_00718 hypothetical protein
MISKHDILNIFGENVRKHRRILDISQEELAHRADLHRTYIGMIERAEKNITLVNMEKIAN
ALQVKIEDLLKN
>KACEBFPM_00719 hypothetical protein
MEITIEAFTELLDNKYIIVEAFREHSKASEKYIDVTIVQKDGYSWKGSIPYFYRRTGLFI
ETPEDLVEYLNNIYPLFSKKLVDEFLLTESKRWNNEMSGKGTTKGFFDKLLNLEWNSVQH
DLPVNRNFARRIQDIKEFGYTLSTDTRRKVKGTYETDTHIQLIPLPKGGVTGYEIMSPAF
KAKAIAVMEAVNVYELSTANKHGLLPDHKFPEIRWDEETRAENPDEMSEAQIKEKFQLVD
NQRNQQKREACRKCFQTGQRGKLYGLNFFYQGDENWSKEFPRVGKDAEKGCIGCGWYDIQ
KWRESLNDFISKNKK
>KACEBFPM_00720 Modification methylase HhaI
MKDKLTFGSVCSGIEASQLAFAPFGYEQLWSSEIAEFPSKVLEHHYPNIPNLGDMTELPD
LILNGKVKAPDMFCGGTPCQAFSLAGWKNGLADKRGQLTITFIEIANAIDEIRAKEKKER
SIILWENVEGVLNDKTNAFGNFIAGLAGFNDEIKVSKWTKSGYLEGPNRNVAWRVIDAKY
FGLPQQRKRLYVLAGGKDFRPDQVLFEFDNKDIVKKKKAEKQTFNNGNIFNLFSQNISKI
EIKDEKTFYKDNIKFEIFREYTDCLYAAYGTKWNGNAAAYNGSLYIAQNDKIRRFTPLEC
ERLMGFPDNYTLINGNSDTNRFQAIGNSWAVPVVTWIGKQIDKFLNTKHNQEVICWYKST
RKTANNLNADLYLLDNILLVSQELYLNSSTITNKPIESTIENIVQTENVPEKFYLSPQAC
RGILRRKEERDLKMNEQLEKLMTIIGEENLIKTTTEEKRQHVTGVLQNGGFSAKLNISSS
IKV
>KACEBFPM_00721 hypothetical protein
MEYLGYFASILIGISLGLIGGGGSILTIPILVYLFKINPENATSYSLFIVGITAGIGSYK
HYLLGNLKIKSALYFAFPSVLSLLFVRKIILPNIPNHLFVVNNFEVTKNSLIMIVFAILM
IFASISMIKKSNSNKKTEGIGFVQLSFIGLIVGFVTGFLGAGGGFLIIPALVFFASLEMK
QAIGTSLFIIFINSMIGFGGDIINGIEVDYKLLLIISSIAILGMFIGTHLSKKIDGAKLK
PAFGWFVLVMGGYIIYKEFFL
>KACEBFPM_00722 TonB-dependent receptor SusC
MRNFTILFIFFISFSAISQETIISGTVINDNTLSPLWNINVVNINLVKGAVTDAKGNFKI
PANVNDVLLVSSLGFQSIEIKVTNDWIKSNANRIHLTEKAYALEEVVILPYDLTGYLEVD
SKLIPEKENYWYNISGLTSRYEAGESSPGAFGRVMNSLFNPADMLYNFFGKKPKELKRLK
ELKKDENLRNLLQTKYDHQTIYLLLGIDKKELTEILQRCSYSETFVKTANDLQILDAING
CYEEYKVLKK
>KACEBFPM_00723 ATP-dependent RNA helicase CshA
MNKFEQLGLTESLLRAIIDLGFENPTEVQEKAIPMLLEKDIDLVALAQTGTGKTAAFGFP
VIQKIDANNRNTQALILSPTRELCLQITNELKNYSKYEKGINVVAVYGGASITEQARDIK
RGAQIIVATPGRMQDMINRRLVDISQINYCILDEADEMLNMGFYEDIVNILSTTPDEKNT
WLFSATMPAEVARIGKQFMTDPIEITVGAKNSGSATVSHEYYLVNARDRYEALKRLADAN
PDIFSVVFCRTKRDTQAVAEKLVEDGYSAAALHGDLSQAQRDGVMKAFRGRQIQMLVATD
VAARGIDVDNVTHVVNYQLPDEIETYNHRSGRTGRAGKLGTSIVIVTKSEIRKISSIERI
IKQKFEEKVIPSGIEICEIQLLHLANKIKDTEVDHEIDNYLPAINSVLEDLSKEELIKKM
VSVEFNRFIAYYKKNRDIANQSSGSDRRERDDRDGAPRENNNNGATRYFVNIGSRDDFDW
MQLKDFLKETLDLGRDDVFKVDVKEGFSFFNTDAEHTDKVMQVLNGFDLNGRRINVEISK
NDGGSSSGRRDHNGRSGGGRSSGGGGFRGERSAAPRSGGGAFGPRSSAPREGGFSRGSAP
REGGFGRNESSDRAPRNERRSGSGFTPRGASESSSERPKRPRRS
>KACEBFPM_00724 Non-canonical purine NTP pyrophosphatase
MQLVFASNNKNKILEIQSMLPESIKILSLSDIGCHEDIPETANTIEGNAILKANYVTQKY
GYDCFADDTGLEVEVLNGQPGVFSARYAGEQRNDNDNMDKLLTELDDKTNRNAQFKTVIC
LNINNKQHLFTGIAKGNIVKNKIGNQGFGYDPIFQPEGYQYTFAQISLEEKANISHRGKA
TRALIDFFKN
>KACEBFPM_00725 Inosine-5'-monophosphate dehydrogenase
MLGSLLAGTKESPGETIIFEGRKFKSYRGMGSVEAMQEGSKDRYFQDVEDDIKKLVPEGI
VGRVPYKGELNESMQQFIGGLRAGMGYCGAKDIATLQETGRFVRITTSGIGESHPHNVTI
TKEAPNYSR
>KACEBFPM_00726 hypothetical protein
MTTHLALLRGINVSGHNMIKMDALKSALENIGFQNVQTYIQSGNVFVDTEEENGPSVGFT
IKQEIFKVFGHDVPIVIIGKQDLEDCFNNNSYLKEKEADTKKLYVAFISKELNASALNDL
KISQFKPDAASIDSSRIYIKYDIGAGKTRLDQKYIEKKLNVTATIRNWNTVTKLLEIFSE
RV
>KACEBFPM_00727 23S rRNA (uracil-C(5))-methyltransferase RlmCD
MGKKITDKIVFDTVKVLDAGAKGVSVAKAPDGKVIFISNVVPGDVVDVQTFKKRKAYYEG
KAIYFHEYSEHRTEPVCEHFGVCGGCKWQNMKYSQQLFYKQNEVFNNLKRIGKVEMPEFE
TILGSEKQFFYRNKMEFGFSNARWMTEAEIKSDQEFDDRNALGFHIPKMWDKILDITKCH
LQGDPSNAIRNEIRRFAIENNLEFFNPRNHEGLLRTLMIRTASTGEIMVLIQFFEENKVQ
RELIMNHLAETFPEITSLQYVINGKPNDTIYDQDIKLFKGRDYILEEMEGLHFSINAKSF
YQTNSEQAYELYKITRDFAGLTGNELVYDLYTGTGTIAQFVSKQAKKVIGVEAVPEAIAD
AKENAKRNNITNCEFFVGDMKNVFNDAFIAQHGHPDVIITDPPRDGMHADVVKQILSIGA
EKVVYVSCNSATQARDLALMDEMYQVTRVRPVDMFPQTHHVENVVLLEKRK
>KACEBFPM_00728 hypothetical protein
MKKLKIIAIAVFIANLFLGCEKDDICEAGTPTTPRMIVEFYDNLNPTAKKMVTNLGIIAE
GMTTEILKNNVSKIEVPLKTTADITKYSFIYDSKNTNASLQNTDEITLNYTRTDLFISRA
CGYKTVFSLLDNPNGIVKTIDTDNWIKEIVIQKYKILNEDEVHVKIFF
>KACEBFPM_00729 hypothetical protein
MKFMLKFSFNIFKKSKVESHKVTSLCYKWLQYFFVFQTFEKKQKNKNQYTQDFMTLRLYD
LQLIAILILFLSFGSFAQDKKKDTLVPKTQRYGLRVGADLSKLARTFYDKNYKGIEFVGD
YRLTKKMYLAAEIGNENKTTEENTVNFTTKGTYFKVGFDSNNYENWLDMENMIHIGLRYG
VSTFSQELNSYKIYNTDTYFPTALPVAAGTKYDGLTAQWVEVVAGMKVELFNNLYAGFSV
RMNYLVANKKPDNFDNLYIPGYNRTYDGKFGAGWNYTISYFIPLYKSSGKKKVNPKKK
>KACEBFPM_00730 hypothetical protein
MKFIKLVLTISIISFSLTLNAQINDSLFKKTFENKKFKTNQIIGLKDFKYNPNVSDIELQ
EPNDNYPYGNITTFENGKFTSGNIGFCGNECRITVSGNYYIKRNKIYLFLQTISFWKDCK
NRPTENINKEIGKFTWKKDKNGKIKLTAVK
>KACEBFPM_00731 hypothetical protein
MNKKTKSFVYNFLGFAIIFFTTRYLVAIYTNLEGYFIPITAFVVGTLLAPKFQTIQTNEG
EKLFMKWIFIKGFKQIK
>KACEBFPM_00732 Ribosomal RNA large subunit methyltransferase L
MIAKTFFGFEEILAKELTQLGAQDVEMGTRMVSFAGDKGFMYKANLSLRTALKILKPIYY
FRAKSDENLYKNMQGIDWSKYLNTNQTFVIDTTVHSDYFKHSQFVSQKCKDAIVDQFRAK
TGIRPSVDKDFPDLRINIHIDKDQVSVALDTSGASLHQRGYKTATNIAPINEVLAAGMLL
LSGWEGQGHFIDPMCGSGTILAEAAMIACNIPANINRKEFAFEKWNDWDNELFDNIMNSL
LKKIKEFHYTIIGHDKAPSAVQKAIANIKNANLDEYVTISEQNFFNTEKNTEGKLHMVFN
PPYGERLDIEMERFYREIGDTLKQSYPNTNAWFITANLEALKFVGLKPSRKIKLFNGSLE
ARLVKYEMYEGSKRTKFQISESNDL
>KACEBFPM_00733 Glycine/sarcosine N-methyltransferase
MLESEKSNTSNLEPKQKNWFATWFDSPYYHILYKDRNLQEAQVFMDNLTHYLNLPEGATV
LDLACGKGRHAIYLNQLGFNVLGVDLSPNSIAEASKNNNMHLNFRVHDMREPFEEKFDAI
FNLFTSFGYFESDADNLKTLISIKESLSEYGFAVIDFMNVNHVIENLVPEEVKTVDGINF
YIKRYLKEGYIYKEINFEDKGEKHHFTEKVQAITLQNFEQMMEEAGIYLLDIFGDYKLKK
FHKTESERLIMIFK
>KACEBFPM_00734 hypothetical protein
MEYLLPLLSVILGFAIALFFRPKNKTNLKLLLAFSGSFLLALTVIHLLPEVYESKNHAIG
IYIMIGILFQIILEFFSKGAEHGHVHGHDKLTQMPWALFISLCLHALLEGFPVGHHHDLA
IGIAIHHFPIAIILTTFFLNAQLNKATLFLFMITFAVMTPLGTLVSESLPVLNKYYTQIT
AVVIGILFHISSTIIFESSEGHKFNIAKISMIILGIGLAYFI
>KACEBFPM_00735 hypothetical protein
MGLFSALLGNAGAVDQATLTKEYAKLLIEGEEIELGFKLIRDTFIFTNKRLILIEKQGLT
GSKTEYKSISYKSISRFSVETAGTFDLDAELKIWVSSETIPSIKKQFNKSVNVYDVQNVL
AFHVLK
>KACEBFPM_00736 N-acetylmuramic acid 6-phosphate etherase
MTFTKTTEQASKYEHLEKMSVHELLANINNEDKTVPLAVEKALPQIEKLVTKIIAQINLG
GRLFYIGAGTSGRLGIVDASECPPTFGVPFDLVNGIIAGGDKAIRRAVENAEDNTTQAWI
DLCEFDINKNDVVIGIAASGTTPYVIAGLEKCNENNIITGCITCNEESPLSQTARFPIEV
VVGPEFVTGSSRMKAGTAQKLVLNMISTATMIQLGKVKGNKMVDMQLSNDKLVDRGVKMI
MSEIKVSYEEASELLKKYGSVRKAIDNFN
>KACEBFPM_00737 hypothetical protein
MSTNKEILFKGIKYIAWALPLYFIGPSIIYNAFVNKGNIWHYLVLAIGIIASFFAVFLTF
RGLKTIMQSLFDGNK
>KACEBFPM_00738 hypothetical protein
METNSQYLESIKKQFLYYKTLGEKAIEQLYTIIH
>KACEBFPM_00739 hypothetical protein
MKKLFILPLLLLLASCYNQERNCKDFKTGKFTFTQVIDKVKKTSTFERTQNLQIETFEGK
TDTATVRWVNDCECILQKLHPKNMQEKKSISMRIMTTNKKTYTFEYSYVGEAKKEIGTVT
KTD
>KACEBFPM_00740 hypothetical protein
MIELLTNPDAWIALLTLTFLEIILGIDNIVFLSIVSGKLAEKDQPKARRIGLLLAMAFRI
ILLFGITWVLGLQKSILDINLSFFSAHITGQSLIIFGGGLFLLYKSVSEIHHKMEGEEEE
GTAKSGNTLVAAIIQIAVLNLVFSFDSILTAVGLISMKSPAEGGFGYDGALAIMILAIII
SVVIMMIFAGPVSKFVNNHPTIQILGLSFLILIGVMLLAEGSHLAHFRFGNDVEVGSIPK
GYLYFSIFFSLFVEFLNLRMKKTKNPVKLHNSTIKDKELENSDITD
>KACEBFPM_00741 Extracellular ribonuclease
MIKKLLLLLLFCNSGFSQVVINELDPDTPSTDVLEFIELKSVTPNFLLDGYVLVFYNAGG
APYAGTGSYYALDLDGYSTDVNGIIHFGNPQVSPTPAFILPITTIQNGPDVAALYLGDAT
DFPINTTAHASGLIDALAYSNAATTKPTALMTILGLTTCINENLNSLPATQSIQRKNDGT
YELKVPTPGMNNDGSGIVLNYLRLTTNVSIITEGQSLTVTFSTTNAVTGSDLVINFSLNN
GAFTTADYSGTTSITIPIGQTVGSTVIPILNDRINDGDEEIKIVVGALRTGYSLYNNNII
IRVNDINFVTLPFGSPANPTRGLVASTAPVGYYSSIEGLSGAALKQGLQDIIANPSVIHA
HVYGDIYDILKVADQNPENSNQVWLIYNEAPRSKIDNQTGNSIVGKWNREHIYCQSRGGF
ADATSNTPQGINVWNTSGIPGPNNISTGHADAHHIRAVDGQENSSRNNRNYGVDYNGPIG
NPGTWKGDVARSLFYMAVRYNGLNIINGNPIDTILGQIGDLSSLLQWNRNDTSDDFEMNR
NNYIYTWQLNRNPFIDYPDLADYIWGPKVGLPWSVTLSRPDFNELQIAMYPNPTKDFITI
SGLTHEAKIEISSMAGLNVYKGSYKNNDKLNLNLASGIYMVKIIEDTKWVIKKLIIK
>KACEBFPM_00742 hypothetical protein
MTVVLNEVSHSLIVTQTIQFINNSDKPLSKLVLNDWNNAYSNKYSPLGKRFSDEYVRNFH
LAPNRDRGNTTITKILVNDSIAQYNRAKNHLDIIEIVLKNSLKTSKSVTLTIEYSLKIPN
SKFTRFGYNDGKYILNNCFLSLARLASNGQFAYYSNENLEDIANAIYTTINIDFVIPKSY
EITCNLNFSNQTENETTKTIRYKNQNSDQIQLAIEKNNSYESFKNDNIEVQTNLSETKLN
GIQKAIIIDKIVNYVTHNLGEITEKTIMISQADYERNPFYGLNQLPAFISPFPNDFLYEI
KFLKAYLYNYLKASLKIDLRKSGYIFDAIQVYMMMKYIDENYPELKMLGNLSKYKILKGY
NLVNANFNEQYKYLYLLMARDNLDQTIGESKESFIKFNEQIAGKYKAGLSFKYLNLVLKD
STVENSFREFLALNKEKQTTSSDFETILSKKANQNIDWFFSNLINSRKIIDYKFGTINKT
KDRISITIKNNSNAIVPITITGLKNKEVVFSQWLYNVKNDTTFAISRNIADKLVLNYNNS
IPEFNARNNYKSLKGFLSLNRPLQFNFFKDLENPAYNQIFYLPEITYNLYDGIITSLSLH
NKSFINRTFIYDVSPSYSSKTKSFTGYGSIAFRQQYRDKKLYEIKYGLSGSYYHYIQNAA
YLKINPVVQFKFRDSDLRSNKRQYLTFRNIFVNKDLAPITSATKTITTDTPLRYSVFNAR
YSVSNSEIAKGFGLGTDLQFSGDFGKISTEIGYRKLLENNYQFSLRLYAGTFIYKNTSTE
FYSFGLDRPKDYLFDYNYYGRSESTGLFSQEIIIAEGGFKSKFANPYANKWMTTINATSS
IWHWIEMYGDIGLYQNKGQNPKFVYDSGLHLDLVPGYFELFFPIYSSNGFEMGQKNYQEK
IRFTASFNPKTLIGLFTRKWF
>KACEBFPM_00743 2-oxoisovalerate dehydrogenase subunit beta
MTQVEEKQPLTFEDFKTEVIQDYTIATTSRECSLLGRREVLTGKAKFGIFGDGKEIPQLA
MAKAFKNGDFRSGYYRDQTFMMAIGQMTMQQFFAGLYGHTDLAHDPMSAGRQMGGHFATH
SLDENGNWKNLTQQKNSSADISPTAGQMPRLLGLAQASKIYRNVSGINQTNFSEQGNEVA
WGTIGNASSSEGLFFETINAAGVLQVPMVMSVWDDEYGISVHARHQTTKENISEILKGFQ
RDQKNKGYEIITVNGWDYPTLVETYQKASVIAREEHVPVLIHVRELTQPQGHSTSGSHER
YKNAERLEWEANFDCLRQMKLWMIENNIATAEEIETIDNQAKKNVLEAKKAAWTAYLNPI
KEERDELVSLLNTIENTSENKVFIAKYAANLASIKEPIRKDTITTARKVLRLIVKENKKD
QLANWITNYTNKIQPKFSSHLFSQSDKNIFSVKEVLPTYNNSAEEVDARLVLRDNFDAIF
TKYPESLIFGEDAGNIGDVNQGLEGMQEKYGELRVADVGIREATILGQGIGMAMRGLKPI
AEIQYLDYLLYAIQIMSDDLATLQYRTAGRQKAPLIIRTRGHRLEGIWHSGSPMGMIINA
IRGIHVLVPRNMTKAAGFYNTLLETDEPALVVECLNGYRLKEKMPTNLGEFKTPIGIVET
IKSGNDITLVSYGSTLRLVEQAAKELLEIGIDAEIIDIQSLLPFDINHDIVKSLTKTNRL
LIIDEDVPGGASAYILQQIIDEQKGYMVLDSQPETLAAKAHRPSYGTDGDYFSKPSAEDI
FEKVYAIMHEANPIQFPSLY
>KACEBFPM_00744 hypothetical protein
MAFTFSYICKLNLSLQMKIVISPAKSLDFEKTLPNNQFTKPAYLKQSKEIVSVLNKLNPK
ELSELMHISDNLAQLNWQRNKNFTTPFTTQNARPAIYTFNGEVYNGLDSYSIAEEKLAVL
QNKLRILSGQYGILKPLDLMQAYRLEMGTHLPINEHKNLYSFWKEIVTNDLNKELKNNEL
FVNLASNEYFSVIDTKKLKVPIITPEFKDYKDEKLKIISFFAKKARGLMVRYIIDNDIET
LDGLKGFNYEGYSFDANLSKGNTLVFTR
>KACEBFPM_00745 hypothetical protein
MNSFWKLIIAQTILKYKNKKSVAKKEYSNFVLAKGYREFLIHVKRLLKDLILVTIGVFSA
SFGFKGFLLTNHFIDGAIIDGTEVLTIYLSRKFGTYNSY
>KACEBFPM_00746 hypothetical protein
MKKNIISCLIILLMSSCISTKLTIQNIDELAIKPALNEDFSSFIITKNATSKKYGYDPDY
PVNVNFTSEEDGLNNQIRFLKALAGPKGEKIKYTQKDPCCPFPSKRANTGAGIIDVFEIT
WEGQNKPILLYINKFEKGELFIPIGLSARK
>KACEBFPM_00747 hypothetical protein
MEYITHTWHWSISGFLIGIIMLLLIYFGKHFGMSSNLRSLCSMTGVGKYVSFFDWDWKTQ
RWNLIVVIGAMIGGFVAVHFLSDPSNVALNPETIKQLSKFGIEAPDGKIAPNSMFGFEVF
QSFKKIFILLIGGILIGFGSRYAGGCTSGHAISGLSNLQMPSLKAVVGFFIGGLIMAHFI
FPLLF
>KACEBFPM_00748 hypothetical protein
MKLLKYLAVGFLFGLVLTKSEAVSWYRIYEMFMFQSFHMYGIIGVAITTGIIGIQIMKRN
NLKDINGLPIEIIDKEKGSFRYWIGGLIFGLGWALVGSCPGPIFILIGAGFMSVGIILVG
ALLGTFLYGVIKDKLPH
>KACEBFPM_00749 putative membrane protein
MRNSFIYFIVISTIYLLLFIFNQDNIAWYFKPFLLPFLILATYKSDAFETKKWLLYALTF
SWIGDIILLFASKNELYFILGLVSFLIAHILFIVLFIKQKSEGNYTKKCLFWLGFVVVLV
YIISILSLLFTKLGNLKIPVFVYAFTISIMLITAIKGYFTWQKPMNILILIGALFFIVSD
SFLSINKFYNPILSAQFIIMFTYLVAQYCITAGVLKMNKKN
>KACEBFPM_00750 hypothetical protein
MEQYGKILIIAMPIFLLLIIIEKIYGYYKGINYAPVINSISSISSGMANAVKDVLGLSVS
VFSYEWLVSKMAIFTLEASVYTYIIAFLVIDFYGYWTHRWSHLINFFWNKHAIHHSA
>KACEBFPM_00751 ATP-dependent Clp protease adapter protein ClpS
MATIEKTQTETDVLEYVAINNEIVLFNDDVNTFDHVINTLIRVCHHEELQAEQCALLVHY
KGKCVIKTGTFDELKPQCSSLLEAGLSAEII
>KACEBFPM_00752 Ribosomal protein L11 methyltransferase
MSNIYLGYHFIVEPKELGSEILIAELGEKAFESFVETETGFSAFVQKSLWTEDIMNDVYI
LENPEFKISYTFEEIEQVNWNEEWEKNFEAIDVNGNCHVRAPFHPKTDAEFDIVIEPKMS
FGTGHHETTHMMIQHLLEIEVTGMKTLDMGCGTAILAILAEMKGAQPIDAIDIDNWCYLN
SIENAERNNCKHITVYEGDAALLKDKKYDLIIANINRNILLNDMQAYVDCLNPKGTILFS
GFYTEDIPFINASCTEKGLTYVKKFERNNWVSLKYVI
>KACEBFPM_00753 L-methionine sulfoximine/L-methionine sulfone acetyltransferase
MNIEIRPFQIEDTQAILAIINYNILNSTALYDYNPRNLATQIAILEEKTTKGFPIIVATE
NKMVTGFGYYSEFRFREAYKFTVEHSIYVHKDFHGNGIGKLLLLELISLAKAQKLHTMIG
VIDAENKSSITFHEKFGFKNVGIIKESGFKFNRWLDSVFMQLILE
>KACEBFPM_00754 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase
MIYPKIPLAQSIIEICNTKGLHHIVISPGSRNAPLTIGFTNNPVFTCYSIADERCAAFFA
LGIAQQLKKPVAVVCTSGSALLNYYPAFAEAFYSQIPLVVISADRPQSKIDIGDGQTIRQ
ENVFANHSLYNANLVENVSEENDAKIQEAIHLATTKKGPVHINVPFEEPLYETVDTISVN
TKIIDFDTENKPLENLDVFVNRWNDAKKKLILIGGCDPNVIQQFIIDFLANDTSVVVMTE
VTSNVHHANFITNIDAIITPFTDDDFTNFQPEILITMGGMIVSKRIKAFLRKYKPQQHWH
IDELRAYDTFGSLTKHFEVLPSVFFKEFIPKINSLKSNYLPYSLEIKKVRTQKTNTYLAT
IPFSDFKAFEIILPKLPLYSQLQISNSSAIRYAQLFSIHSSIEVFCNRGTSGIDGSTSTA
IGAAIASGKETILITGDISFLYDSNALWNNYIPENFKIILLNNGGGGIFRILPGHKENET
FNTYFETSHRLTAKYLAKMYNFGYEKAVDEKTLEEKLKITINTKKSIILEVFTPTKVNDL
VLLNYFKNLT
>KACEBFPM_00756 hypothetical protein
MQIKYDYIFAGAGLASLMILDKMMNNKLLEGKKVLLLEPNDKNNNDRTWCFWEDKLGDFE
SLVSKKWQQALFINEKATIECLADGTNYKMIESIRFYNYVFDKLKKHSEISCKKESFIAF
EDKKSHVIVTSNVAKYATFKFFNSVFDVSKIEINKKHPLLKQHFIGWFVKTSNPIFNVNC
ATFMDFSIPQKGNTRFMYVLPFSPTEALVEYTLFSANLLQTQEYEVAINDYLKEKGATSF
EIVAKEQGNIPMTIFPFWKNNSRNVLHIGTAGGWTKASTGYTFRNTIKQSEKLVGLLKKP
TIDFRKFHQKNRFLFYDKIFVSVLYKDNDLGKKIFSNMFLRIKPKKIFNFLDETSNLKTE
LEIILACPKIPFIKALLGFK
>KACEBFPM_00757 HTH-type transcriptional repressor CarH
MNAVKTIFSIKDLENLSGIKAHTIRIWEKRYSILEPMRTDTNIRLYDIHNLQKLLNITLL
HDYGYKISRISKLSPDKIPALVREIVSEKSAKSHAINAFKMAMMNFDQTLFINTYNNLLL
EKSFRAVFYEVFIPLMNEIGLLWQSNTITIAHEHFITHLIKQKLVTNIEKIQVLEPTRTD
TIFVLYLPSNEIHELGLMYLNYEFILSGYKTIYLGESVPIESLKDIQRYFDKITFVSYMT
VQPTKDEINNYIEKIKTEILGENSSECWFIGKMTTEINPEILNEKTKIFQSIASIIEEI
>KACEBFPM_00758 Dehydrosqualene desaturase
MRKNIAILGSGFSSLAAACYLAQAGNDVTIYEKNSTIGGRARQFEKEGFTFDMGPSWYWM
PDVFEKFFAHFGKKPSDYYDLKKLSPGYQVFYDTNDFITISDNLKEIVDTFENIETGSGS
KLQKFIQKAQSNYDIAIKDLVYRPGESPLELVTIETAKKIDQFFSTISKDVRKQFKNKKL
IQILEFPVLFLGAKPSKTPSFYSFMNFADFGLGTWQPTNGFYDVANAMATLAKQLGVTII
TDANVEKIIVDHKTTKGILVNKKIIYTDIVLSGADYHHTETLLEPEYRQYSEKYWDKKTF
APSSLLFYVGFDKKLENVIHHNLFFDVDFDLHSEEIYDNPKWPTEPLFYANFTSKTNHTT
APEGCENGFFLIPIAPGIEDTQELRDTYFEKIISRFEKVTNQEVKKNIIFKESFCVNDFV
KEYNSYKGNAYGMANTLLQTAFLRPNLKSKKVKNLYFTGQLTVPGPGVPPALISGKLVAD
LIKKYSF
>KACEBFPM_00759 15-cis-phytoene synthase
MKSLFDTVSNDCSKIVTQSYSTSFSSAVKMLSSSIRQDIYNVYGFVRLADEIVDSFHDYD
KEALFNTFEIDLKNALEQKISLNPILNAFQHTVHKHKISYDLIDAFMNSMKLDLAKKEYK
TKDEYDQYIYGSADVVGLMCLTVFVKGNVELYESLKNAAMRLGSAFQKVNFLRDLKADFE
DLNRTYFPNTDLSQLNETSKQEIIKEIEADFKAGYEGITHLPIEAKFGVYTAYIYYKKLL
SKLKKTPSREIKNTRIRVSDYQKISLLANCYVKYRLNLL
>KACEBFPM_00760 hypothetical protein
MWLYILVFVFTFFFMEFMAWFSHKYIMHGFLWNLHADHHKKDHNSWFERNDAFFIFYAIV
SIIFFLLWKNNILEVGLAIGLGIFSYGLTYFLVHDIFIHQRFKFFRTANNKYAKALRRAH
KMHHKHIGKGDGECFGMLFVPFKYFK
>KACEBFPM_00761 Thioredoxin reductase
MSDTIEKIKCLIIGSGPAGYTAAIYAARANMNPVLYQGIQPGGQLTTTNEVENFPGNPEG
ITGPEMMIGLEAQAKRFGTDIRVGWATKVDFSGDIHKVWINDEKELHCETVIISTGATAK
YLGIDSEQHYLKTGGGVSACAICDGFFYRNQEVVIVGAGDSACEEAHYLSKMCKKVTMLV
RSEQFRASKIMEARVRKTENITILMNHDTVEVLGDGQVVTAVKAKNKTTGAIFDIEATGF
FVAIGHKPNTDIFKDYITLDETGYIVNTPGSSKTNVAGIFVSGDAADHVYRQAITAAGTG
CMAALDAERYLASKE
>KACEBFPM_00762 Replicative DNA helicase
MENFKNVNPVRVDKTAIINLEKGKLPPQVLDLEEAVLGAMMIDKKGVDEVIDILQADAFY
KDGHKYIFEAIVTLFNDSQPVDLLTVSAQLRKMSKLDLAGGDFYLIQLTQKISSSAHIEF
HSRIILQKYIQRSLIKISSEIIEESYDESTDVFDLLDKAESKLYEVTQGNIKRSSETAQS
LVIQAKKRIEEIAGKEGLSGIATGFEKLDKVTSGWQPSDLIIIAARPGMGKTAFVLSMAR
NVAIDFGHAVALFSLEMSSVQLITRLISSETGLSSEKLRTGKLEKHEWEQLSVKVKDLEK
APLYIDDSPSLSIFDLRAKARRLKSQYDIKIIIVDYLQLMTAGGGKGPGNREQEISTISR
NLKALAKELEVPVIALSQLSRAVETRGSSKRPLLSDLRESGAIEQDADIVSFIYRPEYYK
IDEWDDDEHSPTQGQAEFIIAKHRNGSLENVRLKFIGNLGKFDNLEDYSGGDDYLPSGMN
LGQDDNPFQTKNLPSANEAFGSSSNNFDDDSEVPF
>KACEBFPM_00763 Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha
MEYLDFELPIKELLEQLDKCQIIGTESNVDVTETCKQISQKLEDTKKDIYGNLTAWQRVQ
LSRHPSRPYTLEHITNLTKGTFLELFGDRNFKDDKAMIGGLGKIGDQSFMFVGQQKGINT
KMRQFRNFGMPNPEGYRKALRLMKMAEKFNIPVVTLIDTPGAFPGIEAEERGQGEAIARN
ILEMARLKVPIICVIIGEGASGGALGIGVGDRVLMMENTWYSVISPESCSSILWKSWEYK
EQAAEALKLTSADMKRQKIVDDIIPEPLGGAHYDKATAFKTVEEYILKAFNELKDLSTTD
LVAQRMDKYSKMGEYNE
>KACEBFPM_00764 hypothetical protein
MQKDKNIQSYLKLHLIVFIWGFTAILGKLISLEALPLVWYRMAFALAFIILFIAFKKKPL
KLPKKTIVGLLFAGLIIALHWLTFFKAIKESNISVTLACLATGAFFASILEPIFYKRKVI
FYEVLFGLIVIIGLYIIFQVEGNYVYGIILALSSAFLSASFSVINGKYAIKYDATIISFY
EILGGLLSLSIFMLFNQNFTTSFFQLSTNDLLWLLVLSSFCTAYAFIASIGVMKYLSPYT
VMLTINLEPIYGIILALIIFNDKEKMSTQFYIGALIILSTVILNGVFKNRKK
>KACEBFPM_00765 Lipopolysaccharide export system permease protein LptG
MLTILDKYILKRYLATFLVMLLLFIPIGITVDIAEKINKILENKVPIDKVLSYYVDFIIY
FTNFLFPIFLFLSIIWFTAKLANNTEIIAILSSGISFSRFLRPYIIGATIVSFFALLMGF
FLAPKASEGFKNFRYLYLIGNGKDEMRETNDVYRQISETEFIYVSNFDIEAKTAYNFVFE
KFNAEKLVYKISASSIQWNSKEKTYTLLNYSKRTVGALNDKIETENSKPMKFNFDLEDLT
PVVYIAETLSFTDLNKFIEKEKKRGSANINTYLVVKYRKYSIPISAFILTIIAVAVSSMK
RRGGMGINLAIGIAIAFSYIFLDKIFATLAEKSSIEPIIAIWIPNFIFGILAFYLLRNAK
R
>KACEBFPM_00766 Queuine tRNA-ribosyltransferase
MKFDLLKKDPQTKARAGSITTDHGVIETPIFMPVGTVASVKGVHQRELKEEINPDIILGN
TYHLYLRPKTDILEKAGGLHKFMNWDRNILTDSGGYQVYSLSANRKIKEEGVKFKSHIDG
SYHFFTPENVMEIQRTIGADIIMAFDECTPYPCDYRYAQRSMKMTHRWLDRCINHLDKLP
FKYGYEQTFFPIVQGSCYKDLREQSAEYIANAGAQGNAIGGLSVGEPAEEMYAMTEIVTA
ILPEDKPRYLMGVGTPINILENIALGIDMFDCVMPTRNARNGMLFTANGTINIKNKKWEA
DFSPVDEMGITFVDTEYTKAYLRHLFAANEYLGKQIATIHNLGFYMWLVREARKHIIAGD
FREWKDMMVKNMSQRL
>KACEBFPM_00767 hypothetical protein
MKLKIIIVVFITNLAFGQKVCNEFYNKKFTKCELVADIEFIKEKILNAHINPFTEISKEE
FEKSIIQVENSLEEGMTQKDFYFLAKPIFVKLNDEHSALNDFCITDSIKNSLTFFPLRFK
YENQKVILTENYSGKSIANGDELLSINEFSIQSIIDGCSNQVFGVSEERKTIAIEKLWFY
LSKFCFFITDDFNLKFKSGKATLIKGQNWEVLSKNIQKTKKTDTDISILKYEKIKNFGYL
TINTFNDKELKYDKWELKIDSVFSKIKKDKVQKLIIDVSNNSGGNSEIGNLLIDYFSDKK
YKDYGGKWKKSKEYSDLMKNNNSEYAPYEKLQNGEILPFVSDENKPLKNKNRFNGKTYVL
VGENTFSSAMMFAVMVLDNKLATVIGKTPSKGHPNHFGELIGFTTPNTDLYFRFGVKEWI
RPSGKTEHNKLIPNIAIDLYNMSKEDIIKLLK
>KACEBFPM_00768 hypothetical protein
MGQIVQYLPYILIPLVFYFFMIKPQNDKIKKEKSFEASLKVGDKIVTKSGLHGKVAELGQ
QTIVIETMSGKLKMERSAISNEMSEALHKK
>KACEBFPM_00769 hypothetical protein
MTKNIINFVAVMSLLSTISCKEKADNSSIVLDANNMVVAQYQSGNTVVVPKKNMKSGEYS
KIEIENSDFDFGEIMQGDKVSHIFKFKNVGKGDLVILEAKASCGCTVPEWTKTPIKSGES
GEVNVIFNSQGKIGQQQKTVTLTTNTEAGNEIIHFKANINPKTGENPAKTK
>KACEBFPM_00770 N utilization substance protein B 
MWSERISFAPLIFKCSYKVLNRRHIRVKVMQTLYSMRQAQSDNLEKEEKFLFQSIENVQD
LYLIMVSILVEIQAKEDTLIEISRNKHLVTKEEKNPNLKFVNNKILTILAQSRSLLTALE
DRRINNWKLNDDYILILLKDIKESTLYSDYMRSTKSDFDEDRDFIASVFADIIAPNIKLY
EYLEDQKLTWIDDIPIINTLILKQLNAIKNTENGNFYVPKLYKDTEDKEFVGNLFRKVAL
NDQQLAKEFADKTPNWEADRIAEIDTIILKMAICEFLKFPSIPVKVTINEYLELAKEYST
PKSSIFINGILDNLVKEFESNDKLKKTGRGLM
>KACEBFPM_00771 Leucine dehydrogenase
MITESVKANELHKIDPVFGQLSFDNHEQIVFCNDKDTGLKAIIGIHNTVLGPALGGTRMW
KYANEWEALNDVLRLSRGMTFKSAITGLNLGGGKAVIIGDSKIDKTPEMIAKFGEYVNSL
SGKYITAEDVGTTTGDMDLIRLQTPHVTGVSIEKGGSGNPSPVTAYGVYMGMKAAAKYKF
GSDVLEGKKVLVQGIGHVGETLVDYLTKEGAKVIISDINQARLEEIGHKYGAQIYSGEDL
YGADVDIYAPCALGATINDDTIYKIKAKVIAGAANNQLANENIHGAILQDKGIVYAPDFL
INAGGIINVYAEIAGYDMAESMRRTENIYNTTLEIFDYADANKITTHQAALRIAQNRIDL
RKKEIQK
>KACEBFPM_00772 putative multidrug resistance ABC transporter ATP-binding/permease protein YheI
MKELRYLNPYFLKYKYHFLLGILFTIAARIFSLFTPKLIGSSITAIEDHLKLNKSNPLIV
REILLENILLILGTTILAAILTFFMRQMLIVMSRHIEFDLKNEIFKQYEHLTQNFYKQNR
TGDLMNRISEDVSRVRMYVGPAVMYTINTVISFTIIIIYMCQISPLLTLYTLLPLPILAY
LIFRLSTKINSRSTIFQENLSALSSFSQEIFSGIRVIKAYSIETVKQEEFDILTQQSNEK
SLKLAKTQALFSPLILLLIGICNLLVVFLGGMMYISGSIKSIGDIATFILDVNMLVWPVA
TIGWVSSLVQEAAASQKRINEFLKIEPEIKNNNFAPMTFNGNIKFDKVSLIYQDTNIKAL
DNISFSVNKGETLAIIGRTGSGKSTILSLISRLYDPTLGNITIDGVQLPEANLKDLRNSI
GVVPQDAFLFSDTIKNNIKFGKENASDEEVITAAKNAVVHNNIIGFKDKYKTILGERGIT
LSGGQKQRVSIARAIISNPKILLLDDCLSAVDTETEETILNNLQIICKDKTTIIVSHRVS
SAKNADKIIIIDGGKIVQEGTHNQLVNQDGYYKALYLKQIAEKEML
>KACEBFPM_00773 hypothetical protein
MNRNENDMLEKEEIFSKVLRAGRRTYFFDVRSTKADDYYITITESKKFTEEDGSFHFKKH
KIYLYKEDFTAFAEILEEMTSYVLNNKGEEVISERHQKDFKKEYLSDKSSGEIPSTESFT
NIDFDDI
>KACEBFPM_00774 putative chaperone CsaA
MNTITWSDFEKVEMRIGTIIAVNDFPEARKPAYQLMIDFGIEVGVKKTSAQITKCYTKDY
LLNKQIVAVVNFPAKQIGKFMSECLVLGSIGSDGHIVLLSSDSRVENGLKIG
>KACEBFPM_00775 hypothetical protein
MHNRGLIKFIAIIFALVSIYQLSFTFVANKVKSDAKAFAAGKPENEVKYLDSIGKENVFN
LGFTNFTYDEVKTKQINKGLDLEGGINVILQISVKDVLKQLANNSTNPVFVKSLADAKNN
QKGNQTYLNAFYDAFDANSNGTTLLSSPDIFGNRNLAEEIKMQMSDSDAKKIINKKVEES
IESAFRVLRERIDKFGVTQPNIVKLGTSGRILVELPGAKDVDRAKKLLSSTAQLEFWETL
KVDEIGSYLGSVNEALKKTEKATVAVDTAKSKTSSKIEGLLVDKTTKDSTATKKADAGPF
FNKIVSGGQQGSPVLAYVKSKDTAVINAYFKRSDIKALLPSNLVDTRFVWGKPSAKTGDV
VELYALKGNRTNTPPMSGSVLLDASNSYDQTGKPSVTMQMSGKGAKIWEELTGRAYTQKS
NIAIVLDNIVYSAPGVSSGPISGGRSEISGSFTIDETKDLANVLRAGKLPAAAEIVQSEV
VGPSLGQKAIDSGLNSSIVGLLLVSLWMLIYYGKSAWYANIALGVNLLFLFGVMASFGFV
LTLPGIAGIVLTMGTAVDANIIIYERAKEELRAGLSLDEAVKKSFSWTGAMRSIIDANVT
HILTGSILYIFGTGPIKGFALTLLIGIITSLFTSIFITRIFLDRAVAKGTKLEFANSWSK
DWFTGFNFDFLKIKKGTYIFSSCVIIVSLVSIFFVNGLDQGVDFVGGRTFQVKFEKPVEP
TAIAAELSKKDVFESAEAKIFGTEDQLKITTKYKIKEEGVSVDTEVNKKLYNALKPHFSS
SMTYEKFINSYEGKEFGVLQASKISPAISADIKTNSFWAVLGAMLVVGLYLVLSFRKLGY
SLGAIAAVLHDVVFVLGIYSLCYKFMPFHMEMDQHFIAAILTVIGYSMNDTVIVFDRIRE
FLAGNRKGNFNQIVNDSINTTLSRTINTSLTMLLVLLIMFIFGGESIRGFIFAMLVGIAV
GTYSSLFIATPVLVDTMSAKDKEEIDTRHANANV
>KACEBFPM_00776 Malate dehydrogenase
MKVTIVGAGNVGASCADVISYRGIASEVVLLDIKEGFAEGKAMDIMQCATNTGFNTQLSG
VTNDYTKTANSDVVVITSGIPRKPGMTREELIGINAGIVKSVVENVLVYSPNTIVVVVSN
PMDTMTYLALKATGLPKNRIIGMGGALDSSRFRYYLSKALDKPANDVSAMVIGGHGDTTM
IPLTRLASYNGIPVSEFLSQEQLEKVAADTMVGGATLTGLLGTSAWYAPGASVAYLVDSI
LNNQKKMIACSVMLDGEYGQSDICIGVPCIIGKNGIEEIVTINLNDNEKALFAKSAEAVR
NMNADLKSVLA
>KACEBFPM_00777 DNA gyrase subunit B
MSDEIKKDNYSADSIQALEGMEHVRMRPSMYIGDVGVRGLHHLVYEVVDNSIDEAMGGHC
DTIRVDINEDGSISVEDNGRGIPVGIHKKEGVSALEVVMTKIGAGGKFDKDSYKVSGGLH
GVGVSVVNALSNHLRATVHSSDGKIYEQEYEKGKALYPVKQIGETTKRGTIVTFYPDPSI
FTQTIEYSYDTLSARMRELSFLNKGITITFTDKREKDKDGNFVSEIFHSTEGLKEYIRYL
DGNREPIIAHVISMDNDKGEIPVEVALIYNTSYTENIFSYVNNINTHEGGTHLQGFRTGL
TRSLKKYADSSGMLDKLKFEISGDDFREGLTAIISVKVAEPQFEGQTKTKLGNREVVSPV
SQAVGDMIENYLEENPNDARIIVQKVILAAQARHAAKKAREMVQRKTVMGGGGLPGKLSD
CSEQDPAKCEVFLVEGDSAGGTAKQGRDRAFQAILPLRGKILNVEKAMHHKVFENEEIRN
IFTALGVTIGTAEDSKALNLEKLRYHKVVIMCDADIDGSHISTLILTFFFRFMKELIEQG
HIYIATPPLYLVKKGNKKEYAWNEVQRDQANERMGGSATIQRYKGLGEMNAEQLWDTTLN
PEFRTLRQVNIDSLAEADRVFSMLMGDEVPPRREFIEKNAVYANIDA
>KACEBFPM_00778 Asparagine synthetase B [glutamine-hydrolyzing]
MCGILAIIGKGKDQELVKTSSKRMSHRGPDESDLQVTKNGHILSHERLSIIDLHSGRQPI
QGSSSAWMIHNGEIYNHQELRDGVLKHHTFRTKSDSEVIVHLYEEFGYDFLNVLDGDFAF
VVINGDDYIAGRDPMGVKPLYYGLDERGRMYFASEMKPIADQCKTFFTFPPGHYYTPKTG
FVKYYKPEYCDYKKATNTLDLKLIRDTLTEATRKRLMSDVPIGVLLSGGLDSSLTSSIAS
RLLKEKGKTLHSFSIGLDENAPDAKAARKVAEFLGTKHHEVHFTIEQGIEILDKLIWHLE
TYDVTSVRASTPMYFLSKAITDMGIKVVLSGEGADEIFGGYLYFRNAPTTEDFQKETIER
VQKLFTADLLRADKSTMAHGLEARVPFLDKAFLDVAMLIKPEEKQPKTYGGKEKYILRKA
FDTPDNPYLPDEVLWRQKEQFSDGVGYNWIDQLIEYCASKVTDKQLELAKELYSYNTPTT
KEAYYYRTIFHKYYPQQSAAETVRKWIPKWQENQDPSGRANAAHVQADLEIAKASILH
>KACEBFPM_00779 hypothetical protein
MVVKQEIHQQYLQLVQDKIDVFQDMISSLTEDSKNDAKGSAGDKHETALSMMHIEQEKLT
HKLKESIAQKAILDKIDASQIHHKVAVGSLVITNNLTVYISVALPKITIQNKNIFAISPQ
SPLAIQLMGKGVGYEFEVNLIKYIIQEIF
>KACEBFPM_00780 Aspartate-semialdehyde dehydrogenase
MKIAVVGATGMVGEVMLQVLAERNFPVTELIPVASERSVGKEIEFKGTKYKVVGMQTAVD
MKADIALFSAGGETSLEWAPKFAAAGTTVIDNSSAWRMDPTKKLVVPEINASILTKEDKI
IPNANCSTIQLVMVLAPLHKKYKIKRVIVSTYQSITGTGVKAVQQLENEYAGISGEMAYK
YPIHKNAIPQCDSFEENGYTKEEMKLVRETQKILDDKTIAVTATAVRVPIVGGHSEAVNV
EFANDFDVNEVRQLLHNTPGVVVQDNNDTYTYPMPMYAQGKDAVFVGRIRRDESQPNSIN
MWIVADNLRKGAATNTVQIAEYLITNNLV
>KACEBFPM_00781 hypothetical protein
MINFVKFKRIFFFALLHLHGMNKKFVVINSLLAMVVLFSILFQSVHSYEHLAKQISQKHC
HHKPTSGSQITHQHHNFDHCFICNFTLGGFVCSGVSCFQFIKKIIFTRYSFLYSREITNF
FKGSLFALRAPPSFMF
>KACEBFPM_00782 putative TonB-dependent receptor
MKSFLVALLLGFAIFCNAQNKITGAITNSENKILETVLVSIPELNKETISDSNGNFLFLD
LPKGKFKISFSLVGYDEKLVSVFINKAEINLNIRLESSSNHLEEVKIAATIFNKIQSQNV
MKIEHKSIRELQQKGAATLMEGLASIAGVSQVSTGTSIGKPVIRGLSGNRVLVYTQGVRL
ENQQFGEEHGLGLNESGIESVEVIKGPASLLYGSDALGGVLYFNPEKFAKPNSYLADFSQ
KYFSNTNGSNTSFGLKSSSENWKFLIRGAYNNHGDYKMPSDSLVTNTRFEEADVKTALGF
SNSKFSSVLRYNLNHLNLGIPEQIGLQTTKRDPDYPRQGVVNHILSLHNNFYFRNSKFDA
DFGYISNSRKEFADSTIPVLDMNLNTLNYDLKYYLPNIGKLEAIIGVQGMSQSNKNLGSE
LLIPDAKTNDIGALLTTNYEWKSNVIQAGFRYDTRKINTESHGIIGDEGYFEAISKKYTS
FNASVGYKTKLTDNLSFRLNVASGFRSPNLAELTSNGVHEGSNRYEIGNSNLKNEQNIQT
DLNLEYGNSHFEFFANGFYNNISNYIFIAPNGSIMADNDVYDYVQANAKLYGGEFGVHFH
PHPLDWLHITSSFETVTGLKENGEYLPLIPANKWNNNIRTEFNLNNWIKKGFATLNIESV
FKQNNNSTFETKSKDYTLVNVGLGGNININKLKFDISINANNMLNKSYISHLSRLKTDRI
SNIGRNIVLGVSFFL
>KACEBFPM_00783 hypothetical protein
MKNKIIIILLITFQLSFAQKKDENIGTEVVNVVKPYTPTISDAFKVKEIPSLNDNETSKK
EEVKYQIFSFPVASTFTPSKGKAAGVEKAKQEKLFSNYAVLGFGNYGTVNTELFVSHQLD
NYQYVAGKIQHQSSQGGIKNVALNDKFSESSINVMYGYNRQQTNFKLDLGYKHEGYNWYG
LPLQNPNFYNIRLDTINPSHQYNTISLGSELAISTGFFEKANLNFMAFSDNYGSKENRFI
IKPIFNFDFGNTAIKAKFNLDYLTTSFDTSYLLQYPVVGVNTNIKKSNLIFSVNPSYQLL
KDDLSIELGAEVTFLSRPKNVYLGINNESKSSLFIYPKVKLSYKVVSDLMIAFAGAEGGL
NQNSYANFVSQNKFLSPTLFIEPTDKQYDIYAGLRGKLASTLSYNVKVSYISSKNQTLFK
ANPYLLAPSQNYSYGNSFDVAYDNIKNLSFFGELKTDVNKNISLGLNVELNDYKTNFEAQ
PWNLPAIKASFTTNFNVAKKWYAGTQLFYVGERKDAFTNYKSFAFSDSVRTLAAFFDLNA
HVGYKYNERLTAFLKGNNLANQNYNRWLNYAVQGAQVIIGASYKFDF
>KACEBFPM_00784 Lipopolysaccharide assembly protein B
MQKYLLSLFVFLSFVFTSMFAQQSAIYTNDLAAYNKALSLFNDKQYQSAQILFDKVKQEN
SNPELEADCTYYSANCAIRLNQNNADEKMQSFVKNYPTSTKQNLAYTEVATYYFEQGKYP
QALEWFDKVDESSLTEDELDKYNFYKGYSFFNSSKKKEATQYFNKVVNSQEYGSQAKYYL
GFLAYEGDDYKEATKYFDQVSGEEKYKEKLSYFQADMNFKLGKFDKAIQLGQAAMNNSND
FEKSELNKIIGESYFNLKEYNQAIPFLKEYKGKKGKWNNTDYYQLGYAFYKQNDFENAIN
QFNKIIDGKDFVAQNAYYHLGESYLKTDKKPQALNAFKNASEMTFDIKIQEDAALNYARL
SYDIGNSYQSVPDVLNGFMTKYPSNPNKPEIENLLINSYITSKNYKEALNLLEKNKSFEN
KTAYQKVAFYRGLELFTDGSYKEALAIFKKSIAEQKDPKFSARGTFWKAETEYILNDFTN
ALLSFKQFLGYPEAKETVEFANVNYNMAYSHFKLKEYEQAGNFFQKYIEVSKDDKTRLTD
AYLRLADSKFVTTRYAAALEAYDKAIILKTFDADYAAFQKAICYGFMGKNDKKIAGFNQF
LKTYPNSQYRDDALFELANTYTTENETASSIKTYDQLIAENSNGSYVSKALLRQGLIYYN
ADKDEQALTKFKKVVANFPKSEEALEAVKTARLIYVDNGKVDEYATWVKSLDFVNISDSD
LDNDSWEAAEKQYLQGNNKQAITNLSSYIKTFPNGIRILKANFYLAESYFKEESANSIPY
YEYTISKARNEYTEQSLSRLCQIFLRNTNYTKAIPVLLRLESEADFPQNKTYAQANLMKS
YYTEKDYANSVIYAEKVLENPKTEDKIKSDAQIIVARSAIKVGNEAKAKVAYAKLQKIAK
GELAAEALFYEAYFKNAASQFEESNKVVQKLAKDYSGYKYFGAKGLVVMAKNFYGLKDSF
QATYILESVIKNFTDYADVVLEAKKELDLIKFEEAKTNSSITK
>KACEBFPM_00785 Cell division ATP-binding protein FtsE
MSKTILSLQDVNIYQSGNKIISDINLSVNPGEFIYIIGKTGSGKSSFMKTLYGDLPLTDG
QGTIVDYDLNGLIDHDIPYLRRKIGMVFQDFKLLPDRTVANNLLFVLKATGWTDVQEMDH
KIEEVLQKVGMFSMANKMPHQLSGGEQQCVAIARALLNDPELILADEPTGNLDPQTSGEI
LELLKKINAQGKTIIMATHDYALLMKYPSKTLKCEDGTIFEVVQRAV
>KACEBFPM_00786 FAD-dependent urate hydroxylase
MKKEENLATNWSICTECQGRGKKRKRITKKAQLSYQLAFNQFEKIKNEQSPPVSPKGHLF
SCLNCNGSGLVSSLNPPTANTENYPHIAIIGAGIAGVALAIACLHRSIPFTLYERDTSFD
VRSQGYGLTLQQASKAIEGLGIFSLKEAVVSTKHVVHTTEGKVIGEWGMRKWMRSETKKP
SKRTNMHIARQSLRLALLEQLGKHDVVQWGHQLVGFKESDTNQSINLTFQVNGQLMSTKA
DLLVGADGIRSSVRKLLIDEDVLPLRYLGCIVILGICSLEALKGIDSSLLDSATVFQTAN
GNERIYMMPYSSKSVMWQLSFPMLEAEAKVLSAQGAQALKEEACRRTQWHDPIPQILLAT
LEAHISGYPVYDRELLEPKFMKKWGKATLIGDAAHPMSPFKGQGANQALLDALALARGVS
MGCKPLSQWQKLGIRKSVLTEFELEMLQRSASKVKDSANAAKFLHSEIVLQEGNEPRGSH
LKKKMT
>KACEBFPM_00787 Thiosulfate sulfurtransferase GlpE
MNLSQEAWWAKAQEDENAVILDVRTEDECNEGIIPNAITIDIYKGQGFIYKIEELDKSKN
YYVYCKAGGRSGQACNIMNELGFKTTYNLLGGMIEWNGPVVAI
>KACEBFPM_00788 hypothetical protein
MEIKKNYEFANFGIRLGALLIDFVLLIVIMSYIIPKVIRLLKNNITDLSFEYFLGLIFAY
LIGVPILGLIYRSVFESSKFQGTPGKIITGIKVVDHNFERLKFKQALARNFMKIFSALVF
YIGYLIALGNQKCLTWHDKFAKTYVIREIKGIIIK
>KACEBFPM_00789 hypothetical protein
MKQIYNSDKPIFAKAQDRFNRNKFSNRIADTITKRIDNDGLVIGLYGIWGEGKSSVLNMI
EEELNINDEILIVKFNPWRFKDEEALILNFLKNISEVLNRELNTKTEKFVDFLKKYGSVT
SILNFDLSKLSENFSDTQLEDLKNRVNDFLKESDKKIVVIIDDIDRLDKQELFSLFKLIK
LTGDFSKTYYILSFDDEMVASAIGERFAEGNRNSGHNFLEKIIQVPLRIPQALSKDLLNY
TFELLNNILSENEIELGTNEEQNVGYLISQNILLKIKTPRLAIRYSNSLSFLIPLLKGEV
NISDLILFEGVKIFYPKHYEFIKDSPEYFIESYNNKFSNGKDNSKVEEFKSKIEELNSKL
TKNEKQAISNLLKKLFPYIKEAIENYSFSNAGQDWAKEKRIASSKYFNRYFIYSVPKDDI
SDVYFDSYMNSLDSKTFEDVLTETNEILKNVDVSEYLNKISFYEDNLDWNSRQIISKIVC
QNENKFEGMKGGVFMFGFNNPKSQAAITISRILLKHNNYPEKLEFSKYLMTNEIPFEFSK
EINRWLRVGNTEDEKVIKSSDMNLMDNILLERALQDCSTNKTNLFEKYENNIFSLLEIWY
EKNSQELREYIIELINLNSKIVSKIIYALTSTIYSSSNPNPYKVDFKIESFELLKKYCDI
DNFCNILIKEYSIEIGNEEVIFFDNNEGQDIINSMRQFIHWYNLENKSTIVELDEN
>KACEBFPM_00790 hypothetical protein
MNPLLNQNLFLIKEKVGMFKASNSYDIFDPNSNKHIMTSKEPNLGVFTKIFRFTKYKKHT
PFNVLVTTTEGKPILNMKRGVAIFRSDIEVFDEKAQLIGYFKQKFWSFGGKFEIVDKNQK
PVCTLQGKWTGWDFKFNKDNKELGAVSKKWAGIGKEFFTSADNYVLSINEIVPQDSIERQ
LIFAAVMVIDMVLKE
>KACEBFPM_00791 hypothetical protein
MQKFQLSEYLKISGIGAASGIVFTNHSLYIISDNAGYLYQYDLKSDKLTKHQIIKNPSQN
IPKKEKPDFESITLKENKLYIFGSGSTQNRNKNIIFDIKKQQIQENDLSKTYQNIKNTIS
LSNEDLNIEGALFYNEKLYLLQRGNSANAKNGIIIIGNTVHFKPISLPKIKHTETSFTDA
TLVHNKIYFLAAAEDTLSTYNDGEILGTIIGCIDLKTFKIDFTTQISNTHKFEGITLFKN
SKSHLEFLLCEDNDTEVLQTKIYKLTISKK
>KACEBFPM_00792 hypothetical protein
MNWINPDDFKVVDKIELSKISTELKIDADGDEKKEALSKVQIKLSKKQDAMYAHNKYSFL
ICLQGMDTSGKDSLIREVFKEFNPRGVVVHSFKTPNSTELEHDYLWRHYLALPEKGKFAV
FNRTHYENVLVTRVHPEYIMYENLPGIEKVEDIKPEFWENRFEQINNFEKHIAQNGMVVL
KFYFHMSKEEQRKRLLKRLENAEDNWKFSPGDMKERERWDDYMQYYEEAINKTSSQMAPW
FVIPADDKDMARYIVAKIIWEEMQKLTDIKEPQLDEKVKANLEFYKEQLQ
>KACEBFPM_00793 hypothetical protein
MKKIILPLFVFVSLVSCNKDSESISASTPVEGVVLANHSVTPTLLKKQAGFENLQLFSLI
GSDDVLAGSPNFVFGGSADGSGLLRNADGTFTFLVNHEDNFSVSRITLDKSFKPTKGEYL
LNSNGGTWRLCGATMATPAEHGFGPLYLTCGESGEESRTHALDPFGTIGLAGISKELPSL
GRLSAENALPLNKNAFAGKTVIVIGDDDSGTSGGQLFMYVSNAVGDLSNGSLYMMKRNDD
NQREKDMVTNQTYNVSFVKIDNHTTLTGAQINASVNTLKAIKFGRVEDLDYRKGGQAADR
EIYFNVTGQNLSGNNADASRTKYGRVYKLNLDANNPLAGTLEVILDGDDRSGIAGKFQNP
DNICVTKNYAYIEEDANDYGDETHDGYIYQYNFATKQLKVVVELDHHRTATDAAKYNVIT
PGTPTPDRKGSWEYGALIDVSEQLGIEDTFMLSVQSHSWRGARYKGVDGGTNRPNEDQAS
QIVVLKGLAR
>KACEBFPM_00794 Cytochrome c551 peroxidase
MKKCFLLIIIFSVFSCKNQPKHEKINEIFKTDIGLLIQRVAILENAIQSDATLAQIQTHF
LEAHQAYKQVEMISEYYFPVVSKAINGPALSEFEEDEGKTVPPEGFQVIEEFIFPKYDKK
SKKDLLKEIGILSANLKRLDTVSQTNELTDSHIFDAMRLEIFRTITLGITGFDSPIVQNS
IPEALSSIKSIEKYYKVYTKDSDDATFKTVLKTIEEAKSYLKTHHNFNAFDRGFFITKIA
NPLSIAICKTQNALKIPVIKEMRGLRTTAQTLFEENAFDAEAFSGFPDYQTTPEKIELGK
LLFNDPILSSNNTRSCASCHHSESAFTDGLEKATSFDGKSVVKRNTPTLSNIAFQRVFFS
DSRVNYLEDQALAVIANKNEMHGSLAESILRLKKEANYKTRFIQAFPKKEIDEFAVKNAL
ASYIRSLSNYDSKFDEYMRGNETLTNDEKEGFNLFAGKAKCATCHFIPLTNGTVPPHFEK
SESEVLGVPNNYKKIDEDLGKFELTKAEIHKYSFKTPTLRNIALTAPYMHNGVYKTLGEV
INFYNDGGGKGLGFNLSNQTLPEDKLNLTAIEKKQLIAFIKTLTDKNKINIKNQYQKSMK
I
>KACEBFPM_00795 hypothetical protein
MTSIFSFWWIILIVLSVLFYKFVLRVFFGMVIVPEDKIGLVTKKFVLFGADKSLPDSRII
ATKGEAGFQAQTLAPGLYWGMWIWQYSVDMTSFTIIPEGKIGLILSKDGKEIPTGRILAR
KVPSDNFQDAKSFLDNGGQKGRQTAFITTGSYRINTFLFEIVIADQIKIFENMIGIVTAL
DGEPIPLGQIAGTNVVGHNNFQDFDEFLTKGGNRGLQPQVMLAGSYYINTWAVQIEQNPM
TDVPIGYVGVVISYIGEDGQDVTGDTFKHGNIVSKGQRGVWMEPLGPGKYALNKYTTKLE
PVPTTNLVLNWADARSESHNLDQNLSTITVRSKDGFPFNLDVSQIIHVPANEAPKVIARF
GSMNNLVSQVLEPTIGNYFRNSAQESDVISFLSTRKERQESAKNHIKVVLDEYNVNAVDT
LIGDIVPPESLMKTLTDRKIAEEEQKTYQTQKMAQEQRQGMEKETAIADMQKEIVKASQS
VEIAQRTADATVKKAEGDATSLKLNVNAEAEATKMRANAEAEATKARAGAQAEATKLTAS
AEAERISKTGLAEAEKIMAVGKSTAEAYQLQVTAMGEDNFAKYKITEEIGKGNIKVIPDV
LITGTNGSEGGISGLLGMKLMEMMDTNNVNQNPKKK
>KACEBFPM_00796 Cysteine desulfurase IscS
MKKVYLDNAATTQLRPEVIAEMTQVLMNDYGNPSSTHALGRHSKNLVELSRKIIAKNINC
TAQEIIFTSCGTEANNFIIQSCFRDLKIERIITSKIEHHAVLHTVQILQKSYNIRIDYVN
ILPSGEIDLVHLSDLLSIEGKTLVSLMHVNNEIGTILNLNRVAKICKQYQAYFHTDTVQS
IGKTAFNLQETPIDFLVASAHKFHGPKGVGFAFIRKGILLNPILLGGEQEKGMRAGTECV
HNIVGMAKALELSYLHLDEEEKYILKLKEYTISQLKSHFPEIKFNGNPEETFYNILNIIL
PFSEEKTSMILFNLDMKGIAVSRGSACQSGSVKPSHVLAEILSKEDLKKPSLRISFSHYN
TLEDIDYLIENLKTV
>KACEBFPM_00797 hypothetical protein
MKKILLLSDTHSHIDDVILKYVNLADQVWHAGDIGNLLVTDTLQKHKPLRAVFGNIDDAK
ARLEFPLHNRFMCEGVSVWITHIGGYPGKYSPNIIEELQQNTPQLFISGHSHILKVQFDK
KLNLLHMNPGACGKSGFHNVRTMLRFAIDGDKIKDLEIIELGSK
>KACEBFPM_00798 Oxygen sensor histidine kinase NreB
MNIKSLGNKIFLILVLFSNNIFCHDFDNNNNNIKDSVDFYVDKNNPAKAINFARKKTAQL
LYEKKYDEYCTAMLKKSSLYEQFNDKENALKVLFEALSVAEKHNLTEKKILIYKKTGDIN
NQIFEYTKSKKYLKIAEKTALKYNNKELLIQVYRGLFKVYSETSSDSTFYFLKKIEFYSK
GLNNLEIKYKNYSNFSQYYLSVSDNKLGKKYIDSAYSYALKIGDKKFISRSYGNLGYYYM
VVEKNYQKSKDIFIQLIKTFPKNSEPEILGNAYLNAAESFRGLGDFENAYLYQDMYIALQ
DDVVNGKISQSNQALELKYTTNKVENEFKEKEKKILEKQERNQKLLLLLASLFIFAGIIF
YFYYQNLLLKEKNKLKDIDAKLQYKIISATLDGQDQERNKISAILHDHVSAVLSSVGLHL
SAFESSLTKEQIADLKKTRSLLKNAHDKVRDLSHELVPPLLVKFGLQFALRDLCENNTNS
IIQFEFYSTLEKNQRYNAEFETKIFFIVSELLNNVMKHSKASKSKLLLEEIDGKLHITIE
DNGIGFNLKNISISNGFGITQIRARIKNMKGDLKIKSKIGQGTIIYIKIDDCK
>KACEBFPM_00799 hypothetical protein
MLISLLAFSVSTSLTSCMTTKTNIGAYRETQGTEYTYGKGKQIWLFWGLLPIGRTNVSTP
GDGNCQVVTRFNVSDAIISAITGGVVTTHTIKVKAKKKV
>KACEBFPM_00800 hypothetical protein
MKSNYFKVSILLLAAVFTISCSKDDSTGKTETTTTTSSVTTTNTLAKISVLTSSGVPKPN
YILMVFDQQFSTTAPLPPILKQVTTDANGLASFDLSTIVTNTTPKSYYFEAFVQNGNDFV
LKSIVRTEIKLAKGSSLTTAVIVN
>KACEBFPM_00801 hypothetical protein
MDLKDQLKLIADRTKHKENIQTEEATKNAFVMPFLQCLGYDVFNPLEVVPEFIADIGIKK
GEKIDYAIFKDGHPTILVECKDWRQNLNVHEGQLLRYFHVSKAKFGLLTNGIVYRFYSDL
VAPNKMDEKPFLEFNITEIKDNQIEELKKFHKANFDAESIVNTASEMKYMNELKHLLNKE
LTEPTPEFVKHFAKQVYPSVVTAKILEQFTELTKKSVQHYISDLITERLKTALSKEDEKN
KSENSAEILAEKNLEDISKINTTEEELEGFLIVKTILRQKIPATRVTYRDAQSYFAIFLD
DNNRKAVCRLYLNGGKKFIGTIDENKKETKNEIQLLDDIFNYSAELLNTIEQYEK
>KACEBFPM_00802 hypothetical protein
MNFKLLVLAFFTSIISFSQEINFKDLSTSSRGEFTSYISQDNATYKVGDRVKIGFPSSNK
TFAFITEGDGLLSPITNLTST
>KACEBFPM_00803 Oxygen regulatory protein NreC
MLKTNSDFEVVGFSLNGEGLVNKIARNKADILIMDINMPEKDGIQVLREMNELGFTCKVI
ILSSYDDSKLIKEVIKLGASGYLTKQCAGESIIDAIKTVAYGNQYFSDAIKDKIFNIYTG
NNNDHNQSLNPQDLISSITARELEILNLIGQERSGKYISNLLNISVNTVETHRKNLMKKL
NVKSSIGLVIFAVKHDLITN
>KACEBFPM_00804 hypothetical protein
MRVNIKKLIKKTHLWLGLATGIIVFIISITGCLFVFQKEISDIYYKDTFFIAPQSTKTIA
VTKLKEIADKTLSAPSTSITIYKEKNRAWEFMVYKSGDEDANTWFGTVKTYKSVFINPYT
GAVTGNINYKYNFFIIVEMLHYCLLINRQIGEPIVAYSTLIFVFMLITGIILWWPKNKAA
AKQRFWFRWKDTTKFKRKNYDVHNILGFYTMFITLILALTGMIFSIQWFQATVYVIASQS
ITPPEQIEKLSDTTLVSLKQPLDIALNSAKIKIPDANRYSLILPKKRSDVILISGIRGEE
AHYNSDKIQFDQYSGKQLHRSNYENKNNGEKLITMNYDIHTGIILGLPGKILAFLASLVA
ASLPITGFMIWWGRKKKKTSVK
>KACEBFPM_00805 hypothetical protein
MLSFFLVRLYTNPSVMSDPAEYGVLTIVMAYMVFLNVLLSYGFETAFFRFYNSEPNKNKV
IATATISIFWSSIAFLFLALLFRNAIAHYTKVDVQYITYSVWILVLDALVVIPFSKLRAN
QRPIKYAIIKIGNVIVNLTLNFFFLLYLPKITQSNPDSFFTTIYRENFQIGYVFIANIIA
SLLTFIALSPDYINIHWKIDKPLWKRMMHYGIPILIAGIAFAVNEHLDKILLGKLLPANI
AESEVGTYAACYKLGLFMVLFRTAYTMGIEPFFFSHASNENAPQTYATITKYFVIFGSFI
SLVVIVFADLLKIFLIPNPNYWQAMSVVPLIVFANFFLGIYTNLSVWYKLIDKTKIGAYI
SVVGAAVTLLLNFLLIPTMSYYGSAIATIAAYGSMMLISYTLGKNQYPIPYDKNRILGYL
TLSVAFSAISFYIPYIRENYFIKTGIIILYLYFIYFSEKETLIRILKRK
>KACEBFPM_00806 Deoxyuridine 5'-triphosphate nucleotidohydrolase
MQIKIINKSQHELPNYETIGSAGMDLRANIQAPITLQPLERTLVKTGLFIELPISYEAQV
RPRSGLAFKKGITVLNSPGTIDADYRGEIGIILVNLSHEAFVIENGERIAQLIIAKHERA
EWIQVQDLSETSRGEGGFGSTGVK
>KACEBFPM_00807 UTP--glucose-1-phosphate uridylyltransferase
MKIIVPMAGRGSRLRPHTLTIPKPLIPIAGKPIVHRLVEDIASVLNQSIDEVAFIIHESF
GKKVEEELIAIAQKLGAKGTIYYQNEALGTGHAIMCAKDSLSGPAVIAYADTLIRADFDL
DQTADAVIWVKQVAQPEAFGVINLNDKNQIVELVEKPKEFVSDLAVIGIYYFKDVAVLKN
ELQLVLDNNIIHGGEYQINDGIKQMMAKGMTFVPGKVDEWMDCGNKEVTVETNSRMLGFL
HNDGEHLVDYGVQLENSTIIPPCYIGEDVVLVNATVGPNVSLGKGTHVVNTTIKNSLVQT
HVHLKNAKLNNAMIGNHARFDGDFTSISIGDYSVLE
>KACEBFPM_00808 hypothetical protein
MNDRNLHKYLFYFSENKVDLSDDEKKKDIDNIFGWQVFIKNLEILEYESLIIENNDRNSY
SLTEKGKLTLTEIENEIDFENNKQNSELESLKTSTEVNKFLLRTKWLPHIVAILSFLFSI
YTYFGAQNDSKKLEERIHKLETFINKSKKQI
>KACEBFPM_00809 hypothetical protein
MITINNNVEYLKVDGTKIVDINESINELFTELLLQIEARI
>KACEBFPM_00810 hypothetical protein
MNTTNNLISIFGNIEDPRSDINQLHDLVNILLVGIILVICGAQTWKQMLDFAYSKEDFLR
KFLNLDNGIPSEDTINRFFSVIDSSEFENCFIEWVNSISIIEKGQVIV
>KACEBFPM_00811 hypothetical protein
MGKFYFNNRKRSSYSLGQVRVNDKSNEITAIPKLLDKLMIKGNIITIDAMGTQTNIVDKI
IKNEADYILALKDNQKQLLEEIKDEFRFGKEIELVSNIDIGHGKKLNQIIRIESII
>KACEBFPM_00812 Beta-barrel assembly-enhancing protease
MKYTSLAFLMVFFTINIFSQEYKNIDTTATNEKKLFLKDFKNRHDTNIEYVKNNFSGNTK
KDLIKRYIDAFNDFSKTVTKGELYFNKDDQEYLEKIVTTIKNVNPILKEKDFYIYLSRDP
SINAFSIGDGTLIINLALFNALKSEGELASVICHEMAHYYLDHRGRSIKKSIDFLNSDTF
KKEERSIKKEKYNKYKRADKLLKNLEYTRKNKSRIFEFQADSLGYCFFKNTKYNPQQAVD
LLNHLSDSDKEKETLEEADYKMFFTTKNQSFIKEWLQMEDFSDYHYSKENSHRWDIDSLK
THPDCKERITRIKLDNQKKTNFSVDSSCFEKIKNISPYETVYNYYYFKEYGICLYESLKL
YRKNKKDAFLLELIAKNLELLAKAKKEMKFNTYITSINPKEHTISQQRFLNFMNNLTLTE
IEQISKDYNNLTKKL
>KACEBFPM_00813 hypothetical protein
MKKLLPLLLLYLTSTISLGQSYKIMQSASGVIEQFNAIYDNEENLFGYVELRKMEQESKE
TMVFKYIVLDKNMNTVCSGNLKENIVKRRCQKINYDISYNNGHIMFSFFEQLGKSDRVRC
SYQILKIDTNTILANAFFDEFVKTQTSIKKLIKNYKSYQITGLGKEGFLIRSENYNPWHT
PKLYYYAINFKGEKIWEQAYKTPEKKRFYYRYKLIDNDNKYVVLLAAKYRRKNKKSDNLL
ILDAKTGAQIAFTNLYNKKYSLTYENIKIKDDKIYIVGRFFKKEAHDLLIDNESLGLYQR
IVNLKDGSIISDKFLDYDKFNGLDITKKGKVRGDGYLNFTKIEMNPDGSYFLLGETYGSY
TLGFYYYGLYSFNINKDFNMEKIYTFDTKRSIGTKYVFSQTLLNKSGKVYFFFDKNEEKE
PELNILNFNYANKESVVEKIKITNKDSEIKIIPAKPGYVGIVEIFKDPKEGEKALELRLE
KLNYKR
>KACEBFPM_00814 Streptopain
MYRKRRLNLFKNFILAIAGLFIIFSCENEKINETTTINQHEVTQKIAEKVALNVFRFKNN
KLAKSAQITKSIENVTTYKMSTTSDVNAFYVFNYNEGGFSIVSADDRVSPVLAYCDEGAF
STNINEIPEPVQSWMEEEKEISQTVKIENSIQTPEIKLDWDSALNKLPPPKDPNWCTDNF
YQKGPLLTTTWDQGSTYNNLTPMVCPNSSGGRAPTGCIATAMAQIMKYWHKPNSYNWINM
PNSYGTVDTQSLMRDIGNGWINYGCNGSSQQSNNISGRFNNFGYNASFTDNYSASLITQQ
LSWNRPVIVTGGRKKDGISWNMYTEGHAWVCDGYQQIDIRYMDENNNCQGWGYLYLHMNW
GWGGYCNGWYNAHNFNPSTYTFNFKRKIVYNITP
>KACEBFPM_00815 hypothetical protein
MKNFIFLSIISIISSCTKDNPEPTSTNLDNSVIIYLNSSEGNNLLNTINYNSNNYRIYYK
NGNEYIEQNNSNLDYPKNFFINSETNPISMKLFLNHLSTETNPITVVKWNDTESDTLKTF
FRRGTDNNTDYEICEKIWLNDALIWDINNNQNSRQITIIK
>KACEBFPM_00816 DNA-3-methyladenine glycosylase 1
MKNRCSWCLSSNLYKEYHDAEWGKPVYDDQTLFEFLILETFQAGLSWITILNKRENFRLA
FDSFDYKKIATYSEAKQEQLLQNAGIIRNKLKVKSAVTNAIAFIKIQEEFGNFSQYIWGF
VDEKPIDNKPKTLKEVTATTAISDALSKDLKKRGFKFVGSTVMYAYMQATGMVNDHVEDC
WVRG
>KACEBFPM_00817 hypothetical protein
MKTIIAQGLLKSISYSEYRKRITELLLQNKSTGNEQSDDLLQYSKLNDTRMNRLDKTIRI
EEKVLKSFNSLKKKYYWLVISESWCGDAAQLIPVFNKIANESESIELRLIFRDENEALMN
LFLTNGSKSIPKIIILEKETMQLKGSWGPRPEGAVNLIKSYKEQYGIVDETAKTDLQLWY
LHDKGLSTQNELATLMRDLEQLAN
>KACEBFPM_00818 hypothetical protein
MNYKISLLFLLFNFCAFSQKFDARYTQFEFSMPFKSNGFYGSTNSDGSRNDYLFIPDGLS
AKIGYGIHYEENISFGLHSGIDWKINEKLVVAPIFLNTRLNLEVGQGAIALQFGWGKALA
IGRGNLSGTYRRFNIGYKNDDDLTLFADLSLYNFAISGYKDFGTISIGINKIIFY
>KACEBFPM_00819 tRNA pseudouridine synthase B
MTPEDYLNGQVLLIDKPLKWSSFQAVNKLKYSLINKLGLPKKFKIGHAGTLDPLATGLLI
VCTGKLTKSISEIQGQAKEYTGTFYIGATTPSYDLETQIDATFPIAHITEALIHETVKQF
LGEIDQKPPVFSAIKKDGVRLYEHARAGVEVEIASRKTQIYEFEITRIALPEIDFRVVCS
KGTYIRSLAYDFGLALQSGAHLTVLRRTKIGNYDVKKAIDVTLFDELIVAKNEL
>KACEBFPM_00820 Undecaprenyl-diphosphatase
MNYIQAIILAIIEGITEFLPVSSTGHMIIASSFFGIAHEDFTKLFTIVIQLGAILSVVVL
YFKRFFQTLDFYFKLLVAFIPAVVLGLLFSKKIDALLESPVTVAVSLLVGGIILLKVDDW
FNNSSETEITYLKAFKIGLFQCIAMIPGVSRSGASIVGGMSQKLARTSAAEFSFFLAVPT
MLGATLKKCYDYYKDGFILTHDQINILIIGNIVAFLVALLAIKTFIGFLSKNGFKVFGYY
RIVAGIVLLLIHFFIHPLTLI
>KACEBFPM_00821 hypothetical protein
MENKEPGFLFEKVNYTILLIGIAIIAVGFILMSGGGSDNPAVFNKEIFSFRRIRLAPTMV
LIGFGITIYSILKNPKKDN
>KACEBFPM_00822 Cell division protein FtsX
MSSSFDNFQKRRLITSYFSVVLSVFLVLFLLGMLGLFIVNSKKLSDDFREGIAMSVYFKD
EAKDTTFTQFKTQLKASKFTKTFAYITKDQAAKEHTDIIGENFMEFLGMNPLQNSFDIHL
KADYVVADSIYKIESKLRENSLISDIVYDKQLVNMVNDNIKKVSFWILIISAIFCVIAVL
LINSSMRLSIHSNRFIIKTMQMVGATKSFIRKPFIWRGIKLGMIGAAIAIAALLGVLFYI
DANFPNLGIFNDKLAIVAILLGVLGTGILITLLSTYFATQRFLNLRTDDLY
>KACEBFPM_00823 hypothetical protein
MKKSLFYTLFAVIASLQFNLVAQEIDSLKQIENKHEKTRASQEYEFSDGTTRTYSKPKLL
EIVTKAPKDFLNTNIDFVAKDHAWYLAGALASTLVLLPIDQQITDQSRAWSERNGLSESN
RYGKLGPLENKPENIGAAFYLLGNGTTVVLLGAGFATYGLLKNNYRAQATASSLIESLLV
SGVFVQSLKRITGRESPFIAMQKGHPGGEWNPFPSFPAYAKDTPNYDAMPSGHLTTIMSG
LTIIITNYPDYKWLKPVCYTAMAGLCFQMVQSQVHWTSDYPMAIFMGYFIGKTIAKNRFK
ETKKAETSQKKYTYNFSASRQYGINTVGVTVKF
>KACEBFPM_00824 hypothetical protein
MKNITFILLLVLTSAIYAQDTIKTSPNHVKEKLNLKQLILPTTLIAAGGILKINYLQNNI
QQGIRNAFGHDFHTTADNYLQFVPLAQIFAAKAIGLKSKHNYKQIITNSIISNLTVGGVV
FLGKTAAHDWRPDGSANNSFPSGHTATAFNNATLLFLEYKDSNIWYASSGYLFATSTAIL
RMANNKHWSGDVVAGAGVGIAIATIINHWNPFNFDNKNKDLSLISYPIINNKNYGLGLIY
QIK
>KACEBFPM_00825 hypothetical protein
MQKTLALLLLIATLAQAQTKETATINSVLDNWHKAASQANYDNYMHAMTNDAVFIGTDPT
ENWNKKDFMTFAKPYFDKGKAWSFTALERHIYLDKSGKTAWFDELLNTQMKICRGSGVLI
KTKKEWKIKHYVLSMTIPNDNTNQVIKIKEATENKIIDKLKNP
>KACEBFPM_00826 PKHD-type hydroxylase YbiX
MENSFEVLIASFIETRVGVSECFLSDELANHLKDNLLSLYRDNKLRTAGTGNADKLVHNT
AIRNDVIYWLDKRNNNAYENAFFVQIEAFIAYLNVSCFAGITGYEFHYSLYESGSFYRKH
LDQFEDNSSRQFSMISYLNANWKEDDGGELLIHQLDNDQKISPTQGKTVFFRSNELVHEV
LVTNERRMSVTGWLKRD
>KACEBFPM_00828 Putative zinc metalloprotease
MDTLIQIAQIIFILSVLVILHEFGHYITARMFKVKVEKFYLFIDLGFSLFKKKINDTEWG
IGWLPMGGYVKLSGMIDESMDTEQMAQPAQPWEFRSKPAWQRLIIMLGGIAVNIILAILI
YTILFSTVGQKYASAELYQKNGLTFSESAINAGFKNGDKILSVDDQVQPKFNRMIIDVLL
GDKVAIERAGKKQTLAISDEQKSKILGSEGRDFIQPRLTEVYIDSVIPKGEANKAGLLKG
DKITKANGQNITFFDEFTTILKSKKSDSIQLTVLRAGKEISLNSKITPEGKLDFYPTIED
NEDFIIKNKLSLAEAIPAAVKESYTQFVYNIKQFKLILRPKTEAYKQVMSPIGITQKLPK
EWNWEFIWGFTAMFSIGLAFMNLLPIPGLDGGHAIFTIAEMITGKTLSVKAAERVQTVGM
IILLILMTLTFGKDIYSIILKNFL
>KACEBFPM_00829 Aminopeptidase N
MKKTKLITLLLLTTVFAFSQTEKSNIASIAEAEMKSASKTINFAVNPNTQSYDVTYHKLE
ITVDPAVYFISGKVTTTFTALSNMNTVTFDLANELTVSLVKQGATNLVFSRNTNNELIIT
LPTMLATGNATSVEITYSGEPPVNGSDAFSSKIHNGSPIIYTLSEPFGARDWWPCKQDLN
DKINSIDVYITAPSQYVSVSNGIEPQLPVTVGANKTTHFHHGHPIPAYLIAIAVTNYTIY
NQMGGTAPNDYPIINYLYPETFASVTPQLAVTPRILNLYESLFEVYPFHDEKYGHAQFGW
GGGMEHTTVSFMVGFNRGLIAHEMAHHWFGDKVTCGNWKDIWLNEGITTYVTSLVIENFD
GQAAFTAEKGNMINNITSSADGAVYLTDLEATNVNRIFSNRLTYNKGAMVMNMLRFKLGD
VAFFQGMKNYLADPTLAFGYALTPQLKTHLETVYQGSGSLTEFFKDWVYNQGYPTYAINA
FNSGAGQATVQINQTQSHASVSYFEMPVPVRLTGSSGQQLDVVLNNTTNGQSFVIPVGFT
VTGVVFDPKKDIISRNSTALLGINNFNFENAINIYPNPTKEVLNIDLPTNMTLQKVNLYN
TLGQKVAETNQNKIDVSGLSQGIYIVNFETSEGAFHKNFIKK
>KACEBFPM_00830 Single-stranded DNA-binding protein
MTKKNNFNTNLNLHAMSTLRNKVQLIGNVGNDPEIKILEGGKKLAKLTIATNESYYNDKN
EKVTDTQWHNLTAWGKTAEIIESFVTKGKEIAVEGKLTHRNYDDKDGIKRYYTEVVVNEL
LLLGSK
>KACEBFPM_00831 hypothetical protein
MKNCLECNEKIIGREDKKFCSDGCRNAYNNKINKDSTNLMRNINNKLRKNYRILSDLNPE
GKGKISRTKLLSKGFDFEFFTSVLITKTGNTYYFLYDQGYRILEDDYYMLVKKEN
>KACEBFPM_00832 hypothetical protein
MTCKNISILGCGWLGLPLARALVATDFFVKGSTTSQGKLSVLAQSRIEPFLLSLNENEVM
GNIDAFLENSEVLIIDIPPKLRGNASENFVAKIRNLIPFLEKSSVTKVLFVSSTSVYADD
NLIVTEETTARPETQGGKQLLEVEKMLQNNKNFETTVLRFGGLIGDDRHPVRMLSGRENI
ENPNGAINLIHQKDCIAIVLMILGQAQNDRLVWQEIFNAVAPFHPTREEYYTQKAIELGL
ILPRFNKQKPSVGKVISSEKLIKTLGYRFEVLL
>KACEBFPM_00833 Neutral endopeptidase
MPGTHVDGKFTLGENIGDLGGINAAYDGLQLYLKQNGNPGLIDGYTPEQRLFISWATIWR
SKMRDEAIKNQVKTDPHSPGMYRAYVPLTNLDAFYKAFDIKEGDKLFVKPENRVRIW
>KACEBFPM_00834 hypothetical protein
MQLCDSEKKSLNGFYTIQIYTMKYLLYTVCFLIFSTNPALAQSTNLIKHKVQKGETITQI
SKKYSVTPANIYQLNPDAQKGVEENNILIIPNKVKAKNETPTKAITNKHTVLAKETLYSL
SKLYDITISDLEKANTETLKEGVKIGMILVIPAKGKLIPTQKPKPNNLKTPVYHEVKAKE
TKYAIAKQYEITIEQLEKLNPEIINTELPIGFKLLISGKKTIAAPKPIIVNTPAPKPAEN
LYVIKAKETLYGISNQFEVTQEQLLALNPELKDSVIEGISIKIPVKPSTLAIKKEYKDLT
KSIQKATNKKLALLLPFNLTKLDQDTINSTKARLKKDKFLNMTLDFYAGALVAIDSVKKM
GLNIDVAILDSNETKSTSNITSLLQENNLKTFDAIIGPFYQNNVEKTADLLSANNVPVFS
PLSKDYVKKFSNLVQSTPSVDDIKNAMFDFMRAKNANIIAIVDPKKGSVKQYISENQKDV
LFAQFTEKGTLDIENLKTILVKDKTNFVIMETAKTNLILNITNTLVNLLPNYDIKLVTLG
ENEALDYDEIPMTRLTKLKMHYPSLTRVNQSGEASIFENNFRRKNKILPNQFATRGFDIT
FDVLLRLAQEKNIIETLNETATEQVENKFYYKQNPDGGYANKGVYILFYDTDLTIKEAK
>KACEBFPM_00835 hypothetical protein
MKYLVLLFLCISNFVFAQQEKTLNHKVIKGENIFQIAKTYNITPSDIYKINPGTENGIQE
NQILIIPNKAIILYDSKNTHQVQPKETLFGIARLYNVSVQDLDNSNTEALKDGLQIGENI
VIPNKKKTLNGQARIINAETIFHIVASKETKYSISKKYGISIEQLETQNPEIINGLIEGN
KLAINTKKIKPNNDNEELMIALAEKQAAIEKNKAKTTEIEDLQDKLTVQKQMNQKVLKVN
SLKVNLNEIDETKGGSAKKLKLVLEANKNIQEILISKLDSLVVTMSDNLETLKNKDINDL
EESKNLEKDSYKNISETNGMIIELKKDLADNRKIYTGLMTKVQRITLAENHEYKKKINEN
QKIKNNTSEDAELLEVIKNIQTKQEANEKRNKQLFTKIDSLGVQKNIELKRRISKATFYS
SEARDYDDKLAQVKLKRYQNKAVETNKKLLDNSENKPTAEQIKKALKDHNYSLGKAVKIE
ILRNLKDIENGYYIIADTFSEAEPRDLLTRKLTDSGEINTGFFYNVNIFSYYVFTKKLKN
ANEALFEYNLKKENPLYKNMFIVQIEKE
>KACEBFPM_00836 GMP synthase [glutamine-hydrolyzing]
MHQAIGKNLYCIFVNNGLLRKNEFQSVLDQYKGMGLNVKGVDAGDRFLSELAGISDPETK
RKTIGRVFIEVFDDESKIIENVKWLAQGTIYPDVIESVSVKGPSATIKSHHNVGGLPDYM
KLQIVEPLRMLFKDEVRRVGATLGIDAELLGRHPFPGPGLSIRILGDITPEKVQILQDVD
AVFINGLKEHGLYDKVWQAGAILLPVNSVGVMGDERTYEKVVALRAVESTDGMTADWVHL
PYEFLMKISNDIINKVKGVNRVVYDISSKPPATIEWE
>KACEBFPM_00837 D-alanyl-D-alanine carboxypeptidase
MKKTILLLVFIFSLSLSAQQKTRFDKIDSLLVYLNQNKKFMGQVCIRQAGNVVFEKAYGF
ANVENNLSANKNTKYKIGSITKTFTAVMIMQLIEEKKLKLDSKLSKFYPQIPNATKITIH
DLLHHRTGILDFINGDSTVNVYKKVSKEEMIAKISGYKPVFEPNTKFEYSNSNYYILGKI
LEEVTKKEYATNLEERITNKLQLQNTSIATNTDPTKNESYSYNYTNKKWTINKEWDLSQA
FGAGNIAATTGDLTLFLEAIFNGLLLKKTSVDEMIKLEQSYGKGLVAFPFGERKFYGHTG
GIEGFRAVVGYYPTEKTGISLIVNGDNYNRNDIMMGILSIYYKMPYQFPNLTTFEVPKDK
LASYQGIYASAQLPIKITIKIDKGELTAQGTGQNSFALNPISETEFVFDPAGIKLIFDTK
SMTLKQGAGQYLFTKE
>KACEBFPM_00838 DNA polymerase I
MSQKRLYLLDAYALIFRGYFAFIKNPRINSKGMDTSAIMGFMNALMDVIKREKPDHLAVA
FDKGGSTYRYEMYQEYKAHRDETPEAIKIAVPYIQDLLKAMHIPIIEVAGFEADDLIGTL
AKQAEKEDFKVYMVTPDKDFAQLVSENIFMYKPARMGNDIEIWGVPEVLAKFEIERPEQV
IDFLGMMGDAADNIPGLPGVGEKTAKKFLKEYGSIENLLANTHQLKGAIKDKIEANKEKG
ILSKKLATILLDCPVTFNASTYELSKPDVEKTDELFQELEFRQMKTQFDKYFGTGKDYDE
IDTNENDNSQIQKKTVAKKTNEDQFDLFGFSDQESGEIKTDSHYAKLENTEHFYQSIEGD
FAVKLLLQNLLNQTSVCFDTETTGIDALNAQLVGMSFSFEKGKAFYVPFPENQEDAQVLA
DKFKPFFESESIEKIGQNIKYDLKILSHYGVQIKGKLFDTMIAHYLINPDMRHNMDVLSE
TYLKYSPKSIEDLIGKKGKNQKSMRDVSLEEIKEYAAEDADITYQLKQNFSPILDKAETK
KLFEEIEIPLIPVLAAMELEGINLDVPFLKSMSAEMALESNALEQKIYETAGEKFNLASP
KQLGDVLFDKMKIGGAKQKKTKTGQYATGEEILSYLANDNPIVKDILEWRQMVKLQSTYI
DALPNQVDKKTGRVHTDYMQTVAATGRLSSNNPNLQNIPVRTERGRLIRKAFIPRNENYT
LISADYSQIELRIIAALSGEENMIAAFQNNQDIHKSTAAKVFNVALEDVTKEQRSNAKTV
NFGIIYGVSAFGLSNQTSLSRKESAELIDAYYATYPKLKSYMSNQVDFARENGYVQTVLG
RRRYLKDINSANMMVKSGAERNAVNAPIQGSAADIIKIAMINIHKKLTQENWQSKMLLQV
HDELVFDVHNSELEKIQPMIKYEMENAFKIDVPLDVEIGIGKNWLEAH
>KACEBFPM_00839 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MFIRFIIVFFILLFVEVYSYQAFKIIIKTKWVLQTYLIISVLVLFYVIYHVLQFDRKIGQ
TQQTLFTIGLFLLVYIPKIVLSLFVFGEDLFRVGAGVVNHFMGNKEDDLGFLGSRRKFVS
QIGLGLAAVPFLSLIYGMTIGKYNFKVIKQNIYFPDLPDAFDGFTITHISDIHSGSFDNP
EKINYAIDLINEQKSDILLFTGDIVNAKAEEMHPWIETFNRLEKPAFGKFSVLGNHDYGA
YIDWDSETEKAKNFIDIKDLHRQIDFKLLLNEQVKIKKGNDAFSLIGVENWGKHFGAFGD
IDKALEGVSTSDFKILMSHDPSHWEEIVKNHKKNIQLTLSGHTHGMQFGIEIPGWFKWSL
AQYMYKQWAGLYENVGRYIYVNRGFGFHAYPGRVGVMPEITVIRLKKGQNVA
>KACEBFPM_00840 Thioredoxin
MSKFGELINAQIPVLIDFYTDWNESSQSMDPVIKDVAAALGDKAKVIKIDVDKNQELAEA
LRIKGLPTLMIYKDGQMMWRQSGELDANTIITLVQEQL
>KACEBFPM_00841 Peptidoglycan-N-acetylglucosamine deacetylase
MNFYWIKTPPIIKRLFSNQVWDIPNSENKIYLTFDDGPIPEITEWVLEILKKNNIKATFF
CLGNNIQKHPEIFNKVISNGHSIANHTYNHKNGWKTTTAHYLQNVELCQNLFLNLRSKIF
RPPYGKIKPSQSKKLRKLGYKIIMWDILTADFDEKVSKEKCLENATQKVTSGSIIVFHDS
VKAFQNLKYALPKTIQILKEKGFVFDIIR
>KACEBFPM_00842 Inner membrane transport permease YbhR
MKNILQLIAREFKLFFGNKILRMLFIGAPIMYGFLVGSVYEKGKVTNLPIVVVDEDQSAM
SQKLIQMFSENEVLKIVNVLNNTNQSRTVALKRDAPCVVVIPRDFESQILQKHYPELVVF
VDASNTLTANFASSNINLCVATLKAGIQIEGLKKQGLSQKIAETQYEPFKTTFIKENIRS
GNYLYFMLPGVLLTVFQQVLLLGLALSFSSEFENNTFKDLVKKMSNPFGLIFVKVIPYLL
MSMGILWLYYGFSVYYRLPLHTDWFPFASATFLFIFSVCCIGILGSILLPNQLKATEVLM
VVATPSFILSGFTWPLSQMPVWVQNIANAIPLTHYLKIYRILFVEKGDFTKIVNPLWAML
IIGMVCFSLATVFLHLKIRKLKRNN
>KACEBFPM_00843 hypothetical protein
MKKTFYLISKNSYITLIITFLVISCKDKNENTITLDGKIEREQISVVSKLAGKVQNVLAE
EGQDVEAGDTLIILELPEVEAKKYQAKGALLSAEAQYQMAKNGATQGQIIQLNAKVAGLK
EQLSFAEKSMRRMQNMLSDSLVPQQKFDEVFAKYQGAKNQYTASVAERDEAQNGARIEQQ
TMALGQQERALGGIDEINIAANERFIKAPQKMSIENITLKKGELALPGYSIMNGFLNETT
FFRFTIAESQLSSVKKGGQIQVHIPYENKTITGKVVWIKPLSSYANITSAYPDFEQGQTL
YEIKIAPINPKETENLLIKSTVQISIQSVNKK
>KACEBFPM_00844 hypothetical protein
MKTYLFVLVFYLSQSSAFAQSIISNDLKVPIQNALNTSYEITNKQLEAHKTEINAESVLA
KLKPEISANAVLSHFYQRGIIDVPTVTLPITGLNLFEGSQSFSANGNIGTVGLSATQIIF
SGNQIPNAAKALKEKAEAQHLLAEADKDAIAKEVVTTFDQLMLLKEAEKLIWDTQKRLDK
ESEKVKKAIINGLAIPYDRDKIALALLELEAKKVEIVGNRKLLNQRLTQLTHIDNSQISN
IQYPLETIVLFDIDSTTQNRKELKALIHSSKALDYMRKKEKNSGLPSVFAFGNISYMNIF
NSKITFKDVANLNDVHLKLDQFSVAPNILFGIGAKWTIYAGGEHKHKVELVKIDQEINEN
KTKDTDEKLKLLIQKSKIEYENAFEKLKISHQQVTISNNNKLLATKQYTEGLISVTERLE
AENDFFKASLNHIININSQRKTALDLLQANGTLLTKILN
>KACEBFPM_00845 hypothetical protein
MSFNFNKWNTALGWLTFFIALIVYSLTVEPTMSFWDCGEYIATAAKLEVGHPPGAPLFQM
IGAFFAMFAIDNQHVALMVNMMSVFSSAFTILFMYWSTSIILRKVVSRFSDPSLKGEQAK
QINQTNSIVILGSSFVGSLAFTFSDSFWFNAVEAEVYAMATLLIALLFWLGLRWEEEMHT
PRGNKWLLIISLVVGLSFGVHFMALLTIPSIGFLYYFKNYKNITIKSFIIANIVVVAVLL
FIFKLLLPWTMTFFGDTEVFMVNNLGLPFDSGTIFVTLLLIALFYFGLKYTQEKGKPLYN
TLILCVLFIMLGFSTWMMLPIRANANTPINENKPSDAREVLAYYNREQYGVNPLFYGPQF
SDTYAGLDEDNPYTDDKPNYERDYKKGKYVIVNNYKNGSQNSDDNHKAILPRMWSTDHAE
NYMKFTNVLAFRIKPEYSEEKELTDIVSQFRTSYASGKLDVEDYAKFLKAYGQYLDIEKP
TTIDNLTFMVQYQFGYMYWRYLMWNFVGRQNDKQGEYTTLDGNWLSGINVLDAIRLGSQE
NLPATWQNNKARNTYFFLPFIIGLIGFFFHIKKDIKSFYVVLALFLFTGIALKIYLNERP
FEPRERDYALVGSFYVFAIWIGIGVYAIFDFLKSYIQPKIAAPIVITACLFAAPILMATQ
NWDDHDRSGKYTAVSSARAYLDSCDKNAILFTIGDNDTFPIWYLQEIEGYRTDVRIVNTS
LLMTDWYIDQMKAKAYESEPVPISFSHKDYVDGKRDYLVFDQKTEERLDVKEFFDFVSSD
DPRTLIEMKNGQKIQFYPSNKIRIPVNKNNVITNKIVSPKYNDSIVPYIDVDIKGDALYK
NRLMMLDIVRNNNWKRPIYFSPGAFADDDYIWMKDYLQLNGMVYKLVPVKTPIDKEASGF
DMGSIDTDKMYDIMMKLDWGNSESTKIYHDPETRKNSISYRTHLTRLMNQLIAEGQKDKA
KKIIELALTKLPLDYYEFYSMVDPFADGYYKLGETQKARTLLKQLEAKYQDELKYFSRTK
ASEQNTNAIDIITNIERYRGLLEIMKNNKDTNFYNTEKEVFNSYNKRFDRFGRDME
>KACEBFPM_00847 Fructose-1,6-bisphosphatase class 1
MFSKIIIDICTNNYINLEMEERNKTLGEFIIENQQSFQYSSGELSRIINSIRLAAKVVNY
KVNKAGLVDIVGAAGEQNIQGEDQQKLDVYANEIFIQTLINREIVCGIASEENDDFITVA
GSDNSHNNKYVVLMDPLDGSSNIDVNVSVGTIFSVFRRITPVGTPVTIEDFLQPGINQVA
AGYVIYGTSTMLVYTTGDGVNGFTLNPAIGTFYLSHPNMKYSKDGHIYSMNEGNYVHFPQ
GVKNYIKYCQSEEGDRPYTSRYIGSLVSDFHRNMIKGGIYIYPTSSKAPKGKLRLLYECS
PMAFIAEQAGGKASDGYNRIMEIQPTELHQRVPFFCGSYNMVEKAEEFMKNTK
>KACEBFPM_00848 putative ribonucleotide transport ATP-binding protein mkl
MITVKNIEKSFGNSKVLKGISTVFETGKTNLIIGQSGSGKTVLLKSLLGIHLPEVGTISF
DGRIYSELSADEKRELRTEIGMVFQGSALFDSMTVEENVGFPLKMFTQNSKSEIQDRVDF
VLKRVNLIDAHKKLPSEISGGMQKRVAIARAIVNNPKYLFCDEPNSGLDPNTAILIDNLI
GEITEEYNITTVINTHDMNSVMEIGQNILFLKNGLKAWQGTKEEIFRTDNEAVTDFVYSS
ELFKKVREAVLKEGI
>KACEBFPM_00849 putative phospholipid ABC transporter permease protein MlaE
MMLLRYLSQIGRYFLMIVEIFKKPTKWSVMRTLIFKEIDDLIIGSLGIVAFISFFVGGVV
AIQTALNLTNPLIPKYLIGFATRQSIILEFAPTFISIIMAGKMGSFITSSIGTMRVTEQI
DALEVMGVNSLNYLVFPKLIALLLYPFLIGIAMFLGILGGYIASVYGGFGTHADFLNGLQ
KEFIPFHITYAFIKTLIFALILATIPSFHGYYMKGGALEVGKASTVSFVWTSVMIILMNY
ILTQLLLT
>KACEBFPM_00850 4,4'-diaponeurosporenoate glycosyltransferase
MKYYIIIPAHNEESFLGLTLQSIIEQTILPSKIVIVNDNSTDKTENIALAFAENNPIITL
VNTTSQAIHLPGSKVIQAFNKGLETVNDDYDFIVKADADLIFPTNYFETIINHFKSDSTI
GMVGGFAYVEKNKAWILENLTDKDHIRGAFKAYRKATFKQIGGLKPAMGWDTVDELLCKF
YHWKVVTDQSLQVKHLKPTGANYNKTARYKQGEAFYSLGYGFFITAIASAKLAMMKKKPL
LFLDYIKGFWKAKLAKKPLLVSQEQAKYIRKYRWQKMKSKIL
>KACEBFPM_00851 Putative glycosyltransferase EpsH
MALNKKIFVIIVTYNGSKWIEKCINSLLRSIYPINILVVDNCSTDDSVELLKQFSEIHLI
QSKENLGFGKANNIGIDYALNNKADYVFLLNQDTWVFDDTISNLVVMAQNNPSFGIVSPM
HFSGDEKTLDKGFVTYYNRNVEENAGKNIAIVPFVNAAAWLVSSACLQKVGGFESLFGHY
GEDRNYCDRVLYHQFQIVIAKNAKICHDRKISRSFKKDLIQSKYKMLSQVLDINNTLFAS
YANALQSVFGLPKYFKQSYSFTFITQLFYNLVVYYLQLIFRMKVIKMTRKKTMI
>KACEBFPM_00852 hypothetical protein
MLNKISQKQAFFFTIINYIGIVIGVVSTLFIYPNNKELLGIFRYIDAISYVLFPIMLIGA
SQALVNFTPKLDELHKKKLFNYSVFSILMISVFILATLFIVSFIPAFTDMKYVYIAFPIA
LCLAFIELFKKQATIIQKIAVPTFLDNIIPKISLPIIFLLLIYHRITFNQSVLFYVFSYG
LIFMLLTIYLCKYFKPKFNLNFSSLFNEVSKRDYYHFSMYAFAGSLGSVFAFRIDALMIP
KFISMQANGTFSIGVTLASALAIPATGVFALYAPIVSNYLKTNNLSELDLKYKEISKLLF
FIGALLYSCIFLGIENLFMLLPTHDQLITSIPIILILGFNVLVNMGTGFNGEIITYSKYY
KFNLIAIAILIVLNVGLNLLFIVHFKFGIQAVAVASLLSMVVFNFAKLLFIYKKFQLLPF
DYNYLKLVLILVMTLGFVYFLPKCTNQICTLVYKILLSLFLNIFIVYKLKLVYQVTISIN
KIRNYTR
>KACEBFPM_00853 3-oxoacyl-[acyl-carrier-protein] synthase 3
MNIKITGSGSYIPNQIVTNSDFAKHQFLNEDGSIFNASNEIIAHKFKQITGIEERRYVDE
NLVTSDIAHFAAQKAIEAANINPETLDYIIFAHNFGNVKQNAVQGDAVPSLAARVKQKLR
IKNPKCVAYDLLFGCPGWVEGVIQAQAFIKAGMAKKCLVIGAETLSRVVDIHDRDSMIYS
DGAGATIIEATNENGGILAHASATFATDEADYLFFGNSFNKNLDQDVRYIKMQGRKIYEF
ALTEVPKAMKDCLDESGIPIAEVKKVLIHQANEKMDEAIIDRFFKLYNQETPVGIMPMSI
HKLGNSSVATVPTLYDLLINGKIENQEINKGDVIIFASVGAGMNINAIVYRV
>KACEBFPM_00854 Group 3 truncated hemoglobin ctb
MNDIQNQEDLYLLVDEFYKKLLSDESISYFFTDVVKIKLEEHLPILVTFWSQAILGTGGY
ANNLTQIHLDINKKEPLTPALFKIWLNHFNTSVDENFTGQKAEQIKTQALSIATIMQIKI
TNQEH
>KACEBFPM_00855 Glycine dehydrogenase (decarboxylating)
MAGMKVVVTKTLENGNIDVEDLREKAILHKDNLSCLMVTYPSTHGVYEASIIEVTKMIHE
NGGQVYMDGANMNAQVGLTNPATIGADVCHLNLHKTFAIPHGGGGPGVGPICVAPQLVPF
LPTNPVIPTGGEKAISAISAAPWGSALVCLISYGYICMLGAEGLKKSTEYAILNANYIKE
KLNGHYDTLYSGEMGRAAHEMILECRPFKEKGIEVTDIAKRLMDYGFHAPTVSFPVAGTL
MIEPTESENLEELDRFCDAMISIRKEIEASSADDSNNVLKNSPHTLAMITTDDWTYPYTR
EQAAFPLDYIAENKFWPTVRRADEAYGDRNLVCSCAPIEAYM
>KACEBFPM_00856 Tyrosine--tRNA ligase 1
MKNLVEELKWRGLFHDMMPGTEEQLTKESTTAYIGFDPTADSLHIGSMVQIILLVHLKNF
GHKPIALIGGATGMIGDPSGKSDERNLLDEATLNKNVAGIKAVLSSFLDFNTTNANAPIL
VNNYDWMKDFSFIDFARDIGKRITVNYMMSKDSVKKRLGAEGEGMSFTEFTYQLIQGYDF
QYLYKNHNCLLQMGGSDQWGNITTGTELVRRMGGEGAKAYALTTPLITKADGSKFGKSEG
GNVWLTADKTSVYKFYQFWLNTSDEDAEKYIKIFTFLDKNTIDGLIEEHKTAPHLRVLQR
KLTEEITILVHGKEELEKAIKASNILFGNSTSNDLKGLDAATFLEIFDGVPQAEISKTDI
EAGINIVEVLNEKSGFLKSNGEARRALSANSIAVNKEKVTEEFTLTTKDMINNQFVLLQS
GKKNYFVLNVK
>KACEBFPM_00857 dTDP-4-oxo-6-deoxy-D-allose reductase
MVLVTGATGLVGSHLVLHLLEQGESVKALFRDENGKQKVKAVFDYYNQQELFAKIHWYQA
DVLDIPSLEGAFHDVNYVYHCAALISFDPKDEGNLRKINIEGTQNIISFCIDFKIKKLCY
VSSIAALGDLAPQETIVTETCEWNPEMQHSDYAISKYGAEMEVWRAQQEGLDVVVVNPGV
ILGPLFWTEGSGEIYTKVHNGLPFYTKGSTGFVSVIDVVTILLLLMKSDIVNEKFILISE
NKTYQELVFAIAETLNTKKPKLYASKFLTSFAWRTDWFFGAFFGKKRTLTKDLASTLHAK
EVYCNRKIITQIDYKFLEVSVYLKAIKKASS
>KACEBFPM_00858 hypothetical protein
MKKIILALSFLIIISACSNKNEIPKPAKPIDKDVMENILYDLALLQALKIYSPEKLTTNS
IDSKTYIYQKYKIDSLQFVENNKYFASNTETYKLMFENVSNRLQKEKSELDTIISKELKI
KTKKTQDSLKKIPHTANNPR
>KACEBFPM_00859 Allantoinase
MKQVLIKNAKIINEGILFEGDVLIENEFIIEIGNNISPKSSDCKIIDAEGNYLIPGMIDD
QVHFREPGLTHKGDIASESRAAIAGGITTYIEQPNTVPNAVTQELLEQKYQIAAQSSYAN
YSFMMGATNDNLEEVLKTNPKNVAGIKIFLGSSTGNMLVDNEAVLEKIFSSTKMLIAAHC
EDETTIQNNLEKYKAEYGDDIPMKFHHLIRSEEACYISSSKAVALAQKTGARLHIFHVST
AKETTLFSRIPVEDKQITAEVCIHHLWFTNDDYAKKGTLIKWNPAVKTQADKDELWKALL
DGRIDVIATDHAPHTFEEKQNPYTTAPSGGPLVQHALVALFEAFHQGKISIEKIVEKTAH
NPAKIFKIDRRGFIKVGYYADLVIVNIGMPWRVNKDNILYKCKWSPFEDYPFKSRITHTF
VNGELVFHNAKTKEIHCGKRLEFNR
>KACEBFPM_00860 Polyprenol monophosphomannose synthase
MKDGIVIIPTYNEIENIETIIRAVFSLSKKFHVLIVDDNSPDGTSNKVIALQQEFSNELF
LETRKEKSGLGTAYVHGFKWALQHDYEYIFEMDADFSHNPADLEKLYNACNTGKAGMAIG
SRYVTGVNVVNWPLNRVLMSYFASVYVRFITGMKIHDATAGFICYRRKVLETIDLDKIKF
TGYAFQIEMKYRTFINKFKITEVPIIFTDRTKGESKMSNAIIKEAIFGVIMLRVRKILNR
L
>KACEBFPM_00861 Outer membrane porin F
MKKLFIYILFLVNIYLANAQEQFSVYFDSNKYELSGQENKELQTWISQNPTSKVLAINGY
TDEDGTNQYNDSLALKRVQKVYQNIKQKINIREDFKTRSFGEHSQQSKNKSENRKVTIYY
LLQKDIIHEDEILGLKSKEKTKIKKPIVFPNKVVIDNFNGTKSEYKLDVKFMEALCYAVP
GTKLKLNNLNFITNTFAVTNDSRGKLYELLLVMQQRPEMIISIHGHLCCVSVDRKDLSTQ
RAKAVKQFLELNGIEKTRMDFKGFGSSIPLFPLPENTEEERAANRRVEIEVIEN
>KACEBFPM_00862 Glutamine synthetase
MSTIRFQALKEASGRKPVKFEEADRKSNIFGANVFNDKAMKQFLTSDAYKGVKDAVQHGT
KIDRKLADYIAMGMKEWALSKGVTHYTHWFQPLTGTTAEKHDAFFETSYDGSESFEKFGG
AQLVQQEPDASSFPNGGIRNTFEARGYTAWDPTSPAFIFGTTLCIPTVFISYTGEALDYK
TPLLRALHSIDQAATDVCKYFDKNVKKVTATLGWEQEYFLIDVALANSRPDILMTGRTLL
GHTSAKGQQLDDHYFGSIPTRALNYMRELEQECMYLGIPVKTRHNEVAPNQFELAPIFEE
TNLAVDHNSLLMDVMHKVGERHDFKVLFHEKPFKGVNGSGKHNNWSLATDTGINLLSPSK
TPMSNLQFLSFFINTIKAVNDYEELLRAAIATATNDHRLGANEAPPAIISVFIGEQLTKV
LAELEGVTTGKLSPEEKTDLKLNVVGKIPDVLLDNTDRNRTSPFAFTGNKFEFRAVGSSA
NCANSMTILNTIVAKQLKDFKIEVDALIESKDMKKDDAIFNVLREYIKKSKKILFEGDGY
SDAWEVEAKKRGLSNFKTTPLALKAKVSKQALDLFSEMNVMNHVEVEARYEIELEEYTKK
IQIEGRVLGDIARNHVIPTAIKYQNTLIENVKGLKDIFGDEFKKIGKEQIVLIKEISEHI
EGINTKVEAMTEARKKANVITNAQKMAESYCDAVKPYFDKIREHCDKLELLVDNESWTLT
KYRELLFTK
>KACEBFPM_00863 hypothetical protein
METLKNNQYPSLKISGQFLQLTDANIDPKIKLGASGTAVKVNQLFLGQANVSMPLFNGFK
LKNSIWASENLYKAETANAANTKEKLSLYVVELFAKLYQSQQTTTLIEDNLKSAQQRTKD
FSAMVHNGLMARNDLLKAQLQESNIQLSLDTAKKNVNIINYQLVTILQLPENTQIDIDIE
TIKNDIVRNKNIAIQAKRNDLEALTYQQKASEAGIKIAKSGYYPALALVGGYIAFDLKDV
MTVTNAMNVGVGLSYDLASVFKNGKEVKLAQSKSEQTKTAVTILTNKIKEETHEAQENYN
LSLNQNAVYKQAVEQATENYRIVKDKYDNSLSTTNDLLEADVQQLQTKINLALSQADIAL
KYYQLQFAEGKLINSFNTSKN
>KACEBFPM_00864 Multidrug export protein EmrA
MKNKKTNSKFILIFSVLILLGGTYGVYKYMHALAHETTDDAQIEKNMNPIIPRVSGYITK
VYVKDNQSVKKGDTLFTIDNRDYSIKIEEAKAALIGAEQGYAVSKADIGTAQANVSVSDA
NVQSASGNIETAKIRLNRASNDYERYNNLYKNHSITKQQFEQAEATKLEAQSQLQILQEQ
QKASTYQKTVASSRSNVSSKQAEVAAANIKRAQAILESAKLNLNYTVVTASIDGQVSKIA
IQPGQFIQPGQSLFYIINNQEVWVIANFKETQLSKMVEGQKVTVKVDAFPDTDFSGTITS
FSPATGARFSILPPDNATGNFVKTIQRLPVKISLDATNEAAKIKLLRPGMNADVDVHIK
>KACEBFPM_00865 Multidrug export protein EmrB
MTTTIVEDDLVEYGFRRIIITITAVLCALLEIVDTTIVNVALTNMRGSLGATLTDVAWVI
TAYAIANVIVIPMTSWLSQQFGRRNYFAVSIIIFTIASFLCGNATNIWELVTFRFIQGLG
GGALLVTAQTIITESYPIAKRGMAQAIYGMGVIVGPTLGPPLGGYLVDHFSWPYIFYINI
PLGIIATFLTLTFVRSPKYGEKLKANQVDWWGIIFLAAFIGSLQFVLEHGQQDDWFSNST
IVTLCIVSITGLLLFIWRELTYKHPIVNLSVLKDGNLRIGILMGFILGFGLYGSTLIIPI
YTQSILGWTATDAGLLLIPGSITTAILMPFVGRMIQKGIPQGYMIAVGFLVFFLFTFWMR
NAMTPDTGVEHFYWPLILRGIGLGLLFVPITTLSLSTLKGKHIGEGAAFTGMMRQLGGSF
GIAIITTFITRFSQKHRVNLIAHLDGSRLEVQQRIQLLQKGFMAKGFSTNEALNKAHQVI
DFTVLKQSTVMSYMDIFLYLGIMFLCCIPIVFLIKKSKNIINPADAMH
>KACEBFPM_00866 Peptide chain release factor 2
MQMLRSQLYEIELKKQQEQRNDIEAGKMKIEWGSQIRNYVMQPYKLVKDVRTGHETSDVD
SVMNGNIDAFLKAYLMKMGQKEA
>KACEBFPM_00867 hypothetical protein
MTNYIKRFYDQEIWKQVELKSPFAEKYELHVSNHGNIKKINILKGTNYNITQTLTQGYPS
VHFTTILPIQEKDQAYFTIIRNSMKFLKLDIASMTEAINLAEKPDTTLAQKIIETQELLK
TINTNYIKNYKKREQKRKRNFSALIHRLVAIYFLEPAPEDKNLVAHIDYDKLNNHHSNLK
WMTREESSLHQRSSPFVIKAKEKVLINGGHRGNTKLDEKQVMILKKRINEGIPLRELAKR
TKVTETQLLRIKRGINWGKVPAAL
>KACEBFPM_00868 Putative cystathionine beta-synthase
MYDASIYNYMKEDIKAYNNVLELIGNTPLIKIDKITEGLKGNFYAKVEAFNPGHSTKDRI
ALYIIEEAEKQGILKPGDTIIETTSGNTGFSLAMVSIIKGYDCIFAISSKSSADKIDMLR
SMGAKVYVCPAHVSADDERSYYSVAKRLHEEIKGSVYINQYFNHLNIEAHYKSTGPEIWE
QTNGKITHLIACTGTGGTISGIAKFLKEKNPNIRILGVDAYGSVIKKYHETKEFDKDEIY
PYRIEGLGKNLIPSALDFDLIDKFVKVTDEESAHMTRNIAKVEGLFVGYTSGAVVQAIKQ
YAEEGEFDEKSNIIAIFPDHGSRYMSKVFNEEWMEAQGFFDSVNEEEIQQIEYIK
>KACEBFPM_00869 Protease 2
MSEKIIAPLATIKPHTLEKHKDIRIDNYYWLNDRENPEVIDYLNKENEYYNEMTAHTKAF
QAELFEEMKSRIKEDDQSVPYLYNGYYYITRFEKGQNYPIYSRKKGNLEAKEEILFDCNE
MAKGQTYFQLGGLSVSPDNKWAIFSSDLIGRRIYTIEIKNLETNKILSDKIENTSGSAVW
ANDNFTIFYSTQDSVTLRSDKIFKHKLGSNSSEDVLVYFEKDETYNVDIAKSKSKKYLAI
ESGSTLTTEYQILEADNPDGKFRMFQKRVRGLEYSINHYGDSFYIMTNKDEADNFKLMKT
LETATSKENWTEVIAHRDAVLLEDIEIFKDYLVVEERENGLHKIRIMPWSGKGEYYLPFD
SETYSAATGANVDFDTEILRYGYQSLTTPSSVIDFNMRTKTKEIKKEQEVLGGKFDKKNY
IEKRVWATANDGTKIPISIIHQVGVKLEGNNPLLQYAYGSYGYSMDCTFSTTRLSLLDRG
FIFAIAHIRGGEDLGRPWYEDGKLLKKKNTFTDFIDCSKYLISEKYTSAKHLYAEGGSAG
GLLMGAVINMAPLLYNGIIAQVPFVDVITTMLDDSIPLTTGEYDEWGNPNKKKYYDYMKS
YSPYDNIVAQKYPNMLVTTGLHDSQVQYWEPAKWVAKLRTLKTDNNLLYLDTNMDAGHGG
ASGRFESLKEVAKEFSFLLDLEGIKR
>KACEBFPM_00870 Threonylcarbamoyl-AMP synthase
MSQFIKIYPDNPNEAAIKKVVDVLKNGGLIIYPTDTVYGLGCDITNTKALERIAKIKGIK
LEKANFSFVCHDLSNISDYVKQIDTATFKILKRALPGPYTFILPGNNNLPKEFKKKTTVG
IRVPDNNIALEIVKMLGNPIVSTSIHDDDEVIEYTTDPELIFEKWQNLVDLVIDGGYGDN
VGSTIIDLSGHEPEVIREGKGSLDIL
>KACEBFPM_00871 ATP-dependent DNA helicase PcrA
MQKYISQLNEAQQAPVLQKDGPMIVIAGAGSGKTRVLTVRIANLMSQNVDAFNILALTFT
NKAAREMKKRIADIVGNAEAKNLWMGTFHSVFARILRSEADKLGYPSNFTIYDAQDSVRL
LGAIIKEMQLDKDIYKPKQVFSKISSYKNSLVTVKAYFNNPELQESDAMAKKPRLGEIYQ
QYVERCFKAGAMDFDDLLLKTNELLTRFPEVLLKYQDRFRYILVDEYQDTNHSQYLIVRA
LSDRFQNICVVGDDAQSIYGFRGANINNILNFQKDYENVKMFRLEQNYRSSKNIVEAANS
VIDKNKTKLDKVVWTANDFGQKIKVNRSVTDNDEGRFVAGEIWTQKMTNQMTNGQFAILY
RTNAQSRAMEDALRKRDIPYRIYGGLSFYQRKEIKDVLCYLRLVINPKDEEALIRVINYP
ARGIGDTTIEKLTIAANHYKRSIFEVMQVIDKIDLKLNSGTKAKLQDFVTMIKSFQAINE
TQDAFYLADHVAKKTGYIQELKKDGTPEGIARIENIEELLNGIKDFTDGQVEVDGARGAL
SEFLEDVALATDLDKDTSDDDRVALMTIHLAKGLEFPTVFVVGMEEDLFPSAMSMSTRSE
LEEERRLFYVALTRAEHQAYLTYAQSRYRWGKLTDSEPSRFIEEINGEYLEYITPPETNY
RYKPQIDHDIFGDVDKSKLRLAKPITGTPPKYIANNEPKLDTNIRKLKPLSNNAGSSSPN
LFDNKLVAGNIVMHERFGKGEILNLEGVGADKKAEIKFEVGGIKKLLLRFAKLDVMG
>KACEBFPM_00872 hypothetical protein
MDNSKIFEILAYTLPSLITGAVAYYLFNAHFKDQQNTRRWLLQKENQKDSLPLRLQAYER
MALFLERINPSNLLIRITPFSSDKYQYENLIIEHINQEYEHNITQQIYLTDECWTIIQTA
KNTTIQNIRKTNMSDKVDSANKLREAILSDLLDSQSPSTIALSFLKDEVGQII
>KACEBFPM_00873 hypothetical protein
MKKGFIYILSNNSLKENLFKIGKTSKSTSQRTKQLSSSTSIPESFEILHEFEFSDLNWAE
REVHKELDKYRYNRKKEFFNCEIEIAKSAILKIQVIDKENQINLLKSNLEIAKKTINSNE
FIKSKWSYFLNNIQWNFKEQNFLNSKSEPDFIIETKDWFGQSNEETQEDEIIIFDKKTLV
FVVPNLDFEETNFDIIQNIKEIQSQITENNRLLIVSNKPFTTLNEIYIGWKYEFHYRVWE
KCKFIETKINFGLFEENQTWFCFVNGIFLTKENLWPEPKKIIELWK
>KACEBFPM_00874 2-aminohexano-6-lactam racemase
MEYFNTFGGNPVSMAAGLAVLNVIQEEEMQAHAKEVGNYLIDGLNTLMQKHTIISDVRGH
GLFIGAEMVKDRTTMEPAITEIDIVVEKMKEKGYLLSTDGPLHNVLKIKPPMPFSKQNAT
EMVQLLDVILSELKI
>KACEBFPM_00875 Chaperone protein DnaK
MGKIIGIDLGTTNSCVSVMEGQEAVVIPNAEGKRTTPSIIAFVEGGEIKVGDPAKRQAVT
NPTKTVASIKRFMGHSFSETTDEAKRVPYSVVKGDNNTPRVDIDGRLYTAQELSAMTLQK
MKKTAEDYLGQTVTEAVITVPAYFNDAQRQATKEAGEIAGLKVMRIINEPTAAALAYGLD
KKGIDQKIAVYDLGGGTFDISILELGDGVFEVLSTNGDTHLGGDDFDQTIIDWLADEFKA
EEGIDLRLDPMSLQRIKEAAEKAKIELSSSAETEINLPYVTATASGPKHLVKKLTRAKFE
QLSDTLVKRSMEPVAKALKDAGLTVKDIDEVILVGGSTRMPRIADEVEKFFGKKASKGVN
PDEVVAIGAAIQGGVLSGDVKDVLLLDVTPLSLGIETMGGVMTILIESNTTIPTKKSQIF
STAADSQPTVELHVLQGARAMAVDNKTIGRFNLDGIPPAPRGVPQIEVAFDIDANGIIKV
SATDKGTGKSHDIRIEASSGLTSEEIERMKKDAEANAGADKIARERVEKINEADSLIFQT
ETQLKELGDKITDEHKTAIEYALTELRMAHQSQDLEAIQKGLDNVNAAWKTATEAMYAQG
EQGQAAQPQAETQGDDVQDVEFEEVK
>KACEBFPM_00876 hypothetical protein
MITVKYIKKGVEKPKISTPFLIYLSKKRLF
>KACEBFPM_00877 26 kDa periplasmic immunogenic protein
MKNLVVTLITFFTVMTYAQDQKMNQIPQITVSGEGKIKAIPDQGIISLGVENSGKEAVEV
KKANDIIINKILKFIKSNNIPSTDFQTTNVSLNKNYDYEKKKYNFLASQTVTVTLKDLTK
YNEFMMGITETGVTNIHGVEFKSSKIEIYEAEARKKAILNAKQKALDYVSVLNQKIGKAL
IISDNSQVFYPQPMYKDVKRAMFEDVSVPRETLAIGEIEISANVQVTFVLD
>KACEBFPM_00878 hypothetical protein
MNIFLILIIASNLIFSYKGFTDISFFRKNEFHIGSIRAGEQSRMFSSAFLHADWGHLFFN
MFTLFMFAPIVINNLGNIFFLVIYLSSLFAGSLLTLYFHKNDYGYRAIGASGAVTGILYS
AILLQPEMSLYLYFIPIPIPAYIFGIGYLLYSIYGMKAKNDNIGHTAHFGGAIAGYLITI
CKEPIMLTENTNMVILLALPIILLFVLTKMGKL
>KACEBFPM_00879 hypothetical protein
MINQQNFTFIKTDKKLVKLNFDDILFVKGLGNYVEIFVKNKRKYIYYKTLKDLIDKLPDE
FMRVHNSYIINLKNVQHIEDNHLIIEEHKITVAKSYKDCLTNCINNLLL
>KACEBFPM_00880 hypothetical protein
MKHLLFCLTLIATALTNNLNAQNNLFENDVKTIDALIKASYEVVSGEKGAKRQWERDNYL
HHSKAVYSYFDGEQKKQATMTLEEFHKETDEMVFGTAFYESEVNREVRIFGNIAHVWSTY
ETRLVKDGKVERRGINSIQLIFENNRWYIISWTFSGENDKNKIPKTFDRN
>KACEBFPM_00881 hypothetical protein
MRSYIALEEIKKEYQKDYIQDFEYEKAIKILSENFDKISQALESDFKIITGNELVIYDSK
VYLDDEDFRQGATAYFFRGKFAEDENYLINIECLLDFDKIGIKNQTEPKIEALQKLNQAI
LSKSNSEGFAELRNL
>KACEBFPM_00882 hypothetical protein
MKRIDFIEKYFTNNFYCINKDNFKKLQEIAIEMNCVNPNGDKSIIDLHDGFKNLGIRTKN
GIAKFQKECFLLHNEKTTDYDEMISSYEDLIKSCY
>KACEBFPM_00883 NADH-quinone oxidoreductase subunit L
MEKNLALVLLLAPFCGFLFNVFFGKKAGKMIVGVIGTLSVLISFFATTYFFALIQSNGKP
IQIDLFQWISLEKFNVNFSFLLDQLSILWLMFVTGIGTLIHLYSISYMHDDENMHKFFAY
LNLFVFFMITLVIGSNLLVMFIGWEGVGLCSYLLIGFWYKNQAYNDAAKKAFIMNRIGDL
GLLVGIFILGYLFNTLDYATLKTGVLSNSSILSNPLLSIAALCLFIGACGKSAQIPLYTW
LPDAMAGPTPVSALIHAATMVTAGIFMVTRMYFLFDLAPYVQDIMAIIGAITSIVAASIG
LVQNDIKKVLAYSTVSQLGLMFLALGLGAYEVAVFHVITHAFFKACLFLGAGSVIHGLHG
EQDMRKMGGLKKYMPITFWTMMISTLAIAGIFPFAGFWSKDEILMTAFHGSMTLWIIGSI
ASIMTAFYMFRLMYLTFFKEFRGTEHQKNHLHESGSLITIPLIILAFLAAVGGLISLPGN
SWLNHYLAPLFGKVGHAEHHLDGNAYMLMALATVGALVGIGLAYFKYIKNSEVPSEDSEI
TGVAKVLYNKYYVDEIYDAVIVNPLYKASHFFRKYVETAVSGFVFGLGKITNEIGNQGKI
VQNGSIGLYLFAFVLGVSSILIYLFLV
>KACEBFPM_00884 NADH-quinone oxidoreductase subunit M
MNVSFILIFLLFGAVATYFAGDKLAKTVALFFSLASIVGSIFILNQYNHGINSDFIANWI
SNPNLYIALKVDGLSLAMLLLTTVLTSIIIFSSFGNEYKNSKSFYALVLFMSFAMVGTFL
SADAFLYYIFWELSLIPIYFIALIWGSGDPEARKKAVIKFFIYTLAGSLFMLVAFIYLFQ
KVGSLMIGDLYAIHLTNQEQFWIFLAMFLAYAIKIPIIPFHTWQANVYQKSPTVGTMLLS
GIMLKMGLYSVIRWQLPIAPFAAKMYMPILIGLSIAGVVYGSIVALQQRNIKKLLAYSSL
AHVGLIAAGAYTLTLDGLRGAVLQMIAHGFVVVGLFFAAEVIERRFNTQEIAEMGGIRIQ
DNKFASMFMIVMLASVALPGTFNFVGEFTLLYSLYSANIWFAVIAGTTIILGAVYMLKMF
QHVMLGEANEKTFKSITANESIVFVVIIVVLLFFGLFSKPITDLVTPALQEILLKINKV
>KACEBFPM_00885 hypothetical protein
MKKLFWNILKFILSIFIIFGGIQHFVKPSFYIPFVPLFLPYTTAIIYISGIIEIVLGILL
LLNKKYARYGALGVFFLMLLFLPIHIWDVFSKNPAIGSHNAALIRLPIQFVLIIFAWKIY
DKLSKKEEN
>KACEBFPM_00886 HTH-type transcriptional activator RhaS
MENYKNLQDTLSFFNIDCNNSYYISTGKSIFEFPNEPFRMDYYTFCICTKGEIDLEINGI
KYKISLGSIICSAPSTIVHFLNATNDFQMQLVFFDKIFLLTNISDPYIIEKMGLFQNDSY
SIVNTSKKNIKNVLNIVGKLKNEEKNTSDFIIPKIRTLIFLLLIEIAEIYIKVAPETIAD
KDPQTNLFFRFNKLIQENILLHKEVTFYANQLCVSNKYLIEITKKTTGKTPHEIINEALF
KESVVLLGNPNLSISEIAYKLQFNSISAFGRFFKHQNNCSPSDYKRGR
>KACEBFPM_00887 hypothetical protein
MNTFETQTGFSIELIDNRLILKGEYKNLPLYESIGGKITAIAIVKTPAVEINSIADEDTK
MLYGVVMSPNLNIFRDTGRNGIKENCYWYFSAHTIKKLHESYNGKIKIGH
>KACEBFPM_00888 hypothetical protein
MNLEQYIDNINRRYKLGNATEHTFRGDLQQLIESLIPEIRATNEPKRITCGAPDYILTKK
DIEIGYIEAKDIGDKDLSGVKKTGNKEQFDRYKSALPNLIFTDYLDFHLYIEGVFITKIA
IAEIQNGTIVALPNNFATFTNLLKDFCSFVGQTIKSSKKLAEMMAGKARLLSDVIELALT
NDENNSEDSTLKDQMNAFKEILIHDITPKGFADVYAQTIAYGMFAARLHDPTLPTFSRQE
ASELIPKSNPFLRKLFGYIAGPDIDDRIKWIVDSLVEIFLACNVAEILKNYGKSTKMEDP
IIHFYETFLSEYDPKLRKAKGVWYTPKPVVNFIVRTVDEILKTEFDLQQGLADNSKTKIK
VNLQATDKRFKDNIRTVEEEVHKVQILDPATGTGTFLAEVVKHIHSKFKGQQGVWSNYVE
THLLPRLNGFELLMASYAMAHLQMDLLLTETGFKPTKDQRFKIYLTNSLEESHPDTGTLF
ANWLSSEANEANFIKRDTPVMCIVGNPPYASSSTNKGKWIESLTADYKKELKEKSYNSLS
DDYVKFIRLGQHFVDKNGTGILAYISNNSFIDGITHRQMRKSLLESFDKIYILDLHGNTT
KKEVCVDGSVDKNVFDIKQGVSINIFIKTGNKKKNELGKVFQYDLQGKRDFKYDFLIENT
LKSIEWKTIDIIKPEYLFLQKDNSVKLIYENGFSINEIFSKSSSGVQTEFDELAIHNTRE
KAERTLLDLKNLTEIDFATKYNLHSKINKITIAKNDVLTNNVSIQKIDYKIFNKLFCIYT
GKTNGLMGRPRFEMMKNIISKQNYSLCLLRSLIDSTNFSSIFVSRDMVDKNLYGFQTSLF
PLYRYPETNGQLSTELNTERIPNLKAEIVDKIANELNLKFTNEKEKTASSFSPIDILDYI
YAVLHSPKYRTKYKDFLKTDFPKILYPKNEKTFWKLVELGSQIRQIHLLESPKVEEYITE
FNIDGDCIVSKPNYKDGKVYINETQYFENVPEVAWNFYIGGYQPAQKWLKDRKDRKLEFD
DIAHYQKIIVALTETDRIMNEIDKIEIE
>KACEBFPM_00889 Alginate biosynthesis protein AlgA
MNKDYYAILMAGGVGSRFWPVSTTEFPKQFHDMLGSGETLIQKTFSRLAKLIPAENILIL
TNESYNHLVLEQLPMVKQEQVLLEPAMRNTAPCILYASLKIQKANPNAVMVVAPSDHWIE
DETAFARNLQECFDFCAKENALMTLGIQPTFPNTGFGYIEYDKTDANPIKKVNQFREKPD
YETAKLFLDSGNFLWNGGIFIWSVKTITEAFSVFQPKMNDLFLQGLESYNTPAEKQFIEE
NYALAENISIDYAVMETAKNVYVLPATFDWNDLGTWGSLHEKLDKDENNNAVVNAKVLLE
NSSNNIVRSDADKLIVIDGLHDYIIVDKEGILLIYPKSKEQDIKSIVKKLEQN
>KACEBFPM_00890 Protein SprT
MKTVLEKYIPEHSVAPVFELIKINQVHLKIVNERVTRHGDYRKSLSGKHEITVNTSLNKY
RFLITLIHEIAHLVAFEKYGRSIKPHGEQWKLTFQRLMVPFIRPEVFPNQLLPLLARHFR
NPKASSDTDATLSLALKEFDPENDKNYIFEIPYGSMFRIHNGKIFKKVALRLKRYECLEI
NSGRTYLFNPNAEVELLKN
>KACEBFPM_00891 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKNIIITGTSRGIGYELALQFANAGHNVLAISRKIPQTLIDNNNVTCLSVDLSNEEALQE
VEKFLSQTWKKVDIIVHNAGSLLLKPFGEITSQEFENIYKVNVFGVANLTRICLPYLQKG
SHVVTISSMGGIQGSMKFAGLAAYSSSKGAVITLSELLAEEYKEKGISFNVLALGSVNTE
MLQEAFPGYQAPLSATEMADYIYNFALTGHKYYNGRVMQVSTTTP
>KACEBFPM_00892 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MATVITMPRLSDTMTEGTVAAWLKKVGDKISEGDILAEIETDKATMEFESFNSGTLLYIG
IPEGESAPVDSLLAIIGNEGEDISGLLNGDTVSLIKEEKAEIAPVANTQDLKPETTLPKG
VVVVTMPRLSDTMTDGTVATWLKKVGDKVAEGDILAEIETDKATMEFESFNAGTLLFVGI
QEGESAPVDSVLAIIGPEGTNIAGIAENYKKVGNVTPEASEPVAEKAVEVSNPTSNNQNS
SSNPTDRIFASPLAKKIAQDKGINLSQVKGSGENGRIIKEDVARFAIESQKPKVESQPTT
KAQGASPVTQFVPAGEKFSEEIKNSQMRKTIAKRLSESIFTAPHFYLTIEIAMDEAMKSR
ATINTIPDTKVSFNDMVVKACAMALKKHPQVNSQWREDAMIINHHVNIGVAVAVEDGLVV
PVLNFTDQMSLTQIGSSVRDLAGKAKTKKLTPAEMDGSTFTVSNLGMFGITEFTSIINQP
NSAILSVGAIVEKPVVRNGQIVVGNTMKVTLACDHRTVDGATGAQFLQTLKQFVENPVTM
LA
>KACEBFPM_00893 Acetoin:2,6-dichlorophenolindophenol oxidoreductase subunit alpha
MKEITKEVYLKWYEDMLLWRKFEDKLAALYIQQKVRGFLHLYNGQEAVLAGALHAMELGK
DKMITAYRNHVQPIGMGVDPKAVMAELLGKVTGTSKGMGGSMHIFSKEKGFFGGHGIVGA
QIPVGAGMAFADKYFGRDGVTLTYFGDGAARQGSLHEAFNMAMLWKLPVVFIVENNGYAM
GTSVERTANHTDIWKLGLGYEMPCGPVDGMNPVKVAEAMHEAIDRARRGDGPTFLEMKTY
RFRGHSMSDAQLYRSKDEVEEYKKIDPITQVLDVIRDEKYATEEEIEAIDERVKNLVEEC
ATFAEESAFPEVQQLYDVVYDQENYPFIPHRL
>KACEBFPM_00894 Cytidine deaminase
MKEININTRLSVFESMQALPSDVNELMQKAIEIRKNAYAPYSKFNVGAAILLDNGKVALG
SNQENAAYPSGLCAERVAIFHAGAIYPNAKIIKMAITAGSTKTATTKPIPPCGACRQSIF
EYEFKQGIPIEIYFMGETGEIYKSDSIQNLLPLTFDKNFL
>KACEBFPM_00895 hypothetical protein
MKKVVFILAGLFIGINANAQTERPITTGVPFLLIASDARAAGMGDNGVATSPDAFSQLYN
PAKYAFSIKKQGFAVSYTPYLTALVNDISLGQLNYFNKINERSAIGTSLRYFSLGEIQLT
DDQGNNKAIVKPNELALDLSYSLKLSEKFSMAVAGRYIRSSLKVSSETVDASAASTFAID
VAGYYQSDEIAYSDFNGRWRGGFNLQNIGPKLNYDGATGAENNANFLPSNLRIGGGFDFI
LDDYNKISTNVEFSKLLVPTPQIVVPVDLNGDGDTSDQGENGIAQANTNYKAIGWTSGIF
KSFGDAPGGFSEEIKEFTYAIGAEYWYQDSFAFRLGYFHESEEKGKRKYFTLGAGFKYNV
VTLDVSYLFSASKVPNPLENTLRFSLTFNFGDDYDQN
>KACEBFPM_00896 hypothetical protein
MYRQNITTATSQVESSVLKTGNWRKFYVEKSGVYAISKPFLSGLGFNVNVDPRTIKIYGN
GGRMIPLLNSVPYPTDLAENAIQFVGENDGVFNEGDFILFYAEGVDNYNNDSDTHVNLYA
DKSYYYVTSSASIGKRITPILESPQPPDAIFTTYDEYQYHEIDKTNLAHLGRRWFGEPFN
INNNQNFDFSFPNIVTTNPVSVKVQVGAVSTNNSSFSIKVNNLNVGNINLFGVSSYALGS
EGAFSNTINTTSSNISVNLNYNNNGVPSGIGYLDYITLKAKSNLKGYGKQFRFSVDAVSS
SIGICEYQISNAASIGQVWDITDIYNVSTKFNTGQAQFSLKTFMGEAKKYIAIDNVDFYT
PLKDLNTNVFNQDLKGTIFFTKQGVFEDIDYLIITPASLSSQAERLANFHRINSNLNVKV
INLENLYEEFSSGKQDIGAIRNFVKYVYDNASIPARRLKYLCLFGDASYDFKDRIKNNTN
IVPVFQSMESFSLSGSFVSDDYFGLMNANEGNMLGALGLDIAVGRMLVSSLPQAEQMVSK
VIDYYDKKSFGRWRNNLVFISDDIDKVSDATLQTDLDDLANKITLEKPFFNAKKIHADSY
VQETTSGGQKYPKAKLDFINSFGQGALVFNYFGHGGEEGLAGERLFEAKDAMALNNKYKY
PLFITVTCEFTRFDNPSRPTAGEQTYWNPLGGAVSMITTTRQIGQSTGEIFNVNLASKLF
AYGSENYTSVAESVRLTKVMSADSGNNVISYIGDPALKLAIPKPKVKLTKINGVPITGTP
DVLQALGYVTLTGEVTDQFDAPLTSYNGELAINIYDKNINRTTLANDAISLNGVLQIMNF
TTLGETIFRGNASVTNGQFEFSFVVPRDIKIPVGNGKISFYAKNNNALEDQRGHDFSIKI
GGLNTNAVADVVPPKIKIYMNDTSFVSGGITNQSPLFLAFLEDEHGINTASGIGHDIVVY
LDGDEAKPYVLNDFYETELNNYTKGKLKYPFRNLAIGLHTLTFKAWDVYNNIATASLQFV
VVGDEGLALTNVLNYPNPFVNHTEFWFTHNRPFEPLEVQIQVFTITGKIVWTKNQIVSNE
GFTSRDITWDGRDDFGDKIGKGVYVYKLTVKSNLTNKKIEKFEKLVIL
>KACEBFPM_00897 hypothetical protein
MTAAVPIAIKSGFILPSLVGPIELNSDFTSAEVTEPTVIAKAASAGVPTCGSAVDPSFPA
EITHIIPFEKAISTALEATDVCPFILA
>KACEBFPM_00898 hypothetical protein
MIDTNNLRDFNSTSTSLSWSDGNKNYKFTFGDSQIWQKFDSSKQDTFKLKQFDVNIIQDP
FKFLLDSYLNLIGTTKLVENDLVEIYLPLYSFDSKEVEEKSGLNAWNGASKNKGSNTLRP
LNEVYIPVPIDFHRKYPTFFTKDILTLIKDRANYDGSKENRPTVRFHLQLPNGKRIPSLL
TGDNLKNFQSGSNTEYDENGKRFGQSALGQWLLLDVLGLKERKLVTREWLQKKGTDSVRL
WRKKDDYSIINIDFAPVGSFESFMKDEPIPQDEEL
>KACEBFPM_00899 hypothetical protein
MKDYSILDIPTVLNSPIVLKDISFNCPVCDFEIEIDLILINENSIECENCEHITLIKIKN
I
>KACEBFPM_00900 hypothetical protein
MEQKGNKHENYEILNLLGYGLSKFDNSFIKEFGFTTKTNFFNYFVEIGIVETGSVVKNRM
DLFDPFFPNNGRKGWWQKGDAYIHRKYLIDSLFGNENVKGYSDIVKLYLKENYKIKELFV
EVKPIVKSRFKKLQETGLEAELYFMNNFNEISSFNNGILEDARLYGDGYDFQINVNENSY
LAEVKGIREKKGIFRLTEKEFLMASEYKNDYIVTLVLNMNDLPTFLTIENPINNLKFHER
IIKSKETKEYHLISDIC
>KACEBFPM_00901 Modification methylase HpaII
MIAVKEKISIEEFDGKNYQIKLIEPYDKALITHYLHNIRNGVSQHYKEDAVKVLNNFVEY
KQVEEQVNIVVEDALKQLLFEVENVPFPTPNNYTFKFIDLFAGIGGFRLAMQNVGGKCVF
TSEWETSAQKTYRENFGEIPFGDITKERVKNYIPQEFDILCAGFPCQAFSIAGNQKGFAD
TRGTLFFDIEQIVVKHKPKVVFLENVKNLVSHDNGNTFKTIISVLEDKLGYKVFTKILNS
MTHANIPQNRERIFIVAFDPNQGENYSYKFVA
>KACEBFPM_00902 Energy-dependent translational throttle protein EttA
MSDDKKVIFSMSKLSKTYQGADKQVLKNIYLSFFYGAKIGILGLNGSGKSSLLKIIAGVD
KNYQGDVVFAPGYTVGYLEQEPILDDSKTVIEIVREGVAETMAVLDEFNKINDMFGLPEY
YEDADKMDKLMDRQAALQDKIDSLGAWEIDTKLEIAMDALRTPEADTPIKNLSGGERRRV
ALCRLLLQQPDVLLLDEPTNHLDAESVLWLEQHLAQYAGTVIAVTHDRYFLDNVAGWILE
LDRGEGIPWKGNYSSWLDQKSSRMALEEKVASKRRKNLERELDWVRQGAKGRQTKQKARL
QNYDKLLNEDQKQLDENLEIYIPNGPRLGTNVIEAKNVAKAFGDKLLYDNLNFTLPQAGI
VGVIGPNGAGKSTIFRMIMGEQETDSGEFLVGETVKIAYVDQSHSNIDPNKSIWENFSDG
QELIMMGGRQVNSRAYLSRFNFGGGEQNKKVNTLSGGERNRLHLAMTLKEEGNVLLLDEP
TNDLDVNTLRALEEGLENFAGCAVVISHDRWFLDRICTHILAFEGDSEVYYFEGGFSEYE
ENKKKRLGGDLTPKRLKYRKLIR
>KACEBFPM_00903 Asp/Glu-specific dipeptidyl-peptidase
MQHYKLYNAMKYLKLFLLLFIIQTQAQQGGMWIPSLLSGMNETEMKNLGMKISADDIYSV
NHSSLKDAVPHFNGGCTSEVISPKGLILTNHHCGFDAIQNHSSVDHDYLTNGFWAMKMED
ELPNENLVVTFIVSINDVTAQILDGVASITSETEKQNKIQENITKVTASFAKEAWQENKV
RTFFEGNQYILFVTEVFKDVRLVGAPPSLIGKFGSDTDNWVWPRHTGDFSMFRVYANKNN
HPAAYSKDNVPYIPKHFLPVSLDGVQEDDFTMVMGYPGKTQEYLPSFAVAQIVNETNPAK
IEIREAALKVQDGFMRKDNAIKIQYASKYAGVANYWKKWIGESQGLKKSNAIGLKQNFEK
DFQQKVIAAGKQNEYGNLLADFQKYYTEITPYAVSRDYFNEVVVKNTELLSLGYKLYQLE
QVFITKGEQAFNDRKENLIKSQADFFKDFNATVDEKVFEQLVALYATKAPKEFLPISLLN
VEYKKFAPSIYSKSKLVDYANFKALLSGDAKAVLKKISLDKGYAFVKSLADNYSKNIAPR
YDEINLKINALQRIYMKAQLELYPNSRIFPDANSTLRVTYGKVKGYSPKDAIYYNPTTYL
DGAIEKYIPGDYEFDVPKKLVDLYNNKDYGQYGENGKLPVCFIGTNHTTGGNSGSPAVDA
QGNLIGLNFDRVWEGTMSDIHYDPSICRNVMVDMRYVLFIVDKFAGAKHLINEMKLVHPK
KK
>KACEBFPM_00904 hypothetical protein
MRKHILMKKILPFFSYLFHPIFISVLATVFYFFITKDRYFIYEAIYLYTIQVLIVTVFIP
LAIFYLLIALEKIDSVMVTNVSQRKIPLIIHISLLSLFIIRSGTKETVPELFYFFLGSII
SSLIALLLVYFGKKVSLHMLGMASLTVFCISSCMYFQVREIIIISTLLLSTGLVASSRLY
MKAHSIKELVLGYLIGLFSQLLLLFFWL
>KACEBFPM_00905 hypothetical protein
MQKLFNVVLLLFCLNVFSQEELNFSAIDSLYREDQFYFGVTYNILNLKPIDVSQNSFSTG
LNLGFLRDFPINKMRTFAVAPGLGFSYSNYKENLRVDDFGGSINYSVIPSGVSYEKNKLA
LYFVDLPVEFRWRTSTFESHKFWRVYAGFKLSYLFLSQSRYVDGDKIFKINNNPDVNKIH
YGAYLSAGYNSWNLYAYYGLNNMFKNGALSRDPIELSTLNVGLMFYIL
>KACEBFPM_00906 Alternative cytochrome c oxidase subunit 1
MAAASHDHDHAHDHDHEHHHKDTFITKYIFSLDHKMIAKQYLISGIIMGIIGVIMSLLFR
LQIAWPEQPFKIFDFLLGDKLAPGGVMRNDIYLALVTIHGTIMVFFVLTAGLSGTFSNLL
IPLQIGARDMASGFLNMLSYWLFFTSAVIMLSSLFVESGPASAGWTIYPPLSALPQAIPG
SGTGMTLWLVSMAIFIASSLMGSLNYVVTVINLRTKGMSMTRLPLTIWAFFVTAIIGIVS
FPVLLSAALLLIMDRSFGTSFFLSDIFISGEVLHYQGGSPVLFEHLFWFLGHPEVYIVLL
PALGITSEVIATNSRKPIFGYRAMIASILAIAFLSTIVWGHHMFVSGMNPFLGSVFTFTT
LLIAIPSAVKAFNYITTLWKGNLQLNPAMLFSIGLVSTFISGGITGIVLGDSTLDINVHD
TYFVVAHFHLVMGISALYGFFAGVYHWFPKMFGRMMNKNLGYIHFWITAICAYGVFYPMH
FIGMAGLPRRYYTNTNFPLFDDLADVNKVITTFALIGAAFQLVFMWNFFTSIFYGKKAVQ
NPWRSNTLEWTTPVEHVHGNWPGAIPEVYRWPYDYSKPGHDEDFVPQTVPMKEGEEELHH
S
>KACEBFPM_00907 Alternative cytochrome c oxidase subunit 2
MTSLLVIIVLLLVGVAIWQMTKIFDLTQIGANKNSSQIADNKDNNLQGYLMFGFLAFLYI
FIIFGLFKWSHLVLVDPASEHGKDYDSLMAITFCVVFFVVAITQALLHYFAFKYRGAEGK
KAIYFADNDKLEFIWTIIPVFVLAGLILYGLYTWTNIMFVDEDEDVMYVELYAKQFAWTA
RYSGKDNVLGKANVRLIEGVNTMGVDMEDPNAQDDISVSELHIPKGKKIVFKLRSQDVLH
SAYMPHFRAQMNCVPGMVTQFAFRPIMTTDEMRQTEHMIEKVANINKIRAKKSIELVANG
ESPLDPYTFDYLLLCNKICGASHYNMQMKIVVDTPEEYQDWLKSQKTIVNAIADEKAAKA
AESTPVATTVVIKKVDSAKVAVVATPVAVK
>KACEBFPM_00908 hypothetical protein
MYTFSSKLKNLSFILMLLGALGIGYGFFTAPKNTQDVEAILASSHGEHHEVSAHELKATH
VDVAHATSVVKNSVALNENHLDSVSKMATEKHIVSKEKVSLTDAHVEHEEHVAHVLGQLQ
NKPWAALYVAALFFMLISLGVLAFYAIQHAAQAGWSPVLFRVMEAITSYLVPGAIIVYVL
LVLSGLHFNHLFIWMNEGVTELGNENYDEIIAGKSGYLNVPFFLIRAAIFMGGWILYRNY
TRKNALALDETNDVTYYKKNFKASAGFLAFFLVSESMMSWDWIMSVDPHWYSTLFGWYVF
ASFFVSGITVIALITLYLKSKGYLENVNNSHFHDLAKFMFGISVFWTYLWFSQFMLMWYA
NIPEEVTYFKFRIEHYNLPFFGMVAMNFVFPILILINTDFKRVPWIISMAGVVILCGHYL
DFHNMIYPASVGDQWFIGISEISSILFFVGLFIFVVFTTLAKQPLLPKGNPLIEESKHFH
Y
>KACEBFPM_00909 Cytochrome c6
MKKVYTLAVLMGMSSLLFSCQDKLKPNYQFFPNMYESAGYETYSESSAFKNGKEGQLPVQ
GTVKRGFVPYEIPNTPEGYLASKKINTTPLDSTKVDSDKGKVLFDIYCAICHGEKGDGKG
NLVKREKYLGVPSYADREVSVGSIYHVETYGLNSMGSYANQLSQTERWQVAAYVLKLKSE
L
>KACEBFPM_00910 hypothetical protein
MSNKVIHALYNDDDVLMDAVKQTRLAHHHIEEVYTPFPVHGLDKAMGLAPTRIAICAFLY
GLTGLSFGTFMMNYIMIQDWPQDIGGKPSFSYIQNMPSFVPIMFEETVFFAAHLMVITFY
MRSKLWPFKQAENPDVRTTDDHFLMEVAVNNNEDELTSFLKNTGAVEVKVVEKH
>KACEBFPM_00911 hypothetical protein
MSSHYEAPIRKPLVFGNKSYHDVTVDVARPVEGRANKQWWTVFYIALAAFLWGLSCMIYT
ITTGIGTWGLNKTIGWAWDITNFVWWVGIGHAGTLISAVLLLFRQKWRMAINRSAEAMTI
FSVMQAGLFPIIHMGRPWLGYWVLPIPNQFGSLWVNFNSPLLWDVFAISTYLSVSLVFWW
TGLLPDFAMIRDRAVTPFNKRVYSILSFGWSGRAKDWQRFEEVSLVLAGLATPLVLSVHT
IVSFDFATSVVPGWHTTILPPYFVAGAVFSGFAMVNTLLIIMRKVSNLEDYITIQHIELM
NIVIMITGSIVGCAYITELFVAWYSGVEYEQYAFLNRATGPYWWAYWAMMSCNVFSPQFM
WFKKLRTSIMFSFVISIVVNIGMWFERFVIIVTSLHRDYLPSSWTMFQPTFVDIGIFIGT
IGFFFVLFLLYSRSFPVIAQAEVKTILKSSGDNYKREREQNGHNHDNH
>KACEBFPM_00912 Menaquinone reductase, iron-sulfur cluster-binding subunit
MTVANQKQALVQIYNVITGSSIGSSKDEAVMKAAQQLKAAGSKGVLVCGIDDKNAQLLVL
AINKVLSSEAFNTANTRQIRKGNNADVKQLLADMKSGAVHTLIMNGVNPVYSLPNGKEFA
NSLKKVKLSVAFAMKEDETAAVANIAVATPHYLESWGDVSIVKGSYALTQPTIRPLFDTV
QFQDALLSWTGNAQTYYDYLRSSWSGAKSWNQLVHDGVVFTEGISASAGAGADYNGAAST
LAKATSKGLELVLYTKTGLGDGQQANNPWLQEFPDPITRASWDNYLTISQADATTSGIEN
WNVANGGLNGSYVTLTVDGVKLEKVPVIIQPGQAKGTVGLALGYGRKAAMKEEMQVGVNA
YTLYNNFSNVQNVSIAKEEGEHEFACVQLQRTLMGRGDIIKETSLDIFNTKDAEEWNLVP
MVSLDHKEVPATSVDLWESFDRTVGHHFNLSIDLNACTGCGACVIACHAENNVPVVGKSE
VRRSRDMHWLRIDRYYSSETTFEGDNKAKEGSEGLIDSVATLRGMEVPSDNPQVAFQPVM
CQHCNHAPCETVCPVAATSHSRQGQNHMAYNRCVGTRYCANNCPYKVRRFNWFLYNGNDE
FDYHMNDDLGRMVLNPDVNVRSRGVMEKCSMCIQMTQKTILTAKREGREVKADEFETACS
NACTSGAMVFGDVNNKEDKVTELSEDKRMYHLLEHIGTKPNVFYHVKVRN
>KACEBFPM_00913 Inner membrane protein alx
MAITSDPFLVFSSNIFAILGLRSMYFFLANMLEKFSYLEYSLIAILSFVGLKMISHDYIE
IPEWASLGFIAVSLLVGILVSLKMGSEQELND
>KACEBFPM_00914 hypothetical protein
MIKKKHSKNKTNDLELQSKDVLTFSVKSNFYSYSNYPYIVKVITK
>KACEBFPM_00915 hypothetical protein
MPQIKRNKRFHAEIATSSLSDIMFFLLLFFLIISTLANPNVIKMTLPKSKNNEKTNKQHI
TLSVTEDKKFYLDKQEVPFDNLETTLLSKLGATKDQAVIVRIPYNMQVQDLVDVLQIGVK
NNLKFVIATSAGK
>KACEBFPM_00916 hypothetical protein
MIGFFLQAQNDTIAAASSAVIQNVVKDNEISVLGFIMKGGFFLIPIALLLFYTIYVIIER
YLYLKKHTKYDTHLMKDIRIHLNSGHIEMAIASAEKDTTASGNVIKEGLHTIGRPIAEIE
SNMEKVANIEIGQMEQRLGHLGLIAGIAPTLGFIGTIGGVIKIFYSISITENISIGNISG
GLYEKMISSGSGLIVGLVAYSAYHLFNGVIDSFSLNIQRHVLEFVNIIQRPNATNKTK
>KACEBFPM_00917 Folylpolyglutamate synthase
MNYQQTLDWLFAQLPMYQQQGASAYRKDLVNTILLANHLGNPELKVKTIHVAGTNGKGSS
SSMIASVLQEAGYKVGLYTSPHLKDFRERIKINGLAISEDFVIDFVAKNKPFFEENNLSF
FEMTVGLSSDYFAKQEIDVAVIEVGMGGRLDSTNIIKPLVSVITNIGLDHTLFLGNTLEA
IANEKAGIIKPNTPVIVGEYNDKTKGVFLAKAKDCKADIYFASDLITKEYPSDLLGDYQQ
QNKKTAIQTIRVLKPHFSVSEENLKDGLLNVVKNTGLLGRWQQIHSNPKVICDTAHNSHG
LKIVLNQIQKEEFDNLFFVLGFVNDKDLDDVLPLFPKKAKYFFSKPNIFRGLDAKILQEK
ATNFGLTGNIYNSITEAYKEALKLSSQNDFIYIGGSTFVVAEIL
>KACEBFPM_00918 hypothetical protein
MKKIFTFLICAFVIISCKNEKQKSADKKSTEIQKVQQKIIDENNSIQKIEVQKNPNDFIP
NGYIIHKYEGGISASGWEEIKGDLNKDGIEDVVLIIKGTDKNKTVIDENRGKLDRNRRGI
IVLLNKGNYYELAAKNYDCFSSDNEDGGVYFAPELDVNIEKGNLNINYGHGRYGNWSYTF
RYKKGDLELIGFDSYSSRGPVPQFEVSINFLTKKKLTRDNLNKDDDGDNYEENFKDTWEI
IKDKKIIKLSEIKDFDELDF
>KACEBFPM_00919 hypothetical protein
MVWSVQGALTFTSSGNTITVTTTSTIGSTAIIKATLSNGTVITKTISIGSPLLPATGADS
KPIWVRKGMAIGFAVTPIVGATTYDWSIVRTPYPDFPTVCALPIQAKFTLNGTQTINNTT
LTTVNINVGTCSSEYMITCTAKNGCGIGTEVYYRYLTAGASGTSPCRKTTTTLSRYNVAQ
NPLKEGVLKIKIGGPKVVLDDDLGGDSPGIVDGDGPCEGPYPAPVSKPVRTITVLIYDFN
GEKVYANKFEIVNEDKENGMVLKEELTIDDLKLKADKYILVIDDGNKPEKQIIVVE
>KACEBFPM_00920 Calcium-dependent protease
MMKKTFIILALLLTFGIYSQEKVSYNTKNEAVNFIKSNNLIYLETNEPLSKFSNEKITDS
GDNFIIIQTTEENYREKFETFSKAFKNVEPVLIYEDGIKQICFDEIIIKTKSNLEDILKG
IDYTFKANEFEKNQYLVRLNNYDTSKTFDLINTLFKDDRIEYVEPNFIKLNVLQAPPNDP
LLSSQWSINNNGYLGGTVDADMDVDDAWALATSTGIKVAVLDVGVDLTHPDLQANLLPGY
DAINGVPGGGYVGASFHGTACAGIIGAVANNGIGIAGVAYNSKIIPIRVGSATSITVSAA
ATGTNWAWQNGADILSNSWGGGSASTAVNDAINNAVTSGRGGKGCIVLYSAGNSNSSVAW
PALNPQVIAVGATSQCDQRKSPTSCDGETFWGTNYGTNLDVSAPGVKIYTTDIVGSTGYE
TGDYAPSFNGTSSACPNTAGVMALILSLKPTLTGVEARQVLEQNTDKVGGYNLHSRSYRS
AKRNMVQRFRIW
>KACEBFPM_00921 hypothetical protein
MKNLKTIGLLILLTVVTVSCHKDDPTPTPVVSPCDCDTSTTIETKSNVTGVLKKNSGTFK
IDNVTANYYIQVGTPPGITYYYLICNDSILSGITVTENVAINVTFSGSVKEFCAPTGIIF
LYPTQQIKLTQIQQ
>KACEBFPM_00922 Putative oxidoreductase SadH
MKNVLITGAGSGLGKALALHFSKNGWNVIATMIHLDHGKEIMGLPNINCHILDVTSTEII
ENAKTELLQKYKTIDVVINNAGVGYRSFVELSEDDKIESIVNINWLGVVKVCRTFIPVFR
AQNHGLFINISSVAGLVNLPLGSFYHSTKKAVESFSECMAYELIDFNIKVCTVQFGNAKT
NFQANVTKSEKSEIESYNNLMDKITNLLHKKTAKNKDLLPTITQKILSIAQNPPRRFKRF
TIGFDANAISFLRRILGYRLFNSIIRRSVLK
>KACEBFPM_00923 Phosphoribosylaminoimidazole-succinocarboxamide synthase
MNTITTTNFNFPNQKSVYRGKVREVYNINDELLVMVATDRLSAFDVVLPEGIPYKGQILN
QIATKFMELTQDIVPNWLIATPDPNVAVGHLCEPFKVEMVIRGYLSGHAAREYALGKRTI
CGVTMPEGLKENDQFPTPIITPTTKADNGSHDEDISRSAILAKNIVSEQDYLVLEKYTRD
LYQRGTEIAASRGLILVDTKYEFGKTKDGKIVLIDEIHTPDSSRYFYAEGYQDRQNNEEE
QKQLSKEFVRRWLIENGFQGQDGQEIPEMNQEYITSVSERYIELYENILGEKFVKADISS
INDRIEKNVLEYLQNK
>KACEBFPM_00924 Putative aminopeptidase YsdC
MIEKKIEGDTKIGKGPVVTYAPAVQNNLRELIINTALEKEIPFQRLASSRVTGTDTDAFA
YSNGGVASALISLPLRYMHTTVEMVHRDDVENVIKLIYETLLKIENNETFSYFK
>KACEBFPM_00925 UDP-N-acetylgalactosamine-undecaprenyl-phosphate N-acetylgalactosaminephosphotransferase
MMNVKTKIHFEMSERKILLRFFDVVSVLGLLDLLGIVFDFYYFKISETNFYWTIILSVYL
LFFGSVFEMYNLQVASNQFQITKSILLVTFSTVLLYLLTPIITPALPENRFQILLFFSSI
LVSLFLWRIIYVRFFASTRFGKKAILICNKSELEELVKGLQSVDPHYKIEGYINSDTKDL
KEFDSNYLTLINLDTIEDFIIKKGISEIVIASQKTEGITVELYSKLMKLLENGFVIREYT
QVYESITQRIPVQYLARDFYKYFPFSRSNHNKLYLIIVRVLSVLTSVFGLLIGLSMLPFV
LLGNLLGNRGPLFYTQDRVGKNGKIFKIYKFRSMIINAESSGAVFATANDSRITPFGKFL
RKTRIDEVPQFINVIKGDMSVIGPRPERPFFVKEIAQIMPFYETRHILKPGVTGWAQVNY
SYGETIADSLIKLQYDLYYIKHRSIYLDLNIMVKTISTVLFYKGQ
>KACEBFPM_00926 hypothetical protein
MKSKNLSYTTIILLHIGLGILIYMASKLSIPYGLAILSVGLLTILKTQNTKNQVLYFCAY
IVGSEVILRMTGGSLSYEIGKYSVILFMLMGIYFSGFSRNSFLYWIFLILLLPGVLLATV
TLKLDTDIQKSIAFNISGPVCLGISALYCYQRKITLKELDNILFCMLCPIITTVTYMFLY
TPSVKKIITSTQSNFETSGGFGPNQVSTIVGLGVFIMFSRLVFHSKNKQIIVLNTTLLLI
MAFRGIITFSRGGMLSSAVMIALLLLILFFVTQRAAKIKLFWMVVFSFVAFLIIWSYSSS
QTNGLIAKRYANEDASGRVKSTLLSGREEIIGSEFDMFLANPIFGIGVGKGRENRLESTG
ESIASHNEISRMLAEHGSLGALGIVILFVTPLVLYTNNRRHIYLLSFFAFWILTINHAAM
RLAAPAFVYALSLLHIYSIEDQKKLNENIE
>KACEBFPM_00927 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MRVLQIIDSLNAGGAERMAVNYANALADKIEFSGIVVTRKDGILKKQLGNNVPFFFINKT
KTVDFDAIRSLKNIVIENKIDIIHAHGTSFFTAFLLKMTCYHIKIVFHEHNGDRSNQSFF
KNIPLFVSLFFFNKVLVVNKQIEKWFHKKGIKNTSYFPNFASLESFNFETTKLEGETGKR
IICLANLKNPKNHQVLLKAFAVLSLKKEDWSLHFVGENYQDEYSQKITKLAKALGIAESV
FLYGAKSDIANILSQATIGVLCSTYEGFPVALLEYGLAKLPVISSNVGFCSEVILHKKTG
LLFNPMHLQELVLQLGNLKDDFNLRGYLSEELNNLVVSNFSKETIIANLIIIYNSINEK
>KACEBFPM_00928 Glycosyltransferase Gtf1
MKLVVISNAPIIKKHDQRFAYSPYVKEMAVWAKYADEVAFCCPEWKNEKGLLISEIPFSV
SKNFLLSDFNITTIGGVFKAFFQIIYNCYIIFRAMFWADQIHLRCPGNVGLLGAVVQIFF
PHKIKTAKYAGNWDPKAKQPLSYRLQKYILSNTFLTRKMQVLVYGTWEGSTKNIKPFFTA
SYKESDKQSVLPRSLKGIVKMVFVGTLSSGKRPLYAIQLVEKLQKKGFSVQLSIFGEGEE
RKTLEAYILNKKLSQSVILNGNQNSEVVQKNYQESHFVLLASQSEGWPKVIAEGMFWGCV
PLATAISCVPFMLDFGNRGVLLAVDLENDAKDIQDLIQQEQRFQKMSLNAIEWSREYTLD
KFEQEIKLLLHA
>KACEBFPM_00929 Serine acetyltransferase
MNTIRLVISDYKKFKKYGGNFITILFFTQGFWAVLQHRIAYVIYTNFHLPILRQLLLLLC
LCWQKTIEITTGISIPASVRIGHSFYIGHFGGIIINANVIMGNNCNISQGVTIGISGLED
KRGVPVIGNNVYIGVNSVVAGKITIGNNVLIGACSLVTHHVTENAVVLGVPAVKISNKSS
KGYI
>KACEBFPM_00930 tRNA (mo5U34)-methyltransferase
MKTTQEILETNKKQAAFYNNVKQNYITKLWSKFRGGVLNKIRKNIGVHDQAYNLHKVWFD
DLATKKVLDLGCFEGNYLSLYLAEHAKEYIGIDLSDVAIAKLNERLKPFPNAKALAVDFL
SDDFKERDFDLVYAYGVLHHFPNTDILINRLNEIMAKKANIISYDPLETSWPVKLVRVLY
RPFQSDAAWEWPFTKKTVYKYKAAFNILERRGILGKSKWVYLVNILPLSDAKKQAIGKKW
HQQDWENSAVSNSALFRCMHITMKMEKK
>KACEBFPM_00931 hypothetical protein
MKFTLIVCTYMRPAPLLQLLQSVRAQSLYPDEILIVDGSKNHDTRKMLQENLFSNLHYFL
VDDKDRGLTKQRNFGITKVNNATDVVCFLDDDTVLTANYFEEIMQTYALYPKALGVGGYI
VNESKFTFVGQNYTPNLKEFYYDGWKIKDGTRFILRKLLKLDSDQPPGYSSNYSHGRSVG
FLPPSGKIYPVEQLMGGVSSFKKKVFEKLQFSTYFEGYGLYEDADFTIRVSKTGPLYLNT
AAKLNHYHNEVGRPNKYTYGKMVVRNGWYVWRVKNPNPTFIHQWKWNCITIVLTLIRFSN
TFTTAKHKEAFTEALGRTVGWFSLFFNKPR
>KACEBFPM_00932 hypothetical protein
MIIIYYNKQEILEIYHEDLQQKIAVTSTNMAQCICDLSYLFAHQIMVWCHIEAKKYLNAS
SIPELFNFQNKIISYHPKYNYLHNGIGYVDEKLFVAVNKQVTYPTWMMSSFVGAIPSDLI
KRLNAKDFVSNDFDYFLTSVAKLSQPLGVFCYSDPRLLLLDTAFVSSVQSMPSIRKVFQF
VKQHYKFRWVLILFFNYCLYERKIYIIPFLNTVFYKKREIKGSFSEDNTAVPKPVSPVLK
DIDVLIPTIGRKPFLYDVLKDLSKQTILPKNVIIIEQNPLVGSTSELDYLQDKNWPFAIK
HIFTHQSGACNARNLGLKEIKSEWIFLADDDIRFEPDFFEEVFQKIACIGEKAYTISCLR
AGEKKEFKMPVQWNTFGSGCSVVKKTELEGINFDLRYEFGFGEDADFGMQLRNKGTDVIY
LDSPEITHLKAPVGGFRTKHVFDWDADLVLPKPSPTVMLHRLQYNTKEQLRGYKTVLFAK
FYKHQQSKNPFRFVKQMKKKWNASIFWAQYLINKK
>KACEBFPM_00933 Putative teichuronic acid biosynthesis glycosyltransferase TuaC
MKIAFLTSEYPHPKTKGFGGIATSIKNLASGLAQAGYTPSVLVYGQDQDDFFEDNGVAVY
KIKNIKVKGLSLFLTQRKIRILIDDLYAKGIIAVVEAPDWTGITSFIKPKKCPIVIRMNG
SDTYFCAIEKRPSKFKNRFLERRALQKANALLSVSEFTANYTRKLFGLTQKITIIPNGIA
LENFTKKEESITPNTILYFGTLIRKKGCLEIPYIFNEVVKTNPSAKLLLVGSDTSDISTG
SKSTWALMQEMFSPKALANVTYLGRKPYHEIRSIIQNAQVCIFPSYAEALPVSWLEAMAL
EKPIVASNIGWANELMTNGIEGFLIYPTAHQSWANAINMLLLDPILAQKLGSNARDKVKK
HFSNEVLLSKNIDFYSTIS
>KACEBFPM_00934 Serine acetyltransferase
MIKQLLLSDYKRYGIDSVSFFVLCKVFFIMPNPGLKFITIFRLTQYFRKKNRLLFYFFFL
WLRKLKVKYGFDISYRTQIGSGFYIGHFGNIVIHGDTIIGNNCNISQGITIGISNYGKVG
VPKIGDNVFIGPGACVFGDIVIGNKVTIGANTVVTDDIPDGCTVMGSKMTIIAKDLSNFY
IHNLQK
>KACEBFPM_00935 hypothetical protein
MANNKGSLNTTINSFFKSHYLGVTTRVGLYVTIFLRQKKPQKGFPLQSLTQNAINNRIKP
KVFILLPDGIGLRNFAYSNFYDIGRKKQMKVVFWNSTPFLLANLGFEEIKINKTKNNPLT
EIYKNAKTQAELNCNIHKEKDTVYNTYRFPFSYRNIKAIAKSVTIRTLAFSNSSSRGLRF
LRRKMKSEERKTDAYKQAIQTLLAEQPAMVFCTNQRHISSIAPLLAAQDLGIPTATFIFS
WDNLPKATLVVEPDYYFVWSNHMKLELLQYYPDIKDEQIFITGTPQFESHFDASRLLPRT
TFFKNHGLDLAKKYICFSGDDVTTSPDDATYLDDVAQAVAALNAKGNAIGILFRRCPVDF
SDRYDAVIKKYKDIIVPVAPQWEKIGADWSTILPTNNDVTLQVNTIYHTEMVVNLGSSMV
FDYVAHKKPCAYINYDIPKPKDKNWSVKKIYKFVHFRSMPHKNAVVWLNTKQEIAAKLEQ
TLATAATVPWAQKWFEKINQHPPQEASERIWNAITKIIQNKND
>KACEBFPM_00936 UDP-N-acetylglucosamine 2-epimerase
MNKKILFLTGTRADFGKIKSLIQILEAHPNFEPYIFVTGMHLQEEYGYTFLEVQRCGFRN
IHTFQNHTHETTMDLTLAKTITGLSAYVKDCQPDMIVIHGDRVEALAGAIVGSLNNILVS
HIEGGEVSGTIDELIRHATSKMSHIHFVSNDQAKKRLLQMGELHESIFIIGSPDVDIMFS
KSLPDLQTAKKYYEITFNDYAVVMFHPVTTEAKYIAQYANDFVHVLLADTHNYVVVFPNN
DLGSHAIIQAYEKLKNNKRFRVFPSLRFEYFLTLLKNAQFIIGNSSAGIREAPYYGLPII
NIGTRQQNRAAHTHIINVDYNKLHIQEALSSIDSHKVQPSKNDFGQGNSAKLFLASLEKN
DIWQINYQKQFNDI
>KACEBFPM_00937 N,N'-diacetyllegionaminic acid synthase
MAIFDKHNIPVALLHTTNLYPTPIHLVRFGAMQAMHEAFPDKVFGLSDHTLNNNACLGAV
ALGASILERHFTDHMQRTGPDIICSMNEKACAELIVNSAEIALMRGGTKKPAHEEQVTID
FAFATVCTIKPIKKGDVFTKENIWVKRPGTGKILAKHFNTILGKVATQAINDDTQLTWSD
VK
>KACEBFPM_00938 hypothetical protein
MNAYATNLSTTDTYHIKLVIADGVNDNKIDSAVFLGGGSFDFGQDVLGPDLTIANGTAPC
NNNNTNQPYTIYSGLDPNLFDFVWKDINGIPIPGETDPNLTINESGTYLLTYYVQSTSCE
VATNNIVIEYNIPISTPDPINLYKCNNGSANYTFDLATNTPIVGLGSNYLISYYALQNEA
NAGNTSPLPTSYTVASASLPKTIWIRIQNLTTGCYYSKSFILELTPSPIANFPANMLECE
TISASGRADFYLGNIAQTNTVLGAQSSSIYGISYHLTATDAASGANPINTAIAFNSGNAT
IYIAVYVKTEPSCSSIINFNLIVNTKPIIEDKPDQFVCASYYLPALTPALGNYYSGINGT
GTLYAIGHQVSISQLIYIYYQNPTTGCNAQTDFQVTIVKEQDLTPGNVTACDSYPLPNYP
YLGTRYFTNAGGPINGNTELFPPPTGMPITSLGVTTIHVYYQSPTDPTCIIFTSFTVTIS
KTPTITGSYPNLFDCTVVNSLQPISTDIGTAKYYTLAIPTGIYTPVVLPITTNTTVYLFA
ENNNCKTPILNFSVVIGTDSFLDNTDSCGPYNLAAPLVGEYRTQANGGGTIITPRLINTT
TTIFHYVAGAPCTYNYSFTIRIIKPTLTAPAPETRCNLYTLPVNLEGGTYYTLSGGPTTP
LNTQLAVGHIITNTTTLYIYKESTTALLPICYNEQPWTITINQKPALAPIATEYTVCYDF
TIINQPPVGNYYHKPHNPLIPETPIALPYTIFQESTPSNLETIYIYAENPNDASCNSETS
FIIKFDGVAITNEMKKDRYACDTYTLPTLPTNFYYYTATGGPHGTGSIVTQQTYTTSTSA
PIFIYTETNVHQICSDETSFNIIINKTPTAYPVNVIEKCDTFKLNDGIFEFDLTQSETEV
LGTQTPTTDYSITYYTSLAEANNPNAIPIPNSTTYKNNNPNNDSVWIRVSKNNNIPITSC
FAITELKLKVDLLPNPQLNPEYFICKDHKTGTLLNFVTLNTELSNPNYTYTWTLDNAPYA
ANTSVITTNKVGAYSVTVTDTSTILNCPKTITTKITLYEPYITFDYSDAFENSTYITVNV
LGAGSGNYEYQLDNGLYQSSNIFYNIYPGEHTISARDKNEHCAPSPVKAIIINYPKFFTP
NGDGYNETWNIPNLKITNPNAMIFIFDRFGKLIKQMTPTSDGWNGTYNEQPLPATDYWFT
INYNEKETSKIFKSHFTLKR
>KACEBFPM_00939 hypothetical protein
MKIKILILITLLNFTFVKAQNSVPETKNSGSISGKVIDKKTNEVIPYASITIKDGTKIIS
GAITKENGIFSITNLALQELTVEVQFIGYKKQVNNITLTTQNKNITLKTIALEEEATQLN
EVSIVKERSSIEQKIDRKIVTVGKDLIASGTTASEIMNNIPTVSIDPQTKELSLRGNTNV
KVLVDGKPTNISATQLLQQIPSSSIKQIELITNPSAKYSPEGMSGIINIILHKNANTGFN
GSINSGVTFGKTPKLNTALNLNYKIGKVNIYTNYGLNHGKNKNHGYINSFRPMLENEQQF
EFDNLNTSHLLKLGLDYYINDKNTFSIYTNQNITNGSGYGLTDINYINATNSDSSQLFKS
KSDENTQTYDLDFKHDFTKKGENIEFQVNVSNTKDKENTNYDLTQFNPISSALKTNIIHG
KTNYIQFNADYVNPLTETTKLEVGLETRIQNTENNFDESTNKPTTFNSTTTNNAFTFNRN
ITALYTNYSKQWEKWSGQVGIRIENYTIDGDFQRNENAINPTKKFNGNQTIKDNILSFYP
SAFFTYAASEKNAFNFNYSRRVDRPSIEQISPIREWTTPLVESRGNPELKPQFTHSFEIN
YTRTTKIGSITSGVFYRQINSEISRSIYKNPSNNNQDILSYANFNSNNAYGIETSANLKF
TKWWSANASADAYFKTVRGTVENAISGLQEKAAIDVISFNARLNQTFSATKNLKINLFGM
YRGRDLGLQFERSPMYKADIGATYTVLKGKGSITGRLNDVFNTMHFQFDSSIPYKQTGAF
YWESRTVYIGLNYMFGGGKNKALQRKQRDENETQSGGGLL
>KACEBFPM_00940 DNA topoisomerase 4 subunit B
MGPDLPSVRTFVNDFIKTKLDNFLHKNPETADLLLRKILQAERERKELSGIRKLAKDRAK
KSNLHNKKLRDCRVHLTDAKNARSLESTLFITEGDSASGSITKSRDVNTQAVFSLRGKPL
NSYGMSKKIVYENEEFNLLQAALNIEESMEDLRYNNIVIATDADVDGMHIRLLLITFFLQ
FFPEMIKEGHLYILQTPLFRVRNKKETIYCYSEQEKRDAIEKLKPKPEITRFKGLGEISP
DEFKNFIGETIRLDPVMLDKSTSIEKLLEFYMGKNTPDRQTFIINNLKVELDVVEAN
>KACEBFPM_00941 hypothetical protein
MENQDIRWKQRFQHFVNAFKQLKNAKQLKSERAFTELELQGVIQAFEVSQELSWKVMKDF
LEEQGKTDLFGSKNAVKEAFNVGLILNGEIWLEMIKSRNITSHIYDQTEVLAILEIILND
YFPVFIGFEEKMKTYL
>KACEBFPM_00942 hypothetical protein
MFGIYPKSYKEILNIIDSCQSINEVIIYGSRAKGNYKEGSDIDITLLGEISKEDFSKLWH
NLDDSYIPYKFDISIYNNLKSESLIEHIKRVGKTLYKRKY
>KACEBFPM_00943 L-allo-threonine aldolase
MKYHLDGARLWNALVAKRQSPSQFGELFDTISVCLSKGLGAPIGSVLVSDAKTIARALRI
RKIFGGGMRQAGYLAAAGIYALDNHIERLADDHRRAREIAQVLQSLPWIAHIEPVETNII
IFSIQTYLDEKVIIEKLREKGISISSMGYGKMRIVTHLDYREVMHGYVLETFFRLKV
>KACEBFPM_00944 Nucleoid-associated protein
MAMMGKMKETQQKIEDTKKRLDTVLIHEQSSDGLLKVTITANNAIKNISVSDALLEDKEQ
LEDYLVTVINKAIEKATRVNLTELDAVTKVDMPMIPGIEDMFK
>KACEBFPM_00945 Single-stranded-DNA-specific exonuclease RecJ
MRWTIKPKPAEEKVKHLVEVLNIKDFVASLLIQRGIETYDQAKTFFRPSLDDLHNPFLMK
DMDKAVRRIEKAIANNENIMVFGDYDVDGTTAVSLVSSYLKSYYKNVATYIPDRYDEGYG
ISYKGIDYADDNNITLIIALDCGIKSVEHVAYAKAKNIDFIICDHHRPGVFLPEAVAVLD
PKRPDCFYPYDELCGCGVGFKLIQALGENRNQTITDFIPYLDLVATAIAADIVPITGENR
VLAKFGLEVINTNPRPGIKALIQNIKKETLTITDVVFIIAPRINAAGRIKHGNYAVQLLT
EFNLPQAEEFATQIEIFNADRKDLDKQITKEALQQIENNKEENNFTTVVYQEDWHKGVIG
IVASRLIETHYKPTIVFTKSGDKLAASARSVKDFDVYNALEESAAFLEQFGGHMYAAGMT
LKEENYKKFKNKFEEVVKNSIQPDLLIPEIAIDAELKLSDINEKLVRILKQFEPFGPENM
TPVFISKDINDTGYAKTLGKDEEHLRLFVKQNNSEGFAAIGFNLANKKALTENQKPFDAV
YYIDENIWNGNVTLQLRLRDIN
>KACEBFPM_00946 hypothetical protein
MKNRYIILMILLAIALFWNQNTIKPSLWIKIIGLVLFFYGMMKLSAKTPSKNQDNQDNQE
>KACEBFPM_00947 Endonuclease MutS2
MLAKGDNISVLDDAINGVVLKVNGNIVTIETEDGFELDYNEKELILIESSNDLMHNISKT
NFLAVAKEKEIPKPRSFVKEKKSKKEEFVLEIDLHIEKLVPNKRGMSNYDILNIQTETVK
RQMDFALRNRIPKVVFIHGVGEGVLKSELDFLLGRYENITFQDANYQKYGVGATEVYFIQ
KKNNL
>KACEBFPM_00948 Tail-specific protease
MNAIMNFMKRNYKIILAVLAISAALCSFMSKKEKDPEKDKTLLDLITFVIEKAHYNPMAI
DDNFSKGVYKDYLDALDPSKRFFVQADIDEFKTYESQIDDMIHNRDLTFFKLTYERLQKR
MREVEVVYKSLNEKPYDFTIDETINLDSDKNAFAKNYSELKNRWRLQMKLSILATVVEKE
KQETAKKEKDPKYVVKTFSQLEKEARETTIKTLKDYFDFIKESNENDWFVAYVNAIVTQF
DPHTYYFAPDEKEKFDVSMSGKLEGIGARLQKTNDFTEISELISGGPAWRGKELEPGDLV
LKVAQGSNEPVDVTGMRLDEVVKKIKGPKGTEVRLTVKKVDGSIVVIPIIRDIVEIEETY
AKSSIVEKNGVKYGVIYLPKFYIDFENNDNRDAAKDVAIEIEKLKKDGVEGIVMDLRDNG
GGSLKTVVDITGLFIDEGPVVQIKSAKGKKEVLSDHDPKIQWDGPLVVMINNFSASASEI
FAAAIQDYKRGVIIGSKQSYGKGTVQNVIDLNQFVANNAMGDFGALKTTTQKFYRINGGS
TQMEGVSSDITMPDRYSYIKIGERDVKNAMPWDKIDEASFEALKSVNNFETVVADSQKRI
LENAQFKLIDENAKWINDRKEDNVISLNLTKFKAEQTSIEEGTKKFKAISKFQNSLKFTS
LPQETELIKKDSLLGQKRKDWHESLSKDAYVEEAINVLSDIKKPALASKDKVLNIKNRKD
KLVKS
>KACEBFPM_00949 5'-nucleotidase SurE
MSKPLILVTNDDGISAPGIRSLIAVMQEIGTVVVVAPDSPQSAMGHAITINSTLHLNKIS
AENAAVTEYSCSGTPVDCVKLAVNEILKQKPDLCVSGVNHGSNSSINVIYSGTMSAAVEA
GIEGIPAIGFSLLDYDWNADFETFKPYIKKIALEVLQKGLPDSVVLNVNFPKRKEEDLKG
IKICRQAKAMWEEKFDKRKTPQGKDYYWLTGEFVNHDKGEDTDEWALQNGYISVVPVQFD
MTAHHAIQALNNWDLNK
>KACEBFPM_00950 hypothetical protein
MNKTDLFIGALIGFVATFLGTYFFFTFCTEYSFSEGIIGMKNQGFLGKVITLGAILNLVA
FFILLKINKELMARGVVLATILLAVFTMFV
>KACEBFPM_00951 Lipid-A-disaccharide synthase
MKYYIIAGEASGDLHGSNLMKGIYKEDSQADIRFWGGDLMQQTGGTLVKHYRDLSFMGFL
EVVLNLKTILNNIKICKADIISFKPHAIIFIDYPGFNMRIAKWSKKLGIRNHYYISPQIW
AWKENRIKAIKNDVDKMYVILPFEKDFYEKKHHFSVEFVGHPLIDAINNRQKTNATQFKK
DNNLDGRPIIALLPGSRKQEIEKMLSKMLSVVKDFPNHQFVIAGAPSQEYSFYKQFLTNN
QVHFIANKTYDLLSISQAALVTSGTATLETALFKVPEVVLYKGSWASYQIAKRIITLKYI
SLVNLIMNKEVVTELIQDDCNSEKIKAELEKIIQPSYRSTLLENYDLLEKQLGGAGASDK
TAGLIVRDMFKQSSKS
>KACEBFPM_00952 ATP-dependent dethiobiotin synthetase BioD 1
MKLFITGISTDVGKTIASSILVEALEADYWKPIQAGDVNNSDSHKIESYISNKKTIIHKN
SYLLNTPSSPHLAAKIDGITIALPQITQPETKNHLIIEGAGGLFVPLNETDCVIDLIKPD
YKVVVVSRHYLGSINHTLLTIEALQNRKINIAGIIFNGNKNKATEDIILSKTGIKQLGRI
DDEPYFDKNVILEYATLFRENLENL
>KACEBFPM_00953 Adenosylmethionine-8-amino-7-oxononanoate aminotransferase
MNLSERDQKHNWHPYTQHKISQPEIAITKGKGALLWDDNNKEYIDAIASWWVNPYGHSNQ
IIANAIYKQLTTLEHVLFGGFTHEPAVLLSEKLIEILPDNQQKIFYSDNGSTAVEIAIKV
AMQYFYNKNEKRTTIIAFENAFHGDTFGAMAASGISFFTEAFNESLIQVVRIPVPTAGNE
KASAIALTNAIKEHHCATFIFEPLVQGAAGMVMYEASELDKLIKICKENQVFTIADEVMT
GFGKTGKTFACNYLAQKPDMMCLSKALTGGTIPMAITTFTQEIFDGFYDDDVNKALFHGH
TFTANPTGCAAALASIQLLKSDEMQENIKRVNTQHLQFQETIKRHEKVKTTRVLGVIFAL
EIKTNNQESYYGNLRNKLYNFFIKNGIIMRPVGNIIYILPPYIITNEQLQKVYQTIQEAL
EIV
>KACEBFPM_00954 3-oxoacyl-[acyl-carrier-protein] synthase 2
MNKKIVITALSSFSPLGNQPKLIWEQYLKETSLISEKQIGNQTIPVATISEELQKTVEAL
KTSDNKYKSLDNSVLYAILASREAVKNAGWTKNDVFGINIGSSRGATQLFEKHHQEFIQT
GKTGTLASPTTTLGNISSWIAHDLKSSGPEISHSITCSTALHALLNGVAWLRAGMVDKFL
VGGSEAPLTPFTIAQMQALKIYSKEENEYKCQAFDLHKTKNTMVLGEGAAMICLEIDQSK
NALAYIEGIGYATDILEHGISISTEADCFQKSMKMALQNTNLSDIDVVVMHAPGTIKGDL
SEYKAIQKVFNKSLPMLTTNKWKIGHTFGTSGMLSLELAILMMQHNQFIGVPFAEKQTER
KSIRKVLVNAVGFGGNAVSVLLSL
>KACEBFPM_00955 Thiamine-monophosphate kinase
MIEDKTPQRTSIAQLGEFGLIDHLTKQFENTQPSTLKGIGDDAAVLDFASKKIVVSTDLL
IEGVHFDLAYMPLKHLGYKAVVVNISDICAMNARATQITVSIAVSNRFPLEALEELFAGI
NLAAQEYKVDVIGGDTTSSQKGLIISITAIGEADEAEIVYRNGAKETNLLVVTGDIGAAY
MGLQVLEREKQVFNVNPNSQPDLDAYTYLIERQLKPEARKDVRTLLHALEIKPTSMIDIS
DGLSSEIMHLCKQSKVGCNLYEDKLPIDPQFISVCEEFNIDSTTVAINGGEDYELLFTIA
MEDFEKIKGNPNFTIIGHMTQESEGVHLVTRANTKIALKARGWNALEE
>KACEBFPM_00956 NAD/NADP-dependent betaine aldehyde dehydrogenase
MATIAEQFGMTEALAQLGIKAVNEGTSTGSQWFSNGELLESYSPVDGLLIGKVKATTAAD
YERVMQSATQAFKSFRAMPAPQRGEIVRQFGNKLRELKEPLGKLVSYEMGKSLQEGYGEV
QEMIDICDFAVGLSRQLNGQTIPSERPGHVMREQWHSIGVVGIISAFNFPVAVWAWNTAL
AWICGDVCVWKASEKAPLCSVACQNIIADILKANNLPEGISCIINGDYKVGEMMTTDVRI
PLISATGSTRMGRIVGSTVAQRFGKSLLELGGNNAIIITPTADLKVVVPGAVFGAVGTAG
QRCTSTRRLIIHESVYDKVRDAIVGAYGQLTIGNPLDQKNHIGPLIDKESVSTYLAAIEA
AKAEGGKVLVEGGVLEGLGYESGCYVKPAIIEAENTYKIVQHETFAPILYLMKYSGEVEN
AIEVQNGVAQGLSSAIMTNSMKEAEKFLSFSGSDCGIANVNIGTSGAEIGGAFGGEKETG
GGRESGSDAWKVYMRRQTNTVNYSDELPLAQGIKFDL
>KACEBFPM_00957 hypothetical protein
MTPIQAIIKNIIAIFLLVYLFFLLSKTNDKKNFYVVIGITLATIISLFLLAPIKKNTNDF
TVSPIENTLIDSTKNEIIAPILKDSVITTVKVDSVKKAIPTKIEEVISTTEPTKHKSGYA
KLFPKIDTGRKTLCFFVPGCDHCRKAAKELTELKQKNANFPEILIIFMNEEVDLIPDFFK
ETGAEYPYKIIEIIPFWNALGTGKDTPGVKYIWNGNTYKYYNGITDNKFNPIDYQALINK
PFSELKK
>KACEBFPM_00958 Thiol-disulfide oxidoreductase ResA
MQKLIGLLFVIALNISCSNAQKTEFAKETLISKLVAPDASETNLAEIIKKHKGKTLVVEV
WASWCGDCVKNIPNIKELQATHSNTDFVFLSCDKTLEAWTKGIEKHELKGDHYLIPEGMK
GTFGKSIDLDWIPRYIIIDKTGKIALYKAIETDKEKVNILLKSLN
>KACEBFPM_00959 Triosephosphate isomerase
MRAKIVAGNWKMNKNSEETEDLINELIDKLPTNSNAKIIIAPTFINLASAVDHTEFTNIR
VAAQNMHQAENGAYTGEISADMLKSIGVNTVILGHSERRAIFHETDAIISFKVDTALRHE
MTVIFCFGEELKDRQNKQHFNIVENQLRDGLFHIDKSAWANIILAYEPVWAIGTGETASP
EQAQEMHEFIRETVRKVFGSDIAEDVSILYGGSVKPDNAKEIFSKPDVDGGLIGGAALKA
DDFVVIVNGI
>KACEBFPM_00960 hypothetical protein
MSKLTDYYKSLNPLHLFIFGTVFMLLARTAKDNFTFEISCLLASLILYVLALIKYLKK
>KACEBFPM_00961 Signal recognition particle receptor FtsY
MNFFKKIFSSEKKENLDKGLEKSSNSFLSKLTKAIAGKSKVDDDVLDNLEEILVSSDVGV
NTTLKIIQRIEARVSNNKYLGTDELNKILREEIAGLLSETNTGEATKFEIPAHKKPYVIM
VVGVNGVGKTTTIGKLANQFKKSGYSVVLGAGDTFRAAAIDQLQIWADRVGVPIVRQQMG
SDPASVAFDTLQSAVAQNADVVIIDTAGRLHNKIGLMNELTKIKRVMEKVIPEAPHDVML
VLDGSTGQNAFEQAKQFTAATEVTSLAVTKLDGTAKGGVVIGISDQFQIPVKYIGVGEGI
NDLQVFNKYEFVDSFFK
>KACEBFPM_00962 Dihydroxy-acid dehydratase
MNTINKYSKTITQDETQPAAQAMLYGIGLTEADMYKAQVGIVSTGYEGNTCNMHLNDLAK
DVKFGVASENLVGLIFNTIGVSDGISNGTDGMRFSLVSRDIIADSIETVVSAQWYDAVLA
VVGCDKNMPGSVMAMGRLNRPAIMIYGGSIHSGKWKGESLNIVSAFEALGKKFNNTITPE
DFKGVIKNACPGAGACGGMYTANTMASAIEALGMSLPYSSSNPALSQEKKQECLDAGKAI
RVLLEKDIKPKDIMTKKAFENAMTMVVVLGGSTNAVLHLIAMAHSVDIELTLQDFQKTSN
NIPVLADLKPSGKYLMEDLHAVGGVPAVMKYLLENKLLHGDCLTVTGKTVAENLANIPSL
HQGQTVFLPLKTPLKATGHLQILYGNLAPEGSVAKISGNEGDFFEGKAKVYNDEYTVIDG
VKNGEVASGDVVVIRYCGPKGGPGMPEMLKPTSAIMGAGLGKNVALITDGRFSGGTHGFV
VGHITPEAYDGGTIALVKDGDTITINTKNNTIQLKVSEEELTKRKSEWKQPKLKATKGVL
YKYAQCVSSASKGCVTDN
>KACEBFPM_00963 Branched-chain-amino-acid aminotransferase
MYYNNNTLIYLDGKFVKANEATTDLYSQTLHYGYGVFEGIRAYKTAHGTHVFKAQEHYER
LKKSAELVNIPFGYDVQELVEATYALLEKNNLSDAYVRPLVFCDPNMALARPNKVSVMIC
AWEWGAYLGDKQLRLTVSSYCRPHPRSIKIEAKVCGHYINSILATNEAKDKSFDEALLLD
SDDYLAEGPGANLFFEKDGKLFTPQLGNILPGITRATILELAEKLGVEVIQGLFTTNDLE
AADSAFYCGTAAEVIGIESVDATVFPKEWSKTLGKKLQDEYSKLVRKSEKK
>KACEBFPM_00964 hypothetical protein
MQKKILSIVMLTALTLNSCKNNSEVTKTVPDEIITSSETDNKGNKLDIDFNNTKSTATLK
LNGEIIEMVLDTTMASGANYKNEHYHYTNWHNMTILEKDGKVIFEAGKEKTPSASNMSNF
EGTYIYGKKEGANDWVEINIKSLKNQDSCSIVVNSKTINNKKGCEFNKLGLLKNDTIFIK
TTDWKRPVTVIITKKTNKITIDAIEKQTDDRFVLNWYCSGGGSLIGDYIKK
>KACEBFPM_00965 hypothetical protein
MVLSEVLSPCEYLILRVAGSVPAVALVPIEKESNDEVFQVAVTLCTLSTVTVTSAGCAA
>KACEBFPM_00966 hypothetical protein
MAGRPKPTYHCPSFMPPLFITGSAEVVYILCPSIPVGKQAPGPLKFGVVQAPWCGPPYNM
SLLRKLVVLVVAPE
>KACEBFPM_00967 Peptidyl-prolyl cis-trans isomerase C
MPVEHAEALFNLAPGQFYGPYMFGDYYGITKNLGRKVNANAKASHILISYEGTQVPNKKE
KRTKEQAKAKAVSLLAQVLANPSAFQMLAYTNSDDSSSQQGGDLGYFSQGQMVKPFNNFV
FSNPVGKIGLVETDFGFHIINVTDKQDAVRLATLAQKISPSEVTSDKVFTTATKFEMAAN
EKAFDVAAKEMKLIVAPAAKLLALDENVQGIGNQREIVRWVFGAKEGEIKRFNIPTGHVI
ARLKKVNEAGLLPIEEAKMAIGTKLRNEKKAELIKVKMSGSTLEAVSKATGSPVKEVLDV
VAANAYIQTIGVEPRVVGTAFSLKNGVVSQTIDGNSGVFKIKVKSSIKAPVAANYTDISA
RLSGQSKGSVSGRVYNALKKDATIEDNRAQFN
>KACEBFPM_00968 Glycine--tRNA ligase
MAKQEDLFKNVISHAKEYGFIFPSSEIYDGLSAVYDYAQNGAELKKNIREYWWKSMVQMH
ENIVGIDAAILMHPTTWKASGHVDAFNDPLIDNKDSKKRYRADVLIEDYAEKLNQKAEKE
IEKASIRFGESFNREEFVTTNTRVIEYLSKKNEILTRMARALETENLADVKALIEELEIA
CPDSGSRNWTEVKQFNLMFGTKIGASADSAMDLYLRPETAQGIFVNFLNVQKSGRMKIPF
GIAQTGKAFRNEIVARQFIFRMREFEQMEMQFFVKPGEEMKYYEYWKTTRLNWHLSLGLG
KENYRFHDHEKLAHYANAAADIEFNFPFGFKELEGIHSRTDFDLKAHEKFSGKKLQYFDT
ETNANYTPYVVETSVGLDRMFLAVFSNSLKEETLEDGSTRTVLQLPSVLAPTKAAVLPLV
KKDGLPEVARKIIEKLKWDFNVAYDEKDAVGRRYRRQDALGTPFCITVDHQTLEDETVTI
RHRDTMKQDRVKISELRDIINNEVSVKNWLMKM
>KACEBFPM_00969 hypothetical protein
MTSRTVLTMIKLSSIISISIAMVFAVKYHDSQNKYKKLKEAIQIDKKTYSNDLREIFNLY
DSELLKNKKLIQYKNLKKENETVSNKRDLKNNKNLDNQVLALKNNFINKIDSLNSNLKAQ
TEEKKHLENQLIALINKNKELQKHHANNENTAAISKNLKAIDISAKAIQIASNSIIETNR
LSKTEQIKVCFTLLENKAALKGNKDLYIQILNPNNKIVNKNGEIAKTEDKLLNFSAKTNV
FYDNDKLDVCLFVDPNKDDMQKGDYKINIFSGINLIGNTVFSLK
>KACEBFPM_00970 hypothetical protein
MYFYSTANIIDKMLKNLIKLFFPAICSGCSEILLQNEHTICILCRHKMPFTTDLLVDDNQ
SFKKFYGRIPIEHASSMLYYHKKGIVQQLIHNLKYKNHQEVGLILGEWYAHDLNKSEKLK
NIDYIIPVPLHKKKLKERGYNQVATFGKAIAKGLEKEYDDTVLVRCQYAVTQSKKNLINR
NAVSENSFEAHFSEGHHNKHFLLIDDVLTTGATLEACGKAIFKIPGAKLSIVTIAMSQS
>KACEBFPM_00971 hypothetical protein
MKKVLVLVVLFVSSVMAAQDMEVTKGDFNFLKDQKEINVEFLYGNLKLFKENKADAQYVA
ERTAELNEKTKGVGTAWAKKWYSSRDLSFEPKFLELVNIVLTKDKKELSFQEGLKDSKYT
LIVDLEWVYPGYNVVMAKKGAKVSTVLKFVETTNRNNVVLAIKSDEAPGDVFGGSFSNED
RIAEGFAKTGKSLAKLILKRAYK
>KACEBFPM_00972 hypothetical protein
MKNIKIILSIFTFGFLSSCVNDTFEDPKTKDCISAGLVKNKEVADIYAIAINPTGSIPNT
PTYTANDIIEGYVVSSDEGGNFYQNMYVQPIGGGKGYNLSVDLGNVYNKGYEPGRKVFLK
MKGLAYGNPTNFAAGLIFGAPPTDKYTVDRLPALDLPKHLIPSCDAVNEDAIVNHITLTQ
AKAPNNPYLNTLVEFDNVQFETEGISYDTDRSDKFDSSITIEDGITSFIVRTSRYAGFAG
NIVPSKKGKIRGVLTKYGTSSYQLILRTERDVKLTQPRVDFATPIVGNANVFTGTLNEPF
TTYAVDQVNFPKYINDANVSSRYWSLKQYPTGTGNKYIEMSSYGGGGVTAKTYFLVPVDF
TAANTFTFKKQARYYSGGTPLQVYYVSSANYVPGSVINSSVFTNITSNFTISYPAVSGSE
TAFSSVGTYSIPAGLTGNGYFVFEYSGTPALTTTIQVDDIVIN
>KACEBFPM_00973 hypothetical protein
MKKLVISTLFVLQAFFGLAQTNTGITGKVLDAKTQKSLQNVVASIQNTNFTQLTNADGKF
TFSGLSQGSQLLQIKSDGYKSQLFPIEILTGQMLDLGVVVLEEDASQEEKATLINITEDD
LGDEGSGSEGTASLLQSSRDTFLQAAAYNFGQARFSVRGIDNEYANIMINGISMNRVADG
RPQYGDWGGLNDATRNQEFTNGSAPSDYTFSGIAGTQEINTRASLYRKGTRLSFLNTNTN
YSFRMMATHVSGMRTDGWAYVISAGRRWAENGYFDGTNYSANSFFASVEKKINEKHSLNF
TSIFAQNKRGKNSPNTDEVTGLTSEKYNSYWGWQDGKKRNSRFKDSEEPIMMLTHYWKVT
PKTNVNTTASYQTGRIGNSRFDYKYADNPDPIYYQNLPSYKLNYFNSTGDYLGNTSGYIN
AAADLKKNFTNDPQVNWDNIYKINKDNIANGSRIVQYEDRNDEDIITANTNIASQLSDNI
FLNAGANYQYSYTKNFKNMLDLLGGTYFTDINTFGPTADQYQSDLNNPNRTLGVGQKYGY
NYNIDVRKLDAFTQFKFVYKKVDFYLAQTFSRSTYQREGLYKNGYYPNDSFGKSKKIAFD
NFGFKGGITYKISGKNYIDFNSIYMSKAPNAKDVFPNARVNNNIIPNLTNETIQGADLSY
IVKTPKFKGRLTGYFSETLNATDVNFYFADGVGSGAFVTETITGINKKNRGAELGLEYQV
TSTIKLTGVAAYGEYTFTNNPNVFLQNDSDPLNATGFYGDKGTASLQGYKQAGSPQQAFS
AGIEYRDPKFWWIGLNANYIGENFIDVSFIKRTASYFDKANNTGVTIDQEKAGKYLEQEK
FNPIRLLNLVGGKSWRIGNGYTLGLFANLNNVLDVKYKTGGFEQSRNASYKQDDQDHFSG
GPLVFGSKYFNGYGRTYTANIYLTF
>KACEBFPM_00974 hypothetical protein
MKIRNFFTTLLLFSLTIGANAQAKKFAIHTVAFYNFENLFDTINNPNIDEEWLPNGAQNW
TSKKYKEKIHNLARVINEIGTGENQKNAPTFIGGAEIENRGVLEDLVKDPQLISNDYGIV
HFDSPDKRGIDVALLYQKKHFQPTSYINIPLLIYKKDTKAKAEKETDEDKADKDKIEISQ
DSRVYTRDILLVTGLLDGDEINVIVNHWPSRSGGEKKSSPFREAAGRMDRKIMDSIYKVN
PNAKIINMGDLNDGTYNKSVKEGVGAKLKKEEVEKFGVYNPFEEMAKKGNASLFYRDAGD
IFDQIMVSQTLIEKDYSSFRYWKAGIYNKPYMITTTGQYKGYPLRHGNNEIGFSDHFPVY
IYLIKEVK
>KACEBFPM_00975 hypothetical protein
MKNILILFFFFFSINSFSQDTITTAKAKDYINNLACVTGKVVSYKLAFEGKTTNYINLDA
TYPNNIFTIVVTNEYLETAKIKIEDLKNKIIFVYGRITTYKNDPKQIPQIFNPRWIEVKK
Q
>KACEBFPM_00976 3-hydroxyanthranilate 3,4-dioxygenase
MAIAKPFNLNKWIHENRHLLKPPVGNKNLYVNSGDFIVMIVAGPNNRKDYHYNETEELFY
QLEGDITIYIQEDGEKKAMQLSAGDMYLHPAKVPHSPVRSANSIGLVVERKRNNIDAKDG
LLWFCDNCNYKLHEVYFELNDIENDFHKHFKHFYGTENLRTCKKCGTVMQRL
>KACEBFPM_00977 Penicillin-binding protein 1C
MKAKITAFLQRIINTIKRNKIKSSIAFILLMVYYFSLPSTLFQEPYSTVIESKEGELLGA
KIAHDGQWRFPAQDSVPYKFKKCIVYFEDEYFYKHPGFNPVAMVNAIKQNRKAGKVVRGG
STLTQQVIRLSRKGKNRTYFEKVIEIILATRLELRHCKDKILELYAAHAPFGGNVVGLEM
ASWRYFGVQSHQLSWAESATLAVLPNAPSLIYPGKNQQKLLKKRNNLLLKLKTEGVIDAQ
TYELAIDEPLPQKPYDLPQIAPHLLQRVAKNKEGTRLKTTVDIALQNRINQIAKYYYNQY
KQNEVNNLAIIVIDIKTRNVISYVGNSPTDLNHQKDVDIIEAPRSTGSILKPLLYAEMLD
EGELLPNTLVADIPTQISGYTPQNFNLTFDGAVPAHRALSRSLNIPSVLMLQDFGVNKFY
EELQRFKLRDISKSPDHYGLSLILGGAESNLWDLCRTYAGLSSTIDYFNKNNGNYRTKEF
VELNYDHNFTPDFGYDSKQKTILGAGAIWQTYNAMEEVNRPEGDEAWKFYDSSLKIAWKT
GTSFGNRDAWAIGTNARYVVGVWVGNASGEGRPTLTGVTSAAPILFDVFNLLPRQKWFGM
PLLDLTEVEVCKLSGHLAQEDCPKIKQLVSLKGKTTSICPYHKTVHLDKTGKYRVNSSCE
NVENIMTKKWFVLPPVMEWYYKNQHVDYLPLPPYRSDCAGTLTPSMDFIYPKTNSKIYLT
KNFNSEVQPVILKIAHSNRETEVYWYVDNVYKGSTKTFHEMAITPTQGFHYITVIDESGY
EIRKKIEIVRD
>KACEBFPM_00978 putative lipoprotein YfhM
MKTKNFVYLCIAVLIFQACGRKSAADFNSDFSLFKGIISNFTGGIVSAQSDIRVVLAFDK
KDWVKDQVLDNDLFNISPSVSGKVVALSTNTIAFIPEKKLDPDTEYQVTLKVDKILTTVK
KELADFNFTVKTLKQDFLVTTQDIQSYSKDYQYLNCTLKTADNIDFETAQKLVTAQYGGE
NMAVKFIKSASTATEFKFIIDSIQRSDNDSNLEILYDGNDFDIDQKGKIDYTIIGKENFK
VVNVSIPEGDSQTLLINFSDALQKGQDFKGLISIQNAKNLKFSTQGNLLKVFFSDETEKE
PIKPAVVEAIAEAVDTAAVVIDSAAVTTELPAEEVVEYVEPVPEATTPEQILSGNLLVEV
FQGIESENGYKMKENFSTTISFDQIKPNVKFTKNGTILPSSNNLKLNFEAVNLSAVDVKV
YKIYKNNILQFLQYNDLNGAQNLKKVAQPIAKSTINLKENKLVNFSQWNTFALDLSKIIT
PEPGAIYRVEFSFKKKYSLYKCDGSTDEETTTDEEETDENDVNYSQNNYDDYYYEDYDWR
ESEDACSQSYFYNTTIGTNILASDLGVIAKRGENKSYLFAVNNIVTTEPISNAKVELYNF
QQQKLATEATNSEGIAKFELDKFAYFAIVTLGDQSTYVKLDDGNSLSVSNFDVAGEALQK
GLKGFIYGERGVWRPGDNLYLSFIFNDAANKIPNAHPIKFRLSDPNGKITYQTIQKSNEL
NHYSFIVPTDADAPTGSWEAMVSVGGAKFYKNIKIETIKPNHLKIKNVFKNAVLSSSYPN
TSNLQVNWLHGAKAKDLKVEMQAKFSQDVTNFKGYEKYDFDDEVRQFNTEEINVFSGKVD
ANGKASVTIDPKLQGQAPGMLKVAFMTKVYEEGGDFSTDVMATTYSPYKTYVGLKLPELT
KYQMLETRINNRFDVVTVDEKGRPKSVKNLEVKVFKVAWRWWWDSSNDGISNYNSSNATS
SYKTLRVNTDAHGKGSFQFALTDEEWGRYMIRVTDPTDGHATAQTVNIDYPYWSGKTRNT
DASTANMLVFSTDKKNYAVGEKAQISFPSSEGGRALISIENGAKVVQTLWAKTKKGETKV
EVPITAAMAPNVYFNITLLQPHASTKNDSPIRMYGIIPVEVIDKNTILEPKIAMPDVLKP
EQTFNVNVSEKSGKAMTYTIAVVDEGLLDLTRFKTPNAWDSFYVREALGVKTWDIYDDVI
GAYGGKVNQIFSIGGDQDLGGGKAKKANRFKPVVIYLGPFKLEAGDTKTHQIKLPKYIGS
VRTMVVAGDAKTSAYGAVEKATPVRSPLMALASLPRKISPSEKVTIPVTIFAMENHVKNV
SVQIKTSPGLKIIGKAIQNVTFTSPDEKMTYFNLEVGATTGIAKVQVIATSGKEKSTYDV
EIDMTNPNPVTNTFTDVVLEPNSSKSISWKTFGVAGSNKARLEVSSMPSINFNGRLQYLI
QYPHGCVEQTTSSVFPQLYLNDIADIDANRKALIQKNITAGITRLGGFQLANGGMSYWQG
DTSADDWGSSYAGHFLIEAEKKGYVLPINFKQKWVSYQQKEAKKWRFEAKYGNDFAQAYR
LYTLALAGSPDLSSMNRLRETSGISNESKLRLAAAYALAGQKQAGMALLLKSKIDEDYNN
NYSYYYYGSSDRNRAMTLETLILLGQKQKAFIMANKLAKQMSADQWMSTQTTAYCLYSMS
KFAQFNGGKGIHVQFNDGGKTLGINTNKTLAERSLTIKNGTNGITIKNNKNNTLYIRVLN
SGILPVGQEQVVQNNLSAKVVFKNRKGSIINVSKINQGTEFIAEITIKNLKNERVDNVAL
SQILPSGFEIVNTRFTDFGDATNNVADHIDIRDDRTNFYFPLGSGETKTFRVLVNASYLG
TYYLPGLQCEAMYDNTFLARTKGFWVEVVK
>KACEBFPM_00979 NAD(P)H-quinone oxidoreductase subunit 3
MQSNQLDYLPIFMQMGLAVGFVVLTIIGSSFLGPKRSSVNKDKNFESGIESIGNARVPFS
VKYFLVAILFVLFDVEVIFLYPWAINFQELGMQGMIKMVIFMSLLLVGFFYIIKKKALEW
D
>KACEBFPM_00980 NADH-quinone oxidoreductase subunit B
MSSNINIVEAPEGVTGEGFFATKLNDVVGLARANSMWPLPFATSCCGIEFMATMASHYDL
ARFGSERVSFSPRQADMLMVMGTISKKMAPILRQVYEQMAEPRWVIAVGACASSGGIFDT
YSVLQGIDKVIPVDVYVPGCPPRPEQIVDGVMRLQELVKSESVRRRSSPEYQELLASYNI
K
>KACEBFPM_00981 NADH-quinone oxidoreductase subunit C
MALENTQIQDKLTATFGESVVNFRQEKDIFTFEVTADEMTSVILFLKNEESLNFHFLTDL
CGIHYPDNNVNEQFAVVYHLHNWIENKRIRIKSFINGETPEIKTISNIFLCANWMERETY
DFYGINFIGHPQLKRILNMDEMVSFPMRKEFPMEDSGRTDKDDRFFGRTTNNG
>KACEBFPM_00982 NADH-quinone oxidoreductase subunit 4
MSELLLPPEHRYAKIIKEKLNEDGSELSILNLGPTHPATHGIFQNILLMDGERIVDAEPT
IGYIHRAFEKIAENRPFYQITPLTDRMNYCSSPINNMAWWMTLEKLLDIEVPKRAQYLRV
IVMELARITDHIICNSILGVDTGAYTGFLYVFQFREKIYEIYEEICGARLTTNMGRIGGF
ERDWSPKAFQLLNTFLEEFPIAWKEFENLFERNRIFIDRTVNVGAISAEKAMAYGFTGPN
LRAAGIDYDVRVAEPYSSYEDFEFIIPVGKSGDTYDRFCVRNAEVWESLSIIRQALAKMP
EGNVYHAEVPDYYLPPKEDVYHNMESLIYHFKIVMGEVPVPVAEIYHAVEGGNGELGFYL
TTDGSRTPYRLHFRRPCFIYYQAYPEMIKGALLSDAIVILSSLNVIAGELDA
>KACEBFPM_00983 hypothetical protein
MRQFSLYKSNIAVKNSIFILLFFFSITVHAQVNPEPKDTVKGYNIGSLKLPNPNSILEAY
TYDPITDRYIYTKTFEGFNINYPIVLTPKEYQELISREAMRDYFQKKSDAIDGKKTASKD
TQKNLLPRYYIRSGLFETIFGSNTIDVKPTGTVEVDLGMRYSKQDNPSFSPRNRQSTTFD
FDQRISLSLLGKVGTRLKVSANYDTQSTFAFQNLIKLEYTPTEDDILQKIEVGNVSMPLN
STLIRGAQSLFGVKAQFKFGKTTVTGIFSEQKSQTKTVVSEGGGAISEFNLFGIDYDADR
HFFLSQYFRNRYDEALKNYPVVDSRVQITRMEVWITNRQNRVNTSPDGNNLRNIIALQDL
GEGPLQNSSFTDITAQTVGVYAQAIPNFFVFTPFNTPTSNKNNLFDPALIGTTGLLNSGI
REIATASAGFTGVTVSEGTDYAKLENARKLNSNEYTFNTQLGYLSLNQRLSNDEVLAVAY
QYTIGDKLYQVGEFGTDGVSATSVNAAGVPLTQSLILKMLKGNLASVAKPAWNLMMKNIY
QIPGAYQLDPKDFKFNILYTDPSPLNYISEIGGTSFPANPLPENEVSLAPLLRVFNMDKL
DSSNDPQKKGDGFFDFLPGLTVDAQNGRIIFTTKEPFGELLFKKLKNTGSLEDYADVNTY
NANQKKYVFSGLYRKTQTQALQETDKNKFQLKGKYKSSGGEGISLGAANVPRGSVVVTAG
GRVLQEGIDYSVNYQAGRVQILDPSLQASGVPISVSVENNAVFGQQTRRFMGVNVEHKFS
DKFQIGATFLKMTERPFTQKSNYGQESVNNSIFGANANFSTEVPFFTRLVNKLPNIDTDV
PSNLSFRGEVAFLKPGTSKIDQFQGEATVYVDDFEGSQSTIDMKSPLAWSLASSPVGFGG
EIAENNLSYNDKRAKMSWYSIDPTFYSSQRPAEINDNDVSRNNSRRIYNSELYPNTDIAV
GETTVVSTLDMTYYPTERGPYNFNPLAVNNILPTPQNNFGGIMRSISSTNFEQANIEYIQ
FWMLDPYYGTASDTNAANTGKLTFNLGEISEDVLKDGRKLYENGLPAGGSNPNVTNTAWG
KVPASQSLIYAFDTNEANRSQQDVGLNGLSDAEENQKYPSFAGPDPAQDNYQYFLNASGS
ITDRYKKYNGLEGNSPINVSDTNRGSTTTPDVEDINRDNTMNTINAYYKFAIDIKPNLVL
GDKYVSDVRTTQVLLANGNTTDARWVQFKIPILEATAANIEGGISDFKSIRFMRMFMSGF
SDKVTVRLGSLDLVRGEWRRYNNTLQTSDTDPTDDPTGFDVTAVNIQENSSRSPIKYVSP
PGVEREQLYSNNSVLRQNEQSLSLKVYDKGNPQSGSKGLEAGDSRAVFKTVDVDMRRYKK
LKMFMHAESLRRTGAGFPNGENTPIRDNEMVGFIRFGNDFTNNFYQIEIPLKVTQENAIS
ASDIWPAENEIDIQTALLTQLKILNIKGTQPVDANGIFFQEANILDPSAKAGMRVGIKGN
PNFGYVRTLMVGVKNPSTLANTYNRGEVWFNELRLAETDNKGGMAAIASLDTNFADFMTL
SATGRMSTIGFGSLEQSPNKRSREDAQQFNIVTNMNLGKLLPKKWGINLPFNYGIGEEII
TPEYDPFNQDIKLKQLLDVTTDPADKAEFKNRALNFTKRKSINFIGVRKDRAAEQKQHIY
DPENLTVSYSFNQTEHHDFEVEGLLDQQVRTSADYAYTFQSKAVEPLKNTKFLKKSSYWK
MLSDFNFNYLPTSINFSSTILRQYNKQQYRQIDVQGLPLNPLYKRNNMFNYNYGFNYSLT
KALRVNYTATTANLVKNYLDENNDPIDSFTIWDDYWNIGTPNQHSQQLTVNYELPINKIP
ALAFIKSDYTYSGDYSWQRASLALQSFKATDGNTYDLGNTIQNASSHKLNTAFNMDTFYK
YIGLRKGFAKKPVPIVPPSVPKPGEKLVAKPKVKEIKPNVFLDGLIGLATSVKNIQINYN
ETSGTMLPGYLPSIGFLGSSRPTLGFVFGLQDDVRFEAAKNGWLTNYAEFNQNFTQVKTK
HITGNANIELFPDLKIDLIADRTFSENFSEQFDAVGGVYNSHSPYNSGNFSISTVLIKTA
FSESDETRSVAFDNFRKNRLIVADRLAEISYGTSDFPRVTDVSNPNYGFPKGFGKNNQAV
LLPSFLAAYTGSDASGVSLGAFKNIPIPNWTLKYTGLMRYKFFKNTFKRFSVQHAYKAAY
TINSFRSNLKYTDPGTYDVGGNFENKNIIGNVNLTEQFSPLIRLDFEMKNSIKILAEMKK
DRTMALSFDNNLLTELKGVEYVIGLGYRIKDVRIKSRLADNATGEIKSDVNIKCDVSFRN
NKTVVRNLDYNNNQLAGGQNIISTKLTADYSFSKNLTTLFFFDYSFSKAVISTSFPLTTI
RAGFTIRYNFGN
>KACEBFPM_00984 Holliday junction ATP-dependent DNA helicase RuvA
MIAHIQGKLVEKSPTEVVIDCNGVGYHVNISLHTYGLLPTTDFVKLFTHLIIKEDSHSLY
GFAEKSEKEIFKLLISVSGIGANIARTMLSSIEPKQIINAIGSGDVGTIQSIKGIGVKTA
QRTIIDLKEKVLKLYDLDQVSISQSNTNKDEALSALEVLGFIRKSAEKVVEKIVATMPDA
TVETIIKQALKNL
>KACEBFPM_00985 NADP-dependent malic enzyme
MKMAAVKSLAYLAKQSVPEQVNIAYGETKLNFGRDYIIPKPFDPRLIIEVAPAVAKAAME
SGVAQIEITDWEKYKEELLDRLGSDNKLVRLLTSRAKTNKKRIVFAEADHLDVLKAAQIV
HEEGIGIPILLGNKEIILELKEEIGFDAEVAILDPKTKEEDARRLRFAEIYWESRRRRGI
TLLDAQKWMRERNYFAAMMVNEGEADALVTGYSRSYPTVVKPMMELIGKAPGVTRIASTN
MMMTARGPMFLSDTAINTNPSSDDLAKIALMTAKTVKMFGIQPVIAMVSFSNFGSSNSES
ASKVREAVSYLHNEFPDMIVDGEIQTDFALNPEMLKSKFPFSKLVGHKVNTLIFPNLESA
NITYKLLKELYKVDSIGPIILGMDKPVHIFQLGASVEEMVNMAAVAAVDAQEKEKKLKLN
KKSENISLIE
>KACEBFPM_00986 TonB-dependent receptor SusC
MKNIILIFTVLVSVISFAQKPIFVSAKVKSATVYFNAAEISQSTNVQLPSGTSEIVVKNV
ANYLNENSVQIGAPSSLTVLSVQFTNDYMSEYDTNENSPAIKKVKDSIILVQKELNRVIN
SRNSESKTIELLDKNQQVFGQNSGLSVIELTKMVDYYKSKRTEISNTINTLEEKEKKLNE
LITKLNNKLETDTTKEEKTSSGKLVLQVMNTTAGNIPLEISYVTNNAWWSPFYDLRADNV
TSPINMMYKAQVVQNTGIDWKKVKLTLSSGNPNQNNQAPILSSWFLRYGYTQQYGYNQNG
TQNAIQSLSGKIAGLQVQQDKEEERVVLRGSRSITRNNQALVVIDGVISTAEILAQLPPQ
SIKSTEIIKGAQGVALYGDQGANGVIVVTTKQGMGDYTSINENQLNVSFDIDIPYDILSN
GKAHSVALKEIKLPASYKYYAAPRVEKEAFLLAEIANYSKYNLLPGEANIIFEGMYVGKT
MINPSQTSDTLNLSMGRDKKVTIKREKVVDKSGTKFLSSKKEQTFTYDITVRNNKKEAVV
MLLKDQYPLSSDKEIEIELLQKEGAKANAETGILTWNLDLKPNETKKIRISYLVKYPKDK
IIDNL
>KACEBFPM_00987 Biosynthetic peptidoglycan transglycosylase
MRSKKQKFFLFLKIIILFLLFSVAGVYFFRDALLQKAIAKATSKFDTDYNCRFCVQKASF
DGISSIQLNNIILVPKEADTLFSIEKVKTKINLLQLITGNIQLQNLEVKNGFIQLVKNEQ
GRNFDAFLKKDKNNDINKKKNYAKLAYRLLSKVLNLVPTEMQLENISLRMDDLGIKVTMQ
LPKLELKNHQLQTNINVTESECSQKWNISGFVNPRAKKANVQIYNNDTSKIQLPYVYKRF
GFKSSFKNVNLKLDKFDLESNELHLDGLVSVEDFTINHPKIAKKEVLIKTASFDYHFLLG
SDFVSIDSTSSAQINKIKLKPFAQYNTEKDTIYKFKILIPKMKAQDFISSLPNGLFTHFT
GMKTEGNFDYKLNFKYNKNKPNALVFDSNLNKERLKIVKYGEANLNKLNEEFVYRAIENN
VLQRPILVGNSNPNFTPLDQISPYLQKCVLTSEDPSFFSHHGFINEAFKQSITKNIRTKK
FSRGASTISMQLIKNVFLTREKTLSRKLEEILLVYLLENNRIASKERMLEVYFNVIEWGP
NVYGIGEASSFYFQKKPIDLSLKECLFLASIVPKPKKFMYQFDDQGKLKSFANKHEEFMS
KLMLRRGLLTPEDTIGQQMPIFISGRARKHMKFKVQDSIAVDSLFTDFDFN
>KACEBFPM_00988 hypothetical protein
MLFFIPVETQARNHNFLMKPYSEILQLVNSYHEIGETIQAANFVVEEYGIKHPNFEGFEL
REKAKADYILMTTEGTFGLPQIIRIPENTFEFEFVLMLNLIAHEMVHVDQKMAGSFVEDR
NEREWQAYYEILFHKKYPQIPNVAKHQQLFFANKALSYYAKMGTNSDLQIKYAAQKHEVD
TFVASLSQ
>KACEBFPM_00989 hypothetical protein
MKHELIIKEEASLEIIESYLFYESKSIGLGERFLNNPDDYFNRIQNFPEHYQIKRKPYRE
AFVKKFPFVIVYEISENEVIVYAVFHSSRNPSEKP
>KACEBFPM_00990 hypothetical protein
MDLQLEKIELIELLLNIRKESVLKKLRAILEKEHDINLTPEQYEIVDKRRELHLKNETKS
YSWEQVKSNARLANQ
>KACEBFPM_00991 Murein DD-endopeptidase MepS/Murein LD-carboxypeptidase
MRHIIPVLFFFITLNVFSQENTIKHIVAKGESIYKIAEKYNVKQADIFKLNPKAKKKLKL
NSVLLIPKPETILDKKVLTINHEVLPKETLYGISKQYKVSIDDIKKANPIIEKEGLPIGL
KLIIAVGKNYKPEKVVVSEPSKLPKIIEPEKKQTAISEEEEITHLVLAKETKYGISRKYG
ITISELEKLNPEIIRDLPIGFHLFIKKGIKKEAIIAEIPVIKEAKESIEVKKEEIKPQIE
EEFEEEVEEKTKETSQIKILEIIPHKEEVVVEAKPLSTEGMTKAELLIAKASENIGVRYR
SGGTSKSGFDCSGLMINTFSTYDIKLPRSSSEMARFGSHVSASEAQKGDLIFFATMGKHY
VSHVGMVVDVQGDEIKFIHSSTSAGVIISSNKEPYYAKRFVKVNRVLE
>KACEBFPM_00992 Catalase-peroxidase
MENNTNPISGQGKCPFSGGAAKQSAGAGTRNSNWWPNQLKLNILRQYSSLSNPMGEEFNY
AAAFKSLDLITLKKDISDLMTNSQDWWPADYGHYGPFFIRMAWHSAGTYRVADGRGGAGF
GMQRFAPLNSWPDNVNLDKARLLLWPIKQKYGKKISWADLMILAGNCALESMGFKTFGFA
GGREDVWEPAEDIYWGSEGKWLDDQRYSGDRELENPLAAVQMGLIYVNPEGPNGNPDPLA
SARDIRETFARMAMNDEETVALVAGGHTFGKTHGAADPNQYVSAEPAAASIEEQGLGWKN
TFGSGSGEHTISSGLEGAWTTTPAKWSHNYLENLFGFEWELTKSPAGAHQWKPKNGAGAG
TVPDAHNSSKSHAPTMLTADLALRADPIYEKISRRFLENPAEFEEAFARAWFKLTHRDMG
PVARYLGSDVPKEVLIWQDPIPAVNHQLIDDNDITILKAKILDAGFSVSEMVSTAWASAS
TFRGSDKRGGANGARICLAPQKDWKVNNPIQLSKVLDALKEIQVTFNNAQSIGKQVSIAD
LIVLTGCVGIEKAAKNIKVPFTPGRTDALQEQTDVASFAVLEPEADGFRNYMKTQYTVSA
EEMLIDKAQLLTLTAPELTVLIGGLRVLDVNFNQSKNGLFTNRSGELTNDFFVNLLDFGT
TWKASSESQDIFEGRNRKTGELKWTGTRVDLIFGSNSELRALAEVYGCTDSQEKFVKDFV
KAWDKVMNLDRFDLV
>KACEBFPM_00993 Efflux pump periplasmic linker BepF
MKKIFLTSIVLSLTLFLSCGKEKTEITNNTPAIAVKVSGISANTNSPFVTASGKIEAENS
ANVSTRMMGYVTKVYVKVGQKVGAGQLLVSVNNTDLQAKKAQVEASILQATAAFSNAKKD
YDRFTALFNQQSASQKELDDMTSRYEMAKAGLEGAKQMRNEVMAQFSYANITAPFLGEVT
NTFVKEGDMANPGMPLVSLEGASRLQVTAMVSESDITSIKNGMNVKVLVKSTNQELSGKV
VEVSGSAKNTGGQYLVKINLNTTGNKVLSGMFVNVQFPVANQVTTLTKQSDKVLIPESAL
VKQGQLTGIYTIGNGNRAILRWLRIGKTFGNQVEVLSGLSFNEQYIVSADGKLYNGAKVS
F
>KACEBFPM_00994 hypothetical protein
MKKINLIVLLATISFSTISYSQDTLAISKKDIWQKASGKNLQIKIGNQNFKSAQADYKQS
NSLFLPSITASHTAISTTNPLMAFGSKLNQEIVTASDFNPDLLNNPAKIQNFATKFEIQQ
PLINIDGIYARQAAKVKMEAFQLQTERTKEHLELDLSKTFMQLQLAYKAVKVLEKANATG
KANLKLVGNYFKQGMVQKTDLLNVEVRVNEITNQLQYAKSNVQNVSDYLGFLLNEDTTNK
VFKPLEELDNIIFIEAVNAQLSDNRKDIQAMNKLAEAYKKMLQSSKMNFLPRLNAFGSYE
LYDHTLFGTSAKGYLVGAQLSWSFFDGYKSIGKTEKAKADFQKAAIETQQYKAQSQLDLN
KTNRQLKDAENKVTLSRLAFEQSEEAYRIRQNRFSQGLEKTTDLLQSETQMIQKELEHLQ
SVFEYNFTKQYLQFLTR
>KACEBFPM_00995 hypothetical protein
MKKLISTLAIVTFLFTTNINAQEAKPKDKKECTTHKDKKTCDHKDKKTCTKEEMKSCTKD
KKAGCCAKK
>KACEBFPM_00996 Thioredoxin-like protein
MNNTFHDIINSEKPVLIDFFGTWCGPCQMLAPILKEVKNSIGNRISIIKIDVDKNQELAA
KYQVRGVPTMILYQNGKQLWRQSGVLSKDEIIRIILEKSN
>KACEBFPM_00997 hypothetical protein
MKDLLFLNWHLMRWVRLVFAIFLFGQAYTTGQWAFIAIGLFFLVQVIFNLGCSQNGCTIP
TNRKK
>KACEBFPM_00998 Thiosulfate sulfurtransferase PspE
MFNFFKKLFSGSSTINLKEIITNGAFLVDVRSQGEYLAGHVKGSTNIPLDQIKNKIEKFK
GKKNIVVFCQSGMRSSQAKGILEKNGFTNVINGKTWKNIDNLLNS
>KACEBFPM_00999 Beta-lactamase hydrolase-like protein
MQIEQIYTGCLAQGAYYITSNGEAVIIDPLRETKPYLDRLERDNVKLKYIFETHFHADFV
SGHLDLSTKTGASIVYGPTAKPDFEFISAHDNQEFTIGNIKIKVLHTPGHTMESSCFLLI
DENGKDKAVFSGDTLFIGDVGRPDLAQKAASMTQDELAGILFDSLRTKIMTLADDVIVYP
AHGAGSACGKNMSKETVSTIGEQKKSNYALRANMTKAEFIAEVTDGLLPPPSYFGMNVAM
NKSGIPSFENVLHAGMKALSVTEFEAIAEETTALILDTRSNSDFAKGHIPQSINIGIAGD
FAPWVGALIANVNQPIIIVSDIGKEEETITRLSRVGFDTILGHLQGGFQSWKNTGKEIDT
VNRITAAEFENKVKIGESKIIDIRKETEYSAAHIEEAFCKPLANINDWIKDINPKEHFFM
HCAGGYRSMIAASILQARGYRNFTEIEGGYNAIAKTNLPKTDFVCQSKILKQN
>KACEBFPM_01000 SCO1 protein 
MLNFLRKFKTLFIVLSILSVIIISLFYNVLNRKTLPVFTPSMVNPELVDSTIQYVANKHI
IANFAFTNQNGKIITQKDYAGKIYVADFFFTTCGTICPMMTDNMVWLQDQIKDNPKVMLL
SHSVTPDTDSVSVLKEYAQRKGVIDAKWNLVTGRKKDIYYIARKSYLAVKTGKPSELYDM
VHTENFVLVDDKRRVRGFYDGTKREEVQQLLVDINWLLENKK
>KACEBFPM_01001 hypothetical protein
MNLTISNLAIGQKAIIKDFDINMIPLKLLEMGCLSGNMVEIIQIAPFGDPLYLNINDSHV
AIRLEMASIIEVEIPTENQV
>KACEBFPM_01002 Fe(2+) transporter FeoB
MKVGNINIALIGNPNVGKTSVFNQLTGLNQQVGNYPGITVEKKQGVCKLSSNLKATILDL
PGTYSLNASSLDENVVIELLLNKNDKDYPEVAIVVTEVENLKRNLLLFTQIKDLEIPTIL
VINMSDRMSYKGISLDIPYLEDRLKTKIALVSSRKGEGIDDLKNLIVNYKNITTEPCLNA
SNIDVAYFDNLRHAFPNDSLYKLWLVITQDVNFANLNRNELQITSFTKSKEALKKLQQKE
TIKRYQFINEVLKVGQKIDLDSAKGLRSKLDKILMHKVFGYVIFFLILMLIFQSIFDWSS
IPMDFIDTSFTALSSWTQSKLPAGVLTNLIVQGIIPGLGGIAIFIPQIAFLFLFISILEE
SGYMSRVVFLMDKSMRKFGLSGKSVVPLISGTACAIPAIMATRNIENWKERLITILVTPF
TTCSARLPVYAIIISLVIPDTRLFGLFNLQGLTLMLLYLLGFSMAFFSAWILNKILKIQS
KSYFVVEMPNYKLPMFKNVAINVIEKTKSFVFGAGKIILALSVILWFLASYGPGENFKNA
REIVSKQKSSTKNLENDIASYKLENSYIGIIGKSIEPAIRPLGYDWKIGIAIVTSFAARE
VFVGTLATIYSIEETGNQEATIKNKLSAEINPITGNKLFNLASGISLLLFYVFAMQCIST
LAVTKKETNSWKWPAIQLVFMSGFAYTVALIAYQILK
>KACEBFPM_01003 hypothetical protein
MNCIICNKIADEVGSHLIPASLIKNCVGKHYSEESYNIDVKTSKIEVYYGRDNLKNESTE
IIRNHYKRDNVLCKVCEKKLGILESHFAVEFLQKFRDGKYLNNFISSKSSNNLEILEPKK
ISNIEIQAYFYSIILRFCCTYKAEGGDSFVEENDLLKIRKFIYNYLYDNLSKENYGIEDF
KIIIIFNKYSKNSLLISNLEIVKNPYTFYFCEAIIVLYIGETPCKEKSIYADCLNSITDE
SSKIIVGPASLYDELTVLKTYILARNFMTKGIKNISELNKKSYKENEIEVREIIKMYEGR
DDKGLYIDKLFNDLITKYSR
>KACEBFPM_01004 hypothetical protein
MAKSTMLKSSIAKKVAMALSGIFLITFLSLHFFINMISVFSAETFNMMSHFMGYNPVIQF
VMQPILITGVVFHFVMGIVLELKNKSARPVSYAKYNGAANASWASRNMIVSGLVVLAFVG
LHFYDFWVQEITYKYIDGNVIDATRYHRELVAKFVSPVRTGLYCLAFVLLAIHLWHGFNS
SFQSVGFNNKFSKSLHKLGYAFAIIVPFGFIFIALFHHFKN
>KACEBFPM_01005 Fumarate reductase flavoprotein subunit
MKLDSKIPEGPIADKWTNYKDHLKLVAPNNRPKIDVIVVGTGLAGSSAAASLAEMGYNVK
AFCFQDSPRRAHSIAAQGGINAAKNYQNDGDSTFRLFYDTIKGGDYRAREANVHRLAEVS
GNIIDQCVAQGVPFARDYGGNLDNRSFGGTQVQRTFYAAGQTGQQLLLGAYSSLSRQIGQ
GNIEMFNRHEMLDLVKIDGKARGIIARNLVTGEIERHSAHAVIIATGGYGNVYFLSTNAM
GSNVTAGWKIHKQGAAFANPCYVQIHPTCIPVHGTNQSKLTLMSESLRNSGRIWVPKKKE
DAEAIRAGKLKPTQIAEEDRDYYLERKYPAFGNLVPRDVASRAAKEVCDEGHGIEANDTN
EGVYLDFSSEIQSKGRQTAFAKGNHHPTDEEVTKLGKQWLEEKYGNLFTMYQKITDENPY
ETPMKIYPAVHYTMGGVWVDYNLQSTIPGCFVAGEANFSDHGANRLGASALMQGLADGYF
VLPYTVSNYLADEIRTGKISTESQEFVDAENRVKDSINKFLHNKGSKTVDHFHKRLGLIM
WNKVGMGRNEAGLKEAISEIAALKEEFYKDVYVPGSADELNQELEKALRVADFIDLGQLM
AMDALQRKESCGGHFREEYQDSEGETLRDDENFSFVGAWEYMGYDISKEILNKEELKYEF
IKIAARNYK
>KACEBFPM_01006 hypothetical protein
MSEIKSYKDLLIWQKGIDIALLSYKLIKDFPKEELYALSSQIKRCSISIASNIAEGYGRH
STQSYIQFIKIARGSLCELETQLLIAQKLGFIKEEEIFFELLNQITEESKMINSFINKLE
LSKS
>KACEBFPM_01007 Fumarate reductase iron-sulfur subunit
MSAAKNININLKIWRQKNAKAKGSMETYKLDNVSTASSFLEMLDQLNEELVNEKKEPVAF
DHDCREGICGMCSLYINGRAHGPDTGTTTCQLHMRKFNDGDTIFIEPWRSKAFPVVKDLV
VDRSSFDRIQQAGGFVSVNTSGNTIDANATPIKKGDADKSFEAAACIGCGACVASCKNGS
AMLFVGAKVSQYALLPQGKVEATERVLNMVRQMDEEGFGNCTNTGACEVECPKGISLENI
ARMNREYLSASLKG
>KACEBFPM_01008 DNA polymerase IV
MDAFYASVEQMDNPNLKGKPLAVGGSEARGVVSAASYEARKFGVRSAMSGAQAKRNCPDL
IFVPPRFDRYREISKKIKKIFYEYTDLVEPLSLDEAYLDVTQNKKGNPSATLIAQEIRKR
IFEEVGLTASAGISANKFVAKIASDYNKPNGQKTINPEEIEGFMEALDIKKFYGIGKVTT
EKMYQHGIFTGKDLKRKTSEYLEVHFGKSGAQYYNIVRGIHNSEVKPNRTTKSVAAEHTF
DTNLTSEIFMEERLEQIATELGRRLKKHKISGKTITLKIKYSDFTQQTRSKTLPYFISDK
GIISETVKELLYQERMKDSVRLLGISLANLNTEIKKSIVVQLKFDF
>KACEBFPM_01009 hypothetical protein
MEKLIITLSLFLVGTSAFVQAQEKPLDVKYRRSSLHTMVVESEKFPQKDVVLKAFNNAPF
PEKYNNHQIAQKSFNPANYTLTAEEKAKFNSTSKTAKINLDEPESVDKELPARIQKYFEK
EKIAHKLVAKWFNRKADGSFDSNLVSERGVFNASFLDQKTAQASSEGDALLKTAGFELID
NTFVVVNKFNFVENEPVARVIRDAAKIAASKLPMGQEVAMRLADKAYDKAKEGYSIWATS
YLYKLVWNETVSNTFYADLYMDKTNLDPAKKKAFDNSDLFKLEFVGDESASALVTFSLKE
NRTEEQIIALSTVRITDNVYAKLQKKYDVFKTKTPLFTGNPITAKIGTKEGLEGGEKFDV
LEQTINEKTGIATYKSIGTIKVEKDLIWDNAYNGTEKENTEATPAIDRTTFSGGKKYYPG
LLIRQIK
>KACEBFPM_01010 hypothetical protein
MKKLSNTIVILFVIIFSLNQTVNAQARKKAEKDTQEWRYEIEAIQTGTQGTYLIKVWSYS
KRPDVAIEQAKKNAVHGIIFKGFAGNATVPGQSALTNNTNLEVEKEEFFKPFFEDGGKYM
KFVSTSTDGAVAAEDRMKIGKEYKVGVIVSVNVSALRKDLEAAGILKSLNSGF
>KACEBFPM_01011 hypothetical protein
MKKIILLLITSALILVGCKTKNTVSANYPHETECLGSELDGSVTLKSWGKGKDRNDAIEQ
AKKEAVNAVLFLGIRSGNKQCDSRPLLNAPNIRENKSEYFNTFFKDGGNYKNFTSNQDES
FGKKEKEKGTDGEVMYGYIIRVMRSDLKKQMITDGILNN
>KACEBFPM_01012 hypothetical protein
MKKTVLKLNQVILLLLCTTSMVFSQAKKPRLMVVPSDAWCIDHDYYFEFDNQGEITKLPD
YKRAFQENHELGGVVSGIGELMTERGFPLDRMEDILKELASESAEDAILTSKSGAGIAES
PIDKLKKTAKADIWMQVDWKVNTFGPKKSITYTLTGIDAYTNKGIAGGMPKTGNQLIGST
EIQMLKTAILSDIDGFNVQLMAHFDDMFKNGREIVIRIKKFDSWDGDLEKEYDGKELNSY
IEEWLTKNCVQGRFSTVESTENMMYFKQVRIPMYNEAGTAIDAKGFCKGLQSYLKKAPFM
ITNKLMTKGLGQASIVLGEK
>KACEBFPM_01013 hypothetical protein
MKKIILLLVVLFSGQIFSQIKGRVTDHKDLALPLVTIFIENSYNNTSSNEKGFYELNVQK
AGKYVVVFQYLGFKTRKISVTIDAFPYELNTKLIEENFAIHEVAISNKEDLAKQIMRSAI
ASKKENSASMAKYNARFYSRGLMRIKEAPKKILGQKIGNFDGALDSTRTGILYLSETVSK
LNFQKPNKMKETIIASKVSGKDNGFSFNNAASVDFDFYENYLPFDINVISPLSDNAFNYY
KFKIEGSFYTQDKQQINKIKIIPRRDTEPVIEGYIYIVDDSWAIYAVDVNLKGYRLQTPF
LNNLVLKQNFSYNKTNNIWVKNTQSIDFSAGILGINMSGRFTYVYSDFDFEPKFDKKTFT
HEVLTFEKDSNKKDTVFWNSVRPIPLTTEESNDYVKKDSIQILRKSKTYLDSIDKKENKF
HILQLLSGYHFKNSQTNTSLGYDGFLQSFQFNTVQGYRLQTGFSYNNKNKDERTYTNLGI
GFDYGFAENKLRIKGTFSKKISNHNNALFDFSAGSEATQFNQNKPISEIVNTISTLFFKD
NYTKLFDNNFVKLSYSQEIANGFSVYTNFDYSERKPLFNTTNYTFIQNDDLYTSNHPLLP
SDNLTPAIVKHNLAKGKITGKVSFGQEYWTRPDGKFNIPNDKYPVLYFTYEKGFAGSKNR
YNFDYLEAKVTQDFTLGNKGKLGTNVSTGKFFNANNIAFVDYKHFAGNQTRIGQLESYLN
VFNLMPYYANSTNNAFFEAHLEYNDKGFLVNKIPLFNKLKSNLILGYHNLSVSSKLPYHE
FSAGLDNLGFGKFKIFRLDYVRSYQNGFQTDGVIFGFKISD
>KACEBFPM_01014 hypothetical protein
MNKIHVYFMPGLAASSSIFENIKLPQDVFEIHLLDWITPEKTESLTAYAARMAKFVKHDN
AVLIGVSFGGILVQEMAQFLKIRKLIIISSIKSNKELPSRMKIAKTTKAYKLIPTGLLSN
VEALTKYAFGTMVKERVELYKKYLTMSDKVYLDWAIEQVVCWERTIADNKVIHIHGDNDS
VFPFQNIKNCINVNAGTHIMIINRFKWFNENLPSIILNDRLN
>KACEBFPM_01015 Restriction enzyme BgcI subunit alpha
MKNWSLEDNVNDWVKSEFARIKQNKYTVESVMSDYLKNAIQQGVLIKRIELEEAGETEKG
KSWKPDFHLETFDIPVLIENKLGISKLSATNGDKIKNDIKSVKNFAVNGAIHYAQCAIMS
KKYKEAIAIGISGDNPTNVAIQVYYVFGATDETYKLVETYTTLDFLESKKSFAEFYKEAN
LTEDEKHKILIDSQAKLQEHAKKLNKLMNNHAITAPQRVLYISGMLLAMQEIIINEDVEK
GLVPEDLKGINLDNKRDGDIIVTQIENYLKLKEIPQDKLHLMMSSFKEINKDNDRDTKTD
LDAIVGNLLPEVSSVNKQIFTYVHKYIFQSIDAMSGHIDIMGEMYSEFLKYALGDGKEIG
IVLTPPYVTKMMSQILEVDENSKVMDLATGSAGFLISSMELMIDCAEQKYGKNTTKAIDK
IKEIKKNQLLGVELNAEMFTLASTNMILRGDGSSNIRKGSSFNEPLKLYQEFQADKLLLN
PPFSFKENGMPFILFGLAQMQIGGKAAIIIQDSAGNGRGVASCKAILGQNQLLASIKMPI
DLFQPMAGVQTSIYVIEHTGKSHDYKKQVKFIDFRNDGYKRTKRGIIELDNPVQRYNDII
EIYKNGATANVSDTLWNLKQTVVMSVITNAGNDWNYDQYQKIETKPTLQDFKKTVGDYLA
WEVSNILKQQTQNENLGK
>KACEBFPM_01016 Restriction enzyme BgcI subunit beta
MEWGEEIYLSELFKIKRGKRLTVSNRIKGERPLITAGKENTGVAEFIGNENQEIFPEDTI
TIDMFANVFYRNYCYSADDNILILFDKIKIKSKTKLFIVNSINKALSSTFSYGKQYRMNN
FLNTKIQLPTKKGKIDFEFMETFVAELSAQRVAELSAHLKVTGLNNYILTNEEQKVLEDF
ENGKIVFKEFTFTTIFNKILQGRRLKKEDQIIGNIPFVMAGTTNTGIAKYISNPVASFPK
NSITIDIFGNTFYRNYDFGAGDDTGVYWHDERNYSEKTMLYLTSSMSKLVQGKFDFGNKL
RSSQSLDFKVQLPAINNKPNYKLIETFITAIQKLVIKEVVLYADRKTEATKLATQN
>KACEBFPM_01017 hypothetical protein
MASTSETGHAKNVANFQNLIAFVTGYGATYNPSKNTLMLRQLIALKADADTKLADVVTKN
TAYNNKVNERQTAFGGLKSLATRLVNALQTTEATDQVIKEAKGFNRKMQGQRASATATTP
TNPNTPVPNTISSSQQSYTQQIQHLAGLISVLESEPSYTPNETDLQIATLVAKQNELTTK
NNAVATSYANVSNSRMARNTTLYSTEGSIFEVASEVKKYIKSIYGASSPEFAQVKGIEFK
KPKT
>KACEBFPM_01018 hypothetical protein
MILIFYLLVRQKIYINAEGINKTAVAIFYFAVAINETSEGINKTAVAIFYFAVATNETPE
HINKTAVTTNATAIIINSFAWQDY
>KACEBFPM_01019 Membrane-bound lytic murein transglycosylase D
MKIKKKTGIILAVVLVSSFLIFCKTYNKNSNIGINNNFPNEIDFAGEKTPLQIYDIKERM
DRELLINENLHSSTILILKRAYKAFPIIEPILAKYGVPDDFKYLAVIESSLVNAVSVAGA
RGVWQFMPETAREKGLEVSETVDERYHLEKSTEAACKYLLAAKQKFGSWTLAAASYNGGM
AGITKQIEFQEVNNYYDLLLNEETSRYVFRILALKEIMKNPVLHGFSINKEALYTNLLTR
KIQVDTTISNLVTFAKLQGINYKILKYHNPWLRDKKLDNPTKKTYNIEIPTEGYN
>KACEBFPM_01020 Tyrosine recombinase XerD
MKWQSKIIKYKGTSRIAVSFEKNTILIERIKQIEGRQWSSSLQVWHLPDTIDNRIRFKIE
TPISRVPSEEKREQIQKFSKWLFSKRYSPSTIKTYTEALQSFLLFFDQKPITEITNQDVI
VYNNEYILKNKLSASYQNQIVNAIKLYFKTIKEVKIEVDKIHRPKRSKLLPNVLSKEEIK
LILEAHSNIKHKTMLSLIYSCGLRRSELLHLKPTDIDSKRGIVIIRQSKGKKDRIAPLSP
KILVMLREYYSNYKPKSWLFEGQIPGETYSEKSLQNVLKQALEKAKIAKPVSLHWLRHSY
ATHLLESGTDLRYIQELLGHSSTKTTEIYTHVSTKNLQQIKSPFDDL
>KACEBFPM_01021 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MNKKVILMILDGWGKSPDPKVSAIDNANIPFINSLYKNYPSAQLRTDGLNVGLPEGQMGN
SEVGHMNLGAGRIVYQDLAKINLAVQNKTLSQEKALKEAFQYAKENNKPIHFLGLLSDGG
VHSHTSHLRGLLDAAQNFGLKKTFIHAFTDGRDVDPKSAIATIENLNKYIHNTPAKLASV
IGRYYAMDRDKRWERIKLAYDLLVNGKGKPSQDAVLSISNSYQNNITDEFIEPIIMTDDN
NNPIATIQEDDVVIFFNFRTDRGRELTEALSQQDFHEQNMHKLNLYYVTLTNYDETYKNV
KVIYNKDNITQTLGEVLEKAGKKQIRIAETEKYPHVTFFFSGGREQPFLGESRILKNSPK
VATYDLQPEMSAYELTEALIPEIEKTEADFICLNFANGDMVGHTGIMSAAIKACEAVNKC
VEKVITAALAHNYTTIVIADHGNCETMINPDGTPNTAHTTNPVPIILVDKELKTIHDGVL
GDIAPTILDLMGIKKPEVMTRNSLL
>KACEBFPM_01022 Glutamate--tRNA ligase
MSKQVRVRFAPSPTGALHIGGVRTALFNYLFAKKHNGVFYLRIEDTDQNRFVPGAEEYIL
EALKWLGISPDETIEKNEKFGPYRQSERKHLYKQYADLLINSGWAYYAFDTSESLDTLRK
ITEAAGNTFIYNHTVRETLDNSLTNSPEKVAERIANGEDYVIRFKTPVNETLHLKDIIRG
DIKFETNLLDDKVLFKSDGMPTYHLANIVDDHLMETSHVIRGEEWLPSMPLHVLLYRAFG
WEAPEFAHLPLILKPVGNGKLSKRDGEKLGFPVFPLQWKTNEGTSLGYKENGFFPETVIN
FLAMLGWNDGTQQEIFSLEELVQKFDLNRIHKAGAKFDPEKNKWFNHQYLVKKEDSTLAE
LFLPILASKGIVTNLDYTTKVVALVKERAHFVNELWDLSDYFFIAPTSYDEKATKNWKEE
TPELMKQLIVVLNGIEDFTSLNIETIVKDWMTQNEIGMGKVMQPFRLSLVGKMMGPHLFD
IIEMIGKKETINRIEKAIATL
>KACEBFPM_01023 Modulator of FtsH protease HflK
MSTIFIITIVIGLFILLSSFFTVKQQTAVVIERFGKFTGIRQSGLQLKLPVIDNIAGRVN
LKIQQLDVMIETQTKDNVFIKMKVSVQFKVIPEHVYEAFYKLEYPHDQITAYVFDVVRAE
VPKLILDDVFVRKDDVAIAVKRELNEAMTTYGYDIINTLVTDIDPDIQVKNAMNRINAAE
REKTAAMFESEAQRIRIVAKAKAEAESKKLQGQGIADQRREIARGLVESVAVLNEVGINS
QEASALIVITQHYDTLQAIGADTNSNLILLPNSPQAASDMLNTMVTSFAATNIIGEQMKK
QTPRVKSKNHTSTDYNPSDTSEANETK
>KACEBFPM_01024 hypothetical protein
MEKKIYSSYTEIERDLEILKLEKEIYYEKILLSIDKTKESILPSKSVTLIGNVYQKVFSG
TYVSILKMFIPYVYNWYLKIKRGN
>KACEBFPM_01025 hypothetical protein
MAFEDLKENAEAIQENSKAYLESSMAYYKLWGFKVAMKSTTLLLKFFLIAICLSVVLLFV
SIAAAFTLGNLLDSYSLGFLCIAGIYLLLAILLFLVKDKIVEGTILEKFSEIFFND
>KACEBFPM_01026 hypothetical protein
MSNKNGNNVLALLLGAAIGVGAGILFAPNKGSKTREKIKGNLNDWKIDLNNKLADYEEDI
REKFSGSKEDLKQSVDNLLSNSSYKAEETILFLEEKLAELKKQNAKLQK
>KACEBFPM_01027 hypothetical protein
MSAFIISKRINDEYKFEFTSRRGKVIFTSNNFELKFECEDEIEFLKATVGDAVFLKFKSS
RGKFFFRLIIHDKEMAISRKYTTQLLLQKGIDEIIKYASKSEILDFSNNDFTFFDDLKQE
Q
>KACEBFPM_01030 DNA mismatch repair protein MutS
MSTKEIKETPLMKQYNEIKRKYPDACLLFRVGDFYETFGDDAVRASKILGITLTKRGAGS
PTETALAGFPHHSINTYLPKLVKAGLRVAICDQLEDPKMTKTIVKRGVTELVTPGVSMND
EVLNSKTNNFLASIYFGKKIIGVSFLDVSTGEFLTSEGNEEYIDKLLQNFSPSEILVPKQ
NKGDFKEKFGDNFHAFYLEDWVYKEDYATETLTNHFQTNSLKGFGIEELASGIIASGAIL
YYLSETQHNKIQHITSIHRIAEDAYVWMDRFTIRNLELYHSYNPNAVTLLDIIDKTLSPM
GGRMLKRWLALPLKNATIIKSRHEVVAYFKDHQEILQKVQNQIKQISDLERLISKVAAGR
ISPREIIYLKESLDAIIPIKELALKSPQEAVKVIGDSLHSCDLLREKIKTTLNQEAPVAI
SKGNAIAAGIHPELDELRGISALGKEYLEGIEKRESEKTGISSLKISFNNVFGYYIEVRN
THKDKVPTEWIRKQTLVNAERYITEELKEYETKILGAEEKIQQIENQLFEQLVSWIATYI
KPVQLNANLIAQLDCLISFTQLAIDNKYVCPQINDSFALDIKNGRHPVIEKQLPIGVPYI
ANDVYLDRDTQQLIMITGPNMSGKSAILRQTALIVLLAQMGSFVPAESVQMGIVDKIFTR
VGASDNISMGESTFMVEMNETASILNNISDRSLVLLDEIGRGTSTYDGVSIAWAIAEFLH
ENPAQPKTLFATHYHELNEMTESLPRIQNYNVSVKELKDTVLFIRKLVKGGSAHSFGIHV
AKMAGMPQIVLQKAEKILKKLEKNHSAEALSGTKGNKDDMQLSIFNLDDPLLEEIKEEIL
NLDINTLTPVEALMKLNEIKRMLSKK
>KACEBFPM_01031 hypothetical protein
MKKLIFILSAIAFFGANAVSAQEVATKAKVEVTKTKKAIKAKKGAVAALPKVEGAGMVFE
NETIDYGTIAHNAEPNRQFVFTNNGNKPLIITNTQGSCGCTVPTTPKEPIAPGAKGIIGV
KYATDRVGPFTKTVTVSSNAEGMPSKILTIKGTVLPDATPAAGTVTVEPVKS
>KACEBFPM_01032 tRNA (guanosine(18)-2'-O)-methyltransferase
MRKLENSELDRKSISDFKEAKKTPIIIVLDDIRSLHNIGSVFRTADAFLIEKIYLCGITA
TPPNKEIHKTALGATETVVWEHHENVLEVIENLKKDEISVFAIEQVENAIFLNDFKVEAT
KKYALIFGNEVFGVNQEAIKLCDGTIEIPQLGTKHSLNISVSTGIVVWDLFCKLNDLKNR
II
>KACEBFPM_01033 Deoxyguanosine kinase
MKMQQKVILSLGSNQGNRLKNIENCIQLIHQKIGLILRISNLYETPSWGFSSDAFYNCAL
ILHTSFAAEKILEKIACIETDLGRIKHHTGHYQARVIDIDIIAIDEQIHNSETLTIPHQQ
MQNRLFVLLPMLDLKLEWQHPILQKSVPELIKACEDISDCKVISNLNLFLKKYKINALNY
IAIEGNIGAGKTTLTTKIAQDFNAKTVLERFADNPFLPKFYKDQNRYAFPLEMSFLADRY
QQLSDDLSQFDLFKDFVVTDYHIFKSLIFAKVTLQEDEFRLYKTLFDIIYKEMTKPDLYV
YLYQNTDRLLQNIKKRGRSYEQEIEAEYLEKINHGYLDYIKSQTDLNVLVIDVSDFDFVE
KQEDYVKILDIIQEKLDLQI
>KACEBFPM_01034 hypothetical protein
MTCRILPLLLVFLMSFALKSAVTRTDPKLVASVAANNLAAKIELVYYSLDSNHFAFPQIA
CFKKAMEGFYSLKSKGLVLKDVLTVIDFSMSSTKKRLWVIDLSTNTILYNTVVSHGINSG
GEYATSFSNSQSSNKSSLGFYTTGETYSGKHGLSLKLDGLEKGINSNARVRAVVIHGASY
ANPSIIKSQGYLGRSQGCPAIPEALKFQIIKTIKGKSCVFIYHPSRGYEIVSRLVS
>KACEBFPM_01035 hypothetical protein
MKPIYLLIPLIVFICCKKNTLDKNPDNSSFIHFPFLNYSVKIDSVVISNLNNPNLVAFYK
NYNNETVWVLEEDRTAVLNEFKDATNEGLLPNDYNYTLLNTLSSNYNHLEDKKLIEFDLL
LTQSIQKYISHIYKGKINPRTIYKDWDLKEKNIDINTVLFEIIEKKSFASKFEDLKPKHP
IYKNLKQALQVLNAFPKDSVPFVILKPKDKIALNKSNKAVKIIKSRLMYWHDMKQANTIT
NIYDKETQDAVKTFQSRHGLTPDGLIGKGTILALNFTKNQRIEQVISNLERWRWFASDFG
QNYLLINIPDYSLLAIKNNDTMQKQRIVVGKDTRQTPILESKVSNINLNPNWTVPPTILK
EDIYPDAIKDKGAFKKKGLVILDHKNKEINPWSWTIEDAKKYKYVQNPGKNSSLGLMKIN
FPNKYSVYLHDTNHRDFFGLNYRSLSSGCVRLEKPLEMAEYLINNPEKWNLKTIQDTTDI
NHYNKLQKEKEKKIAIKNAKLLAKNPLLVIPEKTYPKQELKTIVVRIADDIFIHQLYWTA
WLQKETLQFREDIYCLDSDLYNKLRN
>KACEBFPM_01036 hypothetical protein
MIKEITAQETLLVRNLVLRPGKLVETCSFDGDNLEQTKHFGYYEGKKIVGIVSVYKNKNS
TFKSPNQYQVRGMAILEEFQEKGFGKLLMKHCKDYLISNQASLIWFNAREAAVPFYEKLG
YTKNGLPFAIANVGIHFLMFKNL
>KACEBFPM_01038 Peptidase E
MKKVILASTSTLYNGSFLDYLLPTLSEHFIGCKTLLFVPYARPNGISYDDYTQKVSQVFA
KINITVNGIHEHQNPTEAIQKAEAIFTGGGNTFLLVSQLYKNNLMTVLKNTIEAGTPYLG
TSAGSNIGGMTMNTTNDMPIVLPESFQTLGLIPFNLNPHFLDANSQSTHMGETRETRINE
FHTISNIPVLGLREGSWLEIYKDNFILKGTLSAKLFRQNEIAVELETNTNLSFLT
>KACEBFPM_01039 hypothetical protein
MKQFYLLLFTVFLFSPSIFSQTLLEGKVISDALNIGEIYVTNLSANIKTTTNSNGFFSIE
AKPNQVLVFSGLKIERKILNLKSLDFSANFLSVKVYPKTIQLEEVVVKNYPQINTASLGI
VSKNIKTYTPAERKLMSESSGMGIVQLINAINGRTDELKKNVEVEKKEMLLDKLSVLFEE
NFYTETLKIPAEYIKGFQIYVIDDERLIASVKSKNKTMTTFLLGELAEKYKQITFAKKE
>KACEBFPM_01040 hypothetical protein
MKKSIVYILFFLSIISLSSFAVHKFYMSIYQVNYNQKKQMLEITSRIFIDDLNDVLKAKY
NQKTHIGEPNEMPQDVLLMKKYLLDNFFVKINGKQKSINYLSKELEGNVVICYYNVKEIS
KIASVEFKNTALFDLNSDQQNIIQTTIYGKKQSLLLTLDNVKGLLKP
>KACEBFPM_01041 hypothetical protein
MKKNIPFLLFFAVFSSVVIAQEKPKAKEQGHEDKNKFRQMYDLLATPNMYRTASGAPGPE
YYQQQADYKMDIELDDKNAKLFGTETITYTNNAKESLEYLWIQLDQNLMAKTSKTPLIEN
SKIDPVISAQGFSRKYLEEKFDGGFKIDYVKDVKGNPISYTVNETMMRINLVKPLAHGEK
MVMHIKWNYNINNYMLDGGRSGYEPFKDGNKLYVLAQFYPRMAVYNDVEGWQNMQFWGSG
EFALPFGNFEVNITVPADHIMEATGDLLNRTEVFTPEQVKRYTLAQNSFDKPVVIVTQAE
AEATEKGFSDKKKTWKFKAENVRDFGISTSRKFILDMMAVQLAGKTVMAVSLYPKEGNPL
WEQYSTKAVAHTLKSYSSYTFDYPYPKAVSVNAQDQGMEYPMICWNFGRPEADGTFSDRV
KYGMLGVVIHEVGHNFFPMIVNSDERQWTWMDEGLNSFMEYLAEMSFDKNFPADRGPVAK
IVPYMSGDQSNLEPIMTNSEAIKQFGNNAYGKPAAGLNILRETIMGHELFDYAFKTYANR
WKFKHPTPEDFFRTMEDASATDLDWFIRGWFYTTDFTDIGIKEVTQYYVSNDAPKDFKAP
EVTRRNRRKMAGPLVYMVSSTSQDLLAENKKALNTKEIKTLDEFVQTNFKPEEIAKLASP
KYFYEVTFNKPGGLVMPIIVQLIFEDGTTETQTFPAQIWRMNDAEVVRTFATQKVISKII
VDPKLETADVDITNNTWPKGIVKSKFD
>KACEBFPM_01042 hypothetical protein
MMLSSEKQEMTTPHKKREETQQVSSLFFLFNLFKKI
>KACEBFPM_01043 Serine/threonine exchanger SteT
MQEEKQTFKRELGLLNATSLVTGSMIGSGIFIVTAQMARDIGSAAWLLVIWLITGLLTMT
AALSYGELAGMMPNAGGQFVYIQRAYGKLISFLYGWTVFTVIQTGGIAAVAVAFSNYSAV
FFPFLENKLFAIGESYTFSNKQILAMTSIILLTYINTKGIQSGKTIQLIFTLAKIFALFA
LIILGLYVGLHTDVLFNNFSHMWEASKTVLNTDGTVTVTKLAGVALLGAMGATIINSLFS
SDSWNNVTFIAGEIKEPKKNIPRSLFLGTLIVTIIYILANIAYLSLLPMQGTPVGESVMS
NGIMFASQDRVGAAAANVIMGNIGVFVMAGLIMVSTFGCNSGLVLSGGRLFYAMSKDGLF
FEKAGHLNKNNVPEKALWFQCIWACILCVSGKYGDLLTYATFASLLFYILTIYGIFILRK
KEPNANRPYKALGYPIIPSIYIVITSLICITLLIYDTKSTGLGLLIVSLGIPVYYLTKRE
V
>KACEBFPM_01044 Holliday junction ATP-dependent DNA helicase RuvB
MNENLDPTNQKYNPEELDLEKKLRPLSFDDFTGQEQVLENLKIFVQAANLRGEALDHTLF
HGPPGLGKTTLANILANELGVGIKITSGPVLDKPGDLAGLLTNLDERDVLFIDEIHRLSP
IVEEYLYSAMEDFKIDIMIESGPNARSVQINLSPFTLVGATTRSGLLTAPMRARFGIQSR
LQYYNAELLTTIVQRSSSILKMPITMEAAIEIAGRSRGTPRIANAMLRRVRDFAQIKGNG
SIDIEIAKFALNALHVDAHGLDEMDNKILNTIIDKFKGGPVGLSTLATAVSESSETIEEV
YEPFLIQEGFIMRTPRGREVTEKAYKHLGKVKANVQGGLF
>KACEBFPM_01045 Epoxyqueuosine reductase
MSCGISKAGFLEAEAPRLENWLNKQMNGQMSYMENHFDKRLNPTLLVDDAKSVISLLLNY
YPSEIQNTNSYKISKYAYGQDYHFVIKEKLAALLHFIQTEIGEVSGRAFVDSAPVLDKAW
AAKSGLGWIGKNSNLLTKQVGSFYFIAELIIDLDLEYDNPTTDHCGSCTACIDACPTDAI
VAPYIVDGSKCISYFTIELKENIPTEMKGKFNDWAFGCDVCQDVCPWNKFSKPHNEPLFN
PNPEVLSFTKKDWEEITEEIFKKTFKDSAVKRTKIGGLKRNINFLKD
>KACEBFPM_01046 hypothetical protein
MTGIFNSSTNRLSISKDSGALISSKLIPPKVGAMAFTVSTNLSISVASTSISKTSIPEKI
LNNKAFPSITGLEASGPIFPSPKTAVPLVITATKFPLAVYL
>KACEBFPM_01047 hypothetical protein
MNKVLFNREGGGLARRLPGEDHLSGLVVYGEPNLAKTLLIEAEQLETLGITQATHPVLHY
HVFEYFRVNPGSKLYIVSILDNDGQFVAIKQLQQFADAKLRQIGIVDLVTTFANLSTMAT
TIATVLNELAIANMPLNAVWSIHSITPANLIALPNLHTFNCERLSICIGQDGSGRGNYVS
GIVGKKVGIIGACLGAISKAKVHESIAWVEKQNLVTGTYPKALTGNVVVARELDVVSFID
GTLLGDLTPAQVQSIHDKGYLFPIKHIGYTGTFFNDSFTCTALDSDFVYLENNRTIDKAQ
RGVYIKLLPKISGPIYINPDTGEISADSIASLEAIASIPLEQMERDGEVSGFKVFINPSQ
DVLATSKITVVLKIVPVGVLREIVVNIGFAKQV
>KACEBFPM_01048 hypothetical protein
MPLVDITPLINGREYGWADIVVNISATPIVGIRAIKYEEEQEKENIYGAGRNPVSRGYGR
VKTTGSITLLSATVFAMQAVAPRGKLHNIAPFPVVVLYQPETGGMVKHTLKNCEFKKTTF
DWKEGDMSKEIELELLISHIA
>KACEBFPM_01049 hypothetical protein
MESAVGTSEKLVCGLTEPQIEALKKKHGFLVVVDVKQGENTFNAIFKEPTFEVLEATGAI
GKNSEIKGTIALYENCVVKVDEEINQRDFAKLKALEGLAQHMNSFSVSVKNL
>KACEBFPM_01050 hypothetical protein
MLTQILTLAIILSIIGLITTFTHSNSIAFSDSNYSEKIEKYKARKLRFGLSFFALLVLSL
FLIDKVI
>KACEBFPM_01051 hypothetical protein
MDNTVNFNIQFNALGDNKITATIQGINAQINGVSQSVQIAGNNINNSFNGIRESIKRISF
TNVLDQIDRVTTGLDSVSQPGLKLSSNMADLSAITGVTGEKLKEIEGYARDSAKVFGVDA
ANGVESYKLILSQLSPEIAKQPSALKSMGESVSYLSKTMGGDTTAATEVLTTAMNQFQVS
TIDPIKASKEMATMMNIMGAAAKEGSAELPQIKEALENSGMAAKSAGVSFAETNAAIQVL
DKAGKKGSEGGIALRNIMSKLGQGRFIPKDTKIELEKAGIDINRLGDKSLTLAERMKPLK
AIMKDGALVTKFFGEENSNAARALVDGISEQERLTKAIQGTNSVYEQAAIVMESPAEKSA
RLQEKIDDFKISLFNGTNGLLGYMGAIGNVTRDMTNLAPAISIAGSVLGTLTSKKKLDLL
WTDITIARMKVSTIVTNAWTFAQSVGAGVVSFLTKATKAGAISAALLSIQTGIATGAQWA
WNVAMTANPIGLIIAGIVALIATIAYVVYAFDGWGNAWNHTVKAAKLGWEGFVGTFELLW
LKVKNSFMNGIGTIQLGWYKFKNAVGLGDQSENNAMIAKINSDADARKKAIVDGQKKVKN
AKQSAGKEAVLAVNSIHSNGKGFGTIMTDIKAKIGIETPKQKAEKKEPDNKKDKNAFDVT
KGSAGIIPATKPIGGVGAKDKKESSGTGGGSGSRNITIGKMIENMHIHIGGTIRESKESI
KQSITEVLLTAVNDVNLAN
>KACEBFPM_01052 hypothetical protein
MQINFPSPAQAAITLAGQAIVAGAFSYGKFTPLLVTKEDIELKGSNYIGVSTLTSLAFNY
KGKKIDFPECIITVNQEKNIVTTPMEGRDGTVKEYISDGDYTIAMEAAVCSYIINQKGEA
DYQTSHAYPKEQLEKLIRFLKIKDALDVQSDFLTLFGITSVVVKSYEMVQETHSNRQAFT
IQMLSDTPYEIKINQDVAINK
>KACEBFPM_01053 hypothetical protein
MLRLTSEIIIEGSQTWKFNALNNCTIVEDMATLTDTCELILPKRVDWQGAKHFELPIKRG
DKITVKLGYDGNLKTRFVGYIRTVDAKKPVKIMCEDGMFLLKTIDVKKKGYKNVNLKQLI
TDLLEGTGVQFELIDKEEIPLGQYRISQNTVAEELNEMKNKYGLRAYFRTLNGDSKLYVG
LGYPFDNRKKESFIYGENIISEDFVYRIAEDVKIKVKATSYDNKDKKTEIEIGDKDGELY
TVFRNNITPEGLRLFAESELKRFKTTGFKGSFETFGEPFVNKCDIAHIEASDNNKGDFLI
KKVEINFGINGYRQKIEIGQPLT
>KACEBFPM_01054 hypothetical protein
MENEPNIAGVIKKISKSSDEVYAKICEVLEVNTEDKTIDVKPIDDTAEIFNVRLQAESET
GGLVLIPKVGSMVLVVFLNKNNAAVVNTSEIEKLSLLISPCKFEVDNTGFLLQKENETLK
KIMIDLVGAVKQMSFTLTTPDTINGTTTLLNNISQFTSIETRINQFLK
>KACEBFPM_01055 hypothetical protein
MRDILLDENNDLKIVNGDFLIGESTNQNVELLFTTSPGEWKEHIETGIAIQRSNNGNLDR
FLDRTIRVQMEADGYHIEKLVINELGVSIDGQYE
>KACEBFPM_01056 hypothetical protein
MNDYKVYENQTLYDVCAHVYGHIDAIMEISMINGISPTDVLVTGQTIKFIDIKPNTLVKK
ALENRNIIPACELTNLQKQQLETTGIGIMIIENTFKVA
>KACEBFPM_01057 hypothetical protein
MARSITEIKAQMLSNIAGNDDLQDLNSTSRVSIFGAFAYIVAVAHFTVEKLFDIHSQQVD
KAIYENKPGTARWYRNMSLAFQFGFNLLTDDDQFNNIGFTTEQTEASKIVKYCSVKESLE
SSRLIIKIAGESGDNLIPLTAAQITSFKYYMREIAYAGVKLEIVNNPADKLQLMMRVYRN
PLVINENGNNIITGGKTVEDAIKKYIKNLPFDGELVINDLIDYLRNVHGVINVHIISAQS
SYKDLVTNLYKPFVSIDVKTIPVAGYFEVENFNNITYVI
>KACEBFPM_01058 hypothetical protein
MLFDINFKKMGIGFLPINLRQPKNIAYVLALLEPVEWLYYQWLQKRDFDWYRLKHTGQVC
KLRKVLNDNLDKSLRRIYIAQGTAFPRKYIYTKAENKPKYLGTYFIKSQDEYENTGVDFI
VFVPTEIKTASIDQLKYLLNYYKLAGKRYKIEAI
>KACEBFPM_01059 hypothetical protein
MNYQNFNQSGGFPFQTETLHEMQKAYTLFNKFCDLAGNYAIISGCLVTGGAVSNGAVFIN
GELLEFKGGQLGADVIIVEEITAQEFEDGNDKDVLFVRYATFGIGATSFPWTNFKRPKTT
IELTEKTQAIQTKLDNIEDGAEVNVQADWNETDNTKKSYIKNKPTITDPFLLKGTYPIGD
PMGGEDSKTVTFSSVGTSNYMVLGSLVSKGTFNFDNDINYAIKDKTPTSFKIILNDAGTP
SQVQNLDFDYALLKL
>KACEBFPM_01060 hypothetical protein
MAKVSLTTIYNWFTTGSKPTQAQFWDTWDSFWHKDDKIPIAQVEGVQPIYDAINNHIKDT
NAHAGLLAYSRIYPFGTFQIFKAAGNTNGETLEIRDFGTGFINEATFMPFGIFLGGNPKE
LASWDTSPMYYPTPEVIPTLPIPGEVSR
>KACEBFPM_01061 hypothetical protein
MKRILLIFALTISLVASSQTQNFTGVKTFISPPKFKNLIQNDLNTKILTLSASDVLQWKN
ASSLGSTPNIESVLTAGNVTTKSIVFDNAGSNTRIGGGFISIANANDDPACYLDNSSIWF
RKGGLSNILRARDVECPESDVYLPNKPGNLGVSVNNIPFDASGNVNLITTTAPLHATDTG
RVGEIRVTPQYLYVCIATNVWVRVAVSSFDEIYG
>KACEBFPM_01062 hypothetical protein
MVKNINMKNLFSKNWAFIGWLLAVLLDKSTGFVAHFVSDAFWQNFIYMIGTGILGYFWTS
KYNVAIAKKRLRK
>KACEBFPM_01063 hypothetical protein
MKLKTKNFTKAPLPFMGQKRKFLKQFKPALNKYSESATYVDLFGGSGLLSHTVKSIYPGA
KVVYNDFDNYRIRLENIGKTNQLIADLRVILKDSPKDKIILGEFRSKVLERVFLEENSGY
VDYITLSSSILFSMKYALSFEALQKETLYNNMRQSEYTADGYLDGLEVVSLCYKELFAKY
KDLPNVVFLVDPPYLSTESGTYKSFWKLRDYLDVLQVLDGTKYFYFTSKKSSIIELCEWI
ETKMPMSNPFTGASLETMNATVTYQSSYTDIMLYKYE
>KACEBFPM_01064 Thymidylate synthase
MNKYHQILAKILDKGKVQNNKKGAITYLLNQSLELKPIDLLELFESHAVAKKKLKDELVL
FMAGERSTEAYRNIGVSWWDYCGPILVNSYPTYFEQLPKLIEKINKEKRTSKNYVLFLGS
NNTESNQQPCLSLIQFQIDNGKLVVSAYQRSSDASLGLPSDIYHLYLISKQIDLTLKSIT
LYLGNVHIYDNNIENTKQLLAGEVVKFSLNIG
>KACEBFPM_01065 30S ribosomal protein S1
MTNIQFIAKQVATTPKNIESTVKLLNEDCTIPFISRYRKDITGNLDEVFIEQIAKLNKEY
DLIVKRKEGILKSIEEQKALTPELKQKIDNSFDLQEIEDFYLPYKKKKKTKADVARENGL
EPLAKIIMNQKNDAVDFLATQYLNSNVINEEAALQGARDIIAEWVNENIYVRKQLRRLYE
RKATITTKVVKKKEEEEAAQKFNQYFEWSENLTKAASHRLLAMLRAEKEGFVKIKIEVDL
DEAYDLIDEIIIKNTNSAAISHVQLAIEDSYKRLLTPAISNEALQEAKAKADANSIQVFA
NNLGQLLLAPPLGEKRILAIDPGFRSGCKIVCLDEKGDLLYNETIYPHAPQNETAMAMKK
IKSMVNAYNIDAISIGNGTASRETEFFIKKIAFETRAVGEQGEAKPVQVFIVSEAGASVY
SASKIARDEFPNYDVTVRGSVSIGRRLSDPLAELVKIDPKAIGVGQYQHDVDQTKLKEEL
DNTVIRCVNSVGININTASKHLLSYVSGIGEKLAENIVQYRSENGPFENRKQLKKVPRLG
EKAYQQGVAFIRIHNAKNPLDNSAVHPEAYAIVEKMAKDLKLSVHDLIANKEKTALIKLE
HYITPEIGLLTLKDIIKELEKPGLDPRKPAKAFEFDPNVKTIKDLRTGMILPGIVNNITN
FGCFVDIGTKESGLVHISQLKAGFVSDVNEVVKLHQHVTVKVTEVDEDRKRIQLTMIL
>KACEBFPM_01066 Sec-independent protein translocase protein TatA
MLKVLFLNCASIILSIMGRLGVTEILMILAVVLLLFGGKKIPELMKGLGSGLSEFKKAAK
GDEVPDSKKDETKE
>KACEBFPM_01067 hypothetical protein
MSEKRLKRKAFFDKIKTKRRLIILNEETFEEKFSFKLNILNVFIVATLGAMFLISITSYI
IAFTPLREYIPGYASTELKKDALNLGLKSDSLEFALKKNDAYIQSVKKVLTGDLEYAKVN
KDSIMASEYVDPSEYNFEASPEELELRKKVEAEAKKAKK
>KACEBFPM_01068 hypothetical protein
MYIKAFLAKQFAKKIHKKTLKWSQNPIETQKKVFQSLLFQSKETLFGQNHNFFDIKNHTD
FIKNVPIRDYEALKPYIDQVVKGEKDILWIGKPLYFAKTSGTTSGAKYIPLTKESMPFHI
QAARNAILSYIHETGNANFVNGKMIFLQGSPILEEKNGIKLGRLSGIVAHFVPKYLQKNR
MPSWETNCIEDWETKVNAVVEETYHENMTVISGIPSWVQMYFEKLHQKAKKPVGELFKNF
NLFIYGGVNYEPYRAKFENLIGRKVDSIELFPASEGFFAYQDSQTAKGMLLLLNSGIFYE
FVKSDEFFTEKPKRYTIGEVELGVNYVLIISTNAGLWAYNIGDTVQFTSLKPYRVIVSGR
IKHYISAFGEHVIGKEVESALQEAMQNTLVRVNEFTVAPQISPANGLPYHEWFIEFENEP
ENIENFALQIDHAMRKQNTYYDDLIVGHVLQTLIITKVNKNGFQEYMKSIGKLGGQNKIP
RLSNDRNIVDKLIINK
>KACEBFPM_01069 hypothetical protein
MQKTLLLFLVSFSITAQIKGVVKDSISGKPIPYVNIWVQNENIGTTSEENGEFTISSTDK
NKNLIFSALGFEKKIMSASKSILVNLKPMLYQLDEVMISEDRLETKTLEIGNTDNQIYQS
FDNGPRIDTKFFPYRLAYKKTKFIQKIAIETDSRIEEATIKIHFYTVDEKGYPSEEMLHK
DFIVSVKKGTKKSLFDVSKFNLTMPKKGLFVGFEKLIIEKNKLEKTIIDSKTNKTQIQKT
YFPFVMYNFVERAFLYTFSGGKWNRQTKHNDSDSPNKIMVYEPAINLIITN
>KACEBFPM_01070 hypothetical protein
MKEIKNISRSRAQESSAAIERLYITMRHLFNRGFYKPMGISGETLREALLALRPEIYGTI
AEEKVELNGLLYVIERLPVGIEECRYINLTSDEGYSNSHFQAIVPPKRRRNCYRIDEEQM
NVEITRGRSDIYDILTHLTFIFIESHKIKDRVLIDDLGKVSRDWKKLEQAALQNKKLSLI
EREKAISHVANILGRTFAEVSAIYDDFGNTTSPDRFLHIIYWLGKIAIEEVVDNNKRTIT
FSPILRERLGHHIHGEIWANDIKEVLQKNDLLSRPIHVISANMHSVMNSIFATHVLKTKF
KDKTDFDIYEELSKSGANDLRDKVSAFALQHGMISLPDTSGTNIDVQIFDTAKIDWTKSA
FAKAKIEKESPVLIVMDYAFGEQAFETIDELLKPYKIGKEKIFLNVESVSIMGKAGILEG
GKGDIMIPNAHINEGTADNYSFHNELTAKMFEGNDIPVFAGPMITVLGTSLQNRDLLKFF
HESTWEAIGLEMEGSYYQKAIQSASKIRKSINENVKVRYAYYASDNPLETGSTLASGGLG
TTGVKPTYLITIKILEQIFNVK
>KACEBFPM_01071 dTDP-4-dehydrorhamnose 3,5-epimerase
MNFISTNLAGCFVLEPKIFHDDRGYFMESFNENTFEKGIGQKVHFIQDNQSYSSKGVLRG
LHYQTGAHAQAKLVRVLQGEVLDVAVDIRPQSPTYGQSFSILLSAENQKQLYIPRGFAHG
FLVTSETATFFYKCDNFYNKESEGGLIYNDPTLNIDWNFPEKELIISEKDIILPTLENAK
KVW
>KACEBFPM_01072 dTDP-4-dehydrorhamnose reductase
MVILVTGASGQLGQSIQYIASNYANCEFIFASSTALDITNKEAVSHFFNTNKIDFCINAA
AYTAVDKAELETEKAEAINVAGPKNLAVLCKKHQVKLIHISTDFVFDGASNKPYLETDIT
NPLGIYGKTKLDGEQAVINNTDEYFIIRTSWVYSQFGNNFMKTMLRLASERDSLSIVSDQ
IGSPTNAVDLAKAIMQIIAKTQHPTASTAYGIYNFSNEGIASWYDFAVEIFRINNVVIDV
NPILSEAFPTPAKRPKYSLLDKSKIKNTFGIEIKTWQESLLQTI
>KACEBFPM_01073 UDP-glucose 4-epimerase
MKRILITGAAGFLGSHLCDRFIKEGYHVIGMDNLITGDLKNIAHLFKLEHFEFYHHDISK
FVHVAGDLDYILHFASPASPIDYLKIPIQTLKVGSLGTHNLLGLARVKGARILIASTSEV
YGDPLVHPQTEEYFGNVNTIGPRGVYDEAKRFQESITMAYHRFHGLETRIVRIFNTYGPR
MRLNDGRVIPAFIGQALRGEDLTIFGNGMQTRSFCYVDDQVEGIFRLLHSDYAYPVNIGN
PDEITIKDFAEEIIKLTGTNQKVIYHDLPENDPLQRQPDTTKAKELLGWEAKVSRSEGMK
ITYEYFKSLPQAALLQEEHKDFSGYIR
>KACEBFPM_01074 UDP-glucose:undecaprenyl-phosphate glucose-1-phosphate transferase
MTKGRYSKYIRPISIIIDCVLLVVLASFFLKEFAIQLSYFMIYQLVSWCILAYFTKFYEV
YRFTKPVEIMSMLFKQLFLFSLFLIAFFSITREIIFSFRLLFYFIGLSFIGITFFKGLLF
YYLKKYRIVLGGNYRNAIIVGYTDSSKSLQQLFQNRPDYGYRFKGFFSDTINNENIKGNV
STIQDFVLYHKIDDIYCALEELSNNQLRELVEFAEYHKITIKFIPESSEIYAKNLKIDYY
EFFPILSLKRIALNQPLLKFVKRLFDILFSLLVITFLLSWFIPIVAILIKLESKGPIFFK
QGRPGLYEKEFFCYKFRSMRMNDKTETSVVKNDLRITKIGALLRQTSFDEMPQFFNVFLG
DMSVVGPRPHLWLHNNEYQTKIKRYNLRLHIKPGITGLAQVKGFRGEVETDEEMVNRIKY
DLFYIENWSLLLDIKIIVLTVINIFKGQEKAY
>KACEBFPM_01075 Putative teichuronic acid biosynthesis glycosyltransferase TuaG
MNELVSIITPTYNSEQFIAEAIKSVQNQSYSHWEIIIVDDCSKDKTVNIIQNFIDEDHRI
YLIQLDKNSGAGVARNNAINNAKGRYIAFLDSDDLWKPDKLSKQIKFMQRHNIPFTFSFY
DCINEKGDLLNKRIEAPKKLSYYQLFFCNFVGNLTGIYDSNYFGKMAISSIRKRQDWIVW
LTILKKIKTAKPVPESLALYRIRENSISASKVSLLKDNYAIYRKFHHLNIIVSLACMLGF
LFTQLLVKPKFVKIIKT
>KACEBFPM_01076 hypothetical protein
MFRLFDLTLIINGFPMQKAKAELNKIVSFSEEEHQQFIENKKQEIVNFHLKNNKSYQDFV
KKKCFNPKIWVWNELPIMTKKDFQKPLAERISKGYTLKSIYINKTSGSSGNPFIFAKDKY
SHALTWASNIYRFKWYAIDFNTSCQARFYGIPLDIIGNKKERLKDFLKNSYRFTIFDLSD
EILEKILFKFRKKKFDYINGYTSSIVLFAKFLQKKGIVLTTVCPTLKCCVVTSEMLFPED
KVLMEKQFGVKIINEYGASELDLIAFQNPNDEWQVNAETLFVEILDENNNALPYGKEGRV
VITSLFNKAHPFIRYDIGDIGILDQKSTLKKPILKKLIGRTNDISILPSGKKSPGLTFYY
VTKSIIEDDGNVKEFVIKQTKIDTFEVEYVSEKKLTDYQIENIEAAIALYLEPNLTFTFT
RKLSLERTNRGKLKQFRSLLSSQI
>KACEBFPM_01077 Phosphoribosylamine--glycine ligase
MTILLLGSGGREHALAWKMLQSDKCSKLFVAPGNAGTQQIATNVDINILDFEAIKAFVIQ
EKVTMVVVGPEDPLVLGIYDFFKNDSSLKDIPVIGPSKKGAQLEGSKEFAKEFLVKHNIP
TAAYDSFTAETVEKGCLFLETLQPPYVLKADGLAAGKGVLIIHDLAQAKEELRNMLVHAK
FGEASAKVVIEEFLDGIELSCFVLTDGKNYKILPTAKDYKRIGEGDTGLNTGGMGAVSPV
PFADAILLEKIETRIVKPTIAGLQKDEIEYKGFVFIGLINVKGEPIVIEYNVRMGDPETE
VVIPRLKSDLVALFEAVGNGKLDQVSLEIDKRSATTIMVVSGGYPEDYEKGKVISGLENI
EDSIVFHAGTKTENGAVLSNGGRVLAVTSFGDDFQEAIKKSYQNIDKLHFDKIYFRKDIG
FDLL
>KACEBFPM_01078 hypothetical protein
MKSFFEGIQWLFDNILLASHEVLRSLELSNWWLANLISWAFIIICSYYIWYWIKQLKSHK
ENNEENQDTTAHSFLK
>KACEBFPM_01079 hypothetical protein
MITSVFSKSRPINYILITTLLVLCFLLFQFQSNFNTISTLEIAKKIILLLLLVGSLYITN
FITKKNGLSKDNSYTFLLFFVFLILFPKTLSNAALIISNLFVLLALRRLISMQSLITPKE
KIFDASFWIFTASLFNFWCILFIILVFISIIFHVSRDYRNWTIPFIAFFSVLVISVFSAL
IYDPTLITTYLSQIVLDFDLKYIETIFQNIALFIYITTALVAFVSMLFILPSKLSNLQPS
YRKMIFAFIIGLIIFFISPKKDNSFLIYTFVPVSIMLTNYLETINKYWIKESILAIILTA
SIITFVLQLL
>KACEBFPM_01080 Uracil phosphoribosyltransferase
MQIHYISEENSILNHFLAQIRDVNIQKDSMRFRKNIERIGEIMAYELSKTLSYKDINVQT
PLGIKTTTTIAQNVVLCSILRAGLALHTGFMNFFDDAENGFVSAYRHHYNHDDAFDILVE
YQAAPSFEGKNLILIDPMLATGQSIVAVFNKLMTEETPNEIHIAVVIAAPEGIQFLEENL
PKNCHLWVAALDEKLNEKNYIIPGLGDAGDLAYGNKL
>KACEBFPM_01081 hypothetical protein
MFSQFAFPIFEQCINDYHIHDTVNQPINNPFEKDKIEHLLYAKNWVDTVQWHYEDIIRDP
NIDPVEALVLKRKIDASNQVRTDMVEYIDSYFLQKYTTVKVKPSAKINSESPAWAFDRLS
ILALKIYHMNEEATRKEASAEHRIKCQEKLNVLLEQKKDLTTAIDDLLTDIEAGDKYMKV
YKQMKMYNDDELNPVLYQNKK
>KACEBFPM_01082 Lipopolysaccharide core heptosyltransferase RfaQ
MGDAAMTVPVLRAFILQYPDVKITVVSKPFFKPFFDTIPNVNFFGIDINGRHKGFLGLIK
LFLDLRKLNIDAVADLHNVIRSKAIRKLFLLFGKKVAASNKGRADKKALTRVKNKIFKPL
KTMFILHCDTFAKLGFDINLNNPNFANKAVLSPKIISITGNKNQQWVGIAPFAQYESKVY
PQDLMQQTINDLSKNNDYKILLFGGGKKEIEALDLLAKGNKNVINIAGRITFQEELNLIS
NLDIMLSMDSGNAHIAAMLGVKVITLWGATHPFAGFSPFNQPLENALVSDREKYPSLPTS
VYGNKDLAGYQDAMRTILPETIVKKLKESLSE
>KACEBFPM_01083 1,2-phenylacetyl-CoA epoxidase, subunit E
MSTFYKLSIQEIKKETPQAVSILFNVPIEFKDFYKFDAGQYVNLKLTLDGQEIRRAYSIC
SSPSSGELRIAVKAIKNGLFSEFANNELKAGSIIEVGTPEGKFTFEPNLDKQKNYLAFVA
GSGITPVMSILQSVLLQEPKSTFVLVFGNKSEQETIFHDQLIKFQQKYLGRFFVHFVYSQ
SKSDDSVFGRIDKSVVNFVMNNKHLGTNFSKFYLCGPEEMINTVSDVLKEKSIPEKDIKF
ELFSASTKEKKIDTTKNEHTTITILVDGDQATFEMSPKQTLLEAALKQGIDAPYSCQGGV
CSSCLARVTKGTAEMKKNVILTEKEIAAGLILTCQAHPTSSEIFVDFDDV
>KACEBFPM_01084 hypothetical protein
MKTNSLKHISLSLLFVLAVACSTKKNTFVSRNWHAINSEYNVLYNGGVALQLGINDLKTG
YKDNFWEILPVERMQILEEAILPGQKAKNQNFERAETKATIAIQKHSMNIEGKEKNMQMD
EAHLLLGKSRYYDQRFIPALEAFNYILYKYSNSDKIYEAKIWREKTNIRLENDALAVKNL
KRLLKNYKIKPQIFADANAILSQAYLNLEQKDSAIAPLKKALVSTKLKEEKARYHFILGQ
LYQSLEYKDSAYAAFEEVIKMKRKSPKQYVMQAYAKQSELVDQTQDTVLFLKKYAKLFKD
RENRPHHDILNYQMASFYDKLNKKEQAIKYYNKSLRSKSDDSYLQATTHKNLATIYFDKA
KYIMAGQYYDSTLTRLVQKNREYFSIVKKRENLVDVIKYEGIVQHNDSILNIVALSKYDQ
KSYFEDYILKIKAKEEAKKLLEAKQKKTNQDTGIQDIDMVKVKPKNISSDPSFLPPGAGF
GVSTDNSFYFYNPITVNYGKVAFLKKWKKRPLTDNWRWITELSDIKNTDQVIANTVIAKT
EEVPENFQADFYLKQLPTSQKTLDSLARERNFANYQLGVIYKEKFKEYKLSASKFEFLLK
SNPEERLVLPAMYNLYKTYEIINKEKSEIIKNKIITNYPNTRYAQILNGTIVEENAIVQT
PAAVYKTIYNQFNNQEYVAVLETIEKSLAQFAGDDLIPKFELLKSSVIGKLKGVDEYKKS
LNFVSLNFPNTKEGKQAEEILQNNIPVLEKMTFVNDTLSKNWKILYKAATKEDNETKTLI
EKINKYIKEKQYDTFSVSYDVYTETENFVVIHGIKSKEYSDYLINILKDTKDYKIVTPAK
VISSENYSVIQVKKNYNQLLELK
>KACEBFPM_01085 hypothetical protein
MFEKRNKSYTELLGKTNRIVEATTIKGDIESVSDFRLDGHLIGNFTSKGKLVIGPAGSVT
GDIYCQNVDVEGTVKGKITVDDILSVKNKARIHGEVICGKLSVEPGADFSATCTMQATSK
PALTTNG
>KACEBFPM_01086 hypothetical protein
MDSNKDKKNNVQWLPLINIPIQMGAIIFLFYKLGFWLDSNYASQKICYYKTLTLLGVFFA
LYNVYRQVNEIGKNA
>KACEBFPM_01087 hypothetical protein
MFKKNIKSIGLLALIIGVVYLVHKFVFYVCKFDQSAFIYSLEQLYLFFGLFSITIELILI
SVKQKNIDIVGNVFLLLTLVKMMVCFVFKSSVFKKGFEDNPVQKWNFLILFLLFLAIETI
ATIIILNKKETI
>KACEBFPM_01088 hypothetical protein
MRKKILISFIGLFYISLSAQCWQSVSAGGSHSLGIRTGGTLWSWGRNYFGQLGTAGTPAT
FSNIPIQVGTATNWQTIAAGNAHNVAIKTNGTLWTWGHNQASQLGDGSTTNSNIPIQIGT
ATNWRFITAGDEYVIAIKLDGTLWAWGDNTYGQLGDNTTVNKIVPTQIGSDTDWLLVSAG
TNHTLATKTNGTLWAWGRNNTGQLGDNTTLNKIIPTQIGADSDWQNVMASILHSAATKSD
GSIWTWGNNTNGQLGDGTVVGKIIPVNITTVTNCNWIAKGHQHTIAKKSDGSLWAWGGNA
SGQLGDASTTQKNSPVAVSGLTTDWLTVNSKLSHTIALKNDGTLYTWGANLYGQLGDASN
IAKDIPTLITCPFLAIDEKVFARKLSVYPNPVTSILNIQRDNLVFNKIIITNLYGQIVFE
NKENISLINIENLASGLYFIQAFSEEGSYQNKFIKN
>KACEBFPM_01089 hypothetical protein
MRYNYLLLLFLVGITSQAQLYVSNNTDVYVNNQFVYVTGKVALNAGASNLYLRNQSQLLQ
GNLVSGAAKLPGGENTGLGALSVYQEGTVNNFQYNYWCSPVGGSLAVAGNSPFSITQLGV
PTTATGTTPATILALGNHDGVSGTGTLSIAPYWVWKYTTASTYAQWILVASAPILAAGEG
FTMKGTSGSDATIPPSETTANKVSGAGQRYDFRGKPNDGTINVPVTNGTLTLTGNPYPSA
IDMRIFLFRNPGPDLSFGTADDGPLENPLCDGTALYWEHDKTVNSHLLAAYKGGYGIYNG
ATGVYTPALFFAYDGAGTQLAGSTGAGTIKERRFAPIGQGFMLNGIGAGNVQFKNTHRVY
RKEGLLTNSEFERTTATASEFYEDIPNIAGIDYTRMSKLPTPHIKINTLLNNQGIRQVDL
AFMDSAIDGVDRADSRSPDAEESLPSDMYFALDNSEYVLSTTSFNINKKFAVGFKNSTEA
TFRVKVLEFVNFDGAQNVYLHDKITDLYHDIKNSEYEFSLPAGVNNNRFEVTFINNTLST
TNNVAADFDVFQNNGNQLLTIKNPKVINLKSCTLYDISGKTILSKTNLGSNSTYEYNTAG
LSEGIYIVKLITEANQEISKKISILNKK
>KACEBFPM_01090 hypothetical protein
MKVRFIALFIFVFSSIFAQKSISGKSYIVNKNDYSFLDNILKNKKIVLLGEQSHGDGATF
DEKINLIKYLHEKLGYNTIVFENGLYDNYKAFQEYSKHNQKSLIFNESIFELWSDTKSFQ
DLLSYIDERASKNDTIKIAGFDNQEGSLFDDNYLNDLKNTLRNHQIKIPENTIQKLEKAF
VSRDLDNIATSKTDSINLSENYDFILKSFQKISNLSYHEKMLQQVFISKIADVNFDIQQL
QKQKIAVQNPRDLQMARNLIFLSELNPNEKMICWGASYHFANDIKYDYTDVTESYMNLQA
ELEKKAIGQTDYKLGDGKTMLDGAKPMGIFLKDYFKNEMYTIAFSSFEGNYGVVDSKQYL
IPKPPASSVEQQLFDTKNEKVFLDFDKSDNTNFYCSALGNIPIKANWNQMFDGLLFVKTA
YQPETRTYEKSNILENSSNSFVITGKILNSKNNTTIVNADVSITNSNKSIIGNKNGGFGF
TIPKTNFNDKLIISALGYYSDTISIAKLVSANKVLLKIRLKPQIFDGYLLNEVVISSKQK
TLSADEIVEKARKNVEFNYCQNPYNQKFYFKTQIMFDDKIKKNEEAIVNTFNAKGLNSSN
DPSQNFYGEIEQIRNTTNNLSQEQYAQGSNGLWLVLDKNLILSKENVLFRTSSYDLKKEG
VVIYNNKRVYKISFINNSPGSYSTGFGYPAPKSSSGILYIDSESFAVLRYEHCVEREIFS
FKNKPNNPIQQFHKIIETYKLVNGKYFLNYSSNTDKMVKLNDPDINSWKEYYLVYNLMSL
DIEINNIQKINRPIEKLTQNVELLDNKEFWNNNLFNLEDGKYKFDNCN
>KACEBFPM_01091 Carbamoyl-phosphate synthase small chain
MQHTTKQAAILLLSDGTIFHGKSIGISGTTFGEVCFNTGTTGYQEIFTDPSYFGQIMVAT
NAHIGNYGVNAAEVESDKIMISGLVCKNFSNFHSRPDSESNLFDYFKKQNLVCISDVDTR
ALVSYIRDNGAMNSVISTDGTSIEELKKQLAQIPDMKGLELASKVSTKTPYFYGNENAKY
KISALDLGIKTNILRNLAKRDCYIKVFPYNAKYQDLKEFNPDGYFLSNGPGDPDPLESAI
SVAKEIIANNNPLFGICLGHQVIALANGVSTYKMFNGHRGINHPVKNLITGKGEITSQNH
GFAVNKEALDNHPDLEITHLHINDGTVAGMKMKNKNCFSVQYHPEASPGPHDSSYLFDDF
IENINKAK
>KACEBFPM_01092 50S ribosomal protein L17
MRHGKKFNHLSRQKGHRAAMLANMACSLIEHKRINTTVAKAKALKQFVEPLITKSKDDTT
HNRRICFAYLRSKYAVTDLFRDVAAKVGDRPGGYTRIIKLGNRLGDNADMAMIELVDFNE
LYNGGKKEEVKTKSRRGGKAKKAEPTTEAPANTTEETTDSAE
>KACEBFPM_01093 DNA-directed RNA polymerase subunit alpha
MALFNFQKPDKVIMIDSTDFEGKFEFRPLEPGYGLTVGNALRRVLLSALEGYAITSIRIE
GVDHEFSTIPGVVEDVTEIILSLKQVRFKRQIEDIDNESVTIAISGKNQITAGDFQKYIS
GFQVLNPELVICNLDSKVNFNMEMTIEKGRGYVPAEENKKQNAAIGTIFTDSIFTPVKNV
KYAIENFRVEQKTDYEKLVFEIKTDGSINPKDALTEAAKVLIHHFMLFSDERITLEADEI
AQTESYDEESLHMRQLLKTKLVDMDLSVRALNCLKAAEVDTLGDLVSFNKNDLMKFRNFG
KKSLTELDELVAIKNLTFGMDLAKYKLDKE
>KACEBFPM_01094 30S ribosomal protein S4
MARYTGPSTRIARKFGEAIFGDDKSFEKRNYPPGQHGMAKKRGKKSEFAIQLMEKQKAKY
SYGILEKQFRGLFKKAAASKGVTGEILLQLCEARLDNVVYRMGIAPTRRAARQIVSHRHV
TVNGELVNVPSYHLKPGDKVAVREKSKSLEAIDRSLSNSSHVYEWITWNTAQMEGTFVSV
PARLQIPENIKEQLIVELYNK
>KACEBFPM_01095 30S ribosomal protein S11
MAKASTKKRKVIVESIGEAHISATFNNIIISLTNKKGEVVSWSSAGKMGFRGSKKNTPYA
AQMAAEDCSKVAMEAGMKKVKVYVKGPGNGRESAIRSLHNAGIEVTEIIDVTPLPHNGCR
PPKRRRV
>KACEBFPM_01096 30S ribosomal protein S13
MARIAGVDIPKNKRGVIALTYIFGVGRSRAIEVLEKAQVSQDKKVQDWNDDEIGGIREAV
SFYKIEGELRSEVSLNIKRLMDIGCYRGIRHRSGLPLRGQRTKNNSRTRKGKRKTVANKK
KATK
>KACEBFPM_01097 Translation initiation factor IF-1
MAKQSAIEQDGAIIEALSNAMFRVELENGHIVIAHISGKMRMHYIKLLPGDKVKLEMSPY
DLSKARITYRY
>KACEBFPM_01098 Protein translocase subunit SecY
MKKLIESFLSVWKIEELKNRILITLGFLLVYRFGNQVPLPGIDITKLQNLTNQTDKGIGW
LIDVFTGGAFSHASIFALGIMPYISASIVVQLMGIAIPYLQKLQKEGESGRKKMNQITRW
LTIGITLVQGPGYIYNLYRTLPQDAFLLGNSPAFIFSSVIILATGTIFAMWLGEKITDKG
IGNGISLLIMAGILARMPQAFIQEFSSVTTNNTGGIMLIVLEIILWLLVIIGCILIVMAV
RKIPVQYARRSVTGDLEQDLLGGDRQFIPLKLNASGVMPIIFAQAIMFIPAAVAGLSKSE
TAQSIASRFQNVFGWEYNLLFALLIVIFTYFYTAITVPTYKMADDLKRSGGFIPGVKPGV
ETADFLDHIMSLITFPGSLCLALLAVFPAIVVSLMGVQTQWAHFFGGTSLLIMVGVVIDT
VQQINSYLLNKHYDGLMKSGKNRKAIA
>KACEBFPM_01099 50S ribosomal protein L15
MNLSNLQPAEGSTHNQNKRLGRGEGSGKGGTSARGHKGAKSRSGYSKKIGFEGGQMPLQR
RVPKFGFTNINRIEYQGVNLDNLQLLVDNGIVTDTVDMTVFITSRLATKTEVVKILGRGE
LKAKLKVSAHKFTATAKAAIEAAGGEAIEL
>KACEBFPM_01100 50S ribosomal protein L30
MAKLLVKQVRSKINCPLDQKRGLEALGLRKMGQVVEHDSNPTILGMINKVKHLVSVEEAK
>KACEBFPM_01101 30S ribosomal protein S5
MYHKYKNVELVKPSGLELKDRLVSVNRVTKVTKGGRAFGFSAIVVVGDENGVVGHGLGKS
KDVSEAIAKAVEDAKKNLVKIPLSGKSVPHEQKGKFGGARVNLMPASHGTGVIAGGAVRS
VLESVGIHDVLSKSQGSSNPHNVVKATFDALLQMRSAYTVSRQRGISLEKVFKG
>KACEBFPM_01102 50S ribosomal protein L18
MSLTKSDRRQRIQYRIRKIVSGTAARPRLSVFRSNKEIYAQLIDDVNGVTLATASSREKG
VNTGTKIEVAIAVGKLIGETALKAGIDTVTFDRGGYLYHGRVKSLAEGARAAGLKF
>KACEBFPM_01103 50S ribosomal protein L6
MSRIGKNPIAIPAGVTVEVNNSIVTVKGKLGQLTQNYTNNVTVKVEEGQVIVERAADSKQ
ERAQHGLYRALINNMVAGVSTGFTKELELVGVGYRASNQGQKLDLALGFSHNIVLEIASE
VTLETISEKGKNPIVKLTSFDKQLLGQVAAKIRGFRKPEPYKGKGVKFVGEVLRRKAGKS
A
>KACEBFPM_01104 30S ribosomal protein S8
MYTDPIADYLTRVRNAAKANHKVVEIPASNMKKEITKILFDQGYILSYKFEDNAVQGSIK
IALKYDKVTKESVIRDIQRISKPGLRKYSGSSTIPRILNGLGIAIVSTSKGLMTGKLAKQ
LNVGGEVICYVY
>KACEBFPM_01105 Alternate 30S ribosomal protein S14
MAKESMKAREVKRENTVAKYAEKRKALKEAGDFVGLQKLPKNASPVRMHNRCKLTGRPRG
YMRQFGISRVTFREMANNGLIPGVKKASW
>KACEBFPM_01106 50S ribosomal protein L5
MAYIPRLKEEYKSRVISALTEEFGYKNVMQVPKLEKIVISKGVGAAVSDKKLIDYAVEEL
TKITGQKAVATISKKDVASFKLRKGMPIGAKVTLRGERMYEFLDRLVTSSLPRVRDFSGI
KATGFDGRGNYNLGVLEQIIFPEIDIDKVNKISGMDITFVTSATTDKEAKSLLTELGLPF
KKN
>KACEBFPM_01107 50S ribosomal protein L24
MIKLKIKTGDIVRVIAGDHKGAEGKVVKVDREKNKAIVEGVNMVSKHTKPSAKSPQGGIV
KKEAPIQISNVSLIDPKTKEATRVGIRVEGDKKVRFSKKSNQVL
>KACEBFPM_01108 50S ribosomal protein L14
MVQQESRLRVADNTGAKEVLTIRVLGGTKRRYASVGDKIVVSIKDTAPNGSVKKGSVSTA
VVVRTKKEVRRADGSYIRFDDNACVLLNAAGEMRGTRVFGPVARELREKQFMKIVSLAPE
VL
>KACEBFPM_01109 30S ribosomal protein S17
MEDKRNLRKERIGVVTSDKMDKSIVVAQVTRVKHPLYGKFVLKTKKFVAHDETNDCNVGD
TVKIMETRPLSKSKCWRLVEIIERAK
>KACEBFPM_01110 50S ribosomal protein L29
MKQLEIKNLSAAELQAKLVQLKKTYSDIKIAHAISPIENPLQIRSLRRSVARIATEISKR
ELL
>KACEBFPM_01111 50S ribosomal protein L16
MLQPKRTKYRKVQKGKMKGNSQRGHELSNGMFGIKSVHEDGMFLTSRQIEAARIAATRFM
KREGQLWIKIFPDKPITKKPLEVRMGKGKGAVEYWAAVVKPGRIMFEVGGVPLSVAKEAL
RLAAQKLPCKTKFVVARDFEA
>KACEBFPM_01112 30S ribosomal protein S3
MGQKTNPIGNRLGIIRGWDSNWYGGNDYGDKIAEDYKIRKYIHARLSKASVSKVIIERTL
KLVTVTITTARPGIIIGKGGQEVDKLKEELKKVTDKEVQINIFEIKRPELDAFLVATSIC
RQIESRISYRRAIKMAIAASMRMNAEGIKVLISGRLNGAEMARSEGFKEGRVPLSTFRAD
IDYALAEAHTTYGRMGIKVWIMKGEVYGKRDLSPLAGMDKKQAGQGGGKGGDSPRGDRKP
FNKGGKPDARKRK
>KACEBFPM_01113 50S ribosomal protein L22
MGVRKRETADARKEANKSIAFAKLNNCPTSPRKMRLVADLVRGQKVDRALNILRFSSKEA
SRKLEKLVLSVIANWQAKNPEANMEEAGLFIKTITVDGGMMLKRLRPAPQGRAHRIRKRS
NHVTIVLGSINNTQAIN
>KACEBFPM_01114 30S ribosomal protein S19
MARSLKKGPFVHYKLDKKVQENIAGGNKGVVKTWSRASMITPDFVGQTIAVHNGRQFVPV
YVTENMVGHKLGEFSPTRSFRGHAGAKNKGKK
>KACEBFPM_01115 50S ribosomal protein L2
MSVRKLKPITPGQRFRVVNGFDAITTDKPERSLIAPIKNSGGRNSQGKMTMRYTGGGHKQ
RYRIIDFKRTKDGIPASVKSIEYDPNRTAFIALLAYADGEKTYIIAQNGLQVGQKVVSGE
GSAPEIGNTLPLSKIPLGTVISCIELRPGQGAVIARSAGTFAQLMARDGKYATIKMPSGE
TRLILLTCSATIGAVSNSDHQLIVSGKAGRTRWLGRRPRTRPVAMNPVDHPMGGGEGRSS
GGHPRSRNGIPAKGYRTRSKKNPSNKYIVERRKK
>KACEBFPM_01116 50S ribosomal protein L23
MSIIIKPIVTEKMTKAGEVFNRFGFVVDKKANKVQIKKAVEAAYGVKVVDVNTMNVRPDR
STKYTKSGLITGKTNAYKKAIVQVQEGETIDFYNNI
>KACEBFPM_01117 50S ribosomal protein L4
MEVKVLNINGKETGRKVQLSDSVFAIEPNKHAVYLDVKQYLANQRQGTHKAKERAEVAGS
TRKIKKQKGTGTARAGSAKNPLFKGGGRVFGPRPRSYSFKLNKTVKRLARRSAFSIKAQE
ANIIVVEDFVFEAPNTKNFINVLKALGLEDKKSLFVLGDSNKNVYLSSRNLKATNVLTNS
ELSTYAILNANNLVLLEGSLEGIEENLSK
>KACEBFPM_01118 50S ribosomal protein L3
MSGLIGRKIGMTSIFDENGKNIPCTVIEAGPCVVTQVRTIGVDGYEALQLGFDDKNEKHS
TKADLGHFKKAGTVAKKKVVEFQDFVSEHKLGDVISVDLFSEGEFVDIQGVSKGKGFQGV
VKRHGFGGVGQATHGQHNRLRAPGSVGASSYPSRVFKGMRMAGRMGGDNVKVQNLRVLKV
VAEKNLLVIKGCIPGCNNSYVIIQK
>KACEBFPM_01119 30S ribosomal protein S10
MLVDKSAEKIVKTVKSTGAVVTGPIPLPTHKKLFTVLRSPHVNKKAREQFEVMSYKRLID
IYSSSSKTIDALMKLELPSGVEVEIKV
>KACEBFPM_01120 Elongation factor G
MARELKYTRNIGIAAHIDAGKTTTTERILFYTGKSHKIGEVHDGAATMDWMAQEQERGIT
ITSAATTCEWNFPTTQGKMLPETLPYHFNIIDTPGHVDFTVEVNRSLRVLDGLVFLFSAV
DGVEPQSETNWRLADQYRVPRIGFVNKMDRQGSNFLMVCQQVRDMLKSNAVAITLPIGEE
NDFKGVVDLVRNQAIVWDDAGMGATYEVVPIPEDMLAEVKEYRGILIEAVASYDENLLEK
FMEDESSITEDEINVALRAAVMDMAIIPMIAGSSFKNKGVQFMLDAVCKYLPSPMDKEGI
EGIHPDDADLLEEDQTKILRKPDVKEPFAALAFKIATDPFVGRLAFFRAYSGRLDAGSYV
LNTRSGNKERISRIYQMHANKQNPIEYIEAGDIGAAVGFKDIKTGDTLCDEKHPIILESM
KFPAPVIGIAIEPKTKADVDKMGMALAKLAEEDPTFTVRTDEASGQTIISGMGELHLDIL
VDRMKREFKVEVNQGEPQVEYKEAFTKSAQHRETYKKQSGGRGKFGDIVFKLEPADEVDG
KPAVGLQFINAVKGGNVPKEYIPSVEKGFREAMKTGPLAGYQVDSLKVTLLDGSFHPVDS
DALSFELAARMGYREVAKAAGAIVLEPIMKMEVITPEENMGDIVGDINRRRGQVNDMGDR
NGAKTIKADVPLSEMFGYVTTLRTLSSGRATSTMEFSHYAETPSNISEAVIKKAKGNA
>KACEBFPM_01121 30S ribosomal protein S7
MRKRAAKKRPLLPDPRFNDQLVTRFVNNLMWDGKKSTAFKVFYDAMDIVEAKKQDQEKSS
VDIWKDALTNVMPHVEVRSRRVGGATFQIPMQIRPDRKISMAMKWMILYSRRRNEKSMAQ
KLASEVLAAAKEEGAAVKKRMDTHKMAEANKAFSHFRF
>KACEBFPM_01122 30S ribosomal protein S12
MPTIQQLVRIGRTKMTKKSKSVALDSCPQRRGVCTRVYTTTPKKPNSAMRKVARVRLTNG
NEVNAYIPGEGHNLQEHSIVLVRGGRVKDLPGVRYHIVRGALDTSGVAGRTQRRSKYGAK
RPKEAKK
>KACEBFPM_01123 hypothetical protein
MKFIFSFLVVFICQNALAQFSYLQIKGAGDSECSIIDSIGYSKRHANTKSVVEQANLFAD
KLLKNGYLTAKHEGVITVNDSTFLFNYTLGVRNKFIHIYIGKDFELLNLKSDLLKIPIAE
TESFMNTALRFLEKKGYSLARLQLTDFKTDSNELFANLSLGAEKIRTLDDIVINGYDKFP
AGHKKQIKRLYRNKVFNQENLKKVYNDFGKFRFVSQPKYPEILFTKDSTKVYVYLEKAKP
NTFDGYIGFTNNEQKKLIVNGYLDLQLENIMNGGEKISLYWKSDGRNQKTFNGAIEIPYV
FKSPLGIKAQLNIFKQDSLFQNTQTAIDLGYYFNYNTKAFLGYQSAESSDIQNTNSATLR
DFKNAFITTHLDFSVYNPDDYLFPDKTKIYFKIGIGKRDLEIRSNSQFFSTLNLSHNFYL
NKKNIVNIRSLNYYLNSDSYVINELQRFGGINSIRGFSENSLQGNALSLVLTEYRYIANS
NIYIHSIIDYGYYQDKSSNISKTLVGLGFGLGLLTKNGLFNLIYANGSTKEQAIKLSNSI
VHVSFKAKF
>KACEBFPM_01124 TonB-dependent receptor SusC
MCFLLNFAQNKLKHINMKLKLNRFLVLLFALISQLALAQEKNATGVVTDASGLPLPGVNV
VVKGTTRGASTSFDGTFKIQAQQGEILVFSFMGMNTVERPATKGMAVKLNDESTKLADVV
VTALGIKREKKSLGYATQEVKGDDLNKVNSGNVANSISGKVAGIEIRRSGNIGGSTSVII
RGSKSITGNNQALWVVDGVPVSNDNTNSREVAKGNSGYDTGNPAADISPDDIESINVLKG
AAASALYGSRASAGVIIVTTKKGSKNNKGLGITISSGITTGYVNNQTLPEYQTEYGGGYG
GTSFGGASVQIPAGSGGFNKRVITKWDASFGAPFDPNLNVFQWNSFSPELPTYGKATPWV
AGKNNPNSFYKPSTTYNNSVSLAGGNENGTFRISYTKFDQNGFIPNSQMKKDNINISGSY
NLSPKTSISANANYIKTDILGQNEVGYGDGGNNIFASFRQWWQTNADMKDLEDAYNLTGR
NLSWNAKSRFDTSPEFHDNPYFVRYNNYNTVNRDRFFGNLTFTTQLAKWLSFTGRGSADT
YLELDEERIAPTSSRTTNRLGAYSRYNRNSKEINLDAFLNFDTKIVSDLTLKAMLGGTAR
RNFVDAIYATTSGGLIVPGVYNLGNSIGQVPTPTETLLRKGINSVYANATFGYKDTYFVE
GSYRIDQSSTLPVENAIYNYPSISGSWIFSNNLKQVAPWVSFGKLRVNYAQTGSDADFAV
VKSTYAKTDTNFGSAYLFSTEDWKKNSLLKSELTTAKEIGLELALFKKRINLDASAYTSD
TKDQIIPVSVSNASGYYKAYVNGGTVQNRGLEASLNVTAIKTNNFSWNTRINWARNISKV
LSLPDNTPNFEYGFYQGISIKAEVGQPLGVLRGSGYTYQNGQRLVNSAGNYVLTQGAVIG
NINPEWTAGINNTFTYKNVSLGVLIDGRKGGNIFSLDQYYGQGSGLYANTVGTNDLGNPI
RNSVANGGGQILEGVQANGSTNTVRQEYSSDTQGYNSFPHESFVYDASFIKLREVTLGYK
LPSKLLKNTSITNVMFSLNASNLWIIYKKLPYADPESGGTGNTQGVQGAVMPTTRDISFN
VKIQL
>KACEBFPM_01125 hypothetical protein
MKKINKTLLGLTLGLLVVTSCSDIDSLNQNEKAFEKPIAEALMSSAQKSYADQLTIMDVN
SNIFRYLSQHWTNIYAIGNRETKYNFSRDIGGSLFGNTYVTVLQDLNNSRKLIEASTALT
TTEIAEKQNKIAIIDIQIANTYLFLVDCFGDVPYTEALQENNYNPKYDDAKSIYLAMGAK
LTNAINKLDVTNNSFAKEDLIYNGNVAKWKQFANSIRLKAGLHLHDVAPMEAKALIEASA
SGAIASNANNAELKYFDNGEKSKNPNYLLNSGSQEFVPTKLFVDELNAKTDPRADKYLDP
TSKIGANYAGAVYAADGDYTDYSHFTTTFNNPTYAAVIFDYAETCFLLADAKDKGYAITG
TTQDWYNKGITASMESWGVATADITTYLAKPSVAFTSAIGINGEAVNATQKIAYQLWLSY
GNRGFEAWTEYRRLDYPKLQAPANAEQEAGNKVPVRLFYSRSDISTNNANYQAAANKIGG
DKLTTKIFWDKF
>KACEBFPM_01126 Putative TrmH family tRNA/rRNA methyltransferase
MEKENQIFGIRAIIEAINAKKEIDKVFIQSDAQSELMQELQKLMKKNSINFSYVPVEKLN
RLTPNNHQGAVATIAPIAFQDLEKLIDTVIESGKKPLFLILDQLSDARNFGAIIRTAECT
GVDGIIVQKQGSAPVNGDTVKTSAGAVFNVPICKVDHIKDAIFLLQASGIKTVAATEKTE
SNIYDISLNEGVAIIMGSEDRGVNPSVLKIVDEKAKLPMFGTIGSLNVSVACGAFLYETV
RQRG
>KACEBFPM_01127 hypothetical protein
MTIIYYLLVYYLLSSMKETDFKFSLSVLAWPLYLVLLLWLVYTVEIVFPGNFSHFGIWPR
TVWGLRGIVLSPFLHGDIGHLFNNSIPLFVLVAALRFFYRRESLKVLILGVLFSGFGTWL
IGRESYHIGASGLIYVLVSFIFFKGIQSGYFRLVALSLAIVVVYGGMIWFVFPSAEENIS
WEGHLSGFIAGYLLAFYTKRTKYEKPIRYDWERPDFDPSQDEFMKHFDDNGNFVSISRVV
VEQELSSYFVFNPIVNYEFVKSKEANNFMNSPDRGDSSR
>KACEBFPM_01128 Replication-associated recombination protein A
MEAPLAERIRPQNLQDYISQSHLVGQNGSLTHQIAKGIIPSLIFWGPPGTGKTTLSQIIA
QESKRPFYILSAINSGVKDIRDVIEKAKQSGGLFTTKNPILFIDEIHRFSKSQQDSLLAA
VEKGWITLIGATTENPSFEVIPALLSRCQVYILNAFSKQDLEALLHRAITTDTFLKTKNI
ELAETEALLRLSGGDGRKLLNIFELVVNATNEDHILITNEKVMQLVQKNTVLYDKTGEQH
YDIVSAFIKSIRGSDPNGAVYWLARMIEGGEDVKFIARRMLILSSEDIGNANPTAFIMAN
NTFQAVTTIGYPESRIILSQCAVYLATSPKSNASYIAIGEAQKVVKQTGDLPVPIPLRNA
PTKLMKELGYGEEYKYSHDYSNNFAAQEFLPNEISETVFYNPGNNSRENATREFLKNRWK
DKYGY
>KACEBFPM_01129 hypothetical protein
MKKYFSILVFALISSVTYSQSSLNDYEMAIIPSKFEFQKEDNQYRISSTIKAFLKQKGFE
AYVSTDVLPEGFLDYNCNKIFVNVLEENTLFSTRIKIEFKNCKQLVLFTTDLGESREKEL
GKGYNQALLLALKSFDKARYKFSGKTYYDEEAQEKIKSRDVHSISSEVTKITKSEKGVTY
EKVTKQDALVTSEVFVKVVNQANQQELLLYKTSREGIYLCNQNGKNGVVFAKDEVWFFEY
LENGKLISEKLDVNF
>KACEBFPM_01130 Pyrimidine 5'-nucleotidase YjjG
MKHSIKHIFFDLDHTLWDFDKNSELAFGLILSNYFPDIKIEDFVAIYAPINQACWKLYQK
DKITHQELRYKRLKDTFDILNQKISDKQIDLISDEYIEFLPDFNHLFDNAIEVLNFLSEN
YQLHIITNGFAQVQDKKLNNSNISHYFQTITNSELAGAKKPNPIIFEHALKVANAQKHES
IMIGDCLDADVKGALDFGIEAIFFNPNKIQVPQSINQIANLAELIKLF
>KACEBFPM_01131 hypothetical protein
MEENNSFSIKYWSEDDKPREKLMLKGKQVLSDAELVAILIGSGSRAESAVQLSQRILASV
DNNLNALGKLSIKQLTNFKGIGEAKAISIVAATELGRRRRTEETVELAKITSSKAVFEIM
QPIIGELVHEEFWVLFLNNANKVIYKSQISKGGITGTVVDVRVVFKMALEQNATSIILTH
NHPSGKLEASDADKNITKQLKLAGQQLSIPILDHIIITEKGYLSFQDENIF
>KACEBFPM_01132 UDP-N-acetylmuramate--L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptandioate ligase
MRTHFIAIGGSAMHNLALALHNKGYQVTGSDDAIFEPSKSRLEKKEIMPKELGWFPEKIT
SNLDSVILGMHAKADNPELLKAQELGLKIYSYPEFLYEQSKNKTRVVIGGSHGKTTITSM
ILHVMHYHNIAVDYMVGAQLEGFDTMVHLTEENDFMVLEGDEYLSSPTDLRPKFHLYQPN
IALISGIAWDHINVFPTYENYVAQFEIFIQKITNGGILVYNEDDLEVKRVAEASTNPIRR
IPYHTPNYSVNDGITLLETPEGDMPIEVFGAHNLNNLAGAKWICQNMGVDEADFYEAIAS
FKGASKRLEKIAESKTKVAYKDFAHSPSKVAATTKAVKEQYPNRNVVACLELHTYSSLNA
EFLKEYEGALQYADVAVVFYSPDAVKIKQLEEVTYEQIAKAFNREDLIIYTNPKDFKDYL
FNLNLENSALLLMSSGNYGGLNFDEVKELIIN
>KACEBFPM_01133 hypothetical protein
MLPILIWSQTPFEKAKNLFEQGKYALAKPLFENDLKENPMNAKTIEYLGDISGYEQKWDN
AIYYYKKLKTAFPKNANYWYKFGGALGLKAKSVNKFKAFGMIDGIENAFLTAAKLDSKHI
ETRWALVIFYIELPAIIGGSETKAQKYANELLSISKVDGYLSKGYIDECFKRYQDAEKNE
IKAHQIGHSKITFNTLYELYLNKLNDKQKAQKLKEEFDKKV
>KACEBFPM_01134 Dipeptidyl-peptidase 7
MKKIILSLIVAIMLVPASVKADEGMWFLMFIERLNHRDMEKMGLQLTAEEIYSINHHSLK
DAIVQFNGGCTAELISKDGLVLTNHHCGYDGIAELSTAEHNLLKDGFWAANRADERKPSS
LYVRFFVRMDDCSKRILAKVNPSMTELEREAAVNKEIALIEKENNEGGKYTVSVRPFFQG
NEYYYFVYQDYKDVRLVGVPPESLGKFGGDTDNWEWPRHTADFSMFRVYADANGNPAEYS
TNNVPLQPKHYLPVNLSGVKEGDFAMILGYPGRTNRWMPAGGIEQNVKFAYPAWVEGAKT
GMDNMKKYMDQSDASRLVYASKYASTANYWKNRQGMIDALSKFGTAKSKAIQETKFDKWA
NLPANKAKYGNVVSNINKFYALTNQKSRHDNYLQQLFRTTAFGTIGKTLGKQLDIYVKAD
VNKRAQMAPVIIETSEEMFKDLLIPAEKDLLAAQLKLYATKATGYAIAPMVDKLAKENNN
DFTTYINTAFDTSLLTSKEKIKAFLDLPSQELLDKDPLYALTNDMVAHFTSKSEDITKAQ
NDYGASFRLLVEGLRESKIGTIKYPDANSTLRLSYGKVRALPADKRNDAKVNNYTTLNGQ
VKKYKKGDEEFDLPIRVLEMNKNKDFGRFADKDGSLHVNFLTDNDITGGNSGSPVLNGKG
ELIGLAFDGNIEAMAGDVIFDKKLQRTINVDIRYVLWVIENFSGAKHIVDEMTLVK
>KACEBFPM_01135 hypothetical protein
MGLFSFIKGAGKKLFGAKEEAAPAEEKSQLKASALLAHVQGLGLSFKSLKISVMADDSVV
VSGEVEQQADAEKIVLALGNIDGVETVNNQMTVMVPAPEARYYTVVSGDSLSKIAKEYYG
DMMKYHVIFDANKPMLTDADLIYPGQVLRIPNL
>KACEBFPM_01136 GTPase Obg
MTEGNFVDYTKIYVSSGKGGKGSTHLHREKFIEKGGPDGGDGGRGGHVYLVGEKSLWTLF
HLKFARHVKAGHGGDGGSSRSTGSDGEDKYIEVPLGTVVRDKETNEILFEITEHGEKRII
AEGGKGGLGNWHFRSSTNQTPRYSQPGLPAQEADIVLELKVLADVGLVGFPNAGKSTLLS
VLTSAKPKIADYPFTTLKPNLGIVAYRDYQSFVIADIPGIIEGAAEGKGLGHYFLRHIER
NSTLLFLVPADADDIKKEYDILLDELRRYNPEMLDKDRLIVVSKCDMLDEELQVEMKKQL
DKDFAGIPYLFISSIAQQGLVELKDKLWAMLNVEA
>KACEBFPM_01137 Magnesium and cobalt efflux protein CorC
MSEIALISARKNRLESAAKKGNTSAKTALDLANSPNKFLSTVQIGITLIGILTGIYSGDK
ITTDVRLFLEKFTVLQPYSHNLSVGIVVVILTFFSLVLGELLPKRIGLNHPEAIAKAVAV
PMKVISVITAPFIWLLTTTTDFILDILKIKPTADGKVTEEEIKAIIKEGTEGGEVQEIEQ
DIVERVFHIGDRKVNSLMTHRNSLVYLSIEDDDIKSLKSKMLNELHSVYPVCEDNLDEVV
GIVFLKDLFASFEKGNFDLRAITKEPVYFIEHTSAYKALEIFKKSKVHYALVTDEHGMIQ
GIITLNDILEALVGDAADFYEEEFQLNAREDGTWLVDGHYSLHDFLTYFDMDDLINDYDV
TTVSGLIMTELSYIPKVGEKLIWNKMQLEVIDMDGRKIDKILVSSIKEK
>KACEBFPM_01138 Adenylate kinase
MINIVLFGKPGAGKGTQAEFLKEKYNLTHLSTGDIFRFNIKNETELGKLAKTFMDKGDLV
PDAVTIKMLESEVDKNQHSKGFLFDGFPRTLAQAAALDTFLASKDQEITATIALEADDEI
LVQRLLERGKTSGRVDDQDEEKIRNRYQEYNEKTAPLMSYYKNNKKFHAVNGIGTIQEIT
KRLSEVINNL
>KACEBFPM_01139 Hypoxanthine phosphoribosyltransferase
MEIKLHDKYFVPFISAQEINFAIATMATQVEADFAHEIPIFIGILNGSFMVVSDFMKHYK
SPCEVSFIKMASYAGMQSTSEVKQLIGINQDLTGRTVVLIEDIVDTGNTVEELKNLFENQ
GVKNLKIATLFFKPEAYKKDIKLDYIGIRVPDKFIVGFGLDYDGLGRNLPEVYQLRD
>KACEBFPM_01140 hypothetical protein
MNFDLLTRIENSTAHRKSREDNAHYILDNPELFLDLLELAFNINNKNHYKSCWVLELVLE
KQLHLLTPHLDIFCSTISNFKNESAIRPVSKICMFLAKHMILTEEQEGKIVTNCFDWLIL
DNGKVATKAYSIRALYEFGRKNNWIYPELKQILAKDYLKHSAAYKAVTREILKKIK
>KACEBFPM_01141 N5-carboxyaminoimidazole ribonucleotide synthase
MNYFSSNFKLGILGGGQLGKMMLFDTRKFDIQTYILDPSDEAPCKIACNHFFQGSLMDFD
TVYNFGKLVDVLTFEIELVNLEALEKLENEGLKIYPSPKTLKLIQNKGIQKEFYAQNNIP
TAPFEKYADVQNLKSAILNQNSSIKIPFVWKCTQFGYDGNGVKVVRAIEDLENLPNVECI
AEEMVAFKNELAVIVVRNPSGEVKTYPVVEMEFHPEANQVEYVICPARIEDKVAQKAKKI
ALNVSEKFNHVGLLAVEMFQTQNDEILVNEVAPRPHNSGHHTIEASYTSQFENHIRAILD
LPLGNTNSKVAGIMVNLVGAEGFSGDVIYENIEKILAINGVTPHIYGKRETRPFRKMGHV
TIVNENMTEARKIAEEVKNSIRVIA
>KACEBFPM_01142 hypothetical protein
MTKEQIQATGNFLTSYHNDLNYIKKFRDFKENKISENEYIEKKYGTFYSFLIEFRVARNF
SQGMVDKLLEETYSFVNGKYPNDVDLFAENLAKSNLTRGKVMASMASKILFLNNPWEIIP
MDTLARKTLNQKENKYKTYEKNLEIYREQNKTVIENCIIFTKPLTEIVNKEFENKIENLN
KISENRIMDKLLWTIGK
>KACEBFPM_01143 hypothetical protein
MSENINVSLSTFDRSVSVINTYNTYKNRKISEQILVQQAKSNAHLTDMKNQLKVANETNR
KILENQIRQEELKEEQKFYKALSYNSNEIIEQLEKINDPMVLNYLINGFYEKTKISLLKA
NDTLEEINDKLFSKQILEKLNEIKEKAEINASVYSANILNNIDNLLLDLKQKEDELSNIK
KNELKETKIRDKWKINPFRIFGIIFFGFCTFVNFVSFFISENNTTNLIANIVSFLIFAIP
LFFLIKKERKWRKEFSEYKMLQNQKRITEQNKVIEAEQEYQQEIQKHQEMLMQHPAFIAM
QEINSKHPTFETMTTKISEIEKSFLNKWGISFENRNDGKVSEKVLKYIQKGEKLNAMKVY
KDENNVSLNVARNYIDKISKDYKYKL
>KACEBFPM_01144 hypothetical protein
MNWIFQKKGEINHYREKFHFGNQPIRVLHHMNVFIFQNTNPDFEKELSKTIEEKGISKQI
NIKYGDHKITKTPYINFEDRAIYLEETFLSYLWCICQSIYTIYLQKIDFPKHNAYYGREA
YKIDEEILDNAYELFRYAKFLIVDFEKWDKNKLPNPEIYNAELRDYIEQPNCFYTEANKF
ILCHEYIHAIKHIDEILNNKLENSHFIEFEKEADFEAIELIKKGIFPNKINELPIQIGIT
LGILSMFYFKATTSGIKHPNTEDRLVSALNQLNLSDDSECWGIALMGIELWGEQFELNLK
WNKELKVKDAFDDIIMQIKKNTNG
>KACEBFPM_01145 hypothetical protein
MKTKFTLLLFIFTLYSFAQTARVKGIVLDENNQPIAGVNVIFQENRTTTNTNGFYSLTMP
CNIKSNLKFSHISLKAAVVSLQLKANEDYEFNIILKNNVEQIGEVIITNTNRKRVEGITT
ISPKAVRLIPGANAGVENILKTLPGVYSNNELSTQYVVRGGNYDENLVYVNEIEVYRPFL
VRSGQQEGLSFTNADLIQNIDFSAGGFQAKYGDKLSSVLDITYRTPKKFGASLEASFLGG
SIAVETASKNQKWTTITGVRYRDNALLVKSQETQTNFRPRFLDVQSYITFTPNAKWQFSF
LGNIAQNKYDYIPLTRQTNFGSISDPIALLVTYEGQEKDRYNTLFGAFKTSYKVNENFNL
KLITSVYHTTEQEYFDILAQYRLGEIDSNLGSETFGNVNFSRAVGSQLTHARNDLDALIV
NTEVKGFHKKNEDQIEWGIKYTRESIRDRLIEWEVIDSAGFSINPPKINPRNEQPYNPYY
GPLLPYHNVRATNYANISRFSGYAQWNRRTKWKNNDVFTNIGIRGQEWQVSGENISGKSQ
ITLSPRAQFAIKPDWDKDMLFRISGGLYHQPPFYRELRNQDGQVVPNVKAQQSVHIVLGN
DYSFKLWNRPFKLVTEAYYKSLTNVNPYTLDNVRIRYEANNNAVAYAQGLDLRLNGEFVH
GTESWLSFGYLKTEENSNNKGYIARPTDQRLKFAILFQDYIPNIPTFKMYLNLVYNTGLP
GGSPSYADPYNYQLRLRDYRRADLGFSYVFTDRARAKEEGHWLKKFKDLSVGLEVFNLFN
NQNAITNTWVRDVVSKDQKGVPNYLTTRVFSLKLNVKL
>KACEBFPM_01146 Murein DD-endopeptidase MepM
MRIIVVFLFAFNVVFAQNNYPKDYFRSPLDIPLAIAGSFGELRPNHFHSGIDFRTQKKEG
FPVYATADGFVSRIKISTGGYGKSIYIDHPNGYTTVYGHLQSAAPAIQGILNAVHYSKKS
YEIEIFPKPNEISVKKGDLIAYSGNTGSSGGPHLHFEIRDTKTEKIINPLFFGFDSGFLD
TKSPQISELLVYPLSETSQINGSENPVAISLSLQKDGSYLASKIIANGKIGFGINAYDIS
EDNYGKNGIYKLDTYLNGIPNFGYEFDSFSFEETKHINTFIDFFRYKTQKQRFQKLFVGY
IYPKNIIKMIKDDGLVNVSSNFTMNFKIVLQDFHSNKTIVNVPISYGILPITQQKITKAT
PYLLKSRNDNNYVKDQISVFIPANTFYDDFYLKFDVKNNELFLHDDSVAVAENMTISFDA
TKNTVLEREKMFIANLNGTRTEYNTTSKNDSLFVIKTKKLGKFFLSKDTIAPQIYNPNFS
DGANLDKQQTLKISISDDLSGIASYDAYLNGEWILMEYENKINRLTHNLSNNKYINGNNK
FKIIVKDNVGNATTFESNFNKTK
>KACEBFPM_01147 hypothetical protein
MSDIREIIDSLEIRFEKFLKKMEDLEDANRILSMKLDESERFILNQNQEIKTIKANFDSI
KITNSLLGSDEYKRDTKLKINSLIREIDYCIAQLSD
>KACEBFPM_01148 hypothetical protein
MSEKLKIKISIADRIYPLTVDVSQEEGLRSASKKIDAMMKQFEQNYEVRDKQDVLAMCAL
QFASQVEQKQIDKSATEQNTILKLSKLNELLGKYLDK
>KACEBFPM_01149 Ribonuclease Y
MDIITIIIAVIAGIGGGFGISKFLEKSGVSNLIKNAKKEASSILKDANLEGENIKKDKIL
QAKEKFIELKSEHEQVILTRDRKVAEVEKRVRDKESQVSGELSKAKKINDDFEAKTNEYN
TKLENLEKKQVEVEKMHKSQLQQLEVISGLSTEEAKNQLIEGLKSEAKTQAMAHIQETIE
EAKLTAQQEAKKIIISTIQRVGTEEAVENCVSVFNIESDDVKGRIIGREGRNIRAIEAAT
GVEIIVDDTPEAIILSCFDPVRREIARLALHKLVTDGRIHPARIEEVVAKTTKQIDDEII
EVGKRTVIDLGIHGLHPELIKVVGRMKYRSSYGQNLLQHSREVSKLCGIMAAELGLNVKL
AKRAGLLHDIGKVPDAESDLPHALLGMQWAEKYGEKEEVCNAIGAHHDEIEMKSLLSPIV
QVCDAISGARPGARRQVLDSYIQRLKDLEEVAYGFNGVKSAYAIQAGRELRVIVESEKVS
DDNASNLSFEISQKIQTEMTYPGQVKVTVIRETRAVNIAK
>KACEBFPM_01150 DNA mismatch repair protein MutL
MSSIIQLLPDHVANQIAAGEVVQRPASVVKELLENAIDAGASDIKLICKEAGKVLIQVID
NGKGMSVTDARLCFERHATSKIRQAEDLFDLHTKGFRGEALASIAAIAHVEMKTKQDQEE
LGTHIIIEGSKFVSQDVAVLPKGTSFLVKNLFFNIPARRNFLKSDIVELRHIIDEFQRVA
LAHHNIHFTFYHNGSELFNLPQSNVRQRIVNIFSGKTNEKLVPIQENTDILSIQGFIGKP
EFAKKSKGEQFFFVNDRFIKSGYLHHAIMNAYEGLLRDGAQPSYFLYLDVPPHTIDINIH
PTKTEIKFDDEQALYAILRSATKHSLGQFNVAPVLDFERDFNLDTPYSYQNKEAETPTIQ
VDSNFNPFQEEKKQSNFSYKPKTEKQPHWESLYVGLDTKSIDLDEMSFESETVTSSLFSD
SEVEKAPTTTYQIHKKYIVNPIKSGMLIIDQQRAHQRILYEQFLTNITIHQANSQQLLFP
VTLYFSGNEMALIQEIKQSLESTGFVFEALNKDSIVISGLPVTVSESEASIVLEQLVSDL
QQEVPDSSFSQMDSMAKSMAKSLAVKTGTYLTEEAQVNLVNNLFACKEATVSPFNKTTFI
TLSVEDLDKKFSI
>KACEBFPM_01151 Rhomboid protease GlpG
MMNNMTPTVKQLLIINIIFFLGSIVVPNAEHLLALYYFENPSFKIWQPVTHMFMHGGLMH
IAFNMFALVSFGSLLENIWGGKKFLFFYFSCGLGAALVHSGMNYYYFHDSLNILTAHGNT
TQDVLKILADGKYNTSWQEVLSTSQFDNLMSSFSVPAVGASGAIYGLLIAFAFMFPNAEL
ALMFIPVPVKAKYFVPVLVGIDLFSGLTGYSIFGGGVAHFAHVGGALIGFIIMWYWKKNA
FNNKRWN
>KACEBFPM_01152 hypothetical protein
MNILDDLKLQYKNGDMATKLIFWNLLLFTIPEIVFAVLQLFHININYFNYVALSNHFGNL
AGQPWTIVSYSFFHSGFFHLLFNMIMLHFASRLFITFFTQKQLFGLYVLGGIFAGIIYLV
CYTFLPSLSNQNTLLVGASASIMAILFATMTYQPFMNIRLALFGSIKLWHIAILYLAIDL
IQLPLENTGGHLAHLGGAFFGFIWVNFLQNGTDLTSRFNAIIDGFANLFSPKKETPFKKI
HRNPKPISTVKTASKIVTKDKTQQQIDEILDKISKSGYDSLTADEKEFLFKVGKSQ
>KACEBFPM_01153 hypothetical protein
MKNLSWFNKLAFFCNIVLTILTFLAYFLPFLAPNWFPFLSVLTLILPLFLILNGLFFLYW
FIQFKRQMILSGLVLILGITFINKFYKFSAKDLEASDKDFVVMSYNVRLLNLFNWIPRDN
VAQDILHFVNENNPDLLCIQEYSTSAKIDLKIYPYSSIVMKGKKIRTGQAIFSKFPIVNE
GELAFPESNNNAIFADIKIGKDLVRVYNIHLQSIKISPDVKEINENVEGINKQKSQIIFN
RISEAFKKQQQQGEIIMNHKKSCKYPIIICGDMNNSAFSYVYRSIKGNMQDCFEQAGKGF
GQTYSFKYYPARIDYIFANSKMRVKNFTNFPDFVNSDHLPIMTRLSVD
>KACEBFPM_01154 hypothetical protein
MKKGKSIELSWEETQKLITLANEERNPFEIIKKELGIEEKQVLEIMKKKLPADKFEIWKK
KANAGKPKPKQIKIDEFDDDLDGKYYIKNKFD
>KACEBFPM_01155 Transcriptional activator protein Anr
MSKCEQCIVRQFSSLKTLNKAELLRMADSKTSYVIKKGAPVFEEGETVNGIFCIKDGVCK
LSKLSSNGKDQIVKLVKPGELLGQRSMISDEVANLSAVALEDMEVCFIPKAEILGFFNHN
NDFSMDVMKNICIDLKDADEHMVSMAQKTVKERLAEILLYLEDTFGKNEDQSLRIQLSRE
ELAGMVGTATESCIRLLSEFNKDNLIHIIGKKITILQRSALVKLAQ
>KACEBFPM_01156 Copper-exporting P-type ATPase A
MDTQNCFHCGLDIIKEEEILFDGKNFCCNGCKTVYEIFSLNDMTCYYDFEKSPGATPQEI
KGKYDFLDNETIVTKLLEFQERSTAIVSLNIPHIHCSSCIWILENLQRLQKGINTSQVNF
PEKKVRITYNPEIVSLKTIVLLLSSIGYEPYISLENYETGKNNIDRSLTYKLGVAFFCFG
NIMLLSFPEYFEVTEYWLDQYRGFFRWLIFALSLPSFLYSASGYYISAYKSVKSGMLNID
IPIALGIIIFFIRSTFDIVMNYGSGFFDSLTGLVFFMLLGKMFQIKTYSFLSFERDFKSY
FPIAITKINTDTPDQSIPIYDIQKGDRLLIRNQELIPVDGILISTQASIDYSFVTGEAIP
ITKHSGDKVFAGGKQIGKAIEMEVLHSVSQSYLTQLWSNDIFQKNVAQKHKTITDKISHY
FTPILLLIAFAGFTYWIFIDANIAFNVFTSVLIVACPCALALTAPFTFGNILRILGKKKF
YLKNALVIEQLAKVDTIVFDKTGTITTNKKSNISYQGTPLSNQQLVLIKNTLKASNHPLS
RLLYDFLPEAEKIKINHFEEITGKGIQAQSNAFEIKIGSALFVIGIQENSIQQTAVHIKI
DTTYYGKYIFNNEYREGLSALFENLSINYQIKILSGDNEGERKTLTNLLPKGTELVFNQK
PEQKLEFIKTLQENGKNVMMVGDGLNDAGALAQSNVGISISENVNVFSPACDAILDATQF
EKLNYFLKLSKKAILTIKMSFALSLLYNLVGLSFALSGNLSPLVAAIIMPLSTITIVSFV
TLMSNFYSKNLK
>KACEBFPM_01157 hypothetical protein
MSVIYLLISISILVAIGFFAAFIRAVKTGQYDDDYTPSVRMLFDDELIPKKEIRPKTKAK
NETKK
>KACEBFPM_01158 Putative acyl-[acyl-carrier-protein] desaturase DesA1
MKLKNKRLEVMQFLEQKIDTYVDNYLIPIEKIWQPSDFLPDSQSDTFLDEIKELQEIAKD
LPYDFWVALVGDTITEEALPTYESWLMDVEGVDNLERNGWSKWIRQWTGEENRHGDVLNK
YLYLSGRVNMKEVEITTHHLINDGFDIGTGRDPYKNFVYTSFQELATYVSHNNVSQIAKS
YGDTRVTKLCKIIAGDEMRHHLAYSEFVNQIFKVDPSEMMLAFLYMMKQKITMPAHFLRE
SGQKISAAFDHFSDSTQRIGVYTTTDYVEIMQKLISKWQIDKITGLTQEAEKARDYLMKL
PARMMKISERLVIPEEQFKFKWVIPSK
>KACEBFPM_01159 Cbb3-type cytochrome c oxidase subunit CcoN1
MEMQQFYYDNKIVKKFLYATILFGVVGMLVGLLLATLFLFPNLTEGISWLSFGRLRPLHT
NAVIFAFVGNAFFAGMYYSMQRLLKTRMYSDFLSNLHFWGWQLIIVAAAISLPLGYSTSK
EYAELEWPIDIAITLIWVVMGINMIGSMIKRRERHLYVAIWFYLATFVTVAVLHIFNSLE
LPVSAMKSYSVYAGVQDALVQWWYGHNAVAFFLTTPFLGLMYYFVPKAANRPVYSYRLSI
VHFWSLIFIYIWAGPHHLLYSALPNWAQNLGVVFSIMLIAPSWGGMINGLLTLRGAWDKV
RTEPVLKFFVVAITGYGMATFEGPMLSLKNVNAIAHFTDWIIAHVHVGALAWNGFIAFGM
IYWLIPRMTKGNLYSTKLANFHFWIGTLGIILYTLPMYVAGFVQASMWKEFNPDGILKYG
NFLETVNAIMPMYWMRAVGGSLYLVGMLVLVYNIIQTIRANPSIEDELAEAPELVKISSG
RVKGEKFHPWLERKPIQLTILATIAILIGGVIQIVPTIMVKSNIPTIASVKPYTPLELQG
RDLYIREGCVGCHSQSVRPFRSEVERYGPQSKAGEFVYDHPFLWGSKRTGPDLLRVGAKY
NDNWHFNHFWSPQSISAGSIMPSYKWLFDNQAMDISLTQNKMKAMVALGVPYTDYEVANA
EKTLRIQALKIEENLKSDPDFVKSYAQSKKKAAAKGEKFVPMNEREIVALIAYIQRLGTD
IKVKNK
>KACEBFPM_01160 hypothetical protein
MFEQIKHNMETINGVAIYPILSLLIFFIFFLGLGIWVFSYKKETIEELSNIPFGNENSND
FIN
>KACEBFPM_01161 hypothetical protein
MARQKGVIKYVGTLGDIRHFKIKGQEGYFAGMVGGPTGDQVLTAPEFERTRENMNEFGAC
AKAGKAVRTGLSQLMKQMADSQVTGRLTSIMKKINLEDQTEARGYRKIEITTQRSYLKGF
EFDKNTSFNGIFNAPFSLTHTFDRESGDLVVPAFNPANLVNAPSGATHFRLVTSVSVVSD
FEYNATTNSYDPMDADLNEVNDIQYSSFLDLYAPVPATTITATLPGGVLPTVNTSVLQCI
GIEFYQQVGANFYLFASGNCLKVEDAF
>KACEBFPM_01162 hypothetical protein
MESKIIRVAQGKESTLSQLYINGIFQCYLLEDKIREVKIASETAIPKGVFSLKLNTYGAK
NVDYKKAFGKLHEGMIEISGLPNFNFVYIHTGNTIKETAGCPLCGFGFQFVDGNFQVSQS
VAAYKMIYPKLVALAKEASNKISIENNFQF
>KACEBFPM_01163 hypothetical protein
MENINNITVLFGTLITLLLSVVAYFIKQLHTDFKSMEKDLVEVKTMALIIKTEFKSGNDL
LNQKVEYLEKRVHNIELTILKNQDYEK
>KACEBFPM_01164 hypothetical protein
MKNNNLNLVERTLAPTPKWFKILRTIGIALASVGGVIIASPIALPVGLVSAAGYLVLDGS
IISVVSQTAVKSEEEPKIIP
>KACEBFPM_01165 hypothetical protein
MYRVVFFLKNLFFLKPPLEVRLSFFSFFLLKILCVACGSKAHHLKTERMMNFIIKTHKVG
TIYTKPHLFVLNKGMNSGKPQKEPFTNSFVVIFQNEEDCESLFFIAYSLWQTKFWHQHLV
GSVIPFLRLPDFAKEFNPKASIMMQEHEQHQKNVAALKLLEQKEKQFHENINLINDLRRT
ILYRYCRK
>KACEBFPM_01166 ATP synthase gamma chain
MANLKEIRNRITSVSSTMQITSAMKMVSAAKLKKAQDAITAMRPYAEKLTELLQNLSATL
DGDAGGEFTKQREIKKVLVVAITSNRGLCGAFNTNVIKEVKNRADFYAGKQVDVFAIGKK
GNDVLSKTLSVIDNQSSVFDALTFDNVAKIAQMLTDKFVAGEYDRIEVIYNQFKNAATQI
VQTEQFLPLAPIKSDLPVSTGDYIFEPSKEEIVLTLIPKSLKTQLYKGIRDSFASEHGAR
MTAMHKATDNATELRDQLKLTYNKARQAAITNEILEIVGGAEALKG
>KACEBFPM_01167 ATP synthase subunit alpha
MAEIKPAEISAILKKQVEGFESGATLEEVGSVLQVGDGIARIYGLSNVQYGELVEFDNGL
EGIVLNLEEDNVGVVLLGASTGIKEGSTAKRTQRIASLKVGEQMVGRVVNTLGFPIDGKG
PIGGDLYEMPLERKAPGVIFRQPVTEPLQTGIKAVDAMIPVGRGQRELVIGDRQTGKSTV
CIDTILNQKEFYDAGKPVFCIYVAIGQKASTVAGIAKMLEEKGAMAYTVIVAANASDPAP
MQVYAPMAGAAIGEYFRDSGRPALIVYDDLSKQAVAYREVSLLLRRPPGREAYPGDVFYL
HSRLLERACKVIADDDIAKNMNDLPDSLKSIVKGGGSLTALPIIETQAGDVSAYIPTNVI
SITDGQIFLDGDLFNSGVRPAINVGISVSRVGGNAQIKSMKKVAGTLKLDQAQFRELEAF
AKFGSDLDAVTLNVIEKGKRNVEILKQGLNSPYTVEDQVAIIYAGSKNLLKNVPVNKVRE
FEKDFIEYLNNKHRDTLDALKAGKLDDKITDVIEATAKELSAKYN
>KACEBFPM_01168 ATP synthase subunit delta
MSSTRAAIRYAKAIIEIATSKNAANEVSNDMFLIATTINSNSELDTFIQNPTIKVEAKEN
ALLEVFANTNEVTKSLFHLLFENKRFEILGAIASEYNKLFDEINGIQVAKVTTAIAMDAN
LEAKVKAKIATFSDKKVTIENTVDASIIGGFILRIGDKQYNASVANRLQVLKRELSN
>KACEBFPM_01169 ATP synthase subunit b
MEQLLGQFSLGLFILQIILFVGLILLLKKFAWKPILDAVNEREDGIKNALLSAENARTEM
QNLQADNQRILQEARLERDNMLKDAREIKEKMIADSKTEAQAQGIKMIEQAKAAIESEKN
AAMAELKSQVSNLSIEIAEKLLKDELSNKDAQTKLVEKMLGDVKLN
>KACEBFPM_01170 ATP synthase subunit c
MGTIPNLVGAGLIVIGASLGIGRIGGSAMDAIARQPEASGKIQTAMLIAAALIEGIGFAA
FFMGK
>KACEBFPM_01171 ATP synthase subunit a
MSSEFHHGEKVAESNGNYYMIGHHDGMVYKTDLAGSESHIKPLDLSITKNIVMIFVVALL
MFVMFRNLGKSYGKNGGIATGAGRFFEPIILYVRDEIAIPNIGEKHYKKYMSHLLTVFFF
IWFLNMFGLTPLGVNVTGNIAITAALAIVTYLITTLTANKNYWAHIFWMPGVPPLMRIIL
APIELLGTIIKPFSLTIRLYANMVAGHIVLMSIIAMMYTFNNVAGSGFSFVLAFILSILE
ILVAGLQAYIFTMLTALYFGSANEEHHHDEDAHH
>KACEBFPM_01172 hypothetical protein
MVNASGSINDYLQYNIQNTSTGIQAQSGYSATADNGSSTTGFAWLGINNSTFNFPTPYNI
GNANDVSFVGSGQDMHIANANNTKSIIFSTGKAVSPFFNERMRITNTGAVGIGTTTPNGA
LDINAGASNYGFVAPRVALTASNTQVPVTNPQGGAILAGTTIYNTATAGVSPNNVGPGLY
YWNGTKWVAFAGSPGGLDWTLTGNAGTTAGTNFIGTTDAVDFVTRTNNTEKMRVGSNGSV
TINTGAAPSAFEKLQVNHAGASNDAILAINNDDAIGKGNAIWAKNTNATGTAIIGSSGAT
PPSLFPNIGAGISGSHVDGYGVYGSCGNGAPSNAAYNGHAAANFVLDSDNNSATNNFSAV
AKLAGKDNVSPDGILSSQNVLYGGYFQGGITTSSYSYAGIKYNHDAAGGAGTNYKIIGNG
AASTIIPDKNSKPRVMFCPEAPEVLFEDYGIGKLNDGEVYIILDEILANSLKVDNKHPLK
VFIQLEGDSNGVFVSEKSINGFKVKEVNNGKSNISFSWHIVGNRADSKDASGNITSEFEN
LRLPIGPTKLKEDKLVTKKTEK
>KACEBFPM_01173 hypothetical protein
MNLPEFFEKYLNKPLVLSGLKSKWLGQDLNVNKYNTQTITFRNKFKILMQKCGRCVSLCC
DSISVPKKGKPNRNIGYLKRVVIEDLKSETINKEVEE
>KACEBFPM_01174 hypothetical protein
MISYNPKEWFTFIFRFHKADTFRSLLPLISGISLYCAIIVYFICDYFNLTDSDHLKNITI
MHTMLGFVISLLLVFRTNTAYDRWWEGRKQWGSLVNNSRNLALKLSAILTEKEDKIFFKK
IIPYYAHALNLHLKNRNISQELFEEYNINVDLKKHKPNQVAKLLFKKINEIYLSKKITGE
QLLYINIEITSFTDICGACERIKNTPIPFSYSVFIKKFIFFYVMTLPIGYAFILGYYTIP
VVIFILYVLASLELIAEEIEEPFGNDQNDLPTEIIAENIKKNIDEIL
>KACEBFPM_01175 Low affinity potassium transport system protein kup
MSASSHHDLHSKLSLGGILVTLGIIYGDIGTSPLYVMKSIIGLHTIKPEVVLGGISAIFW
TLTLQTTLKYVLITLSADNHGEGGIFALYALVKRTKVKWLIIPAIIGGSALLADGIITPP
VSVASAVEGVRTYYPDINTVPIVIAILVVLFTIQQFGTKLVGKFFAPMMMIWFAMLAILG
ILQITQNTSVLCAVNPYYAYKLLSIHPDGFYVLGFVFLCTTGAEALYSDMGHCGRKNIRI
SWIFVKIALLLNYFGQGAYLIKHAGHTLKSINANNGNPFYLVMPEWFQPFGIVISTMAAV
IASQALISGSFTLINEAMRLNFWPKVKIKYPTDLKGQIYIPSINWLLLAGCIGIVLHFEE
SSKMEAAYGLAIVLCMIMTTILLTYFMILKRISWFIIAPLILLYLVIEFSFLIANLDKFP
HGGYVTLIIASALTFIMSIWYTAKKISKNYTKIVKIQTYKKVLAELSVDLSIPKYATHLV
YMTNANRVDEIEEKVMYSILQKRPKRADLYWFIHINITNEPYKKEYKVTEIIKNDLFRID
FNLGFREPTKINLMFKEVIKDMVAKGEVDITSRYESLSKNNIIGDFKFVLSEKFLSNDSF
MHWHEKLVMNTYFFFKKMSLSEEQAFGLDSSSVKVEKFPMVLHAPEKIELCRIK
>KACEBFPM_01176 Ycf48-like protein
MYLYCIKNSNLGCLIIFMKNIFFISLIISALYSCKVAENFISNPRFSKIIVDTLFTEKIS
CRALTIDNNKVWYAANNGNYGFILLDSSANYSKQITNENLKIEFRSIAQTSKYIFILSVA
NPALLYRISKNDYKVTLVYQENHEKVFYDSMQFFNDNEGIAIGDPTENCPSIIKTTNGGE
TWQKISCEKLPKFYDGEAFFAASNTNLVIKQNKIWMISGGKKARVFYSENKGNTWQTFET
PMVQGQTMTGSFTADFYNQKIGFIAGGNYEKLEQNLQNKATTNDGGKTWQLMSQNQGFGY
ASCLQYVPNSGGKSLVVVSATGIFYSRNAGKKWKKLSSDNDFYTLRFLNNNTAIAAGKNK
IVSIKFK
>KACEBFPM_01177 hypothetical protein
MKKIITLFLLLVCAVSFAQDFEKRAQRVKALRVAYIATKLDLTSQEAEKFWPVFNKFSNN
QMELHKQKRQLMMKLKPENTAGMSDTATLKLLNESENIESDLESKKRQFIKDLQGLIPPQ
KILLLKKVEEEFKSTLLKKFNEKRNDTPPLRD
>KACEBFPM_01178 hypothetical protein
MKYFDFDNGTKTDNGFRIPEHYFEQFETKMMNCVLEKEVKVISVFVTRKFWFSAVAAVVV
FGLCTTLYLNKLNTKGISTEDYLAYATTISTEDIIEHLSDDDITKIEESLNLYDPEITNY
AKECLY
>KACEBFPM_01179 ECF RNA polymerase sigma-E factor
MHDEKDFIAKLLNPKTQNDAFGLLLQLYQKPLYYHVRNMVLNHDDADDVLQNTFVKVFRN
LQNFKGDSKIFSWMYRIATNEAISFMQQRAKKNGISSQQTQLKAINKLESDVYFDGNEMH
IKLQKAIASLPQKQQLVFKMKYFEDLKYEQIAEITGTSVGGLKASYFHAVKKIEVFLKLD
>KACEBFPM_01180 Phosphorylated carbohydrates phosphatase
MIQTVIFDMDGVIVDTEPVHHYAYSQHFTELNIEVSTEMYATLTGNSTRNVFQKLKEKFN
LNHDVEDLILRKRHLFNQAFDTKPDLELITGVQKLIQDLYANNIQLIVASSASKSTINRV
FTRFDLHQYFTHIVSGEDFPKSKPDPAIFIHAATLSVAPKEKCVIIEDSTNGIKAAKAAG
IYCIGYDSVNSKLQDYSLADKVISHFADLQINNLKS
>KACEBFPM_01181 tRNA modification GTPase MnmE
MIYHDTIVALATPSGAGAIAVIRISGNNAITIASEVFQSVSGKDITKQKSHTLHLGHITD
GTKVLDQVLLSIFKGTNSYTGENTIEISCHGSTYIQQQIIQLLLRKGCRMAQAGEFTLRS
FLNGKMDLSQAEAVADLISSDNEAAHQIAMQQMRGGFSNEIAKLREELLNFASLIELELD
FAEEDVEFADRTQFDDLLNRIEFVLKRLIDSFAVGNVIKNGIPVAIVGEPNVGKSTLLNA
LLNEERAIVSEIAGTTRDTIEDELVIGGIGFRFIDTAGIRETKDVVESIGIKKTFEKIEQ
SQVVVFLFDSSEFKISGLKLKVALEKIKNQFPLKPLIIIGNKSDKLSETEIQNIKTEIPE
ILLISAKEKLGVEDLKNQLLSFVNTGALRNNQTIVTNTRHYDSLLKALDEIQKVKFGLQT
NLPSDLMAIDIKQALYYFGEITGQVTNDELLGNIFANFCIGK
>KACEBFPM_01182 hypothetical protein
MANINLSELQSFLDEKVILYNNLNFIESDPIQIPHLFSLKEDIEIAGFLSATIAWGNRKM
IINNSHKMMQLMGNSPYDFVLSHNENQLESLNKFVHRTFNGQDFVQFIKSLQHIYTNHNG
LEAVFAKNATKDSMQKSISEFKKIFFENNHLPRTQKHISDPISGSAAKRINMFLRWMVRQ
DTHGVDFGLWKTISSSALSCPLDVHSGNVARKLQLLLRKQNDAKAVYELDTNLRLLDPND
PVKYDFALFGLGVFEKF
>KACEBFPM_01183 Lipoprotein-releasing system ATP-binding protein LolD
MVSHIFFLNKTLFDVQAISLFLCENDYMIKATNIQKNYDTLQVLKGVNLHIEKGEIISIV
GASGAGKTTLLQILGTLDKPSENKDSLLEINGQNVLKMNDKDLSKFRNLNLGFIFQFHQL
LPEFTALENVCIPAFIAHKSKAETEIEAKKILTYLGLEHRIKHKPSELSGGEQQRVAVAR
ALINKPAIIFADEPSGNLDTASAENLHQLFFKLRDELGQTFVIVTHNEELANMADRKLIM
VDGNIKN
>KACEBFPM_01184 Peptide methionine sulfoxide reductase MsrA
MKKILISFLSLLAMSCQSKVTNVEKIEPNTMNIEKGKEIAIFAGGCFWCTEAVFLELNGV
ESIKPGYTGGKIVNPTYEEVCSGTTGHAEGIKILFDPSKISYEELLEVFFATHDPTTINQ
QGADVGTQYRSEIFCANPKQKQIALAYIAQLNKENTYGKKVVTKVSDATTFYVAEDYHQN
YYNQNKKKSYCNYVITPKVDKVRKEFKDKLKK
>KACEBFPM_01185 GTP cyclohydrolase 1
MSILTDKEITEILGDNHQMTSANSPIRSDAFVKTDDQKMQNIEKHFYDIMQELGLDMTDD
SLQGTPHRVAKMFIQEIFSGLDPKNKPTISTFDNEYHYDKMLVEANISFNSTCEHHFLPI
FGKAHIGYISSGKVIGLSKLNRIVDYFSRRPQVQERLIMQIFNDLKIALNTENVIVVMEA
KHLCVSSRGIKHESSFTSTIQYGGIFNEKENRNDFFNMINSEK
>KACEBFPM_01186 hypothetical protein
MTQKTQAEVKFRVKPQATVAKLILGLILDFIGMLSYIILGVAENIDLIWAPVSGVLLVIM
YKGTVGKVAGFIGTLEELIPFTDIIPTFTITWFYEYFQDKKNK
>KACEBFPM_01187 hypothetical protein
MNKLKERWGITSNFQLVVIFIIFAINGSLSAKISYFLMYYIGLSKENLNTLVYHFILIIL
VMPLYPFLLMAIGFLFGQFPFFFSFSKKMLKSMGLGFIFKS
>KACEBFPM_01188 hypothetical protein
MKHFLFFVLILACLLSCKTKNTTVTNTSSPIKGDTIKIANYALEYEVTIVDPGFSSWLNT
RAFPRNYYSESYLESKNKMYISQWNNRNSQPMRYDSSLYEMQINYDYTVHYGYEVNYLIY
NYMIYFQNTYKQQLFGFVPPR
>KACEBFPM_01189 hypothetical protein
MAGLIDLLNSDLGKQIISGVSAKVGTSEDETSSVLASALPSLVGGMINNAATPEGQSGLL
SALLGGKHDGSILDNLSGFITGGDHSDGASILGHVLGNNQENVQNQVSQNTGVSHDKIAM
IMKMAAPILMGYLAKQAQGNGLNNNGTTKNGGGITDILGGLLSSDQLQQQAPAMGGSILT
SILDQDGDGQLGLGDAVAAATKKGGLGGLLGNLFGK
>KACEBFPM_01190 Hydroxypyruvate reductase
MKILANDGISKSGIIALEKYGFEVITTKVAQEQVINFVNTNQIAVILVRSATKVRKDIID
ACPSLKIIGRGGVGMDNIDADYAISKGIQVINTPASSSNSVAELVFAHLLSGVRFLYDSN
RNMPLEGDTRFNDLKKAYADGIELRGKTIGIIGFGRIGQSVAKMALGLGMKVIASDNYVG
KAEIKVDFYNGQFINVKIETEPIDDLLKHSDFITLHVPAQKDYIIAKREFDLMKDGVGII
NCSRGGIINEVELVAALDSKKVLFAGLDVFENEPTPAVQLLMHPNITMTPHIGAATIEAQ
DRIGTELAEQIIALLKTEI
>KACEBFPM_01191 Phosphoserine aminotransferase
MSTSKISQIIGAEKEKSEHIHKPNFNLEALINSGKNTSITQQHTMKKHNYSAGPCILPQE
VFEKSAQAILDFNHSGLSLLEISHRSKDFVAVIEEARALVLELLGLKGKGYQALFLAGGA
SLEFLMVPYNLMKENGKAAYLDTGTWASGAIKEAKHFGETVVIASSKEENYNHIPKNYSI
PSDANYFHCTSNNTIFGTQMKSFPEVNIPVVCDMSSDIFSRVLDFSKFDLIYAGAQKNMG
PAGTTLVIVKEEILGKTGRYIPSMLDYEKHIKAESMYNTPPVFPIYASLLTLQWLKNLGG
ISAIEKINNAKANLLYSEIDRNPLFKGTANAEDRSNMNATFLLNNKNHTELFDKMWAAAG
ISGLSGHRSVGGYRASMYNALPLESVQVLVNVMKELENKI
>KACEBFPM_01192 hypothetical protein
MLQNDKKKSFIELGKFLSQFSSNNSVKNETISHNDLFFNDFTSLINLSQSHNGWYTAENV
CFAINSWAEALTEENLEKWLSNYSFSNTKSKTVALILAGNIPLVGFHDFLSVLISGHKVL
VKTSSNDQHLLPFLAKYLIAVNPEFKNYITFVEGKLENFDAVIATGSDNTARYFEYYFKN
KPSIIRKNRNSVAVLDGSESATQMIALGEDIFRYFGLGCRNVSKLFIPKNYNFDLFFNGV
FPYQDVIKYEKYANNYDYNKAVFLMSNFNLLDNEFLIIKEDSSYASPISSVFYEFYDDIN
DIKNRLETDKDKIQCIVSNNLIESSIAFGVTQKPNLWDYADNVDTIHFLINL
>KACEBFPM_01193 Ferredoxin
MAIIITDECINCGACEPECPNTAIYEGADDWRYKDGTKLSGKIILPDGTEVDSDAAQTPI
SDDIYYIVPGKCTECKGFHDEPQCAAVCPVDCCISDDNYVESDETLLNRQAFLHNE
>KACEBFPM_01194 hypothetical protein
MKQILSFILLFSTSFVFSQNIEFAVIVKDIQTGLPISEVTITALKTKQGFLTNKNGEANI
SLSKESDLQFENSAYKTYTAKPLDLDKKINEVYLESNAKRLEEVILTSDHPQEILKKLVR
NSQNKITIPVNLKVYLREFYKKNDQVVFFNDGLINFQIAGSLKNMKTDILVEQNRAVGLL
DTDLNEDLLGYNLNDIIENYYQFQYLEELLEPSAKRKYDFQIKSYPNNENYLLIKVTPLE
EISGVLSEFTIVYHNSKMIIIEVSSMVPDSRLEDLRQSFLKSSKIYKLEFKNTFRLDNDL
YYLANSKEVIGFEKKYKDENRRIEVNNHMIITNFDKKMFKYNDENVFKEQSLINKKTSFF
TDYWDFESGFLPTKEEKDIIERLSHL
>KACEBFPM_01195 Ribosome-binding ATPase YchF
MKAGIVGLPNVGKSTLFNCLSNAKAQSANFPFCTIEPNIGVVNVPDPRIEKLEELVKPER
VQMATVDIVDIAGLVKGASKGEGLGNQFLGNIRECNAIIHVLRCFDNDNIIHVDGNVNPI
RDKETIDIELQLKDLETVEKRLEKVKRAAKTGNKEAQTEESLLNRIRETLLQAKSARTVE
PKGYEEEELFEGFQLITSKPVLYVCNVDEGAAVTGNKYVDQVRELVKDENAEVIVLAVGT
EADITELETYEERQVFLEDMGLSEPGASVLIRAAYKLLNQQTYFTAGVKEVRAWTINVGA
TAPQAAGVIHTDFEKGFIRAEVISYEDYVHYGTEAKAKEAGKFKVEGKEYIVKDGDVMHF
RFNV
>KACEBFPM_01196 Ferric enterobactin receptor
MKKHFLLSLLFIGFSFLGYSQKTISGLIIDSNGQPLTGVNILEKGTNNGALTDYSGKFSI
TIKSNESKLILSYLGFKKSEIKASENATITLEEEGVGLQEVNIQAVGSRNTKRTVIDSPV
AIDIINMADVITKTGQIEINALLQYLAPSFNASKQSGSDGADHIDPATLRGLGPDQTLVL
INGKRRHQSSLVNLFGSRGRGNTGTDMNAIPAAAIKRIEILRDGASAQYGSDAIAGVINI
VLKDNVEEFTGNISYGAYTAKTPYADKITSSGIDGNTVQVSGNYGFKLGEKGFLNATLDF
ANKKNTNRPANENTYAIYRRQFGDGEAKNGSIFLNGSYSITNKTSIYLFGGSSYRDSDAY
AFTRTFDSSRNIPAIYPNGFDPIIGTKIIDHSVSGGLKTKLGNWDLDFNNTFGTNNFKYD
IHNTLNASLGVASPTAFDAGGHSLSQNTTGIHFSRNFDKIRNGFNVALGTEYRIENFKIT
AGEEASYKTYNLSSPGASQGFPGYSPENTVNKSRNNFAAYIDTELDYTENINLAIAIRYE
KYNDFGSTFNAKIAQRFKISPSSAFRYSMSTGFRAPSLAQKYYNLKFTDYVSGVGSETLL
SSNDSPITKAFGIKQLKEEKAFNASLGYTFKKGKITATVDGYFVNIEDRVVLTGKFNGSG
LGLNIDKVQFFANALSTQTTGVDFVLSYDEKINNHSISTSFVGNINKMTIGNVASGSLDS
ETFFGKREKYFLLASAPESKLGINLNYNYNKKFFTNLRFTRFGQVELIDWLDTVDHYGAK
IVSDASINYQFTKNFNITVGANNFLNVYPDIQDTETETGGNFDSVQMGSNGAFGFLRLGV
KF
>KACEBFPM_01197 hypothetical protein
MELKDKILHYFEGKVVRKDLTSKIKGNAVVPTYVLEYLLGQYCAVDDQAIIEEGIEKVKE
IIKNNYVHRSESEVVKANIRDKQNYKIIDKVNVSLNDRANIYEAELANLGIRNVPISDNL
VMQNQKLLSGGGVWCIVNMGYSHEEDIKVRWQIEDLKPIQVSNISVPEYIEARKNFTNEE
WIDLLMHSIGLNPEFFNKRGKLIQLSRLITHVENNYNFIELGPKGTGKSHIFSELSPHGV
LVSGGDVSKARLFVNNTGNKIGLVGYWDVIALDEFEQDKGSKKVDGDLVKILQNYMANQS
FNRGKETYQATASLAYVGNTKHTVPYMLKNSHLFESIPEGYIKGAFLDRMHIYIPGWEVR
ILKNSMFSTEFGFIVDYMAEILKELRKSDYSGILDQYVDFDGSLSQRDKTAIRKTFSGLM
KLVYPHKIINENELLELLDFAVEGRKRVKDQLYIIDETFRTEPVNFEYEIKSSGVTVSPE
TLEKINYKTEIEAKQLEVTENSKIDNKINNQKETISEQAKISLTPHQTIIKDNQTGISYK
NLFAGYLKGATKITIQDPYIRLPYQFKNFLEFCVMLSNNKEPEEEIDLEIVTWNTEEYLS
DSKTYLDEIQESVQEIGIHLSYRFENLHDRNIIADNRWKITLGRGLDIFEKSENRFSVAD
LEQTRRKCKACEITYLTT
>KACEBFPM_01198 hypothetical protein
MPKAKGYTKDNSRFVISDSFEGKTDGYVFDMKNTTNIDTDLKIAIPRAINRYRKQGNIGV
QFVHGGASIQELITPVIKYYKQKKETIETVTFRRIDNVNKITTGNIKITVLQNEPVSNEF
KSLEVNVGLYNDKGELLSNEMELSCNATSNNPKERMFEIILTLNTLGSKTSFCYLKAFDN
KDKNKLNPIVLNDLITISTLMEMDF
>KACEBFPM_01199 50S ribosomal protein L13
MDALSYKTQSASKATITKEWIVVDADGHNLGRLASKVAMILRGKYKPSYTPHVDCGDNVI
VINSEKINLTGNKMDEKTYIRHTGYPGGQRSLTAKVLQSKNPALLVEKAVKGMLPKNKLG
AELFRNLNVVVGSEHKQGAQKPKTVNLNDLK
>KACEBFPM_01200 30S ribosomal protein S9
MAAIHKIGRRKCAVARVYVSEGTGVITVNKKAFATYFPTATLQYKVLQPMSMTENVTNYD
VKVNVYGGGSTGQAEAVRMALARVMCEVGEGNRAILKPEGLLTRDPRMVERKKFGQKKAR
KRFQFSKR
>KACEBFPM_01201 30S ribosomal protein S2
MANKIEVKDLLEAGVHFGHMTRKWDPNMAPYIYMERNGIHIINLYKTAAKIEEANEALKK
IAASGRKILFVATKKQAKDIVAEKAAAANMPYITERWPGGMLTNFVTIRKAVKKMSTIDR
MKKDGTFMTLSKKERLQVDRLRAKLEKNLGSISDMSRLPAALFVVDIKAEHIAIKEAQKL
NIPVFAMVDTNSDPRLVEYVIPANDDASKSIDKILTLVTEAIIDGLANRTSDKEADTTTE
EVAQEEVTDTKADEKAIVAEAAKTKE
>KACEBFPM_01202 Elongation factor Ts
MATITAADVNKLRTITGAGMMDCKKALVESDGDFDLAIENLRKKGQKVAANRSDRESTEG
AAIAVVNADNTVGVVITLNCETDFVGMNENFVKMAVEMANLALNFNNKEEFLASDFNGIT
IADKLIEQTGVIGEKLEIRTFEKLEGAFVGSYIHSGNKIATLTAFSAKADGIEEAARNVA
MQAAAMNPIALNEEGVDADTIAKEIEIAKDMLRAEGKPEAMIENIAKGKLGRFFKDNTLV
NQDYIKDSSMSVANYVKSIDANLIVTGFKRAALG
>KACEBFPM_01203 Aerotaxis receptor
MGNNNSNVTPINKEANWDKSKTIISRTDKYGTIVSVNKAFVETSGYTEKELVSKSHNIIR
HPDMPKCIFKILWNNLKNGENFFGIVKNLTKNGEYYWVLTDFDIIKDKKGVIVNYEAKRI
AIPQEIITIEIEPLYGRIAKLEAFYGENGGENYLNGFLEKENKSYVEYIRFLIDKYGVVN
DYTEVSLNNEEDNRGFLRKLFSKTNKN
>KACEBFPM_01204 ComE operon protein 3
MFSFVAIGIFLNRKTNVFHTMLVSLFLILLVAPLFLFDIGFQLSYIALFFILWLQPMLKM
LWKPKSELVAYFWDIITVSFAAQIGAMPLSIYYFHQFPGLFFVTNLVLIPCLMVIMAIGV
LLMILAYFDFVPVLLSKTVALSITFTNTYINWIASIETFVIKNIPLNFWLLIASYLVIFS
CIIWFKKPNFTKIILALGSILIFQILFVTTNWQSEIKKELIVFNARKSTIIGKRIGKKIM
LYTNNGLTENGFEKKMIQTYATANFCGISNCKPITNTLYFNKNKILIIDKSNIYKKTMNA
DIIILRESPKINLERLLSSIKPKIIIADASNYKSYVTNWKQTCAKEKIPFHSTYEKGFYK
L
>KACEBFPM_01205 Disulfide bond reductase DsbH
MNKFKYLLFLVPVAAVLLFSSFNYNQNTATTAITKKSTKEDLVWHTNVKEAIDLAKKEDK
PLFLFFTGSDWCGWCIRLQKEVFKTPEFEAWAKEKVVLVELDFPRRTEQTTELKDQNNQL
QQAFAVQGFPTVWFAKGTNKSGKINFEQLGSTGYVAGGPGAWLSGADQIIAKFVHDSKKE
SAAKRLKPKK
>KACEBFPM_01206 Thiol:disulfide interchange protein DsbD
MKKILLAFFLLIGAISVQAQEIRWVTLDEALAKQKKNPKTIFMNVYTDWYAPCKMLDKET
FQDAEVIDYINKNYYAVKFNAEGNSAVIFKGSNFSNPGFDPNRKGRNSAHELTTFLKVQG
YPSIYIIDKNGDTQQRIVGYKTNEELLKILR
>KACEBFPM_01207 Dipeptide and tripeptide permease A
MFQTYKKSCRFVFLKSKTMSQDLTLDQIQNFEGKYPKQLWYLFIVEMWERFCFYGMRGVL
TFFMVDQLLLKDGAANLQYGAIQAFVYAFTFIGGIFADKILGFKKSLFFGGIVMIIGNLL
IAFSPQHLFYYGIAFSIIGTGFFKPNISSMVGELYHENDNRRDAGFGMFYAGINIGGLLG
GALCIYLGKYQSWSLCFLAAAIVMVLGLVTFLFTKKHLGPIGDSPLINLAPKTRQIREIA
VYVGSILTIPFIHKMVKNTKYTDYFMYTIGIIALAYFIYELLNLKDIKLQKKLFAAFIFI
FFYFLFNTIYEQSGGSLSLFAKDNLNDSLLFFHIDPNIVNNSSNTLFVVIFSPMIGLLWL
WMAKRKIEPNTLIKFGIGFLFLSASFFVFYYTKFFANAKGVTSLNIFTFGYLVTTIGELC
LGPIGMSIITKLSPKRLFGMMMGLWFLASAFGQLAAGKLGAEISKSNSGTTLVTKLQSYT
EGYHQLAIYALIAGVVLIVVSPLIKKLMQEVN
>KACEBFPM_01208 Di-/tripeptide transporter
MSEVVAQKGHPKGLWVLFGTEMWERFNFYGMRAILTLFLVNSLMMREEDASLIYGGFLGL
CYLTPMLGGFISDRFFGNRNCIMLGGLMMAVGQFLLFFSASVFSSNISLATTLMWSALGI
IIFGNGFFKPNISSMVGSLYPKQEKSKLDTAFTIFYMGINLGAFLGQLICPIVGDVKDAG
GIRDIHAFKWGFLAASIAMLIGTIIFYFLKNKYVVTPEGKPLGGLPKDNDDSHYEEGESQ
KAVFSQTALISALVAFCGLGLLFYFVFGQNPIYSLIYASGITLAGLIISDSSLTKVERDR
ILVIYIVAFFVIFFWAAFEQAGSSLTFIADNQCDRNFFGYNMPPSMVQIFNGLFVVAFAV
PFSMLWDYLRSKDREPISPMKQAFGLALIALSYFIIAHNVKDLGNSGLLAIKWLILLYLI
QTCAELCLSPIGLSLVGKLSPKRFSSLLYGVFFLSNASGYALAGTLGSIMPATGDKFNKA
KELGIDLQAVLDKKIVPTAEQLKLLATNQISDHNPIFAGFEIHNLFEFFMVFVVLTGLAS
LILFALTPVLKKMMHGVR
>KACEBFPM_01209 Dipeptidyl aminopeptidase 4
MKTVQRTFILFLFASLSAIAQQKITLEEIWGGAFRTKGMTELAALKNTNQYTVLNSDKNS
SAIDLYDFATLNKVSTLINSKDFSDLQGIDSYTFSSDEKKILIANNTNQIFRHSFLANFY
IYDMVNKSLTKIADDKIQEPTFSPDGSKIAFAKENNLYVYELASKKTTQITTDGKKNAII
NGVTDWVYEEEFAFVRAFDWNATSDKIAFIRFDESQVPEFSMNIYGKDLYPVTDVFKYPK
AGEKNSDVSLHIYDIKTANVKKVDLGNYNDFYIARLNWTNEANTLSAQVLNRHQSTLDLL
FIDGNTGAKRIVLNEKDKAYIDVTDNLTFLKDNSFIWTSEKDGFNHIYLYDKTGKLKNQI
TKGNWDITNYYGFDEKTGTIYYQSVENGSINRDVYSIKLNGSGKTRLTSATGTNAATFSP
NFQYFINSYSSAKNTPKYTLNESKTGNSIKTIVSNEALETKLSSYNLPAKEFFELTTAKG
NKLNAWMIKPTGFDANKKYPVFMYQYSGPGSQQVNNDWNGADDYWFMMLAQQGYIVACVD
GRGTGFKGADFKKCTQKELGKFEVEDQIDAAKVFGTYTYVDKTRIGIFGWSFGGFMASNC
IFQGADIFKTAIAVAPVTSWRYYDSIYTERYMQTPQENASGYDNNSPINHVNKLKGNFLL
IHGTADDNVHVQNSMKMIEALIQANKQFDWAIYPDKNHSIYGGKTRLQLYTKMTNFIKEK
L
>KACEBFPM_01210 hypothetical protein
MKPSKSNIKEKLIEFLNAFSKNELHIIEELNAFLEKTFSKYEDLFYKIVSNLLNYQVVYV
SEDKPQVLRKFKKDLLKNLKFPFKYKKLICFDNILIRDYIFKAHTIVYFVNEPKKYSRSF
RIY
>KACEBFPM_01211 3-hydroxy-3-methylglutaryl-coenzyme A reductase
MPKLTTGFSKLSKEEKINWIASTHFSNAEEATQTIKKYWNSDLELQKLHDEFIENTITNF
YLPLGVAPNFLINGKNHTIPFAIEESSVVAAASKSAKYWGTRGGFKTTVLNSEKIGQVHF
IFKGDSRNLIAFFNQIKSKLFAHTESITTNMQKRGGGILDIELRDKTSDLENYYQLHATF
ETKDSMGANFINSCLEQFAKTLKEEALQSEILSETEKNIEVVMSILSNYVPNCIVRAEVS
CPVSDLSEKNIENPQEFAQKFIRAVKIAEIEPFRAVTHNKGIMNGIDAVVLATGNDFRAV
EAGIHAYAARNGQYSSLSHAKIENDIFTFWLEIPLALGTVGGLTSLHPLVKMSLEMLEKP
SAQELMQIVAVAGLAQNFAALRSLTTTGIQQGHMKMHLNNIINQFEATQNERVLIKNHFT
ENTVSHSAVVAFIESLRK
>KACEBFPM_01212 hypothetical protein
MKKTFYSNGKLLITGEYVVLDGAVALALPTKMGQNLIIENGFDKKIVWKSYDFDGSIWFD
DTILFSDIRSKKYFENNITKTTLVEILYESFLLNSDFINHSDGYIVSTNLTFPKFWGLGT
SSTLINNIASWLQIDAFVLLKNAFGGSGYDIACAQNDLAILYRLEKEKPIIKTINFNPTF
KENIYFVYLNKKQNSKNAIANYRKKQGDFANSIAIINEITKAIINTTELEEFAKQIEKHE
VLMSKILEMQTIKEVLFPDFDGAITSLGAWGGDFVMAISKNNPIDYFSTKGYDVVLLYDE
MIL
>KACEBFPM_01213 Beta-barrel assembly-enhancing protease
MNKKGSNIKHLIFGMCIISASVLAQTQPEDVVSEKDDFKESYYESLIQKGIENYDKAIVS
LEKCVKIQPENAVIYHELGKNYFLQKDNQNAEQAFIKATQLDTKNKWYLIDLYDVYYQTK
NYNRALDIAQKIIPLDAKFKEDLVSLYMYTQQFDKALVLINELDENVGNTELRDRYRLQI
TSQTKTNLSDKNTLEKAIEQSPNNEENYLSLIYMYSDNNQEEKALQVVHKLEKNIPNSSW
AQVFLYKYYINNNDGNSAFNSLNIVLNSAKIDKKVKYKMYNEFLIFVLKNPPFETQLNKA
TSYFENDSEFNVYKEIGKFYYKKKNWELAIKNLEKATNTDLESNLFLLASYEETSKFEVL
ATKASELIDTFPNQPEYYFFAGKASNKLKKYKKANDFLLSGIDYVVDNIALEIDFLTQLA
EASKGLGDNQKSTQYLASANNLKTKQK
>KACEBFPM_01214 hypothetical protein
MRRILPFLLVFTLLSCKSKQKIIASQPVATGETATISNIIKNHYAIKRDFTTAYIKANID
YADNKQSLSLSADIRIKKDEIILVSVKFFGIVVAKAIITPTQVRYYEKAGGKYFEGDYKT
LSNLLGTDLDFLKAQNMLLGQAIDDLYKGNYSLSIEEDSPKLEETTEENFNKTYLFDINS
FWLKSQEITQKTPERKMRVNYSNYNSFPECVLPGELLIFANQDNKTTNITIEYKNATFNE
DLTFPYSVPSGYEQIKL
>KACEBFPM_01215 hypothetical protein
MLKYIIFFLLILSTSLSWGQEEERQRKLEQQKERLQEEIRAQEKLLQSQKTKEKSVVKVV
IQQTEKINLQQKLINTTAKQAKVLGNSMYINQVSVNKLNDDLRILREDYAKMIVKSYKSR
SAQSKAMFLLSSENFLQAYKRAQYMKQYSSFRKLQGEEIKVKTIELERYNSKLSGQKKEK
VKLIAESEKEKEALEKDKQEQQRLLFSIKKDKGKIIADIRKKQKESKAIEKQIDRLIRES
IAAANKKAGNTTNTTTFVLTPEAKELANDFKSNRGRLPWPVEKGLLTKKFGRQPHPLEPS
IMIESSGIEISSERGVKARSVFAGEVSDVQQAANGTATIVLRHGDYITTYSNIGKVFVHK
GDKVSTKQVLGEVFFNTFTNKAILKFLIFQNTTKLNPQSWITNM
>KACEBFPM_01216 Potassium-transporting ATPase ATP-binding subunit
MNSGTQAAKEAGNMVDLDNDPTKLIEIIEIGKQLLMTRGTLTTFSIANDVAKYFAIVPAL
FITAIPALEGLNIMRLHSPESAILSAVIFNAIIIPILIPLALRGVNYKPIGASAILKRNL
LIYGLGGLIVPFIGIKLIDMAVALFM
>KACEBFPM_01217 Potassium-transporting ATPase KdpC subunit
MKNIFSILKLTFLMVILFAVIYPLAIYGIAQFAPNKGKGETISVNEKVVGYQKIGQKFDQ
SNYFWGRPSAVDYNAAGSGGSNKAASNPDYLALVQKRIDTFLIAHPYLKKLEIPADMVTA
SGSGLDPNISPEGALIQVKRVAEVRKLSEEKVKALVENKINKPTLAGTSTVNVLELNVAL
DELK
>KACEBFPM_01218 hypothetical protein
MKKIIVTALIAFGFTTISAQEVSKSPIAFSGYVDIYYSYDFGKPDNHTRPGFIYNYNKSN
EMNLNLGMVKVNYAKENVRGNFALMAGTYPQYNMAGEQGLLKNVYEANVGVRISKDKNLW
VDAGVMSSHIGFESAIGKDCMTFTRSILAENSPYYDTGVKIGYTSASEKWYLAAMYLNGW
QRIEKVDGNQTPAFGTQITYKAVSGVVLNWSTYVGNEQPDVDKKWRYFNNFYGQFKVTEK
TSMIAGFDIGAQQAAKGSSNYNVWYSPILVAQYKPISKIQLAARGEYYNDAKGVIIATGT
PNGFKTFGFSTNFDYLPAENVMFRIEARTLNSKDNVFLKGNNPTDNNVFVTTSLAISI
>KACEBFPM_01219 Sensor protein KdpD
MENEKENNVKHFLDLIQKSRRGKFKIYIGMSAGVGKTFRMLQEAHTLLKNGIDVKIGYIE
THNRKETQELIDGLPIIPRRTLFYKGKQLEEMNLQAIINLRPEVVIVDELAHTNIEGSKN
EKRWQDVLEILEAGINVISAVNIQHIESLNKNVKLITNIEVQERIPDSVLKLADEVVNID
LTADELIARLKEGKIYTADKIPTALNNFFKSDQILQLRELALKEVASQVVRKVENEVPKN
LALKHDKFLACISSNDTMAKIVIRKTARLASYYNSKWYVLYVEIPSENSDKIALDKQRHL
INNFKLATQLGGEVIKVQNKKITDAILEVVKQKEVTTVCIGKPHLSLFKVILSTTIFNKL
LHNLSSSNIDLIILS
>KACEBFPM_01220 Alginate biosynthesis sensor protein KinB
MRIKTKLNLGVGLLFVLILILTFVSGFYMFSIKKDTENILKANYNTLEYSRNMLLLLDEI
NDSEIDKITVFETNLLKQVNNVTELGEAKATNDLKNKFDLLKYNFSAISIKNQIRVDIFE
IMGLNMKAIKQKSDIAKHTAETANLWIAITGTLCFLIAFNLLVNLPNNIANPIQELTESI
KEIANKNYSKRVHFMSHNEFGDLAKSFNTMAKKLEEYHNSNLYKLSFEKKRLETLINNMH
DPIVGLDEQGFILFANNEALKIMGVKLDEVIGKLAANLALKNDLVKSLIMTELEDEKQKA
VPMKIFADGKESYFEKEIVNIIIKPTGEENTIYIGDVIILRNITPFKELDFAKTNFIATI
SHELKTPISSIKFSLQLLEKEQTGILNEEQKYLVESIQDDSQRLLKITGELLELSQVETG
NIQLNIEKSNPYDIVYYATEAVKIQAEQKQIELVVEADEKLPNIKADKEKTAWVLINFLT
NAIKYSSENSKIIVKLKQENNHIIFQVIDTGKGIDNRYKSKVFDKYFQIPGSHKLGTGLG
LAISKEFIEAQNGTISVESELGLGSTFAVKLKLFNI
>KACEBFPM_01221 Toxin RTX-I translocation ATP-binding protein
MKQHKINFIPQHDNMDCGPACLSMIASVYDKKYPLQYLRENSFITREGVSLLGLTEASKN
IGFEVLTAKLEKENFAEMPLPCILHWNQNHFVVLYKISKNIFSKKQYFHITDPAHGFIKL
STETFKKSWITDNNKGVALFLEPTELFYKLAPPKSETLNLKYILGYLKPHKKQIIYMSIL
LLLGSILTLIFPFLTQNLIDKGVNKKDLSFISIILLAQLAVFFGSIVIEIIRNWIMLFIG
TKISITIISDFLKKILQLPINFFDTKMMGDFNQRIQDNERIENFLTSQSLVTLFSIITFS
VFFGVLCYYDFSILIIYFLLTFISISWSFFWLKKRKILDYLKFQQRSENQESIYEIINGV
TEMKLNQFEDFKRFEWENIQKKLFKVNIKILKLDQIQMSGFNFLNQIKNIIVTFLAATLV
VKGKMTLGELLSVSYIVGQMNSPVSQLVSFFRSLQDAKLSLERLNEVKNHETEENKEQKQ
LILEKNENSGIFLNNISFQYEGPKSACILKDINFRIPDGKITAIVGASGSGKTTLMKLLL
KFYDPTQGELFFNEENINNISPKNLRENCGVVMQDGFIFSDTIERNIATGDENINKEKLQ
NAVKIANIEEFVNSLPLGYNTKIGASGNGISGGQKQRILIARAVYKNPHYIFFDEATSSL
DAENEKIIHDNLQQFFKGKTVLIIAHRLSTVKNADQIIVLKNGEIVETGNHHQLVQNKGD
YFNLVKNQLELGN
>KACEBFPM_01222 hypothetical protein
MDFKQKLKKAKKYNYSDDRYIPEFSYQPIENRNLIKIRRKFNLDSIAGTGNEISKILNLL
HWIHNIIRHDGSRESPKLKNAIDLIKICKKESSGVNCRMMATILNECYLSIGIKSRFVTC
MPKETEFNDCHVINTVYSYDLKRWIWIDPTNDAYVMDEKGELLGIEEIRERLINGKRLIL
NPEANWNKKQSRTKEEYLDNYMAKNLYRMQTPLISEYNSETWRDGKEITYIELLPLDGIE
QIPQKSECVHIKLGVTFTYYKTNNPNLFWTKPMP
>KACEBFPM_01223 7-carboxy-7-deazaguanine synthase
MKYSQFNNFFNYEDKKIGYNAFSNEFTLLDPELFELLDAAIRESNFEELNKLHPDFFTHL
VEKGFLVDTEIDEIQNVKDLVRKIDSENEVSYKLIINPTMNCNFKCWYCYETHIKASKMS
ENTIISITKFVDNLLIEKENLEYFNLSWFGGEPLLYFDKTVLPLLQNIYPKMIDRKINFT
SEFTTNGLLINQKMLNLCKEFGVNDFQITLDGHRERHNQVRYISKEKGSYDEIVSNIILC
LKNKLSVRVRLNVSEETIETLPKIIDDFINITKTEKKYLSFSFHEVWQEKKDIHSDIQFI
VDLFREREFNTLYKGVNQDTVRSSCYADKRNHATLNYNGDVFKCTARDLESKSKEGYLNE
EGIIEWNEKFEDRMDSKFKNPPCLKCSILPICNGGCSQQAIEHKGIEYCVYNFDENRKLD
IIKDKFSYAIS
>KACEBFPM_01224 hypothetical protein
MKKELKKVPSLKTKNGTLSGGFTSLNASQMEKIKGGIAVPNYNKCTASDPANGPCNILNE
>KACEBFPM_01225 putative lipoprotein YiaD
MKLSEQRAASVKTYLSAKGLASTRFNTSGLGEADPIAPNETADGKSQNRRVEFAITANDK
MVNDAKKESGN
>KACEBFPM_01226 hypothetical protein
MATAKKKESKKDMIDDNKIISLYMNDVLENNHNTKNVYVFCKNNAIEESDFYSFFGSLEA
VKQSIWNKFFENTISTLEKDENYANYPDKNKLLSLYFTLFEILTLNRSYVVFSLLENKEG
IRNLKDFKEFRNHFKHFINNMIENNNSIVNDKIAKITKPVFSEGAWIQFLFILKFWLDDT
SKSFEKTDIIIEKSVNTVVDLLDTKPLESLFDLGKFLWKEKMI
>KACEBFPM_01227 putative protein kinase UbiB
MKTLDSIPTTKIERASQLLKTGVKVGGNYLSYYSEKIVNPSLTREKLNENNAEDIYDGLK
NLKGSALKVAQMLSMDKSIMPQAYVDKFSLSQFSVPALSAPLVRKTFKKYLGKFPEEIYD
TFSPDSVNAASIGQVHKATKNGKNLAIKIQYPGVADSISSDLALVKPIATRMFNLKGKDS
EKYFQEVESKLLEETDYILELKQSQQMSHACKNIENLKFPKYYADLSSEKILTMDWMEGE
HLSEFVAHNTNREKGDKLGQTMWNFYMFQMHNLKRVHADPHPGNFLIDGDSNLIAIDFGC
IKAVPNEFYIPYFELATPEIINNPTIFNQKLYELEILRADDSEKEIAYFTDVFYRLLSLF
TKPFHGDYFDFSDEDFFGAIATMGEEFAKDTQLRKMNGNRGSKHFLYINRTFFGLYNLLH
DLKSRVHTQEYKKYM
>KACEBFPM_01228 Fe(3+) ions import ATP-binding protein FbpC 2
MLQVKNISFGYTDKIIINNINFTVTQGQNIAILGESGCGKSTLLKLLYGLYDLGEGQIFW
KEKEVLGPKYNLIPGMPFMKYMAQDFDLSPYETVSENIGKFLSNAFNALKKLRVEELLEI
VEMTEFAKVKVNLLSGGQQQRVALARVLALEPEILLLDEPFSHIDNFRKNALRRNLFSYL
KSRGITCFIATHDSTDALSFSDQTIVLKDGKIIDKAPSADVYTYPMNKYVASLFGEVNEL
KLSQLIEIEGEDEDVLLYPHQLKISEKGTLTAIVKQTYFKGSHYLIKAVLNRKVIFFEHD
SSLNTNDEVKLTIM
>KACEBFPM_01229 hypothetical protein
MRKEDYLTTQINQLGYVLKRILEKLTGTKSNDQLGVVWVVDNFKLKEKLGFDLAILDTIS
DENLIPFLITKEGFNDSNIELFADVLVKIDKEKYAKKALQIYNYVNQITATFSFERDLKI
KEINL
>KACEBFPM_01230 hypothetical protein
MYYSIICLFALLGSALTLFSGFGLGTILLPIFGLFFPIEIAVVLTALVHFMNNIFKLFLF
GKKANKEVVFKFGIPAIFFAFIGAYLLKLLTQMQPIFKYFIAEKSFEIMPLKLIIGLLLI
IFSLFDFIPKLKNLEFDKKYLSIGGVFSGFFGGISGHQGALRSAFLIRSGLSKESFIATG
VVIACLVDVSRLSIYIPKIINNELSINYKLVLLATLSAFLGVYFGNKLLQKTTYKFIQNI
VAFMLLGYGFLLIFGII
>KACEBFPM_01231 3-oxoacyl-[acyl-carrier-protein] synthase 3
MYHSKISGLGYYVPDNIVTNNDLAKIIDTNDEWIQERTGIQERRHIIKGEDTTTSMGVKA
AKIAIERSGVAYNDIDFIIFATLSPDHYFPGPGVAVQKELGLKTVGALDIRNQCSGFIYA
LSVADQYIKTGMYKNILIVASEVQSLGLDMTTRGRNVSVIFGDGAGAAVLSREEDVTKGV
LSTHLHSEGEYAKELAVLAPGMGGRWVTDILAENNPDDESYFPYMNGQFVFKHAVVRFSE
VINEALEANNLQVSDIDMLIPHQANLRISQFIQKKFELNDDQVFNNIQKYGNTTAASIPI
ALTEAWEQGKIKSGDTVVLAAFGSGFTWASAIIKW
>KACEBFPM_01232 3-oxoadipate enol-lactonase 2
MIHYSIYENKDSKQWVTFVHGAGGSSSIWFKQIRDFQKHYNVLLLDLRGHGSSNEQIKKA
FHNKYTFKSIASDVLEVLDYLKIEISHFVGISLGTIVIRQLAETHPERIKSMILGGAILK
MNFRSQILMRLGNMFKYLLPYLVLYKFFAFVIMPNKNHKQSRLLFINEAKKLYQKEFIRW
FKLTAEINPVLKWFRQVEVNIPTLYIMGEEDYMFLPSVRKVVERHYKSSKLFVVEQCGHV
VNVDQPLVFNATVIKFINAMK
>KACEBFPM_01233 Vitamin B12-binding protein
MKQFTDQLGNTHTFESAPKRIISLVPSQTELLCDLGLEENLIGITKFCVHPYYLKSIKKI
VGGTKKINYDKISALNPDIIICNKEENTLEIVEELRKICTVWVTNIITIEDNFQMISDFG
QLFSCRTEAQKINDKLSFGLTEFKKFIKDKPIQKAAYFIWKNPYMVAGSDNFINELLKLN
NFENIYDKGERYPTIELKKIRLEGDPDLVFLSSEPFPFKEEHAFEIGRFTHHAKTIFVDG
EMFSWYGSRLLKAFEYFKILHSKI
>KACEBFPM_01234 Orotidine 5'-phosphate decarboxylase
MTTPQLIAQIRSKKSFLCIGLDVDLTKIPEHLLELEDPIFEFNKAIIDATHDLCISYKPN
TAFYEAYGIKGWQSLQKTINYINENHPEIFTIADAKRGDIGNTSTMYAKAFFEDLHFDSV
TVAPYMGKDSVEPFLAFKDKHTIMLALTSNEGAFDFQTLNANGKQLYKQVLETSITWKNS
QNLMYVVGATKAEYFSEIRKIVPNSFLLVPGVGAQGGSLSEVCKYGMNDNIGLLINSSRG
IIYASNKLDFAKKAREEALKIQLEMQEIMSFKFSI
>KACEBFPM_01235 hypothetical protein
MIEKINLNNILFLDIETVPEEENYNSLDDEMKQLWELKTQYQRKEEFSGQEFYDRAGIWA
EFGKIICISVGYFTIKGDIRNFRVTSFFGEEKKILHDFINLLNNHFNQPQHLLCGHNAKE
FDIPFIARRMIINQITIPNKLNLFGKKPWEIPHLDTLELWKFGDYKHFTSLKLMCKVLGI
PSPKGDIDGSQVGHVFYVEKDIDRIITYCEKDTIAVAQIFLRLRREDLLIEEEIIHV
>KACEBFPM_01236 Methylated-DNA--protein-cysteine methyltransferase
METTYIQTPLGITQITGDQTGITQISAWPKGTVCQEIPKNLEEAANQLREYFEGKRTNFT
FKLNPKGTIFQEKVWKELLNIPFGKTISYLDLAKKLGDPKVIRAAASANGKNPLWIVVPC
HRVIGTNGSLTGYAGGLWRKKWLLEHENPTNQQSLF
>KACEBFPM_01237 hypothetical protein
MKKIIIIAVATLAFSCKKESEESFGKTEEKTETTTTEVKSPSDLGKEIFEGKGTCTTCHK
PDVKTIGPSIQDIAKIYKEKNANIITFLKGKADPIVDPTQYEVMKANFALIKTFSDEELQ
QLEAYVYSNVK
>KACEBFPM_01238 Delta-aminolevulinic acid dehydratase
MFPLQRGRRLRINQSIRSLVRETTLSPSDFMFPMFITEGENIKVEIPSMVGIYRRSIDLT
VEEVKEIFALGIRAVNIYVKVNESLKDNTGKESWNPDGLMQRAIKAIKTACPEMIVMPDV
ALDPYSIYGHDGIIQNGDIANDATNTALVKMAVSHAQAGADFVAPSDMMDGRVLRLRQGL
DSAGFHNVGIMSYAAKYASAFYGPFRDALDSAPVNNAEIPKDKKTYQMDYANRIEAIKEA
LMDVEEGADMVMVKPGIAYLDIVREVKNAVNIPVTVFHVSGEYAMIKAAAERGWLDHDKI
MMEQLMCIKRAGASLISTYFAKEAAILLNK
>KACEBFPM_01239 hypothetical protein
MKSKLICLLFLFFSFANAQERDSLYAKKNKYNPEYRVNYFDKMIFQMEINSNSDNFYIQN
LSYTKTRQKSLVPNNVLRLKLSFDYKFLGLNFSISPNFLQSNNDPRKGETKTLDFSFKFF
YSDRLRQEVTYKEIKGFYLEDLKSSEPIRPLNDLQIKTIGGKTFYILNKNFSYRSFESMT
ERQIKSNGSFIPSISYYHNNLETNQPATKNIQLIRINSFDAYIQLGYMYNFILYKKWVTT
VGVHPGIGLNKSISFFKNSSYQDYTKVSSTNVNYNVDANIAIGYNNKNFFGGLKSTYKNF
DYNNKNSTEIKNEKTSFGIYAGYRFDENKRMKKGFEYIEKKFKI
>KACEBFPM_01240 Oxygen-dependent coproporphyrinogen-III oxidase
MKNKFYTYIQNLQDQICKGLEIAEGTTNFREDIWERPEGGGGRTRVIENGSVIEKGGVNI
SAVHGKLPQSMQQLFNVGEADFFACGLSLVIHPKNPMAPTVHANWRYFEMYDNNANVINS
WFGGGQDLTPYYLFEEDAIHFHQTCKTACNKHSLDFYPKFKKQCDDYFWNAHRNEARGIG
GLFFDYCKKTDDMSMTDWYNFVTEVGNSFLEAYVPILEQRKNLPYSPEQRTWQEIRRGRY
VEFNLVHDKGTLFGLKTNGRIESILMSLPPHVQWHYDHHPEKGSEEEKLISLLKKPKNWV
>KACEBFPM_01241 hypothetical protein
MTKLSKKTLYYLSFMVFCYANTWSQTNIKANITTLVGIPQIAIETKVGNKLTFQLDVMCS
LWKSINNGPQEFIIVTPELRYHFSTLEKGFYIGAHIAGSKYKMQKWNYINTDLYQTGYSL
LYGATVGFKVPIDNHFALDLFVGGGNQQGYYKGYNISTGERYENATKYNKSGEWLPYRGG
VMIVYKI
>KACEBFPM_01242 Putative ribosomal N-acetyltransferase YdaF
MTNVVINKLELADANELYQFIINNNERLQRYFPVTLSSNSTLEKSIKYIIIKNKEIKEKT
NFTFAIREKNNQEIAGLIIIKKIDWNIKQGEFAYCIGSKFEGKRLTTFAVKKMLEFAFDE
LKLKTLQIISHKTNLGSIKVAKNNGFIWQKTLLNEFYPTIGAPLDMELYELKK
>KACEBFPM_01243 hypothetical protein
MKKTSSIIMLITSIIIMTASAQKKEVSSTEKIPYQIVSNYFVKNNFKKEHFTNPKITTQK
DFDALFGAAAFMGKKGEPTAINFAKQYIIAVTIRETNYITTITPVSLKKIANKIVFTANV
SSAEKTTSTTKPILLIAVNKKYTGKIETKIEEKKQVPNGLPISSQWILESFNADFQLITK
NTYITLSQDLTTFTGNGGCNMIKGSLKVSQNKIKFSKITGTEMFCPAMNQESKFTSLLAI
ANTYKINGAQFFLYQDDKLLMTLESYR
>KACEBFPM_01244 Uroporphyrinogen decarboxylase
MIKNDLFLKALKGETVQRPPVWMMRQAGRYLPEFIALRDKYDFFTRCQTPELAAEITVQP
IRRIAPDAAILFSDILVVPQAMGIEVLMKENVGPFLPNPIRSIQDVERVIVPDVHQTLGY
VFDAIKLTKQMLNDEVPLIGFAGSPWTIMCYAVEGQGSKSFDKAKGFCFSHPEAAHVLLQ
KITDTTIAYLTEKVKAGCNAIQIFDSWGGMLSPVDYQEFSWKYINQIIEALADITPVIVF
GKGCWFALGEMGKSKASALGVDWTCSPRHARYLSGGNITLQGNFDPSRLLSPIPVIKKMV
HEMIDEFGKDKYIVNLGHGILPNIPVDHAKAFVDAVKEYNQ
>KACEBFPM_01245 hypothetical protein
MSQINILSTKKLSTIQKEALVNANFNVIEADFIKTEHQDFDLKNIKDNLIFTSQNAVYSI
LQHTKCDELKTKNVFCVGLKTKILLSENGFNVDVYTGYASDLAEIITLIHGSDSFTFFSG
NLRREILPQTLKEANVNFNEIKVYETTLTPQKIKNSVEAILFFSPSGVESYLKDNTLKKE
VCFCIGETTAEALQKTTKNIIIAENPTIEDVIEECINEYK
>KACEBFPM_01246 Porphobilinogen deaminase
MAKKTIKIGTRDSELALWQAHHVEKMLNDLGHKTKIIAVKSQGDIILDKPLYELGITGIF
TKTLDIAMVNGDIDIAVHSMKDVPTALPQGIVQAAVLERANEKDILVYNNNLDFLNTQAT
IATGSLRRQAQWLHKYPNHKVVDLRGNVNTRMQKLQDNNWNGAVFAAAGLERINIKPENY
INLDWMIPAPAQGAMMVVAMGNDTYCLDALAELNHIETEITTYIERQFLRTLEGGCTAPI
GAYARFNEKDETIHFQGVLFSLDGSQKIEIKKIVEIQEWKQLGYHAGQEIFENGGVQLMK
TIKEKLKK
>KACEBFPM_01247 Glutamyl-tRNA reductase
MENNTIPKHNTFYAIGLNYKKADAEIRGKFSIDAQSKSNLLQQAKTEGIESLIVTSTCNR
TEIYGFAQHPFQLIKLLCENSKGTVEDFQKVAYVYKNQEAISHLFKVGTGLDSQILGDFE
IISQIKIAFTESKALDLANSFMERLVNSVIQASKRIKTDTDISSGATSVSFASVQYIMKN
VANIGEKNILLFGTGKIGRNTCENLVKHSKNEHITLINRTKDKAEKLAGKLNLIVKDYAD
LHIELQKADVLVVATGAQNPTIDKAILNLKKPLLILDLSIPKNVNSDVNELENVTLVHLD
DLSQITDETLEKRKLHIPAAEAIIEEIKNEFSSWMNGRKYAPTIHALKAKLNTIKEKELI
FQRKKLSNFDEEQAELISNRIIQKITNHFANHLKDEETMVDESIDYINKIFQL
>KACEBFPM_01248 Regulatory protein PchR
MSSAEEIKIDDDFILIRFQNDSDKTVSFERQVNNGLIQFHFGLKGNAKFIFNQGNYTLDL
KEEKSLLFYNPQKELPLHLEIEPKSWLISILVSIKKFHRLFSTDTEHIPFLSDENRDKKY
YGEENISPSMAIVLNQMFYYNLNPSIKNLYYKGKGYELLSLFFNRSEDPNAEQCPFLIDE
ENVLKIKKAKEIIIANMAEPPGLQELADEIGLNLKKLKMGFKQIYGDTVYGFLFDYKMEQ
ARKLLDSGSYNVNEVGLKIGYSTGSHFIAAFKKKFATTPKKYLLEKSL
>KACEBFPM_01249 Ferrochelatase
MKGVLLVNLGSPESPTAKDVKPYLDEFLMDKYVIDVPYLLRALLVRGIILRKRPEKSAEA
YAKIWTPEGSPLIVISKKMHKKVQALTDIPVSLAMRYGTMTILKGLQELSDKGVNEVMLF
PLYPQHAMASTTTILVLAEELRAKHFPDMSFTIVPAFYNKPDYSKALANSIQKHLASYNY
DHLLFSYHGIPERHIRKTDVTKSHCKIDGSCCNTPSPAHEFCYRHQCYETTKQVVKLLGI
PEGKYSQTFQSRLAGDKWLTPYTDVEVNKMPKKGIKKLAVVTPAFVSDCLETLEEIAMEA
NHQFKENGGEEFLAIPCMNDEDQWCEVIANWIKDFQKKG
>KACEBFPM_01250 hypothetical protein
MEYYNYIKSLHLIFVITWFVGLFNIVRFFVYQIEANEKPSPDREILLAQFKIMTYRLWYI
ITWPSAIVASIFAFWLLYLNPAILQADYFQIKLVFVCLLYLYHLKCHQIYNQLQNGKFKY
SSNVMRLWNEGATIILFAIVFLIILKNAFNWIYGVIGIFLFSVLIMLGFKFYKRIREKNK
>KACEBFPM_01251 Sensor protein ZraS
MNSIFKIKSWSLRVRIFLSMILITIISSILIAGVSLIHFQYESKEYNQELLISKENQIKQ
HLQYVLATTPHPLTTFNIPSIFKGKIFEISNIHDIEIDMYDLTGRLLITSNAPIIKGQIA
PNIPNIVIEKVKESANNRYINSIENKENNFQFSYSYLMDYVEKNPIGIIRLPYKEDNTFY
QKQIEEFLKIFGFVYLAMFVISIWIALYLSRYITKSLETISNSLTKTSLTEKNKKIELIS
NSYEIDNLVHSYNNMIDELEESANKIAQSEREGAWREMAKQVAHEIKNPLTPMRLTVQSY
QRKFDPTDPNVTQKLNDYSKTLIQQIDTMSAVASAFSNFASMPAQQNETINVVDVVKLTL
DIFNEGFIEFYSNLDEIITTIDRTQLIRIITNLVKNALQAIPEEQVFKKIWVSVNKEANN
AVITVKDNGKGIAIADFDRIFEPKFTTKSSGMGLGLGIIKNIIENYNGTITFDSEINKGT
TFTVSLPITNQ
>KACEBFPM_01252 Short-chain-enoyl-CoA hydratase
MALENIILEHEKGIATIFINRPEKLNALNKATIQELHETLKMIDANEAVKVIIITGSGEK
AFVAGADISEFAHFSDHEGAMLAAKGQEILFDFIENMKTPVIAAINGFALGGGLELAMAC
HFRIASENAKMGLPETSLGVIPGYGGTQRLPQLIGKGRAMEMIMTAGMIDAITAKAYGLV
NHVVSQTDLMSTYMTIADKIMRNSPAAISKAIEAINANYKDGTNGFDAEIKAFGECFATD
DFKEGTTAFLEKRRAVFVGK
>KACEBFPM_01253 hypothetical protein
MGRASFDKIKNFKIIENRLNPFPKERIFCKTEIMKNLINKTILFVKQKLENAEGGHDWFH
IERVYKNAILIASAEKCNEMVVKLGALLHDIADSKFYNGDETVGPKMAREFLEAENVSEE
IISHVIKIIENISFKGGNFNKNFASKELEIVQDADRLDAIGAIGIARTFNYGGFKNRQLY
NPEIVPNLSMNKEEYKNSQSPTLNHFYEKLLLLKDKMNTETGKKIAQERHHYMETFLEQF
HFEWNGER
>KACEBFPM_01254 Putative acyl-[acyl-carrier-protein] desaturase DesA1
MSTKNIRLEVMQFLENKIDGFVDQYLIPIEKIWQPTDFLPNSESETFFEEVKELREIAKE
LPYDFWVTLVGDTITEEALPTYESWLMDVDGVGQAEQNGWSKWVRQWTGEENRHGDLLNK
YLYLSGRVNMREIEITTQHLIADGFDIGTGRDPYKNFVYTSFQELATYISHNRVSQIAKQ
YGDNKLAKICKMIAGDEMRHHHAYSEFVNQIFKVDPSEMLLAFNYMMKQKIVMPAQFLRE
SGEKISSAFVNFSDSAQRIGVYTASDYVDIMQKLIEKWEIEKLSNLTDEAEKARDYLMKL
PARMAKISERLIIPAESQLFKWVEPALIR
>KACEBFPM_01255 hypothetical protein
MEKLISYPISLIAYTLFLVCLLVFHPIQWVCFNIFGYQTHKKSVDYLNFCLLKVGHILGS
TYTIKNREIIPKGVPIIFVSNHQSLYDIIGIIWFLRAFHPKFVSKKELGSGVPSVSYNLR
HGGSVLIDRKDPKQAISTIAQLSKYIEANKRSAVIFPEGTRSKTGEPKKFAESGLKILCK
YAPSAHVVPISINNSWKMVKFGAFPMGLGSSLEFIIHKPMAVKDYSFEEIMTMTENAVIQ
SIKV
>KACEBFPM_01256 hypothetical protein
MQINNIFNTKIMYPEEMVKPMRTELSEAGFQDLYNAQAVDMALAKEGTTLVVINSVCGCA
ARNARPGVKMSLDGAKKPNQLIAVFAGVDKDAVEAARKHMFPFPPSSPCMALFKDGELVH
MLERHHIEGRPAELIAENLKDAYAEFC
>KACEBFPM_01257 hypothetical protein
MNLKVIAFDADDTLFVNEPYFQETEHKFCALMADYLSHQGLSQELFKTQIENLDLYGYGI
KGYILSMLESAMKISNNTISIEIIEKIIEYGKELIQKPIELLEGVEETLQALSGKYKLIV
ATKGDLKDQQSKLHRSGLGHYFHHIEVMADKQEVNYQKLLTRLEINAEEFFMIGNSLKSD
VLPVLGIGGYAVHVPFYTTWEHEKISHKVEHPNFRTLDKITDVLPILLK
>KACEBFPM_01258 Methionine--tRNA ligase
MIQNPKRYTITAALPYTNGPIHIGHLAGVYVPSDIYSRYLRLQGKDVAFMCGSDEHGVAI
SMKAKKEGITPQEVIDKYDGIIRKSFVDFGISFDNYSRTSAKIHHDTASEFFKKLYDKGD
FIEEVTEQLYDAKADQFLADRFVVGTCPKCGNEEAYGDQCEKCGSTLNATDLINPKSTIT
GETPIMKSTKHWFLPLDRYSDFLTKWILEGHKSDWKPNVYGQVKSWIDGGLEPRAVTRDL
DWGIDVPVAGAEGKKLYVWFDAPIGYISATKEWAAREGKDWELYWKNEDTKLVHFIGKDN
IVFHCIIFPAMLKAEGSYILPDNVPANEFLNLEGNKLSTSKNWAVWLHEYLEDFPNQQDV
LRYALTANAPESKDNDFTWKDFQARNNNELAAIFGNFINRVVVLTNKYYEGVVPTPNKFS
EVDEATLTELKAYPAVISSSIERYRFREALGELMNVARLGNKYLADEEPWKMVKTDPERV
KTQMYVALQIATALRVLCEPFLPFTAEKLNKMLKIDAKLSWNDVTTNSDLILAGHKIGEG
EILFAQIEDEQIQKQIDKLEATKTANIAENKKAEPQKELIQYDDFAKMDLRVGTIIEAEK
MPKANKLLVLKVDTGIDVRTIVSGIAESFSPEEIIGKQVTVLVNLAPRALRGVESQGMIL
MTNLPDGKLAFVNPDVAGVSNGEGIN
>KACEBFPM_01259 putative murein peptide carboxypeptidase
MITPPYLKKGDTIAIVATARKNIDDNLKFAKDLLTSWGLNVKIGSTIGLDLNQLAGTDAQ
RAADFQNQMDNQNIKAIWCVRGGYGTVRMIDLLDFKKFKENPKWIIGFSDVTVLHNHLNT
MGYKSIHGIMPVSSKATQEAKESLRIALFGERLEYEIDSHFMNKPGKASGELVGGNLSIL
YSLLGSKSAINCDDKILFMEDLDEYLYHIDRMMINLQRNGCLESIKGIIVGGMTKMKDND
IPWGKNALQIIDEVTKKYNIPTIYEFPAGHIQDNRALVMGNKVSMSVNNECSTVVFE
>KACEBFPM_01260 hypothetical protein
MAEHNDLGKFGEDLSVEFLQKKGYSILETNWTFQKAEIDIIAQKENILVIVEVKTRSSID
FGSPQDFVKPAKIQLLVKAVNEYVISNDLDLEIRFDIIAVYKERKEFKIEHFEDAFYHF
>KACEBFPM_01261 General stress protein 69
MKYNTLPNTNLKVSTICLGTMTFGNQNTEVEAHSQLDFAIEKGINFIDTAEMYPIGGNEH
IFGSTERFIGSWIQKIGQSKREDIILATKIAGPNRGMAYIRQPLNFSKKSIHQAVNLSLK
NLQTDYIDLYQMHWPERIMNMFGQRGLSKIDEQWKDSIFDILTVFDELIKEGKIKHLGVS
NENPWGVMRFLMQSEKHNLPKIATIQNPYSLLNRLFEVGLSEICMRENIGLLAYSPLGFG
FLTGKHLNGIRTNSRLELFPNFTRYTNENCYKATKLYQDLAQDLGLTVTELALAFVNHQQ
FVTSTIIGATSIDQLEENINAFDVMLTDAVLSEINKIQELIPNPAP
>KACEBFPM_01262 putative lipoprotein YiaD
MIKKISLGLLVLSLTTSCVSKKIFADLETKFAELKKERNALSDENETLKTTKNQFQLDNA
TLKTELDKLKAERDKLAADYAASSNNLKTLQSSYNALEKNSDESLKANMDKNRDLLAQLE
AKEKALAAEKGRLAKLSGDLKDRSDRVNELEALIAAKEASMKKLKETLSKSLKAFEGKGL
TVQQKDGKVYVSMENKLLFESGSWAVGTEGKKAVVAVAKVLGDNPDISILIEGHTDNDKF
AGAVGQIENNWDLSTKRATSIVNILGENPKVNKQNLTAAGRGEFSPLMSNDTPEGKAKNR
RIEIILTPKLDEISKMLNDI
>KACEBFPM_01263 Exodeoxyribonuclease
MPIFSILLIKKTPISMKIISYNVNGIRAAITKGFIDWLQTANPDVICLQEIKATQDQIPT
DAITAAGYPYQYYFSAQKKGYSGVAILCKTEPKNIVFGTEIDHMDFEGRNIRVDFDDLSI
MSLYLPSGTNIERLDHKFMFMDDFQNYINNLKTKIPNLIICGDYNICHEAIDIHNPTQNA
KTSGFLPEERAWLDAFIKSGFVDSFRHFNKEPHHYSWWSYRAGARGNNKGWRIDYNLVSE
TLKERIKRAIILPDAKHSDHCPVLVEVE
>KACEBFPM_01264 hypothetical protein
MGLVTAKEVAKAINTDKYGVLGTFSGWLLMKALKISTLNEIYDKNKHLSELEFLNAILDE
FQIKFEIPEEDLKRLPKEGAYITVSNHPLGGIDGILLLKLMLEREPNFKIIANFLLHRIE
PMKPYIMPVNPFEDHKDAKSSVIGIKETLRHLRDGKPLGMFPAGEVSTYKDGKIMVDKPW
EEGAIKVIRKAQVPVVPIYFHAKNSRFFYFLSKISSTLRTAKLPSELLTQKDRVIKVRIG
KPISVAEQNEHETIEAYSEFLRKKTYMLANAFEKESKLLTVPSLKLPKNPKEIVTGANLE
KMIVEIDHLRKNDDRLLQSKNYEVFFAKADDIPNVLHEIGRLREITFREVGEGTNESIDI
DSFDKHYHHLFLWDSEAKVVAGAYRMGLGSEIFAKYGIDGFYLQDLFRFEPELYDMMSKS
IEMGRAFIIKEYQQKPMPLFLLWKGIVHTTLRHPEHKFLIGGVSISNQFSDFSKSLMIEF
MKSNYYDPYVAQYIHPKKEYKVKLKDADKDFIFNEAEADLVKFDKLLDELEPGSLRLPVL
IKKYIKQNAKVVAFNVDPLFNNAVDGLMYIRIADIPESTMKPVMEEFQAELERKLAEKGE
C
>KACEBFPM_01265 hypothetical protein
MKKTFTFLLFSIITFSYSQNISGIILDSISKKPLELASVTLNKTNRGVYSDAEGKFKISL
TNENDYLLISYLGYTTKKVCASNFIKTKENNSIFYLSSTTERLNEVFVQNKKIEYGWEKT
IKFYRGKTRQVGFQFGTENCTYIENSEHKKGKITAVILDLKKITQYNKDNPKWKLDYISD
YNIKFYEIDLQNNRPGAEIYNKDIIVNPENKTRNFKINIDSLNIPFPESGVCVGVEMINT
RYKNPKEVFATIGPRINFTENRDTNPVMAWSRFRYDKEWKFEPVARIQDRKGRRYNMMIV
DLIIKPEK
>KACEBFPM_01266 hypothetical protein
MKNKITILFVLITSTLFAQGFQGTAIYQWKQSSEDFKNTVLSDPKMDPAMRKVIEDRMSK
LFNKTFVLNFDKNISIYKEEKTLDINKQDGGGDWSPNGIIISYYKNIKTKQSITQTDLMS
KIFNVQNSLADYKWELSSQTKQIGSYLCYKATTIIPVTQKEKADYEEEKAEQEKNNTQFF
KIEEPKDKTIIAWYTPEIPVSNGPENYFGLPGLILEVNAGKTTLLCSKIAMNIKDKKEIK
APTNAKLITQKKYDEIVAKKMDELNHTHQDHDGNGGMQIRMGR
>KACEBFPM_01267 TonB-dependent receptor SusC
MKIKNIFSLLLLLATTISFCQNITFQGIVKDTTNAPLEMANVMAINQVTKTVDSYSITNN
KGKFQLSLKANANYNIKFSYLGLKTKSLVMATKAEDISQTITLNADVTELAGVEIVREMP
VSIKGDTIIYNADSFKTGTERKLEDVLKKLPGVTVNKDGEVEVEGKKVSKLMVEGKDFFD
GDTKLGVKNIPADAIDKVQVLRNYNEVGALKSLENNEDNVAINIKLKSGKKNFWFGDMTA
AIGVGHIESRHEVNPKLFYYSPKYSVNVLGNFNNIGELPFTVQDYFKFTGGFKNMMKKGG
TNFNISSNDLGISLLRNDKAKEIKTKFGATNFSYNPIKTLSISGFVILSATETNLETKNQ
TNYLNADHTTRGTEKRNEITHQKSNLALYKLSGSYKPNAKLQIDYDALAKQSKQDENNNL
SQDVFEPNSIFIHNQDIITNKKQNPFSLNHCFNAYYTKSDKNVFALEVQHLHQNENPFYN
ANLENQPFLFSGYVLGEARNNINQNRFIKTNKTDSKLDYYDMLTPKSNINITLGNTYSYQ
SFNSNIFQILDNGTTNNINSVENRNDVKYSFNDLFLGLHYKFLTGKFTFNPGLSVHKYNT
TDAQLGTNLKNDFYRILPDVYALYQIKKSETLTYNYGLTTDFTDINKFATGNVFSSYNSL
FKGNRRLENTLLQNHSLRYFKYNMFNFENIFASISYSRKVNPVKNASVFLGINQVSTAVN
SNFADESISGAANYERSFLRYYKASLALAGSWSKFNNIQNNLTQTNESLTQNYTIKGSTN
YKNLPNIELGYNYLINDYQNSKFYTKTPSVKIDYYFLDAFSFVSEYEFYNYANSTKTVKN
EYDFLTASLIYQKKGGKTEYKISGTNLLNTTSLNDDKFDQVRISTSQYTVQPRYLIFSLK
YNL
>KACEBFPM_01268 S-adenosylmethionine synthase
MAYLFTSESVSEGHPDKVADQISDALIDNFLAFDAQSKVACETLVTTGQVILAGEVKSNT
YLDVQNIAREVIRKIGYTKSEYMFEANSCGILSAIHEQSADINQGVDRASKEEQGAGDQG
MMFGYATNETENYMPLALDLSHALLIELANLRRENNDIKYLRPDAKSQVTLEYSDDNKPQ
RIDAIVISTQHDDFDEETTMLAKIKTDLVSILIPRIKAKYPQYAHLFNDQITYHINPTGK
FVIGGPHGDTGLTGRKIIVDTYGGKGAHGGGAFSGKDPSKVDRSAAYATRHIAKNLVAAG
ICDEILVQVSYAIGVAKPTSINVVTYGTSKVNLTDGEISKKVEAIFDMRPYFIEQRLKLR
NPIYSETAAYGHMGRTPETVTKTFSAPGGLTKTVEVELFTWEKLDFVDTVKTAFGI
>KACEBFPM_01269 DNA repair protein RecO
MQIKTKAIVISAIKYQEKSLIVKCFTLSDGLKSYFVRDAFSSKKSNQKIAYFQPLTILEI
EAVHKNKGTLERFKEVKIATPFHSIHYDVIKSTIVIFISEILHHSIHEEEKNEAFFTFLE
TALHWLDNHDQIANFHLILLLETTKYLGFYPDISNTEHPFFEMTEGLFSPFHAISSLTEH
ETNLFKKLIDLKFDNSNTNTLHSTERQILLKILINYYSYHLDGFKKPKSLEVLKEVFS
>KACEBFPM_01270 hypothetical protein
MKNIFLYILVLISSFAYSQENKLWKGYFSYNTIKDLSQSTNQIYSAAENAYFKKNLATNE
ITTVSTVEGLSGQNITQIYHSEIYKKTLIGHTDGLVIIINDLDGSVLNVVDILNKPSVPP
NSKKINHFMEYNGKIYISTDFGISIYDLNLSEFGDTYFIGSGGSNIEILQTTIYNGFIYA
VANGYGLLKATVTNPNLIDFNQWTNISPGSWKTIEATATQLIAVNLSGSIYKLINDNPNL
ITSYPQITLDTRHNSNHLIITTQNHIYIYNEQLIEVLHLTSIPNITANFTCATVINDKIY
IGTQENGVFATSLNNPTFFENITPKGPDKNRIFAIQSFSNGLWAAYGDYDSNYNPYPIDS
FSVSKYTTNNSWTSTPYQDLFGAKSICRIIVNPKNENQVYFSSNFSGLLKFENNLPSTLY
DNSNSSLQKITINGYNAIDIRINGSVFDKDGNLWITNSLVSKGLHVLKTDNQWQGFALTS
LAAPLALSYGRLAIDKNGTKWACTNHEGLIGFNEKYNNKCLSINEGQDHGNLPNKDVSAV
AVDNKNKLWIGTKYGLRILQNVDSFLNQNELTTNAIIILEDGLAQELLYGQSITDIVVDG
ANNKWISTSGAGLFYISSDGQKTFNIFTKENSPLPSNTILDIDINSLTGEVFIATEAGMV
SFKGTATNGAENFENVIVYPNPARPEYSGSIFITGLMNKANVKITDIEGNLVHEEISEGG
TIIWDTKAFGKYKVASGVYMIFMSSSDGEETKVKKVMIVR
>KACEBFPM_01271 NAD(P)-specific glutamate dehydrogenase
MSQSIDAFIQAVSKRNPNEPEFMQAVKEVAETVIPFIEKNKKYEGKMLLERMVEAERVIM
FRVVWLDDAGKTQVNRGYRIQMSSAIGPYKGGIRFHPSVNLSILKFLAFEQTFKNSLTTL
PMGGGKGGADFDPKGKSDNEIMKFCQAFMTELCKHIGANTDVPAGDIGVGGREVGYMFGQ
YKRIRNEFTGVLTGKGISFGGSLIRPEATGYGDVYFAYSMLKTKGESFDGKTVVVSGSGN
VAQYATQKATQLGGKVVTMSDSAGYIYDEAGIDAEKLAYVMEIKNVNYGRISDYVTKYPS
AKYIAGKRPWEVKCDIALPCATQNELNEEEAKTLVANGCICVAEGANMPSTPEAVTVFQN
AKILFAPGKASNAGGVATSGLEMSQNSLRLSWTSEEVDDRLKVIMKDIHEACVQYGSDGN
GYVDYVKGANIAGFVKVADAMLAQGIV
>KACEBFPM_01272 hypothetical protein
MIKSFNTLEDKYIKTSNISEKKACYFNINSKMTLTQKYLGYIFIKCIFATHNENVYFKH
>KACEBFPM_01273 hypothetical protein
MVLFLLVSLNTARAQFGFSHEVGIIAGPVAFQSDYGQRHNFATNAGNTGIGIGLVHYLNF
SYKAECNCYTPETYFNDHFKVRSELSYSKTKFNMFGEWVTPEKVNKPDPAPGVPNDAKQL
KSMEGSTAVTDIGMQLEFYPFSIRDFAATNGAFAPFVSLGAHFSFYNPEVHSTLGKLNDV
NINPKYWAPSEGEAHGFTNKNGTVWSVVSSIGTRYKLTPLSDLMLDLRAQYYFSNWVDGL
NPNPAVYKENKANDWNIWLNFGYIYYLN
>KACEBFPM_01274 hypothetical protein
MNIQTINNKIQPQKDILLQHSLYKKVQTIEDLHQFLENHVYAVWDFMSLLKALQANLTCT
TTPWFATTNPEIRYLINEIVLAEETDLTLDGRRQSHYEMYVEAMQDCGANTGNITHFLLE
VHSLQNVFIAIKKSNLHPNIKDFLDFTFRVINEGKPHNIAAAFTFGREDLIPSMFTEILK
NFQINFPETDLSKLIYYFERHIELDADEHGPMAMQMITELCGTDAKKWKEIEAVSIEALE
KRIGLWDAIEEQIDKSRMVIT
>KACEBFPM_01275 Thiol:disulfide interchange protein TlpA
MAFQAEIANRNGDIIYIKDAKDKTIKEIKANDKGFFKDTFEIEKEDVYFFFDGTEYTKLF
LKNGYNLKLKMDAKQFDESIVYTGKGAKENNYLAQSVIREGQITAEKLASLNEEDFKKMT
EEKKLTEEMFLDKSSLDKTFVEIQKKNIAINIRGLQQYYNESKAIQKLNNATAPTFNYAN
HKGGTTKLEDFKGKYIYIDVWATWCGPCRGEIPFLQKIEEKYHEKNIEFVSISIDAQKDF
EKWKKFVSDKQLGGTQLFADNDWNSDFAKKLNITSIPRFILIDTYGKIINANTERPSSPK
LQEVLDKLLN
>KACEBFPM_01276 Putative cysteine protease YraA
MKKITAFTILALTVSCFMATAQKQKNKKMKKVLFVVTSHDQLGNTGEKTGFWTEELAAPY
YALLDQGVSIDIATPKGGQPPIDPKSADASSATEDTKRFDADTVLLEKLKNTKKLANVNQ
ADYDAVFYPGGHGPLWDLVEDKKSIALIESFYTNKKPVAFVCHAPAVLKNVKVNGDFLVK
GKKVTGFTNTEEEAVGLTKIVPFLLEDALQENGATYSKAADWHPYAVEDGLLITGQNPAS
SKLVVEKLLNQLNLNQ
>KACEBFPM_01277 HTH-type transcriptional regulator TrpI
MVNLEWYRTFKSVYKNGNFSLAAKELFISQPAVSQQIVMLEAHVGYKLFNRKSKGVEPTE
YAKLLNNLIIDALDRLENVENGFRSKAFNANRVLSVGISRHLMSSIGSALLIKFDFIDFT
FHNNDALFDLVNSKKLDFAIVTKKFDTFDTIQKKVGAIKQVIVGSANIDLSVIKTKIKTK
ELETIENWLNEQKWYSHDAEIPHIKLFWLHVFAKKRPSMIANYIIPSEYEMLEILSKNTG
VAVTWNINAKNMIEEKKLQMIWNSTEIPSTDVFLLSGKNDNLSDFFEDIELELKGIF
>KACEBFPM_01278 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MKIAIVCYPTFGGSGVVATELGLELARRGHEIHFITYRQPVRLALLNPNVHYHEVNVPEY
PLFHYQPYELALSSKLVDMVKLHKIDLLHVHYAIPHAYAGYMAKQMLKDQGIIIPMVTTL
HGTDITLVGNHPNYKTAVTFSINKSDKVTSVSQSLKDDTLRLFDIRNEIKVIPNFIELEN
KILDNIPCKRSVMARPEERIITHISNFRKVKNIPDVVKVFYKIQQKIPAKLMMVGDGPEK
AKAEKLCDKLGISDKVIFFGNSNEISQILTLTDLFLLPSETESFGLAALEAMACSVPVIS
SNSGGLPEVNIDGVSGYLSNIGAVNEMAENALKIISDEDNLNLFKKKALEVAKQFSVEKI
VPLYENLYLEAIAESKKNIFNQI
>KACEBFPM_01279 O-acetyltransferase OatA
MIVENKNKQKFYGLDHLRALAIVLVFWFHYQIPIFGYPEWLPDYAKFGWTGVDLFFVLSG
FLISSQLFLEIKKGNKILYKDFFLKRFFRIIPAYLVVVAIYFCFPLFREKESLPSIWKFL
TFTQNLGANLKDYGTFSHAWSLCVEEHFYFFLPIILMFLQISNYLKKGYWLLIILFILGF
IVRIYSWNNFYIPKINDENSWLYWYKYIYYPTYNRLDGLLVGVSIAGIYQFYPNLWNKIS
ILGNLNVVLSLVILVLAYFLCYEEQTFYASVFGFPLVAIGYGFLVIGAISPTCFLYKWSS
KTTTFIATLSFAIYLTHKGIIHITQNVFENLNVKTESSLMMFICMVTCIICAYLLNLIIE
KPFMKLRNQVISKKKIS
>KACEBFPM_01280 hypothetical protein
MKRILFTISILLNVAFFYTYVQNNWKVNKSENSKIETNKIVGTWKLVAFADLDTVTGKWI
YPFGKTPKGYFTYTKNMIVNLNVSAEEPLHISADSSETCKINLDNYIWHHSFGYFGSYSV
NLKKSVITHHVKGGTITYYIDTDQPRPFSFRGDTLVIGDNKTRKRLLIRAD
>KACEBFPM_01281 hypothetical protein
MLHDEKHLKSSDFITDAVIGMSDGLTVPFALAAGLSGAVSSNSIILTAGIAEIVAGCIAM
GLGGYLAGKTEQEHYQSELIREYEEVETVPEKEMQEVMDIFADYGISKEGQNILATELAK
DKTKWVNFMMKFELGLEAPHPQRARNSALTIGIAYFIGGLLPLSAYFLTNSPSNGLKLSL
LITTICLFVFGFFKAKVTGQNPVKGAFKVTLIGLIAAAAAYFVAIGFENIFK
>KACEBFPM_01282 Beta-hexosaminidase
MKNSVFKFLLFSILTLFMVNCSVNKNRGIENIAVDNNEAKSKTEKFIDPSKVGFNLFEDN
HSEKKWVDSIYNTMTFQEKLGQLFMVAAYSNKDSIHFNSLDKLIKNYKIGGLIFFQGGPV
RQAKLTNRFQAVSKTPLFIGNDAEWGLSMRLDSTYRYPWNMTLGAIQDMKLIEELGEQMG
KETKRMGIQFNFAPVIDINTNPNNPIIGNRSFGENKEEVTKRAVALMKGFQNQGVFSTGK
HFPGHGDSETDSHHSLPIINFSKERLEDVEFYPYKKMFNLGLASVMVAHLNVPSLETRAN
YPSSISYNIVTNILKKHLGFKGLIFTDALNMKGASNFKKPGEIDLEAFLAGNDILLFPED
VPTAIQKFTQAYKDTLITDDRIEFSVKKILKYKHKAGLDKYKPIETSTLYKDLNKPITNS
LQYKLYENAITLLKNKDSILPINDLAKSKIAYVKLGDDSGNVFLSTLNKYAEVTEVFNEN
IDSLNQDLKQYTTVIIGFHKSDKAWKKHEFTEKELLWIQKIAQNNTVILDIFAKPYTLLQ
IKNFDNIKGLILTYQNGDIAQEVSAELIFGSIEVKGKIPVSIANFFNQGDGLTTKMTNRL
GFTTPENVGMNSEILSKIDAIAKKAIDGKMTPGAQILVAKKGKVVYQKSFGYHTYKNETK
VKNSDIYDVASLTKIVSTLPNVMLEYDAKKINLATTLGTMIPEARGTNKDSISFKDLLSH
YARLQAWIPFYKSTLDSNKIPLKKYYNNTYSENFKNQVSENLFIRNDYNDTIIKKIISSK
LLDKKEYKYSDFTFILLKEYLEKSNNQTLDVLSQENFFSKLGMNNTLYNPLRKFDISVIP
PTEVDTYFRHQIIQGYVHDMGAAMQGGVGGHAGIFSNTIDIAKMMQMYLQKGNYGGIQYF
SEQTFNDFNTCYFCAQGNRRGLGLDKPQLSGTSGPTCGCASLTSFGHTGFTGTMAWVDPE
TEIVYVFLSNRTFPDSNASNKLSKENIREDIQKIIYEAIIK
>KACEBFPM_01283 hypothetical protein
MDSKKLIFQKLEDFIKKFYTNELLRGTIFFVGLGLLYLFATSFIEYFLWLKPRGRTFLFI
LFVLVELFLLVRFIAFPIFQLFKLKKGIDYTDASKIIGNHFAQVNDKLTNFLQLTEDKNK
SELLLASIHQKANALQPIPFSNAIDFNKNKKFLPLALIPLFFVLFLMLSGQQKLITESMN
RVVNYKQQFLPPAPFSFTLVNKKLQTEQNKDFILKVKTVGKVVPEKAMIFIGDESYFMEN
TKQGEFEFVVTKPMQNIDFHIEANQVSSADYTLNVITVPAIANFEMLLNFPNYLNKKSEI
IKGTGNAIVPEGTQITWRINTVATQNINLIEANKSYLFVNVGNTFNLSKNIFQNTEYQIF
TSNKVVKNYEKLNYAINVVKDQFPTIKVEMAADSLKGSKEYILGQISDDYGFSKLSVVYF
PKDNPKASKRGTIAVKQNNFDQFVFSFPSTLPIVDGVAYEYYFEVSDNDAIHHYKSTKSS
EFSYREATAQEKENENLQQQNENINALEKSLSKQDKQLSELQKLQKTNKEKNDLDYKDKQ
KLDDFIKRQKQQDEMMKEFSEKIKDNLEKFKAEDNDPKKKILQERLEKSKEELEKNQKLL
DELKRLNEKLDQDEIQEKLEKFEQKSKNQTKTLAQLVELTKRYYVEKKAEQLADKLDKLS
EKEDKLADDKKENSEEKQNEVNKEFDKIEKELKDLDKENKELKSPLAIPHDKEKEESISK
DLQKASEELQKKQQDKASAKQKNAAKKMKEMSQKMTQEMEGGEKEQLEEDVAMLRQVLDN
LLAFSFSQEALIKNFKAITNTSNAFSKHLKTQQDLKQQFKHVDDSLFAMSLRQPKISEQI
TTEIGKVYYNIDKSIDLLSDNQIPRGTSSQQFSLTSANNLANYLSDVLNSMQMSLSGMGK
GKPKQGKGKGQGSGMQLPDIIQKQQDLGEKMKDGKSKKPGDKPGEGKAGKLGKDGKTGKG
SNGNSNGENGDDGEGEAKSVLEILKQQQQLREALQKELEKNGLGGMGQNALEQMKQVEKQ
LINKGFSNDAIQKALSLKYELLKLEKAIQEQNQDSKRQSIANKKSFNNTTNPLPQKLQEY
LNSIEILNRQTLPLRSNFNRKVQEYFKKND
>KACEBFPM_01284 Endoribonuclease YbeY
MISFNYEIDFEIQEETSYTNWVSSVILSENKSEGEINYIFCDDNYLLEINQQYLNHDTLT
DVISFDYSLGDEIHGDIYISIERVRENADDFKVPFEEELKRVMIHGVLHYCGYKDKSDAD
ELLMRSKEDEKLKLFHVKQN
>KACEBFPM_01285 tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG
MFLEEYDVIVVGAGHAGCEAAAASANLGCSTLLVTMSLQNIAQMSCNPAMGGIAKGQIVR
EIDALGGYSGIVSDNTAIQFKMLNKSKGPAMWSPRVQSDRMRFAEEWRLMLEGTPNLDFY
QEMVSGMVIENNKVLGIKTSLGLTIRGKSVVLTNGTFLNGLIHIGDKQFGGGRAGESAAY
GITEDLVKAGFESGRMKTGTPPRVDGRSLDYSKMNVEAGDINPSKFSYSDVTKPLVHQRD
CHMTYTSLLVHDILREGFERSPMFNGRIKSLGPRYCPSIEDKINRFADKDRHQLFVEPEG
WNTCEVYVNGFSTSLPEDIQFKALRSVVGFEKVKFFRAGYAIEYDYFPPTQLKHTLETKL
ISGLYFAGQINGTTGYEEAASQGLMAGINAALKVKEKEPLILKRDEAYIGVLIDDLITKG
TEEPYRMFTSRAEFRTLLRQDNADFRLTPMSNTLGLASDARLRRMEHKLNESEKMVAFFK
ETSITPTEANPVLIAKKTAEVNQTDKIFKILSRPQIDLSDVLKFENVANYVASNNVDQEI
LEQAEIQVKYSGYIDKERANAEKLTRLEDLKIPEKFDYHQIKSMSIEAKQKLSKIRPVTI
SQASRISGVSPSDISVLLVFLGR
>KACEBFPM_01286 Ubiquinone biosynthesis O-methyltransferase
MNFQTHSVFIKVKDNSISKESFELLIDEELQLLKTHPQPLLDILPKYYESEDYISHTDGK
RSLFEKMYQIVKSYSLNKKVSLINTLHLQKGSLLDIGAGTGDFLATAKKQGWQITGIEPN
EKAKIISISKGVSFAENLESISSHSFDVITMWHVLEHVPDLENQIKLLKRLLKPNGTIII
AVPNYKSFDAKYYGEFWAAYDVPRHLWHFSKTAIEKLFANENMKLIKILPMIFDSFYVSL
LSEKYKNGKMNFIKAFYIGLKSNMKAKRNLEYSSHIYVIKNS
>KACEBFPM_01287 hypothetical protein
MKKVVLLAAIVFSIISCDKKTEAKEYKTAYVDTQKMMEDYTELKELQDKYKTKGEVMGRE
LEVAAKRLKAEEAGFQQNAQIKGQAWAQQKAAEFQQREQQLQYAQQAMMQQLQGESGGKM
DTIVKSMKQIIKDYGKEKGYDYIYGTGAEATVLYAKDSYDITKEVVKLLNDKYAAKPKTE
EKAAEKK
>KACEBFPM_01288 ATP-dependent RecD-like DNA helicase
MENISAEANYTLQFINQTQRNIFLTGKAGTGKTTLLREIIQTTHKNCVVVAPTGIAALNA
GGVTIHSMFQLPFGGFIPDNTVPQFSEYIKFESKATLNRNFRMSGLKKSVIKNMELLIID
EVSMLRADLLDGIDFMLQSIRKKKIAFGGVQVLFIGDLLQLPPVIKDEEWKTLRNYYKGK
FFFHSHVIQQNPPLYIELSKIFRQTDEIFISILNNLRNNRISPQDIENLNQYVKPNFDLK
ANKGYITLTTHNAKADGMNAKALDDLEGKQYQYKPEITGDFPEKIYPIDQHLQLKIGAQV
MFVKNDLSLEKRYFNGKMGIIKSLSEAEILVHFPDEDVTIEVEKYEWQNIRYSVNNLTKE
IEEETLGTFVHYPIKLAWAITVHKSQGLTFDKAALDVSQVFQPGQAYVALSRLRSLEGLV
LLSPLQMNGISNDADVMDYAENKATQEKLEKSLQQETTKFLHNYLKSTFDWADLAQEWRN
HLYSYSEKDESATKSKHSLWAKKQTDIVTKIQEPARKFLSQLDKLFSAEPFDIHFIKERI
DAAYTYFFAQMDGIVYDILWKIEEVKRIKKAKMMFDELSVLEEVQIKAVFKLMKAKLLVK
TIASGDIISKENLTSNDIKSYKTNKIDAIHEEFKRLNITLIDDNLDVERYAKKKKEVKEV
KKSTVQETYELWQQKNTIKEIAALRKLTPQTIGGHLAKLIESGTIAITDVLPADKISALA
EAFFGYKEETLNPLKEKYGDEFTWDELKMYKSSLNAG
>KACEBFPM_01289 Ribosome-binding factor A
METNRQKKIGGVIQKDLVDILQGEIRKNGISNLVISVSKVSVTTDLGVARVYLSVFPQEK
APEILESIKSNMYLIKHDLSQRVRLQLRKVPNLAFYIDDSLDYIEKIDNALAGKENPIEN
RDLLEKRKKI
>KACEBFPM_01290 Lipoprotein-releasing system transmembrane protein LolE
MNFPFYIAKRYVFSRSSNNAINIISKIALGGIVIGAMVLFVFMSIFSGLKEFSLSFSNNF
DPDLKIIPKYGKSFLISEDQKRRIGANTDIAFCSKTIEEKVLFLYKNKEQVAYLKGVDSQ
YNLVNNVSKVMYEGQWLVPKTPQVVVGNMIAQKLSLGLFDLDNAFEIFVPKPGKGAISNP
ENAFNKSNLVPIGIYAVNDELDSKYVFADLELAQELLEFKPNQISGLEIKLSSKAKSETV
VDDLNVVFSNQVIIKNRAQQNDSLYKMLNTENTVLYLICTLVIVLILFTLAGAIIMMVLD
KKDNLRTLYNIGTPIADLRKIFLLQGTLLTVFGGFLGLFLGIIIVLIQQFYKVVMISESL
AYPVIFNLQNVAIVLVTIIVLGFIASFIASSRVSKKLLE
>KACEBFPM_01291 S-adenosylmethionine:tRNA ribosyltransferase-isomerase
MKLSHFQFNLPDELLAEYPAENRDESRLMVVNRAKGTIEHKMFKDVLDYFDEGDVLVLNN
TKVFPARLYGNKEKTGARIEVFLLRELNAEQRLWDVLVDPARKIRIGNKLYFGDDDSLVA
EVIDNTTSRGRTLRFLYDGSYEEFRNKLTELGETPIPKYISREVTPEDAERYQTIYAKEE
GAVAAPTAGLHFSKHLMKRLEIKGIQFAEVTLHVGLGTFNPVEVEDLSKHKMDSEELKIT
QEACDIVNAAKERKSRICAVGTTSMRAIESSVSSARTLNPYDGWTNKFIFPPHDFSLATC
MITNFHTPKSTLMMMISAFCGHDLMKEAYAEAIKEKYKFYSYGDAMLII
>KACEBFPM_01292 3-phosphoshikimate 1-carboxyvinyltransferase
MNLHLHSIIINQQSTIKISGSKSETNRLLLLQALYPNITLDNISSSDDSQVMIKALASKT
QEIDIHHAGTAMRFLTAYFAQKEGKEVILTGSSRMKERPIKILVEALQQLGAEIEYVENE
GFAPIKITGKKIVQHKISLLANVSSQYISALLLIAPKLENGLELTLVGEIASTPYIKMTL
ALLNDLGIETSFIDNKISVLPQFIIHNSQFTIESDWSSASYFYSIIALSEIGTQITLSSY
KQNSLQGDCVLAEIYKDFGVETVFNLNKTISITKINNCQLSTINYQLNNAPDIAQTIAVT
CFGLRVGCHLTGLHTLKIKETDRLEALKVELTKLGATISVTNNSLTLEGSSNIHSDIKIK
TYQDHRMAMAFAPLALRTSIIIEDAGVVSKSYPNFWNDLQSIGFRINEI
>KACEBFPM_01293 hypothetical protein
MNLKNAQLEVDNWIKNHGVRYFNELTNMAQLTEEVGEVARIIARRYGEQSEKESDKNKDL
GEELADVVFVVLCLANQTGIDLQAAFDKKLDLKTNRDHDRHHNNEKLK
>KACEBFPM_01294 hypothetical protein
MNNTMIEYNEGSHIYYVYIITNKYRSTYYIGVTNNLSIRLQQHKENIEKGIKTFASKYNI
EFLVYYEKFTWIQLAIAREKELKGWRREKKLDLIKSFNNNFEFLNDRFVKNNAIPPVSE
>KACEBFPM_01295 hypothetical protein
MEAVLVSAKEKNYGTFIHLSVLTKYFIPFGNYVLPIVLWASRKDSSKFTDYNGKQVINFQ
LSMLLYSVVLLVVSIPILLFSIFNTVSFNDFDKGNFIFEKLCAGNVSSIVIVALVAIGLF
CFMKIAEFFLIIYGAIKTNEGEYFKYPLVINFFK
>KACEBFPM_01296 hypothetical protein
MNIENTKAQMRKGVLEFCILSVLKDKEAYTSEILDTLKSAKLLVVEGTVYPLLTRLKNDN
LLSYRWEESTSGPPRKYYGLTGEGQIFLNELNSTWTELSDAVNIITIQK
>KACEBFPM_01297 hypothetical protein
MNKTVNMNLGGFFFHIDEDAYQKLNRYFDAIKKSLSSDGREEIMNDIESRVSELFSEKLT
GTKQVISLKEVDDVIAVMGQPEDYKIEDEAPRQPNYNYASSGSRKLYRDKENGIIGGVLA
GLGYYFGIDKVWLRLIMLVLLLSFGTGFLLYIILWIVMPEAVTTTEKLEMQGEPINISNI
EKKVKEEFENLSEKFKNADVNFKDGMDTVSEKVKIFSNDFSDKMKSNSSRVGSNLGDVII
SILGIFAKFLGALIVMVASISLLGFFVASIVMLFSSTMPDSFALNYISTPIGLETPLWIQ
GILFLLVFGIPFFFLLILGLKLLVTNLKSIGSIAKYSLLSLWIIALAILIVLGIKEATQL
AFDGKVVQKQSINISPTDTLFVKFKNNDFYSKDIDNHDDFRLMQDEHGKEIVYSNNVSIE
IMPTDEKLPYLQIEKLANGKTPDEAQKRAEKIIYNLKIEGNKLILDNYLLHNVKNRFRDQ
RVALFLYLPKGTYLKPDSSLRRYEETNGDYFSWNPESKNDVYKVEDNKVKCTNCPANENE
ESDYEQDDDTNIRTPNVTINEDGISIKNDTTISSAKDFKELKINKDGIIIKTK
>KACEBFPM_01298 hypothetical protein
MIKIITLLTKFVVGLLIAILFSSCKYDIKLGNKITGSGHVITRERSLAPFTKIEVSQGLD
CEVTQGDIQKVVIEADDNLQAGIITTVTNGVLQISSKYSNFNNVKAKKIKVQIPIILGLE
ATSASILVTKNNIKGNIIYLKTSSASNIIANVEAEKIILEATSGSDLNIEGKALEVTTAS
SSGSSIDASRLLANDISSQSTSGSTTIVNPILKLKAHASSGSTIQYSKTPKNLAVEENSG
GSVDKE
>KACEBFPM_01299 hypothetical protein
MKKINLLIFAVLFTTITFAQKKEKVKGSKIVTIEKIEVSAFTELEIEDNLEVFLVKGDKN
ALEIETDENLHTAINHQTYGNSLRLNTNKEISGFKKLEIRVTYTDSLKLISVKHEAKLNA
VSDIVLKGITIKTYDYSKTVISANTPNFTLLANDKSKVELNLKSEEAFIEMSKNAAIKAK
ISSNKLKFDLYQKSEAVVEGNTNEMKLRLDSNATYEGKMMTSKTLDLTTESNTKCSVYTN
GNLAITATGKSEISVFGEPKIELKKFADQSILYKKILK
>KACEBFPM_01300 hypothetical protein
MATIQQNIKTCGLVTELTKSQTENFKIIQKHWITFNEELKKHKLNQNDKNWTKYGITFKT
SEKYFYLTAIPTNNYLFPDHFTSLEIPKGEYEIFAHKGKMENIKDTIHEIYKVLLPKLDL
KIEDHTKTGFLHFEKYDYRFQWNKPTSIIDIYLPIKTYR
>KACEBFPM_01301 hypothetical protein
MPITANDPTRKSWLNITKDTDFPIQNIPFGVFLTKENIVTVGTRIGDYAIDLGALQQLNY
FSGIELTDDIFMQDTLNDFISDGKKTWRLVRNRIADIFDSNNPTLKDNKKHRDIVIFNVA
DVEMQLPVFIGDYTDFFSSKEHATNTGTMFRDPANALLPNWLHIPVGYHGRSSTIVPSGI
PVHRPNGQTLPNGETVPVFGPSKLVDFELETAFITTDANLMGENIPVNEAEDHIFGMVLL
NDWSARDIQKWEYVPLGPFLAKNFASSISPWIVTMDALEPFRCASPKQEPTPLPYLQQKG
DYAFDINLEVAIEPENAEAITISRTNLKYMYWTMSQQLAHHTSNGCRINSGDMMGSGTIS
GPTPDSYGSMLELTWGGKNPIKMNDGSERKFINDGDTVIMKGFCQNDQVRIGFGEVSSKL
LPANKMK
>KACEBFPM_01302 Serine hydroxymethyltransferase
MLRDQQIFDLIIEEQDRQIHGLELIASENFVSDQVMEAAGSVLTNKYAEGYPGKRYYGGC
EVVDVIEQIAIDRAKDLFGAEYANVQPHSGSQANTAVFAACLKPGDTILGFDLSHGGHLT
HGSPVNFSGKLYNPTFYGVEPETGMLNYDKIQEIATKEQPKLIIAGASAYSRDMDFERFR
KIADSVGAILMADISHPAGLIAKGLMNDPIPHCHIITTTTHKTLRGPRGGLIMMGKDFEN
PWGLKTPKGEIRMMSHVLDMSVFPGNQGGPLEHIIAAKAVAFGEALTDEFFRYAMQVQKN
AKAMAAAFVKRDYHIISGGTDNHMMLIDLRNKNISGKEAENALVKAEITVNKNMVPFDDK
SPFVTSGIRVGTPAITTRGLLEEDMETIVAFIDKVIMNHTNEEILEEVADAVNEMMGERA
IFVF
>KACEBFPM_01303 Negative regulator of genetic competence ClpC/MecB
MDDNFSPRVKDVITYSKEEALRLGHDFIGTEHLMLGMLRDGNGTAISILNNLSIDLNHLR
RKVETLSPANPNVIVSNNKKNLHLTRQAERALKTTFLEAKVFQATSISTAHLLLCILRNE
NDPTTKLLNKLQIDYDVAKEQYLNMTPTNNEEDYQDNFPKNESSYGDDSGQDDSIKADNF
SNPANKSNKKSKTPVLDNFGRDLTEMAEEGKLDPVVGREKEIERVSQILSRRKKNNPLLI
GEPGVGKSAIAEGLALRIIQKKVSRILFGKRVVTLDLASLVAGTKYRGQFEERMKAVMNE
LEKNNDIILFIDEIHTIVGAGGATGSLDASNMFKPALARGEIQCIGATTLDEYRQYIEKD
GALERRFQKVIVEPTSVEETITILHNIKDKYEDHHNVTYTDEAIEACVKLTDRYMSERFL
PDKAIDALDEAGSRVHITNIDVPKKILELERQLEEVRELKNSVVKRQKYEEAAKLRDDEK
KLEKDLAIAQEEWDDDAKNNKIIVSEDNVADVVSMMTGIPVNRIAQTESNKLAHLPELIQ
NKVIGQNEAVLKIARAIQRNRAGLKDPNKPIGSFIFLGQTGVGKTQLAKILAKELFDSED
ALVRIDMSEYMEKFAVSRLVGAPPGYVGYEEGGQLTEKVRRKPYCVVLLDEIEKAHPDVF
NMMLQVLDDGYMTDSLGRKIDFKNTIIIMTSNVGARQLKDFGQGVGFGTAAKVSQADDNS
KSIIENALKKTFAPEFLNRIDDVIVFNALEKEDINSIIEIELNKLYARVKELGYSLSLSD
KAKAYVAEKGFDRQFGARPLKRAIQKYVEDVLAEEIITSKIASGDEIFMDFEEGETELKV
SIRKKTEEPTS
>KACEBFPM_01304 ATP-dependent DNA helicase RecG
MNNLFETPIEYLKGVGPQRGDLLRKELGVYKYGDLINFYPNRYLDRTKYYKISELQNSSA
EVQIIGKVIHIKSVEFAKGKSRLVATFIDDTGQMELVWFQGQKWVKESLKLNVVYVIFGK
TTSFNNTFNMAHPEMELLSEHEQSIRLAMQPVYPSTEKLTNRGISNKVVNKMMQQLFSET
HTLFSETLPIYLIEELKLISKKEALINIHFPKNAEALAKAQFRLKFEELFFIQLQLITKN
LIRKHKIKGFPFDKVGNYFTEFFNNHLPFNLTNAQKRVLKEIRNDMGNPAQMNRLLQGDV
GSGKTIVAFMSMLLALDNGFQACLMAPTEILANQHFIGLLELSKPLNINIKILTGSSNTK
ARKIIHEELENGSLHILIGTHALLEDKVQFKNLGLAIIDEQHRFGVEQRSKLWKKNTIPP
HVLVMTATPIPRTLAMSLYGDLDISVIDELPPGRKPIKTVHRFDSNRLKVWHFIREEIEK
GRQIYIVYPLIQESEKMDFKDLMDGYESLSRDFPLPKYAISILHGKMKPADKEAEMKRFS
DGKTNIMVATTVIEVGVNVPNASVMIIESAERFGLSQLHQLRGRVGRGADQSYCILMTSH
KIGEDSKTRMETMVATNDGFEIAEVDLKLRGPGDIMGKQQSGVLNLQIADLVRDKDILLL
ARNYALKLLKDDAPMEKPEHQTLRKVFIEISKKKNIWNYIS
>KACEBFPM_01305 hypothetical protein
MKKKAIFNWSSGKDSALALYKTLQDTEIEIVSLLTSVNKKHNRISMHGVRTQLLVQQAKS
IGLPLHIMEIPEMPSMNDYEEVMQKTLKNFKEKGISHSIFGDIFLEDLRKYRENKLAEMQ
LEAIFPLWKIPTKALILEFLALGFKTIVVCVNERNLDKSFVGRVIDAQFIADLPDDVDLC
GENGEFHTFTFDGPIFKKPIEFEIGEIVYRKYEKPKQESSNTACDTSSSDAFDFGFWYCD
LIPK
>KACEBFPM_01306 Aminopeptidase N
MKYIILLFSVFSFAQQTQKVDFISMNGSVYPNAIQKSISGSIKYDFTVISSIDTIKIDAQ
RIEFSSVKINGNEVKFKNTVKELQLFEGFKIGKNILTFNYKATPKQTLYFIGQDENLQIW
TQGQGKYTSNWLPSFDDVNEKLIFNLSIDFRNDFEVLSNGKLVNTTTNNKGNIKTWNYSM
QKPMSSYLVMLAIGKFEKQVLQSKTRIPLAQYLKLEDKKKFEPTYKYSKEIFDFFETEIG
VKYPWQIYKQVPVNDFLYAGMENTSATIFSQDFVVDAIGFNDRNYININAHELAHQWFGN
MITAKSGKDHWLQEGFASYYALLAEKKIFGKDYFNYELLKMAKELKKASKTDTIPVLNAK
ASSLSFYKKGAWALHILREGIGEKNFKKALKNYLNNYKFKNVITDDFLAEIKKISNYDTA
NFKKNWLEKSGFNTTEAMAIISKNKFIKQYLDLQKNENISFAEKKNQFEAILKSDLFYPI
KEEVIYQLAATPFEEKKELLQIAMKTGDVNIRQAIAQTMPKIPLEFKPEYESLLDDKSYA
TREIALQNLWIQFPENRTILLEKGKIWEGNNDRNLRIIWLTLALGTKEYEPTKKTKFYNE
IVNYAGTNFDSSIRQNALEVLIKINPSDEIVLQSLANATTHHKWQFVKFAKETIRGMIKK
EGFRKLFEELLPKLIDKERLNLEKLLEE
>KACEBFPM_01307 hypothetical protein
MEALQLVPNNSLITATPEEGRQLAVKLSRLIIKATQPDASIREKLRPIYSEDATMLILIG
QTVATEFATIAAANNYWK
>KACEBFPM_01308 Putative lipoprotein LppC
MKNIFLSLSMLFCIYTNAQTFTLKSNDIGGQATNKQVFSGFGCTGGNTSPELSWSNAPVG
TKSFAVTMYDPDAPTGSGWWHWVVFDIPENEMQLKQNAGNLTLDLAPKGSVQSLTDFGKA
GYGGPCPPEGHGFHQYIITVYALKTKMLGLDKNANPALVGYYLNGNTIEKASIVAYYKR
>KACEBFPM_01309 Regulatory protein SoxS
MKEEIYSLPDDFFNGNITDINYYFYTTDQSTQNNKVQFNQNVLCFMQEGHKEVINRVTKT
YINNDSVFLLKAGNVLMTEKITIEKKYQSTLLFFSDNYLIRFLAKNLIILPKNPAENNII
YFLKDDYVLNYEKSLSLLKGSLSKNKNLLDAKIEEILLYLFQKNPILLSDFFRTILNQNK
DIPFLKIIQEQSDKHLTIDELSFLCNMSKSTFKRKFFELFHTTPKQYFIEQRMLKAASLL
QENNRPTEIYNDLGYENLSAFSTEFKKYFGVSPKNYNTKS
>KACEBFPM_01310 hypothetical protein
MKNTLFFLLFTNILTAQLTVPKEKFTHRDSLQGGFRAERTCFDVQRYDLNIKVNPTEKFI
IGYNDITFKVVENTNKIQIDLFENMQVDSIIFNHKKLNYKRDNLAVFITFNESLKTGNQE
KIRFYYSGNPTIAKRAPWDGGFVFTNDKQGKTWIGVACQGFGASCWYPVKDSQSDEPNLG
ATIKVAVPNGLMNVSNGRLLGSEDLKNGYTRWDWEVKNPINTYDITLNIGDYIHFGEKYK
GLDLDYYVLRENEEKARKQFEEVKPMMDCFQSKFGEYPFTTDGYKLVETPYLGMEHQSAV
AYGNHYNNGYLGKDLSRTGMGMLFDFIIIHESGHEWFGNSITARDIADMWIHEGFTCYTE
TVFLECQYGYEKSQIYINGLKDNVNNDQPIIGHYGVNKEGSGDMYYKGALMLNTIRSIIN
DDSKWWALLLKYSKTYRHQIIDTKTVIDFFNQEAGLNLTPVFNQYLRYVSIPRLEFRHSR
TKNQFEYAWKTNEPNFEMPIDLIFKNKKTRLIGTNKWQKVPFKMKNVLEIEVVKNKFYIT
TNL
>KACEBFPM_01311 hypothetical protein
MKTKFIKKITCVIIIVQSIISCSSIKKYNAHLNDLISEQDLKYDAHFIYKKLQNLHPKLY
WYINKETLDFKFDSLKATINKPMTSYDFYKKITPIICEVRQGHIFVIPLTKKYSKKETAS
MKKRGEGPLSQFDFEIFDGKLYVTKNKSNNKSISVGTQVVAIDGKNVSTLLDDYKNNFTS
DGFNTTLKNNFLGQRFSSLYYLNNDIKDSLQYNFKIKNELKSIIIKRQIVDSTEIKKIKT
VLTKEQKKAIAKKKDIFGFDTKSKKYMRNLKFIEKDSSIAVMKINGFREGDAETFYKESF
LKIKKFNTKTLIIDLRNNGGGRLNEIAKLYTYLTDKDFYFIEKSLVTKKTSLLYANYYKG
GGIGTKIIKTIFAPFYYPIMYFSVHKNGTNYYNYTNSKIKKPDTNNFKGKLYVLINGGSF
SASSIISSNLKGAKRALFVGEETGGAYNGTVAGRMPVLKMPHSKLNVRMGLMACVPIYKT
QVEGRGIFPDKEIIPTLDDRINNTDPEMNWILQDINTNKFDLSKN
>KACEBFPM_01312 putative propionyl-CoA carboxylase beta chain 5
MGSCVAGGAYLPIMSDEAMIVDKTGSIFLAGSYLVKAAIGETIDNETLGGATTHCEISGV
TDYKAKDDKDALNRIKSIVGKIGDFDKAGYNRVKSEKPALDPNDIYGIIPKSRADQYDMY
EIIKRIVDNSEFDEYKGDYGKTLITAYARIDGWAVGIVANQRKVVKNAKGEMQFGGAIYS
DSADKATRFIANCNQKKIPLVFVQDVTGFMVGSKSEHGGIIKDGAKMVNAVSNSVVPKFT
IIVGNSYGAGNYAMCGKAYDPRLIFAWPSAELAVMGGTQAAKVLAQIEASSLKAKGEVID
QAKEKELFDKIKARYDEQVSPYYAASRLWTDAIIDPLDTRKWISMGIEAANHAPIEKKFN
LGVIQV
>KACEBFPM_01313 hypothetical protein
MCKDRKKQRSASNAVILKILAEKYGVTEQYVRVCVKGFSESDKAAEIQADYKVVKEQITN
ISKQL
>KACEBFPM_01314 hypothetical protein
MIYFGKNLAFLRGKEKLTLDKMSEMVGFGRSQWNNYEKETSFPKFLDLIQISEYFKISET
DLIHKNLEIEGISIQEKHKVSFDINLELLMMQKEKIARLEIELQEAREANKDKS
>KACEBFPM_01315 Leucine--tRNA ligase
MKYNPNEIDAKWQKNWANNQTFAASNTSIKPKYYILDMFPYPSGAGLHVGHPLGYIASDI
VARFKRHKGFNVLHPQGYDSFGLPAEQYAIQTGQHPDKTTKENIARYREQLDKIGFSFDW
SREIRTSNANYYKHTQWIFIQLFNSWYNKSNDKAEDITTLISLFQKEGNTNINAVCDDNI
APFSAQDWTGFSSSKQQKILLQYRLTYLAETEVNWCPGLGTVLANDEIINGVSERGGHPV
IRKKMTQWSMRISAYAERLLQGLNDIDWSESIKESQRNWIGKSVGAMVSFKVKNQKSQVT
SEATLSDLRPSTLDYIEVFTTRPDTIFGVTFMTLAPEHPLVQEITTPEQKAAIEAYIEKT
AKRSERERMADVKTISGVFTGAYAEHPFTKEQIPVWIGDYVLAGYGTGAVMAVPCGDERD
YAFANFFKGQNGMPEIKNIFDNVDIATEAYGSKDNVIIANSDFLNGLNYKQATKKAIAEL
ETLNQGKGKTNYRLRDAVFSRQRYWGEPFPVYYVNGLPQMIDAKHLPIALPEVEKYLPTE
DGQPPLGNSAKWAWNTITNEVDFNENINNTTIYPLELNTMPGWAGSSWYWMRYMDPHNDN
EFASPEAIKYWESVDLYIGGSEHATGHLLYARFWNKFLKDKGYAPTEEPFKKLINQGMIL
GNSAFVYRVIPGIISKDKTVFIAKGNKLPPIFISKSYLGSLTQNDSKGLKYFVRDEKSEI
IFSHIEKLIENSTDYFELNQDNDFEVSFNLQNNLYTDVSFVNTSDELDINAFKNWREDYK
DAIFITEDNGKYIVGREVEKMSKSKYNVVNPDDICNEYGADTLRLYEMFLGPLEQSKPWN
TAGITGVFGFLKKLWRLYFDDNGLIVTNNEPSKESLKSLHKTIKKVTEDIENFSFNTSVS
QFMICVNELGTQNCHERAILEPLAIILSPYAPHIAEELWSQLGNSESISTVAFPICHEKY
LVESDKEYPVSFNGKMKFTINLPLDLTPAQIEEIIMKDERTIKQLDGNTPKKVIIIPGKV
INLVG
>KACEBFPM_01316 hypothetical protein
MLSHEGELMEQRLKRDKHPTKMFFSYANTVATIDFAKKFKGHGWVGIRYQIEADEAYNEI
LLHIRFKETDAKLQQETLGKLGVNLIYGAFYKHNDPKRLLRYLYDHIDYDQLEIDTVNFS
GPRFADVDNRLMSLQLVKNGMTDAVMFDPTGKNILPAATLYKKNILALRGSFRPVTKVNM
DMYEKSLQMFIDGNKVKKENTLVIFEITLSNLRSDGEIDERDFMDRAELLCSLGQTVMIS
NFQEYFKVVEYFSSYTKERMGLALGVNNLIDIFDEKYYRHLSGGILEAFGKLFYRDLKVF
LYPMEDEVGNIINSQNLKVHPRMKELYKFFAYNGKVTDITDFEKENLKIFSREVFKMIHN
GTPGWEKMLPDGIADIIKKDHLFGYDSNKTLIEA
>KACEBFPM_01317 Putative peroxiredoxin bcp
MTILKKGDKAPNFSALDQDGKLHKLSDYTGKKLVLFFYPKANTPGCTAEACDLSNNYDKF
VSNNYALLGVSADAAKTQLKFKEKFNFPFPLLADEDKAVIEAFGVWGPKKFMGKEYDGIH
RTTFVIDENGIIDAVITSVKTKEHTKQILD
>KACEBFPM_01318 Potassium-transporting ATPase potassium-binding subunit
MKERTTDKLGNFYNFFIKSCTRILLPLSVIVAVALLFSGTPMTFEGKDTITTLQGDTVEV
SRGPAAAFIAIKHIGTNGGGFFGANSAHPLENPTYFTNAVELWAQLIIPFAMIFALGFYL
KKRKFSYVIFGVMTVGFLLLVIPTVISELNGNPAIERMGITQATGAMEGKEVRFGPAVTG
FWSIATTVISTGSVNSMHDSSMPVSGSMELLAMMINAFYGGCGVGILNFYIFIILAVFIS
GLMVGRTPEFLGKKIEAREVKIAAFIAILHPLLILSGTALASYFAANDTAMGYWFSGNAT
GWLNNPGHHGFSEMLYEYTSSAANNGSGFEGLADNNPFWNITTGIVLLLSRFLPIIGPLA
IAGLLANKKYIPESAGTLKTDTTIFGVMVFAVIAIIAALSFFPALALGPLAEYFTLK
>KACEBFPM_01319 Beta-barrel assembly-enhancing protease
MNKVKFLSITLVAFSLSSYAQEVELAKKAIDGEQYEKAKSILKTAIQTKPDNGKIAFLLG
SVYLQQSQQDSAKIFFQKGLAAKEFASFNYIGLGQLDLNSGNVEAAQFNFDQATKDIKKK
DIEQFIYIGKAFTNAEKPDFKKAIANLTRAKAINPNDAQTQMALGDAYYGDRNQNDAYAA
YSNAFVADPTLIRAKMQLGVLLKGAKAFAEAKSALDGVVAIDSNYGPVYRELAETYYQWG
TNDKTKYKEYTAKGLEYYEKYMTLTDYSLVSRFRHAEFLILAKDYKALEKEAEEMKKLDK
VNPRIFRYLGYALYENGNADGAIKALTDYTSNPTNKIIGRDYLYLGLAQLRNATPAPVAP
ETKSVINEALFQTAVANFRKAVDLDKPMANDLNEIGKKYFEQKQYKHAAAIYEVATSNPN
SKNYLYDNFYLGYALYFDNSDKESSKIDIVALKKADKAFDNVSIASPTTQDAYIYRARVN
SLMQNDVVAKEQMAKSYEDYIRVVNEKGAIELDKPANKTKFVEAYQNLALHNKKDKIKAT
EYIAKALVLEPTNSDSLNIQKGLK
>KACEBFPM_01320 hypothetical protein
MRKTNLLVLISFLFIVVFSCDKKGKKQEETILRGEATILVDETLLPIIDDQKQVFENQYN
ATITLVAKSESEIVQILSKNKQQLAVLSRELTENEAEIFKIKKITPRITPLATDAIAFIS
FKSNKDTLIDLEKVIAFVQGKDQSNFKGLVFDNPNSSTVRYIKELAKINDLPKQKIFSFQ
TNNEVIEFVAKNEGMIGIVGVNWLLQPSTKMKEKVGAVKVLSVKSLKTKSFVKPSQDNIA
TGFYPLTREIKMLNYQPFSGLGMGFASFVSGEIGQRIILKSGLVPAKIPNRNLIIRKEIT
KK
>KACEBFPM_01321 hypothetical protein
MHNKSINNTKKKSLKERFLLVIGILFFCLYLSFGLAVIFWKGLPLSMSNGYRIVLGIIVI
VYAFLRFIRFFQKSES
>KACEBFPM_01322 hypothetical protein
MKLDIFKSQWLDLVFEGRNKKYGAYELRKENPKTSVKALFGGAFVFAFAIGLPMLLDMIP
ASETKSTLDEKVVLVNIEKPKVDPLKPPPPPPEPPKPKIDEVKFVAPKVVAKERVVEEIK
TIDELKDKNIAAKDQKGDKDAKIVIDQPTGDGEKDAEIVDNTIYNSAGIEVQPGYPGGMD
KFGGFIKKNFNTDDIASKLSSDLNGKVIVKFVVEKDGSLTDIEVIRDLGYGTKEEAIRVL
RKGPKWTPGIQNGKPVRTNCILPINLSITAGE
>KACEBFPM_01323 hypothetical protein
MAELNTGDGGGKGDKKVRSKKGNSRVDLTAMVDLAFLLITFFMLTTSLNKPQSMDLGMPD
KQKDNEPVENVLVADNRSLTILLGENDKVKWYLGQFVTPLAGPEQVTYGKEGIRKELLAR
VKSVIAETGDPKKGLIVIIKPSKKSTYRNLVDILDEMAICKVKTYAIVDITKEEVSLLDK
>KACEBFPM_01324 hypothetical protein
MAKAKSQKKAAAIDMTAMCDVAFLLLTFFILTATAKQPEPLPVDTPSSTVQTKLPEKDLA
MLTVGNGKVFFGVTGKEVRKRTLELMGTKYGMTFTPDEMNRFSQMDGFGVPMAQLKSLIA
KSSAERNQKNLQSGIPKDSLDNQLKEWIFNARTATAEIAGAQLKVAIKGDAKQEYPQIKK
VMDILQDQQINSFNLVTGLRGDDF
>KACEBFPM_01325 Biopolymer transport protein ExbB
MANVKKESSSNGGDVFSGIVIVSCIVVGWLTWKFVMGSGANFAGGISGGTPLPGNYRAMV
YNGGPIVPVLMGLLLMVVVFGIERFMVISKAAGKGNLDAFMKKVQASVTSGDIDGAIDAC
DKQKGSVANTIKAGLVKYQAVKAEGFSSEDATETIHKEIEEVTSLEMPMLEKNLTIISTL
VSLGTLAGLLGTVTGMIKAFAGLAGGGGADSAELANGISEALINTATGISTSALAIIVYN
FFTSKIDTLTYSIDEAANTIVNTYRRFKGSVK
>KACEBFPM_01326 Citrate synthase 1
MSNTATIEIDGKKYEFPTITGSENEVAIDISKLRDLTGAITMDPGYKNSGVCKSEITFLD
GEEGILRYRGYSIEDLADKADFLEVSYLVIFGELPTKAELERFENNIRKYTLVNEEMKNI
IDGFPKTAHPMGVLSSLTSALTAFNPKVVNVENEKEMYEAVCKTMGKFLVLATWTFRKSM
GYPLNYYDNTIGYVENFMQLMFRLPTSPYAANPVIVAALDKLFILHADHEQNCSTSTVRM
VGSSHAGLFASISAGVSALWGPLHGGANQAVLEMLEEIQKNGGDAEKYLAKAKDKNDEFR
LMGFGHRVYKNFDPRAKIIKKAADEVLRTLGVDDPILQIAKKLEESALVDEYFVSRKLYP
NVDFYSGIIYRALGIPTDMFTVLFAIGRLPGWIAQWKEMRENKEPIGRPRQVYTGHPLRD
FVAVEKR
>KACEBFPM_01327 Arginine deiminase
MLQLNVKNESSRLRAVVLGSAVNNGPTPTAHEAYDPKSLEHILAGTYPVEEDMTNEMEAF
NKVFQKYDVKVYRPETISNYNQIFTRDIGFVIDDVFIKANILPDRERELDAIQYVIDQIN
PAKVVRPPEEVHIEGGDVMLHNEYIFIGTYKGSDYKDYITARTNMEGVNYIKKLFPNKIV
KEFDLVKSKIEAHDNALHLDCCFQPVGNGKGIIYKSGFREEADYMFLVNLFGKENLFHIT
RDEMYNMNSNVFSIAPDVVVSEKNFTRLNTWLRDNGFTVEEIPYAEIAKQEGLLRCSTLP
LIRD
>KACEBFPM_01328 hypothetical protein
MKTYKDLDVYNLGLDLFYKCHSYLLKLPKHEMYKLGSQLRRSSDSVPTDIVEGYERKRYK
ADLIKFLAYS
>KACEBFPM_01329 Carbonic anhydrase 2
MIIHSDMNMLSVLDYAVNVLKVKHVIVCGHYGCGGVKAAMTNESYGIIDNWIRHIKDVYR
LNKKELNDIHDEGKRFNKFVEINVKEQVSDLAKTSIVQSAWKSGQELTLHGWVYGLNSGY
VTDLEVNYSSNQDLPEVYQLNI
>KACEBFPM_01330 putative membrane protein
MNNFDWKQLFNPEFYILLEFNGIKIGLIVVLFIVFAETGLLAGFFLPGDSLLFLSGIYSK
TLTQQISVGNDFLNVTFLASLVAIMGIIGNMFGYWFGAKSGTYLYNRKDNFLFKKKYLLD
AKAFFDKYGSKAIVFARFMPIVRTFTPVIAGIVGMNKKSFMFFNILGSILWAFGMIFSGH
YLYQIFLEEFHINLKHYIEYIVILIIVITTFPVLFKLLKKSVHLDDGDND
>KACEBFPM_01331 IMPACT family member YigZ
MEIQDTYFTINKPATEVLFKEKNSKFFGYTFPITSEEDVKRHIENLKKQHFSARHWCYAY
QIGTDKIQYRANDDGEPNNSAGMPIYGQIQSYNVTNILVVVVRYFGGIKLGVGGLITAYK
TTAQMALDESEIIEKTINIHFVVGFDYKNMNKVMRVIKEKNITIVSQKMEESCQIEIASR
KKNASSIFDVFDQIFEVEIKKVND
>KACEBFPM_01332 D-ribitol-5-phosphate phosphatase
MINTIIFDFGDVFINIDSKASLNALKKLGLNSWNDELEKLNQEFERGKINEAQFMIELKK
IIPNASIDDLKTAWNLVLLDFPLQRLEFLQQLSMLNYKLFLLSNTNETHIEKFEHMLGAT
FTREFYQCFEKVYFSFEIGVCKPDPQAFDYIIRKHNLLAKNTLFIDDKKENTDIAAALGM
QIWNIIPEKEDITQLFDKKFIVNKSHLTNS
>KACEBFPM_01333 hypothetical protein
MGQTWAVLGTQGPNWYNSNRTPATSGTDCDNCPGAQWLGTNTTLTDYFYPLNSLIGQSNV
IFRIVFHSDSGTPALGVVVDNFIIDGTLSNEDFQLKNIAIYPNPSTGLFTISTGNKAIDK
VEVYDVTGKIVLSKNNFSNENSQTILDMKNVSNGIYFIKISSENQNVVKRIIKN
>KACEBFPM_01334 Cyclic AMP receptor protein
MNKNLKKLFPSFSNALIEDINANAIDQSFVVGDVVMRTGQYIKNTILVLSGSIKIYREDA
DGGEFFMYYLQPGQACAISMICATKNEQSQIMAKVVEDTELVMVPLTLMNKWMMEHRSWY
EFVIDTYRSRFEEVLEVVNSIAFKAMDERLEFYLKRHKDTCGCLNLKLSHQEIATDLNTS
REVISRLLKKLEQRGVLKLQRNHIEFLK
>KACEBFPM_01335 HTH-type transcriptional repressor NicS
MQISEKQQAIIEASGKILTSFGTSGFTIKKLASAMQFSESAIYRHFKSKEEIIITMLTFL
AENIDQRLSQNYISNQNSQTKFVQLFQNQFIFFKANPHFLVALFSDGLWEESTKINEAIL
NLMRIKIKHLKPIIIEGQNKGLFKNTISADDITHIAMGTFRLQMYKWRIANFKFDIETQG
NKTIQSLLTIIK
>KACEBFPM_01336 Macrolide export protein MacA
MKEKKYFRNKNSTKILNKISPVIALLSLFACGKKTEQTKVERKNITEMIFASGTLKADKE
YNLMSQTEGYITKINFNEGDEVQTGTILAIINNPQSATNTNSSSKLLKIAKNNSTYKAPL
LLQTKANLEVAKAKLQQDELQEARYKRLIEANATSKLEYENKIIATKTSKATLLSLAQQY
QNLLIQANEQVIILNQQLENSQTIQDFNQVKALANGKIYKQKKQVGDYVRKGDIIAILAN
NKKIYANLNIDETNIAKIKLNQEIIIKLNVNALKRYKAKVSEILPTFDEQSQSFIVKAIF
TKPIDFAISGTQLEANILVSQCKNTLVIPRSYLGYGNKVLNTNKKQINVQTGIISSNYVQ
ILQGLKENQTILKELD
>KACEBFPM_01337 Lipoprotein-releasing system transmembrane protein LolE
MAKNYNHNINAQIAYTHLFSKKKQTLVAAFGVTIGIAIFIFMNSLMHGFEVYSIESLFKS
TPHLRIYKEEKISQPLVADSANNLAILANPKITKENKRLINPNLIIETLKKQPGVIGVTP
NVSANVFYNNGEAQVIGRTSGVNIEEQNTMFHLENYIVEGKYSDLKSNQNGIIIGVSIAQ
KLNVRLNDNISVATAYGVSKVMKVVALLRTGVSNTDKTLSYTNISAAQQLNKQGANYITD
IFVNIKDFETAKKVLPEFKQLSGYEVEDWETANASASASNKIRKMMAMAISLSIMLVAGF
GIYNILNMTIIEKLNDIAILKAIGFSGKDVIKIFVKEAMIIGIIGIAFGLILALILVKLM
GNMWVGGDIGFFPIRFFPTFFASGIGLGLLITTLSGYIPARKAAKLDPITIFRK
>KACEBFPM_01338 Lipoprotein-releasing system ATP-binding protein LolD
MIQKELLLQAKNVSKYFYEPEKFKVLNNISFDIHKGEFVTMVGKSGSGKSTLLYLLSTMD
TDYEGNIFFDSENLTHKTKEELAAIRNEKIGFVFQFHYLLPEFSSLKNVMIPALKLGKYS
KPEIEERAYSILTKLDLKDQALKPANKLSGGQQQRVAIARALINDPKIIMGDEPTGNLDS
KNAAIVFDLFKQLTTQFDQTVLAVTHDNDFAKASDRIIEMADGIIL
>KACEBFPM_01339 Cbb3-type cytochrome c oxidase subunit CcoN1
MKLKNKNLISKPQKKFTLLGLMAFFYPLIASAQTDNGVSFFPNKSIGFIEILTIFVMIIV
GFVLFLVLKIITKANDNLEDTNLGNDKKFKKYLVNLNSWQIEVLKKKRNQINKIISILIL
GFISLAPQFTFAQTAPAKREGIFSQPGVLITLVLIFIPLFLALLYLATKVYKGFNDYFYF
QKTKEAEDFAAYISLADNIPTNAKLERIRKKMNYSITSNELSGNKKANDAKGLLKNISSE
TNYRFFASKRPAIKRPKIDPELTKLVLWFLGTAVFWLLIGSSIGEYVGIKFIAPDADTYS
WLSIGRLRAVHTNLVFWAWSTIGIMGLGYYIVPMVSNTPLNNIKNGWKALIAVNLAMFVG
AITLMAGINNAGGEYREIIWPIMAVWAYGLLLTVTNFIKTIAKRTTHEIYISNWFIIASY
IFILIVAFLSYIPMGQDGIGETIVQGYYMHQAVGMWFMFSMLGILYYILPQQVNKPIYSY
SLGVLAFWSQILFYTTIGTHHFVFSSLPWWLQTVAIIGSVGMLIPVTSGTINYLMTFKGS
WSKVSNSYSLPFLLVGVVYYFTGSFQGTAEAFRSTNLIWHFTDFTIAHSHITMYGIITFL
LFGSIYAIVPRLTGQEPPQLGVGAHFWLALIGLQFYTIPLMIGGTLKGLMWAEGKPFIDS
VVMMGPYWLWRAIGGSLMWLSHIVLVYNMYKMIKPNNEIDVKEKAFEIINQNLELNSVES
KQ
>KACEBFPM_01340 Alcohol dehydrogenase cytochrome c subunit
MNIFNDHKKLYLIATLFFGTLTLFVAVFPSVHNEMISQPLYGSIPLTAEQEAGRQIYISN
GCVSCHTQQVRDVDMDKIWGDRPNVASDYALSTRKSIWQSAGTLMGTERTGPDLSNIGVR
QPSQDWHLVHLYNPRIVMPQSIMAPFPWLFEIKDKATKDDIKVNVPEEFMHGQKGIVVAT
KDALNLVAYLQSLKQVKLPDGMPSPEFLYKKAKTQANTAPSDTKTELNGSDLYAANCMAC
HQQNGEGLNGAFPALKASKIVLDDNPEIMVGIIMNGYNPREEYGVMPPVGINANLSAQEI
AAIMNHEKSSWGNNAKKVSPEQVQKLMDLAKLSAPKQ
>KACEBFPM_01341 hypothetical protein
MEKKLYAILLATISITTYACPMCEKQQPKVLRGITHGAGPESNLDYVIVWTMVITVLITL
FFALKYLIKPKENQTNHIKRTIINFE
>KACEBFPM_01342 hypothetical protein
MDSKSKVIIFVDNEIQPIGKFEAPVNFELDTHKLPDGLHQLKIVSKDPTGKEGIKIIPFI
VRNGPAITIEGLNDNDVVDGVLPLMINAYGKGNQKQFLINGSETPKSVPSWLFAAIIAFV
AWAIYFTITSLG
>KACEBFPM_01343 HTH-type transcriptional activator RhaR
MCDIKNIKCSEVTQNELKFAVYHTSDFLPFMQKLNIPHRHNYFMILLNENNFGSQLIDFK
EFDIEPLSVTCLHYGQIHQWLNFDKIEGYILVFESDFFALRYQNYQLSEFSFLTCRHKQP
YVKVSEEKFQHLKSIVLWMLKEWNDNQTDFEKSLRSLLNLMLLDLNRLFEPMPKNKEFSQ
SLQLICHFEELIDKHYKQKHFVKDYASVMYVRPNYLNAVCNEITNISAGELIRNRILLEA
KRLLIHEQKTVSEIAYELGFEDNSYFGRFFKKYENITPDGFKRKFINASKFFQI
>KACEBFPM_01344 hypothetical protein
MLLFLKNLLSFKCPRCHKGELFVNKWYNFSKSNKMVERCAVCSQRTELEPGFYQGTGYVS
YALTVGFSIVTFIIWILITGYTFKNKELFWWLPINITALLFMQPWLMRLSRVIWLTAFYG
GDDQYHKNNTKIK
>KACEBFPM_01345 putative peroxiredoxin
MEDKVFLMPRIGDMAPDFDALTTTGMLKFSEYNKGSWVVFFSHPADFTPVCTTEMSGFAK
EKEFFTKNNTKLMGLSIDSIHAHIAWVNAVNEKTGILFDFPIVADISMEVSKLYGMLQPG
ESQTAAVRAVFIIDPEGKVRLMMYYPLNIGRNMAEIKRALLALQTSDEYKVAMPLDWQPG
DKVIVPAPKTIEALAERKSSDLEMVDWYLAKKSI
>KACEBFPM_01346 hypothetical protein
MQPKLPIQCPSCESSLLVTQLSCSNCTTLVSGHYPLPILLQISEEEQNFILQFFLTSGSL
KEMASQMGNSYPTVRNKLDDIIQKINNLKTKS
>KACEBFPM_01347 hypothetical protein
MKILFLNPFKKYSDTILLLFGITFTVLGSLLAYNFNAKFDGVIDLHFDSQVNFFESATYQ
FLAILILTASLYWVGKYINKKTRLVDVLITVLISRIPLYFCTLFNINNKSYSIGNKILEL
AVSKKINTLNTNDIGFILFQSIILIIALIWFISLLYNGFKIATNSKETKHTLLFILAIII
AEITSKIIIYKLL
>KACEBFPM_01348 hypothetical protein
MVKIITTENEFIFEVKGLHKIWSLKSNIKIAKKNIVKVYQNKEELKGFKGIKFGTFIPFL
ITAGTYYYKGKRNFWDVCNKQNAIIVELKDSSYNKLIIEVENPIETMNLLNNTI
>KACEBFPM_01349 hypothetical protein
MKKIIYTLAFASVLLSCKTGQTSATTISPEVNVSIDLNTIQDDKVMVTLLPTPTNLDIVT
FSIPKTVPGTYSTDNYGKYIENVKAFDAKGNELAIAKIDENSWKITNAKKLQKVTYWVND
TFDTETGKGDFGGGDIFSPAGTNISPENFMLNTHGFIGYFSDKLEVPYTTTILHSANLFG
ATSMTDTDLSATQDVFKSFRYADLVEHPIMYAKPDYTTFKVDDMEILISVYSPNGTYKVA
DIAPAMETMMRAQKKFLGAINSTKKYAVLLYLSDMKKPDAKGFGALEHPTSTTVVMPEMI
PKKEMAEQLKDVVSHEFFHIVTPLGVHSKEIQYFDFNAPKMSKHLWMYEGVTEYFANLFQ
VNQGLISEDEFYNRMSDKIRQAAKMNDTMPFTTMSANVLNKPYKDQYLNVYQKGALIGMC
LDIIIRENSHGERGILDLMQKLTNEYGATKPFNDNELFDKIVSLTYPEVKNFLETYVSGP
TPIPYDKYFAKVGVTQSKRKIPGNVFLKDQKPYITINPNTKEIMVLPTIELPSFYANLGI
KNGDIIKTVNGTNYNLDNIYDLITESQKWEENTPITIKIKRDTKETELKGIVKLPYDEAE
GLQATDASKKTIKNAWLKG
>KACEBFPM_01350 hypothetical protein
MMNKIIIALLSITMLTSCGDEKKSENTLEITGNIKGLKKGKLYIQRVQDSTLVVLDSIII
NGKSSFASTIKLDSPEMLYLYLDRGVSNSIDNNLLFFAEPGKMNIDTDLEFFLAKAKITG
SKNQELYEQYKDIVSKFNDQQLGYIKDELLALKAKKDISKENTKKQEILLKRRYLYAGNF
ALTNANHEVAPYIALTDIYDINIKYLDTIAKSMSPKVAKSKYGKKLNEYLAQRKKQE
>KACEBFPM_01351 Succinate--CoA ligase [ADP-forming] subunit beta
MNIHEYQGKEILASYGVRIQRGIVANNPVEAVAAAKQLTTETGTSWYVVKAQVHAGGRGK
GGGVKLAKNLQQVEEISEQIIGMQLITPQTSAEGKKVHKVLIAEDVYYPGESETSEFYIS
VLLNRSTGRNMIVYSTEGGMDIEEVAAHTPHLIHNEEIDPSVGLQAFQARRIAFNLGLSG
NAFKEMVKFIDSLYNAYIGSDASMFEINPVLKTSDDKIMAVDAKVNIDDNALYRQPKYAD
MRDIREENPIEVEAKEVGLNYVDLDGTVGCMVNGAGLAMATMDLIKYAGFEPANFLDVGG
TADAKRVETAFRIILKDENVKAILINIFGGIVRCDRVAQGVVDAYKNMGDAIKVPIIVRL
QGTNAEIAKELIDNSGMPILSAVQFQEAADQVKAALSK
>KACEBFPM_01352 hypothetical protein
MKKLILLFVVVIMNVTFVAAKEVNPVDDYPKALKEITKLLGPLNIEGEFEKTVRIKFTAM
VNSDNELIVLQVGTENIIFKKHIVEQLNYKKIAREIMTPGKEYTFIVKFRPE
>KACEBFPM_01353 hypothetical protein
MTNNDIFKKLRVALMLRDDQIVEILELVDFRITKSEIGAFFRDEKHENYVECGDQILRNF
LNGLVIHLRGTKENPKNPNDVLAKHRSEIPKKTSDKPKTEFKPKTDFKKKPASNNKKVEP
KVQVVEKVRFNNGKAKK
>KACEBFPM_01354 Pyridoxine/pyridoxamine 5'-phosphate oxidase
MKDLSNYRKSYEKSELLETNIPEDPITLFKKWFHEVEDFGGIEEVNAMTVSTIGLDGFPK
ARVVLLKQFTYEGFIFYTNYDSEKGRAIANNPNICLSFFWHSLERQIIIKGKVKKIAENL
SDGYFESRPNGSKLGAIVSNQSEVIASRIILEEKLKQLEDNCVGKEILRPKNWGGYIVEP
QEVEFWQGRPNRLHDRIRYKLSADFYWKIERLAP
>KACEBFPM_01355 Ribonuclease Z
MNLTILGCYAATPRTFTNPTSQVLEIRNRLFLIDCGEGTQVQLRKNKIKFSAINHIFISH
LHGDHFYGLIGLISTFNLLNRNNNLTVYGPKGIQEIIKLQLKLSNSWPQYELHFVELTST
KSEIIFEDDKVIVKTIPLKHRVYTNGFLFQEKIKERKLNANAVQNYKIETCYFQNIKNGK
DITLEDGRIIPNSELTFDPETPKSYAFCSDTIYNESIIPVIKNVDVLYHETTFLESEAEL
AKKTMHSTAKEAARIALQANCKQLILGHYSTRYESIKLFKEEAQTIFLNTLLGDDGKFFK
L
>KACEBFPM_01356 Proline dehydrogenase
MDKIFDNTQNAFSLKSDNELDRAYFLFKMIAVKPLVRIGTAVTNFALNANLPVQGLIRAT
VFDHFCGGISEDDCIPVVDKMFTKGVSSVLDYSVEGKEDEAHFDDAMNMTLKIIDFAKEK
KAIPFAVFKPTGFGRFELYEKLGEKQTLTNAEQEEWARVEARFEKVCKKAFENNISLLID
GEESWMQDAADELVARMMQKYNKEKPIVYNTLQMYRWDRLDYLKKLHEQAKTEGFYIGMK
LVRGAYMEKENKRAEEKGYKSPICESKQATDDNFNAAVSYMINNIDKMAVFAGTHNELSS
YTLMQKMQEKGIPKNDERLWFGQLYGMSDNISYNLANEGYHVAKYLPFGPVKDVMPYLIR
RAEENTSVAGQTSRELLLIKTERNRRKGKN
>KACEBFPM_01357 3-dehydroquinate synthase
MVSIVSNGYSIHFSQDGYDFLNRNIKDHNYSKIFILVDNNSNEYCLPQLLPMIEAQSEIE
IIELESGEENKTIETCVQIWNVLIELGADRKSLIINLGGGVITDMGGFIASTFKRGIAFI
NIPTTLLSMVDASIGGKNGVDLGGLKNQIGTITNPEMVIIDSSFLESLPQNQMRSGLAEM
LKHGLIAKKSHWEKFKNLKEINFDDFDDLIFESITIKSDIVTQDPTENGIRKALNFGHTL
GHAIETYFLENPDKTNLLHGEAIAAGMILESYISLQQKLISETEYTQIKTTLNNIFDKII
ITKKEQEDIIKLLIHDKKNEYGKVQFALLYGIGNIRTNQTTDNETIIEAFLNYKN
>KACEBFPM_01358 hypothetical protein
MINFTTLGEENYNYSNEINIFPNPSDGIFNISKKTEVNIDTIRVFDINAKLIRTISLKNN
HFTNAINLEDLTSGKYFLELSNDSEKTVKTVIIN
>KACEBFPM_01359 Iron-regulated protein A
MKFFLRITLTMAGIVLLSCNNDKEEAVVAPVKNVTKKEVIENYANIAYENYKKAYDDAVI
LKSAITTFTTTPTQVNFDNAKNKWKVARESYGTTEAFRFANGPIDNTTGPESFLNSWPLD
ENFIDYVNGAPNAGIVNNEALFPIITKSVLKEQNELGGEKNISVGYHAIEFLLWGQDLTA
PSVNKPGQRPYTDYIIAGGTAANQARRTAYLVACSDLLTDNLLEVVNQWKVGGAYRTTFL
GLPENEALKNMYLGITTLISAELPVERMEVALGNADQEDEHSCFSDNTHRDIILNLQGVI
NVYQGKYGSIDGASLEDLVSQANVQANTETNASIALSLTKANALFNPFDLAISGGATSVE
GAKVKLAAMQFKDLGSNLLNGATKIGIIVN
>KACEBFPM_01360 hypothetical protein
MKHIIKILVFIFFVQFISCNTDNDSKYQEVPALLLPENGEEYSGGQATVFNSSEEAFGFF
ARNLTQEEQTDFGMGNSFFRQSWVSAPASTTARDGLGPFFNAVSCSSCHFKDGRGRPPAF
DGELGRGLLLRLSLAGNHPNGSSFSDPIYGGQLQDNAVLGQTVKGKYTITYQLISETLAD
GTVIQLRKPIYQINNLGYGALAGGVLVSPRIANQMIGLGLLEAVPESTILGFIATNNSNE
ISGKANYVYDVESNSQKLGRFGWKANQPTIRQQAAGAFSGDMGITTSIFPNENAPPSVNL
NTIPNGGSPEISDDNLAKVVLYSSSLAVPARRNYTEQNVLKGKKIFQEINCTACHVPKIQ
TSTNYPILAFRNQTIRPYTDLLLHDMGEELSDNASDFLANGNEWRTQPLWGIGLINTVNG
HTNLLHDGRARNITEAILWHGGEAQTAKLKFKQLTTIDRNNLLEFINSL
>KACEBFPM_01361 Signal recognition particle protein
MFNSLSEKLDKAFHILKGHGKITEVNVADTLKEVRRALLDADVNFKIAKDFTAKVKEKAI
GADVLTTLQPGQLLVKIVKDELTELMGGDVAGINLSGTPTVILMSGLQGSGKTTFSGKLA
NFLKTKKNKKPLLVACDIYRPAAINQLHVVGGQIGVEVYSEPENKNPVEIAQNAIKHAKA
NGFNVVIVDTAGRLAVDEEMMAEISRVHKAIQPQETLFVVDAMTGQDAVNTAKAFNDILN
FDGVILTKLDGDTRGGAAISIKSVVNKPIKFVGTGEKMDAIDVFYPERMAERILGMGDVV
SLVERAQEQYDEEEARKIQRKIAKNEFGFDDFLSQIQQVKKMGNMKDLVGMIPGAGKALK
DVEIQDDAFKHIEAIIYSMTPTERSKPAIIDVKRKARIAKGAGRKLEEVNQLMKQFDQMS
KMMKIMQGPGGKNMMKMMGGMKGGMPGMK
>KACEBFPM_01362 Bifunctional protein FolD protein
MILLDGKKTAQDIKNEITAEVNKMKANGEKVPHLAALIVGSDGASLTYVGSKVKACELVG
FESTLVKMPSTTSETELLKKIKELNQNDDIDGFIVQLPLPEQIDTQKVLMTIDPSKDVDG
FHPENFGKMALDMTTFIPATPFGILELLERYGVETKGKHTVVIGRSHIVGRPMSILMGRK
GFPGNSTVTLTHSYTKNIAQITTQADIIISALGVPNYLKAEMVKDGAVIIDVGITRVPDE
TNEKGYVITGDVDFENVSKKASHITPVPGGVGPMTIAMLLKNTLLAREQRKVNN
>KACEBFPM_01363 Acetyltransferase
MKISVATKSKLEIIKKLAYKIWPSTYGTILPEVQLKFMLDKFYNLDYLTNLLIHENQVFL
LIEENNEYLGFCSYELNYQSSNKTKLHKIYILPETQGKGIGKFALAAVEKIALENKNTIL
LLNVNRGNKAQEFYKKQGYLIVKTIDIEIENGYLMEDFVMEKEL
>KACEBFPM_01364 Tetraacyldisaccharide 4'-kinase
MNFLRKTLFPFAILYGFITSIRNFLFDCGILKSHAFPIPVIAVGNLSVGGTGKTPQIEYL
IRLLSNKYQIATLSRGYKRKSEGFILANPTSNAEILGDEPFQFYKKFPNIQVAVAANRKN
GIERLLSLPNKPEIILLDDAFQHRKVKAGFYILLTAYNDLFINDFMLPTGNLRESRSGAK
RANMIIVTKCPKDISELAQNKIKEALINYNNKKAEVFFTFIDYDDKIYSANKALNVNEVK
TASKLLLAGIAKPESFFAHLQSQNDECLVYPDHHHFLEKNITDIKEKAKNKIIITTEKDF
VRLSEKLNSDNLFYLPIKSLFVNNEKKFDKKIINYVESSTTNG
>KACEBFPM_01365 Purine nucleoside phosphorylase 1
MWNLVQQTVNYIVGKTNFSPEYGVILGSGLGNFTDDINIEYILPYSEIPNFPVSTVEGHK
GALVFGTIQGKKIVAMQGRFHFYEGYDMKQVTFPVRVMKYLGVEKLIVSNASGGVNPNYK
VGSIILIKDHINMMPEHPLRGKNDERFGPRFVNMSEPYSRKMIVKAKEIASYLDIQVQDG
VYLGLQGPTYETLSEYKMVKNVGADCVGMSTVPEVIVARHMNLECFGLSIITDMGNEASI
ETVSHAEVLEAAQKAEPHVRNLIKELIIQY
>KACEBFPM_01366 Transcriptional regulatory protein TcrA
MTPNNYDLVLMDVHLPGINGTIATAEIRKFNTTTPIIALTAISLNENREILLSYGMNDVI
TKPFNPDNFYKVIECALLIEPNIV
>KACEBFPM_01367 PhoH-like protein
MRYAKLTYFFNLIFLLLNERIIELHDIAPKEFWGAQDAHLETIKKYYPKLKIIARGATLK
AFGEKEELDEFEKRFNRLIVHFTRYNKIDNNVIDRVILSDSREEQKMAETDKILVHGIGG
KLIKAMTPNQQLLVDCINKNDMVFAVGPAGTGKTYTGVAMAVKALKEKQVKRIILTRPAV
EAGENLGFLPGDMKEKLDPYMQPLYDALRDMLPPQTLEDYILKGIIQIAPLAFMRGRTLD
NAFVILDEAQNTTHSQMKMFLTRMGKNAKFMITGDPGQVDLPRRTISGLKEAILVLKDVE
GISIIYLDDKDIVRHKLVKKVIDAYKQIENND
>KACEBFPM_01368 5'-fluoro-5'-deoxy-adenosine synthase
MSIITLTTDFGLKDHFVGTLKGKLISEYPEVQIIDISHDIDLFNISEASYIINASYNSFP
KGTVHFIGIDNERTTENKHIAIQWNDHFFVCADNGILSILTQKIVPQKMVEINIHDRLTD
ASTNLDVFVKVACHLAKGGSLNVIGKDISAIKIINELQAVVASDSSSIKGYVVYVDHFGN
CVTNISKKMFAEIGNNRNFEILFGTKIIKKIHHNYSDFKISEKYTLRDYEGEKLALFNEA
GFLEIAIYKSNPKTVGSAKSLLGLKYRDVVNVNFRI
>KACEBFPM_01369 hypothetical protein
MKIEVTEKHINDFLFNLYFDLTDGIEMAAIKRAYRNFNKTLENFPHIEDEKSILRNNWIE
LIKIKN
>KACEBFPM_01370 hypothetical protein
MFGFKHIQFDAMTYVLHFKNGTIKKEGRGLSFFYFSPNSSIVAIPMGSNDLPFIFSESTN
DYQSVTIQGQISYKITNPKTLSDVLDFTVQDNGQYKKNDIEKLNQRLINEAQTATSSFIH
GIKLKDAIRSAKTIEESIIEGLKNSTAINMLGIEILGANILAISATPEMSRALETETREK
LQQEADQAIYERRNFAVEQERKIKETELNTEIAIEEKQKQITEKKMESEVIKAENDRKLR
EMKLEADISVENQRKLLIEEKTENDKIEAETQGYVIEATLKPYKDIDWKILTALNNNPDP
KFNISLAFRQLAENADKIGNLNISPDLLDSLLN
>KACEBFPM_01371 NAD kinase
MSTEYAIIVKNKTRLELLIERFNTKAQAKFYIERLGGNFDDYEIENEIFQNSLQSLQIQL
SKVIKNKIVERNFVPSFIFSENQLIIVIGQDGLVANTAKYSKNIPIIAVNPDKERYDGIL
LPFDISNFIGGVENVITNKYNSKTMRFAEAKLNDGQRLLAFNDLFIGASTHISAKYKITY
NNNIEEQSSSGLIVSTPAGSTGWLSSIFNMSYGIANMFEKNLKPKRPKLKDNELLFAVRE
PFQSVRTQIGITSGIIKTQNSLTIESLMPTSGVIFSDGVESDFLRFNSGSIATIGIAKET
AKIVMKE
>KACEBFPM_01372 hypothetical protein
MKKLEKFGILKFKIAWRKIPNYESYYQYQIAVRNAFENRITMEVEFELFNLKSKILCSYA
S
>KACEBFPM_01373 hypothetical protein
MFVRIVKLSFHEENITAFLENFELMKEKIRNAQGNRLLELYQDKNNKCIFFTYSYWETEQ
DLENYRNSELFYDVWTFTKKLFNDKPEAWSLDKLITVL
>KACEBFPM_01374 hypothetical protein
MNIITRKIYYSLPIPLRYAARKIIYFPSDMLTKKNNLVPPKGIIFTGSGNYLQTGKVFFS
YFQKYCDFTPQSSILDIGSGIGRMAIPFTNYLSTTGKYEGFDIVKIGIDWCTKNISSRFP
NFNFKLIPLKNDKKCFATFFIIDDQSSKSMHEKGHKNFPFDRGNYALMDKSVKEANVAYK
KDYIIHLLESYNFEITNFIRGNWSGIQNTPLNEHQDIIIFKKK
>KACEBFPM_01375 hypothetical protein
MKAILFKEFRSFFGSPIGYLVIAIFLLLTGLFLWVFDGDYNILNSGFADLTPFFTIAPWI
LLFLIPAVTMRSFSDEKKQGTIELLLTKPLSLWQIVNGKFLGAFLLLIIAIIPTLVYVKV
IYDLGLPEGNIDFGSTLGSYFGLLFLMATYTAIGIYTSTLSDNQIVAFIVSVFLCFVLYF
GFQGIANYKILGDFSELIKSFGMDYHYKSMSRGVIDTRDIIYFVSITVLFLSFTVYKLKS
YKS
>KACEBFPM_01376 hypothetical protein
MIPIKKKKIKTLLLTIAIILIINGIGSQFFHRFDLTHDKRYTLSETSLNIIKNAKEPLYI
DVFLEGNFPPEFKRLQNETKQILEEFKAYNPNIIYQFVNPLENPEEADAIIESFVQRGLT
PTNITVDDKGKQSKEMVFPWAIATYKNKSTKISLLKNKLGATTEQKVISSVQHLEYAFAD
GFHKITTKKQKKIAVIKGKNELPDLFKADFLQSIRENYFIAPFPLDSVSKNPILFAKALK
TFDLAIIAKPKTAFSDQEKQVLDQFIINGGKTLWLVETVNIDMENLNKTGSSFAFPFDLG
LNDMFFKYGFRINPILVKDIQCAPISLASGNKGNQTQYEKYPWYFAPYIFPEAKHPIVNN
IDGVKLDFANAIDTLKNGIKKTILLQSSIYSKKVGTPVEIDLKMVNEKPNPQDFQPGNIP
VSLLLEGNFTSAFENRVLPFDDASFKAKAKPSKMIIVSDGDVIRNQIDEKGQPLELGFDK
WTNKMYANKEFLMNCVNYLLDDNGLINIRSKEVDLPLLDKEKVAKNYTYTQLLTVLFPLF
LLLFFGISITYLRKKQFSR
>KACEBFPM_01377 DNA polymerase III subunit beta
MKFIVSSSYLLKQLQVLGSVINSSNTLPILDNFLFELKKNELLVSASDLETTMSASLTID
SDSQGSVAVPAKLLLEILKTFPEQPLTFTVEENNTIEISSQSGKYALAYAPGDEFPKAVN
LEEPSKTIVPAEVLSTAVSKTIFAAGNDDLRPVMSGVFFQFSPEGLIFVATDAHKLVKYA
RTDVKASQVADFIMPRKPLNILKGILATSNEEVTIEYNDSNATFSFDNYILTCRLIDGKY
PNYEAVIPKENPNKLMIERTQFLSSVRRVAIFSNKTTHQIRLKIAGTELNISAEDIDYSN
KAEERLTCDYQGDDMQIGFNSRFLLEMLGNLQSDMIMLEMSMPNRAGILTPIDGLDEGET
VTMLVMPVMLNN
>KACEBFPM_01378 ATP-dependent RNA helicase RhlE
MASFEQFNLPKSVQKALNDLQLTTPTPIQEKSFAVIMSGRDMMGIAQTGTGKTFAYLLPL
LKQYTFTNTNTPKIVILVPTRELVVQVVEEVEKLTKYMSVSTLGIYGGVNINTQKKQVYE
GVDILVGTPGRVMDLALDAVIRFDDTQKLVIDEFDEMLNLGFRVQITSILAMLRTKRQNI
LFSATMTDEVDAILNDYFDFPEEVSLAMSGTPLEKIEQLSYNVPNFNTKVNLLKHLLHTN
EEMSRILVFVNNKKIADMLHERIEGDFPDQFGVIHSNKSQNYRLTTMATFQEGELRGLIT
TDIMARGLDISNITHVINFEAPELPEQYIHRIGRTGRADASGIAISFIAPREEEIKFGAE
VLMGKEIEILDLPEEVEISKLLIGPEKEKEVIKFLLKKVKLEGGASHHEKSEKNKKVNLG
GPSKTKKKTGTSVNRNILKTRAAKKKKK
>KACEBFPM_01379 hypothetical protein
MQFKHPEVLYFLFLLVIPILVHLFQLRRFKKEFFTNVKFLKELSIQTRKSSKIKKWLLLA
TRLLLLAFLIFAFAQPFFKAKDSQNTNNELFVILDNSYSMQAKGQKGELLKRAVQDLLEF
APKNSNFSLITNNENYWNTNINAIEKDLQKINYSAIPFSLETALTKIKSRKTFANKDIVV
ITDAIGLNKNHLKDSNKKDKTYFIIPEAEQLKNIAIDTVYLAQTLDNFYEISVQFSSKFE
EKKAIPVSVYNQKNLIAKTILNLEKNKEIINFTIPKANFNGYVSINDNSLAFDNTLYFSI
SEPKTINILSIGLPEKSDFLARIYTKTEFNYTNSLITTLDYSQLNKQDAIILNELDNIPV
ALQTNLKSFVAKGGNVVFIPSEKNDVSNLNSFFNHFGGIQFSNLQNQEKKITKINFSNPL
FSNVFEKKITNFQYPNTIQSFAIKSNAPQAISYEDQTAFLTSIQKQMSSVFVFSAPINKT
NSNFQNSPLIVPTFYKMAINTNNNGVKYETIGNTNSFLITAKTNHNEIISIKNSSEEFIP
SQQIMSDKIKISCADNPTLAGNFEIIQSKKNIGNISFNFDRKESNLTLPSHETLTDLNVV
SNIESFFDTIQINRTDSQVWKWFLIFALLFLLLELFIQKFVK
>KACEBFPM_01380 Dihydroorotase
MNLILKAARIIDTKNALHNQVVDIKISNGIIRKIASNIEKTEGFEEIKLDNLHVSQGWFD
TSVCLGEPGFEDRETIANGLQVAAKSGFTAIALQPNSFPILDNQSQINFVKQKANGFATE
LFPIGALTQKSEGNDLAELFDMKNAGAIAFTDYNKSLDNANLLKISLQYTQDFDGLVIAF
AQDNTIKGKGMVHEGILSTMLGLKGIPSLAEELIVARNLFILEYTGGKLHIPTISSAKSV
ALIKEAKAKGLQVTCSVATHNLILTDAVIEGFDTRYKVLPPLRTEEDKKALIEGILDHTI
DCITSDHNPIDIENKKMEFDKAKYGTIGLESAFGALQTILPTEIIIRKLSAGRSLFGQET
FSISEGQKANITLFNPEGESIFTEKNILSKSKNSAFLNTLLKGKVYGIYNQEKLVLA
>KACEBFPM_01381 hypothetical protein
MEEQKDGKTAAILSYIILIGPLIAMSINSENKNSFASFHTRQGLGITILFIALGLLISNF
KNDMILISMWIFVSVLSMYGMLTATKGEMKAIPFLGNYFQKWFKNI
>KACEBFPM_01382 Carboxylesterase 2
MTLHHLVREPKIKLDKNPLLLLLHGYGSNEEDLFSFASELPDHYYVISARAPYDLQYASH
AWYAIDFDADENKFSDLNQARSSRDVIANFIDELVANYPIDAKNITLIGFSQGCILSYAV
ALSYPEKIQRVVAMSGYFNTEIAKEGFESNDFSNLKIFASHGSVDQVVPVDWARKAKPLL
DNLGIENVYKEYPIGHGISPQNFYDFKNWLEKV
>KACEBFPM_01383 hypothetical protein
MKKLVLYGLIFSVLLNIFQYMYSTKKFNFDENRAEKFKLKMTDSISKIVAQKEEGDYFSL
AYDEKAQDYLEGYDVQKLMPQVKEKLMDMNSNPTGNKLIPYDNMVINKVRFLNHRWIIAD
FTGDSNWGEVILKYFLEKDGSVTFETAETVMYPQQ
>KACEBFPM_01384 Phosphoribosyl 1,2-cyclic phosphate phosphodiesterase
MKVYFLGTGTSQGIPVIGSNHPVCHSQDKKDKRLRVSIWVEWDNNSFVIDCGPDFRQQML
ASGCSKIDAILFTHEHSDHTAGLDDIRPFFFKQGDIPIYAHERVLKNLEKRFDYIFETEN
KYPGSPGVFPIEVENNVAIDIDSKKIIPINAIHGGLQVFGYRFDAFAYLTDVKTIEPAEI
NKLKNLEVLVINALREELHNTHFNLQEALDFIAIVQPKKAYLTHIGHTFGFHQEVQKKLP
KNVFLAYDNLIINI
>KACEBFPM_01385 hypothetical protein
MSKFDTIRPYYDAEVNSALQDSLKHPMLKAMMNFAFPGVDDEVWKNQLRKTHSIRDFQCN
FIYETIRKVLKKSSEGLSTSGFEKLKKNTSYLFISNHRDIILDTCLLNTALFEHELIMTA
SAIGDNLVKKDFLKLLAKLNRNFVVQRGLSPRELLQSSQLLSEYIGHLLLHENRSVWIAQ
REGRTKDGNDATNSGVLKMLTMASKKDAMDYCKELKIVPVAISYEYDPTDALKMPQLMAE
ANQETYVKSGNEDFQNILSGVLGQKKRIHIHIGDVLEAELDTIKAEFSNTNKQIQALTQV
VDQSILKSYKLWPTNFIAYDILHKTNKFSSHYTENEKSLFERRLELKIDAKNPQMVESFL
AMYANPVANKMKYNNAI
>KACEBFPM_01386 putative metal-dependent hydrolase YcfH
MPLIDTHTHLYANEFDSDRDEMIKNAISRGVSRLFIPSIDASYTQKMYDLEAQYPKNIFL
MMGLHPCYVKENYLEELQHVETQLAKRKFAAIGEIGIDLYWDKTTLNIQKKAFQYQIQLA
KKYKLPINIHGRDAFDEIFEILELEKGDDLFGVFHCFSGNYEQALQAISYNMKLGIGGVV
TFKNGKIDQFLHQINIENIVLETDSPYLAPAPFRGKRNESAHVALVAKKLSEIYNLPTEK
IARITTKNALSIFRNC
>KACEBFPM_01387 3-(3-hydroxy-phenyl)propionate/3-hydroxycinnamic acid hydroxylase
MLKEFVDVLVIGAGPSGCVSASHLHNNNIKVKVVEKTKFPRIVVGESLIPRVMDHFAEAG
LLESLEAMNFEKKLGARFIRGQEICVFDFSNKYGEGWDWTWQVPRADFDNTMAQEVIRKG
IDLEFESEVISVAFEGKNSITVVKDKKGVEKEIHAKFIIDSSGYGRVLPRLLDLDTPSKL
DPHSAIFTHVVDINRPQGEEGTLISFDILETEVWLWVIPFSNGNTSLGVVGPTHFINSLS
QDNNKIEALNNAIKMSDYYINRFGGVEFAFEPVKLENYSRSVKSMYGDGFALTGNSSEFL
DPVFSSGVAFATESGMLAAKLFIKETQGITVNWETEFTEYMRRGINVFTTYVKEWYTGNL
QTLFFHQPENPDVKRKICAVLAGYVWDQTNPFVKKHDNLIKNMAHIINSEKEMTEKI
>KACEBFPM_01388 Tyrosine 2,3-aminomutase
MNIINEFLSLKEFEAIVFNDSKIEISDIVLDRVNKSFDFLKAFSENKVIYGVNTGFGPMA
QYRIKDQDRLQLQYNLIRSHCSGTGKPLNPLCVKAAILARLNTLSLGNSGVHPSLIYLMK
ELINKDITPLIFEHGGVGASGDLVQLAHLALVLIGEGEVFYKGERRLTQEVFELENLKPI
QVEIREGLALMNGTSVMTGIGVVNVHNANKLLDWSLKFSCAINEIVQAYDDHFSAELNNT
KRHKGQREVAEKMRTHLADSTLIRKREDHLYTGENTEDVFKEKVQEYYSLRCVPQILGPV
LETINNAASILEDEFNSANDNPIIDVKNQHVYHGGNFHGDYISLEMDKLKVVITKLTMLA
ERQLNYLLNSKINEILPPFVNLGTLGFNFGMQGVQFTATSTTAENQMLSNPMYIHSIPNN
NDNQDIVSMGTNAAVITAKVIENAFEVLAIELITIVQAIDCLDQKEAVSSVTRKMYDEVR
KIIPTFTQDQVMYPFVQNVKDYLINN
>KACEBFPM_01389 hypothetical protein
MKPQIYKCQKIDVKKRSKKVIFFLVLLMQFANAQELALVRKEGKFGYISKTGEFAIMPQF
KTAKNFSEGLAAAEENKKWGFINTKGEWIIPATFDDVKYFNSGYCVVAKDKKWFYINKKG
EQQKAPNSDKVYDFEEGVAFIKQGDKIGLINTKLTVILEPKYDVIKSFQNGFARVKNNDR
WGIIDKTGKIVVEIIYDDIGDYYKKTTWAKNGTAFGLVILGKFKAIEGVDKIWDFLVQDL
TYAKKNEKIGFIDLKGNWIIEPKFDKARAFVKNLAPVQIGKKWGYVNLKGTIAIEPLYND
AEIFSADGLAPVKDKEWGFINETGKLVVPCEYGITAGLFAMFRDDEKGFVNGLARVKKEK
KWGFLKINGEALANQWFDSAEPFKK
>KACEBFPM_01390 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKCALVTGGSRGIGSAICKKLATDSDYHILINYKENKQAAEKTLEEVLKLGGKGEIIQFG
VCNFEEVKNVLTQWQEANPEAIVEVIVNNAGIAKDGLFMWMTPEDWTSVINTSLNGFFNV
TNFFIQKMLRNKYGRIVNMVSVSGVKGTPGQTNYSAAKGAVVAATKALAQEVGKRNITVN
AVAPGFIRTDMTSNLDEKELVKMVPANRFGEAEEVADLVSFLVSRKSSYITGEVININGG
IYS
>KACEBFPM_01391 3-oxoacyl-[acyl-carrier-protein] synthase 1
MNKRVVITGMGIYSCIGTSLDEVKNSLYEGKSGIVIDPERSAFGFQSSLTGMVPKPELKN
LLSRRQRISLGEETEYAYMATIEALKNAKIDDAFFNDNEVGIMYGNDSVSKAIIEATDII
REKKDTSLIGSGAIFKSMNSTVTMNLSTIFKLRGINLTISAACASGSHSIGLAYFLIKSG
FQDMIICGGAQEINKYAMSSFDGLGVFSPRQDEPTKASRPFDASRDGLVPSGGGATLILE
SYESAIKRGANIIAEVIGYGFSSNGGHISTPNVEGPATAMQRALDEANVKASEIDYINAH
ATSTPVGDGNEAKAILEVFGESNPYVSSTKSMTGHECWMAGASEVIYSILMMQNDFIAPN
INLENPDEDAIKLNLVKTTLNKKIDIFLSNSFGFGGTNSALVIKKFKKGDE
>KACEBFPM_01392 Acyl carrier protein
MNKEEIVKKINDFLVDEFEVNQDDIQPEANLKDTLGLDSLDYVDLVVSVESNFGVKLVEV
DFVGVASFQSFYDLIENKIKLKG
>KACEBFPM_01393 Lipid A biosynthesis lauroyltransferase
MAQWEGKSKGTVLGYKIFVFFIKKAGIKTAYFILYFVATYYFLFLKKSNRAIFYYFKERL
GYSYFKSKKMVFRSYYTFGQTILDKVSISAGMRDKFSYEFDGVEILKKLLEEKKGGVLIS
AHIGNFEIAEHFFSEIDVDFQINLVTTDLEHSAIKNYLEKISKKSGIKLILIQDDLSHIF
EINAALARNELVCFTGDRYFEGVKSLTEKLLGQEAKFPAGPFLIASRLKVPVVFVYVMKE
PNLHYHLYTREAKVNHRNEKALLKEYTQSLESMLKEYPLQWFNYFDFWTQLEKENK
>KACEBFPM_01394 Phytoene desaturase (lycopene-forming)
MEEFDTIIIGSGVGGLATALCLSRAGQKVLVLEQHYVPGGWSHSFTINGQRFSPGVHYMG
LVDEGYSTNNLYKGLGIANDLVFFRMNKKGYDHCIIDDKKFDLPAGTKNLEASLIKAFPK
EEKNIKEYLYLIQKVNEELQLIPTLKGFWQNITVPFRTKHFGKFALFNLKRVIDWHIKDP
MLKAVLNSQCGDHGLPPNKASFPVHCSVMNHYLEGGFYPMGGGGGIVKAMTNKIKSHAGI
IRTQQSVAKILLKENKAYGVQLADGTQILAKNIVSNADPTVTFLKLIGSENISKKLNKKL
TNTKYSVTSLILFLTLDIDVTKLGIDSGNIWRFKDENLDQHFETLTKGDILSDDEFPALF
LSCSTLKDPTSFNGRYYNFEAVTYVDYASFKQFEGINDYHCLEYQKFKERIIEKFMNSIE
KMIPNAKQHIAQVELGTPKTNQFYINATQGNVYGTEKTLSQIGPFAYKNKTEIDNLYLCG
ASTLSHGVTGATFSGIETAARILNCTKDDLLIEEPNQKLRIYDAEDKTTWPEWIHVKRSD
KVRNFKQVANT
>KACEBFPM_01395 hypothetical protein
MKNILVIYYSQSGQLESIARNIAKPLLNSDEVNVVFHEIQLEKPFPFPWNKDAFFDAFPE
SFLQIPTALKPVPTEILNTKFDLILLHYQVWYLSPSIPINSFLKSSEAKTLFNNTPVVSI
SGSRNMWVMAQEKIKVLLKSNNAQLKGNIALVDRVGNLISVITIVEWMFSGVKKKYLGIF
PLPGVSEKDIVESSKFGEIIFKNLQNNNFDNLQAQLLESKAVKISSYLVKVDKTANKIFN
KWSNIINNKKQSRKIWLKIFNIYLWLAIWLISPIVYILHLFLYPFYIKKIRREKAYYQGV
>KACEBFPM_01396 3-oxoacyl-[acyl-carrier-protein] synthase 3
MFDVYITKSGKYLPNKVISNDEMENFLGLINEATSKARRIILRNNKIVARYYAIDENGNS
THSNAELTKNAITELFDESFTAQDMQLLSCGTSTPDVFLPSHAAMVHGLLKNKSVELNSS
TGVCCAGMNSLKFGYLSVKSGNTKNAVCTGSEKVSTWMKSEKYEQEVANLKHLEEQPIVA
FKKDFLRWMLSDGAAAFLLENEPKGERSLKIEWMEAFSYAHELEVCMYAGGDKLENGELK
PWSDYHPEQWLNESIFSIKQDVKLLDKNILIKGAQSMKEALDKNKVSADQIDYFLPHVSS
HYFVEGLKKSFAENGMVIPSEKWFMNLAQVGNVGSASIYLALNELMNSETLKKGDKILLS
VPESGRFSYAYAYLTVC
>KACEBFPM_01397 hypothetical protein
METLKAIFEKEFVENLLPQKFPFVMVDKLYSYTETSLTSGLKIQSDNIFYHNENFVEAGL
VEHMAQSVALHTGYQFYLKQEPAPTGYIGSIKDIEIRELPKLDDEIQTTVSILQEFAGIT
LVDIVTKLNGVEIATGQMKTVLAK
>KACEBFPM_01398 hypothetical protein
MDTTINIKNYLPHRKPMLMVDMILIMDDEKVETIFEIKGDNIFIQNNTFIEAGLIENAAQ
TCSSIVAKDYFVDENNEDKSGVDVVGFISAIKTLKIHKLPEVGSTIKTISTLVSKFVTDD
YSLCTMSCKTFNNEELLLEGEINLFIQENHSKQ
>KACEBFPM_01399 hypothetical protein
MKENEVPQDKGNLSKSNMKELVYATDEKGNYTTALSTGWEPKTIALSNAIDAINERIATA
KEQVKKGEVSPIVYFMECSKMDIGVLSSYVGMWQWRVKRHFKPTIFAKLKETVLQKYAET
FNISIHELKNFKTD
>KACEBFPM_01400 hypothetical protein
MEINFTHHQSAHCENGVASNLLKNNGLNISEPMAFGIGSGLFFVYLPFIKVNYAPAISYR
PMPGAIFNKLAKRLGLKIKRQKFSSETNAVRALDENLKNNIPTGLQVGVYNLTYFPDEYR
FHFNAHNLVVYGKTETNYLISDPVMETVTTLTHQELNKVRFAKGAFAPRGQMYYPIHIPA
TIDLKSAIIKGIKNTCRDMLAPAPIIGVRGIKFVASRIRKWPVKHGTKKANHYLAQMVRM
QEEIGTGGGGFRFIYAAFLQESAVILENEKLKELSQEMTIIGDLWRDFAVNASRVYKNRS
TQADVYNTIADQLLDIANKEEVFFKKLKVAVK
>KACEBFPM_01401 Modification methylase HpaII
MKLKENISINEFDGKRYQIRIVEPNNGKAVLTHYLHNIHNGVSKYYKNDALKVLEDFVTY
KQEEEDLSIVAEDAMQQLLFEVENVPFPTPKNYSFKFVDLFAGIGGFRMAMQNLGGKCVF
TSEWDKEAQKTYRANYGEVPFGDITKQQIKDYIPSEFDLLCAGFPCQAFSIAGKRGGFDD
TRGTLFFDVAEIIKKHKPKAIFLENVKGLRSHDKGKTLETILNVLRNDLGYYVPEPQVVN
AKNFGVPQNRERIYIVGFRQDLNISSFEYPEPLENNPTFESVKEKLVPPTKYYLSTQYVQ
TLINHKARHASKGNGFGYAIIPDNGIANAIVVGGMGRERNLVLDHRITDYTPTTHIKGTV
NREGIRKMTPREWARLQGFPDDYIIPVADASAYKQFGNSVAVPAIQATANKILKLIEISK
DAIRK
>KACEBFPM_01402 hypothetical protein
MLSGNKGEWSEVYALFKLLGDKQLFAGDANLNKVEELFYPIIKIIRNESGGNFQYEINGD
LVIISGGKEELRIPVKTFTEQSAKLLSTIKGSTGAFNIPEIETFMNSINCSSLKAKSTSK
SDIRIVIHDQRISQTAELGFSIKSQLGGQATLLNAGKTTNFVYQVSGFQPIENEIQTINE
IDTKSKIKDRIESVKQFGGNLDYLSLEQDVFKNNLVLIDSLLPNILAEIVKTFYTSNLSS
IKDLTENINKTNPLNYDNQFAHTFYEYKIKRFLTDVALGMTPSKVWNGIYDATGGYLIVK
ENGDVLCYHIYNRNQFEDYLFQNTKLETASSSRHEFGKIYAENGKTYFKLNLQIRFK
>KACEBFPM_01403 ABC transporter ATP-binding protein NatA
MYSLSDFTLSIYEGQIFGLLGPNGAGKTTLISMLCGLVKPTSGGFSIDDLTYAKNSSEIK
KIIGVVPQEYALYPTLTARENLLYFGSMYGLKGNDLKEKVIESLDLLGLLKFADKRIETF
SGGMKRRINLIAGILHNPKVLFLDEPTVGVDVQSKNAIIDYLKKLNKNGTTIIYTSHHLS
EAQDFCTDIAIVDRGKIYAEGTPNNLIASTANARNLEDVFIALTGKELRDDI
>KACEBFPM_01404 Inner membrane transport permease YbhR
MIYKLFMSVYKEFLLLKRDLGGVVILFIMPLVLIITVTLIQDSTFKTVSDAKIPILLVDN
DKGNVSKTVFDNLQKSNIFTVVTKINDEQLTESSAKEAVFKGKYQLAIIIPEKLSADLQS
KIDQNVEKITASLGMTDTLAKAEKTKIVNQKEVKLYFDPAVQMSFKNAVMSSIDKMISQI
ETKSIYATFQAQLGEETTSFEQKSFITFKEIVPKVNNEEIIPNSVQHNVPAWTLFAIFFI
VIPLSINIVKEKSQGTFVRLRTNPVSNVIVIAGKTITYLMICMIQFYMMILVAIFLFPHI
GLPSLNVEGNLFLMSIVALFSGFGAIGFGILLGTIAKTQEQSAPFGATSVIILAAIGGIW
VPVFAMPKMMQLIAQSSPMNWGLNAFYDVLLRHGSIVDILPEISLLFLFFIITTTIALQY
DKKKRAV
>KACEBFPM_01405 Putative esterase
MIRRKEQFNEAKELSISHEIRVRFNETDPLGIVWHGYYITYFEDGREAFGRHHGLSYLDI
FDSGFTTPIVKSTCEHKLSLRYGDVARIETTIVNTPAAKMIYRYVIYDANNEIACTGETV
QVFLDKNGDLMLTNPPFYEEWKRKVGLIK
>KACEBFPM_01406 3-oxoacyl-[acyl-carrier-protein] synthase 2
MTKEVFITETNCITPIGFNVTTNIQNIERGFSGIQLHQNAMLNKPFYASTIDNKELNTAF
AKITQSQNYSRLEKMMILALQPIVENSKLDLNNKVGFLLSTTKGNITALANPSEQSFQSA
QLHQLAKNIAAFFGFKSEPIVVSNACVSGILAVSVAKRLIQSEMFDNIFVVAGDEVSEFV
LSGFNSFQAMSDLPCKPYSKNRTGVSLGEATAAVLVSANRENAKIKIIGDGAINDANHIS
GPSRTGEGLFRSIESALAEAKIKANQIDYISAHGTATPFNDEMEAIAFNRLGLENVPINS
LKGFYGHTLGASGLLETVIGIQSVLENKLFVSLGFDEIGVSQPINIIKENQDKNCNYFLK
TASGFGGCNTAVLFEKIKQC
>KACEBFPM_01407 hypothetical protein
MLENKTYIQSFCTIQNNEIILNGESIFKSDSNLFSDFSKKAYQNFDINYPKFFKMDNLSK
LAFLAAELLLKNEIDNTKENNIALLFANNSSSLDTDVKYQNSISDKENYFPSPAVFVYTL
PNICIGEISIKHQLKSENSFFIFDAFHSEFMTNYANVLLHTKKAEKVLCGWVEYYNEEYK
AFLYLVANEGKVAHNIQTIENLYNK
>KACEBFPM_01408 Acyl carrier protein
MEALKQELKAKIIEVLNLEDINIADVADNDALFGDGLGLDSIDALELIVMLDKDYGIKLV
DPKEGKNIFQSIETMAAYITANRTK
>KACEBFPM_01409 hypothetical protein
MTTNELKLRTKNFSILIINLVEKLPNSIAGKTIANQIIRSGTSVGANYRAVCRARSDREF
ISKMNIVLEEADETMFWLELIIDRKWFDINEVSNLLDEGNQLTAIFVSSLKTVNTRISNS
KI
>KACEBFPM_01410 3-oxoacyl-[acyl-carrier-protein] synthase 2
MKMKGVAITGMGIISAIGNSVEENYASLLNNKTAITTIENISTVHANLRKVGEIKKTNQE
LADELKLSTDNNFSRTAMIGAIAAKQAVANAGITSINEYKTGLISATSVGGMDMTERYYY
DYFEKPETIKYISCHDGGDVAQKIANELGLNGMVTTISTACSSAANAIMLGARLIKSGKL
DRVIVGGTDALAKFTINGFKTLMILSDGYNMPFDNDRKGLNLGEAAAFLVLESDEMVAKQ
NKKVLARVSGYANANDAFHQTASSENGEGAFLAMEKAFQVSGLKPAQINYINVHGTATPN
NDLSEGRAIVRVFGENNIPDFSSTKPFTGHTLAAAAAIEAVYSVLAIQNNVVFPNLNFKT
PMEEFNMMPQTILKHKNIEHVLSNSFGFGGNCSTIIFSKSE
>KACEBFPM_01411 hypothetical protein
MRKTYINGVGCISAQKTFDTIFLEEAKINEIANVLPLEIPVYKDFISPTAIRRMAKGVKN
GIVASALAMREANTETFDAIITGTGMGCIDDSDKFLRALIDNNEEFLTPTSFIQSTHNTV
GSQIALGLQCKAYNFTYVNGSVSFESALLDAKLQFDENEASSILIGAIDEMNDYTASLFK
LAGFIKQDNESPYKVLNSTTKGVVHSEGATFFVLEDKKHDNSYVEVLDVEIINKLQIEEV
ETKIIDFLKSNSLQISDIDALVLGYNGDVETDGYYKTLSLNTFENTQQIYYKHLCGEYNT
ASAFGLWVGAKIIKTQQIPEILKVNHLEKTDYKTILLYNQYKGIDHSFTLISKC
>KACEBFPM_01412 Peptidoglycan-N-acetylglucosamine deacetylase
MLNYRNTNIVFLTLFALLLLFSFFVTVHWWFFLILFAIRFVILVVGSSFIQLGFHLQAYC
NNPFEKEKNIALTFDDGPHEMTLLVLDVLKKHNAKATFFCIGKNAEKHPEIIKQIISEGH
IVGNHSYNHSRLFDFYRKDKLVEEIVQTDALIKKISGKKTILFRPPFGVTNPSIKKALQV
TKHHVIGWNVRSLDGVIKNEKLVFNRIKKLISPGGIVLLHDTSLQSVNALEQLLQFVEEN
KYKVISLEQLLEIKAYED
>KACEBFPM_01413 Outer-membrane lipoprotein carrier protein
MKIKTAIIALILCFCHSLLLAQEQKMNDTEIISFKKTVKEVATKIKSLSTDFVQYKHLDF
LSKDIETSGKMAFKEPNMLQWQYKKPYNYSIVFKNGKIFINDEGKKSAMDVSSSKIFAKI
NKLIVGSVSGDMFDDAAFSISYFKNKINNITKFIPKDAALKKYIKQIELTFDKDDATVIQ
VKLLESSEDYTRIVLKNKVLNAKIDNFIFN
>KACEBFPM_01414 hypothetical protein
MQKSTILFLISILFLVTSCATNKLEKALKPVVVEKTVYNVPYFANPEIDYVYKANISVYG
NNLSGIFIAKKINETTHRVVFTTEFGNKLLDFEISETDFKVNSIVDELNRKILINTLKTD
FRLLLKKQFLIKEQFEDAENKVYKSEAEARINYLFVSKLEEKLLKIIYSNKRKKKININF
TSENNTFAESIVIQHDNIKLKIELNYLKH
>KACEBFPM_01415 hypothetical protein
MKKLFIVAIIALLGVVQAEAQVTFKPGLRGGLNFAHFTKGDYYNDSSTNINVDKFSSKTD
FYLGFYGALHLTKYYTLQPEIDYSNQGSTINYIDRNNISRDTKLNASYLSIAVINKFTFN
KFNVLLGPSLDFVVDKNFHVENDVDLTFQLGAGYDITKNFGIEARIKKGIVPAYKSNNYN
GVGYYSNSRADHTNVVFSLGATYTFDIK
>KACEBFPM_01416 hypothetical protein
MLLKDFYKVISLEKNDSQKYLAIILVNEKHEVFKGHFPGNPIMPGVCMMQIIKEITEQIT
ERLLIMQSLTNVKFMALINPEVTPELRLELDITVTDEGLVKVKNTTYFNQTVALKLSSVY
KKV
>KACEBFPM_01417 hypothetical protein
MKLLISIFCILISFNNLEVSEIRRLYPNAANSEITSKEFASKLSDITSESNKTLVAYKGA
SITIFSKFEKKISNKVKTFKEGAKLVEFAIASDPNNIEIRLIRLSIQENTPKIVKYNKNT
KEDVAFILAHYKEQTNATKEYIKSFVKQSKSFSSDEKLTIK
>KACEBFPM_01418 Polyprenol monophosphomannose synthase
MNHSISDINSIKSLNYCVIVPTYNNHKTLTRVLDSVLEYTTNVIIINDGSTDSTAEILKK
YSNLTQIHHSKNAGKGIALQNGFRKALELNFDYAITIDSDGQHFASDIPSFIDEINANGE
ALLIGSRNMTQENVPKKSSFGNKFSNFWFWFETGTKLEDTQSGYRLYPLQKIPKNYFTNK
FEFEIEVIVRTAWKGIAVKNIPIQVLYDPTERVSHFRPFRDFTRISILNTVLVAIAIFYI
KPIRFFLSLKKKGIKKFVLENILHHDDSNLKKSLSITLGVFIGVAPFWGFQTIIVLFLAI
FFKLNKLIAFAFSNVSFPIFIPFIIYGSLKTGSYFVRTGKPLLLDTSMTLADVESNVTQY
LIGSFVLATIMSIIFGLFGYFLLTIFSASKSKK
>KACEBFPM_01419 hypothetical protein
MQNFFFNLNSFANKNKLLFSAMVIALLLFFCFFASRISFQENITQLIPSNDRSGVTSKVL
EQVNFADKITIVIKSNKNGSPDDLTKYANEFINDLETKCKPYIAKIQGKIDEENIQETFN
FVYAHLPLFLDKSDYATIQNKINNDSISKVVEANYKSLVSPTGMVTKDFILQDPLGISFI
ALKKLQQLSIGGDFELQNGFVLTKDKKNLLLFITTKLPANETNKNTLFIDELEKIKTNLN
AKLGNKVVMNYFGATPVAVANATQIKDDVQKTSIFATVTLILILAFFYRNIATPILIFIP
SIFGAIFALAVLYFFKGTVSAISLGISSILLGETTDYSIYVLTHLRNKKDIKLLYKDISK
PLMLCGITTGITFLCLFFIKSEALQDLAIFAALSVVATSFFSLILIPLLYKTKNEIAVQK
LNLIDKLGAYSYHKNKFLIISVFILFIISLFTYSKVTFNNDLSSLNFMTPELKKTQKYLE
NIANEEGTKSIYVVTHGKDYDVVLEGNNKLFSVLEKDKKAAKILNFSSVGGIVFSAKIQK
QKIQEWNNFWSSEKKSNLKNNLISNGNKYGFKENTFSAFYETLNQNFSAISFQEYAKVKS
FFLDEFVANKRGFYTVSTLVKVPNDKRNSFVTGIKKQPNTVVIDRQETNEVFLNTLKSNF
QNLENYSFMIIFLVLFIAFRRLELAIVSIIPILISWIFTTGIMGIFEIQFNVINIIVCTL
IFGIGVDYSIFMTMALQKEHTFGKTELPTYKTSILLSVATTILGIGVLIFAKHPALKSIA
LIGIIGIFSALIITFVIQPLVFAFFVTNRTKKGKQPFELRSFIHGILSFFYYGFGGFLMS
VFSVTILKILPFKTEVKMKYFRYVMSKFMKSVLYTNPFVIKKISNIQNEKFDKPAVIIAN
HTSFLDILCVGMLSPKIIYLVSDWVYHSPVFGGAVKAAGFYPVSEGIDGGLEHLRPKIDE
GYSIVIFPEGTRSESNVIKRFHKGAFYIAEHFNLDIIPILIHGNSETLPKNDFIIYDGSI
TVKILERITPKNSVFLGNYTERTKKIGTFFKQEFQQLRCEIENKNYFEKIILLSFAYKET
EIINIVKADLKSNLLCYFNLNKYIHKKAKILHLANDFGQLDVLLTLQEAQRKTDSYLANE
LYRSIAKENLWTKKRTINYLASEDKMAQDYDVVLISDAINDINIQKIVQITSTIVLINNF
KLLNSFFDSGFEIKLQDDQLIVLKKKS
>KACEBFPM_01420 Ferredoxin--NADP reductase
MKEHYDIVIIGSGLGGLVSAIILAKEGYSVCVLEKNNQFGGNLQTFVRDKTIFDTGIHYI
GGLSEGQNLYKYFKYLGIIDDLKLKKMDEDGFDIISFEDTNKEFPHAQGYENFTNQLVKF
FPEEKNNIEKYCKEVVATCDSFPLYNLKHEGEYDSEILAINAKQFIDSVTQNKELRAVLG
GTNFLYAGIANKSPFYVHALSVNSYIQSSYRCINGGSQITKQLIKQLKKHGGEVYKYKEV
VQFESEENEVKRAVMKDGTSVSGTIFISNVDPKATLKMVGEDKFRKAYINRIDSLEGVIS
AFSLYIVFKPKTFKYKNHNYYHYKNSDHVWTAHEYDQKSWPKAFMASMNAGKDPIWADGM
TFMTYMKFEELKAWEHTYNTTADKEDRGETYNEFKARKAEKFLEEIELKFPGIKDCIRSV
HTSTPLSYRDYIGGYKGNMYGYEKDSNNPMKTFIASKTKLNNLYLTGQSINMHGVLGVTI
GAVVTCSEIVGKEYLVDKISQFTQG
>KACEBFPM_01421 hypothetical protein
MKRLFQYSILLLFLSMLLSCGTSKSLHHKPQLVGYNNAIPVVKKQSNTLFSTGNNFLLKN
KQNLWELYVEGDALERGLLTGSLTDSLLNKQQHIFFDKIKELLPSKFKQNVLRNFLKWYG
RKLYLNIPDEYKTEIYGISQYSTHDLDNIASPYLRCLYLHASHDIGHALQDLALVGCSSF
AAWGNKSEDGSLILGRNFDFYAGDDFAKDKIVAFVNPKEGYPFMMVTWAGMIGACSGMNN
QGLTITINAGKSKIPLIAKTPISILTREILQYAKNIDQAIAIAKKRQVFVSESIMIGSAN
DNKAVLIEVSPNNFGVFDVENSDQLICSNHFQSENLKNDDRNKDQIKNSHSKYRYDRMVE
LFDENPKINPKIASEILRNKEGLNNLPLGYGNEKALNQMIAHHGIIFKPEQGLVWVSANP
YQLGEFVCYDLNKIFNKNNAKSEIVSLQQENLNISKDLFLETPQYINYELFRIEDRKTDA
FLKAKKELPSDFIKNYQSLNPNYWVVYYKVGLSFYQKKQYQLAKEQFVKALTKEITTLPE
KLEIEKYLKKIERKLR
>KACEBFPM_01422 Phenylacetate-coenzyme A ligase
MIPKIEIATTDEIKSFQEQKLLELLAYINQNSPYYKRLFAKTAIDISKIKTLEDLQLLPV
TSKEDLQKYNDDFLCVPVTKIIDYATTSGTLGEPVTFGLTDNDLERLAYNEAISFDCAGI
KEGDVVQMMTTIDRRFMAGLAYFLGLRKMKVGVIRVGAGIPELQWDSILKYKPTHLITVP
SFLLKLIEYAENNNIDYNKSSIKGAICIGESLRNQDFSMSVLSKKITDKWNIKLFSTYAS
TEMSTAFTECEHSIGGHHHPELIIIEVLDENNKPVKNGESGELTFTTIGVEAMPLVRFKT
GDIVQLHDKPCACGRNTLRVGPVIGRKQQMIKYKGTTLYPPAMNDVLTHFENIENHIIEI
STNDLGTDEILIKIAVKNKSEVFLQELKDHFRAKLRVTPKIEFTTKEILNPLIFNPMSRK
PITFFDKRKNDY
>KACEBFPM_01423 putative tRNA-dihydrouridine synthase
MPKIGNIILPDFPLLLAPMEDVSDPPFRRLCKLHGADLMYSEFISSEGLIRDAIKSRQKL
DIFDYERPVGIQIFGGDEEAMAMSAKIVDAVHPDLVDINYGCPVKKVVCKGAGAGVLKDV
DLMVRLTKAVIRSTNLPVTVKTRLGWDDNSINIDEVAERLQDIGVQALTVHARTRAQMYK
GHSDWTHIERVKNNPRITMPIFGNGDIDSPEKALEYKNKFGLDGMMIGRAAIGYPWIFNE
IKHYFATGEHLPAPTVIDRVEAARNHLTWSMDWKGERVGIVEMRRHYTNYFKGIHSFKEY
KQRLVTLDDPEELFKVLSEVEEVYAGYQFV
>KACEBFPM_01424 hypothetical protein
MKKMLNIGFWAFVARVILRNRIVFLSGIVLITILFSMQWKNIKFTQTEANLIPFDDQINV
DYRSFLKNFGEEGNLVVIATKDPKLFTPKVYKAWNNLMATIQSHNEVDLVISISNLKKLV
KNDSLEKFELRPLIDTNKTQNQAYLSQIKSDLLNKLPFYEGLLFNKKSGAIRSAIYLDKK
IINTKARKDFVLNQLIPEIESFEKETGVDLRTSGMPYIRTLNAKTILDEIGLFIGAALLI
TGLIFFFFFRSFRATLISLVIVIIGVMWSFGLLGLLGYEITVLTALVPTLVIVIGIPNCI
FLINKYHQEYQVHGNKAKSLQRVITKTGTATLMTNLTTALGFATFIVTNNVLLTEFGVVT
SINIIALYLLCLFIIPIFFSYIPAPIPRHLGHLEREYLTSFMGWILRTVKYNRIGVYITS
ILLLVLGIIGIYEIRISGSIIEDMPKRTAFFDDIRFFEKEFDGVMPLEIMIDTKRKKGVM
KLSMLKRMEELEETIQEIPELAKPLSIVNLVKYSKQAYYNGNPEYYELPTQQEQAFILSY
AKKATQNSKENLMKSYVDSTGQFARITTFIKDENGEKMNAIEAQIRAKANKLFPSPQYNV
IITGKALVFQKGTQYLLDNLLSSLAFAFLITSLLVLIMFRSVKMVIVSLIPNLLPLILTA
GLMGFLGIPLKPSTILVFGIAYGLSVDDTLRFLAQYRLELARNDWKIKKSVIATFNDAGI
SMFYTSIVLFFGFSVFMLSSFGGTVALGGLVAITLFFGMLSNLVLLPALVLSLNKTLSNE
QEFIEPTIDILERTDAEVDAMENKNKN
>KACEBFPM_01425 Asparagine--tRNA ligase
MRHTRILDLLNSTKTLQEVNVKGWVRTFRNNQFIALNDGSTIHNIQCVVDFENTADETLK
RITTGAAVSVTGALVESQGAGQKYEVQVVKLEILGDSDAEKFPIQPKNKPSLDFLRENAH
LRVRTNMFGAIMRVRSVLSYAVHSYFQEKGFVYVNTPIITGSDAEGAGEMFKVTALPFDN
TPRTEDGNVNYKEDFFGKETNLTVSGQLEGETFAMALGQIYTFGPTFRAENSNTSRHLAE
FWMIEPEVAFNDLTDNMDLAEDFIQYVIKYTIDKCSDDLKFLESRLLDEEKSKPQAERSE
MALLEKLNFVLENNFKRVSYTEAIDILRDCPPNKKKKFNYIINEWGADLQSEHERYLVEK
HFKCPVILFDYPANIKAFYMRLNEDGKTVRAMDILFPGIGEIVGGSQREERFDVLVEKMK
ALGIDEEELWWYLDTRRFGSAVHSGFGLGFERLVLFVTGMTNIRDVIPFPRTPMNAEF
>KACEBFPM_01426 RNA polymerase sigma-54 factor
MLKQFLNFKLSQKLSPQQIQLMKLIQLPTQAFEARLLEEMNENPALEGGDDQEEIYEKDE
FDNNDDYDEYEDNDSIDSGDINIDEYLSNDETPDYKTQANNYSDDDDERESPLSAPVSFH
QDLINQLNTFILTDDQRNIAEFLVGSIDDMGYIRRTIQDIVDDMAFTQGIYTDEKTVEKI
LHIVHELEPSGVGARDLQECLLLQLKHKTPTESVALAMNIIQDQFEAFTKKHYDKLMLKF
SVSREQLKNGIDEIERLNPKPGGAYTGSNKITEHVVPDFAIKIIDDELELTLNGRNAPEL
HVSKDYQDMMKTYKDSKDKSNAQKDAVQFIKQKLDSAKWFIDAIKQRQETLYVTMNAIMH
FQQEYFLDGDEANLKPMILKDIADMIGLDISTVSRVANSKYVDTPYGTKLIKEFFSEAMT
NDQGEEVSTIEIKNILQTVIAEEDKNKPLPDDQLAEILKEKGYPIARRTIAKYREQLDIP
VARMRKKM
>KACEBFPM_01427 hypothetical protein
MKESSVEIYNRWGVLVYEVSGYDNKEKSFKGISEGRVTLERGSLLPVGTYYYIVRYVDLK
NESIEKAGYLHLTR
>KACEBFPM_01428 hypothetical protein
MKKIISSFIVLCLSQMSYGQQDSQFTQYMYNTVTVNPGYAGSRGVLSVYGLHRTQWVGLE
GAPVTNNFTISSPVTERLGLGLSVINDRLGISSQNNIMLDVSYWIPTSDNFKLAFGVKAS
ANFLNVDYGKLTKRHSVDVLFENKNIDNKFRPNIGAGLYWYSDKTYVGLSIPFMLETKYY
DNNIQSTASQRMHFDAIAGHVFDLTEQVKFKPAALVKYVAGAPLQVDLSANFLFYDKLTL
GAAYRWSAAMSALVGFQISDSFLIGYAYDKDTTRLGSFNSGSHEIFLRYEIFKKYDKIIA
PRFF
>KACEBFPM_01429 Outer membrane lipoprotein Omp16
MKNILKTITLLLICFCANAQTGKLDKANKQYENLAYIDAAKTYEKVAEKGYKSVDLFEKL
GDSYYFNAKLKEANKWYKELFALNEKVEPEYYYRYSQTLKAVEDYANADVYMERFRINLP
GDNRAKLYNDQKDYKEVIAKNSGRYEVKPTKVNTKMSDYGSAILGDKLIFASSRDHVGLV
KSSSKWTEEAFTDLYAADKSEDGTLSNPKKFSNSVNSKFHEDSPVFTNDMKTVYFTRNNY
KDGKTGKDDRKVILLKLYKATLIEGKWQDITELPFNSDQYSVAHPALSPDNKTLYFASNM
PGSKGQSDIFAVSIISDNTYGTPVNLAKINTEGRETFPFVTSDNELYFASDGHQGLGGLD
IFATKLTKSGLPGQVINVGAPVNGPMDDFSFMIEKPSRTGYFSSNREGGLGLDDIYYFKE
NEAINLDSSHLLEGIVTNSETGEILDNAKVTIYDEEFNPILSVTTDDKGYYTFAVEQGKK
YHVRAEKDEYETKELPVTIPRTPGKTYVPIATAKKIRVIKVGSDIAKALSIKMIYFDLNK
SVIRKDASVELAKILTVLNLNPTIKIDIRSHTDSRQTAAYNMSLSDRRAKSTIEWLVQKG
ISPDRLTGRGYGESQLVNECSDGVNCTGEQHQLNRRSEFIIISM
>KACEBFPM_01430 Cyanophycin synthetase
MHLAPSEGLPRNVASPVIDMLYPPGKPSRIPIIAVTGTNGKTTTTRLLAHIVKNNGYKVG
FTTSDGIYVQNHMMEKGDTTGPVSAEYILKDPTVEFAVLETARGGILRSGLGFSRCDIAI
VTNIQEDHLGLSDIYTLDDLARVKATVVRSVKKEGWAILNAEDDYCIKIAKELSCNVAYF
SLTEDNAVIKKMCKEGKTVAVYENGYITIKKGEWKIRVERATHVPLTLGGKAKFMIANVL
AATLASYLYGFKTEDISLSLQTFIPSVAQTPGRMNIFEFKKFKVLVDFAHNPAGYRGIEG
YLENIDAIKKIGIIAGVGDRRDEDIKECGLIAGRMFDHIIIRQEKYLRGRTEEEIIDLIL
EGIAESGREVTHEIIPKEIEAIKHAIDNAEVGSFITALSDVVTNAIDIVQEYLDKENEEG
NI
>KACEBFPM_01431 Prolyl tripeptidyl peptidase
MNNRILLLLSLFITVFASAQNKKITLEESVLQQNRLFRADKLAGFQWIPNTNKYTYYVEN
GTKLMLANATDNKLALILNLDDLNKSLNTKLNSFFGYQWKNENTLTISNGTKFYSYQIAT
KTGKTTQETLEFAENKTFDNTNENLAFTEQNNLFFFNKNKEKITVTNNSDKNIVSGQTIA
RSEFGISGGIFWSPKSTYLAFYQKDETNVADYPLLDITQTPGKLESIKYPMIGQKSEKPR
VGVYNLATSKTVFILPKGNPEDYLTNLSWSPDEKYILIAEVNRAQNDMNLNVYDANSGTF
VRTILNEKSNKWVEPENAAFFPNSKSNNFVWISEKDGFNNLYYYTIEGKLIKKLTSNLFP
VREIISTNTAGTEIYFKATGENATNMLAYKVDLKGKQTLITKEFGVHTVIPNFDGSFIFD
EYSNHTTPSKSLIYDKNLKPTIVLESKNKYDGYVMGTTEIKTIKSADGITNLFTRLIKPS
NFDASKKYPVLIYVYGGPHAQMITNSYLDGANLWMHWMAEQGYLVFTVDNRGSDNRGVAF
ESVIHQRLGVNEMEDQIKGVDYLKSLPYVDENRLAVHGWSFGGFMTTSLMLRKPDTFKVG
VAGGPVTDWKWYEIMYGERYMDTPAENQKGFDEANVLNYAKNLKGKLLLIHGTSDDVVVM
QNNLGLIKKFIEAEKQVDFFPYPMHKHNVQGKDRVHLMKKVLDYIIENNK
>KACEBFPM_01432 hypothetical protein
MQLNKSFFILVILISFSVKANFILLPMDETSQKNHLKAYGITYWALEKQYKASWLLNYRG
GSFLLPDVSDIRKECQIRGVSFEVLSDNQTNNILADISSPSQNMEVVVLEKAPKVAVYSP
PGKQPWDDAVTMVLTYAEIPFTTIYDQEVLSDQLILYDWLHLHHEDFTGQYGKFFGAYRT
APWYIQQKQDAEALAKKLGYNKVSQEKGAVARKIRDFVIGGGFMFAMCSATDSFDIALAA
EGIDICESMFDGDESEANYQSKINYSKTFAFKDFILDRKPEHYEFSDIDMTEKRRIPFEK
DYFTLMEFSAKWDVIPTMLCQNHTSLVKGFMGQTTSFERQLIKTNVLVLGENQINEEARY
IHGQKGKGFFTFYGGHDPEDFQHRVGDEPTVLDLHPNSPGFRLILNNILFPAARKKKQKT
>KACEBFPM_01433 Ribosomal protein S12 methylthiotransferase RimO
MGCFAYSHEENTGAYELVDDVPDEVKQARSLEIMDLQSQISWDLNQEKLGQTFRCIIDRK
EGGHFVGRTEFDSPDVDNEVLIDATKHYVKTGEFVNIKIIEATEFDLYGEPA
>KACEBFPM_01434 hypothetical protein
MNTIKTSFLALTLGLMSFATVAAITWKSETIDVGDIPQGKPKAIIFEFKNTGKTDVIITN
VQGSCGCTATDYTKEAIKAGKSGVVTVSYNAANVGAFTKTVTVTTNADASPKVLTLKGTV
KMAVIQS
>KACEBFPM_01435 Alkaline phosphatase synthesis sensor protein PhoR
MKTNKLNTIIVLGLIATIGILMAQLLWTKQAFTLEEKKFSQKAHIALLEVVKHLYEGTNH
DLPAENPIKKIANDYYVVNIDNDFEAEILEYYLNSEFKKANLNTDFEYAMYNCQSDEMVY
GNYVSATNKTAKKASVYFPKHKNLIYYFAIRFPTETSYLFNSLRFWFLLSIALIIVLLVY
VYSIYTIIQQKKYSELQRDFINNMTHEFKTPLSSILIASNYLKQQESIKTDEKLEKYAQI
IINQSNKLNNHIEKILNIAKWDNIPMALEKQKLEIITIINQVIENIKLKYETVDIKIKSQ
SDTIFINADEFHFSNLVYNILENAIKYADQKPEIIIHIFATKTHLLLQFIDNGTGISEKN
IPFVFDKFYRITSQKTTEVNGFGLGLYYVKKVCILHQWKVFIKSNTKKGVTVSVQIKPI
>KACEBFPM_01436 Response regulator MprA
MTNFKILYTEDDETLAFLTKDNLEQNNYNITHCNDGQIALDTFKNNPFDICILDIMMPKI
DGFELATAIRKLNTNIPILFLSAKTLKEDRIKGLKLGADDYLIKPFSIEELLLKIEIFLK
RSLKNNFEEKNIYTLGKYQFDSKNYVIFTDDQKIKLTERESQLLKFFLNNKNVVLKREEI
LKSLWGDDDYFMGRSLDVFISRLRKILAHEEKIFIENLHGIGFRFNI
>KACEBFPM_01437 hypothetical protein
MKDLLLITPPFTQLNTPYPATAYIKGFLNTKNISAFQIDLGIEVILELFSKKGLEVLFGK
SSQVNSPNSKRIFSLKDDYIKTIDAVIAFLQGNNPTLARQICSGDFLPEAFRFEQLDDME
WAFGSMGMQDKAKHLATLYLEDLSDFVVECIDDNFGFSRYAERLGRSANSFDDLYSHLLK
ELTYIDAIALAILKEKMHAIQPKLVCISVPFPGNLYSAFRCAQFIKTNFPGVKTSMGGGF
PNTELRSLTDVRVFEFFDFITLDDGELPLQLIIDSIQLTVSNEFKRTFLLEDNQVVYKNN
TLQRDYKQSEVGTPDYSDLLLDKYISVIEIANPMHSLWSDGRWNKLTMAHGCYWGKCTFC
DISLDYIKVYEPILAKTLVDRMEELIAQTGENGFHFVDEAAPPALMRELALEIIKRKLVV
TWWTNIRFEKSFSQDLCVLLKASGCIAVSGGLEVASDRLLQLIKKGVTVEQVAQVTRNFT
EAGIMVHAYLMYGYPTQTIQETVDSLEMVRQLFELGILQSGFWHQFAMTAHSPVGMFPDE
FGVIPQSNEITFANNDIQFTDKTGINHDQFSFGLKKSLFNYMHGLCFDYTLQDWFDFKIP
KTTVKPNFIYNSIQKEENFSTKPSARIVWIGGKPLTEIFIKSKKGNAWEMIKMTFHDKKE
TFVIDIEKEKGDWLLKILNIISIHNDKKNTFLVLKTDFEENFDDFELFWYSKPINTLRNF
GLLVL
>KACEBFPM_01438 Putative cysteine ligase BshC
MPTDCISYQKSGYFSKLIVDYLDKKPELKELYNYFPSIENFKHQIEEKNHNFKNNDKRKI
LVDALKKQYTNFEISELTQKNIALLENEKTFTITTGHQLNLFTGPLYFLYKIVSTINLCK
ELKRNYPEYNFVPIYWMATEDHDFEEINHFNFKGKKLSWNTASKGAVGRLSTKSLTNFFT
VFKAELGLSNNAEYIKKLFSDSYLQHSNLADATRFLANKLFGKYGLVILDGDAAALKKQF
IPYIKDELLYQNSNKKVLESIAKLKDYSIQVNPREINLFYIEANLRERIIYENGNYKVNN
TFITFSETEILKLVDANSEKFSPNVILRPLYQEVILPNLAYIGGGGEIAYWLELKAMFDF
HKVTFPILLVRNSAVLINEKQEKNRQKLNITWQELFLKQQVLIDAKTKEYSEIKIDFSEQ
KAHLKKQFEALHQIALKTDKSFSGAVKAQEKKQTKGLDNLEKRLLKAEKKMHSEKLKKII
ELQNNLFPNESLQERKFNFSEIYVEIGEELINKISDQLHPLAATFSIIKHA
>KACEBFPM_01439 Nucleoside diphosphate kinase
MATNRTFTMIKPDGVQNGHIGGIVNMITEAGFKIVSMKLTQLTVADAQKFYEVHAARPFY
GELVAFMSRGPIVAAILEKDNAVEDFRTLIGATNPADAAEGTIRKKYATSIGENAVHGSD
SDENAAIEGAFHFAGREQF
>KACEBFPM_01440 hypothetical protein
MKKFLYKTAVFVVPFLLIFLLSFKYYTDTKGDLLRLGFIADIYNYDFNKVFKKEMARKIN
YTVFSELNLKKQNNFTVFAIGDSFSEQGAAGYQNYLANNSAIKVLHYDRFLHENPIETVT
GFLNGNVLDNIKVDYIILQSVERVFVERALVFNKKIKITNDSLTTLINKHKEKLREVVKE
KTKDKFFSREILRFSLNTICYNFDDNAYLSTVYQVKTKNNLFSTNNHNLLFYTEDYEFLK
TNNDVKKINILNNELNTLAKRLKNKGIKLIVLPCPDKLDFYYDEIISKDKYAKPIFFDCL
KNLNKEYIYIDAKKVLQEKAKNKKDVYFYDDTHWSPIAAKIIGSKLDEIINTK
>KACEBFPM_01441 Peptidoglycan O-acetyltransferase
MLFNSLNFALFLPVVFLLYWLVFHKNLKHQNILLLVSSYFFYACWDWRFLFLLVFSTLLD
YFTGIKMEESKSEKQKTFWFWLSISINLGFLGVFKYYNFFATSFANAIANVGLEINPWTL
KVILPVGISFYTFHGLSYVIDIYKNRIKAEKNFIEYSVFVSFFPLLVAGPIERATHLLPQ
IKEKRTFNYTNAVDGLRQILWGLFKKIVIADQCAEHANTIFNNYQNYSSLGLIAGAVFFS
IQIYCDFSGYSDIALGVARLFGINLLRNFAFPYFSRDIAEFWRRWHISLSSWFKDYLYIP
LGGSKGGTWMKVRNTFIIFLVSGFWHGANWTFIIWGLLNALFIMPSIIFNTNRSNIEIVA
KGKTFPTLKEFLSILTTFALAVFAWIFFRAENLEHAINFISRILSNASFVTELKVRGDLI
FIILFFLIVEWFGREEQFALAKIGLNWKSPIRYALYFALIIMLFWFGGKEQQFIYFEF
>KACEBFPM_01442 hypothetical protein
MANVVNNYTQSVSLRNTILYVEITSSVLREELSYGKHKIIKIKN
>KACEBFPM_01443 hypothetical protein
MKNKTYFYILLFFIWLPFLNKYICYRAIHSLEGNVVLREKPSLNKTTWFSGKYQEDFENY
INDNIGGRPFFVRVKNQIYYSLFDIIKANGIVDGKDNFLYEKSYIDAYYGKDFLGKDTLH
STVLKIQKLQSLLEKQNKTLIICLAPSKARLYPEFFPSDFLDKETDKTNYDYYKDDLKKE
KINFIDFNSLFLKLKKSKCDCPIYPKYGIHWSEYTSGTLATDSLIKYIEAKRNIDMPNLI
VASTEKSLTPIGQDFDIGASMNLLVDLKITTPMCYAKIKWDSDKKLVKPKVLTIGDSYYW
GIFITGVPTRSFSLGGFWYYNNQVYSTSNQKFDTTVDKLDLKKQISKNDVIVIMATEPNL
SKLGWGFIDNAIKVLQ
>KACEBFPM_01444 Peptidoglycan O-acetyltransferase
MVFSSVLFILIFLPFFLLAYYLANPKYKNLVILIGSILFNAWGTPKYILLIFTSLILNFY
VIKQMYKHKNYSKILMILSIVINLGVLAYFKYFNFFIDNINLILSLTSIHPLSWVRLALP
VGISFFTFHSISYTVDVYRDVHKPLDKLSDYAIYLLMFPHLIAGPIIRFSTIADDIVDRK
HKETAENKLLGFYRFSIGIGKKVLIANIIGETVDKIYALPINELSSQLAWIAIIGYSFQI
YFDFSGYSDMAIGLARMMGFTFPENFNMPYVSKSITEFWRRWHMTLGDWMRDYLYIPLGG
NRVKSQARLYFNLAIVFLLSGLWHGSSWNFIFWGAWHGLFLILDRVFLLNLYKKIGAIPS
MLITYFIVLIGWLFFRVEGFMNAINYLKIMFSCKTSFVKFPINVDFWFVLILAILISLIG
SLPFGEKLKDIIYPSNLKPKTGFIYFLATFILLLVGVSLITATGFNPFIYFRF
>KACEBFPM_01445 hypothetical protein
MAKRINNQSIVGDILNQIIKTNKLESGLNQVSVIDAWKNLMGNGVNNYTRSVSLRNNILY
VELTSSVLREELSYGKDKIIKMINEELGKEVVKDVVLR
>KACEBFPM_01446 hypothetical protein
MKKKLSLVFLVSICFGCSQKVDISKTDTINGYWQITKALNTNGDKKDYPINEVYDYYEIK
GKTGFHKKVTWQPDGVFLVNDLSESVKLSNNSEGVFIQFRSKFGKHTEKIESISEKELVL
ETPDKAKLYFSKVILNTRK
>KACEBFPM_01447 CRISPR-associated endoribonuclease Cas2
MYDEHYTRLNQYRSLWILVFFDLPTETRKERKIASEFRKKLLDDGFSMFQFSIYMRFCAS
RENAEVHTKRIRNSLPEHGKIGVMQITDKQFGMMELFYGKKPVETDKPSQQLELF
>KACEBFPM_01448 CRISPR-associated endonuclease Cas1
MIKRTLFFGNPAYLSTKNEQIVISYPNKEQETKTVAIEDIGVIVLENQQITITNGLLEKL
TNNNVALINCDQYHLPIGLLMPLNGHTEQSERFKNQINASVPLKKNLWQQTISAKIMNQA
GLLKEKGIPCRKMELWAKEVTSGDALNHESRAAVFYWQSLITVPNFTRGQKGIPPNNLLN
YGYAILRAITARAIVSSGMLPTLGIFHRNKYNAYCLADDIMEPYRPYVDLIVCHIIDTED
SYDELTIEIKKQLLSIATIDVCIDGKNSPLMVAMSRTTHSLQECFAGAARKILYPIYV
>KACEBFPM_01449 CRISPR-associated endonuclease Cas9
MKKILGLDLGTNSIGWALTNNDFDNKLGNIEGLGSRIIPMSQDVLGKFDSGVSISQTAER
TKYRGTRRLVQRFLLRRERLHRVLNVLDFLPQHYAEAIDFEKKFGQFKPEKEEKLSFYKN
ENGKNQFIFLDSHQEMLAEFQLINTDLKQVPYDWTIYYLRKKALTQKISKEELAWILLNF
NQKRGYYQLRGEEQEDNKNKLEEFHTLTVVDVIEREKGKSGIWYNVILENGWIYKRESKI
ALFDWIGKQKNFIVTTELNDDGTVKLNKDNEEKRSFRSPKEDDWGLVKIRTEQTINQSEK
SVGTFIYDALLKNPNQKIKGELVRTIERKFYKDELSKILKAQIAFHHEIFGDRNLYKKCI
DELYRHNDSHKNNIKDKSFEYLFLEDIIFFQRPLKSKTSLISDCSLEFVPIKDENGILVK
DDNGKQVVKPLKCIAKSNPIFQEFRLLQFVKNLKIYKKEIVNDVDVTHDFIKTEEDLVEL
FNFLNDRKEIDQISLIKHLLRPLKLKGKLLDAEVAKLRWNFVEDKIYPCNETRNQFLNAV
AKIDVDKSFFDAKNTQDLWHILYSVTDKIEITKAITTFAKKHNLPDEFITNFSKLKPYKK
DYGSFSEKAIKKLLPLMRFGSYWKESNIDIKTLARIDKIQTGEFDENMRTRVREKAIHLS
KTTDFQGLPLWLASYIIYDRHSEASDVSKWKTPADIQNFLKYDFKQHSLRNPIVEQVITE
TLRVVKDIWQHYGDGKENFFTEIHIELGREMKNDKATRERMTKKISENENTNLRIKAILT
ELKNDGLNDIRPYSPSQQEILKIYEEGVYSSEIKKEKLEEIDKIRKNAKPTPSEIIKYKL
WLEQGYISPYTGKLIPLSELFTTKYQIEHIIPQSRLFDDSLSNKVICESEVNELKSNMTA
YEFIQNNEDRIVILTGGKTVKIFTKDAYNQHITAYYSKNKSKQKRLLSEEISEKFIERQL
NDTKYISKIVKNLLSRIVREEEEQEVTSKHIVSLNGSITSRMKQDWGLNDVWNNIITPRF
ERLNALTNSNDFGQFELKKDAYGNKGKQIFQTTVPDAIAKGFTKKRIDHRHHALDALVIA
CVSRTHINYLNNLNARDTDDKAVKHELRNKLCFKTKPDSNGNYKWEFYKPWKDFTTEAED
KLNTTIVSFKQNTRVINKTVNKYTNYKDEKGNLNIGTNGLVEKKIITQTKGDNWAIRKPM
HAETVSGKVFLKRIKQSPITIANAIEQIEFIVDKEVKKQLASKIKQYPNNMVGLKKHLKA
FPVMIDGKVIDKVQIYETIEATATRKTLDITFDEKKIEKITDTGIQKILLNHLKQEMYQN
AIHENGEKIPAHEVAFSENGLDELNKNLTTLNNGKKHQPIKKVRVFEESNKFPLGETGNK
KNKFVETAKGTNLFFAIYQDDLNNKKFITIPLNVVIQNLKDGLSPVPDKYLDNKTKVEYK
LTQFLSPNDLVYTPTNDELENSNQININNFNKDQVCRLYNVNDFSGYTIYFTPNQFAKNI
APKELDTSFDSKLSKSLEGITIKENFWKLEVDRLGKIKKIIR
>KACEBFPM_01451 Acetyl-CoA acetyltransferase
MKKVVIVSAVRTPIGSFMGALSSVPAPQLGAIAIKGALNKINLDPALVNEVYMGNVVQAG
VGQAPARQAAIFAGLSNDVACTTINKVCASGMKSVILGAQAIMCGDAEIVVAGGMENMSM
IPHYVHLRNGVKFGPTSMLDGMQKDGLVDAYDQQAMGVFADLCATEYKISREDQDNFAIQ
SYERSSKAWDAGKFDNEIVPVTIPQRKGDPIVVCKDEEYTNVKLDRIPTLNAVFTKDGTV
TAANASTINDGAAAMVLMSEEKALAMGLKPLAYIKGYADAAQEPKWFTTAPAKALPLALK
KAGLSTSDVDFFEFNEAFSVVGLANAQILGLDNDKININGGAVSLGHPLGCSGARIIVTL
INVLEQNNAKIGAAAICNGGGGASAIVIERA
>KACEBFPM_01452 Gamma-D-glutamyl-L-lysine endopeptidase
MFGICNLANIPLRIEPSDRSELVSQVLFGEHFSILEKTQKWSKIRLNFDDYEGWVDNKQF
TTITEEQSEQLSKDSIILSSDLIEYITCSKNSLIPIPLGSSLSFLNYESINKDNFSFDGL
KINGIKQKSNLINTAFMYMNAPYLWGGKTPFGIDCSGFTQMVYKLNGYKLFRDASQQATQ
GEALSFIEESEPGDLAFFDNEEGNIIHVGIIMDDNYIIHASGKVRIDRLDHLGIYNADAN
KHTHKLRVIKKII
>KACEBFPM_01453 hypothetical protein
MEGIPTNKKIIIFDGICNLCNSSVQYIIKHDKKDVFRFVPIQSKLGQNIINYIGISSKNI
DSVILYNPGKAYYYKSTAALEIAKSLGGFFTYATLFRIIPSAIRDILYDYIAKNRYKWYG
KNESCSIPTPELKLKFLE
>KACEBFPM_01454 hypothetical protein
MKNLILPLYSWGNGAFIMIIVFGLVIFGLIGAVMLMMNTDKKKKDNDL
>KACEBFPM_01455 C4-dicarboxylate transport protein
MNSTESTIETKKTFFSNLTVQILIAMILGAILGVFIHNNYSAAAAKEFSGYIKMLATVFI
RLVQMIISPLVFTTLVVGIAKLGDIKSVGRIGGKAMVWFFTASFISLLIGMFWVNILHPG
AGLELSNIDVSAATEVTEKTQSFSAQNFVEHIIPKSIVEAMANNEILQIVIFSIFFGLAA
ASLGDFTKPVVNALDKTSHIVLKMVTYVMKFAPIGVFGAIAGVFAIRDLNELLLTYAKFF
GSFLVGISTLWIFLLLIGFVFLGHRMKTLLKHIVSPLIIAFGTTSSEAVFPKLTEELERF
GIKDKIVSFMLPLGYSFNLDGSMMYMTFSSIFIAQAYGVHLDIPTQLTMLFVLMLTSKGI
AGVPRASLVVVAATCGMFDIPIEGIALILPIDHFCDMFRSATNVLGNALATSVVGKWEKE
>KACEBFPM_01456 Ornithine aminotransferase
MNVIKPGQHGSTFGGNPIAAAVAVAALQVVTDEKLAENAEKLGIIFRSELAKFIQTSTIA
TLVRGKGLLNAVVINDTEESDTAWNICMALRDNGLLAKPTHGNIIRFAPPLVMNEEQLLD
CVSIIIKTLKQFEN
>KACEBFPM_01457 hypothetical protein
MMENQNNNEMHLNTSALEFLKESAKWSKFLAIIGFVGIGFMVLAAIFMGAVMSMIPMATQ
TMAFSPLGAIQEFVSIIYLIIAAIYFFPVYYLYKYANDTKIAIENNDSQLLSNGFGFLKS
HHKFLGITMIVVLSFYALMFIGLITMGLFAASSVI
>KACEBFPM_01458 hypothetical protein
MKIEEFMIPCLSKMLFGVDCLGCGTQRALILVLKGKFTEAFYMFPAIYTTILFFIILGLN
FFNKSKKYNKLIILLAIINAVIMIISYIYKLN
>KACEBFPM_01459 hypothetical protein
MLGLKLKTDPRWVTIVESNIQEILTDHAWCEQKAATNVITMITYNSEHEELVTELLKIAK
EEIDHFQMVHDIIKERGLTLGRERKDHYVNELFKFLKKDGSRNDAFVDRLLFSAMIEARS
CERFKVLSQNIQDKKLADFYRELMISEAGHYTTFLGFARKYSEKVDVDKRWAEWLAFEGE
LISNYGTKETIHG
>KACEBFPM_01460 hypothetical protein
MKKKTLLIIGLVWPEPKSSAAGTRMLQLIALFQKKGFAIVFASAAQESDFSYDLKSINVV
TKKIVLNSNSFNDFINELNPEIVLFDRFVIEEQFGWRVYENCPNALRILDTEDLHSLRLT
RQNAVKKNIAFELSDLLASDIAKREIASVLRCDLSLIISEFEIKVLAETFKIDPNLLHYL
PLSYDFILENELLDFHQKKDFVFIGNFLHEPNWDAVKQLKEKIWPEIRNQLPDATMHIYG
AYPSQKVLQLHNKKEKFIIHGRAKNANEVIVNAKILLAPMRFGAGLKGKLLEAMQAGTPS
VTTNIGAEGIKGNYNWNGFVEDDFLAFISKAVLLYCEEAIWNESQKNGFEILKNRFKSDL
FENLFLDRVCFLQSNLENHRNLNFMGRLLLHHTALSTKYMSRWIEEKNRL
>KACEBFPM_01461 hypothetical protein
MKWIGNRESDNVEDRRGMSRGGKVVTGGGVLGIIILLLNIFGGEQAHQFIPVLEQFNRGQ
QTEQAQPPELSEEDENTGKFVKTVFAYTEDTWTKVLAENNVAYRKPKMVLFTDAVETACG
GASSASGPFYCPADEKVYMDLAFFQELQTRFGAKGGDFAIAYVIAHEVGHHIQNVLGTSG
KVSKLQQSRSEVEANKLSVALELQADFYAGVWAKQNQKYLDVDDIDEALSAAQAVGDDAI
QSRMQGQVIPESFTHGTSEQRKYWFMKGYNTGDIRQGDTFAEIH
>KACEBFPM_01462 hypothetical protein
MNEYLEIIIRSVSVYFFMLIALRIFGKKELSQLNTADVILILLISNAVQNAMVGANTSLL
GGIIAAFALFCINYIFKKVMLKSDFIKDLVQDKPEILIHNGKTEYKTLFRLGITSDELEE
AIREHGVEHYNEVKLAMFEIDGNISIISGNKHLKQTKHKRRIHKTLI
>KACEBFPM_01463 Ribosomal protein S6--L-glutamate ligase
MGGTASVIKPTAEEKRIAIKAAKAMDLKVAGVDIIRSSKGPLLLEVNSSPGLEGIEGATH
KDIAGEMILAIEKNFKTKP
>KACEBFPM_01464 hypothetical protein
MSDPNDANGDGISGVPNWILIPEYINPVDAISQNGKHIGRFGKKAATFNLLHQTVTAYNQ
DIGITSTYNPIDVYTNQEIDPEIATNIVNDVDFYLKTLKAPPRRNSGDSQVIQGENLFNK
INCVGCHKADLSTGYSPISALSFKTFSPYTDLLLHDMGSELNDGYTEGSAKTYEWRTPPL
WGLGLSENAQGGNVFLMHDGRARSIEQAISMHGGEATNSKTAFNNLSQGEKNALIKFLKS
L
>KACEBFPM_01465 Cytochrome b6-f complex iron-sulfur subunit
MNRKEFLKTCGFGCLAGIISTSILESCSTSRVLTKEIKDSNILIPITDFEIKTNKKTGYK
KYLIVQNEILRYPICVYRFDAKNYAALLMKCTHQGAELQAFGDKLQCAAHGSEFNNKGIV
ESGPASSDLKKFPIIIENNTLKISLK
>KACEBFPM_01466 hypothetical protein
MRSLVTTFLLIISLLCLTKTHAQIDASLLKRIQKDTTKTLNMDALYNRPALNIEKTPISI
GGYLETNWQHLTTDGVSEGHQFQARRLSIFMSSAISKRVKFLSEIEFEDGGKEVAVEFAS
VDVEFHPLVNFRAGILLNPIGSFNQNHDGPKWEFTDRPISATQMLPGTFSNAGAGFFGKK
YSGKWMIGYEAYFTGNFDNSIIENKENKTFLPAAKKNPERFEEINSGQPLFTGKLALRNN
KIGELGISYMGGIYNKFQDDGIILDEKRRINVFAIDFNTTLPKIKTFITAEFAWINVDVP
TTYTQQFGNKQHGGFIDIVQPIVNKTILDWEKATLNLACRLEYVDWNVGKFNETGGNMGE
DIWSIMPAISFRPTPETVIRLNYRFQKQHDILNNPPAITDGFSLGLSTYF
>KACEBFPM_01467 Serine--tRNA ligase
MLQIAFIRENQEKVIKALAKRSIDATSIVQEVVQIDEKRRATQVELDTILSESNSISKEI
GDLMKSGEKEKATALKEKIATNKEKTKELSEITETLAKDLLDKLYTLPNLPADIVPEGKT
PEENLNIFQEGDIPVLHEEAQPHWELIKKYDIVDFELGTKITAPGFPVYKGKGAKLQRAL
ISYFLDKNTDAGYQEYQVPHMVNEASAYGTGQLPDKEGQMYHDAKDNLYLIPTAEVPVTN
IFRDVILNENELPVLCTGYTPCFRREAGSWGAHVRGLNRLHQFDKVEIVRIEHPDKSYEA
LEGMVEHVKSILQELKLPYRILRLCGGDMGFASALTYDFEVFSTAQDRWLEISSVSNFET
FQSNRLKLRFKDKEGKNQLAHTLNGSSLALPRVLAGILENYQTPEGIVIPEVLRKYTGFD
IIN
>KACEBFPM_01468 hypothetical protein
MKNLFLYIVLLLPMFVFSQNEQLAQNYFDRGEFDKATLIYEDLIKAQPNNYNYFQKQVTC
FQQLKQFDKAETIIKNRIEKTKQPNLYIELGYNYQLQKNTDKADKNYRIALEKIKENPNN
VYAVARDFEQKVLVEQAIEAYRLGTLGNPEANFDYQVSLLQGQLGKIDLMIDTLLDYSFK
FPINAPLVQNQLTRFISEDSQKKFSDSLKKALLIRTQKSQDIFWNQFMSWFFIQQKDYGK
AFIQEKAIFKRSANNISNIINLAKLTIDDKEIETATEILNFILLNTQDLELQMEAHYQLI
SIDINKAIRKDYPIIKEKLDLLLTKYGISPYSIRLQILNAHFDAFYLKQFESAKTVLTKA
LDLPLNNYQKAAVKMELADVLLLDEKFNQAIIYYAQIQDGLENDQVAHEASLKMAKASYY
KGDFDWAQKQFTVLKSSTSQLIANDSMELFLLISDNTVEDSTQVALKKFSKADFLGYQNK
NTEALQAFETILLQHKGEKIEDITLLRIGKLYEKQNNFIQALNYYQQIIDQHANGIYIDE
ALFFTAEIYRKQLPDIAKAKTYYEKIIFAHQDSIYFVEARNNYRKLRGDTNL
>KACEBFPM_01469 hypothetical protein
MIIYNVTINIHESVHDQWFSWMQEKHIADVLATGKFTSARMVKVLIEEEMGGITYSVQFT
TNNKETLQKYYEEDAPKMREEGLKLFGDKMLAFRTELELISEHI
>KACEBFPM_01470 hypothetical protein
MFEKLPFTIEEQIERLQTRGLIVTPEDNATHYLSHISYYRLGEYWHSMQSDKVKHIFKEN
SKFKDVIALYQFDGELKILLFDIIEKIEISLRTKLIYHLSHEFNPWWFQNFDLFIDSKAL
VKTLSSLEEELERSKEITIKNHLKNHKDDLRFPPAWKSLEQTSFGSLSKLYGNLKNTIHS
KDIIAREFGVVNHTFLPSWLQSIAQIRNYCAHHSRLWNKNLPGNPKLLPNPPFNWVEDVP
KQNEKLYVHLCIMKYLLDRIQPENNFGERLNNLFIKYPNVDPNAIGMKPNWKNENLWK
>KACEBFPM_01471 Ribosomal RNA small subunit methyltransferase A
MEAVKAKKHLGQHFLKDESIAKDIADTLNLEGYDNVLEIGPGMGVLTKYLLAKEVTTYVI
EIDTESVTYLDQNYPKLKDKIISKDFLKYNINEIFEGKQFAIIGNFPYNISTQIVFRALE
YRNQIPEFAGMFQKEVAQRICEKKGTKAYGILSVLVQAFYDAEYLFTVDETVFIPPPKVK
SGVLRLRRKKDYSLPCGEKLFFTVVKTAFQQRRKTLRNSLKTLNLSDILREDEVFNLRPE
QLDVQQFIELTKKIEADGI
>KACEBFPM_01472 hypothetical protein
MQTEATGQYSRKIWFLYEWLMQEQLPIPDLTIKNYIPLVDEEIQFASPISSNSSRHRIKN
NLPGNVGFCLLIFKTQKLNDYISENLSSKKNSYLNAVHKDVLQRASAFLLLKDSKSSFTI
EGENPTNNRAVRWGRAIETTQWRCSFGF
>KACEBFPM_01473 Succinate--CoA ligase [ADP-forming] subunit alpha
MIKANDYIKGKNCRLIGPNCPGIITPGEAKVGIMPGFVFKKGNVGIVSKSGTLTYEAADQ
VVKQGLGITTAIGIGGDPIIGTTTKEAVELLMNDPETHCIVMIGEIGGQLEADAAKWVRA
DGNRKPVVGFIAGVTAPAGRTMGHAGAIVGGEDDTAEAKKRILRENGIHVVDSPAEIGKK
VKEVLG
>KACEBFPM_01474 Homogentisate 1,2-dioxygenase
MPIYHKLGNFPQKRHIQFEKPEGGLYYEQLFGTEGFNGHSSLLYHVHRPTQVKEIIKSYS
VEPKIAIGKNIKSLLLKGFELKPEDDFLDSRKDMLINKDCIIGLAAPKKSLTEYFYKNAD
ADEMIFIHKGKGKLRTMLGNIPFEYGDYLIIPRGMIYQIEFETSDNRLFYVESYTPFYTP
KRYKNESGQHLEHSPFCERDFKLPSELETHDEKGDFLIKTKKEGMMHEIVYATHPFDVIG
WDGYNFPYAFSIHNFEPITGRVHLPPPIHQTFETSTFVICSFVPRLYDYHPKSIPAPYNH
SNIDSDEVLYYVDGDFMSRNNIEQGHITLHPKGIPHGPAPGAMERSIGHTQTQELAVMVD
TFRPLMVTEAAMGLDDGQYYKSWVE
>KACEBFPM_01475 putative amino acid permease YhdG
MAGLCYAELSSSIPISGSAYTYTYATMGELLAWIIGWDLILEYAVGAATVGIAWSEYLNN
LLVNVLHTSPIPYSLSHSPFQISASGEHGIINLPAFFIVAVISLLLIKGTQESAFVNGII
VLVKVSIVIMIIVFGWNFINPINHTPYIPQPSIFIDDSGVGHNYGGIMGILGAAGTVFFA
FIGFDAVSTAAQETKNPKRDMPIGILGSLAVCTVLYILFAHVLTGLESVEFFRTSGKEAS
VANVITTAMVGYEWLAQFVTVAILFGFTSVILVMLLGQSRVFYAMGKDGLLPKAFGDLHS
KYKTPYKANLVILVIVGAFAAFVPGDIVGDMTSIGTLFAFILVCVSVIVLRKTDPDMKRE
FKTPFVPFVPILGIIVCLAMIYGLGWTNWLRLAVWLAIGLIVYFGYSKKNSVLNNPDKK
>KACEBFPM_01476 hypothetical protein
MKKIIFKSWIINLVISISLFVIYRLIIAETNYLESMSMFEKFLFFIDVLLNIWVSILSLI
AMFFCSLFFFLNLVVNIRNNYYLSSLSFLGIPTIWIIYLTRWV
>KACEBFPM_01477 Succinyl-CoA:coenzyme A transferase
MGKYVSAQEAVKIIKSNDRIYVQAAAATPTVLTKALTERASELKNVEVCHLHTEGEAAYA
NPELSESFHVNSFFIGKNVRHTLVAGNGSYTPVFLSELPYLFRKNVVPLDVVFIHVSPPD
IHGYCSLGVSVEATLAAIENAKTVIAQVNPKMPRTFGDGILHVSEIDYLVEVDTPIYEHE
IGIISSIEDKIGTYIASLIEDESTLQMGIGSIPNAALTKLTNHKNLGLHTEMFSDGVIDL
IEKNVINCDYKGISRGRALATFLIGSQRLYDFVNDNPFVEMRESSYVNDTSKIRKNPKMV
AINSAIEVDVTGQVCADSIGAKMYSGVGGQMDFIRGASLSNGGKAIIALPSITKNGVSRI
VPYLKQGAGVVTTRSHVHYVITENGIADLYGKTLKQRASEMVKIAHPSHQEWIEKSYFEM
IN
>KACEBFPM_01478 hypothetical protein
MNNLLSNIKIQVNEKLYQKDPETSVLGKKIIEHSIILIDDIGFDDFTFKKLGEKIGSNES
SIYRYFENKHMLLLYLSSWYWSWIEYRMVLSTNNIENVFEKLKIAVTIATEKIIDDSTTK
HINEAILNKIIISEFTKTLLTKEIDQENKEGFFLVYKRVVNRIVSIIEQVNPEYSFAKSL
ASTIIEGSLHQHFLKEHLKTITNCNQEITPTDFYLNLITTLFKK
>KACEBFPM_01479 Putative multidrug export ATP-binding/permease protein
MSPLKRFFYLLSLDKKDVYQVFFYAIFAGLISLSLPLGIQAIINFIQSGRVSVSWIILII
LVVIGVALVGILSLMQLRITENLQQKLFVRSSFEFAYRLPKIKFEEMYNTYPPELANRFF
DTLTIQKGTSKLLIDFSAALLQIIFGILLLSIYHPFFIIFGLLLLLLLYGIFKFSYNKGL
ETSMKESKFKYKVAGWLQEMARKNTSFKKNTAFNFSLQKNDDLVTDYLKYRESHFSIIKK
QFSQLIIFKVIITASLLLIGGYLVLNQQMNIGQFVAAEIIILLVINSVEKIILGLETFYD
VLTAVEKIGQVTDMNIEDSNELEDHSLNYSNISLETDNLSFRFPDSQNDILSGINLKIEP
GEKIVLLGKNGSGKTTLMRILSGAIEKTSGSFSINDNTFRKMDLNQYRSQIGAIVHGETP
FEGTILENITYNDPTISNEDLKWALDAVQLTPYIKTLPKGLDTKIFPEGKQLSSSNAQKI
VLARSIIKKPQLLFFEEATDLMDEPVANQIIDFILSDKNNWTVLTTSKNKHWQNLATRKI
TMKNGQILNDSKK
>KACEBFPM_01480 Colicin V secretion protein CvaA
MLNLSNNSKSKIEQKTIARFRTIQNLSNRPHYKILNKIILFVSILGIIILFLPWTQNISG
SGFVTTLKPNQRPQTIQTAIAGRIEKWYIKEGDFVKKGDTILFISEIKEDYFDPNLVGNT
KNQVEAKKMALESYDGKVSSLGSQINAIENEKKLKLEQAKNKIKQSLLKIKSDSIDLEAV
KTQLKIANTQFIRSSQLNKEGLKPMTDVEEKRLKQQEVEAKIITQENKFLTSKNEYINTK
VEINRILAEYSEKSAKAKSDKFTALSNQYDTEAQVNKLQNQYVNYSIRNGMYYIKAPQSG
YINRSLQSGIGETIKEGTSIVSIMPAHYEIAVETYVSPIDLPLISKGEKIRVWFDGWPTI
VFSGWPDMSYGTFGGKVIAIENFISENGKYRILIAPDENEAKWPKQLSIGSGAQTIALLN
TVPVWFEVWRTLNGFPPNYYKQNTKKDNKEKK
>KACEBFPM_01481 hypothetical protein
MRIGFLIYLLFTIGTTFAQSKDSNELLYNEFLGYVKKFHPLVKKANLELNMAQANLMMAR
GAFDPKFEVDFSEKQFKSKDYYSKLNSSFKIPTWYGIEIKAGLDSNDGLYLDPENSTSNQ
ALTAIGITVPLGQGLFINQRMADLKKAKIQYNLSQAEIKLQATAVLYDASLAYFNWEKNF
AEVKLYEKYNKQADSRYTAIKKLIELGDKPAIDSIEAGIVVKNRALNLLDSQLKLTKAKL
ELSNFIWLENMIPVEISDNLTPEETLPITIEETLKTNQFSNPEKTLDNHPKINALENKIE
ILTIDKKLKANLLLPKIDFSYSYLSEPRYFDNYQFNNYKVGIHFYYPLFLRKERGSLKLA
QFKLQDAQYSLYLERLQLKNKISSYQAEIQSIKNQKKIINSLVEDNITMLNSEERLFSFG
ESAVFLINTRENNLVSAQLSKISLENRYFVSHAELFKIIANPN
>KACEBFPM_01482 Methionine aminopeptidase 1
MIIQKTREEIELMRESALIVSKTLGMIASEIKEGVTTLYLDKLAEEFIRDHGAVPSFLGL
YGFPNSLCMSPNSQVVHGIPNNIPLQSGDVISVDCGAFKNGYHGDHAYSFEIGEVAPETK
KLLQVTKESLYVGIREFKAGNRVEDVGNAIQKYTESHGYGVVRELVGHGLGQKMHEDPEM
PNYGKRGRGKLFVEGMVVAIEPMINMGTKNIKQHKDGWTITTADGKPSAHFEHDVALIDG
KPELLSTFAYVYKALGIVSNEEDEFRKVPFVI
>KACEBFPM_01483 hypothetical protein
MKLKLQNIGIIEEADINIDGITLIAGQNDSGKSTVGKVLYALIRSVNIDEDRFNASKNEF
VRNRIRDVRNLLLRTKLSNSEDEKIREKFVSEFLENPESRFGRYIYRMNTDDSEKLDTLI
SELDNLNKLYNSFSNVSIKTQLGTFINDITNRISISIDSNEVLHYELESFFDNEFGNQIK
NKFKKGNSYINIEGIKEKKITFEEPIHFEGFNSMSNFYYDEVFFIESPIKLEDRNLLRFN
NNILRDKNQYLNSKIFEPNKEQDIFSDRSNDTEKLNLIISDIIKGAFEFNSKNQLIFKKN
EIEFDLNNVATGIKSFGILQLLLQKGKLNSNSLLIIDEPEVHLHPTWQVKYAEILVRLSK
EFAIPILLTSHSPYFIEALEGFSKKHDYEKSTNFYFAEKNEDGLSSKIVDVTENISPILS
SISEAFYEIQDINYED
>KACEBFPM_01484 hypothetical protein
MRINEIELFFEENVAKKSLTELSFDCDNGISLLNSENQSFDFDTLDKPVIHKDKIKTSDT
IYFKDDKIIFVEFKRGQKIPEIQFRLKATESIITFYNYIFTQNFQEKMYFPNTFFQIYFV
YNKANISATALPFFANIERKLRIQYKHLLSEYHIIDSEKFERIFNS
>KACEBFPM_01485 Ubiquinone/menaquinone biosynthesis C-methyltransferase UbiE
MKKLFKLILNTIPRPILIRLSYVARPILALLLKGSKFTDPIDGKSFRMFLPYGYGTQRNN
VLSPSTLSLERHRLLWLYLKNETDFFTSKEKKKVLHFAPEQEFYKRFRKQQNIEYTTTDL
LSPLADVKADICNLPFYDNQYDIILCNHVLEHIPDDTKAMQELFRVLKPNGMAILQIPQD
LSRATTFSDDTITDQKERAKIFGQYDHVRIYGRDYFNKLRSIGFTVIEEDYTNKIAPELV
TKYCLAKGEIIPVCFKKQ
>KACEBFPM_01486 hypothetical protein
MAKRVFLLFISILLMNSVIGQTISETIPPFNIKTVTFTQNTNNVIPVFKLGEPFQLSFDD
LFGTEEDYYYTIAQYNYNWTPTLLSKNEYLNGNDNQRIQDYENSFNTLQIYSHYRLNFPN
NYTQITKSGNYLVSIFNSNKEIIFTKKIIIYEELVDVPMQVKRARNVTDNKYKHNLEFSI
KSNSILFQNPVQNVKIILLQNGKWDNAIVNIKPQYTIGNDLIFKYDKETQFFAGNEYLYF
DNKEIRVATNTIAKVNSNTGLYNSHLYTDSARKYKSYSYYPDINGNFKIRNLTAQNNDIE
ADYSWIYFTLFAINAPASTNIYITGMFNNNTISPENKMDYNTNKGVFEKAILIKQGFTNY
NYTILDPQNNISDKDPIDGNFYETENQYTAIVYYRQNGELYDRVIGKGNANSTNITN
>KACEBFPM_01487 Protein ApaG
MVIQTTRGIKISVLTTFEGTYFKNNKMHFAFSYHITIENHSKDSVQLITRHWEIHDALNY
LETVDGEGVIGKKPVLKPGETHTYSSGCLLCAPFGTMKGHFEMINFTTTKSFKVIVPAFK
LNALFALN
>KACEBFPM_01488 1-pyrroline-5-carboxylate dehydrogenase
MLKGFFNIPKAVNEPVKTYAPNSPEKTRVLEAYKTMWNTKIDVPLYIGAEEIRTGNTKNM
TAPHDHQHIVGTYHLAEKSHVEKAIANALESRTKWANMAWEQRAAIFLKAAELIAGPYRA
KINAATMIAQSKTIHQAEIDASCELIDFLRFNVEFMTQIYQDQPASNSDMWNRVEYRPLE
GFVYAVTPFNFTAIAANLPASAALMGNVVVWKPSDSQVFSAKIIIDIFKEAGVPDGVINV
VFGDPVMITDTVLASPDFAGIHYTGSTFIFKEIWKKIGTNIHNYKTYPRIVGETGGKDFI
IAHPSANVKQVTTAITRGAFEFQGQKCSAASRAYIPQSMWQAVKEQLITDVKSMKMGSPE
DFSNFITAVIHEGSFDKLASFIDQAKKDTDAEIIVGGNYNKSKGYFVEPTVIVTTNPKYA
TMETELFGPVMTIYVYEDKNWSDTLQLIDSTSEYALTGAILSQDRYAIEEATVALQNAAG
NFYINDKPTGAVVGMQPFGGARASGTNDKAGSAQNLLRWVSPRTIKETFVTPEHYAYPFL
G
>KACEBFPM_01489 Ribosomal RNA small subunit methyltransferase G
MEEILKHFPDLTNLQITQFEKLEALYQDWNAKINVISRKDIDELYTKHVLHSLAIAKIQK
FEAGTYVLDVGTGGGFPGIPLAILFPETRFYLIDVILKKIKVVQAVAEALELKNVKAEQI
RAENVKGDFDFIVSRAVTNMPDFVCWIKDKIKKTNKHELKNGILYLKGGDLTEELQDFPK
AKEYNISEFFAGDFFETKKVVHVPLKFKL
>KACEBFPM_01490 NADPH-dependent stearoyl-CoA 9-desaturase
MNTTTPTFARNDSMKFFKTLNTRVNSYFKDNNIQKTGNWKLHLKTVIMFSLFFLPFFAIL
YFTNMPFWIYFLSSIIIGIGMAGVGMNVMHDGNHGSYSSKSWLNKIMGGSIYILAGNVYN
WQVQHNVLHHTYTNIPGHDEDLDAGRVIRFTKEAKWYKFHAFQHYYSVFLYGLLTFNWCL
TTDFKQMGGYLKRNLSYGDAPNPTNLWIGLVISKIIYFSFWIVLPLVVGITWWKVLIGFT
VMHYTAGLILSIVFQLAHITDDTTNPNPNEEGEMENTWAIHQLFTTVNFAPKNWIVNWYT
GGLNHQVEHHLFPNISHVHYGQIAEIVKQTAKECELPYHEYETMTSAVLAHFRHLKDLGQ
KPQLA
>KACEBFPM_01491 Aspartate aminotransferase
MNNFLSDRINKLSTSQTLAMAALARELKNQGKDIISLSLGEPDFNTPNFIKEAAKKAIDE
NYSTYTPVEGYAALKDAICRKFKRDNNLEYKPANIVVSTGAKQSLYNIAQVMINDGDEVI
LPAPYWVSYYEIIKMSGGIPVEVPTSVESDFKITPAQLEAAITPKTKMIWYSSPCNPSGS
VYNREELTALAKVLEKHPNIFIVSDEIYEHINFSGTFCSIASIPGMFDRTITVNGVAKAF
AMTGWRIGYIGAPEFIAKACTKMQGQVTSGANSIAQRATIAAVDADPSVLNEMVTAFKSR
RDLVVALIKEIPGLKLNTPEGAFYVFPDVSAYFGKTLRGKTINNADDFSMYLLGEANVAT
VTGDAFGNPNCIRISYATSEEILTEAIRRIKEVLA
>KACEBFPM_01492 Penicillin-binding protein 4*
MILKTNIKNILLFAIITICFSCSEKKKALKKKEENKIGSLYTMQPFDNNLPDLKSSEKEK
LRQTIETFYAKNYIPNDFSGSILIAKNGHIIYENYRGMSNFEEKTPITDQTPLHIASMSK
VLTATAVFLLIDSKKITLDQKVNTILDDFPYPEITIRTLLNHRSGLRNYSYFTDKKIVWN
QKDTLQNKDLISVINKNNIDLEYKTDTHFAYCNTNYAFLALVIEKITKMEYRTAMKKLIF
EPLSMKNTFVFDYKKDGKNSSQSYKGNKIKYAYNYLDGIYGDKNIYSTPRDLLKFDMATY
NSSFLNKKLLAEVYKGYSYESKGTRNYGLGIRMLEWKDGKKMFYHNGWWHGSTSAYVKLK
DEKATLICISNKYTRCTYKLKLLSSLFGDYPFEIKSKEEGLE
>KACEBFPM_01493 hypothetical protein
MKFGLIKERKNPPDRRVVFTPEELAKLKQQFPLAEIKVESSDIRVFNDEQYSELGFDITT
NLSDCDVLIGVKEVPIDALIPNKKYFFFSHTIKKQPYNRKLLLACLEKNIELYDHETIVD
AKNHRLIGFGRYAGIVGAYNGIRAFGIKFELFNLAKAETLKDKNALVERLQRMVLPNIKI
VLTGHGKVGLGAKEMLDAMKLKEVSIENYLTKNYDRPVYTHIDLEDYNKRIDGKPFDKQD
FYANPELYTSNFERFTKVSDIFMAGHFYGNGAPVILSREMLKAANNKIKVVADISCDVDG
PVACTLKASTIAQPFFGYYPSEHKEVDFMHPGSIVVMSVDNLPCELPKDASEGFGEMFLE
HVIPAFYNNDKDGILQRAKITEKGKLTQRFSYLQDYVDGK
>KACEBFPM_01494 Aminopeptidase YwaD
MKKLSFLLLFTSLFGFAQNSDQNQLKEIYKSALTNSKCYAWLDDLSNKIGHRLSGSAGAQ
KAVEYTKSQMEALGGFDKVYLQEVMVPKWVRGEKETAYILDHKSKVKVPVCALGGSVATS
KKGITAQVIEVHAIKELETLGIDKIKGKIVFYNRPMDNTQIESMNAYGAAGDQRWSGAKE
ASKYGAVATIVRSLNLRLDDFPHTGSQSYDDIPKTQYIPTAAISTNGAELLSKTLKENSK
LKFYLKQSCQQMEEVLSYNVIGEIKGTEHPENIIVVGGHLDSWDLADGSHDDGAGCVQSI
EVANIFKNIKYKPKNTIRVVLFMNEENGGRGGKKYQELAQINKENHIFALESDLGGFSPR
GFSLETDDANYARISNWKSLFEPYLIHSFTKGHSGSDIEPITGTKIIKAGLYPDTQRYFD
YHHAANDKFDAINKRELELGAATMTSLIYLIDKYGIE
>KACEBFPM_01495 1,4-dihydroxy-2-naphthoate octaprenyltransferase
MKHWIQAARLRTLPLSVSGIMVGSLYALANPTNDILTPTQVFSWIIFGFAMLTTLGLQIL
SNFANDYGDGIKGTDNKDRIGPIRAIQSGVITPAAMKKAMIITAILTFASAILLIYFSFH
DKHLWYSLFFLLLGGSAIVAAIRYTVGNSAYGYKGFGDVFVFIFFGLVSTLGVNFLYSKQ
FDWQLVLPASAIGLLSVGVLNLNNMRDEVSDAKAGKNTLVVKMGGAKAKIYHYCLIITAM
ILILIFAIIYNGIGFRIDQYVFLVAYFPLLSHLKTVYNCSEPRALDPQLKKLAISTFLLS
LILAMVLIF
>KACEBFPM_01496 1,4-dihydroxy-2-naphthoyl-CoA synthase
MNKIDWKTVREFEDITYKKCNGVARIAFNRPDVRNAFRPKTTAELLQAFHDAQEDTSIGV
VLLSAEGPSSKDGVYSFCSGGDQKARGQQGYVGEDGYHRLNILDVQRLIRFMPKAVICVV
PGWAVGGGHSLHVVCDLTLASKEHAIFKQTDADVTSFDGGYGSAYLAKMVGQKKAREIFF
LGRNYSAQEAFEMGMVNAVIPHNELEDTAYEWAQEILAKSPMSIKMLKFAMNLTDDGMVG
QQVFAGEATRLAYMTDEAKEGRDAFLEKRKPNFEKKWLP
>KACEBFPM_01497 Conserved virulence factor B
MYLCHFDTKIMIEIGKYNTLTILRETKVGLYLGLPEENKDPSKDILLPIKYIPNEFEIGE
ELIVFVYLDHEERPVATTLEPYILLNEFALLRVNYVNQVGAFMDWGMEKDILVPFKEQAR
PMEKGKRYLVYLYMDEKTNRLVASSKTNQFLNNDNITVENGEEVDLIVSHITEVGINVII
NEQHKGLLYKNEVYDDLRTGDRIVGYIKNIRPDGKIDVSATKLGFEKVEPSAQIILDELK
ASRGFLRLNDDSHPEDIKTVLKMSKKTFKKAIGTLYKEKLIEIKEDGIYLVKE
>KACEBFPM_01498 GTP-binding protein TypA/BipA
MESIRNIAIIAHVDHGKTTLVDKIMYHCQLFRDNENTGDLILDNNDLERERGITITSKNV
SVQYKGTKINIIDTPGHADFGGEVERVLNMADGVCLLVDAFEGPMPQTRFVLQKAIDLGL
KPCVVINKVDKENCTPEEVHEKVFDLMFELGATEEQLDFPAVYGSAKNNWMSDHWENITD
NVEALLDMVIANVPAPKVSEGTPQMLITSLDFSAFTGRIAIGRLERGVLNEGMPISLVKR
DGTVVKSRIKELHTFEGLGRKKVQQVIAGDICAVVGVEGFEIGDTIADFENPEALQTIAI
DEPTMSMLFTINDSPFFGKEGKFVTSRHIRDRLNKELEKNLAMKLGETDSADKFMVFGRG
VLHLSVLIETMRREGYELQIGQPQVIIKEIDGKKCEPIEELTIDLPETLSGRAVEFVSFR
KGEMLSMETKGERMIIKFNIPSRGIIGLRNQLLTATAGEAIMAHRFIGYEPYKGEISGRN
KGSLISMEKGKAIPYSIDKLQDRGKFFVEPNAEIYEGQVIGENSRGDDMCVNVTKEKKQS
NVRSSGNDEKARIIPPIIFSLEEALEYIQKDEYVECTPKSIRLRKIHLTETDRKRFKI
>KACEBFPM_01499 Succinyl-CoA:3-ketoacid coenzyme A transferase subunit A
MAGAAKTTIAEVEELVEAGTLDPNQIHIPGIMVNRIFQGEKFEKRIEQRTVRTR
>KACEBFPM_01500 putative type I restriction enzymeP M protein
MKDLIKIVGFQAKENASAIYIKKYLDGYAIEIDFDKKTFHFGGKIKIGGKDSQNITKPED
WVVLECVNRLLETGYKPENISLEKVYPAGHGFSGRLDICVNREDGSEYLLIECKTYGKEF
DKEFTRIKKDGGQLFTYFKFSNKADVIMLYASQLINNEIIYPNEIVKIEENYKLGGTKDF
YNSWNKKTYQNIVWENKPYNSETKKTFTKDDLKPLSKEQSDTIFHGFASILRKHSVSDKP
NAFNKIFNLFLAKLYDEAKGDDMELDFHWREDDNPIDFQVRLINLHKKGLEAFLAKEIAG
IEDSDFEGYKNAEELLERKKKILMFNNVFAIKEVDDDETFNNNQRVLKEVVQLLEKYQIR
YPRKQQHLSDFFELLLTTGLKQEVGQYFTPPPVTKFIVRSLPIKKMILQEINNQEPKLPA
VIDYAAGSGHFITEALEEYQDIINKIDINKELTFPKAKTAVQSWVADPYNWAAKYVYGIE
KDYRLVKVAKVGCYFYGDGVAQIIHGDGLDSFATSKTYKGLLQENINIEDSSKAKFSVVI
SNPPYAVNDCKDDLEYIGAQHEYTLYQSLSDKSKDIECLFVERTKHLLKDGGVASLILPS
SILNNTGIQTKTREIILQYFDIVAIAELGSNTFMATGTNTVTLFLRRRANKLSAEWKKSV
ANFFENKTDITINGIEKPVAKYVNHVWENISFSDYISLLEKTPNEAIQNHEIYKEYRKKL
KAKTEKDFWNLLLDREADKLLYFIIAYNQKVVLVKSGQKDIEKRFLGYEFSSRRNSEGMH
AMQRGKTVDECTQMYDAKLFDNPEKASTYILKAFNNVDFDIDAKMQNHISRHDLVDMLTF
DRVEFEKTISLSVKKKVIIDTKYKQEKLGNVFLEIKNGKNVNQSDEIGDYRVSRIESIAD
ANFNIDATKWTTDKVSENDFLQKGDILLSHINSVQHLGKTAFFDLSEKIIHGVNLLRFRP
DVNKVIPKYISEILKQKSIIFEMQKYAKKAANQASLNQGDLVQIQIPLPPLNIQQKIVAE
IEVLEAKEKKAKEEVEKLKIEASNLFNFDGEMVKLQDITTKIGSGATPRGGESAYAQSGI
TLIRSMNVYDNEFYPKGLAFIDDEQARKLNNVTVEENDILFNITGASVCRCCIVENKYLP
ARVNQHVSIIRTNEKALPKFVQQLLISSKFKTELLELADNSSTREAITKLQLEDFKIPLP
PLSEQQKIVSEIEKIEAKITTLETEIASIPKQKEAILKKYL
>KACEBFPM_01501 putative succinyl-CoA:3-ketoacid coenzyme A transferase subunit B
MALDKNQIAKRIAQEVQNNYFVNLGIGIPTLVANYVREDISVEFQSENGVLGMGPFPFEG
EEDADIINAGKQTITTLPGASFFDSAFSFGMIRAQKVDLTILGAMEVAENGDIANWKIPG
KMVKGMGGAMDLVASAENIIVAMMHVNKAGESKILKKCTLPLTGVGCVKKVVTELAVLEI
TPKGFKLLERAPGVSVHDIIKATEAELIIEGEIPEMTL
>KACEBFPM_01502 hypothetical protein
MEQKLLNEIISLKESNENLNSTIKSLSNDLKDFREELEKVRFRMSELECALSNE
>KACEBFPM_01503 NADH dehydrogenase
MNIPQTTLPRIVIIGGGFAGIAIAKKLRNKKLQVVLLDKHNYHTFQPLLYQVATGGLEAG
SIAYPIRKVIQEYKDFYFRLTSVKEIDTQNQKIISEIGELHYDYLVIATGSKTNYFGNKE
IERNSMAMKTIPQSLNIRSLILENFEQAVLTKDPADKNSLINFVLVGAGPTGVELAGALA
EMKKAILQKDYPDLDVSKMEINLIQSGDRILNTMSEKSSKAAEEFLLSLGVKIWKNVRVT
NYDGRTITTNSNLTFDTATLIWTAGVQGAAIAGLDAKSLVQKVERIRVNQYNQVVGHNNI
FAIGDIASMETDKYPQGHPMMAQPALQQGELLGENIIKLMQNKPLKPFQYHDKGSMATIG
RNKAVVDLPKYHFSGVFAWFVWMFVHLFSLIGFKNRAVVFLNWVYNYIRFDREGRLIIRP
YKKKSFVTFTSDEV
>KACEBFPM_01504 ECF RNA polymerase sigma-E factor
MSNALERSFVGQLKDNQNIIHKICRLYTQDNDAHNDLFQEITIQLWKAFPKFRGDSKFST
WAYRVALNTAITLYRKNTKALNTIEFETGKHFVLQEEYNYEEEEHLRLLYKAVQELNDIE
KALVFMYLEEKDYTEISETLGISEVNARVKMNRIKSKLKKIINP
>KACEBFPM_01505 hypothetical protein
MKELDLLKKDWNRNDNYPKFSEQEIYVMLHKNSSSSVKWIFYISVIEFVFLNGIGYLLTD
KKEEVFFALHPFLNVLQYINYFVIIVFIFLFYKNYKAISVLESSRKLIELILKTRKVVTY
YIFWNIFIGGISGAYAALAGWKEGYNANRLATSKAITEINYIALLLVMICIMGGIWYFYK
LIYGRFLSKLKNNYEELKKFDF
>KACEBFPM_01506 hypothetical protein
MGLFKRNPFGHILFLKKWLIRIFAAITHKRYRGFNELQIEGSEIIKNLPDTNVLFISNHQ
TYFADVVAMFHVFNASLSGRQDNIKNLGYIWQPKLNIYYVAAKETMQSGLLPRVLAYAGA
ISVERTWRAGGKDVSDTAKKDVNPNDTENIKIALADGWVITFPQGTTKSFKPVRKGTAHI
IKQHRPIVVPIVIDGFRRSFDKKGLRMKKKGILQTFTIKEPLAIDYDNDTIEEIVEKVEY
AIEQHPSFLKVIPSEIIEEQEELNKMRKWEY
>KACEBFPM_01507 putative Nudix hydrolase NudL
MKFSHFLKYVPKIAKESLPAAIAHAKMIPPERIEFLNNQDFSKIIPKKAAVLMLLYPKNK
MTHLALIVRNSYPGIHASQIAFPGGKVEDSDLSLCETALRETEEEIGVAAKKVTVIRSFT
QVYIPPSNFLVSPFLGFAKEELLFTLSPDEVDQVIELPLYEFLDEKNVISTKMSTSYASN
IQIPAFKINEHLVWGATAMMMSELKEILKKVL
>KACEBFPM_01508 hypothetical protein
MYTKEEAQRLKREFWISFAEKYPRKWILYDTKIKDFSFKFFVDNKKAHVLIDIEMRDAEK
RKSYFEKLESLKAILEEEYIKDLVFENKYTLESEKTISRIWVEKLDVSVSNRQYWDEIFD
FFNEKMNELERFYLEYEDYIKDI
>KACEBFPM_01509 hypothetical protein
MKKLILLAFLVPMASQAQFDGLIKLGKEVINTVLKTDDSFDIAAGLKEALNNGVAIQVTK
LTATDGFYKNDAVKILMPSELQKVEQTLRKLGMNKLADDGVKALNRAAEDAVKEATPIFV
DAVTGMSFTDAKNILMGNQSAATTYLQGSTSTALYGKFNPVIKNSFGKVGADKIWTQIIT
KYNSIPLVKKVNPDLTDYVTNQAMTGVFKMIAVEEKNIRSNVNARTSNLLKNVFAMQDKK
>KACEBFPM_01510 Ribonucleoside-diphosphate reductase 1 subunit alpha
MYVIKRDGHKEPVMFDKITERIKKLCYGLNDLVDAVKVAMRVIEGLYDGVATSELDNLAA
ETAASMTIAHPDYAQLAARIAISNLHSNTNKSFSETMNEMYHYVNPRNGQEAPLLSEEVH
TVIQENAAFLNSHIIYTRDFNYDYFGFKTLERSYLLKINGKIVERPQHMLMRVSVGIHLN
DLKSVIETYDLMSKKFFTHATPTLFNAGTPKPQMSSCFLLAMQDDSIDGIYDTLKQTAKI
SQSAGGIGLSIHNVRATGSYIRGTNGTSNGIVPMLRVFNDTARYVDQGGGKRKGSFAIYI
ETWHADIFEFLDLKKNTGKEEMRARDLFFAMWTSDLFMKRVEENGDWTLMCPNECPGLYD
VYGEEFEKMYTNYEKAGKGRKTIKAHELWEKILESQIETGTPYMLYKDAANRKSNQKNLG
TIRSSNLCTEIMEYTSKDEIAVCNLASLSLPMFIENGTFNHDLLFTVTKRVTRNLNKVID
RNYYPVKEGENSNKRHRPIGLGVQGLADAFIMLRLPFTSDQAKKLNQEIFETLYFAAVTA
SMEMAIEEGPYSTFAGSPISQGEFQYNLWGLKDEELSGRWDWASLRKEVMKNGVRNSLLV
APMPTASTSQILGNNEAFEPYTSNIYTRRVLSGEFIVVNKHLLNDLVERGLWTEDLKQQL
MRENGSVQKLNIPQDLKELYKTVWEMSMKDIIDMSRQRGYFVDQSQSLNLFMQDANYSKL
TSMHFYAWKSGLKTGMYYLRTKAAVDAIKFTLNNDKKAEPITIEVKQQTTLTEVEPQTTT
MTNEEYSAMIQLAKNATPEDCEMCGS
>KACEBFPM_01511 Ribonucleoside-diphosphate reductase subunit beta
MSFVEPILQENKNRFVIFPIKHHDIWEFYKSMEASFWTAEEIDLSQDLNDWNNKLSNDER
YFVKHILAFFAASDGIVNENLAENFVNEVQYAEAKFFYGFQIMMENIHSETYSLLIDTYV
KDEVEKDELFNALEVFPAIKKKADWALQWIESDSFAERLIAFAAVEGIFFSGAFCSIYWL
KKRGLMPGLTFSNELISRDEGVHCDFAVHLHNHHLVNKVPKERIRSIIVDALNIEREFIT
ESLPVSLIGMNAVLMTQYLEFVADRLLVELGCDREYNTANPFDFMDMISLQGKTNFFEKK
VAEYQKAGVMNTDSEAQKISFDADF
>KACEBFPM_01512 hypothetical protein
MFQLGKTIVSEDILQKEFVCNLSACKGACCVDGDAGAPLLEDEVRILEEIYPKVKPFLRK
EGIAAIEALGTSVIGTDGTLETTLIDNKDCAYVIFDGKTALCGIEQAYNQGIIDWKKPVS
CHLYPIRVKDFTEFAAVNYDKWDICSPACSLGKELEVPVYKFVKEALVRRFGQNWYTELE
KVAEELKNE
>KACEBFPM_01513 hypothetical protein
MFDISLKEIVTVGMVLFAVIDIIGSIPILVDLRSKHGHIESEKASIVACFIMISFLFAGK
ELLNLIGIDVNSFAVAGSFVLFFLALEMILGIRLYRDEEAKSASIVPIAFPLVAGAGSMT
TLLSLKSQYHDINIILAILLNIVIVYGVLKSAGKIEKMLGSTGLGIIRKVFGVVLLAIAV
KLFAANVKGLFL
>KACEBFPM_01514 hypothetical protein
MKIFTYIIIALAIVFIGINMTRLDFNNLLEGESLIAIIGIISIICAVVILLIFRLSKSIE
DKLKNQE
>KACEBFPM_01515 hypothetical protein
MFDVLIVGGGVSGVSCALILGSAYKKAFVQDKNIVVITHQKTSSLQEAVFYNAYGISSGK
LGSEILTESIQQLQENYPHVTQIEDEKVVSVAGQAGNFVVVTTKNTYQTRIIVIGIGSSN
LFSIDGLQQYIEPHNKSLAEKNRIQLQNTDQKVANGIYVVGTLAGHRSQLAIAAGSGAAV
ATDILTLWNNGVETHVHDSIKK
>KACEBFPM_01516 hypothetical protein
MPFEDGSTVRLTIARYYTPTGRSIQKSYKNGNQEYINEFTNRYKNGELYAKDSIKIADTL
KFKTPKGRIVYGGGGIVPDVFVPLESAKGNEVIPMIMQSGLVSNFVFKELDIYRNQFVNL
NLRQIITKIETSDLYYNKFKKIIELNDSFINLNSSKKYIKRYITAEFCRQLLGENQYYQV
VLKEDAMVKEALKN
>KACEBFPM_01517 hypothetical protein
MSKRDELIAVYAADLKEKCAHTADIDLLTKVTVGCGPSIYNKDAATVAGSQQSELDTVKN
NFLIKKLGLADGDHLDNGIDAVLEKYGKSNKNKYRAVVYYLLTIHFNKESVYDK
>KACEBFPM_01518 hypothetical protein
MKNIKITLGILIATASIFVSCKKENTVSKTEKTSVTTTISKTDSSISKQAKQTTSFNIEG
MTCAIGCAKTIENKLVSLDGVQKATVDFDKKMAIIQYDATVQTPEKLVQTVEAVADGKTY
KVSNVK
>KACEBFPM_01519 putative amino-acid metabolite efflux pump
MHIKNNKWILLIVLSLIWGSSFILMKRGLVGLNPYQLGSLRIIFATIFLLIVGFKSLAKI
PIVKWKFIVFTAFLGTFFPVFLFAYAQTGIKSSVSGILNSLTPLYTMLLGALAFGFSFRR
NQIIGVVLGLSGCLILVINGNSANGDTNFFCTILVVIATVCYALNVNLIKKYLSDVSPLS
ITTGNFAVLLIPAIIILFGSGFTNVIAQATVQHSVLFVMLLGVLGTGVANILYFQLVQIT
SPLTASSVTYFIPVVAMSWGILDGEMLNPLQFLGAFIILLGVYMATKK
>KACEBFPM_01520 hypothetical protein
MTLNHPELVDLIKKAYSAEKAAAFAYQGHAASLKDETEKKEIRQIEIDEWFHRKEVLQIM
NDFDISISKYYEFKFHIIGKAISASCHIIGWFMPFYFAGRLESGNVCEYFRMKQFFNSLG
INTYDTMLYEMGIKEKEHEIYFLEKIKTNKFLPFYEKYFSWGNNQSFNNIDLDKKYPVEN
SNHYCKK
>KACEBFPM_01521 Ferredoxin--NADP reductase
MIETDILIIGAGPTGLFTVFEAGLLKLKCHIIDGLPQPGGQLTELYPKKPIFDIPGYPSV
LAGDLITNLIEQIKQFQPGFTLNETAETIEKLEDGTFIVTSNKGTKHHANSIAIAGGLGS
FEPRKPILKDIEFYENDKGVEYFVKDPEKFRDKKVVISGGGDSALDWSIYLSNIASEVTL
VHRRNEFRGALDSVEKVQELKSAGKIKLITPGEVVGFKGSEKIESVDIQVNTTLTTVPCD
YFIPLFGLTPKLGAIANWGLEIEKNAIKVNNALDYQTNIEGIYAIGDVNTYPGKLKLILC
GFHEATLMVQSVYQRINPGKKYVLKYTTVSGIDGFDGTRKEAEKQVVKSIE
>KACEBFPM_01522 Fe/S biogenesis protein NfuA
MTPEELTLNVEKALEEIRPFLNSDGGDIELVSIEDSKHVKVRLQGACNSCSVSQMTMRAG
VETTIKKYAPQIETVVNIA
>KACEBFPM_01523 hypothetical protein
MNYNDIIGTIGVSIVLAAYFLNIFSLIPKEGALFFILNILGACITCYTSIIIDYKPFAML
EGIWVLVSLFGLIKSLEK
>KACEBFPM_01524 Putative ribosomal N-acetyltransferase YdaF
MGVSCQAKINRTKTRNLKMQSLFFPCLKTKRLIFRQITPTDIQNIYKGLSNPKVIKYYGI
SFDSLEATEEQMIWYRDLEQNETGIWWAICSLDNNVFYGAGGFNNLNKEHKKAEIGFWLL
PEFWGQGFMQEAFPLICDYGFNKLDLNRIEGFVDSENTNCKKAVERLNFKFEGTMRDCEI
KEGKYLSVAIYSKLKND
>KACEBFPM_01525 L-amino acid-D/L-Glu epimerase
MKATYHKYILDFKKPSGTSRGVLTQKETWFLVLQNNEKKGIGECGILRGLSCDDRPDYEE
KLQWVCNHIHLGEKALWEALIEFPSIQFGVEMAFQSLAASSPFLLFPSGFTLGTKSISIN
GLIWMGEAQEMKQQIEEKIALGFKCIKLKIGAIDFNKELELLGYIRKNFTPEQIEIRVDA
NGAFSQTEALIKLNKIAGYQLHSIEQPIQKNHTDSMSELCKNSKINIALDEELIGVFSTQ
DKEDLLLKIRPQYIILKPSFVGGFRGTNEWIRLAEKHNISWWITSALESNIGLNAIAQFT
FLKNNTMPQGLGTGGLFTNNFDCPLEVKNGQLFYNPDLKWMIEINDFLK
>KACEBFPM_01526 hypothetical protein
MKIIKTAFLFLTTIAFAQDGYWDNQRITNKEIKLSAGKRKIIKSEDFPDGTTEFVYRITL
LDENQKIASDLSSVLKAIPDPTGITQGTGGAISLTSKISGDDKCTYAIFSNNSKYATDYF
RTGKTEKACLYQNEPISKEVKVISIEKSTCFNEINQTVWFGFESKNWILGQKIILEIVPW
VNIKASKIWSNAKKQLVLNYIRKSNEASQILKSEAFDYNILEKLQNEYKFSHFQKFSNTE
KLSLINKFEEKALTETNTVEEYNKAIQQEAKNLAKQGKYDNAIVLINHKIINKSKASVLD
YNTLGELYLYTKQYEKALKTFKIAENLDSSELLVQLNLAHTYMFLGKMSESREIHNKYKE
QNVSTNQTWKNKTINDLDKFQKSSLPNDNFKKILRLVD
>KACEBFPM_01527 hypothetical protein
MKNIQYIFLLLITFTGFSQDIAPEKYTAHNKGKFYIYWGGNRDVYSKSDIHFTGADYDFT
LYDVTAQDKPKGWHIDYINPGRMTIPQTNFRLGYFITDKYNISVGVDHMKYVMYQDKAVN
YTGHYPNKGTFGEVLPNNQILLTEDFLTFEHTDGLNYVNTEIARVDDISKIIGLPNTDKF
QINFTEGIGAGVLYPKTNAKLLGKERHDDFHISGYGFSAKAGLNFTFFKYFFIQTELKGG
YINMNDIKTTFSNADKASQHFWFLEKVIAVGGVFRL
>KACEBFPM_01528 2-dehydro-3-deoxyphosphooctonate aldolase
MSHESMKHAVQKVLDCNNPNVMLTDRGSMFGYQDMIVDFRGIPTMQTMATTVLDVTHSLQ
QPNQVAGVTGGRPDMIETIAKAGIAVGVDGIFIETHFDPANAKSDGANMLHLDYFEGLMT
KLVAIRQTINNF
>KACEBFPM_01529 C4-dicarboxylic acid transporter DauA
MTKKTNLFANLNSDFPAGLVVFLVALPLCLGIALASGAPLFSGIISGVIGGIVVGYLSKS
HLSVSGPAAGLTAIVLTAITALGDFRVFLLAAFIAGILQLILGYIKAGSISNYFPTNVIE
GMLAGIGIIIFLKQIPHAFGLDKDFLGDLSFLQSDGKNTFSEIMLVVENINLGSVIITIV
SLAILILWDKVTFLKKLKLVPAALIAVIVGVFINELFIRSGSSLAITSKHLVSLPVPTTF
DEFKNIIITPDFSAIANKQVWVVAFTITIVASIETLLCIEAADRMDIHKRYTDTNVELKA
QGIGNVISALLGGLPMTSVVVRTSANSNAGAQSKMAAIIHGVLLLVSALAIPFLLNKIPL
ATLAAILLLVGYKLANPKIIKHFFEKGKYQFIPFICTLLAVVFTDLLKGVALGVIISIIF
ILKGNMQRAYVFRKETLLDGDTIHIDLAQEVSFLNKAAIKLTLASIPENSKVIINASDTV
YIAHDVLDLIQEFEKIKSIEDNINVKLVGFKKAYDLVNTGEEEKHVFVEHKPV
>KACEBFPM_01530 hypothetical protein
MKFFTRIILAVFILFQFSTIIICVVNARNESKITLNITEEEDCSKDVKEIKAVFVVDSYK
LLPVFDEVPKKKVHDYYLLKKYMADATIFLLPPKQV
>KACEBFPM_01531 hypothetical protein
MKNIILILMVSFLGLSMNAQEVKKNKNAQYTIEVNGNCEQCQKRIQKAALSVSGVKQASW
SIETHRLKFILNEEKNTVVNVEKAIAKVGHDTEAVKANINDYDNLHTCCKYER
>KACEBFPM_01532 Vitamin B12 transporter BtuB
MKNIILFFVVLLSFPAFAQDTLQTVRVQMGRKKLQKSLLKTTNTTVLSGQELLKAACCNL
AESFETNPSIDVNFSDALTGTKQIKMLGLTSPYLLITEENIPSVRGASQAYGLSFTPGTW
VESIQITKGAGSVINGYESISGQINTELIKPAKDIPFFLNVYGSSDARMEINTHLNKKIS
DKWATSLFIHGNNRLSKNDMNNDGFLDNPLGNQINILNRWQYTNANKGWVSFLNFRYMND
KKQTGQVNFNPNTDKLTTNSWGSEINTNRFDFSSKIGYVWPEMPYQSIGFQNAYNSHNQE
SYFGLVQYNIKQNSFYSNLIFNSIISNTLHKFSTGLNFTSDIYKEFVNTKDYSRKDYSLG
AFFEYTYDNTENFSIILGGRLDYQNRLEFFVTPRLHARYNPWEGGVLRFSAGRGKRSANI
FAENQQLFGSSRSFNILESSGKIYGLNPEIAWNYGAGFLQKFKIFAKSADVSVDFYRTDF
QNQVVVDLFQSAQQVDFYNLKGKSFANSLQFEFNLEIIKHLNLRTSYKFYDNKTNYNSGN
FQRPLQAQQRFFGNLEFETHIKEKGQQWKFDYTFNWIGKQQLPNTASNPIQDRLSDFSKS
YSLMNAQITRTFSSKFEMYLGGENIGNYTQKRTILGAENPFGTSFDSSIVYAPVFGQMYY
AGLRFKVK
>KACEBFPM_01533 hypothetical protein
MLLLVSNVGLAFNVHYCGDEIASVTLKNPFFNKNAEDDCCGIAKKKSNCCNDKVFKFDKK
SDNSIVKIVSFHFDTPFIFQDWKPVVFSKKPVFKKCKITSYICNANAPPIFMRHCQLLFY
A
>KACEBFPM_01534 hypothetical protein
MLQKLLNNKLKIIQFVFLVGSLTLVRIFENDLFYDPFLKYFKDENASNYPEIESFKFFLS
LIFRYFINATISLALLYVVFKDLSLIKISSVLYILFLVLLMIGFYIVLNFFDESQKTILF
YIRRFIIQPIFILLFIPAFYFQKKSE
>KACEBFPM_01535 hypothetical protein
MKKYFLQHKPFLLFLGKFFFAYLAFTFIYQFYLSSFNNSIDAITENVSVLTEKLSNLVGL
NLSIVSNDTHYNLVYNNRITAKIIEGCNAISVIILFTSFVIAFSGKLKQTVLFILSGSLF
IYGLNIFRIMILTFLLYYYPAQEHILHGVVFPLIIYGAVFILWVIWVNKFSKYATKTPK
>KACEBFPM_01536 Free methionine-R-sulfoxide reductase
MTFEALKPKVTEITTNVAFSRDEKLLKVCQLLEANITYYTWVGFYFANHETKTLHLGPYV
GAETDHTVIPFGKGICGQVAVSNENFVVPDVAAQDNYIACSFTVKSEIVVPLFVNEKNIG
QIDIDSNVLDPFTSADEEFLEFVNKQVAVLF
>KACEBFPM_01537 hypothetical protein
MSVSQKIELDDMAIDRIIEMAWEDRTPFDAIKFQFGLAEADVKALMKKEMKFSSYKLWRK
RVENCKTKHLAKRIEGINRFKCKLQRAISNNKIAKR
>KACEBFPM_01538 hypothetical protein
MKKEKPDNVVFSEEKGYNASLLPYATSVGAPVIKTDDVVAWKIRGIHNVNKEFENKFNEL
KQQYQKLMLEYEWNEMVYNAKFSFEPVIGEIYHLYTGHDGINFLSLISPQEWNKEHIATF
KLNSDKKWLILNEKDDSFS
>KACEBFPM_01539 hypothetical protein
MQKHISSTEIMNMEKQERVHFINSLGGFKSVSLIGTTNNDRQTNLAVFSSIFHIGANPAL
IAVVFRPSPPDRDTLKNILETGFYTINHINEKIYKQAHQTSARYDANISEFDATGLQPEY
KNNFKAPFVKESNIQLGVEFREKIALTINNTIMIIGEIKDVYFPENCLLKDGFLDLEKAN
TITCSGLDSYHKTIRLNRLSYAKPDKEIT
>KACEBFPM_01540 Cryptochrome-like protein cry2
MEKKVVNIVWFKRDLRFTDNEALFHAHHSGLPLLLIYVFEPSVMNYDDSDVRHWRFVYES
LLDMQLKLNLVASKIYFFHNESKIIFSELIKIFNVQTIFSHQEIGNKITFDRDIEMQAFF
NKNNIIWKEFQLHGVIRKLKSRQNWDKKWEDVMRASPRIIDLKDLKIEILSDSFYQEFKG
EILNPEITTHNKNFQQGGENFAWRYLDSFVKKRYVNYSKHISKPLLSRKGCSRLSPYLTY
GNISMRAIYQYTNQHYETSKNKRAILNFVSRLHWHCHFMQKFEDECTMEFENANRAYDVL
IKPKNETYIKAWQEGKTGVPIVDACMRCLVTTGYINFRMRAMVVSFFTFNLWQDWRELHF
LARQFLDYEPGIHYPQIQMQSGTTGINTIRIYNPIKNSEEHDPEGIFIKQWLPELAEIPL
SLLHEPWKMNDMEQQFYNCKIGEDYPTLIVNIDQTRKYASDIVWSFRKKDEVKVEGKRIL
QKHVTNPNKPKNERHKKTKPTQ
>KACEBFPM_01541 (6-4) photolyase
MLKTLRLILGDQLNINHSWFQTNDDSITYVIMEIRSETDYATHHIQKIAGFFSAMRNFAS
ELKQKKHNSIYFHLNDTNNLQAFDKNLQQLINKEHYTHFEYQLPDEYRLDELLKNFCQTL
SISTSVADSEHFMSTREELGNFFDGKKTFLMESFYHMMRKKHNVLMQGNKPLTGKWNYDG
ENRKKLPKNHKPTSPLGFNNDVSEIVAEIHKTNIKTIGNIDAKNFVWPTTRTQSLKLLDF
FVTECLTLFGSYQDAMTPNQWSLYHSRISFSMNVKLISPLEVINRAIQEWESRPDQIAYN
QLEGFVRQIIGWREYMRGIYWNKMPQYATMNYFENQNKLPQWFWTGKTKMNCLKDTINQS
LNFAYAHHIQRLMITGNFALLAGVNPDEVDAWYLGIYIDAIQWVEITNTRGMSQFADGGI
VGTKPYVSAASYIDKMSHYCGSCFYKKSIKTGDKACPFNSLYWNFYDKNQDKLSKNPRIG
MMYNMWQKMKPDDKVALLQQADYYLKNINKL
>KACEBFPM_01542 Cryptochrome DASH
MIKTAIVWFKTDLRVEDNETIIKAILQSEQIIPVYCFDDSHFETTKYGFKKTGSFRAQFL
LESLQDLDKNLRAIGSGLVITKGKPEIEIPKIAKEYKAQKVFSKREVSFEEKKTEKMVQN
ELFKLRCELETFSTSTLYHAEDLPFSIRNIPDVFTNFRKKTEQDATIRTVFKKPEKINSP
KITTLSLPTLEDLGLECKTIDSRAAIQFKGGETEAINRLNYYFFQTNSISNYKKTRNGMV
GENYSSKFSPWLALGCISPRFIYNEIKKYELQFGANDSSYWLIFELLWRDFFRFMFKKYQ
TKFFIYLGIKTEKGNSKSLNDKLFSQWINGKTKSDFINANMLELKLTGFMSNRGRQNVAS
YFCNELNMDWRLGAAYFEEQLIDYDVCSNWGNWAYLAGVGNDPRGHRYFNIEKQASDYDK
NKEFRELWLK
>KACEBFPM_01543 hypothetical protein
MKILLTGANGYVGKRLLPELLEQGHEVVCSVRDKTRLGLDAITLARVSIWEVDFLNEVNY
TNCPKEIDIAYFLIHSMASSINSFDKMESIVAQNFNKYSSHINIKQVIYLSGIVNDPNLS
KHMLSRENVEKILNSGQHQLTTLKAGIIVGSGSSSFEIIRDLCEKLPLMIAPKWVLTKTQ
PIAIRDVIQYLIGVQNKQECLNKSFDIGGPNIITYKQMMQLYAKTRGIKLAIWTIPLMTP
KLSSYWLYFVTSTSYKLAMNLVDSMKVEVVCSDNKLQKILNIKPISYVDAIKLAFEKIEQ
NLVISSWKDSLSSSRFKKKLSNYIQVPNFGCLKVSKQIQITNPEQVLQNIWTIGGNKGWY
YGNWMWQFRGIIDKLFGGVGLRRGRTSPTHLDNGDSLDFWRVLLADKQEKRLLLFAEMRL
PGEAWLEFRIDENNILHQIATFRPIGILGRMYWYSMVPFHFFIFDGMIKNIAKAK
>KACEBFPM_01544 30S ribosomal protein S15
MYLTKEIKEEIFAKHGEKTNTGKAEAQIALFTFRISHLTEHLKKNRHDYNTERSLVLLVG
KRRSLLDYLKKKEINRYREIIKELGIRK
>KACEBFPM_01545 Polyribonucleotide nucleotidyltransferase
MIPQLFVESIDLGDGRNITIETGRLAKQADGSVVVRIGKTVILGTVVSSRKATPGIDFLP
LTVDYREKFAAAGRFPGGFFKREARPSDSEVLTMRLVDRVLRPLFPSDYHAEVQVMIQLM
SHDEEVMPDALAGLAASAALALSDIPFETLISEARVGRIDGKFIINPSRAQLELSDIDMM
IGASTDSIAMVEGEMKEISEAEMLEAIKFAHEHIKVQIAAQERLAAAFGKKEVRTYEKEK
SDDAIYAKVKEAAYDKIYNIAKVGSAKQERTAAFDAVKEEVKALFTEEELAENGDLVSKY
FYKTNKEAVRNVTLDLGTRLDGRKTTEIRPIWCEVDYLPSVHGSALFTRGETQALATATL
GTSREANQIDSPSQQGEEKFYLHYNFPPFSTGEARPLRGTSRREVGHGNLAQRALKNMIP
ADCPYTIRVVSEVLESNGSSSMATVCAGTLSLMDAGIQMIRPVSGIAMGLITDGERFAVL
SDILGDEDHLGDMDFKVTGTSEGITACQMDIKIDGLKYEIMEAALAQARDGRLHILNILT
ETLATPKVDVKAYAPKIIMRTIPGNFIGALIGPGGKVIQELQKATGTTIVINEVDEMGVV
EILGTDPAGIEAVLAKIESITFKPQIGEAYEVKVIKMLDFGAVVEYTAVPGNEVLLHVSE
LAWERTENVTDVVNMGDVFMVKYLGLDPKTRKEKVSRKALLPRPPREEKKE
>KACEBFPM_01546 hypothetical protein
MINLMKNILQGTKMLVMFLFFIVYNVEAQQIVKDSVKSCLVCPVFYVGKKQAKSNFFLNL
SSLKLIYYVEYFNTNRSQLKGGFEFYLNPNARNDNRFFFGLGYGLVNSFGYIKGLPDYHI
SYNKNNGYFFKFGGSDRNLYALTGISFLNAIDLGVGYSVSIGENRLPEIRGFTVGFTIRM
SANDAVYEKLKIGF
>KACEBFPM_01547 RNA polymerase sigma factor SigA
MRQLKITKQVTNRETASLDKYLQEIGKVDLITADEEVELAQRIKAGDQRALEKLTKANLR
FVVSVAKQYQNQGLTLPDLINEGNLGLIKAAQRFDETRGFKFISYAVWWIRQSILQALAE
QSRIVRLPLNKIGSINKINKMYALLEQSNERPPSAEEIAKELDMTVNDVKESMKNSGRHL
SMDAPLVEGEDSNLYDVLRSGESPNPDRELIIESLRTEIERSLETLTPREADVVRLYFGL
ADQHPMTLEEIGETFDLTRERVRQIKEKAIRRLKHTSRSKILKTYLG
>KACEBFPM_01548 Iron-sulfur cluster insertion protein ErpA
MIKVSESASKKIVDMMKDDGFDATQDYVRVGVKSGGCSGLSYDLTFDKEIGENDKVFEDN
NIKIAVEKKSFLYLAGTILEFSGGLNGKGFVFNNPNASRTCGCGESFSL
>KACEBFPM_01549 putative quorum-quenching lactonase YtnP
MRLYPIETGNFKLDGGAMFGVVPKTIWNKTNPANENNLIDIAARCLLIEDRNRLILIDTG
MGNKQTEKFFGYYSLWGNHSIDKSLAKYGFSRDDITDVFMTHLHFDHCGGSVIWNKEKTG
YEVAFKNAKFWTNENHWQWATKPNAREKASFLSENILPMQESGQLNFITKANSDFEMASE
LNFDIFYVDGHTEKMMIPHIKYQDKTIAFCADLIPTAGHLPLPYVMGYDTRPLLTMPEKL
KFLTSAAENNYYLFLEHDAHNEIITVEKTEKGIRLKETFSCSEILT
>KACEBFPM_01550 Thermophilic serine proteinase
MQKIELNYNIMKILKPIFISGIIAFTMASCGGAKTIMSTNVANIDKMPLKTTPISEANMK
RWSHLDLVKDTVPGMSIDKAYGFLKGKKMTPVIVGIVDSGVDIDHEDLKGKIWTNPKEIA
GNKKDDDNNGFIDDVHGWNFLGDTNNEQLEMTRIVKKGNDGSQQFKDASAELEKSKTELA
PQKQQIDMLLGADKAVREYLKKPNFTLADVKAMQTTDPTMVQYKGMFTQILSGTTKAEFD
SQIQEYQDYVYDQLNYNLNTEFDGRKVVGDNPYDMTNKHYGNNIVYGPKKEGAKHGTHVA
GIIAQVRNNNKGGDGIASEVVRIMSVRAVPNGDEYDKDIALAIRYAVDNGAKIINGSFGK
SYSPNKEWVYDAIKYAESKDVLFVHAAGNSSEDIDTAPNFPNDTDGANPEYADNVLTIGA
LNYEYGASQMANFSNYGKINVDIFAPGVKIYATTPKNTYSFLDGTSMASPNVAGVAALVR
AYYPSLTASQVKHIIMDSGTLLTNSFNLAGAEGTQTTLASISKTGKIVNAYNALVLAEKM
TAKK
>KACEBFPM_01551 Aminopeptidase N
MKKIHLLTLFSFGSLIAQNNPNPGYWQQKVDYKMEVEMNVKNYQYKGKQTLVYTNNSPDT
LHRVYYHLFNNAFQPNSCMDARLKAIKDPDGRMVTKVKIGDKEVKESRISALKANEIGFL
KISNLKQDGIELKNKVVSTILEVDLAKPLLPHTSTTFSLDFDGQVPVQIRRSGRNNKEGV
ELSMSQWYPKMAEYDYEGWQADPYIAREFHGVWGNFDVSITIDKNYILGGSGYLQNPNKI
GYNYQDSGIVVTLPEKQKTLTWHFVAPNVHDFTWAADKNYIHDKLVTNFGTTLHFLYKNN
PKIIDNWKNLQPKTAQLMEIYNKTVGKYPYKQYSVIQGGDGGMEYAMCTLILGEGTFDGL
LGVTAHEMAHSWFQHILASNESKNSWMDEGFTTWLENYGLNEIADKKAENPHTDSYTGYI
SLVKSGKEQPQTTHADRYDENRPYSIQAYSKGNIFLSQLEYVIGKENFMKTLKRYFADYK
FTHPTPNDIKHTAEKVSGANLDWYLNDWTKTTNTIDYGIKLVENHGENTKITLERIGRMP
MPLDVLVTYEDGNQESFYIPQTLMRWTKENQNLAIKRTVLEGWDWAYPTFEFNVNTKSPI
KNIAIDPSGLMADVNKENNFFKK
>KACEBFPM_01552 hypothetical protein
MKKMLLIVMVLLASQLIFAQAPLGETKSLPVSYEDAEVKPEFPGGHNEFMKFIGENFALP
EVEGISGTIKLSFVIEISGKITEIKILSDLGSGTGEEAKRVVAKSPNWSPGEYDGKQVRV
KFLLPIIIKN
>KACEBFPM_01553 7-carboxy-7-deazaguanine synthase
MLTKEIQIAVEKGEMLPLMEEFYTIQGEGYHTGTAAYFIRIGGCDVGCHWCDVKESWNAA
LHPPTKTDVIVENATKYAKTIVVTGGEPLTWDMTVLTQRLKAENLQVHIETSGAYPVTGA
WDWFCLSPKKNKLPVAEAYEIAHELKVIIYNKHDFIFAEEQAAKVNKNAILFLQSEWSKK
EEMTPFIVDYVMNNPKWRVSLQTHKYLNIP
>KACEBFPM_01554 hypothetical protein
MSCKPAISQEVYAKFGENFTKFKYKNTYGENSIKFYALPSLAFEAGLSFYLNRKENLLLN
SSLIYNQYNAEAFIHEKQYNWKANYIGFQNTASFKFFEAWTSLNLKGKLGFNVSHIISGT
QNNNNIVHDLTKEKEFKGIFIQPLAGLEVAYVISDLVYISFDINKMMGFNTVNNPEKLSF
STNQFLIGFHFLPR
>KACEBFPM_01555 hypothetical protein
MTKIFCLLNLFFTSIIVAQNSNSISIQRATIGVGASIISYPTSSFTAVQSIGQSSVIGNF
KQSNLELRQGFIQPLDFGVYSFDKINYTASIFPNPFINTFQITFNKDIEFPKNVQIFNIN
GKLVFNKMFSEKNNLLIEVENLEISTYILILSIQNQIISKKIIKLN
>KACEBFPM_01556 hypothetical protein
MKTNFEGTPTGQIDEGIEKVAWLNPDEIKEALKNSYENIKLLFEEEKLITN
>KACEBFPM_01557 ATP-dependent RNA helicase DbpA
MNNNPHSNNILLNLGIESLNEMQEVAQDAILNDNNVLLLSPTGSGKTLAFLLPIFEMLQE
NITSVQCLILVPSRELALQIEQVWKKMGTSYKVNVCYGGHSIDTEIKNLSNPPAVLIGTP
GRIADHIDRRTFSVDAIQTLILDEFDKSLQLGFHEQMSFIINRLPKLNKRVLVSATSDIE
IPKYTRVINPTVLDFIPSEEEKTNLLFQLVVSKDKDKIGSLFNLICSLKSESAIIFCNHR
DAAERISDTLNEKGIYATYYHGGMDQDERERALIQFRNGSVSYLITTDLAARGLDIPEMK
HVIHYHLPSKEDEFTHRNGRTARMLATGTAYLVIHESEKKLEYIDYKMPVLEVENSTSLP
KAPEFQTIYISGGKKTKLNKIDIVGFFSQKGKLEKGDLGLIEVKDFISFAAVKSKKVKDL
LNNIRDEKMKGKKFKIEVARKVLKKEED
>KACEBFPM_01558 hypothetical protein
MRYSILFILALVICITSCRKDFETVPSSGKLEFSKTTVYLDTVFANIGSSTYMLKVYNRS
NNDITIPSIALGKGNASKYRLMVDGMRGTNGKIFPNVQLLAHDSLFVFIETTVDIAAANP
ADMLYTDEILFDAGALQQKVNLVTLIQDAVFLFPDRTINEQLQLDNNDPNSYTYGFELTG
TKLHFTKAKPYVIYGYAGVDSGKKLIIDKGARIHFHDKSGIFVKRGGSIQVNGLPSPTAT
PLVNEVIFEGDRLEPSFAETPGQWGIIYLAEGSTNNLFNHVTIKNSTVGIFIDRQDATAV
QISNTQIYNSSNYGIIARKGKINGDNIVINNAGKSSLACILGGTYNFVHCTFADYWQGTS
RQSPTVYLDNAYTENGRIVSVSLQLQANFTNCIIYGPNNIEMGINKVDTPGLNFMTNITN
CLIKFNDTNNQFSGNPLYTNLFAPSNNNLRSNSTTTFDPKFKNAAKNNLRIGLASAAKGR
ANSNAPYYITLDADGNSRTFPTSDIGAYEHASN
>KACEBFPM_01559 Putative esterase
MTFDKDKILAMCNTMCKNTLMETLKIEFTNAGEDFLVATMPVNSGVHQPMGLLHGGASVA
LAESVGSAASMLFVNPELSEIRGIEISANHLRAKREGIVTGTARIVHKGRSIHLWEIKIT
DENDKLISLCKLTNMVLPKRKI
>KACEBFPM_01560 Isochorismate synthase EntC
MNIIFNKGKDFLSKKIPFVIYCKPNSNKLVGVFQKNDNLFEIENFEEIGFAFVSFDGKKK
YLIPKNESDIYIETITKIDHCTENKININIDANAKITFENLVKKGINAIQNKQFDKVVLS
RKETLKINVFDFQNVFNKFLFNYQNTFKYCFYHPKIGFWMGATPEQFLQSYQNTIKTVSF
AGTQPYCEKEKYIWEEKEKQEQQFVTDFILDNLKKHSTQILFSEPYTFRAGSVVHLKTDI
EAIINTQNNFSNIIKNLHPTPAVCGLPKDRAMQFIINNEAYDRTYYTGFLGELNIDFETL
KNKKSDLFVNLRCMNIEDNLANIYIGCGITKDSIAENEFTETVNKSKTMTKVL
>KACEBFPM_01561 hypothetical protein
MKKIIAIAFLLINYVGFSQIRVIETVPIEKIGRIGDNGNNNIYIQKEGNEYTVSFKNIED
VDNGIVKFNFKDLAGDFETLYTIISNGYNASPVSDIKLDLPNDIIWLHYTKSLQKLVTMQ
FMSKNKVTTATGISDSMTKADINSLFGKK
>KACEBFPM_01562 N-acetyl-alpha-D-glucosaminyl L-malate deacetylase 1
MKLDILAFGAHPDDIELGCGATIAKEISLGKSVGIIDLTRGELGTRGSAEIRDTEAAKAA
KILKVSVRENLGFRDGFFKNNEKHQLEVIKMIRKYKPQIVLCNAIDDRHIDHGKGSKLVS
DACFLSGLSKIETNIDGNIQEAWRPKVVYHYIQWKNIEPDFVVDVSGFIDIKMQAIMAYD
SQFYNPKSNEPESPITSKNFLDSVKYRAQDLGRIINTQYGEGFTTERYLAINNLGDLL
>KACEBFPM_01564 Phosphopantetheine adenylyltransferase
MRKAIFPGSFDPLTLGHSDIIKRSIPLFDEIIIAIGVNAEKKYMFSLEDRKRFIKETFKD
EPSVSVISYEGLTIDLCKKLGADFILRGLRNPADFEFEKAIAHTNRRLSKIETIFLLTAA
STSFISSSIVRDVIRNGGDYSVLVPEAVRVK
>KACEBFPM_01565 D-alanine--D-alanine ligase
MNVAVVMGGYSDESVISLRSGQLILNNLDKSKYNIFEVHILLKDWSVVIEGEKYPINKAD
FSFTKNGIITKFDVAINTVHGTPGEDGHLQSYWELIDIPYTGCNFYQSALTFNKRDTLSV
LTKFNIPKAKSIYLRKGDVIDGNEIKKALGLPFFVKPNQSGSSLGVSKVDALDQLEKALE
FAFAEDNEILIESYLNGTEVSVGVLNYKGQTKVLGITEILSQNDFFDYEAKYLGKSEEIT
PARISKEEEILVAESAKKIYNSLGMSGFSRTDFIIMNGIPHFIEINTNPGLSPQSIFPQQ
AMFAKMDMPQMLDNEITLALSRKPIWKK
>KACEBFPM_01566 hypothetical protein
MSFKKFLFSFTFIKQVLIAITIVCATLYLFIVWIGFTTNHGQEIVVPNLSKLTLEQAESK
LDELDLDYELLDTVDYNADFPKLSIVQQDPNPGEKVKQNRVIYLKINSTGYSKVRIPDLI
QKTYRQAVPTLAALGLEVGDTTYVPNLAKDMILEMKMNGHPIKAGQQVLKMTKVDLVLGD
GKIGFEEEELNGSENDSIKNDLTK
>KACEBFPM_01567 Ribosomal large subunit pseudouridine synthase D
MNENITTDSELDQELFEHHKFVATKGQSILRIDKYLMHLLENATRNKIQQAATSGNIFVN
NIPVKSNYKVKPFDVVTIMLSHPPFENRVDPEDIPLDIVYEDDALLLINKPAGLVVHPGH
GNYTGTLVNALAFHFQNLPLNSSERPGLVHRIDKDTTGLLVIAKTEQAMTHLAKQFENKT
SEREYIAIVWGNVQKDEGTIEGNLARHLKDRMQMAVFADPEIGKPAITHYKVLERFGYIT
VISCKLETGRTHQIRAHLKHIGHPLFNDERYGGHLILKGTTFTKYKQFIDNCFKILPRQA
LHAKTLGFEHPTTKEMMRFDTNLPSDMQECIQKWRTYSNTNTLNEED
>KACEBFPM_01568 Macrolide export protein MacA
MTKKTKYIVLGIAVTAIIGAIYLKKSGAIGDSNKGKEVEIATITQRTVTETVSGTGKIQP
EIEVKISSEVSGEIIALPVKEGQTVKKGDLLVQVNPKLYTQGLNKSQAGLSNTKAGLSQT
DAQFKEAKASYERSKKLYDKGIISRAEWDKSVATYESAQAAKQAAYYNVQSASATVNESK
ENLGKTAIYAPVDGTISKLGVELGERVLGTQQMAGTEMMRVADLNNMEVEVDVNENDIVK
ISIGDLAKVEVDAYLKKEFRGIVTSISNSASTALTADQVTNFKVKVRIIKDSYQDLMSGK
PASFSPFRPGMTATVDIITTRKENVIAVPISAVVMRTDTSASRKVLMVKDDNSDNSEQEP
EVKNEKRYECVFVKMGDKVKLRIVTTGIQDDSYIEVLSGLKKGETIITGPYTTVTKELNP
DDAVYVKTKKQIETEKKKENDNKES
>KACEBFPM_01569 hypothetical protein
MQKIKYSFLIITTLLYCGVSFGQPKKWTLEECVAYAIEHNISIKQAALDKELSDISKKDA
LGKFFPSVNAQSSHSWNIGLNQNITTGLLENQTTQFTSAGVNISIDIYKGLQNQNLLRKA
NLSSIASQYQLTKMQEDVSLNIVNGYLQILFNKENLKVQQLQLAYDNKQLERSKELVEAG
VTPRGDLLDVKATVATDNQRFIAAENALFLSKLSLAQLLQIDDFENFDITDAEIPIQENT
ILMQDPKVILDKAKKTRTDLKIAQTNVQIAEKNLQISRGAYQPTLQGFYSFSTRAGYSDR
VVGFAPNTSNPTSIIGYVEGTNQSVLQPNYSRILDKPDAIFNQFSTNKGQNFGLNLNIPI
LNGFSVRNNVARSKIALDRSKITLKQQELDVERTVFTAYTDTKGAQKTHEAALATFEARQ
KSFNYAKERYEVGLMNIFDFNQAQTLFTNAQSEVLRTKYDYIFRTKILEFYFGIPIIKKQ
>KACEBFPM_01570 hypothetical protein
MKNILRIIGLFAVTFFYTSCSTTQKIELMKPEPDDATPIIYPVTSSYISFPVTLTLKDIE
KQANNALMGLIYDDHNIDDDKTEMKIWKNAPILISEDNNKLKTIIPLKIWAKVRYGTSVL
GINLYDTREINLNGTITFLSNVKMSNWKITTTTELQDFEWQESPTIIIGGKEIPITYLVN
PTIRIFRNKIEKIIDESLEKSLDFKSNILEMMQKASEPFEMSSTYQTWLKVTPQEIYATE
ANLEKKAVSMTVGLKCLMESCIGQKPKPNFVKEKIVLKPIVNLPEKVVANIAAVSTYQDA
SRVMTANFKGKEFGEGKRKVTIQNVEIWHKQGKMVIALDMLGSLNGRIYLSGFPQYNTQT
KELFFDDLDYALETKSKLMKTANWFAQGLILNKIRATCRYSIQPNLDEGKQNILKYLNNY
SPITGVFVNGKLNDIVFQKVQLTNHAIVAFLNITGNVTVNINGM
>KACEBFPM_01571 hypothetical protein
MLAKVENSGKRIAFLLLIAHCLLPIASNAQCAMCRASLESSADVSQAEAVNDGIIYLMII
PYILVVLIAIAVYRMYRKKQ
>KACEBFPM_01572 hypothetical protein
MKKKILEKKYNVWITILSIVIPVVVAILFKIKLRDLGFDVKPLSFLPPIYATINAITAIV
LVWAVIAIKNEKQKLHENLMKTAIGLSVAFLAMYVAYHMTSEATKYGGAGILKVAYFFIL
ITHITLSIITIPLVLVTYVRALAEKFDKHKKIAKITFPIWLYVAVTGVIVYLMISPYYVS
>KACEBFPM_01573 SCO1 protein 
MKNKSYIGTAFIILVFGIYFVPKIIDRIKNNDIVKGDRLNIEGTHVATKSDLMTIGKAPV
FSLINQDKRTISNESYKGKVYVAEFFFSTCPSICPIMNRNMKLVQEAFASNTNFGVTSIT
INPEIDTPEVLKKHAETIGAKGKNWNFLTGDKSRIYEIANKGFNLYVGQNAKIPGGFEHS
GFFALIDKEGNIRCRKDEFGNPIIYYDGIKDEGIKQIKQDISKLLAE
>KACEBFPM_01574 hypothetical protein
MKNKLVLIILLILPVLIYLIFATATHNSLFLPTISRNNKELPKWKSLDGKPVSLINKITV
LGFLGNDIYKNEENLFNLNQKIYGKYEGFHDFQLVMIAQEGSEKQVEDLLEKLTRFSEDL
SGWKFVFAKPQEIQSYFDSFKLHDRLNENFSSTKVIIIDKDKNHRGRKGKNKEGKNEYKE
SYNTNSAADLHNEMSDDIKIMLREYRLALKRNNKRKDFRLHENK
>KACEBFPM_01575 hypothetical protein
MSQEHVSNVGRIWKVFGLLSIITIIEVILGIVKPDFLYFNTFFSMNLLNWIFIMLTIYKA
YWIMWSFMHLEGEKASLRWAVAGTIVFLIIYLVFILLVEADYIFEVFKNSTIKWNF
>KACEBFPM_01576 Cytochrome c oxidase subunit 3
MATTVTTSAEGKTWGGGNEPMNASYGKMMMWFFIVSDALTFSGFLAAYGFSRFKFIQTWP
LADEVFTHFPFMHGVSAPMYYVAFMTFVLIFSSVTMVLAVDAGHQMKKDKVIIYMFLTIV
GGFIFVGSQAWEWKNFIKGEYGAVETKGGSILQFEKIDKEHSTTDNIVYKRVALAEFAAD
IPSERTEDTKSKGIWFFGDETLPSYSITEVKEGFKAHSDILIRTEAIDPKTKTKITLSRE
ESLKRIEDTKYVVEGANLIRNEYGQKLFADFFFFITGFHGFHVLSGVIINVLIFFNVLLG
TYDKRKTYEMVEKVGLYWHFVDLVWVFVFTFFYLV
>KACEBFPM_01577 Cytochrome c oxidase subunit 3
MTIEEHNNRKARSYKLLLLFAMISMFMVFAGLTSAYLVSSSRKDWIHTMVLPPAFTFSTI
VIIISSLTIYLAKKAIQKDDRQKTTLFLVTTLILGIAFVILQLKGFSQVIEMGYFFTGSA
STVTSSFLYVLTILHLTHLAGGIISLLIIIYNHFKQKYNSSQSTGIELGAMFWHFLDILW
VYLFLFLYFVK
>KACEBFPM_01578 Protoheme IX farnesyltransferase 1
MSAINTLPPIKSIFNDFKEITKAGLAISVVFSSLAGYLLGIHEFNLETIYVLLMLAIGGY
CMVGASNAYNQIIEKDLDTLMNRTKNRPIPSGRMSVNTAFTIATILTITGLTILYMINPK
TAMFGAISIFLYTCVYTPLKTVTSLSVFVGAFPGAIPFMLGWVAATNDFGIEAGTLFLIQ
FFWQFPHFWAIGWFLFEDYKKGGFYMLPTGKRDKGTAMQIVLYTLWLTAASILPSFGYTG
RLYLTPVSAIIVVLLGLWMLVYAIKLYKNKTDKSAKTLMLVSVAYISLIQVVYILDKFLR
>KACEBFPM_01579 tRNA threonylcarbamoyladenosine biosynthesis protein TsaB
MTYILNIETATRNCSVALSQDGNIIACKEIAEAGYSHAEKLHIFIDEILKENTITYKDLS
AIAISQGPGSYTGLRIGVSAAKGLCYSLDIPLVAIDTLEVLARKITIDSGVIIPMIDARR
MECYTAIFDANYINKREVKAEIIDANSFCEITQTIHLIGDGASKCNAVLTDAKFVYHSEI
QFPSASEMSKIAFDKYKKNDTVSVAYFEPFYLKDFMMTVASK
>KACEBFPM_01580 hypothetical protein
MGVASFFKGIFGSKKVDEIIDQAGNFADDAIAKAKQSAAPLIDKVEDFAEQAGDKIKEYV
PQATATIDNAVETVKEKAGDLIEKVEDMAHGAVGTAQEKATNLAADTTEKTADKVAE
>KACEBFPM_01581 hypothetical protein
MARISTTIGAKPTSMNQLNLETSPYLLQHANNPIHWQAWSKNTLATAQKENKLIIISIGY
SACHWCHVMEHESFENQEVASVMNLNFISIKVDREERPDVDAIYMKAVQMMTNRGGWPLN
VVCLPDGRPIWGGTYFQKEEWTNTLQQLHELYVSNPQKIIKYAQKLHQGIQVLGTIQHHT
AQEQNHTNNIKPLVEKWSKSFDWEYGGYARAPKFMMPNNYLFLQRYGYQTKSQELLNFVD
LTLTKMAHGGIFDTIAGGFSRYSVDIRWHIPHFEKMLYDNGQLVSLYAQAYKRTQNPLYK
EVIEKTLTFVEREFLNSDNGFYAALDADSLNQNNELEEGAFYVWTKTELQEILKNDFEIF
SHLYNVNDFGFWEHDNHVLIQNQPSKSIASKFGLTENELQNKRKNWEQLLFTKREKRPKP
RLDDKSLTSWNAIMLKGYTDAYNALGNQKYLAIAEKNAQFITTKQWSAEGFLYRSYKKNK
STIEGFLEDYAFTIDAFISLYQATLNEKYLQQAKQLTDYCFDNFYNEKQHFFAFNSRKSA
QLIAQHFETEDNVMPASNSVMANNLYVLGLLFSNNYYEKIALQMLHHIIPNIDYASAYSN
WMNLWMNLSQDNKELAVCGNNAVANNHKIKAKYLPHIITAGTTKNSRLPFLENRFIEEEN
LYYICQNKACLMPKFTIEETFNNLEI
>KACEBFPM_01582 Putative pre-16S rRNA nuclease
MLFFSKKIQNVPNNKCFQNWKHFYYINILNKCINKLILPKKMPRILAIDYGQKRTGIAIT
DEMQIIASGLTTIASETSIAFLRDYFTKEKVEKVLIGEPKQMNGEPSQSTDIIEKFVTKF
KNNFPDMAIERVDERFTSKMAFQTMIDSGLKKKQRQNKALVDEISATIMLQDYLTRKI
>KACEBFPM_01583 hypothetical protein
MEAFFIYLIKVNSLIVIFYLAYTLLVQKETFFNTNRWFLLSGLFTSVLIPLFFIKKIVFI
EAPKFASTKFASIKNATINPIIEIEESINWHNMLLLAYSFISIILLLKIASELISFFKLI
KNKKRTINKPFTMVDINENINPFSFFKYIVFNSAKYSNSELDNILNHEKVHSKEKHSADI
LIAKVFCTFFWFNPFVWLYKKAIIQNLEYIADQKAIQNIEDKKAYQMTLLKVVTDHNCLS
ITNSFYQSLIKKRIVMLNKNQSKQKKIWKYALVIPALVAFVIFFQVKVIAQEKLENGTLT
TLRTDGITEMIIDKNSTDSDIKKDCDALKKVFNVDLKVTIIKRNKKGEITAISITANDHK
GSTSTHDVTSDQAITPFKFSMRRDLNGKGEFRFYDETDTSKYETIAKEENNSDEYPTPPT
PPDGPDMSNMPSPPAAPNFPPPPTVRFPKNPNDKKAIKKYEAEMEKYSTNWESTEIKKYE
ADMAAYEKAIEAYQPDMTEYEAKMEKYEKEMEAYQEKINDYQEKIRDEKQDKLDASRDKI
EIRKKILIKQKKR
>KACEBFPM_01584 Methicillin resistance regulatory protein MecI
MQKLTNKEEEVMHILWKLKKAYVKEVLAEITQEKPHYNTLSTIIRNLEEKGFVSYNAYGN
THQYYPIISIENYRKRFMNTAIDNYFGSSYKNMVSFFAEEKKISADELREILAIIEQKK
>KACEBFPM_01585 Inner membrane transport protein YajR
MFYSFFTRYINNFRGFSREIWILAIVTFINRAGVMVVPFLSKYLKENLHFTYSEVGWIMV
GFGVGSVCGSWLGGKLSDKIGFYKIMLFSLFVSGIVLILLQFVNSFWGLVLGLFVLMVIA
DMFRPAMFVAIGAYAKPENRTRALTLVRLAINIGFAAGPALGGLIIMYIGYSGLFWIDGS
TCIISIILFGLLVKEKKKFVDPEIETVTIAEVNSVFHDKPFWIFLVACLISGVLFFQLFT
TIPLYHHEQFNLTELQTGLLLTLNGLIIFFLEMPFVSYIERNKISKLKVCGWGLLLMTIS
LSLLMINFWSGILIVMMVFMTFGEMFVFPFSNSFALSRAPKGHEGRYMAIFTMSYSCAHI
FSSKAGLDVVSNFGYQKNWFLMTILGIISIFLIIWVIKLVDKENTNLKNS
>KACEBFPM_01586 hypothetical protein
MKKYLILFTVLFFVISYAQDNKAETSQEFQNNLNKEYADKKQSPLSDEDFQVFKSLDFYP
INEKFIVEAKFVRTKNEKIFVMKTSTTRLPRYKKYGELSFVIDEKQFNLNVYQNIDLSKR
EGYKDYLFLPFSDLTCGKESYLGGRYIDMRFPKSETVIINFNKAYNPYCAYNHKYSCPIV
PLENDLKIEILAGVKKFND
>KACEBFPM_01587 D-aminoacyl-tRNA deacylase
MQFINLHTHRLTKALNVLEIVNQYPQEFDSIIAFYSIGIHPWYINESRVEADLKIIEEKL
QTENCLALGECGLDKRIEISIEIQKQVFEKQLKLAIKYNKAVILHCVSAYQEIIEIKSRL
QVEVPMIIHGFSKNKQVAKLLLDNGFYLSFGKYLLRNPALETIFASVPNDRFFLETDTIE
ETLEEVYKLAAKYKNIEVSELQKIVENNFQNVFYNIKK
>KACEBFPM_01588 tRNA threonylcarbamoyladenosine dehydratase
MAEWTERAALLFKKEGLNKLQNANVLVVGLGGVGSFAAEFLVRAGIGKITIVDGDVVDIT
NINRQLPALHSTVGKPKIAVVGDRLIDINPELKLTRIQEFLSPERAFEIVSDEFDYVLDC
IDSVTPKLNLIIAAKRKRVKIISSMGAGGKMEAAKVKVSCITNTTNCMLAKTIRKRLKAE
KIDKLKVVFSSEIQDETSLKMTDGSNYKKSFYGTNSYMPGLFGLHAAETVIRYLLK
>KACEBFPM_01589 hypothetical protein
MRIAKYIFLLLLLITITISVFVATKDGSYVVTKHKEINVPKEIVFNYVSNSKNWETINPW
KGENAKIQSVQKIDGEIILQNIVINKIPAELKLTIKDTLIKKTIVTWTTRGKLSFKDKFL
SIINRGTHNDFGEKFDNGLTLLNTILTTEINSFSVKIDGFVNRDTVFYIQQVISCKVEEL
PTKIKKTLPKLNELLKITNTPKKGDPFVIYHAVDSLANKITISVAIPTKNKVFTSSESDI
YTGQTNPFQAVKATLTGNYNHKKEVLEQLYDFMSKNKLERSDRNKIFEIIPKNSLTEKSA
AKWVTEIYIPVRPKKITVRIKPVKADTINTVIESNFKSVANP
>KACEBFPM_01590 hypothetical protein
MFSSGQLLFAAIFAISFIVIMIFAYRKDLKIHKQYYKGSLWILVGFIIFISFLFIIKSLM
KE
>KACEBFPM_01591 hypothetical protein
MILRYIISTKIFYSGFCFIKVVSFTKKIYKLIMKKQIKSVHAFHTAFRLGINTNPTGNLG
ERKNLLRYNLMKEENEEYLEAVANNDIVEIADALGDMLYILCGTIIEHGLQDKMEAIFDE
IQRSNMSKLGHDGKPIYREDGKVLKGPNYSKPNFKGILNL
>KACEBFPM_01592 Branched-chain-amino-acid transaminase 1
MGLDIQSEIDIVKVASSKINEVDFENLAFGNVFTDHMLMCDFKNGKWQKPIIKPYEPFLL
DPSAKVFHYGQAIFEGMKAYKDDNNDIWLFRPNENLDRFNKSATRMAMPEVPEHIFIDGL
KEILKIEKEWVKKGLGNTLYIRPFMIAIGTGVIAQPSSQYRFMIILSPAKSYYSGEVKVI
IAEHYSRAANGGIGAAKAAGNYSAQFYPTKLANDQGFQQIIWTDDATHTTLEEAGTMNVF
FRINDTLYTAPTSERILDGVTRKSLIELAKREGIKVAVQPVLVSEIVEAAKNGSLKEIFG
AGTAAVVNPIVGFSYQDVYYELPKIEDSIALELKEKLTNIQHKLAEDTFSWTVKI
>KACEBFPM_01593 tRNA 5-methylaminomethyl-2-thiouridine biosynthesis bifunctional protein MnmC
MKREIIKTLDGSTTIHLPDWDECYHSKNGAIQEAYHVFIKNGLSLVEEKTISILEIGFGT
GLNAFITLLEAQKNNIKVYYTGVEAYPVAKEEAIEMNYLQELKAEEFEAEYKKMHDCTWE
EKHIFSPNFLLTKRKQFFQDIQDKNTFNLIYFDAFGYRVQPELWSTEIFKNMFEALTNNG
ILVTYAARGVVKRSMQEVGFTVKKVAGPPGKREMMIGFKKL
>KACEBFPM_01594 hypothetical protein
MSKLMVNYSKSILERVSFDPILFCKELEKAVKALLPFELEELVVWFFNFTKEKPELRRCE
IYLDL
>KACEBFPM_01595 hypothetical protein
MTEWLKTDQAVISTYITYLQSLKIIFVGISQKIV
>KACEBFPM_01596 Hydrogen peroxide-inducible genes activator
MTITQLQYVLAVAEHKNFTLAAEKCFVTQPTLSMQIQKVEEELSILIFDRTKKPIQLTDV
GQKIVAQAKNIVNEANRMQDIVAIEKGFIGGEFRIGIIPTIMPTLLPMFLNNFIKKYPKV
KLIIEELNTSEIIKKLNNGQLDAAIAATPLNEDKIKEIVLYYEPFMVYIPEYHLLSPKNE
IEISDLDIDEILLLQDGHCFRDGILNLCKNTAINSESKFKIESGSFETLIKLADEGLGIT
LLPYLHTLDLKEKDKLKLKHFVEPKPAREISLLFPKNELKIHIIDALRNVISGVLRGAIT
FQNVEIISPIQKK
>KACEBFPM_01597 hypothetical protein
MINPSAPSWVEKFFTEQNDKNQTVINNYEQFYENTRATGFLVGYTTHFVTSKNIETKGLT
NEELLKIALLNTLFGVYQLVKKNRNHSEFIYQCSTFYKNLHPKESSLLEKILPQDSYSSK
LEKIINSRIQTNENIISKNFSNILTNALLFIDVLAFRKYLDEGNIPDKYLKKTEEIIVNI
VSLALKTKEVKTKYDDLLQKLFESSVRYTKFNKLQIVSLDNLDLSYFNHDYEKYYLIDLA
GMAMWNDAKIEKSEKNFLFQLAKKLAISNSFLEKSISEMNVFLTTNKTKIQHFNYSNPVK
HFYDQTTQNVQTLISRNKNRLVVEISQSKELMKLLSQSTKRELNPDEKKKVRNQLLDILK
TIPSLTIFLVPGGSLLLPILIKFIPQLLPSAFNENLEK
>KACEBFPM_01598 Superoxide dismutase-like protein YojM
MKNLLLLSCALIFTLIACKSSAGNKNEIKTIFSPKSQSNVAGTANFIEKNGTVTMVANLS
GLTPGEHAIHIHEKSDCSATDGSSAGGHWNPTFKKHGKWGSAEHHKGDIGNFTADLNGNA
TIKFSTSEWCIGCQDPTKDILGKGLIVHKGTDDFTSQPAGNAGARVACSAIIK
>KACEBFPM_01599 Dihydrolipoyl dehydrogenase
MSSFDVVIIGSGPGGYVSAIRCAQLGFKTAIIEKYSTLGGTCLNVGCIPSKALLASSHHY
QELQHFADHGIEVSGEVKVNLEKMIARKQAVVDQTSGGVKFLMDKNKVTVYQGLGSFEDA
THVKVTKADGSSEVLEAKNIIIATGSKPSSLPFIKLDKERIITSTEALKLPEVPKHLVII
GGGVIGIELGQVYLRLGSQVSVVEYLDRIIPGMDASLSKELTKVLKKQGMKFYVSHKVKS
VERNGNAVTVLAENTKGETITLEGDYSLVSVGRRPYTDGLFADKAGVKITDRGMIEVNNH
LQTNISNIYAIGDVVRGAMLAHKAEEEGVMVAEIIAGQKPHIDYNLIPGVVYTWPEVAAV
GKTEEQLKADGVNYKAGSFPFKALGRARAGGDTDGFVKILADAKTDEVLGVHMIGARCAD
LIAEAVTAMEFRASAEDISRMSHAHPTFAEAIKEAALAATDNRALHV
>KACEBFPM_01600 Leucine-responsive regulatory protein
MNLDEIDKNLLKLLQTDSKKTTKELSLKLNLSVTAIYERIKKLEREGIIEKYVVILNKKK
IEKGFVVFCHIKLIQHTKEFLTKFENQVTKLNEVLECHHVSGDYDYILKIVLKDMEEYRN
FLVEKLTTLDHIGSTHSTFMISEVKNTNIIEI
>KACEBFPM_01601 Cystathionine gamma-lyase
MKNFNPADKIQDLQYFGEFGGVNPSISDSSTYTFLSAKTMFDTFEGNAEGCYLYSRHSSP
SNLYLDRALAAMEGTESANVAASGMGAITPTLLQLCGNGDHIVSSRTIYGGTYAFLKNLA
PRFGVNTTFVDITKLAVVEAAITPNTKVLYCETVSNPLLEVADIAGLSKIAIKHNLKLVV
DNTFSPLSVSPIKLGADIVIHSLTKYINGSSDTVGGVVCASQEFINDLKNVNSGTSMLLG
PTMDSLRSASVMKNLRTLHIRMKQHSHNAMFLASKFEENGIKTVYPGLKSHASHDLYSGM
INHEYGFGGMMTIDVGSLDKANALMELMQQRNLGYLAVSLGYYKTLFSAPGTSTSSEIPL
EEQAEMGLTDGLIRFSIGLDNDITRTYEMMHACMKELEIL
>KACEBFPM_01602 putative amino acid permease YhdG
MSFSKLFRKKTVQDILKQVAKNEADGHNSLGKHLKTRDLAAFGIAAIVGAGIFSTIGKAS
YDGGPGVIFLFLFTAIACSFAAFAYAEFASMVPVSGSAYTYSYVAFGEIIAWIIGWALIM
EYAIGNITVAISWSDYFTGLLDSMGLHLPQYVQMDYLTASNGFKEATALMQGGKSYENLS
DGLKSAHTAWTTSPTLGGFHFVADLPALFIIILITALVYRGMKESRNASNFMVVVKLCII
LLVIAVGVFYVDTANWHPFAPNGVGGILKGVSAVFFAYIGFDAISTTAEECENPQRDLPR
GMMWAIIICTVLYIIIALVLTGMVNYSELNVGDPLAFVFEKLNLKWMSGIIAVSAVIAMA
SVLLVFQMGQPRIWMSMSRDGLLPKRFSKVHPKFKTPSYATIVTGFVVAIPALFLNLTMV
TDLCSIGTLFAFVLVCAGVLVLQNKPNIPRGKFKTPYINSKFVMPFLIIIGLVITFTYSK
QSTIDFLTNEKQINAPATIVTSLNKEQTTAVVNYISKNNSNKVKPSEDLEQVLSDFQQKD
DASYKTLVDSLPIDNALKYESGFSLFKHKIPMWIFLIVLFGLTIWSNRQNLSLIPLLGLI
FCLYMMAELSIWNWIYFTVWLLIGLCIYFGFSRKNSKLNFTEPNSDIQN
>KACEBFPM_01603 hypothetical protein
MKKNTFKTILLLVFLCSKSFSQDKEFQLKPRPNDFQYFQNSGDSIITLKTPNIINTNKTT
ATLSKLPYPIIFIHGLNSNSETWNLTSNYFDAQYAYTFGGRFDFCLNADSNNSIANKKFY
PTPGADIAAFETTIIANADYYYVNFNVNPNGSIGTTTLSNQAAIAKQGIAIKKVIERVLA
LTGKDKVMLVGHSMGGLASREYIQNPSNWQADGRHHVAKLLTAGTPNGGSNASDNILAGL
VGTDVSSEAIRDLKSAYYYSGEGSHFLFGGSEIQNSTSMSDNSYSPNFYNVDINCNGILG
EKIIGLNQKPIDNLIDFSNIIGRITNGIGTNLSTDGIVAEPSSKLNQYYPSLTYPAKVFY
FNSRYDLIENHTELPSKYYELMQGLDEPNFKELAYIVNTNKKYIGYTTVQNPVEADKDFY
KFTISENSNAIVSVSSITTSAMNGTILDDLGHPVGSVQNNNSTTLNFTRVLTPGNYFLKL
VSTNPTNTNYQIPYQFAINTTLSSDESNFLTFNYYPNPVKDILNLEHVNLTKASIYSLLG
QLIDVKNFDNNTISKTIDLSSLKSGIYIVVFENDNQQKTIKIIKE
>KACEBFPM_01604 hypothetical protein
MDTNNDGKINSSDIKTIYLSDISGSKFTKIAADFEELIDWNLIESNSRLYFRTIEDINKN
GAFDKTDKVHYHFVNFQNKDWKVEEYSAIH
>KACEBFPM_01605 hypothetical protein
MYINHHNISLPENPDTIVWKYLDLSKFLDLLLSQKMFMSRSDKFEDQYEGTFSEPTFEEI
KKIAANNPEFLYYYKSHREKVAISSWHTNEYESFAMWQIFTKNQEGLAIQSTIGRLKEAL
QLEKKSKQYIGEVNYIDYKKEYIPFDDNFFPFLFKRKSFQYEREVRIITDVTEQNISIND
GLKINVNINALIEKIYIHPKSENWYKKLVIELVTQLGFDFEIEKSDLESDILI
>KACEBFPM_01606 Lipid A export ATP-binding/permease protein MsbA
MDNNIKKIFPFVKPYKNHVVWNIFYNILYALFSTLSFIALMPMMQVLFETTKAVNKKPIW
TDIWDITKYGKELLYYNITLLDKKDALILVIILIIFTFFFKNIFNYLASYHMMHLQNNVL
KDLRIQLFEKIISLPIGFYSEQRKGDVMSRMLGDVGQFQNTFFVVLELIVREPLTILFTI
IAMFNISVKLTLFVFVFIPISGFIISRLGKNLKSKSNKAQAESGFFISILEETLGGMKVV
KSYNAENTFTKKFTDSIMRMIKLSTSIGNKNNLASPLSEFLGIVTIAILLWYGGKMVLVD
HTLEGAVFIVYMALAYNILTPAKAISKASYSVKAGMAAAERVLVILEHENPITSKENAIE
KNTFEDKIEIKNINFRYEEENVLKNFTITVPKGKTIALVGQSGSGKSTIANLLTRFYDVN
EGNITIDGIDIKDMKLESLRGLMGLVTQDSILFNDTIKNNILLGKENATDEEVIEALKIA
NAYEFVMNLPNGIETNIGDAGNKLSGGQKQRLSIARAVLKNPPIMILDEATSALDTESEK
FVQIALENMMQNRTSIVIAHRLSTIQKADNIIVMKKGEIVEQGTHTELLALNGTYSNLVT
MQSFE
>KACEBFPM_01607 Phosphoglucomutase
MAAQAKENGSSLYEELLKLYVDFGFYKEHLISITKKGIEGANEIKQMMVNLRENPLKEIN
GERVVFIEDYQNLTAKNIFTNEIEALHLPKSNVLIYYLEDGSKICARPSGTEPKIKFYFS
VNCTVENISEVTEAENYLDNKIKNIIVSMNLN
>KACEBFPM_01608 Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta
MSWFKRKEKGITTATEDKMDVPKGLWYKSPTGKIIDAEELARNLWVSPEDDFHVRIGSAE
YFHILFDNNEFTELDANMTSKDPLGFVDTKKYADRLVDVMQKTKLKDAVRTAVGKSKGRD
LVICCMDFAFIGGSMGAVVGEKIARGIDHSIKNKIPFVMISKSGGARMMEAAYSLMQLAK
TSAKLAQLAEAKIPYISLCTDPTTGGTTASYAMLGDINISEPGALIGFAGPRVVRDTTGK
DLPEGFQTAEFVLEHGFLDFITPRKELKDKINLYLDLILNNEVR
>KACEBFPM_01609 Fructose-bisphosphate aldolase class 2
MAHNIKPGVATGDQVQEIFNYAKQKGFALPAINVTGSSTVNAVMETAAKLNAPVIIQFSN
GGCLFNAGKSLSNENEKAAILGGIAGAKHIHTLAEAYGATVILHTDHCAKKLLPWIDGLL
DASEKHFAETGKPLYSSHMIDLSEEPIEENIEICKTYLARMSKIGMTLEIELGITGGEED
GVDNSDVDSSKLYTQPEEVAYAYEELMKISPRFTIAAAFGNVHGVYKPGNVKLTPKILKN
SQDYVQNKFNTGANPVDFVFHGGSGSTLEEIREAIGYGVIKMNLDTDLQFAYTEGVRDYV
VKNVDYLKTQIGNPEGDELPNKKYYDPRKWIREGEITFNTRLEQAFADLNNVDTL
>KACEBFPM_01610 Outer membrane protein assembly factor BamA
MGNITTKISLFILIIALITACNVVKKVPAGKHLLLKNEILVNGEKNSQENIISQLAQQTN
TSIFGYKLRLNMFNLAKNNTDSIFRAKYIANPAKYKQQAKWLSKKQVDRLGQSFWYSGWH
SFLRRTGEPPIIIDTLKAKKSAKRLKDYYFNQGFFDANVKFLVTYQEKKRGNIQYTVTTG
DATFLDTISHEIETPALDSLYLLSKSKSYIKKGQQYKAANFSNERSRITNYFRNHGVYYF
QQQSIHFVVDTLNPNKKAPVKINITDQVTKTEDSIRSKPYKIYHISQVNLFVDNTTAKNK
SKNDSTTYKNFNLYSPNKLRYRAKAITDAVFIQKDSLYNDDKRSLTLRSLSNLKVFNYPN
VQYIEDTISKSLQANIYLTSKPKFHFNANADFTRSNIQIFGITGGSGVSIRNIFRGAETL
EIGLHGNIGSSRDVAITGNKFFNISEVGADIRLNFPRIFLPFKTNRIIPKTMLPSSIISA
GYAKQTNIGLDKENFTAAINYNWIPKKNTIAKFDLVNIQYVKNINIDNYFNVYRSTYNKL
NGLAKTYNNNNNDLSKENGGVNNFIDDALNHKYALLTTQTADYKLIKSIKERKDRLTENN
LIFAANFSYSKDSKTDIFDKEFYSFRGKLESAGNILSLASSLAKQTKKEDGTRNVFGLQY
SQYIKGEFDYAKNWDLTNGKSFAVRSFFGIAIPYGNSKSVPFARSYFAGGSNDNRAWQSY
SLGPGNSGGLNDFNEANMKIALNAEFRYKLFGNLNGAVFADCGNIWNVFDSETDETKVFS
GISSLKSLALGTGLGLRYDFKFFVFRLDFGFKTYNPAKLETERWFKELNLSKTVVNFGIN
YPF
>KACEBFPM_01611 Putative TrmH family tRNA/rRNA methyltransferase
MVTRNQIKLITSLVQKKYRKQYQLFFAEGAKVIQELLQSNFELEHLYCTKPMFSDVSELK
KTIISDSDLKKITALTTANDCLAVFKIPQEKQIENSGLIVALDDIRDPGNLGTIIRLCDW
FGIAQIVCSEQTVDVYNPKVVQATMGSITRVNITYLDLETYLAEAKTAVFGTFMDGKDIY
KTQLPPSGIIVLGNEANGISKLIEEKVTQKITIPRFGDLQRTESLNVATATAIVLSEFKR
TC
>KACEBFPM_01612 hypothetical protein
MSKKSLLIVLITISTVANAQVFRKSMFAKKALLNLENFDKQRVYFGFYLGFNNYDFKIDK
KYDDQDIIIDSQTGFNVGFIADLRLMEYLNLRFEPGLSTAQRNLHFPHFTNSVDALREVK
TTNIHFPLLLKFSSKRIGNVRPYVLGGISTDMNLSSNANSPDDNSSNRFRMTKNTSNYEL
GLGIDLYMEYFKFSPSIRGVFGMKNELIPDNNPNSPWTGNIDQMRTRGIFINFAFH
>KACEBFPM_01613 Demethylmenaquinone methyltransferase
MSISTKPYKDSELGKKEQVAKMFDTISSKYDNLNRVISFGIDVKWRKKILKMVAAKNPNN
ILDIATGTGDLAILLANTKAKKIIGLDISIGMLEVGKQKIEAKKLSPKIEMILGDSEKIP
FEENTFDAVTVAFGIRNFENLEIGLTEILRVLKPNGVFVILETSVPEKFPFKQGYGFYTK
NILPIIGKMFSKDKVAYQYLSDSASIFPYGEKLNNILQKIGFIEVKHLPQTFGVATIYCA
SKK
>KACEBFPM_01614 Dihydrofolate reductase
MITIIAAAGKNNELGIDNQIIWHLPDDFKRFKAITSGHHIIMGRKTFESFPKPLPNRTHI
VITRNKNYSLPEDCFVVDSIEKAIDICPKNKTIFIIGGGEIYKQSINIANCIELTRVHGD
FDADAFFPTIDLTKWELVSSQFHEKDEKHQFSFTFETYTKII
>KACEBFPM_01615 hypothetical protein
MENAQHEQYEYARQRLKQKKQLYFHFVFFVLLSIFSVVINKLLGFYPETYWFLWVITILS
FLFVLHFIRVFITDSFMNKNWERTQIDKLIAKQERKIEQLQKDLDTNNK
>KACEBFPM_01616 hypothetical protein
MYQGVMINLMANYTKKVQTTRNKVEIKGINQYNTPILTNNPETNWAINSSISKKIYRFSL
KLNTHLNWLNYIQTVNKITTINDKNNQKIGFSLKTAYRKWPDFNIGYTKGFNQLSGLTKT
AYRSDEINADFELTFLKFWTYKMEYQNLKNTNSMNQSNFYEVANTSIRYQKNNNPFEFEI
FANNLLDNKVKNNYSFSDYMISEQITYVLPRIFILSVTYKL
>KACEBFPM_01617 hypothetical protein
MKQVSHSDDLAINVKLKEDKKKFVFGDIEAGVELAGNNGFYLGHAGIFFYSPKTNISYIG
DSNNIGKSTFTFDDLTGTLIYKIRYSFPKTNLKTTTIVQF
>KACEBFPM_01618 DNA mismatch repair protein MutS
MQYIIALILMIIVYITLIRKKKSEKINSNNWFNEKDTNFDFYLISKYLNNRINIEKKYYQ
FITDKVSIDIDLDDVFKKTDRTISKIGQQYLYYKIRVIKNDFKQLEVFQNLIDYFKINQK
QRNECIKELSNLNTSNGYYFEELFNKDVITNKRLVKICLTINIVFIILIIITFFKHIFFL
TLIPVFCTNLFFHYRNKGAINYHLDNISEFSKTLNTAKNILKIDPAIKTFFENIDFFEPL
LKYEKTIKAIIIEKYFKNEYLLPFWLILELLKVSFNIEVILFNSLLQNINKHKEQMNDLY
KFIGEIDSSISFVGFNLSGNHFCKPTFVNTKEIFVENLYHPIIPNCITNTLELKNKSMLL
TGSNMSGKTTFVRALAINSIYSQTVNISFADSYKAPFFKIFSSIRTQDNINSNKSFYLDE
VLTIKDFITSNNINEPHLFILDEIFKGTNTLERIAIGKAVLSFLNKQNNFVFVSTHDLEL
ADLLVNDNFNLFHFSEDISDESLTFSHKLQKGKLQTRNAIRILGLYDYPNEIIDEANKIY
TKSLEKVINQKE
>KACEBFPM_01619 Ribosomal protein S12 methylthiotransferase accessory factor YcaO
MNLQSKRPYKEALPKNTILKIKNILKEIDILTIETLWGNPFDEIYSVRIEAITEDGEFGQ
NGKGRNQLFCLASAYAEYMERIQNLLLTGTSGFNRVLMESNFKEVDIYYYPDEKEITKED
FLKLPNEILSDFFSTNDITIFKEVIDCFFDTVEKNNHSGIYSMPFYSLKRKEVVNIPHNL
LFSITGSNGMASGNTLSEATFQAMCEIYERNAASIIYSEHLTPPTIERIYLSNFPEELNI
IVEIDRNGYEVIVKDFSCNRNLPVVGLIIVDKKSGKYKLNIGSDTDFQVALSRTLTEIFQ
GLKDGKDIQNTLLPKPNEENSPFLYNQDSESVFERERNLVNFMKNGSGIFPETLFYNNSS
YEFNPNTFNPKKSYEEEVKELLVLAKNLNYDVYIRDVSFLGFPTVYIYISGVSLLGRKFN
LNDSGLINEKTEIQNELENLLYPFSEFINDKTKLKRAIENIETLDFIRNNEIKSKDIFRL
KFKDRSKWNDLPLSFLMVIFCYLTEDFVNSKKYLDLFIDEFKLIDNDYYSGISKYIDCKI
ENKSIKGIHQSIIDGFKDSEAIFQYIGYPNCPDCENCKLSTTCLTTKNIQKYTNIKRKFK
ENLINQNKFATLV
>KACEBFPM_01620 hypothetical protein
MDFLLAGSSLSNASAFYQAALADGPALVGASEAAAAAVKAGMTRLIM
>KACEBFPM_01621 hypothetical protein
MYHLLFFATLSYIIVKKKTEFGYDFATIIAVANIFLFTFWFSNYAFVEHEHYISTGIYQR
FAFYLHYVSLLIIIYFAYQLYKMEKEKVIPEFFNTNISIWIAAFFIIFLASSEIMLHGLV
ITNSPVTLQDIKSSTMYADYKNDPKYLRILISDNFISETRTRIWKAAFPILWGFLAFIFL
IIGIKKQNKTIRIIALSLLGLTVVKLFVYDISNVSETGKIIAFILLGVLILIISFVYQKL
KILVIDDTKTEEHKEINKINENE
>KACEBFPM_01622 hypothetical protein
MRMNKFFILLFIANLSFAQNRIATAKIKYDGKEGFHKLVLPTELRSFSNDDLSDFRIFDS
KKNEVPYYFETKNNQSYNNLFVAYKIISKTAITNKNTVLIFENPKTTISKATLEIANSNI
TKSYSISGSMDNEKWFGLVNKDSLSPIYSEETSSGFYTIPIPTCFYKYLKIDFNDKKTLP
INILNIGSINHKMSKTTLLAVPYKSKLVTEIKDKKKTKIQINFNNPQIINQISFTISNPK
FYKRNISVYKKATRKVKHKFENYEEQIANFELNSDTNNTFNIAQIFEKELFIAIENKDNQ
PLTISKIELFQIPFYIITDLKNNENYTITTGNKDLDTPQYDLENFKNSITTNLPEAQITE
TKQIKNSCKTAANKTFWQQSWFMWLCISLAGIAITYFVISLVKDMNNKS
>KACEBFPM_01623 hypothetical protein
MINNDINDLLEINPEKRINQKNQNIVKHVLIRAGVAVLSLLIIVLYLDRCDLGMYGFLAL
FYIMGSFLLLWIIFLLIEALILHNNKKPLLRNANLIMILTLVILVFGALNTLS
>KACEBFPM_01624 Uridine kinase
MLIIGIAGGTGSGKTTVVHQIMNELPDTEVGIISQDSYYKETQNLSYEERSQINFDHPRA
IDFELLVQHLKDLKAGKIINQPVYSFVKHNRTDDTITTHPRKVMIVEGILILTNPELREL
FDIKIFVHADSDERLIRRLKRDIAERGRDMEEVLNRYQTTLKPMHQQFIEPTKAFADIII
PNDKYNTVAIDVVRAVINQRIS
>KACEBFPM_01625 hypothetical protein
MNNPFKNNIPYKTLLNKYVIVCFFFVIWILFLDNYSYLDHCALNSEINELEDNKIYYQEE
IKKDIDQIKKLKNPAQIEKYAREKYYMKKDSEDIYIIEFEGDTLEKR
>KACEBFPM_01626 Methylmalonyl-CoA mutase
METNLFNDFDSLSSKQWKQQIQFELKGADYNETLVWESAEGIKVKPFYHKDEDYKKTAIT
TEASKVKIVQNIFVFDIEKSIRKANDSIARGAESIRFTIENEDIDLTKLLSQIAIDKIPV
YLNLKFLSANFIKKTNEIAVSKNTIIYCLIDPIHQLASDGNWFETETKDNFGVLNTVSKD
CKNISFININATLYQNAGANMVQQLAYTLAHTNEYFNHIQNHHHPITIEVSVGTNYFFEI
AKIRALRLLFNTLAKEYNHDFDCHIIATPTKRNKTLYDYNTNMLRTTTECMSAILGGANA
VANLAYDAIYHKDNEFGDRISRNQLLILKKESYFDIVNNPADGTYYIENLTAQLAEKALL
LFKEIEGNGGFLKQLKEGNIQKKIQESAQKEQELFDSGKEILLGTNKYPNKNDKMSHDLE
LFPFVKIKPRKTLITPIIQKRLAEKMEQERLEQEKNN
>KACEBFPM_01627 hypothetical protein
MKTILSFIVLFISINTFSQTRKLEVTDNQSGKSIFFQEAQRVKITTTKREQLVGTLTFEN
PESITINGMPIPINNINSIKYFPKKGAVLKNIILGTGLGLVAGSGIAAAFGNGNAFSLFA
AGAGTTIAGGLIGGNKTYIKQRSTFKIIE
>KACEBFPM_01628 Methylmalonyl-CoA mutase large subunit
MRKNVQHITLEKAETKSQEAKGKSYLTAEGIEVKSDYSEQDIENLKHLDFGAGFAPNLRG
PYATMYVRRPWTIRQYAGFSTAEESNAFYRRNLAAGQKGLSIAFDLPTHRGYDSDHERVV
GDVGKAGVAIDSVEDMKVLFDQIPLDEMSVSMTMNGAVLPIMAFYIVAAEEQGVKPALLS
GTIQNDILKEFMVRNTYIYPPTPSMKIIADIFEFTSKKMPKFNSISISGYHMQEAGATAD
IELAYTLADGLEYIRTGLATGMKIDEFAPRLSFFWAIGMNHFMEIAKMRAGRMIWAKLVK
QFEPKDDKSLALRTHCQTSGWSLTEQDPFNNVARTTVEAMAAAFGGTQSLHTNALDEAIA
LPTDFSARIARNTQIYIQEETKICKTVDPWAGSFYVESLTTEIANKAWALIEEVEELGGM
TKAIEAGIPKLRIEEAAARKQARIDSSQDIIVGVNKYRLEKEDPLHILDVDNQMVRKQQL
EQLDKIKANRNTKKVEDSLKKLTLCAQTGKGNLLEIAVEAARNRTTLGEISDALETVFGR
YKAQIKTFSGVYSKEIKDDKSFEKAKQLADKFSKKEGRRPRIMIAKMGQDGHDRGAKVVA
TGYADVGFDVDIGPLFQTPAEAAKQAVENDVHILGVSSLAAGHKTLVPQVIEELKKYGRE
DIMVIVGGVIPAQDYQYLFDAGAVAVFGPGTKISEAAISILEILLID
>KACEBFPM_01629 hypothetical protein
MNILLHPTYFPSISHFVAMAKATTVTLEMEDNFQKQTNRNRMYLYSPNGIFMLNIPVKNS
NSKQMTKDVKLETSFDWQKQHFKTLEASYRNSPFFEYYEDALMPIFTKKHTFLMDLNIET
IEIVSKCLKLDFTPQKTIEYFHEVNGLDDFRVLANGKKDTNTFSSYTQVFQEKQGFINNL
SILDLLFNEGRFALDYLKKEMLIAL
>KACEBFPM_01630 hypothetical protein
MFTYSFEKLEVWVESKNFSKSIYLVTSKFPDNEKYGLISQLRRASISICSNIAEGSARNS
FKDKAHFTTMAFSSAVEVLNQLIICFEIEFISENEYFKLRGDLESITNKLNALRTYQVNK
STEASK
>KACEBFPM_01631 Signal peptidase I
MSILQWFIFFLILQIVHYLGTWKLYEKAGRKSWEAAIPVYNAIVLMKIINRPTWWTALLF
VPIVNLIMFIVVWVETLRSFGKNTTKDTILGVVTLGLYIYYINYFEEVTYKRDRSLVATT
KTGDTVSSLLFAIVVATMVHSYVLQPFNIPSASLEKSLLIGDFLFVSKFHYGARTPKTAI
ALPMVHDSIPVVGMKSYLSWPQLPSFRFPGLQAIKRNDIVVFNWPNDTVYRFFDTSKRHA
DKPLDKRTNYVKRCQGIPGDNLSIKNGDVYINNKRLILPERAKIQYSYTVVTDGSVLDGK
YIMQDLQITDGVYAIGENTYLFRAVTDEAAAKVRQIPGVKSVIKLINTKPDLAVFPHTQN
WNIDNYGPIYIPEAGKTVALNKETLPFYRRLITVYEGNKLEEKGGQIFINDKPAINYTFQ
QDYYWMMGDNRPNSEDSRYWGFVPFDHVVGKPVFIWFSVDPNLPWSQAIDKIRWDRLFCT
VGGDGQPTSYFKYFLILLVVWFGFDYFRKKKKG
>KACEBFPM_01632 4-hydroxy-tetrahydrodipicolinate reductase
MKIALLGYGKMGKVIERIALERGHEIVLKKGRTSNYEGLEKADVAIDFSIPDSAVCNIKQ
CFDTNIPVVCGTTGWLEHYDEMVSLCASKNGSFIYGSNFSLGVNIFFELNNYLAKMMSKF
NQYKVSMQEIHHTQKLDAPSGTAISLAKGIIENSDYLNWTLENPAKNEVHIDAKRVENVP
GTHSVFYDSDVDQIEIKHTAHNREGFALGAVIAAEWLANKKGVFTMKDVLSLNDK
>KACEBFPM_01633 hypothetical protein
MKNWFYTVFVVAIFGNFSGFSQNDLRRIALDTTTTKINPLAPSKAAFYSALLPGLGQAYN
KKYWKIPLVFAAVGTGIYSYVWNKQKYDEYRDAYKERLLLGAQSTDAFNNKNTGGIYLSE
AKLIDAQKQFERQKDLSLLVTVALYILNIVDANVDGHLHQFNVNGKLTVRPDIYQNYTDY
TQNLGVTLNYNF
>KACEBFPM_01634 putative chromosome-partitioning protein ParB
MALAKKQAMGRGLSALLKDPENEITSVNDKNADKVVGNIIELELELIEINPFQPRTNFNE
DSLQELATSIRELGVIQPITVRKTEFNKYQLISGERRLRASKIVGLTTVPAYIRLADDNE
SLTMALVENIQRHDLDPIEIALSYQRLIDEIQLTQEQMSDRVGKKRSTVANYLRLLKLDP
IIQTGIRDGFISMGHGRAIINVENHDVQTDIYQKIVSQNLSVRETEALVKNYQEGFKQKT
ELVTKTSSFDVNEDEKKSFNDYFGTKVDVKVAGNGKGKITIPFHSEEDFNRIIKLIKA
>KACEBFPM_01635 Sporulation initiation inhibitor protein Soj
MGKIIAIANQKGGVGKTTTSINLAASLGVLEQKVLLIDADPQANASSGLGIDVENVEIGT
YQILEHSNTPEEAIIKSSSPNVDVIPAHIDLVAIEIELVDKENREYMLKQALASVKDKYD
YIIIDCAPSLGLLTLNALTSADSVVIPIQCEYFALEGLGKLLNTIKSVQKIHNPELDIEG
LLLTMYDSRLRLSNQVVEEVQKHFNNMVFDTIIQRNTKLSEAPSYGESIINYDATSKGAA
NYLSLAHEIIKKNAK
>KACEBFPM_01636 putative 2,4-dienoyl-CoA reductase
MNFSEKMLRDNALSDKVIVVTGGGSGLGKAMTKYFLELGAKVAITSRDLEKLQNTAKELE
TETGGKCLPLQCDVRHYDQVEAMLAAVLKAFGRVDVLLNNAAGNFISPTERLSANAFDTV
IDIVLKGSKNCTLAFGKHWIEAKQTNCNVLNIVTTYAWTGSAYVVPSATAKAGVLAMTRS
LAVEWAKYGIRMNAIAPGPFPTKGAWDRLLPGDLAEKFDTSKRVPLRRNGEHQELANLAA
YLVSDFSAYINGEVVTIDGGEWLQGAGQFNDLSAIPKEMWDMLEMMIKAKKNK
>KACEBFPM_01637 Threonylcarbamoyladenosine tRNA methylthiotransferase MtaB
MENRKKVAFYTLGCKLNFSETSTIARNFQDEGFDRVDFEEIADMYVINTCSVTENADKQF
KQIVKKAMKLNDKAFVAAVGCYAQLKPEELAAVDGVDLVLGATEKFKITDYINDLSKNDR
SEVHSCEIEEADFYVGSYSIGDRTRAFLKVQDGCDYKCTYCTIPLARGISRSDALENVLK
NASDISKQGIKEIVLTGVNIGDYGKGEFGNKKHEHTFLDLVQALDKVKGIERLRISSIEP
NLLKNETIDFVSKSRTFVPHFHIPLQSGSNEILGKMKRRYQREVYTDRVANIRQVMPHAC
IGVDIIVGFPGETEAHFLESYNFLNEMDISYLHVFTYSERDNTEAATMDGVVPMNVRNKR
SKMLRGLSVKKRRAFYESQLGTNRTVLFESENKEGYIHGFTENYIKVKTPWNPELVNTLQ
EINLTKIDEDGSVRVEFLAISV
>KACEBFPM_01638 hypothetical protein
MNYILFDGTVRNALLPFTFTRPVADIRVGILTIREKWEKYLGSTTTTLTEEYLSEKFPMV
ELEENVMINASFLPNEILSEMVSNLEANQAIFRGEEVIAFFTEDSQEEIDFDTYQIIEYH
DDCLTIEHTWDIFQKNDLAIREDFELITQGRISQRIPKSVNVISPENIFIEEGAKLEFVT
LNASTGPIYIGKNAEIMEGSVIRGPFALCEEAQVKLATKVYGATTVGPHCRIGGEVNNSV
LFGYSNKGHDGFLGNSVLGEWCNIGADSNNSNLKNNYEEVKLWSYETEGFAKTGLQFCGL
MMGDHSKCGINTMFNTGTVVGVSANIFGSGFPRNFVPSFSWGGASGFATYITKKAFEVAK
VVMSRRHVDFTEEDARILECVFEQTKKWRKE
>KACEBFPM_01639 50S ribosomal protein L31 type B
MKKGVHPENYRLVAFKDMSNEDVFISKSTVETKETITHEGVEYPVFKMEISRTSHPFYTG
KSKLIDTAGRIDKFKTKYAKHAK
>KACEBFPM_01640 hypothetical protein
MNEIVKKNGINYGIITGVLSVLTTTLIYVIDLKLFTSTWLGFLSIAIYIIIGVVLLSKTR
KDFKGSLAFKDAFTTYFVSAVIGILISVVFNIILFNYIDPSAKATIKELTMKYTVEMLQK
FDTPAKVINETIKSLEENDQFAPLKLLQGSVFSIIFSALFGLVLAAFFKTKSSFPK
>KACEBFPM_01641 Dodecaprenyl-phosphate galacturonate synthase
MNISIIIPLLNEQESLPELTSWIEKVMLENNFAYEVIFIDDGSTDASWETISQLSSKNSN
IKGIRFFRNYGKSQALHAGFAKAQGDVIITMDADLQDSPDEIPGLYNMIVSDNYDLVSGW
KKKRYDNAVTKNLPSKLFNAAARKTSGVRLNDFNCGLKAYKNVVIKNIEVSGEMHRYIPV
LAKNAGFSKIGEKIVIHQARKYGESKFGMSRFVNGFLDLITIWFLSKFGKRPMHLFGALG
TIMFLIGFLSAGYIGVSKLIKLFYLHEDTILVTNNPWFYIALTTMIIGTQFFLAGFLGEI
ILRTKNNEERYKVSKEINL
>KACEBFPM_01642 hypothetical protein
MPFSKTILPWVFLTATPTRSESGSVPITISALVLSARAIAIVKASGSSGLGDFTVGKFPS
GIACSATISTFLYPAFSKTSGISFIEVPCKEVKTIFNFSLAVANVLKLAFSIVEFIKASS
TFTSIYSIKFSLASNFI
>KACEBFPM_01643 hypothetical protein
MVSIKIKTDDFINLINTKTIEISASDLQELKSKINIVPKKNGESFLLSNDVFLEEFKRVF
STYSVLFELI
>KACEBFPM_01644 hypothetical protein
MLKEDKKAFIDGNAIINKQIKSIIDDKIKKIKRINSTHSAKVTISGDVNNFSFNIESEDN
ETIKLIQKELNM
>KACEBFPM_01645 hypothetical protein
MKLELKHLAPYLPYELKVKDIDDASIKTLFGLKLKNKDLWLYYQNGTKDRGRIRPILRPL
SDLDKPIERDINLIVVPSRAFDLVKNEEGFWCDEYYAEYCESPTAKVEVTQFNFWLFEYH
FDVFELIEKGLAISIHDVE
>KACEBFPM_01646 hypothetical protein
MSCSTVTSDKIIVFKDKGNNKCQIIFNNPNQISVTKIRVDDCVIKNGCRCDFKLDCPNYE
NYIEIKGKDIYHACDQIEETILQLSSNIKLKAKNSFVIATGAPNINGKIQIITKKFKIKY
NSNLIIKTNKHTVNL
>KACEBFPM_01647 hypothetical protein
MERIKINGFGGLKNAEVQINNINVFIGKSASGKSITIKLIYFFKSFFREFFEAAENEETK
SELSKKLLVKFEEFFPFESWNESTFEIIFYYNENDYSKITKGSLKSKITIEYSKTVFKQY
NNAKRLIKVDKEKFQAKDKFEVYRPDFKVFERYINLVKTELGEKCAYSQIFIPAGRSFFA
TLQSSIFSFLSNNKAIDPFLVEFGSFYENIKGIVTRESISSKNKTDFKIIDDLIIEILGG
KYQRIKSKDYIIHEDKRKINLAYASSGQQETLPLALILKALTKISFTGGGLTLYIEEPEA
HLFPSAQKKVVELIVSVFKLSKCESQIILTTHSPYIISSFNNLLQAGLIEEKSNDEKLYE
IVNKLFIIPKNNLNAVSVEKQQFKSILDEDFGLIDSEYLDSISSIISNEFNQLIDFEHEL
>KACEBFPM_01648 hypothetical protein
MFKLFSIDQNNKEREVYPENGIYVVYELYEYKFQFVGTVTEKIVFIEDEVFDYENKLLIF
TDNGISTKEKKRIFEDYFGYLKINICNNEFNFEVRIQKLKVPELEEILLYLWNQDPIIFD
NFFSKSTLKSKLDKENKNLDFSSKFVNIFEDYHSFFKNSFFVFKSLPHNVLRTKNTIKDY
ELADISNNSIDWLINNLDELHLDYSYKNVENSIQINNNYGLVEKILTEEKISDFNIYENQ
IILGSFEYVILEIAKIKNKIKGYLSTKQYYEKDFYSINEFKIIPFLKLKDDLEKIESKIK
SLQRKYKDVFVKANSKNTFPKLTPVFSNKRHYTDAYNKIKLIRDIKINLDGELNLLNIKK
LSTLYERFNLFVLINSIKAKNPISHKFENPKPEDNTFQEFYFQFPNYKLSIYYDNYIGNI
ENKIGLQRISKGYYRPDYVIKLETQNNTFFYILDSKYSSENTVKDRHMLKCIKAYILDIG
ISDLPSTKVEELILIYPGENEEIIFGNDIFKPKISILPSKVKNRNLNEFIERILLNN
>KACEBFPM_01649 hypothetical protein
MVLVTDSHNILTPKEKIREVSVNRGWSSQKDFIGFVNPLTKRFHSSSTDIYSLTKQMNEE
SKDEEIYLNTPMSFIILDEANLSPLEHYWSSFYNLTDSTGMLEVKLGHNETIKFPNNLRF
IGTINYDHTTEELSPRVLDRINIIQLNKSEDINFSNISNSKIKNIQLSFKRCIEFFELTD
NNQIELKIEDKTEKAYREIKSEFKNLKIFISPRVEIAIKRYITLASKYMSDVNKPLDYCV
AQRLLPLINLQGSENKQKLVLLKEKLENNKCEISTRILEDIISIGSEKGIYEDNFNYFLT
LSNV
>KACEBFPM_01650 Protease 4
MTKKYGINTELVETHENASGYSLFKPLEDNFRQITQEGVEHIYNVFVTRVAKGRKMTFAQ
VDAIAQGRVWAGSDALRLGLVDKIGGLDDALAYASNLVKLKEYSTVDYPKYEKDFKELFS
GSGLPFMKSRENLIKEEIGIENYKIIEQIRKMNAQKGVQAIMPFEINVK
>KACEBFPM_01651 hypothetical protein
MKKKIFIGIGVFLLIIIASLAAIPIFFKDQIKAKIEKSINENVDAKVTFADASLSLFKNF
PQANVGIQKLIIINKAPFAGDTLVAFEELNLQMSVKELFNGENQPMTLKAISVKNGKANI
LFNKDGIGNFDIAIKDNNKEESKSKPFAMNIQNYALENFNFKYYDERSKIKMVINELNHT
GTGNFAAQILDLDTKSTAKISLDMDKMNYMKNVAISLDAVLGIDLEKSKYTFKDNTAKIN
ELPLQFNGFIQLLEDGQDYDLTFKTPTSSFKNFLGLVPAAYAGDLNTVKTTGDFTVAGFA
KGKLTNATIPKFNIAIASNNASFQYPDLPKSVQNIIIDTKIINETGLMNDTYVNLDKLSF
KIDQDVFTAKANIRNVATNALVDAALKGTINLGNVTKAYPVKLAMPLSGILKADVTTKFD
MKSVETSQYQNIQNAGNMTLTGFNYTGEGMAKPVQIKQAIVAFNPKQIRLNQLDMKTGNS
DIQLTGTLDNFYGFLFRKQILKGNFDMNSSNFLVSDFMAPTAVTTTEGKKTTKEAVKIPA
FLDCAITAKANTVVYDNLTLKAVSGKMIIRDEAVTLQNIKTNIFDGQIGLSGLVSTKGKV
PTFSMNLDLNKVDIAKTFTQLDMLKKIAPIAGIINGKLNSNIKLSGNLNAIEMTPDLNTI
SGDLLGQLLSTTVNSSNSKVLSALGAQVKFLDVSKLNLNDIKAAISFNDGKVTVKPFKIK
YQDIVAEIGGSHGFDQNMNYNIKMDVPAKYLGAEVNKVLAKLTPADAAKIDNIPITALVT
GNFANPKVSTDMKQASTNLASQILKSQKDKLINQGASALGNLLGGGKKDPADTTKTKDPK
KEAIKNAAGDLLNGLFGKKK
>KACEBFPM_01652 hypothetical protein
MQYEGVLTKMQTEIGNPIQYYLVFENSFLNMNQLLGKELEINFQGYQCLNCKKKKKIFRQ
GFCYDCFMGSASAGDWIMKPELSTAHLDIEDRDLVYEKKVQLQPHIVYLALSSEVKVGVT
RGSQVPTRWIDQGAVQAIPIVEVPNRYLAGITEVALKSHYADKTNWQKMLKNEVPVADLI
KERASLKYLIPKEAQEYFDANKNDLYQLHFPVLQYPKKVTSLNLDKSPNYSGKLSGIKGQ
YLIFEDGTVFNVRTFEGYVVKISL
>KACEBFPM_01653 N-acetylmuramoyl-L-alanine amidase LytC
MKLSIVVLVFLCFAFIPKNDKITVVIDAAHGGSDLGATMNGFSEKEIVSSIAQKIENLNL
NSNIEILLTRSDDQNIPNQERVAFINAMKPDLVISLHVNASKNSEFNGLEVFVSEKSTEY
LASKEFASKFHASITNKMPLKIHPLKNANFLILRRSDVPAMLVELGYLSNQNDKAYLENK
DNQIEIAQNILTFVANLKS
>KACEBFPM_01654 hypothetical protein
MSLPIINSIASWFLKQRIHQIELFLKYPNEVQEELLINLIRSSENTIIGKQYGFDSIKSY
HTFQERVPVSTYEDLEPLIERTRKGEQQVFWQEPIKWFAKSSGTTNAKSKFIPVSNSALE
DCHYKGSKDLLCLYLNNNENSQLFTGKSLRLGGSKQLYEDNNTFFGDLSAILIDNMPFWA
EFSSTPSNKTSLMSDWETKLLAIVNETKIENVTSFAGVPSWMMVLLNKVLEETGKNNLFD
VWANLEVYFHGGVSFDPYRGQYKKILPKQDFKYYEIYNASEGFFAIQDLNNSTDLLLMLD
YGIFYEFISMDIFGTPNEKIIRLAEVEINKNYAIVITTNSGLWRYLIGDTVRFTSLNPYR
IRITGRTKHHINVFGEELMVENTDMAIAKTCKMTNSEVKDYTVAPIFMEGKAKGSHEWII
EFRKQPDNITFFTKILDENIQALNSDYEAKRYNNMTLNQLTVNIARENLFYDWLKKHDKL
GGQHKIPRLSNKRDYLEELLLL
>KACEBFPM_01655 3-deoxy-D-manno-octulosonic acid transferase
MLFIYNLIVHFASFLLKIVAFFSPKIKLFVSGRRTVFATLRSKINLEDKTIWFHAASLGE
YEQGLPVIEKIKEQFPAHKIVVTFFSPSGYETRKTNKVADVTVYLPLDTKSNAQDFLKLV
HPEMVFFIKYEYWPNYLHELKKQNIKTYLISGVFREKQSFFKWYGGFYRNALQSFDYFFV
QNESSKKLLQSIGFNNVKISGDTRFDRVASVLERDNSLGFIEQFKNNTTTIVIGSSWPKD
ENLLVNYINKSSNEVKFIIAPHNIKSEQIQELKKAITKKAVLFTEKENQDLSSFNVFIID
TIGILTKIYSYADIAYVGGGFGNPGVHNLLEPATFGVPIVIGTNFSHFAEATALVNMTGC
VSISNQKELNEILDNLIQNPDERFEKGHICSTFVNMNKGATNVVLKHIC
>KACEBFPM_01656 UDP-2-acetamido-2-deoxy-3-oxo-D-glucuronate aminotransferase
MKKIQMVDLKSQYEKIKDTVNTSIQEVLDTNAYINGPEVHKFQKNLQEYLDVKHVIPCAN
GTDALQIAMMGLDLKPGDEVITADFTFAATVETIALLQLTPVLVDVDMHNMNINIEAIKK
AITPKTKAIIPVHLFGRTTNMEAIMQIATQHNLFVIEDNAQAIGANCEFSDGTKKKAGTI
GHVGATSFFPSKNLGCYGDGGAIFTNDDTLAHKLRGIVNHGMYERYHHDVVGVNSRLDSI
QAAVLNAKLPLLDTYNKARQEAARKYSVAFEGHKNIVAPNICDICDCHVFHQYTLRIVDA
DRNGLMNYLLSKDIPCAIYYPIPLHSQKAYLDSRYKEEDFPVTNQLVQEVLSLPMHTELD
DEQIKFITNSVLEFLNK
>KACEBFPM_01657 Pantothenate synthetase
MIYNTLAEAKKLFGTKSANEVTKWVTKTFENQSMFELEYFEITDEQTLLTCKRKNKNKKY
RAFIAVFVNNIKLIDNISLK
>KACEBFPM_01658 Aspartate 1-decarboxylase
MQIEVVKSKIHRVTVTGADLNYIGSITIDEVLLEASNIIEGEKVNIVNINNGERFETYAI
KGAKNSGEITLNGPAARKVHKGDIIIIMSYARMDFEKAKTFKPWLVFPNEKDNSLK
>KACEBFPM_01659 hypothetical protein
MKKKIGKWLSIGLPLILGIYLIYYKYNEFTTEQIHEIKGYFKNANYFYIYLSLVIALFGF
ISRAYRWKYAIQHLGYQTHFYNNLMAVCVGYFMNLTIPRSGEFSRALVLKNYENMPFDKA
FGTIVAERVVDTLIFLLFVFASLLFQFNVLKNYVLTKIPVENLIILASIGFVGFVLFLLL
WIYSNWKIVSAIKEKLSGLIEGMSSILKMEQKWKFLFHSFFIWFTYILMFYVTIFALKET
SNISFGAVIIAFVFGTLAVGFTNSGFGVYPLLIAEIFMLYGVPDTAGTAFGWLTWASQTI
LMIVLGGLSFLFLPILNRK
>KACEBFPM_01660 hypothetical protein
MKNTLLIITLFFSIALFSQTTTQTIHSTKLEADREITIKLPASYNKKTEKKYPLILVLDG
EYLFAPFEGNLAFANYWDDIPEVILVGINQNKKEERYDDSEFDPATGLPSAKGGAFFEFI
ATELIPSLEKKYRIAPFKIIAGLDATAGLLNSFLYKEIPQFNAYISLSPELAKGMTERIP
QRLAATKEPLFYYQATADGDLKKFQNQIKALDKNITAVKNSSLNYKFDDFKNASHYSLVL
NGIPNALYQIFSIYRPISSLEYQEKIAVLPDSHAKYLTDKYETIQKSLGIKMNVRLSDFK
AIEAAILKTGDFKGYEELAQISGQQYEKSMLYDYHMAMFYEKTNDIKKAVKFYQNAFMKE
EIRELTKEMMMNKAEDLKKLIPVKAKGLKGGKAKEIIEDVPASDTPTTDIPPTEKPAETP
TEEKKP
>KACEBFPM_01661 hypothetical protein
MRYFFLLYLLMTILLTGCKDNNDNNTHERQIAKALKEKELVFSSINKTWNFVPLNLTPEA
QAITNNWSDWRLFTSELYQKPKGTIGAFQRKTKSLVLKVETLNNTIPERISKPQIKSRLM
AIITKVKALHTFINLDRIPEKKVVTLITDLNIELNAFQDQIEEIVRRSHIQKEEGEQEML
NLLNGSQPTNTTPITEEKNIED
>KACEBFPM_01662 Adenosylhomocysteinase
MSTATMPYVAFKVKDISLAAWGRKEIELAEAEMPGLMALRAEYKNEQPLAGARIAGCLHM
TIQTAVLIETLIALGAEVTWSSCNIFSTQDQAAAAIAAAGIQVYAWKGLNEPDFDWCIEQ
TLFFGEDRKPLNMILDDGGDLTNMVIDRYPHLVEGIKGLSEETTTGVHRLYERVKAGTLP
MPAINVNDSVTKSKFDNKYGCKESAVDAVRRATDIMLAGKRVVVCGYGDVGKGTAASFRG
AGSIVTVTEIDPICALQAAMDGFEVKKLNTVVGNADIIITTTGNKDIVLGSHFEQMKDKT
IVCNIGHFDNEIDMAWLNKNHGASKIEIKPQVDKYTIAGKDILILAEGRLVNLGCATGHP
SFVMSNSFTNQTLAQIELWKNSAAYNNDVYMLPKHLDEKVAFLHLAKLGVELEVLRDDQA
AYIGVGVDGPFKPEYYRY
>KACEBFPM_01663 4'-phosphopantetheinyl transferase sfp
MPLHKIITPNSSTKIYIWKIEETFEDLFDQVVLNDINLIRLNTMKSEMHQRGFLSVRKLL
QEAGYADTDLHYNQDGKPHLKDNKFISISHSSQFSTIAISDKPIGIDIELAKEKVLKIAS
RFMNISHLEGLSVSEKIRKATVVWGIKESIFKIKNEKGISFPDHIFENPFLLSDKKATAQ
LSFNNTIASFDIFFEEINADNSLNYTLVYAFEN
>KACEBFPM_01664 Geranylgeranylglyceryl phosphate synthase
MSTIYNQILKAKAENKKLLAILLDPDKIDLENIQQLIEKINQSPATHIFVGGSLVENNIL
DQLLSEIKKICALPIVLFPGNPSQISDKADAILFLSLISGRNSDYLIEHQVNAVPILNKT
NLEIISTGYILIESGSETAVALVSKTKPLPRNKPEYILQTAQAGEMLGKKLIYLEAGSGA
KISVSKEIIALVSQNINIPLIVGGGIRNLSDIKKAHNTGADLVVIGTAFENNSNFFNQNL
>KACEBFPM_01665 Nicotinamide riboside transporter PnuC
MIESLFSQYKNYPTYEIVLELVAIFFGLSSVWCAKKNNIWVFPTGLISTFIYAYLLWQWD
LLGDSMINGYYFIMSIYGWYHWTRKKEDAQEFPISVITNKEKIIGLIIFVLTLIFVIIVY
IYFGKFTNWYSYIDTFLTAIFFVGMWLMAKRKIENWLFWILGDLISIPLYFAKGYTFTSF
QYIIFTIIAVFGYLEWKKILNSNKVTS
>KACEBFPM_01666 Trifunctional NAD biosynthesis/regulator protein NadR
MEENLKQQQSNIIKITVFGPESTGKTTLTKQLAKHFDTVWIPEFARNYLQEKLDKTGNTC
LAEDLLPIAIGQTKSENEALLKANKFLFCDTNLLVTKVYSEAYYGFCNPIINKAAAEHQY
DLFFLTDIDLPFEKDDLRDSQENRDKFFTVFENSLIENNKPYIKISGNKKQRLEKAILII
NDLIYAKKMGFSSHDFVQIHKHGIPLNNLEKQRELLTKGIPKITLQSPATLQNGIWKLSQ
NEYKEKAVFFDEIKSVLKLEKFIPASGAASRMFQFLNEFLNDFDVETDTINGYINKNKAT
SLTVFLTGMEKFPFFEAINKKLEATFPNIDTWTTDKKNYYFIKFLINSENFNFGNKPKGI
LPFHQYKNHIATPIEEHLNESTFYASSNGISNLHFTVSKEHQQQFEHILSIVKSKIELDN
HTKINITFSYQNEKTDTLAVDFQNNPFRDENKKLVFRPGGHGSLIENLNTIDADLIFIKN
IDNVIQNHIKTIALYKKALAGILIQLQNQIFAYLKTIDANLVSKKEIEEIIFFAEKKLNI
VIPNHFNQLTYNDKIIYIKELFNKPIRVCGMVKNENEPGGGPFWVLDTNGEISLQIIEGS
QIDLQDKKQMQIFQLATHFNPVDIVCSIKNYQGNKFNLLQFIDEKSGFIVEKNKNGTSYK
AYELPGLWNGAMANWLTVFVEVPLITFNPVKTVNDLLKPTHQPK
>KACEBFPM_01667 Peptidyl-tRNA hydrolase ArfB
MESEKIKTELTYKAVRSSGAGGQNVNKVSSKVVLSFDLQNSQALSEEEKELILVKLSSRL
TSENILILNCDEDRSQLKNKAIVTKRFLELLKNALIVPKIRKATRIPKSVIRKRIKDKKN
ISEIKNNRKKPNFE
>KACEBFPM_01668 2,3-dehydroadipyl-CoA hydratase
MNTLINPNGFIATIIDNKTATITFSHPASNSFPSNLLKDLTREFNALSQNESVSVIILKS
EGNGAFCAGASFDELLSITNYNDGKLFFSGFANVINAMRTCRKIIIGRVQGKAVGGGVGL
ASACDYVFATNSASVKLSEIAIGIGPFVIEPAVSRKIGKTAMSQLTLAAHDWKTAQWAFE
NGLYSEIFTSAENLDSELMVFASKLASYNPEALQEMKKVFWEKTAHWDTLLCERAGISGQ
LVLSDFTKNALSAFKK
>KACEBFPM_01669 hypothetical protein
MKVKTILVSQPEPKVENSPYFELQNKHKVKIDFRPFIHVEGVLAKDVRTQKIDLNNFTAI
ILTSKNSVDHFFRVAEEMRYKVPEDLKYFCQSEAVAFYLQKYVVYRKRKIYVGQKDFVDM
STLFKKYKDEKYLLPSSDQLNADITQTLNNLKVDWIAGTFYKTVMSDLSDLKDVYYDVLA
FFSPTGIKSLFKNFPNFEQKDTRIAVFGSTTQKEALEHGLRIDILAPTPETPSMTMALEK
YVAEANKGK
>KACEBFPM_01670 hypothetical protein
MRKTELIPRILENKDWVTVLFLLAFALLVVTKTAFENRFRDFVNLLINDKYLKIYKDSSN
LMSWFTILLFVVQLISMSFFLQLVLSYFGYTTKTNWITFIQIFTFLSFFILSKFLIEKII
ATSFDIENFIEQFNLFKVSYRTYIGLLLLPVDIIMYYTNIMNTYAIIGIMVILLMINAIT
YLVSLKNYQKLLLSKLFYFILYICALEIAPYYFMYYIITKS
>KACEBFPM_01671 Endonuclease III
MPAVGHKTASVVMSQAFGVPAFPVDTHIHRLMYRWNLTNGKNVAQTEKDAKRIFPKEIWN
DLHLQIIWYGREYSPARGWDLNKDIITRTVGRQSVLKDYYKKRT
>KACEBFPM_01672 hypothetical protein
MQLFFKQFGEDLKKNIPGFIAVTITEVRTGIVYYSQSEDPNYDSELSSSFCVEIVRAKMN
SIIATNLKYQKIDTIIINMTSQIHLIDVSDNGKYFIYLTLNDNKNFNLGITKLRLNRYKQ
EIKLVQQKKK
>KACEBFPM_01673 hypothetical protein
MFKNYISNFKGFPREIWVLTILTFINRAGTMVIPFLSKYMKDDLNFTYSQIGWIMVFFGI
GSIIGTWLSGKVMSYVGFYKTMIISLFASGILFFVLEQIKTFEMLCIGILLLTSVADMFR
PAMLLSLNSFTRKENRTRALSLVRSAVNLGFLFGPALGGFLIMKMGYKCLFYVDGATCML
AVLIFVLYIREKKLPFKLNENIVAVSGGNKFAILRDKPFVLHLIISMISGILFFQVFTTL
PLYHKEQFNLPEFYSGLLLGLNGIIMLFFELPIVTFVESRNINKLRIISLGLFCMITAYM
LLFFVKIDLVLVIMMVFITFGAMLTFPFANSFASSRAHIGLEAKYMSVFTMSYSFAHIFS
AKMGMEIIQKFGYDINWLSIATLGTIALLLNLLLYNITKKEKVIANDKIMNSLFFENK
>KACEBFPM_01674 Aerotaxis receptor
MNQEIEFIKPIPIEKEVAWDKTKIIMSKTDLYGTIEYVNEVFTDVSGYEDCELISKPHNI
IRHPDMPQIIYKILWDNIKQGNQFHGIIKNLAKSGRYYWAITDFEYVMDENNNVIKYIAR
RKAVPQDVITKHIEPLYRRLLQIEQVSGVDASENYLIGFLEESGVNYVDLITNLMIDDDK
AGQLQGMKGKGLEANGEDSKEKRQGFFSKFFSKN
>KACEBFPM_01675 Aerotaxis receptor
MSQEINFVKPTPIEKEVAWDKTRTIMSKTDLYGTIEFVNEVFTDVSGYEDYELIAKPHNI
IRHPDMPQIIFKILWDNIKQGNQFHGIVKNLAKSGRYYWAITDFEYVLDENEKITKYIAR
RKAVPQDVITKHIEPLYRKLLQIEQVSGVDASENYLIGFLEEAGVSYVDLITNLMLEDDK
AEQLREMKEKGLEANGEEIKEKRQGFFSRFFSRD
>KACEBFPM_01676 hypothetical protein
MAKKYFKKKNIIPNLLPKNETLNFIFNYSKALRINKIGKETFETILN
>KACEBFPM_01677 RNA polymerase sigma factor CarQ
MATIQLPDGLLVRHYISGDENALSILVKRHESKIFGFIYSKVLDRDVANDIFQDTFIKVI
KTLKGNSYNEEGKFLPWVMRIAHNLVIDHFRKAKKMPMFRETEEFSVFSMMSDNSQDIES
KIITNQVEKDLIKLLKELPDDQREVVEMRIYQDLSFKEISESTGVSINTALGRMRYALIN
LRRIIDKNQVILIN
>KACEBFPM_01678 Signal transduction histidine-protein kinase BarA
MPKQLFVFLFFIFSLSAFSRNAEEPILKTDSSTFYTKKANYFKTNKRFDKALENAKKSIA
FGKKNNNKSVVANGYYCLSTVYIDLKKYDIAIENLLRTVCILNTVPVNSKLALTYYNLGL
CYMQKESFNKAESYFQKANLVYESINLSNAINMVNLEKGLMYLNKKQVNQAENIFLQISK
LPIGKDKFKLQSEALYQLGLIKSKEKTYNLAVNYLNRGYKLSVENDNTSQQLKISKKLSD
VYDNMKQTRNSLNFLKIYTQLKDSLNSVLKNSDKTLIKVDDMIASLDKLDKEKKQQEKSN
KFSKLINILSIALITILSLLSLSLYKNNIIRNKSNELLRDKNNELEIAKERIEKASKARA
EFLSTVSHELRTPLNAINGISHILLDDNPKPRQIEYLKSLKFSGNHLLTYINEILEINRI
ESDNIEIENISFNLKELLNNIQNSLKEQARQNNNHFILTIDNDAPEILIGDPTKLSQIFI
NLISNALKFTENGNIIVNARVVNRDDTSCLVKFEVKDNGIGIPTDKQESIFESFSQGSVE
INRKYGGTGLGLTIVKRLLALMNGKIEVHSQIGIGSTFTFNLSFTIGQEIIPSTLNNLID
EKIFINKNVLLVEDNKINQMITRKFLEKKKIRCQICETGEDAIIKMQTNNGSRKKNGEKS
>KACEBFPM_01679 Glyceraldehyde-3-phosphate dehydrogenase
MKTRIAINGFGRIGRNLFRLLLNHPTIEVIAINDIANNKTMAHLLKYDSIHGVLPSDVSS
NEEAILVDAKPYLFFHEKEISKLNWKSLAIDIVIESTGKYKTFNDINAHILAGAKKVILS
APAEVENIKTVVLGINEHILDGTETIISNASCTTNNAAPMIKVIQELCGIEQAYITTVHS
YTTDQSLHDQPHKDLRRARGASQSIVPTTTGAAKALTKIFPNLEGKIGGCGIRVPVPDGS
LTDITFNVKREVTIQEINLAFKTAAENKLKGILAYTEDPIVSVDIIGNKNSCLFDAQLTS
VIDKMVKVVGWYDNEIGYSSRIIDLILIIHKK
>KACEBFPM_01680 Lipoyl synthase
METVLDSNILPVGKPKWLKVKLPIGQKYTELRGLVDKYKLNTICTSGSCPNMGECWGEGT
ATFMILGNICTRSCGFCGVKTGRPETVDWDEPEKVARSIKIMNIKHAVITSVDRDDLKDM
GSIIWIETVKAIRRMNPETTLETLIPDFQGVERNLDRIVAANPEVVSHNVETVRRLTREV
RIQAKYDKSLEVLRYLKAKGIKRTKSGIMLGLGETEEEVIQTMRDLREANVDIVTIGQYL
QPSKKHLPVKEFITPEQFEKYELLGKEMGFRHVESGPLVRSSYHAQKHIL
>KACEBFPM_01681 hypothetical protein
MINISHKITYKKTANNYYIYYLHTIIANFIIKYAAIRNTQFAIMKDEKSYQVTQIMRFLI
PRITIYAPNITQRPIKKN
>KACEBFPM_01682 hypothetical protein
MSKLNINKNEWLELVFEGKNKEYGAYQLRQENGKTTMKAFFSAIALISGIALLPVVLSSF
TKKPVIVAIPTMYCPITPVNLQPKKEEPKKEETTVKKEEPKTPKTHAIPVVVKKQDAPKT
EIPETKPTNNNTTKTGNNPETGNTNTGGGDGGGGGEIILPIEKPINDPFSPETLDRNPNF
PGGINEFLKTVGKKFTTPELDEEKIIKILVYFVVERDGTLSNITVPDNPGFGLDIEAIRV
LKAIKTKWEPGIYKGKPVRTSYSLPIVVKTQ
>KACEBFPM_01683 ECF RNA polymerase sigma factor SigW
MEIKQHIDKAKLGDQIAFTFLLDSYWNEVYGFMLQRTENETDAEDIAIETFSKAFDKIAT
YNPEFQFNTWLIAIAKNVHIDLLRKKKSSLFIDITDEENDIAYSVADTSPSAEDKLITEQ
NLSRLLQFIKELKPAYQEVIQMRYFQEMSYQEIADDLNEPLNNVKIKLLRAKKLLAEIIT
KA
>KACEBFPM_01684 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MTQFLFILLYLFIGIVVIQTIYYLFVFGKFSFSKTQESTTKHISVSVIVCAKNEEENIQK
FIPLLANQNYSNFEIILIDDASSDETLEIFEQFEKQYTNIKLVKVANNEAFWGNKKFALT
LGIKAATKDYLLFTDADCYPKSENWITEMSSHFTLHKTIVLGYGAYEKESGFLNKLIRFE
TLLTATQYFSWAKIGKPYMGVGRNLAYKRDEFFKVNGFINHIKIRSGDDDLFINEAANKH
NTAIAYNPESFTYSTAKKTFPDWIMQKRRHISTAKYYKSPDKIQLGIFYFSQIFFLLIPI
ILLIFQFQWIIVTSLIVYRYIIAWISLGYSAGKLKEKDVMYWFPILETILIFTQLSVFIR
NIFSKPVTWK
>KACEBFPM_01685 Hemin transport system permease protein HmuU
MAKQKRNTILFFALIIGLFFLFFINISFGSVTIPFKEVYTSLTGGQASKSTWEYIILNYR
LPKAITAILVGMGLSVSGLLMQTLFRNPLAGPYVLGLSSGASLGVAFVILGACYLPAILA
NYFLSPYGIMLASCSGSLLVLFLVLLVSKQMRDTTIILIVGLMFSSFAGAVVSVLTYFSS
AEQLQKFTFWSMGSLGNLSWNQIVILFTSVTIGLFLSIMNIKALDALLLGENYARSMGIN
FKKAKLIIIIATSLLAGSITAFAGPIAFIGLAVPHIAKIVFHTSNHWVLFWSTLLFGAII
MLFCDMVSQMPGTNITLPINAITSIIGAPVVIWLLVRKRGFN
>KACEBFPM_01686 hypothetical protein
MAFKFEKVMKLNLLKLYCFILFLAVVGCKKNETTRTETSTIAGNLIRYSKSLVLIKHEGY
TVIKVSNPWPDAHKSFTYILKEKNGVVPDSLQKYITIGVPLQSIVVTSTTNVPFLEMLGV
EKSLVGFPHTDYVSSEKTRKLIDAGFVKNVGQNEKLNVEQLIELAPNLIVAFGVDNTNPM
IDNLQKSGLKVLIEADWMEQSPLGKAEWIKLFGALFGKEKEAKTLFDNIVKNYNNALTLV
ASKKAKSTVLYGSMYQDQWYVARGNSWVAQFMKDAKANYLWANVAGTGSMSLSFEKILEK
AKTAQYWIPTGAYKNIAALANTNPHYSQFDALKSKNIYSFESKLGATGGTIFYELSPSRP
DLVLKDYIKIFHPELLPDYTFTFAQKLN
>KACEBFPM_01687 hypothetical protein
MRASFPINTIQIKNCSSCATPFNCGNTPEGRQCWCHDFPPIFTPSQAIDCLCPNCFKVSC
SSRTDEYLATITPETASENIAKNLPKTTTLQEGIDYYIENGNYVFKAFFHLKRGHCCTNG
CRHCPYGFKKTTKK
>KACEBFPM_01688 Bifunctional adenosylcobalamin biosynthesis protein CobP
MIYLITGGERSGKSSYAENLAKQLAENPMHVATARTWDDDFQNRINRHQKDRDQRWTNIE
KEKHLSEIDFSGKVAIIDCVTLWLTNFFIDTKNDVPLSLEQAKAEINAIAKQQNTTIIIV
TNEIGMGVHAQTHIGRKFTELQGWINQYIAQKANKVILMISGIPVTIKEE
>KACEBFPM_01689 hypothetical protein
MIVKLSNLNLQEKHLNFLFSIFLTFTLLLNSFSNIVIYVNFKINQNEIAKTLCVLRKQKN
NTCNGHCVLRAELKKQANNEKKYENTLKEKTESIYTIASTEYQLNPILFAEFDKVVIFEY
NSKPNSVSFSIFHPPTV
>KACEBFPM_01690 hypothetical protein
MTTAKTARIVFNGAYIFGNTDKEFASTFSHEFGHFLNLIHTFDGGCTGTDQVADTPIEDG
THGLSCTPGTNCTGDKVNIENYMGYNGARGCYKMYTQGQVARMITALGHPARTTLWQTAN
LTATGVSTSTGSALASTTVRFKEDALNNGALAGNAVIILDGTKTFALATGTLTQGTHYTV
TNLPTGLTPVLAVNTNKQLTLTFTGTATSHTASNSGDISVKFLAAAFSGGLTGVRCNGLT
FATKFIDPYGIFFVDMADVTVQGAANSWKFFATDFGQDYGAWRFAANQLKIETYGNKLAC
QTGTKNISLLVSGTIINATSNFTAPTAYPGQLDLRTATYTAWDGKTGYVGFEHLIDGEVC
YGWFKVRVDANGDGYTVLEYAYNTQPGANIVAGMTTKIATSLSATTIYEADTNDGAIDPA
GVSLKLVTNNGTYTQSSGVVAATKYTLTGVPAGLTATLTAISNNELKLTFAGRATANALS
NTANLVLTLKDAIVTGGVAGLDTSVFTIKLDFEDPYGIFSEALTGATANATQTWKYIDLA
KGDNTEYGVWRFAANNLKIETYGKRLIGTTGTINITKLPFSSVIDGTKTFIAPGAYPNQL
DLRSATYTAWAGGTTGFVGFEYFRRGRPCYGWMQITIDANGDGYTVTKFGYNTKPNGAIT
TPSSLANATFDNAELLGVYPNPFANEVTISTSEMSGKNVTLSIYNLLGQEVYNKTVTNSA
DSILLTTNNLDKGVYILKVTVDNEKFISKKIIKK
>KACEBFPM_01691 tRNA-specific 2-thiouridylase MnmA
MKRVVVGLSGGVDSSVAAYLLQEQGYEVIGLFMKNWHDDSVTISNECPWLEDSNDALLVA
EKLGIPFQTVDLSQQYQEKIVDYMFSEYKKGRTPNPDVLCNREIKFDVFMKIALSLGADY
VATGHYCRKGEIEVDGKPVYQLLAGVDDNKDQSYFLCQLSQEQLAKSLFPIGELTKPQVR
EIATKIELVTAEKKDSQGLCFIGKVRLPEFLQQQLKPKEGLIFEVDATNQIYNQEKINFD
SVQEKLAFEAKDIQYTPEVAKVVGKHQGAHYFTIGQRKGLNVGGTKEALFIISTNVETNA
IYTGQGHKHPGLFKKALFVTNDEIHWIRPDLALTNGQTIQVMARIRYRQELQKATLHQFE
NGLYVEFETPQSAITQGQFVSWHIGDELIGSGVIS
>KACEBFPM_01692 Na(+)/H(+) antiporter NhaA
MKITGLFKEFFESEKSSGLFLISCTLFSLVIANSAIANSYLHFWHANLAGNSLEYWINDG
LMTIFFLLIGLELEREVYDGELSNIKDAMLPIFGAIGGMIVPAGLFLVMNFGTKTQSGAG
IPMATDIAFALAILSLLGNKIPLSLKIFLTALAVIDDLGAILIIAVFYTKTLLWTNLCIA
LGIFGFLLILNRLKIRNLIPYLIGGVFMWYFMLHSGVHATITGVLLAFAIPFGNGDSRST
SYILQHFLHKPVAFFILPLFALANTAIVLSSNISETLIQNYSIGIALGLIIGKPLGIFLL
SMLAVSLGICKLPDDLNWKSILAVGFLGGIGFTMSIFITLLAFNDDTIINNAKFVILISS
LIAGIIGYFSLKYVLKNTIIENKN
>KACEBFPM_01693 Voltage-gated ClC-type chloride channel ClcB
MPSRILVSFQLFVRKIIRRFESIFFLAKEVLSERNFIYLSSVVIAISCSFAVIILKSFAH
NVFLFANYLNTFLKLPYSNSILPVIGILLTVFVIRRFLDGKLEKGSSHILQAVAKKGGVV
PKKQMYAQIITSSLTVGLGGSAGLESPIVITGAAFGSNFAQKYKLSQKDRILLLACGVAA
GIGSAFNAPIAGVLFAIEVVLTDVSISAFIPIMISAATGALVSQMILSRDILLSFKQEET
FNFHNTPYYILLGVLAGFVSVYHARNFRKVEHFFSRFKSSPYKKALFGAILLAVLIFFFP
TLFGEGYESIRTLSTNHPEVLLDNTILKNHKNNQWILLAFIGITVFLKSFATGITLGSGG
NGGNFAPSLFVGSYLGFFVAKSINLLGISSALPVGNFAIVGMAGILSGLFHAPLTAIFLI
GEITGGYDLMVPLMIVSSISFAVSKRFEKHSMDVKSLADKGEVFTSNKDKNILQSIDFLA
LIKTNIKTITIENSLENLVEHLSTLHQEIFPVIDEKEKLVGIVDFNDIRTTIFNPFRIKH
TCIKEILKQPIGVIQYDDGIEIVMEKFQITNQTTLPVIKYGKFFGFISKIDILEEYREKL
KEMIIE
>KACEBFPM_01694 LPS-assembly protein LptD
MNKIYFRLVLLLILFSQTTLWSQDAKQIVIQHSDFLDISEKEVPGAIVLTGNVVIIHEGV
RMTCNKAYHFTKSNFVKIFGNVNMVQGDTLSMNSKYAEYNGNTKFAYATGDVVLRDPKMT
LATDTINFDRNSQQAYYNSKGTIRDPENTLVSNSGKYYLNQKKFQFSDAVTVTNPRQTIK
TNHLDYYTNSGHAYVFGPSTITSATNTIYTTKGFYDTKKDEGKLQKGSKITYKDRLIEGD
DIYYDRKLDFARAKNNVKVTDTINHFVVKGNYAEVYKQKDSMFITKKAVAITLFEKDSVY
FHAKKILVTGKPESRIIRGSNNARFFKKDISGKCDSIHYDKKKGLTQMIGKPVLWNGKNQ
MTGDVMHLVSNQKTEKIDSLKVLNNAFIISKDTIGEGFNQVKGQNLFGKFKKNKLHEVNV
IKNTEVIFYMRNEKNELIGINKNVSSKINMILEANNIETITFFTDVEGIIYPEEELPENA
RKLKGFIWRGDEQILTKEDLFPKEELELDAKAQKESKAKSKDINIPMQPSQETLEYDKQN
VEKKVGKKKKK
>KACEBFPM_01695 hypothetical protein
MENNLAPLNIKSLLSEGKYNIPIYQRNYAWGEREITQLIQDIVDYSSKEIKTNYYLGTLV
VYERKTQSSLVYETIDGQQRLTTLSILLSVLKNEYNLQNSPANWFKLNLEFDSRINSTDT
LQALFFDNKLDYKNYNPEINQAYIDIKKVLDRILKESKQTVDEFCEYLFEKVMILRVSVP
EDTDLNHYFEIMNNRGEQLEKHEILKANCLDFLKDNETESYAFNLIWEACSNMEKYVQYG
FSVEQRHHVFGRNDWNNLAYKQFDELSETVFTNKPKNDIDTTSSKLVSLLENNKTVKTDD
GLQDDENPERFNSIINFSNFLLHVLRVQTKENIPLDDKQLLDIFEEHINSKDFVKTFALN
LLKCKFLFDKYIIKREFSKGTDKWSLKRLKWNKDNKVSYVNSFSTTEEEETDYENKTALM
LLAMFHVSTPTLVYKHWLNAALKYVFENQEIYSNGYVQYLENLSKAYLFDRFLAIDSKDY
FEIIYENSGNHINTISDIDDSQLNNGTAVENFIFNYLDYLLWKTTSNFKNFEFTFRSSVE
HYYPQNPMEGNKELEKEYLNNFGNLCLISSSKNSRLSNYMPQAKKDHYQSSTSIDSIKQR
IMMTEPIWSKKEITNHNEQMKKILLNI
>KACEBFPM_01696 hypothetical protein
MSTLVPPKIIKVKELLLKDNLNIPAYQRPYKWTLKNVNQLIDDIILHQDKTAYRIGTLVI
HQDVNDNKEEVLNIVDGQQRSITLTMIAYAILKHKKEVIKSNSLKNDFAHFTPKLLELEF
NSDISIFNIQNNYKEIERRIKTFDEKTINFFFNKCQLVQIILTDISEAFQFFDSQNSRGK
DLEPHDLLKAFHLREMAHLSTEEKLQSVASWEALKTVELVDLFSNYLFRIRNWSKGYSAR
YYTKNEVDVFKGISINQSINYPFAQLHKIGHFYTENYNNDYHRNIDENRANYPFQIDQVI
INGKRFFEMIEYYKKRVDTMQEFENSDTIHNDNDKATSSKIFKALSEYEGRNRTGDRYVR
NLFDCCIMYYGDKFGVQNTPKVIEKFFIWAYTLRLEHQAVQLASMDNHALYNNNIFTTIR
EAIHPNDLMNIKLKTLSEVKSTKTTDIENLFKELSYYGE
>KACEBFPM_01697 hypothetical protein
MAKKTEKDWFKLKRYPHIGLPLNPCDRLKWIEPYVTSKEEVAKHAFLPFIHRTARVKKFR
KKYNTTTGKLEFVLDNGKKVVRNPNEKKRELFYASHLDSLIFSYYSQQLNESYEDKLSDF
GLNDVVNAYRSVPINPDKEDSSNKCNIDFANDVFKHILEYDQKEFSVIAFDISSFFDNLD
HKLLREVWCDVLKVEKLPADHFNVYKNITRFSHVDIVDIFNEFKDKIHTQKTNKFGLKLK
RRKKKIDKIKFLRDQDAIAFCTEKEFFKVKNKLLQPSKTKIIDDKVVYRNFGIPQGSPIS
SVLANMYLLHFDKLINDFTTSVGGIYRRYSDDMIVVCPLNQKANLVELVYSEIKKYKLEI
QPTKTQIFQFEYKNGKLECGEEYQDGKLINWNKNFIYLGFEFDGQSVLLKSASLAGFYRK
MKRSIRRAKYYSKKTKKEIFKRRLLKRHSYIGAKRTRKYIWNENKKKFIKSEYYNWGNFL
SYAFKAADIMINNKIKRQTRKHWNILNREINKK
>KACEBFPM_01698 Type-1 restriction enzyme EcoKI specificity protein
MSFKKYKLKDLVDNFSVRARDYGGSDGLEFLGVSNDDGIVKSKSAAEHKGEEYKIIEKGC
FAYNPYRVNIGSIAYHNEDVKGLISPAYVIFKTKPNSIKDNLLFKFLKSAEGLRQIRFHG
RGTVRQALRFEDLCKIEISIPSFEEQENLISNIEKTEFETKQIFEELTNQLDIIKQLRQA
FLREAMQGKLVGSGKRSLGSETGQQLLEKIKDEKTKLIAEKKLKKEKVVPPITDEEIPFE
IPEHWAWCRLGEVVEFLNGYAFKSEWFKNDGIPLLRNINIGINELVWNNVERISEVKAQE
FEQYYLKEGDIILSLDRPIINAGLKIAQIKKSDLPCLLLQRVLKVKSISLNENFVYKWFN
SELFINYINPGRSIGIPHISHNDVSKILFPLPPLHEQEQIVAKLEELMTFCDGLEESIKE
SQGYNEMLLQQVLREALQGEEKINTI
>KACEBFPM_01699 putative type I restriction enzymeP M protein
MSNISSILKSIQNIMWQDTGLNGDAQRIEQLGWMLFLKIFSDKDKELEILDENYTSPIPD
LFHWVNEKGNWAGDDEGMTGDVLLEFVDRQLFPALRNIDVSTGNRRALIVREVFEGNNNY
MKSGTNIRKVLNKLNEMDFNIAKDRHAFGELYESILKGLQSAGKSGEFYTPRAITSFITE
MINPQLGEKILDPACGTGGYLTCVIEHLKKQANSVEESKSIQENVMGWEYKPLPYLLATT
NLILHDVEVPNIRFGDALDQPLSNFTEKHRVNAILANPPFGGIVANNNETNFPQNFRTKE
SADLFLILMIHLLKQGGRAGIVLPDGSLTGDGIKQRVRQKLLEDCNLHTIIRLPNSVFQP
YATVATNLLFFTKGTPTKEVWYYEHRLPEGQKAYNKTKPIQAKEFNPIKTWWNDRKESDI
AWKVDIQNIIDRNYDLDIKNPTKQEETHEYNSVEIMELLHTSFDKSNTLLNQLKKAVK
>KACEBFPM_01700 hypothetical protein
MEEGISIDYKSLKKVVDTAGKLKSEGLRDLAVTSVAFANVHGGKIVIGIEDKDKQPPVNQ
TISVRTANDTVTRLKSLCFNVGFQLGDIENHANGSQFFTITVYPTLKSVATTADGKIYIR
IGDQSQPARSEDIVRLASEKDAFQWELQPRNVTYTEIPEMSMRWFADEIRKSDRVKQNIK
DLTDIEIIEHYNLIDKGKLTNLGVLWLGTASQRSRLVYPLTVQYIVYDDLEKKIRKEDWQ
DYSKNPKELLLEIEKEAIELTYYDEFPLGLFRNKIRHYDARLIRELLINAIAHKSYTISG
DIFIKVYQDRLEITNPGGLPLGITKDNILHTTYRRNPHLIRILHDLKLMEGEGTGYNLIY
EITSRDAKAFPIPISDYNATSVTQYSKILDEEAVLLLDFIAKNYQLSQKEFIALGVITRH
KKILATQLTKELQLTDEDRLRSYISKLSSQSIIINRGEKKGREYLVNPKLIASSKINIKP
TLKTIEQPRLKALIEEVLKMTPNISASTIHSKIGDVAIADVRKCIFKMVKEEVLDFGGAN
KNRVYFLAKKR
>KACEBFPM_01701 hypothetical protein
MIIDLKFHAENHKLKVLNELDKMITTVRLIEDFQKVNFDFLNYNDIDFKSLDLKNVIYIF
KVTDFGEKGNSVSFCNRIQKIKETRKKVKYPKVNSNHALDENTTLYIGKSSGSFKNRIRQ
HLGLVSEKTYSLQLQSWLQFPDLSEVKLELYYTSIDFDKLGIIEHEEQKTLIELLETALH
NHYKPLLGRSGH
>KACEBFPM_01702 Putative DNA repair helicase RadD
MSKKDLSERDICTKFITPALQKAGWDLHKQILEEVFFTDGKIYVRGKLTARGERKRADYI
LYYQDNPVAVIEAKDNKHSIRSGIQQALGYATILDIPCVFSSNGDGFLFHDRTVNDSNIE
TEISLDEFPSPEELWNKYKQYKNIATLDGEKIALQKYFSDGSGRKPRYYQQIAVNRTVEA
IANGQDRIILVMATGTGKTYTAFQIIYRLWKSRTKKRILFLADRTALIDQTRKGDFKHFK
DKMTIIKKKVISNANGKDELVSNKKRGIDTSDKAYEVFLGLYQGLTNNEPGIEDAYKDFS
PDFFDLIIIDECHRGSANEDSAWREILTYFNKATHIGLTATPRETKETSNTEYFGEPVYT
YSLKQGIDDGFLAPYKVIRIALNVDAEGYRPQQGKTDKEGKEIEDRIYNRKDFDRKLVID
ERTDIIAQKVTEYLNGLDRFAKTIIFCVDIDHAERMRNAMAKHNADLVAENYKYVMQITG
DNEEGKRELDNFINPEEKYPVIATTSELMTTGVDAQTCKVIVLDANINSMTKFKQIVGRG
TRINEEFDKLYFTILDFRNATDNFADPAFDGDPLRVKPITEETDLTTIIDEEEDESTPII
DDVTGAEIIIAKPVIRNTFNEPNTEYEKREKQYINGVNVSVLVSRELFFDSNGKPITISL
KDHTKEIINGKYASLEDFLLTWNKADKKEAIIKELQEQGIMVEALYEAVDKQVDLFDLIC
HVAYDQPPLTRKERANNVKKRNYFSKYGEQARKVMETLLDKYADEGVVNIESIDVLRVKP
FDDFGSPLEIIKEFGSKQKYLEAVKELEIELYKSFA
>KACEBFPM_01703 hypothetical protein
MVTIFKNFNEVVEHKSLLTILDEIKTGKYKPGIVYLRKSLAENKIEAYNKAKKSLPAFTP
SAKFVGGRKLEFLAEYSKCIILDIDKLTEKDLQNATHLANQSEFTFASFISPSGNGLKIL
VNINSDKANHKEAFLLVQAHYENILKLEIDKSGKDVTRLCFYSFDENLFLNENAKTFETL
ENEEVQNSVIPSAVAGTQPEPVQDYEAIYNHCIKFTEKKVQYANGSRNVFVHQLACNMNR
KAVPMDIALNFIQTDFNFDDKEVSQAVTGAYGNILEFGKTEKATIQNEKHNKKTSKNTDD
EDDEDDEKPRVTQIDKLENFLSGKYVFRHNIVSGKLEFQYFGGKKWNVMNDFIENSMLRE
CLKGRIKTNLSSLRNLLYSDFCQLFNPFEDYFKNLPKYDEKTDYIFQLANTITTTKQELW
QQCFKKWLVAMVGCVLDDKVINHTVIVFSGKQGLGKTTWVEKLVPKQLKEYLFSGTINPN
NKDTLVQLAECMLINLDELENLNRSEIGSLKEIITKTQIRMRKAYGHNNETMPRRASFAG
SVNTAQFLNDSTGSRRFLCFELEGIQYQHNVDINMAFSQALFLFKSGFRFWFDQEEIKSI
TENNEQYQLHSPEEELLLTWFEPCEKEKANTFLNASQIAAKLAEKAKINITDGTINKLGK
ALKKHNFIRLKKNGIAVYALIENTWEEVDNRNKVVEE
>KACEBFPM_01704 hypothetical protein
MDAIIFTKDQFTNLMSKLDTIQSQISIKADPKKETFLDNQEFLLLMKISKRTAQTWRDEG
KISFSQVGNKIYYKLSDVEKLLTEHYNKSFKGR
>KACEBFPM_01705 hypothetical protein
MTPKVQIIQTSQFVQLVAVPLAQSTNTTFDIIIETEITLQNYCEALVNKVFSLDQSQFTD
FINYQSNMVDDALVWLNKFEKLISNNEELFTSKCAFTRISKLINLIEQKRKEMQSSRIVE
IKYETPKRFINAESEDRIFSFYEAKKHIETLEDFDDKIFYLTEELLEYEEADIVSTHRTL
KEFNIQCEKLINKLERLKCLNENRVKSKQNLVSNQMPFKKMQINCNLNQFIDIHYQFTRE
LFVDGKSMIDGSVNDLVAIIVNSYVDKDGKEISPETVKTILTPSRTEKRPKHHKRIDIDK
ML
>KACEBFPM_01706 Tyrosine recombinase XerD
MASIKLILRTHQADQTGHSPLYIRIIKDRKTKFITAGVKLKESEWDETKQKVKKNHPNSA
RMNASLSQKIADAEGQVADLERKVKTISIKKLKEAIKGKEVPNFFEYAYARCEKIKGSVS
FGTYKNYTLYTKKFENYVGSKDVYFDDITVSVLKDYMAHMGNVLKNGATTQRYSIMILAI
MFKEAIKEDIIPEYMYPFNKLTLKKDTEKRVFLNKDQIEILTNLELKEGKKADLWRDLFL
FSIYAGGLRFSDVIELQYSNFNEEEQRIKKVIRKTGRLHQFKIGKVALDILSKYKKENVQ
QDDFIFPIITDKVGYYKSEETRYFISSRENHSANFQLNRMGKMMKLPFSLSFHISRHSFA
TNALNNGMRIEHVSKLMDHTDISTTQIYAKIISEELDKAVDNYIF
>KACEBFPM_01707 hypothetical protein
MLKRKSKLLLIKIFSLFSVVRGYNIPVVVLAQYLSSIFILSPEKRALDVILDWRLFLLVF
VSTLTISSGYIINNFYDSEKDLINRPNKTRLDRQVSQTTKLQVYFVLNFLATALSLIISF
RAALFFATYIFLIWFYSHKLKKYPIVGNLTASLLAVLPFFGILLYFKNFYHVIFAHAMFL
FLLLFIREMIKDLENIKGDIANNYQTIPVRFGERVSKQIITFLTISTIIPVYILIEKYDV
GYMDIYFYISLIILILFLLKLWKSQTQPEYVQLHVVLKILIVAGVFCIVLINPSVLINGK
ALLKI
>KACEBFPM_01708 hypothetical protein
MKGPLFYSKILLFGEYGIIRDSKGLSIPYNFYNGALKSDENPSVEAIKSNQNLKKLASHL
ASLQEEQPALVTFNLESLNSDIESGMYFDSSIPQGYGVGSSGALVAAIYDKYAHNKITVL
ENLTREKLLTLKNIFSQMENFFHGKSSGLDPLNSYLSIPILINSKDNIEATGIPTQSLNG
KGAVFLLDSGIVGETAPMVNIFMENLKEEGFRKMLKSQFIKHTDACVDNFLGGDIKSLFA
NTKKLSKVVLNNFKPMIPEQFHGLWQRGIDSNDYYLKLCGSGGGGYILGFTQDLEKARMS
LKDYKLEVVYQF
>KACEBFPM_01709 hypothetical protein
MRNIIFSKNAQVNLDDLLQYLEFKFSLRTQSEFIKKLDKVIFLIQSDPEIFSFSKVNKNY
RRCVLSKQTTLLL
>KACEBFPM_01710 hypothetical protein
MNIQLEKLEIIKMLVETNDSSIIESIKKIFKSEKKRFLGRIVG
>KACEBFPM_01711 hypothetical protein
MILEKNFLMQNKSITVDTGNFEWSAPSNIALVKYWGKKENQIPANPSISFTLNNCKTITK
LSFTKKDNHDDFSFDLLFEGKPKEEFKTKIQNFFERIAMYCPFLKDYHFTIDTQNTFPHS
SGIASSASGMAALAMNIMSLEKALNPSMNDDYFYKKASFLARLGSGSACRSVKGSIVVWG
ENDSVAGSSNLFGVEFSSTIHQNFKNYQDTILLVDKGEKQVSSTVGHDLMHNHPYANRRF
EQAHENLSKIKTVLENGNLDEFIKIVENEALTLHAMMMTSMPYFILMKPNTLEIINKIWK
FRNENNIPVCFTLDAGANVHVLYPENKKEIILQFIKDELVGYCQNGQYICDEIGLGAIER
>KACEBFPM_01712 Tryptophan-rich protein TspO
MKKAKLTKIIISISACVLVGLLSSLATQSSVNTWFLTLKKPFFNPPSWIFPLVWTILYIL
MGYSFAIIWSNESQSKRNKETIKKAMFLFAVQLALNALWSVLFFGLCNPFLALIEILLLW
LMILETIKMFTKIDDFASKLLIPYLAWVSFAVILNGSIWFLNS
>KACEBFPM_01713 Ferredoxin--NADP reductase
MNSKYDIIIVGGGAAGFFAAINIVENSPKTKVCILERGQEVLTKVRISGGGRCNVTHACF
VPNDLVKFYPRGEKELRGPFHQFCSGDTIDWFEKHGVELKIEDDGRMFPTSNSSQTIIDC
FLTATKKLGIDVLTGQSVQSVFKSDAFWKVETNHETFACKKIIMTTGSNPKIWDMLQDLG
HSVVEPVPSLFTFNIKDTRIKDLMGLSALASVKVKNSTRGKAEQSGAKLEASGPLLITHW
GMSGPGILRLSAWGARELANKKYQFAILVNWLNDKTVEEVATILRALKLEHSKKTVSKKS
PFDIPNRLWESIVLASQIDVEAKWADLTKNQLANLTHQLTNAEFQVNGKSTFKEEFVTAG
GIDLKEINFKTMESKILPNLYFAGEIVNIDAITGGFNFQNAWTSGFIVANSVLEN
>KACEBFPM_01714 Putative monooxygenase
MKKNVIARLKIKSDAIDNFIKSTETLITETRKESGCITYKLYQEIADEKNEFLFYEIYED
DKALQMHADSPCLEDFLNNISDFLLEKPIVEVHEMNQF
>KACEBFPM_01715 Alpha-1,4-glucan:maltose-1-phosphate maltosyltransferase 2
MNHLIVFLIPRNSKSCISYFSNFNKMVAFIVTIFVFKIFRNFFIMIKLYFWHSYSKRQNK
FSMKKIFIILFLFSFFINCKKEKPKNITEKTIEIAPITPEMEDNAVIYEANIRQYSPEGT
FNAFTKDIPKLKKLGVKILWLMPIHEIGLKNRNAKPDLSVDDITDSIEKKKYLGNPYSIK
NYRSINANFGTKADLQKLIKTAHKNGIYVILDWVAHHTAWDHAWTTQHQDYYVHNKEGNM
IAPYDWKDVVALDYSNPNLRKAMFEEMKYWLTNYNIDGFRCDLAAEVPTDFWESTKTELN
KIKPVFMLMQAQKATLMANAFDMQYGWESHYIFNEIVKEEKTAKDFDKLIRKNDSLYQKD
DINMNFTSNHDENFWNGTEYERLGNATEIFAALTYVMPGMPLIYNGQEYDLNKRLPLYEK
DTIAHAVGKMMAIYEKLGKLKTENKALHGGKTPASYKRLLTTNDDNILAFEREKNNKKVI
FIGNLSKTNKTFTIPVEGVFTDYMLGAKIEFTKKQKINFNPWEYKILIVE
>KACEBFPM_01716 hypothetical protein
MKKILLLSMFFVLSNTLFAQETETKAQKAKTEKISKAKEKAEAKKEELKKAKADAKKAAT
KEKAEVKKEASKAKKEAEASVKVSEKSLKEKTKTEANKAEAKVKEESDKAKTKTKKAKEV
VEAKVVKPAKETKATETKEKATKIIAKKEKVSTEKANPNTKDKVTGEYNGKKVFTGSRGG
RYYINKNGNKTYIGDEQGN
>KACEBFPM_01717 hypothetical protein
MFKKLIFLIVIFIFPGLYAQEIKTPYKSKKIVVSQDSIQIDSVSINASFFKLLDPKGKAI
DTSFYSVNFSKGILIFRNNFKTTDTLNVRYLKFPTYLTKEYAIYDKSRMVSNNSGLNNLY
KISADGFKKFAPLEGLTTTGSISRGISVGNNQNTSVNSNLDLQITGKLSDKVSLRASIQD
SNIPLQSGGYSQKLDEFDQVFIELFSDKWSVRAGDLFLENRKSKFLSFNKKVQGLSAQFA
FGKPENKTEVYASGAIVRGQYAKSNFVGQEGNQGPYKLKGSNGELYVLVISGSEQVYVNG
ILLKRGENNQYTIDYNAGEIRFTSLFPITSEMRITIEYQFSDRNYTRFVTYLGANHEEKK
WSLAGYLYSENDVKNQSLQQNLSPEQAQILVAAGDNQNAMNASSAVPDTYSENKILYKKI
TTGLVEIFEFSTNSLDILYNVKFSFVGNKLGNYIVSSTIANGRVFKYVTPISGIPQGNYE
PIIRLVAPTKIQIATVLGKYSPSEKTIVDFEVGISNYDKNLFSSIDDNDNQGLAGKLNIK
QRLLSKKWHIDAFGNCQLVQKNFKTIERLFTIEFNRDWNLLNPLGNQTLVVSGLLFSLAG
KSNWKYQFEKLDFSENFSGNRHVVSGYYKHKNWLFSNDGSFLNSDGNISTSKFIRNQSQT
KFHFNKNWIGTSFRFENNQEKTKLTHQFSNLSQRFSEYGAFVGRGDSTKVFVELGYLNRV
NDSLQLGQLKRVNASQSYYLKSKLIQTEKNDLSVFINYRNLKFEDSNRGSEPSLNSRLLY
NDRFFNQLLQTTTAYETTSGTIPQQEFSFLQVDAGKGIYAWNDYNRNGVQEIQEFEIAPF
PDQAKYVKIFLPNQIFIKTHQNKFSQSLTLNPSEWQNSIGFKKFLSYFYNQSSYLTERKI
KRESNHFDLNPFAANAENLLGLNSSIRNSLFYNRGKQNHSVTYTFISNKIKNLQSSGEQE
AKNTSHQLQYDHLLKKYWLFTLSGKLVVTSNNAQNYASRNFEIKGNQLEPKISYLFSKNA
SLDVFYEMQIKENKLGEKESLKQNKFGSSFSFSSQKKLTLNGEFSWFDNKFIGNEFSPVA
FQMLEGLQPGKNMTWRLLLQKNITQYLDVNVNYLGRKSETTNTIHTGNIQLRAYF
>KACEBFPM_01718 Lysine-sensitive aspartokinase 3
MRIFKFGGASVKDADGIKNVFDVLQKVGYEDVLLVVSAMGKTTNALELVIKNYFDKSPAL
NTSVQEIKTYHNKILLDLFENEEHEVFLDIKDHFADLEYFLRSNKSPNYNFVYDQVVSFG
EIISTAILSHYMNFRNINTEWLDVRNYIKTNNTYRDAEVDWETTQKSISKIANKKILFIT
QGFLGADENGFTTTLGREGSDYTAAIFAYCLNAESVTIWKDVPGVMNADPRYFENATLLN
QISYREAIELAFYGASVIHPKTLQPLQKKEIPLYVKSFINPLLPGTSVSKGKDLDPKLPC
FIVKKHQLLLSLSSIDFSFIMEENISEIFSLLHLHKIRVSLIQNSAISFSVCLEDKFGNF
DELKKTLSKKFKLSYNENVSLYTIRHFDEKAFQIVEKNKTVLLKQMSRETMQIVTKE
>KACEBFPM_01719 hypothetical protein
MIVRKGEKKDMSAVLNLIKELAIFEKEPQAVEVTANDLLRDGFSDNPLFYTFIAEVEGEI
IGMALYYYRYSTWKGKTIHLEDLIVQEKSRGTGAGYALYTAIISQGEKDNVRRIEWNVLN
WNTLAINFYNKSGAKLLQDWRVVNMDEAGINAFLAKK
>KACEBFPM_01720 Metalloprotease LoiP
MDDNEILAVIGHEIGHVANHDSRDAVKAAYKKEALLEAASSQSDKVAAITEGQIGNIGKA
LMNSSHSRQQETEADTYSYDFMKRNGYNVNAVESAFSILAKMSEGTDSTFITRMMSSHPD
AKSRAENAKKRAEADGLYKPYVKNVKAKTTSKKKK
>KACEBFPM_01721 hypothetical protein
MAKKGLVFIQNEYPKQNENFLYRQIYRFIPEFGKSIKTIVEVEIYKSNICVISFYEHNKG
TEKNKYKLRSDIGPGHTRAIFKACLEAYYNLKEDFALVFSASNDVGKIDEDNSRYSAYLL
FLSYYFNNYEDYDRQGSIAINTLMLYHRTFQYKDEADFFYTEFEKKVELNINDSGQYNDK
P
>KACEBFPM_01722 hypothetical protein
MKTNYSALGISSFFIKKGVSPLKLQKLLYYSQLWFFVKNDRMLFDDKIQAWIYGPVVYDV
WANFKFMKRSSIIPSSRAVVLNLDDIIVNHLNDIWLSYGHLTGSDLVDLTHNDLPWKNSR
KGLLGNQPSDKEVIINKDTTVDFTLDSYNRIPVVITQNTLGYFSNF
>KACEBFPM_01723 hypothetical protein
MAKISKKKKAAIFVDGECELWYFQMMKRNENAINLDLLPKLPRKKKLFDLYKEVKKSASD
YDLVIWIVDLDKVLEEERSKKKEGKNPKEEFLKYYKDLSRLKNVKVIVSNPCLEYWLLLH
YEYTAKPFKDCSEANQLLKKHLKDYDKSEKYFVKNDLYKKIKNNQETAVKNAKKLGEFSS
ESFDSSICEMYKLFDSDEKVNILTGLK
>KACEBFPM_01724 hypothetical protein
MIISFSVTNFGPIREKQTISFEAKKYDDLENYYVIEPIKGLRLLKLIFLYGANASGKTTM
LNAIEFLRDIVLDPFEKKNEKFDFNPFLFDNESKNLDSTIEIDFVHKSKKYSYRVEFNKK
VISQETLLVFNPNKATVFKRTTNVNNNLTEIVFGSKVKLNKDYVNTLVSNTLSNNTVFGG
FLKTNIDIVELREVLDWFESALRPMISPRTDLDGFVTRNLNDGGNISKENVLEVLRKADL
NIEDIIIEEKERDIPEGLLEFLETSTKSEEDRKKISSIREKGKVTAVNLEFVHKFGDKNY
NLPFENQSQGTQRFYGLAGILDILVRQNSIVPIDELESSLHPDLYIHFILMHLVNSSKSQ
LIATTHNREILKNRDIFRDDCIWFADKTEEGNTEIYSLEDFDTKTIRNSSNVYNAYSIGK
LGGVPELGDYFLDFKYDEDGEN
>KACEBFPM_01725 hypothetical protein
MWWLNGKSSYHLPQSQFQYPGSIIPNGANDMFMALGKNDQKIYIIPSKKMVVIRMGDAAD
GANLALSDFDNILWQKINALYQ
>KACEBFPM_01726 hypothetical protein
MPYTNSNFYYPIKKVNPTNLLIKKTRQLAGFTVIAQKY
>KACEBFPM_01727 Glutathione peroxidase  BsaA
MKQLLCLFSLMILMTCKSQETNIKNQSSSEKQKTTKMVRESIYQFKVIDIEGKEFDFSSL
KGKKIMIVNTASECGLTPQYKQLQELYTQFKGKNFVIIGFPANNFGHQEPGANVAIATFC
SKNYGVTFPMMEKISVKGDDMHILYQFLTQKAKNGLEDNEVQWNFQKYLIDTTGHLVKVI
APTTLPTDNEIVSWIKG
>KACEBFPM_01728 Cytochrome c biogenesis protein CcsA
MEKLKSILFSTRLMAILFLGFAIAMATGTFIESKYNTTTARILVYNAWWFEGIMLVFVLN
FAGNIKRYQLLKKEKWATLMLHLSFIFIIIGAGITRYISYEGMMPIREGASENHFYSDKT
FLSLNVDGEYKGEMKRRTFEQPVLFSQATNNHFSINENFDKTPFTIQLKKFIMGAKETII
ENKNGIDFLKMVESGGGSRHEHFLKSGEVVNIHNVLFSLNKFTKGAININTTLGAYTISA
PFEGEFMRMADKLQGKVAKDATQPLMMRSLYNVGGAQFVFPEPAKKGTIGYESSNNYKAK
EEDDALVLIIKSAGQEREVTLVGSKGKMGEPKVVKIGKLDYTLSYGSKSYELPFKIKLND
FAAQKYPGTEKSYSSYESSVTVEDKPNFDYKIFMNHVLDYKGYRFFQSSFDPDEKGTVLS
VSHDFWGTWITYLGYFMLFFALMAIMFTKDSRFADIKRKLELVKIKKANLTILFLLFGLS
GFAQNHQEKKITQKQIDSVLDKRKISEKHAEKFGRLIVQDLGGRMKPINTFSSELLRKVS
HSDTYQNMNSDQVFVSMTQYPTVWYEVPLIYIREGNDSIRSIIGIDKKQKLAKFIDFFDE
KGNYKLSKYLDAAYKAANPNNFEKGFVETDKKINLMNSALSGSILKIFPIPNDENNKWAS
YAELNHVALKGMDSVFTKQILPIYLMSLETAAANNNYKESDFYLDGIVKFQKKHGSKVMP
SEEKITSEILYNKYNILQKLFNYYSLSSILMLIFTLLSIFFDKKWLRITVDTFHVFIGFL
FGMHTLALAARWFISGHAPWSNAYESIIYVAWATMFFGLAFDKKSKLTVASAAFVTAMIF
MQANANWIDPEIANLQPVLNSYWLMIHVAVIVGSYGPFALGMILGFVSLVLMFFTNEKNK
AKMTLNITEITYINEMALTIGLIMLTIGNFLGGQWANESWGRYWGWDPKETWALISIMVY
AFVIHARFVPSLRGKWFFNLMSMYAFVSILFTYYGVNFHLVGLHSYASGEAKSLDWIYYS
LGTISLIGLITYPKYRKYYKK
>KACEBFPM_01729 hypothetical protein
MIRVVIIGSGNVAQHLIKSFAKSNIIQIVQAFSRHKESLKNIIDYSKITSNFSSLVDADV
YIISVSDNAIAEVSHQLNLNNKLVVHTSGSINITNLDDKNRKGVFYPLQTFSKNAAINFN
EIPICVEAENESDYKLLETVARSISKKVFQINSNQRKTLHVSAVFVNNFVNHLYKIGNDI
CTENNIPFEILQPLIQETANKISLLSPDEAQTGPAKRNDTQTINAHLHFLTNENQKEIYK
ILTKSIIDNGKKL
>KACEBFPM_01730 3-deoxy-D-manno-octulosonate 8-phosphate phosphatase KdsC
MAKSYKEIMNDITTFIFDVDGVLTNGKVHVSPTGEMLREMHIRDGFAMKAALESGYNVCI
ISGGSNEGVRIRLRNLGITDIHLAAPNKVETFKEYIELYNIKPEQVLYMGDDIPDYHVMQ
LVGLPTCPQDATPEIKGVSKYISHINGGNGAVRDVIEQVMKVQGKWLTYFDGKHD
>KACEBFPM_01731 Transcriptional regulatory protein YehT
MKIKVIIVDDEMHARSFLRKFCERYHSETIEVVEECNSVEAAVRAIKKYQPDLVFLDIQM
PDENGFEFLKYFDKINFEIIFTTAYKEYAIEAIKKSALDYLVKPFSKEDFNIALSRFMSK
KNVKIDFDRFKLLTENINNQFTDKQRIVFPTKSGFEVIQANSIVYCKSDGSYSNIFIIDK
ELFTSKSLKEIEDILVDSNFIRIHKSYIVNKNYIKGFKSDEFKLDLITGDSIPVSDTLFS
KKKLMDAISS
>KACEBFPM_01732 putative sensor-like histidine kinase
MRFLLSIFLLVLTTAFAQKLPSFNYTTSDGLPNNAVRSLFIAKDNVLWVGTENGVSRFVN
GQFYNLSEADGLGHNSCWDISQDTDGNMWFASYGGGISKYDGKKFTPFISKDGLAADKTR
KLFPFKNNIYVGTEQGISIIDVKTNKIVTPKVPKAKEDFICINFFVYKNEVYFVSVFDGI
FKIDESSTIPKVVPVYSGKNFYGALLDKNDLLLSREGFIEKINIKNLLNANYKANRFGTS
FVFQYAKVQDSLIFAAADGVYNPDGGLYKIENDKMINVSNQFEIDSKIILNVVYDTLRNV
LYVGSNDKGIYEIRLDATIKYEDFKNLSIVDFEFLDQSKFVLHNKGLSILNSSDKITNTI
LLNEFKNFQTNYFQNNRKKLNTIYRESHDFELNFNIKANEIVFYELVNNKKSIWIGSNLG
VFEINSKCKIINYIPKHSLKIGFTSDNKFIETITYAGVHVYDNVYQLQGKHYSKFDNKTP
QFIVKILNNKDKTYLISVFNGLFVHQNGKFKSYLFENIWKEKKFKHIAINNKGQLVLAAE
FGTVFIVDDSNKFKILKTISKKEIIGNSINFLECYKDYIFIGTEKGVNIYHNGKIRLIDK
EQGLKDCIFKTSQIFENELWLGTQNGFYKLNLDKLLSKQKTVEKVVIQSILINNQSFVGT
NSRWFTFNSNELTTDYKHNSFSIDFIPVGHPFPNKLKFRYRLNSKNNWSPYTDKPTVFLS
YLPYGKYHLEIEILDLNSGETKQFKVLKLVITPPFWLTWWFAIIVFSVLSALVFVVVKRK
KKNAEEKALINQRIAETKLEALKSQMNPHFTFNAMNTIQDFIISNDIDNSLNFVSELAKL
MRLTLDNSTKKTITLQEEISFLKNYIFIENTRFGNKIKVNLKVESNINAQEIEVPTMLLQ
PFIENVFVHAFNAEHLNPTIDILFQLKETNILECYIKDNGKGKASFNKVKLHQSKALLLA
EERLRLIQPQILNPITTNFTESNGTFVVILLQV
>KACEBFPM_01733 hypothetical protein
MSNCYCEYCGSKSSSISSLTASSCSRHPLGSNKGKHKLYEGSEKPKYSCKFCGSSSSSIS
SLTSSSCSRHPQGSNKGKHAPIL
>KACEBFPM_01734 hypothetical protein
MENNIINKENFDNAKSFLNQVTELATKSNENLQLTNQKLQNTSDLLNKAGNIYLESKKID
NDNLKLKNELVTIVSDFKIKQGYLHAIFDERSRIIDKHFEVIDKGIRENNDELILKGLRG
ASEFVSTNPLDNFDNFKNILLDKNAPLELDF
>KACEBFPM_01735 hypothetical protein
MRKNIIFAILSVLLISCGSKISYKDQIIQYNNFVSVADSLNKIKDYKQAIVASTEAIKIT
DTLSQAYLKRGDSNLGLKNYDDAEDDFSDVIKIEGEKSIAYKGRAIAYYFKNEKDDFIDD
IDIYITNHSNDIYAHSLRGDYYTEEEDCEKAILDYSICLKNNPRNSIFYLKRGNVYAIDG
QNDLSIIDYENYTRLNPNVNNDPIFYKRGLLNIKADNFQKAINDFSLISKSFTNSKIFEL
RGDCFFALKNYNDAIKNYSLFLASNPNNIDVITKRGDSYFNNNDLKNANSDYKNSASLKW
KSKGFFYKYGWYILFVLGYFLIALILENSFKEEYDNKKIKKSYWYYFLTGLFGGHYFYIN
YVWRYALYTILVLVLFSLNSFNIRSFYNHNDLLWTGIVSTQYSMSLIYVILALFVIDLLI
LPYSVFSYNHNLRLSINDEISKQREIEINEMAVLLEKQNTKFKSLK
>KACEBFPM_01736 hypothetical protein
MSWFKNAITGGNFDKLQNEQREFNKLANSFSLLQDGYMDLNLTRLNVLRFLKEEREEVVK
NLSLAKSMISKVKSITNDKNQEVKNDFITHVENQNIEFQLGDVSIDFQGKLDNVSETFVK
SLDSSSKKLGNKKKITKDDLKSELAIVAVETLIKGVGEIINLNGEVNEKRKHIVASTKKM
IDATSKMTNQAPKIYIEVKRMIEIAVLLNKHNQVFSIKYQAIHQEINKKSKFTIFINELF
NKKIIPDETMQTHLHSLIKISSEYGRFNNDANI
>KACEBFPM_01737 hypothetical protein
MTNNSVLKGVFLVGLGATSYGMLATFVKLAYSHTGITGNPFTPAEVISAQFIIGIIAILI
INGYQKSKKGTAVIKASANNIKQLMIAGTSTGLTSIFYYLAVKYIPVSIGIVLLMQTVWM
GVVLEMFLEKKMPSKIKIVAVFVVLLGTVLATNLIQNKINFDWRGIILGLLAAASFTTTM
FTANSVATQISSAQRSLYMLLGGAIIVFVFTLFTQTTPFNYDIFYKWGILIAIFGTVIPP
MLMNAGFPLTGIGLGSIVSALELPVSVMMAYFILNETVILTQWIGIILIIFAIVIMKK
>KACEBFPM_01738 hypothetical protein
MNRRNFLSLTGTFTGGALLLPDFLFAFGSQQNLIISEQCLVFVQLNGGNDGLNTFVPFEN
PLYYDLRPKIAISKNEVISATQGMAFHPALKNFATMQQNGDLAVIQNVGYPEPIRSHFRS
QEIWQTGSASNQYLNDGWLGRYLDLQCKEHHPTAGINLDSIDNLALKGQEPNSITVKNPN
LFKTKSKNDDPIELSTNPQLDFVRKIANSVTEGSDEIQKALAKSISEVSYPKTGLSKNLE
WIARLIKGNLNSKVYYTSIGGFDTHDNQLAIHNNKLTELNDAIFSLYTDLKNAKLMQNVT
IVVFSEFGRRVKDNGKGTDHGTAAPMFIIGGSNTGKVLGNNPNLYDLDNGDLKYETDFRS
IYTSLLQNKLNFDATKIGIQNKKVEGLF
>KACEBFPM_01739 hypothetical protein
MINNNTLWSLRLGFSNEQAKNILGLGLQKFLEKSFQAKYDSQIPSFLDESPKSLTALRDI
RQKIKSDPESTKEIRKKEEQVSNEMKAWWIKKMMTHEFPLQEKMTCFWHNHFVATYQKVK
VNYWVFQHNQLLRENAFGNFKELTKKVLKSNAMVRYLDNVDNRKDKLNENLSRELLELFT
LGIGNYTESDIKNGAKALAGLGIGENQAQYHSNFEDHDAITYLGRTGQFKADDLVDIIFE
QKNTPYFITQKILKWFIYDNPSTELVTYYGDYFKKMNFEIKPLLTKIFTEEFTKKTAGSK
IKNPLEYSLQLISELQIELENPKVLVFFLKDQGMDLLNQPNVKGWVGGNSWLTSQVYLQR
NNVANLFCSGRTINRKMFKVEEKDNEVLFQKINIKLDWNKNGNNKQIITELKNRLLFEVD
DNTQQDFEKILKYDFDSTTEGSENAVLRLFNAMVKTPEYQLI
>KACEBFPM_01740 hypothetical protein
MRDFSFCIVLFFYFFSVSAQETSKKTTALNEVSVTKEKKAIEQRADRTIFDFGGQSHLNS
GSVLEGLKKLPGLILSDVAGMMYQGKQLDVYMDGRPLNISSNELNAYLEGMPANAVEKIE
VITQPGAEFPATSGGAIINIITSKKAKSYLSAAYSAGLNFTSYDKLRSRINNSLLLNAKN
KYFGWQLNIGQSYRESALWSTITKNENNIVTNLSDTDSDRMSRSYYAKSALTFDLKKDRL
LLNYDVNHNNNDASTIGNGFGFVSNDASKTKIIRQDAVAAYQKRFEDKNKKLDFKFNFTR
NDNSFILESNIFNDPVLKNTYLQDYLNFKIDYSQGLNILDKGKISIGTLVDDLSFEAKNA
GIANLNYTRITSAGYVELQSTYKKFDFILGGRAEDYNITGKTNTANLIPFKQFRFFPNAS
LQYNFGSQIYFNANYNKKISLPSTSSLNPNNTNYQNQNVSYSGNPQLQPTVFDNYEIKIS
AFDYAFVGYNVSVAKNQVANKVVSNNNLVSNTSVNISEIEIHNFNFGIPLPYMLFTKGLK
ETLKFDVNPDKINFLYIYTGYQIHKLPDVKTKGFWIINLMSQIILPKEIKFVANYNYTTT
KGNYFYYVSTQPYGHSLDMSFSKKFLKDQLSLSLNFDDILNTSKQGFTAVGMPVLLENKY
DTRRFGFTLNYKIPTKNKLVKEEANLLNKEKKEDSGIITN
>KACEBFPM_01741 Chaperone protein HtpG
MTTGKINVSVENIFPLIKKFLYSDHEIFLRELISNGTDATLKLKHLTSIGEAKVEYGNPI
IEIKIDKEAKKIHIIDQGLGMTASEVEKYINQVAFSGAEEFLDKYKDSAKDSGIIGHFGL
GFYSAFMVAEKVEIITKSYKDEPAAHWTCDGSPEFTLTSANKTSRGTEIVLHIAEDSLEF
LEEAKISGLLNKYNKFMPIPIKFGTRTEKIEQKKGEFVETEDKENIFTEVEVDNIINNPN
PAWTKQPTDLTDADYKDFYREVYPMQFEEPLFHIHLNVDYPFNLTGILYFPKLGSDLQIQ
KDKIQLYQNQVYVTDNVEGIVPEFLMMLRGVVDSPDIPLNVSRSGLQADGAVKKISNYIT
RKVADKLKALFTENREDFEQKWNDIKIVLEYGMLSEDKFYEKAGAFVLYPTIDGKYFTLE
EIKENLAAKQTDKDGKLVVLYAGNKEAQHSYIEIAKDKGYEVLLLDSPIISHLIQKIEGD
NENLTFVRVDSDHIDNLIKKEETAISKLSDEEKASLKTSLEAFIPKAYSVQLEALDSNAS
PFIITQPEFMRRMKEMSQSGGGSMFGMSHMPEMYNLVVNTNSDLATSILNNKDKNAQENL
VKQALDLAKLSQNLLKGEELTAFVKRSFELIK
>KACEBFPM_01742 hypothetical protein
MKKILLVSLLAFFAACKTPAPVAATNVDRKSQVAIKGNWTIASVTYTGSEMFKITSFDAA
DSKCFEGSTWKFISNNDSGDMALTQANCTNFASKIKWYVNKEGQFVLKFLDEGVKARKMQ
QGYILTVADQTAESFKLIDKVNIGGKMTNVVYQFKKSN
>KACEBFPM_01743 Octanoyltransferase
MNKTIQLQDLGHKDYKATWDYQEQLFQNVLDIKIQNRREERQDQTPNYFLFVEHPHVYTL
GKSGDLSNLLLSEKQLEAKGATFYKINRGGDITYHGPGQIVGYPILDLENFFTDIHKYLR
LLEEAIILTLAEYNIIGTRSEGETGVWLGVGTPFARKICALGVRASRWVTMHGFALNANA
DLGYFDNIIPCGIKGKAVTSLNVELGVEKVNEEEVKEKILKHFTQLFDCTMI
>KACEBFPM_01744 Ribonuclease HII
MLSSFFLTQHLEAGTDEAGRGCLAGPVTAAAVILPENFESKILNDSKQLSEKTREQLKPI
IEALAISFSVTHLDPLIIDEINILNASLKAMQECVLQLNPTPLYIIADGNRPLLSKNSFK
KCSGKIFTNREIEILQSIPSSSIIKGDSKYLSIAAASVLAKTYRDEYMNTIHEEFPMYNW
KKNKGYPTKEHREAIRKYGVTKYHRMTFRLLPEQTVLDL
>KACEBFPM_01745 TonB-dependent receptor SusC
MRSKFKWIFTLLVALTMQLSFAQEKTVKGVVTDANGPMPGVNVLVKGTQRGVSTGFDGTY
SIKASQGEVLVFSFMGMGDVSRTVGASASISVKMQDDAKQLGEVVVTGALGIKKKKDAIT
SVQQVVGSRELTQAMNPNVARSLTAKVSGLQIDNSSGGVNGNTRIVLRGPRSVSGNTEAL
IVIDNAISTGSALAQLPPDVVESVTVIKGAQGAALYGDQGSNGVILVVTKKGTAGGKLSI
SVNSSIEMEQISFLPKKQSLYGQGWDGDHASIENGAWGSLLDGSLKVTGVNGDLKPYSFV
KDNMKAYYQDGISTQNGVTLNFGGEDGYVLLSANRSVQDFVVEGDGSRRNSFLFKGGKKI
GKWKFDGSVRYVSTQTEQGEADNTLAHLLQSAPNIPVGDFENTGIFGWNIYYKNPFWERK
NNRLNRSSDFFDVSASLGYAFNKHINVTYLANVQTQTSIQTTHNAAGFTSGNSFDAVPVA
YSFGQKSNFYRSNNHTMNFYGDLLLNFDYKLFDKVSFKAALGSNMQDKYSERISQGGENL
QIPGWYNLQNVANIDLAKDLSNNMFRTRKVSGFGNVDLGYADYLFLNLTGRRDATSVLTS
SNNVYNYYSGGLSFVPTKLIEGLKDKKTLNYLKLFVNYAKVGNSSAVNAYDVEKLSPLGY
GFPFSGLTSYSQFNSATNGGIKPEFINTVEAGASFGFLDNRLTLDATVYQSKVTDLISEK
GISRASQGVANFKTNIGDLTNKGMEFDLGFMPVKTENFTWEGRLSYSAYQTKLTKLDGES
TEIELYNHANDSNSNVNSGTYAIVGESFPSIKGTTYLRDVQGRVIVDAVTGMPKISVNRS
LIGQVNPDYILGFSNSFTYKGLRLAVVADYRTGNSFISGVKHNLSWVGNLEESADYDRTV
GFIYPNSVLSTTGLPNTTVYTGGDYTGTTAYDNTINYYNDYSKLGEAQLLDGTALKIREI
SLSYNLPKRFLDKLKLESVRFGVNARNPFVFFVDKNNFFKPSNNRNYSDPEASNVNNANS
SVGAVRTSSLSNTSLNAGGFSQTGQYPSTRTFGFSVNLTF
>KACEBFPM_01746 hypothetical protein
MKNKIYVLLFALSPVIFSSCTDYLDVNESTNSAHTERVEPPGFLAAALATTFRTQAVSMN
EYGSVMTNAWGGNASYYTNPYQTEFRGDLKTTTRQAIWNDIYVGVANFQNMINFPSNGEY
DNHVAIAKIMKTYYLAYLVDLYGNIPYSKAFLGATVNATPSFDKDTEVYKGLFKNLDEAN
LLFANANAKAVGSEDIVFKGDMDKWAAFANTIRLRMCLRMSEVTDPAMVSLRTANLAIAA
SRPFVSADVTINPGYNNSTEAQYNPFALNFSRIVSGNVVKENVYSSRLPCASGYVAKVLN
GTVNQPGVIVSSVVDPRRSRMFRATTIIGIDQGTGFAPTSTNPSLLGSGVTGFNSTIAAD
NESKFKNATSRDGFIMTLAESLFLQAEAAQRGYISGSPQTLFNSAIAASFNFYQKPYGNY
TPLAIVPNAAAYTTSVDGMLGLGWTGTANKLQVILTQKWLALFGIHGIEPFLDKVRTGFP
NNPLATGANASVHSTSPRRLLYPSTEYSANGANTPVVSLEDLFSVNAYTPFWVRN
>KACEBFPM_01747 hypothetical protein
MKHIFTFLLFILTTSIFAQVDNELSINKSDTIKKSLRDKPKENPKAPINQYRIITLQKDT
TYVDTSLTIYKEYKFNHLRKDNFGLLPFANDGHTYNTLDFGLNKSNTLPQFGFKAKHFNY
SNEKDINYYSVATPITELYFKTVLEQGQSVDAFITLNTSEQLNFSIAYKGLRSLGKYINS
LSSSGNFRFTASYFSKNKRYLANLHYTSQEALNGENGGVSNLSDFQSGNAQFSKRSRLDV
YFQDAKSLLEGKRYFLDHSFRLNNKGSEYNIAINHQFSYEAKMFEFSSKSPIKRFGNAYL
ASNYFDVTKNTTTYNKIGANFSNKKLGDIHFFLENYQYNYSYKRVSISNNQVSIPNLNHD
NLNAIGAKYLYSKRNLKGEALFSKSISKQTFSTLDLSAQYKWNEKNNFSLQYTNQSKVPD
LNYTLYQSSFVNYNWYNNFKNEKTNTIKLKANTQWLSAQVQLTRLDNYLYFSNNDTSDTI
VISTPKQYNKTINYLSLKVSKELTFRKFALDNTILFQEVTQENNILNVPKLVTRNTIYFS
DYVFKKAMYLQTGFTFQTFTKYYANHYNPLIGEFYVQENTKIGNFPLVDFFINARVRQAR
IFLKAEHLNSSFTGRNYYSAPNYPYKDFIIRFGLVWTFFQ
>KACEBFPM_01748 Benzil reductase ((S)-benzoin forming)
MMTKAVAVEQETIKNRTKIIAIYPGVVDTDMQFQIRKSSLENFIDIQRFIDLKESNSLIN
IETIGQEIFKIDTLENYPNGAILTVSDYRN
>KACEBFPM_01749 Aconitate hydratase A
MAFDIEMIEKMYANMASRVDKARELVGRPLTLTEKILYAHLWDGTPSSVFARGKDYVDFA
PDRVACQDATAQMALLQFMHAGKSKVAVPTTVHCDHLIQAKEGAKTDLAFANSQSKEVFD
FLSSVSNKYGIGFWKPGSGIIHQIVLENYAFPGGMMIGTDSHTVNAGGLGMLAIGVGGAD
AVDVMSGMSWELKFPKLIGVKLTGKLSGWSSPKDVILRVADILTVKGGTGAVVEYFGEGA
INMSCTGKGTICNMGAEIGATTSTFGYDDSMRRYLAATGRQDVVNAADKVADYLTGDAAV
YANPNEYFDQVIEINLSELEPYINGPFTPDRGTPVSKMKEEAAANGWPIKVEWGLIGSCT
NSSYEDMSRAASIVEQAVAHGISPKAEFGINPGSEQIRYTIERDGIIATFEKMGTKVFTN
ACGPCIGQWDRAGADKGEKNTIVHSFNRNFSKRADGNPNTHAFVTSPEMVAALAISGRLD
FNPLTDTLLNDKGEMVKLLPPKGDELPSKGFDVEDAGFQAPAEDGSGVQVAVSETSDRLQ
LLAPFAAWDGKNITGAKLLIKAFGKCTTDHISMAGPWLRFRGHLDNISNNMLIGAENAFN
KEANKVKNQLTEDYDTVPAVARAYKAAGISSVVVGDQNYGEGSSREHAAMEPRFLGVKAV
LVKSFARIHETNLKKQGMLGLTFANEADYDKIQEDDTINFTDLVDFAPGKPLTLEFVHAD
GTKDIILANHTYNDSQIGWFVAGSALNLIAAGKA
>KACEBFPM_01750 Oxygen-independent coproporphyrinogen III oxidase
MSISLVQKYNVPGPRYTSYPTVPYWDENDFSYQIWINTLKKSFAESNKLEGISLYIHLPF
CESLCTFCGCNKRITKNHTVEKTYIEAVLKEWSFYCKILEPKPIIKEIHLGGGTPTFFSA
ENLESLINGIFCHASKAENYEFSFEGHPNNTTREHLQILYDLGFRRVSFGVQDYSDKVQK
AIHRVQPFQNVAKVTLWAREIGYTSIGHDLIFGLPFQELDDVVDTIEKTKSLLPDRLAFY
SYAHVPWIKGNGQRGFKDEDVPKDDAKRKLYEVGKQSLYKNGYHEIGMDHFALKTDGLYA
AFENGKLHRNFMGYSASKTQLMIGLGVSSISDSWYSFAQNVKDIETYYQRLESDKLPILR
GHFLTNEDLIIRKHILNLMCQFKTSWQNKSDYFEELPEVLLQLVEMEKDGFLIINENTIE
VTEAGKPYVRNICMAFDLRLKRKAPETALFSMTV
>KACEBFPM_01751 hypothetical protein
MEKHNLLNEFPEYQEKIYHLKTENNHFKKLISEYDEIEHQIHRINIGEEVMIDEAFKELK
LKMIHIKDEIFNMLKA
>KACEBFPM_01752 hypothetical protein
MLYTAFIFGLISSLHCIGMCGPIAMMLPVDRDNPAKKITQIITYHLGRLSAYGTIGLIFG
MLGKGFFLAGFQQHLSIFIGFSMILIILIPEKVFMKYNFSKPIFILISKIKSTLGSQFRN
KSYKSLFTIGLLNGFLPCGMVYVALFGAIAMQSAGFGVLYMILFGLGTVPMMSSVTYLNG
FLTISIRNKIKKAIPYTAVFIGFLFILRGLGLGIPYISPNNMSLFIQATPNCHN
>KACEBFPM_01753 hypothetical protein
MKINWGTGIVIAFALFISFILYFVFKVQSNAKYDNELVVEEYYKHDAKFGDEMIRAENAQ
DLKLKPIITVAAEAISIVFPNTFIPKKIKGKVSLYRPSNKKLDFEIPISLTNTTLLIPKK
SLVGGRWDINMEWQYDGKSYLTKEIVYIK
>KACEBFPM_01754 Putative electron transport protein YccM
MSKKLDETFRDSIGTIDDQGHRKFIFPKKPSGKLYEYRKWVSYFLLIILVANPFLKVNGN
QFMMFNVLERRFNIFGFPFWPQDFYLFVLFMIVGVVFVILFTVIFGRIFCGWICPQTIFL
EMVFRRIEYWIEGDRGAQIRLSKQEWNPEKIRKKALKWTIFLVISFFIANVFLAYLISSD
ELFKMIKEGPENHVSTLISLLIFTGVFYFVFAWFREQVCIIACPYGRLQGVLLDNKSINV
AYDFVRGEKEIGRAKFNKKEERETTGKGDCIDCFQCVNVCPTGIDIRNGTQLECINCTAC
IDECDSIMKSIGLPKGLIRYASEDEIEKKAKFKFSNRMKGYTAVLAILIGILTGLLFLRN
EVETVILRLPGQLYEHKGDNISNIFTFKIINKTNDDFNDIHFKLHNIKGTIKVVGKQSFK
VKKQAINKGTLFVEINQFLLENDKTKIEVEVYNGNKKIETTTTSFLSPRSFD
>KACEBFPM_01755 Cbb3-type cytochrome c oxidase subunit CcoP2
MKATDTILDTLLTEEQRKQKEIDENRSFIETDFYKNWIQRLTKTEPIENEGQLLLDHDYD
GIKELDNNLPPWWVYLFYGCIAFAAIYLVRFEMMDGDNQETELRKEMAQAKIDVEQYMKT
APDMTDEKTVTVLTKPEELAEGKTIFTTNCIACHRADGGGNIGPNLTDEHWILGGGIKNV
FHTITNGGRDGKGMIAWSKNGLKPKEIQKVASYVLSLQGSNPKDGKAPDGDIWVNPSAEK
TATANPPESLPLKK
>KACEBFPM_01756 GTP pyrophosphokinase
MHDVVEDTDITVKEIEQMFNPKVAQLVEGLTKISQVKKDMNISMQAENFRKMLLTLNDDV
RVIIIKLADRLHNMQTMESMVDHKQVKIASETLYIYAPLAHRLGLYNIKTKLEDLGLKYT
EPGVYNDIVSKIKETKEEQDEYIRNISDILKESLDKEGVEYVIKGRPKSIYSIRRKMAAQ
NVTFDEVYDKFALRIVYKSNPNDEKFLAWKIYSIVTDHYRPSPSRLRDWISSPKSTGYEA
LHITVMGPLGRWVEIQVRSERMNEIAEKGYAAHYKYKQGATEESGLDVWLNLLKEALENS
ETNAVDFVEDFKMNLYAKEIYVFTPKGEIKSLPKGATSLDFAFSIHSEIGIRTRGTRVNG
KLVQLNHVLKSGDQIEIITSQNQKPTINWLDYVTTSRAKNKIRNFLNEDIKKIAEDGKET
LVRKLKQLKLSLTEATVNELVNYFKLKTSLDLFYRVGIGAIDNQQLRDFAAQRSNAFMNF
FKNKIKRSPSTNTDIIHKNELSSNYDMLVFGVEQDKLDYKLSACCNPIPGDSVFGFVTIN
EGIKVHKRDCPNAISMQSNYAYRIMQAKWIDSSQQEFKAILEITGMDSIGLTNEITRVVS
NNMHVNIQSISLSGDAGIFKGTLTVVVPNNTILKKLIDNIRKIDGLDRVARVYNN
>KACEBFPM_01757 hypothetical protein
MKILLVGEYSRLHNTLKEGLEKLGHQVFVNGLNDGFKDYPVDFKIYRKYNKGIISKIKNL
VFVLTGFDISSYATYNQVKHNASRFSGFDVVQLINENSFMCQPKHEIKIIAFLVKNNTKL
FLLSCGDDYVNVDYNFKNPYRKSVLNPYFEQSSIKKNFVNSLKFRKKSFKKLHEYIYENC
NGVIATDFDYHLPLLKNSKYLGLIPNPINSTHLKYINLAITDKIMIFLGLNNQNYYKKGG
NHFEEALSIIKAKYSEKVAIIITQNIPYSTYINLYNNCHILLDQTYANDQGYNALEAMAK
GKVVFTGAEKEFSDYHNIQERVCINAKPDINYLVNELSFLIENPKEILAISKRAKAFVEK
EHNYIKIAERYLEVWSNN
>KACEBFPM_01758 N-acetylgalactosamine-N,N'-diacetylbacillosaminyl-diphospho-undecaprenol 4-alpha-N-acetylgalactosaminyltransferase
MSITPKKKILLVTTSLAEGGAERSTGLLSVLLSEMGYKVHIVTFLDKVEFRYEGVLFNMG
KLKEANNTFLGRIKRFLIYKKYIKTHKFDWIIDNRTRYRTLVEIIFSKLFYTKKSNLIYM
VRSFNISWYFPKNKIVAKNIYKSAKYIIGVSKEIKNEIEKTYQYNNVRSIYNPIDFENIN
ELALKYKISEKYILAYGRIDDEVKNYSLLIDAYSFSELPKNNIFLYILGDGKDLKKLKDK
VVKLKLSDKVKFCDKQVNPFPYVKQAICTVLTSKFEGFPRVVIESLALNTPVISVNCKSG
PEEIIINKKNGLLVDNNNIELLSEAMNKMVLDHDLYSLCKKYAKDSIEYLSLENISKEWN
KLLES
>KACEBFPM_01759 TDP-4-oxo-6-deoxy-alpha-D-glucose-3,4-oxoisomerase
MTTIQDVRLIEIPKIEDPRGNLSVIEGSTISFEIKRVYYLYDVPSGAERGGHCHIHQHAI
LIALSGSFDVILKDGYKQKKITLNKPNFGLLIVNGIWRELANFSSGSVCLVVSSDVFDEE
DYIRDLEEFKLFKNRISNS
>KACEBFPM_01760 putative glycosyltransferase EpsJ
MPFFSIIIPLYNKENYIEYTLKSVLNQSFIDFEIIIVNDGSTDNSEQIVFQFNDKRIHYF
HKKNEGVSIARNFGIEQAKSDFICFLDADDFWYENYLEIMQTYIEKFSTYKVFSSAIEIE
TSKTIFPAQYSIKKNADFEIINFFEASEKECAIWTSSSVFHKSIFKKTGVFDPNIKIAED
TDLWIRIGLQYPIVFIWKTIARYVYDEQSVSRASNYIFEENSFLKYAEKEKTNKELKKYL
DLNRFSAAIKNKLNDNYVNFEKVRKEINLTNLSFKKRLLLKLPTPILKKIILLKLFLANL
GIGNSIFK
>KACEBFPM_01761 hypothetical protein
MLSILIPTYNYNAFSLVEELNNQALATGIKYEIIVLDDGSNYFLKENQKINELDNCSLNE
LSQNIGYSKIRNVLAKKAKYDWLLFLDSDTFPRSSSYISNYIKLITKNKKVVFGGIEYPK
NKPENDKLLRWKYGKKREVSSLSNRIKKPYNSVFVYNFLIEKTIFSSILFDEKIKKYGYE
DFMFIQNLKLKNINIYHCENTVFHLNSDTSDVFLTKTRTALKTLQFLFENQNIFYIETKI
TKTYNILYRLKLVATISRLFQKHQNKLETNLKSKKPSLFILDLYKIGYFCLINTK
>KACEBFPM_01762 Ribosomal RNA large subunit methyltransferase H
MYFIKFVFIYTNNMNIKLIAIGKTDNKNLQTLIDDYTKRLSFYIKFDLEIIADIKNVKNL
SETQQKEKEGELILSKITPTDQLILLDENGKTFSSVAFSDQLQKKMNSGIKTLVFVIGGP
YGFSDDVYKKTFGKISLSQMTFSHQMVRLFFIEQLYRGFTILKNEPYHHQ
>KACEBFPM_01763 hypothetical protein
MKNKIAKSFITTLFITFVLTIVNTNTFGTLPFFFIWIRSWCIAGTIASFFNVFIFSKTNT
HLKNVFSYFNK
>KACEBFPM_01764 HTH-type transcriptional repressor NsrR
MKLNHFTDFSMRILMYLNHQKEGKTTSLDELSDQFKISRNHLIKVVQFLSKNQYIHTKRG
KNGGIHISNETKTIPLGNLINILEQDNSPIINCDSKPCVLAPHNCKLKYIFQLGYQSFIN
TLNQFTLSDLTFENWDKIF
>KACEBFPM_01765 Flavohemoprotein
MQLIKNVLVLYKIFKNNKMTSTQKDLIKATIPILKSNGEDLVKYFYNRMFIHNPELKNLF
NMGNQSSGKQQSALTGAVLAYAENIDNPTVLINTLKLIGNKHVSLQVTAKQYDIVGNHLI
ASIKEVLGAETATEELLHAWTIAYTQLAQIMIDIEEGMYKENIEKEGGWNGWRDFKISKI
VTESTEIKSFYLEPTNGEKLPSFKPGQYLSIKTYIDALGHEQPRQYSLSSANSDKWYRIS
IKKEMGNQNKPNGIFSHAMHDKKTGDIIQVSAPSGVFYIDNENKNPLVLISGGVGITPLM
SMLEANTHELKQHKTVWIHSCRNKEVHAFKEDIKKLEQANQWLTTHLYYETNTSGEHDAK
LGRINIPELQKEILVNDAKYYICGPELFIKAQYTALLEIGVKEEFISFEEFGPQLLNLN
>KACEBFPM_01766 Nicotinate-nucleotide pyrophosphorylase [carboxylating]
MYYFSLIILYNMISETQFNQELELIITNGIREDIGSGDYSSLACIPVSAMGKAKLLVKDT
GIIAGVEFAKMIFNHVDSNLIVETFIQDGSQVAYGDVVFHVSGSSQSILKAERLVLNSMQ
RMSAIATKTNKYVQLLEGTNTKILDTRKTTPGFRAAEKWAVKMGGGENHRFALYDMIMLK
DNHNDFAGGITLAIAKTKQYLAENNLDLKIIVEARNIAEIEEILQSEGVYRILIDNFNFE
DTKTAVKLIGNKCLTESSGNINEKTIRDYALCGVNYISSGALTHSVYNIDLSLKAI
>KACEBFPM_01767 hypothetical protein
MSQTTEEILKKIPVIKQLIIILQNIKLPWLQGISLYELIDFYLSGIVQGALSYRAAAVAW
SFFMALFPFMLFILNLIPYIPITGFQEDFLGFVRANVPPTTFDAIDNIINDILHNSHSGL
LSTGGILSVFLMTNGVNAVMSGFETSQHIVEKRAYFRQYFVALFISMLLTFILLITVSAI
IIFEVFIQRTIIQDVLSSRISDKISLIEFGRYSFIIIMIIMSIGILFKFGIRQTRKRAFI
TIGVVFTTILIILSSYFFGIWVVRFSKYNELYGSIGTLLIVMFYLWLNCMVLLLGFELDA
SIYKLKHHPTKNPHL
>KACEBFPM_01768 hypothetical protein
MMIKKMTLLLLLIGSFQMQSQTVFGKWKTIDDKTGQAKSIVEVYENSGKVYGEVIEIIDP
SRRNRKCEKCEGLDKNKPVLGLVIIKGLKKEDDEYNGGKILDPETGNIYKCFIKLAGKDK
LEVRGYMGFSLIGRSQTWVRVK
>KACEBFPM_01769 Primosomal protein N'
MPFFIQVILPLTLPQTFTYSVSEAEFEYLKIGMRVAVPFGKSKFYTGLVLELHHNAPTLY
EAKEIHQIVDQKPIVTEVQLQHWQWIASYYMCTLGEVFRCALPSALQLESETIISAKKDF
IINENELSDEEYLLVEALKQQSSLKISEVTSVLNKKKVLPIIQQLLAKNVITLQEEMIEE
YKPKLVRYIRLFSQFNSNDKLEELLLVLKNAQKQKEILLSYFQLQATTKKPISVKGLTEF
SGGTLAVIKALIDKEIFEEYYIQEDRVSFDDVNISQIVLSEPQDKALSAIETVFASKEVC
LLHGITASGKTEVYIKLVEKFLEQKKQCLYLLPEIALTTQLVSRLTKHFGNKVAVFHSKY
SNNERVEVWNQVLNSSEKAQIVIGARSALFLPFQDLGFIIVDEEHEQTFKQTDPAPRYHA
RDAAIVLANFHKAKVLLGSATPSIETYFNTKNDKYGLVELHERFGNAVLPEIELVDLKDS
YFRKKMTGHFSQNLIDAIAEALSNGEQVILFQNRRGYSPVIECMTCGHVPQCPQCDVSLT
YHKFKNQLRCHYCGYSIAKPTNCHACSSIDLTSKGFGTEQIELELASLFPTKNIKRMDQD
TTRGKYAFEKLIGSFKNREIDILVGTQMLAKGLDFDNVSLVGILNADSMLYFPDFRAFER
SFQMMTQVSGRAGRSDKKGKVIIQTYNTNHNTIQQVVQNDYLSMFNEQLYERKIYHYPPY
FKLIKLTLKQKDFDKLKEGSMWLYQVLKQQFDIPVLGPEEPAINRIRNEYIRTILIKIPQ
EKSLGNTKKTIQKILNSFESVSQFRAIKVGVNVDFY
>KACEBFPM_01770 Transcriptional regulatory protein YpdB
MKLNCIVVDDSAIQRILVNKLVESHPNLNLVDDFSNAIETKNCLITKPIDLLFLDVEMPI
INGFNLLDGLKEKPQTIFITSKAEYAVKAFDYDATDYLQKPITKERFNAAVKRALDMHQL
RRDNLEEEGDHIFIKSNLKKLKIYTAKIKWIEAYGDYVKIATEDDNHLVLSTMKSFEQDL
PKEKFIRVHKSYIINIEKIEKFNSKFAEIGVTKIPLSRNKKEDLTKALNY
>KACEBFPM_01771 30S ribosomal protein S6
MNHYETVFILNPVLSETQVKETVSKFEDYLTSKGATMVSKEDWGLKKMAYEIQNKKSGFY
HLFEFTVPGEVLIGFETEFRRDERVMRFLTVSLDKHAISWAERRRAKLKATKA
>KACEBFPM_01772 30S ribosomal protein S18
MSTLQQSASGKKDGDIRYLTPLNIDTNKTKKYCRFKKSGIKYIDYKDADFLLKFVNEQGK
ILPRRLTGTSLKYQRKVSVAVKRARHLAFMPYVADLLK
>KACEBFPM_01773 50S ribosomal protein L9
MELILKQDVQNLGFKDDIVSVKAGYGRNYLIPQGFAHMATSSAKKVLAENLKQRAHKEAK
VVADAKTLGDALKAIEIKISAKAGGEKLFGSITNIDIAEALAKGGQSIDRKFITSGIVKR
TGKYNASVRLHRDVIVELAYEIVAEQA
>KACEBFPM_01774 hypothetical protein
MKYDRLTKEQFEELHPEFINFLSTQSIDKGEWDKIKLEKPEVAEQELDVFSDLIWEGVLT
RAVYLEHFSKNYIFLFHCFDTHVQSIVLKSVVPETNFLTKEGLQWLSDNMFTDNIEMKVG
KKEFTEERNTSLFELIKQGAFLSDGELFKQINGIMNS
>KACEBFPM_01775 DNA ligase
MTVLQKIQSLREELNLHNYNYYVLDNPTISDYDFDVKLTDLQSLEKNNPEYFDENSPTQR
VGGTITKNFETLKHDYRMYSLDNSYSKEDLLDWENRIQKALGDVPLEYICELKYDGASIS
ITYENGRLVRAVTRGDGFQGDDVTNNIKTIKAVPIKLKGDFPEKFDIRGEIILPFAGFEK
MNQDLIEIGETPYSNPRNTASGSLKLQDSAEVAKRPLDCLLYSLIGNNLPFQSHFEGLEK
ARLWGFKVPKQSHLAKNMNEVFDFINIWDKNRHTLPYETDGVVIKVNDLHLQDELGYTAK
SPRWAIAYKFKSEQVFTQLNSISYQVGRTGSITPVANLEPVQLAGTIVKRASLHNADQIE
KLDIRINDTVFVEKGGEIIPKIIGVDLQKRPSNSQKTAYITHCPECQTKLERKEGEANHY
CPNFYGCRPQIIGRIQHYISRKAMDIEGLGGETVALLYDNGLVKNYADLYDLSVEQILPL
ERMAQKSAENLVQGVQNSKNIPFENVLFALGIRYVGETVAKKLAKHYKNIDAIANANLLE
LVMVDEIGDKIAQSVVEFFDNQENISVLERLKNNGIQLAISEENNTVVSDKLLGKIFVVS
GVFEIYSRDELKKAIEDNGGKVGSSISAKTNYVIAGQNMGPAKLEKANQLKVSIISESDF
SALLTS
>KACEBFPM_01776 hypothetical protein
MQINNSSLFLYLFASIFASIGIFIGNELMILLMKPMIIPAILFYYIQIRTEKVNWLFLII
LLSNFISDMLVLFELPEGNFPIALLNMFGYLIFIYLSVKDISLKNLSNLNFLYFVLIVMG
CVLILHVVLDLMPGIDSFTNNLYTIYGILLSILASIIGFNYLNQENEKTFYALLMGICFI
TSDVFFVIYNFYLNLVIFMFLNVTIQFISYYYMVKYITSNSKKEILLQNEK
>KACEBFPM_01777 hypothetical protein
MKNKTINIKAANEVNILILLFFGVTLTEVVAEFFCFVSFIYFLKALICPLLILICWKSSV
KRNNCFILALIFGLIANIFFVAKDFNSILLGSLFFMFYRILIIYLVVKIVSMPNYLPVIL
ATIPFAIIFLYVTTLAIDELGSGLYIYNAGSIY
>KACEBFPM_01778 Putative ribosomal N-acetyltransferase YdaF
MTFNFDFSTNYILENDTVRLEPLQESHFANLFTESLQNPEIWKYSSLPTIGAENFRKYIQ
LALNNREKLTEYAFVVLDKRTNEYAGSTRFYDMQLSNKTLQLGYTWYGKQFQGTGLNKHC
KYLLLEFAFEKMNVERVEFRADNANETSKAAMKSIGCKVDGILRSNMTKLDGGRRDSIIL
SILRSEWFDGVKENIRKKLLR
>KACEBFPM_01779 hypothetical protein
MYELVFWNYKETIYLNHHLVYEAISEEKIVDGLEELPIEIILNRIANVFSKWEKVDEKSW
KNNDGVGAFHIRTTPQSIKIDCYGTQGKTMNTLVDILQEYKCPLYDPQVPERHDEFNE
>KACEBFPM_01780 Phosphoribosylformylglycinamidine cyclo-ligase
MRTLIVDSTVTARIKRKDVVDNANIKAGDVIVGLASFGQANYEKSYNGGMGSNGLTSARH
DVFDKYLAHKYPESFDAQVPHELVYSGNVKLTDAVENSPIDAGKLVLSPTRTYAPIIKKI
LENYTPNDIHGMVHCSGGAQTKILHFIDNLHVIKDNLFPVPPLFKLIQEQSKTDWKEMYQ
VFNCGHRMEIYVPEDIANDMIQISKSFGVDAQIVGRVEASENKKLTIQSEYGTFEY
>KACEBFPM_01781 Transketolase 2
MSNTQQLEDFSTQVRRDILRMVHAVNSGHPGGSLGCTEFLVALYQNIMKRNDGFDMNGIG
EDLFFLSNGHISPLFYSVLARSGYFPVSELATFRKLNTRLQGHPTTHEGLPGIRVASGSL
GQGLSVAIGAAQAKKLNNDNNLIYALTGDGELQEGQNWEAIMYASAKNVDNLIATVDYNR
QQIDGSTKDVLNMGNLKAKFEAFDWDVLEITKGNNIDAIITGMNEAKARTGKGKPVCVIL
HTEMGNGVDFMMHTHAWHGKAPSNDQLANALAQNPETLGDY
>KACEBFPM_01782 1-deoxy-D-xylulose-5-phosphate synthase
MTKYTNTGSKDTRSGFGAGMTELGQKNENVVALCADLIGSLKFDDFKKNHPDRFFQIGIA
EANMIGIAAGLTIGGKIPFTGTFANFSTGRVYDQIRQSVAYSDKNVKICASHAGLTLGED
GATHQILEDIGLMKMLPGMTVINTCDYNQTKAATLALADHHGPAYLRFGRPVVPNFMPAD
QPFVIGKAILLNEGTDVTIIATGHLVWEALIAAEALEAKGISAEVINIHTIKPLDEEAIL
KSVAKTGFVVTAEEHNILGGLGESVARTLALNNPTPQEFVAVQDSFGESGTPEQLMEKYK
LNNQAIVEAVERVMKRK
>KACEBFPM_01783 Outer membrane porin F
MRICYFLLFLCLVENASAQEKLEIYFDFNKTDINPKTKIKLDSLITSKNKIEILKIYGFT
DSVDTTTYNDSLSIKRAKKIFNYCKENKVQISNQVEIKGFGENYNQSKNSNKNRKAIIFF
KSILSDKPKPNPNNSENGNFYSSENPEILKQFLASEKSIFEKFKNAKKGDIIIINNILFQ
INSEKLANGSSQIIIDLLDYLTNNPKIKIEIHGNICCNPNTNDVKLSYRRAKYIFDYLIK
NGIATSRLGYHGYGSANPIYKIPEKSYQEELANRRVEILIIEK
>KACEBFPM_01784 hypothetical protein
MEIVNYIFACITIYYLLNIIWLIYGFTKVKPFDNENVSPKTRFSIVVPFRNEQYNLPKLL
LCIDQLNYPKDLFEVILVDDDSEEELQITNYELQIIIVHNIRVSNSPKKDAINTAIAIAK
NDWVITTDADCLVGPNWLSTFDAFIQKNKPKMVAAGVFYKTNSGFLDAFQQLDFLSLQGT
TIGSFGNNQAFMCNGANFCYQKAFFYELNGFDGNDKIASGDDVFLLQKAIQKAKNEVCFL
KSEWAIVQTKSEKTWKYLFNQRVRWASKTGNYNGLYSMQLGVSVLLMNLFWVLGFLFFVL
GMINLNCFVLLFFSKFIVDFFLLYKASSFFKASLNYLLFGSLLYPLFCVVVGFYSFFGSY
SWKGRVFYK
>KACEBFPM_01785 hypothetical protein
MISISHKAKQFLILAIKLSIVVAAFYFIFHQLATNDKLDWTKFIVLFKKKQSVLGIVFIL
FLSFVNRFFEILKWQNLVSSFKIISLGEATKQVLASLTAGIFTPNGIGEYAGKTLYFEKS
NAKKIIFLNLLCNGIQLILTIILGTIGLLFLGYTFWGFAILVFVLVFLVFCFFSKKIQLK
GYSLENLLSKINEIPKKIHKKNIVLGAVRYLVFSHQYYFLFVAFDVHLPYFTLMATIVTV
YFLASSLPSFQFLDFAIKGSVAVFFFSLLGVNEWIVVFVTTLMWFLNVVIPVIIGGFYVL
NFKPQWKL
>KACEBFPM_01786 Crossover junction endodeoxyribonuclease RuvC
MANERIILGIDPGTTIMGFGLIKIINKKMEFLQLNELILSKYDNHYQKLKVIFERTIELI
DTHNPDEIAIEAPFFGKNVQSMLKLGRAQGVAMAAGLSRDIPITEYEPKKIKMAITGNGN
ASKEQVAKMLQQLLGLKELPKNLDSTDGLAAAVCHFFNSGKVIGTTSYTGWDAFVKQNEE
RVKK
>KACEBFPM_01787 Oxygen-independent coproporphyrinogen-III oxidase-like protein YqeR
MVLAIAKEIAMRKNEFKNQTIETIYFGGGTPSLLNVSDLIFLINQVYSNYNVSQNTEITI
EANPDDLSENRIIELSKTPINRLSIGIQSFFEEDLQLMNRAHNSAEAKKCLEIATQYFDN
ISVDLIYGTPGMSNERWLENIKIALDLNIPHISSYALTVEPKTALHKFIKDGMMPQLDDA
MAHEQFLILVDTLETNKFIHYELSNFGKENYFSKNNSAYWLGKKYIGVGPSAHSYDGKNR
SWNLSNNGRYLKSISENTLPSETETLSKTDKYNEYIMTGLRTIWGVSLNKIESEFGEKYL
KYLLKNTQKYLDDTKLILENNILRTTRKGKFFCDGIASDLFYLDLE
>KACEBFPM_01788 Kynurenine formamidase
MKAIINNQEIDLSKPIDISIPLTNTDKNPIAWYLNKPEIEPVTVGDWIGKVSEGKSSTNF
NNIFFNPHGHGTHTECLGHITNAFYSINQCLKQFFFTAELISVKPKTINGDLVITKEQIK
NALNKKTPEAIVIRTLPNIEEKKHKKYSHTNPPYLAQEAAVFIREIGIQHLLIDLPSVDQ
EEDEGKLLAHKAFWNVKDVNNLNEDARLNCTITELIYADNTILDGSYILNLQIAPFENDA
SPSKPILFKI
>KACEBFPM_01789 hypothetical protein
MNIQELYEFCLSKKGATEHFPFDKDTLVFKVGAKMFCVTSLKGFENGNPSLNLKCNPEKA
LELRAEYEAVKPGYHMSKAHWNLVSFNKDISSKMIYELINHSYELVFKSLTKKVQNEIQ
>KACEBFPM_01790 hypothetical protein
MIDNLKKILNEDQDPKAIEKITAKLESLLMKNEEVGYIGVQKKPAITVLPDSIVMTNKRI
IVCKPKNLGLSMDFIDYDWDDIAGAFVKENILGSEFSFSTKTELVISIDYIPKNQARKLH
TFAKEQIDLLKNPVVIASIIEEITPEEPIPVSNTIPYEEEIIEELETEEVTNFSEIMPVV
PTFSEPINTTSTEKKLADFSQDELFEKLQNYKKLLDNGLILQGEYDTYKKEILSYM
>KACEBFPM_01791 Pyruvate kinase
MLTNKKTKIVATLGPACSTKEVINEMIIAGVNVFRINFSHADYDDVKSKINIIRELNEEF
GYTTAILGDLQGPKLRVGVMKEDVVVNPGDIITFQTAEDVPGTAHSVYMNYKEFPKDVNP
GEKILLDDGKLMFEAIETNRTTEVICKVIQGGPLKSKKGVNLPNTKVSLPALTKKDIKDA
LFAIEQKVDWIALSFVRTAEDLMELQDLIAKHSEHKIPIIAKIEKPEGVANIDKIVAHCD
GLMVARGDLGVEVPAHEVPLIQKKLIHRAKTARIPVIVATQMMETMITSLTPTRAEVNDV
ANSVMDGADAVMLSGETSVGSYPVQVIEQMTQIIEAVEDSPLIQVPQNTPQIRTNRFITK
TICHHAATMANVIKAKAICTLTNSGYTAFQISAWRPSAHILVFTSNKSILTQLNLLWGVK
SFYYDKFVSTDDTIIDINEIARVKGFVEKGDFLINLAAMPVTEKGMVNTLRVSEIE
>KACEBFPM_01792 hypothetical protein
MAIHKLHLEDFDQVDYNLIAIHTSQEDYKLAFKLNQKLTISLSKNENEIPVKIQEQLTHF
SRFTYDDEEKMVAWDLIQNKQKIDLPVENLPTNLFENKNFTRRVSLLSELKKVDFFLKIA
HDSQYKIKDIISKINKIDSISAVYEIDANEIKSKNNLIF
>KACEBFPM_01793 Ribonuclease 3
MSFIKKIFLSSRSSEDGLFFSKLEKILGFKPLNLTHFRRAFTHRSMNKLDEKGNPMNYER
LEFMGDAMLGSVIAAHLFNMSPTGDEGYLTKMRSKIVSREHLNELGKDLNLIQFLESKVT
LQNFGENIHGNLFEAFVGAIYLDRGFVYCEKFIHKKVIKPYVDIDKLEGKVISYKSLLIE
WCQKEKRVFHYDIYEDEDAGKLKYFGVKLSIDGKVVAKARATSKKKAEEIASKRGYFVFQ
SEIDGK
>KACEBFPM_01794 3-oxoacyl-[acyl-carrier-protein] synthase 2
MQLKRVVVTGLGALTPIGNNIQEYWEALISGKSGAAPITYYDTEKHKTKFACELKNFNIE
DFMDRKEARRMDKFAQYAVAASEEAIKDAGITDTNVDKHRVGVIWGAGIGGLGTFQEEVL
SYAKGDGTPRFNPFFIPKMIADIAPAHISMRNGFMGPNYTTVSACASSANALIDAFNYIR
LGMCDVIISGGSEAAVTIAGMGGFNSMQALSTRNDSPETASRPFDATRDGFVLGEGAGAL
VLEEYEHAIARGAKIYCEVGGGGMSSDAYHLTAPHPEGLGVIAVMNNTLRDAGMKPEEVD
HINTHGTSTPLGDVAELKAISHVFGAHAKNININSTKSMTGHLLGAAGAIEAIASVLSIK
HGIVPPTINHTTVDENINPELNLTLNVAQKRDVKVAMSNTFGFGGHNACVLFKKID
>KACEBFPM_01795 hypothetical protein
MRHYPKVVIQKIKHKKVLLSLDFTVFRYTFLSENKNKSKDITSSLLGCVFLELYKYFYDC
NTTNMCFFYKSTKDFKDIKK
>KACEBFPM_01796 Acyl carrier protein AcpP
MSDIASRVKAIIVDKLGVDENEVVTEASFTNDLGADSLDTVELIMEFEKEFDIQIPDDQA
ENIATVGQAISYIEEAKK
>KACEBFPM_01797 Phosphoribosylglycinamide formyltransferase
MKKVVIFASGSGSNAENIILYFKNNNQVNIASVFTNNINAKVLEKAKQLKTHTEVFDKTQ
LSDGAILNKINKIKPDLIVLAGFLLKFPESIIQAYPNKIINIHPALLPKYGGKGMYGMNV
HRAVLENKETKTGITIHYVNKNYDEGEFIFQKNVSITNCKTPEEIAVKIHELEMECFPKE
IEKLLIPKT
>KACEBFPM_01798 Ribonuclease HI
MNYQVHIYTDGAAKGNPGPGGYGVVMELVGTAFKKEFYEGFRHTTNNRMELLAVIVGLEK
LKNPNMKVLVVSDSKYVVDSVEKKWVLGWEKKGFKDRKNSDLWKRLLIIYRKHQVDFKWI
KGHNSHPQNERCDQLAVFASNQKTLSVDAFYEKEEAKLL
>KACEBFPM_01799 putative sugar kinase YdjH
MNKLLIVGTVAFDAIETPFGKTDKILGGAGTYIGLSASHFNLQSAIVSVVGDDFPQEYLD
LLTARNIDISGLEVVKGGKTFFWSGKYHNDLNSRDTLATELNVLADFQPKVPQNFKNADV
VMLGNLHPMVQSSVLDQMEVKPKLVVLDTMNFWMDCALEDLLNVIKRVDVITINDEEARQ
LSGEYSLVKAAAKIHTMGPKYVVIKKGEHGALIFHDKEVFFAPALPLEEVFDPTGAGDTF
AGGFAGFITQSENVSFENMKTAIIHGSNLASFCVEKFGTERMLKLSKEEVVARLKQFKSL
TQFEIAL
>KACEBFPM_01800 Amidophosphoribosyltransferase
MSDAIKHECGIAFLRLLKPLEFYKEKYGTAFYGIQKMYLLMEKQHNRGQDGAGFASIKLD
MKPGERYISRVRSNDAQAIQDVYAQINSRINEEMIANPEYANNVALQKENIPYLGELFLG
HVRYGTFGKNSIENVHPFLRQNNWMHRNLLLAGNFNMTNVKELFNSLIELGQHPKEMADT
VTVMEKIGHFLDEEVTNLYQDCKNEGFSKREASAIIAERLDLVKILKRASKNLDGGYAMA
GLLGHGDGFVFRDPAGIRPAYYYQDDEIVVVASERPVIQTVFNVDFEKVKELQPGNALII
KKSGKISEEQILTPTVKKACSFERIYFSRGSDAEIYQERKNLGKLILPAVLNAIDNDTDN
TVFSYIPNTAETSFYGLVEAAQDFLNQRKNNYILANKDTLTTESLQELLSVKIRTEKVAI
KDAKLRTFITEDSSRDDLVAHVYDVTYGVIKPTDNLVIIDDSIVRGTTLKMSIIKMMDRL
KPKSIVVVSSAPQIRYPDCYGIDMAKLEGLVAFRAALELLKERNLHHIIDEVYTKCKAQE
NLKDEAVVNFVTEIYAPFEPQEISDKIAEMLTEDSVKAKVKIIFQTVEDLHIACPKNLGD
WYFTGDYPTPGGNRVVNRAFMNFYEGKDARAY
>KACEBFPM_01801 Inorganic triphosphatase
MIEIERKFLVSNNDFIALAVAKNRIVQGYLNSNPERTVRVRIKGDKGFLTIKGKGNESGT
TRLEWETEIPLIEAEKLLSICENGVIDKIRYEIPSGKHTYEVDVFAEQNNGLIIAEIELN
DENESFEKPSWLAQEVTGNNKYYNAYLNNNPFGSW
>KACEBFPM_01802 hypothetical protein
MRSKLVPVVNIASSYMQWILLAGILMIRTFPSLLLVGIVIFAATTLFSIVTLPVEYDASN
RALAWLENKHMLNPAEQAGAKDALKWAARTYVVAALGSIATLLYYISIYMNRR
>KACEBFPM_01803 hypothetical protein
MNKYSLLLIAILTLSCHKDSVVNDNTYLPNYSFSVVINTSLPSYNNLNFPSNPVLITNAG
AGIKGIVVMKVGTDDYRAYEASCPNQYPSDCSLMTLNGINAKCPCDGKEYSLYTGVGSGQ
YPLKAYRVEVNGSNLRVYN
>KACEBFPM_01804 Transcription elongation factor GreA
MSTVSYYTAEGLKKLKDELEQLKAIERPKASADIAEARDKGDLSENAEYDAAKEAQGLLE
LKIKKMEEVYSNARLIDESQLDVSKALVLSHVKIKNQSNGMEMSYHLVAESEADLKTGKI
SVTSPIGKGLLGKSVGEIAEITVPNGILKFEVLEITRD
>KACEBFPM_01805 putative HIT-like protein
MSSIFTKIVNKEIPCYKIAEDDNFLAFLDLNPNAKGHTLCIPKQEINKIFDINDDLYLGL
MAFAKKIAIALEKSVPCKRIGMAVIGLEVPHAHVHLIPLNEMNEMRFENKVTLTPEEFLA
LVATIQGNL
>KACEBFPM_01806 Dipeptidyl-peptidase 5
MKKILILTLFTMSLNLVAQNTMSPELLWKLGRVTALGISKDSKNVIYSVSTPSIAEDKSN
SKFYTIPVIGGKATEVKDTKSLLLDKNISPNGKYLVYSEEVKIDKVHGKDYYPELEKSNV
QIYNGLDYRHWDTWNEGKFNHVFYKENKEKSAGIDILKDQNFDSPQKPFGGDEDYIWSPD
SKSILYVCKKEAGTKYAISTNTNIYQYNLETQKTINRTEDNLGYDTNPAFSSEGNLAYLQ
MKRDGYEADKNDIIVDFKGIKINLTENWDNSVSSFSWSKDGKKVYFIAATDGTQQLFEVN
FPGLTRIAITVTQLTFGDFDVHDIVDITANNAIVTRTDMNHALEIYSYNLKKKTWLQITK
VNNDAYAKLALPKYERRYVTTTDGKKMLVWVILPPNFDATKKYPTLLFCQGGPQSPLTQS
YSFRWNFSLMASQGYVVVAPNRRGMYGHGQAWNEQISGDWGGQVMQDYLSAIDDVATEKY
VDKSRLGCVGASYGGYSVFYLAGIHNNRFKSFIAHDGVFNTQSMFGTTEEVFFNNWDFGG
AYWEKDNKIAQQTYTKFNPINYVDKWNTPILIIQGGNDFRVPIGQAQEAFQAAQLRGIKS
RFLYFPEENHWILKPQNAQVWQKEFYKWLKETL
>KACEBFPM_01807 Aminopeptidase E
MNTIKCLFIATSLIAGASSFAQDNLVNSLKINASEKSKEAFKFTDVVNVENTSIKNQGSS
GTCWSYSANSFLESEMIKMGKKPIELSQIFSARNAYVEKGRNYVRMHGAVTLGDGGAFHD
VMNMYRKYGAVPQSVYTGLNYGTDKNKFGEMAALGEALLAAVVKNPNGELTPNWEKAYTA
VIDSYLGETPKSFDYNGKKYTPETFAKEVVGINAEDYIEISSLQEYPYYSKFVLMVPDNW
AFDQVYNVKINELTDVIDNALKSGYSVAWGGDVSEKTFSWKNGVAFVPEKKIDDMTPEEK
ADLFNGPKKEAVVTEEMRQKAFDNYTTTDDHGMHIVGLSKDQNGKEYYIVKNSWGTTNDY
KGYLYMTKEFVKYKTTDIMLNKKALSADMAKKLKI
>KACEBFPM_01808 Vitamin B12 transporter BtuB
MKHLLQARSKRAKTNPSLKPKAAKQSLITGVMLIIAYCLLPIGVIAQETDTTKTKKLDEV
MVQAIRVNEKAPVSFSNFTKKELGKRNLGQDIPILMNYLPSVVTTSDAGNGFGYTGIRVR
GSDATRVNVTVNGIPYNDSESQGTYFVDMPDFASSLQSIQLQRGVGTSTNGSGAFGASLN
MLTDNYSEKANGEISNSFGSFNSRKHTVKFSTGLINGHFEIAGRLSDLRSSGYIDRAFSN
LKGYFLQGTYVGKTTLIKAMVFGGNEKTYQAYYGIDEATLKINRTENPIGAFTDQAGNHR
FYDNETDNYKQDHYQLHWNEKISEHWNTNLAFHFTNGLGYYENYKEDQKLVKYGISDIIL
GGVTIKKSDLIRQKWLDNDFYGTTFSANFKNQKLDFILGGSANKYEGKHYGKVIWTRFAS
NTELGDHYYDDFATKTDATVFAKATYKVVNKINLFVDLQYRNVGYKANFVPALVNENLNF
LNPKAGITYLLNNNNHIYFSYAKANREPNRTDYENGTPKAESLDDYELGWRFATQKTQIN
INGFYMQYKNQLVLTGALNAVGSPIRTNVGKSYRVGLEIDANIKIANKWAVRPNITISEN
KNKDFVNDNGTSLDKLGNTNLAYSPKIVAGNILSFVPIKNWEISLLSKFVGEQFLSNLED
KNSKLKDYYIQNFHLSYVIEPKKIVKAIEISFLANNIFDTQYISNGADYGGGYVVYFPQA
GANILAGLTLKF
>KACEBFPM_01809 UDP-2,3-diacylglucosamine hydrolase
MTISTSKKIYFASDQHLGAPTAEASFPREQKFVAWLDEIKQDAEAIFLLGDLFDFWFEYK
TVVPKGFVRVLGKLAEIRDSGIPIYFFVGNHDLWMDDYFEKELNIPVYHTTKEFTFNNKN
FLIGHGDGLGPGDKGYKRMKKVFVHPFSKWLYRWLHPDIGMKLAQYLSVKNKLISGSEDV
VFLGEDNEWLVQYAKYKLESKHYDFFVFGHRHLPMEIEVGKNSKYINLGDWIGYFTYGSF
DGSIFELKKY
>KACEBFPM_01810 Regulatory protein AsnC
MRTNQLQIEIDGIDKEILRFLMEDARKPILQIANNIGISGAAIHQRLRKLEEAGVISGSR
LIVNTKVLGYNTMAFVGVYLEKASSNPEAVKELKKIPEVLECHYTTGNWSILIKIICRDN
EHLMNLLNKKIQPIAGVSRTETFISLDQQIERQIQL
>KACEBFPM_01811 hypothetical protein
MRNVLIIGAGRSASSLIKYLLDKSETENLHLTIGDLSLELAQRKTKNHKNATAIALDIFE
ANQRQIEIQKADIVISMLPAHLHIEVAKDCVLYKKHMVTASYISDAMQELDAAAKENNLV
FMNEIGLDPGIDHMSAMKVIDEIRSKGGKIILFESFCGGLVAPESDNNLWNYKFTWAPRN
VVLAGQGGAAKFIQEGTYKYIPYHKLFRRTEFLEVEDYGRFEGYANRDSLKYRSIYGLDD
ALTLYRGTIRKVGYSKAWNMFVQLGMTDDSYIIDDSQTISYREFVNLFLPYHPTDSVEIK
LRLSLGIEQDDIMWDKLLELDLFNKNKIVGLKDATPAQILEKILTDSWTLQPQDKDMIVM
YHKFGYELNGNQHQIDSKMVCIGDDQTYTAMAKTVGLPVAMATLQILNKKITTPGVQLPI
NSEVYLPILKELEEFGIHFKETQMPYVGYNPDKIRN
>KACEBFPM_01812 hypothetical protein
MNKKIILTALVFGFVSIILGAFGAHALKKVLTLEQLSSFEVGVKYMMYHALFLLFVSMTT
FMEMKQKKVVFYLTLFGTILFSGSIFLLTSGTIIGLNFKFLGPITPIGGLLLIASWVITF
YYIGIKKE
>KACEBFPM_01813 Phosphoenolpyruvate carboxykinase (ATP)
METYKQSTNPISLEKYGITNASEIIHNPSFEFLYQEELNPALEGYERGQLTELGAVNVMT
GEFTGRSPKDKYIVKDAITENTIWWTSEKAVNDNKAISQDTWNALKQTTVSQLSGKRLFV
IDTFCGANENSRLKVRFIVEVAWQAHFVKNMFIRPTDAELETYGEPDFVVMNGSKTEFKD
FAAHGLNSEVYVAFNLTEKIQLIGGTWYGGEMKKGLFSMMNYYLPLQGMASMHCSANKGK
DGDVAVFFGLSGTGKTTLSTDPKRELIGDDEHGWDNDGVFNFEGGCYAKTIDLSQANEPD
IYKAIRKNALLENVTVDANGKIDFKDGSVTQNTRVSYPINHIDNIVRPVSKAGHATKVIF
LTADAFGVMPPVSKLTPEQTKYYFLSGFTAKLAGTERGVTQPEPTFSACFGKAFLSLHPT
QYGQELVKKMEEHKATAYMVNTGWNGTGKRISIKDTRAIIDAILDGSIEKSETTIVPIFN
FAVPTSLHDVNPDILDPRNTYPDASQWITKAEDLAGRFIKNFVQYTDNEEGKNLIQAGPQ
L
>KACEBFPM_01814 Ribonuclease P protein component
MKNTYPIAERLKSKTTIDLLFSGGKSISKYPLRLVYTPICLGEEEQIKMGVSVSKKYFKK
AVDRNYFKRVLRETYRLNKHLLLENTEKKYGFMFFYQTKDRLTYQEINEKTIQLFQKFVQ
YQENENKKELL
>KACEBFPM_01815 Biotin carboxylase
MFKKILIANRGEIALRIIRTCKEMGIKTVAVYSTADAESLHVKFADEAVCIGPPPSNLSY
LKMSNIIAAAEITNADAIHPGYGFLSENAKFSKICHEHNIKFIGASPEMIDRMGDKASAK
STMIEAGVPCVPGSVGILESYEQAEQLAAEFGYPVMLKATAGGGGKGMRAVWKQEDLLKA
WEGARQESAAAFGNDGMYLEKLIEEPRHIEIQIVGDSFGKACHLSERDCSVQRRHQKLTE
ETPSPFMTDELRDKMGLAAVKAAEYIKYEGAGTVEFLVDKHRNFYFMEMNTRIQVEHPIT
EQVIDYDLIREQIMVAAGIPISGKNYLPQLHAIECRINAEDPYNDFRPSPGKITVLHSPG
GHGVRLDTHVYAGYTIPPNYDSMIAKLITTAQTRQEAINKMKRALDEFVIEGIKTTIPFH
RQLMDDERYVAGDYTTAFMDTFVMKEQR
>KACEBFPM_01816 Biotin carboxyl carrier protein of acetyl-CoA carboxylase
MDLKEIQNLIKFVANSGVAEVKLETGDVKITIRTTLEGSTETTYVQQIPAQNMLQQAVAP
QQIVPVVPTTIAPAVDENARYITVKSPIIGTFYRKPSPDKPMFVEVGSTIGKGDVLCVIE
AMKLFNEIESEVSGKIVKILVDDSSPVEFDQPLFLVDPS
>KACEBFPM_01817 3-oxoacyl-[acyl-carrier-protein] synthase 3
MNTITAAITAVGAYVPEFVLSNKVLETMIDTNDEWITSRTGIKERRILKEKGTGTSYLAI
KAAQNLIEKSGINPAEIDMVIMATATPDMPVASTGVFVATQIGAVNAFAYDLQAACSSFL
YGMSTAAAYIQSGRYKKVLLIGADKMSSIIDYTDRATCIIFGDGAGAVLFEPNTEGLGLQ
DEYLRSDGIGRDYLKIDAGGSLLPSSKETIENKQHTVVQDGKTVFKYAVSGMADVSEKIM
QRNNLTHENVNWLIAHQANKRIIDATAQRMGVDESKVLINIERYGNTTSATLPLLLSDFE
NKFKKGDNLIFAAFGGGFTWGSIYLKWAYDKKD
>KACEBFPM_01818 50S ribosomal protein L32
MAHPKRKISKTRRDKRRTHYKATVAQIATCPITGEAHLYHRAYWHEGKMYYRGQVVIDKQ
TAVA
>KACEBFPM_01819 hypothetical protein
MHSLIKEQIVVKMKVTNEFLIPFIGLKLGKHQFEYQISKAFFSHFEFDEFESANIKVSIV
LEKKNTMLELNFNHSGTINVPCDLTSEEFDLPINGNLKLIVRFGEIFNDENEDLLILPIG
EHQVDVSQYIYEMVVLSIPLKKIHPGIQDGTLETEALSKLKEISVTEQAQDENVQEETEI
KAENTDPRWDKLKTLLTDK
>KACEBFPM_01820 4-hydroxythreonine-4-phosphate dehydrogenase 1
MTKRAENIIVGISIGDLNGIGSEVILKSFEDSRMLELCTPIIFANVKILSFLKKELRLEA
PLHGIDRLDQMVIGKINVLNVWREGVNINYGQLDNAVGKYAIKSFVAATNALKEGGIDVL
VTAPISKANIQTEDFKFPGHTDYLDQELEGDALMFMIQDNLRVGLLTDHVPLSEVAKHLT
EELIRKKIKTINKSLIQDFGIRKPKIAVLGLNPHSSDNGVIGNEEDKIIKPTLKKIFDEG
TLVFGPFSADGFFGNNQYENYDAVIATYHDQGLIPFKTLSFGKGVNYTAGLNKVRTSPDH
GTAFEIAGKGIANNNSFLEAIYTAIDIFKSRSEYQEMTIRPLKTKEKQL
>KACEBFPM_01821 Riboflavin synthase
MFTGIIETLGTIKALEKDGENIHIKVASNITNELKIDQSVAHNGVCLTVVNIDNDVYTVT
AIKETIDKTNLSHWNVNDVVNLERAMKLGDRLDGHIVQGHVDQTAICKGIEEANGSWYFT
FEYDKILNNITIEKGSITVNGVSLTVVNSKENEFSVAIIPYTYEHTNFCDFKIGTKINLE
FDVIGKYVARLHSLHVDK
>KACEBFPM_01822 hypothetical protein
MNLIKIFSEIKQQKLFGRYITNKHIEPILETFSNDFEVSTIGYSVNKKPIYAVEIGTGSR
KIFMWSQMHGNESTTTKALFDLFSFLKQDSEQANKIKKEFTLLCIPILNPDGAEVYTREN
ANKIDLNRDSVNLSQPESQLLREMFKCFKPDYCFNLHDQRTIFAVNNTRNPATVSFLAPA
YNEARAYNDTRGKAINVIVAMNDELQKHIPNQVGRFDDSFNINCIGDMFQSLNVPTILFE
AGHYQGDYEREETRKYIFVALLSGLQFIYNNNTKDDKTINYLNIPQNKVSFVDFIYRNFS
VNYKSLNIITTFAAQFKEILINDKIVFEAYFTEIEDEMTFFGHQEYDGKKGDYSDDSNNF
PEIGKKANFRLNKSIKFVNGLIKTQ
>KACEBFPM_01823 Regulatory protein AsnC
MSKFRLDEVDHQILDMLIDNTRIPFTDIAKKLLISAGTVHVRVKKLEDAGIIQGSSLTLD
YEKLGYSFIAYVGVFLNNTSQTKFVLERISEIPYVTVAHVTTGKFNIFCKIRARDTKHAK
DVIYMIDDIDGVYRTETMISLDESINDKKRLMHTIFKNM
>KACEBFPM_01824 hypothetical protein
MKNLLEKDYPAYYGTYINHVKNDDCVLAMEENLNDFVTFIENISIEKHNYKYQDNKWSIK
DIVRHIIDTERIFAYRALRFARFDSTPIAGFEENDYAANVNTTAIEMPDLLQEFILVRKS
TIKLFDSFTQEMLVAKGTASGKEISVLAIGFIISGHAIHHQNVIRERYL
>KACEBFPM_01825 Cytokinin riboside 5'-monophosphate phosphoribohydrolase
MKLKDFDHDEDKVIQDKLKQKTWNEIRTNDSWAIFKIMSEFVNGYESMARIGPCVSIFGS
ARTKPDDKYYILAENIAYKISKAGYGVITGGGPGIMEAGNKGAHRGEGTSVGLNIVLPFE
QHYNPYIDKDKNLNFDYFFVRKVMFVKYSQGFVVMPGGFGTLDELFEAITLIQTKKIGKF
PIILVGTTFWSGLMDWVQQVMIEREKTVSQDDMKLIQIVDTEDEVVDALDRFYKKYDLSP
NF
>KACEBFPM_01826 UvrABC system protein A
MFFTSTMLENDNTIEVIGARVHNLKNIDISIPREKLVVITGLSGSGKSSLAFDTIYAEGQ
RRYIETFSAYARQFLGGLERPDVDKIDGLSPVIAIEQKTTSKSPRSTVGTITEIYDFLRL
LFARAGEAYSYNTDEKMVSYSDEQIKDLIIKDFSGKRINILAPIIRARKGHYAELFQQIA
KQGFLKVRINGEVKDITTGMKLDRYKTHDIETVIDRIVVDTTDDVQKRISESINTAMHYG
ENVLMVLDQDSNQVRFFSRNLMCPTTGISYQNPEPNLFSFNSPKGACPNCNGLGTINEIN
IKKIIPNPKLSIKAGGFEPLGEYKSSWIFKQLEFIAEKFDFKLTDAIETISDEAMQMMLN
GGKEKFSVTSKTAGVTKEYKIEFEGISAFIKSQHDDSGSSTLKRWAAAFMDEVNCPTCQG
SRLKKESLYFKINEQNIAHLSNMDISDLTAWFHDLDNHLSDKQKRIATEVIKEIKDRLNF
LMNVGLEYLAISRSSKSLSGGEAQRIRLATQIGSQLVGVLYILDEPSIGLHQRDNEKLIH
SLEQLRDIGNSVIVVEHDKDMIERADYVIDIGPKAGKYGGEIISKGTPKEILKGNTITAQ
YLNGTMKFDIPKKRREGNGKFLKLTGATGNNLKNVSIDLPLGKLICITGVSGSGKSTLIN
ETLYPILNAFYFNGVKKPKPYKKIEGLEHIDKVIDIDQSPIGRTPRSNPATYTEVFTEIR
NLFTMTSESMIRGYKAGRFSFNVKGGRCETCEGSGVRTIEMSFLPDVYVECENCQGKRFN
RETLEIRFKGKSISDVLNMTIDEAVPFFEMIPKIHRKVKTLQDVGLGYITLGQQSTTLSG
GEAQRIKLAGELSKKDTGNTFYILDEPTTGLHFEDIRVLMDVINKLVDKGNTILIIEHNM
DVIKLADYIVDIGPEGGKAGGNVVAKGTPEEVAKNKKSYTARFLKKELL
>KACEBFPM_01827 Acyl carrier protein phosphodiesterase
MNYLAHLFLSGNNDLLKIGNFMADGIRGNDYLNFPEEVKNGIILHRHIDTFTDAHPMYRK
SKHRLHEKYGHYAGVIMDILYDHFLAKNWSHYCDEKLEDYAANFYKSLEDNYNILTEKTQ
HLLPYMTQRNWLVNYATIAGIEMILFQMDYRTKHRANMQEAVVELQEFYVEFEEEFTLFF
EELSAFCLEQIKNKTRK
>KACEBFPM_01828 Phosphomannomutase/phosphoglucomutase
MTLIKSISGIRGTIGGKVGDNLTPVDAVKFASAYGTFLKQSSNKDKLKVIIGRDARISGP
MIHNLVMNTLLGLGIDVIDLGLSTTPTVEIAVPLENADGGIILTASHNPKQWNALKLLNA
KGEFLSSDDGAKILEIADAEAFDFSDVDTLGEITVNDSYMDIHIDEVLNLPLVDVEAVAK
RKYKVVVDAVNSSGGIIIPNLLEQMGVEVVKLYCTPNGDFPHNPEPLKEHLGDICKLVLE
EKAHFGIVVDPDVDRLAFISNDGEMFGEEYTLVACADYVLSKTPGNTVSNMSSSRALRDI
TNKHNGSYQASAVGEVNVVELMKKTNAIIGGEGNGGIIYPELHYGRDSLVGVALFLTYLA
NQEKTVAQLRASYPQYYMSKNKIELTPQINVDAILTAMTEKYKNENITTIDGVKIDFAEN
WVHLRKSNTEPIIRIYTEAATQEEADKLALRIIDEIKVIAGI
>KACEBFPM_01829 hypothetical protein
MEIFLSIIVGFVLGYFTSYANEKGKNKAVIEDTQQITEEREKVTSKYNLDSTKRKIQYET
KSNSYMKYFNLLDELSQNGNLEAQEEFLPILAKFNSDYIPNAENVEKASKAAADFSNSMQ
KIMFKSQDKYLKFKNETNALKLIAGEDVLKLMNEIDEICQLSFNVSSQMMEDLAESIIEK
KLSKLDLQKNNLENLATKTIVLREELTKEIRKELSEI
>KACEBFPM_01830 hypothetical protein
MNRIILIGNGFDLAHGINTSYNHFISDYWENTIKEIHKCEINSIFENSEIHIDIIPRLWL
PGFGYDNLMDSLKNHKSKLRFKNRFLQIITSQKQEKNWVDIENEYYMLLKKSFKDAECDY
EISDLNSDFNEVQKLLEIYLKKVEEKFIEGFGRDINNVRIKSDIGHKIYSDFKFKDFTES
SINKKAELEFSKLQNDIKGLKDNQVEISELKEENRNLISRIGENNPIKEIRKLLISDSAP
NYFLLQPEEILFLNFNYTFTEKIYSNHNEFESYHSNRGLKKKYIHIHGTTDKYDRNDVIF
GFGDEIDEDYKSIENLNNNEYLENIKSIKYLETDNYKQLLEFLNSGDYQIFIFGHSCGIS
DRTLLSTLFEHKHCASIKPFYHKRDDVTDNYSDIIRNISRNFNSKSNMRDKVVNKEYCES
LK
>KACEBFPM_01831 hypothetical protein
MNKLFLISIFTLLLSPLYSQNISGKIVDSLNVPIKYANIGIKGQNIGTVSDENGNFNLSL
QTLKEDSKITISNISYKTKEYSIKDFISLINTKKQIILEENYQELEEVVITSKRLKKDNL
GNKTTSSIIEAGFKNNSLGSEVGIKIKIKNKPTNIDSFNFFITSCKYDSLFFRLNIYSIK
DEMPYENLLSENIYFSTDIKKGKVSIDLTKYNIVVNQDVIITIEYIKELGKGGLNFSGGL
FGNKLYHRQTSFSEWKKTGTVSLGFNVDVRY
>KACEBFPM_01832 Putative peptide zinc metalloprotease protein YydH
MEFKNYMLSVSPDISIFNSADKKYIIANERIGNNVLVGKQIIDIIDLIKSGNNSQIIDLL
KIKYSPFLSDEKLISIIDELINNEILIDANIENIPKKGFQKSHIKFKINILREDTINNFT
YLLSKLFNKSMFFCTFIFAFFNTVTLLYVIKNNSLSYANLRFNSEFLYFIPLLLFDAFFH
ELGHMSALKKFKLRHGNIGFGFYLFAPTLFADVNNSWRLDMKQKIIVNLGGVYFNLIFIN
ILFILFYFTQNSNLLILLILLIFRILFNLNPFLKTDGYWVLSDFTKVYNLRTKSKNILNE
MFFNIFKKAKINFTFKQYLLSVYALLSYLFILLYVIILFNSYTILYFPIFFFKQIIYLKN
LSISFLDISKMVVATVFYAIIINQIFIFIKALKNAIIKKN
>KACEBFPM_01833 Squalene--hopene cyclase
MDDLINFITKNSLPDNIKKFILSNKLVIEKNHKIYLNYSTFFCSETESKNNFDFIKLINI
SGFLYYLSITKQDEVFDEIRKVDEKYILNNLLISNLQDETIKILSNIFESSSVFWEYWDK
RKKEYFDALLSEKLINKSIPYSNYTNIAKNKSAFGKVAIDAMSVYFKKENSDEHKDLLSS
HDFFSIGIQIIDDIQDLVEDYNNKQFNCAYNKTILKLKRKKDLNPEKLDIQTIKKLFYLE
GVAVDLYKKALQNFTQAKAVISEYNYTNWIKIIQKKEFETRNYISKIEGFLLIESTRKQL
LNLKIITDVNVVIKNKTNKIKNTSIQKSLQYLISEHEKGYNELKHLMYLDKIDGFNNKTK
LHIGEVFQRAILTEIYCDVVENLELPEWKELINQQIDYIKNNKLKTRIGGWSYFPTCKEI
SADADDLGQIIQVFKRTSNEILIGKYCKNPIEILLKERSNQDGGIETWILPKNNLNSLEK
LQEHYNKTKWGEGPDNEVVANFIYGLLLLNEEKYQKKVDLSISFLLNTQNTKGFWTSRWY
YGNYYGTYVCLRLFSKLNIQNDSINKAIFFIENFQNIDGGWGLNDKSDPLNTALALLSLS
YYKNDSIIVKKAIAYLKKTQFEDGSWCAVDFIRPKTNEPYKSKTITTAYVLKALIRFEKN
GI
>KACEBFPM_01834 hypothetical protein
MNNVNQIEEQVEDFNVEALEEKLEMIVLWSW
>KACEBFPM_01835 hypothetical protein
MKNLTDEELEKLLLDTDSFYDCPTEEDKQRMRDSYRKVEAETNKQIEEAGSVTKWYESGI
GRVIDFG
>KACEBFPM_01836 Multidrug resistance protein NorM
MSIGIGFSTAITPIIAEADAAKDDKKIRSTFHHGLFLCTIIGVILFMLIVLSKPIMLLMH
QPKAVVDLAAPYIDWVAFSLIPVIIYQGYKQFADGLSKTKYSMYAIFFTNVVHVFFNYVL
IYGIWIFPKLGIIGAALGTVISRIIMVVFMHFMLRKNHEMKKYFKHFSFKEIRKSAIKKI
INLGFPSAMQMLFEVTLFTAAIWLSGSIGKNHQAANQIALTLATTTFMFAMGLNVTAMIR
VSNQKGLNDYKNLIIVAKSIFILAIILETIFALVFIVFHNFLPHLFLNMNDANQALDNIE
IIKITAQLLLVAAIFQISDGIQVVVLGALRGLQDVKIPMYITFIAYWVVGFPISFYLGLY
TNLKATGIWIGLLAGLTVAALFLYIRFHNLTKKLVRENHK
>KACEBFPM_01837 hypothetical protein
MTLFIIIGIVLLAVSFSIKNNLNNPFSKFSSILRTVGIVVIFLGIFSSMFKQIDAGKVGV
QSLYGSVKADVLESGLQLINPLMDVTIFDTQTQNYTMSAIHSEGAQEGDDAIRVLSNDGL
EVVIDLTVLYRISPTDAPRILKTIGADYSNKIVRPITRTRIRDNAVYYDAIALYSTKRNE
FQQRIFKSIEADFKSRGLILEQLLIRNINLPQSVKATIESKINAEQDAQKMTFVLQKEKQ
EAERKRVEAQGIADYQRIISTGLTDKQLQYEQIKAQKEIATSPNTKIIFMNGKNSPVILS
DK
>KACEBFPM_01838 hypothetical protein
MELPKFLLGDNTDFPDDIFIIHLDYPRFIINLKDDEVEFMEEAEDLDEGELNTEMEGLIE
QANAFYDREMERYEKE
>KACEBFPM_01839 putative GTPase
MKLKNKNKKSALTENQGIEKPEIISTVAVAQIQRFRRIQPSSEALVSGILSGNITALSRA
ITLVESTSFSHIDKANKVINTCLPYANKSVRIGITGVPGVGKSTFIEAFGKHLTGLGKKV
AVLAVDPSSTISHGSILGDKTRMEELVKDQNAYIRPSASGETLGGVARKTRETITLCEAA
GFDTIIIETVGVGQSETAVHSMVDFFLLLKISGAGDELQGIKRGIMEMADAIVINKADGD
NIRKANLAKTEFNRALHLFPAKKSGWIPTTSTCSAITHEGIPEVWKTICDFTALTKLNHY
FFEKRKEQNQYWMLETINEQLKTNFFNHPQIYKLLEENKKAVANDEISPFAAAQNLLETY
FKK
>KACEBFPM_01840 Fosmidomycin resistance protein
MATESVILENKSNLVQKTIFSILFSISFAHLLNDLIQAIIPSIYPILKQNYGLTFTQIGL
ITFSFQLTASIFQPFVGYYTDKYPKPFSQVYGMIFSSLGIISISYANNLPWIIVSVMLIG
LGSAIFHPESARISNMASGGKRGLAQSIFQVGGNLGTAIAPLLVAAIVVPNSQKYILWFL
VTSSLGLIIISKIAFWYQDNLKLKLHKKQLFIAQHDLPEQKVKIAIAILLFVIFTKFFYS
ASLSTYYQFFIIEKFNLTIKQAQYHMFLYLIAYALGTILGGPLGDKFGRKYIIWFSVFGA
TPFALLLPYANLFYTDILMIIIGIIISSAFPAIIVYAQELLPKKLGMVSGLFYGFAFGMG
ALGSALLGILADHTSITFVYQLCSYLPILGIICYFLPNINKKKV
>KACEBFPM_01841 putative FAD-linked oxidoreductase
MQITTQILQKLHKIVGETFVFTDQETCNHYGHDETEDYIFPPNVVVKPANAYQVSEILKV
ANQHKIPTTPIGARTGLSGGALSIYQGIGMSMERFNKILNIDEKNLQVTVEPAVITQVLR
EAVAEKGLFYPPDPSSQGSCWIGGNVAENAGGARAVKYGVTKDYVLNLEVVLATGEIIWT
GANTLKNSTGYNLTQLMVGSEGTLGIITKIVMKLLPKVTHSVLMLVPFYQANQACEAVSA
IFRAGIIPSALEFMERDAIDWTLKFNNTININIKDNIQAHLLIEVDGNYPEILLQEAEKI
MNVVEEFETDEILFADNEEQKNTLWKMRRSVAEAVKANSIYKEEDTVVPRYELPKLLSGI
KEIGAKYGFKSVCYGHAGDGNLHVNIIKGDMTNNNWNTQVTRGIREIFELTVSLKGTLSG
EHGIGLVQKNYMDIAFSKTHLELMERIKFVFDPNNILNPGKIFPDEF
>KACEBFPM_01842 hypothetical protein
MPNSHTYTTIFNKFKESINDGTFAKLTLAKTIGNTQLMNIYVRTIVVDDQLLLCLKFKFQ
QEEIIENHGIDEAIFILTPYMNNPFLSILLFTTQADVTLKLNKKRVATITEKEPTFKNAD
PTLLEFMAR
>KACEBFPM_01843 hypothetical protein
MAKSQDAKKTEKKEPLKTAKEKKEEKREKKNNPKRD
>KACEBFPM_01844 hypothetical protein
MAAIVAETGIVKIQAHNKLIVTPQRTALSRFVAPTPIIDPVIVCVVETGIPILETVNKVN
APAVSAQTPSSGVTFVIFVPIVFTIFQPPINVPRPIMR
>KACEBFPM_01845 hypothetical protein
MAPLSTVFATVFPTLMSNIQKASTLKKAAQTTACPGVKTLVETTVAIEFAAS
>KACEBFPM_01846 hypothetical protein
MALKDIFQFFVPKDKTFFPLFIKASNDLYALSENLHEAVNISKDEKENRIDYYKQVEILV
VSIEETTHKMNLELSKNFITPFDREDIHSLITSINEVANNIYSASNRMRLYNVGKINKSI
RKLTEINVESCNHINNAVAQLKDLKNLDKINNAVKNIYKLESKADVVFDKAVADLFENES
DAINIIKYKEVLSALHNATDKCRSVARTLEAISVKHA
>KACEBFPM_01847 hypothetical protein
MKYLKNFIVGFLISFVGSIPLGYLNFIGFEIYNKSNLIKLIYYLFGVVIIEGIVISSTFY
FANKLILNPKLKRSISIFSIIFLIFIAIYFYPSEYQSAKKHHNLATFLIYPPFIIGLIVS
SLNFSQIPFWLGWTIFLVNENYISSLKSLKYIYILGTLMGTFSGMLLFVLLLKKITNQGI
ISHNFISNNTSVH
>KACEBFPM_01848 hypothetical protein
MKLFLHRLTHWEYWPSKIVYFPINFLWAFYALQSKTIFFFNTSNPTIKNGGFFMESKKEI
YDLIPQKYYPKTAFIKEKTSFDGVLNAKKNSNITFPLIVKPDIGLRGSAVKKLNFFDELK
EYNSRANFDYLIQNLIPFPNEIGVFYVRFPNQEKGKITGIVAKEFLIVTGDGKLTIKELI
KQNTRFELQLATLEKEYKNKLDEVLNKDEKLNLVPFGNHSRGSKFIDASYLISDKLTNVI
HEMCLQIDGFYFGRMDIMYNSIAELEAGKNFQIVEINGAASEPTHIYDPKHSIFFAWKEL
ARHISYMHKISVENNKKGVPFLTHKQGMYQYKLHLAQNNKILNF
>KACEBFPM_01849 hypothetical protein
MCTVSFINSNGKYIFTSNRDENVAREKAIEPKICLINDKKIFFPKDQKSGGTWYAIDDKA
HIIILLNGAKEKHEIKDNYRKSRGLIVLDLMSSKSVILSWQEIDLNTIEPFTLVVFENQK
LYQLQWNELEKEMTELDTKKNHIWSSSTLYSFAIREQRKQWFYDFLETKKIISELDILHF
HKNTEDNNKENGLVINRNNLLKTLSITQTVIEKNKVSLTHYDIIENQEFTNSFIVI
>KACEBFPM_01850 hypothetical protein
MTFIIIRDTLEKLKDLINQLSNEDFVLPILYLGNSSIGEHSRHIIEMFQCLLNSYKSGLL
NYDDRQRNNLIQTDTNFAIQTIENIINSIERENKNIALNQMLYENQVSIQTNYFRELLYN
LEHCIHHQALIKVAVFQLENIKVTENFGIAPSTIEYKKQCAQ
>KACEBFPM_01851 Putative peroxiredoxin bcp
MKKLIYLVVSFFSLAISAQTDLPKLETEISPLLIGQKIPSSILQTIDGKAVKFEDFTKSK
KTILVVYRGGWCPYCNLHLSALAEAEEKLIEMGYQIIAVSPDSPESLRETITKDKLNYTL
LSDNKGSFIKALRIAYAIPEGLKNKLKTVLHGVKNDFLPVPSLFIISDKNEIEFEYISPD
YKTRISNELLLAVATALKK
>KACEBFPM_01852 CRP-like cAMP-activated global transcriptional regulator
MYNELKYWYLRDHKLFKTLSLAQTKQLCIISGFKKANKGEIIYFSDSDLPRIFLLKTGSI
KIVALDEDGNETIKDIIQKGDLFGELSLDNDIQVNEYAKVLTPEVSICSFLQSDFEDLIL
RNPQLALGYTKFVGLKMKRLRNNYTNLISKDAKTRLITFLKEWAQKEGVFNNNKVTIENY
LTQNDIAQIICTSRQTATTLLNEFVDNGIIEYNRKEITILDFKKI
>KACEBFPM_01853 hypothetical protein
MKTTKLKFITFFLFISVSYTNSFAQGCSDAGFCSLGKGFNPHEANIKNSVDLGVVYGIAE
EGVTVFSQYLTYTRELTDQFAISTKLTSAIANGDFGTRGNIGDLFLTGNYKFKNKFSNLE
GSKTWSLLFGFKIPLTNSNDKINTVSLPMAYQASLGTFDFIGGVNLTYKKWDFNTAVQIP
LSDNKNSYISNPLITDKFATTNLFERKSDVLFRTTYKVKTTNEKFTFKPNLLFIYHLGED
NFTNIFGQRETIVGSDGLTINSNLIVSYKLNKKSYLETSIASPFVVRKKRPDGLTRVLTL
GLSYKVNF
>KACEBFPM_01854 hypothetical protein
MNDDKKRLCNVFRNVKMMRNVFVLLLGIFLFTSCEKEGKLILKSLKNDIIGSGAVLKYSG
VFSPTSGITTSGFAKIYLDNNEYKVKLENFSVSDGPDLKVYLSKENTPINFVNLGNLKGN
KNKFYTVPTGTNVSNINMY
>KACEBFPM_01855 Dihydrolipoyl dehydrogenase
MSILRIPFLQIKNKTKKMKYDIIVLGSGPGGYVTAIRASQLGFKVAVVEKENLGGVCLNW
GCIPTKALLKSAQVFDYLKHASDYGLTVKEFDKDFSAVVSRSRNVAGDMSKGVQFLMKKN
KIDVIDGFGKLKPGKKIDVTDKDNKVTEYSADHIIIATGARSRELPNLPQDGVKVIGYRQ
AMTLPTQPKSMIIVGSGAIGVEFAHFYNAMGTEVTIVEFMPNIVPVEDEDISKQMERSMK
KAGVKIMTSSSVERIDTSGSGVKAYVKTAKGEEILEADILLSAVGIKTNIENIGLEEVGI
STDKDKILVNAFSQTNIPGYYAIGDVTPGQALAHVASAEGINCVEKIAGLHVDPIDYGNV
PGCTYATPEIASVGLTEKQAKEKGYELKIGKFPFSASGKAKASGTPDGFVKVIFDAKYGE
WLGCHMIGAGVTDMIAEAVVARKLETTGHEILKAIHPHPTMSEAVMEAVADAYGEVIHL
>KACEBFPM_01856 hypothetical protein
MVWVFQAIFVFAFNLNEFIASIVAKSYEQLAYLRFSSMRFIL
>KACEBFPM_01857 Chaperone SurA
MAINNFKMNIISSKLSFIIALLAISLGVSAQEKKQKVDGVIAVVGNYVILDSDIDKTTLE
LKQQGVNVKDVTRCQLLGKLLEDKLYAHHAIQDSIVIEDKEVNSKLDEQVSYMVEQLGSM
DKVIQYFKKSNEQDFRTELFDIIKINKLTAEMQKKVVDAVIITPEEVRNFFKAIPKADLP
VFGAEMEVAQIVVKPTVSQEAKQKVIDQLKAIKKEVQEGSSFFGKAVLYSEDKGSSSNGG
YYKMDRRTQFVKEFKDVAFGLKEGEISEPFLTDFGYHIIYLEKIRGQEVDLRHIVISPKV
SDEALKVSKEKIELIRKRILDKEITFSDAARTMSDEKETRNDGGVLTNPKTQDTRFELTK
MDPALYSQVSNLKDNQISNPIIDEDRTGGKFYKIVTVTNRYDEHTADYSKDYIRLKELAL
KEKQIKAIAKWSEEKIKETHIKINSEYRDCVFTNNWLKK
>KACEBFPM_01858 Chaperone SurA
MKINKIIACFALAINSLAFAQSDKKEVLFTIDDKPYYTDEFSRVYNKNIDLVKDESQKDL
NKYMELFVGYKLKINKANKIGLQNNEKYINELKSYRSQLSKNYTSDTKVTKALIEEGYNR
SLKEIRASHILITVDENAVPADTLKAYNQAIDIRKKALVGEKFEDLAVTFSQDPSSKENK
GDLGYFSAFRMIYPFETVAYNTKKGQISMPVRTKFGYHLIYITDSRENRGEITVAHIMIL
KSPKAESEITTTEKAKATIQDIYTKLKQGENFESLASQFSQDKNSAPKGGLLPRFASGQL
SSEEFENAAFALTKPNEYSAPFESQFGWHIVKLVEKQPIKKLSEMEKELDEKIRKDDRSR
LITNSLTNKLRKKYTIVRNEKLYAQIKTLVTDKIYVSQWKLPANLKDYDSNLFKIENKSI
TGTQFLSILEAQQKSDLKIKPVGKLVDFVYQNFVDAQMTDYYNDNLEKEFPDFANVIEEY
RDGLLLFDLMEKEIWEKAKQDTLALKKYYNANKLQYQWKNRAEVLVASSTKEGVAKEARK
LLNKDQTDDFIKTTLNTKEVVNVMIKKENYEEGAENFPKKVEFKTGVSEIYKDGEFYFVN
KVSKIIPASVKTFDEAHGRVVNDYQQYLEDNWVSNLKKEFKVNINQEVFERMKASMKK
>KACEBFPM_01859 Lysine--tRNA ligase
MQLSEQEIIRREKLNALRQLGINPYPADLFPVNHTSKQVKESFEEGKKVTLAGRLMSVRD
QGKASFAELQDSQGRVQLYFNRDVICEGDDKTLYNQVFKKLTDLGDFIGVEGELFTTQVG
AKCIRVSNFTFLSKTLRPLPLPKTDEEGNIHDAFNDPELRYRMRYVDLVVNPQVKEVFVK
RTKLFTAMRNFFNESGYMEVETPVLQSIAGGAAARPFITHHNSLDMPLYMRIANELYLKR
LIVGGFDGVYEFSKNFRNEGMDRTHNPEFTAMEIYVAYKDYNWMMTFAENLLDHCATAVN
GSSEVTFGEHKISFKAPYARVTMTQAIIDFTGFDISGKSEAELFAAARNMGIEVNETMGK
GKLIDEIFGAKCEGNYIQPTFITDYPKEMSPLCKSHRDNPDLTERFELMVCGKEIANAYS
ELNDPIDQRERFEHQLKLSEKGDDEANGVIDEDFLRALEYGMPPTSGMGIGMDRLIMFLT
NNASIQEVLFFPQMRPEKKQLELTDDEKHIVEVLKANEGISISDLKEKAALSGKKWDAAS
KGISKHGLMKIVVDGDRKIAVLN
>KACEBFPM_01860 hypothetical protein
MKKSLLIFVLFLSFSLSANAQTEKKITTKELSIEGKAKQNLESITTVMSINDPAMSEALS
QLFYKKHKWLSKKNITVAEKQNIANEIDAKLRATLDYELIQKLIAKDIYKDLIN
>KACEBFPM_01861 hypothetical protein
MKITTEEINRIIKEDLIELLKYRIIYKYSSFDVAVNNILTEQTLKFVNPSTFNDPFDCNE
HTIKIDIDDEFIPNKNII
>KACEBFPM_01862 Leucyl/phenylalanyl-tRNA--protein transferase
MHFLTQELSFPNTNESTRDGLLAIGGDLSTQRLLLAYENGIFPWFEEGEPIMWWSPRQRM
VLFFDALVVSHSMRNVINKNIFKVTFNKAFREVIQNCQSVKREGQHGTWITNEMIESYCK
LHELGKAISVEIWQNDTLVGGLYGVDMFPVFCGESMFSKVSNASKMAFISLADYLKTNHY
NLLDCQIYNDHLNSLGCREIPRDEFLKFLKKNS
>KACEBFPM_01863 hypothetical protein
MEVTGKIKVVGAEQQISASFKKRELVVTTDEQYPQSIMIEFVQDKADLLNSYNVGEDVKV
SINLGGREWVNPQGETKYFNSIKGWRIERLATAQAPSPQSPPMPTAETFEPAVSFKEEEH
DDLPF
>KACEBFPM_01864 hypothetical protein
MILDNYFYSIAFLIFVENKIIMLSLSPKDITTAQLQGYLQGAVSPRPIAFASTIDADGNP
NLSPFSFFNVFSANPPILIFSPARRVRDNTTKHTLENAKTTREVVINVVNYDIVQQTSLS
STEYAEGINEFLKAGLTPIASDVVKPFRVAESPVQFECKVNEIIELGQEGGAGNLIICEV
VRIHINENILDKNGAIDQYKIDLVSRLGGNWYSRSNKGLFEVPKPLVTLGIGVDNIPNFI
KESTVFDGNDLGMLGNIEALPSEEEITIFVHENFAVKGVLSSDDEQKIQLKAKEYLNNQD
VLSAWKVLLAKR
>KACEBFPM_01865 Sensor protein ZraS
MQFSNNKNTTRWFLIISSFLITVLILWNTYTFFQIFKNEERLKIELWAEAQKSINDASSD
TDLDLPFQIISNNNTIPILLTNEKDSILQSINIDERIIKDSIKAKALLLNFKNANKRVEM
EYVKGKFHYLYYTNSPLLNKLKYYPIALLLIIFLFGALVYNYYKTNKISGQNKLWAGMAK
ETAHQIGTPLSSLIGWVEIMKSDNVDETMVEEIEKDIHRLLNITDRFSKIGSEPVLEQTD
LVEETQKSYEYLQSRFSKQVIFTFKAPEHKIPISINPILHSWTIENLVKNAIDAMKGRGS
IAIIIEDDWKTTKIKITDSGKGIPKNQFKTIFEPGFTTKKRGWGLGLSLTKRIVEEYHNG
RIKVLQSELNKGTTIEISFKR
>KACEBFPM_01866 L-2-hydroxyglutarate oxidase LhgO
MNLSYWELKNWFTNVDYTIVGSGIVGLHTALRLREKFPESKILILEKGMLPEGASTKNAG
FACFGSLSEIIDDLKSHTEEEVIQLVQKRWQGLQLLRKNLGDEALDFKPFGGYELFLKND
ESTYYECLQKLPFINNILKPIFKAEVFEKNIDRFGFNNIQEYTIFNPFEAQIDTGNMMQA
LLKKAQSNGILILNNQTVSTFHDNQKDVQVQANDFTFNTKKLLFATNGFAEKLTKNQVKP
ARAQVLITAPIPNLDIKGTFHLDKGYYYFRNINDRILFGGGRNLNFDDENTSQFGETEII
QNKLEEMLKTVILPNTNFKIAHRWSGIMGLGNSKRPIVEALSENVYCGVRLGGMGVAIGS
LVGQELADLI
>KACEBFPM_01867 Biosynthetic peptidoglycan transglycosylase
MATKKVVKPKLKPTPKKGNTSFGSKIKSFIFKCILWFVGLSVFWVIIFRFVPIFYTPLMI
FRAFEHHEAGKEMVCSHQWVPLEDISLNLPKAVIASEDGLFLKHNGFDFSAMSKAFSGNL
KGKKLKGGSTISQQTAKNVFLWQGRSYLRKGLEAYFTVLIELIWGKERIMEVYLNSIEMG
DGVYGAEAASKHWFHKSAKNLTKYEAASIASILPNPRKYKATNSSAYVEKRKNKTLRVMK
SVGKIEY
>KACEBFPM_01868 hypothetical protein
MENTINKFDRTGIILYVTKYEECVDFYKNILGLKILFDTKVLTCFEFGDAYLMVELDDEK
PNDNELQRIKTCLRMNVSNVKYFAEKLSNHNIPVNYQEHSWGTIVKFFDPDGNLCAFKDT
EKFEIQVNEFTK
>KACEBFPM_01869 putative CtpA-like serine protease
MISLFKKKYIFPVIASAFLFIGASFREDFFEIAKQIEIFTTLFKNLNMNYVDQTNPGELM
DKAIKSMLAQLDPYTNYFTEQDVVKAKINNTGEYTGIGAILSRKEGKLIVREPYKNYPAD
KAGLKAGDEIIQIGDVNLIDFKDDATQLLKGGKNTKIDLKYKRNGETKTTQLILEEVEIK
AVPFFGKIDDKTGYIVLEKFNAKASSETKEALEKLKEQGATQIILDLRGNPGGLLSEAVN
VCNLFVANNETIVTTKSHIAKHNNTYKTAKNPTDLDIPLVILVDGHSASASEIVSGALQD
LDRAVIIGSRSFGKGLVQRYVDLTYGTQLKVTISRYYTPSGRCIQALDYTKKDANGKAIR
TEAKNYNAFKTRKGRPVFDGGGVLPDIELEEAKTNTIIDVLTRNDAIFNFATQYCTKNLN
LGTKIPVLTDADFIEFKKFLKSQSFSFDTKTDIALKEMLEEAKKEKIDTAIKLQYDALLA
SLQKAEDLEVDKNKPEILNLLRDEIITRNQYKEGLYLFYTKNNSEIKKATQLLNNTAAYN
KILKK
>KACEBFPM_01870 hypothetical protein
MQKDNLYGVINPYIVNDIIPLRYKNIITLFDKYYIVQNAEDKSGLLLENGVMVLKEEYKF
YNNYENKIFATKKTNKS
>KACEBFPM_01871 hypothetical protein
MINLEDEKFSEKEVFLDAFVKFKYEQEFLKNANQIFKLKGKFGVINYKNIIVIPFKYQLI
ENIYDSNEFIVKKNNKYGVVNSENKIIENIDYDQFNILKESILFTKTNKRIKKHYGISYK
>KACEBFPM_01872 Polyphosphate kinase
MAGETAEKILGGITSQKLLKEITKIVIHQQSESLRILSNIEKELENKNVYIINETEISKA
QESFVKDFFIQKVSPALVTIILNDLAEFPLLKDTSGYLAIKLVMKPKQNSSILEKIKIKK
EIRYAVIEIPKTINRFVVLPSQNEKQHIILLDDLIRYNLHNIFNIFDYESISAHMIKITR
DAQLELDSDLNKSFIEKISSSVKDRRIGEPVRFIYDQTIEKDTLKFFLRNMEINSKESII
PGGRYHNRRDYMDFPNLGRYDLLYKTNLPLPVEGLSLEGSMLKKIEQKDYLVNAPYQSFS
YIIKFLREAALDPKVSAIKITLYRLAKNSQIVSSLINAAKNGKKVTVQIELQARFDEASN
ISYAEQMQTEGIELIFGVKGLKVHSKVCLVERISDDGKLKRYGIISTGNFNESTAKVYTD
VTLFTAHQQILKDVSKVFEFFLINYRVYRYKHLIVSPHYTRIRFNRLIDREILNANSGKP
AFLKLKMNSLSDNKMIDKLYEASRAGVKIRLIIRGICSLIPGVKGMSENIEAISIVDNYL
EHSRVYIFCNNNEPEVYISSADFMTRNLDSRVEITCPIYDQSIKKELIDTFDIGWKGNVK
VRYHSEKLDNKYRMRGDSPIFRAQLETYNYYRNKIEVVI
>KACEBFPM_01873 Exopolyphosphatase
MISIKKYAAIDIGSNAMRLLITNIVEQQGKETQFNKSALIRVPIRLGQDAFTVGEITEEN
IDRMVDAMKAFKLLMKVYKVEQYMACATSAMREAYNGKEVVEIIKKKAEVKIEIIDGKKE
AAIIATSDLHQFIKTEQTYLYVDVGGGSTEFSLFSDGKMVVSKSFKNGTVRLLNNMVNDI
VWEEIEKWIKTNTERYDDITLIGSGGNINKIFKLSGKLQEKPLSYMYLNTQYQYLNSLTY
EQRIAEMGLNTDRADVIIPALSIYLKAMKWSGANKIYVPKIGLSDGIVKAMYYGKV
>KACEBFPM_01874 hypothetical protein
MEKFKKTIIAIGILCLIFGIIFDTFFAGIPSQDSSQEMLVTYDKNALLSIFLMISGIFII
LFGLILKKEK
>KACEBFPM_01875 hypothetical protein
MVNSVNILTPKSEIANQQSTILGPKVSALSMKSIQAKRALEAQLKPKEKHHDELPTEPFT
ETQMLEQWVKYANRLGNKGYKILESLLLLDDPKLAGTTIIHELPNESSKIDFDGEKHDLL
GYLRGKLHNHNITIEIKINETIETKKAFTIQEKYDRLKEINPALELLRKAFDLDL
>KACEBFPM_01876 DNA polymerase III subunit tau
MGQQAITNTLLNAIETNHLASALLFTGPRGVGKTTCARILARKINQPGYDDPNEDFAFNV
FELDAASNNSVDDIRNLIDQVRIPPQTGQYKVYIIDEVHMLSSAAFNAFLKTLEEPPKHA
IFILATTEKHKIIPTILSRCQIFDFKRITVKDAKEHLAEVATNQGVIFEDDALHIIAQKA
DGAMRDALSIFDRVVSFCGKNLTRQAVTENLNVLDYETYINVTNLILENKIPELLLAYND
ILAKGFDGHHFVAGLASHFRDLLVSKTPATITLLEVGEQAQKMYYVQSQKASQDFLLQGI
DLANDCDLKFKLSQNQRLLVELCLMQLASITFDGEKKKLNNI
>KACEBFPM_01877 hypothetical protein
MIQRVQSIYLLLAFIVTGALPFVFHLWKLENNQTIYFMSNLKYTALFGLSTALSLVSIFT
FKKRQQQFVMNRLNIILNLILLGLFVYRTLTVSGETTVSEKGIGMFLPIVAIFLLVLANK
AIKKDEDLVKSVDRLR
>KACEBFPM_01878 Transcription termination factor Rho
MFDISVLKEMKLPELQEIAKVAKIAKFKTLKKDELVYQILDYQAANPEKIAPIATETISV
IDEKPKRARVVEAKEAKPIVSKKVIAKPPVQQEVITFEEPKAQTTPELEKPVVEAIQKQR
APKVIRFTKDENNVTKVDNSHRNKKIVKPVIVPANTEEGVSEILENPETVQKEKSSNPNQ
NQKKPQERKRADEVNQNPNAKNKNNFREPDYEFEGIIESEGVLEMMPDGYGFLRSSDYNY
LASPDDIYLSTSQVRLFGLKTGDTVKGVVRPPKEGEKYFPLVRVLKINGHDPQVVRDRVS
FEHLTPIFPTEKFRLAEKGSSISTRIIDLFSPIGKGQRGMIVAQPKTGKTMLLKEIANAI
AANHPEVYLIVLLIDERPEEVTDMQRSVRGEVVASTFDREPQEHVKIANIVLEKAKRLVE
CGHDVVILLDSITRLARAYNTVQPASGKVLSGGVDANALQKPKRFFGAARNVENGGSLSI
IATALTETGSKMDEVIFEEFKGTGNMELQLDRKIANRRIFPAIDLTSSSTRRDDLLLDEK
TIQRMWIMRKYLADMNPVEAMEFINDRFKKTRNNEEFLISMND
>KACEBFPM_01879 Blue-light-activated protein
MLEQYDKAFAKYRKSLKTIPLPIICWDFHSIKNLELLDFDAIQKNWNEKISFLKIVNNDK
KDIIVTDENFKIIFVTKNIVAITGYNSDEIIGKSPKMFQGVLTSESIKNNIRKAIINKKP
FKEVIINYKKDGSTYLCEIEAIPKFNKKGEFLNYIAFERIAS
>KACEBFPM_01880 hypothetical protein
MLDYTIFILEKVSFNLNLFSKELQKALKILIPADIMQLQDWFYYFTKDKKELLIFESYFL
KFKIEANSFSKL
>KACEBFPM_01881 hypothetical protein
MKNHFFKVAVLALTIFVSSCSKDEPATAVLTPQPQITTLEVKTVSNLNAPQVGMSFGPVS
GEFTKFSFSENAVVTNDNWDVAFRGTTILVNGGAAIGIAGEPSRTGMGAVSIANNTLSGV
TAFPAADTFRQDGNSSYAIPIGSGNGWYNYNGATNIVTPLAGKVFVVKTHNGKYAKFEIL
SYYKDTPANPDAATSVGRHYTFKFVYQANSTTSF
>KACEBFPM_01882 hypothetical protein
MSKTIARTRIFGVVNLFLRLFLGGMLLLGGVSKFDKPMPLATSQIEQVKKGTLTTENVEV
LKMENYLFGMKQTNYFWQFLGAVDILFGLLIVSQVFGLLGEIMALPITINIFLFHLFLER
NEIAELVEVSLILAVNIWLIAYEYNRWKGIVFKKQIFN
>KACEBFPM_01883 Colicin I receptor
MVINKAFGLHLLLLSFVGFSQEKQLSDSVKVATLNDVVITATRTERQLSSLPLPISIITS
ADISKAGISRLNEILTEQTGLITVPDFGGAEGIQVQGLDAAYTLILIDGVPLVGRSAGTL
DLSRISVGNIDRIEIVKGASSSLYGSEALAGVINIITKKPKSDHFSGNLSYRYASFNTHD
ATANFVWKKKKFSGSFFTNYFDTNGYDLDKKNSLQTVEPYYNTTIQPKLYYDFSDKLKLI
VGTRFYHQKQDNKTIINNKNYQGDAVINEWNSQIKLEHNWNSKINSEYEIYLTNYKTDAF
LNNSKNILFEESFYDQWLIRPEIRTTFSINNNKLTAGIGINHETLDRTYFGINANFNSQY
GFLQYDYNPSKKWNILAGFRYDNHNQYKSQLSPKIAINYKVTDHLSLKTAVGYGFKAPDF
RQLYFDFTNSSVGYTVLGYNVADTRLNALDNQGQILKRIKDISFDNPLKPESSLNFNLGI
FYQRSKLKIEVNAFYNAISNLIDTRAIAIKYTGQNVFSYYNVGKIFTYGTEFNSAYSFSN
NLKISLGYQYLIAKDKSVIDDFETHQYIRDSQTLETIKINKVAYFGLFNRSKHTANVKFL
YMIPKIKTDINLRVFYRSKYGLFDTNNNQILDVYDDFVKGYFITNVSISKQIKEKFSFQV
GANNLLDYTNPKEISNLSGRQIFGKLQFNF
>KACEBFPM_01884 hypothetical protein
MKIKTILFSTSIILIGFSAKSQDSKKQEDIKAIKSMCGCYEVKFNFSETFNYSKDSINYK
PSKTKHDSGLEWVELLEDQPNKIALQHLLIVGEKEDDIVKHWRQDWEFENTNFYEFYKDL
TWKFKTLSKKEVKGQWTQKVYQVDDSPRYEGTATWIHADNRHFWQNITDAPLPRREHTIR
NDYNVLKRNNTHEITNFGWIHNQDNDKIVRANNQKDFLLAQEKGYDVYTKVDDSKCIIAQ
NYWKKNNGLWKKLRDKWELVFAKNKDLSLEKAVDNQPLFVKLFSLKPDTPREEVNKIIDS
YIIK
>KACEBFPM_01885 hypothetical protein
MCKFLNTSLNGNLIQCTSSENFQLSYKNLTFSLTPFELESFKIYLSKIDVSYWEKEYENS
IYEKKIPIPTLQTNLMLLIDRFELYELIDLLNLKQRNVYLSVEDIKYTMILN
>KACEBFPM_01886 Arginine--tRNA ligase
MSLQEILNPSIKTAIHQLFDLTIEKIEFQSTRKEFDGDITMVIFPLLKLIKTPQATPNGA
KLNPADLGNKIGNYLVENVAQVEAFNVVSGFLNIVIANDYYINFFNTIKTDAQFGFVSPS
EHDKAIMVEYSSPNTNKPLHLGHVRNNLLGYSVAEIIKASGKKVYKTQIINDRGIHICKS
MLAWQKFGHSETPETSGLKGDKLVGKYYVAFDKAYKVEIAELMLQGKTEEEAKKQAPIII
EAQQMLLDWEAGKPAVIALWKTMNQWVYDGFATTYKNLGVNFDSYYYESNTYLLGKEVVQ
IGLDKGVFEKDPDGSVWIDLTQDGLDRKIVLRSDGTAVYMTQDIGTAIQRVKDFSDVGGM
VYTVGNEQDYHFRVLFLILKKLGFDWASSLYHLSYGMVELPSGKMKSREGTVVDADDLME
EMTSTAQKLSEDLGKLESYSEEEKAILYKTIGLGALKYYILKVDPKKSMMFNPEESVDFA
GNTGPFIQYTYARIQSILRKANFDITVTISTKLHPKEKELIKQIEMYPEVIQHAAANHSP
ALIANYIYDLVKEYNSFYQTVSILGEEDNDKKVFRVQLSKKVADTIKTAFTLLGIDVPER
M
>KACEBFPM_01887 hypothetical protein
MGERGLKSNSKTVAFLETIVIPANARAISRSESPAQASVPSLKTVLFGPGAFITFPVVRI
TPFCKGKAGFVFVK
>KACEBFPM_01888 hypothetical protein
MRKEKSEADAKALADETTERLRKEADAKAKIDEAKTTEDKELDNLSQVLEDSKKNQKQSL
SRLDSITKAKDNELKELRRVNDLSDKGIVSEAKDFQNTSAANRALESLKSEIAESSKNQN
NFIKEFETLTNERLKKVPNRNDIVNQSNLKSLEKLKLDKLNSDKQNADLLTKLETIKAET
VIEKSRRIKRAQFDSDDAKYQKDRETLKEIKTSTAPTGQTYKPTDFDFGEEQAGTQIIKN
NDNIPEGYYIVIAIHKDVAKRDAFVKKAIQAGQKDIDFFYNASNGNYYIYYDRQNQIQEA
TTAMESKGSKPYNGKMVIVKVEK
>KACEBFPM_01889 hypothetical protein
MVTLYSPAAVASKFDPITGLIQCVASQLVLVFAQLGFTTAVQDPPKLNFSQVIEVAPEIV
V
>KACEBFPM_01890 hypothetical protein
MFTLTVVVAVPLQAKTGGATAIVGGVAGGSNVMLIEKTQLLESLIHIV
>KACEBFPM_01891 hypothetical protein
MGLGKSIFEGTLLGKVLGFTTRIINPDRLLDKITGKERLFTNSIFDDRTRQIIAKNKTPL
GILVDNELNYTDKIFVPFFGTEDAFLVDYIQKFVYNNNSKIKIIDINNQIENNFLIKNAI
QTLEKTYPDNIALVNENQILKSFLIKQDLMVISLDSWKKLVDSQSVWLSNLPSVLIIKP
>KACEBFPM_01892 hypothetical protein
MTSKKRLFFICFFLFFLANVKTIAQKNISLVDTIIKKTILFRTRNNPKNYEFIAYNKLII
TANPNLIEGRIDSVFTTKHKKKMFSRIDSSDYIFKKIITKQHLYQTEKISKFQVKNNHQK
EIILATKMAGFKEPIYEYFALQLQPFSVYDDEYSLVEKEYISPISNNGIKKYDYTFLETI
FLEGRKIYKISFVPQKKSNVYQLEGVLFIDAKKFSLAKMQLKVSGLVQIKSNYDFQYDKQ
LDNWFPAKSNLSIKKGNSKVPIKILGETITFEGNDAKLYPKTKKYASDFLEIKSNTTYFE
PKFNETPKIKQPDIAISISETAISKKEPLWYNYFNDSTDVRSSATYFSLDSLIQKRKYEN
KIKIGRKVLKGYYPIGFFDIDLRYVFRYNNYEGFRLGMGGITNEKLAKNYKLEGYYVYGT
KDGFFKGYVANSFRVDNYSETWLGFSYKDDLSEIASTSFDIDKRTFKIYDPRPFNISTFY
NHVTWRGFVETKIIPKTESIWQITQSSIVPKFDYLYNLNDNLYKNFKTTLVTISLQWNPF
SKYMQTPTKTIEINKNYPKFTLQFSKTIPKLWSNDFDFGKVDFRFDYQKKFNSNHKLMFF
LESGYAFGDIPITNIYNHSPNNLSKDKVIQRITFAGKDSFETMYYNEFFSNKYAFFQIEH
QFPKFEISKKIKPVFSLVTKYGIGSLANADRHLNLTIKTLERGYVESGFELNQIYQGLGF
VVFYRYGANQLPNFEDNIAIKLSVKIDLGF
>KACEBFPM_01893 hypothetical protein
MSKKRKATQNNKSFKTIIILLACTMLVGLFYTYKITSRSKREIITLREDKENMLKDLEKS
QLFLNQIMTSNKMLSSKLVAEQDKIKQLILDLNSKNITEKNIADYKKTANNVDARIKSLL
NEIDRYKKKIDSTNIVLAKTNIDLTKTSASLIKEKNKNDTLTVSNVKLANKISDASKLYF
FDLKTNFFKLKSSGKLIETDNANKINLIKFSFMIAENNLAKPTTKDFYIQIIDSKNNVLG
SKNVEKFGNETLNYSTLLKVKYQNKNTKVEGEIPVTNLQGGILFINVFDKSKLILNSAVT
LS
>KACEBFPM_01894 hypothetical protein
MKSYFNAYFDNFKGFSKEVWVLTLITYINRAGAMVMLFLTKYLHDNLFFNLTQIGWMLVC
IGVGALFGNWIGGKLTDILGFYTIMLASLFLTGFGIISLMFLCDFVEICIGLFLVTAIAD
MYKPAMYVAVSNFTNRKNRTRALTLVRLAVNLGIVSGPIIAGLVIQKDDYDMLFWIDGLT
CIIAISVFMLLIDENNITRARQKITRDREKEKVVNKKIKTDTNYIIFLLASFLTAFLFFQ
LFTTMPLYNSDKLKLNEFEIGMLLALNGLIIFLFEMPLIGFLERKKTQITKIILQGSVFM
TSGFLFLLISKSVFVIIISIFLITLGQILLFSFSNSFAFTRAVQGQEGKYMAFYAMSFSA
AQILSPKIGFSVIENFNYFYNWLLMGGIGVIGIMLYYKLDKNITFETLEKRMK
>KACEBFPM_01895 Guanosine-5'-triphosphate,3'-diphosphate pyrophosphatase
MNIRKTLLNIVIFSFFFQNLSFSQETPENLFAGIEIGSKGIKMSVLDVKNIRRGDFEIKS
YWSENIGIAKGIAIDGNLAKEDIDKAAATVLSNYIKIKNDFKVTDENIFIVGSSGVAMAN
NTQELIDKVKLSINKNLDFIDAQTEGKMLLKGCVPPSDYKDSIILDIGGGNTKGGYIDVR
NNDTFVFFPLSVNYGTITLTEAVIKKTRKDDISEYNDKSFGFLPTLRDQVNAMYNASPVA
LEKDKIFMSGGAVWAFYTLYNGVAKENFNKFNLEDVLNYDAVLKNNFRKFEELAKTDKDV
EKVLKTYSQKHLISGSNILLVCLEAIPKVNSKKLYFAKEGQIAWLVSYIADRSKKIKKIY
>KACEBFPM_01896 Ribosome-recycling factor
MTEEIDFILDSTKESMEGSIAHLEKEFLNIRAGKASPAMLGSVFVDYYGSATPLSQVAKI
SVPDARTITLQPFEKNMLQVIEKAIMIANIGFNPMSNGDVIIISVPPLTEERRRELAKQA
KTEAEDAKIGVRNVRKDSNSDIKKLEKEGTSEDACKIAEESVQKLTDSFIRKVDELLVAK
EAEIMKV
>KACEBFPM_01897 Uridylate kinase
MKYKRILLKLSGEALMGDRQYGIDPKRLAEYADEIKQIHDLGVQIAIVIGGGNIFRGIAG
ASNGMDRVQGDYMGMLATVINGMALQGALEEKGMLTRLQTALKIEAIAEPYIKRRAVRHL
EKNRIVIFGAGTGNPYFTTDTAAVLRGVEVDADVILKGTRVDGIYNVDPEKNKDAVKFDN
ISFEDVLKKGLNVMDTTAFTLSQENKLPIIVFDMNKEGNLLKICKGENIGTVVNI
>KACEBFPM_01898 putative adenylyltransferase/sulfurtransferase MoeZ
MSKIQEFLRYNRQTMLPEIGDSGQEKLKKAKVLVIGAGGLGCPVLQYISTAGVGTIGIVD
FDKIEMHNLHRQILYTEKQVGLSKALTAKERLEKLNPLIDIIAFDEKLTFENATQIIQKF
DVVLDGCDNFETRYLVNDTCVALGKTLVYGSILKYQGQMAIFNHNGSKNLRHLFPEPPNS
SDVPNCNLNGVIGTLPGIIGTMMGHETLKLIIDLPVLKNELVLFDTLYWDFRKLKF
>KACEBFPM_01899 2-iminoacetate synthase
MNTFNSIFESYDWDTIQNKIYQTTATEVERALSKNKRNLNDFLVLISPAAQPFLEQMAQL
SSELTQKRFGKTIQMYAPLYLSNECQNICTYCGFSLNNKIKRKTLTESEITLEVEALKKA
GFDHVLLVTGEANYTVNINYFLKSVAQIKKDFSTISVEVQPLSVEEYKQLHEAGVYSVLV
YQETYHRDVYKTYHTKGKKSNFDFRLETPDRVGMAGMHKIGLGVLLGLEDWRTDSFFNAL
HIDYLQKTYWQTKYTVSFPRLRPAEGVIKPNFIMSDKDLAQLICAYRLWNEDLEISLSTR
ENEKFRNNIIPLGITSMSAGSKTNPGGYVVDQQSLEQFEISDERSAQEIAKLISSQGYEP
VWKDWDKSYATVD
>KACEBFPM_01900 Thiazole synthase
MLSFKIRDKTFESRLFLGTGKFGSNQQMEEAILASGSELVTVALKRIDLETQTDAILAHL
KHPRINLLPNTSGARNAKEAIFAAQLAREALETNWLKLEIHPDPKYLMPDAIETLKATEE
LAKLGFIILPYIHADPVLCKRLEEAGTSAVMPLGSPIGSNKGLKTIDFLEIIIEQSKVPV
IIDAGIGAPSDAAKAMELGADAVLVNTAIAIAGNPKLMAEAFKEAVMAGRKAYEAKLAQK
ASQAVASSPLTAFLYE
>KACEBFPM_01901 Thiamine-phosphate synthase
MYNKLQYISQGKTIEEQLLNIRKALENGCQWIQMRFKGTHSDNVFTLAEAVKRMCQEYTA
TFIINDNVYLAKKINADGVHLGLNDMNIAEARTILGEAKIIGGTANTFEEVLQRTAENCN
YIGLGPFQFTATKEKLSPVLGLEGYHLIIQQMKTKKNKIPIYAIGGIQLENVDDIMKTGI
YGIAVSGLITQSENPFQLITQLNKKL
>KACEBFPM_01902 hypothetical protein
MYDFIQKFHSGWAYFALLLLFLAFANSALGFFSKREFTTKDKKIALFALIVTHLQLTVGF
VLYFLSPLGSSVFGEMKNAALRLTSLEHPLVNVIAITLITIGWSKHKKGLESKTKFKSIA
VFYGLGLLLVLSRIPWSLWFK
>KACEBFPM_01903 Transcription-repair-coupling factor
MSTKIISKKYSEQAKIVNLLKTIKGDNKIHIKGLVGSSFSFVIEALFAKSENSFLLLCNE
KEEAAYILNDLEQLVSDQDVLFYPSSYRRPYQIEDTDNANVLLRSEVLNRLNSRKKPAII
VSYPEAIFEKVVTKKELDKNTLKISVGDLVSIDFINEVLFEYEFKRVDFITEPGEFSVRG
GILDVFSFSNDNPYRIEFFGNEVDSIRTFDVATQLSIEKKNKIAIIPNFENKFLQENRES
FLEYINPKTTIFIQNTDLLLTQLDKLFSKAQETFEKLNKDVKHALPEQLFLNQKEFIKQA
LNFCVVETASKPTFRTSETFEFHIKPQPSFNKQFDLLLNNLKENQAHNYKNYLFCSNEQQ
AKRFHDIFESLDEQNHETITKQYETIVLPLYQGFIDEENQIACYTDHQIFERYHKFSIKN
GYSKKQTITLKELTSLVVGDYVTHIDHGIGKFGGLQKIQVEGKTQEAIKLAYADNDIVYV
SIHSLHKISKYTGKDGAPPKIYKLGSGAWKALKQKTKARVKHIAFNLIQLYAKRRLDKGF
AFAPDSYLQHELESSFIYEDTPDQLKSTQEVKADMESDRPMDRLVCGDVGFGKTEVAIRA
AFKAVDNGKQVAILVPTTILAYQHYRTFTERLKDMPVTINYLNRFKTAKQKAETLKDLEA
GKVDIVIGTHQLVSKNVIFKDLGLLIVDEEQKFGVNVKDKLKTITQNVDTLTLTATPIPR
TLQFSLMAARDLSVITTPPPNRYPIETHVVGFNEETIRDAISFEIERGGQVFFINNRIEN
IKEVAGMIQRLVPDAKVGIGHGQMDGKKLEELMLAFMEGEFDVLVATTIIESGLDVPNAN
TIFINNANNFGLSDLHQMRGRVGRSNKKAFCYFICPPYSVMTEDARKRIQALEQFSELGS
GLNIAMKDLEIRGAGDLLGGEQSGFINEIGFDTYQKIMNEAIEELKENEFKDLYENDNET
VEKEYVKDLQIDSDFELLFPDDYINSVTERLALYNALAIIKEENGLLEYEKQLIDRFGPL
PKQAIALLNSLRIKWIATQIGVEKLILKQGKMVCYFVSDQQSDYYQSKRFHQVLQFVQKQ
PQLCKMKEKETKNGLRLLLTFENVKSIKKALELMEMV
>KACEBFPM_01904 Peptidoglycan D,D-transpeptidase MrdA
MRKLLLPGIVIIAGILITARLFYLQIIDDTFKLKSENISIKIKYDYPERGYIYDRNGALM
VANQPSYDIMVIPRETKSMDTIEFCNLLNITKTDFIKKIQKAVVYSPMLPSVFLGQLNKL
EYAAFQEKERKFEGFYIQKRSLREYQLTAGANVFGFITQANEAMVKQNPYYKSGDLLGKQ
GVEETYEAELRGTKGVKHIQRDRFNREIGPYKEGKYDTIAKQGKDITLTIDAELQKYGEA
LMKNKRGGIIAIEPSTGEILCLVTAPSYDPAILVGRQRSRNYTKLYNDSLAKPLYDRSLL
AEYPPGSPFKILTALAGLQAKVIDTSSSFICNRGFSYGRGRFMGCHCGGGVRKLHMGIAK
SCNTYFANTYLRTIAKFPTPTAGVDFWSHNIKSFGLGQFMGYDLPTGRKGKIPTSETYKK
MYPNGGWRGTAVISNSIGQGEVLMTPIQLANMMATVANQGYYYTPHIIKKIKGQQIDPKF
RTKHVTSIDKKYFKPVINGLAEVFKTGTAYFLKVDGIEICGKTGTADNFARVNGKKVMLK
PHSVFVAFAPKVNPKIAIAVLVENGGFGSTVAGPITTLMLEKYIKKEITMKDREKRVLET
SLQGEYNRFTRKYLDSMYKIKIRKDSILRTINTKKLDSIKKSKPTT
>KACEBFPM_01905 hypothetical protein
MNNALILNIVRFISLLAAQIVIFNNIDLFGYINPYPYILFILLYPVNSNRAGLLITSFLL
GLTVDLFANSGGIHAASCLILAYVRPTFFKFSFGLSYEYQTIKINDRLSPERFTFILVSI
LTHHLILFVLEYFKFTFILDALLRTIVTTVFTLIISILIIYLFKPNKR
>KACEBFPM_01906 Cell shape-determining protein MreC
MQQIINFVFKNSTRMLFLLLLITSLTLTIQSHSYHRSTIVNSTNILTGTVFEKVSEVNTY
FNLREQNNKLAQENATLRKILFNQKDSTTILKKDSLKGYDKIDVIQSRIINNSYNVPENY
LTINSGSLQGIKEDMGVVNSQGIVGIVEKVSPKYATILSVLNIKSQINAKVKKSNHFGSL
VWNAKNAGYVQLIDVPRLATVKKGDTVVTGGRSTIFPENIPVGIIDKIYTDTETNYYTIN
VRLFNDMTNLNHVYIISNKESAEINKLEKETIKANE
>KACEBFPM_01907 Rod shape-determining protein MreB
MGFFDFMTEDIAIDLGTANTLIIHNDKVVIDSPSIVARDRISGKIIAVGKEASLMQGKTH
ENIKTIRPLKDGVIADFDASEQMIKMLIRSIPALQKKLFTPALRMVICIPSGITEVEMRA
VKESAERVNGKEVYLIHEPMAAAIGIGVDIMQPKGNMIVDIGGGTTEIAVIALGGIVCDK
SVKIAGDVFTNDIIYYMRTQHNLFVGETTAEKIKIEIGAAIEDLDSPPEDMSVQGRDLLT
GKPKQVEVSSREIAKALDKSIQRIEDAVMETLSQTPPELAADIYNTGIYLAGGGSMLRGL
DKRISQKTDLPVFIAEDPLRAVVRGTGMALKNLTKYRSILLK
>KACEBFPM_01908 Bifunctional purine biosynthesis protein PurH
MNTTKTIQSALISVFDKEGLEPIVRKLHEQNVIFYSTGGTEDFIKNLGIPVVPVEDVTSY
PSILGGRVKTLHPKVFGGILNRQDNESDVQQMQEYNIPQIDVVIVDLYPFEKTVASSASE
ADIIEKIDIGGISLIRAAAKNFKDTVIIPSVNEYALFLDIISTHNAQTTLEQRKQFATKA
FNVSSHYDSAIFNYFNTNKEEVVLKISQTKADVLRYGENPHQKGFFFGDFDKIFTKLHGK
ELSYNNLLDVDAAVNLMGEFKNDEPTFAILKHNNACGIASRKTMKTAYLDALAGDPTSAF
GGVLIANGNIDLATAEEINKLFCEVVIAPSYDQNAIELLQEKKNRIILVQKELNLPTTSV
RSCLNGILVQDKDLITDAEAHLTTATKTAPSKEEIEDLLFASKICKHTKSNTIVLAKNKQ
LCASGTGQTSRVDALTQAIHKAVSFNFDLKGAVMASDAFFPFPDCVEIAKNAGIAAVIQP
GGSIKDELSINYCDKNNVAMVFTGIRHFKH
>KACEBFPM_01909 Macrolide export ATP-binding/permease protein MacB
MIIYIRLLKESFSFAVNALRNNKLRTLLSLLGVTVGIFSIIAVLAAVDSLDRKIKKDIGS
LDNSTVFLFKYCFGPSEIPDWKIDQFPNVTYEEYKLLKNNLTDVEAVCYQFYAGRENIKY
ESKTVSSIAVIPCTYEFSDIENLDFSEGRFFSEQESNSGENTVVIGADIRNSLFDGVSPI
GKEIRLYGQKFRIVGVLKKVGDRMVSFGSNPDTTIYPTVNKIRSLFGDNNKSFTPIVIIK
PAKNIDTESLKGQIAQKIRNFRGIKSGEMNNFFINFIKGATDMIDEVIGVMNLAGWIIAG
FSLLVGGFGIANIMFVSVKERTNLIGIQKSLGAKNKFILLQFLFEAIILSVFGGIIGLLF
VWLISLILTYALDFEFILGLGNILLGTGLAAFIGLISGILPAISASKLDPVEAIRSGM
>KACEBFPM_01910 GTPase HflX
MYFIKIMLEKETINFEKTIIVGIVTQNQSEEKLKEYLDELEFLTFTAGGEVVKRFSQKME
RPNPKTFLGTGKIEEINLYVLENGISTIVFDDELTPSQQKNISKIIDCKILDRTHLILDI
FAQRAETSYARTQVELAQCIYLLPRLSGMWTHLERQKGGIGMRGPGETEIETDRRIVRDR
IALLKEKIKIIDKQQATQRGNRGAMVRVALVGYTNVGKSTLMNAVGKSDVFVENKLFATL
DTTVRKVVIKNLPFLLSDTVGFIRKLPTQLVDSFKSTLDEVREADLLLHVVDISHQDFED
HIDAVNKILLDIKSADKPTIMVFNKIDAYKHLTIDADDLMTERTSKHYTLQEWKNTWMNK
VGEQNALFISATNKENFEEFRKKVYETVREIHITRFPYNKFLYPDYEDAIDKEEEQDQD
>KACEBFPM_01911 hypothetical protein
MKKIIIAFFMIIFPLLSFAQITEGFEGATFPPATPGNWAVLDNGVGTAVSWTETTDPTRV
HSGLKAAIVDRENIGAGNTSQDWLVSPRITLTINSQLRFFTRQTSVPDNGTTYEIRVSTD
ASQTNQAAYTTVQTWNDLTLNASPLVYEEKIVSLAAYPAGTQLYVAFVRVNTQPTGATSG
DRWLIDDVKVAERCLDPMGLNVTNLASVSATLNWINPGSATQWEVEVVPVASAPTGVGVI
TGAPTYSAAGLTPGTDYVFYVRSLCSAGVKSAWISSLFSTKPLGSICVSPIIIGSSTYSH
SSDTIFYGNDVAVPQGAGCAGGTTNYLAGFDVFYSYTPATSGNISVTMTPTNPNSSLFVY
NGCANVGVTCLGTGVANSSNAPRVIPSLAVVAGQTYIFVISTNTSTQSTPYTLVIQPVTC
TPPAGLIATNIGTATANLTWTNPTAATSWQVAVQPAGGTIPTVPGIIANTNINFGVSGLT
LGTAYQYWVRSDCGAGVFSPWAGPYLFNTNVCEVVDQCTYTFRLESTTAQWSNARMEVRQ
NGYVVATLGQQFTSGTLLNVPVTLCQNYPFQLVWTVAGTVPTRVKVSIINNAPFSQTIYT
KAAGIGTTGPLYATTFNCGQAACLDPTNLTTTAITATTVNLGWTANGSTLWDVYLVPTGS
PAPTVLSVATYAGVTTNPLAVTGRTQNTTYDFYVRAVCGASKSNWSIVKKFTTLPTCLAP
NTLTVTAITSATVTVGWTNVGIATSWNCIALPCGSPAPTAASTGWVTASTNPFVMTGLSA
GTCYDFYVRGACSASDIGPWSGVKTATTSPGCGGGFFDTGGATAGYSDNENSIITICPTN
PSDIVTVTFTAFDIEPKWDGLYVFDGNSITAPQIASTNPAGTGAAMSLAGAYWGTTNPGP
FTSSSTDGCLTFRFRSDSGGQGAGWTANVTCGPPPSCVKPKLLTVSSITQTTAMLGWNQP
LSPNGSQATTWQVLVLPCGSPAPTATSTGWTTTTGNPYITTGLLPGTCYEFYVRASCSAT
EVSLWNGPKSFTTLLINDECIGSILVPVNQNTNCLQTVAGTVNAATASPEANSCGAIEDN
DDVWYHFTATSTTHHISLLGLNYATNPSGLEYTLYTGSCGAMTQFRGCVTDTGANNTTGL
TIGQTYYVRVYSTATTSSTIQFELCIGTTQITCPTALPLCAIAPIVIPNNVGVPKLPNPV
SPYSTTNANVGCLGSAPAPTFYYLTIPTNGNYSFFLEQGRTNVFPSPAGTGLDVDFVAWG
PYTSTAVACASISTATAPATGNFCSYSFANTETFTVNGAIAGQVYVLMITNFSQDRGFVR
ISQTTGPIPSSCCPYTNFSYPGAFFCQNSANILPTLQSGGTAGTFSATPAGLVINPVTGE
INIGASAVGSYTVKNEIVGSGSCTTSTSTWLIKITAPANATISYSAPAYCANDTVVKNVT
QTGTTGGTYYAVPAGLSINTATGAINPSASMPGNYTVNYAIATVAGCPTFLAPTAVTITK
LPLATFNYGVLPHCQNAGSASPTFAAGGVAGLFTSTTGLIINTNTGVVDLAASTPATYTV
TNTITGSGGCGTVVYSNTITIATSAIATFNYASSPYCQNMGTVSPIFTGGGVAGTFSSTA
GLVINGVTGAVDLAASTPATYIVTNTIAPVNGCSLVSAFATIIINPNPRATIASSDADNT
ICSNDSATITVTPINYTTGATYSWTLNGNPIAGTTNTIPATATGTYAVTITLNGCTNITP
LSLAFTVNSLPNFTLTGTNIVKCINETAVLSVVPTNFSLTDPTITYSWTLGGNPLSNTTS
SISILAYGTYAVTVRNAGCTTTHQVNVTLDTASIPIGTNAQCVGQNYILTASPVNGSFTP
GIGNVSYVWKNASGTVVGANTNTFNVSEYIRNNASITLPTTFTVAIVTIPEGCTDTTTFN
VSTSVCIIQKGISPNGDGDNDTFDLRGLDVKQLAIFNRYGTKVYSLANYTNQWAGQSDKG
QELPDGTYYYVIDQNNGETKTGWIYINK
>KACEBFPM_01912 hypothetical protein
MKKLFFTSILALVAFIDAQAQQDPHYTQYMYNMNIINPAYAGSKENLSIGLLFRKQWVEI
QDAPTTFTATGHSPVGKNVGAGLSVISDRIGPVDETNVYGDFSYTLNLGGEHKLAMGMKA
GVSMLKVDNGLIRASLPVPTDGAFSINTATANLNIGAGLFYYTNKYYVAFSVPNMLKSTH
LDYNGRQYGSEIQHYFFTGGYVFDLNPNLKFKPFFMIKSAINAPTSIDVSTNFMFFNKFE
IGATYRLQDSFGAMVNYKISDGIRAGFAYDHIVSDLKVATPSSYEAILLFDLNFPKKIST
SPRYF
>KACEBFPM_01913 Outer membrane porin F
MKKIYIALSFILVLTTGKAQNKDTKIADKLFDRYQYVDAVKEYLKLTDKGKADTYVFKQL
GDCYYNVFNSIEAEKWYTQAVTKQQDAETYFRYAQMLKANSKYNEAAQQMNKFASLAPND
KRAQSISGDSNYLAKLLGKAKMFDVRSLEFNSKYSDFGAYLKDNVIYFASARNTARKSYE
WNDQPFLDIYKTDFKDGKVNSKSVLVEDLNTAYHEGPVTISADGNTMYFSRESFFDKKFV
KSQDKKTKIGKMYIFKATKENEKWTNISPVSFNSKEYNTSSPSLSKDGKTLYFTSDMPGT
LGKTDVFKVAVNEDGTFGTPQNLGDKVNTEGNELSAFIADNNTLYFASNGKKGLGGLDVF
AFDTTKNTEAVNLGKPVNSEKDDFGFTFNQDQKTAFLSSNRDGGQGDDDIYLALPVCNLD
LITTVHDKKTGAILANATITVVDQKLNVLGNSISDEMGIVNFHLECDKTYFINVDKNGYI
GEVIEVEKSSGGEVAINADLNPKAPIITQTEVILSDINFDFNKSNITQEGAAELDKLVAV
MTKYPEMVIFAKSHTDSRGDDKYNMLLSDRRAKSTVQYIISKGIAVNRITGEGFGKSEPK
VQCDKCTEAEHQKNRRSEFMIVKK
>KACEBFPM_01914 Tetracycline resistance protein, class C
MKQNKKSPAIGFIFITMLIDIIGLGIIIPVIPKLIKELIHGDISEAAKYGGWLIFAYAIT
QFIFSPLIGNLSDKYGRRPIILISLFGFSLDYLLLAFSPTITWLFLGRIIAGITGASITT
ASAYIADVSTPENRAKNFGLIGAAFGLGFIIGPVIGGFLGQYGARIPFYAAAILCMVNFL
YGYFILPESLAKENRRDFSWKRANPIGAVLNLKKHPNLIGLITATFILYVASHAVQSNWS
YYTMYKFGWNEKMVGISLGVVGLLVGIVQGGLIRFTNPRLGNNKSIFIGMTLYCIGMFLF
AFASEGWMMFVFLVPYCLGGISGPALQSVVSGQVPATEQGEIQGTMTSMMSASSIIGPPM
MSSVFYFFTHKSAPFQFAGAPFVLGGFLMLVSLGIAYKSLKKK
>KACEBFPM_01915 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex
MILEMKVPSPGESIKEVEIATWLVKDGDYVEKDQAIAEVDSDKATLELPAEASGIITLKA
EEGDAVAVGAVVCHIDTDGEKPSGSAPVAEAPKAEVKVEAPKVAPVAQKTYAAQTPSPAA
RKILDEKNIQPSDVVGTGKGGRITTEDAVNAVPSMGTPTGGSRGSERTKLSMLRRKVAER
LVAAKNETAMLTTFNEVNMTPINNIRNEYKDAFKAKHNGVGLGYMSFFTKAVTRALQLFP
DVNSMMDGDYKVAYDFADISIAVSGPKGLMVPVVRNAELLTFRGVEAEIKRLAIRARDGQ
ITVDDMTGGTFTITNGGVFGSMLSTPIINPPQSGILGMHNIIERPIAVNGQVEIHPMMYV
ALSYDHRIIDGRESVGFLVAVKEALENPLELLLDNNPKKAFEL
>KACEBFPM_01916 2-oxoglutarate dehydrogenase E1 component
MLTKYRKPLIVFTPKSLLRDPRCVSTQDEIANGEFQETIDDISVNKTQVKTLVFCTGKFY
YDITAERENLQRNDVAVVRIEQMFPLPVEQLKAIVASYPNADDYVWAQEEPKNMGAYSFM
LMNFDFIKWRLASLKAYAAPAAGSYTRAKRRHADAIRMVFDKDLFR
>KACEBFPM_01917 Transcriptional regulator SlyA
MKIEDEIKSTIPINIAKKVLLNISFTKNVLHDNFQELIKPYDLSGEQYNVLRILRGQKGK
PVNMCDIQERMIAKNSNTTRLINKLLLKKMVTRSECPENRRKIEILITQKGLEILEKLDP
AVIEHENHFANKLTVEELEKLNNLLEKYRN
>KACEBFPM_01918 Putative NAD(P)H nitroreductase YfkO
MSTFIENQNWRYATKKFDTTKKVSATDLETLKEAIRLSTSCFGLQLYKVIIVENPEVRAK
LQPASWGQTQIVDASHLIIFANQTNIGDAEIDSYLENVSQTRNLPIDSLSGYGDFMKGAV
KPLTEEAKNIWTAKQTYLALGNLINVAAELKIDVTPMEGFDAKQYNEILGFDKLNLNTAV
IAPVGYRHEEDETQHYKKVRKSTENLFITI
>KACEBFPM_01919 Protein YceI
MKNLKSIAVAAILALSTLTASAQTTKKVDISKSKVLWIAKKVGGQHNGDIALKDGNLIFK
DSKIVGGNFIVDMKTINSTDLEGEWKNKLDVHLKNEDFFNVETNPTATLVFKSIGAKSKN
TYTVVGDLTIKGKTAPVTFDLVSNKGVAKAKLIIDRTIYDIKYGSKNFGALADKAIDDLF
ELNVNLKF
>KACEBFPM_01920 Anthranilate synthase component 1
MKTYNLKTKFKQILADTITPVSIYLKIRDKFPNSLLLESSDYHANDNSFSYICCNPIASI
KIENETIFKSFPDGSSEKIEINNQTNIPNEIERFTAQFKSENNDFKFINNGLFGYISYDA
VRYFENVEISKKENDLQIPDIYYAVYQNIIAINHFKNEAYIFCHSVTEENNINEIEQLLQ
TRNLPAYSFSKTDAKKSNLTDEDFKTNVALAKKHCYRGDVFQLVLSRRFTQGFKGDEFNV
YRTLRSINPSPYLFFFDYGDFKIMGSSPEAQLVIKNRKAEIHPIAGTFKRTGNDEQDAVL
AKKLSEDKKENAEHVMLVDLARNDLSRQSHQVQVEKYREVQFFSHVIHLVSKVTGQMHEK
STTMQVVANTFPAGTLSGAPKHKAMQLIEKYENTNRNFYGGAIGFMDFEGNFNHAIMIRT
FLSKNHQLHYQAGAGIVANSDEESELQEVYNKLGALDKALELAEKI
>KACEBFPM_01921 Aminodeoxychorismate/anthranilate synthase component 2
MKILVIDNYDSFTYNLVHYLEDLNCKVTIYRNDEFDIDEIKNFDKILLSPGPGIPDEAGL
LKEVIKTYAATKSILGVCLGQQAIGEVFGGSLINLEKVYHGVATNVNILVDNESLFDGLE
KQIEVGRYHSWVVNTSDFPDVLEITSTDENGQIMSLRHKTYDVRGVQFHPESVLTPNGKK
ILENWVNSRQ
>KACEBFPM_01922 Anthranilate phosphoribosyltransferase 2
MKNILNRLINHETLSKQEAKNMLVNISNGSYNPSQIASFLTVYMMRNITINELAGFREAL
LELCIPIDLSAYNTIDLCGTGGDGKDTFNISTLASFVTAGAGIKVAKHGNYGVSSISGSS
NVMENLGIKFSNDPIFLEKCIDQAGICVLHAPLFHPAMKNVAPIRKELAVKTFFNMLGPM
VNPSFPKNQLVGVFNLELARMYSYLYQNTKTNYTILHSLDGYDEISLTGNTKTITNKMEG
MLKPEDFGVNLLSQTDIQGGTTIQESAQMFVTILSGKGTEAQNNVVCANAGMAIATVNNL
NPIQGFELAKESLLSGKGLETLKKLQQLSL
>KACEBFPM_01923 Indole-3-glycerol phosphate synthase
MNILDKIIVDKKREVILKKTIIPVSQLENSVLFGSRTVSLSKILRNSNAGIIAEHKRRSP
SKAEINYNFSVEEVVKGYQNAGVCGISVLTDAKYFGGSLDDLLVARASINIPLLRKEFII
DEYQILEAKAHGADLILLIAAVLTREEIKNLSEFAQSLGLEVLLEVHNLEELQKSIMPTL
DMIGVNNRNLKTFEVSLDFSKQLASEIPDEFVKVSESGISSIEAINELKPYGYKGFLIGE
NFMKTDNPGKAAEIFIKNLI
>KACEBFPM_01924 N-(5'-phosphoribosyl)anthranilate isomerase
MKLKICGMKYPENILEVSTLLPDYLGFIFWEKSSRYFDLEIPKIPESIKKVGVFVNATLE
EILLKIKKYNLNLVQLHGNESPEFCKELKKSTIKIIKVFSVNDDFNFSALEPFEAVCDYF
LFDTKGKLPGGNGITFNWQILEKYHSRKPFFLSGGIGLDDIKNIKKLNLPIYAIDVNSKF
EIEAGLKNIELLKSFKNNLQTLNL
>KACEBFPM_01925 Tryptophan synthase beta chain
MSFHVNQKGFYGNFGGAYIPEMLYPNVEELRQNYIKITAEPEFQKEFHELLKDYVGRPTP
LYFAERLSKEYNTKIYLKREDLCHTGAHKVNNTIGQILLAKRLGKTRIIAETGAGQHGVA
TATVCALMGLQCIVYMGEIDIKRQAPNVARMKMLGAEVRPATSGSKTLKDATNEAIRDWI
NNPTNTYYIIGSVVGPHPYPDMVARFQSVISQEIKTQLLEKEGQENPDYIIACVGGGSNA
AGAFYHFLDEKEVNIIAVEAAGKGIDSGESAATSALGKIGIIHGSKTLLMQSPDGQITEP
YSISAGLDYPGVGPMHAHLFETKRAQFISITDDQAMNWGIKMSQTEGIIPAIESAHAFAV
LDHKKFKPTDIVVINLSGRGDKDLNTYIDYFKL
>KACEBFPM_01926 Tryptophan synthase alpha chain
MNRINQKLQEDKKILSIYFSAGYPNLNDTVQIIQDLEKSGVDMIEIGLPFSDPLADGPTI
QESSTQALENGMTTKLLFEQLKNIRQTVQIPLIIMGYFNPILQYGVENFCKKCQETGIDG
LIIPDLPVDIYAENYKETFEKHGLTNVFLITPQTSNERIRHIDSVSNGFIYLVSSASVTG
SSSGFDSIQTNYFKRISEMNLKNPQIIGFGINNKETFNQATQYQKGAIIGSAFIKNLTEN
GVSSISKFVSEIF
>KACEBFPM_01927 hypothetical protein
MTTTKKTNLFLTALALGMFASCSKNDDIKTISTEKALDQPSLLNKECSFVDNNWASAATL
YTTLPNSGSTTGASLMTTQNSTIASFWGRSAPSFRFVRDLTTPSSTFNAISYSTGKIYFG
EAIFKWAYNRDNSNLINVMILAHEYGHQLQYAFGLPSVSESTARPNELEADGFSGYYLRR
GYGKSTFASIATAYDAAFAIGDNNVTSPGHHGTPAQRRSAVRLGFLLADPTNAKLTASAF
DSNFFYYYTGVKNGTYRQAKPANFDAKMDANIKIHSDELRRIQSGEMSDQEYFNLQ
>KACEBFPM_01928 HTH-type transcriptional repressor NicS
MTDFNDKQIEIILVAEKLFAEKGFDGTSIRDIAKTAGINIAMISYYFGSKEKLLESVVIF
RISNLKLQLESIYEELLSPIEKIEKIIALYILRLYRNRNIYQILNFETASNKRNINFSAF
TEVKKQNYLSFQKIIEEGQEKGIFKKNINIPLIMPVVIGSLTHFNNSRLFFEDILGLKTE
NEFDNYIENEFTKHIQQTIKALLVYEN
>KACEBFPM_01929 Multidrug resistance protein MdtG
MIKKYFEGYKGFPKEIWILALITFVNRAGTMVIPFMSKYLKEGLGFSYSQIGWIMVFFGI
GSLIGTFLSGKISDKIGSYKVMVFSLFTSGLIFIGLQYVKTFSLLCFGIMLLTSVADMFR
PAMMITLNSYVTKNQRTRALSLTRVAINLGFIFGPLLGGIIISVLGYNTLFFIDGGTCIL
AVLIFAYFVKEKKLLYKLNLKHISSDNYAPLKDHPFLLHWLITMLTGILFFQVFTTLPIY
HRAQFGLTEFHSGLLLAFNGLLILLFEIPIVNYVEKNKIPKTLLIMIGLSIMSLSYLLLA
TINHPFVLIVMMFFMSFGVMLTFPFASAFVTARSHKNREGLFMSFFQMSYGFAHVFSAKT
GMEIIDKFGFRANWFVNFAIGIVGVLLSYILYQMVNKERKKIKENIINSIFKAS
>KACEBFPM_01930 hypothetical protein
MPKKLVKNSTYEIQEIKAYNFESIIEIIHKSKLIGEELLNIDDAVLFIKSKLERNKAKIY
ATFQGVNPIGFVVLFVKINPLSVIKYNWHISYLYVKPEHRRNKIAQEMMLKCIDYAKITK
AEYLSLNTGTDNFAAHKLYENLGFYRRDFIANYFYYELNLNH
>KACEBFPM_01931 hypothetical protein
MSDFLKQFGEDLKKNVSGFIAVAITEIKSGVSYYSLSADKNFDPELAAAFNLEVVKAKLN
AINALGLNQSIDDILINLSSQIHIIDVSDNNEYFIYLVVDASKANMGMTKALLNKYKKEI
SGNL
>KACEBFPM_01932 hypothetical protein
MKNTSQQYDAIIIICRDLFTKKMKDYGSAWRILRLPSLTDQLFIKAQRIRSLQENEVRKV
NEDESSEFIGIINYSIMALIQLDKGVAVQPDLSVDEAVKLYDEKIKLTKELMENKNHDYG
EAWRDMRVSSLTDLILQKILRVKQIEDNKGQTLVSEGIDANYQDMINYAVFALILMNYRK
NI
>KACEBFPM_01933 Dihydropteroate synthase
MTINCKGQLIDLSTPKVMGILNVTPDSFYDGGRFVSEKNVLIQVENMLQDGANFIDIGGQ
SSKPKAAIVSIDEELKRVVSIVDLILKKFPETMISIDTFNSKVAQIAVENGAAIINDISA
GNLDDNMFETIAKLQVPYIMMHMRGTPQTMQEMTNYDDLLKDILFYFSEKVAKARSFGIN
DLIIDPGFGFAKTLEQNFELLNKLELFEMLELPILVGVSRKSMIYKTLETTPENALNGTS
VLNTIALTKGGNILRVHDVKEAVECVKLYNQLHKFAQIN
>KACEBFPM_01934 hypothetical protein
MIRKINTLKNFGVFQNFTWDILPEFNEKNIFYGWNYSGKTTISRLLSSLKNKELNKSYSE
AEFEITLDDKSKITHKNIENNNLNLLIFNSDYIRENLKWDLNSQFNGITFDVGETIGLRE
KIEKLEEQILKVNGSNEIISKKSPFELLKTEFDSFEDNKYTQESRTIKNDIFNSLIEFNK
SHLKSIIPQVVNDLESNLITDLDELNRIKKLSLSTNDKEEIQIIHNDVNLKSLYDSVVIL
LNQEPKKNNIIQILEENPYVSNWVKSGIPLHKGKEKCFFCENDLSKERLNNLLLYFNNES
SNLRNEIITKIEQIKHKIDELNNIELPKSKFEFFDNFQNDFQAQLDSFILIKDKIFLFYN
NLINELEIKNNESIFISKRIADYDNALQLDIDKWTEITNKLINNHNQLFTDFDTKQIEAR
NLLKKHQVSLFLTIEEYIKKKKESEFGIRCISKFDSYIKKVKIEIAKLESELKSIVKGKD
ELNSFIQKFLNRSDIFIEVIEDDKFILKRNGKIADNLSEGEKTAISFSYFLVSLESLFQD
KKIFDYIICIDDPISSLDGNHIAQIYSLINSFFFRQNINPAVPEQYVNCFKQLFISTHNF
EFFSFIKDSNRINKKSTKEYYFIKRISNTESNIQELPKSLRDYKSEYIYLFDLIFKFFIN
GCQETDEKLILMPNAVRRFLEIYTLMKLPDSTDQVDERIRILMPEHMELKTLHHFSHFTT
FEKVMKHDEIILNLSQAIGELMTLLGKDELHFESLKRAVTR
>KACEBFPM_01935 hypothetical protein
MKTYYYFTKKTLLKSFAGLLSLTAISCGSYQNKSYYDNDGIYGGERQKSNIETNNASGTD
NKYKEYFSSNANNYNTNQTEVLTDVDNYSTVIKNQNDNSNNNNNYSGWGNNSNDHLTINV
YDNSWGYHNYGYYNNYWGYNSPWNNGYYSSWNNGWYNPWSYYGSNWGWNNLYYGNYYGYN
NWNNSGYYRNNYSYAHGRRGAMYSDRYSHENGGKNYSSDIRNNASAIDNPRSNYSNNNYN
YTPRPVRTENPEINNPRSNYSNNNNYTPRPVRPENTTIDNPGSNNSNNNNYTPRPVRTEI
PRTYEAPRNYTPSSGGGGNYGGGRSGGGGGRR
>KACEBFPM_01936 Proline--tRNA ligase
MSKNLTTRAEDYSKWYNELVVRADLAENSGVRGCMVIKPYGYAIWEKMQAELDRMFKETG
HSNAYFPLFVPKSMFEAEEKNAEGFAKECAIVTHYRLKNDPDKPGKLMVDPNAKLEEELI
VRPTSEAIIWSTYKGWIQSYRDLPLLINQWANVVRWEMRTRLFLRTAEFLWQEGHTAHAT
RKEAIEESEKMMNVYADFAQNFMAIPVIKGLKTETERFAGAEETYCIEALMQDGKALQAG
TSHFLGQNFAKAFDVKFANAEGKQEHVWGTSWGVSTRLMGALVMTHSDDNGLVLPPNLAP
IQVVIVPIFKTDEEFEKISALANDLISQFKKLNISVKFDNRTTQKPGFKFAEWELKGVPV
RIAIGPKDLENETFEIARRDTLTKEVKPKEGIVKYISDLLAQIQSDLFSKALQYRDTHIT
EVSDFEEFKKVLENKGGFISAHWDGTPETEEKIKELTKATIRCIALNRKEEIGNCMFTGK
QSVGRVLFAKAY
>KACEBFPM_01937 Sec-independent protein translocase protein TatB
MFGIGGGELVFIMFVALMLFGSDKIPDIARTMGKAMAQLKNATNDIKSEIQRGAESNDID
IKSLTGDFTSEIDKVKQGFNKIITDNTSDSLGTKSITDDITSEIEKVKENLDDLTGPIKR
QL
>KACEBFPM_01938 hypothetical protein
MLEKIITIDKELLVFLNTLGSKDFDSLWLIITKQSSWIPLFVFLLYLVYKQLGAKQTIIV
VLFVAVLLTVNNTITELFKTMFQRLRPCNDPAIKDVIRNIKPSSTFSFFSGHSSNTMAVF
VFLYAIFKKQYKYFWILILWPLIFAYSRIYLALHFPTDILAGYTCGIITGSITFTGYKWF
QLKYFKNYL
>KACEBFPM_01939 Putative O-methyltransferase
MHFLSQDLEDYIEQHSENEPELLAQLNKETYQKILLPRMLSGHFQGRVLSMLSKLIRPVN
ILEIGTYTGYSGLCLCEGMQENGQLHTIDIKEELIDFQRKYFDKSPWANQIVQHLGEAVD
IIPILDLKFDLVFIDADKENYINYFNLILPKMSKGGIILSDNVLWSGKVVLPLEKNDLST
KILLEYNLLLKNDPRVETVLLPIRDGLTVSRVL
>KACEBFPM_01940 putative dual-specificity RNA methyltransferase RlmN
MQIEKKDIRALSKDQLRDFFVINKDKAFRGNQVYEWLWSKGAHSFEDMTNVSKETRQMLV
ENFVINHIKVDTMQRSSDGTVKNAVRLHDGLIVESVLIPTETRTTACVSSQVGCSLDCNF
CATARLKRMRNLEPGEIYDQVLAIDRESKLYFNRPLSNIVFMGMGEPLMNYNNVIKAIDM
ITSSEGLGMSPKRITVSTSGVSKMIKKMADDEVKFKLAVSLHSAVEEIRNKIMPFTKSFP
LPELREALQYWYHKTKSKITYEYVVWKGINDNKESVDALVKFCKHVPCKVNLIEYNPIDD
GEFQQASPESINAYIKALEANGIIAKVRHSRGKDIDAACGQLANKEI
>KACEBFPM_01941 hypothetical protein
MKSKILLFGLFLALITIGCSKDKETTDDSTVTAEEAGINAKVDTQNNDVHNIVENQYDNI
DSNTLSYKNAASQENYFSPCAIITRVPDFGVVLTIGQTVTKTIDFGTIGCTMSNGNILKG
KIILSFVYNPNAPIQTINCSFDNFYHNLRKIEGTKTFTRTMSMATAASPSHPIWVMHMNL
TIILPDGRIITRVGTRTSEIIAGYNTPNWTDNVYSATGNWTTTFPNTVTQTSTITSPIII
KLACTPTNSALSKGVISFVRNSHIATLDYGNGDCDNLAVFTINGVSHTIALGN
>KACEBFPM_01942 All-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific)
MLSLNRYMDITSQIKKPILEEMELFEKKFQQSMSSKIALLNRITYYVVNRKGKQMRPMFV
FLTAKMISGGTVLERTYRGALVIELIHTATLVHDDVVDDSNRRRGFFSINALWKNKIAVL
VGDYLLSKGLLLSIDNGDFDLLKIISVAVREMSEGELLQIEKARRLDITEAIYYEIIRQK
TATLIAACCALGAQSVSNDEVQVEKMRKFGELIGMAFQIKDDLFDYTEDAIGKPTGIDIK
EQKMTLPLIHVLNNCTAKEKSWLINSIKNYNKDKKRVKEVITFVKNNSGLAYAEHKMRQF
QQEALSLLQDFPNSAYKDSLILMVNYVIERKK
>KACEBFPM_01943 ECF RNA polymerase sigma factor SigW
MKVINLHQVEKELIELATGNNRQAQQKIYSKFSGKMLSVCRQYIKDIHQGEDVMITAFMK
VFANLKNFEHKGSFEGWIRRIMVNECISYLRVQKPIKFVDDSQYLEEGFNNIESQFSVED
IQFLIDSLPDGYKMVFNLYAIEGYKHQEIAQMLDINEGTSKSQLFHARKILQTQIAKLKN
YENGTE
>KACEBFPM_01944 hypothetical protein
MEPNKLENQIQEKLNAREIQPSAQAWDRLDAMLLVTEKNKPKKRLAWLYIAASMIGFVFV
GLLFYDQENKNTNTNNQTVVEVNDDKKPVLLEEVNQSKIINNPKEAVLAIIETKKELAKA
KNTNKKIQEFTKEPLENIEIIAEIIPQKTEEKLKTETNPTTLIASVETKNEQTKNVNKPK
LKIDASALLSQVDGEITLTFRQKAFKLISKNYDSAKEAVVSRNQE
>KACEBFPM_01945 hypothetical protein
MRNLIIYLTVFLCSIASSLQAQESFEARAKAIATNIEKITKEEKEALKKQVEEVNVALGK
NSITQQQADEKKMQLATTSANNIESRIAVEESKLSELVKEKVEGNVGNVDTTRVFGRVLS
ISILDKEKKKKYKNESSEKRTTSQIVIATGFNNLVTNGRIANSDFGYLRSEFLEWGYTHN
TRLLESNNLLHLKYGFSFMYNTLTPTNNRSFEVNGDHTNLVTNQFKLRKNDSYFKNVFIT
IPLHLEFDFSKSKTINDKVFFRSHRGFRLGIGGFVGYNTNAKQFLSYDLDGHRVSVKQKG
NWNTNDWNYGLSSYIGYGQISLYAKYDLNPMFKNNPVKQNNISLGIRLDLN
>KACEBFPM_01946 hypothetical protein
MCIFRSFACTKLIPTYPMRIKILLFLLTTFYVSNAQKNQGIIGESNWFDGWTNFRPKSTE
YDQATRILVGDIKENMTLTKNNVYLIMGTVHVANKAVLTIEPGTVIRGDFNTTGTLAIVK
GSKIMAVGTDTNPIIFTSNKPVSERKPGDWGGVILMGDAPINRFGGVSASFYEPNPLYNL
FGGLNENSDSGILKYVRIEFAGKKIDSKISLNGLTLAALGSKTKIEYVQISFSSDDSVEV
IGGNIDFSNIISYRATDDDFDYSMGVQSTMNNSIAIRNPYASDNTRSRCFEIDSYDKIEN
YDPTKKKTYIKLNNVTMTNDEENTMGLVKEAISLKPDSYIEVNKCLVAGFSSFIALDDKC
LERDNFKKNKIYNSTIDSCAELFTDEALVKALNVNDWFMQTDKLLNITKVGINSLFINNN
VKHKPDFRLK
>KACEBFPM_01947 hypothetical protein
MKKTVLAVIFLIHVFSLNAQVTNGIIGSANWFNNWTDFKPKTTEYSESTHILNGIIDANT
TLYKKNTYLLIGVVYLANNAILTIEPGTVIRGDFATCGTLVITKGAKIIAEGVATDPIVF
TSNKNVSERKPGDWGGIIMLGDAPINKFGGIGILDFNLNPKYNFYGGQNPESNSGILKYV
RIEFSGRKLNALKELNGLSLAGVGSKTKIEYVQISFSNDDSFESYGGNVIFNNLISFRAT
DDDFDFTQGAQCNISNSIAIRYPFSSDVSRSRCFEVDSYDKLENYDLDRKLTKITANNIT
LINNEDNDQGLVKEAIYVKYDSFFELKNSVISGFNQFLLLENKAILNSNLNKLKFENLVL
NNCKAKVELETNTPDKLLEEWIANDSFNIITSNTERKKIFEESDIKKNPDFRLKDNNSGT
LVVK
>KACEBFPM_01948 DNA primase
MISKATIDTVYETARVEEVIGDFVQLKRAGSNYKGLSPFSEERSPSFMVSPAKGIWKDFS
SGKGGNAIAFIMEHEHFSYPEAIRYLAKKYNIEIEETEQSQEEKEQASEKESMYLVSEFA
AKFFQNTMMNTDEGKSVGLSYFKERGFTNETIKKFGLGYSPEAWDAFTKEGLGQGYKLDY
LDKVGLTILREDGKHFDRFKARVMFPIQSMSGRVLGFGGRILTNDKKAAKYLNSPESEIY
HKSKVLYGIYHAKQAIAKQDNCFLCEGYTDVIQMQQAGIENVVSSSGTALTPDQIRLINR
LTKNITVLFDGDAAGLRASIRGIDLILEEGMNVKVCTFPEGDDPDSFAKKTPLNELLLYL
ENNAMDFIQFKASLLMKDAKHDPIKKAELIRDMVNSISKIPDRIKREIYIQECSRIMDIS
EEVLFNTLAQLVQKDISEVGKKQKQEQKNQVFEVYKNENTAVGAKVDVLYELELKIIEIL
LLYGNIEEDFEDFVFKANEEGELLEIKEVNRYKVFQRIYLSLQEDEVELGTPIFKDIYNN
LIAYFNENENFEIEQYLMRLSPELAQEVTTIIMDDEKTSLHNWEAQQIYVKQKDKTISQY
VSETILTLRWFLVNKIIEEIKSNLSNATDSDNYENLSMVMDYSKLVNNFSNKLGRVMSRY
S
>KACEBFPM_01949 Putative transcriptional regulator
MVKIGLADNHPVVHYGIKAYYKEHPDVSLEAIVDNFEMVSEMLKIKEIDVLLLDLELEGL
SSINLIKNLLKDFPNLKIILFSNLNEQIYAPNAIKAGVFAFVQKSEKLDVLTSTIIKVNR
GAVIFSDAVKKNMALISKQIKSERLYRKLSSREIEVLRYLSNGKKNKEIAEALHLNEKTI
STYKLRLLAKLNVTNLVDLVNKAKTLDIV
>KACEBFPM_01950 NH(3)-dependent NAD(+) synthetase
MPIHQAQSHINRAQEHIMQLKKNFANVTDTRVNLTPVFESFKTEVPVSNNEAKLNLSLAN
TRARLRMTSLYYLAGIHGLLVAGTGNKVEDFGVGFFTKYGDGGVDLSPIADLMKSDVRAL
ATYLNVPESIQKAAPTDGLFGDDRSDEDQLGASYTELEWAMIALENGKKSDDFTDREKVV
FEIYERLNTINQHKMNPIPVCLIPEIYK
>KACEBFPM_01951 hypothetical protein
MEYVETELQKSNSEDEEIENLISETIALKNNLQNLTKKVVIRKMSIIFSKVKKKGLKLFL
DIIDVAKKEIIKKALYGGIGEIEHLTNTLW
>KACEBFPM_01952 hypothetical protein
METQPNQACRKNGYQKVTFEHKLFVIDQINNGQISANFASKKYNISRATIQYWMKKLSNY
TNKKTFVSKDDEIRKLKEKIADLEGIRYFQQDVIIAFEKITGEELSKKLLPESLSDPIQK
RKKKLSK
>KACEBFPM_01953 hypothetical protein
MGRDAVNDLLRSRGILIKKTKRYFITTDSKHFFYKSPNLLTDLKITHSEQVFVSDITYIK
TDAGHSCLALVTDAYSRKIMGWSLQDNMKVSMVKEALNMAYKNRVFNHKNIIHHSDRGIQ
YCCPDYSQYAENKGFILSTTQQYDPYENAIVERINGILKYEFGLRNTIKSVDIAQKMVTQ
AVDLYNNLRMHWSLDFKKPQEVHLQYNKQENKNYKKEKKVA
>KACEBFPM_01954 hypothetical protein
MVLIVIIIFISFIALSIAGLKLLKKGANSREITIATFYIFSIALFAIGMTTHSNSYYKAI
DPVDMECYSPFSDKNAITLIFYTLVFNISLLLVWVKGNILPPLALTLSLIFILIGTFLNV
GVLFQISVHNTETLNTYNSRGEQILFLFAPLFSVILGVYFIYKATTQEIKEAFEKAYSNK
IINALNTFLSTKSRNPFWIVLLMFPVFFIVTLLLILFGQDTNSIIKVFTDTATWKFSQQV
HPPILDHKGHYLCTVATSGHPKIVKPIRFGKRNGNRIIVNRQLLIANAFEEMIQDISPRL
HFKIRTIYDQYGYNLSKKINTTFLASATYILMKPLEWIFLICLYLICNKPEQKINKQYAQ
>KACEBFPM_01955 Zinc-transporting ATPase
MEHIHTHDKKGKQLCCKHKEKKACCTTHTHSHDDHAGTEQTMFQMFLPAMISFILLLVAI
GFDNYFSQTWFAGWVRIAWYIVAYIPVGFPVLKEAFESIGKGEIFSEFLLMCIATIGAFS
IAQFAEGVAVMLFYAIGEIFQTLAVQKAKSNIQLLLAQRPDEATVLKNGNAITKKASEIN
IGEIIQLKSGEKLALDGKLLTHNATFNTAALTGESKPDTKQKGDTVLAGMINLNTIAQVE
VTTAYTNSKLSKILQMVQEATARKAPTELFIRKFAKIYTPIVVLLAMAICVLPIFFTANY
VFRDWLYRALVFLVISCPCALVISIPLGYFGGIGAASKNGILFKGSSFLDIMASIQMVVM
DKTGTLTKGVFKVQKVVAVGVSEVDLVKFTSALETKSTHPVGTAILQYANGTEKNVTVTE
VQEIAGHGLKGKVDGNEILAGNVKLMKKFNISYDAQIDNTPFTIIIVAINQKYSGYFLIA
DQIKEDAKQAIESLHKINVKTMMLSGDKQAVVNAVAKQLNIDLAYGDLLPEDKVAKVSAL
KLQNLKIAFVGDGVNDAPVVALADAGIAMGGLGSDATIETADIVIQNDQPYKIYTAIHIG
KKTKQIVWQNIGLAFTVKVIVLVLGAGGLATMWEAVFADVGVALLAILNAVRIQRMRFDN
>KACEBFPM_01956 Sulfur carrier protein ThiS
MELKINNKTKQFAANSLTVQALLDLEIPTKQKGIALAINNIVIPKSDWNFHLIKETDDVL
IISATQGG
>KACEBFPM_01957 Phosphomethylpyrimidine synthase
MNNEEKISRTPFPNSKKVYIDGEIHSIKVAMREISLADTKMSNGRIEKNPSVTVYDTSGP
FTDPNIEIDIRKGLPRIREQWILDRNDVEELTEITSEYGKLRLNDEKLNNLRFEYLHKPM
RAKKGTNVSQLYYAKQGIITPEMEYIAIRENQRIEQINAQSKEMQCQHAGHSFGANTPKS
KITPEFVRSEVARGRAIIPNNINHPESEPMIVGRNFLVKINANIGNSAVTSSIEEEVEKA
VWACRWGADTIMDLSTGKNIHETREWIIRNSPVPIGTVPIYQALEKVNGIAEDLTWEVFR
DTLIEQAEQGVSYFTIHAGVLLRYIHLTANRVTGIVSRGGSIMAKWCLFHHKENFLYTHF
EDICEIMKQYDVAFSLGDGLRPGSIADANDAAQFAELETLGELTKIAWKHDVQVFIEGPG
HVPMHMIKENMDKQLEHCDEAPFYTLGPLTTDIAPGYDHITSAIGAAMIGWYGCAMLCYV
TPKEHLGLPNKKDVKDGVITYKIAAHAADLAKGHPGSQYRDNALSKARFEFRWEDQFNLS
LDPDTAREFHDETLPADGAKVAHFCSMCGPKFCSMKISQEIRDVAEAERGMKEKSEEFAV
QGSEIYS
>KACEBFPM_01958 Thiamine-phosphate synthase
MIVITNPNTISNEINTIHSLFESGLELLHVRKPDFSEVKMSAFLSEIKLEYHQKLVLHSH
HQLASEFEINRIHFTEKSRIETAEEILKTNKQIGFTLSTSVHKIADFEALSSLFHYALFG
PVFKSISKPNYISNLDFKKELEKRTNNKTALIALGGISSESITTALKYGFNDVALLGSIW
NSNKPIEKFKLCQQIALSY
>KACEBFPM_01959 Thiol-disulfide oxidoreductase ResA
MVSLYKEFHSKGLNIIGVSLDKEATHWKEAIAKDKLTWIEVSNLKEWNDPIALIYNIESI
PTTYILDASGNIVAKNLIGNELKAKIAELLAK
>KACEBFPM_01960 hypothetical protein
MKKIILIALSAFVMSCTGIIGNGFKISGEIKGLADGTNVFLEKQNSSAAAGGPITIDTVQ
VKNGKFTFEGKAEEPEIHSIRFDKTQGGFIVVVEKGNINVIINKDSIQNAKVSGTFNNDE
LVKYNAEMMKIQKRMMAFQNTNMSVMQTASEKKDTVVINKLRKEYTAFQEEFTTTNYKYI
ENNPKSFLSVLLVEGMFNDPQANFEKIKKYYSALDADVKATKPGKNIETKLDAEKKNLKK
>KACEBFPM_01961 hypothetical protein
MKNCYCNKNKLFSECCEPYILGAKKAPTAEALMRSRYAAYCISDVSYILETTHISTRKFH
KKKEILAFASQNEWVKLEIVNVTETIVTFNAFYLDSKQKYAMHCEKSTFKKEGDTWFYVD
GEWD
>KACEBFPM_01962 hypothetical protein
MRIVVFFVSLFFLLVGAKDSSFAANCHSHVLYSSAKTFVSKLNAGFMNEDFDFTMIDDTD
LDEDYLTSHDVTENKLFLKKYNIQNIWFLPKFCSSTIKSCNNRFKIFSNFCGYSYPIYIS
QRVLRI
>KACEBFPM_01963 Efflux pump periplasmic linker BepF
MKKNVLFIGVMALLCLTSCTTKKQEKEEAIKFTVTNAMVIDTSFTKEYVSQIKSVRNIEI
RAQEKGFLQNIYVDEGQYVAAGQLLFRIMPKLYEAELLKAQAEAKGAEIELLNAKSLADK
NIVSKSEQALAQAKLEQARAEVAMAKLHLSFTEIRAPFAGTIDRLPKKLGSLIDEGELLT
SLSDNSKMFAYFNVSEPEYLEYQANVKGRGSNTVGLLLANGKPLKYKGRVELIESEFDSE
TGNVAFRSSFPNPDKLLKNGETGKVLMTIPVINALVIPQKTTYEIQDKKYVFVIDKNNIV
KSREITITGEMTDLYVVKSGISATDKILLEGVQKVKDDDKIVYDFEKPETVLSHLKLHAE
>KACEBFPM_01964 hypothetical protein
MAFLVALSGPKCSSSILACTASMTTMASSTTTPIANTRANSVTKFIFIPKKFIKANVPTS
DTGTAIAGIIVERQSPKNKKTTNPTRINASIKVCSTFSIEASKNLEAS
>KACEBFPM_01965 hypothetical protein
MVKDAKGCTVSSTVYTINALVPVAETNTQVNNKCFGDTAGSVTITPSGGVAPYVIQWNGV
GPFTSTTTYSGLAAGTYSYIVRDAKFCTKSGSVTITAPLQIAYTAVVNSIICGSGTTYTL
GSICVNGLSGGVAPYTYTLVDLTGGNPAQTHIEPLGAAYCFPNIDFGLYNLSVTDANGCT
IVKSNLAMASPPGGLTFAISSIATCGAGASLTATISGGITSAGPYQFGIVTQMNSPYSLN
FFNAVPGTPPSYTFTGLIPGATYTIVVRDIISNCYYFHTAPVTNTNSTLTAVVTPKNVSC
KGAADGALSFTLAGMGAGVTQFTYQVMNSFTNLPFGSPIPITISSPFTFPYTTVPLPVGT
YTILVRELDGTNGGCGKTFGKFDILESATNLVLSATTTNDNCNVNAGVITPTVSGGTGPY
LYQYLPTGSSAPTATLPGAWTATNTFNGESGTYDVYVRDAYGCIKTVPVTIGLDPSPIIT
ANLVDACVAQGTYKINVAMPTAGMPPYTFSIDGGAFVANTTPFIISGLSSGVHTVQVKDK
NGCGNTVSVTILTPLIVSAVFTTQPTCFNNNGTITASASGGSAPANYTYTLLSNASVVLA
GPQAIPVFTSQPAACYIIRVTDSATGCSANTPFCLTVPTPVTFSTVPKDVTCSGGTNGTI
TVNLTGLSDNPPYTYQITAGPVTTIIQSSNVFTGLPAGTYTIEVVSGRTCKLIDNNVIVG
IPNPIVVPPATITQFGCAAGTNTVNLATIAVSGITGGSGVYTNYEFVLGGVVLQTGSSNT
YSTSNAAGGIYTINVSDSKGCLGTATAVINPYISISNPTVVVNNPITCTTNEQITVSVAV
AGGVPPVFSYTVTGYPTNTIPYNVTQNTPTFAGLTIGNYLITVLNTVTGCSVQTVHYVFN
PNTFSLLINNIVDVTCIADNNGSANITIIDDDVTPTNDAGSFNYTILNSLGATVASGVSA
SAGPLTITGLTSGIYTANVTLVNPPRCSVTKNFTISGPTSGLAIATTSSPITCVGANNNG
TITASATGGWGAPYEFQLQIGASIVTAYNANPQFIGLTAGTYTVFVKDGRGCKLPSTNIT
LTNPTIINASVAAATPNLACFGDKTSITISNIVGGQGSNYSYTIKGPLPTIQSGAFPMPA
SGTVTIPNLAVGNYDIEIRDGWNCSNNFPIVIAQPTVVSASLTQTNILTCAPGSASVTLT
GSGGTPPYSYSATGIAGSFIGSFNPSILISGLNAGTYSYYIQDANGCKSLASGDVKITAL
EPLVLKLLSTSQTNLNCFGDTGVINVVAQGALGNYVYTLTNIVTGAVVTNATGSFASLPA
GNYQVAVVSGNCNIPPISVVIAGPIKFEVSSFSELPVTCFGSRDGQIILKIKGYVGPGPL
EYYITTSNPVVYSSQTLQLPVTQTPPVTNPITSFDPLVWYATIANLPSNTVSSAPGVIPV
VYSDFYSIHLQNGPSGCPADLTNLFIKRPEPIAARLNTPVVQALCLGDTASFSITIAGGN
PDYSVSLDSSTGPFTLGSVGQTVFSFTALNGGTHKVYIKDKNGCTENIVVVLNKPANFTP
IVNHDCVLNAREYSVDVNSTPRNQVATYSLDGVAYNSTSIYTGLTPGLHYVDVNVAGCIK
RVMFTVEAPIVLTVSNGGLNEIVATSTGGSGGNSYTFNGHNNGTNSYIITETGVYTVKVT
DSDGCYDEKTFPKTFVPITIPNVYTPADGSGWAPLNTSNYPNLMIRVYDRYGRLVVELPE
GQKWYGKYNGQELPSGDYWYVVKVDDRNSDEFVGHFTLYR
>KACEBFPM_01966 hypothetical protein
MKKFLIAIVLLSFTKNFAQELNVPPATQYLADNPFVIAPVYAGIGDNFRIRLNGFAQWVG
IKDAPRNQALYADFRIAKQSGIGLSIYNDKNGYTRQTGLKLSFAHHIILDYYSKQYLSFG
LSYNFNSFRIDTQNLDYNPLVLNDRYTGNDNFDVSLLYRKKAFYIAFSTSNVLNKNIEKF
KSSPINLEPNLLRNYQVYTGYTFRGNRDSRTEIEPSAFLQYFQSDGRSSTDLNVKLRYLD
NQRTGYFWVGATYRFLNDQPMKPLTVGPMLGLKKEGFYMGYSYQLTLNELSAYNSGTHMV
TLGFDFLQKASNCPCTQKENNDN
>KACEBFPM_01967 Phosphoglycerate kinase
MVQKFKQHKANTQYKSMKTIYDFNFHNKKALIRVDFNVPLNESHNVTDASRIEAAKPTIN
KILADGGSVILMSHLGRPKGIQAQFSLQHIVAKVSQILGISVQFSPNCIGEETEKAALNL
KPGEVLLLENLRFYNEEEAGDIEFSKKLAKLGDIYVNDAFGTAHRAHASTTIIAQFFPDY
KCFGALLAKEIESINKVLKNSEKPVTAVLGGSKVSSKITVIENILDKVDHMIIGGGMTFT
FIKALGGKIGNSLCEDDKIELALEILRLAKEKNVQIHLPVDVVAANSFSNEAETQIIDIN
NIPDGWQGLDAGPKSLESIKKVILESKTILWNGPLGVFEMSNFANGTIQLGHFIAEATKN
GAFSLVGGGDSVAAVKQFGLEDKMSYVSTGGGAMLEMLEGRVLPGIAAILD
>KACEBFPM_01968 Membrane-bound lytic murein transglycosylase D
MTYKKFTFLLLLFSITNIFAQDIVLHDSIKKPELKLSFLDSLKTTYVIDEMSACVDEKCF
KELTNEDISKELLADLKNINLDEKVDFELSTELLKERLRLMDEKSPFNIEYNVGLENIIK
SFLKNRKRSFQRLLGISQYYFPMFEEAMAKYNVPLEIKYLAIVESALNPKAVSRVGATGL
WQFMYQTGKQYKLRVNSYIDERSDALKASEAAAQYMSNMYKIFGDWELVLASYNSGAGNV
TKAIRRSGGHQNFWNIKKFLPRETAAYVPMFLATMYIFEYHKEHGIMPEKAIANHFATDT
IAIKSKMSFKQISQLLDMPEAQIEFLNPSYKMKVIPYVTNETHFLCLPKDKIAIFASNED
KMYAYVNYEEKNRERPFAEKPKAKIMNNSITQNNEVAEVLVETKTIIKNVSKTKFYKVKS
GDNLSDIARKYNIAMSDLKKWNHLKSNNVQLGKSLKIIIDERIAVVQKVKKPTLDANLEL
KSESTVDKTVAVLDKPVSKKEIIRKEKMAKADAVLEKTAVVLDHIVKQGETLSSIAKENK
LYVADLKKWNNLKDANIKLGDKLKLSNATSLAIANEVVKPSTETAFYTIKKGDNISLIAK
KNDVTIDDLKQWNDLEDNVIKVGTKLKIEKVLEVVAEVSKKETKKKSKYEEQKLYVVQKG
DSLFSISKKHNTTVAYIKKLNDIKDENLQPGMKLKIKG
>KACEBFPM_01969 Acetyltransferase
MTLLAFKIKPFKEISTQELYEVLRLRSEVFVVEQNCVYQDIDSKDQEAIHVLGYYNGELA
AYCRLFDAGNYFDNASIGRVIVAQKFRGKKWGNNLIVEAITVIKQCFGKREITISAQLYL
QKFYESHGFAKTSEMYLEDDIPHIEMKKY
>KACEBFPM_01970 Peptidoglycan-binding protein ArfA
MRHFLFLLLFLSFSEAIMAQEEIIHSIYFDFDKFKLEEKQANETVNFIKNIDSTRIESVQ
IYGYCDDRGKESYNFKLSNNRASIIQKKLVESGIKNKIIVTIEGKGRVMIDDDIIENLPE
VRSKNRRVDVVVNMKPLPKIKIPGMFDMVQKNHILGDRIFLGDVLFQKGSSKLNVNAKND
LEKIAKMLLKYKNLQFEIQGHVCCTPPYQKEAIDRDTRKRELSINRAKVVYNFFVAKKIS
KNRMIYKGYGTGKPLGKEPQYDRRVELVITKV
>KACEBFPM_01971 putative adenylyltransferase/sulfurtransferase MoeZ
MQLYNTLSAEERAELIDQAGKQRLTLSFYAYAKIENPQQFRDDLFLAWNKLDALGRTYIA
KEGINAQMSVPAENFEAFRETLEAYDFMKNIRLNVAVEHDDHSFLKLTVKVRNKIVADGL
NDETFDVTNIGVHLKANEFNQILEDPNTIVVDFRNHYESEIGHFKGAITPDVETFRESLP
IINEQLKDFKEDKNLVMYCTGGIRCEKASAYFKHQGFKNVFQLEGGIINYAKQIKEENLE
SKFIGKNFVFDHRLGERITNDIVSQCHQCGKPCDNHTNCENEGCHLLFIQCDQCKLAMEN
CCSSECQEIIHLSLVDQVKLRRGIKNGNMIFRKGKSDKLLFKHSGELSDVTLAKAIDTKD
IRQKIKTKKVLIGKAEHYYVKSEIGSFLIENKELKIGDKVLISGPTTGDQQLVLEKIFVN
GKEDSEAKIGDKITFHIPFRVRLSDKLYKIIA
>KACEBFPM_01972 hypothetical protein
MACTSCSTSDGGAPKGCKNNGTCGTDSCNKLTVFDWLSNMTLPGGQAPFDCVEVRFKNGR
KEFYRNSEKLTLSIGDIVATEASPGHDVGIVTLTGELVKVQMKKKAVNHEGEVAKIYRKA
SQKDIDIWSTAREREEPMKVRAREMAIALKLQMKISDIEFQGDGSKATFYYTAEDRVDFR
QLIRDFASAFSTRVEMKQVGFRQEAARLGGIGSCGRELCCSTWLTDFRSVNTSAARYQQL
SLNPQKLAGQCGKLKCCLNYELDTYMDALKDIPDMETKLSTEKGDAICQKIDIFKGLMWF
AYIGNFAQWHILKVAQVKEIMAQNKEKIKVTALEDFAVEIEKPAVEKTFQNAMGQDSLTR
FDQPKKSNNNKKPNRNRRPEIVGKEKNVNVAPKVIQKITPNLKPNKPEQVKLKPNNPNQN
KANSNNPNQNKANQNNPNQTRPTQPKPKTNGPKIRNEKKDSNK
>KACEBFPM_01973 Gliding motility lipoprotein GldH
MKRKILTNSFLLFFVAFGFISCDKSQIFDEYHTFEDGWKKNSIINFTFNQSASNEPRNLF
INIRDNNHYEFSNLFLIVKLESPSGLIKVDTLEYQMAYPDGNLQGELIGNGFSDIKESKL
WYKENMIFPKTGKYKVSIQQAVRQTGKVKGVEKLEGITEIGFRIESLEKK
>KACEBFPM_01974 Penicillin-binding protein 1A
MAQKLNTQKPDYSQYVKKFWKYFFIAFGGILLFFLLASWGLFGSMPSFSELENPESNLAT
EIISADGVTLGKFYNENRTPIKYKDLPKHLVDALISTEDERFREHSGIDGKRTLSATLSL
GRRGGASTLTQQLAKLLFHGEGSKFLPFRMIQKVKEWIIAIRLERQYTKDEIIAMYLNKA
DFINTAVGIRSASKVYFAKEPKDLTVDEAAMLVGMLKNPSLFNPLRREEKVRERRNVVLK
QMEKNHCLSKSAKENFQSKPIKLTFTPEKYNEGSATYFREYLRDYMKNWAKENKKEDGSD
YNIYSDGLKIYTTIDSRMQLYAEEAVKEHLKNLQEEFFLEAKQNKTAPFIRITQPEIDKV
MSRSMRNTERWRIMSEEGKDEAEIIKSFSVKTKMTIFTWDGDKEVEMTPTDSIRYYKHFL
QPGLMSMEPQTGQVKVWVGGIDYRYFQYDHVGLGARQVGSTFKPFVYATAIEQLGMSPCD
TIIDGPFRIYKGKHNVTEDWEPRNSDGKYRGMVTLKKALANSINTVSAKLIDKTGPDAVI
ALMRKLGVNSQIPSQPSIALGAVDITVKDMVAAYSAFANQGIYMKPQVIARIEDKNGNVI
YEPKMESRDVLSKDIAYAVIKLLEGVTESGSGARLRGTGSGGYAYKRVTGYPYGFTNPIA
GKTGTTQNQSDGWFMGMVPNLVTGVWVGNEDRSAHFRTIANGQGATMALPIWALFMKKCY
ADPNLHVSKESFERPKNLTINVDCATERKRIRDTTARDSTAVKPEEQNTDEFGI
>KACEBFPM_01975 Outer membrane protein assembly factor BamA
MEKQVNRLNNLFNTVNSTKLVLLFLFLGSAVQVNAQDRVPFDQGKTYILKKVSVTGKITY
NEQTIVTFAGLTKGESITIPGEEISNSIKKLWKLGLYNDVNFYIDKIEGDSISLELNINE
LPKLKEVKFIGIKKGKLESITKDTELTPEKIVNENLITTTKNYIENKYKKEGYYNTKVNI
ATTEDTETINHVNMVVNVDKGKKVKVSKITVNGNTQFTDEKIRSAMKNTKQQSVFRILKS
SKYIKDKYKEDLTSIINKYKENGYRDARIISDSVTYEKEKNTVAISINVEEGNKYYFGDI
KFLGNTIYNDQLLGRVLGIKKGDVYNGVLLEKRIADKSSPDSEDLTNLYQNNGYLFSTIN
PVEVSTANNIINMEIRVTEGPLAYFNKISVVGNDKTNDKVIYRELRTKPGNIYSKETLIR
TIREIGQLGFFDPESIKPDFENVDPAAGTVDIKYHLVEKGASQIELQGGYGGGGFIGTLG
LSFNNFSIGNIFNKKSYRPLPMGDGQKVSLRLQASTNFQTYSFSFSEPWFGGKKPISFST
SLAFTKQFGYDLTYRTDKSKYMNIFSASIGIAKKLEIPDDYFVLSHAISYQHYDLNNYYG
GLFTFANGASRNLAYTIGISRNSKGNNPIFPTYGSDFSLTGKFTLPYSSFSGINYSNLEN
LEEYKKRDTNGARSNQLDGNGNVVRLGDYLDANGNKVDNYNLAAADNAKVDQKKYNWLEY
YKIKFKAEWFTTLYGKLVLRTLGEFGYLGAYNQGRGIVPFERFVVGGNGLGGNYMTSNEN
IQVRGYKDNGSLSVHRSSGDPIYNKFSLELRYPITLKQAASIYALSFVEGAGSYDNFKTY
NPFILQRSAGVGLRVFMPAFGLLGIDFGHGFDAPQGSNEKNGWETHFIIGQQF
>KACEBFPM_01976 Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)
MSLLKDINNSNLPKHLAIIMDGNGRWAKKQGFLRAIGHENGTKSVKVIVEACAKIGIENL
TLYTFSTENWNRPKLEVDLLMKILINSLKKELATLVKNNIKLNSIGNLDNLPKSVQKELL
EVIAQTKNNTRMTLTLALSYGSREEIINAVKIISDKVKNNIISIDSIDDSILNKHLYTHN
LPDVDLVIRTSGEHRISNFLLWQIAYAEFYFTDVLWPDFSEENLYEAIISYQKRERRFGK
TSEQIK
>KACEBFPM_01977 hypothetical protein
MRKTTYILTLFFLFQIANAQTHEIGVFAGGSNFIGDVGSTDYINPRHVAFGLLYKWNVNP
RYSWRLSAMQSKVGGNDFAAANTARKNRGLNFENTITEFSAGFEFNFFDFNLHKFGFVST
PYLYSGVSYYLSDNLYTINKKYYSSGVSGGVALPIIAGFKAKISDNFILGLEAGARYTFS
DDLDGSIPKKKEFKQYAFGNTNSKDWYVFTGLTLTYTFGNKPCYCND
>KACEBFPM_01978 NAD kinase
MKIAVFGQFYQNSTSPIIARLFAFLNQNNIQVVIEEKFAAILIENKSIANTYQKFSSHKD
LDKSFEMLISVGGDGTFLRATTLVRNSGIPILGINAGRLGFLATVQQENIETFLQLVLEK
KYTISKRTLLSLKCASKIEEIKDLNFAMNEITVSRKDTTSMITIETYLNGEYLNSYWADG
LIISTPTGSTGYSMSCGGPILTPEANCLVITPIAPHNLNARPLVIPDNTEIKLKVSGREE
NYLVSLDSRIASVKNEDILTIKKTPFKINMIEIPEETFLKTLRNKLLWGEDKRN
>KACEBFPM_01979 hypothetical protein
MNTLSDYINNDYKPLDIHESIGMAQDFFVETPFSHFPVTEEGVFIGNLSSDDIETFDFDK
KIIDYKYTLEQFFAKSNSIWLEILEDFAKNKTTILPIIDQSNKYLGYYEIADIISFLNQT
TFLKESGSIIIIEKNITEYSFSQISQIIEGNNGKILGLFISDSTGAKTQITIKIAAGGIN
EIIQTFRRYDYEIISDHQEDNYINNLKERSEYLDKYLNI
>KACEBFPM_01980 hypothetical protein
MLDMVSFCVGTSIFRGTIVFSQEISRFAKLLSVLFIPIVNVSTFLAKISGFAFTFSTILD
SSQTSGFPQLLVSE
>KACEBFPM_01981 hypothetical protein
MKIYTLQSKQNLPITLQQAWDFLSDPKNLKAITPEYMGFIIKSGANKPMFAGQIIQYIVT
PILGIKTKWVTEITHVEDKKYFVDEQRFGPYALWHHKHFLREIPGGVEMEDIVDYKIPMG
ILGQLVHPFLVKPKLKEIFEYREKKLIELFGEFKPQ
>KACEBFPM_01982 2-(S)-hydroxypropyl-CoM dehydrogenase
MKNILLIGGSYGIGLAIAKELESGNKVFVASRTNEGLTNLNVTHIPFDVITDTLDTTKLP
AIIDGLIYCPGSINLRPFKALKIEAFENDLQINFIGAVKVIQTVLPNLTASQQSSIVLFS
SVAASMGMPFHTSVAAAKSAIEGFAKALAAEYAPKIRVNVIAPSLTNTPLADKFLNNDEK
KEKSALRHPLKRFGTANDIAQMASFLISNNSSWISGQIFHVDGGMSTLLVNN
>KACEBFPM_01983 Deoxyribodipyrimidine photo-lyase
MNIFWFRRDLRLDDNVGLFHALNSDQTILPIFIFDHNILSQLSKDDARVTFIHELLSKMQ
KKLQEKGKSLAIFYGKPSEIFEKLISENKVKTIYTNHDYEPYARKRDKELNQLFANHNIQ
FLTSKDQVIFEKSEVTKDDGKPYIVYTPYTNKWKEKFKQTTLKNYNSENYLEKIVTHPYP
FLSLESIGFETSKITVASYDISENLIDNYEATRNFPSLNKTSFLGIYLRFGAVSVRKMMQ
EAIKSKNETFFKELIWREFFMQILWHFPHTINKSFKEKYDAIIWENKEDLFQKWCQGKTG
YPFVDAGMRELNATGHMHNRVRMIVASFLCKHLLIDWRWGETYFATKLLDYEQSSNVGNW
QWAAGSGVDAAPYFRIFNPTEQIKKFDKDLKYIKKWIPELQTSHYPEPIVEHKFARERCL
KVYKEAVG
>KACEBFPM_01984 Response regulator rcp1
MAKSLNILLIEDDTIEIMKFNRVLKTIEANHKIIEANNGEEALEILKEKENTPDIIILDL
NMPRINGIEFLGILKQDPVLKYIPAIILTTSNNHTDILECYKIGIAGYVLKPLKYDDYVD
RIKKMLDYWSINELISQ
>KACEBFPM_01985 hypothetical protein
MYGIVNKAIEDLVIANFGEAKWNAIKDRTGIDIDFFISNEPYDDEITFKLALAVSQEMNM
TINQVLITFGEWWVIKTTSEKYPGLMNSGGNNLRDFLVNLPNFHNRVMLIYPKLTPPEFK
ISNITENGLNLHYFSKRQGLQEFVRGLIQGLGKMFNTQVTIALIQTRNQGSTHKIFKINW
>KACEBFPM_01986 hypothetical protein
MAAELTTGAMVMLHIQKSKQKISMLVANNKGNFTKKATGRITFICNDGHLIEEAVKKTIE
TGEGQTFWMKSIGTNEKGEQVSEMDFEWSIRLK
>KACEBFPM_01987 Epimerase family protein
MKVLITGATGLIGTVLTELLLQNGIKINYLTTNKQKITHQPNYNGFYWSPESGVIDENSL
IDVTTIIHLAGASIAKRWTPKYKQEIIESRVLSANLLYNALKNNPHQVKQFISASAIGIY
PDSLNNYYTENFTKFENTFLSNVVIKWEESVNQIERLNINVCKLRTGLVLSTKGGALPEI
LKPIKLGVGSAIGSGKQMQSWIHIHDLANMFLFALQNNLQGIYNAVAPNPVTNYELNYTA
AQILDKPFFMPNIPRFIIKLALGEMHTLLFESQNVNAKKIEQTGFEFQYKSIQSALKQLL
KK
>KACEBFPM_01988 Protein GrpE
MTTENTEIDKELDEITLSENANGEQLIIEELSVEEQLTKDLANEKDKFLRLFAEFENYKR
RTTKERIELFKTANQEVLQAMLPVMDDFDRAIVEISKSDDENLIKGVELIHSKLKDTLFS
KGLEIVEIKTGDAFDADFAEAITQIPAGDKLKGKVVDVIEKGYKLGEKIIRFPKVVIGN
>KACEBFPM_01989 hypothetical protein
MIPENSIFLFENKKGKSYQCDLTDSIIICFGETISSYKVQDFLIFQRKVNQVAVLDMLYN
LSDSCDSTLIEATKRNFSKNLTICEIVQLRELLNGTKFTLVLHSMLHAVLNDVLV
>KACEBFPM_01990 putative bacterial non-heme ferritin
MKDLLRKQTSLKEEIEILLNTQSKIESDASSKYLAMASWLDRNGFQNTAEYLYKQSVEER
EHFLKIFRYITEMGGVAITPTVGEVQQEFSSLKQVFEVALQNEIAVTNAVNKVVAKCRLE
NDYATEEFMMWYVKEQREEERNARRALELFDLIDENAASGRFELDKQIAKIGSQE
>KACEBFPM_01991 hypothetical protein
MSTVEFPKKALFICNGSKCGKHKEIKKQFKSSIKEGGLHKTIEIFKIECSGRCKYAPIVY
AQPQNNWYENVDLEKAKKIIEKM
>KACEBFPM_01992 Imidazolonepropionase
MKTLIINIKELLQVRDNHIDKVSGTEMGVLPKIDDAFLLIEDNLIANFGSMSNCPTIKTD
QTIDAKGKIVLPTWCDSHTHIVYAGNRIQEFVDRIKGLSYEEIANRGGGILNSAKNLNQT
SEEDIYNQSKVRLEEIMQQGTGAVEIKSGYGLTVDGEIKMLRVIKKLAANYPIKIKATFL
GAHAFPSEYKENHADYINLIVNEMLPKIAAEKLADYIDVFLETGYFSVQETEKIIEAGKK
YGLIPKIHVNQFTAIGGIKSCVKHEALSVDHLEIVTNEDIENLKGSKTMPVALPSCSYFI
SIPYTPARKMIAAGLPLALATDYNPGTTPSGNMNFVVATACIKMKMTPEEAINAATINGA
YAMGISQTHGSITKGKSANIIITKPLTTYYEMAYSFTSNLIENVFIEGKII
>KACEBFPM_01993 Cobalt/magnesium transport protein CorA
MRKIKYKKGKKVVPAFLEYTGSHKNVVTEMQLFVYDSEKLTECADHKCQNLLSIIDFSKV
NWLNIHGLNEILVIKEVGDFLKVDNFMLGDILNTTKRTKLEEYHDVLFFNVKSLLPIENS
DNINVEQISFLLKNGILSSFQEKKSDFFTHIRERIRTHSGIVRDKKADYLLYLLLDAIME
NFYITIENEEDRVETLINLTKTSSKPVILEQIEKHRDNFNFLKRSIIPLRDSLYSIKSMK
DDNVFNAIEKENYSFFERLHQKCLELLEQIEYDITTLDSASNFYFSAQSHKMNEIMKTLT
VVSVFFMPLTFIVGVYGMNFENMPELHWKYGYFVILGSMFVLLLGMVFYFKKKKWY
>KACEBFPM_01994 hypothetical protein
MKTFVSAISEKEFPIIDKIKGGMIRKSIFDFIQKECPNFSENDEIAISELNLFREKYISV
FLLKGVDELNLLEKKVFDAVQSETILTNKIDFDTKKYTFGQQLADNVAKFGGSWTFIISF
VIFLIIWILLNFFVFINKGFDPYPFILLNLILSCLAALQAPVIMMSNNRQEEKDRERAKN
DYMINLKSELEIRMLHEKIDHLIMHQEQALIEIQKVQIDMMNDILNRIEK
>KACEBFPM_01995 Shikimate kinase
MKKIVLVGYMASGKTEIGKLLSKKVNLPFLDIDYLIEESLSKTVNEIFEEKGEVFFRKKE
HEVFKNKINSKQSFILSLGGGTPCYAENHLFLQKDDVISIYLKGSVATLVDRLKMNKDKR
PLLKNLANDELAEFVAKHLFDRNFYYSHCKYTIIIDDKSPFDIVEEIHKILF
>KACEBFPM_01996 Bifunctional protein PyrR
MSQNNILNHQEIEFKIKRIAYQIYETFIDENEIVIAGIEGNGSVFANKIATELKKISPLE
VILCDVNINKRNPNSPITTSIAKKDYENKGLVLVDDVLNSGTTLIYGVRHFLDVDLKKFK
TAVLIDRNHKKYPIKADFKGISLSTSLLEHVQVVFTENQDCAYLE
>KACEBFPM_01997 Thiopurine S-methyltransferase
MKKIDQKYWQNRYQTNDIAWDTGKITTPIKAYIDQIEDQSIKILIPGCGNGYEYEYLIKK
GFYNSFVADYAQTPIDNLKKRIPNCNANQLLISDFFELEGSYDLIIEQTFFCALNPELRV
KYAQKMLSLLSPKGKIIGLLFQFPLTEAGPPFGGSKEEYLKLFSTNFNIKTIETAYNSIK
PREGNELFFIFTKK
>KACEBFPM_01998 hypothetical protein
MVTEACKKNHITVNNQVAKASKEVFAGDKVTFRRDQITYIISVLGIPDNRVGAKLVDIYR
KDETPSESFAHLELLKLSKEHYRKNGTGRPTKKDRRDIEDFGTDTTDKQTDEED
>KACEBFPM_01999 putative FKBP-type peptidyl-prolyl cis-trans isomerase FkpA
MIRFFKVAFIFAMSLMIFSCHKNEDPTPEYVVPFAEQYPRDIAAIDKYLDEYHMDVAVLD
GSYDVTFKKISIMPTPGVSIRNQTDYPLLNKTVNRNGVNYKVYYISLREGTKERPTKVDS
AFVSYKGYLLNETVFDQAQNPVWFTLDRVIQGWRDIMPLFKSGTFATDADGTVNYTNFGA
GVMFLPSGLAYYNGSRGAIPSYSPLIFTFKLKGVNYVDHDYDRIDSKDEDVDGDGDPTND
DSDADGHPNYLDIDDDGDGYSTKSEIKKPTPLSAGQGTSLYYPFSPIVDDPTTTINESEP
KGIPSLSGDGDTPTRLRRHLDKNAKPPYITY
>KACEBFPM_02000 Exodeoxyribonuclease 10
MELKLTRPICFFDLETTGIDIGKDRIVEISVFKIFPNGNKESKTWLVNPTIPIPAQTTAV
HGITDEKVANEPTFNELASQVYNMIKDSDLAGFNSDRFDIPLLAEELLRAGVDFDMKGRV
SVDVQTVFHKMEERTLSAALKFYTGKSLENAHSAEADTMATYEILKAQLDRYPELENDMK
SLSEFTTRKKIADFAGMIAFDKDNEEVFTFGKHKGVKVNKVLETEPGYFSWIQNADFPLY
TKKVLTAIKLRKLNTK
>KACEBFPM_02001 Ureidoglycolate lyase
MKIICIGRNYTEHIAELQNERPAEPVVFLKPDSAILLKQHPFVIPEFSDDIHHEIEIIVR
INKVGKYIEAKFAHKYYDEISVGIDFTARDLQQKLKDKGLPWEKSKAFDGSAVIGDFLSK
KNYNSIENLTFELTNNGTTVQKGNTNMMLWKIDELIAYVSQYFTLKIGDVIFTGTPAGVA
KVNPNDVLEGFLENNKLFRIQVK
>KACEBFPM_02002 hypothetical protein
MAIHYNLAKVYAISDDDKDFVLQIVKLFVEEVPLDVKQIKEGINAKDYDHAYGYAHKINP
TLSLLGMEAAHDEILQIEQWAKNKGKKKEIKEIYKSMSGRIDLALSEIKKNYSLHKV
>KACEBFPM_02003 hypothetical protein
MQKNSLLKYSLTLSFFLFTIITNAQLYGGIEIGSKGIKMTVLDVDNIKRGDYVVKSFWSE
NAGIAKGVAIDGNLAKQDIDNAGAIVLSNYIKIKQDFKVLDENIFIVGSSGVAMAKNTEE
LKDKIKALTNKDLDFIDVQTEGKMLLKGCVPPIDYPNAMVLDIGGGNTKGGYVDVRNGDV
FVFFPVSLNFGTVSLTEEVFKRTWKGTLGEYNEKSFSFLPEVRKQIAAMYAAGSLALEKE
KIFMSGGAVWAFYTLMNGAAKENFSQFKLEDVIDYDAILKNNFVKFEELAKTDKEVEAVL
KTYSQKHLISGSNILQACLEALPNINNKKLYFAKEGRIAWLVSYVADRSKKIKKVF
>KACEBFPM_02004 Nicotinamide-nucleotide amidohydrolase PncC
MKATIVTVGDEILIGQIIDTNSSFIAKSLDKIGIGVHEMLSITDDKQHILQTLSLLQNKV
DVVIITGGLGPTKDDITKKTLCEYFNDKLIINEKVLVHVTQLIEDYFKRPITQVNKDQAL
VPSKCEVLFNQVGTAPGMWLQKENTVFISLPGVPYEMKYLIENEVIPKLIAKYERPFIIH
KTILTYGVGESLLAERIETWEDNLSKFIKLAYLPSPGRVRLRLSARGVDENVLKNEISLQ
VQKLQLIISDCIVGFEEDETLEVVLGKLLTEKKLTISTAESCTGGKIASTITSVSGSSNY
FKGSIVSYATEAKVAVLGISQEKINKFSVVSTQVAEEMATQVQKKFKTNFAIATTGNAGP
NKGDANAEVGTVFIAIATPKGVFSEKFNFGQPREKVIDRALNQALEMIYKEILKNYSK
>KACEBFPM_02005 50S ribosomal protein L28
MSRICDLTGKRAMVGNNVSHAMNKTKRKFSVNLIKKRFYLPEEDRWITLRVAASTIKTIN
KNGISAVLKKAQTEGFIK
>KACEBFPM_02006 50S ribosomal protein L33 2
MAKKGNRIQVILECTEHKASGVAGTSRYITTKNKKNTPDRLEIKKFNPVLKRVTVHKEIK
>KACEBFPM_02007 hypothetical protein
MAKKTVASLQTASKRLSKAIKMVKSPTTGAYTFVEAIMTPEEVDTFLKKK
>KACEBFPM_02008 L-serine dehydratase TdcG
MEHHLGLTCDPIAGLVQIPCIERNTMGAIKAINAAELALETNPKNAKVPLDKVVNTMWQT
AKDMNNKYKETSEGGLAIAVNMADC
>KACEBFPM_02009 3-methyl-2-oxobutanoate hydroxymethyltransferase
MSVAKKDYKRITVKSLIDMKANGEKISMLTAYDYTMAKIVDTAGVDVILVGDSASNVMAG
HETTLPITLDQMIYHASSVVRAIERALVVVDLPFGSYQSDSKEALRSSIRIMKESGGHAV
KLEGGREIKESIKKILNAGIPVMGHLGLTPQSIYKFGTYTVRAKEEEEAEKLLDDAKLLE
KLGCFALVLEKIPAHLAEKVAQSISIPVIGIGAGGGVDGQVLVIHDMLGMNNEFSPRFLR
RYLDLYDQMTKAIGNYVADVKSKDFPNANEQY
>KACEBFPM_02010 hypothetical protein
MKKSTIFILLFTLNISFAQSTKSEITDDKKIFGLSKLWSDVKYNFVNFDLVDIDWDKTYQ
EYIPKVLATKSTYDYYQELIKVMASLKDGHSNVYYTSPDYGRPPLRTKLIENKVLVTNVY
NDTLVSKNIAIGDEILEINNLNAIEYGKKFVMPYQSASTVQDLDNRTFHYAFFYGKINEP
IVLKIKKKDNSVFTTTISRKLKSNDKKQSFELKITKDNIAHLIINDFENKNYRKIFDSLY
VNILKSKALIIDVRNNGGGNGSHGYYILSHLIDEKIPTSKTKTRQYIPLYKASGYSDIFL
EMSPYFLEPVQNKERYLKPVIVLTSVKTFSAAEDFLVAYDNSKRGIKIGQRTGGSTGQPI
SFDLPEGGKMRICTKRDMYPDGKEFVGIGIIPDIEINETIESIQKGKDIVLEKAIEVINK
KPLKS
>KACEBFPM_02011 Ribosomal large subunit pseudouridine synthase D
MTEKIISHKNNLQILHQDNHIIVVNKRVGDIVQGDKTGDKPLSEVVKEYIKDKYDKPGEV
FLGVVHRLDRPTTGIVVFARTSKALTRLNEMFSNRETQKTYWAVVKNKPEKNEAKLVHYL
KRNERNNTSKAHIKEVPESKLASLDYKIIKELNNYFALEINLHTGRHHQIRAQLSAIGTP
IKGDLKYGFDRSNPNGGIHLHARKLVFIHPVTKENIQIIAPVPDDVIWKAV
>KACEBFPM_02012 Aldehyde dehydrogenase
MMNNLPSISQRKDALKKLLKNIIIHEEEILEALYKDFKKPRFEGIVTETSYIISELKNTI
NKIDSWSKPKWVFPSLLNFPSSDYIYSEPYGKVLIISPWNYPFQLAISPLIAAVAAGNTV
TLKPSELTPYTSGILSKIIRESFEVKHVVVVTGDYTIAQDLLKKRWDYIFFTGSVTVGKI
VAKAAAENLTPITLELGGKNPCIVDESANLQLAAKRIIWGKILNAGQTCIAPDYILVHHK
MKSKLINYLIDEIKKALGENPQESEDFARIINLKNWERQLSLIENQNIISGGQSSKNDFY
LAPTLLDEPHLDSPVMKDEIFGPILPILSYQSKTDIESTISKYEKSLSLFIFSENKSFIK
EVLNKYSFGGGCVNDTIIHFSNSRLPFGGVGHSGIGAYHGKLSFDTFSHKKSIVRKGNWL
DLPLRYAPYKNKVNIIKRILNWL
>KACEBFPM_02013 hypothetical protein
MQEMNETKKYLSLEETIDDAFQIWKKTALMGGLAFLFLILILTALVSVGMGYFFNAKELP
ELIKDFNPEILSSNALLIYFGIVIGFTVLISPFVAGMLKMAYDADNGKEVTFSSIYHYVN
SPKFLDIILATATISLFSVLLDNLIKNMLPNTLGEILGFMVSYAISILTFIAIPLVLFKN
LNFIDALKLSCSRILNNFFPVLLLMIIAGIFSIIGIIAFCIGLFFTIPFAYAMQYSIYKR
LG
>KACEBFPM_02014 hypothetical protein
MNDETFIFCLEGVLNIDTNTITKVVKNLEKLAIEDNITSIYKTCDSIEGLEESLNNLLYD
DHNFKDYEIIYLVMLGEGNNICLNQYYYTLEEIAELFEGKMRGKILHFSNAKTLELSQEE
AQYFLDITGALAVSGYGTSYKNINSISIDIAFFKLLQEQDNIVKIVETLYQKNNELCKLL
DFRLYY
>KACEBFPM_02015 Alkaline phosphatase synthesis sensor protein PhoR
MKKKINLLILFSVVVLIALSVMQFYLVKTTYDYKVAQFRAEIKTKIADITNDYSDIDSTI
FNKKDLLYRELAMRYILDPKTRNRIKNAILQNQFKEELTHKLQLKFEQEIPDLKLDFAIV
LNKFVLYNNAKAADTIFAEKPIIGNKLYGDLASLDDAFLVRNYVGTTSGNTLNSDFKLLT
EDALYVSVANWETIILRRMAMILGFAILSILTLISLFVFAIKALIKQKKVSDIKTDFINN
ITHELKTPLATLAISTKILERKEIRDNQQHFDNLVATISRQNNRLQQLIDQVLNNSLEDS
EIKLKKEKINSEVFLNVITNDFKISNPSIAISTEFKTVQTSLFLDKFHLTTAIQNVLENA
AKYGCHHINIRTSLVNNQFNISIEDDGIGISKNKHSLLFDKFYRVEQGNLHNVKGLGLGL
YYVNQIIKAHKGTIMVISDLGKGAIFNISIPF
>KACEBFPM_02016 hypothetical protein
MLLISKNYAIAQKTPEDFGYKQMSFKFQDDKVDLIVISKKGEEKIAKPLFFFCQGSLPRP
VVIYDEKGLYGTLPFNETPFLDDFHIIIIAKPAIPIIANANILGKNFMYLKDKENEIPPK
GYTDRNYLDYYVFRNNFILKQLSKERWVSKKKLVVAGHSEGSSIASKMAILYPKITHLIY
SGGNPFGRIVNILSEERDKENTINYWKTVVENSAVINYNGGDTYKATYSFSLPQRQNLVQ
LKIPILVTYGSKDVAANYNDLFQIEIIRDRKQNFKFINYPDLEHNFFAVNEKLEPIYEKE
NWDKVAKDWLDWLHNSTN
>KACEBFPM_02017 hypothetical protein
MKKALIILFGLMISNLALAQNEVKQDTISKKLEEVIIKTEKKVFTNKNGNLKVDVANSIL
KSVPNTIDLVSKLPNVIIDANKETINIIGKGNPLLYIDNQKVSINDLNALSVDEIKSIEI
INNPSAKYEAEGRVVILIARKLSKKEGFKIDLTETASVKKRFNNYVGINASIKKKKLEIK
ANFNYNQLTIWEGHDIKYEIPEENIISNYDVEAYTKRPQFIFGSGLFYKINEDDYFSMSG
NARVQKDIFGINTKTFNKQNTIENNILTQSSNDNNRVYINLFANYAKKIKSINTQFFSGF
QFSNFNQKMVTLVENSYNNISFEQAQNRNQQFNVSVISGRTDLEKTFKNEIKLEIGGLFL
SANAKTNSDISNLINLTLATSKYNFKEQNISGYSQVSGKIKKVQYSAGFRIENTNIIGKY
TNEILPLIKKDYTNFFPKVQLDIPLDSSKTITLNYAKSITRPNYSATNQGSTYINPYFIY
GSNINLDPTINDEIAANFQYNDKSIRLRYYKNSNPVYGNFKYDNFQNILTFSEKNFDKEM
GLEIDFTIPFTYKFWTVNNSLSFILNKIEDKLALQKESKPYMYYYSNHVFKLPKEYTIST
TVWGLTTQHEGVFERKQPNFLIDLAISKKFLKQWDCTLSFNDIFKNFVYKENFTVNKVSS
KSHYLSDTHEISLAIRYSFGKIKDSEFKEKSINDNENRIR
>KACEBFPM_02018 Ribosomal RNA small subunit methyltransferase D
MRIISGKYKGRRISPPKNLPVRPTTDMCKEALFNILNNNFNFTELRILDLFAGTGSISYE
FASRGCKPITSVDGDMGCVNFIRKTTKEFDFDITPIKSDVFAFLEKNKASYDIIFADPPY
AMEQKDFEKIITLVFKNQLLEDDGMMVIEHSKYTKLNHIENFSYDKGYGGSVFTFFELAH
DEEETGHEDDDEIDA
>KACEBFPM_02019 hypothetical protein
MSSGNATILEKKYKNLVLQVSLTEVSFCIKDTLKDTIDTIRSFSFHKISNPTEIEQSLIK
YFEETPELNTNFDEITVLHNNNLLTFVPSVLFDPQYLGSYLQYNTKVFESDFFAYDLVSN
NDMVTVYIPYVNINNFLIDRFGTFNYKHSFTILVKKVLDFSKNIDEPQLYVHIQSDNFQI
IAAKNQKLLLFNTFDYKTEADFIYYLLFATEQLNLNPETIQVKLFGTVSKESDLYQIAYK
YIRNVSLFFDYNRIENSISQQEYLQNFIPIHTCE
>KACEBFPM_02020 hypothetical protein
MLQTIQIIGLIQGIFVLIILFTNRKDYKKTTFWLLFGSLLSVLLYILGDDKNNLFVKNTD
WFLFDNTLFITFLFLFFKYHKKEREIFIKSDYLFFLPNIFYLILEVFEIQLPKENLNIEL
LEVLLKLTFVIYLGVILYSVFTDKRRIWVTYFVIPIVILLVFSCINDILKIIGLEELSFF
SNQNFDSYLLLIVAFLFYFISFKLLSKGKDILPKNEISKYKNSNLNRKLIEQYKSDLIHS
MEMDKLYLNGKLSIQDVSNELNIPKQYISEVLNEHMETNFQDFINEYRVEEFIKRLKNDP
NNQFTLLGIATEVGFNAKSSFNAIFKKFKGLTPNQFKKNLAENK
>KACEBFPM_02021 TonB-dependent receptor SusC
MSLQETSKKVLYFLILLLSFFSISNAQTSVTVSGLIKDKNTQSVLSFVNVVLKTEKDSTF
VSGTVTNEEGRFSLSKIKSGNYYLEVSYIGYKTSKKSLFVGTLTEYLDIKIIEIEEKTTS
LQEVLVTGKTAEISEKMDKKTFSLKDNISQSGGSVLQAMQNMPSVTVHDGKVQLRGNDKV
TILIDGKQTALTGFGNQTGLDNIPASAIEKIEIINNPSAKYDANGNAGIINIIYKKNKKD
GFNGKFGFTTGVGSLWVQKENLPTIRPQYTFTPKINPSVSLNYRKNKVNVFFQGDYLYTE
TLNKNEFVTRNYDNGDVINSQLKRNRNTHFTTLKSGFDYAINDQNSLTISGLFGSEKIID
RGDQPFFNGDFSQRNRLWQFLEDELKTTIMATASYQHKFAAAGHLLNIGFNYTFHREDEK
YFYDNYLPTSTGTDAFKLLSDEQVYDFNFDYIKPLKYGRIETGIKFRNRNIPTNMQFIPG
TNSVLDANAGGWATYKELIPAVYGNYIFENKKWEGELGLRIEYVKIQYDVNPNHIVYKSD
VYNYTQPFPNLRLAYKISDNNKVSIFYNRRVDRPNEVDIRIFPKYDDAEIIKVGNPALRS
QFTNSIELGYKKSWKKGSLYNAIYHRFADGTITRISSTVAPSHLIYATFQNVNKSYNTGV
EMVLAQEISKLYAFNINLNAYKNQIDAFTVENKYPSTHTFSANKQEIFSGNLKINNTFHF
PKNIDLQLTAIYLAPDIIPQGKIKSRFSLDFGLKKAIQKGKGELFFNATNLLNTMIIKKE
INGQGFNYTSNDYYETQVLRLGYSYKF
>KACEBFPM_02022 ATP-dependent RecD-like DNA helicase
MSASLFYNVLQKKFPFNPTIKQDIFFQQIAEFVTNNTKDQIFVLKGYAGTGKTTVISTIV
NNLIEINKKYVLLAPTGRAAKVIANYSNKPAFTIHKKIYFPKKSSGGGVSFTLQPNKHKN
TIFFIDESSMISDVNTESKLYENGSLLDDLISYVYSGDNCKMILLGDTAQLPPVQLDISP
ALDTDTLSLHYNKDVYSIEFDEVMRQEENSGILYNATELRELLKDVFFNSFKFNLKGFKD
IIRLSDGYDIQDAINTAYSNYSIEDTAFIVRSNKRANQYNQQIRTKILDKESELSTGDFL
MVVKNNYFWLKDSDQAGFIANGDIIEVLDIRNIKELYGFKFANVKIRMVDYPDQKPYETV
LLLDTITSESPSLSYEESNKLYEEVIKDYENETTKYKKFQKVKENEYFNALQVKFSYAIT
CHKSQGGQWNTVFIEQPYLPNGIDKDYIRWLYTAMTRAKDKLYLIGFKDENFVN
>KACEBFPM_02023 3-deoxy-manno-octulosonate cytidylyltransferase
MKIIAVIPARYASTRFPAKLMQDLGGKTVILRTYQAAVETNLFDDVFVVTDSELIYNEII
TNAGKAIMSIKEHESGSDRIAEAIQNLEVDIVVNVQGDEPFINKEPLEEVIQVFRNDTHK
KVDLASLMRNITHKNDIQNPNNVKVIVDQKGFALYFSRSVIPYPREENVGVRYMQHIGIY
AFRKQALLDFYHLPMLSLEASEKLEQLRYLEYGKRIKMIETTHVGIGIDTLEDLEKARSM
L
>KACEBFPM_02024 hypothetical protein
MKAFLKKLLVGKISKKEKIRFNPIEKRILNIRSIWNNDHQEDNGIEKIFRLFLSISQLLF
PGIYIKYFANKKGSEYQDLALDVYILAKVMFPFMILINEWQHNIYIIFVMTYVLLETVLY
IPTLIFASDLFSRPRSYKRSMLLLFFNYMEIVLAFAVLYSCGNYLNKDFTHWFDALYFSI
ITSSSIGYGDFYPVTIFGKFLVSMQALLFLFFVILFLNFFSTKIKSKGYFDHENED
>KACEBFPM_02025 hypothetical protein
MSNTNKLKIFNDPIYGFITIPNPLIYDLIQHPYFQRLRRISQMGLSSLVYPGANHTRFHH
ALGCLHIMQKAIQVLRFKNTIISAEEENALYIAILLHDIGHGPFSHAMEHSIVEAVHHEE
ISLLFMNKLNIEFDGQLNLAIQIFKGEYPRKFMLQLISSQLDMDRMDYLKRDSFYSGVEE
GKINSDRLIQMMNVVDDVLVIEEKGIYSVEKFLMARRLMYWQVYLHKTSLVAELTLTNTL
KRAKELYQKGIAITCSENLLFFIENKISLTDFNDQILNKFAQLDDTDIVGAIKHWQNHQD
FTLSSLSKMIINRDLLKIKMNEENFSKEEIQELIEQFSKANNIAIQEAKYFVFKGKIRNQ
AYSKSAEPIRILKKDGSIEDVALLSDQLSLKALSKQVTKYFLCFPKQLNKN
>KACEBFPM_02026 UDP-3-O-acylglucosamine N-acyltransferase
MKFTAEQIAEILEGEIFGNPKATVFKLSKIEEGTEGCLTFLANSKYTNYIYDTKASIVIV
NRTFVPDNEISTTLIKVEDAYKSFAKLLEFYNQVKNNKTGIEAPCVIAQSAKYGTDFYLG
SFSYIGENVIIGDHVKIYPNSFIGDNVQIGNNTIIFAGAKILSETVIGNNCNIYSGTTIG
ADGFGFAPNPDGTFSKIPQIGNVVIEDNVDIGACTTIDRATLGSTIIRKGVKLDNQIQIA
HNVEIGENTVIAAQTGIAGSTKIGKNCMIGGQVGIAGHLTIGNNVKIQAQSGVGKNIKDK
ETLQGSPSFGYSEYSKSYVHFKNLPKIVTEIEELKKIIK
>KACEBFPM_02027 UDP-3-O-acyl-N-acetylglucosamine deacetylase
MVKQKTINNEISLTGVGLHTGNEVRITFKPAPINNGFSFVRVDLEGSPIIEADANYVVNT
QRGTNLEKLGVKIQTPEHVLAALVGCDLDNVIIELNASELPIMDGSSKYFVQAIEKAGIA
EQEAERNVYVVKEVISYLDESTGSEIIVMPCDDYQVTAMVDFGTKVLGTQNASLKNISQF
KDEIADCRTFSFLHELETLLENGLIKGGDLNNAIVYVDKEISAETMNRLKIAFGKDKISV
TPNGVLDNLTLHYPNEAARHKLLDVIGDLSLIGTRIKGKVIANKPGHFVNTQFAKKMSKL
IKNEQRNFVPVYDLNKEPLMDIHKIMSILPHRPPFLFVDRIIEMTDCSVVGLKNVTMNET
FFVGHFPGAPVMPGVIIVEAMAQTGGILILSSVPDPENYLTFFMKIDNVKFKQKVLPGDT
LIFKCDLITPIRRGICHMQAHAYANGKLVAEAELMAQIAKKQ
>KACEBFPM_02028 Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase
MNQPLAYVHPGAKIAKNVVIEPFTTIHNNVIIGDGTWIGSNVTIMEGARIGKNCNIFPGA
VISAVPQDLKFGGEDSLVIIGDNTTIRECVTINRGTIASGQTVIGNNCLIMATAHVAHDC
HVGDNAIIVNGVLLGGHVTIGKYAIIGGLSAVHQFISVGDHAMISGGSLLRKDVPPFTKA
AKEPLSYVGINSVGLRRRGFTTEKISEIQSIYRTLYQKNYNTSQALAIIEAEMEATPERD
EILDFIRNSSRGIMKGYTGV
>KACEBFPM_02029 Elongation factor P
MASTSDIRNGLCIKFNHDIYKIIEFLHVKPGKGPAFVRTKLRSLSNGKVLDNTFSAGHKI
DEVRVETHTYQYLYAEGDQFHFMNIESFEQITLDKKILDNPGLLKEGTNVMVQVNTETDL
PLSVDMPASIILEVTYAEPGVKGNTATNATKSATVETGASINVPLFINEGDKIKIDTASG
SYMERVK
>KACEBFPM_02030 UDP-3-O-acylglucosamine N-acyltransferase
MKFIQTQTLEEIANIINCQYVGDANFPVLGMNEIHVVEAGDIVFVDHPKYYDKALQSAAT
IVLINKNVHCPQGKALLISDDPFRDFNKLTNHFRPFQKSNVAISASAKIGKGTIIQPNTF
IGNNVLIGENCLIHSNVSIYDNTIIGNNVIIHAGTILGADAFYYKKRPDGFDQLISGGRV
VIHDNVGIGALCTIDKGVTGDTTIGQGTKIDNQVHVGHDTIIGKKCLIASQTGIAGCVII
EDDVTLWGQVGTTSGITIGTKAVVMGQTGVTKSIEGGKSYFGTPVQESREKLKQLANIKR
IPEIINKLK
>KACEBFPM_02031 hypothetical protein
MTAKELVKDFYKSNAFLDSKLLDIYMHADVSLDWNSSKGFIQMNKEEMVKIIDQMSKAYH
SSRIYITHLLEDNNKITVRYNHYVKTIENPREEMILANFMVIWEIKDEKLYRGFQMSQLS
>KACEBFPM_02032 4-hydroxyphenylpyruvate dioxygenase
MDMMKEDLTKIENLAIMVDADEDGYLLQIFTKPVEDRPTLFFEIIQRMGAKGFGAGNFKA
LFESIEREQAKRGTL
>KACEBFPM_02033 hypothetical protein
MKKKLLLFSLIISLNTFAQNQGAFDVGEWFKFRIHYGMITAGYATLEVKEAAISNKKVFY
TVGHGYTSGMAKTFFKVEDHYQSFIDKTTYKPYQFLRKIDEGGYTKNQEGFFNQDKNTVL
VKDHKNNTDKSFNVSENVQDIVSAFYYLRNHPNINRLNVGESIMIDMFFDDEITKFKLKF
MGRETIKTSFGKVKAMIFRPLVQSGRVFKEEESLTVWISDDENKIPLRIKASLAVGSLKA
DLEIFKGLKNPFMVIN
>KACEBFPM_02034 Tryptophan 2,3-dioxygenase
MTNKFENIVQEIDEKYKAINQKTEAHLEGLLWAKPITYWDYIQTDALLNLQIQRTTLPDE
NVFIMYHQVNELLFKMILWEIKQLSYTQKPTTAFFTERLMRISRYFDMLTTSFDIMGEGM
EVEQYMKFRHTLTPASGFQSAQYRMIEFCSTDLINLIDHRFRATIDRDTAFEHAFEHLYW
QAAGKDYDTGEKSYLLTEFEKKYKKQFLDCMQEYNTINLWQKFKEIPENDQHNPELIAAM
RHYDYTVNITWVMGHLNAARKYIDNGKGDGEATGGSDWKKYMHPKYQRRIFFPELWSKDE
LANWGENL
>KACEBFPM_02035 hypothetical protein
MELDESKYLYLLFLLPILAAIFLYVEFWKRKKQKEFGDLELVKKLSPEKSNFKPALKFGV
VLLAIAMLILGLVNPKIGTKVEKVKREGIDIVFAIDVSKSMLCEDIAPNRLEKSKQVVSQ
IINNLGSDRIGIIAYAGSAFPVLPITTDYNVAKMFLQSMTSDMVSSQGSNLDEAIKLSAK
YFEGSPNTSKLMIMLTDGEDHSEGAESAAEEAKKIGMKIITIGIGTTAGGPIPNKKNGVI
ESFHRDKSTGEVVVTKLRPEALEAIAKAAKGGYINGNNTEEAVNFIKKSLNNIQKTEFDA
TEVASFQAQFQWFLGIGFFLLLLDVFLLERKTKWVQKLNLFNEKKN
>KACEBFPM_02036 hypothetical protein
MTENDISRVVFESALKVHQALGPGLLESAYEECLFYELKKHNLKVEKQKALPLIYDEIKL
DAGYRIDIIIEDKFIVEIKAVEALTDVHLAQLLTYLRLSNCKLGLLINFNVSLLKNGVRR
VINGTL
>KACEBFPM_02037 hypothetical protein
MTNITFLNPAFFWLFLLLPFAMGWYFFKRKEEKPTLKISSLQGFKASQSVLPKLKPVLFA
MRLLALSALIVAMARPRTVDVSNKRNTTNGIDIVMAIDLSSSMLAKDFKPNRMEALKEVA
ASFVEARQSDRIGVVVYTAEAYTKTPVTSDKAVVLDAINTIKYDNVLQDGTGIGMGLATA
VNRLKDSKAKSKVIILMTDGVNNAGFIEPVTAAEFAKEFGIKVYTIGIGTNGNAPFPYAI
APNGGFLYKMLPVEIDEQLMKDIAKKTGGKYFRAQSNSSLESIYSEINKLEKTEIEDLKF
VNYDEKFRPLVWLAGLLLLIEIILRNTIFRSFI
>KACEBFPM_02038 hypothetical protein
MKLKLYILLLLSFSLFAQKVETSIDTTKNKIGAQFTLTLKTKVKPTSKVVFPKVTNFGSL
EVIESYPIDTIKENDKFELIKKYGLTQFDSGKYVIPRISVLIDRIPVFSDSIKVEVFNVK
VDTLKQKMYDIKPIILVEKPTGDWWKYLLGFLLLLGLGFFGYFLWKKYRKVPEKAIVYNS
PIEKATSLLQLLEKKELLAKGEVKEYYSELTDIARDYIEEAIEIPAKESTTSELILALRA
ASTKKKMKLSKETLLGLEKVLKQADLVKFAKVKPLDFEIADDRERIEKTIVTLDKSIPVI
VDENSKKWELQQQELKLKKEKRKKKMTFAGVLVGIIAFIITYTIATKGFDYVINGFSGYS
TTELLEGDWIKSDYGNPSVIIETPKVLTRLDTKKAVPNDAMALIKDMQMFGYGSLIGEFN
IIVSTIQFKKDTQIDLTQSLNGTIQTLESQGCQNIITKQEEFTTDKGIKGIKGYGTFSNN
KHKMYYEILLFSQSGGLQQIMIAHKEGDENAEKISERMLNSLELQITN
>KACEBFPM_02039 hypothetical protein
MTARYNEAHVKVFEEERELTMMLMVDISGSESFGTKNQLKSEIVTEIAATMAFSATQNND
KIGLILFTDEIELYIPPKKGKPHVLRIIRELIEFKPKSNKTDISQALKFLSGTQKKKAIV
FMISDFITEDDYEKTLKIAGKKHDITGIRVYDIREEKMTNIGLVAMQDAETGETQWVNTN
SASVRFEYEKYYNEKVSYFAAIFSKCGSGTVSTRVDESYVTKLLGYFKSR
>KACEBFPM_02040 Lipid III flippase
MFIFSNYWNQVVFGDNLDYSHVFKVLAIALPLYASSIYLLAIINGLGLFKTVIYINISGN
IIGFFVSLLFIWKWSILGALLAIIITPSLLFFITLYYINKEVSIKNAIKLSLFDFKIIKE
LLHYFLMTLVSGILGPIVFLAIRNQAITIVGLKEAGFWEAMTRISTYYLLFINTLLTIYY
YPKLILAKTTEETKLIFWSYYKNVLPLFALGLFIIYLFRSLMIRILFTPDFEPVGDLFIW
QLVGDFLKATSWILGLQFFAKKMTKAFIATEILSLTILYISSVYFIGIFKIEGVIIAHAF
TYGIYLLVLVIYFRKCLL
>KACEBFPM_02041 hypothetical protein
MKKIIICALIYLSFGFFADTPTLKLAKSSAEKIVNDWSKGKVELIEFTKTDGQFGDMFGV
KTYAFDFKGKVRYNESGYIGKNKGDRNQFVSNVLKIEQKISKSVESYYIKVEKGDLVEIE
GYLDFQKKESGWIHKNLMSQIRLKK
>KACEBFPM_02042 Isocitrate dehydrogenase [NADP]
MAKIKVANPVVELDGDEMTRIIWTFIKEKLILPYLELDIKYYDLGIESREATKDQITIDS
AEAIKKYNVGIKCATITPDEERVKEFNLSKMWKSPNGTIRNIVGGTVFREPIIMSNVPRY
VQGWTKPIVIGRHAFGDQYKATDTVIKGKGKLTMTFVPENGGETQNWEVYNFEGDGVAMS
MYNTDESIYGFAHSSFQMALTKKWPLYLSTKNTILKAYDGRFKDIFEEVYQSDYKSKFEA
LKITYEHRLIDDMVASAMKWNGGFVWACKNYDGDVQSDTVAQGFGSLGLMTSVLVTPDGK
TVEAEAAHGTVTRHYRMHQQGKATSTNPIASIFAWTRGLEHRGKLDNNQALIDFCLKLEQ
VCIETVESGKMTKDLATLVKPEGLTDADYLTTEDFLAAIKENLDKKLA
>KACEBFPM_02043 50S ribosomal protein L19
MADLMKFVQDEFVTRKDFPVFGAGDTITVFYEIKEGEKTRTQFFKGVVIQRRGSGNTETF
TIRKMSGAVGVERIFPVNLPALQKIEINKKGAVRRARIFYFRELTGKKAKIRDKRR
>KACEBFPM_02044 tRNA (guanine-N(1)-)-methyltransferase
MRIDIITILPELLRSPFEASIMKRAIDKGLVEVYFHNLRDYTTNKQKSVDDYPFGGGAGM
VMNVQPIDDCITHLKSERTYDEVIYMTPDGETLNQKMTNSMSLLGNIIILCGHYKGVDQR
VRDHFITREISIGDYVLSGGELGALVLCDALIRLIPGVLSDETSALTDSFQDNLLSGPIY
TRPADYKGWKVPEVLTSGHFAKIDKWREDMAYEHTKNRRPDLLDN
>KACEBFPM_02045 Chaperone protein ClpB 1
MNINKFTIKSQEAIQAAQQLAQSFGQQQIENEHIFKAIFDVDENVAPFILKKLNINVPLF
QQILDSTIQSFPKVSGGEIMLSRTANTMLNEAEIIAKKMNDEFVSIEHLLLAIFASKSKV
AQILKDQGVTEKGLKASIDELRKGERVTSASAEENYNSLNKYAKNLNELAKNGKLDPVIG
RDEEIRRVLQILTRRTKNNPMLVGEPGVGKTAIAEGLAHRIVDGDVPDNLKDKIVFSLDM
GALIAGAKYKGEFEERLKAVVKEVTAAEGDIVLFIDEIHTLVGAGGGEGAMDAANILKPA
LARGELRAIGATTLDEYQKYFEKDKALERRFQKIMVEEPDTESAISILRGIKEKYETHHK
VQIKDEAIIAAVELSQRYITNRFLPDKAIDLMDEAASKLRMEINSKPEELDVLDRKIMQL
EIEIEAIKREKDESKLKILGMDLANLKEDRNEIYAKWKSEKDVVDNIQAIKTEIEDFKYE
AERAERDGDYGKVAEIRYGKIKESQERLDVLQKQLIENQSGTSLIKEEVTREDIAEVVAK
WTGIPVMKMLQGEREKLLHLEQELHRRVVGQEEAIEAVSDAVRRSRAGLQDLKKPVGTFL
FLGRTGVGKTELAKALAEYLFDDENAMTRIDMSEYQERHSVSRLVGAPPGYVGYDEGGQL
TEAVRRKPYSVILLDEIEKAHPDTFNILLQVLDEGRLTDNKGRLADFKNTIIIMTSNMGS
QIIQDKFENLKGSLDAATEAAKVEVLALLKQTVRPEFINRIDEIVMFTPLTNANIAQIVG
LQLKSVTKMLALQGITMDATPEAIAYLSEKGYDPQFGARPVKRVIQRDVLNQLSKEILAG
TIATDSIILLDAFDGKLVFRNQSNTI
>KACEBFPM_02046 hypothetical protein
MQDKQHDNLPVVDGNEVLESEKEVQDSRNEAIETIENLNAEVSEDVTIGESHDIPMPNYD
AMDMESLVAALEKIVVSDKIMAVKNHIEEIKSVFLSKYNHFIEEKKEAFAHENPEFSEEF
DYNFPLKSKFDSLYSEFRSKKNTYFKGLESDLKANLQTRLALIEELKSLINPGENIKDNL
KQFNDLRERWKTAGAIPKDKYNHVWNNFHFHVENFYDYLHLDREARDIDFKHNLEAKLKI
IARAQELINESDVMKAFRELQSLHKIWKEDIGPVSRENREEIWAVFSDFTKQMHDKRELI
FEKQRGSEVENLNQKKEIIAAIDAITSEKITVHSGWQAQVEKIEALRDRFFSAGKVPAEV
NEETWSDFKNAVRNFNVHKNSFYKDIKKDQNTNLDKKNALVTRAKELQESTDFNVSTPIM
KKIQEEWKQIGHVPKKYSDSVWVAFKEACNHYFDRLHAEKNENEEVELAAFEKKKEYLET
LKSFELVGEHKTDLDAIKSHIETWKNIGKVPFARRHIEGKFNKILDVLFEKLSLSKKDAD
MMRFSNRMDNLSESNDTRKIDNEKIFLTRKVEEVQNEIFQLENNIQFFAKSKKDNPMVLE
VMKNIERHKEELATWKEKLKQIRQM
>KACEBFPM_02047 Thiamine pyrophosphokinase
MSSHHIVRDDQEPALIIANGAACSSELLGQLLEWSPLVIVLDSAIERVLELGIKVDVLLG
DFDRGFDPEYYIDKQFPIEIVHAPDQNKTDLEKAFDYLIERKIPMANVVWATGKRADHTI
TNLTNIVRYRNLLKIVIIDDHSKIFLLPTKFKKWYTANTPISLIPIGIVSEIYSKNLFYP
LENDTLTIGYRTGSSNHVVEDGIVTIEHQKGDLLMMECLD
>KACEBFPM_02048 Ribosomal RNA large subunit methyltransferase F
MKAKIVPEKTNLHPRNLHKFGYDFEALTTCSPELKNHVFTNEYDTQTINFSNPEAVKALN
NALLIAYYNIKNWGIPQDYLCPPIPGRADYLHYIADLLATTNNQIIPEGENVIGLDIGIG
ANCIYPIIGNAIYDWSFVGTDIDEKAIQNCKKIIENNPKLIDAISLQQQVESRFIFKNII
LTDDKFAFTICNPPFHNSAAEATKSSARKVNNLQEIRTKNPVLNFGGQNTELWCDGGEIG
FITQMIYESAKYPMQVLWFTTLVSKRENLSSIYKTLNKVSAVEIKTIDMAQGQKNSRIVA
WTFLSELQQKAWTF
>KACEBFPM_02049 Shikimate dehydrogenase (NADP(+))
MKKLGLLGKNISYSFSQNYFTNKFKQEKNSNDFSYENFDIQSIEEFTKILQINSNLIGLN
VTIPYKETIIPFLDELSQNAKEIGAVNTIRISPNGKLFGDNTDYFGFNKSLKPLLKSHHK
KALILGTGGAAKAVAFGLKKLNIESLFVSRLEKESTITYNEINAKIFDDYQIIINCTPLG
TTPKTELFPDIPYSFFTPKHIAFDLIYNPEKTVFLEKAENKGAIIKNGYDMLVFQAEKAW
EIWNE
>KACEBFPM_02050 Beta-barrel assembly-enhancing protease
MYLSQEEDDQNLSLSKFESMLKTNKVLFFDSEEFEDIILHYLDIGKPALAKKALKLALDQ
HPKSTGLKLVQVEMLVYDDKLDIAEKMLNELYAIEPTNEEIYIQKANICSKRDQHEKAVE
YLKIALKYTDDLPDAYNLIGMEYLFLDNLELAKENFILCLESDPEEQASLYNVVYCFEFL
DQHQEAIEYITKYIETNPYSEIAWHQLGRLNYGLKEYEASLIAFDYATIIDDEFLGAFME
KAKALERLKRYEEAIENYNETIKLDDPTSYALLRIGKCYEKLGNEVQAIKFYNQTVHEDP
LLDKGWIAITDFYFRKKNYPKALYYVNKAIQIDAENKLYWKRFATINKALNLFEEAEYGC
RKAVKHGDYQLDTWLFWTDILQFLGEFEACIQTLLQACEHFPEEFEVEYRLASFYFMLNE
NEKGFFHLSNALRQNFKKRNIIEKLFPVVWEQKIVQDYILRHKK
>KACEBFPM_02051 hypothetical protein
MFLPSAETMVALLSKIAGADVPTISDDTNSLFSEYLICSTSSPSKAYFFMMLFTSSTEVV
LPTSRFKTTSEPLGTGTRIAFEVSFPAKLGKAFATALPAPVSVITMLSAAARPRRYFLCI
LSTKFWSFV
>KACEBFPM_02052 Periplasmic pH-dependent serine endoprotease DegQ
MKKFASLFFVSLLSGATTLGAYKLFMEEDSSSKLSIASGNYAKNVGLNAENIDFTTAAEN
TIHTVVHVKNMSVSNIPSNPMFEFFYGSRGGGQQTQIGTGSGVIISQDGYIVTNNHVVKE
ATQLEITLNNNKTYKAKLVGTDSKMDIALLKIEADEKLPYATFGNSDNLKVGEWVLAVGN
PYNLTSTVTAGIVSAKARDLSNNGIQSFIQTDAAVNPGNSGGALVNTRGELIGINTMISS
QTGSYVGYSFAVPSNLTRKIVEDLMEYGNVQRGILGIEAGELNSATSKELGIKQSTGVLV
NKVSKNSGAEKSGLKKGDIITKLDEKSILSFADLTSYINTKRPNDEIKVGIIRDDKNMTI
PVKLTKKELINYDLKGLELADIDNADMKRLNIKYGVKIENITNDELSGYAEQLKGAVILS
IDNIKATDIETVTKVLSKKAENQRSQIELITVNGQILRFLL
>KACEBFPM_02053 Diaminopimelate epimerase
MKLYKYQGTGNDFIMIDNRLQIFPKQNTALIQKLCDRRFGIGADGLILLENDQSTDFKMV
YYNSDGNQSTMCGNGGRCLVAFAKKLNIIKNKTTFIAIDGLHHATINENEIISLQMKNVE
EVNIHDNYVFLNTGSPHHVQFADNLSNFDVKNEGAKIRYSDLYGQAGSNINFVHQTSPTQ
FSIRTYERGVEDETLSCGTGATATAIAMKATGKTNSNNITINVQGGKLEVSFNQENSIFT
NIFLKGPAEFVFETTI
>KACEBFPM_02054 Spermidine N(1)-acetyltransferase
MITLKGNNIYLRALEPEDLHFVFRLENNETIWEVSNTQTPYSRFLIKQYLENAHQDIYEA
KQLRLAICKNNESKPLGLIDLFDFDPKNNRAGIGIIIENTENRNQGIGKEALSLLVNYAF
KKLNLHQLYANIGSNNEISLKLFTTFGFQKIGNKKDWTFHEGKYFDEELYQLIHTKK
>KACEBFPM_02055 Endolytic murein transglycosylase
MNKKKIAIIVSLILIASVAIYGYINIFSNNTKFDKNELYVFVPTGSTYDDVLKIVGPNIK
NINKFKFVAEKRSYNQNVFPGRFLFKKGMSSFQMITALRHNEPLKLAFNNQESLEKLVSR
LSSQIEVDSTTLINSLRDTVFMKKNGFNNETILGMFIPNTYEVKWNISAEKFREKMAKEY
TNFWNKDRLAKAKALGMSSQQVITLASIVHKETVKGDERPRVAGVYLNRLKLEMPLQADP
TVIFAAKKESGDFDQVIKRVRGDMLHSASPYNTYVHTGLPPGPIAMPDISAIDAVLNAEK
HDYIYFCASVTRFGYHDFASTYEQHQVYAKKYAEWVTKLGIEK
>KACEBFPM_02056 hypothetical protein
MKLYPNKYLSLLFLSTSIFAQKSIDDFLKPVDSLLISRRNTIVITEAVAISGAVIGLNEL
WYKDYPKSNFHFINDNKEWLQMDKLGHLYSAYHIGNAGANLLQWSGATKQQQLLYGSTLG
FVFLTAVEVLDGYSQEWGASPGDIIANATGTGLYVSQELLWKEQRIVPKFSFHTTSYAPL
RPNTFGKSLNEQVLKDYNGQTYWLSANVHSFFPNSKISKWLNVAVGYGAEGMISGNKGIS
DLNSSFEDKRHRQFYLSLDADLTKIKTKSHFLKTIFSILNTIKIPAPSVELTSNGNFSFH
YLYF
>KACEBFPM_02057 hypothetical protein
MTKKQIFYIGIFASITILSSGFKPLSSKFFPWFHVFQKEEVFYTVPTETELNQTFFDIPF
TGKTFVGFQQALAVRESQGRYYMVNTLGYLGKYQFGAETLRALGIKDTVFFLSSRKLQEK
AFLANLSRNKWQLGEQIIKYSGKRINGIEITESGILAAAHLGGPGSVKKFLKTNGRRKCK
DGYGTSIKEYMKDFAGYDTSCIEPSEKAKAKHY
>KACEBFPM_02058 Ribosomal RNA small subunit methyltransferase I
MTILGKLYLIPTTLGEMNADDVLPQTIKRAIDFIDYYIVENEKTARKSIKMVHADKKQSE
LKLFLLNKHTDSKEHLDFIKPLLEGHNVGLMSEAGCPGVADPGAVIVKIAHEKGIQVVPL
VGPSSILLALMASGMNGQSFTFNGYLPIDKSEKKQAIKGLEKLSFDKNQSQLFIETPYRN
NKLLEDILQTLQPNTLLCIACDITLPTEYIKTMNVNLWKKQKVDLHNRPCIFIIHKTY
>KACEBFPM_02059 Low molecular weight protein-tyrosine-phosphatase YfkJ
MICLGNICRSPLAEGILRSKLPSNFVVDSAGTGHWHIGNPPDARSIKIAKEKGIDISNLK
GRQFSKQDFSDFDYIYVMDNQNYKDVIALASHENEKAKVKLILNELFPNENVDVPDPYYG
LQDGFNNVYNMLDEACNVIKEKLLKK
>KACEBFPM_02060 Chromosomal replication initiator protein DnaA
MFFFVNITLIILKLSMHTMNKTAESVWDNCLSFIKDNIQEQAYKTWFEPIKSVELTDNAL
YIQVPSKFFYEWLEEHYVKLLKVALTKELGKNAKLLYKIKMENTYGNKLPFTEQLPSAHR
SPVRTQEIDVPVQQKNPELRNPFIIPGIRNLKIESQLNANYSFDNFLEGDSNRLARSAGM
AVANKPGGTSFNPLLIFGGVGLGKTHLAHAIGVEVKEKYPEKTVLYISAEIFTQQYIESV
KKNNRNDFIHFYQLIDVLIIDDVQFLSGKTGTQDVFFHIFNYLHQNGKQVILTSDKAPVD
MQDIEQRLLSRFKWGLSAEIHQPDYETRISILKNILYRDGVEMPEEIIEYVARNIKSNVR
ELEGAIISLIAQSSFNKKEVTLELAKQVVEKFVKNVKREVSIDYIQKVVSDYFQLDLEVL
QSKTRKRHVVQARQLAMFFAKRYTKASLANIGSQIGDRDHATVLHACKTVDNLVTTDKQF
KKFVDDINKKLSL
>KACEBFPM_02061 Acyl-CoA thioester hydrolase YbgC
MREYQFKVRVRYAETDQMGVVYHGNYAQYFEMGRVEWLRNLGISYKWMEENGIMLPVVSL
TMNYKKPARYDDELTVKTIFKSQTSVKIEFDYEIYNQSNELLTTGNSVLVFVDMKTGRPT
LPPEYVNEKLKEL
>KACEBFPM_02062 hypothetical protein
MSRFKVATKLGKYTFSLYCLHNIAVAISKKKKCFNSSLLSLGKLTIVSLIIVVIFSIINY
HTFEILVSSIKTEVLDRLIFYSSFNFSFTYSGGKVGRPVFMSTKTKTEFPVVNNSLLWL
>KACEBFPM_02063 D-cysteine desulfhydrase
MLSINQNIETQNSTITLTIKREDLLHPFVSGNKFRKLKYNILDAKNNNCKKLITFGGAFS
NHIAAVAFACKEEGIKSVGIIRGDELLDKIPSNPTLLFAQNCGMKFEFVSREVYQNKMTE
SFISGLNARHENYYLLPEGGTNELAVLGCKEILTSEDSHFDYICCAVGTGGTISGIINSA
NLNQKIIGFPALKGDFLKDEIRKFAKNNNWELNNNYHFGGYGKVTDELIGFINQFYIDTN
IPLDPIYTGKMVYGVMHLLANNYFPDGSKILMIHTGGLQGISGMNELLEKKRKKKIVFDE
>KACEBFPM_02064 Exo-glucosaminidase LytG
MNKIAFIILTLLLVSCGASKPKVQPKKVVHTTQKAAVKQKVESLAGKVEIKTPQKDSTTP
KTEVLEATQKVRVTTQIVLNYITQFKTVAKENMIRDGVPASITLAQGILESGAGTGDLSV
QANNHFGIKCHKEWTGASIKHDDDTLQECFRSYDHAEQSYRDHSYFLTSRAWYKPLFSLP
KDDYKAWARGLKKAGYATDIKYPDKLIGIIERYELQQYDAEVLGSDFLPKKTSTKEEIID
NANQYTVIKGDTLYSISKKFNITIDELKKKNNIIDNLLSLGQNINVK
>KACEBFPM_02065 Glutamate-1-semialdehyde 2,1-aminomutase
MLYKRSSQLFLEAEKVIPGGVNSPVRAFKSVGGTPIFAKSAKGAYVYDEDGNRFVDYINS
WGPMILGHAYEPVVTAVIEKAKSGTSFGMPTELETEIAKLAVSMVSNIDKIRFVNSGTEA
CMSAIRLARGFTKRDKIIKFAGCYHGHSDSFLIQAGSGAITFGSPNSPGVTSGTAKDTLL
ASYNDIQNVKNLFDANKNEIAAVIIEPVAGNMGCIPPQKGFLEALQQLCHENNALLIFDE
VMTGFRLAKGGAQELFNVQADIVCFGKVIGGGLPVGAFAARNEIMNYLAPLGPVYQAGTL
SGNPLAMAAGLAMLKALNENQEVFARLEEKTAYLAKGIADVLTSNNVVHTINRVGSMVSV
HFDANPVFDFETAKNGDNDTFKKFFHGLLAEGVYIAPSAYETWFISDALTYEDLDFTIRA
VDKVSKNL
>KACEBFPM_02066 putative peroxiredoxin
MSLVGKKFPSIAVDAISEMGDNLKINIFEEATKNNKKVLLFWYPKDFTFVCPTELHAFQA
ALPEFNKRNTIVIGASCDTNEVHFAWLNTPKNNGGIEGVTYPILADTNRNLANVLGILDI
DSTSYSEETDSIIVEGSNVTFRATYLIDETGKIFHESVNDMPLGRNVNEYLRMVDAYTHI
QEKGEVCPANWEAGKEAMTADRNSTASYLSMN
>KACEBFPM_02067 Thioredoxin-like protein
MLVELENDNLAEIINTNNIVVVQYSASWCGNCRIMKPKFKKLASENENVTFVIADAENFP
ESRKLANVDNLPTFATFKNGAFVSQTQTNKAEVLIDFVNEVLN
>KACEBFPM_02068 hypothetical protein
MKLPVIKHLTQFIDENDQDYLVETIEVLEALTEVSSLKDEELDVIGELISNMYGALEVHK
MTKTGMDKKEALNAFMKRVLGSIDK
>KACEBFPM_02069 putative acyl-CoA dehydrogenase
MSDKTRGGQFIVKETKCEAIFTPEDFNEEQLMMRDSVKEFVDKELWAHKDRFEKKDYAYT
QECMKKAGDLGFLSVAVPEAYGGMGMGFVNTVLVCDHISGATGSFSTAFGAHTGIGTMPI
TLYGTEEQKQKYVPKLASGEWFGAYCLTEPGAGSDANSGKTKAVLSEDGKTYSITGQKMW
ISNAGFCSVFIVFARIGDDKNITGFIVENTPDNGISMNEEEHKLGIRASSTRQVFFNETK
VPAENMLSERGNGFKIAMNALNVGRIKLAAACLDAQRRVITQAVNYSNERIQFNTAISQF
GAIRSKLAEMATSCYAGESATYRAAKDIEDRITEREAAGSSHQEAELKGVEEYAIECSIL
KVAVSEDVQACADEGIQIFGGMGFSEDTPMESAWRDARIARIYEGTNEINRMLSVGMLIK
KAMKGHVDLLGPASKVQEELMGIPSFETPDYSELFAEEKEMITKLKKAFLMVAGGAVQKY
GPDLDAHQQLLMAASDILIEIYMAESTILRTEKLAKTNGADKVKEQIAMAQLYLYQAVDI
ITQKGKESIISFAEGDEQRMMLMGLRRFTKYTNMPNVVGLRETITTKLVAENAYCF
>KACEBFPM_02070 3-ketoacyl-CoA thiolase
MKTAYIVKAYRTAVGKAPKGVFRFKRPDELAAETIQFMMNELPDFDKTRIDDVMVGNAMP
EAEQGLNVGRLISLMGLKVDDVPGVTVNRYCASGLETIGMATAKIQSGMAHCIIAGGAES
MSFIPMGGYKPTPDYAVAKAGHEDYYWGMGLTSEAVAKQFNISRADQDEFAFQSHNKALK
AQAEGKFDKQIVPITVEQTFINENGKKETKSYVVNKDEGPRAGTSLEALAGLRAVFAADG
SVTAGNSSQMSDGAAFVLVMSEEMVKELNLEPIARLVNFASAGVEPRIMGIGPVKAIPKA
LKQAGLTLNDIDLIELNEAFASQALAVTRELNLNPDIINVNGGAIALGHPLGCTGAKLSV
QLFDEMKRRGSKYGIVSMCVGTGQGSAGIYELL
>KACEBFPM_02071 hypothetical protein
MHNFEKLKIWQKAMDIAVEVYEVYTLLPNDEKFNLIHQIKKCAVSIPSNIAEGSGRNYDK
EFIQFLGIANGSTFELITQLILAKRLKLVNEDLIQPIINQLVEVSNMNFSFQKSLKEKIN
INIGKS
>KACEBFPM_02072 putative 3-hydroxyacyl-CoA dehydrogenase
MKRIIKKVAVIGSGIMGSGIACHFANIGVEVLLLDIVPRELTDAEAKKGLTLESKIVRNR
VVNEHLANSLKSKPSPIYSQKFASRITTGNTTDDMAKIANVDWIIEVVVERLDIKKLVFE
QIEKFRKPGTLVTSNTSGIPIHFMSEGRSEDFQKHFCGTHFFNPARYLKLFEIIPGPQTS
TEVLDFLTIYGEKFLGKTSVVAKDTPAFIGNRIGIYGIQSLFHLVKELGLTIEEVDKLTG
PVIGRPKSATFRTVDVVGLDTLVHVANGIYENCPTDEQHELFKLPDFVNKMMENKWLGSK
TGQGFYKKVDKDILSLDLDTLEYRPAKRASFATLELTKTIDKPINRFKVLVKGKDKAGEF
YRKSFSGMFAYVSNRIPEISDELYKIDDAMKAGFGWENGPFEIWDAIGVEKGIEIMKAEG
LEPAAWVTEMLASGSTSFYTIKEGATYFYNIPTKSQTKVPGQDAFIILNNIRESKKVWSN
SGAIIQDLGDGILNLEFQSKMNTIGGDVLQAINKAIDLSEKEYQGLVIGNQASNFSVGAN
IGMIFMMAVEQEYDELNMAIKMFQDTMMRVRYSGIPVVVAPHGMTFGGGCEMSLHADKVV
AAAETYMGLVEFGVGVIPGGGGSKELAMRASDLFRKNDVELNVLQEYFMTIAMAKVSTSA
YEAFDTGLLQHGKDIVVVNKDRQIAEAKKHALLMAEAGYTQPIRRTDVKVLGKQALGMFL
VGTNQMVAGKYISEHDLKIANKLAYVMAGGDLSEHTLVSEQYLLDLEREAFLSLCTEKKT
LERIQFMLTKGKPLRN
>KACEBFPM_02073 Organic hydroperoxide resistance transcriptional regulator
MKEKTIDYVLRATWQAVARMYNEEAAKFDGTMATGFALLSIDKETGTPSTALGPRMGMEA
TSLTRTLKSMEEKGLIIRKKNPEDGRGVLIYLTEFGKEKRELSKNTVLKFNEAVKHNVSI
EKLQNFMEVSEIINELIQEKKIFNQTEKIENEAYY
>KACEBFPM_02074 Gamma-glutamyltranspeptidase
MYLKKTFLLLLIISLPTCNAQQTNTGLVTQKAMIVSAREEASKIGIEIIKKGGNAFDAMI
ATELALAVAYPNAGNIGGGGFMVYRKANGDIGSLDYREKAPLKASKNMYLDKKGNIIDGK
STQTAFAVGIPGTIAGIFEVHKKFGSLPISEIINPVIALAEKGVIVTQKQENSLAEYREV
IIKANGKKTLFARNFKQNDTIKYPALAATLKRIAKNGKDEFYKGKTAQKFVNYIQKKGGI
ITMEDMSKYEAKWRTPITFNYHDLKIISMPPPSSGGICLAQIMKMIEPYPIAKFGHNTIQ
TIQIITEAERRAYADRNYYLGDPDFITNPINQLSDSDYLKNRMSNFSLEKATLSSDIAQG
KINFNESTETTHYSIVDSFGNAVSATTTLNDNYGSKLYCKELGFFLNNQMDDFSIKAGTP
NLYGLIGGKANSIAPQKRMLSSMTPTIVEKDNKLFMVVGTPGGSTIITSVLQTILNVSQF
NLTMQEAVNAPRFHHQWVPDVVTFEPNGFPKDTLDALKQKGYLINEKNNPIIGKVDAILI
QPNGNIEGGADKRGDDKAVGF
>KACEBFPM_02075 Long-chain-fatty-acid--CoA ligase FadD15
MTKITRLFDFPYYQLDKQNLPDALVTKYDGVWVKTSTQEYINKANTISRALLRLGIQKND
KIALISTNNRTEWNIMDIGILQTGAQNVPIYPTISEDDYQYILNHCEAKYCFISDAEVLR
KINMIKNNVPTLKEIFSFNDIEGCKNWNELLTLGSDKSNQNEVEERKKAVLTTDLATIIY
TSGTTGKPKGVMLSHQNIVSNALDSSNRIPFEEGTSKGLSFLPICHIFERMILYLYQYYG
VAIYFGESIEKISDNIKEVKPTVMTVVPRLLEKVYDKIYTKGSELTGIKKNLFFWAIDLG
LRYEPYGANGFWYEIQLKIARKLIFSKWKEGLGGNLDLMVSGSAALQPRLTRIFAAAGIP
VMEGYGLTETSPVISVNDMRNKGFKIGTVGKVIDKLDVKIGPDGEILCKGTNVMMGYYKD
EAQTKEVIKEGYFHTGDIGEFDNEGFLKITDRKKEMFKTSGGKYIAPQLLENTMKQSRFI
EQIMVIGDGQKMPAAFIQPNFDFVKEWGVLHQVTLGNTNEEIIANPKVIERIQQEVNSLN
EKFGNWEKIKRFELTPDLWTITDGHLTPTLKLKRKIILEKYQKLYEKIYN
>KACEBFPM_02076 Peptide methionine sulfoxide reductase MsrB
MKYPVEKTEAAWKLELGEEKYRILREKGTEYPHTGTYNLHTQKGTYICGGCKEPLFESNA
KFNAHCGWPSFDESIPKKIQHLKDNTHGMIRTEIVCANCGSHLGHIFDDGPTKTGVRYCV
NSLSIDFK
>KACEBFPM_02077 Peptide methionine sulfoxide reductase MsrB
MKKTIILLVSILSLTASHSQEKKAEKTNSKNKIHKTDAQWKTQLTPEEYNVLRKKGTEAS
FSGKYWNHFEKGYYACAACKNPLFTSDAKFNSECGWPSFDQAIKGSVIYKTDTSFGMQRT
EAMCANCSGHLGHVFDDGPTETTGKRFCTNSVSILFIPKK
>KACEBFPM_02078 2-hydroxy-6-oxononadienedioate/2-hydroxy-6-oxononatrienedioate hydrolase
MKAKKTKHTQIPKIILYTVKIVEFFSLDLVTKLASRIFTMPIKHKTPNRELAMDKNTIQE
TIFIPKINKKIVVYHYGNSPKKVLLVHGWSGRGTQLVKFADELIKLGYSTISFDAPAHGK
SGTRTTLMPEFIASILELEKLYGPFEFAIGHSLGGMALLNSVKQGLQLKKLIVIGSGDKI
EDILDDYVKKLNLKPIIAKKMSELFEKRFGEPMQDYAAYLAAKQVNIPTLVIHDENDYEV
PLFCGKNILKHLPNGEIYVTQRLGHRKILGDTNVINKTLNFIQN
>KACEBFPM_02079 Beta-barrel assembly-enhancing protease
MILAIAVLVASCATNPFTGKKTMALVPDSEIFPSAFQQYGQFLSENKVLVGTKDAQRVEN
VGTKIKVAAERWLTANGKPTYLANYKWEYKLVESKEVNAWCMPGGKIVVYTGILPITKDD
AGLAAVLGHEVSHALANHGQQRMSAGMLQQLGGVGLAVATGNKSQETQQMIMQAYGVGSQ
VGVMLPFSRDNESEADMIGLTLMAIAGYNPENAVVLWERMSAQAGGNAPPEIMSTHPANA
TRIANLKSLLPQAKAEAAKFGVIFK
>KACEBFPM_02080 hypothetical protein
MRAASKVIYFYDLMLLITVFAFGIKPEMFFEAFAVSKRFLYFHFYCSLANFVCNEKQYPV
ITPK
>KACEBFPM_02081 hypothetical protein
MKTLQKGDKKLLNAWAFYDWANSVYSLVIASAIFPIFYEMIFKKRGNNVVYIYGNEIKDT
AMITFVTALAFLIVAIISPFLSGIADYVGNKKVFMRFFCYLGGLSCISLYWFNLENLFLS
YTAYLLGLIGFWASLVFYNSYLPDIAYPEQQDRVSARGFSMGYIGSTLLLIINLAMVMFP
DKFYITADNPDRAREIAMRTSFLMVGIWWIGFSHVTYYYLPKGSSKGHKVTKAIVFDGFK
ELKLVWKQLQQNITLKRYLSSYFVFIMAVQTVILVATYFGATEVNWETSSQQTTGLIISI
LVIQIVAVIGAFITSRASGKYGNINLLIFLNIFWAIFCVFAFFVETPNEFYAVAGFGGLG
MGGIQSLARSTYSKLLPETDDTASYFSFYDVTEKIGIVIGMSIYGIIDQITGSMRNSFVF
LAIFFIIGVILLLRIPRNNALNTKSNTRL
>KACEBFPM_02082 Lon protease 2
MSQQKIITIDNLSLQEFDSEADLIPLLTPEDEEEMANEELPSDLLILPLRNTVLFPGVVI
PITAGRDKSIRLIDAANAGDKIIGVVSQKNEEDEDPTENDINKVGTVAKILRVLKMPDGN
VTVILQGKKRFEIEQVTSTEPYMKASIKEVTEERPTKKDKEFSAIIESVRDLAIQIITES
PNIPTEATFAIKNIDSSSFLVNFVSSNMNLSVVEKQDLLEINNLKERALATLKYMNIEFQ
KLELKNDIQSKVRFDLDQQQREYFLHQQMKTIQEELGGVSQEEEIEEMRAKSKTKIWDEK
TQKHFDKELSKMQRSNPNSPDFGIQRNYLELFLDLPWGKYSKDNFDLKRAQKILDKDHFG
LEDVKKRMIEHLAVLKLRNDMKSPILCLTGPPGVGKTSIGRSIAEALGREYVRVSLGGLR
DEAEIRGHRKTYIGALPGRILQSLKKAGTSNPVFVLDEIDKLSNSNQGDPSSALLEVLDP
EQNSEFYDNFLEIGYDLSKVMFIATSNNMATIQPALKDRMEIIKMSGYTIEEKVEIAKQH
LLPKQLAIHGLTSKHLQIGKKQLEKIVEGYTRESGVRGLENKMAQVIRNAAKCVAMDEEY
NIKVSDDDIVKILGVPRLERDKSENNEVAGVVTGLAWTSVGGDILFIESLISPGKGTMTI
TGNLGTVMKESATIALEYIKANAQLLGLNSEMLAKYNIHLHVPEGATPKDGPSAGIAMLT
SLVSVFTQKKIKKSLAMTGEITLRGKVLPVGGIKEKILAAKRANIKEIILCHENKSDIDE
IKPEYLTGLTFHYVKEMNEVLAIAITKDNVKNAKTL
>KACEBFPM_02083 hypothetical protein
MQKKHLILLLFTIYTSTYSQIGGQGVYQFLNLISSPRQAALGGKIITNYDYDVNQPLFNP
ASINTEMDGRLALNYGNYFGDVTYGTAAFAYTYDRHLETLHGAITYINYGKFDGYDEFKA
ATGQFTGNEIALSLGYAYNIPWTKIYLGANAKLISSTLESYNSFGVAADLAAMYKDDKND
INYALVVRNFGTQIKSYNDTNEKLPFEVIAGISQELENVPIRWHLTLENLQHWNVSFANP
ARSQPTIDGEPIEEKVSFLGNTMRHVIVGAEIFPKKTFTLRLSYNFRRAAELKILEQRTF
SGISAGFGIRFRKFRFDYSYSRYTLAANTSLFGLTINLYNNEQ
>KACEBFPM_02084 Cytidylate kinase
MKKITIAIDGFSSTGKSTLAKQLANHLGYIFVDSGAMYRAITYYALQNEYINQDLFNKEK
LIKNLPQIKLEFQFNPKLGFAEMYLNDANVEKEIRTIKVSNYVSQVAAISQVRAKLVEQQ
QQMGKNKGIVMDGRDIGTVVFPTAELKIFMTASAQTRAQRRYDEMSSNSENVSYDEVLKN
VQERDFIDTHREDSPLVKANDAIEIDNSHLSREEQFKIVLDLVNNI
>KACEBFPM_02085 Xanthosine permease
MSIKNRLIIMSFLQFFVWGAWLITVGNYWFTTKQWSGAEFGAIFSTLGLSSILMPALTGI
IADKWVNAEKLYGVLHILGGLAIAYLPQVNNPTSFYWVIFAAMMCYMPTISLSNSVAYYI
LKDNNYDIVKVFPPIRVWGTVGFIAAMWLTNLSGNKASVNMFYISAFAAMVLGIYSFTLP
KCPPQKLISESDSFLKKLGLDAFKLFGNYKMALFFVFSMFLGGALQLTNMYGDTYLSDFA
KVPQYANSFVVKYSTIIMSISQISETLFILAIPFFLKRFGIKQVMLISMLAWVLRFGLFS
YGNPTNGLWMIIMSCVVYGMAFDFFNISGSLFVETTTDSKMRSSAQGLFMMMSNGFGAFF
GGIISGFIIDKYFTINGKRDWHNIWLAFAIYALVVAILFAVFFKHKHNPKDVENVGH
>KACEBFPM_02086 hypothetical protein
MKRVIVDYSKLTGEILNLLVDKFPDGYDDSNIVRFKNAKNETIEAVEVRTIDTIFLVKIS
TKLSDRIINYDEDDELADHIGDGSIDALKELEIETDDDDDDDDDEKNHANDNDSDDDDDD
KDEPIDDDSDEDDED
>KACEBFPM_02087 Deoxyhypusine synthase-like protein
MKGPISQFIEKHYLHFNAAALVDAAKGYEEHLLDNGKMMITLAGAMSTAELGKSLAEMIR
QDKVHIISCTGANLEEDIMNLVAHNSYKRIPNYRDLTPTEERELLDNHFNRVTDTCIPEE
EAFRRLQSHLFHIWNKAEQAGERYFPHEFMYQMINSGVLQQYYEIDPKDSWMVAAAEKNL
PIVVPGWEDSTMGNIFSSYCIKGELTATTMKSGIEYMMWLAKWYPENCQGKGIGFFQVGG
GIAGDFPICVVPMLYQDMEMHDIPFWSYFCQVSDSTTSYGSYSGAVPNEKITWGKLDIDT
PKFIVESDATIVVPLIFAYILDL
>KACEBFPM_02088 DNA gyrase subunit A
MQYHPHGDASIGDAMVQIGQRELLIDCQGNWGNILTGDSAAASRYIEARLSKFALEVLYS
PKITDWGMSYDGRRAEPNNLPVKFPLLLASGAEGIAVGLSTKVLPHNFNELIDASIKILK
GKPFTIYPDFQTAGIADVSNYNDGLRGGRVRVRAKISQLDKQTLVITQIPFSTNTSTLID
SILKANEKGKIKIKKIEDNTAAEVEILIHLFPGVSPDKSIDALYAFTACETSVAPLGCVI
EDNKPLFIGVSAMLKISTHRTVQLLKSELEIQLSELEEQWHFLSLERIFIENKIYRDIED
KTTRENVIKAVDDGLKPHIKHLKRAVTEEDILRLLDIRIMRISKFDSNKAQDKIESLEGD
IEQVKHDLENLIDFAIAYFTRLKEKYGKGRERQTELRSFDTIEATKVVLRNTKLYVNKEE
GFFGTGLKKDEYVADCSDIDDVIVFLRDGRLMISKVDDKKFVGKDIIHIAVFDKNDKRTI
YNMIYRDGKNGSSFIKRFNVSGVTRDKAYNLTNGTAGSQVLYFSHNPNGEAEVITILLRQ
VGSIKKLKWDVDFADIAIKGRVSKGNTVSKYPIKKIELKEKGISTLRPRKVWFDDTVQRL
NVDGRGELLGEFRPNDRLLIINQSGKLKTIIPELTTHFEQDMVVLEKWHPKKPVSAIYYD
GEKERYYVKRFLVENENKEEIFITEHANSQLEIVSTDWRPVAEIIFAKVKGVQKENQTID
LEQFIAVKGIKAIGNQLTTDKLKQVNLLESLPYDEPVVPVAEELEVLVDEIIHTELDDDG
QITLSLE
>KACEBFPM_02089 Cobalt-zinc-cadmium resistance protein CzcA
MLNKIIEFSIKNKLIIGLFTLLLMGYGSYQFTKLPIDAVPDITNNQVQVITSVPSLGATD
IERLITFPIEQANSNIPGLKEIRSFSRFGLSVVTIVFDDATDVYWARQQVTERLSTVKDQ
IPKGIGSPILAPVTTGLGEIYQYVVRAKNGYEKKYQETELRTIQDWIVRRQLLGVNGVAE
VSSFGGKLKQYEIAIDPNKLQSHNITIADVFTALEKNNQNTGGAYIEKGPTLLYIRSEGL
LSTIENIKDTSIKNTYTGSPLFIRDVADVRIGNAIRYGAMTFNKKGVQSGEVSGAVVMML
KGANSNVVIKNIKERIAQIQKTLPEGVVIEPFLDRTKMVNNAIHTVSKNLLEGALIVIFV
LVLFLGNFRAGLIVASVIPLAMLFAVIMMNLFGVSGNLMSLGALDFGLIVDGAVIIVEAV
LHQLSYHKTTKLSAQQMDSEVSNSASKMMNSAVFGQIIILVVYIPILTLEGIEGKMFKPM
AQTVAFALIGAFLLSLTYIPMVSALFLNNNVSNKKNFSDLIMERIIEVYTKYLKKMIEYP
KTVISSVIALFVLAIVILSFMGGEFIPSLEEGDFAVETRVLTGSNLQTSITAVSQGAKIL
LDKFPEVQKVVGKTGSSEVPTDPMSVDASDMMVILKDKSDWTSASTFNELSAKMAKELEA
VPGVSYGFQYPVQMRFNELMTGARQDVVCKIFGENLDTLALYANKLGKIVNTVNGTSALY
VEKVTGMPQIVINYNRPAIAQYNLNIEDINRIVNTAFAGQSTGLIYEDEKRFDLVVRLAG
EKKQSFSDVQNLLIPTPSGSQIPLSQLANVTITEGPNQIQREDAKRRIVIGFNVRGRDVQ
SIVTELQDKVNKKLKLPVGYYTTYGGAFENLNAAKQRLFIAVPISLILIFVLLFFAFKSV
KQGLLIYSAIPLSMIGGIFFLALRGMPFSISAGVGFIALFGVAVLNGLVLIAEFNRIKKL
GETNLKSIVIQGARIRLRPVLMTAFVASLGFLPMALSSGSGAEVQKPLATVVIGGLLIAT
FLTLFVLPILYIMFEKGTKLEPKNIKKITPIIVLGLFLFFQNANAQEKITINKAIETALQ
NNIKIKSQKLNSDYLQKMTKTAYDIPNTGIISEYGQFNSNVNDLKIGVSQNIKFPTVYKR
QKQLLVAQAKTGEYNEALQIKELTKQVRTVFYEMIYLKEKEKLLQKSDSIYSEFLRKMTL
RFDKGESNILEKATAQNQSGQIKIQLQETQFDYKILQTQFKYLLNDDKDFMPFCDKYKMN
FDEFLDKNTISDQPSIKLKEQEINSSKAEIALEKSKKMPELIGGVYWQTFKTNTTLQDSY
QGIYGQFGVALPLFNSSFKSKEKALEINYKIAENELTSEKINLQTQYQELLQNYKKIKET
ITYYESQALKNVGLVHNAANKKLINGEINYLEWVILINQNIEIQNNYIEAIRKQNETIIN
LMNLTSK
>KACEBFPM_02090 hypothetical protein
MSFSKTVNAKCISVGFTISNKTSLGFTYLPMFTFTFETKPLIGEYTLMLFEIDFVVTKFG
FIPANFNFSP
>KACEBFPM_02091 putative 3-hydroxybutyryl-CoA dehydrogenase
MNYKNITVAGSGVLGYQIAFQAAFHNFNVTVYDINDEILAKAKLKFSSMSDAFKRDLHAS
EADLAVAFRNLKYSSNLADAVKDADLLIEAVPENPSIKIDFYKKLAQVAVAKTVFATNSS
TLLPSQFAQVTGRPSQFLALHFANDIWRNNTAEIMGHTGTNPEIFNDVVAFAKAIGMLAL
PLQKEQPGYILNSLLVPFLTAATSLLVKEVADPKTIDKTWMKATGAPIGPFAILDIVGIN
TVYNINKMASEKSQDPFEIKTTAYLKEHFVDTNKLGVSTGEGFYTYPNPAYKEKDFLR
>KACEBFPM_02092 Oleate hydratase
MNTNQENRKAYFIGGGIGSLAGAVFLIRDAGISGKNITIFESLPHLGGSLDAFGNPENGY
IMRGARMLTMNIYECTWALFKTIPSLTDPTKTVYEETIAFNERVKSNAKARLIDKNRAII
DASKLGFSITDRIELLKLSEASEDKLDNTTISDWLSPSFFETNFWFMWRTTFAFSPWHSA
IEFKRYLHRFMQEFAEVETMTGVRRTVYNQYDSMVRPLEVWLELQGVNFRNNCTVTDLHT
ELNDNQEILASSIEYQEAEKSHQITVHKNDLVFYQNGSMTDAYSFGSMKNAPKPLTKKTS
KGWEIWEKLAKKHSGFGNPAVFNSSIPETAWESFTVTLKDTAFFDKMEAFSGNKSGTGSQ
VTLKDSNWFLSFALNSQPHYSNQPSNVQVFWAYGLHPDRVGNFVGKPMTECSGEEILQEL
CGHLKFDYDTVFGNAICIPCRMPYITSMFMPRKKDDRPLPVPKKSKNLAFISQFVEIPDD
VVFTVEYSIRAAQMAVYELLNIDLKIPPIAPHDKTLKVKMETIIKAFE
>KACEBFPM_02093 hypothetical protein
MKFVCPIFLFFFNIGLVTAQENYPKPIKTKTLLFYIQHSNNYNTYLYDINMNGQTINSID
PIKEYRILYATDSSKRPLTKMQKKLAYGIVLKSSRDNLYKFNLAATDELLFYLNFDKKQP
SKIYVTVNNQKMYLNKMFIQLEKAVLLENINIAYILFYGNDYNSNKAVVEKFILK
>KACEBFPM_02094 hypothetical protein
MKKVLLLLLLTTSLYSQEKKNIKGIVLVFDNPYKNVSVKNLSSNKEVVTNERGEFILGAN
PKDTLLFSSIQLMNLRFIVLEKHFGTSNLEVPMDKKTIKLKEVIIKNSPNINAVSLGIIS
KNQKKFTPAERRLYTAGDFKPIHLLGVLTGCLAIDPIINSINGKTTRLKKEIKIEKNESN
LEFLVNNYYSYLNDNLKLSNDEINKIFYYAIEEKDIQILIDNNENEKIKFLLCDIKSKI
>KACEBFPM_02095 hypothetical protein
MQIILYPSTKQNSMDEKFYVLISKNTASACEPLVYGLKKEKNITIVGENTAGSILSPSIF
DIGQNYYLILPTADYLTSDGNSLDGTGVAPNIKIKSDDALDFVLKELKK
>KACEBFPM_02096 hypothetical protein
MKLTIFYDNYCPNCTKFANHIQKIDWLNLIDFKKLRNENHTNQFKEINIELAKQQMASYT
NKWNYGYISLYLIFLRIPLFWISIPFFWLLKVTKFGQYLYKELALKRKIIPLHCDSETCE
I
>KACEBFPM_02097 hypothetical protein
MIKLIKLLFAILFSINCYSQSITYTGSILNQQIQKKEYIVLLTNQKDPTKVYSEATINNK
FNFINLEIGYYKRCVLFENSKQCDTINLQSNLVDDIITINNVNNLEEVVIASKKPLIQNK
AGILLVNVENSAIMSSGSVFEMLSKMPSVTYNITNNSFKLKGKDNIQIQIDGQTLYLSGN
ELAEYLKTISANDINIVEINSSPSSKYDATGNGGIINIKTKRTKREGFYAGIFYNGTQGK
YYKGNQGAKLQYNTKKNRYLFHYINSSNNNFEKAETNRVFTNNSTNQKTYAKILGKTNTI
NTQFEHQFKKSNLLLISSLSFYNEDISQNTGLDFFSNATHIDSTLISKQQSINSLKDYTF
GVNYKIEKAKSKTTIKSNYVSYNINNQSNLSAYSNPSNYNYATLINKSPNKINLFLSQID
YEYKIDSLSTIELGAKTVFQKIDNINNFYTITNNQEISDYNKSNDYKYKEWILGSYLQYN
RKINKFDFTLGSRIEKSISNGFNQKNNYELNANRTNFFPFANIEYSYSDNSNCNLSYSKR
INRPSFKKLMPFEYYVDPYTKLLGNPNLTPYISHQLEFQYILKQKFIFGADYSYNQNQIF
QTPIQNNQTLETVLTPINIKKGYSFSINSNLTFDFTKWWNFNVNAQLFYDNINSNTNNLN
INRSIWAHQITTTNQLKLPKNYKLEFSSDYISPTIQGSYKTNSIFSINTSISNTFFNKKL
NVSLVANDILNTYKVVNNSIVEGVTSNIKQTFDTRWIRLSLVYKFYSGIKKDNRPADELT
NEIKSRIK
>KACEBFPM_02098 Sporulation-delaying protein SdpB
MNKPFDKKIGITILRVVLGIVILKDFINYFFNRNFLFNNKSIVSYETYLDITKHYNLNWL
YIDFNNPDNTNIFCIIAIAFSLLFTLGVLKKLSTLLIFFLLFIFKIRVIYLIDGGDNVIS
VLLPFLFFTNSYSLIDKYEQFSQRIKSKYESYFNITSVLFSFAIMFQICIIYFFAALHKL
SGQVWQDGTAIYYILNSEDFSASTLNFYLTKPVWLVYFFTWFTILFQFTFPFLVWVKKTK
NIMLLIGVLFHLGIFFLMRIDNFSLVMLACYAIFLSDNEYKNINKKIQSKIFKND
>KACEBFPM_02099 hypothetical protein
MTTKKIFAYSTIVLLSIHFILVLLNQCYQQNWAYFKTKPIEQINSNYINPFFEQNWGMFA
PNPPHGNQYIVVQFYTKKDSTELINIHEKIMQSSFKRFFSLDQRILKYFNSCYNDIIIKK
SNKYSNEEMIKKSHGLQSILNYSRIVLQKQNLFLDKIKSNDSIYMNLYLVNEPLNNIEFS
TIKNEKFYIDIKGLFLTSKSKKNE
>KACEBFPM_02100 hypothetical protein
MKNLKSVMFTALVCAITVASYGSSIGEGVSTKISGNKAPELLGLRRSTTTTTTETTTTTE
TTTTTSSSSSLV
>KACEBFPM_02101 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MPVSVNGGDEIIEMDRMRKLISGYMVASVQTSAHVQSFIEVDVTNIVKWRNKVKDAFEKR
EGEKLTFTPIMMEAVAKALKDFPGMNISVDGDYIIKKKNINLGMAAALPNGNLIVPVIKN
ADQLNLVGMAKAVNDLGNRAKAGKLKPDDTQGGTYTVTNVGTFGSVFGTPIINQPQVGIL
ALGAIRKVPAVIETPEGDFIGIRQKMFLSHSYDHRVVDGALGGSFVKRVADYLEAFDVNR
DF
>KACEBFPM_02102 hypothetical protein
MKIITNISSIKLISIGLAISLFCCLGFSYKIYHDFKITERILNAKKNEIISELKKSKDSL
ELAISENSLLKTDLIIERQKVTNLLDEINNTNIDLASLIKYKTEINRLKNIVASLTKEKL
QLKKNNELLKIQRDSTILVLTQSKKYNDTLVAMNEDLNRVIRKGSKISIINLKTSTLKQT
KSGDLESTDKASRVNLLQITFMVVGNKITKPCEKEYYVQIIDSKNNIIGEKNTKNFGVMI
LNYSYYSLVKFKNESLEVTAEITLENIKKGNYFVNVFDKYNLVSKTTFALK
>KACEBFPM_02103 hypothetical protein
MDKSTKQIRSKYNSNITKSLADKYKISERYVRMIISNERSPDFQEEIINDYNKMIIKVNN
ALIPILNKD
>KACEBFPM_02104 hypothetical protein
MTEVERIKLAVKTLISLGVAKNQEEIGKLMGYSNKSSFSQVLNGIVPLPDKFIDKLCRLD
KRLRRDWIVNEFGHILIKNNNSKQVYIDKNIDTYDKEEGKGVEIKKTHPYNNNFQYRELA
ESRLETINTKDKLIEVLEKNIIQLEAQLNTLTQNKSFKRGEMNSEEISTGSDYENV
>KACEBFPM_02105 hypothetical protein
MWYATVTGGVGSASPPTPLTTAVGNTNYYVSQTVGTCESPRAVITSNISEPPATIVATPS
NYFADLQTITVTVTPAGEYEYQIDNGAFQNSNIFANVSAGLHNITVRNECVSKSTTAYIV
DYPRFFTPNGDGYHDTWNIPELKNQANAKVLIFDRFGKLLTEIRPSGSGWNGTFNGKELP
STDYWFVVTYEENGITKEHKSHFSMKR
>KACEBFPM_02106 hypothetical protein
MEKFLYQILTVFFVGLITWFFARRKNNAEAKTVEIETEIKAADFYRTLLDDAMKRLDLYQ
TKI
>KACEBFPM_02107 hypothetical protein
MPAAFPEMWESRVRALLQDEQLAPWLDGIPEIDTQVLEVGSGSASESNIIHIPITTFRPG
VLINNTTYPIALVAYDDTNMTVQLDKYQTKVTTLTDDQANGSSYKQIDTITKSHRDDITE
SKFAKAIHSIAPQAAVANKTFVIQCTGDEVTVGGRRKMLWKDLVAARKAMNDAKCKKRGR
RIVLCDDHVTDLLEDNSNKYADKLADYLAGTIKGVLAGFEVYENVDNPMYTAAGVKKTWG
AVPGGTDRNASVIFHPENIVKKTGLTKQYFADAKSAPQTQQNEYAIRHYFIAVPVMDRYS
GVII
>KACEBFPM_02108 hypothetical protein
MPKPINPFIFNDEAIKNSYGFCILTDGISLTRFNTNPVMLDQHYNSTWAVIGKWVEVEKT
TGLLMGKPVFDTEDEDSKKIQGKVERGFIKAASMGIAFNREDLQMIDGVLTLIACELYEV
SIVAIPSNANAVRLYAENGELMKEEEIKTLCLSITPTEEKINLNQMKKIILSMATLMALG
FKDNPTDGHDSSDVEAKVLGLSQSVVALTSENETLKLAAKNAKDAQEAAAKTRITTKVEL
GITQGKFGADKKEEMITLGLASENALDTVLGSITPKQNFSAGVTTPVGNGSAIVSSMDDF
EKLSHELKLSFKESNPEAYKKLFNQ
>KACEBFPM_02109 hypothetical protein
MAVRKETEKEYAKLLFIKHNIDQKEIAIKVKVTEKTIGKWITEGKWREQKRSLIHTRTNI
IQKFEDQLERWNSAIENRDDQLASSKEVDLLNKLASGIKKLETEIGVGEIITTSMELVSF
IRTIDFEFSQKLTDYADLYINSKIK
>KACEBFPM_02110 hypothetical protein
MAKQTDKNYLKAWQEFRDNTRKATPVDLTESAVDKAKRIKHLESHPEEWFKYYFPNFYTS
EPAPFHIKATKRVLSNMEWFEVRSWARELSKSGRTMMEVLYLAMTGKKKNIIMASSTFDN
ACRLLLPYKSILEANNRIINDYGEQQSIGNWEAGEFVTRKGVSFRAIGKGQTPRGTRKDE
VRPDVLLIDDFDTDEECRNIERIKASLKWIEEALIPTRSISGHLLIMVCGNIIAKFCCVT
ELAKKADYHDIVNIRDKEGKSTWPNKNTEASIDRVLNTISFNSAQKEYFNNPISEGDIFK
ELTYGKCPPLSYCEDVVVYADPSTSNKDKGNASTKAIAIIGYRQQKYYVYKMWVDTMSNS
KFVDCLYEAYKYLSLNKVDTKRIYIENNSLQDPFYEQVLLPLIYQRSRENGFTIPITPDS
RRKPDKFFRIEGTLEPHNRLGRLIFNVDQKEEPNMVRTHDQMLAVSPTTKIMDAPDAIEG
ACWLIQNRVVKKNSIYVVGQRSSRKY
>KACEBFPM_02111 hypothetical protein
MFLEKEDLGSVIYAYQVEEITEGNDDLVSQALGAAIEEAKSYLTANVNSLKTFDGRIVYN
VEVIFSQTGLDRNSLILQHCLTLAKFHIAVLCNADFIYEQAKERYDRAIDWFTKLAKGTV
VLTSLPRINIEETEDRKPFSSGSRTKFNHDY
>KACEBFPM_02112 hypothetical protein
MGKFQDIINIAFGTTTLAAGTGTITQTKKANSYVPTIAPKTISQTRQDIKNYTDAKNMFL
NADNPKRYPWYNLLDTIIVDLHLQSQINNRMLKTLSQPFLIKDLKGNLDQDLTSLLQNEK
FIYQVNKAILQTVYYGHSLGEFDYVNGRLVFNLIPRQNVDPVNGYIFKDYTDDKKIEYRL
QKEYGSWLIEFGNNKDFGLLDGCVPHVLFKRFAQSCYSELCEIYGIPPRVLKTNTQDRTM
VARGEKMLKDMGSAAWFIIDENETFEFAQGVSTNGDVYKNLMQFCNNELSMGISGAVVGQ
DTKNGSNGKEKTSIGILQDLIDSDLSLIEQTWNTTIIPALKVLGVVTKDAVYTYPPAEDL
DKLWKMTTEADKFKNIEVDPVWIKDTFGIEVKEVKPQSASGTKLNLEDYERFFV
>KACEBFPM_02113 hypothetical protein
MYNCGCDDCKDKATLLNLSISDDFKQLLNAGKSAFKRLHEIGNYKPQDLKTEKVYQDLIH
QTYDVFNFAITDNDMPNEMRTALQSDAFLFGGLKTHAQLFEASKLLLDENGNLKPFNQLS
NEFDKLNLTYNKNYLEAEYEFAVSSSQMAAGWSELGSSERYFLQYRTSKDNRVRDEHAAL
NNTTLPKEDPFWDSYYPPNGWRCRCIAIEVLKDKYPISDSEKSIKAGEAATTQIGKDGKN
RLEIFRFNPGAQKVVFPPAHPYTKVLGAKVVESQISKIIKTSKRVENIQEVLKKPIKEQY
KTILNHTSGARVDIHLLVNTNAEDYKDVLNAAKAFARTGKTAKLLPEINIKDKEARDIIF
KGLKSKSSNPDLLIGNEYVDVKRPSAIKNITGNANSASKQGATALISDIRLDKNLSNEIL
NERAKDIFKNKNYTSDKLYFYRDGKIVIKNRTGDK
>KACEBFPM_02114 hypothetical protein
MQDFIKNILSDVSKDLNGEFLQGFDDKNFFGSPWPKSTKGLTDTGKLRRSVFVPGPKIQG
NQIIWSSSLPYASIHNQGGEIIVTEKMKRFFWAMYFESSGAISKSIEQKDGSRVLFVSSD
SKSRMYKQATSKSKRNIRRNAEALMWKNLALQKVGAKMKIKQRQFIGDHPQVRQRIEHVV
NKNMEEIGKTIFNKFKQ
>KACEBFPM_02115 hypothetical protein
MSKIVLQSIQNLLSTIPELKYVDEDWGQLDDYSPNPPTKFPLALIDLGNLQYSNIGKDRT
AMPQNRQMATGAIVISIANLRLTNTSARAPQTQKDQAWSIWDIVQNVHEKLHGIAVGGSA
GAMMRTAMRKVKRDDGIQEYEVTYAIGMTNV
>KACEBFPM_02116 hypothetical protein
MATSASYIRNCRMINNFKLKTHFKKVGFFIPKKFYIFAYMSISLNRSLGIQRNKLLRYKL
IKELYQKTISEHPHTPLTQIHKQYIFPVYPISRTTLYQVLFTPITSELKNIEDVINSQTK
LFS
>KACEBFPM_02117 hypothetical protein
MKFSYRLSYYLFGFLVGCIFLFFVLNKKNTRCTYFPNDRVLNNLRSKPFYYSNVASKELA
EDWLDTIDVKNTLEYGDVDFSRSNLKISKGKLYTIIGKTIKNQPIEVIVENYEDKVVLKE
VKKQ
>KACEBFPM_02118 Alanine dehydrogenase
MTITPFSKQDLLPQEEKLEIAKHKSELFIGIPKETSYQERRICLTPDAVNAMTAQGHRVL
IEAGAGENSSYSDKNYSDAGAEITNDTKKVLACPMILKVEPATLVEIEMMHPKTIIISAI
QLKTRKKEYFEALQKKKITALAFEYIKDEDGSFPAVKSLSEIAGTASVLVAAELLTASKF
GNGLLFGNITGVPPTEVVILGAGTVAEFAARTAIGLGASVKVFDNSITKLRRLQNNLNQR
IFTSTIQNKTLLKSLQRCDVAIGAIRGKYRAPIVVSQTMVEHMKKGSVIIDVSIDTGGCF
ETSEITTHENPTFIKNGIIHYCVPNIPSRYSKTASLSISNIITPYLLQIADDGGIESAIR
CDSGLKNGVYFYHGILTNKTIGEWFNLNHRDINLIVF
>KACEBFPM_02119 tRNA threonylcarbamoyladenosine biosynthesis protein TsaE
MKIEFNLDEIEIVSKKILSKNPEKVILFNGEMGAGKTTLIKVLCKQLGVKSPTSSPTFSL
VNEYKSDNNKLIYHFDLYRLKNQNEALDMGIDEYLYSENWCFIEWSEKISDLIPEKHSII
TISVLNNNKRLIELK
>KACEBFPM_02120 hypothetical protein
MSGLETLAEIKEKKSSIPVIMITKSEEEHIMEEAIGSKIADYLIKPVNPNQILLSLKKNL
DHSRLISEKTTLDYQKEFRKISMEMNMVNSYEDWVEFYKKLIFWELELENIDDQNMFQIL
ESQKAEANNLFGKFIEKNYEDWFEPKADKPVQSHDLFKKLVIPELKKEENVLFVVIDNLR
YDQWKAFENVVNNHYKLESEVPYFAILPTATQYARNAIFSGLLPSEMEKQFPQYWKNDTE
DGGKNLYEAEFLTAQLKRNGLNIEQEYFKITNLNNGKKLAENFKSLKDKKLVTVVYNFID
MLSHAKTDMDVVKELASDDKAYRSLTLSWFKNSPLLEIIQQAQKLGFKLIITTDHGTINC
KNPSKVIGDKNTSLNLRYKTGRSLTYENKEVYAVKDPKKIGLPSINMTSIYIFAKNDIFL
AYVNNYNHYVSYYRNTYQHGGISLEEVIVPFLVFSPKK
>KACEBFPM_02121 hypothetical protein
MKNKILIIAVLSLLSNKVISQTTEIVNPKGKCFFGAEIGLNAITSVHPSRMTSIQGGFLA
EYYFAKNWSINGRIKYFETGVINKNNSSKGVFEGAVISVPLNIIWKYRIVNNFSGNLKLG
IALNQEIKSNYYYPLNEKTDYSKFYGSFNPGIGFNYFISKNTAVYMNYEVYVLGNDRDDA
DWLQIVPNSPNNNLFNIGIKHNFKTESENK
>KACEBFPM_02122 hypothetical protein
MANTSKELKNYNKKIYSLLIWFTAIFSLLFCIQWYSLCNNLEEYKVEKQSQLENLKTLKT
NLFDVSKYEKTKKIIVLNKENIEEINENLNRLAEEIYNEKNKAVTLIDKDIDRLNLYMAI
GIGFLALFGIFVPLVINFLSYDDLKENQKNINSDLVLINNEVVALKKITDEIPDKKVIND
AIKKSNDLLEKTKQIDEIKTKTDDVLPKISTISLQIAINRLFNVSTIAVRKLIRGDNTMY
LSLFGQIKDDLIKCKEDNLHKINGHSSLKQTLQDFSEMLKVEQFRFSTILQKRKLDIQFT
NLAHNIDNLIISEAENEGENYEVAIRTLEMIITILEKEK
>KACEBFPM_02123 hypothetical protein
MNTINFRKTLIELALEENSESKIAKVIAFYYANLNLTNREGLFESLLNFYKISDNQEFDF
RNLSTELESNHEIINTSKYLNKDFRIKNVEISNVRGIPSKEESDNIPYGINLFQDSNSVY
NSIILANNGNGKSSIFSALEMIYANDIGEKNLRTQNFKSLNDNDYLNYLERFPNGGKPIC
KIETFEGNYSIDKRIFEPELVNIFNPKSHFITEFDIIENGRNVYSSNPNIDYSFHNIIAK
NLGLDEFLNFINVSEQIPNYKRRKEYTFRDTIQSELTTNNITIEKRIEEVKFKSEELNNL
KEGKDKNVEKNNTTNDIKQLRTFLNKDIDIVFNKESYNKIINDYIKSYQNYLSKNISKKN
SIEKNFLNSGKDLLHYYDNCPFCLNSNKSKEEINSEVEKRLKELEDIEVVEKEIRENFRL
LTSALLTTVKDLRKFYNIIETERIELTKFTNLDSINIKQNELYIELSPQLNDDELIDLLN
ELSKIQFPTEIDFKRLFNLIDENQIIFQDHFASFSLKAILYTNERKSQIESEIQKLSSNS
DELSLEQKTLKLEQEINEIKNSILSLEKRNSDLKPELENANKIVGYFDRIKSEIINYNLK
FNDRKDKLVAEAFEPMKNTIEQIMNDFISKNENIKLEIKLEDYNYKVDGEQYTSKIIIAK
IIDLKSNKETTPDLYFNTFRFKLFCLMISLSIALATRIKYKINLPLVMDDLFYASDFINK
ISFTEFFKELIKLFHKYTPEMSLQFILFTHDDLVFTSAIEAIEEYSEIENDLIIDKTLIT
RMFEVKDKEEIPSKFENGENFWNLLYQLPKQTLVN
>KACEBFPM_02124 hypothetical protein
MRKTLLIVFLIISNLTFAQKVSFKIITEKTEIDDIGAVTLYVDVINNSKKDITILKPATD
FNQKWRFYDVKNECDNIPEWQGEKQKKMAYSESDLLVIPAKTKVEIIINGRMNANMLSCT
SKMFQLELFYDANELIKNPETRNCNSDELKIIKKLTPFIIKSKRENIVIN
>KACEBFPM_02125 hypothetical protein
MTFRYARHTTDLKQIERFYTEIVGLEKLGGFEKHNNYDGLFLGHKNSNWHLEFTTSIEKP
ESKFDEDDILVFYVNSEVEFKKVKKTLNQKNINLEIPKNPYWAENGIMISDPDNFKVIFS
VRHQNFNSTDNLTTLVKDNGIKNWSELIEFTQNLPYGRNQNREDFSLVIKENKGTCSSKH
SFLKKVADLNNFENVKLILGMYRMNNLNTPKIGETILESGLEYIPEAHCYLKLNNQRIDI
TNYNSDIENLICDIIEEIEIEPEQVNTFKVDYHKKYIQNWVIENEVKMDFEKIWKIREQC
IKKLEQ
>KACEBFPM_02126 hypothetical protein
MTKYIRFQKNQKFYILKDFKEDVLKKISNEMFRINRELRTNKFNFYSIEDFISLESFKGE
TLENIKKFSFNIEFINLQIDSEKHDIKSTRVMHRDPLESFKSLYLNTILTSKVYNIEKYV
EEDIIKIEGLKDNINLKDIYFKYDIR
>KACEBFPM_02127 hypothetical protein
MSIIKLSTFSKKRIFFEKSFKDEEQFFINILDKNGKPKLQWVGTVENLKYALRIT
>KACEBFPM_02128 hypothetical protein
MPQAPKWVSNSEVSYYPKWFPNLRTSIEWQYVSSYYQDQINSLKYEGYNFFNARIGYTYK
GLEFYTNIMNLTDKLYAYNVSKGNNTTDKATYTVSAPRAFMFGIEYKFNLKK
>KACEBFPM_02129 hypothetical protein
MKTENQFKKKDSKFVKKIKQNMYRWHRILGLITLVPVIFWTLSGIMHPFMAHFFKPEIAH
EKLELKPIDHSKIKLSLQEVLARNEIHLFKNFRIIDFKNQAYYQIKSSANTYRYFDAKTA
KELGNGDQKYAEYLSRYFIDDLKSTVSRIELVTKFTTQYKYINRYLPVYKLTFNRDDAMQ
VYVETSSSKLANYNPRSRQIFVWIFDTFHNWGFIDAIANNYLRIIIMLLLLFVISFSAIS
GIVIYGFLWKKFKKVTPINSEGFLRKNHQKIGIMVSFLTLTFAFSGGYHAMQKWEPNVLP
KMIYEPIINVSDIKIASTKTNVDWSKLTNISVIKFKKDYYYQCDLYDTETEKTQKKFINA
NTNILEKNIEIEYAQYLVFKFKKMLLSSTSNCCDVENSETFNPNFTLKTSAVLTDFDKRE
YGFVNKRLPVVKLEYNSDDGTTYYIETSTSRLASIINNDTRREGYSFAIFHKFLLMEWAG
RNIRDFMTIISALGILVVSVLGLILFMRRK
>KACEBFPM_02130 hypothetical protein
MKNIIIFALIFNLISCKAQEFEKISVSKTDISELYVNDENSTELFYYKYLPKNNIIGVLV
VIPSGGELVENTLRQITLQKIAVEKGIMVIVPSINWGTDNREAEFKLLDKIFSEIVAKHK
VSKDKFIIGGLSNGAMISLTYAEKATKNPEKYFIIPKGVFALDAPLDQARFYKYCEREIE
RNIYEPAVNEAKWMKNNWDSIYGGSPEKFPEKYIENSIYSYRAKDGGNAKYLKKTPLLMF
TDLDTDWLINQRHRDLNDWNGIDIISMINKLKIMGNENARVIVSQGKGVRLDGTKNPHSW
SIMDSEVCLNWMIETFEK
>KACEBFPM_02131 hypothetical protein
MGVVISASNKRKSFVITAMIYTLLLLILFFIRFWPPANLQELAEGGGGGVTVNFGDTEFG
SGNNFESDVLAIKNETKQAVKPVETAENQIIAQENSAEENEVVIAKKIITKKQKVDIVKS
ESKPALAKPTVAKNTNDALANILKGGNKGGDGNSSTHGNQGSANGSLSNDGYGSGGSGGG
TGGGNGSGSGTGNGSGSGSGNGGGVGYSLGGRKALSKPAPKYTCNESGKVAVEVSVDRNG
NTISVVPGVKGTTNTAKCLLDQARIAAMNTKWQSKDDAPERQVGKIVYSFSLN
>KACEBFPM_02132 hypothetical protein
MGVKIVGIIDRDGGLINENGFTFEEIRTLFLNKDGNKLVAKNMIPFEEINAKIWSIGAEI
FTPCAASRLVAKSQVDSMIAAGLEVISCGANVPFADKEIFFGPIMEEVDSKVSLIPDFIS
NCGMARVFAYFMEKKVEMTDESIFSDTSDIIKKAIEKAHILNSDKKNISATAFEIALKQL
V
>KACEBFPM_02133 Threonine--tRNA ligase
MIKITLPDGSIKEFENGVTPMDVAKSISEGLARNVISAAFNNITVETSTELTTDGSLVLY
TWNDKDGKKAFWHSTSHVMAQVLEEMYPGLKLTLGPAIDNGFYYDVDFGDTKIVEADFKK
IESRILEISKEKHEFKLRPVTKADALELYKDNEYKFELISNLEDGTITFCDHATFTDLCR
GGHIPNTGIIKAVKIMSIAGAYWRGDEKNKQLTRVYGTSFPKQKDLTDYLELLEEAKRRD
HRKLGKELELFAFSQKVGQGLPLWLPKGAALRDRLEQFLKKAQKKGGYEQVVTPHIGQKE
LYVTSGHYAKYGADSFQPISTPAEGEEFLLKPMNCPHHCEIYNVRPWSYKDLPKRYAEFG
TVYRYEQSGELHGLTRVRGFTQDDAHIFCTPDQLDEEFKKVIDLVLYVFGSLGFENFTAQ
ISLRDKENRDKYIGSDENWEKAENAIINAARDKNLNTVVEYGEAAFYGPKLDFMVKDALG
RSWQLGTIQVDYNLPERFELTYKGSDDQLHRPVMIHRAPFGSMERFIAILLEHTAGNFPL
WLMPEQAIILCLSDKYEIYAKKVLNLLENHEIRALIDNRNESIGRKIRDAEMQKTPFMLI
VGEEEEKNNTISIRRHGQEGKGNITVTIEEFARIVNDEISKTLKTFEV
>KACEBFPM_02134 Translation initiation factor IF-3
MKLADQLELDLVEISPNAEPPVCKIMDYKKFVYMQKKREKELKAKSTQIVVKEIRFGPQT
DEHDYEFKRKNAEKFLKEGSKLKAFVFFKGRSIIYKDQGQILLLRLATDLEEHGKVEAMP
VLEGKRMIMFIAPKKKK
>KACEBFPM_02135 50S ribosomal protein L35
MPKMKTKSSAKKRFKVTGSGKIKRKHAFKSHILTKKSKKRKLALTHSALVHATDMKSIKQ
QLRII
>KACEBFPM_02136 50S ribosomal protein L20
MPRSVNSVAKRARRKKIMKQAKGFFGRRKNVWTVAKNAVEKAMCYAYRDRKVNKRNFRAL
WIQRINAGARLEGMSYSQFMGKVKKHNIELNRKVLADLAMNHPVAFKTILNKVK
>KACEBFPM_02137 Glycogen synthase
MEDKRILYVSSEVVPYLAENEVSLMSYDVPKMINDQGGQIRIFMPRYGNINERRHQLHEV
IRLSGMNLVVNDVDMPLIIKVASIPKERIQVYFIDNDEYFKRKATFADEEGVMFPDNDER
AIFFAKGVVETVKKLNWVPDIIHVQGWMAAMLPIYMKHYYKDEALFADTKIVTSVFNQSF
DGSLDPQMGKKVQFDGIPQSVIAELDNPTFENIMMASINHSDGVVIASDSLSSNLTKFIE
ASKKPFLPFAHKDTFSEAYTEFYKNQILG
>KACEBFPM_02138 hypothetical protein
MMNTIFLRKLTIVLVAVFFASCDKDFNTLGSDIVGSDDFTATPELFPVKAYNQKLPAVQT
NNLPVNQLGVMCNSVLGTTKSNFVTQLSLAIEKPTFKSNITIDSVVLTVPYYSTKILVDA
NGVGTYTLNSIYTTNTAGTYDPIDLKVFRNGVTLRDSDPSGVAHKYYSDQDANFSAFVVG
SKLNTSTNVKENTAFVPDTREYKKYKVVNNSVTTDVESHNSPRMRLHLDTDYFKENIIKA
SAANLDNNNAFSSYFKGLYFQVSESVIGKGTSMALDFAKGDVTIYYKQDVIDVPGSVTPS
VNREMASLTLNMTANTVNLFNNAYSSGYTNAVSTTSTDADVAGNGAKNLYLKGGQGSIAF
IELFPGVAGETKLTELKNKKVLVNEASLTFTVNKTNMLSSYNKPKRIYIFDADNNIPLYD
YYLDNSENSTDITLNKILHGGIIREATVSTTDDTYKIRITEHVNRILRGVTGSKNVRLGV
AITENIGLNSLGYLNPSQVPAHSSDDATKIIDKSPVSSTISPLGTVLYGSNYLPTDGADY
EKRIKFEIYYTKPN
>KACEBFPM_02139 Glutamine--fructose-6-phosphate aminotransferase [isomerizing]
MCGIVGYIGHREAYPIIIKGLKRLEYRGYDSAGIVLYDGKELKLSKTKGKVSDLEEKSSK
EISTNGVIGMGHTRWATHGVPNDVNSHPHLSNSGNLAIIHNGIIENYEPLKKELINRGYT
FKSDTDTEVLVNLIEDVQKTHNLKLGKAIQIALNQVVGAYAICVFDKQKPNEIVVARLGS
PLAIGVGNDEFFIASDATPFIEYTSNVIYLEDEEMAIVRLHKPLKIRKIKDDSLVDPYIQ
ELQMNLEQIEKGGYDHFMMKEIYEQPSVIKDTYRGRLHANEGLIKMAGIEDNLDKFINAK
RIIIIACGTSWHAGLVAEYIFEEFARISVEVEYASEFRYRNPIIDKDDVIIAISQSGETA
DTLAAIKLAKEKGAFVFGVCNVVGSSISRETHAGAYTHAGPEIGVASTKAFTTQITVLTM
IALRLAKAKGTLSKSDFHRYLQELEIIPEKVTEALNTNEKAKEIAAVFKDATNFLYLGRG
YNFPVALEGALKLKEISYIHAEGYPAAEMKHGPIALIDEHMPVVVIAPKQGHYDKVVSNI
QEIKSRSGKIIAIVTKGDTQVRDLADYVIEIPDAADAMSPLLTTIPLQLLSYHIAVMRKC
NVDQPRNLAKSVTVE
>KACEBFPM_02140 TonB-dependent receptor SusC
MRIYFIILSLFFCGLSFAQNTISGTVTDASNQPVPGANVKIVGSASGASTGFDGKFNIKH
QQAFPFSIEVSMMGFASQTVVVHSKEQEIILVLLEEATSLNEIIVSASRAPERILESPVT
VERMGLKDIKNTTAPSFYEGLENLKDVHFNTSSFSFKSVNTRGFATVANTRFLQLVDGMD
NASPALNFALGNLLGISDIDVANVEVLPGASSALYGANAFNGIMFMNSRSPFLKEGISTY
MKYGQTSQTTAGNNPFYDFGFRAAKKFTEHFAAKGNFSYLNAKEWIASDDKNVSNGAVDS
RAIGHANNQNYDGVNLYGDEVSTFIPNVGQVSRTGYKEQELTDNKIESVKADFSLHFKPW
ANDFEIIAQHKIGFGNTIYQGANRYALKNFYMEQTKLEVKGKNFFARIYRSAEDAGDSYD
TRFAAWNVNRAAKSDTEWFTNYATAFQLSQAYLGSNADQAAVIGRDYADHNNLPTTANFN
LLPQFTAAPPVGQPRFEPGSAQFNAALAGVIKNADFTKGAKFQDKSKLYHADVNYSFKDV
IKFADIQVGGSGRQYVMNSKGSIFTDYDGPIKYSEYGVYTQVQKKLMDDRLKLTGSLRYD
KSKNFDGSFSPRLSVTYAAGTNKQHNFRISYQTGFRNPTTQDQYIGLDLGPFALIGSAPE
NLERYVEYRTPSVAGSAFLDPGQTQFKLTGENAYHNAYTVESYKAYASARSSGIIQSTAS
SLLVVASPTLVKPERVQSIELGYRTILKDFSVDLNGYYNTYNDFLSQTNTIAPLYGIVGT
AKAATALDNGDRRTFQVYTNSKSQVKSLGFGIGLSRKVYKNFELGGSYNYSQVNFDQLSD
PSFEVGFNTPKHRVKASFGNDKLFKNFGFNTSVRWNSEYLWESSFLDGMIPENVVFDAQI
NYAIPVLKSVLKVGGANLGGKDYIQVLGAGAIGTQIYASWTINP
>KACEBFPM_02141 hypothetical protein
MKKNIKWLLLASLSFVACNKNDDTITEVPVTAGSANFSKYVALGDSFAAGYSDGALFKKG
QENAYPNILAGQFAQAGGGIFNTPFMADNIGGFAGSMVYTPRLIFDGSGPASLGLPPYSQ
AATTNQLAHLSGSFNNMGIPGAKSFHLLTAGYGSPAGNPYFARFASNPMAKVIDDALAQA
PTFFSLWIGGNDELGYATAGGDPAVNPLTSNANFDAAYNALASQLAAGGKKGVVANLPYV
TTLPYFYVIKYNQLKQSDLTVSGVNQVSALNTQLYAPLHNALAFLGQGSRINLLSTTGNN
PMLMIDENLTDLSTSLTAVLVGGGLDVPTATALGQVFGKARQTISTDLICLGAAQRIGKE
PSMSLDGVASPSPLLSQLGVTFPLPDRYVLLPTEVAEIKVATDHYNATIENAANANGLAF
VDAKAIMDQLVNGGVRFGNYHMTAQYVTGGAFSLDGVHPSARGYALIANKFAEAINAKYG
STLKPVDIGNYQIQYPASL
>KACEBFPM_02142 ATP synthase subunit beta
MSKVIGKVSQIIGPVVDVVFNGKDVELPKIYDSLEITKKDGTLLVLEVQSHIGENTVRTI
SMDSTDGLSRGYEVVGTGNPIKMPIGADVYGRLFNVIGDAIDGLGNLPKDGDNGMSIHRQ
APRFEDLSTSSEVLFTGIKVIDLIEPYSKGGKIGLFGGAGVGKTVLIQELINNIAKGHGG
LSVFAGVGERTREGNDLLREMLESGIIKYGDDFMHSMENGGWDLSKVDMPGMRESKATFV
FGQMNEPPGARARVALSGLSIAEYFRDGAGSDQGKDVLFFVDNIFRFTQAGSEVSALLGR
MPSAVGYQPTLATEMGAMQERITSTNKGSITSVQAVYVPADDLTDPAPATTFAHLDATTV
LSRKIAELGIYPAVDPLDSTSRILTPQILGDEHYDCAQRVKEILQKYKQLQDIIAILGME
ELSEEDKLSVSRARRVQRFLSQPFHVAEQFTGLKGVLVDIKDTIKGFNMIIDGELDHLPE
AAFNLKGTIEEAIEAGEKMLAEA
>KACEBFPM_02143 ATP synthase epsilon chain
MILEIVSPEASLFKGEITSISVPGVDGSFEMLNNHAPIVSLLQKGTVRITAPSFKFSKES
DDLFTRVNDQDYTLAISSGTLEMKDNKVIVLVD
>KACEBFPM_02144 hypothetical protein
MIVAAFFYTIAFGLVALFVLSIIKTSFSNLKQSKDLTSLIYLIVFFFMGGLNFSLVTNIF
FDLEKEKMKVQYRVGYFKVNRLSEIPELKYVSIFFKTENSYLVNLWYKGNKHFEIAEFAE
FDSALEFGKVFSNKLKLDLLDATEKGNSKWIE
>KACEBFPM_02145 Putative pyridoxal phosphate-dependent acyltransferase
MDVFPKSLLLKLEQRKRNNALRKLPITSCLVDFSSNDYLGFSKSETIFCKTHQFLCDRNI
KINGATGSRLLSGNHHLYQETEDFIAGFHQSEKALIFNSGYDANIGFFSAVPQRNDIVLY
DELCHASIRDGIIMSHAKAFKFNHNDYEDLESKIIELKFKYKTSEFYIATESVFSMDGDC
PNLQELIIISENYNVHLVIDEAHALGVIGAKGQGLVQELQLQNKVFARIITFGKGLGCHG
AAVLGSQNLKEYLVNFARSFIYTTGLSPHSVATILVAYHQLENDTIQIGKLRENIIHFNQ
EKQMLGLRQMFVRSKSAIQSAIIPGNQNVKNIAKQIQEKGFDAKAILSPTVPEGQERLRI
CLHSYNSKDEISEMLRLLSNCLFLA
>KACEBFPM_02146 hypothetical protein
MKKNYVYIMFFILLFSLGVLAQEARLSSFAAKNQEQQFDNLNVYPNPVGNGRVFITSKTA
DPKDVEIFDVLGKRVIQTTIVTKELNVSSLSPGVYIIKIKEGEQRATRKLIIK
>KACEBFPM_02147 Beta-agarase D
MKKIYTLSLLLACTLSFGQASDAFLGTGSLNANGWISHSGTTPGQVSIVSGSLSYAGLTS
QGNKTQITSGNTEDVSLSSAAPLTTVGYYSAIINVLNTTGINATGDYSLMFGSMSTTASP
TFSVFTARLFVKTGSVANTVNVGILNSSGGTVTPTFSGDFPINTPLFIVVKYTPSTNTAN
LWINPLIGGTEGSPTLTNSTGTGTAPTQLERLAIRQGTSTGNIEIDEVRIGSTWAYVTSA
TLPINGFDAISGLKIYPNPAKNLLNITSDSFETKNVAIYNVLGAQVLAANVTNAPINVAN
LAKGVYVVKVTEEGKTATRKLVIE
>KACEBFPM_02148 hypothetical protein
MALKVFRYQYENNIVYHEFCTYLKTEIHKVKTIQQIPFLPIQFFKSHAVLSNSNAIEAVF
TSSGTTGMVTSKHLVTNVSLYEESYRNAFSHFYGNIEDYVVLALLPSYLEREGSSLIYMV
DDLIKLSNNAHSGFYLHNHEDLIQKLVALDNEGQNVVLIGVTYALLDLVEKQKFTLKNTI
VMETGGMKGKRKEMIREELHEQLCDGFGINAIHSEYGMTELLSQAYSLGNGIFECPNWMQ
ILVRDAQDALAYVGVGKTGGINVIDLANINSCSFIATQDLGKEYTNKTFEILGRFDNSDI
RGCNLMVL
>KACEBFPM_02149 hypothetical protein
MVVVFRQEKLVFLLKRLSVTIWARHLYKNNINSKNQPIYMKSDINNLPIVENVFLAAVQE
WSDDFLENIWNIYLINDSDFQLDGVMLVSKAFGTIDGEMKKTSSLRHAFLEIPPVSVKKV
EMIEKSVLKLNNEFMLTYFIGNTLYDKKFIFKTNFANDNTLEEVPILFVDGIIMR
>KACEBFPM_02150 Phenylalanine--tRNA ligase alpha subunit
MTDKIKEYIAEAKAFSTQNKEKLEEFRIKFLGSKGLVKDIFAEFKNVPNDQKKEFGQVIN
LLKTIAEEKVKTITEELESKEEIKSLYGDLSRPSEHIKIGSRHPISLIKNQIIDIFSNIG
FNVSEGPEIEDDWHNFTALNLPEYHPARDMQDTFFIQTNPDILLRTHTSSVQVRYMENNK
PPIRTISPGRVFRNEAVSSRSHCIFHQVEGLYIDKDVSFADMKQTLLYFTKEMFGKSKIR
LRPSYFPFTEPSAEIDIYWGLKTETDYRITKGTGWLEIGGCGMVDPNVLKNCGIEPDQFN
GFAFGMGIERIAMLIYQIGDIRMFYENDIRFLEQFKSTI
>KACEBFPM_02151 hypothetical protein
MSRDIQLKERWEQLVNILTDQFSQGEDLDLDAIIYLIGVQELGKFHQIYKKDEKLNLMHI
AICRLLEPYGYYEFEFFDNDGWPHYKVKEELPPLKAGEQSVLMKDAIVNYFLEKKLIE
>KACEBFPM_02152 hypothetical protein
MEIIDVVLGALLVFGFYKGFKNGLFVELASLISFFVGIFVAVKFSYVVSDFLGKHVSWSP
KTIQISAFVFTLLLVIIAIHSLAKIFTGIASFAFLGWANTLAGGFFATIKTALLIGVVLS
LFQKVNLNNMIVSKETQESSLFFNACMITSEALLPTLTDWFKDLKGKAESKSTLTP
>KACEBFPM_02153 hypothetical protein
MKNILFIFLLITQTFWAQTAFDKGNNLYQKGNYQEAITVYESVVKSGQQSAELYFNLGNC
YYKLNKVAPAIFNFEKALLLNPNDSEIRNNLAFAQKMTIDEVVETPKVGFPKIIRDFTSS
YHYDTWAWIAIVFSVLFLICFVGYYFSNTTMLKRIFFTSMLFILLFAMVSVFAGFFEKNQ
SNNDRPAIVFADITLVKSEPKSTAQDAFVLHAGTKVFVLESLNNYKKIQLLDLKEGWIEK
SAIKELK
>KACEBFPM_02154 hypothetical protein
MKKYISLFAITLCFSGIQAQDVADAYRYSQDNPNGTARFRAMGGAFGAVGGDLSAITVNP
AGSVVFANNQISVTASNFNTKNNSNYFGTNTSKNKNSLNLNQFGGVFVFENDTENSPWKK
IAIGINYENVSSFENSLFSAGANNNSIDNYFLSYAKGLKLSIVDGHDYAYGDLTFREQQA
YLGYNAFIINQSATYNDNTNRSYVSLVPSGGNYYQTNTTQTSGYNGKLTFNAATQYKNIL
MIGINLNTHFTDYRRSNRFTENNNNNTSPVNYLVKNINFNNDLYTYGSGFSFQIGAIVKP
IKEIRLGLAYQSPTWYKLNDELIQSISANSSTINNSLNTDIIDPKTTMVYAPYGLQTPGK
LTGSFAYIFGKKGLFSIDYSVKNYSKAQFTPKNEFMKSANNPDNDTDNDISNLLQKSGEL
RLGAEYKIKQWSLRGGYHFEQSPYKNKKIVGDSNGYSGGIGYNFGGTKLDLAYSLSKRTS
NQSFFAQGLTDAAQINTTKNNVTLTLAFEL
>KACEBFPM_02155 hypothetical protein
MEMLALKIIKNHKMKKYLLLIATFFLAQNLFSQVSNQEKFPVFPACSNAMNQELVTCFNN
QLQDFVYHNFQLPAVVKQNNFKGKIITLFEVDSTGTFKVLYADAMYSELITETKRVFSVL
PKITPPTYNGKPTYAKYTFTIAIPLQSTTQIAQEKLFQENKILNSSLISNIENPEFESVT
LNYAAFKNPQFKSHLNIPFSHNLYTNFDGEMNQVGTNSHTASKPYTYSEVVKYHDFYAAY
NAIKINKEGWWGRKIFNENLVSIQGEDYWFTLNPIFDLRMGKNNPSTQKYTYVNTRGLQI
QGALGEQLSFATTIYESQGVFADYYNRYANSLRPNGGDPAIIPGIGIAKDFKTTKYDFPS
ADANIAYTPSKHLNLQLGYGRNFIGDGYRSLLEGDGASPYPYVKINTTFWKIKYTNTYMW
LKDVRKDVTLDRTYATKYMANHYLSWNASKRLNIGFFESVIWTNDNNRGFDLNFVNPIIF
YRTVEFTSSARSGNAVLGLTSKYKWNNNINLYGQFLLDEFSLGEVKSGEKSWKNKYGYQL
GAKYFNAFGIKNLYLQAEYNQVRPYVYAHSKAITNYGHNNQSMGHNWGSNFKELTAIARF
HKNRLFADAKLSIGIRGLDFDTATDALNYGANIYKDYGDNRAYDKGVVIGQGDKTNVFIA
DVQAGYLLNPTTNLKLFGNLIYRNFSPQVNTTTNFKESTSWFSIGLRADVFNWYLDY
>KACEBFPM_02156 hypothetical protein
MKNIILTTCLMLGITTMNAQTTSTEKNKDAQGYTYEIVKNDKTGVRLYTLQNGLKVYLAQ
NKDEPRIQTYIPVRTGSNNDPANNTGLAHYLEHMVFKGTSKIGTQNWEIEKKLIAQISDL
YEQHKAETNPEKKKALYKRIDEVSQEASKYSVANEYDKLISSLGAKGTNAHTWLNETVYK
NNIPANELEKWMIVEKERFSELVLRLFHTELEAVYEEYNRAQDNDGRLLNTQLMKDLFPT
TPYGTQTTIGESEHLKNPSMVAIHNYFDTYYVPNNMAVVLVGDLEFDKTIKMVDTYFGTM
KYKELPKLKVLTEKPMTSVVRSEVKSPTAERLMVAWRTAGAGTKEAILAEITSSILSNSG
DVGLIDSNINQKQLALSAASYTSIFNDYGYQALMLSTKDGQTLEEGEKMLLGEIDKIKKG
NFEEMMIPAIINNMKLDVMKTFETGDGLATTIYQAFIQGRSWSDIIAETDEAAKITKADV
VKFANDFYKNNYVAVYKTKGVNDKLVRVSNPGITPIQLNREAQSEFYKTFAKINSGDLAP
VFIDFKKEIQTKKVKNTTVSFVKNKTNEIAKLYYIFNMGSDHNKKLPLAIEMLDYLGTDK
MTVEDIKKEFYKIGITLSVNAGNDLSYIYLSGLESNLPKGITLLENLLKNVKPDQEVYNT
TVATILNTRSNAKKRKENIMNALTNYAKYGANSRFRDIISEKELKEMNASELTDLLKDLN
NYQHEIFFYGNDLNPILASLEKNHNLNANKAIPTAKEYAEPVTDNKVYFANYDMVQTEMT
RIAKGEKYNFANTGTVNVFNNYFGSGLSSIVFQEIRESKSLAYSANAVYRMPADKLLSDY
MQVSIGTQANKLPQAVDAISVLLNEMPKIERQFNNAKESSLKQIASTRISKTNIFFSQLA
LKKLGFDYDNRNDVYKNIQNLTLENTNNFFNKEVKTKKYNTAIIGKKESLDFEALKKLGT
IEEVTLEEIFNY
>KACEBFPM_02157 hypothetical protein
MKNFIFSFFILFLFFESNVVTAQTQFETDGVIVPRTIPFQNSTLQLNGFGTRSKMWVDVY
VQALYVTSLSQDAQYIINGETEMAIRIQIKSSMVSSAKFSKNFDKGFEQSAGKDIYSFKP
RIELFKKMLKNKIVKEDIFTLVYNPKDESVWVYKNNDLKGKIPGLDFKKILFGIWLSDNP
VDEGLKKELLGKE
>KACEBFPM_02158 Anhydro-N-acetylmuramic acid kinase
MIKQYYNVLGVMSGTSLDGVDLAHIIFFEENEKWSFEIKESQTVSYSEFWINQLKEAVGF
CDSELAKLNSDYTILLAEIISNFIKNNKIENIDAVCSHGHTILHQPQNGFTLQIGNLPQI
AKLINQNVVCDFRVQDVALGGQGAPLVPIGDQILFSAYDYCLNLGGFSNVSFNENGNRIA
FDISAVNTVLNFYANTLGFDYDDKGQTARSGIVSQELLSELNELDYYHKSYPKSLGFEFV
KTILLPIIENYQLSIEDKLRTFTEHVAIQIALALPIKTGSLFITGGGAYNDFLIEKIQCF
LPKMTIVIPNAKTIEFKEALIFALLGVLKLRDKINVLASVTGAKKNHSSGKIYTK
>KACEBFPM_02159 hypothetical protein
MSDFLKQFGEDLKKNVSGYIAVAVTEIKSGISYYSDSISSDFDPELAAAFNLEVVKAKLN
AISALGLKQNIDDIMINLSSQIHIIDVSENNEYFIYLAVDSTRANLGMTKALLNKYKKEI
SGKL
>KACEBFPM_02160 Energy-dependent translational throttle protein EttA
MNYLSVENISKSFGERTLFDKISFGINKDQKIAFIAKNGSGKTTIMNILNGIDDPDTGQV
VIRKDIRMAFLSQNHNLQDELTIEESIFASDNETLKIIEAYEKALENPEDSEAYQKAFDG
MDQHNAWDFETQYKQILFKLKLEDFKLKVKNLSGGQKKRLSLAIILINRPDLLILDEPTN
HLDLEMIEWLESYFAKENITLFMVTHDRFFLERVCNEIIELDNGKLYQYKGNYSYYLEKK
EERLISENASVDKAQNLFVKELAWMRRQPKARTTKSKSRQDDFYVIKEKAESRRRENVVE
LEINMERMGSKIIELHKVSKKFNDKVILNEFSFDFQRGARIGIIGKNGTGKSTFLNLLTS
TIPADSGKVVVGDTIKIGYYTQSGINPKPGQRVIDIIKEYGEFIPLTKGKIISASQLLER
FLFDSKKQYDYVEKLSGGELKRLYLCTVLIQNPNFLILDEPTNDLDIVTLNVLESFLLDY
PGCLLVVSHDRYFMDKIVDHLFVFRGEGEIENFPGNYSDFRAYEDSADVAQKEENKAEKK
DWKQNNPTGNLTFNEQKEYQKIEKEIKDLEAQKIAIEQLFSQGKVADADISSKAKELESI
INKMEDKEERWFELSAKIEG
>KACEBFPM_02161 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase
MQLSVIILNYNVRYFLELCVLSVQKSLKNIDAEIIVIDNNSSDDSCKMMKQRFPQVKLIE
NKENSGFPKGNNIGVAQAKGKYICILNPDTVVSEDTFAKTLAFAESQKNLGIVGCKLIDG
TGNFLPESKRGVPTPFVAFTKIFGLYKFSNYFGKYYAQHLSENKTGKVDILVGAFMIMKR
ELYLEVGGFDEKCFMYSDDIDLSYMVLQKGKSNYYFHQTTVIHYKGESTIKDETYMKRFQ
EAMNFFYKKHFKVSLFFSLFMKTGIVVFSFIKMFQGKQKARIAPKSYVLISDNKLIKVKL
QTELKKDVFLVGKDIFNINYSQNFTNKQPLEFIFDNNYINFKDIMQLMQLKEYKKHTFKI
LPQTTDYLIGSNSSNDRGGVILMSDFKN
>KACEBFPM_02162 hypothetical protein
MLSNSATETPSALAMFLTNGEKNLSESEKLTGTETASFAASTVLVTSATATGVASCFATA
TSPPSVSIIAIVCPT
>KACEBFPM_02163 Protein RecA
MSTEKEAKLKALQLTLDKLDKTYGKGTVMKMGDKAVEEVETISSGSLGLDLALGVGGYPR
GRVIEIYGPESSGKTTLTLHAIAEAQKAGGIAAFIDAEHAFDRSYAEKLGVDIENLIISQ
PDNGEQALEIAENLIRSGAIDIVVIDSVAALTPKSEIEGEMGDSKMGLHARLMSQALRKL
TGTISKTKCTVFFINQLREKIGVMFGNPETTTGGNALKFYASVRLDIRRSTQIKDGENVL
GNRTKVKVVKNKVAPPFKTAEFDIMYGEGVSKTGEILDLAVEFEVIRKAGSWFSYGDTKL
GQGRDAVKGLIKDNPELADELEVKIKDLIKESK
>KACEBFPM_02164 1-acyl-sn-glycerol-3-phosphate acyltransferase
MRLFKIIFWVLWRVWFYVVMGIPIIIMFPLLFISILKETWYPYFFRIARIWAKIILFGMG
FYYKIEKEQDVESGKSYMLIANHTSMTDIMLMLVCVKNPFVFVGKKELVKIPLFGFFYKR
TCILVDRNDPKSRTEVFALAQKRIDQGLSICIFPEGKVPDDELIVLDEFKDGAFRLAIEH
HLPIVPLVFPDNKKRYSYTFFSGSPGKMRVKILRFIETKNKTLNDRKIIKTEARDVIYNE
LIAFETVK
>KACEBFPM_02165 Tryptophan--tRNA ligase
MARILTGVQSTGTPHLGNLLGAIIPAIQLSAKPENESFLFIADLHSITQIKDAKTLKENT
YSTASAWLACGLDSNKIVFYRQSDVPQTTELSWYLSCFFPFQRLTLAHSFKDKADRLEDV
NAGLFTYPMLMAADILLYDANVIPVGKDQLQHVEITRDAASRFNHQMGETFVLPEAKIQE
DIMLIPGIDGHKMSKSRNNIINIFLNDKALRKQVMSIETDSIPLEEAKNPETCNIFAIYK
LLANESQIEKMTENYKNANRDYGYGHAKQALFELITEKFSTEREKYNYYMNNLTELDEIL
KIGAQKAANVANEVLQRVREKLGY
>KACEBFPM_02166 hypothetical protein
MSKIRITKQFSFETGHALYGYDGKCKNVHGHSYKLSVTVIGTPISDRNNVKFGMVIDFSD
LKKIVKEDIVDIFDHATVFNQTTPHIELAQELKSRGHEVILVDYQPTSENMVIDFAEKIK
RRLPSHVSLHSLRLQETETSFAEWFADDNA
>KACEBFPM_02167 hypothetical protein
MLLTVATALLEEIQGLVVFAVPDPVSWVVVPIQAFKAPVIVGSACIVTNVVAVTGEQPAD
AAGIV
>KACEBFPM_02168 hypothetical protein
MSDSQNEVLGVLGKLYDIAAVGGVQLFATQLLLLDEKQLPNGPVGVTVITTVSAGVNPDT
K
>KACEBFPM_02169 hypothetical protein
MKFIYLQIAFIFMISQFIYSQENTNCNVKYKTEVTEYTKQDVYTDKFALVNWDFSDVKEA
AIKIEIVPILDCFNKEKAIEYKDPFFINIGNTENGVTGSKVLIHTEMMSKCFKWRVIITK
TNCEKTSDWQYYYFISVTNYKK
>KACEBFPM_02170 GTP cyclohydrolase 1
MAHNDDFQDEIGNNHIATNAKNPVREDAFLLTDDQKIDSIKKDVENILQTLGMDLTDDSL
SGTPNRVAKMFVKEIFGGLNPERKPKPSTFDNNYKYGEMLVEKNIVVYSTCEHHLLPIIG
RAHVAYISKGTVIGLSKMNRIVEYYSKRPQVQERLTMQIVQELQIALGTDDVACVIDAKH
LCVNSRGIKDIESSTVTSEFGGKFKNLDTKREFLDYIKLETKF
>KACEBFPM_02171 Cysteine--tRNA ligase
MPLYKSQSIKIYNSLSGEKEIFSPINEGNIGMYVCGPTVYSNVHLGNVRTFMSFDVIYRY
FLHLGYKVRYIRNITDVGHIVDDVDHGEDKIAKKAKLEQLEPMEIVQRYTVDFHSVLKAY
NLLPPSIEPTATGHIIEQIEIVKTIINKGIGYESNGSVYFDVVKFNESNHYGKLSGRNIE
DMLANTRDTDGQSDKRNHQDFALWKKAEPEHIMRWPSPWSDGFPGWHLECTAMSTKYLGS
HFDIHGGGMDLKFPHHECEIAQGEACTGQEPVNYWMHANMLTLNGKKMSKSTGNNILPSE
IYSGGSPFLTKAFSASVARFFMLQAHYRSNLDFTNDAILAAEKGFYRLMEAIGSLKNTAQ
FTTSNTTSIDIKAWKRNCYDAMNDDFNTPILIAHLFEGVRFVNVLKENKETITTEDLLDF
LTTMNAFVFDVLGLEDEKLATNNNDKLDGVVEMLIQMRKQARDNKDFAMSDQIRDQLLAL
GIQLKDSKEGTTFSI
>KACEBFPM_02172 Prolipoprotein diacylglyceryl transferase
MTHFLQIVWNPSEGINIGSFTLHFYSLMFVVAFMLGWLIMKPIFKRENEPIEKLDSLFIY
MVLAILIGARLGDVIFYNWSSYYPDHLLEIFLPIRENPNATLFYFIKGWEFTGFRGLASH
GAAVAVIITMYFYATKTLKRPILWILDRVVIPVASGAIFVRLGNFFNSEIYGPIVSGKPF
YGVKFIREDEFWIDKNIYQITQTSDLNKAYKLIETDPNFIETLNKIPFRHPSQLYEAFGY
VFVFAILFFLYWKTDARQKQGFLFGMFLIMLFSVRILVEFVKESQGGFESALGLLSTGQW
LSIPFVIAGLFFVFRAKKEVI
>KACEBFPM_02173 Bifunctional ligase/repressor BirA
MLIANTYKNLLMKLIKLDAIDSTNDFLKGLSQKENLENYTVVTAKTQTKGKGQMGAKWDS
ETGKNLITSILIKETILNIHEIFNLNIVIAVSIIQVLKDIKIPNLNIKWPNDIMAENKKI
AGILIENSIKENGKIESIVGIGLNINQTNFDNLPKASSLKNITHQDYDIDTLLEKIVTKI
ENNSNKLKNNDVDCFWNDYESYLFKKGKPTVFEDINKQRFMGIINGVNRRGQLEIVLEDD
SLKCFEVKQLVMV
>KACEBFPM_02174 Ribosomal silencing factor RsfS
MAKKEINNDVLLANIIKGIEEVKGNDITILDLRALENTVCDYFVICNGNSNTQVNAIVNS
IQKVVSKELKDKPWHVEGSDVADWVLMDYVHIVVHVFQKHIREYYDIESLWGDAKITTIE
NKY
>KACEBFPM_02175 ATP-dependent zinc metalloprotease FtsH
MSKEIKKNSFKFNPWWIYGVITAIFVTMWFSGQSRWVEPTKTSISKFYEFLDANQVDKVE
IVNDKTVEVYLKKEALTQKVHAKIPKLDLLQKPNLGPHYTFQIATNSESFQNKLEEARKT
NSIGVDYKTSSEWTDLVGFLPIILLIGFWIYMMRRMSGGGSGAGGPQIFSIGKSKAKLFD
EKTDIKTTFKDVAGLEGAKEEIQEIVEFLKNPTKYTNLGGKIPKGALLVGPPGTGKTLLA
KAVAGEAQVPFFSLSGSDFVEMFVGVGASRVRDLFKQAKDKSPSIIFIDEIDAVGRARGK
GNMSGGNDERENTLNQLLTEMDGFGTNSNVIVIAATNRADVLDKALMRAGRFDRQIYVDL
PNITERAEIFAVHLAPLKKVENLDTEFLAKHTPGFSGADIANVCNEAALIAARNNKTAVD
KQDFLDAVDRIVGGLEKKNKIITPEEKKAIAIHEAGHATVSWMLEHAAPLIKVTIVPRGQ
SLGAAWYLPEERQIVRPNQMLDEMCATMGGRAAEKVIFNNISTGALSDLEKVTKQARAMV
TVYGLNDKLGNITYYDSSGQSDYNFSKPYSEETARTIDQEISILIEGQYQRAIALLELHK
DKLNQLADILIEKEVIFKDDLETIFGKRPFDKENFVEAIPQIV
>KACEBFPM_02176 hypothetical protein
MSIFRKIFGSSSETPNDTNENDFNPFQGIDSQIPVDEQFTYNFKKNGGKFLYCENTAELS
EQFENILEENDWFESEAMCLESRLFRMLEDNKISFDKPQDPKFLLASCENLIADEGSVLF
SSNQIKQNKPNDLPDNIVLVATTSQIILNKGDGLRGIKKRYTTDYPTNITTFKYFEKVKE
EDFLHYGSSPKHLYLLLLEDL
>KACEBFPM_02177 Phosphatidate cytidylyltransferase
MNENVTRSLSGLVYILLLVSATLYSRESFLLLFGVFMLQTVREFCNLIFLPKIPAMLMAG
LLYFIFACFLTENRSTDFGLILASLFVSIRLLFWLFKEKRIAIDTQGKWVNLIGYIILPF
IFIVKISSFNGIFAPTLLISIFVLIWTNDTFAYIVGKTIGRNKLFESISPKKTIEGFIGG
LVFAIIAAVIIANYDPLKPTYFWIITAIIVSFFGTIGDLVESKFKRMANVKDSGNIMPGH
GGMLDRLDSIIFVAPFLFLFYKIIVYVS
>KACEBFPM_02178 Phosphatidylserine decarboxylase proenzyme
MFHKEGSKIILVATFLFVTSIVLAGEFINLSWLKITVQLVALLFYIIILQFFRNPNRNIV
ANDSQIVAPVDGKVVVIEEVFEPEYFKDKRLQVSIFMSPINVHVTRYAVSGVVKYSKYHP
GKFLVAWHPKASTENERTTVVVENKVFGEILYRQIAGALAKRIVNYAEEGTQVIQGTDAG
FIKFGSRVDLFLPLGTKVNVKLNEVAIGNKTIIALG
>KACEBFPM_02179 hypothetical protein
MFEKDLETQFQEAIHLAQTIAQSSLPQDVQLRCYAYYKQATFGSLGSVNYSNLDVRDAFK
NNAWLQISHISVEEAKQSYIDIINKISNK
>KACEBFPM_02180 Superoxide dismutase [Mn] 2
MKTQQLFVIILALTVVVSCKKSTLVEQVDVPVTPLEVVKVKEGTSNATDVKAVEGAFKMY
ELPYTYKALEPNFDATTLEIHYSKHHLGYVNNLNKAIIGTKYETLALNDIFKNLNLSDTE
IRNNAGGFYNHNLFWENMAANAGGEPEGDLLEAIIRDFGSFDGFRTQFTEASLKVFGSGW
AWLVSDKYGKLRIVTTPNNDNPLMKNLGFTGIPLLNLDLWEHAYYLKFQNKKREYVNTFF
SVINWNEVLKKYDAFPKVTSSFVAPTATTETAVPDQAKETVIPDEFKK
>KACEBFPM_02181 Peptidoglycan glycosyltransferase MrdB
MTLVIKPQYVILIAFIGIAIQYLRSRRINRNILASAIILLLISGFVFSVDYVFENVFKQH
HRDRFNILLGKDVDMNGIGYNTNQSEIAIGSGGWIGKGFLEGTQTKGNFVPEQHTDYIFT
TVGEEWGFAGSFVLILLFVGLILRILYLAENQKTKFSRVYGYGVASVLFTHFFVNISMVI
GIFPTIGVPLPFMSYGGSSLWGFTILLFIFIKMDANKVNEW
>KACEBFPM_02182 Nuclease
MFCGCNKQKSDQDKDVVIKNNLASAVVPIDRNYYLPTSTTHVVVEHSFYTLSYSERYEQA
EWVAYELKKNELSHSNLERPYFIDDPEVKTGSASWRNYKRSGYDKGHLCPAADRRFSRKA
FDETFYTSNISPQRNDFNAGIWNTLEQKTRYWAAKYDGVYVVTGGVLTNNLERIGKEGVA
VPNYFYKILLDNSRGEYKVIAFLVPHEASQKSLDSFVVSIDKIEKMTGIDFFPNLPDGIE
KRLEMGHDFKGWSF
>KACEBFPM_02183 hypothetical protein
MKTKIIIAAITLLLGVTTNAQETTVLTKEQIKLVHQKDSLINIQAKKEEIQAEIQAEKER
EKEKKRAEKESEDRIKKEEKRRKEADKATQKLEAAQKKMEKEREKVEKEGKKIAKAQDKL
ASEKDKLTAINNDIAKSTEKLDKQNKKGKLSPQDITKWNEKLAKMKEKATNQQKKIEKAE
KEANKITD
>KACEBFPM_02184 hypothetical protein
MKIQKTSMRLVKYSEMLSEIENTENHLLLGNGFNYSLGVNTGYKNIFEVMKEHNPIYNTL
NIENDNF
>KACEBFPM_02185 hypothetical protein
MKNEIIHTLTNNFESHANQTEEGIEFWLARDLQHLLGYTKWDNFVGVISKAKTACEISGE
DIEHHFADVGKTIQMPKGAEKEIQDIMLTRYACYLIAQNGDSRKESIAFAQRYFAIQTRK
AELIEQKTLEYERVQARNKLKVTEKELSQVIFEQTGGNQNFAIIRSKGDTALFNRTTQQM
KVKWGLASTKPLADHMPTILLKAKDFATEITIFNAKQHKMKSENQISKEHITNNKSVRST
LLSRGIVPEDLAPEEDISKIERRLVSDEKKALKNPDKLNEK
>KACEBFPM_02186 Type IIS restriction enzyme Eco57I
MSLFQNSVVSKYLKNQNATLLVQKWEAYKNHFLNLKVQEDIKGLKEEQYQGEFLEDLFVK
ILGYTKPASSTETKFNLTTEYKNVKDSKKADGAIIINDKVIAVIELKGTNTTDLGKIETQ
AFGYKNNQPDCVYVITSNFEKIRFYIDNAIEFLEFNLFQLTKTEFELLYLCLAYDNLSKG
IAKTIKDESVSQEDVITKKLYKDYSLFKRELFQNLVALNPQYEPIELFKKSQKLLDRFLF
IFFAEDRNLLPTNLIFRINKEWQNLRTMRIEVSLYDRYKIYFNDLNSGAKVQLPAFSQTT
SNVVEEHQIFAYNGGLFKADDILDHIKIDDAVLFKHTENLSNYDFASEVDVNILGHIFEN
SLNELDEIKAQLEGESIDKTKTKRKKDGVFYTPKYITKYIVENTIGKLCEEKKTELQLVD
EDYTTDKKRQKKTLQALIDKVETYRSWLLQLTICDPACGSGAFLNQALDFLIAQHQYIDE
LKAKLFGDTFVLSDVENSILENNLFGVDLNEESVEIAKLSLWLRTAQPNRKLNDLSNNIQ
CGNSLIDDVAVAGDKAFNWQTAFEKVFAKGGFDVIIGNPPYVLCQPSNTNEITLDYYKKF
EVASYKIDLFHLFFEKSITLLKEKGKLGFITPNTYLTNKYIQKLRNYILNNTSIETIVNY
EDSVFVDAGVDVATIILNKKENLKTNVYTSNKGNLTFIKSLNQNEWLDDVDNIFNLNNEF
TFKFIDCIKVDNICSVTFGLQTKDKSTYVLENKVSEEWENCYTGSDINRFNLKESTLFFK
NNPKEVKAGGSWNMDIHHSKKIVVRQVGNPEPIFAFDNFGYATLNTMYSIVVKDDTFSYY
YLLAILNSTLIKFYFLSKYSDGKQLFPKVKGFQLKELPIKNSSIENQKPFIEKVELMLSL
NKTLQQQQAKVINMLQRDYGLTKPTKKLDTWYELTVQDFFKELAKAKIVLSAIQKDEVQE
YFETYQKQAVATKNQITATDKQIDAMVYELYGLSNEEIEIVENS
>KACEBFPM_02187 D-aminoacyl-tRNA deacylase
MKVVIQRVSQASVTIDSKIVAKIQKGLLILVGIEDSDNQEDINWLSSKIINLRIFEDKNE
VMNLSVKDINGEIIVVSQFTLQALTKKGNRPSYIKASKPEIAIPLYQSFVSQLETELGKK
VQTGIFGADMKVSLINDGPVTIIIDSKNKE
>KACEBFPM_02188 Small ribosomal subunit biogenesis GTPase RsgA
MTGIVYKSTGSWYTVKSLQGHFMECRIKGKFRMKGIKSTNPIAVGDVVDYDLDENSDVVT
GTITKIHDRKNYIVRKSVNLSHQMHIIASNLDYVFLLITINNPPTTTNFIDRFLVTAQAY
GIETILVFNKIDTYNEAMLDEQLFMQYIYQEIGYKCLRVSSTEGKGIEELKNIMKNKVTM
FSGHSGVGKSTLVNAMEPTLHLKTKTISEQSKQGQHTTTFAEMYDLSFGAQIIDTPGIKG
FGIVDMEKEEISGYFPEFFKLKDQCKFNNCLHKDEPKCAVKDALEKDKISYSRYNSYLKI
LEGDDETYRTDIYNDDRIASDETRNK
>KACEBFPM_02189 Phospho-2-dehydro-3-deoxyheptonate aldolase
MENSTSLRTWLDDFKLSHPLVIAGPCSAETEEQVLKIAHELKNSDVSIFRAGIWKPRTRP
GGFEGVGEIGLKWLQKAKAETGLLIATEVANATHVKLALEHDIDVLWIGARTTVNPFAVQ
EIADALQNTNKIVLVKNPVNPDLALWIGGVERLYNAGIKKLGVIHRGFSTYEKTKYRNIP
EWQIAIELQNRFPDLPLIIDPSHITGNRNMIQEVSQQALDLNYDGLIIETHTDPDNAWSD
AAQQVTPTVLKQIFEDLKVKKTTVEEDGYNTEMIKLRANIDIYDSKILEILGNRMKIAEQ
IGALKKANNVAVLQNKRWNEILGKMILDGEEKGLSEEFILKMFKAIHQESITHQEKIINA
>KACEBFPM_02190 LL-diaminopimelate aminotransferase
MIPIANRLKTVEEYYFSSKLREVRELINQGKPIVNMGVGSPDLQPSKTVTQAMQKAIYEP
VAHQYQSYQGLPELRQEMANFYKNNFQVNLNFNNEILPLMGSKEGIMHISLAFLNKGDEV
LIPNPGYPTYTSVTNLVEAKPIFYDLTAENNWEPNFEALEKTNLTKVKLMWVNYPHMPTG
ARGSLHLFEKLINFAKKHHILVINDNPYSFVLNDNPISILQAKGAKEVALELNSLSKTYN
LAGWRVGMVSGNSQYIDAILKVKSNIDSGMFYGIQKGAIEALKLDKSWFEEQNKIYHKRR
NLVFRLSDKLNCSYNKKAVGLFVWAKLPEEITNTEDFVDKLLYEKDLFITPGTIFGSNGE
GYIRFSLCVSEERIEEALKRFQKSIPLSKTNKPKENFNIAQIP
>KACEBFPM_02191 P-protein
MEIEIKKIAIQGIEGSFHHQVAATLFDKNIPLEECMSFELLVKSLKQNTSQKGIMALENS
IAGSIIPNYALIDANDLHIIGEYYLDIHMNLMVLKGQKIEDITEVHSHPIALLQCGVFFK
NYPHIKLVESGDTAETARRIQQEKLTGIGAIASPIAAEMYNLDIIASGIHTIKSNKTRFV
IVKTQNKEISKEQINKASIKFELDDTPGNLATILNVMNNCKLNLTKIQSMPIIETPFQYS
FFVDIVFAKYKHYEKAKKILELMTTHFKVLGEYKKGAQ
>KACEBFPM_02192 ABC transporter ATP-binding protein NatA
MSIEVQNISKNYGTQKALDNISFSVKKGEIVGFLGPNGAGKSTLMKILTTYINADGGLAM
VNGFDVNANQLEVQKSVGYLPEHNPLYLELYVREYLAFNADVYKVAKSRIEEVIVLTGLL
PESHKKIGQLSKGYRQRVGLATALLHNPDVLILDEPTTGLDPNQLVEIRDLIKNIGKDKT
VFLSTHIMQEVEAICDRVIIINHGKIVTDKNLDLLVSEKTEQIIEVEFDKVIAEKLFDKL
PNIQSYKNLHGLVWELSFATQADMRPVVFDFAHENGLKTLQLNLKSKNLESIFREMTK
>KACEBFPM_02193 Arabinose operon regulatory protein
MYIKTNTYTQFDAIEIKESLFKEFLLPNHFHDTVCIGLLSNGIKKSVIEETPQLVHSNSV
SIINPYQVHSDNNIDTGDCLYKMIYVNTDVINYFSKEITGKNYTNLLFTNDLITNPLVSS
AVLRFFDDKHNENLLEQKLKNLIEILISKGFLAENIIIATESKNAIDDSIENARLNFSDK
IDIAKMANESKLSKYQFIRYFKKKTGITPASYILIHRINHAKLLLIQGIPFGQIALEVGF
YDHAQFCKFFKYYTNLSPTAYKSNCNIVQA
>KACEBFPM_02194 hypothetical protein
MKNCFTFLFTFFCLTITVGQNNPLITDNTISLPKDSLVAKQLVTSLNDLLIAKEKPNDEN
NNVLISERIETYILLDEMNGIEKSGKYKDDNFYKPYLTNVVKLNDNEYYIQLSYIGIYEN
KPMLRASFELIAHKTAHSFLFSSLLLRNTKDWKTEKVGNNIFHYKQTINKVKTKEFNKLT
ASFDLKLKSTQKTTEYYCTDNIIEMQKLIGVDYKLDYNGRKESVWSSSFGDRKLYVLGNN
SSTFNDFDPHDTWHNSLYSVASRSKINRPIDEGCAYIYGGGSWGISWKDVFAKFKDKVAS
NANTDWAVCKEKPLNFNTPEIYLYADYVVNALLIRKIENEKGFAGVWEFLNCGKLEKGNE
NYYKSLEKLTGITKANYNDKVWELIKMSK
>KACEBFPM_02195 dTDP-3-amino-3,6-dideoxy-alpha-D-galactopyranose transaminase
MIRFLDLNKINKPYEVAFQEKLQFVMNSGWYILGNEVKTFEENFAKYCDSKYCIGVGNGL
DALVLLFKAHIILGKLQKGDQVIVPANTYIASILAILQADLIPVLVEPKLETYNINPDLI
TSKITSKTKAILAVHLYGQLADMNAINAIANQHNLLVIEDAAQAHGASLEGNFKKAGNLS
NAAAFSFYPGKNLGALGDAGAITTNDHELAKTIKSLRNYGSETKYYNDYIGANSRLDELQ
AGFLNAKLPHLDSDNKRRKAVAKRYLLEIKNNKITLPFWDNSTNHVFHLFVIRTENRNKL
QQYLLENGIETLIHYPVAPHKQKALLNYNNLSLPITEKIHHEVLSLPISPVITDHEVSFI
IEILNQY
>KACEBFPM_02196 hypothetical protein
MIDYSVRPYQTKDYTLWNTFINEAKNATFLFHRDFIEYHKDRFDDFSLMVFCKEKLVAVL
PANKIEDAVFSHQGLTYGGLVYSDKLKLATVLTIFQTVLRFLKNSNINTVNIKTIPAIYH
TKPAEELLYALFLVDAKLHRRDSLSVINLPNNSHYSTIRKRGIQKGFSNDLVIKEVNLFT
SFWEEILIPNLEQRHSAKPIHTLTEIESLQAKFPKNIRQFNVYYDNKIVAGTTIFESNQV
AHAQYISANERKNELGSLDFLFHYLITTVFKNKKHFDFGISNENLGKKLNNGLSYWKESF
GASTIVQDFYEAKTSNYILLDNVII
>KACEBFPM_02197 hypothetical protein
MFYLLDIIGTMAFAMSGALTAMNKKMDPFGVFIIAFVTALGGGTLRDVMIGNTPVGWMKD
LKGVYAIIVAFLLAFLFRNRFDKLRTSLFLFDTIGLGVFTLIGIQKGINIHLHPVICVAV
GTMTACFGGVIRDILCNEIPVIFRKEIYATICIIGGIFFFVLKKLNFEDDLIYIMTSLII
VIIRLMAVKFKWSLKPIVNKS
>KACEBFPM_02198 23S rRNA (uridine(2479)-2'-O)-methyltransferase
MKQITSSQNPYIKSLVLLQEKSKARKQSGTFLIEGQREIELAQKGGFVIETILFLPDLIS
QKQITQITNQAHDIIEISKEVYQKLAYRDTTEGILAVAKTKPFLLSDLKLSQTPLILIAE
APEKPGNIGALLRTADAANLDAVIIANPKSDLYNPNIVRSSVGCLFTTQIATGTTQEIIT
YLKENKINFYCATLQNATPYHTQDYTPPTALVVGTEATGLTQEWRNNATQNIIIPMQGEI
DSMNVSVAAAILIFEAKRQRGF
>KACEBFPM_02199 Lipid A biosynthesis lauroyltransferase
MCDMFLEMIKTITISQSEIEKRFKFNNLEVYLELEKKQKSIAILCAHYASYEWVVSMNYH
INFTGYGIYKKISNEYFDKLVKDIRSKFKAVLITTKETSKTIQENAISGKLGVFGFASDQ
TPRWSDNLYWYHFMGIETPIHIGAEILAKKYDMNVIFLKTKKIKRGYYEASFEVLTEDVK
SVPNYKISEDFMSRVEQQIYEQPEYYLWTHKRWKHKKKV
>KACEBFPM_02200 Cysteine desulfurase SufS
MIATQTSTELEQYFQQFRNNIIGINQEFESPFGTQKIIYTDWTASGRLYRPIEEKLMNEF
GPFVANTHTETTVSGTAMTMAYHEARHIIKRHVNANGDDVLINDGTGMTGVINKFQRILG
LKMPENLKEFANIPNEIKPVVFISHMEHHSNQTSWLETIADVVVIPSCEQGLFCVDNLKK
LLEQYKDRSFKIASITSCSNVTGIRTPYHEVAKLMHQNKGVCFVDFACSGPYVTIDMHPT
DSESYLDAIFFSPHKFLGGPGTSGVLIFNKNLYKNNIPDCPGGGTVSWTNPWGEHKYIDN
IEDREDGGTPGFLQVIKTALAIQLKEQMGVATILKREHEIVSFVFESLGNIENINILASQ
HKDRLGVISFYITDLHFNLGVKILNDKFGIQTRGGCSCAGTYGHHLLHVDQKMSHDLVCQ
IDLGDLLQKPGWIRMSIHPTTTTSEIEFVCNSIKSLAENHKQWSSDYHYNAKSNEYVHKK
ALNKELEMVKSWFKI
>KACEBFPM_02201 hypothetical protein
MSNANNLVKETTVQIGSTQTTRTTTNQYLYNAQDYPIAQKKYDETNVLKRTTIFEY
>KACEBFPM_02202 hypothetical protein
MQFTTPIPIAKSNHLINYNSKIVSLGSCFAENMAKKFEYFKFQNTVNPFGIIFNAVAIEK
LIFRSIHKHYFTEAAIFFHNQSWHCYEVHSELSNPNKEEFLKTLNELIDSTHVQITQATH
FIITLGTAWVYRDIGTNEIVANCHKVPQKQFTKELLPIETINKSLQNIVTLITEINKEAK
FIFTVSPVRHIKDGFAENTLSKSHLISAIHKVANCQLSIINYFPSFEIMIDELRDYRFYT
EDMLHPNQTAINYIWIRFFENYIDSKEFATMQQVCDIQKGLHHKPFHSQSDSHQQFLSKL
RDKITKLVVIYPFMKF
>KACEBFPM_02203 hypothetical protein
MRNRIITGIVLIIIVVFLFKFCTFKKEDHSSLENSTALIQQQIINVGKLVVTEGHFAEVL
TYKDQNTYFGGMISFDKKALIIVNADVTVAYNLHEMKYDIDEKNKIITILNIPKEEIKIS
PDIQFYDVDQSKLNPFTGDDYNKINKQAKTSLANKIEKSTLKSNAQNRLISELSKMLILT
NSMGWKLQYEGNIIGKESDFSSKIKS
>KACEBFPM_02204 Phenylalanine-4-hydroxylase
MEAHFESNPLINRLPKHLKQFIKPQDYSEYTPINQAVWRYVMRKNVNYLSKVAHESYLVG
LEKTGLEINNIPNMYGMNRILKEIGWAAVAVDGFIPPNAFMEFQAYNVLVIAADIRQLEH
IEYTPAPDIIHEGAGHAPIIANPEYAEYLRRFGEIGCKAISSSRDYEMYEAVRLLSIVKE
AEGTPQAEIDAAERQVEFLQNNMGEMSEMSQIRNLHWWTVEYGLIGTIETPKIYGAGLLS
SIGESAWCMTDNVIKIPYSIDAVNQSFDITKPQPQLFVTPDFSYLSEVLEEFANKMALRT
GGLSGIQKLINSKAIGTIELSTGLQISGLFANVIEDQGKPIYVQTTGKTALSYREKELVG
HGTSYHAEGFGSPIGKLKGINLAIEDMSPRDLKAYDIYESGKVTLEFEGNIVVSGEIITG
SRNLQGEIILISFKNCTVTHGETILFQPEWGIYDMAVGKKVISAFSGPADVQSFNMITHI
PSSQTIKAKKTPERHELEGLYENVRNIREGKSTHLSLEDTFGKLLENHPKDWLLSVEIVE
LVQAKDTVLSSKIISHLESLKNSRPEVKKLISNGLELIFEKESV
>KACEBFPM_02205 hypothetical protein
MKTIKFLAILVPFLFASCSAVRVNSDYDKKTDFSVYKTYAFYKIGIDKVEISDLDKKRIL
RSIDEQMTTKGFTKSETPDLLININTKAEKNINVNQFNAYYGYGWGFGWNPYFGANYSIN
TNTEGTLTIDLIDAKKKELIWQGEGVGYLTKNTNKKDENIKCFVNSILLQYPPVSK
>KACEBFPM_02206 hypothetical protein
MNNQLKIILQQKSEEKTNKQIEDISKKLQKIEKLNTDFEKLKTKITNIRQLVDKKTTEIK
INLCHTKEQFVILLIKKFCMKSFTKWEKEIIANLINEELELLTNYNHESEDLQKALDQYF
KSQKENLNKFETEIIQESIKDMLAQFDLDFEDEDLDFEKINDPAFKKRVEEKMRTKQKEA
NERQKQLEKEQKIEKTDIDFQKIYKKLAKLAHPDLYKSKDEKATKEEQMQRLTKAWNERD
YYELLMLWLEIDPQNTIELEINQTNQKNIIAQLNSKIKEIEAETYQVKFHFDDTAFYYQF
NASSEKAIHTNIEKYKKTLKENLEMTASKHLEVEKTKTFKIILNNIYQSNQESDFRNYLD
DLGIDFD
>KACEBFPM_02207 Urocanate hydratase
MVLDGSKEASKRLESMLFWDVNNGISRRSWARNNNAIFAIQRAMAAQPLLKITIPNIVED
KLFDF
>KACEBFPM_02208 Putative DNA repair helicase RadD
MLDNELELEVEVEAKKILYDYQSRDIDAIFNKMNNVGNSYHLLYQLPTGGGKTVIFSEIV
RRYLELYDKKVVVLTHRIELCKQTSKMLKGFGVKNKIINSKIKDLPDQDEYSCFVAMVET
LKNRLNDEKLIIDNIGLVIIDEAHYNSFRKLLGSFNNAFILGVTATPLSSNVKLPMYESY
KELIVGDPINKLIQNGFLAKANTYSYDVGLSSLKVGINGDYTIKSSDELYSQLDMQNKLL
HSYEEKSKGKKTLIFNNGINTSLYVYETFKEAGYPIRHLDNTTTAEDRKDILIWFKQTPD
AILTSVGILTTGFDEPTVETIIINRATKSLTLYYQMIGRGSRKLPNKDEFTIIDLGNNAA
RFGLWSEPVDWQHIFKSPEYYLDNLREDAEIELYFKYQMPPELREKFSKTEIVTFDVDAE
HKLAISLNLRSKVVLEKSLDQHAEMCVYNTEELIEAKNLSKELHDDIECRMKRYTKCLSQ
CSKNYREWLVDDYKVKLLLLIGKKYREKLFAEED
>KACEBFPM_02209 hypothetical protein
MSKRDLKKYLSELNNTQLQEQLIELYDKFISVKTYYDFVFNPNENGLVKEAKLKISSEYF
PIRGKKAKMRRSVAQKFIKHFITLGVDPFLIADVMLYNIEIAQTLSSEREIKTELFYKSM
LTSFNQVIKFLIEKGILNDFKNRIVAIKDQTLAQNWANHSDFNAIIERFEY
>KACEBFPM_02210 hypothetical protein
MLKFFKYLAITEGISALLLFFFAMPMKYVFHNPIYVKHLGMAHGILFTTYIILATILKFK
ENWTVKKYAEICLASIPPFGTFYIEKKYLKDA
>KACEBFPM_02211 Miniconductance mechanosensitive channel YbdG
MLKFTEKLFGWCDKLLMKFGFNEIIASYLGLLVNLVILFAISYFLYIVFRFILVTIMAIV
ARKTKTKFDDLLVSNQTAKYISHLIPLIYVYKSVPVILENFNSWESIFGKLVGIYIILLV
LWIIRTVFNVLRDHLKTIPSYSDKPIDSYIQVIMIILWMIGFTAILSKLFEIEIRDLLTT
FGAISAIILLIFRDTILGFVASIQVSVNDMVRIGDWITMDKFGADGDVIEINLATVKVRN
FDNTTTTIPTYSLISDSFRNWRGMLNADGRRIKRHILIKSSSIRFVKEEELEDFKQIQLI
KTYIEKKQADINKYNLQYNVDKSLSVNGRNLTNFGLFRKYLTNYLENYPSLNKDMILLCR
HLQPTAQGVPLEIYAFTSDKRFENYEYIMSDIFDHILASVVYFDLEIFEMPSHKNGFTEA
>KACEBFPM_02212 putative acyl-CoA thioester hydrolase
MRFHTRKWVKPEDLNPNHSLFGGKLLAWIDEEAALYSIVQLENPRVVTKHMSEINFVSSA
KQGDIIEIGLDVVKFGNSSLILKCEVRNIMTRETIITIDSITMVSLGEEGKPKAHGKTEI
EFVRNRIK
>KACEBFPM_02213 Bifunctional NMN adenylyltransferase/Nudix hydrolase
MRISKIFVTVDAVIIRKSTDNQLLLIKRKNKPFENCWALPGGFVDHHEDLEVAAKRELEE
ETQIKIDSLQQFGTFGKPFRDPRGHMISVAYFGEVPENTIAIASDDAKEVAWFAVNELPN
LAFDHQEIIEKALKTFKI
>KACEBFPM_02214 hypothetical protein
MENRDTIIFNLRGGALGIVTTQSSGEEAFQNITLRPILKLQNDLLIRVFVNYAQKQKSVF
FALSPEKKQSYIENVIQKDIKFRNLLKGIIIGFFTVHEYQDYIKNSSNLNKRMMQLLIER
FKSQLQLLEE
>KACEBFPM_02215 hypothetical protein
MIDVKINIGEIIINIVLILYMIDNSVLKLIMNFINRMSSDVYASYISNRFLILKSIRYLS
GSLNLTL
>KACEBFPM_02216 Threonylcarbamoyl-AMP synthase
MDINQEIHNAYEVIKEGGIILYPTDTVWGIGCDATNPEAVAKIYKLKQRAETQSMICLMN
GEKMMYNVFKDIPEVAWQIMDVSEKPTTLILDNPRNIAPNLIATDKTLGIRIVKEPFCFK
LLERMKKPLVSTSANISGQPTPIAFKDISPEILKGVDYVVNLHHEKIGGKPSTIIKLTND
SQVKVIRK
>KACEBFPM_02217 Multifunctional CCA protein
MNYKSALNNKIFEIISEASQELSIDSYVIGGFVRDLILKREFKKDIDIVAVGSGIELALK
VSALLPHKPKVQVFKTYGTAMLRFEDTEIEFVGARKESYNLESRNPVVENGTLEDDQNRR
DFTINALAISLNKTNYGELLDPFDGLTDLENKTIKTPLDPDITYSDDPLRMLRGIRFATQ
LGFAIEENSLNSIAKNTDRINIISGERIVDELNKILSSDKPSIGFLLLFKTGLLDIILPE
LTALNQVEEIEGHTHKNNFYHTLEVVDNICPNTNDVWLRWSALLHDIGKAPTKRFNKKQG
WTFHGHEFLGGKMAKKIFERLHMPLNQKMKFVQKMVMMSSRPIVLSEDIVTDSAVRRLVF
DAGQDVENLMTLCEADITTKNPNKFKKYHKNFEIVRQKIIEVEERDSVRNFQPPITGEQI
MEIFDIKPGREIGVLKEAVKEAILEGEIPNEYQAAYKFVLKKAEKLGLKKVLN
>KACEBFPM_02218 Heme A synthase
MKNNKSVIIWLLSGCFLVFIMVVVGGITRLTNSGLSMTDWHLVTDTFPPLTEAKWEETFE
KYKLFPEYQKINIHNDFTLSDYKFIYFWEWFHRFIGRIIGLVFIIPFIYFLIKKKLNTET
LRKCAILLGMGAFQGFLGWFMVKSGLIDAPDVSHFRLSLHLTFAFITFAYTLWVALDLIY
PEKKQVILPLRNIARITLAIIILQIIYGGFVAGLNAGLIHNHWPLMSDGQFFHESIILEK
ESWFARFTEGKSGVQFVHRTIAYFVAGLIVFLTFKSKKHTLSLEQKNGLNALLIIVFIQF
TLGVLTLLYSVPLWLGVIHQAMAFILLATTTYTLHRFSK
>KACEBFPM_02219 hypothetical protein
MSKLAAQDKFLDLSDYGRSFGKLLANSLKKTRFTPIHVTLLFGLSGLIAIGCILSKNYFF
ASLFIILKSAIDAADGELARLKNTPSYSGRYLDSVFDIVLNFMFLMTICYVSKTSFLITI
LAFFCVQLQGTLYNYYYVILRNKLVGGDTTSKVFEYKSPRALPGESQKTVNILFKIYTLV
YGIFDKIIHYLDSNAYKVKTFPNWFMTLVSIYGLGFQLLIIAVMLPMNLIQYIVPFFIIY
TIPMFVFIGIRKVYFKA
>KACEBFPM_02220 Sensory transduction protein LytR
MKTIIIEDEKPAARLLQRKLDKLGVKVDVMLHSVEEAIAWFSNNKHPDLIFLDIQLSDGL
SFEIFEKVTIKSAIIFTTAYDEYALKAFKLNSIDYLLKPIDDDELSIAIFKFRNQFQKTE
NIPVNLDFEAIKKMFQNPFDKNFKTRFIVKIGQQLKIILIEEIECFFSENKGTYIHTFDN
RNYLIDLTLEVLEQDLDPENFFRISRKFIVPLKSVKEIILYSNSRLKIVLPTYKEEEVVV
SREKVQEFKSWIG
>KACEBFPM_02221 hypothetical protein
MRMNNRFLDDNILSNISSNTRYDRALKRVKRIKSFYIHLLVYILVNAFFLCSSYLRHQSE
SEIFWRWETFSSGLYWGVGLVAHGISVFGKNIFFGNEWEEKKIKALIENDKDEKWE
>KACEBFPM_02222 hypothetical protein
MENKYHNEDRYYAAKKRVNEIKGFYGNLVSYILVNLILLAINFATSPECLWFFWPLLGWG
VGVVIHGMIIFQWLPFFGKDWEEKKIKEFIDIEKRTKERFK
>KACEBFPM_02223 hypothetical protein
MKKNQNYYQNKEILNIAQSKVARLKGFYIHTFVFSIGVIIFVLKEYFKMKLNFFPIKHIN
YFAMAIWIVAYLISVLGMFFEYKVFGEKWEDQKIKNMIKKQSEKTIWR
>KACEBFPM_02224 Sensor histidine kinase YpdA
MENQRIRTFSEIKKGTIACLKISVLFTLISVLINQEYSLENIGFSFLISSLYSFGLGFGN
GLINNVLDKNWDWLEQTNLRVYLGVIATILYTIPVVLGVNYVIFVILMKLPIADFFSERI
VLIHLFYIILSLGISTFMHARSFMINWKNVSKKEVIEQKIIAGTASAKFESLKNQIDPHF
LFNSLNVLSSLIEENPENAQRFTTSLSKIYRYVLEQKDKELVSVDEELAFAKTYMNLLKM
RFENSLTYEITINHIAPSIAIKEAKVVPLSLQLLLENTVKHNVVSEQKPLHIKIFIDSDY
LVIQNNFQKKDVLQDRKGLGLQNIINRYGIISNRKVLIEQTENTFSVRIPILTKQITVLE
TNANYAENNAYYRAKKRVEELKGFYGNLISYCCVIPILVFINLRFSPEFQWFWYSAVGWG
FGLMMHAFKIFGYTTHWEERKIQEILDKQDKNNCK
>KACEBFPM_02225 hypothetical protein
MTKVIIAIAFFVTSLVSAQTQFEQGMGKAFGLWKEGKNTEASDMFERIASAEKSSWLPNY
YVALVNTTEAFKPENKEKVSVFLDKANAALDIELAKNKNNAELLVIQAMAKTALLASNPM
AYGMTLSPKIAQIYALASLLAPENPRVVYCKAEFAIGGAKWTGADVKQLCGEVEKAIGLF
ATFKPETVFSPKWGLERATAAIKNCK
>KACEBFPM_02226 TonB-dependent receptor SusC
MSNGVINKNLAQKKHSNSSLYFYNSVNINFKFIGYNSTLHYQKNIMKIILNIVILLLSIM
GFSQITVSGKVVDKKNIPISGVNIFIEGTYDGATSTENGDFIFETSAKGNQVLVLSLMAF
ETLKINIDVTNYQNKNIVLKQSINMLDAVVISAGTFRAGDHSKITALKAMDIYTTAGSNA
NIVAAMQTLPGTQKVGEDGRLFVRGGEADETQTYVDGIRVSQPYNASVSNLPTRNRFSPN
LFSNMSFSTGGYSAEYGSALSSVLLMNSINEPADDVTNIGIMTLGLGIGKTSKFKKSSLS
FDVSYINLAPYQLVVPQKIDWNKPVQAISGQSIYRYKCNKGLFKLYVTYDHTSLDLNQED
INYTNKIRFDLHNDNFYINSSYKGEVSDRLQIQTGLSFGYNKNTIGIVSDKLNNTERDFH
YKLKFRESFSNYFKLNFGTEIFNTHFDESYTATTHSAINYGYKNIQTALFTEAEIMFSPK
VALNLGVRGSNASVVDKFVVEPRISFGYKMAKNSQFSVAYGTFNQTAKQDYLKFDPHLDY
EKASHYILNYMYNTNGKMLRVETYFKDYSNLIKYDSNKATYNSTYNNDGFGYAKGLDIFW
KDSKTIKNLEYAISYSYIDSKRNYKNYTQQVTPSFVATNSVSVVTKYWIESLKSQLGLTY
SYSSGRPYNDPNTNNFMAEKTKSYTDLLLGWAYILRPQKIIYISISNLLNTNAIYGYQYA
NAKNSNNIYESQAITPPANRFFFVGFFWTISTNKKTNQLKDL
>KACEBFPM_02227 hypothetical protein
MYNAIVFVRMIYKKNYTAILIILMIFCIRDKYANWAG
>KACEBFPM_02228 hypothetical protein
MKLKLPLIIWILLFFTTIYYTQAQEKKILFVGNSITYFNDMPILFRNIANNKAKNVVTQM
YAIGGKGFVNHVADPAVYNLFKNNVWDTVVLQPGTGESSGTSSTVNTTIQRGQKLIDSIK
KYSPCAKIILYQIPYGVPSSTTYPAYFNIQTKIRDSIIKMADNLHVAFAPAGESARMHYT
AQQDLLLHSSYNDIHPNLNGSYLVAATMFATIFQEPVTGSTFYGGLTQATAEYFQGIADQ
VVLPNKPLWRINNFDLHADFNFIVNSNLISFTNTSSNATSLEWDFGDGDISTNNNPTHIY
TTLGIKIVKLKVIRNNCEETIEKEIVIRTLNTNSFEKKAPSIYPNPTYSQLNISNTNEFN
IKITNSIGQEVFTSKHLKKTWQIDVSNYSTGIYYINIQNQSVYKFIKL
>KACEBFPM_02229 hypothetical protein
MVYKFRVILDNEDDVFRDIAILADDTLEDLHNAIFNSFGFDGMEVGSFYTCDDTWNQEDE
IPLFDSGDILGQMKIMSDYLLSDILDKENRKIIYVYDFINMWTFLVELAAIEEISASATY
PETIFSHGEMPDDSGEKNFLADQDEESYNEYEDDIDDEDLDMFSGDDSYENYGFEDNWN
>KACEBFPM_02230 hypothetical protein
MALVTEVYQMTNTFPKEEIYGLTSQIRRSTISVPSNIAESYERDGNKDYLKFLNIGISSL
FEMQTQFEIAYNLKYINEIQFNKINEESKRMLSSFIRRIKERV
>KACEBFPM_02231 hypothetical protein
MINLFNTHIESLSIHRVGNVSRNEDMFLSENPYGLNDEIMPLLKEYFLKSFREKEENYFQ
FAHEVDLEYNEMFKFATEIFENPSKTHDISKKITKHLFEQSNHPHIKNGEVYVTHLTNIS
IDNNVVDAIGIFKSELKADFLQFEEKGTTLEMILQQGINLNKLDKGCLIFNYKKEEGYKI
LTVDSNRYDARYWLEHFLSVDAFQDENFKTKKYLKFCQDFAKDVVFPAEDKKEEVMFMNR
AVNHFAKNDQFEESNFLNEVIDNPDLISEFKNYKVDKGEKYSIEDLTSFPIANAAVSDAR
RTMKNVINLDTNIQIKLDFINPESAEKFVEKGWDEEKQMYYYLVYFNKEQKS
>KACEBFPM_02232 ABC transporter ATP-binding protein NatA
METILTITNLNKIYNKHVHAVKNLSIKIYKGNVYGILGPNGSGKSTTLGIVLNVVNKTSG
SYSWFDGKTQTHEALKKVGAIIERPNFYPYMTAKENLELVCKIKNINYAKVQEKLELVGL
VDRKDSKFSTFSLGMKQRLAIASALLNDPEILILDEPTNGLDPQGIHQIRDIIKHIASQG
TTILLASHLLDEVEKVCTHVLVLRKGEMLYSGTVNGMTNNEGFFELKSENHQTLKLVLAN
HQAVDKIVEEEGKVLVYLKGNLEPADLNKYLFDNNISLEHLVKRKVSLEEQFLELTANHS
DNNFKNR
>KACEBFPM_02233 hypothetical protein
MKRLLSIELQKIWKNKASRVLTITYFVLLSFIALIASIKFDLGAFKLNLAEMGIFNFPFI
WHFNTYIAAILKFFLAIVIVSMMANEYSYGTLKQNLIDGMSKKEFILSKFLTVILFALCS
TVFVFVMSIILGYSFSSYTELGIVFSGLEYILAFFVKLVGFFSFCLFLGIFVKRSAFALG
FLFVWNIVEGIAKGMLTFKIFPNSNTAQNITQFFPLEAMSNLIVEPFSRLSVIKTIGTQI
GVNNIKDYTVHFTTILIVLVWTVIFMLMSYKVLEKRDL
>KACEBFPM_02234 hypothetical protein
MKLHLQIFIFSIILFVSTNTFSQYIQITDNVTAQDLVQNTLINSSCALVSNFSATGGNFE
TGKQSYAYFNAGTSGFPFAKGIVLSTSRAASTKGPNNSLLSENATGWFGDTDLEQALNIS
NTSNATILEFDFIPFASNISFDYLFASEEYHGTAPCKYSDGFGFLLKVAGSSAPYQNLAL
VPNTNTPVKVTSVHRDIPNGCSAINETYFGSYNGPNASINFNGQTVVMTAKATVIPGTKY
HIKLVIADETNPQYDSAIFLGAGTFQVGTDLGENKLIATKNPLCQGETYLLDATEAGINS
YKWFKNGIEIIGQTNPTYQVSTTGTYSVEVSLGAKSCIAKGEVTIEYSPIPVLSNKTLVQ
CDDDNDGSTIFNLTKLDDLIKNSNDNTLSAVTYYETIGGIAITNPSNYTSIPKTIFAEVS
NSNNCKSIAQVTLQINNTVYLPYLKKKCDTVGAQDGITSFDLNTEITPNIAPGLVVKYYA
TKNNAITQNSPLPNNYTNVIANSETIFARIINGPDCSGIIDVNLKVDVLKPDNFEDEIIG
LCQGSSVFLSVDPIFLNYTWSNGDANFETEIFTPGNYSIEVTNSNGCKATKTFIVQPSAP
ATNIDAVINDFSENNNTITITYTNNGGDYIFSIDGVNYQESPVFTNISLGEYTIYVKDKN
GCLPTPSKVIYVLDYPKFFTPNGDGINDTWIIQNIKIRPSATINIFDRFGKLLKQLDSNS
AGWNGTYNGENLPSDDYWFVLTLLNNKTIKNHFILKR
>KACEBFPM_02235 hypothetical protein
MKLLKNVTFFIFLLISQTIYSQNDCTDALTACGNNSYTDLYITGSGVNEISNANTCDGNE
TNSLWIKVNIRTAGTLGFTLTPQNTNLNVDFDFYIFGPTATCGNLGNAIRCSTTNPAAVN
ATNNTTGMNGTETDTSEGPGANGNSFIKWLDVQIGETYYIVIDRFDGNSNFSINWTGTAT
FNQPPTINTNPNAENTLNIEKCDSDNVQDNKTSFNFTQNATLAIGNQTGVTASFHTSLND
ATVNANPITNSTNFRNTSNPQNIYIRLTNIATKCFTTSGFSLHVTPFDTNNPNDLKECDL
NNDGFVTYTLSANNATLINGNSDIAVSYHPNNNDLITLANNYTNQTAFTNETIWAKIKNT
VTGCYAYKSLNLILNKIPPTNPATLIQCDLELFPDGLTTFNLNEANAILTNNDTNLSTNF
YLNPTDAQSQSNSIAPNFQNTTNPQVISVRVINNTTGCYSITTLTLKGITNPTRNVTLEE
CDDDDITTIGFTKFNLSQAGFEISGNTATYFQNLNDALLEEHAIATLFTNTQANNQTIYA
RIENGNNCKEINLITLKVNPLPSFEIQNNEILCLNNPTKPVNLIVKTIDDPNLYSYKWTP
NEQITQNINTFLPGNYAVEVENKLTHCKKSRSITITPSETAIIKNITITDLVNNNTAVVN
ISGTGDYVYSIDEEFGPFQESNIFSNVTAGIHQIYVKDLNGCGTVPQEINVLGVPKYFTP
NGDGIHDYWNVEGITATFNANTTITIFDRFGKLIKQISPLDQGWDGTDNGQKLPATDYWY
TIQFENGKNIKGNFSLKR
>KACEBFPM_02236 hypothetical protein
MFNKYITSLFFIGITTCIVSCKDDVLPKPKAYLSLNYPKPKYSNFDKTCGYTFQYNTLGK
VVDKGNCNFDIDYPKLKATVYLNYKSVNNNLKDLLRDAQKLTYEHVIKADGISEQPYANK
ERKAYGMFYEVGGNAASQSQFYLTDSTKHFLVGSVYFYAKPNYDSVLPAADYIKNDLRIL
MESLKWK
>KACEBFPM_02237 Single-stranded DNA-binding protein
MNGTLNKVMLIGHLGEDIKMHYFDGGNCIGRFPLATNEIYINKSTNEKITSTEWHNVVVR
NKAAEICEKYLSKGDKIYVEGRIKSRQWQAEDGTVKYTTEIQVTEFTFLNTKKDSEIVKT
ASEAPKTTSFDSTVENDLPF
>KACEBFPM_02238 Adenine DNA glycosylase
MNFTEKIIAWYLENKRDLPWRKTSNPYAIWLSEIMLQQTRVAQGLPYYKAFTEKFPTVFD
LANATEEQVLKLWQGLGYYSRARNLHATAKFIANDLNGIFPSDYKNLLKLKGVGEYTAAA
IASFSYNEVVPVVDGNVFRVLSRYYNVATDIASGKAKKEFTLLAQELISKDNPALFNQAI
MEFGALQCVPKNPNCYFCPLNTSCAALSLKIVGQLPVKIKRLKVKNRFLNYLYILDNNNE
TTINQRTVKGIWHNLYEFPLVETEDLEPENIVLQLIKDKFDDISEILLMETETIIHKLTH
QHLHVKFWKIRRNTILENGLDFENLNKFPFPIVLHNFIENNRF
>KACEBFPM_02239 DNA-binding protein HU
MTKADIVAKISEKLGLEKGDVQATVETFMEEVKNSLETGDNVYLRGFGSFIVKTRAEKTG
RNISKNTTIKIPAHNIPAFKPAKVFVEGVKTNNEATTK
>KACEBFPM_02240 Ribonuclease G
MNKELIIRSSSDAVDFALLKDGKLIELHKEEETSNFQVGDIFIAKIRKPVAGLNAAFVNV
GFEKDAFLHYHDLGPNLASQMKFIKLVTTGKIKDFSLKSFQFEKEIDKDGTITDVIAVNQ
SILVQVVKEPISTKGPRISSELSLAGRYIVLVPFSDRVSISQKIDSKEEKDRLKRLVQSI
KPKGFGVIVRTVAEGKKVAEIDKDLQNLMDKWTSMCKRIPTAHHPSKVLGELNRASSILR
DVFNDTFSGIIIDDEELFNETKEYIQQIAPSKESMVKLYQSKDTPIFEKYSIERQIKTSF
GKSVSMSKGAYLIIEHTEAMHVIDVNSGNRSNKATNQEDTALEVNMIAAAEVARQLRLRD
MGGIICVDFIDMSNPDNRKVLFDFLREEMSDDKAKHKILPPSKFGIVQITRQRVRPEVNI
ETREENPNNENSDIEAPILIIDRIASDLERIIKLHKKVVLNVHPFIAAYLVKGYPSIRSK
WFFEYKKWIKIIPRDSYTYLEYHFNDNQGKEIKD
>KACEBFPM_02241 hypothetical protein
MSASSTPTLKPIFASVTAKFAVTVDFPTPPFPEATAMIFFIPGMAFPFISFAFSGVSTLM
FTFTLAVAKKVSCINFRMSSSARFLMCMAGVESTKSTTTSSPNVITLVIAPLSIMFFPSP
AIEMVSKALSISFLSNFIIYLVSY
>KACEBFPM_02242 hypothetical protein
MVKIVRFLVGCTLALLFSCKSEPSLQKYFVEKTENKDFLAIDLTPKMLNINNAKLTDSQK
EALTSFRKMNVLAFKVNEKNKAQFDIERATVTSILKDEKYQQLMKFGSGAAGVQISFVGT
DEHIDEFIIYGNKKEKGFAIVRVLGKDMNPTYIVKIMSLLKNGNVNLDQLKPLQELMK
>KACEBFPM_02243 hypothetical protein
MKKKSIIIALFVLLPFFSQAQSLFDKYDGQDSVTSIIVNKKMFDLMSKVKMETSDKDAQK
YLALIKKLDNLKVFMTSSVKTTADMRFNVDKYLKSSNLDELMRVNDGGKNVKIYVKSGSS
DTQVKELLMFIENTNAKDNQTVLMSLTGDFDINEISTLTNKMNIPGGDVLKKAGK
>KACEBFPM_02244 hypothetical protein
MEFNKIEILIEKYFQGETSIADENDLRSYFLSQDIAPHLQRYKAMFGYFTQTKKQEFAQE
TLQIAKKRKVMWRSVAASIVFLFGLATFFMINTNKPVNKQHELGTYENPEIAFKETQKAL
ALLSSNVNLGIESVRYVQEYETTKKRVFK
>KACEBFPM_02245 ECF RNA polymerase sigma factor SigE
MNQIEFINHIKPFTNKMFRLAKRLLVSTEEAEDATQEVLVKLWKKNNLLNDFISIEAYAM
TVTKNYCLDVLKSKRAKNLQIVHNNYTEKGASLQQKVEDNDSCNWVEKAINDLPEQQKLI
IQMRDVEQYEFEEIAKILEMSEATIRVALSRARKTIREKLTNTHNYGIQ
>KACEBFPM_02246 hypothetical protein
MKFSKLFLVALMSFPLFFSCSKDEDVPVAPVLGAYENGAFILNEGSSGQGSVSFIGNDLT
SFTQDIHAVVNPGDLLGKYVQSMFFNGDYAYIIAGGSNKINVVNRKTFKLVSKIETGLVN
PRYGVVVNGKAYVTNANTYSFSNAATGNTDDYVAVINLTTNLVESKIQLNATANRILLEN
GKLYITEPFNSTKLLVVNPTTNTLETPIDIGASADTMEVKNGFLYALRSPFGGPSEIVKV
KLSDATTSTVVFPAALNDAKNLDIYENKIYYTVGTSVYAMDIASTTASTTAILSYTSTSA
WGKMYGFAVNGGRIYIADGGDFSANSKAYIYSLTGTLQKELTVGVGPNGFYFN
>KACEBFPM_02247 Vitamin B12 transporter BtuB
MTLRNYILFCLIFLCQLVLAQNDTITNLKEVVVSDTYLHNNNKSQSIQVLNDSVIIKNQS
SLASLLNYNSTIYFKEYGRGMLSTVSFRGTTSAQTAVIWNGININSQLNGSTDFNTVTGN
DYATISVKAGGGSVIYGSGAVGGSVHLNNNLSFKKQFTNTLQLSYGSFDTSGINYKTLLS
NEKWSTQIGFSYHESKNEYPYIELFNWKGAQRKNLNGEYLNISLNANIGYKINSNNLIKL
YSQTSNTDRHLSLVSESDTKTKYVNSFSRNLLEYDSNFYQYSINLKSAYIIEEYQYFANI
ASDYFSFGKSESAIAKLDFSYQILKSLKINTILDYSQTKGYGTSFGNNTRKIGSAALLVK
QQLGKKWQNELGIRQEITDNYKSPLLLSAGTSRFLNNWYTVKINFSRNYRMPTFNDLYWE
GTSDHGNPNLKVESSYQAEVGNVFSFKKIKLSQTFYYNKIKDLISWKPGDGGGWTPQNTN
KVTTYGLETVLGWANNIGKHLFSMSGSYAYTISQDEETKKQLFFVPFHKITASVGYSYKN
FAVNYQFLYNGFVYTRSDNDPKEIIKSYKVSNIGIDYDFKFLSNSKLGFQVLNLFNKKYQ
TLEDRPSPGRNFNIYITLKF
>KACEBFPM_02248 Putative phosphoserine phosphatase 2
MEIYLVRHTETVCEKGICYGQADVQIKPNYLSIFESIKNQIPKGAIVYSSSLKRCTILAN
YISSENYKTDSRLMEMNFGDWELKKWNDISLETMNPWMQDFVNVSVPNGESFIQLHKRVV
SFLNDLKQSNSSNPVVIITHAGVIRSVLCQIYNLPLQDAFQYKVDFGEVKKIKL
>KACEBFPM_02249 Adenosylcobinamide-GDP ribazoletransferase
MKKEIHIFFTALMFYTRIPCPKNIDHNPEYLNKASRYFPVIGWIVGAISFVAYYFSSIIF
SHEIAVILSIIAGILTTGAFHEDGFADVCDGFGGGWTKEKILIIMKDSAIGAYGAIGLVL
LFLLKFQSLNEVFHQSSIINDQWLRVNFLIFVTAHAISRLAAISIVFTHKYSRDDASSKS
KPIAQGYTWREVWGAFFFGILPLLFLSYFYWQFVLVIIPITMTRFFLVRYFQKWINGYTG
DCLGATQQVCEVVFYLSIIGIWKFI
>KACEBFPM_02250 Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase
MPLPSLTRPQPNKMNLDQIIQSRRDTRHFTDDEVPDQVIQKALQAGHYAPSVGLTNATKY
YTIKCKKIKKAIKKIFLDYDQKAINLTDTQQQKQQYQALKLEAIEEAPLGLVICYDRSVL
NNFTIGTVGSNEAIKFSAVCAAQNIWLSLTAQGYSMGWVSILNYYEFKKLLGLPENIEPL
GYFCIGKPATNYNNQPMLQQLNWKQKPEKPSVQEISTLPKKKSEIKWVINKSEKPILSKF
KETLQNKINNKTKPVGSLGVLETLAQQIATVFQTLEPRITKPNMVVFAADHGIANHGISA
YPQDVTRQMVANFLEGGAAINVFCKQNSIKLSIVDAGVNYDFPTNTDLISSKIAKGTQSF
LYEAAMSTTELDLCFTKGSEIVKAIAKTNSNCIGFGEMGIGNTATASVLMSVILELPIED
CVGKGTGVNDEKLKLKQEILKKAIQNYQGTNNLDSKLAYFGGFEIMQMAGAMLQAYNNNM
LILVDGFICTVAFLIAFEKNPAILKNAIFCHQSAEQAHIKLLDYLKVKPILNLNLRLGEG
TGCAVAFPIIESAVAFLNNMANFELAGVNSQQL
>KACEBFPM_02251 Fe(3+) dicitrate transport protein FecA
MNLSNTKLGYYLLTMKLSDFKFLVFILFSFNCFSQNKISGTITSISGAKLPLVEIYNKTT
GTKSFSDKNGAFSIEVEKLSNYDFTFYKENYSIVEIEMAPSEKNKIIILEKITTLSEVVI
KNQKEKIFALNKLRDIEETAIYAGKKTEVIAIEKLTINKSTNNARQIFAQVVGLTINESS
DGGLQLSIGGRGLNPNRTSNFNTRQNDYDISADVLGYPESYYATPTEGLAEIQVIRGAAS
LQYGTQFGGLVNFKIKKPTTKPFEITTRNTVGSYGLFTNFTSLSGTNGKFSYYTFYNYKQ
GDGFRPNSNFESKNYFGNLNYQFTDKTSLHFDYTHFSYLAQQAGGLTDVMFNKNPLQSNR
TRNWFAVNWNLFALRLKHKFNPTTDFSLQLFGLDASRKAIGYRSNRVSNPDALETERDLI
IGEFKNWGAEARFLKRYKIKNNISAFLIGAKYYQSDNSGIQNAGSSGSDANFEVASNEFP
FYQNQSNYKYPNLNLAVFGENIFKISPKFSITPGFRFENIKTQAIGFYRQINRDFAGNII
LDKNISEHIIKDRNLLLLGIGLSYKPKNRIEFYGNISQNYRSVTFNDIRTVSPSQVIDKN
ISDEKGYTSDIGVRGQISDKITFDTNIFGLYYDDKIGEFERRNPNGSAAIVRFRGNIGTA
VTYGFETMLDWSLSKTFFATKKQLTWNVFLNTAITESEYLNSEISNIKGKKVEFVPLYNI
KTGTGIGYKNFMSGIQMAYVSSQFTEANNNFTDKNDNTYGIFGQIPTYYVADFSCSYKLK
HFKIESGINNFTNNSYFTRRATGYPGPGIIPSDNRTFYATLEFVF
>KACEBFPM_02252 hypothetical protein
MNFNLKKYLNTYSEATTLAFFRLAFGFMMLFSLIRFASYNWIEKFYIQPQFHFTYYGFSW
VKSLGIYTYLLFLIAAIAALFVAIGYKYRIAIITFFLSFTYIELIDKTTYLNHYYFISII
SFVLIFLPANAQFSVDAFKNSKIAFQKIPTWNTDILKLLLGIVYFYAGLAKLNSDWILEA
MPLKIWLPSNSNLPIIGSLLSQNWVHYAFSWTGTLYDLSIVFLLLYRKTRVFAFVLVVIF
HVLTKILFPIGVFPYVMIISTLIFFDTNFHKNCLIFISNLLKINVNCFENKKVKIQEYNT
INKLKLMFIGLFITFQLLFPFRYLCYPNELFWTEEGFRFSWRVMLMEKAGYTQFIVKDLT
TKKEIRVNNSSFLTTFQEKQMSFQPDFILEYAHYLCEFYKKQGLKNPEVYVESYVALNGR
LSQKYIDPKINLANQYESFQHKTWILPFNDEIIGF
>KACEBFPM_02253 Iron-regulated protein A
MKKVVLILSLATFLFSCSKNEEETVKTENAYDRTALLTNWANNIIVPSYVNYQEKVQLLV
TNINNFNTTPTVSNLETVRASWLESYKAYQYISIYNFGKAEEIYIKESSNTYPTSRIGIE
ANITSGSYNLEHLSQFDKQGFPALDYLLNGLHTNDATIVGFYTTNTNATNYKSYLLAVAN
RLKTNADAIVTSWNSGFKTSYIANNGTSVSSSINKTANNFVKNLEKDIRTGKLGIPAGVF
SSGVKYPEKTEAYYKNNISKILLNEAVKASQDFFNGKHFNSTTTGEGFRSYLDFLNVVRN
GQKLSTIINNQFTPIYAANNTLNDSFSQQVTNDNTKMLAAYDALQQNVVYTKLDMMQALN
IAIDYVDGDGD
>KACEBFPM_02254 hypothetical protein
MLNEKILLASLAFISLASCTKDDETIPAVVAPTSFNYNIPATYTFERNSVTSVDYAGQTS
RLLMLDEMGNYIKTAATTATAVDDAFLSDMYENKNNRFTGAGLNASGKQLKDKTAASKDY
FSLYQGGGSVVEQTEIRNLYVTQFVNAKAASQGINASAGIAGIYTDGTSKRLFATNGLEP
QQVLLKGMMGSCMMDQICNNYLSLNKLDEGTNRTNNTSKVLETGKSYTTMEHNWDEAYGY
LYGADNTTTTPNTFKFWSSYINQVSADSDFNTLKADIDLAFRKGRAAIVANDYAVRDAQI
DIIKAKIAMIPAVRAVYYLQEGKGKLTTANGAGAFHALSEAYGFILSLRYTNKPGTNNPY
FTKAEVDTMLASMISGTNGLWDINTLGLKLDAISTQIAAKFGFTVLQAATVN
>KACEBFPM_02255 Disulfide bond reductase DsbH
MKQLKTFFFIVITMSLCSASSISGGNDELVIVKKAKDTNKYIAVYFSGSDWCSICHVFKK
EFVEQKEIATILGTDYVYYNADFPQRKKLAKEIAITNDAIAEKLNPNGIFPLLVIADENL
NVRKIITKVMGYDKGLLALKASVKK
>KACEBFPM_02256 FAD:protein FMN transferase
MQSLKNMKTYTESIPSMTSILSISIVMDENDEKEASLLLRKGFDKAKEIIQIISAWEVGT
QMHAVNQAAGICPVVVCDELFYLIQRGLKIAELTNGLFDITFASIDKIWYFDKPMYKLPS
ALEIAKSISNINYKYVELDPENKSIFITNKGTKIELGAIGKGYIANEIKKLLLVNGIQSG
LVNAGGDLVCWGKNSEGFPWRVGIADPNKKESFIAWLPLENQAVATSGSYEKYALIHGEK
YSHIIHPQTGYPVKGLQSVTIISPDPELCDAIATSVFLMGLEKGLAFVNQFNDIQCFMID
DKNQYYYSDNLNTNQYVQTN
>KACEBFPM_02257 hypothetical protein
MFKQIKIILGMLILITTCSRCTPVKAYQRQYVSDYSMQTGTTSIEKLESEGFSFREGASG
GETGKTGGGCGCN
>KACEBFPM_02258 hypothetical protein
MLIIHLFISSLPSLNVLIMLFMLLVGKFSFAQNLKRKEIKDKRPTKITLLSNYYDQDGNK
SAVNGGLGSQKIESFSQEVHLYLPVKSTDALAIDAGVDHFTSASLASIDKYVSQASSGNS
GISGSETRMYANIAFEHQISERLIISPRIGFSSEYDVQSVNAGISLLKKLQNNDGAISTS
FGATLDRWMVVHPGEFRASGLDAETGASVSSVNPYATPFVYSGESISKNGQAYPVDWRAS
YALVNGYSFAINQKMNASVGIDLLAQRGLLSTPFHRVYFNDGIGDEYQKEVRIEKLPRER
YKIAISGRFNYFLDPAIVLRSYARLYKDTWDINSITLGLETVLKFNKSFAATPFFRYHKQ
EGTSYYRAYGQHVYTPGDFYTSDIDLGSFSAIRSGLALRYVPFANLKLDSNGKPVKHFAS
MKDVGLRYGYNNREDGLTGHSLSFEITFEL
>KACEBFPM_02259 Ycf48-like protein
MKTFSIKRLILMLLAIVSLASCTRTDIEAPLVYPNPYKVLEDLNTIKDYATIKVISRTTA
MAVGDMGQVIKTTDQGVTWDKLDLGTTNYLNDVDFTSDQIGWIVGESSVIKKTTNQGLNW
TDKKPATLPSTENVLAVKFLNENIGVCTTATGKILMTQDGGENWTIKVAKNAIGADIVTA
LRSIYIKDTTTFYLVGSAGIILKTTDFGTTFTVLPTAQATNSATTILYRIKSPSNKVAYT
CGSGGMVLKINLENDAITSVKPPMTETMFGISFINDNVGYVVGKFGLIFKTTDAGTSWIR
EKSGVSSTLTDVAYWDENLGYIVGNKLILKSKKD
>KACEBFPM_02260 Ycf48-like protein
MKTSVLKHKAVIGLIIFTILAISCTKESFPEPKPKVTDYAISTNSLILNSIINDIDFKGL
DTGFAVGTFLNGIVQEGVILKTNNAGKDWQKLVSPALLGQFYSNYFIDNQTGWIVGDLGT
ILKTTNGGTTFTTQTSGTTERLYAVTFADANNGVCVGAKGILRTTTNGGATWEVKNSGLT
SSTDLRAVYIYNATTIIVCGSNGVLRRSNDFGLTWGVITTQETVRLQDMHFPIANIGYIC
GQEGVVLKINLTDNTVTKQYLPVDEQMRAIYFVNEQIGYTSGSYGDLLKTTNGGQNWKLQ
NIDPIAYNLYSIDFPTEKQGYIAGVRTLLTTNTK
>KACEBFPM_02261 hypothetical protein
MKTKNILQFLLLFTMFAKAQHKDVFQIARNGTLEEIESLYNSNHEIINTLNDQQYSPLIL
ACYKGNVKVALFLAEKVKDINYNSTSGTALMASVMSGDINILKKLLEHNANVNITDKNQK
TALIYACFFNKTEIAKLLLKAETNINHKDNDGKTALDYATFNKNTELIILLTNK
>KACEBFPM_02262 Hemagglutinin A
MMKKNTSKLLFILALGFASNTVVTAQENASQEPSNGYVRCYTTEHEADLKAKYPNRQTTQ
EFESWLAPQIEKIKADRRAGKNIQTVYNIPVVIHIIHDGDAVGSGENITDAQAISQITVM
NQDYRRMASTPGGANTTNLAVDVEINFVLAQKDPAGNPSTGIVRHTIIPPTNDYPDGANG
NDWELKADVENMKSNTQWDPTKYLNMWTIRPGGNSLSATQNPGLSGLLGYAQFPSTSGLT
GLNTNGGLAATDGVIAAFDAMGTNAANDGSFALNPTYNLGRTMTHEVGHWLGLRHIWGDN
NTCPAANTSADKDFCADTPAANAPNYACTLTANTCPTTPGNDQVQNYMDYTNDACMDTFT
NDQKTRMQTVMAVADRRGTLNASTTAIAPSAGIYYKKIRNTYSPVEATNCSYTDISYPVA
IIKAPSANAVVTFNVNPATTAVVGKDFDIMTPTVTLATGATTPQNLTVRYYNDGVTEATK
KIVIGMTVNASGGDAVIIPGYGEEDNPSLLTCTILDNDVAHVATQQTTVFSENFDGATIA
PRTLTDRDGDTKNWGVYSTSAGSVAAGIVGKFAGSVSYQNAALTPDNLMTFTNAIAVPVG
APSLSFTVSTRLATDFAENYAVYVTTSNDPNTIVQQNPVFTEIIAVGKTAIINTVDLSAF
AGQNIYLSFRHFDCTDQFILMLDDIKVYNTAPADIQVNVNTATQYQASVNIEGTVYAKDA
TTSKAIADLISTTNFDYGCTTVAVTRDQVTAGATAVNYAANTANNQKVMAKTVTVTAGTN
NAAGAGSIKFYISEAEIAAWETATGNSRTALKVIKQGTASVLATTAGTFGPNTTLTATIS
NGLGGVYYFGTAATLGKSDFEFENFSMYPNPNKGNFVLKFTPTSTNDIKINVCDISGREV
YEKSFSNTGAFNQNINLNKVEAGIYLVSISDGAKKTVKRIVVE
>KACEBFPM_02263 Riboflavin biosynthesis protein RibF
MKVFYSISDFKCEKKTVATLGTFDGVHLGHQKIISRLLNNTQNKHLESVVLTFSQHPRSV
LQVESNIKLLNTNAEKIALLEKKGIDNLIIHPFDASFSELTGEDFVKNILVDQLNIKKII
IGYDHRFGKNRASDIHDLIYFGKKYHFDVEQISAKEIDEISISSTKIRKAIQDGNIKLAN
QYLGYNYLFAGNVIRGQQLGRTIGFPTANISIENTQKIIPKNGVYIVEGSWQGKNHQGMM
NIGTKPTVDGKNTTIEVHFFNLNEDLYNLEITISVCEFIRAEVKFNSIEELKRQLQQDKI
ISLDYFFNRR
>KACEBFPM_02264 Biotin synthase
MSVMRNNWTKEEIIAIYNKPLMDLLYEAASVHREYHDPNVVQVSTLLSIKTGGCPEDCGY
CPQAARYHTDIEGNDLMSVQQVKAQALRAKSSGSSRVCMGAAWRNVKDGPEFDQVLEMVR
TINKLDMEVCCTLGMITENQAHRLAEAGLYAYNHNLDTSEEYYKEVISTRGFEDRIETIA
NVRKTNVTVCSGGIIGMGESIGDRAGMLVALSTLSPQPESVPINALVAVEGTPMEEEKPV
EIWEMIRMVATTRIIMPETQVRLSAGRMNMTREGQAMCFFAGANSIFAGDKLLTTPNPDV
NEDMKMFEMLGLNPQKPFTKVSQPTTVEAKDSRYESLGEKPKWSRPSHTIEKNLELSGKG
KN
>KACEBFPM_02265 Chaperone protein DnaJ
MKRVIEYRKLLEVDKNVTLKELKTIYRNSMKDSHPDKFVNDEAGKLAAEETSKKIIGAYH
FLVSISAETVEKNLPEYTDTITNSNIHGFHLEKQTLHIKYFNGMEYEYIGVPRNIYVKMV
NAESPNRFAKRHIYGNFIYRKSGEAAEE
>KACEBFPM_02266 hypothetical protein
MLLKTNYTFRIYKNASQLPEKWDNVAVKNIFLSKKYLQVLDTSSPKNMIPHYIALFKNEE
LIGIAVTQTLNLTQVSSFGVNKSCIKSKLRDFAFRNFAANVLFVGNNMLTGQNTYCFSNH
IEIEEGLLILKKAVFQLKINLKKEGIKIHITSFKDFTVPESENFKIDGFKKYYQFSTQPN
MVFTNDDVWENESDYTAALTKKYRDHYKRARKKSEMVSKRQMGLDEIRVYESKINELYFN
VTKNAPFNTFYLTENHFANLKEILQEKFLFYGYFLDQKLIGFNTMIANGDALDTYFLGYD
DAHQKERMLYLNMLYDMIGYSISKKYSKLIFSRTALEIKSSVGAKPIQMVGFICHSNPII
NKYIGKLFQYFDPEVSWIQRNPFK
>KACEBFPM_02267 putative ABC transporter ATP-binding protein YheS
MLNIHNLSVSFGGTYLFEEVTFRMGAGDRVGLVGKNGAGKSTMLKILAGDFKPDSGSIST
AKEVQIGFLRQDIDFEEGRTVLEEAYQAFIEIKAVEKKLEEVNHQLVTRTDYESEEYSLI
IEDLSDLTHRFDLLGGYNYVGDTEKILLGLGFKREVFDNLTETFSGGWRMRIELAKLLLQ
ANDILLLDEPTNHLDIESIIWLESFLRNYPGVVVIVSHDKMFLDNVTNRTIEISLGKAYD
FNKPYSQYLELRHEIREKQLATQKNQAKKIEETEKLIEKFRAKASKASMAQSLIKKLDKV
ERIEVDEDDNSVMNISFPVSKVPGKVVVEAEYVTKAYGDKVILKDINLLVERGSKIAFVG
QNGQGKSTFIKAIVNEFEYQGSIKLGHNVQVGYFAQNQAEYLDGEITLLRTMEDAATDTN
RSKVRDMLGSFLFRGDDVEKKVKVLSGGERNRLALCKLLLQPINVLLMDEPTNHLDIKSK
NVLKAALQKFEGTLLLVSHDRDFLQGMSNLVYEFKDQKIKEYLGDINYFLEQRNLENMRE
VEKKDIEKKEAPTTNAKTTYEDQKKNKSLQNRLSKIESQIKQLEKDIQTDDKSLASNYDK
HIEDAKFFIAYNKKKSDLDKLLEDWELVQNEIDSNK
>KACEBFPM_02268 hypothetical protein
MRYQNHGKLIFLQMLKKGLKLNSILTGSCPKCHEESMYMDKNPFHLANIFKMHETCSHCG
TRYKIEPSFFFGAMYVSYGIGIAFSVAAFVISFLVFGSTLKVSFLSIGATLVLFMPIIMR
LSRNIWINFFIHFDKDWKKKLK
>KACEBFPM_02269 Glycine oxidase
MVRVFYFYKMIDYLIIGSGIAGICFAETALQNNKTILVFDNDSQNSSKIAGGIYNPVILK
RFSEVWNATEQVKFLNDFYPKVEKRLNIKIDFKIPVLRKFFSVEEQNNWFIASDKPNLTQ
FLSTNILHKTYLGINSPFGFGKVLHTGYLDTALLLASYRTYLNQNKIYSHESFNYSELTQ
HSDYISYKNIKAKNIIFAEGFGLHANPYFNHLPLDGTKGELLIIKAPNLNLDCILNSSVF
ILPLGNNLFKVGATYNWADKTNNPTEDGKQELLERINELLECKFEIIEHFAGIRPTVKDR
RPLVGTHPKYKNIHILNGLGTRGVMLGPSLAHDLWQHIEHGTPLNANSNINRFDKKK
>KACEBFPM_02270 hypothetical protein
MNWRNLLVVIIFIAGSSTSFAQSNLLNAKNPKEIGLKSAAQQLKDNDKPLEYGYVDDRDI
LMSKKTWEIIDLDERINFPLYYPIDTSNVGSDRRSLYDVLVKGIKSGKITEVYGDSYFRE
KKTLKDINASLTKTDTTDAGREQMNEDPQAFRTRVTEVPIYEMVKVGKKTKKKQVGTEKK
TIPATRTISEEFINKFDLASIDVSDYKIVGLWYFDKRQSDLRYRILGICPVIPDVYTMDK
PEKEYIDLFWVFYPGAREILHEWKAFNDKNSAMPITFDDLLNSRRFNALTYKEENVYNDR
EIVDYMKDNSLMQLLESERVKDKVRNFEQDMWNY
>KACEBFPM_02271 hypothetical protein
MAGGKLTPRQKMINLMYLVFIAMLAMNMSKEVLSAFGLMNEKFEGANTSSDAMNAQMLTS
LDSKAAEAKGEFLVASQTAHRVEGITKKFYDYIATLKGTVLEGVEKDKETGKLPYEAMDK
GDNIDNAWFVGEGYSPKGKEIVATIEKYKADMKAACPDKKYANIISEIANKFDLSDVANK
DGVKIKYLEYHFDKFPAVASLAKLSAWQSDVKKAESDVYSAALGKAAVAAASYSNYQAIV
VLEKNAYFQGETVKGKVVLGRYDENTKPTSFQGPGRLENGQAVISLTAGSVGEQKINGQF
TFLEDGKTIPLKFAGNYVVVPRPNSATISADKMNVVYRGVPNPMTISFAGVANNKVHASA
AGMSGSDGKYVLRAGAGTSVMINVTATLPDGKAVSDKKEFRIKGLPAPTGKIRGEVAAKG
QKSNLESCTVSAVMEDFDFPVTVNVTQFNIKVPGQPTIVVSGSKMDSRARSAIAKATRGD
VVVISEIKASFSGIDQVAKRVSTCTYEVQ
>KACEBFPM_02272 hypothetical protein
MAILSKKTMNFAYGMGAAVVIIGALFKITHFEIGPLTGTVMLSVGLLTEAAIFALSAFEP
VEHDLDWSLVYPELAGGAASAKKKEVKEVKEDTQGLLSQKLDAMLKEAKIDGELMSSLGN
SIKNFEGAAKAISPTVDSMAGQKKYAEEMTMAAAQMESLNSLYKVQLESATRNAQANSEI
ADNASKLKEQMQSMTSNIASLNNVYGGMLSAMSNKG
>KACEBFPM_02273 Serine/threonine-protein kinase pkn1
MNIYLTQIYMKKFILLAVLVSFLYSCGSGDKGELVGVKGKAWHTEKPFGMTLVPGGAFIM
GKSDDDLANVQDAPTKTVTVRSFYMDETEITNSEYRQFVYWVRDSIVRTRLAVLADELGE
KNDSKSKSSKKGGSIADYAFVDADTTNMSVYDKYMYDNYYSVGSGDDPYAGRKLNHKVDL
KWKTGQYPDAHYAEVMDSMYIPSEEAYNGLRTIDVDKLKFRYSWMDIQAAAKAKKGKRKE
FIRKEEVKIYPDTTVWIKDFAYSYNEPMHNDYFWHQAYSQYPVVGVSWKQAKAFCAWRTL
FKNSFVKKQKGRDLINSFRLPTEAEWEYAARGGIESGTYPWGGPYARNDRGCYLANFKPS
RGDYAADQALYTLEAQSYEPNDYNLYNMSGNVAEWTDSSYDPAAYEYVSTMNPNVNDVKN
MRKVTRGGSWKDVAYYLQVGTRDFEYADSARSYIGFRTLQDYMGTDATGNAGK
>KACEBFPM_02274 Formimidoylglutamase
MVFDFLQPLDEFFLEFIQRLSPQTLGKNVVFHTNTEFPNLEKVSIAIIGVLENRGLGDTN
EIVDLSNIRKEFYSLFVGNWQTQIVDLGNIAAGESLEDTYYVLKTAMAQLIKNKIIPVII
GGSQDLTYPMYRSYDLLEQMVNVVSIDSKFDFARENSFQSESYLTKMIVEEPNNLFNYSN
IGFQTYFNPQEEIDLIEKLYFDAYRLGEVCSNPTISEPVFRDADLVSVDLLSVKSSDSGN
FTTFVPNGFSGKEICSLSRYAGISDKVSSFGVFNHKNTKQESVLIAQIIWYFIEGFHFRS
NEYPFGTKEDYIKYIVTLEEELIFYKSNITERWWIEIPFISMQNNKLKKSTLLPCVYEDY
LAACAGEVPERWWKAQRKNII
>KACEBFPM_02275 DNA topoisomerase 1
MAKNLVIVESPAKAKTIEKFLGADFQVESSYGHIADLPSKEIGVDVLNGFTPKYEVSPDK
KALVTKLKGLAKKADMVWLASDEDREGEAISWHLAEELKLDPKKTKRIVFHEITKTAILK
AIENPREIDYNLVNAQQARRVLDRLVGYELSPVLWRKIKGGLSAGRVQSVSVRLIVERER
EIINFKPVATYSVQAEFTNEAGKSFKAKLPKNFNTKKEAEDFLNKNIGSIYKVGDLETKP
TKKTPAGPFTTSTLQQEAARKLYLPVGITMQLAQRLYEAGLITYMRTDSVNLSKDAMEAA
QAEIIKSYGKEYAKPRTFVNKSKGAQEAHEAIRPTDMSRHTVNIDRDQARLYDLIWKRTL
ASQMADAELERTNVKIEANNHSELFTASGEVIKFEGFLKVYLEGHDDDEEEQEGMLPSMK
VNEKLINNYITATERYSRAAARYTEASLVKKLEELGIGRPSTYAPTISTIINRNYVEKGN
LEGQERNYTQLTLQSGKVGEKLLKENTGSDKGKLVPTDIGTIVTDFLVKNFDNILDYNFT
AKVEQDFDEIAEGNMQWAKMMQDFYDKFHPTVKDVEANADRESGERILGIDPKSGKPVSV
RLGKFGPMAQIGAADDEEKTFASLLKEQNIGNITLEEVLKLFLLPKNLGTYKGEEIEVSN
GRYGPFIRFGTTFVSLPKGEEPLNVDLNRAQELIDEKLLADAPIAVYKGEGVQKGTGRFG
PFLKWNGIFINVSTKYNFNNLSQQDIETIIEDKIQKNIDKVIHNWEAEGILVQKARWGRS
EITKGKIKIELSKDFDAAKLTLAEAQEMIAKKTPVKKAPVKKAVAKKTAVKKLVAKKN
>KACEBFPM_02276 Modification methylase HaeIII
MKLKKPLTYISLFSSAGVGCYGFKSENFYCVATVEILEKRLNIQRYNSKCVYESAYISDD
ITTIEAKNKIRAELLKWNIKEKANELDVLIATPPCQGMSVANHKKGNELNRNSLVIESIL
LTKEIKPKFFIFENVRAFLNTECTDIDGKDKSIKEAIEVNLAGEYHINYQVLNFKDYGNP
SSRTRTLVIGTRKDLKEITPFNISPSLVKEKTLKETIGKLQTLKTMGEISETDIYHSFKK
YTPTMQSWISDIKEGESAFDNKDLDKIPHKIVDGIIIYNANKNGDKYKRQYWSKVAPCVH
TRNDILSSQNTVHPVDDRVFSIREVMLMMSVPNSFKWTEKSVEELNKLSLEDKKLFLKKE
EMNIRHCLGEAVPTIIFQQIAKKIKTYLVNDNFNEQNIKKLIEENELEKIENLNSFIEKN
SLKFPYSILSKIAELSNTARTENSAYYTSQDICYSVIKDLPEPKEFKNLKILEPSIGVGN
FLPLLIEKYKTVTEVIIDVVDIDENSINTLKLLLKTLEIPKNITINFINSDFLLYNFENR
YDIVVGNPPFKKITNEKVLLASYKKGIFNTETNNIFSFFIEKSLKLGNVVALIIPKSLIN
SPEFNKTRELLENLKVKKITDYGEKGFKGVKIETISFIAYAQKKSNNNVIEIESYITKEI
SIKKQEYIFSKDFPYWLIYRNDLFDNISNKMKFNIFNAYRDRQITKKITKEKGNFRVLKS
RNIASNKTIDIKDYDCYTDEIESLDVKKFINNETAVLVPNLTYNPRACFLPKNTIVDGSV
AILTLRNGSRPINENDLEYFGSAEFSKFYAVARNYGTRSLNIDNNSVFFFGILNEEYD
>KACEBFPM_02277 hypothetical protein
MIKEYLQKFDLDVRKSGDARFMDQKCTPDVVSTIADCVINFVGNEKNKQFTVSDIWESQY
FIKNVKAIFNKPLATNPTTKSEYDKFIQQPLRMLAYANILNIVKIGNKNHYSIANYEILE
YISLKDRNAYLFLCDYLEKVLTDSGIFKYFEEYKSLYENGKLENIGFDELKSKFQKFIIG
NTKINGVIEVNRIYPKILNVFATQNNLPGTIGGFMSKHEFYYTDLMYNRKNWRDVKKSKN
ISRQESEIEYDALISETENPYNNYLIQKAMTAIRKLYTESEIKDQWGNGDATQIHHIFPK
HKFPQLAHYLENLIKLTATQHYTKAHPNNKTKDTSTDYQLVCLLAKSDSIEKSLKKNEMY
YRKESFIYCINTGLTKELKFDLTFRQIKSELATIYNDL
>KACEBFPM_02278 hypothetical protein
MRKIYYAFFILLSIQLHPQDVKKANENNAWISLSGNNSITKNWSILTELNWRRNEGFSKP
IQNELKLGINYKVNKTHTVTLGWAHNETYSYGALSRNIKENIYNNYSYNEQRLFEQLSIT
HPSTNRILYDSRFRFEQRWIQNKVKVNNEYVRPSEEYLALHPDSEDWKFRQRIRYRLRIQ
IPLTKKEMADGTLFFSASDEIFLNVGNKIAANIYDQNRAIIGLGWRFNKNTNIQFAYLNH
FIERSNGIAKENNHTFLSTLNFNIDFSAKK
>KACEBFPM_02279 hypothetical protein
MKKRIFLLLFSSLSLMSYSQNMQVAENISIPTKIVSQGDNLDLNGYALREAKFYKLYFCS
LYLSEKSTDPKVFLDQNKPVALRFHIISSLVQRSRWENTITQGFQNSTGGNITGLESRIE
LIKNIVKSEYKDDDIFLFSYSPVKKTTIIYLNDIQVGSVEGEDFKKAFFGIYFGEKPWNQ
VIKDGMLGIKKF
>KACEBFPM_02280 hypothetical protein
MRTIKLLYILTFTILCVSFGYSQSRLIITGKTTVTKFHEQKELEAMKKGQLIDLYVERTN
AFTYSLHLIGLTTDPKTTAKDLGIIETPEIVKQLDTKRAIEADFANKMATFERIFLPYVD
KIELISSILFYEGILKKISN
